PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Abramov, JP; Wells, PG				Abramov, Julia P.; Wells, Peter G.			Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice	FASEB JOURNAL			English	Article						teratology; birth defects; oxidative stress; hydrogen peroxide; protein therapy	P-GLYCOPROTEIN EXPRESSION; BLOOD-BRAIN-BARRIER; SUPEROXIDE-DISMUTASE; NEURODEVELOPMENTAL DEFICITS; BIRTH-WEIGHT; EMBRYOPROTECTIVE ROLE; MOLECULAR MECHANISM; IN-VIVO; DAMAGE; INJURY	Oxidative stress and reactive oxygen species (ROS) such as hydrogen peroxide (H2O2), which is detoxified by catalase, are implicated in fetal death and birth defects. However, embryonic levels of catalase are only similar to 5% of adult activity, and its protective role is not understood completely. Herein, we used mutant catalase-deficient mice [acatalasemic (aCat)] and transgenic mice expressing human catalase (hCat), which, respectively, exhibited 40-50% reductions and 2-fold elevations in the activities of embryonic and fetal brain catalase, to show that embryonic catalase protects the embryo from both physiological oxidative stress and the ROS-initiating anti-epileptic drug phenytoin. Compared to wild-type (WT) catalase-normal controls, both untreated and phenytoin-exposed aCat mice exhibited a 30% increase in embryonic DNA oxidation and a > 2-fold increase in embryopathies, both of which were completely blocked by protein therapy with exogenous catalase. Conversely, compared to WT controls, untreated and, to a lesser extent, phenytoin-exposed hCat mice were protected, with untreated hCat embryos exhibiting a 40% decrease in embryonic DNA oxidation and up to a 67% decrease in embryopathies. Embryonic catalase accordingly plays an important protective role, and both physiological and phenytoin-enhanced oxidative stress can be embryopathic.-Abramov, J. P., Wells, P. G. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice. FASEB J. 25, 2188-2200 (2011). www.fasebj.org	[Abramov, Julia P.; Wells, Peter G.] Univ Toronto, Fac Pharm, Toronto, ON M5S 3M2, Canada; [Wells, Peter G.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 3M2, Canada	University of Toronto; University of Toronto	Wells, PG (corresponding author), Univ Toronto, Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada.	pg.wells@utoronto.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Dr. Arlan Richardson (University of Texas Health Science Center, San Antonio, TX, USA) for generously providing a breeding pair of the transgenic hCat mice. Preliminary reports of this research were presented at the 2007 and 2009 annual meetings of the Teratology Society (USA; refs 57, 58) and the 2009 annual meeting of the Society of Toxicology (USA; ref. 59). These studies were supported by a grant from the Canadian Institutes of Health Research.	Abel KM, 2010, ARCH GEN PSYCHIAT, V67, P923, DOI 10.1001/archgenpsychiatry.2010.100; Abramov JP, 2011, TOXICOL SCI, V120, P428, DOI 10.1093/toxsci/kfr007; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BARROW MV, 1969, J MORPHOL, V127, P291, DOI 10.1002/jmor.1051270303; Beyerlein A, 2010, AM J CLIN NUTR, V92, P585, DOI 10.3945/ajcn.2009.29116; Ceckova-Novotna M, 2006, REPROD TOXICOL, V22, P400, DOI 10.1016/j.reprotox.2006.01.007; Danielsson BR, 1997, TERATOLOGY, V56, P271, DOI 10.1002/(SICI)1096-9926(199710)56:4<271::AID-TERA6>3.0.CO;2-1; DAS DK, 1991, FREE RADICAL RES COM, V12-3, P653; ELHAGE S, 1990, DEV GENET, V11, P149, DOI 10.1002/dvg.1020110205; ELMAZAR MMA, 1981, TERATOLOGY, V24, P115, DOI 10.1002/tera.1420240202; ERICKSON UJ, 1991, DIABETOLOGIA, V34, P325; ESPEEL M, 1993, CELL TISSUE RES, V272, P89, DOI 10.1007/BF00323574; Fattal-Valevski A, 2009, J CHILD NEUROL, V24, P846, DOI 10.1177/0883073808331082; Fromm MF, 2002, ADV DRUG DELIVER REV, V54, P1295, DOI 10.1016/S0169-409X(02)00064-9; Gaetani GF, 1996, BLOOD, V88, P1084; GUPTA BL, 1973, J MICROCHEM, V18, P363; Halliwell B., 2007, FREE RADICALS BIOL M; HANSEN DK, 1991, P SOC EXP BIOL MED, V197, P361; Himpel S, 2006, J NEURAL TRANSM, V113, P295, DOI 10.1007/s00702-005-0330-4; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Indredavik MS, 2005, PEDIATR NEUROL, V33, P259, DOI 10.1016/j.pediatrneurol.2005.05.002; Ishii K, 1996, JPN J CANCER RES, V87, P680, DOI 10.1111/j.1349-7006.1996.tb00277.x; Jeng W, 2005, FREE RADICAL BIO MED, V39, P317, DOI 10.1016/j.freeradbiomed.2005.03.015; Jeng W, 2006, FASEB J, V20, P638, DOI 10.1096/fj.05-5271com; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kim PM, 1996, MOL PHARMACOL, V49, P172; LIU L, 1995, FREE RADICAL BIO MED, V19, P639, DOI 10.1016/0891-5849(95)00082-9; LIU TH, 1989, AM J PHYSIOL, V256, pH589, DOI 10.1152/ajpheart.1989.256.2.H589; LUM JT, 1985, J CHROMATOGR, V338, P242, DOI 10.1016/0378-4347(85)80093-1; Mahmood B, 2001, J INVEST MED, V49, P250, DOI 10.2310/6650.2001.33969; McCallum GP, 2011, ANTIOXID REDOX SIGN, V14, P747, DOI 10.1089/ars.2009.2946; Nair MKC, 2009, INDIAN PEDIATR, V46, pS71; Nicol CJ, 2000, FASEB J, V14, P111, DOI 10.1096/fasebj.14.1.111; ODA T, 1992, TRANSPLANT P, V24, P797; OGATA M, 1991, HUM GENET, V86, P331; Ou P, 1996, J PHARMACOL EXP THER, V277, P945; PADMANABHAN RV, 1985, AM REV RESPIR DIS, V132, P264; Perstin J, 2007, BIRTH DEFECTS RES A, V79, P418; Perstin J, 2009, BIRTH DEFECTS RES A, V85, P398; PERSTIN J, 2009, TOXICOL SCI S, V108, P355; PERSTIN JP, 2010, TOXICOL LETT S, V196, pP204; Potschka H, 2001, EPILEPSIA, V42, P1231, DOI 10.1046/j.1528-1157.2001.01901.x; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Reuner G, 2009, EARLY HUM DEV, V85, P409, DOI 10.1016/j.earlhumdev.2009.01.007; Roberts G, 2007, MATERN CHILD HLTH J, V11, P161, DOI 10.1007/s10995-006-0158-z; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Tsai CE, 2002, BIOL NEONATE, V81, P58, DOI 10.1159/000047185; VORHEES CV, 1983, J PHARMACOL EXP THER, V227, P274; VORHEES CV, 1994, ENVIRON HEALTH PERSP, V102, P145, DOI 10.2307/3431832; Wang DH, 1996, ARCH TOXICOL, V70, P189, DOI 10.1007/s002040050259; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Wells Peter G, 2005, Toxicol Appl Pharmacol, V207, P354, DOI 10.1016/j.taap.2005.01.061; Wells PG, 2010, BIRTH DEFECTS RES C, V90, P103, DOI 10.1002/bdrc.20177; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Winn LM, 1999, FREE RADICAL BIO MED, V26, P266, DOI 10.1016/S0891-5849(98)00193-2; Winn LM, 1995, EUR J NEUROL, V2, P5; WINN LM, 1995, MOL PHARMACOL, V48, P112; Wong AW, 2008, J NEUROSCI, V28, P9047, DOI 10.1523/JNEUROSCI.2557-08.2008; Yamada K, 1997, ANTICANCER RES, V17, P2041	59	33	34	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2188	2200		10.1096/fj.11-182444	http://dx.doi.org/10.1096/fj.11-182444			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21478259				2022-12-25	WOS:000292242200011
J	Martin, G; Burke, B; Thai, R; Dey, AK; Combes, O; Heyd, B; Geonnotti, AR; Montefiori, DC; Kan, E; Lian, Y; Sun, YD; Abache, T; Ulmer, JB; Madaoui, H; Guerois, R; Barnett, SW; Srivastava, IK; Kessler, P; Martin, L				Martin, Gregoire; Burke, Brian; Thai, Robert; Dey, Antu K.; Combes, Olivier; Heyd, Bernadette; Geonnotti, Anthony R.; Montefiori, David C.; Kan, Elaine; Lian, Ying; Sun, Yide; Abache, Toufik; Ulmer, Jeffrey B.; Madaoui, Hocine; Guerois, Raphael; Barnett, Susan W.; Srivastava, Indresh K.; Kessler, Pascal; Martin, Loic			Stabilization of HIV-1 Envelope in the CD4-bound Conformation through Specific Cross-linking of a CD4 Mimetic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120-CD4 RECEPTOR COMPLEX; CHAIN POLYPEPTIDE ANALOG; CORECEPTOR BINDING-SITE; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; SUBTYPE-B; PARTIAL DELETION; TYPE-1 ENVELOPE; VACCINE DESIGN	CD4 binding on gp120 leads to the exposure of highly conserved regions recognized by the HIV co-receptor CCR5 and by CD4-induced (CD4i) antibodies. A covalent gp120-CD4 complex was shown to elicit CD4i antibody responses in monkeys, which was correlated with control of the HIV virus infection (DeVico, A., Fouts, T., Lewis, G. K., Gallo, R. C., Godfrey, K., Charurat, M., Harris, I., Galmin, L., and Pal, R. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 17477-17482). Because the inclusion of CD4 in a vaccine formulation should be avoided, due to potential autoimmune reactions, we engineered small sized CD4 mimetics (miniCD4s) that are poorly immunogenic and do not induce anti-CD4 antibodies. We made covalent complexes between such an engineered miniCD4 and gp120 or gp140, through a site-directed coupling reaction. These complexes were recognized by CD4i antibodies as well as by the HIV co-receptor CCR5. In addition, they elicit CD4i antibody responses in rabbits and therefore represent potential vaccine candidates that mimic an important HIV fusion intermediate, without autoimmune hazard.	[Martin, Gregoire; Thai, Robert; Combes, Olivier; Heyd, Bernadette; Abache, Toufik; Kessler, Pascal; Martin, Loic] CEA, IBiTecS, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France; [Burke, Brian; Dey, Antu K.; Kan, Elaine; Lian, Ying; Sun, Yide; Ulmer, Jeffrey B.; Barnett, Susan W.; Srivastava, Indresh K.] Novartis Vaccines & Diagnost Corp, Cambridge, MA 02139 USA; [Geonnotti, Anthony R.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Madaoui, Hocine; Guerois, Raphael] CEA, IBiTecS, Serv Bioenerget Biol Struct & Mecanismes, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Duke University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Kessler, P (corresponding author), CEA, IBiTecS, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France.	pascal.kessler@cea.fr; loic.martin@cea.fr	MARTIN, Loïc/E-1627-2011; Dey, Antu/A-1305-2013; , raph/AAF-4380-2019	MARTIN, Loïc/0000-0002-7940-2955; Thai, Robert/0000-0001-9438-4225; Dey, Antu/0000-0001-7438-9379; Martin, Gregoire/0000-0001-8240-6108	National Institutes of Health; NIAID, Department of Health and Human Services [5P01AI066287]; French National Agency for Research on AIDS and Viral Hepatitis [447-52D]; European Union [QLKZ-CT-1999-00609]; United Kingdom Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); French National Agency for Research on AIDS and Viral Hepatitis(ANRS); European Union(European Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health HIV Research and Development Grant 5P01AI066287 from NIAID, Department of Health and Human Services (supervised by Novartis Vaccines and Diagnostics, Inc.). This work was also supported by the French National Agency for Research on AIDS and Viral Hepatitis Grant 447-52D.; We acknowledge Dr. M. Parmentier for the generous gift of stable CHO-CCR5 cells and Drs. D. P. Burton, P. Parren, D. Katinger, A. Osterhaus, M. Schutten, and the National Institute for Biological Standards and Control Centre for AIDS Reagents (supported by the European Union Programme EVA (Contract QLKZ-CT-1999-00609) and the United Kingdom Medical Research Council. HIV-1 V3 mAb (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health) was provided by Dr. Susan Zolla-Pazner.	Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CELADA F, 1990, J EXP MED, V172, P1143, DOI 10.1084/jem.172.4.1143; Center RJ, 2000, J VIROL, V74, P4448, DOI 10.1128/JVI.74.10.4448-4455.2000; Cerutti N, 2010, J BIOL CHEM, V285, P25743, DOI 10.1074/jbc.M110.144121; Cohen J, 2003, SCIENCE, V302, P1309; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Devico A, 1996, VIROLOGY, V218, P258, DOI 10.1006/viro.1996.0188; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Finzi A, 2010, J VIROL METHODS, V168, P155, DOI 10.1016/j.jviromet.2010.05.008; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; Gallo RC, 2005, LANCET, V366, P1894, DOI 10.1016/S0140-6736(05)67395-3; Girard MP, 2006, VACCINE, V24, P4062, DOI 10.1016/j.vaccine.2006.02.031; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; He YX, 2003, VACCINE, V21, P4421, DOI 10.1016/S0264-410X(03)00451-1; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; KANG CY, 1994, J VIROL, V68, P5854, DOI 10.1128/JVI.68.9.5854-5862.1994; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Stricher F, 2005, BIOCHEM J, V390, P29, DOI 10.1042/BJ20041953; Stricher F, 2008, J MOL BIOL, V382, P510, DOI 10.1016/j.jmb.2008.06.069; TSCHACHLER E, 1990, J VIROL, V64, P2250, DOI 10.1128/JVI.64.5.2250-2259.1990; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Vita C, 1999, P NATL ACAD SCI USA, V96, P13091, DOI 10.1073/pnas.96.23.13091; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Xu R, 2006, VIROLOGY, V349, P276, DOI 10.1016/j.virol.2006.01.043; Zhang MY, 2004, ANTIVIR RES, V61, P161, DOI 10.1016/j.antiviral.2003.09.009; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055; Zhang PF, 2002, J VIROL, V76, P644, DOI 10.1128/JVI.76.2.644-655.2002; Zhang WT, 1999, BIOCHEMISTRY-US, V38, P9405, DOI 10.1021/bi990654o	55	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21706	21716		10.1074/jbc.M111.232272	http://dx.doi.org/10.1074/jbc.M111.232272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21487012	Green Published, hybrid			2022-12-25	WOS:000291464700067
J	Benfield, CTO; Mansur, DS; McCoy, LE; Ferguson, BJ; Bahar, MW; Oldring, AP; Grimes, JM; Stuart, DI; Graham, SC; Smith, GL				Benfield, Camilla T. O.; Mansur, Daniel S.; McCoy, Laura E.; Ferguson, Brian J.; Bahar, Mohammad W.; Oldring, Asa P.; Grimes, Jonathan M.; Stuart, David I.; Graham, Stephen C.; Smith, Geoffrey L.			Mapping the I kappa B Kinase beta (IKK beta)-binding Interface of the B14 Protein, a Vaccinia Virus Inhibitor of IKK beta-mediated Activation of Nuclear Factor kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PHOSPHORYLATION; RNA HELICASE DDX3; VIRULENCE FACTOR; N1L PROTEIN; RECEPTOR; TARGETS; COMPLEX; ALPHA; INDUCTION; REVEALS	The I kappa B kinase (IKK) complex regulates activation of NF-kappa B, a critical transcription factor in mediating inflammatory and immune responses. Not surprisingly, therefore, many viruses seek to inhibit NF-kappa B activation. The vaccinia virus B14 protein contributes to virus virulence by binding to the IKK beta subunit of the IKK complex and preventing NF-kappa B activation in response to pro-inflammatory stimuli. Previous crystallographic studies showed that the B14 protein has a Bcl-2-like fold and forms homodimers in the crystal. However, multi-angle light scattering indicated that B14 is in monomer-dimer equilibrium in solution. This transient self-association suggested that the hydrophobic dimerization interface of B14 might also mediate its interaction with IKK beta, and this was investigated by introducing amino acid substitutions on the dimer interface. One mutant (Y35E) was entirely monomeric but still co-immunoprecipitated with IKK beta and blocked both NF-kappa B nuclear translocation and NF-kappa B-dependent gene expression. Therefore, B14homodimerization is nonessential for binding and inhibition of IKK beta. In contrast, a second monomeric mutant (F130K) neither bound IKK beta nor inhibited NF-kappa B-dependent gene expression, demonstrating that this residue is required for the B14-IKK beta interaction. Thus, the dimerization and IKK beta-binding interfaces overlap and lie on a surface used for protein-protein interactions in many viral and cellular Bcl-2-like proteins.	[Bahar, Mohammad W.; Oldring, Asa P.; Grimes, Jonathan M.; Stuart, David I.; Graham, Stephen C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Bahar, Mohammad W.; Oldring, Asa P.; Grimes, Jonathan M.; Stuart, David I.; Graham, Stephen C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford Prot Prod Facil, Oxford OX3 7BN, England; [Benfield, Camilla T. O.; Mansur, Daniel S.; McCoy, Laura E.; Ferguson, Brian J.; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London W2 1PG, England; [Grimes, Jonathan M.; Stuart, David I.] Diamond Light Source Ltd, Div Sci, Didcot OX11 0DE, Oxon, England; [Graham, Stephen C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Graham, Stephen C.] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 0XY, England; [Graham, Stephen C.] Addenbrookes Hosp, Cambridge CB2 0XY, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Diamond Light Source; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Graham, SC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.	scg34@cam.ac.uk; geoffrey.l.smith@imperial.ac.uk	Mansur, Daniel/AAQ-8062-2020; Smith, Geoffrey L/G-2894-2012	Benfield, Camilla/0000-0001-7851-4181; Mansur, Daniel/0000-0001-6773-9334; Graham, Stephen/0000-0003-4547-4034; Stuart, David/0000-0002-3426-4210; Grimes, Jonathan Mark/0000-0001-9698-0389; McCoy, Laura/0000-0001-9503-7946; Ferguson, Brian/0000-0002-6873-1032; Smith, Geoffrey L/0000-0002-3730-9955	Wellcome Trust [075491/Z/04]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Poxvirus T Cell Vaccine Discovery Consortium (PTVDC); Bill and Melinda Gates Foundation; Medical Research Council (United Kingdom); European Commission [031220FP6]; Medical Research Council [G1100525, G19/3, G1000099] Funding Source: researchfish; MRC [G19/3, G1000099] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Poxvirus T Cell Vaccine Discovery Consortium (PTVDC); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Wellcome Trust Grant 075491/Z/04, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil; to D. S. M.), the Poxvirus T Cell Vaccine Discovery Consortium (PTVDC) under the Collaboration for AIDS Vaccine Discovery with support from the Bill and Melinda Gates Foundation (to L. E. M.), the Medical Research Council (United Kingdom), and European Commission Contract 031220FP6 (SPINE2-COMPLEXES).	Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486	36	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20727	20735		10.1074/jbc.M111.231381	http://dx.doi.org/10.1074/jbc.M111.231381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21474453	Green Published, hybrid			2022-12-25	WOS:000291267600058
J	Mueller, K; Anwander, A; Moller, HE; Horstmann, A; Lepsien, J; Busse, F; Mohammadi, S; Schroeter, ML; Stumvoll, M; Villringer, A; Pleger, B				Mueller, Karsten; Anwander, Alfred; Moeller, Harald E.; Horstmann, Annette; Lepsien, Joeran; Busse, Franziska; Mohammadi, Siawoosh; Schroeter, Matthias L.; Stumvoll, Michael; Villringer, Arno; Pleger, Burkhard			Sex-Dependent Influences of Obesity on Cerebral White Matter Investigated by Diffusion-Tensor Imaging	PLOS ONE			English	Article							BODY-MASS INDEX; PLASMA LEPTIN CONCENTRATIONS; LATE-LIFE DEPRESSION; CORPUS-CALLOSUM; BRAIN STRUCTURE; SPATIAL STATISTICS; EDDY-CURRENT; INTEGRITY; GENDER; MICROSTRUCTURE	Several studies have shown that obesity is associated with changes in human brain function and structure. Since women are more susceptible to obesity than men, it seems plausible that neural correlates may also be different. However, this has not been demonstrated so far. To address this issue, we systematically investigated the brain's white matter (WM) structure in 23 lean to obese women (mean age 25.5 y, std 5.1 y; mean body mass index (BMI) 29.5 kg/m(2), std 7.3 kg/m(2)) and 26 lean to obese men (mean age 27.1 y, std 5.0 y; mean BMI 28.8 kg/m(2), std 6.8 kg/m(2)) with diffusion-weighted magnetic resonance imaging (MRI). There was no significant age (p > 0.2) or BMI (p > 0.7) difference between female and male participants. Using tract-based spatial statistics, we correlated several diffusion parameters including the apparent diffusion coefficient, fractional anisotropy (FA), as well as axial (lambda(parallel to)) and radial diffusivity (lambda(perpendicular to)) with BMI and serum leptin levels. In female and male subjects, the putative axon marker lambda(parallel to) was consistently reduced throughout the corpus callosum, particularly in the splenium (r = -0.62, p < 0.005). This suggests that obesity may be associated with axonal degeneration. Only in women, the putative myelin marker lambda(perpendicular to) significantly increased with increasing BMI (r = 0.57, p < 0.005) and serum leptin levels (r = 0.62, p < 0.005) predominantly in the genu of the corpus callosum, suggesting additional myelin degeneration. Comparable structural changes were reported for the aging brain, which may point to accelerated aging of WM structure in obese subjects. In conclusion, we demonstrate structural WM changes related to an elevated body weight, but with differences between men and women. Future studies on obesity-related functional and structural brain changes should therefore account for sex-related differences.	[Mueller, Karsten; Anwander, Alfred; Moeller, Harald E.; Horstmann, Annette; Lepsien, Joeran; Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Mohammadi, Siawoosh] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Busse, Franziska; Stumvoll, Michael] Univ Hosp Leipzig, Dept Med, Leipzig, Germany; [Horstmann, Annette; Stumvoll, Michael; Villringer, Arno] Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany	Max Planck Society; University of London; University College London; Leipzig University; Leipzig University	Mueller, K (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	karstenm@cbs.mpg.de	Moller, Harald E/A-1565-2008; Anwander, Alfred/B-5874-2011; Möller, Harald/AAB-4679-2019; Stumvoll, Michael/ABE-1121-2021; Horstmann, Annette/C-9083-2011; Mohammadi, Siawoosh/AFL-8250-2022; Mohammadi, Siawoosh/H-9539-2012; Mohammadi, Siawoosh/AAG-8251-2022	Moller, Harald E/0000-0002-5659-1925; Anwander, Alfred/0000-0002-4861-4808; Möller, Harald/0000-0002-5659-1925; Stumvoll, Michael/0000-0001-6225-8240; Horstmann, Annette/0000-0001-6184-8484; Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Mohammadi, Siawoosh/0000-0003-1311-9636; Villringer, Arno/0000-0003-2604-2404	German Federal Ministry of Education and Research [FKZ: 01EO1001]; European Union; Wellcome Trust	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the German Federal Ministry of Education and Research (Neurocircuits in obesity to MS; IFB Adiposity Diseases [FKZ: 01EO1001] to AH, AV, MS) and the European Union (GIPIO to MS). SM was supported by the Wellcome Trust. Part of this work is supported by the FET project CONNECT of the European Union (http://neuroimaging.tau.ac.il/CONNECT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Alkan A, 2008, MAGN RESON IMAGING, V26, P446, DOI 10.1016/j.mri.2007.10.004; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen TF, 2009, HUM BRAIN MAPP, V30, P3826, DOI 10.1002/hbm.20810; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Descoteaux M, 2006, MAGN RESON MED, V56, P395, DOI 10.1002/mrm.20948; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Gazdzinski S, 2008, ANN NEUROL, V63, P652, DOI 10.1002/ana.21377; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5F; Haltia LT, 2007, J CLIN ENDOCR METAB, V92, P3278, DOI 10.1210/jc.2006-2495; Hamilton LS, 2008, NEUROREPORT, V19, P1705, DOI 10.1097/WNR.0b013e3283174415; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hiltunen J, 2006, NEUROIMAGE, V32, P93, DOI 10.1016/j.neuroimage.2006.03.004; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Liu F, 2010, BRAIN RES, V1343, P37, DOI 10.1016/j.brainres.2010.04.064; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; MARKS BL, 2010, BR J SPORTS IN PRESS; Matochik JA, 2005, J CLIN ENDOCR METAB, V90, P2851, DOI 10.1210/jc.2004-1979; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Miller GD, 2001, NUTRITION, V17, P105, DOI 10.1016/S0899-9007(00)00511-6; MOHAMMADI S, 2010, P INT SOC MAGN RESON, V18, P3103; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Novakova L, 2007, NEUROENDOCRINOL LETT, V28, P21; Oh JS, 2007, NEUROIMAGE, V36, P606, DOI 10.1016/j.neuroimage.2007.03.020; Oishi K, 2011, MRI ATLAS HUMAN WHIT, VSecond; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Pannacciulli N, 2007, NEUROSCI LETT, V412, P248, DOI 10.1016/j.neulet.2006.11.019; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; SENA A, 1985, J NEUROL SCI, V68, P233, DOI 10.1016/0022-510X(85)90104-2; Small DM, 2007, ANN NY ACAD SCI, V1121, P136, DOI 10.1196/annals.1401.002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Soreca I, 2009, PSYCHOSOM MED, V71, P485, DOI 10.1097/PSY.0b013e3181a5429d; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Walther K, 2010, HUM BRAIN MAPP, V31, P1052, DOI 10.1002/hbm.20916; Wang F, 2008, BIOL PSYCHIAT, V64, P730, DOI 10.1016/j.biopsych.2008.06.001; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Ward P, 2006, PEDIATRICS, V117, pE619, DOI 10.1542/peds.2005-0545; Westerhausen R, 2004, COGNITIVE BRAIN RES, V21, P418, DOI 10.1016/j.cogbrainres.2004.07.002; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	72	98	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18544	10.1371/journal.pone.0018544	http://dx.doi.org/10.1371/journal.pone.0018544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494606	Green Submitted, Green Published, gold			2022-12-25	WOS:000289354100021
J	Hagg, S; Salehpour, M; Noori, P; Lundstrom, J; Possnert, G; Takolander, R; Konrad, P; Rosfors, S; Ruusalepp, A; Skogsberg, J; Tegner, J; Bjorkegren, J				Hagg, Sara; Salehpour, Mehran; Noori, Peri; Lundstrom, Jesper; Possnert, Goran; Takolander, Rabbe; Konrad, Peter; Rosfors, Stefan; Ruusalepp, Arno; Skogsberg, Josefin; Tegner, Jesper; Bjorkegren, Johan			Carotid Plaque Age Is a Feature of Plaque Stability Inversely Related to Levels of Plasma Insulin	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ACCELERATOR MASS-SPECTROMETRY; CORONARY-HEART-DISEASE; ARTERY; ATHEROSCLEROSIS; HUMANS; ECHOGENICITY; ULTRASOUND; SYMPTOMS; GENE	Background: The stability of atherosclerotic plaques determines the risk for rupture, which may lead to thrombus formation and potentially severe clinical complications such as myocardial infarction and stroke. Although the rate of plaque formation may be important for plaque stability, this process is not well understood. We took advantage of the atmospheric (14)C-declination curve (a result of the atomic bomb tests in the 1950s and 1960s) to determine the average biological age of carotid plaques. Methodology/Principal Finding: The cores of carotid plaques were dissected from 29 well-characterized, symptomatic patients with carotid stenosis and analyzed for (14)C content by accelerator mass spectrometry. The average plaque age (i.e. formation time) was 9.6+/-3.3 years. All but two plaques had formed within 5-15 years before surgery. Plaque age was not associated with the chronological ages of the patients but was inversely related to plasma insulin levels (p=0.0014). Most plaques were echo-lucent rather than echo-rich (2.2460.97, range 1-5). However, plaques in the lowest tercile of plaque age (most recently formed) were characterized by further instability with a higher content of lipids and macrophages (67.8+/-12.4 vs. 50.4+/-6.2, p=0.00005; 57.6+/-26.1 vs. 39.8+/-25.7, p<0.0005, respectively), less collagen (45.3+/-6.1 vs. 51.1+/-9.8, p<0.05), and fewer smooth muscle cells (130+/-31 vs. 141+/-21, p<0.05) than plaques in the highest tercile. Microarray analysis of plaques in the lowest tercile also showed increased activity of genes involved in immune responses and oxidative phosphorylation. Conclusions/Significance: Our results show, for the first time, that plaque age, as judge by relative incorporation of (14)C, can improve our understanding of carotid plaque stability and therefore risk for clinical complications. Our results also suggest that levels of plasma insulin might be involved in determining carotid plaque age.	[Hagg, Sara; Lundstrom, Jesper; Skogsberg, Josefin; Bjorkegren, Johan] Karolinska Inst, Dept Med Biochem & Biophys, Cardiovasc Genom Grp, Stockholm, Sweden; [Hagg, Sara; Lundstrom, Jesper; Skogsberg, Josefin; Bjorkegren, Johan] Clin Gene Networks AB, Stockholm, Sweden; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, Uppsala, Sweden; [Noori, Peri; Tegner, Jesper] Karolinska Inst, Dept Med, Ctr Mol Med, Computat Med Grp, Stockholm, Sweden; [Takolander, Rabbe; Konrad, Peter] Soder Sjukhuset, Karolinska Inst, Dept Surg, Stockholm, Sweden; [Rosfors, Stefan] Soder Sjukhuset, Karolinska Inst, Dept Clin Physiol, Stockholm, Sweden; [Ruusalepp, Arno] Tartu Univ Hosp, Dept Cardiac Surg, Tartu, Estonia	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital	Hagg, S (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Cardiovasc Genom Grp, Stockholm, Sweden.	Johan.Bjorkegren@ki.se	tegner, jesper N/R-5095-2017	tegner, jesper N/0000-0002-9568-5588; Rosfors, Stefan/0000-0001-9920-5791; Ruusalepp, Arno/0000-0001-5816-8613; Hagg, Sara/0000-0002-2452-1500	Swedish research Council; Karolinska Institutet; Stockholm County Council; ALF; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; King Gustaf V and Queen Victoria Foundation; Swedish Society of Medicine; Hans and Loo Osterman Foundation for Geriatric Research; Wennergren Foundation; Vinnova Sweden-Japan; Vinnova research grant; PhD Programme in Medical Bioinformatics; Carl Tryggers Foundation; Clinical Gene Networks	Swedish research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); ALF; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V and Queen Victoria Foundation; Swedish Society of Medicine; Hans and Loo Osterman Foundation for Geriatric Research; Wennergren Foundation; Vinnova Sweden-Japan(Vinnova); Vinnova research grant(Vinnova); PhD Programme in Medical Bioinformatics; Carl Tryggers Foundation; Clinical Gene Networks	This work was supported by grants from the Swedish research Council (JB, JS), the Karolinska Institutet (JB, JS), the Stockholm County Council, ALF-grant (JB), the Swedish Foundation for Strategic Research (JB, JT), the Swedish Heart-Lung Foundation (JB), the King Gustaf V and Queen Victoria Foundation (JB), the Swedish Society of Medicine (JB, JS, JT), the Hans and Loo Osterman Foundation for Geriatric Research (JS, JB), Wennergren Foundation (JT), Vinnova Sweden-Japan (JB, JT), Vinnova research grant (JT, JB), the PhD Programme in Medical Bioinformatics (SH, JB, JT), Carl Tryggers Foundation (JT), Clinical Gene Networks (JB, JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agewall S, 2006, PATHOPHYSIOL HAEMO T, V35, P440, DOI 10.1159/000102051; Andersson J, 2009, ATHEROSCLEROSIS, V204, P612, DOI 10.1016/j.atherosclerosis.2008.10.038; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bonfoco E, 2001, J BIOL CHEM, V276, P29242, DOI 10.1074/jbc.M100684200; Bots ML, 2002, CARDIOVASC DRUG THER, V16, P341, DOI 10.1023/A:1021738111273; CAVE EM, 1995, EUR J VASC ENDOVASC, V10, P77, DOI 10.1016/S1078-5884(05)80201-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Finsterer J, 2007, VASA-J VASCULAR DIS, V36, P229, DOI 10.1024/0301-1526.36.4.229; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; GONCALVES I, CIRC RES, V106, P1174; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; GRAYWEALE AC, 1988, J CARDIOVASC SURG, V29, P676; Gronholdt MLM, 1999, ARTERIOSCL THROM VAS, V19, P2, DOI 10.1161/01.ATV.19.1.2; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; Hallerstam S, 2000, EUR J VASC ENDOVASC, V19, P356, DOI 10.1053/ejvs.1999.1010; Handberg A, 2008, STROKE, V39, P3092, DOI 10.1161/STROKEAHA.108.517128; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Henareh L, 2005, DIABETIC MED, V22, P1212, DOI 10.1111/j.1464-5491.2005.01577.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalogeropoulos A, 2007, ATHEROSCLEROSIS, V192, P190, DOI 10.1016/j.atherosclerosis.2006.05.002; Levin I, 2008, SCI TOTAL ENVIRON, V391, P211, DOI 10.1016/j.scitotenv.2007.10.019; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Montecucco F, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/767623; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002; Sabetai MM, 2000, J VASC SURG, V31, P39, DOI 10.1016/S0741-5214(00)70066-8; Sabetai MM, 2000, STROKE, V31, P2189, DOI 10.1161/01.STR.31.9.2189; Salehpour M, 2008, ANAL CHEM, V80, P3515, DOI 10.1021/ac800174j; Salehpour M, 2008, RAPID COMMUN MASS SP, V22, P3928, DOI 10.1002/rcm.3808; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STOTZ E, 1986, STAIN TECHNOL, V61, P187, DOI 10.3109/10520298609110730; Tetko IV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-82; Wendelhag I, 1997, STROKE, V28, P2195, DOI 10.1161/01.STR.28.11.2195; 2009, CALIBOMB	41	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18248	10.1371/journal.pone.0018248	http://dx.doi.org/10.1371/journal.pone.0018248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490968	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700006
J	Piao, XY; Cai, PF; Liu, SA; Hou, N; Hao, LL; Yang, F; Wang, H; Wang, JW; Jin, Q; Chen, QJ				Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Hao, Lili; Yang, Fan; Wang, Heng; Wang, Jianwei; Jin, Qi; Chen, Qijun			Global Expression Analysis Revealed Novel Gender-Specific Gene Expression Features in the Blood Fluke Parasite Schistosoma japonicum	PLOS ONE			English	Article							MANSONI; GENOME; TRANSCRIPTOMICS; DIFFERENTIATION; PERSPECTIVES; INTERPLAY; TOOL	Background: Schistosoma japonicum is one of the remarkable Platyhelminths that are endemic in China and Southeast Asian countries. The parasite is dioecious and can reside inside the host for many years. Rapid reproduction by producing large number of eggs and count-react host anti-parasite responses are the strategies that benefit long term survival of the parasite. Praziquantel is currently the only drug that is effective against the worms. Development of novel antiparasite reagents and immune-prevention measures rely on the deciphering of parasite biology. The decoding of the genomic sequence of the parasite has made it possible to dissect the functions of genes that govern the development of the parasite. In this study, the polyadenylated transcripts from male and female S. japonicum were isolated for deep sequencing and the sequences were systematically analysed. Results: First, the number of genes actively expressed in the two sexes of S. japonicum was similar, but around 50% of genes were biased to either male or female in expression. Secondly, it was, at the first time, found that more than 50% of the coding region of the genome was transcribed from both strands. Among them, 65% of the genes had sense and their cognate antisense transcripts co-expressed, whereas 35% had inverse relationship between sense and antisense transcript abundance. Further, based on gene ontological analysis, more than 2,000 genes were functionally categorized and biological pathways that are differentially functional in male or female parasites were elucidated. Conclusions: Male and female schistosomal parasites differ in gene expression patterns, many metabolic and biological pathways have been identified in this study and genes differentially expressed in gender specific manner were presented. Importantly, more than 50% of the coding regions of the S. japonicum genome transcribed from both strands, antisense RNA-mediated gene regulation might play a critical role in the parasite biology.	[Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Wang, Heng; Chen, Qijun] Chinese Acad Med Sci, Inst Basic Med Sci, Inst Pathogen Biol, Parasitol Lab, Beijing 100730, Peoples R China; [Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Yang, Fan; Wang, Heng; Wang, Jianwei; Jin, Qi; Chen, Qijun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Piao, Xianyu; Cai, Pengfei; Liu, Shuai; Hou, Nan; Yang, Fan; Wang, Jianwei; Jin, Qi; Chen, Qijun] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China; [Chen, Qijun] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Hao, Lili] SW Univ Nationalities, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Jilin University; Southwest Minzu University	Piao, XY (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Inst Pathogen Biol, Parasitol Lab, Beijing 100730, Peoples R China.	qijun.chen@ipbcams.ac.cn	Wang, Jianwei/W-5916-2019; Cai, Pengfe/AAF-2759-2020; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559; Cai, Pengfei/0000-0003-4975-4615	Chinese Academy of Medical Sciences (CAMS); Jilin University, China; National Science and Technology (ST) Key project [2008zc1004-011]; Chinese Natural Scientific Foundation [30625029];  [2007IPB002];  [2007IPB13]	Chinese Academy of Medical Sciences (CAMS); Jilin University, China(Jilin University); National Science and Technology (ST) Key project; Chinese Natural Scientific Foundation; ; 	This study was carried out with support to Q. Chen from grants (2007IPB002, 2007IPB13) to invited professor of the Institute of Pathogen Biology (IPB), Chinese Academy of Medical Sciences (CAMS) and Jilin University, China; the National Science and Technology (S&T) Key project (2008zc1004-011) and the Young Distinguished Scientist Grant (30625029) of the Chinese Natural Scientific Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brindley PJ, 2007, INT J PARASITOL, V37, P465, DOI 10.1016/j.ijpara.2006.12.012; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Cai PF, 2008, BIOCHEM BIOPH RES CO, V372, P197, DOI 10.1016/j.bbrc.2008.05.042; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chuan J, 2010, ADV PARASIT, V73, P327, DOI 10.1016/S0065-308X(10)73011-6; Fan JJ, 1998, BIOCHEM BIOPH RES CO, V252, P348, DOI 10.1006/bbrc.1998.9491; Fitzpatrick JM, 2004, MOL BIOCHEM PARASIT, V136, P191, DOI 10.1016/j.molbiopara.2004.03.014; Fung MC, 2002, ACTA TROP, V82, P215, DOI 10.1016/S0001-706X(02)00013-X; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gu XM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-48; Han ZG, 2009, ANNU REV GENOM HUM G, V10, P211, DOI 10.1146/annurev-genom-082908-150036; Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu SX, 1997, VET PARASITOL, V69, P39, DOI 10.1016/S0304-4017(96)01092-8; Moertel L, 2006, MOL CELL PROBE, V20, P280, DOI 10.1016/j.mcp.2006.02.002; Muro EM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-338; Murphy PJ, 2001, DRUG METAB DISPOS, V29, P779; Rudge JW, 2009, MOL ECOL, V18, P2134, DOI 10.1111/j.1365-294X.2009.04181.x; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; VANDEWAA EA, 1993, ARCH BIOCHEM BIOPHYS, V303, P15, DOI 10.1006/abbi.1993.1249; Verjovski-Almeida S, 2007, EXP PARASITOL, V117, P236, DOI 10.1016/j.exppara.2007.04.005; Wang TP, 2006, INT J PARASITOL, V36, P1317, DOI 10.1016/j.ijpara.2006.06.011; Webster JP, 2010, TRENDS PARASITOL, V26, P103, DOI 10.1016/j.pt.2009.12.006; Wylie T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-525; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009868; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	34	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18267	10.1371/journal.pone.0018267	http://dx.doi.org/10.1371/journal.pone.0018267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494327	Green Submitted, Green Published, gold			2022-12-25	WOS:000289192400011
J	Soto, A; Solari, L; Diaz, J; Mantilla, A; Matthys, F; van der Stuyft, P				Soto, Alonso; Solari, Lely; Diaz, Javier; Mantilla, Alberto; Matthys, Francine; van der Stuyft, Patrick			Validation of a Clinical-Radiographic Score to Assess the Probability of Pulmonary Tuberculosis in Suspect Patients with Negative Sputum Smears	PLOS ONE			English	Article							HIV-INFECTION; DIAGNOSIS; ALGORITHM; VALIDITY	Background: Clinical suspects of pulmonary tuberculosis in which the sputum smears are negative for acid fast bacilli represent a diagnostic challenge in resource constrained settings. Our objective was to validate an existing clinical-radiographic score that assessed the probability of smear-negative pulmonary tuberculosis (SNPT) in high incidence settings in Peru. Methodology/Principal Findings: We included in two referral hospitals in Lima patients with clinical suspicion of pulmonary tuberculosis and two or more negative sputum smears. Using a published but not externally validated score, patients were classified as having low, intermediate or high probability of pulmonary tuberculosis. The reference standard for the diagnosis of tuberculosis was a positive sputum culture in at least one of 2 liquid (MGIT or Middlebrook 7H9) and 1 solid (Ogawa) media. Prevalence of tuberculosis was calculated in each of the three probability groups. 684 patients were included. 184 (27.8%) had a diagnosis of pulmonary tuberculosis. The score did not perform well in patients with a previous history of pulmonary tuberculosis. In patients without, the prevalence of tuberculosis was 5.1%, 31.7% and 72% in the low, intermediate and high probability group respectively. The area under de ROC curve was 0.76 (95% CI 0.72-0.80) and scores >= 6 had a positive LR of 10.9. Conclusions/Significance: In smear negative suspects without previous history of tuberculosis, the clinical-radiographic score can be used as a tool to assess the probability of pulmonary tuberculosis and to guide the decision to initiate or defer treatment or to requesting additional tests.	[Soto, Alonso; Mantilla, Alberto] Hosp Nacl Hipolito Unanue, Dept Med, Lima, Peru; [Solari, Lely; Matthys, Francine; van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Diaz, Javier] Hosp Nacl Cayetano Heredia, Dept Med, Lima, Peru	Institute of Tropical Medicine (ITM)	Soto, A (corresponding author), Hosp Nacl Hipolito Unanue, Dept Med, Lima, Peru.	sotosolari@yahoo.com	Solari, Lely/ABH-2674-2020; Soto, Alonso/ABB-7707-2021	Solari, Lely/0000-0002-8041-8807; Soto, Alonso/0000-0001-8648-8032	Damien Foundation [85561/2005]	Damien Foundation	Funding was provided by the Damien Foundation (www.damienfoundation.org/), grant 85561/2005. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JO, 2003, AIDS, V17, P613, DOI 10.1097/00002030-200303070-00017; Altman D.G., 1991, PRACTICAL STATISTIC; Aris EA, 1999, E AFR MED J, V76, P630; Barrera L., 2007, TUBERCULOSIS 2007 BA, P93; Bergman N. J., 1995, Central African Journal of Medicine, V41, P1; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Finch D, 1997, CHEST, V111, P1174, DOI 10.1378/chest.111.5.1174; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; LUSTED LB, 1971, SCIENCE, V171, P1217, DOI 10.1126/science.171.3977.1217; Matthys F, 2009, T ROY SOC TROP MED H, V103, P52, DOI 10.1016/j.trstmh.2008.07.021; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Pegues CF, 1996, INFECT CONT HOSP EP, V17, P412; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Samb B, 1997, INT J TUBERC LUNG D, V1, P25; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; Scherer LC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-356; Shi Su-hong, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P984; Siddiqi K, 2006, TROP MED INT HEALTH, V11, P323, DOI 10.1111/j.1365-3156.2006.01559.x; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; *STATACORP LP, 2004, STAT STAT SOFTW REAL; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; Tessema TA, 2001, SCAND J INFECT DIS, V33, P355, DOI 10.1080/003655401750173986; WHO, 2007, IMPR DIAGN TREATM SM; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; 2008, ESTRATEGIA SANITARIA	31	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18486	10.1371/journal.pone.0018486	http://dx.doi.org/10.1371/journal.pone.0018486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483690	Green Published, gold, Green Submitted			2022-12-25	WOS:000289191300025
J	Zaravinos, A; Lambrou, GI; Volanis, D; Delakas, D; Spandidos, DA				Zaravinos, Apostolos; Lambrou, George I.; Volanis, Dimitrios; Delakas, Dimitris; Spandidos, Demetrios A.			Spotlight on Differentially Expressed Genes in Urinary Bladder Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TRANSITIONAL-CELL-CARCINOMA; KINASE INHIBITOR PROTEIN; METASTASIS SUPPRESSOR GENE; HUMAN NASAL POLYPOSIS; PROSTATE-CANCER; MATRIX METALLOPROTEINASES; FACTOR RECEPTOR; IN-SITU; PREDICTING RECURRENCE	Introduction: We previously identified common differentially expressed (DE) genes in bladder cancer (BC). In the present study we analyzed in depth, the expression of several groups of these DE genes. Materials and Methods: Samples from 30 human BCs and their adjacent normal tissues were analyzed by whole genome cDNA microarrays, qRT-PCR and Western blotting. Our attention was focused on cell-cycle control and DNA damage repair genes, genes related to apoptosis, signal transduction, angiogenesis, as well as cellular proliferation, invasion and metastasis. Four publicly available GEO Datasets were further analyzed, and the expression data of the genes of interest (GOIs) were compared to those of the present study. The relationship among the GOI was also investigated. GO and KEGG molecular pathway analysis was performed to identify possible enrichment of genes with specific biological themes. Results: Unsupervised cluster analysis of DNA microarray data revealed a clear distinction in BC vs. control samples and low vs. high grade tumors. Genes with at least 2-fold differential expression in BC vs. controls, as well as in non-muscle invasive vs. muscle invasive tumors and in low vs. high grade tumors, were identified and ranked. Specific attention was paid to the changes in osteopontin (OPN, SPP1) expression, due to its multiple biological functions. Similarly, genes exhibiting equal or low expression in BC vs. the controls were scored. Significant pair-wise correlations in gene expression were scored. GO analysis revealed the multi-facet character of the GOIs, since they participate in a variety of mechanisms, including cell proliferation, cell death, metabolism, cell shape, and cytoskeletal re-organization. KEGG analysis revealed that the most significant pathway was that of Bladder Cancer (p = 1.5x10(-31)). Conclusions: The present work adds to the current knowledge on molecular signature identification of BC. Such works should progress in order to gain more insight into disease molecular mechanisms.	[Zaravinos, Apostolos; Volanis, Dimitrios; Spandidos, Demetrios A.] Univ Crete, Sch Med, Virol Lab, Iraklion, Crete, Greece; [Lambrou, George I.] Univ Athens, Dept Pediat 1, Choremeio Res Lab, Athens, Greece; [Volanis, Dimitrios; Delakas, Dimitris] Asklipieio Gen Hosp, Dept Urol, Athens, Greece	University of Crete; National & Kapodistrian University of Athens	Zaravinos, A (corresponding author), Univ Crete, Sch Med, Virol Lab, Iraklion, Crete, Greece.	spandidos@spandidos.gr	Zaravinos, Apostolos/B-2528-2019; Lambrou, George/F-9674-2011	Zaravinos, Apostolos/0000-0003-4625-5562; Spandidos, Demetrios/0000-0002-1146-931X; Lambrou, George/0000-0001-8389-1360				Al-Abbasi DS, 2009, APPL IMMUNOHISTO M M, V17, P307, DOI 10.1097/PAI.0b013e3181941794; Altman NS, 2006, GENET RES, V88, P153, DOI 10.1017/S0016672307008476; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Boulalas I, 2009, J UROLOGY, V181, P2312, DOI 10.1016/j.juro.2009.01.011; Boulalas I, 2009, INT J BIOL MARKER, V24, P17, DOI 10.1177/172460080902400103; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Campbell SC, 1998, CANCER RES, V58, P1298; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chaffer CL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-53; Chikazawa M, 2008, PATHOBIOLOGY, V75, P335, DOI 10.1159/000164218; Choi YD, 2007, J UROLOGY, V177, P1174, DOI 10.1016/j.juro.2006.10.031; Chow NH, 1997, ANTICANCER RES, V17, P1293; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Colquhoun AJ, 2007, J RADIAT RES, V48, P351, DOI 10.1269/jrr.07014; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeBoer WI, 1997, INT J CANCER, V71, P284, DOI 10.1002/(SICI)1097-0215(19970410)71:2<284::AID-IJC25>3.0.CO;2-G; del Rey J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-280; Dominguez-Escrig JL, 2004, CLIN CANCER RES, V10, P4874, DOI 10.1158/1078-0432.CCR-04-0034; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eder IE, 1997, BRIT J CANCER, V75, P1753, DOI 10.1038/bjc.1997.299; Eissa S, 2007, EUR UROL, V52, P1388, DOI 10.1016/j.eururo.2007.04.006; FEINBERG AP, 1983, SCIENCE, V220, P1175, DOI 10.1126/science.6304875; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; FUJITA J, 1984, NATURE, V309, P464, DOI 10.1038/309464a0; Gan YB, 2006, PHARM RES-DORDR, V23, P1324, DOI 10.1007/s11095-006-0136-6; Gerhards S, 2001, UROLOGY, V57, P675, DOI 10.1016/S0090-4295(00)01087-6; GORSCH SM, 1992, CANCER RES, V52, P6949; Gravas S, 2004, UROL INT, V73, P173, DOI 10.1159/000079700; Guo Zheng-Hui, 2003, Ai Zheng, V22, P307; Halimi M, 2009, INDIAN J PATHOL MICR, V52, P155; Hanemaaijer R, 1999, ANN NY ACAD SCI, V878, P141, DOI 10.1111/j.1749-6632.1999.tb07680.x; Helmy Amira, 2007, MedGenMed, V9, P34; Herrera R, 2002, TRENDS MOL MED, V8, pS27, DOI 10.1016/S1471-4914(02)02307-9; Hung TT, 2008, CANCER LETT, V265, P27, DOI 10.1016/j.canlet.2008.02.034; Inoue K, 2000, CLIN CANCER RES, V6, P4866; Izadifar V, 1999, HUM PATHOL, V30, P372, DOI 10.1016/S0046-8177(99)90110-7; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Ke H.L., 2009, UROL ONCOL; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; LEVIDOU G, J CANC RES CLIN ONCO, V36, P1563; Li B, 1998, Int J Urol, V5, P317, DOI 10.1111/j.1442-2042.1998.tb00358.x; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LLENA FRV, 2006, ACTAS UROL ESP, V30, P754; Lopez-Beltran A, 2004, EUR UROL, V46, P170, DOI 10.1016/j.eururo.2004.03.017; MARGULIES IMK, 1992, CANCER EPIDEM BIOMAR, V1, P467; Maslyukova Ye. A., 2006, Voprosy Onkologii (St. Petersburg), V52, P643; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Mellon JK, 1996, J UROLOGY, V155, P321, DOI 10.1016/S0022-5347(01)66653-9; MELLON K, 1995, J UROLOGY, V153, P919, DOI 10.1016/S0022-5347(01)67604-3; Mengual L, 2009, J UROLOGY, V182, P741, DOI 10.1016/j.juro.2009.03.084; Mitra AP, 2006, CLIN GENITOURIN CANC, V5, P67, DOI 10.3816/CGC.2006.n.020; MOCH H, 1993, VIRCHOWS ARCH A, V423, P329, DOI 10.1007/BF01607144; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Morimoto I, 2002, GENE CHROMOSOME CANC, V33, P270, DOI 10.1002/gcc.10020; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Nakazawa K, 2009, AM J CLIN PATHOL, V132, P776, DOI 10.1309/AJCP61KNVHJVHAFN; Nakopoulou L, 1998, HUM PATHOL, V29, P146, DOI 10.1016/S0046-8177(98)90225-8; NEAL DE, 1990, CANCER, V65, P1619, DOI 10.1002/1097-0142(19900401)65:7<1619::AID-CNCR2820650728>3.0.CO;2-Q; NEAL DE, 1985, LANCET, V1, P366; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nutt JE, 2003, BJU INT, V91, P99, DOI 10.1046/j.1464-410X.2003.04020.x; Oates AJ, 1997, INVAS METAST, V17, P1; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Ozdemir E, 1999, J UROLOGY, V161, P1359, DOI 10.1016/S0022-5347(01)61684-7; Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435; Pfister C, 1999, CLIN CANCER RES, V5, P4079; Quentin T, 2004, ANTICANCER RES, V24, P1011; Raspollini Maria Rosaria, 2006, Arch Ital Urol Androl, V78, P97; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Ria R, 2002, EUR J CLIN INVEST, V32, P199, DOI 10.1046/j.1365-2362.2002.00960.x; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Saito S, 1997, Int J Urol, V4, P178, DOI 10.1111/j.1442-2042.1997.tb00167.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SHARIAT SF, J UROL, V183, P1744; Sier CFM, 2000, CLIN CANCER RES, V6, P2333; Simister PC, 2002, ACTA CRYSTALLOGR D, V58, P1077, DOI 10.1107/S090744490200522X; Staack Andrea, 2006, BMC Urol, V6, P19, DOI 10.1186/1471-2490-6-19; STEINER MS, 1994, ENDOCRINOLOGY, V135, P2240, DOI 10.1210/en.135.5.2240; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Symvoulakis EK, 2007, INT J BIOL MARKER, V22, P12, DOI 10.1177/172460080702200102; Townsend JP, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-41; Underwood MA, 1996, BRIT J UROL, V77, P659, DOI 10.1046/j.1464-410X.1996.09386.x; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasala K, 2007, CLIN BIOCHEM, V40, P640, DOI 10.1016/j.clinbiochem.2007.01.021; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; VISVANATHAN KV, 1988, ONCOGENE RES, V3, P77; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WILLIAMS NG, 1994, CANCER METAST REV, V13, P105, DOI 10.1007/BF00690421; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wolff EM, 2005, NAT CLIN PRACT UROL, V2, P502, DOI 10.1038/ncpuro0318; Wood M, 1997, CLIN EXP METASTAS, V15, P246, DOI 10.1023/A:1018421431388; YE DW, 1993, UROL RES, V21, P223; Yin M, 2008, HUM PATHOL, V39, P527, DOI 10.1016/j.humpath.2007.08.005; Zaravinos A, 2010, BRIT J DERMATOL, V162, P325, DOI 10.1111/j.1365-2133.2009.09480.x; ZARAVINOS A, PATHOL ONCOL RES; ZARAVINOS A, 2011, PLOS ONE; Zaravinos A, 2008, CANCER LETT, V264, P288, DOI 10.1016/j.canlet.2008.01.046; Zaravinos A, 2008, ONCOL REP, V19, P385; Zaravinos A, 2007, INT J ONCOL, V31, P1051; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308; Zhang GJ, 2005, UROL ONCOL-SEMIN ORI, V23, P413, DOI 10.1016/j.urolonc.2005.05.029	116	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18255	10.1371/journal.pone.0018255	http://dx.doi.org/10.1371/journal.pone.0018255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483670	gold, Green Published, Green Submitted			2022-12-25	WOS:000289191300014
J	Fukuda, D; Haines, AS; Song, ZS; Murphy, AC; Hothersall, J; Stephens, ER; Gurney, R; Cox, RJ; Crosby, J; Willis, CL; Simpson, TJ; Thomas, CM				Fukuda, Daisuke; Haines, Anthony S.; Song, Zhongshu; Murphy, Annabel C.; Hothersall, Joanne; Stephens, Elton R.; Gurney, Rachel; Cox, Russell J.; Crosby, John; Willis, Christine L.; Simpson, Thomas J.; Thomas, Christopher M.			A Natural Plasmid Uniquely Encodes Two Biosynthetic Pathways Creating a Potent Anti-MRSA Antibiotic	PLOS ONE			English	Article							PSEUDOMONIC-ACID; GENE-CLUSTER; POLYKETIDE SYNTHASE; BACTERIAL SYMBIONT; MARINE BACTERIUM; SYNTHETASE; MUPIROCIN; FLUORESCENS; SIMOCYCLINONE; MUTATION	Background: Understanding how complex antibiotics are synthesised by their producer bacteria is essential for creation of new families of bioactive compounds. Thiomarinols, produced by marine bacteria belonging to the genus Pseudoalteromonas, are hybrids of two independently active species: the pseudomonic acid mixture, mupirocin, which is used clinically against MRSA, and the pyrrothine core of holomycin. Methodology/Principal Findings: High throughput DNA sequencing of the complete genome of the producer bacterium revealed a novel 97 kb plasmid, pTML1, consisting almost entirely of two distinct gene clusters. Targeted gene knockouts confirmed the role of these clusters in biosynthesis of the two separate components, pseudomonic acid and the pyrrothine, and identified a putative amide synthetase that joins them together. Feeding mupirocin to a mutant unable to make the endogenous pseudomonic acid created a novel hybrid with the pyrrothine via "mutasynthesis" that allows inhibition of mupirocin-resistant isoleucyl-tRNA synthetase, the mupirocin target. A mutant defective in pyrrothine biosynthesis was also able to incorporate alternative amine substrates. Conclusions/Significance: Plasmid pTML1 provides a paradigm for combining independent antibiotic biosynthetic pathways or using mutasynthesis to develop a new family of hybrid derivatives that may extend the effective use of mupirocin against MRSA.	[Fukuda, Daisuke; Haines, Anthony S.; Hothersall, Joanne; Stephens, Elton R.; Gurney, Rachel; Thomas, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Song, Zhongshu; Murphy, Annabel C.; Cox, Russell J.; Crosby, John; Willis, Christine L.; Simpson, Thomas J.] Univ Bristol, Sch Chem, Bristol, Avon, England	University of Birmingham; University of Bristol	Fukuda, D (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	C.M.THOMAS@bham.ac.uk	Simpson, Thomas J/P-5058-2015; Cox, Russell John/F-9190-2015	Cox, Russell John/0000-0002-1844-0157; Haines, Anthony/0000-0003-2736-6371; Fukuda, Daisuke/0000-0003-2306-0121	BBSRC/EPSRC [E021611]; EPSRC [EP/F066104]; company Daiichi-Sankyo; UK Research Council BBSRC; UK Research Council EPSRC; BBSRC [BB/E021611/1, BB/E022367/1] Funding Source: UKRI; EPSRC [EP/F066104/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021611/1, BB/E022367/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F066104/1] Funding Source: researchfish	BBSRC/EPSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); company Daiichi-Sankyo; UK Research Council BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Research Council EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by BBSRC/EPSRC grant E021611. LCMS equipment was funded by EPSRC grant EP/F066104. Daisuke Fukuda was funded to work on this project in Birmingham by the company Daiichi-Sankyo, which also made a financial contribution to the running costs of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a grant from the UK Research Councils BBSRC and EPSRC. Daisuke Fukuda was still an employee of the company Daiichi-Sankyo while he was seconded to the University of Birmingham.	Aron ZD, 2007, CHEMBIOCHEM, V8, P613, DOI 10.1002/cbic.200600575; Bentley SD, 2004, MOL MICROBIOL, V51, P1615, DOI 10.1111/j.1365-2958.2003.03949.x; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brown P, 1997, J MED CHEM, V40, P2563, DOI 10.1021/jm960738k; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Cooper SM, 2005, CHEM BIOL, V12, P825, DOI 10.1016/j.chembiol.2005.05.015; Cooper SM, 2005, CHEM COMMUN, P1179, DOI 10.1039/b414781b; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Galm U, 2004, CHEM BIOL, V11, P173, DOI 10.1016/j.chembiol.2004.01.012; Geng HF, 2008, APPL ENVIRON MICROB, V74, P1535, DOI 10.1128/AEM.02339-07; Hothersall J, 2007, J BIOL CHEM, V282, P15451, DOI 10.1074/jbc.M701490200; HUGHES J, 1978, BIOCHEM J, V176, P305, DOI 10.1042/bj1760305; Jeziorowski A, 2007, J BACTERIOL, V189, P7045, DOI 10.1128/JB.00243-07; Li B, 2010, P NATL ACAD SCI USA, V107, P19731, DOI 10.1073/pnas.1014140107; Luft T, 2005, ARCH MICROBIOL, V183, P277, DOI 10.1007/s00203-005-0770-0; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; Medema MH, 2010, GENOME BIOL EVOL, V2, P212, DOI 10.1093/gbe/evq013; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x; MURPHY AC, 2011, ANGEW CHEM IN PRESS, V50; OKAMURA K, 1977, J ANTIBIOT, V30, P334, DOI 10.7164/antibiotics.30.334; Oliva B, 2001, ANTIMICROB AGENTS CH, V45, P532, DOI 10.1128/AAC.45.2.532-539.2001; Pacholec M, 2005, BIOCHEMISTRY-US, V44, P4949, DOI 10.1021/bi047303g; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Rahman AS, 2005, J BIOL CHEM, V280, P6399, DOI 10.1074/jbc.M409814200; Sambrook J, 2001, MOL CLONING LAB MANU; SHIOZAWA H, 1994, J ANTIBIOT, V47, P851, DOI 10.7164/antibiotics.47.851; Shiozawa H, 1997, J ANTIBIOT, V50, P449, DOI 10.7164/antibiotics.50.449; SHIOZAWA H, 1995, J ANTIBIOT, V48, P907, DOI 10.7164/antibiotics.48.907; SHIOZAWA H, 1993, J ANTIBIOT, V46, P1834, DOI 10.7164/antibiotics.46.1834; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Song JY, 2010, J BACTERIOL, V192, P6317, DOI 10.1128/JB.00859-10; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; Trefzer A, 2002, ANTIMICROB AGENTS CH, V46, P1174, DOI 10.1128/AAC.46.5.1174-1182.2002; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Wu J, 2007, CHEM COMMUN, P2040, DOI 10.1039/b700613f; Yanagisawa T, 2003, J BIOL CHEM, V278, P25887, DOI 10.1074/jbc.M302633200	44	50	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18031	10.1371/journal.pone.0018031	http://dx.doi.org/10.1371/journal.pone.0018031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483852	Green Published, gold			2022-12-25	WOS:000289057200020
J	Lower, M; Geppert, T; Schneider, P; Hoy, B; Wessler, S; Schneider, G				Loewer, Martin; Geppert, Tim; Schneider, Petra; Hoy, Benjamin; Wessler, Silja; Schneider, Gisbert			Inhibitors of Helicobacter pylori Protease HtrA Found by 'Virtual Ligand' Screening Combat Bacterial Invasion of Epithelia	PLOS ONE			English	Article							E-CADHERIN; STRUCTURAL BASIS; PHARMACOPHORES; DOCKING; LIBRARY; ALIGNMENT; CAVITIES; MODEL	Background: The human pathogen Helicobacter pylori (H. pylori) is a main cause for gastric inflammation and cancer. Increasing bacterial resistance against antibiotics demands for innovative strategies for therapeutic intervention. Methodology/Principal Findings: We present a method for structure-based virtual screening that is based on the comprehensive prediction of ligand binding sites on a protein model and automated construction of a ligand-receptor interaction map. Pharmacophoric features of the map are clustered and transformed in a correlation vector ('virtual ligand') for rapid virtual screening of compound databases. This computer-based technique was validated for 18 different targets of pharmaceutical interest in a retrospective screening experiment. Prospective screening for inhibitory agents was performed for the protease HtrA from the human pathogen H. pylori using a homology model of the target protein. Among 22 tested compounds six block E-cadherin cleavage by HtrA in vitro and result in reduced scattering and wound healing of gastric epithelial cells, thereby preventing bacterial infiltration of the epithelium. Conclusions/Significance: This study demonstrates that receptor-based virtual screening with a permissive ('fuzzy') pharmacophore model can help identify small bioactive agents for combating bacterial infection.	[Loewer, Martin] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany; [Hoy, Benjamin; Wessler, Silja] Salzburg Univ, Div Microbiol, A-5020 Salzburg, Austria; [Geppert, Tim; Schneider, Petra; Schneider, Gisbert] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland	Goethe University Frankfurt; Salzburg University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lower, M (corresponding author), Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany.	gisbert.schneider@pharma.ethz.ch	Wessler, Silja/C-6309-2015	Wessler, Silja/0000-0001-7011-6162; Schneider, Petra/0000-0001-8296-6105; Schneider, Gisbert/0000-0001-6706-1084	OPO Foundation, Zurich	OPO Foundation, Zurich	We thank Dr. Christiane Weydig for her help with immunofluorescence experiments, and Dr. Heiko Zettl for technical support. This research was supported by the OPO Foundation, Zurich.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barillari C, 2008, J CHEM INF MODEL, V48, P1396, DOI 10.1021/ci800064z; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Bissantz C, 2010, J MED CHEM, V53, P6241, DOI 10.1021/jm100950p; BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P61, DOI 10.1007/bf00124387; Chan AOO, 2006, WORLD J GASTROENTERO, V12, P199, DOI 10.3748/wjg.v12.i2.199; Cole JC, 2005, VIRTUAL SCREENING IN DRUG DISCOVERY, P379; De Wever O, 2007, CLIN EXP METASTAS, V24, P685, DOI 10.1007/s10585-007-9104-8; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gosling J, 2005, JAVA LANGUAGE SPECIF; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Guha R, 2008, J CHEM INF MODEL, V48, P646, DOI 10.1021/ci7004093; Hawkins PCD, 2008, J COMPUT AID MOL DES, V22, P179, DOI 10.1007/s10822-007-9166-3; Hocker M, 2003, LANCET, V362, P1231, DOI 10.1016/S0140-6736(03)14547-3; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Kortagere S, 2010, J PHARMACOL TOX MET, V61, P67, DOI 10.1016/j.vascn.2010.02.005; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; LOWER M, 2009, THESIS GOETHE U FRAN; Mandelbrot B., 1968, PATTERN CLASSIFICATI, V10, P422; Peach ML, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-6; PERONA JJ, 1995, PROTEIN SCI, V4, P337; PICKETT S, 2003, BIOPHORE CONCEPT PRO, P73; Rarey M, 2005, METH PRIN MED CHEM, V22, P59, DOI 10.1002/3527603743.ch4; Rohrer SG, 2008, J CHEM INF MODEL, V48, P704, DOI 10.1021/ci700099u; Ruppert J, 1997, PROTEIN SCI, V6, P524; Schneider G., 2008, MOL DESIGN CONCEPTS; Schneider P, 2003, QSAR COMB SCI, V22, P713, DOI 10.1002/qsar.200330825; Schuller A, 2006, COMB CHEM HIGH T SCR, V9, P359, DOI 10.2174/138620706777452375; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seifert MHJ, 2008, MINI-REV MED CHEM, V8, P63, DOI 10.2174/138955708783331540; Senderowitz H, 2009, CURR PHARM DESIGN, V15, P4049, DOI 10.2174/138161209789824821; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Tanrikulu Y, 2007, CHEMBIOCHEM, V8, P1932, DOI 10.1002/cbic.200700195; Tintori C, 2008, J CHEM INF MODEL, V48, P2166, DOI 10.1021/ci800105p; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; UGI I, 1959, ANGEW CHEM INT EDIT, V71, P386; UGI I, 1960, ANGEW CHEM INT EDIT, V72, P267, DOI 10.1002/ange.19600720709; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Weisel M, 2009, PROTEOMICS, V9, P451, DOI 10.1002/pmic.200800092; Weydig C, 2007, EXP CELL RES, V313, P3459, DOI 10.1016/j.yexcr.2007.07.015; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zhong SJ, 2010, CURR OPIN DRUG DISC, V13, P326	48	46	49	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17986	10.1371/journal.pone.0017986	http://dx.doi.org/10.1371/journal.pone.0017986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483848	Green Submitted, gold, Green Published			2022-12-25	WOS:000289057200016
J	Warmuth, V; Eriksson, A; Bower, MA; Canon, J; Cothran, G; Distl, O; Glowatzki-Mullis, ML; Hunt, H; Luis, C; Oom, MD; Yupanqui, IT; Zabek, T; Manica, A				Warmuth, Vera; Eriksson, Anders; Bower, Mim A.; Canon, Javier; Cothran, Gus; Distl, Ottmar; Glowatzki-Mullis, Marie-Louise; Hunt, Harriet; Luis, Cristina; Oom, Maria do Mar; Tupac Yupanqui, Isabel; Zabek, Tomasz; Manica, Andrea			European Domestic Horses Originated in Two Holocene Refugia	PLOS ONE			English	Article							INFERRING ADMIXTURE PROPORTIONS; GENETIC DIVERSITY; MICROSATELLITE LOCI; WILD HORSES; BREEDS; CATTLE; GEOGRAPHY	The role of European wild horses in horse domestication is poorly understood. While the fossil record for wild horses in Europe prior to horse domestication is scarce, there have been suggestions that wild populations from various European regions might have contributed to the gene pool of domestic horses. To distinguish between regions where domestic populations are mainly descended from local wild stock and those where horses were largely imported, we investigated patterns of genetic diversity in 24 European horse breeds typed at 12 microsatellite loci. The distribution of high levels of genetic diversity in Europe coincides with the distribution of predominantly open landscapes prior to domestication, as suggested by simulation-based vegetation reconstructions, with breeds from Iberia and the Caspian Sea region having significantly higher genetic diversity than breeds from central Europe and the UK, which were largely forested at the time the first domestic horses appear there. Our results suggest that not only the Eastern steppes, but also the Iberian Peninsula provided refugia for wild horses in the Holocene, and that the genetic contribution of these wild populations to local domestic stock may have been considerable. In contrast, the consistently low levels of diversity in central Europe and the UK suggest that domestic horses in these regions largely derive from horses that were imported from the Eastern refugium, the Iberian refugium, or both.	[Warmuth, Vera; Eriksson, Anders; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England; [Warmuth, Vera; Bower, Mim A.; Hunt, Harriet] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Canon, Javier; Tupac Yupanqui, Isabel] Univ Complutense, Fac Vet, Dept Anim Prod, E-28040 Madrid, Spain; [Cothran, Gus] Texas A&M Univ, CVM, VIBS, Anim Genet Lab, College Stn, TX USA; [Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Glowatzki-Mullis, Marie-Louise] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Luis, Cristina] Univ Lisbon, Museus Politecn MNHN & MCUL, P-1699 Lisbon, Portugal; [Oom, Maria do Mar] Univ Lisbon, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Zabek, Tomasz] Natl Res Inst Anim Prod, Lab Genom, Balice, Poland	University of Cambridge; University of Cambridge; Complutense University of Madrid; Texas A&M University System; Texas A&M University College Station; University of Veterinary Medicine Hannover, Foundation; University of Bern; Universidade de Lisboa; Universidade de Lisboa; National Research Institute of Animal Production	Warmuth, V (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	vmw23@cam.ac.uk; am315@cam.ac.uk	Eriksson, Anders/C-9767-2010; Luís, Cristina/AFF-4315-2022; do Mar Oom, Maria/B-9423-2011; Ząbek, Tomasz/AAS-8092-2021; Luís, Cristina/H-8324-2013; Manica, Andrea/N-9013-2019; Warmuth, Vera/H-6876-2012; Manica, Andrea/B-5497-2008; Luís, Cristina/AAE-9871-2022; Canon Ferreras, Francisco Javier/M-5704-2018	Eriksson, Anders/0000-0003-3436-3726; Luís, Cristina/0000-0001-8005-9624; do Mar Oom, Maria/0000-0002-1715-4108; Ząbek, Tomasz/0000-0002-9795-3232; Luís, Cristina/0000-0001-8005-9624; Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X; Luís, Cristina/0000-0001-8005-9624; Canon Ferreras, Francisco Javier/0000-0003-1137-0958	Biotechnology and Biological Sciences Research Council [BB/E527604/1]; German Academic Exchange Service [D/07/44562]; Leverhulme Trust [F/09757/B]; Biotechnology and Biological Sciences Research Council [BB/H005854/1] Funding Source: researchfish; BBSRC [BB/H005854/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially supported by a research studentship from the Biotechnology and Biological Sciences Research Council (BB/E527604/1) and a PhD studentship from the German Academic Exchange Service (D/07/44562) to VW, and a Leverhulme Trust project grant (F/09757/B) to MAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle KS, 2004, ANIM GENET, V35, P270, DOI 10.1111/j.1365-2052.2004.01166.x; Allen M, 1998, J FORENSIC SCI, V43, P453; Ammerman A.J., 1973, EXPLANATION CULTURE, P343; [Anonymous], 2010, R LANG ENV STAT COMP; ANTHONY DW, 1986, CURR ANTHROPOL, V27, P291, DOI 10.1086/203441; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; BINNS MM, 1995, BRIT VET J, V151, P9, DOI 10.1016/S0007-1935(05)80057-0; Boyle K.V., 2006, P10; Breen M, 1997, MAMM GENOME, V8, P267, DOI 10.1007/s003359900407; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Chapman R., 1990, EMERGING COMPLEXITY; Childe V.G., 1925, DAWN EUROPEAN CIVILI; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; ELLEGREN H, 1992, ANIM GENET, V23, P133, DOI 10.1111/j.1365-2052.1992.tb00032.x; Freeman AR, 2006, ANIM GENET, V37, P1, DOI 10.1111/j.1365-2052.2005.01363.x; Gallimore R, 2005, CLIM DYNAM, V25, P755, DOI 10.1007/s00382-005-0054-z; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUERIN G, 1994, ANIM GENET, V25, P62; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hendricks Bonnie, 1995, INT ENCY HORSE BREED; Huntley B, 1988, VEGETATION HIST; Lewis PO, 2001, GENETIC DATA ANAL GD; Linklater WL, 2000, NEW ZEAL J ECOL, V24, P139; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Luis C, 2007, ANIM GENET, V38, P20, DOI 10.1111/j.1365-2052.2006.01545.x; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; MARKLUND S, 1994, ANIM GENET, V25, P19, DOI 10.1111/j.1365-2052.1994.tb00050.x; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; Mitchell FJG, 2005, J ECOL, V93, P168, DOI 10.1111/j.1365-2745.2004.00964.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pantaleon-Cano J, 2003, HOLOCENE, V13, P109, DOI 10.1191/0959683603hl598rp; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; PREECE RC, 1991, J BIOGEOGR, V18, P409, DOI 10.2307/2845483; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Royo LJ, 2005, J HERED, V96, P663, DOI 10.1093/jhered/esi116; Stewart John R., 2007, Acta Zoologica Cracoviensia Ser. A - Vertebrata, V50A, P93, DOI 10.3409/000000007783995372; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; VANHAERINGEN H, 1994, ANIM GENET, V25, P207, DOI 10.1111/j.1365-2052.1994.tb00129.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zabek Tomasz, 2005, Journal of Applied Genetics, V46, P299; [No title captured]; [No title captured]; [No title captured]; [No title captured]	52	51	55	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18194	10.1371/journal.pone.0018194	http://dx.doi.org/10.1371/journal.pone.0018194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479181	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700038
J	Kenerson, HL; Yeh, MM; Yeung, RS				Kenerson, Heidi L.; Yeh, Matthew M.; Yeung, Raymond S.			Tuberous Sclerosis Complex-1 Deficiency Attenuates Diet-Induced Hepatic Lipid Accumulation	PLOS ONE			English	Article							INSULIN-RESISTANCE; CELL-GROWTH; MAMMALIAN TARGET; INDUCED OBESITY; ADIPOSE-TISSUE; FATTY LIVER; STEATOSIS; MICE; MTOR; GENE	Non-alcoholic fatty liver disease (NAFLD) is causally linked to type 2 diabetes, insulin resistance and dyslipidemia. In a normal liver, insulin suppresses gluconeogenesis and promotes lipogenesis. In type 2 diabetes, the liver exhibits selective insulin resistance by failing to inhibit hepatic glucose production while maintaining triglyceride synthesis. Evidence suggests that the insulin pathway bifurcates downstream of Akt to regulate these two processes. Specifically, mTORC1 has been implicated in lipogenesis, but its role on hepatic steatosis has not been examined. Here, we generated mice with hepatocyte-specific deletion of Tsc1 to study the effects of constitutive mTORC1 activation in the liver. These mice developed normally but displayed mild hepatomegaly and insulin resistance without obesity. Unexpectedly, the Tsc1-null livers showed minimal signs of steatosis even under high-fat diet condition. This 'resistant' phenotype was reversed by rapamycin and could be overcome by the expression of Myr-Akt. Moreover, rapamycin failed to reduce hepatic triglyceride levels in models of steatosis secondary to Pten ablation in hepatocytes or high-fat diet in wild-type mice. These observations suggest that mTORC1 is neither necessary nor sufficient for steatosis. Instead, Akt and mTORC1 have opposing effects on hepatic lipid accumulation such that mTORC1 protects against diet-induced steatosis. Specifically, mTORC1 activity induces a metabolic shift towards fat utilization and glucose production in the liver. These findings provide novel insights into the role of mTORC1 in hepatic lipid metabolism.	[Kenerson, Heidi L.; Yeung, Raymond S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Yeh, Matthew M.; Yeung, Raymond S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kenerson, HL (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	ryeung@u.washington.edu			NIH [CA77882, CA102662]; NATIONAL CANCER INSTITUTE [R01CA077882, R01CA102662] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from NIH (CA77882 and CA102662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Korsheninnikova E, 2006, DIABETOLOGIA, V49, P3049, DOI 10.1007/s00125-006-0439-5; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Mauvoisin D, 2007, J CELL COMMUN SIGNAL, V1, P113, DOI 10.1007/s12079-007-0011-1; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004129; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; ZHENG Y, 2009, J ENDOCRINOL; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812	52	51	52	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18075	10.1371/journal.pone.0018075	http://dx.doi.org/10.1371/journal.pone.0018075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479224	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600026
J	Sato, H; Hunt, ML; Weiner, JJ; Hansen, AT; Frank, DW				Sato, Hiromi; Hunt, Meredith L.; Weiner, Joshua J.; Hansen, Andrew T.; Frank, Dara W.			Modified Needle-Tip PcrV Proteins Reveal Distinct Phenotypes Relevant to the Control of Type III Secretion and Intoxication by Pseudomonas aeruginosa	PLOS ONE			English	Article							PESTIS V-ANTIGEN; HOST-CELL MEMBRANES; EXOENZYME S REGULON; SHIGELLA-FLEXNERI; YERSINIA-PESTIS; SYSTEM NEEDLE; DEPENDENT TRANSLOCATION; ADENYLATE-CYCLASE; ESCHERICHIA-COLI; APPARATUS NEEDLE	The type III secretion system (T3SS) is employed to deliver effector proteins to the cytosol of eukaryotic hosts by multiple species of Gram-negative bacteria, including Pseudomonas aeruginosa. Translocation of effectors is dependent on the proteins encoded by the pcrGVHpopBD operon. These proteins form a T3S translocator complex, composed of a needle-tip complex (PcrV), translocons (PopB and PopD), and chaperones (PcrG and PcrH). PcrV mediates the folding and insertion of PopB/PopD in host plasmic membranes, where assembled translocons form a translocation channel. Assembly of this complex and delivery of effectors through this machinery is tightly controlled by PcrV, yet the multifunctional aspects of this molecule have not been defined. In addition, PcrV is a protective antigen for P. aeruginosa infection as is the ortholog, LcrV, for Yersinia. We constructed PcrV derivatives containing in-frame linker insertions and site-specific mutations. The expression of these derivatives was regulated by a T3S-specific promoter in a pcrV-null mutant of PA103. Nine derivatives disrupted the regulation of effector secretion and constitutively released an effector protein into growth medium. Three of these regulatory mutants, in which the linker was inserted in the N-terminal globular domain, were competent for the translocation of a cytotoxin, ExoU, into eukaryotic host cells. We also isolated strains expressing a delayed-toxicity phenotype, which secrete translocators slowly despite the normal level of effector secretion. Most of the cytotoxic translocation-competent strains retained the protective epitope of PcrV derivatives, and Mab166 was able to protect erythrocytes during infection with these strains. The use of defined PcrV derivatives possessing distinct phenotypes may lead to a better understanding of the functional aspects of T3 needle-tip proteins and the development of therapeutic agents or vaccines targeting T3SS-mediated intoxication.	[Sato, Hiromi; Hunt, Meredith L.; Weiner, Joshua J.; Hansen, Andrew T.; Frank, Dara W.] Med Coll Wisconsin, Ctr Infect Dis Res, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Sato, H (corresponding author), Med Coll Wisconsin, Ctr Infect Dis Res, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	hsato@mcw.edu			National Institute of Allergy and Infectious Diseases, NIH [AI49577]; Center for Infectious Disease Research; Advancing a Healthier Wisconsin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049577] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Infectious Disease Research; Advancing a Healthier Wisconsin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI49577 from the National Institute of Allergy and Infectious Diseases, the Center for Infectious Disease Research, and the Advancing a Healthier Wisconsin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.niaid.nih.gov/Pages/default.aspx http://www.mcw.edu/display/router.aspx?docid = 16723& http://www.mcw.edu/display/router.aspx? docid = 16994&	Baer M, 2009, INFECT IMMUN, V77, P1083, DOI 10.1128/IAI.00815-08; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Botteaux A, 2009, MOL MICROBIOL, V71, P449, DOI 10.1111/j.1365-2958.2008.06537.x; Bridge DR, 2010, MICROBIOL-SGM, V156, P356, DOI 10.1099/mic.0.033241-0; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019; Dacheux D, 2001, INFECT IMMUN, V69, P538, DOI 10.1128/IAI.69.1.538-542.2001; Davis AJ, 2007, J BACTERIOL, V189, P83, DOI 10.1128/JB.01396-06; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DeBord KL, 2001, J BACTERIOL, V183, P4588, DOI 10.1128/JB.183.15.4588-4598.2001; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Faure Karine, 2003, J Immune Based Ther Vaccines, V1, P2, DOI 10.1186/1476-8518-1-2; FRANK DW, 1994, INFECT IMMUN, V62, P554, DOI 10.1128/IAI.62.2.554-563.1994; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ganesan AK, 1999, J BIOL CHEM, V274, P21823, DOI 10.1074/jbc.274.31.21823; Giamarellou H, 2000, INT J ANTIMICROB AG, V16, P103, DOI 10.1016/S0924-8579(00)00212-0; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamad MA, 2007, ADV EXP MED BIOL, V603, P225; Hill J, 1997, INFECT IMMUN, V65, P4476, DOI 10.1128/IAI.65.11.4476-4482.1997; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; La Ragione RM, 2006, MICROBES INFECT, V8, P426, DOI 10.1016/j.micinf.2005.07.009; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; MARTINEZARGUDO I, 2010, MOL MICROBIOL   1011, DOI DOI 10.1111/J.1365-2958.2010.07413.X; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Moriyama K, 2009, MICROBIOL IMMUNOL, V53, P587, DOI 10.1111/j.1348-0421.2009.00165.x; MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Quenee LE, 2010, VACCINE, V28, P1870, DOI 10.1016/j.vaccine.2009.11.076; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2006, BIOCHEMISTRY-US, V45, P10368, DOI 10.1021/bi060788j; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; SKRZYPEK E, 1995, J BACTERIOL, V177, P2530, DOI 10.1128/jb.177.9.2530-2542.1995; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stensrud KF, 2008, J BIOL CHEM, V283, P18646, DOI 10.1074/jbc.M802799200; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Vernazza C, 2009, VACCINE, V27, P2775, DOI 10.1016/j.vaccine.2009.03.011; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; Vidal F, 1996, ARCH INTERN MED, V156, P2121, DOI 10.1001/archinte.156.18.2121; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; YAHR TL, 1995, J BACTERIOL, V177, P1169, DOI 10.1128/jb.177.5.1169-1178.1995; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997	76	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18356	10.1371/journal.pone.0018356	http://dx.doi.org/10.1371/journal.pone.0018356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479247	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600048
J	Greenfeld, M; Solomatin, SV; Herschlag, D				Greenfeld, Max; Solomatin, Sergey V.; Herschlag, Daniel			Removal of Covalent Heterogeneity Reveals Simple Folding Behavior for P4-P6 RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE; TERTIARY STRUCTURE; TETRAHYMENA RIBOZYME; CRYSTAL-STRUCTURE; ENERGY LANDSCAPE; KINETIC TRAPS; ION CORE; DYNAMICS; BINDING; DOMAIN	RNA folding landscapes have been described alternately as simple and as complex. The limited diversity of RNA residues and the ability of RNA to form stable secondary structures prior to adoption of a tertiary structure would appear to simplify folding relative to proteins. Nevertheless, there is considerable evidence for long-lived misfolded RNA states, and these observations have suggested rugged energy landscapes. Recently, single molecule fluorescence resonance energy transfer (smFRET) studies have exposed heterogeneity in many RNAs, consistent with deeply furrowed rugged landscapes. We turned to an RNA of intermediate complexity, the P4-P6 domain from the Tetrahymena group I intron, to address basic questions in RNA folding. P4-P6 exhibited long-lived heterogeneity in smFRET experiments, but the inability to observe exchange in the behavior of individual molecules led us to probe whether there was a non-conformational origin to this heterogeneity. We determined that routine protocols in RNA preparation and purification, including UV shadowing and heat annealing, cause covalent modifications that alter folding behavior. By taking measures to avoid these treatments and by purifying away damaged P4-P6 molecules, we obtained a population of P4-P6 that gave near-uniform behavior in single molecule studies. Thus, the folding landscape of P4-P6 lacks multiple deep furrows that would trap different P4-P6 molecules in different conformations and contrasts with the molecular heterogeneity that has been seen in many smFRET studies of structured RNAs. The simplicity of P4-P6 allowed us to reliably determine the thermodynamic and kinetic effects of metal ions on folding and to now begin to build more detailed models for RNA folding behavior.	[Greenfeld, Max; Solomatin, Sergey V.; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Greenfeld, Max; Herschlag, Daniel] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	herschla@stanford.edu			National Institutes of mental information; Training Grant in Biotechnology [5T32GM008412];  [GM49243]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412, R01GM049243, R37GM049243] Funding Source: NIH RePORTER	National Institutes of mental information; Training Grant in Biotechnology; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of mental information. Initial smP4-P6 samples were prepared as Health Grant GM49243 (to D. H.) and Training Grant in Biotechnology 5T32GM008412 (to M. G.).	Akiyama BM, 2009, METHOD ENZYMOL, V469, P27, DOI 10.1016/S0076-6879(09)69002-9; Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Al-Hashimi HM, 2003, J MOL BIOL, V329, P867, DOI 10.1016/S0022-2836(03)00517-5; Andrus A., 2001, CURR PROTOC NUCL ACI; Bai Y, 2007, J AM CHEM SOC, V129, P14981, DOI 10.1021/ja075020g; Basu S, 1998, NAT STRUCT BIOL, V5, P986, DOI 10.1038/2960; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Cappe O., 2005, SPR S STAT; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chu VB, 2009, RNA, V15, P2195, DOI 10.1261/rna.1747509; Das R, 2005, J AM CHEM SOC, V127, P8272, DOI 10.1021/ja051422h; Deras ML, 2000, BIOCHEMISTRY-US, V39, P10975, DOI 10.1021/bi0010118; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Elenko MP, 2009, J AM CHEM SOC, V131, P9866, DOI 10.1021/ja901880v; FRILANDER MJ, 2005, RNA LIGATION USING T; GARTLAND WJ, 1966, P NATL ACAD SCI USA, V55, P948, DOI 10.1073/pnas.55.4.948; Juneau K, 1999, RNA, V5, P1119, DOI 10.1017/S135583829999074X; Kobitski AY, 2007, NUCLEIC ACIDS RES, V35, P2047, DOI 10.1093/nar/gkm072; Lambert D, 2009, J MOL BIOL, V390, P791, DOI 10.1016/j.jmb.2009.04.083; Lee TH, 2007, BIOPHYS J, V92, P3275, DOI 10.1529/biophysj.106.094623; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; LINDAHL T, 1966, P NATL ACAD SCI USA, V55, P941, DOI 10.1073/pnas.55.4.941; Ma HR, 2006, J AM CHEM SOC, V128, P1523, DOI 10.1021/ja0553856; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MURPHY FL, 1993, BIOCHEMISTRY-US, V32, P5291, DOI 10.1021/bi00071a003; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Pan T, 1997, NAT STRUCT BIOL, V4, P931, DOI 10.1038/nsb1197-931; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; ROBERT FE, 2009, RNA METHODOLOGIES LA; Rueda D, 2004, P NATL ACAD SCI USA, V101, P10066, DOI 10.1073/pnas.0403575101; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Sattint BD, 2008, J AM CHEM SOC, V130, P6085, DOI 10.1021/ja800919q; Schlatterer JC, 2008, J MOL BIOL, V379, P859, DOI 10.1016/j.jmb.2008.04.013; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Silverman SK, 2000, BIOCHEMISTRY-US, V39, P12465, DOI 10.1021/bi000828y; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Silverman SK, 2001, RNA, V7, P161, DOI 10.1017/S1355838201001716; Solomatin S, 2009, METHOD ENZYMOL, V469, P47, DOI 10.1016/S0076-6879(09)69003-0; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; Szewczak AA, 1997, RNA, V3, P838; Takamoto K, 2004, J MOL BIOL, V343, P1195, DOI 10.1016/j.jmb.2004.08.080; Takamoto K, 2002, NAT STRUCT BIOL, V9, P928, DOI 10.1038/nsb871; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Travers KJ, 2007, RNA, V13, P1205, DOI 10.1261/rna.566007; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Van Orden A, 2008, BIOPOLYMERS, V89, P1, DOI 10.1002/bip.20826; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Welch L. R., 2003, IEEE INFORM THEORY S, V53; Woodson SA, 2000, CELL MOL LIFE SCI, V57, P796, DOI 10.1007/s000180050042; Xie Z, 2004, P NATL ACAD SCI USA, V101, P534, DOI 10.1073/pnas.2636333100; Young BT, 2002, BIOCHEMISTRY-US, V41, P12271, DOI 10.1021/bi0264869; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013	61	31	31	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19872	19879		10.1074/jbc.M111.235465	http://dx.doi.org/10.1074/jbc.M111.235465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478155	Green Published, hybrid			2022-12-25	WOS:000291027700067
J	Hosoyama, T; Nishijo, K; Prajapati, SI; Li, GH; Keller, C				Hosoyama, Tohru; Nishijo, Koichi; Prajapati, Suresh I.; Li, Guangheng; Keller, Charles			Rb1 Gene Inactivation Expands Satellite Cell and Postnatal Myoblast Pools	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; STEM-CELLS; PROTEIN PHOSPHATASE-1; EXPRESSION; PROLIFERATION; TAUTOMYCETIN; INHIBITOR; PRB; DIFFERENTIATION; SPECIFICATION	Satellite cells are well known as a postnatal skeletal muscle stem cell reservoir that under injury conditions participate in repair. However, mechanisms controlling satellite cell quiescence and activation are the topic of ongoing inquiry by many laboratories. In this study, we investigated whether loss of the cell cycle regulatory factor, pRb, is associated with the re-entry of quiescent satellite cells into replication and subsequent stem cell expansion. By ablation of Rb1 using a Pax7CreER, Rb1 conditional mouse line, satellite cell number was increased 5-fold over 6 months. Furthermore, myoblasts originating from satellite cells lacking Rb1 were also increased 3-fold over 6 months, while terminal differentiation was greatly diminished. Similarly, Pax7CreER, Rb1 mice exhibited muscle fiber hypotrophy in vivo under steady state conditions as well as a delay of muscle regeneration following cardiotoxin-mediated injury. These results suggest that cell cycle re-entry of quiescent satellite cells is accelerated by lack of Rb1, resulting in the expansion of both satellite cells and their progeny in adolescent muscle. Conversely, that sustained Rb1 loss in the satellite cell lineage causes a deficit of muscle fiber formation. However, we also show that pharmacological inhibition of protein phosphatase 1 activity, which will result in pRb inactivation accelerates satellite cell activation and/or expansion in a transient manner. Together, our results raise the possibility that reversible pRb inactivation in satellite cells and inhibition of protein phosphorylation may provide a new therapeutic tool for muscle atrophy by short term expansion of the muscle stem cells and myoblast pool.	[Keller, Charles] Oregon Hlth & Sci Univ, Pediat Canc Biol Program, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR 97239 USA; [Hosoyama, Tohru; Nishijo, Koichi; Prajapati, Suresh I.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	Oregon Health & Science University; University of Texas System; University of Texas Health San Antonio	Keller, C (corresponding author), Oregon Hlth & Sci Univ, Pediat Canc Biol Program, Pape Family Pediat Res Inst, Dept Pediat, 3181 SW Sam Jackson Pk Rd,MC L321, Portland, OR 97239 USA.	keller@ohsu.edu	Hosoyama, Tohru/ABA-2797-2021	Keller, Charles/0000-0003-2505-7487; Hosoyama, Tohru/0000-0002-1825-6923	Doernbecher Children's Hospital Foundation	Doernbecher Children's Hospital Foundation	This study was supported by start-up funds (to C. K.) from the Doernbecher Children's Hospital Foundation.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; CORBEIL HB, 1995, ONCOGENE, V11, P909; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Ho AT, 2004, EMBO J, V23, P460, DOI 10.1038/sj.emboj.7600039; Hosoyama Tohru, 2010, Genes Cancer, V1, P388; Hosoyama T, 2009, DIFFERENTIATION, V77, P350, DOI 10.1016/j.diff.2008.11.001; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; ISHIDA Y, 1992, J CELL PHYSIOL, V150, P484, DOI 10.1002/jcp.1041500308; Jiang Z, 2000, DEV BIOL, V227, P28, DOI 10.1006/dbio.2000.9892; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee JH, 2006, MOL CANCER THER, V5, P3222, DOI 10.1158/1535-7163.MCT-06-0455; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Leshem Y, 2002, J CELL PHYSIOL, V191, P173, DOI 10.1002/jcp.10089; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; Lussac J, 1980, Rev Odontostomatol Midi Fr, V38, P113; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Peschiaroli A, 2002, ONCOGENE, V21, P8114, DOI 10.1038/sj.onc.1206010; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051	45	31	33	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19556	19564		10.1074/jbc.M111.229542	http://dx.doi.org/10.1074/jbc.M111.229542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478154	Green Published, hybrid			2022-12-25	WOS:000291027700039
J	Kitadokoro, K; Nishimura, K; Kamitani, S; Fukui-Miyazaki, A; Toshima, H; Abe, H; Kamata, Y; Sugita-Konishi, Y; Yamamoto, S; Karatani, H; Horiguchi, Y				Kitadokoro, Kengo; Nishimura, Kousuke; Kamitani, Shigeki; Fukui-Miyazaki, Aya; Toshima, Hirono; Abe, Hiroyuki; Kamata, Yoichi; Sugita-Konishi, Yoshiko; Yamamoto, Shigeki; Karatani, Hajime; Horiguchi, Yasuhiko			Crystal Structure of Clostridium perfringens Enterotoxin Displays Features of beta-Pore-forming Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; SITE-DIRECTED MUTAGENESIS; TRANSMEMBRANE PORE; RECEPTOR-BINDING; MEMBRANE-CHANNEL; PROTEIN TOXINS; TIGHT JUNCTION; AEROLYSIN; CLAUDIN-4; REGION	Clostridium perfringens enterotoxin (CPE) is a cause of food poisoning and is considered a pore-forming toxin, which damages target cells by disrupting the selective permeability of the plasma membrane. However, the pore-forming mechanism and the structural characteristics of the pores are not well documented. Here, we present the structure of CPE determined by x-ray crystallography at 2.0A. The overall structure of CPE displays an elongated shape, composed of three distinct domains, I, II, and III. Domain I corresponds to the region that was formerly referred to as C-CPE, which is responsible for binding to the specific receptor claudin. Domains II and III comprise a characteristic module, which resembles those of beta-pore-forming toxins such as aerolysin, C. perfringens epsilon-toxin, and Laetiporus sulfureus hemolytic pore-forming lectin. The module is mainly made up of beta-strands, two of which span its entire length. Domain II and domain III have three short beta-strands each, by which they are distinguished. In addition, domain II has an alpha-helix lying on the beta-strands. The sequence of amino acids composing the alpha-helix and preceding beta-strand demonstrates an alternating pattern of hydrophobic residues that is characteristic of transmembrane domains forming beta-barrel-made pores. These structural features imply that CPE is a beta-pore-forming toxin. We also hypothesize that the transmembrane domain is inserted into the membrane upon the buckling of the two long beta-strands spanning the module, a mechanism analogous to that of the cholesterol-dependent cytolysins.	[Kamitani, Shigeki; Fukui-Miyazaki, Aya; Toshima, Hirono; Abe, Hiroyuki; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Suita, Osaka 5650871, Japan; [Kitadokoro, Kengo; Nishimura, Kousuke; Karatani, Hajime] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Kamata, Yoichi; Sugita-Konishi, Yoshiko] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan; [Yamamoto, Shigeki] Natl Inst Hlth Sci, Div Biomed Food Res, Setagaya Ku, Tokyo 1588501, Japan	Osaka University; Kyoto Institute of Technology; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan	Horiguchi, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	horiguti@biken.osaka-u.ac.jp		Kitadokoro, Kengo/0000-0001-5969-7939; Kamitani, Shigeki/0000-0002-1268-4652	Ministry of Education, Culture, Science, and Technology of Japan; Academia Sinica and National Synchrotron Radiation Research Center (Taiwan, China); Grants-in-Aid for Scientific Research [23121515] Funding Source: KAKEN	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academia Sinica and National Synchrotron Radiation Research Center (Taiwan, China); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Science, and Technology of Japan.; We thank Dr. K. Matoba and Prof. S. Harada of the Kyoto Institute Technology and Dr. E. Yamashita, Dr. Y. Umena, and Prof. A. Nakagawa of SPring-8 BL44XU for help with the X-ray data collection. Diffraction data were collected at the Osaka University beamline BL44XU at SPring-8 equipped with MX225-HE (Rayonix), which is supported financially by the Academia Sinica and National Synchrotron Radiation Research Center (Taiwan, China). We also appreciate the secretarial and technical assistance of T. Suzuki and M. Kobayashi.	Briggs DC, 2010, ACTA CRYSTALLOGR F, V66, P794, DOI 10.1107/S1744309110016507; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dutta S, 2010, J BACTERIOL, V192, P169, DOI 10.1128/JB.00930-09; Ebihara C, 2007, BIOCHEM PHARMACOL, V73, P824, DOI 10.1016/j.bcp.2006.11.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRANUM PE, 1985, J FOOD BIOCHEM, V9, P137, DOI 10.1111/j.1745-4514.1985.tb00344.x; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; HORIGUCHI Y, 1987, INFECT IMMUN, V55, P2912, DOI 10.1128/IAI.55.12.2912-2915.1987; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kokai-Kun JF, 1999, INFECT IMMUN, V67, P5634, DOI 10.1128/IAI.67.11.5634-5641.1999; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2009, J MOL BIOL, V385, P1193, DOI 10.1016/j.jmb.2008.11.039; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Sekiya K, 1996, J BACTERIOL, V178, P6998, DOI 10.1128/jb.178.23.6998-7002.1996; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Smedley JG, 2004, INFECT IMMUN, V72, P6914, DOI 10.1128/IAI.72.12.6914-6923.2004; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x	41	77	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19549	19555		10.1074/jbc.M111.228478	http://dx.doi.org/10.1074/jbc.M111.228478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489981	Green Published, hybrid			2022-12-25	WOS:000291027700038
J	Tian, X; Vroom, C; Ghofrani, HA; Weissmann, N; Bieniek, E; Grimminger, F; Seeger, W; Schermuly, RT; Pullamsetti, SS				Tian, Xia; Vroom, Christina; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Bieniek, Ewa; Grimminger, Friedrich; Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai			Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-A; NUCLEOTIDE PHOSPHODIESTERASE; ARTERIAL-HYPERTENSION; CAMP; PROLIFERATION; INHIBITION; RECEPTOR; PAPAVERINE; ILOPROST	Phosphodiesterases (PDEs) modulate the cellular proliferation involved in the pathophysiology of pulmonary hypertension (PH) by hydrolyzing cAMP and cGMP. The present study was designed to determine whether any of the recently identified PDEs (PDE7-PDE11) contribute to progressive pulmonary vascular remodeling in PH. All in vitro experiments were performed with lung tissue or pulmonary arterial smooth muscle cells (PASMCs) obtained from control rats or monocrotaline (MCT)-induced pulmonary hypertensive (MCT-PH) rats, and we examined the effects of the PDE10 inhibitor papaverine (Pap) and specific small interfering RNA (siRNA). In addition, papaverine was administrated to MCT-induced PH rats from day 21 to day 35 by continuous intravenous infusion to examine the in vivo effects of PDE10A inhibition. We found that PDE10A was predominantly present in the lung vasculature, and the mRNA, protein, and activity levels of PDE10A were all significantly increased in MCT PASMCs compared with control PASMCs. Papaverine and PDE10A siRNA induced an accumulation of intracellular cAMP, activated cAMP response element binding protein and attenuated PASMC proliferation. Intravenous infusion of papaverine in MCT-PH rats resulted in a 40%-50% attenuation of the effects on pulmonary hypertensive hemodynamic parameters and pulmonary vascular remodeling. The present study is the first to demonstrate a central role of PDE10A in progressive pulmonary vascular remodeling, and the results suggest a novel therapeutic approach for the treatment of PH.	[Tian, Xia; Vroom, Christina; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Bieniek, Ewa; Grimminger, Friedrich; Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai] Univ Hosp, Med Clin 2 5, Giessen, Germany; [Seeger, Werner; Schermuly, Ralph Theo; Pullamsetti, Soni Savai] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Max Planck Society	Tian, X (corresponding author), Univ Hosp, Med Clin 2 5, Giessen, Germany.	soni.pullamsetti@mpi-bn.mpg.de	Ghofrani, Hossein Ardeschir/AAD-2856-2022; Ghofrani, Ardeschir/AAD-5293-2020	Ghofrani, Ardeschir/0000-0002-2029-4419; Seeger, Werner/0000-0003-1946-0894; Weissmann, Norbert/0000-0003-2675-3871; Pullamsetti, Soni Savai/0000-0003-0440-8831; Grimminger, Friedrich/0000-0001-8725-6276; Schermuly, Ralph/0000-0002-5167-6970	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 547]; European Commission [LSHM-CT-2005-018725]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 547 "Kardiopulmonales Gefasssystem'', Projekt C6 and by the European Commission under the Sixth Frame work Programme (contract No. LSHM-CT-2005-018725, PULMOTENSION). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI H, 1994, BRIT J PHARMACOL, V111, P489, DOI 10.1111/j.1476-5381.1994.tb14763.x; Baillie GS, 2005, CURR OPIN CELL BIOL, V17, P129, DOI 10.1016/j.ceb.2005.01.003; BAUER AC, 1980, N-S ARCH PHARMACOL, V311, P193, DOI 10.1007/BF00510259; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; Cantin LD, 2007, BIOORG MED CHEM LETT, V17, P2869, DOI 10.1016/j.bmcl.2007.02.061; CHRISTENSEN CW, 1991, CIRCULATION, V83, P294, DOI 10.1161/01.CIR.83.1.294; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dahal BK, 2010, EUR RESPIR J, V36, P808, DOI 10.1183/09031936.00140309; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; Hebb ALO, 2007, CURR OPIN PHARMACOL, V7, P86, DOI 10.1016/j.coph.2006.08.014; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Koyama H, 2001, J CELL PHYSIOL, V186, P1; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacLean MR, 1997, J PHARMACOL EXP THER, V283, P619; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Murray F, 2007, AM J PHYSIOL-LUNG C, V292, pL294, DOI 10.1152/ajplung.00190.2006; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Phillips PG, 2005, AM J PHYSIOL-LUNG C, V288, pL103, DOI 10.1152/ajplung.00095.2004; Pullamsetti S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-128; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Schermuly RT, 2007, CIRCULATION, V115, P2331, DOI 10.1161/CIRCULATIONAHA.106.676809; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Stenmark KR, 1997, ANNU REV PHYSIOL, V59, P89, DOI 10.1146/annurev.physiol.59.1.89; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; Torres-Flores V, 2008, J ANDROL, V29, P549, DOI 10.2164/jandrol.107.004614; Vadiveloo PK, 1997, ATHEROSCLEROSIS, V133, P61, DOI 10.1016/S0021-9150(97)00116-0; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	46	30	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18136	10.1371/journal.pone.0018136	http://dx.doi.org/10.1371/journal.pone.0018136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494592	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100004
J	Yeh, CM; Liu, YC; Chang, CJ; Lai, SL; Hsiao, CD; Lee, SJ				Yeh, Chen-Min; Liu, Yi-Ching; Chang, Ching-Jen; Lai, Shih-Lei; Hsiao, Chung-Der; Lee, Shyh-Jye			Ptenb Mediates Gastrulation Cell Movements via Cdc42/AKT1 in Zebrafish	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PHOSPHOINOSITIDE 3-KINASE; EMBRYONIC-DEVELOPMENT; PHOSPHATASE-ACTIVITY; GERMLINE MUTATIONS; FILAMENTOUS ACTIN; CANCER SYNDROME; MYOSIN-II; WILD-TYPE; NO TAIL	Phosphatidylinositol 3-kinase (PI3 kinase) mediates gastrulation cell migration in zebrafish via its regulation of PIP(2)/PIP(3) balance. Although PI3 kinase counter enzyme PTEN has also been reported to be essential for gastrulation, its role in zebrafish gastrulation has been controversial due to the lack of gastrulation defects in pten-null mutants. To clarify this issue, we knocked down a pten isoform, ptenb by using anti-sense morpholino oligos (MOs) in zebrafish embryos and found that ptenb MOs inhibit convergent extension by affecting cell motility and protrusion during gastrulation. The ptenb MO-induced convergence defect could be rescued by a PI3-kinase inhibitor, LY294002 and by overexpressing dominant negative Cdc42. Overexpression of human constitutively active akt1 showed similar convergent extension defects in zebrafish embryos. We also observed a clear enhancement of actin polymerization in ptenb morphants under cofocal microscopy and in actin polymerization assay. These results suggest that Ptenb by antagonizing PI3 kinase and its downstream Akt1 and Cdc42 to regulate actin polymerization that is critical for proper cell motility and migration control during gastrulation in zebrafish.	[Yeh, Chen-Min; Liu, Yi-Ching; Chang, Ching-Jen; Lai, Shih-Lei; Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Yeh, Chen-Min; Liu, Yi-Ching; Lee, Shyh-Jye] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; Chung Yuan Christian University	Yeh, CM (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	jefflee@ntu.edu.tw	Lai, Ben/AAD-1628-2019; Hsiao, Chung-Der/W-4535-2019; Lee, Shyh-Jye/C-6092-2008; Lai, Shih-Lei/O-1562-2018	Hsiao, Chung-Der/0000-0002-6398-8672; Lee, Shyh-Jye/0000-0001-8452-9152; Lai, Shih-Lei/0000-0002-1409-4701	National Science Council, Taiwan, Republic of China [98-2311-B-002-006-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan, Republic of China, grant number 98-2311-B-002-006-MY3 (URL:http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Becker KA, 1999, J CELL SCI, V112, P97; Becker KA, 1996, MOL REPROD DEV, V43, P536; Besson A, 1999, EUR J BIOCHEM, V263, P605, DOI 10.1046/j.1432-1327.1999.00542.x; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cantrell DA, 2001, J CELL SCI, V114, P1439; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Croushore JA, 2005, DEV DYNAM, V234, P911, DOI 10.1002/dvdy.20576; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Fu CT, 2010, BLOOD, V115, P4715, DOI 10.1182/blood-2009-11-255778; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOWARD TH, 1985, CELL MOTIL CYTOSKEL, V5, P545, DOI 10.1002/cm.970050609; Huang H, 1999, DEVELOPMENT, V126, P5365; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Ro H, 2004, MOL CELLS, V17, P373; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Solnica-Krezel L, 2002, RES PRO CEL, V40, P136; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; THISSE C, 1993, DEVELOPMENT, V119, P1203; Ueno S, 2006, DEV BIOL, V297, P274, DOI 10.1016/j.ydbio.2006.06.001; WARGA RM, 1990, DEVELOPMENT, V108, P569; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Zhou XP, 2003, AM J HUM GENET, V73, P1191, DOI 10.1086/379382; Zhou XP, 2002, HUM MOL GENET, V11, P445, DOI 10.1093/hmg/11.4.445; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	50	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18702	10.1371/journal.pone.0018702	http://dx.doi.org/10.1371/journal.pone.0018702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494560	Green Submitted, gold, Green Published			2022-12-25	WOS:000289354100031
J	Jayakrishnan, B; Hoke, DE; Langendorf, CG; Buckle, AM; Rowley, MJ				Jayakrishnan, Bindu; Hoke, David E.; Langendorf, Christopher G.; Buckle, Ashley M.; Rowley, Merrill J.			An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; STIFF-MAN SYNDROME; MONOCLONAL-ANTIBODIES; SACCHAROMYCES-CEREVISIAE; EPITOPE; AUTOANTIGEN; MELLITUS; ASSOCIATION; EXPRESSION; ISOFORM	Background: Autoantibodies to GAD65 (anti-GAD65) are present in the sera of 70-80% of patients with type 1 diabetes (T1D), but antibodies to the structurally similar 67 kDa isoform GAD67 are rare. Antibodies to GAD67 may represent a cross-reactive population of anti-GAD65, but this has not been formally tested. Methodology/Principal Findings: In this study we examined the frequency, levels and affinity of anti-GAD67 in diabetes sera that contained anti-GAD65, and compared the specificity of GAD65 and GAD67 reactivity. Anti-GAD65 and anti-GAD67 were measured by radioimmunoprecipitation (RIP) using (125)I labeled recombinant GAD65 and GAD67. For each antibody population, the specificity of the binding was measured by incubation with 100-fold excess of unlabeled GAD in homologous and heterologous inhibition assays, and the affinity of binding with GAD65 and GAD67 was measured in selected sera. Sera were also tested for reactivity to GAD65 and GAD67 by immunoblotting. Of the 85 sera that contained antibodies to GAD65, 28 contained anti-GAD67 measured by RIP. Inhibition with unlabeled GAD65 substantially or completely reduced antibody reactivity with both (125)I GAD65 and with (125)I GAD67. In contrast, unlabeled GAD67 reduced autoantibody reactivity with (125)I GAD67 but not with (125)I GAD65. Both populations of antibodies were of high affinity (>10(10) l/mol). Conclusions: Our findings show that autoantibodies to GAD67 represent a minor population of anti-GAD65 that are reactive with a cross-reactive epitope found also on GAD67. Experimental results confirm that GAD65 is the major autoantigen in T1D, and that GAD67 per se has very low immunogenicity. We discuss our findings in light of the known similarities between the structures of the GAD isoforms, in particular the location of a minor cross-reactive epitope that could be induced by epitope spreading.	[Jayakrishnan, Bindu; Hoke, David E.; Langendorf, Christopher G.; Buckle, Ashley M.; Rowley, Merrill J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University	Jayakrishnan, B (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	ashley.buckle@monash.edu; Merrill.rowley@monash.edu	Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Langendorf, Christopher/0000-0002-9049-5283	National Health and Medical Research Council (NHMRC); Diabetes Australia Research Trust	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by grants from the National Health and Medical Research Council (NHMRC) and the Diabetes Australia Research Trust. AMB is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bukhari TAMA, 2002, CLIN EXP IMMUNOL, V130, P131, DOI 10.1046/j.1365-2249.2002.01960.x; Arafat Y, 2009, MOL IMMUNOL, V47, P493, DOI 10.1016/j.molimm.2009.08.022; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Battaglioli G, 2003, J NEUROCHEM, V86, P879, DOI 10.1046/j.1471-4159.2003.01910.x; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; CHANG YC, 1988, J NEUROSCI, V8, P2123; Fenalti G, 2008, DIABETES, V57, P1293, DOI 10.2337/db07-1461; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fenalti G, 2010, AUTOIMMUN REV, V9, P148, DOI 10.1016/j.autrev.2009.05.003; Fenalti G, 2008, J AUTOIMMUN, V31, P228, DOI 10.1016/j.jaut.2008.04.013; GOTTLIEB DI, 1986, P NATL ACAD SCI USA, V83, P8808, DOI 10.1073/pnas.83.22.8808; HAGOPIAN WA, 1993, DIABETES, V42, P631, DOI 10.2337/diabetes.42.4.631; KIM J, 1994, J EXP MED, V180, P595, DOI 10.1084/jem.180.2.595; Law RHP, 1998, J BIOTECHNOL, V61, P57, DOI 10.1016/S0168-1656(98)00013-3; Lernmark A, 1996, J INTERN MED, V240, P259, DOI 10.1046/j.1365-2796.1996.27859000.x; Mayr A, 2007, DIABETES, V56, P1527, DOI 10.2337/db06-1715; Mueller Patricia W, 2002, Diabetes Technol Ther, V4, P397, DOI 10.1089/152091502760098537; O'Connor KH, 2006, J AUTOIMMUN, V26, P172, DOI 10.1016/j.jaut.2006.02.001; Papakonstantinou T, 2000, ENZYME MICROB TECH, V26, P645, DOI 10.1016/S0141-0229(00)00154-X; PETERSEN JS, 1994, DIABETES, V43, P459, DOI 10.2337/diabetes.43.3.459; Piquer S, 2005, CLIN IMMUNOL, V117, P31, DOI 10.1016/j.clim.2005.06.009; Pittock SJ, 2006, MAYO CLIN PROC, V81, P1207, DOI 10.4065/81.9.1207; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; Saiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; SEISSLER J, 1994, AUTOIMMUNITY, V19, P231, DOI 10.3109/08916939409071348; SOLIMENA M, 1991, TRENDS NEUROSCI, V14, P452, DOI 10.1016/0166-2236(91)90044-U; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Tuomi T, 1999, DIABETES, V48, P150, DOI 10.2337/diabetes.48.1.150; VELLOSO LA, 1993, J CLIN INVEST, V91, P2084, DOI 10.1172/JCI116431; Vianello M, 2006, EXP NEUROL, V202, P514, DOI 10.1016/j.expneurol.2006.06.012; Ziegler B, 1996, ACTA DIABETOL, V33, P225	35	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18411	10.1371/journal.pone.0018411	http://dx.doi.org/10.1371/journal.pone.0018411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494613	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800014
J	Kiebala, M; Maggirwar, SB				Kiebala, Michelle; Maggirwar, Sanjay B.			Ibudilast, a Pharmacologic Phosphodiesterase Inhibitor, Prevents Human Immunodeficiency Virus-1 Tat-Mediated Activation of Microglial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN FETAL MICROGLIA; HIV-1 TAT; TNF-ALPHA; CYTOKINE PRODUCTION; COGNITIVE IMPAIRMENT; AIDS PATIENTS; T-CELLS	Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorders ( HAND) occur, in part, due to the inflammatory response to viral proteins, such as the HIV-1 transactivator of transcription ( Tat), in the central nervous system (CNS). Given the need for novel adjunctive therapies for HAND, we hypothesized that ibudilast would inhibit Tat-induced excess production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF alpha) in microglial cells. Ibudilast is a non-selective cyclic AMP phosphodiesterase inhibitor that has recently shown promise as a treatment for neuropathic pain via its ability to attenuate glial cell activation. Accordingly, here we demonstrate that pre-treatment of both human and mouse microglial cells with increasing doses of ibudilast inhibited Tat-induced synthesis of TNF alpha by microglial cells in a manner dependent on serine/threonine protein phosphatase activity. Ibudilast had no effect on Tat-induced p38 MAP kinase activation, and blockade of adenosine A(2A) receptor activation did not reverse ibudilast's inhibition of Tat-induced TNF alpha production. Interestingly, ibudilast reduced Tat-mediated transcription of TNF alpha, via modulation of nuclear factor-kappa B (NF-kappa B) signaling, as shown by transcriptional activity of NF-kappa B and analysis of inhibitor of kappa B alpha (I kappa B alpha) stability. Together, our findings shed light on the mechanism of ibudilast's inhibition of Tat-induced TNFa production in microglial cells and may implicate ibudilast as a potential novel adjunctive therapy for the management of HAND.	[Kiebala, Michelle; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Kiebala, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu			National Institutes of Health [RO1 NS054578, RO1 NS066801, T32 AI49105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following National Institutes of Health grants: RO1 NS054578 and RO1 NS066801 (to SBM) and T32 AI49105 (to MK) (URL: http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL JB, 1995, AIDS, V9, P1137, DOI 10.1097/00002030-199510000-00004; Archibald SL, 2004, ARCH NEUROL-CHICAGO, V61, P369, DOI 10.1001/archneur.61.3.369; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Barkhof F, 2010, NEUROLOGY, V74, P1033, DOI 10.1212/WNL.0b013e3181d7d651; Beardsley PM, 2010, EUR J PHARMACOL, V637, P102, DOI 10.1016/j.ejphar.2010.04.010; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; CARDENAS V, 2009, J NEUROVIROL, P1; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; Cherry CL, 2003, J CLIN VIROL, V26, P195, DOI 10.1016/S1386-6532(02)00118-X; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Coimbra R, 2005, J TRAUMA, V59, P575, DOI 10.1097/01.ta.0000177787.48608.b6; Costantini TW, 2010, IMMUNOPHARM IMMUNOT, V32, P74, DOI [10.3109/08923970903143965, 10.1080/08923970903143965]; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Deree J, 2008, CLINICS, V63, P321, DOI 10.1590/S1807-59322008000300006; DEZUBE BJ, 1995, J INFECT DIS, V171, P1628, DOI 10.1093/infdis/171.6.1628; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fine SM, 1999, J NEUROIMMUNOL, V95, P55, DOI 10.1016/S0165-5728(98)00267-7; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Fotheringham J, 2004, VIROLOGY, V327, P186, DOI 10.1016/j.virol.2004.07.007; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Heijligenberg R, 1998, AIDS RES HUM RETROV, V14, P299, DOI 10.1089/aid.1998.14.299; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; ISRAEL A, 1995, TRENDS GENET, V11, P203, DOI 10.1016/S0168-9525(00)89045-9; Ji Q, 2006, OPHTHALMOLOGICA, V220, P217, DOI 10.1159/000093074; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Kovacs AD, 2004, EUR J NEUROSCI, V20, P345, DOI 10.1111/j.1460-9568.2004.03493.x; Kreth S, 2010, SHOCK, V34, P10, DOI 10.1097/SHK.0b013e3181cdc3e2; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Langford TD, 2003, BRAIN PATHOL, V13, P195; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; Lysandropoulos AP, 2010, CURR OPIN NEUROL, V23, P226, DOI 10.1097/WCO.0b013e3283398c96; MAJOR EO, 2009, ANN REV MED; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McWhinney CD, 1996, EUR J PHARMACOL, V310, P209, DOI 10.1016/0014-2999(96)00272-5; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Mengozzi M, 1999, BLOOD, V93, P1851, DOI 10.1182/blood.V93.6.1851.406k12_1851_1857; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; Navarro J, 1998, J VIROL, V72, P4712, DOI 10.1128/JVI.72.6.4712-4720.1998; NEUNER P, 1994, IMMUNOLOGY, V83, P262; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Oh YT, 2010, NEUROSCI LETT, V474, P148, DOI 10.1016/j.neulet.2010.03.026; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rumbaugh JA, 2006, CURR PHARM DESIGN, V12, P1023, DOI 10.2174/138161206776055877; Rumbaugh Jeffrey A, 2008, Futur HIV Ther, V2, P271, DOI 10.2217/17469600.2.3.271; Saha RN, 2003, J NEUROCHEM, V86, P1057, DOI 10.1046/j.1471-4159.2003.01942.x; Sandoval J, 2009, J PHARMACOL EXP THER, V331, P609, DOI 10.1124/jpet.109.157537; Schifitto G, 2007, NEUROLOGY, V69, P1314, DOI 10.1212/01.wnl.0000268487.78753.0f; Schifitto G, 2009, NEUROLOGY, V73, P1975, DOI 10.1212/WNL.0b013e3181c51a48; Schifitto G, 2007, AIDS, V21, P1877, DOI 10.1097/QAD.0b013e32813384e8; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui ZY, 2006, EUR J NEUROSCI, V23, P2623, DOI 10.1111/j.1460-9568.2006.04813.x; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; Sun WJ, 2010, J BIOL CHEM, V285, P21341, DOI 10.1074/jbc.M110.104224; Suzumura A, 1999, BRAIN RES, V837, P203, DOI 10.1016/S0006-8993(99)01666-2; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; Turchan-Cholewo J, 2009, J NEUROCHEM, V108, P202, DOI 10.1111/j.1471-4159.2008.05756.x; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vidal F, 2010, AIDS REV, V12, P15; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yasui K, 2000, J LEUKOCYTE BIOL, V67, P529, DOI 10.1002/jlb.67.4.529; Yasui K, 2009, CLIN EXP ALLERGY, V39, P1857, DOI 10.1111/j.1365-2222.2009.03365.x; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1177/135245859900500210; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZEN K, 1994, EXP CELL RES, V215, P172, DOI 10.1006/excr.1994.1329	96	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18633	10.1371/journal.pone.0018633	http://dx.doi.org/10.1371/journal.pone.0018633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494611	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800032
J	Dick, CA; Buenrostro, J; Butler, T; Carlson, ML; Kliebenstein, DJ; Whittall, JB				Dick, Cynthia A.; Buenrostro, Jason; Butler, Timothy; Carlson, Matthew L.; Kliebenstein, Daniel J.; Whittall, Justen B.			Arctic Mustard Flower Color Polymorphism Controlled by Petal-Specific Downregulation at the Threshold of the Anthocyanin Biosynthetic Pathway	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; EVOLUTION; TRANSCRIPTION; POLLINATION; TEMPERATURE; UV; ACCUMULATION; PIGMENTATION	Intra- and interspecific variation in flower color is a hallmark of angiosperm diversity. The evolutionary forces underlying the variety of flower colors can be nearly as diverse as the colors themselves. In addition to pollinator preferences, non-pollinator agents of selection can have a major influence on the evolution of flower color polymorphisms, especially when the pigments in question are also expressed in vegetative tissues. In such cases, identifying the target(s) of selection starts with determining the biochemical and molecular basis for the flower color variation and examining any pleiotropic effects manifested in vegetative tissues. Herein, we describe a widespread purple-white flower color polymorphism in the mustard Parrya nudicaulis spanning Alaska. The frequency of white-flowered individuals increases with increasing growing-season temperature, consistent with the role of anthocyanin pigments in stress tolerance. White petals fail to produce the stress responsive flavonoid intermediates in the anthocyanin biosynthetic pathway (ABP), suggesting an early pathway blockage. Petal cDNA sequences did not reveal blockages in any of the eight enzyme-coding genes in white-flowered individuals, nor any color differentiating SNPs. A qRT-PCR analysis of white petals identified a 24-fold reduction in chalcone synthase (CHS) at the threshold of the ABP, but no change in CHS expression in leaves and sepals. This arctic species has avoided the deleterious effects associated with the loss of flavonoid intermediates in vegetative tissues by decoupling CHS expression in petals and leaves, yet the correlation of flower color and climate suggests that the loss of flavonoids in the petals alone may affect the tolerance of white-flowered individuals to colder environments.	[Dick, Cynthia A.; Buenrostro, Jason; Butler, Timothy; Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Carlson, Matthew L.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Santa Clara University; University of Alaska System; University of Alaska Anchorage; University of California System; University of California Davis	Dick, CA (corresponding author), Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.	jwhittall@scu.edu		Kliebenstein, Daniel/0000-0001-5759-3175; Butler, Timothy/0000-0001-5803-1035	NSF IPY; Santa Clara University Department of Biology Technology; DeNardo Senior Prize; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NSF IPY(National Science Foundation (NSF)); Santa Clara University Department of Biology Technology; DeNardo Senior Prize; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by NSF IPY (to JBW & MLC), Santa Clara University Department of Biology & Technology Funds (JBW), and the DeNardo Senior Prize (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, DOI [10.4135/9781412961288.n178, DOI 10.4135/9781412961288.N178]; Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; BLISS L. C., 1962, ARCTIC, V15, P117; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Choi S, 2009, PLANT SCI, V176, P678, DOI 10.1016/j.plantsci.2009.02.010; Coberly LC, 2008, EVOLUTION, V62, P1076, DOI 10.1111/j.1558-5646.2008.00355.x; Coberly LC, 2003, MOL ECOL, V12, P1113, DOI 10.1046/j.1365-294X.2003.01786.x; Durbin ML, 2003, MOL PHYLOGENET EVOL, V29, P507, DOI 10.1016/S1055-7903(03)00196-9; Durbin ML, 2000, PLANT MOL BIOL, V42, P79, DOI 10.1023/A:1006375904820; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Faegri K., 1979, PRINCIPLES POLLINATI; Faktor O, 1996, PLANT MOL BIOL, V32, P849, DOI 10.1007/BF00020482; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fineblum WL, 1997, ECOLOGY, V78, P1646, DOI 10.1890/0012-9658(1997)078[1646:DFPGAI]2.0.CO;2; GRANT V, 1993, P NATL ACAD SCI USA, V90, P990, DOI 10.1073/pnas.90.3.990; Habu Y, 1998, PLANT J, V16, P371, DOI 10.1046/j.1365-313x.1998.00308.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Irwin RE, 2003, ECOLOGY, V84, P1733, DOI 10.1890/0012-9658(2003)084[1733:TROHIT]2.0.CO;2; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; KEVAN PG, 1972, J ECOL, V60, P831, DOI 10.2307/2258569; KJELLBERG B, 1982, OECOLOGIA, V54, P10, DOI 10.1007/BF00541101; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Koch MA, 2001, MOL BIOL EVOL, V18, P1882, DOI 10.1093/oxfordjournals.molbev.a003729; Lankinen A, 2009, J GENET, V88, P205, DOI 10.1007/s12041-009-0029-7; LEYVA A, 1995, PLANT PHYSIOL, V108, P39, DOI 10.1104/pp.108.1.39; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majetic CJ, 2008, ANN BOT-LONDON, V102, P911, DOI 10.1093/aob/mcn181; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Merken HM, 2000, J AGR FOOD CHEM, V48, P577, DOI 10.1021/jf990872o; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; MOLGAARD P, 1989, ARCTIC ALPINE RES, V21, P83, DOI 10.2307/1551519; MOSQUIN T, 1966, EVOLUTION CANADAS FL, P41; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Rozen S, 2000, Methods Mol Biol, V132, P365; SABLOWSKI RWM, 1994, EMBO J, V13, P128, DOI 10.1002/j.1460-2075.1994.tb06242.x; Saito R, 2006, PLANT SCI, V170, P828, DOI 10.1016/j.plantsci.2005.12.003; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Simms EL, 1996, EVOLUTION, V50, P957, DOI 10.1111/j.1558-5646.1996.tb03908.x; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Streisfeld MA, 2009, MOL BIOL EVOL, V26, P433, DOI 10.1093/molbev/msn268; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERMEER IM, 1990, PLANT MOL BIOL, V15, P95, DOI 10.1007/BF00017727; WETTBERG EV, 2010, EVOLUTIONARY ECOLOGY, V12, P457; Whittall J, 2009, NEW PHYTOL, V182, P5, DOI 10.1111/j.1469-8137.2009.02796.x; Whittall JB, 2006, MOL ECOL, V15, P4645, DOI 10.1111/j.1365-294X.2006.03114.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; WINKELSHIRLEY B, 2004, PLANT PHYSIOL, V127, P1399; Wright S, 1943, GENETICS, V28, P139	57	57	63	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18230	10.1371/journal.pone.0018230	http://dx.doi.org/10.1371/journal.pone.0018230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490971	gold, Green Published			2022-12-25	WOS:000289238700005
J	Unsworth, AJ; Smith, H; Gissen, P; Watson, SP; Pears, CJ				Unsworth, Amanda J.; Smith, Holly; Gissen, Paul; Watson, Steve P.; Pears, Catherine J.			Submaximal Inhibition of Protein Kinase C Restores ADP-induced Dense Granule Secretion in Platelets in the Presence of Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED HUMAN PLATELETS; INTACT HUMAN PLATELETS; THROMBUS FORMATION; INTEGRIN ALPHA(IIB)BETA(3); FUNCTIONAL-RESPONSES; FIBRINOGEN RECEPTOR; PHOSPHOLIPASE A(2); GLYCOPROTEIN-VI; ISOFORM 4B; PKC-THETA	Protein kinase C (PKC) is a family of serine/threonine kinases that play isoform-specific inhibitory and stimulatory roles in platelet activation. We show here that the pan-PKC inhibitor Ro31-8220 can be used to dissect these events following platelet activation by ADP. Submaximal concentrations of Ro31-8220 potentiated aggregation and dense granule secretion to ADP in plasma anticoagulated with citrate, in D-Phe-Pro-Arg-chloromethyl ketone-anticoagulated plasma, which has physiological levels of Ca2+, and in washed platelets. Potentiation was retained on inhibition of cyclooxygenase and was associated with an increase in intracellular Ca2+. Potentiation of aggregation and secretion was abolished by a maximally effective concentration of Ro31-8220, consistent with a critical role of PKC in secretion. ADP-induced secretion was potentiated in the presence of an inhibitor of PKC beta but not in the presence of available inhibitors of other PKC isoforms in human and mouse platelets. ADP-induced secretion was also potentiated in mouse platelets deficient in PKC beta but not PKC theta. These results demonstrate that partial blockade of PKC potentiates aggregation and dense granule secretion by ADP in association with increased Ca2+. This provides a molecular explanation for the inability of ADP to induce secretion in plasma in the presence of physiological Ca2+ concentrations, and it reveals a novel role for PKC in inhibiting platelet activation by ADP in vivo. These results also demonstrate isoform-specific inhibitory effects of PKC in platelets.	[Unsworth, Amanda J.; Pears, Catherine J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Watson, Steve P.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Inst Biomed Res,Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Oxford; University of Birmingham	Pears, CJ (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	catherine.pears@bioch.ox.ac.uk	Gissen, Paul/A-4352-2010; Unsworth, Amanda/ABG-9141-2020; Watson, Stephen P/Q-6292-2016; Unsworth, Amanda J/Q-7742-2017	Gissen, Paul/0000-0002-9712-6122; Unsworth, Amanda/0000-0003-3809-5984; Watson, Stephen P/0000-0002-7846-7423; Pears, Catherine/0000-0003-1290-8326	British Heart Foundation [FS/08/010/24527]; Medical Research Council	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Grant number FS/08/010/24527.; Supported by a British Heart Foundation Ph.D. studentship.; Supported by a Medical Research Council Ph.D. studentship.	Atkinson BT, 2001, EUR J BIOCHEM, V268, P5242, DOI 10.1046/j.0014-2956.2001.02448.x; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Bynagari YS, 2009, J BIOL CHEM, V284, P13413, DOI 10.1074/jbc.M808970200; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Cattaneo M, 2002, BLOOD, V99, P3868, DOI 10.1182/blood-2002-01-0313; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; Flaumenhaft R, 2003, ARTERIOSCL THROM VAS, V23, P1152, DOI 10.1161/01.ATV.0000075965.88456.48; Gachet C, 1997, THROMB HAEMOSTASIS, V78, P271; Getz TM, 2011, J THROMB HAEMOST, V9, P608, DOI 10.1111/j.1538-7836.2011.04192.x; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; GRABAREK J, 1992, J BIOL CHEM, V267, P10011; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003277; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Harper MT, 2010, J THROMB HAEMOST, V8, P454, DOI 10.1111/j.1538-7836.2009.03722.x; Harper MT, 2010, CELL CALCIUM, V48, P333, DOI 10.1016/j.ceca.2010.10.006; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Harper MT, 2009, BLOOD, V114, P489, DOI 10.1182/blood-2009-03-208454; Hers I, 1998, ARTERIOSCL THROM VAS, V18, P404, DOI 10.1161/01.ATV.18.3.404; Iorio P, 1996, FEBS LETT, V381, P244, DOI 10.1016/0014-5793(96)00117-2; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; KING WG, 1989, J BIOL CHEM, V264, P6070; KNIGHT DE, 1980, THROMB RES, V20, P437, DOI 10.1016/0049-3848(80)90282-0; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mills DCB, 1996, THROMB HAEMOSTASIS, V76, P835; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; MUSTARD JF, 1975, AM J PHYSIOL, V228, P1757, DOI 10.1152/ajplegacy.1975.228.6.1757; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nucciarelli F, 1999, FEBS LETT, V450, P39, DOI 10.1016/S0014-5793(99)00436-6; PACKHAM MA, 1989, THROMB HAEMOSTASIS, V62, P968; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Pears CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003793; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; Polgar J, 2003, J BIOL CHEM, V278, P44369, DOI 10.1074/jbc.M307864200; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Pulcinelli FM, 1999, FEBS LETT, V460, P37, DOI 10.1016/S0014-5793(99)01313-7; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; RYU SH, 1990, J BIOL CHEM, V265, P17941; Sachs UJH, 2007, CIRC RES, V100, P979, DOI 10.1161/01.RES.0000261936.85776.5f; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Tabuchi A, 2003, J BIOL CHEM, V278, P26374, DOI 10.1074/jbc.M212407200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; Wan TC, 2003, THROMB HAEMOSTASIS, V89, P122; WANG F, 1993, BIOCHEM BIOPH RES CO, V191, P240, DOI 10.1006/bbrc.1993.1208; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	64	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21073	21082		10.1074/jbc.M110.187138	http://dx.doi.org/10.1074/jbc.M110.187138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21489985	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000291464700006
J	El-Osta, MA; Idkowiak-Baldys, J; Hannun, YA				El-Osta, Mohamad A.; Idkowiak-Baldys, Jola; Hannun, Yusuf A.			Delayed Phosphorylation of Classical Protein Kinase C (PKC) Substrates Requires PKC Internalization and Formation of the Pericentrion in a Phospholipase D (PLD)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; RECYCLING ENDOSOMES; INTRACELLULAR TRAFFICKING; MEDIATED ENDOCYTOSIS; MEMBRANE TRAFFICKING; PERINUCLEAR REGION; DEPENDENT MANNER; EPITHELIAL-CELLS; PLASMA-MEMBRANE; DOWN-REGULATION	It was previously demonstrated that sustained activation (30-60 min) of protein kinase C (PKC) results in translocation of PKC alpha and beta II to the pericentrion, a dynamic subset of the recycling compartment whose formation is dependent on PKC and phospholipase D (PLD). Here we investigated whether the formation of the pericentrion modulates the ability of PKC to phosphorylate substrates, especially if it reduces substrate phosphorylation by sequestering PKC. Surprisingly, using an antibody that detects phosphosubstrates of classical PKCs, the results showed that the majority of PKC phosphosubstrates are phosphorylated with delayed kinetics, correlating with the time frame of PKC translocation to the pericentrion. Substrate phosphorylation was blocked by PLD inhibitors and was not observed in response to activation of a PKC beta II mutant (F663D) that is defective in interaction with PLD and in internalization. Phosphorylation was also inhibited by blocking clathrin-dependent endocytosis, demonstrating a requirement for endocytosis for the PKC-dependent major phosphorylation effects. Serotonin receptor activation by serotonin showed a similar response to phorbol 12-myristate 13-acetate, implicating a potential role of delayed kinetics in G protein-coupled receptor signaling. Evaluation of candidate substrates revealed that the phosphorylation of the PKC substrate p70S6K kinase behaved in a similar manner. Gradient-based fractionation revealed that the majority of these PKC substrates reside within the pericentrion-enriched fractions and not in the plasma membrane. Finally, proteomic analysis of the pericentrion-enriched fractions revealed several proteins as known PKC substrates and/or proteins involved in endocytic trafficking. These results reveal an important role for PKC internalization and for the pericentrion as key determinants/amplifiers of PKC action.	[El-Osta, Mohamad A.; Idkowiak-Baldys, Jola; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [HL-43707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL-43707.	Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barwe SP, 2006, CELL MOL BIOL, V52, P41, DOI 10.1170/T759; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; BORGHINI I, 1994, P NATL ACAD SCI USA, V91, P6211, DOI 10.1073/pnas.91.13.6211; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; DAVIS RJ, 1987, J BIOL CHEM, V262, P16041; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Du ZP, 2003, AM J PHYSIOL-RENAL, V284, pF688, DOI 10.1152/ajprenal.00261.2002; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Hu TH, 2005, BIOCHEM BIOPH RES CO, V333, P750, DOI 10.1016/j.bbrc.2005.05.184; Hu TH, 2004, J BIOL CHEM, V279, P35702, DOI 10.1074/jbc.M402372200; Huang RQ, 2007, BIOCHEMISTRY-US, V46, P11484, DOI 10.1021/bi701093j; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Law BK, 2000, J BIOL CHEM, V275, P38261, DOI 10.1074/jbc.M005545200; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Matafora V, 2001, J CELL SCI, V114, P4509; MAY WS, 1984, P NATL ACAD SCI-BIOL, V81, P2016, DOI 10.1073/pnas.81.7.2016; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249; Padovano V, 2009, AM J PHYSIOL-CELL PH, V297, pC835, DOI 10.1152/ajpcell.00212.2009; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; PEARSON RB, 1991, METHOD ENZYMOL A, V200, P62; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schoijet AC, 2008, J BIOL CHEM, V283, P31541, DOI 10.1074/jbc.M801367200; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; TOKER A, 1994, J BIOL CHEM, V269, P32358; Tunaitis V., 2005, BIOLOGIJA, V1, P24; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; White D, 2007, J EXP BIOL, V210, P4053, DOI 10.1242/jeb.007013; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x	57	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19340	19353		10.1074/jbc.M110.152330	http://dx.doi.org/10.1074/jbc.M110.152330			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478146	hybrid, Green Published			2022-12-25	WOS:000291027700016
J	Mao, P; Hever, MP; Niemaszyk, LM; Haghkerdar, JM; Yanco, EG; Desai, D; Beyrouthy, MJ; Kerley-Hamilton, JS; Freemantle, SJ; Spinella, MJ				Mao, Pingping; Hever, Mary P.; Niemaszyk, Lynne M.; Haghkerdar, Jessica M.; Yanco, Esty G.; Desai, Damayanti; Beyrouthy, Maroun J.; Kerley-Hamilton, Joanna S.; Freemantle, Sarah J.; Spinella, Michael J.			Serine/Threonine Kinase 17A Is a Novel p53 Target Gene and Modulator of Cisplatin Toxicity and Reactive Oxygen Species in Testicular Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; DNA-DAMAGE; DAP-KINASE; P53-INDUCIBLE REGULATOR; APOPTOTIC CHECKPOINT; GENOTOXIC STRESS; DEATH; DRAK2; TRANSCRIPTION; RESISTANCE	Testicular cancer is highly curable with cisplatin-based therapy, and testicular cancer-derived human embryonal carcinoma (EC) cells undergo a p53-dominant transcriptional response to cisplatin. In this study, we have discovered that a poorly characterized member of the death-associated protein family of serine/threonine kinases, STK17A (also called DRAK1), is a novel p53 target gene. Cisplatin-mediated induction of STK17A in the EC cell line NT2/D1 was prevented with p53 siRNA. Furthermore, STK17A was induced with cisplatin in HCT116 and MCF10A cells but to a much lesser extent in isogenic p53-suppressed cells. A functional p53 response element that binds endogenous p53 in a cisplatin-dependent manner was identified 5 kb upstream of the first coding exon of STK17A. STK17A is not present in the mouse genome, but the closely related gene STK17B is induced with cisplatin in mouse NIH3T3 cells, although this induction is p53-independent. Interestingly, in human cells containing both STK17A and STK17B, only STK17A is induced with cisplatin. Knockdown of STK17A conferred resistance to cisplatin-induced growth suppression and apoptotic cell death in EC cells. This was associated with the up-regulation of detoxifying and antioxidant genes, including metallothioneins MT1H, MT1M, and MT1X that have previously been implicated in cisplatin resistance. In addition, knockdown of STK17A resulted in decreased cellular reactive oxygen species, whereas STK17A overexpression increased reactive oxygen species. In summary, we have identified STK17A as a novel direct target of p53 and a modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.	[Spinella, Michael J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Spinella, Michael J.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Spinella, MJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, 7650 Remsen, Hanover, NH 03755 USA.	michael.spinella@dartmouth.edu	Spinella, Michael/B-7210-2014		National Institutes of Health [R21-CA124817]; United States Department of Defense [PR093629]; Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE [R21CA124817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-CA124817. This work was also supported by United States Department of Defense Investigator-Initiated Research Award PR093629 and a Prouty development award from the Norris Cotton Cancer Center.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Beyrouthy MJ, 2009, CANCER RES, V69, P9360, DOI 10.1158/0008-5472.CAN-09-1490; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Boswell SA, 2007, J BIOL CHEM, V282, P4850, DOI 10.1074/jbc.M610532200; Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Curtin JC, 2001, ONCOGENE, V20, P2559, DOI 10.1038/sj.onc.1204370; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Fitzgerald J, 2004, TRENDS GENET, V20, P408, DOI 10.1016/j.tig.2004.07.002; Gatzka M, 2009, J IMMUNOL, V183, P285, DOI 10.4049/jimmunol.0803530; Giuliano CJ, 2006, CURR CANCER THER REV, V2, P255, DOI 10.2174/157339406777934681; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Harrison B, 2008, J BIOL CHEM, V283, P9999, DOI 10.1074/jbc.M706040200; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Houldsworth J, 2006, J CLIN ONCOL, V24, P5512, DOI 10.1200/JCO.2006.08.4285; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kerley-Hamilton JS, 2007, BBA-GENE STRUCT EXPR, V1769, P209, DOI 10.1016/j.bbaexp.2007.02.002; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Knipp M, 2009, CURR MED CHEM, V16, P522, DOI 10.2174/092986709787458452; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuwahara H, 2006, BIOL PHARM BULL, V29, P225, DOI 10.1248/bpb.29.225; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Lin Y, 2010, FEBS J, V277, P48, DOI 10.1111/j.1742-4658.2009.07411.x; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; Michie AM, 2010, FEBS J, V277, P74, DOI 10.1111/j.1742-4658.2009.07414.x; PENG HQ, 1993, CANCER RES, V53, P3574; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Spierings DCJ, 2003, J PATHOL, V200, P137, DOI 10.1002/path.1373; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tang H, 2007, ANTI-CANCER DRUG, V18, P633, DOI 10.1097/CAD.0b013e3280200428; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wittig R, 2002, CANCER RES, V62, P6698; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	52	34	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19381	19391		10.1074/jbc.M111.218040	http://dx.doi.org/10.1074/jbc.M111.218040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489989	hybrid, Green Published			2022-12-25	WOS:000291027700020
J	Budinger, GRS; McKell, JL; Urich, D; Foiles, N; Weiss, I; Chiarella, SE; Gonzalez, A; Soberanes, S; Ghio, AJ; Nigdelioglu, R; Mutlu, EA; Radigan, KA; Green, D; Kwaan, HC; Mutlu, GM				Budinger, G. R. Scott; McKell, Joanne L.; Urich, Daniela; Foiles, Nancy; Weiss, Ivy; Chiarella, Sergio E.; Gonzalez, Angel; Soberanes, Saul; Ghio, Andrew J.; Nigdelioglu, Recep; Mutlu, Ece A.; Radigan, Kathryn A.; Green, David; Kwaan, Hau C.; Mutlu, Goekhan M.			Particulate Matter-Induced Lung Inflammation Increases Systemic Levels of PAI-1 and Activates Coagulation Through Distinct Mechanisms	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DIESEL-EXHAUST INHALATION; FACTOR PATHWAY INHIBITOR; AIR-POLLUTION; PLASMINOGEN-ACTIVATOR; MYOCARDIAL-INFARCTION; TISSUE FACTOR; EXPOSURE; PARTICLES; FINE	Background: Exposure of human populations to ambient particulate matter (PM) air pollution significantly contributes to the mortality attributable to ischemic cardiovascular events. We reported that mice treated with intratracheally instilled PM develop a prothrombotic state that requires the release of IL-6 by alveolar macrophages. We sought to determine whether exposure of mice to PM increases the levels of PAI-1, a major regulator of thrombolysis, via a similar or distinct mechanism. Methods and Principal Findings: Adult, male C57BL/6 and IL-6 knock out (IL-6(-/-)) mice were exposed to either concentrated ambient PM less than 2.5 mu m (CAPs) or filtered air 8 hours daily for 3 days or were exposed to either urban particulate matter or PBS via intratracheal instillation and examined 24 hours later. Exposure to CAPs or urban PM resulted in the IL-6 dependent activation of coagulation in the lung and systemically. PAI-1 mRNA and protein levels were higher in the lung and adipose tissue of mice treated with CAPs or PM compared with filtered air or PBS controls. The increase in PAI-1 was similar in wild-type and IL-6(-/-) mice but was absent in mice treated with etanercept, a TNF-alpha inhibitor. Treatment with etanercept did not prevent the PM-induced tendency toward thrombus formation. Conclusions: Mice exposed to inhaled PM exhibited a TNF-alpha-dependent increase in PAI-1 and an IL-6-dependent activation of coagulation. These results suggest that multiple mechanisms link PM-induced lung inflammation with the development of a prothrombotic state.	[Budinger, G. R. Scott; McKell, Joanne L.; Urich, Daniela; Chiarella, Sergio E.; Gonzalez, Angel; Soberanes, Saul; Nigdelioglu, Recep; Radigan, Kathryn A.; Mutlu, Goekhan M.] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Foiles, Nancy; Weiss, Ivy; Green, David; Kwaan, Hau C.] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ghio, Andrew J.] US EPA, Res Triangle Pk, NC 27711 USA; [Mutlu, Ece A.] Rush Univ, Sect Gastroenterol & Nutr, Coll Med, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; United States Environmental Protection Agency; Rush University	Budinger, GRS (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	g-mutlu@northwestern.edu		Chiarella, Sergio/0000-0002-0445-4929	NIH [ES015024, ES013995, P01HL071643]; Northwestern University Clinical and Translational Sciences Institute (NUCATS) [UL1 RR025741]; NMH; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092963, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995, R01ES015024] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Clinical and Translational Sciences Institute (NUCATS); NMH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	Sources of funding: NIH ES015024 (GMM), ES013995 (GRSB) and P01HL071643 (GMM and GRSB) and the Northwestern University Clinical and Translational Sciences Institute (NUCATS) CTI Pilot Award (GMM) (UL1 RR025741) and NMH Dixon Young Investigator Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; BASTARACHE J, 2007, THORAX; Bastarache JA, 2008, AM J PHYSIOL-LUNG C, V294, pL874, DOI 10.1152/ajplung.00372.2007; Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC; BONZINI M, 2009, J THROMB HAEMOST; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; De Taeye BM, 2006, J BIOL CHEM, V281, P32796, DOI 10.1074/jbc.M606214200; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P984, DOI 10.1160/TH08-08-0524; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Ghio AJ, 2001, AM J RESP CRIT CARE, V164, P704, DOI 10.1164/ajrccm.164.4.2011089; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558; Hou BD, 2004, J BIOL CHEM, V279, P18127, DOI 10.1074/jbc.M310438200; Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8; Iochmann S, 1999, THROMB RES, V94, P165, DOI 10.1016/S0049-3848(98)00209-6; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Ljungman P, 2009, ENVIRON HEALTH PERSP, V117, P1373, DOI 10.1289/ehp.0800370; Maciejczyk P, 2005, INHAL TOXICOL, V17, P189, DOI 10.1080/08958370590912743; Matute-Bello G, 2001, AM J RESP CRIT CARE, V163, P234, DOI 10.1164/ajrccm.163.1.9909034; MEADE TW, 1993, LANCET, V342, P1076, DOI 10.1016/0140-6736(93)92062-X; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Mutlu GM, 2006, AM J RESP CELL MOL, V34, P670, DOI 10.1165/rcmb.2005-0329OC; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Peters A, 2001, CIRCULATION, V103, P2810; Plomgaard P, 2005, J APPL PHYSIOL, V98, P2019, DOI 10.1152/japplphysiol.01220.2004; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Renckens R, 2005, J THROMB HAEMOST, V3, P1018, DOI 10.1111/j.1538-7836.2005.01311.x; Rothwarf D.M., 1999, SCI STKE 1999; Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Shoenfelt J, 2009, J LEUKOCYTE BIOL, V86, P303, DOI 10.1189/jlb.1008587; SIOUTAS C, 1995, ENVIRON HEALTH PERSP, V103, P172, DOI 10.2307/3432274; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2008, INHAL TOXICOL, V20, P127, DOI [10.1080/08958370701821482, 10.1080/08958370701821482 ]; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Urich D, 2009, FASEB J, V23, P2055, DOI 10.1096/fj.08-114546; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JCI200419569; Yan C, 2002, J BIOL CHEM, V277, P10967, DOI 10.1074/jbc.M109986200	47	77	77	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18525	10.1371/journal.pone.0018525	http://dx.doi.org/10.1371/journal.pone.0018525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494547	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100016
J	Xu, JA; Wang, MZ; Gao, XX; Hu, BA; Du, YN; Zhou, JK; Tian, XM; Huang, XX				Xu, Juan; Wang, Meizhi; Gao, Xinxing; Hu, Bian; Du, Yinan; Zhou, Jiankui; Tian, Xuemei; Huang, Xingxu			Separase Phosphosite Mutation Leads to Genome Instability and Primordial Germ Cell Depletion during Oogenesis	PLOS ONE			English	Article							SISTER-CHROMATID SEPARATION; HUMAN FEMALE MEIOSIS; CHROMOSOMAL STABILITY; ANAPHASE TRANSITION; SPINDLE CHECKPOINT; CYCLE PROGRESSION; HUMAN ANEUPLOIDY; BUDDING YEAST; MICE LACKING; METAPHASE	To ensure equal chromosome segregation and the stability of the genome during cell division, Separase is strictly regulated primarily by Securin binding and inhibitory phosphorylation. By generating a mouse model that contained a mutation to the inhibitory phosphosite of Separase, we demonstrated that mice of both sexes are infertile. We showed that Separase deregulation leads to chromosome mis-segregation, genome instability, and eventually apoptosis of primordial germ cells (PGCs) during embryonic oogenesis. Although the PGCs of mutant male mice were completely depleted, a population of PGCs from mutant females survived Separase deregulation. The surviving PGCs completed oogenesis but produced deficient initial follicles. These results indicate a sexual dimorphism effect on PGCs from Separase deregulation, which may be correlated with a gender-specific discrepancy of Securin. Our results reveal that Separase phospho-regulation is critical for genome stability in oogenesis. Furthermore, we provided the first evidence of a pre-zygotic mitotic chromosome segregation error resulting from Separase deregulation, whose sex-specific differences may be a reason for the sexual dimorphism of aneuploidy in gametogenesis.	[Xu, Juan; Gao, Xinxing; Hu, Bian; Du, Yinan; Zhou, Jiankui; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Peoples R China; [Wang, Meizhi] So Med Univ, Dept Anat Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Tian, Xuemei] S China Normal Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Nanjing University; Southern Medical University - China; South China Normal University	Xu, JA (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Peoples R China.	xmtian05@yahoo.com; huangxingxu@yahoo.com	Du, Yinan/GPK-0826-2022	Du, Yinan/0000-0002-7678-7546; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [30871429]; 973 program [2010CB945101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This work is supported by the National Natural Science Foundation of China (30871429) and the 973 program (2010CB945101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Clift D, 2009, GENE DEV, V23, P766, DOI 10.1101/gad.507509; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang XX, 2008, PLOS BIOL, V6, P52, DOI 10.1371/journal.pbio.0060015; Huang XX, 2009, MOL CELL BIOL, V29, P1498, DOI 10.1128/MCB.01778-08; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; JONES KT, 2007, HUMAN REPROD, P1; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Mailhes JB, 2008, ENVIRON MOL MUTAGEN, V49, P642, DOI 10.1002/em.20412; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Pacchierotti F, 2007, ENVIRON RES, V104, P46, DOI 10.1016/j.envres.2006.12.001; Pellestor F, 2002, HUM REPROD, V17, P2134, DOI 10.1093/humrep/17.8.2134; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; UZAWA S, 1990, CELL, V62, P913, DOI 10.1016/0092-8674(90)90266-H; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Wolstenholme J, 2000, CHROMOSOMA, V109, P435, DOI 10.1007/s004120000088; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zhao GQ, 2002, DEV CELL, V2, P537, DOI 10.1016/S1534-5807(02)00173-9; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	50	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18763	10.1371/journal.pone.0018763	http://dx.doi.org/10.1371/journal.pone.0018763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494564	gold, Green Published, Green Submitted			2022-12-25	WOS:000289354100039
J	Deplagne, C; Peuchant, E; Moranvillier, I; Dubus, P; Dabernat, S				Deplagne, Camille; Peuchant, Evelyne; Moranvillier, Isabelle; Dubus, Pierre; Dabernat, Sandrine			The Anti-Metastatic nm23-1 Gene Is Needed for the Final Step of Mammary Duct Maturation of the Mouse Nipple	PLOS ONE			English	Article							NM23/NUCLEOSIDE DIPHOSPHATE-KINASE; METASTASIS SUPPRESSOR; REPRODUCTIVE-CYCLE; ESCHERICHIA-COLI; TUMOR-SUPPRESSOR; KNOCKOUT MICE; EXPRESSION; APOPTOSIS; MIGRATION; GLAND	Nm23/NDP kinases are multifunctional enzymes involved in the general homeostasis of triphosphate nucleosides. Numerous studies have shown that NDPKs also serve as regulatory factors of various cell activities, not always connected to nucleotide phosphorylation. In particular, the nme-1 gene, encoding the NM23-1/NDPKA protein, has been reported as a metastasis suppressor gene. This activity was validated in hepatocellular tumors induced in nm23-1 deficient mice. Yet, data describing the primary physiological functions of nm23-1/NDPKA is still scarce. We have characterized in depth the phenotype of nm23-1 deletion in the mammary gland in mice carrying whole body nm23-M1 invalidation. We also asked why the nm23-M1(-/-) mutant females displayed severe nursing disability. We found that the growth retardation of mutant virgin glands was due to reduced proliferation and apoptosis of the epithelial cells within the terminal end buds. The balance of pro/anti-apoptotic factors was impaired in comparison with wild type glands. In the lactating glands, the reduced proliferation rate persisted, but the apoptotic factors were unchanged. However, those defects did not seem to affect the gland maturation since the glands lacking nm23-1/NDPKA appeared morphologically normal. Thorough examination of all the functional aspects of the mammary glands revealed that lack of nm23-1/NDPKA does not impact the production or the ejection of milk in the lumen of lobuloalveolae. Interestingly, an epithelial plug was found to obstruct the extremity of the unique lactiferous duct delivering the milk out of the nipple. These cells, normally disappearing after lactation takes place, persisted in the mutant nipples. This work provides a rare instance of nm23-1/NDPKA physiological functions in the mammary glands and reveals its implication as a modulator factor of proliferation and apoptosis in this tissue.	[Deplagne, Camille; Peuchant, Evelyne; Moranvillier, Isabelle; Dabernat, Sandrine] INSERM, Unite U1035, Bordeaux, France; [Dubus, Pierre] Univ Segalen Bordeaux, Equipe Histol & Pathol Mol Tumeurs 2406, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Deplagne, C (corresponding author), INSERM, Unite U1035, Bordeaux, France.	sandrine.dabernat@u-bordeaux2.fr		Dubus, Pierre/0000-0003-1803-4711	French Ligue contre le cancer	French Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the French Ligue contre le cancer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Dabernat S, 2003, J BIOENERG BIOMEMBR, V35, P19, DOI 10.1023/A:1023561821551; Boissan M, 2005, JNCI-J NATL CANCER I, V97, P836, DOI 10.1093/jnci/dji143; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; CHOUDHURI T, CANC BIOL THER, V9; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fournier HN, 2003, J BIOENERG BIOMEMBR, V35, P81, DOI 10.1023/A:1023450008347; FUKUCHI T, 1993, GENE, V129, P141; Green KA, 2004, CELL MOL LIFE SCI, V61, P1867, DOI 10.1007/s00018-004-3366-y; HAMA H, 1991, GENE, V105, P31, DOI 10.1016/0378-1119(91)90510-I; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; HOWLETT AR, 1994, J NATL CANCER I, V86, P1838, DOI 10.1093/jnci/86.24.1838; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Hynes NE, 1997, J MAMMARY GLAND BIOL, V2, P19, DOI 10.1023/A:1026317428542; Jin L, 2009, LIFE SCI, V84, P458, DOI 10.1016/j.lfs.2009.01.010; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kimura T, 1998, HUM REPROD, V13, P2645, DOI 10.1093/humrep/13.9.2645; Kobayashi T, 2005, DEV DYNAM, V233, P794, DOI 10.1002/dvdy.20406; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; Mahler B, 2004, CELLS TISSUES ORGANS, V176, P169, DOI 10.1159/000077033; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Masse K, 2002, GENE, V296, P87, DOI 10.1016/S0378-1119(02)00836-3; Miller JH, 2002, GENETICS, V162, P5; Murakami M, 2008, CANCER BIOL THER, V7, P677, DOI 10.4161/cbt.7.5.5665; Murakami M, 2008, INT J CANCER, V123, P500, DOI 10.1002/ijc.23568; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Postel EH, 2009, DEV DYNAM, V238, P775, DOI 10.1002/dvdy.21887; Steeg P S, 1991, Basic Life Sci, V57, P355; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Steeg PS, 2004, JNCI-J NATL CANCER I, V96, DOI 10.1093/jnci/djh107; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Timmons L, 2000, J BIOENERG BIOMEMBR, V32, P293, DOI 10.1023/A:1005545214937; Toyoshima Y, 1998, EXP ANIM TOKYO, V47, P29, DOI 10.1538/expanim.47.29; Toyoshima Y, 1998, J VET MED SCI, V60, P405, DOI 10.1292/jvms.60.405; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18645	10.1371/journal.pone.0018645	http://dx.doi.org/10.1371/journal.pone.0018645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490937	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700032
J	Loizou, L; Andersen, KG; Betz, AG				Loizou, Louiza; Andersen, Kristian G.; Betz, Alexander G.			Foxp3 Interacts with c-Rel to Mediate NF-kappa B Repression	PLOS ONE			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; CD28 RESPONSE ELEMENT; ROR-GAMMA-T; IMMUNE-RESPONSES; NUCLEAR-FACTOR; TARGET GENES; EXPRESSION; ACTIVATION; PROTEINS	Expression of the lineage-specific DNA-binding factor Foxp3 controls the development and function of naturally occurring regulatory T cells. Foxp3 has been shown to interact with a multitude of transcriptional regulators including NFAT, NF-kappa B (p65), Runx1 and ROR gamma t, as well as the histone modification enzymes TIP60, HDAC7 and HDAC9. The sum of these interactions is believed to cause the change in the transcriptional program of regulatory T cells. Here we show that Foxp3 directly or as part of a multimeric complex engages with the NF-kappa B component c-Rel. We demonstrate that the N-terminal region of Foxp3 is required for the binding of c-Rel, but not NFAT. Conversely, deletion of the forkhead domain causes a loss of interaction with NFAT, but not c-Rel. Our findings are of particular interest, as c-Rel is crucial for the induction of Foxp3 in regulatory T cells during thymic development, but has to be repressed in mature regulatory T cells to maintain their suppressive phenotype.	[Loizou, Louiza; Andersen, Kristian G.; Betz, Alexander G.] MRC Lab Mol Biol, Cambridge, England; [Andersen, Kristian G.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Andersen, Kristian G.] Broad Inst, Cambridge, MA USA	MRC Laboratory Molecular Biology; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Loizou, L (corresponding author), MRC Lab Mol Biol, Cambridge, England.	betz@mrc-lmb.cam.ac.uk	Andersen, Kristian/D-5006-2009; Betz, Alexander/GQQ-2221-2022	Andersen, Kristian/0000-0001-6431-5982; 	Medical Research Council; Carlsberg Foundation; MRC [MC_U105184296] Funding Source: UKRI; Medical Research Council [MC_U105184296] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carlsberg Foundation(Carlsberg Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All work was performed at the Laboratory of Molecular Biology and funded by the Medical Research Council (http://www.mrc.ac.uk/). KGA is the recipient of a fellowship from the Carlsberg Foundation (http://www.carlsbergfondet.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KG, 2008, PLOS BIOL, V6, P2401, DOI 10.1371/journal.pbio.0060276; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Butscher WG, 1998, J BIOL CHEM, V273, P552, DOI 10.1074/jbc.273.1.552; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li B, 2006, IMMUNOL REV, V212, P99, DOI 10.1111/j.0105-2896.2006.00405.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18670	10.1371/journal.pone.0018670	http://dx.doi.org/10.1371/journal.pone.0018670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490927	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700037
J	Swiss, VA; Nguyen, T; Dugas, J; Ibrahim, A; Barres, B; Androulakis, IP; Casaccia, P				Swiss, Victoria A.; Nguyen, Tung; Dugas, Jason; Ibrahim, Adiljan; Barres, Ben; Androulakis, Ioannis P.; Casaccia, Patrizia			Identification of a Gene Regulatory Network Necessary for the Initiation of Oligodendrocyte Differentiation	PLOS ONE			English	Article							HISTONE DEACETYLASE ACTIVITY; FUNCTIONAL GENOMIC ANALYSIS; TRANSCRIPTION FACTOR; CLUSTERING METHODS; MESSENGER-RNA; EXPRESSION; MYELIN; PROTEINS; REMYELINATION; BIOLOGY	Differentiation of oligodendrocyte progenitor cells (OPCs) into mature oligodendrocytes requires extensive changes in gene expression, which are partly mediated by post-translational modifications of nucleosomal histones. An essential modification for oligodendrocyte differentiation is the removal of acetyl groups from lysine residues which is catalyzed by histone deacetylases (HDACs). The transcriptional targets of HDAC activity within OPCs however, have remained elusive and have been identified in this study by interrogating the oligodendrocyte transcriptome. Using a novel algorithm that allows clustering of gene transcripts according to expression kinetics and expression levels, we defined major waves of coregulated genes. The initial overall decrease in gene expression was followed by the up-regulation of genes involved in lipid metabolism and myelination. Functional annotation of the down-regulated gene clusters identified transcripts involved in cell cycle regulation, transcription, and RNA processing. To define whether these genes were the targets of HDAC activity, we cultured rat OPCs in the presence of trichostatin A (TSA), an HDAC inhibitor previously shown to inhibit oligodendrocyte differentiation. By overlaying the defined oligodendrocyte transcriptome with the list of 'TSA sensitive' genes, we determined that a high percentage of 'TSA sensitive' genes are part of a normal program of oligodendrocyte differentiation. TSA treatment increased the expression of genes whose down-regulation occurs very early after induction of OPC differentiation, but did not affect the expression of genes with a slower kinetic. Among the increased 'TSA sensitive' genes we detected several transcription factors including Id2, Egr1, and Sox11, whose down-regulation is critical for OPC differentiation. Thus, HDAC target genes include clusters of co-regulated genes involved in transcriptional repression. These results support a de-repression model of oligodendrocyte lineage progression that relies on the concurrent down-regulation of several inhibitors of differentiation.	[Swiss, Victoria A.; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci & Genet, New York, NY 10029 USA; [Swiss, Victoria A.; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Genom, New York, NY USA; [Nguyen, Tung] Rutgers State Univ, BioMAPS Inst Quantitat Biol, Piscataway, NJ USA; [Nguyen, Tung; Androulakis, Ioannis P.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Nguyen, Tung; Androulakis, Ioannis P.] Rutgers State Univ, Dept Chem Biochem Engn, Piscataway, NJ USA; [Dugas, Jason; Ibrahim, Adiljan; Barres, Ben] Stanford Univ, Sch Med, Dept Neurosci, Stanford, CA 94305 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Stanford University	Swiss, VA (corresponding author), Mt Sinai Sch Med, Dept Neurosci & Genet, New York, NY 10029 USA.	patrizia.casaccia@mssm.edu			NIH [R01-NS42925-8]; ARRA [NS42925-S1]; Myelin Repair Foundation; National Multiple Sclerosis Society [RG-4059/A8]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925, R37NS042925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA; Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by Grant NIH R01-NS42925-8 and ARRA funds NS42925-S1 (to P. C.). J.C.D. and B. A. B. were supported by the Myelin Repair Foundation and the National Multiple Sclerosis Society, grant RG-4059/A8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett HA, 2003, J NEUROSCI, V23, P9824; Baranzini SE, 2005, J IMMUNOL, V174, P7412, DOI 10.4049/jimmunol.174.11.7412; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Belacel N, 2006, OMICS, V10, P507, DOI 10.1089/omi.2006.10.507; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carson JH, 2008, BBA-GENE REGUL MECH, V1779, P453, DOI 10.1016/j.bbagrm.2008.04.002; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fields RD, 2008, NEUROSCIENTIST, V14, P540, DOI 10.1177/1073858408320294; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Gielen E, 2006, GLIA, V54, P499, DOI 10.1002/glia.20406; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Golan N, 2008, GLIA, V56, P1176, DOI 10.1002/glia.20688; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kondo T, 2000, DEVELOPMENT, V127, P2989; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Larocca JN, 2002, NEUROCHEM RES, V27, P1313, DOI 10.1023/A:1021667515030; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu AX, 2006, EMBO J, V25, P4833, DOI 10.1038/sj.emboj.7601352; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Lyssiotis CA, 2007, P NATL ACAD SCI USA, V104, P14982, DOI 10.1073/pnas.0707044104; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nave KA, 2010, NEURON, V65, P577, DOI 10.1016/j.neuron.2010.02.026; Nguyen L, 2006, MENT RETARD DEV D R, V12, P85, DOI 10.1002/mrdd.20103; Nguyen TT, 2009, OMICS, V13, P219, DOI 10.1089/omi.2008.0074; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potzner MR, 2007, MOL CELL BIOL, V27, P5316, DOI 10.1128/MCB.00339-07; Raff M, 2007, COLD SPRING HARB SYM, V72, P431, DOI 10.1101/sqb.2007.72.007; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Sock E, 1997, J NEUROCHEM, V68, P1911; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Taylor CM, 2004, P NATL ACAD SCI USA, V101, P4643, DOI 10.1073/pnas.0400922101; Tur G, 2010, CELL MOL LIFE SCI, V67, P4065, DOI 10.1007/s00018-010-0426-3; Vanrobaeys F, 2005, J PROTEOME RES, V4, P2283, DOI 10.1021/pr050205c; WANG B, 2001, ARTERIOSCLER THROMB, V30, P536; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	64	75	75	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18088	10.1371/journal.pone.0018088	http://dx.doi.org/10.1371/journal.pone.0018088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490970	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700004
J	Cortez, BD; Quassollo, G; Caceres, A; Machado-Santelli, GM				Cortez, Beatriz de Araujo; Quassollo, Gonzalo; Caceres, Alfredo; Machado-Santelli, Glaucia Maria			The Fate of Chrysotile-Induced Multipolar Mitosis and Aneuploid Population in Cultured Lung Cancer Cells	PLOS ONE			English	Article							PLEURAL MESOTHELIAL CELLS; CENTROSOME AMPLIFICATION; MITOTIC CHECKPOINT; DNA-DAMAGE; CHROMOSOME INSTABILITY; MAMMALIAN-CELLS; ASBESTOS FIBERS; STRAND BREAKS; IN-VITRO; INDUCTION	Chrysotile is one of the six types of asbestos, and it is the only one that can still be commercialized in many countries. Exposure to other types of asbestos has been associated with serious diseases, such as lung carcinomas and pleural mesotheliomas. The association of chrysotile exposure with disease is controversial. However, in vitro studies show the mutagenic potential of chrysotile, which can induce DNA and cell damage. The present work aimed to analyze alterations in lung small cell carcinoma cultures after 48 h of chrysotile exposure, followed by 2, 4 and 8 days of recovery in fiber-free culture medium. Some alterations, such as aneuploid cell formation, increased number of cells in G2/M phase and cells in multipolar mitosis were observed even after 8 days of recovery. The presence of chrysotile fibers in the cell cultures was detected and cell morphology was observed by laser scanning confocal microscopy. After 4 and 8 days of recovery, only a few chrysotile fragments were present in some cells, and the cellular morphology was similar to that of control cells. Cells transfected with the GFP-tagged alpha-tubulin plasmid were treated with chrysotile for 24 or 48 h and cells in multipolar mitosis were observed by time-lapse microscopy. Fates of these cells were established: retention in metaphase, cell death, progression through M phase generating more than two daughter cells or cell fusion during telophase or cytokinesis. Some of them were related to the formation of aneuploid cells and cells with abnormal number of centrosomes.	[Cortez, Beatriz de Araujo; Machado-Santelli, Glaucia Maria] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil; [Cortez, Beatriz de Araujo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508 Sao Paulo, Brazil; [Quassollo, Gonzalo; Caceres, Alfredo] INIMEC CONICET, Inst Invest Med Mercedes & Martin Ferreyra, Cordoba, Argentina	Universidade de Sao Paulo; Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cortez, BD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil.	glaucia.usp@gmail.com	Machado-Santelli, Glaucia M/C-6775-2013; Cortez, Beatriz Araujo/G-6858-2015	Machado-Santelli, Glaucia M/0000-0003-2046-9693; Quassollo, Gonzalo/0000-0003-3298-9688	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil; Agencia Cordoba Ciencia; MINCyT, Argentina [PICT 815, PME]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Agencia Cordoba Ciencia; MINCyT, Argentina	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil and by grants from Agencia Cordoba Ciencia and MINCyT (PICT 815 and PME), Argentina. BAC was a fellow from Red de MacroUniversidades de America Latina y el Caribe, during her stay in Argentina. GQ is a doctoral fellow of FONCyT (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2009, J CELL SCI, V122, P1990, DOI 10.1242/jcs.039115; Bernstein DM, 2005, INHAL TOXICOL, V17, P1, DOI 10.1080/08958370590885663; BONALDO MD, 1991, CELL BIOL INT REP, V15, P229; Borojerdi JP, 2009, MUTAT RES-FUND MOL M, V665, P67, DOI 10.1016/j.mrfmmm.2009.03.004; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Brody A R, 1989, IARC Sci Publ, P93; Brody AR, 1997, ENVIRON HEALTH PERSP, V105, P1165, DOI 10.2307/3433527; Burmeister B, 2004, MUTAT RES-GEN TOX EN, V558, P81, DOI 10.1016/j.mrgentox.2003.11.003; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cassiola F, 2005, COLLOID SURFACE B, V41, P277, DOI 10.1016/j.colsurfb.2004.12.006; Cortez BA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-181; Dopp E, 1997, MUTAT RES-FUND MOL M, V377, P77, DOI 10.1016/S0027-5107(97)00062-6; Dopp E, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-9; Duesberg P, 2006, CONTRIB MICROBIOL, V13, P16, DOI 10.1159/000092963; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hede K, 2005, J NATL CANCER I, V97, P87, DOI 10.1093/jnci/97.2.87; Jensen CG, 1999, CELL BIOL INT, V23, P829, DOI 10.1006/cbir.1999.0479; Kawamura K, 2004, CANCER RES, V64, P4800, DOI 10.1158/0008-5472.CAN-03-3908; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Levresse V, 2000, MUTAGENESIS, V15, P239, DOI 10.1093/mutage/15.3.239; Levresse V, 1997, AM J RESP CELL MOL, V17, P660, DOI 10.1165/ajrcmb.17.6.2854; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Liu ST, 2003, CURR TOP DEV BIOL, V58, P27, DOI 10.1016/S0070-2153(03)58002-4; MACHADOSANTELLI GM, 1994, ANAL CELL PATHOL, V7, P321; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; MOSSMAN BT, 1990, SCIENCE, V247, P294, DOI 10.1126/science.2153315; Okayasu R, 1999, CANCER RES, V59, P298; PATHAK S, 2006, ANEUPLOIDY STEM CELL, P49; QUINLAN TR, 1995, AM J PATHOL, V147, P728; Sargent LM, 2010, NANOTOXICOLOGY, V4, P396, DOI 10.3109/17435390.2010.500444; Suzuki K, 1996, CARCINOGENESIS, V17, P661, DOI 10.1093/carcin/17.4.661; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Xu A, 1999, CANCER RES, V59, P5922; Xu A, 2007, ENVIRON HEALTH PERSP, V115, P87, DOI 10.1289/ehp.9425	38	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18600	10.1371/journal.pone.0018600	http://dx.doi.org/10.1371/journal.pone.0018600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483691	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300032
J	Kaneda, K; Kasahara, H; Matsui, R; Katoh, T; Mizukami, H; Ozawa, K; Watanabe, D; Isa, T				Kaneda, Katsuyuki; Kasahara, Hironori; Matsui, Ryosuke; Katoh, Tomoko; Mizukami, Hiroaki; Ozawa, Keiya; Watanabe, Dai; Isa, Tadashi			Selective Optical Control of Synaptic Transmission in the Subcortical Visual Pathway by Activation of Viral Vector-Expressed Halorhodopsin	PLOS ONE			English	Article							CAT SUPERIOR COLLICULUS; RECEPTIVE-FIELD PROPERTIES; PHOTORECEPTOR DEGENERATION; ECTOPIC EXPRESSION; NEURAL CIRCUITRY; STRIATE CORTEX; RESPONSES; MOUSE; INTERROGATION; ORGANIZATION	The superficial layer of the superior colliculus (sSC) receives visual inputs via two different pathways: from the retina and the primary visual cortex. However, the functional significance of each input for the operation of the sSC circuit remains to be identified. As a first step toward understanding the functional role of each of these inputs, we developed an optogenetic method to specifically suppress the synaptic transmission in the retino-tectal pathway. We introduced enhanced halorhodopsin (eNpHR), a yellow light-sensitive, membrane-targeting chloride pump, into mouse retinal ganglion cells (RGCs) by intravitreously injecting an adeno-associated virus serotype-2 vector carrying the CMV-eNpHR-EYFP construct. Several weeks after the injection, whole-cell recordings made from sSC neurons in slice preparations revealed that yellow laser illumination of the eNpHR-expressing retino-tectal axons, putatively synapsing onto the recorded cells, effectively inhibited EPSCs evoked by electrical stimulation of the optic nerve layer. We also showed that sSC spike activities elicited by visual stimulation were significantly reduced by laser illumination of the sSC in anesthetized mice. These results indicate that photo-activation of eNpHR expressed in RGC axons enables selective blockade of retino-tectal synaptic transmission. The method established here can most likely be applied to a variety of brain regions for studying the function of individual inputs to these regions.	[Kaneda, Katsuyuki; Katoh, Tomoko; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Kaneda, Katsuyuki; Isa, Tadashi] Grad Univ Adv Studies, Hayama, Japan; [Kasahara, Hironori; Matsui, Ryosuke; Watanabe, Dai] Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto, Japan; [Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Kyoto University; Kyoto University	Kaneda, K (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido, Japan.	kkaneda@pharm.hokudai.ac.jp	Kaneda, Katsuyuki/A-8443-2012; Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22700419] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Strategic Research Program of Brain Sciences (SRPBS) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; Bereshpolova Y, 2006, J NEUROSCI, V26, P2250, DOI 10.1523/JNEUROSCI.4402-05.2006; BERSON DM, 1988, J NEUROPHYSIOL, V60, P1861, DOI 10.1152/jn.1988.60.6.1861; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; BINNS KE, 1994, EUR J NEUROSCI, V6, P161, DOI 10.1111/j.1460-9568.1994.tb00257.x; Binns KE, 1996, VISUAL NEUROSCI, V13, P683, DOI 10.1017/S0952523800008579; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; HUANG XG, 1993, J NEUROPHYSIOL, V70, P723, DOI 10.1152/jn.1993.70.2.723; Isa T, 1998, J NEUROSCI, V18, P8496; Kaneda K, 2008, J NEUROSCI, V28, P816, DOI 10.1523/JNEUROSCI.4666-07.2008; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Martin KRG, 2002, METHODS, V28, P267, DOI 10.1016/S1046-2023(02)00232-3; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; MCILWAIN JT, 1973, J NEUROPHYSIOL, V36, P690, DOI 10.1152/jn.1973.36.4.690; METIN C, 1988, EXP BRAIN RES, V69, P594; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; RHOADES RW, 1978, J COMP NEUROL, V180, P617, DOI 10.1002/cne.901800312; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	39	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18452	10.1371/journal.pone.0018452	http://dx.doi.org/10.1371/journal.pone.0018452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483674	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300022
J	Amaral, AJ; Ferretti, L; Megens, HJ; Crooijmans, RPMA; Nie, HS; Ramos-Onsins, SE; Perez-Enciso, M; Schook, LB; Groenen, MAM				Amaral, Andreia J.; Ferretti, Luca; Megens, Hendrik-Jan; Crooijmans, Richard P. M. A.; Nie, Haisheng; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel; Schook, Lawrence B.; Groenen, Martien A. M.			Genome-Wide Footprints of Pig Domestication and Selection Revealed through Massive Parallel Sequencing of Pooled DNA	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RECENT POSITIVE SELECTION; CLASS-I REGION; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; BREEDS; GENERATION; SIGNATURES; CHIMPANZEE; MUTATION	Background: Artificial selection has caused rapid evolution in domesticated species. The identification of selection footprints across domesticated genomes can contribute to uncover the genetic basis of phenotypic diversity. Methodology/Main Findings: Genome wide footprints of pig domestication and selection were identified using massive parallel sequencing of pooled reduced representation libraries (RRL) representing,2% of the genome from wild boar and four domestic pig breeds (Large White, Landrace, Duroc and Pietrain) which have been under strong selection for muscle development, growth, behavior and coat color. Using specifically developed statistical methods that account for DNA pooling, low mean sequencing depth, and sequencing errors, we provide genome-wide estimates of nucleotide diversity and genetic differentiation in pig. Widespread signals suggestive of positive and balancing selection were found and the strongest signals were observed in Pietrain, one of the breeds most intensively selected for muscle development. Most signals were population-specific but affected genomic regions which harbored genes for common biological categories including coat color, brain development, muscle development, growth, metabolism, olfaction and immunity. Genetic differentiation in regions harboring genes related to muscle development and growth was higher between breeds than between a given breed and the wild boar. Conclusions/Significance: These results, suggest that although domesticated breeds have experienced similar selective pressures, selection has acted upon different genes. This might reflect the multiple domestication events of European breeds or could be the result of subsequent introgression of Asian alleles. Overall, it was estimated that approximately 7% of the porcine genome has been affected by selection events. This study illustrates that the massive parallel sequencing of genomic pools is a cost-effective approach to identify footprints of selection.	[Amaral, Andreia J.; Megens, Hendrik-Jan; Crooijmans, Richard P. M. A.; Nie, Haisheng; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Ferretti, Luca; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel] Univ Autonoma Barcelona, Dept Anim Sci & Food Technol, Bellaterra, Spain; [Ferretti, Luca; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel] Ctr Res Agr Genom, Dept Anim Sci, Bellaterra, Spain; [Perez-Enciso, Miguel] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Schook, Lawrence B.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Wageningen University & Research; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); ICREA; University of Illinois System; University of Illinois Urbana-Champaign	Amaral, AJ (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands.	andreia.fonseca@gmail.com	Perez-Enciso, Miguel/H-6057-2015; Groenen, Martien/D-8408-2012; Megens, Hendrik-Jan/M-5300-2019; Ramos-Onsins, Sebastian/B-4822-2015; Crooijmans, Richard PMA/E-2492-2012; Amaral, Andreia/O-8168-2015; Ferretti, Luca/B-4340-2019; Megens, Hendrik-Jan/E-9676-2010	Perez-Enciso, Miguel/0000-0003-3524-995X; Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Ramos-Onsins, Sebastian/0000-0002-1776-140X; Amaral, Andreia/0000-0003-0958-5570; Ferretti, Luca/0000-0001-7578-7301; Megens, Hendrik-Jan/0000-0002-3619-7533; Schook, Lawrence/0000-0002-6580-8364	European Commission; USDA [AG 2008-34480-19328, AG 2007-04315]; USDA-ARS [538 AG58-5438-7-3171]; EU [FOOD-CT-2006-01625]; Centre for Research in Agrigenomics [CSD2007-00036]; MICINN (Spain) [AGC2007-65563-C02-01/GAN, CGL2009-09346/BOS]; CSIC (Spain); ICREA Funding Source: Custom	European Commission(European CommissionEuropean Commission Joint Research Centre); USDA(United States Department of Agriculture (USDA)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EU(European Commission); Centre for Research in Agrigenomics; MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC (Spain); ICREA(ICREA)	This work was conducted as part of the SABRETRAIN Project funded by the Marie Curie Host Fellowships for Early Stage Research Training and as part of the 6th Framework Programme of the European Commission. This work was supported by USDA AG 2008-34480-19328, USDA-ARS 538 AG58-5438-7-3171, USDA AG 2007-04315, EU SABRE project FOOD-CT-2006-01625 and Consolider-Ingenio Programme CSD2007-00036 "Centre for Research in Agrigenomics". MP-E is funded by a MICINN grant AGC2007-65563-C02-01/GAN (Spain). SER-O is recipient of a Ramon y Cajal position and is funded by a MICINN grant CGL2009-09346/BOS (Spain). LF holds a JAEdoc post doc fellowship from CSIC (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat G, 2008, GENETICS, V179, P1409, DOI 10.1534/genetics.107.082198; Alonso S, 2008, MOL BIOL EVOL, V25, P997, DOI 10.1093/molbev/msn049; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-374; Angles JM, 2005, TISSUE ANTIGENS, V66, P173, DOI 10.1111/j.1399-0039.2005.00461.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Birch J, 2006, IMMUNOGENETICS, V58, P670, DOI 10.1007/s00251-006-0137-y; Bonetta L, 2006, NAT METHODS, V3, P141, DOI 10.1038/nmeth0206-141; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; FRANK H, 1980, Z TIERPSYCHOL, V53, P389; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Giuffra E, 2000, GENETICS, V154, P1785; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Hemmer H, 1990, DOMESTICATION; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jiang R, 2009, GENETICS, V181, P187, DOI 10.1534/genetics.107.080630; LANCET D, 1994, NATURE, V372, P321, DOI 10.1038/372321a0; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; MARKLUND S, 1996, MAMM GENOME, V7, P822; McRae AF, 2002, GENETICS, V160, P1113; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Miltiadou D, 2005, IMMUNOGENETICS, V57, P499, DOI 10.1007/s00251-005-0008-y; MOREY DF, 1994, AM SCI, V82, P336; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Ojeda A, 2008, ANIM GENET, V39, P468, DOI 10.1111/j.1365-2052.2008.01752.x; Ollivier L, 2009, ANIMAL, V3, P915, DOI 10.1017/S1751731109004297; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Pages H C M., ANNOTATIONDBI ANNOTA; Paszek A, 1998, J MOL EVOL, V46, P121, DOI 10.1007/PL00006279; Porter V., 1993, PIGS HDB BREEDS WORL; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; PRICE EO, 1969, ADAPTATION DOMESTIC, P34; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Roos C, 2005, IMMUNOGENETICS, V56, P773, DOI 10.1007/s00251-004-0744-4; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; VOLIS S, 2008, POPULATION GENETICS, P279; Wakeley J., 2008, COALESCENT THEORY IN	57	98	107	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e14782	10.1371/journal.pone.0014782	http://dx.doi.org/10.1371/journal.pone.0014782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483733	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058700001
J	Shanaube, K; Hargreaves, J; Fielding, K; Schaap, A; Lawrence, KA; Hensen, B; Sismanidis, C; Menezes, A; Beyers, N; Ayles, H; Godfrey-Faussett, P				Shanaube, Kwame; Hargreaves, James; Fielding, Katherine; Schaap, Ab; Lawrence, Katherine-Anne; Hensen, Bernadette; Sismanidis, Charalambos; Menezes, Angela; Beyers, Nulda; Ayles, Helen; Godfrey-Faussett, Peter			Risk Factors Associated with Positive QuantiFERON-TB Gold In-Tube and Tuberculin Skin Tests Results in Zambia and South Africa	PLOS ONE			English	Article							BLOOD INTERFERON-GAMMA; CELL-BASED ASSAY; LATENT TUBERCULOSIS; RELEASE ASSAYS; INFECTION; DIAGNOSIS; TRANSMISSION; HIV; PREVALENCE; INDIVIDUALS	Introduction: The utility of T-cell based interferon-gamma release assays for the diagnosis of latent tuberculosis infection remains unclear in settings with a high burden of tuberculosis. Objectives: To determine risk factors associated with positive QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin test (TST) results and the level of agreement between the tests; to explore the hypotheses that positivity in QFT-GIT is more related to recent infection and less affected by HIV than the TST. Methods: Adult household contacts of tuberculosis patients were invited to participate in a cross-sectional study across 24 communities in Zambia and South Africa. HIV, QFT-GIT and TST tests were done. A questionnaire was used to assess risk factors. Results: A total of 2,220 contacts were seen. 1,803 individuals had interpretable results for both tests, 1,147 (63.6%) were QFT-GIT positive while 725 (40.2%) were TST positive. Agreement between the tests was low (kappa=0.24). QFT-GIT and TST results were associated with increasing age (adjusted OR [aOR] for each 10 year increase for QFT-GIT 1.15; 95% CI: 1.06-1.25, and for TST aOR: 1.10; 95% CI 1.01-1.20). HIV positivity was less common among those with positive results on QFT-GIT (aOR: 0.51; 95% CI: 0.39-0.67) and TST (aOR: 0.61; 95% CI: 0.46-0.82). Smear positivity of the index case was associated with QFT-GIT (aOR: 1.25; 95% CI: 0.90-1.74) and TST (aOR: 1.39; 95% CI: 0.98-1.98) results. We found little evidence in our data to support our hypotheses. Conclusion: QFT-GIT may not be more sensitive than the TST to detect risk factors associated with tuberculous infection. We found little evidence to support the hypotheses that positivity in QFT-GIT is more related to recent infection and less affected by HIV than the TST.	[Shanaube, Kwame; Schaap, Ab; Ayles, Helen] Univ Zambia, ZAMBART Project, Lusaka, Zambia; [Hargreaves, James; Fielding, Katherine; Schaap, Ab] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Hensen, Bernadette; Ayles, Helen; Godfrey-Faussett, Peter] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Lawrence, Katherine-Anne; Menezes, Angela; Beyers, Nulda] Univ Stellenbosch, Desmond Tutu TB Ctr, ZA-7600 Stellenbosch, South Africa; [Sismanidis, Charalambos] WHO, Stop TB Dept, Monitoring & Evaluat Unit, CH-1211 Geneva, Switzerland	University of Zambia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; World Health Organization	Shanaube, K (corresponding author), Univ Zambia, ZAMBART Project, Lusaka, Zambia.	kshanaube@zambart.org.zm		Ayles, Helen/0000-0003-4108-2842; Hensen, Bernadette/0000-0001-6719-6720; Hargreaves, James/0000-0002-3509-3572; Shanaube, Kwame/0000-0001-7899-0890	Foundation for Innovative New Diagnostics (FIND); Johns Hopkins University; Bill and Melinda Gates Foundation via the CREATE (Consortium to Respond Effectively to AIDS and Tuberculosis Epidemic) consortium [19790.01]; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Foundation for Innovative New Diagnostics (FIND); Johns Hopkins University(Johns Hopkins University); Bill and Melinda Gates Foundation via the CREATE (Consortium to Respond Effectively to AIDS and Tuberculosis Epidemic) consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This manuscript/work was supported by the Foundation for Innovative New Diagnostics (FIND). Further support was provided by a subcontract from Johns Hopkins University with funds provided (Grant No. 19790.01) from the Bill and Melinda Gates Foundation via the CREATE (Consortium to Respond Effectively to AIDS and Tuberculosis Epidemic) consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005; Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004; Canadian Tuberculosis Committee, 2007, Can Commun Dis Rep, V33, P1; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; *CDCP, 2000, MMWR, V49; *CELL LTD, 2007, 142 CELL LTD; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Davidow AL, 2008, INT J TUBERC LUNG D, V12, P152; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; *DEP HLTH REP S AF, 2010, GUID TUB PREV THER H; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; DUNCAN LE, 1995, T ROY SOC TROP MED H, V89, P37, DOI 10.1016/0035-9203(95)90649-5; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Lewinsohn DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003407; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; *MOH TDRC CSO U ZA, 2009, ZAMB DEM HLTH SURV 2; Mutsvangwa J, 2010, THORAX, V65, P315, DOI 10.1136/thx.2009.124891; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; Schaaf HS, 2003, INT J TUBERC LUNG D, V7, P426; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Sismanidis C, 2008, CLIN TRIALS, V5, P316, DOI 10.1177/1740774508094747; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; WHO, 2009, WHOHTMTB2009411; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242	46	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18206	10.1371/journal.pone.0018206	http://dx.doi.org/10.1371/journal.pone.0018206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483746	Green Published, gold, Green Accepted			2022-12-25	WOS:000289058700013
J	Hultberg, A; Temperton, NJ; Rosseels, V; Koenders, M; Gonzalez-Pajuelo, M; Schepens, B; Ibanez, LI; Vanlandschoot, P; Schillemans, J; Saunders, M; Weiss, RA; Saelens, X; Melero, JA; Verrips, CT; Van Gucht, S; de Haard, HJ				Hultberg, Anna; Temperton, Nigel J.; Rosseels, Valerie; Koenders, Mireille; Gonzalez-Pajuelo, Maria; Schepens, Bert; Ibanez, Lorena Itati; Vanlandschoot, Peter; Schillemans, Joris; Saunders, Michael; Weiss, Robin A.; Saelens, Xavier; Melero, Jose A.; Verrips, C. Theo; Van Gucht, Steven; de Haard, Hans J.			Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL-ANTIBODY; RABIES VIRUS; IN-VITRO; ANTIGENIC STRUCTURE; F-GLYCOPROTEIN; ESCAPE MUTANTS; FRAGMENTS; MICE; VARIANTS	For efficient prevention of viral infections and cross protection, simultaneous targeting of multiple viral epitopes is a powerful strategy. Llama heavy chain antibody fragments (VHH) against the trimeric envelope proteins of Respiratory Syncytial Virus (Fusion protein), Rabies virus (Glycoprotein) and H5N1 Influenza (Hemagglutinin 5) were selected from llama derived immune libraries by phage display. Neutralizing VHH recognizing different epitopes in the receptor binding sites on the spikes with affinities in the low nanomolar range were identified for all the three viruses by viral neutralization assays. By fusion of VHH with variable linker lengths, multimeric constructs were made that improved neutralization potencies up to 4,000-fold for RSV, 1,500-fold for Rabies virus and 75-fold for Influenza H5N1. The potencies of the VHH constructs were similar or better than best performing monoclonal antibodies. The cross protection capacity against different viral strains was also improved for all three viruses, both by multivalent (two or three identical VHH) and biparatopic (two different VHH) constructs. By combining a VHH neutralizing RSV subtype A, but not subtype B with a poorly neutralizing VHH with high affinity for subtype B, a biparatopic construct was made with low nanomolar neutralizing potency against both subtypes. Trivalent anti-H5N1 VHH neutralized both Influenza H5N1 clade1 and 2 in a pseudotype assay and was very potent in neutralizing the NIBRG-14 Influenza H5N1 strain with IC(50) of 9 picomolar. Bivalent and biparatopic constructs against Rabies virus cross neutralized both 10 different Genotype 1 strains and Genotype 5. The results show that multimerization of VHH fragments targeting multiple epitopes on a viral trimeric spike protein is a powerful tool for anti-viral therapy to achieve "best-in-class" and broader neutralization capacity.	[Hultberg, Anna; Koenders, Mireille; Verrips, C. Theo; de Haard, Hans J.] Univ Utrecht, Dept Biol Cellular Architecture & Dynam, Utrecht, Netherlands; [Temperton, Nigel J.; Weiss, Robin A.] UCL, Div Infect & Immun, MRC, Ctr Med Mol Virol, London, England; [Temperton, Nigel J.] Univ Kent, Medway Sch Pharm, Chatham, Kent, England; [Rosseels, Valerie; Van Gucht, Steven] Sci Inst Publ Hlth, Rabies Lab, Brussels, Belgium; [Gonzalez-Pajuelo, Maria; Vanlandschoot, Peter; Saunders, Michael] Ablynx NV, Ghent, Belgium; [Schepens, Bert; Ibanez, Lorena Itati; Saelens, Xavier] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Schepens, Bert; Ibanez, Lorena Itati; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Schillemans, Joris] Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands; [Melero, Jose A.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Melero, Jose A.] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain	Utrecht University; University of London; University College London; University of Greenwich; University of Kent; Flanders Institute for Biotechnology (VIB); Ghent University; Utrecht University; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Hultberg, A (corresponding author), Univ Utrecht, Dept Biol Cellular Architecture & Dynam, Utrecht, Netherlands.	peter.vanlandschoot@ablynx.com; J.J.W.deHaard@uu.nl	Temperton, Nigel James/M-1164-2019; Temperton, Nigel James/K-5158-2013; Saelens, Xavier/N-5728-2015	Temperton, Nigel James/0000-0002-7978-3815; Temperton, Nigel James/0000-0002-7978-3815; Melero, Jose A./0000-0001-8148-6521; , Xavier/0000-0002-3861-6965	Flemish government [IWT70050]; Ablynx NV; MRC [G0801176, G0600369] Funding Source: UKRI; Medical Research Council [G0600369, G0801176] Funding Source: researchfish	Flemish government(European Commission); Ablynx NV(Ablynx); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by an IWT grant (Institute for the Promotion of Innovation by Science and Technology in Flanders, IWT70050) from the Flemish government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by Ablynx NV which had a significant input on the design and execution of the research.	Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; BOURHY H, 1992, J CLIN MICROBIOL, V30, P2419, DOI 10.1128/JCM.30.9.2419-2426.1992; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Corral T, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-17; Crowe JE, 1998, VIROLOGY, V252, P373, DOI 10.1006/viro.1998.9462; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; DeVincenzo JP, 2004, J INFECT DIS, V190, P975, DOI 10.1086/423213; Fooks AR, 2003, EPIDEMIOL INFECT, V131, P1029, DOI 10.1017/S0950268803001481; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; GARCIABARRENO B, 1989, J VIROL, V63, P925; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; LEROUX I, 2008, WHO RABIES B, V32; Lopez JA, 1998, J VIROL, V72, P6922; MONTANOHIROSE JA, 1993, VACCINE, V11, P1259, DOI 10.1016/0264-410X(93)90052-Y; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Schofield DJ, 1997, J GEN VIROL, V78, P2431, DOI 10.1099/0022-1317-78-10-2431; Serruys B, 2009, HEPATOLOGY, V49, P39, DOI 10.1002/hep.22609; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Wandeler A.I., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P51; Wu H, 2005, J MOL BIOL, V350, P126, DOI 10.1016/j.jmb.2005.04.049; Wu SJ, 2007, J GEN VIROL, V88, P2719, DOI 10.1099/vir.0.82753-0	35	116	134	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17665	10.1371/journal.pone.0017665	http://dx.doi.org/10.1371/journal.pone.0017665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483777	Green Published, Green Accepted, gold			2022-12-25	WOS:000289058300003
J	Bi, FC; Zhang, QF; Liu, Z; Fang, C; Li, JA; Su, JB; Greenberg, JT; Wang, HB; Yao, N				Bi, Fang-Cheng; Zhang, Quan-Fang; Liu, Zhe; Fang, Ce; Li, Jian; Su, Jian-Bin; Greenberg, Jean T.; Wang, Hong-Bin; Yao, Nan			A Conserved Cysteine Motif Is Critical for Rice Ceramide Kinase Activity and Function	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; SERINE PALMITOYLTRANSFERASE; SPHINGOSINE KINASE; MOLECULAR-CLONING; LIPID KINASE; KEY ENZYME; ARABIDOPSIS; SPHINGOLIPIDS; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION	Background: Ceramide kinase (CERK) is a key regulator of cell survival in dicotyledonous plants and animals. Much less is known about the roles of CERK and ceramides in mediating cellular processes in monocot plants. Here, we report the characterization of a ceramide kinase, OsCERK, from rice (Oryza sativa spp. Japonica cv. Nipponbare) and investigate the effects of ceramides on rice cell viability. Principal Findings: OsCERK can complement the Arabidopsis CERK mutant acd5. Recombinant OsCERK has ceramide kinase activity with Michaelis-Menten kinetics and optimal activity at 7.0 pH and 40 degrees C. Mg2+ activates OsCERK in a concentration-dependent manner. Importantly, a CXXXCXXC motif, conserved in all ceramide kinases and important for the activity of the human enzyme, is critical for OsCERK enzyme activity and in planta function. In a rice protoplast system, inhibition of CERK leads to cell death and the ratio of added ceramide and ceramide-1-phosphate, CERK's substrate and product, respectively, influences cell survival. Ceramide-induced rice cell death has apoptotic features and is an active process that requires both de novo protein synthesis and phosphorylation, respectively. Finally, mitochondria membrane potential loss previously associated with ceramide-induced cell death in Arabidopsis was also found in rice, but it occurred with different timing. Conclusions: OsCERK is a bona fide ceramide kinase with a functionally and evolutionarily conserved Cys-rich motif that plays an important role in modulating cell fate in plants. The vital function of the conserved motif in both human and rice CERKs suggests that the biochemical mechanism of CERKs is similar in animals and plants. Furthermore, ceramides induce cell death with similar features in monocot and dicot plants.	[Bi, Fang-Cheng; Zhang, Quan-Fang; Liu, Zhe; Fang, Ce; Li, Jian; Su, Jian-Bin; Wang, Hong-Bin; Yao, Nan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Greenberg, Jean T.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Sun Yat Sen University; University of Chicago	Bi, FC (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	yaonan@mail.sysu.edu.cn	LI, RUIJIAN/GYJ-0470-2022; yao, nan/F-2095-2011; Su, Jianbin/L-6647-2019	yao, nan/0000-0002-2045-5462; Greenberg, Jean/0000-0002-7213-7618	National Natural Science Foundation of China [30871604]; New Energy and Industrial Technology Development Organization (NEDO) of Japan; Special Fund for Agro-scientific Research in the Public Interest [200803008]; Program for New Century Excellent Talents in University; National Institutes of Health [R01GM54292];  [SKLBC08B02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054292] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Special Fund for Agro-scientific Research in the Public Interest; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (30871604), the New Energy and Industrial Technology Development Organization (NEDO) of Japan in 2009, Special Fund for Agro-scientific Research in the Public Interest (200803008), Project of SKLBC08B02 and Program for New Century Excellent Talents in University to NY and National Institutes of Health R01GM54292 to JTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Bajjalieh S, 2000, METHOD ENZYMOL, V311, P207; BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961; Carre A, 2004, BIOCHEM BIOPH RES CO, V324, P1215, DOI 10.1016/j.bbrc.2004.09.181; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chen M, 2008, PLANT CELL, V20, P1862, DOI 10.1105/tpc.107.057851; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Coursol S, 2005, PLANT PHYSIOL, V137, P724, DOI 10.1104/pp.104.055806; Don AS, 2008, ANAL BIOCHEM, V375, P265, DOI 10.1016/j.ab.2007.12.024; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Greenberg JT, 2000, GENETICS, V156, P341; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kim JW, 2005, BBA-MOL CELL BIOL L, V1738, P82, DOI 10.1016/j.bbalip.2005.10.007; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lidome E, 2008, BIOCHIMIE, V90, P1560, DOI 10.1016/j.biochi.2008.07.001; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Nagano M, 2009, PLANT J, V58, P122, DOI 10.1111/j.1365-313X.2008.03765.x; Nishiura H, 2000, BIOCHEM SOC T, V28, P747, DOI 10.1042/BST0280747; Niu Y, 2007, J INTEGR PLANT BIOL, V49, P323, DOI 10.1111/j.1744-7909.2007.00446.x; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Pata MO, 2008, PLANT J, V55, P1000, DOI 10.1111/j.1365-313X.2008.03569.x; Rovina P, 2009, BBA-MOL CELL BIOL L, V1791, P1023, DOI 10.1016/j.bbalip.2009.05.009; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng C, 2008, PLANT PHYSIOL, V146, P1322, DOI 10.1104/pp.107.113506; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Townley HE, 2005, BIOL CHEM, V386, P161, DOI 10.1515/BC.2005.020; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Van Overloop H, 2006, J LIPID RES, V47, P268, DOI 10.1194/jlr.M500321-JLR200; Wang WM, 2008, PLANT CELL, V20, P3163, DOI 10.1105/tpc.108.060053; Wijesinghe DS, 2005, J LIPID RES, V46, P2706, DOI 10.1194/jlr.M500313-JLR200; Worrall D, 2008, PLANT J, V56, P64, DOI 10.1111/j.1365-313X.2008.03579.x; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yao N, 2004, PLANT J, V40, P596, DOI 10.1111/j.1365-313X.2004.02239.x; Yao N, 2001, PLANT J, V28, P13, DOI 10.1046/j.1365-313X.2001.01109.x	46	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18079	10.1371/journal.pone.0018079	http://dx.doi.org/10.1371/journal.pone.0018079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483860	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200024
J	Wielinga, PY; Yakala, GK; Heeringa, P; Kleemann, R; Kooistra, T				Wielinga, Peter Y.; Yakala, Gopala K.; Heeringa, Peter; Kleemann, Robert; Kooistra, Teake			Beneficial Effects of Alternate Dietary Regimen on Liver Inflammation, Atherosclerosis and Renal Activation	PLOS ONE			English	Article							CALORIE RESTRICTION; TRANSGENIC MICE; CHOLESTEROL; DISEASE	Background: Alternate day calorie restriction (CR) has been shown to be almost as beneficial as daily CR. The question arises whether this concept is also applicable to alternating dietary composition. Objective: To seek evidence that alternating high cholesterol (HC) - cholesterol-free (CON) Western diet can effectively diminish hepatic and renal inflammation and cardiovascular risk factors as compared with daily HC-supplemented Western diet. Design: Four groups of ApoE*3Leiden mice, a humanized model for atherosclerosis, were subjected to different feeding treatments for 16 weeks. Mice were fed CON diet; CON diet with 1% w/w cholesterol (HC); alternate (ALT) diet regimen of CON (4 days) and HC (3 days); or CON diet supplemented with 0.43% (w/w) cholesterol (MC), with overall dietary cholesterol intake equal to ALT. Plasma was analyzed for cardiovascular risk factors, aorta for atherosclerotic lesion formation, and liver and kidney for inflammation. Results: ALT diet but not MC was almost as effective as daily CON feeding in preventing disease development. Compared to HC, the ALT group showed 62% lower hepatic nuclear factor kappa B (NF-kappa B) activity (P < 0.001), a reduction of the circulating inflammatory markers E-selectin (-20%; P < 0.05), vascular cell adhesion molecule 1 (VCAM-1; -15%; P < 0.05) and Serum Amyloid A (SAA; -31%; P < 0.05), smaller atherosclerotic lesion sizes (-51%; 46497 +/- 10791 mu m(2) vs. 94664 +/- 16470 mu m(2); P < 0.05) and diminished renal expression of specific inflammation and activation markers (VCAM-1, -27%; P < 0.05; monocyte chemotactic protein-1 (MCP-1); -37%; P < 0.01). Conclusion: Alternate HC-CON feeding reproduced most of the beneficial effects of daily cholesterol-free diet, including strongly diminished hepatic, vascular and renal activation and inflammation; also atherosclerosis was reduced by half as compared to HC, albeit still higher compared to the CON group.	[Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake] TNO Metab Hlth Res, Leiden, Netherlands; [Yakala, Gopala K.; Heeringa, Peter] Univ Groningen, Med Biol Sect, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Wielinga, Peter Y.; Yakala, Gopala K.; Heeringa, Peter; Kleemann, Robert] Top Inst Food & Nutr, Wageningen, Netherlands	Netherlands Organization Applied Science Research; University of Groningen; Top Institute Food & Nutrition	Wielinga, PY (corresponding author), TNO Metab Hlth Res, Leiden, Netherlands.	Peter.Wielinga@tno.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X	Top Institute Food and Nutrition [A1004]; TNO	Top Institute Food and Nutrition; TNO	The study was funded by the Top Institute Food and Nutrition (www.tifn.nl), research program A1004 and the TNO (www.tno.nl), research program Personalized Health. PYW, GKY, PH and RK are employed by Top Institute Food and Nutrition and PYW, RK and TK by TNO-BioSciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fontana L, 2008, EUR J CARDIOV PREV R, V15, P3, DOI 10.1097/HJR.0b013e3282f17bd4; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Rein D, 2006, J NUTR, V136, P2331, DOI 10.1093/jn/136.9.2331; Turk MW, 2009, J CARDIOVASC NURS, V24, P58, DOI 10.1097/01.JCN.0000317471.58048.32; VANLIEW JB, 1992, AM J PHYSIOL, V263, pF554, DOI 10.1152/ajprenal.1992.263.3.F554; Varady KA, 2008, FASEB J, V22, P2090, DOI 10.1096/fj.07-098178; Varady KA, 2010, J NUTR BIOCHEM, V21, P188, DOI 10.1016/j.jnutbio.2008.11.001; Varady KA, 2009, AM J CLIN NUTR, V90, P1138, DOI 10.3945/ajcn.2009.28380; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Wiggins JE, 2010, J AM SOC NEPHROL, V21, P587, DOI 10.1681/ASN.2009060663; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	17	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18432	10.1371/journal.pone.0018432	http://dx.doi.org/10.1371/journal.pone.0018432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483792	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200077
J	Schulzke, JD; Andres, S; Amasheh, M; Fromm, A; Gunzel, D				Schulzke, Joerg D.; Andres, Susanne; Amasheh, Maren; Fromm, Anja; Guenzel, Dorothee			Anti-Diarrheal Mechanism of the Traditional Remedy Uzara via Reduction of Active Chloride Secretion	PLOS ONE			English	Article							EPITHELIAL-CELL LINE; CL-SECRETION; COLON; TRANSPORT; BARRIER; STIMULATION; CARBACHOL; CHANNEL; CHOLERA; CONDUCTANCE	Background and Purpose: The root extract of the African Uzara plant is used in traditional medicine as anti-diarrheal drug. It is known to act via inhibition of intestinal motility, but malabsorptive or antisecretory mechanisms are unknown yet. Experimental Approach: HT-29/B6 cells and human colonic biopsies were studied in Ussing experiments in vitro. Uzara was tested on basal as well as on forskolin- or cholera toxin-induced Cl(-) secretion by measuring short-circuit current (I(SC)) and tracer fluxes of (22)Na(+) and (36)Cl(-). Para- and transcellular resistances were determined by two-path impedance spectroscopy. Enzymatic activity of the Na(+)/K(+)-ATPase and intracellular cAMP levels (ELISA) were measured. Key Results: In HT-29/B6 cells, Uzara inhibited forskolin- as well as cholera toxin-induced I(SC) within 60 minutes indicating reduced active chloride secretion. Similar results were obtained in human colonic biopsies pre-stimulated with forskolin. In HT-29/B6, the effect of Uzara on the forskolin- induced I(SC) was time- and dose-dependent. Analyses of the cellular mechanisms of this Uzara effect revealed inhibition of the Na(+)/K(+)-ATPase, a decrease in forskolin-induced cAMP production and a decrease in paracellular resistance. Tracer flux experiments indicate that the dominant effect is the inhibition of the Na(+)/K(+)-ATPase. Conclusion and Implications: Uzara exerts anti-diarrheal effects via inhibition of active chloride secretion. This inhibition is mainly due to an inhibition of the Na(+)/K(+)-ATPase and to a lesser extent to a decrease in intracellular cAMP responses and paracellular resistance. The results imply that Uzara is suitable for treating acute secretory diarrhea.	[Schulzke, Joerg D.; Andres, Susanne; Amasheh, Maren] Free Univ Berlin, Charite, Sect Gen Med & Nutr, Dept Gastroenterol, D-1000 Berlin, Germany; [Schulzke, Joerg D.; Andres, Susanne; Amasheh, Maren; Fromm, Anja; Guenzel, Dorothee] Humboldt Univ, Berlin, Germany; [Fromm, Anja; Guenzel, Dorothee] Free Univ Berlin, Charite, Inst Clin Physiol, D-1000 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulzke, JD (corresponding author), Free Univ Berlin, Charite, Sect Gen Med & Nutr, Dept Gastroenterol, D-1000 Berlin, Germany.	joerg.schulzke@charite.de		Gunzel, Dorothee/0000-0002-7998-7164; Fromm, Anja/0000-0003-4091-9612	German Research Foundation; DFG Research Unit [FOR 721/2]	German Research Foundation(German Research Foundation (DFG)); DFG Research Unit(German Research Foundation (DFG))	This study was funded by the German Research Foundation, DFG Research Unit FOR 721/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AJ, 1998, BIOCHEM BIOPH RES CO, V251, P256, DOI 10.1006/bbrc.1998.9453; BAJNATH RB, 1991, J MEMBRANE BIOL, V122, P239, DOI 10.1007/BF01871424; BRAYDEN DJ, 1993, AM J PHYSIOL, V264, pG325, DOI 10.1152/ajpgi.1993.264.2.G325; BRIDGES RJ, 1983, N-S ARCH PHARMACOL, V323, P355, DOI 10.1007/BF00512476; BROWN L, 1983, BIOCHEM PHARMACOL, V32, P2767, DOI 10.1016/0006-2952(83)90090-4; Desjeux JF, 1997, BAILLIERE CLIN GASTR, V11, P509, DOI 10.1016/S0950-3528(97)90029-4; DHARMSATHAPHORN K, 1986, J CLIN INVEST, V77, P348, DOI 10.1172/JCI112311; Epple HJ, 1997, PFLUG ARCH EUR J PHY, V433, P638, DOI 10.1007/s004240050325; Flores CA, 2007, J PHYSIOL-LONDON, V583, P705, DOI 10.1113/jphysiol.2007.134387; Gessner O, 1930, N-S ARCH EX PATH PH, V148, P353; Ghorbani M, 1997, PLANTA MED, V63, P343, DOI 10.1055/s-2006-957697; KIMBERG DV, 1971, J CLIN INVEST, V50, P1218, DOI 10.1172/JCI106599; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Krug SM, 2009, BIOPHYS J, V97, P2202, DOI 10.1016/j.bpj.2009.08.003; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lencer WI, 2001, AM J PHYSIOL-GASTR L, V280, pG781, DOI 10.1152/ajpgi.2001.280.5.G781; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Mandal A, 2008, AM J PHYSIOL-CELL PH, V295, pC100, DOI 10.1152/ajpcell.90636.2007; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Raymond-Hamet, 1930, CR HEBD ACAD SCI, V190, P821; RITTER A, 2006, INT J CLIN PHARM TH, V44, P529; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; SADRZADEH SMH, 1993, J PHARMACOL TOXICOL, V30, P103, DOI 10.1016/1056-8719(93)90013-5; SCHMIEDL S, 2006, INT J CLIN PHARM TH, V44, P526; Schmitz H, 2002, AIDS, V16, P983, DOI 10.1097/00002030-200205030-00004; Schulz V., 2004, RATIONAL PHYTOTHERAP, P1; SMITH PL, 1986, AM J PHYSIOL, V250, pG44, DOI 10.1152/ajpgi.1986.250.1.G44; Stockmann M, 1998, AIDS, V12, P43, DOI 10.1097/00002030-199801000-00006; STRABEL D, 1995, EUR J PHARMACOL, V274, P181, DOI 10.1016/0014-2999(94)00728-P; Thurmann PA, 2004, INT J CLIN PHARM TH, V42, P281; van Wyk BE, 2008, J ETHNOPHARMACOL, V119, P342, DOI 10.1016/j.jep.2008.05.029; WEYMER A, 1985, J CLIN INVEST, V76, P1828, DOI 10.1172/JCI112175; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18107	10.1371/journal.pone.0018107	http://dx.doi.org/10.1371/journal.pone.0018107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479205	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700026
J	Shoulders, MD; Raines, RT				Shoulders, Matthew D.; Raines, Ronald T.			Interstrand Dipole-Dipole Interactions Can Stabilize the Collagen Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; HYDROXYLATION-INDUCED STABILIZATION; EARTHWORM CUTICLE COLLAGEN; XAA POSITION; AQUEOUS-SOLUTION; MODEL PEPTIDES; ELECTROSTATIC INTERACTIONS; MELTING CURVES; PROLINE; 4-FLUOROPROLINE	The amino acid sequence of collagen is composed of GlyXaaYaa repeats. A prevailing paradigm maintains that stable collagen triple helices form when (2S)-proline (Pro) or Pro derivatives that prefer the C-gamma-endo ring pucker are in the Xaa position and Pro derivatives that prefer the C-gamma-exo ring pucker are in the Yaa position. Anomalously, an amino acid sequence in an invertebrate collagen has (2S, 4R)-4-hydroxyproline (Hyp), a C-gamma-exo-puckered Pro derivative, in the Xaa position. In certain contexts, triple helices with Hyp in the Xaa position are now known to be hyperstable. Most intriguingly, the sequence (GlyHypHyp)(n) forms a more stable triple helix than does the sequence (GlyProHyp)(n). Competing theories exist for the physicochemical basis of the hyperstability of (GlyHypHyp) n triple helices. By synthesizing and analyzing triple helices with different C-gamma-exo-puckered proline derivatives in the Xaa and Yaa positions, we conclude that interstrand dipole-dipole interactions are the primary determinant of their additional stability. These findings provide a new framework for understanding collagen stability.	[Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Shoulders, Matthew D.; Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	rtraines@wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	National Institutes of Health [R01 AR044276, S10 RR13790, P41RR02301]; United States Dept. of Homeland Security; ACS Division of Medicinal Chemistry; NSF [BIR-9512577]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Homeland Security; ACS Division of Medicinal Chemistry; NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grant R01 AR044276 from the National Institutes of Health.; Supported by graduate fellowships from the United States Dept. of Homeland Security and ACS Division of Medicinal Chemistry.; We thank Dr. D. R. McCaslin for both experimental aid and helpful discussions. CD spectroscopy, DSC, analytical ultracentrifugation, and MALDI-TOF mass spectrometry were performed at the University of Wisconsin-Madison Biophysics Instrumentation Facility, which was established with Grants BIR-9512577 (NSF) and S10 RR13790 (National Institutes of Health). NMR spectroscopy was performed at the National Magnetic Resonance Facility at Madison, which is supported by Grant P41RR02301 (National Institutes of Health).	Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BERG RA, 1970, J BIOL CHEM, V245, P5759; Berisio R, 2004, J AM CHEM SOC, V126, P11402, DOI 10.1021/ja047069h; Breslauer K J, 1994, Methods Mol Biol, V26, P347; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Doi M, 2003, J AM CHEM SOC, V125, P9922, DOI 10.1021/ja035997v; Doi M, 2005, J PEPT SCI, V11, P609, DOI 10.1002/psc.671; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115; Durschlag H., 1994, PROG COLLOID POLYM S, V94, P20; ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a; GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Glendening E. D., 2001, NBO 5 0; GOLDSTEIN A, 1970, J BIOL CHEM, V245, P5478; Hodges JA, 2003, J AM CHEM SOC, V125, P9262, DOI 10.1021/ja035881z; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; Improta R, 2002, J AM CHEM SOC, V124, P7857, DOI 10.1021/ja020187p; Improta R, 2001, J AM CHEM SOC, V123, P12568, DOI 10.1021/ja010599i; Improta R, 2008, PROTEIN SCI, V17, P955, DOI 10.1110/ps.073301908; INOUYE K, 1982, ARCH BIOCHEM BIOPHYS, V219, P198, DOI 10.1016/0003-9861(82)90149-7; Kawahara K, 2005, BIOCHEMISTRY-US, V44, P15812, DOI 10.1021/bi051619m; Kotch FW, 2008, J AM CHEM SOC, V130, P2952, DOI 10.1021/ja800225k; Kumin M, 2007, J AM CHEM SOC, V129, P466, DOI 10.1021/ja067148o; Liu L, 2001, CHEM REV, V101, P673, DOI 10.1021/cr990416z; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; Mann K, 1996, J MOL BIOL, V261, P255, DOI 10.1006/jmbi.1996.0457; Mizuno K, 2004, J BIOL CHEM, V279, P38072, DOI 10.1074/jbc.M402953200; Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; MUIR L, 1970, J BIOL CHEM, V245, P502; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Okuyama K, 2010, ACTA CRYSTALLOGR D, V66, P88, DOI 10.1107/S0907444909046642; Okuyama K, 2009, BIOPOLYMERS, V91, P361, DOI 10.1002/bip.21138; PANASIK N, 1994, INT J PEPT PROT RES, V44, P262; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Radmer RJ, 2006, BIOPHYS J, V90, P578, DOI 10.1529/biophysj.105.065276; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Ruzza P, 2006, J PEPT SCI, V12, P462, DOI 10.1002/psc.750; Schumacher M, 2005, J BIOL CHEM, V280, P20397, DOI 10.1074/jbc.M501453200; Shoulders MD, 2008, BIOPOLYMERS, V89, P443, DOI 10.1002/bip.20864; Shoulders MD, 2006, J AM CHEM SOC, V128, P8112, DOI 10.1021/ja061793d; Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Shoulders MD, 2009, BIOORG MED CHEM LETT, V19, P3859, DOI 10.1016/j.bmcl.2009.03.168; Shoulders MD, 2009, ADV EXP MED BIOL, V611, P251, DOI 10.1007/978-0-387-73657-0_115; Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w; Umashankara M, 2003, CHEM COMMUN, P2606, DOI 10.1039/b308581c; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V	58	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22905	22912		10.1074/jbc.M110.199984	http://dx.doi.org/10.1074/jbc.M110.199984			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21482820	hybrid, Green Published			2022-12-25	WOS:000292025000025
J	Heissler, SM; Manstein, DJ				Heissler, Sarah M.; Manstein, Dietmar J.			Comparative Kinetic and Functional Characterization of the Motor Domains of Human Nonmuscle Myosin-2C Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; II-C; ADENOSINE-TRIPHOSPHATASE; ATPASE ACTIVITY; ACTIN AFFINITY; CHAIN; ADP; MAGNESIUM; DISSOCIATION; ASSOCIATION	Nonmuscle myosins are widely distributed and play important roles in the maintenance of cell morphology and cytokinesis. In this study, we compare the detailed kinetic and functional characterization of naturally occurring transcript variants of the motor domain of human nonmuscle myosin heavy chain (NMHC)-2C. NMHC-2C is alternatively spliced both in loop-1 and loop-2. Isoform 2C0 contains no inserts in either of the loops and represents the shortest isoform. An 8-amino acid extension in the loop-1 region is present in isoforms 2C1 and 2C1C2. Isoform 2C1C2 additionally displays a 33-amino acid extension in the loop-2 region. Transient kinetic experiments indicate increased rate constants for F-actin binding by isoform 2C1C2 in the absence and presence of nucleotide, which can be attributed to the loop-2 extension. ADP binding shows only minor differences for the three transcript variants. In contrast, larger differences are observed for the rates of ADP release both in the absence and presence of F-actin. The largest differences are observed between isoforms 2C0 and 2C1C2. In the absence and presence of F-actin, isoform 2C1C2 displays a 5-7-fold increase in ADP affinity. Moreover, our results indicate that the ADP release kinetics of all three isoforms are modulated by changes in the concentration of free Mg2+ ions. The greatest responsiveness of the NMHC-2C isoforms is observed in the physiological range from 0.2 to 1.5 mM free Mg2+ ions, affecting their duty ratio, velocity, and tension-bearing properties.	[Heissler, Sarah M.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany	Hannover Medical School	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neubert Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147	Deutsche Forschungsgemeinschaft [Ma 1081/16-1]; Cluster of Excellence "Rebirth"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Rebirth"	This work was supported by Deutsche Forschungsgemeinschaft Grant Ma 1081/16-1 and the Cluster of Excellence "Rebirth" (to D. J. M.).	Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Bao JJ, 2007, J BIOL CHEM, V282, P22102, DOI 10.1074/jbc.M702731200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Clark R, 2005, J BIOL CHEM, V280, P30935, DOI 10.1074/jbc.M504698200; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Ito K, 2003, BIOCHEM BIOPH RES CO, V312, P958, DOI 10.1016/j.bbrc.2003.10.202; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; Kawahara K, 2008, CHRONOBIOL INT, V25, P868, DOI 10.1080/07420520802536387; Kengyel A, 2010, J MUSCLE RES CELL M, V31, P163, DOI 10.1007/s10974-010-9220-y; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; Laires MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P262, DOI 10.2741/1223; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; MAUPIN P, 1994, J CELL SCI, V107, P3077; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Nagy NT, 2010, FASEB J, V24, P4480, DOI 10.1096/fj.10-163998; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rovner AS, 1997, J MUSCLE RES CELL M, V18, P103, DOI 10.1023/A:1018689102122; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; Simerly C, 1998, MOL BIOL CELL, V9, P2509, DOI 10.1091/mbc.9.9.2509; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Tsiavaliaris G, 2004, NATURE, V427, P558, DOI 10.1038/nature02303; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; VERKHOVSKY AB, 1993, J CELL BIOL, V123, P637, DOI 10.1083/jcb.123.3.637; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329	61	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21191	21202		10.1074/jbc.M110.212290	http://dx.doi.org/10.1074/jbc.M110.212290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21478157	Green Published, hybrid			2022-12-25	WOS:000291464700019
J	Verdegem, D; Badillo, A; Wieruszeski, JM; Landrieu, I; Leroy, A; Bartenschlager, R; Penin, F; Lippens, G; Hanoulle, X				Verdegem, Dries; Badillo, Aurelie; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Leroy, Arnaud; Bartenschlager, Ralf; Penin, Francois; Lippens, Guy; Hanoulle, Xavier			Domain 3 of NS5A Protein from the Hepatitis C Virus Has Intrinsic alpha-Helical Propensity and Is a Substrate of Cyclophilin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APOLIPOPROTEIN-E; REPLICATION IN-VITRO; NONSTRUCTURAL PROTEIN; CYCLOSPORINE-A; RNA REPLICATION; CORE PROTEIN; ISOMERASE ACTIVITY; ESCHERICHIA-COLI; BINDING-PROTEIN; LIPID DROPLET	Nonstructural protein 5A (NS5A) is essential for hepatitis C virus (HCV) replication and constitutes an attractive target for antiviral drug development. Although structural data for its in-plane membrane anchor and domain D1 are available, the structure of domains 2 (D2) and 3 (D3) remain poorly defined. We report here a comparative molecular characterization of the NS5A-D3 domains of the HCV JFH-1 (genotype 2a) and Con1 (genotype 1b) strains. Combining gel filtration, CD, and NMR spectroscopy analyses, we show that NS5A-D3 is natively unfolded. However, NS5A-D3 domains from both JFH-1 and Con1 strains exhibit a propensity to partially fold into an alpha-helix. NMR analysis identifies two putative alpha-helices, for which a molecular model could be obtained. The amphipathic nature of the first helix and its conservation in all genotypes suggest that it might correspond to a molecular recognition element and, as such, promote the interaction with relevant biological partner(s). Because mutations conferring resistance to cyclophilin inhibitors have been mapped into NS5A-D3, we also investigated the functional interaction between NS5A-D3 and cyclophilin A (CypA). CypA indeed interacts with NS5A-D3, and this interaction is completely abolished by cyclosporin A. NMR heteronuclear exchange experiments demonstrate that CypA has in vitro peptidyl-prolyl cis/trans-isomerase activity toward some, but not all, of the peptidyl-prolyl bonds in NS5A-D3. These studies lead to novel insights into the structural features of NS5A-D3 and its relationships with CypA.	[Verdegem, Dries; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, Guy; Hanoulle, Xavier] Univ Lille Nord France, F-59000 Lille, France; [Verdegem, Dries; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, Guy; Hanoulle, Xavier] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Verdegem, Dries; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, Guy; Hanoulle, Xavier] IFR 147, UGSF, USTL, F-59650 Villeneuve Dascq, France; [Badillo, Aurelie; Penin, Francois] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR BioSci Gerland Lyon Sud, F-69397 Lyon, France; [Leroy, Arnaud] Univ Paris 11, Lab Biochim Appl, Fac Pharm, F-92296 Chatenay Malabry, France; [Bartenschlager, Ralf] Univ Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Ruprecht Karls University Heidelberg	Hanoulle, X (corresponding author), Univ Sci & Technol Lille, CNRS, UMR 8576, Unite Glycobiol Struct & Fonct,IFR 147, F-59655 Villeneuve Dascq, France.	xavier.hanoulle@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Landrieu, Isabelle/AAF-8495-2019; Hanoulle, Xavier/AAK-7236-2021; Bartenschlager, Ralf/L-2582-2015	Landrieu, Isabelle/0000-0002-4883-2637; Hanoulle, Xavier/0000-0002-3755-2680; Lippens, Guy/0000-0002-8236-0901; Bartenschlager, Ralf/0000-0001-5601-9307	French Centre National de la Recherche Scientifique; University of Lille; University of Lyon; French National Agency for Research on AIDS and Viral Hepatitis; European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance); Region Nord-Pas de Calais (France); CNRS; University of Lille 1; University of Lille 2; Institut Pasteur de Lille; German Research Council [SFB 638, A5]	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Lille; University of Lyon; French National Agency for Research on AIDS and Viral Hepatitis(ANRS); European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance)(European CommissionEuropean Commission Joint Research Centre); Region Nord-Pas de Calais (France)(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 1; University of Lille 2; Institut Pasteur de Lille; German Research Council(German Research Foundation (DFG))	This work was supported by the French Centre National de la Recherche Scientifique and Universities of Lille and Lyon, and grants from the French National Agency for Research on AIDS and Viral Hepatitis and from the European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance). The NMR facility used in this study was funded by the Region Nord-Pas de Calais (France), CNRS, the Universities of Lille 1 and Lille 2, and the Institut Pasteur de Lille.; Supported by the German Research Council (SFB 638, Teilprojekt A5).	Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CammersGoodwin A, 1996, J AM CHEM SOC, V118, P3082, DOI 10.1021/ja952900z; Chatterji U, 2010, J GEN VIROL, V91, P1189, DOI 10.1099/vir.0.018531-0; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Goto K, 2009, CANCER SCI, V100, P1943, DOI 10.1111/j.1349-7006.2009.01263.x; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Landrieu I, 2010, BIOCHEMISTRY-US, V49, P4679, DOI 10.1021/bi1003266; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lin C, 1997, J VIROL, V71, P6465, DOI 10.1128/JVI.71.9.6465-6471.1997; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; MONTEILHET C, 1993, GENE, V125, P223, DOI 10.1016/0378-1119(93)90333-X; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; *NIH, 2002, HEPATOLOGY S1, V36, pS2; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Puyang XL, 2010, ANTIMICROB AGENTS CH, V54, P1981, DOI 10.1128/AAC.01236-09; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WANG AC, 1995, J AM CHEM SOC, V117, P1810, DOI 10.1021/ja00111a021; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v	80	79	79	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20441	20454		10.1074/jbc.M110.182436	http://dx.doi.org/10.1074/jbc.M110.182436			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489988	Green Published, hybrid			2022-12-25	WOS:000291267600032
J	Piette, AS; Derua, R; Waelkens, E; Boutry, M; Duby, G				Piette, Anne-Sophie; Derua, Rita; Waelkens, Etienne; Boutry, Marc; Duby, Geoffrey			A Phosphorylation in the C-terminal Auto-inhibitory Domain of the Plant Plasma Membrane H+-ATPase Activates the Enzyme with No Requirement for Regulatory 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; PROTON PUMP ATPASE; PHOSPHOPROTEOMIC ANALYSIS; BINDING; ARABIDOPSIS; RESIDUES; YEAST; TRANSFORMATION; FUSICOCCIN; HEXAMER	The plant plasma membrane H+-ATPase is regulated by an auto-inhibitory C-terminal domain that can be displaced by phosphorylation of the penultimate residue, a Thr, and the subsequent binding of 14-3-3 proteins. By mass spectrometric analysis of plasma membrane H+-ATPase isoform 2 (PMA2) isolated from Nicotiana tabacum plants and suspension cells, we identified a new phosphorylation site, Thr-889, in a region of the C-terminal domain upstream of the 14-3-3 protein binding site. This residue was mutated into aspartate or alanine, and the mutated H+-ATPases expressed in the yeast Saccharomyces cerevisiae. Unlike wild-type PMA2, which could replace the yeast H+-ATPases, the PMA2-Thr889Ala mutant did not allow yeast growth, whereas the PMA2-Thr889Asp mutant resulted in improved growth and increased H+-ATPase activity despite reduced phosphorylation of the PMA2 penultimate residue and reduced 14-3-3 protein binding. To determine whether the regulation taking place at Thr-889 was independent of phosphorylation of the penultimate residue and 14-3-3 protein binding, we examined the effect of combining the PMA2-Thr889Asp mutation with mutations of other residues that impair phosphorylation of the penultimate residue and/or binding of 14-3-3 proteins. The results showed that in yeast, PMA2Thr-889 phosphorylation could activate H+-ATPase if PMA2 was also phosphorylated at its penultimate residue. However, binding of 14-3-3 proteins was not required, although 14-3-3 binding resulted in further activation. These results were confirmed in N. tabacum suspension cells. These data define a new H+-ATPase activation mechanism that can take place without 14-3-3 proteins.	[Piette, Anne-Sophie; Boutry, Marc; Duby, Geoffrey] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Derua, Rita; Waelkens, Etienne] Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, B-3000 Leuven, Belgium	Universite Catholique Louvain; KU Leuven	Boutry, M (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Croix Sud 4-15, B-1348 Louvain, Belgium.	marc.boutry@uclouvain.be		Boutry, Marc/0000-0002-2315-6900	Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services); Belgian National Fund for Scientific Research; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (Belgium)	Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services); Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Interuniversity Poles of Attraction Program (Belgian State, Scientific, Technical and Cultural Services) and the Belgian National Fund for Scientific Research.; Recipient of a fellowship from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (Belgium).	Arango M, 2003, PLANTA, V216, P355, DOI 10.1007/s00425-002-0856-8; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Bobik K, 2010, PLANT J, V62, P291, DOI 10.1111/j.1365-313X.2010.04147.x; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Duby G, 2009, PFLUG ARCH EUR J PHY, V457, P645, DOI 10.1007/s00424-008-0457-x; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo H, 1999, PLANT PHYSIOL, V119, P627, DOI 10.1104/pp.119.2.627; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Ookura T, 2005, JARQ-JPN AGR RES Q, V39, P99, DOI 10.6090/jarq.39.99; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Speth C, 2010, EUR J CELL BIOL, V89, P145, DOI 10.1016/j.ejcb.2009.10.015; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Treco D. A., 2001, CURRENT PROTOCOLS MO; van der Fits L, 2000, PLANT MOL BIOL, V43, P495, DOI 10.1023/A:1006440221718; Whiteman SA, 2008, PLANT J, V56, P146, DOI 10.1111/j.1365-313X.2008.03578.x; Woloszynska M, 2003, ANN NY ACAD SCI, V986, P198, DOI 10.1111/j.1749-6632.2003.tb07160.x; Zhao RM, 1999, PLANT SCI, V149, P157, DOI 10.1016/S0168-9452(99)00155-7	33	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18474	18482		10.1074/jbc.M110.211953	http://dx.doi.org/10.1074/jbc.M110.211953			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21482822	Green Published, hybrid			2022-12-25	WOS:000290785700020
J	Altindal, T; Chattopadhyay, S; Wu, XL				Altindal, Tuba; Chattopadhyay, Suddhashil; Wu, Xiao-Lun			Bacterial Chemotaxis in an Optical Trap	PLOS ONE			English	Article							ESCHERICHIA-COLI; FLAGELLAR ROTATION; RHODOBACTER-SPHAEROIDES; VIBRIO-ALGINOLYTICUS; SINGLE CELLS; STIMULI; POLAR; MOTOR; SENSITIVITY; ATTRACTANT	An optical trapping technique is implemented to investigate the chemotactic behavior of a marine bacterial strain Vibrio alginolyticus. The technique takes the advantage that the bacterium has only a single polar flagellum, which can rotate either in the counter-clock-wise or clock-wise direction. The two rotation states of the motor can be readily and instantaneously resolved in the optical trap, allowing the flagellar motor switching rate S(t) to be measured under different chemical stimulations. In this paper the focus will be on the bacterial response to an impulsive change of chemoattractant serine. Despite different propulsion apparati and motility patterns, cells of V. alginolyticus apparently use a similar response as Escherichia coli to regulate their chemotactic behavior. Specifically, we found that the switching rate S(t) of the bacterial motor exhibits a biphasic behavior, showing a fast initial response followed by a slow relaxation to the steady-state switching rate S(0). The measured S(t) can be mimicked by a model that has been recently proposed for chemotaxis in E. coli. The similarity in the response to the brief chemical stimulation in these two different bacteria is striking, suggesting that the biphasic response may be evolutionarily conserved. This study also demonstrated that optical tweezers can be a useful tool for chemotaxis studies and should be applicable to other polarly flagellated bacteria.	[Altindal, Tuba; Chattopadhyay, Suddhashil; Wu, Xiao-Lun] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altindal, T (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	xlwu@pitt.edu			National Science Foundation [BP-0646573]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant No. BP-0646573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; ALLEN RD, 1971, J BACTERIOL, V107, P295, DOI 10.1128/JB.107.1.295-302.1971; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1971, REV SCI INSTRUM, V42, P868, DOI 10.1063/1.1685246; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Chattopadhyay S, 2006, P NATL ACAD SCI USA, V103, P13712, DOI 10.1073/pnas.0602043103; Chen XB, 2000, BIOPHYS J, V78, P1036, DOI 10.1016/S0006-3495(00)76662-8; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Endres RG, 2008, P NATL ACAD SCI USA, V105, P15749, DOI 10.1073/pnas.0804688105; FOLLETT EAC, 1963, J GEN MICROBIOL, V32, P235, DOI 10.1099/00221287-32-2-235; FUTRELLE RP, 1972, NATURE, V239, P517, DOI 10.1038/239517a0; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Homma M, 1996, MICROBIOL-UK, V142, P2777, DOI 10.1099/13500872-142-10-2777; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; Kalinin YV, 2009, BIOPHYS J, V96, P2439, DOI 10.1016/j.bpj.2008.10.027; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kojima M, 2007, MOL MICROBIOL, V64, P57, DOI 10.1111/j.1365-2958.2007.05623.x; KOSHLAND DE, 1980, ANNU REV NEUROSCI, V3, P43, DOI 10.1146/annurev.ne.03.030180.000355; LANDAU LD, 1982, FLUID MECH; Levit MN, 2002, J BIOL CHEM, V277, P36760, DOI 10.1074/jbc.M204325200; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; Mao HB, 2003, P NATL ACAD SCI USA, V100, P5449, DOI 10.1073/pnas.0931258100; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Porter SL, 2008, TRENDS MICROBIOL, V16, P251, DOI 10.1016/j.tim.2008.02.006; SAMUEL ADT, 1995, P NATL ACAD SCI USA, V92, P3502, DOI 10.1073/pnas.92.8.3502; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; SOCKETT RE, 1987, J BACTERIOL, V169, P5808, DOI 10.1128/jb.169.12.5808-5814.1987; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	41	23	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18231	10.1371/journal.pone.0018231	http://dx.doi.org/10.1371/journal.pone.0018231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494608	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000289292800006
J	Dixon, E; Clubb, C; Pittman, S; Ammann, L; Rasheed, Z; Kazmi, N; Keshavarzian, A; Gillevet, P; Rangwala, H; Couch, RD				Dixon, Emma; Clubb, Cynthia; Pittman, Sara; Ammann, Larry; Rasheed, Zeehasham; Kazmi, Nazia; Keshavarzian, Ali; Gillevet, Pat; Rangwala, Huzefa; Couch, Robin D.			Solid-Phase Microextraction and the Human Fecal VOC Metabolome	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; LUNG-CANCER; BREATH; BIOMARKERS; FIBERS	The diagnostic potential and health implications of volatile organic compounds (VOCs) present in human feces has begun to receive considerable attention. Headspace solid-phase microextraction (SPME) has greatly facilitated the isolation and analysis of VOCs from human feces. Pioneering human fecal VOC metabolomic investigations have utilized a single SPME fiber type for analyte extraction and analysis. However, we hypothesized that the multifarious nature of metabolites present in human feces dictates the use of several diverse SPME fiber coatings for more comprehensive metabolomic coverage. We report here an evaluation of eight different commercially available SPME fibers, in combination with both GC-MS and GC-FID, and identify the 50/30 mu m CAR-DVB-PDMS, 85 mu m CAR-PDMS, 65 mu m DVB-PDMS, 7 mu m PDMS, and 60 mu m PEG SPME fibers as a minimal set of fibers appropriate for human fecal VOC metabolomics, collectively isolating approximately 90% of the total metabolites obtained when using all eight fibers. We also evaluate the effect of extraction duration on metabolite isolation and illustrate that ex vivo enteric microbial fermentation has no effect on metabolite composition during prolonged extractions if the SPME is performed as described herein.	[Dixon, Emma; Clubb, Cynthia; Pittman, Sara; Ammann, Larry; Couch, Robin D.] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA; [Rasheed, Zeehasham; Rangwala, Huzefa] George Mason Univ, Dept Comp Sci & Engn, Fairfax, VA 22030 USA; [Gillevet, Pat] George Mason Univ, Dept Environm Sci & Policy, Manassas, VA USA; [Kazmi, Nazia; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Dixon, Emma; Clubb, Cynthia; Pittman, Sara; Ammann, Larry; Rasheed, Zeehasham; Gillevet, Pat; Rangwala, Huzefa; Couch, Robin D.] George Mason Univ, Microbiome Anal Ctr, Manassas, VA USA	George Mason University; George Mason University; George Mason University; Rush University; George Mason University	Dixon, E (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA USA.	rcouch@gmu.edu			NIH [1RC 2 AA019405]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019405] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0905117] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was supported by NIH grant 1RC 2 AA019405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI J, 1999, QUANTITATION SPME RE; Alpendurada MD, 2000, J CHROMATOGR A, V889, P3; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Boland W., 1984, ANAL VOLATILES, P371; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; Dallinga JW, 2010, CLIN EXP ALLERGY, V40, P68, DOI 10.1111/j.1365-2222.2009.03343.x; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; Koziel J, 2000, ANAL CHEM, V72, P5178, DOI 10.1021/ac000518l; PAWLISZYN J, 1999, QUANTITATIVE ASPECTS; Phillips M, 2004, CLIN CHIM ACTA, V344, P189, DOI 10.1016/j.cccn.2004.02.025; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005	16	53	54	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18471	10.1371/journal.pone.0018471	http://dx.doi.org/10.1371/journal.pone.0018471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494609	gold, Green Published, Green Submitted			2022-12-25	WOS:000289292800020
J	Vicari, E; La Vignera, S; Arcoria, D; Condorelli, R; Vicari, LO; Castiglione, R; Mangiameli, A; Calogero, AE				Vicari, Enzo; La Vignera, Sandro; Arcoria, Domenico; Condorelli, Rosita; Vicari, Lucia O.; Castiglione, Roberto; Mangiameli, Andrea; Calogero, Aldo E.			High Frequency of Chronic Bacterial and Non-Inflammatory Prostatitis in Infertile Patients with Prostatitis Syndrome Plus Irritable Bowel Syndrome	PLOS ONE			English	Article							CHRONIC PELVIC PAIN; SEMINAL LEUKOCYTE CONCENTRATION; OXYGEN SPECIES PRODUCTION; PREVALENCE; SYMPTOMS; ENDOMETRIOSIS; SEVERITY; PATTERNS; WOMEN; MEN	Background: Although prostatitis syndrome (PS) and irritable bowel syndrome (IBS) are common disorders, information on the prevalence of IBS in infertile patients with PS is relatively scanty. Therefore, this study was undertaken to estimate the frequency of PS and IBS and to evaluate the prevalence of the various diagnostic categories of prostatitis. Methodology/Principal Findings: This study enrolled 152 patients with PS, diagnosed by the NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) in an andrological setting, and 204 patients with IBS, diagnosed according to the Rome III diagnostic criteria in a gastroenterological setting. The patients with PS were asked to fulfill the Rome III questionnaire for IBS, whereas patients with IBS were asked to complete the NIH-CPSI. The simultaneous presence of PS and IBS was observed in 30.2% and 31.8% of the patients screened by andrologists and gastroenterologists, respectively. Altogether, 111 patients had PS plus IBS (31.2%). They had a total NIH-CPSI and pain subscale scores significantly higher than patients with PS alone. Gastrointestinal symptoms in patients with PS plus IBS were similar to those reported by patients with IBS alone and significantly greater in patients with PS alone. Patients with PS plus IBS had a significantly higher frequency of chronic bacterial prostatitis (category II) and lower of non-inflammatory prostatitis (category IIIB), compared to patients with PS alone. The frequency of inflammatory prostatitis (category IIIA) resulted similar. Conclusions/Significance: Prostatitis syndromes and IBS are frequently associated in patients with PS- or IBS-related symptoms. These patients have an increased prevalence of chronic bacterial and non-inflammatory prostatitis.	[Vicari, Enzo; La Vignera, Sandro; Condorelli, Rosita; Vicari, Lucia O.; Castiglione, Roberto; Calogero, Aldo E.] Univ Catania, Dept Internal Med & Syst Dis, Sect Endocrinol Androl & Internal Med, Catania, Italy; [Arcoria, Domenico; Mangiameli, Andrea] Univ Catania, Dept Internal Med, Gastroenterol Sect, Catania, Italy	University of Catania; University of Catania	Vicari, E (corresponding author), Univ Catania, Dept Internal Med & Syst Dis, Sect Endocrinol Androl & Internal Med, Catania, Italy.	acaloger@unict.it	La Vignera, Sandro/AAR-1589-2020; Vicari, Enzo Saretto Dante/AAC-2118-2019; Calogero, Aldo E./AAA-9538-2021	Calogero, Aldo E./0000-0001-6950-335X; La Vignera, Sandro/0000-0002-7113-2372; Condorelli, Rosita Angela/0000-0002-5217-9343; VICARI, Enzo Saretto Dante/0000-0003-0243-2942				Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Rodriguez MAB, 2009, J UROLOGY, V182, P2123, DOI 10.1016/j.juro.2009.07.036; Clemens JQ, 2006, J UROLOGY, V175, P963, DOI 10.1016/S0022-5347(05)00351-4; Collins MM, 2002, J UROLOGY, V167, P1363, DOI 10.1016/S0022-5347(05)65301-3; Collins MM, 2001, J GEN INTERN MED, V16, P656; Diemer T, 2003, ANDROLOGIA, V35, P55, DOI 10.1046/j.1439-0272.2003.00537.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1559; Ehlert U, 1999, PSYCHOTHER PSYCHOSOM, V68, P87, DOI 10.1159/000012318; Endicott NA, 1998, PSYCHOSOM MED, V60, P744, DOI 10.1097/00006842-199811000-00017; Frissora Christine L, 2005, Curr Gastroenterol Rep, V7, P264, DOI 10.1007/s11894-005-0018-9; Gunnarsson J, 2009, DIGEST LIVER DIS, V41, P788, DOI 10.1016/j.dld.2009.07.006; Guo SW, 2006, GYNECOL OBSTET INVES, V62, P121, DOI 10.1159/000093019; Hungin APS, 2005, ALIMENT PHARM THER, V21, P1365, DOI 10.1111/j.1365-2036.2005.02463.x; Kennedy TM, 1998, GUT, V43, P770, DOI 10.1136/gut.43.6.770; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 1996, UROLOGY, V48, P715, DOI 10.1016/S0090-4295(96)00421-9; Lembo AJ, 2009, AM J GASTROENTEROL, V104, P686, DOI 10.1038/ajg.2009.23; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Li Hong-Jun, 2002, Zhonghua Nan Ke Xue, V8, P338; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Maxwell PR, 1997, LANCET, V350, P1691, DOI 10.1016/S0140-6736(97)05276-8; MEARES EM, 1968, INVEST UROL, V5, P492; Milingos S, 2006, GYNECOL OBSTET INVES, V62, P48, DOI 10.1159/000092023; Patrick J., 1993, WHO MANUAL STANDARDI; Posserud I, 2006, WORLD J GASTROENTERO, V12, P2830, DOI 10.3748/wjg.v12.i18.2830; Roberts RO, 1998, UROLOGY, V51, P578, DOI 10.1016/S0090-4295(98)00034-X; Schaeffer AJ, 2002, J UROLOGY, V168, P1048, DOI 10.1016/S0022-5347(05)64572-7; Schiefer HG, 1998, ANDROLOGIA, V30, P7; Sperber AD, 1999, AM J GASTROENTEROL, V94, P3541, DOI 10.1111/j.1572-0241.1999.01643.x; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Vicari E, 1999, HUM REPROD, V14, P2025, DOI 10.1093/humrep/14.8.2025; Vicari E, 2000, HUM REPROD, V15, P2536, DOI 10.1093/humrep/15.12.2536; VICARI E, 2004, MALE INFERTILITY TOD, V4, P139; Walker EA, 1996, J PSYCHOSOM OBST GYN, V17, P39, DOI 10.3109/01674829609025662; Weidner W, 1999, HUM REPROD UPDATE, V5, P421, DOI 10.1093/humupd/5.5.421; WEIDNER W, 1991, INFECTION, V19, pS119, DOI 10.1007/BF01643680; Wenninger K, 1996, J UROLOGY, V155, P965, DOI 10.1016/S0022-5347(01)66359-6; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392	39	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18647	10.1371/journal.pone.0018647	http://dx.doi.org/10.1371/journal.pone.0018647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494624	Green Submitted, Green Published, gold			2022-12-25	WOS:000289292800034
J	Wang, ZJ; Xu, Y; Shao, JH; Wang, J; Li, RH				Wang, Zhongjie; Xu, Yao; Shao, Jihai; Wang, Jie; Li, Renhui			Genes Associated with 2-Methylisoborneol Biosynthesis in Cyanobacteria: Isolation, Characterization, and Expression in Response to Light	PLOS ONE			English	Article							GEOSMIN PRODUCTION; ODOROUS COMPOUNDS; IDENTIFICATION; TASTE; GROWTH; LAKE	The volatile microbial metabolite 2-methylisoborneol (2-MIB) is a root cause of taste and odor issues in freshwater. Although current evidence suggests that 2-MIB is not toxic, this compound degrades water quality and presents problems for water treatment. To address these issues, cyanobacteria and actinomycetes, the major producers of 2-MIB, have been investigated extensively. In this study, two 2-MIB producing strains, coded as Pseudanabaena sp. and Planktothricoids raciborskii, were used in order to elucidate the genetic background, light regulation, and biochemical mechanisms of 2-MIB biosynthesis in cyanobacteria. Genome walking and PCR methods revealed that two adjacent genes, SAM-dependent methyltransferanse gene and monoterpene cyclase gene, are responsible for GPP methylation and subsequent cyclization to 2-MIB in cyanobacteria. These two genes are located in between two homologous cyclic nucleotide-binding protein genes that may be members of the Crp-Fnr regulator family. Together, this sequence of genes forms a putative operon. The synthesis of 2-MIB is similar in cyanobacteria and actinomycetes. Comparison of the gene arrangement and functional sites between cyanobacteria and other organisms revealed that gene recombination and gene transfer probably occurred during the evolution of 2-MIB-associated genes. All the microorganisms examined have a common origin of 2-MIB biosynthesis capacity, but cyanobacteria represent a unique evolutionary lineage. Gene expression analysis suggested that light is a crucial, but not the only, active regulatory factor for the transcription of 2-MIB synthesis genes. This light-regulated process is immediate and transient. This study is the first to identify the genetic background and evolution of 2-MIB biosynthesis in cyanobacteria, thus enhancing current knowledge on 2-MIB contamination of freshwater.	[Wang, Zhongjie; Li, Renhui] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Wang, Zhongjie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Xu, Yao] Nanjing Normal Univ, Coll Geog Sci, Nanjing, Peoples R China; [Shao, Jihai] Hunan Agr Univ, Resources & Environm Coll, Changsha, Hunan, Peoples R China; [Wang, Jie] Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Normal University; Hunan Agricultural University; Shanxi University	Wang, ZJ (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	reli@ihb.ac.cn	Wang, Zhongjie/T-9055-2019	Wang, Zhongjie/0000-0003-3491-417X	State Key Basic Research and Development Plan of China [2008CB418002]; National Water Science and Technology Projects [2008ZX07105-006, 2009ZX07101-013]; Chinese Academy of Science [082303-1-501]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Water Science and Technology Projects; Chinese Academy of Science(Chinese Academy of Sciences)	This work was funded by the State Key Basic Research and Development Plan of China (2008CB418002), the National Water Science and Technology Projects (2008ZX07105-006) (2009ZX07101-013), and the Hundred Talent Research Project of the Chinese Academy of Science (082303-1-501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY R, 1981, FEBS LETT, V125, P220, DOI 10.1016/0014-5793(81)80723-5; BORJESSON TS, 1993, J AGR FOOD CHEM, V41, P2104; BOWMER KH, 1992, WATER SCI TECHNOL, V25, P259, DOI 10.2166/wst.1992.0060; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Dickschat JS, 2007, ANGEW CHEM INT EDIT, V46, P8287, DOI 10.1002/anie.200702496; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Giglio S, 2011, ENVIRON SCI TECHNOL, V45, P992, DOI 10.1021/es102992p; Giglio S, 2008, ENVIRON SCI TECHNOL, V42, P8027, DOI 10.1021/es801465w; Graham JL, 2010, ENVIRON SCI TECHNOL, V44, P7361, DOI 10.1021/es1008938; Izaguirre G, 2004, WATER SCI TECHNOL, V49, P19, DOI 10.2166/wst.2004.0524; Izaguirre G, 1998, WATER RES, V32, P1673, DOI 10.1016/S0043-1354(97)00379-5; Jiang JY, 2007, NAT CHEM BIOL, V3, P711, DOI 10.1038/nchembio.2007.29; Juttner F, 2007, APPL ENVIRON MICROB, V73, P4395, DOI 10.1128/AEM.02250-06; King JM, 2003, ACS SYM SER, V848, P31; Komarek J, 2005, CYANOPROKARYOTA 2; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Li L, 2007, WATER SCI TECHNOL, V55, P43, DOI 10.2166/wst.2007.160; Ludwig F, 2007, APPL ENVIRON MICROB, V73, P6988, DOI 10.1128/AEM.01197-07; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MEDSKER LL, 1969, ENVIRON SCI TECHNOL, V3, P476, DOI 10.1021/es60028a008; NAES H, 1988, ARCH MICROBIOL, V150, P333, DOI 10.1007/BF00408303; Saadoun IMK, 2001, WATER RES, V35, P1209, DOI 10.1016/S0043-1354(00)00381-X; Spiteller D, 2002, PHYTOCHEMISTRY, V61, P827, DOI 10.1016/S0031-9422(02)00282-0; TABACHEK JAL, 1976, J FISH RES BOARD CAN, V33, P25, DOI 10.1139/f76-004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang CM, 2008, J AM CHEM SOC, V130, P8908, DOI 10.1021/ja803639g; Watson SB, 2004, WATER SCI TECHNOL, V49, P33, DOI 10.2166/wst.2004.0527; WNOROWSKI AU, 1992, WATER SA, V18, P203; Young WF, 1996, WATER RES, V30, P331, DOI 10.1016/0043-1354(95)00173-5; Zhang T, 2009, J APPL PHYCOL, V21, P279, DOI 10.1007/s10811-008-9363-z; Zimba PV, 1999, J PHYCOL, V35, P1422, DOI 10.1046/j.1529-8817.1999.3561422.x	33	49	55	7	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18665	10.1371/journal.pone.0018665	http://dx.doi.org/10.1371/journal.pone.0018665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490938	gold, Green Published, Green Submitted			2022-12-25	WOS:000289238700035
J	Sneddon, LU; Schmidt, R; Fang, YX; Cossins, AR				Sneddon, Lynne U.; Schmidt, Rupert; Fang, Yongxiang; Cossins, Andrew R.			Molecular Correlates of Social Dominance: A Novel Role for Ependymin in Aggression	PLOS ONE			English	Article							SUBORDINATE RELATIONSHIPS; MEMORY CONSOLIDATION; GENE-EXPRESSION; RAINBOW-TROUT; CELL-ADHESION; BROWN TROUT; CARP BRAIN; STRESS; HIERARCHIES; PLASTICITY	Theoretical and empirical studies have sought to explain the formation and maintenance of social relationships within groups. The resulting dominance hierarchies have significant fitness and survival consequences dependent upon social status. We hypothesised that each position or rank within a group has a distinctive brain gene expression profile that correlates with behavioural phenotype. Furthermore, transitions in rank position should determine which genes shift in expression concurrent with the new dominance status. We used a custom cDNA microarray to profile brain transcript expression in a model species, the rainbow trout, which forms tractable linear hierarchies. Dominant, subdominant and submissive individuals had distinctive transcript profiles with 110 gene probes identified using conservative statistical analyses. By removing the dominant, we characterised the changes in transcript expression in sub-dominant individuals that became dominant demonstrating that the molecular transition occurred within 48 hours. A strong, novel candidate gene, ependymin, which was highly expressed in both the transcript and protein in subdominants relative to dominants, was tested further. Using antibody injection to inactivate ependymin in pairs of dominant and subdominant zebrafish, the subdominant fish exhibited a substantial increase in aggression in parallel with an enhanced competitive ability. This is the first study to characterise the molecular signatures of dominance status within groups and the first to implicate ependymin in control of aggressive behaviour. It also provides evidence for indirect genetic effect models in which genotype/phenotype of an individual is influenced by conspecific interactions within a group. The variation in the molecular profile of each individual within a group may offer a new explanation of intraspecific variation in gene expression within undefined groups of animals and provides new candidates for empirical study.	[Sneddon, Lynne U.; Fang, Yongxiang; Cossins, Andrew R.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Sneddon, Lynne U.; Fang, Yongxiang; Cossins, Andrew R.] Univ Liverpool, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England; [Schmidt, Rupert] Univ Giessen, Zentrale Biotech Betriebseinheit, Giessen, Germany	University of Liverpool; University of Liverpool; Justus Liebig University Giessen	Sneddon, LU (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	lsneddon@liverpool.ac.uk	Sneddon, Lynne/A-8795-2012	Sneddon, Lynne/0000-0001-9787-3948; Cossins, Andrew/0000-0002-0813-5212	Natural Environment Research Council (NERC); Royal Society of London; NERC [NBAF010002, NE/F001320/1] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, NE/C000889/1, NE/F001320/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society of London(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Fellowship from the Natural Environment Research Council (NERC) and a Royal Society of London Travel Grant awarded to LS, and long-term support to ARC from NERC for the Liverpool node of their Biomolecular Analysis Facility. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Aubin-Horth N, 2005, P ROY SOC B-BIOL SCI, V272, P1655, DOI 10.1098/rspb.2005.3125; Ben-Shahar Y, 2005, J COMP PHYSIOL A, V191, P987, DOI 10.1007/s00359-005-0025-1; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buitenhuis B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-544; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Cherek DR, 2004, PSYCHOPHARMACOLOGY, V171, P405, DOI 10.1007/s00213-003-1590-z; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Leil TA, 2002, J NEUROSCI RES, V68, P127, DOI 10.1002/jnr.10184; METCALFE NB, 1986, J FISH BIOL, V28, P525, DOI 10.1111/j.1095-8649.1986.tb05190.x; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Olsen EM, 2001, N AM J FISH MANAGE, V21, P967, DOI 10.1577/1548-8675(2001)021&lt;0967:AEOVIE&gt;2.0.CO;2; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Pradel G, 1999, J NEUROBIOL, V39, P197, DOI 10.1002/(SICI)1097-4695(199905)39:2<197::AID-NEU4>3.0.CO;2-9; Pradel G, 2000, J NEUROBIOL, V43, P389, DOI 10.1002/1097-4695(20000615)43:4<389::AID-NEU7>3.0.CO;2-X; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; ROTHER S, 1995, J NEUROCHEM, V65, P1456; Schmidt JT, 1998, J NEUROBIOL, V37, P659, DOI 10.1002/(SICI)1097-4695(199812)37:4<659::AID-NEU13>3.0.CO;2-3; Sloman KA, 2000, FISH PHYSIOL BIOCHEM, V22, P11, DOI 10.1023/A:1007837400713; Sloman KA, 2002, CAN J ZOOL, V80, P1221, DOI [10.1139/z02-105, 10.1139/Z02-105]; Sloman KA, 2001, PHYSIOL BIOCHEM ZOOL, V74, P383, DOI 10.1086/320426; Smith RW, 2009, PROTEOMICS, V9, P2217, DOI 10.1002/pmic.200800662; Sneddon LU, 2006, ETHOLOGY, V112, P437, DOI 10.1111/j.1439-0310.2005.01192.x; Sneddon LU, 2005, PHYSIOL BIOCHEM ZOOL, V78, P695, DOI 10.1086/432141; Sneddon LU, 2004, J FISH BIOL, V64, P799, DOI 10.1111/j.1095-8649.2004.00361.x; Sneddon LU, 2000, J EXP BIOL, V203, P537; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suarez-Castillo EC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-23; Tang SJ, 1999, FEBS LETT, V459, P95, DOI 10.1016/S0014-5793(99)01229-6; Thomas JB, 2006, COMP BIOCHEM PHYS A, V143, P162, DOI 10.1016/j.cbpa.2005.11.008; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Weir LK, 2004, J ANIM ECOL, V73, P1069, DOI 10.1111/j.0021-8790.2004.00876.x; Williams TD, 2003, AQUAT TOXICOL, V65, P141, DOI 10.1016/S0166-445X(03)00119-X; WILSON AJ, 2008, P ROY SOC LOND B BIO, V276, P533; Wit E, 2005, J R STAT SOC C-APPL, V54, P817, DOI 10.1111/j.1467-9876.2005.00519.x	44	40	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18181	10.1371/journal.pone.0018181	http://dx.doi.org/10.1371/journal.pone.0018181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483679	gold, Green Published, Green Submitted			2022-12-25	WOS:000289191300009
J	Bohm, SM; Wells, K; Kalko, EKV				Boehm, Stefan M.; Wells, Konstans; Kalko, Elisabeth K. V.			Top-Down Control of Herbivory by Birds and Bats in the Canopy of Temperate Broad-Leaved Oaks (Quercus robur)	PLOS ONE			English	Article							WHITE OAK; SPECIES RICHNESS; LEAF TANNINS; ARTHROPODS; PREDATION; FOREST; DAMAGE; DIVERSITY; ABUNDANCE; INSECTS	The intensive foraging of insectivorous birds and bats is well known to reduce the density of arboreal herbivorous arthropods but quantification of collateral leaf damage remains limited for temperate forest canopies. We conducted exclusion experiments with nets in the crowns of young and mature oaks, Quercus robur, in south and central Germany to investigate the extent to which aerial vertebrates reduce herbivory through predation. We repeatedly estimated leaf damage throughout the vegetation period. Exclusion of birds and bats led to a distinct increase in arthropod herbivory, emphasizing the prominent role of vertebrate predators in controlling arthropods. Leaf damage (e. g., number of holes) differed strongly between sites and was 59% higher in south Germany, where species richness of vertebrate predators and relative oak density were lower compared with our other study site in central Germany. The effects of bird and bat exclusion on herbivory were 19% greater on young than on mature trees in south Germany. Our results support previous studies that have demonstrated clear effects of insectivorous vertebrates on leaf damage through the control of herbivorous arthropods. Moreover, our comparative approach on quantification of leaf damage highlights the importance of local attributes such as tree age, forest composition and species richness of vertebrate predators for control of arthropod herbivory.	[Boehm, Stefan M.; Wells, Konstans] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Wells, Konstans] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Smithsonian Institution; Smithsonian Tropical Research Institute	Bohm, SM (corresponding author), Univ Ulm, Inst Expt Ecol, Ulm, Germany.	stefan.boehm@uni-ulm.de	Wells, Konstans/A-7232-2010	Wells, Konstans/0000-0003-0377-2463	German Research Foundation [1374, KA 1241/151]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (www.dfg.de) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (KA 1241/151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEGRIM O, 1989, OECOLOGIA, V79, P136; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Barber NA, 2009, AM MIDL NAT, V162, P169, DOI 10.1674/0003-0031-162.1.169; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bohm SM, 2009, J ORNITHOL, V150, P799, DOI 10.1007/s10336-009-0401-7; Bridgeland WT, 2010, ECOLOGY, V91, P73, DOI 10.1890/08-1821.1; Brossa R, 2009, TREES-STRUCT FUNCT, V23, P401, DOI 10.1007/s00468-008-0289-5; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1986, OECOLOGIA, V70, P238, DOI 10.1007/BF00379246; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; FEENY PP, 1968, J INSECT PHYSIOL, V14, P805, DOI 10.1016/0022-1910(68)90191-1; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; Gil-Tena A, 2007, FOREST ECOL MANAG, V242, P470, DOI 10.1016/j.foreco.2007.01.080; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; GRADWOHL J, 1982, ECOLOGY, V63, P581, DOI 10.2307/1938974; Greenberg R, 2000, ECOLOGY, V81, P1750, DOI 10.1890/0012-9658(2000)081[1750:TIOAIO]2.0.CO;2; Gunnarsson B, 1996, J ANIM ECOL, V65, P389, DOI 10.2307/5885; Gunnarsson B, 2004, BIODIVERS CONSERV, V13, P685, DOI 10.1023/B:BIOC.0000011720.18889.f7; Gunnarsson B, 2009, FOREST ECOL MANAG, V257, P619, DOI 10.1016/j.foreco.2008.09.055; Gunnarsson B, 2007, J ARACHNOL, V35, P509, DOI 10.1636/RT07-64.1; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hochwender CG, 2003, AM MIDL NAT, V150, P246, DOI 10.1674/0003-0031(2003)150[0246:FCOHOQ]2.0.CO;2; HOLMES RT, 1979, SCIENCE, V206, P462, DOI 10.1126/science.206.4417.462; Kalcounis MC, 1999, J MAMMAL, V80, P673, DOI 10.2307/1383311; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Knoot TG, 2010, ENVIRON MANAGE, V45, P155, DOI 10.1007/s00267-009-9404-7; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Lanham JD, 2002, FOREST ECOL MANAG, V155, P143, DOI 10.1016/S0378-1127(01)00554-0; Lichtenberg JS, 2002, AM MIDL NAT, V148, P338, DOI 10.1674/0003-0031(2002)148[0338:WTIABI]2.0.CO;2; Lill JT, 2003, ECOLOGY, V84, P682, DOI 10.1890/0012-9658(2003)084[0682:EEBCII]2.0.CO;2; Mantyla E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002832; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; Marquis RJ, 2004, SCIENCE, V305, P619, DOI 10.1126/science.1101848; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Mooney KA, 2010, P NATL ACAD SCI USA, V107, P7335, DOI 10.1073/pnas.1001934107; MOORE R, 1991, J APPL ECOL, V28, P305, DOI 10.2307/2404131; Murakami M, 2000, P ROY SOC B-BIOL SCI, V267, P1597, DOI 10.1098/rspb.2000.1184; PAINE RT, 1980, J ANIM ECOL, V49, P667; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; PRESZLER RW, 1994, OECOLOGIA, V100, P66, DOI 10.1007/BF00317131; Recher HF, 2006, AUSTRAL ECOL, V31, P349, DOI 10.1111/j.1442-9993.2006.01555.x; Sanz JJ, 2001, ECOL RES, V16, P387, DOI 10.1046/j.1440-1703.2001.00403.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schwenk WS, 2010, J AVIAN BIOL, V41, P367, DOI 10.1111/j.1600-048X.2009.04963.x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Southwood TRE, 2004, EUR J ENTOMOL, V101, P43, DOI 10.14411/eje.2004.011; Strong AM, 2000, OECOLOGIA, V125, P370, DOI 10.1007/s004420000467; Suwa T, 2008, AM J BOT, V95, P434, DOI 10.3732/ajb.95.4.434; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Van Bael SA, 2005, OECOLOGIA, V145, P658, DOI 10.1007/s00442-005-0134-0; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Wold EN, 1997, ECOLOGY, V78, P1356, DOI 10.1890/0012-9658(1997)078[1356:IDIWOE]2.0.CO;2; Wright DM, 2010, FUNCT ECOL, V24, P52, DOI 10.1111/j.1365-2435.2009.01597.x; Zuur Alain F., 2009, P1	64	61	64	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17857	10.1371/journal.pone.0017857	http://dx.doi.org/10.1371/journal.pone.0017857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483739	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058700003
J	Suzuki, M; Kimura, T; Ogawa, H; Hotta, K; Oka, K				Suzuki, Mamiko; Kimura, Tetsuya; Ogawa, Hiroto; Hotta, Kohji; Oka, Kotaro			Chromatophore Activity during Natural Pattern Expression by the Squid Sepioteuthis lessoniana: Contributions of Miniature Oscillation	PLOS ONE			English	Article							LOLIGO-VULGARIS; BODY PATTERNS; ULTRASTRUCTURE; MOTONEURONS; RESPONSES; BEHAVIOR; BRAIN; STIMULATION; INFORMATION; OPALESCENS	Squid can rapidly change the chromatic patterns on their body. The patterns are created by the expansion and retraction of chromatophores. The chromatophore consists of a central pigment-containing cell surrounded by radial muscles that are controlled by motor neurons located in the central nervous system (CNS). In this study we used semi-intact squid (Sepioteuthis lessoniana) displaying centrally controlled natural patterns to analyze spatial and temporal activities of chromatophores located on the dorsal mantle skin. We found that chromatophores oscillated with miniature expansions/retractions at various frequencies, even when the chromatic patterns appear macroscopically stable. The frequencies of this miniature oscillation differed between "feature" and "background" areas of chromatic patterns. Higher frequencies occurred in feature areas, whereas lower frequencies were detected in background areas. We also observed synchronization of the oscillation during chromatic pattern expression. The expansion size of chromatophores oscillating at high frequency correlated with the number of synchronized chromatophores but not the oscillation frequency. Miniature oscillations were not observed in denervated chromatophores. These results suggest that miniature oscillations of chromatophores are driven by motor neuronal activities in the CNS and that frequency and synchrony of this oscillation determine the chromatic pattern and the expansion size, respectively.	[Suzuki, Mamiko; Hotta, Kohji; Oka, Kotaro] Keio Univ, Grad Sch Sci & Technol, Kanagawa, Japan; [Kimura, Tetsuya] RIKEN Brain Sci Inst, Lab Alzheimer Dis, Wako, Saitama, Japan; [Ogawa, Hiroto] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan	Keio University; RIKEN; Hokkaido University	Suzuki, M (corresponding author), Keio Univ, Grad Sch Sci & Technol, Kanagawa, Japan.	oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014	Hotta, Kohji/0000-0003-4614-7473	Ministry of Education, Culture, Sports, Science and Technology; Keio University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University	This work was funded by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for the 21st Century Center of Excellence (COE) Program titled "Understanding and Control of Life's Function via Systems Biology" (Keio University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arshavsky YI, 1998, ANN NY ACAD SCI, V860, P51, DOI 10.1111/j.1749-6632.1998.tb09038.x; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; CLONEY RA, 1968, Z ZELLFORSCH MIK ANA, V89, P250, DOI 10.1007/BF00347297; DUBAS F, 1986, J EXP BIOL, V121, P1; DUBAS F, 1986, BRAIN RES, V374, P21, DOI 10.1016/0006-8993(86)90390-2; FLOREY E, 1966, COMP BIOCHEM PHYSIOL, V18, P305, DOI 10.1016/0010-406X(66)90189-7; FLOREY E, 1969, AM ZOOL, V9, P429; FLOREY E, 1969, Z VERGL PHYSIOL, V65, P98, DOI 10.1007/BF00297991; Gaston Michelle R., 2006, Invertebrate Neuroscience, V6, P81, DOI 10.1007/s10158-006-0021-3; GILBERT DL, 1990, SQUID EXPT ANIMALS; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Hanlon R. T., 1996, CEPHALOPOD BEHAV; HANLON RT, 1994, BIOL BULL, V187, P363, DOI 10.2307/1542293; Hanlon RT, 1999, BIOL BULL-US, V197, P49, DOI 10.2307/1542996; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; Iwama A, 1999, ZOOL SCI, V16, P407, DOI 10.2108/zsj.16.407; Jantzen TM, 2003, BIOL BULL-US, V204, P305, DOI 10.2307/1543601; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; MESSENGER JB, 1986, J EXP BIOL, V125, P395; MIROW S, 1972, CELL TISSUE RES, V125, P176; Miyan J.A., 1995, P415; PACKARD A, 1971, ANIM BEHAV, V19, P780, DOI 10.1016/S0003-3472(71)80181-1; PACKARD A, 1992, J PHYSIOL-LONDON, V446, pP164; PACKARD A, 1993, J PHYSIOL-LONDON, V459, pP429; PACKARD A, 1995, J PHYSIOL-LONDON, V489P, pP134; Packard A., 1988, P89; Packard A., 1995, BEHAV BRAIN RES NATU, P105; Packard A., 2001, INT SCH BIOCYBERNETI, P397; Packard Andrew, 1995, P331; Packard A, 2011, OPT LASER TECHNOL, V43, P302, DOI 10.1016/j.optlastec.2008.12.017; REED CM, 1995, CELL TISSUE RES, V282, P503, DOI 10.1007/s004410050501; Sakurai Y, 1999, NEUROSCI BIOBEHAV R, V23, P785, DOI 10.1016/S0149-7634(99)00017-2; SANDERS GD, 1974, PROC R SOC SER B-BIO, V186, P1, DOI 10.1098/rspb.1974.0031; Sekiguchi T, 2010, LEARN MEMORY, V17, P372, DOI 10.1101/lm.1867110	38	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18244	10.1371/journal.pone.0018244	http://dx.doi.org/10.1371/journal.pone.0018244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483763	gold, Green Submitted, Green Published			2022-12-25	WOS:000289058300009
J	Cerqueira, FM; Laurindo, FRM; Kowaltowski, AJ				Cerqueira, Fernanda M.; Laurindo, Francisco R. M.; Kowaltowski, Alicia J.			Mild Mitochondrial Uncoupling and Calorie Restriction Increase Fasting eNOS, Akt and Mitochondrial Biogenesis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LIFE-SPAN; INSULIN SENSITIVITY; DIETARY RESTRICTION; GENE-EXPRESSION; RHESUS-MONKEYS; BLOOD-GLUCOSE; PHOSPHORYLATION; METABOLISM; MIMETICS	Enhanced mitochondrial biogenesis promoted by eNOS activation is believed to play a central role in the beneficial effects of calorie restriction (CR). Since treatment of mice with dinitrophenol (DNP) promotes health and lifespan benefits similar to those observed in CR, we hypothesized that it could also impact biogenesis. We found that DNP and CR increase citrate synthase activity, PGC-1 alpha, cytochrome c oxidase and mitofusin-2 expression, as well as fasting plasma levels of NO center dot products. In addition, eNOS and Akt phosphorylation in skeletal muscle and visceral adipose tissue was activated in fasting CR and DNP animals. Overall, our results indicate that systemic mild uncoupling activates eNOS and Akt-dependent pathways leading to mitochondrial biogenesis.	[Cerqueira, Fernanda M.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Laurindo, Francisco R. M.] Univ Sao Paulo, Inst Coracao, Fac Med, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cerqueira, FM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	cerqueira, fernanda/C-8326-2014; Kowaltowski, Alicia J/H-8698-2012; Laurindo, Francisco R/J-6575-2015		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); The John Simon Guggenhein Memorial Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); The John Simon Guggenhein Memorial Foundation	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma) and The John Simon Guggenhein Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Baylis C, 1998, CURR OPIN NEPHROL HY, V7, P59, DOI 10.1097/00041552-199801000-00010; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Boden G, 2005, ANN INTERN MED, V142, P403, DOI 10.7326/0003-4819-142-6-200503150-00006; BODKIN NL, 1995, J GERONTOL A-BIOL, V50, pB142, DOI 10.1093/gerona/50A.3.B142; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Escriva F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hu ZL, 2008, J BIOL CHEM, V283, P25256, DOI 10.1074/jbc.M802455200; Humphrey DM, 2009, EXP GERONTOL, V44, P316, DOI 10.1016/j.exger.2009.02.001; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540; Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003; LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; MONTAGNANI M, 2001, J BIOL CHEM, V12, P597; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Padalko VI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P986, DOI 10.1007/s10541-005-0213-1; Rashid G, 2007, NEPHROL DIAL TRANSPL, V22, P2831, DOI 10.1093/ndt/gfm269; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tainter ML, 1938, J PHARMACOL EXP THER, V63, P51; van Diepeningen AD, 2010, EXP GERONTOL, V45, P516, DOI 10.1016/j.exger.2010.01.002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181; Zhou XS, 2009, AM J PHYSIOL-HEART C, V297, pH2227, DOI 10.1152/ajpheart.00325.2009; Zorzano A, 2009, CURR OPIN DRUG DISC, V12, P597	46	57	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18433	10.1371/journal.pone.0018433	http://dx.doi.org/10.1371/journal.pone.0018433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483800	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200078
J	Martinez, JP; Bocharov, G; Ignatovich, A; Reiter, J; Dittmar, MT; Wain-Hobson, S; Meyerhans, A				Martinez, Javier P.; Bocharov, Gennady; Ignatovich, Anna; Reiter, Jochen; Dittmar, Matthias T.; Wain-Hobson, Simon; Meyerhans, Andreas			Fitness Ranking of Individual Mutants Drives Patterns of Epistatic Interactions in HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; DELETERIOUS MUTATIONS; RNA VIRUS; POSITIVE EPISTASIS; NUCLEOSIDE ANALOGS; GENETIC ROBUSTNESS; DRUG-RESISTANCE; VIRAL FITNESS; EVOLUTION	Fitness interactions between mutations, referred to as epistasis, can strongly impact evolution. For RNA viruses and retroviruses with their high mutation rates, epistasis may be particularly important to overcome fitness losses due to the accumulation of deleterious mutations and thus could influence the frequency of mutants in a viral population. As human immunodeficiency virus type 1 (HIV-1) resistance to azidothymidine (AZT) requires selection of sequential mutations, it is a good system to study the impact of epistasis. Here we present a thorough analysis of a classical AZT-resistance pathway (the 41-215 cluster) of HIV-1 variants by fitness measurements in single round infection assays covering physiological drug concentrations ex vivo. The sign and value of epistasis varied and did not predict the epistatic effect on the mutant frequency. This complex behavior is explained by the fitness ranking of the variants that strongly depends on environmental factors, i.e., the presence and absence of drugs and the host cells used. Although some interactions compensate fitness losses, the observed small effect on the relative mutant frequencies suggests that epistasis might be inefficient as a buffering mechanism for fitness losses in vivo. While the use of epistasis-based hypotheses to make general assumptions on the evolutionary dynamics of viral populations is appealing, our data caution their interpretation without further knowledge on the characteristics of the viral mutant spectrum under different environmental conditions.	[Martinez, Javier P.; Reiter, Jochen; Meyerhans, Andreas] Univ Saarland, Dept Virol, D-6650 Homburg, Germany; [Bocharov, Gennady; Ignatovich, Anna] Russian Acad Sci, Inst Numer Math, Moscow, Russia; [Dittmar, Matthias T.] Barts & London Queen Marys Sch Med & Dent, Ctr Immunol & Infect Dis, London, England; [Wain-Hobson, Simon] Inst Pasteur, Mol Retrovirol Unit, Paris, France; [Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, ICREA Infect Biol Lab, Barcelona, Spain	Saarland University; Russian Academy of Sciences; University of London; Queen Mary University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; ICREA; Pompeu Fabra University	Martinez, JP (corresponding author), Univ Saarland, Dept Virol, D-6650 Homburg, Germany.	andreas.meyerhans@upf.edu	Meyerhans, Andreas/D-3382-2014; Bocharov, Gennady/H-1832-2016; Bocharov, Gennady/GSN-1705-2022; Bocharov, Gennady/T-1322-2017; Meyerhans, Andreas/S-2559-2019; Bocharov, Gennady/AGA-7312-2022; Bocharov, Gennady/AAN-7508-2020	Meyerhans, Andreas/0000-0003-0620-5317; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Meyerhans, Andreas/0000-0003-0620-5317; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Martinez Vesga, Javier Pablo/0000-0003-3333-5272	Deutsche Forschungsgemeinschaft; Deutsche Akademische Austauschdienst (DAAD); Russian Foundation for Basic Research; Russian Academy of Sciences; ICREA Funding Source: Custom	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); ICREA(ICREA)	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Deutsche Akademische Austauschdienst (DAAD), and the Russian Foundation for Basic Research and by the Program of the Russian Academy of Sciences "Basic Research for Medicine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2005, J VIROL, V79, P13572, DOI 10.1128/JVI.79.21.13572-13578.2005; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Armitage P., 2002, STAT METHODS MED RES; Arts EJ, 1998, DRUG RESIST UPDATE, V1, P21, DOI 10.1016/S1368-7646(98)80211-2; Arts EJ, 1996, J VIROL, V70, P712, DOI 10.1128/JVI.70.2.712-720.1996; ARTS EJ, 1994, ANTIMICROB AGENTS CH, V38, P1008, DOI 10.1128/AAC.38.5.1008; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Bateson W, 1909, MENDELS PRINCIPLES H; Beerenwinkel N, 2005, J INFECT DIS, V191, P1953, DOI 10.1086/430005; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Elena SF, 2010, CHAOS, V20, DOI 10.1063/1.3449300; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Elena SF, 1999, J MOL EVOL, V49, P703, DOI 10.1007/PL00000082; Fletcher CV, 2000, AIDS, V14, P2137, DOI 10.1097/00002030-200009290-00010; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Harrigan PR, 1998, J VIROL, V72, P3773, DOI 10.1128/JVI.72.5.3773-3778.1998; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu ZX, 2006, J VIROL, V80, P7020, DOI 10.1128/JVI.02747-05; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; LACEY SF, 1994, J VIROL, V68, P3421, DOI 10.1128/JVI.68.5.3421-3424.1994; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; Neumann T, 2005, VIROLOGY, V333, P251, DOI 10.1016/j.virol.2004.12.035; NOWAK AMM, 2000, VIRUS DYNAMICS; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Otto SP, 2006, BIOCHEM SOC T, V34, P519, DOI 10.1042/BST0340519; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Rolland M, 2007, NAT REV MICROBIOL, V5, P2006, DOI 10.1038/nrmicro1594-C1; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; SLUSHER JT, 1992, ANTIMICROB AGENTS CH, V36, P2473, DOI 10.1128/AAC.36.11.2473; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; van Opijnen T, 2006, J VIROL, V80, P6678, DOI 10.1128/JVI.02547-05; van Opijnen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000271; Wang K, 2006, SCIENCE, V312, DOI 10.1126/science.1109904; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	57	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18375	10.1371/journal.pone.0018375	http://dx.doi.org/10.1371/journal.pone.0018375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483787	gold, Green Published			2022-12-25	WOS:000289057200067
J	Wang, J; Tong, P; Lu, L; Zhou, LL; Xu, LL; Jiang, SB; Chen, YH				Wang, Ji; Tong, Pei; Lu, Lu; Zhou, Leilei; Xu, Liling; Jiang, Shibo; Chen, Ying-hua			HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; EPITOPE-SPECIFIC ANTIBODIES; B-CELL EPITOPES; GLYCOPROTEIN GP41; TRANSMEMBRANE GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN; TYPE-1 ENVELOPE; VIRAL MEMBRANE; VACCINE DESIGN	The membrane-proximal external region (MPER) of the HIV-1 gp41 consists of epitopes for the broadly cross-neutralizing monoclonal antibodies 2F5 and 4E10. However, antigens containing the linear sequence of these epitopes are unable to elicit potent and broad neutralizing antibody responses in vaccinated hosts, possibly because of inappropriate conformation of these epitopes. Here we designed a recombinant antigen, designated NCM, which comprises the N-and C-terminal heptad repeats that can form a six-helix bundle (6HB) core and the MPER domain of gp41. Two mutations (T569A and I675V) previously reported to expose the neutralization epitopes were introduced into NCM to generate mutants named NCM(TA), NCM(IV), and NCM(TAIV). Our results showed that NCM and its mutants could react with antibodies specific for 6HB and MPER of gp41, suggesting that these antigens are in the form of a trimer of heterodimer (i. e., 6HB) with three exposed MPER tails. Antigen with double mutations, NCM(TAIV), elicited much stronger antibody response in rabbits than immunogens with single mutation, NCM(TA) and NCM(IV), or no mutation, NCM. The purified MPER-specific antibodies induced by NCM(TAIV) exhibited broad neutralizing activity, while the purified 6HB-specific antibodies showed no detectable neutralizing activity. Our recombinant antigen design supported by an investigation of its underlying molecular mechanisms provides a strong scientific platform for the discovery of a gp41 MPER-based AIDS vaccine.	[Wang, Ji; Tong, Pei; Zhou, Leilei; Xu, Liling; Chen, Ying-hua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Lu, Lu; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Lu, Lu; Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Hlth, Minist Educ,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Tsinghua University; New York Blood Center; Fudan University; Fudan University	Wang, J (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	sjiang@nybloodcenter.org; chenyh@mail.tsinghua.edu.cn	Lu, Lu/K-7070-2014; lu, lu/HII-7530-2022; chen, ying/HHS-8254-2022; lu, lu/HGA-0894-2022; Jiang, Shibo/L-4500-2014	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135	Ministry of Health of China [2008zx10001-011]; National Institutes of Health (NIH) [AI046221]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046221, R01AI046221] Funding Source: NIH RePORTER	Ministry of Health of China; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Ministry of Health of China (2008zx10001-011) to YHC and a National Institutes of Health (NIH) grant (AI046221) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Haynes Barton F., 2005, Human Antibodies, V14, P59; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Ho J, 2002, VACCINE, V20, P1169, DOI 10.1016/S0264-410X(01)00441-8; Huang JH, 2008, J BIOL CHEM, V283, P14994, DOI 10.1074/jbc.M800525200; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Li H, 2002, IMMUNOL LETT, V84, P153, DOI 10.1016/S0165-2478(02)00175-X; Li J, 2008, BIOCHEM BIOPH RES CO, V376, P60, DOI 10.1016/j.bbrc.2008.08.105; Li L, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-37; Li L, 2010, ANTIMICROB AGENTS CH, V54, P1700, DOI 10.1128/AAC.01046-09; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Lu Y, 2000, SCAND J IMMUNOL, V51, P497; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Mische CC, 2005, VIROLOGY, V338, P133, DOI 10.1016/j.virol.2005.05.001; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; NEURATH AR, 2002, BMC INFECT DIS, V2, P41; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; ROBINSON WE, 1990, P NATL ACAD SCI USA, V87, P3185, DOI 10.1073/pnas.87.8.3185; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shi WX, 2010, J BIOL CHEM, V285, P24290, DOI 10.1074/jbc.M110.111351; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian HJ, 2001, INT IMMUNOPHARMACOL, V1, P763, DOI 10.1016/S1567-5769(01)00017-0; Veiga AS, 2009, CHEMBIOCHEM, V10, P1032, DOI 10.1002/cbic.200800609; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang ZG, 2005, MICROBIOL IMMUNOL, V49, P703, DOI 10.1111/j.1348-0421.2005.tb03657.x; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhu Y, 2010, J VIROL, V84, P9359, DOI 10.1128/JVI.00644-10; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	52	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18233	10.1371/journal.pone.0018233	http://dx.doi.org/10.1371/journal.pone.0018233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483871	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200046
J	Colijn, C; Cohen, T; Ganesh, A; Murray, M				Colijn, Caroline; Cohen, Ted; Ganesh, Ayalvadi; Murray, Megan			Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO; PROBABILITY-DISTRIBUTION; MUTATION FREQUENCIES; BEIJING-GENOTYPE; MUTANTS; EVOLUTION; GENE; TRANSMISSION; CHEMOTHERAPY	The emergence of drug resistance in M. tuberculosis undermines the efficacy of tuberculosis (TB) treatment in individuals and of TB control programs in populations. Multiple drug resistance is often attributed to sequential functional monotherapy, and standard initial treatment regimens have therefore been designed to include simultaneous use of four different antibiotics. Despite the widespread use of combination therapy, highly resistant M. tb strains have emerged in many settings. Here we use a stochastic birth-death model to estimate the probability of the emergence of multidrug resistance during the growth of a population of initially drug sensitive TB bacilli within an infected host. We find that the probability of the emergence of resistance to the two principal anti-TB drugs before initiation of therapy ranges from 10(-5) to 10(-4); while rare, this is several orders of magnitude higher than previous estimates. This finding suggests that multidrug resistant M. tb may not be an entirely "man-made" phenomenon and may help explain how highly drug resistant forms of TB have independently emerged in many settings.	[Colijn, Caroline] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Cohen, Ted; Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cohen, Ted] Harvard Univ, Sch Med, Div Global Hlth Equ, Boston, MA USA; [Ganesh, Ayalvadi] Univ Bristol, Sch Math, Bristol, Avon, England	University of Bristol; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Bristol	Colijn, C (corresponding author), Univ Bristol, Dept Engn Math, Bristol, Avon, England.	tcohen@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Cohen, Ted/0000-0002-8091-7198	Office Of The Director, NIH [DP2OD006663]; NIAID, NIH [U19AI076217]; Ellison Medical Foundation [ID-SS-0693-04]; Bristol Centre for Complexity Sciences; EPSRC [EP/5011214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076217] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006663] Funding Source: NIH RePORTER	Office Of The Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation); Bristol Centre for Complexity Sciences; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TC was supported by DP2OD006663 from the Office Of The Director, NIH and both TC and MM were supported by U19AI076217 from NIAID, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the Director, NIH or the NIH (http://nih.gov). MM was supported by the Ellison Medical Foundation ID-SS-0693-04 (www.ellisonfoundation.org). AG was supported by the Bristol Centre for Complexity Sciences (http://bccs.bristol.ac.uk) and EPSRC grant EP/5011214 (www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer WP, 2001, J MATH BIOL, V42, P145, DOI 10.1007/s002850000053; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Cohen T, 2004, MICROB DRUG RESIST, V10, P280, DOI 10.1089/mdr.2004.10.280; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gillespie SH, 2007, BIOCHEM SOC T, V35, P1317, DOI 10.1042/BST0351317; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Gillespie SH, 2001, INT J ANTIMICROB AG, V17, P171, DOI 10.1016/S0924-8579(00)00340-X; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Kornarova NL, 2007, MATH BIOSCI, V210, P253, DOI 10.1016/j.mbs.2007.04.007; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Luria SE, 1943, GENETICS, V28, P491; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; PAKES AG, 1993, J APPL PROBAB, V30, P991, DOI 10.2307/3214530; Perdigao J, 2010, J ANTIMICROB CHEMOTH, V65, P224, DOI 10.1093/jac/dkp452; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; SHCHERBAKOV D, 2010, MOL MICROBIOL; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shimao T, 1987, Tubercle, V68, P5, DOI 10.1016/0041-3879(87)90014-6; STEWART FM, 1990, GENETICS, V124, P175; TAN WY, 1982, SIAM J APPL MATH, V42, P719, DOI 10.1137/0142050; van Soolingen D, 2000, J INFECT DIS, V182, P1788, DOI 10.1086/317598; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; *WHO STOP TB DEP, 2009, COUNTR HAD REP LEAST; Wrande M, 2008, P NATL ACAD SCI USA, V105, P11863, DOI 10.1073/pnas.0804739105; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zheng Q, 2003, GENETICS, V164, P373; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0	44	62	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18327	10.1371/journal.pone.0018327	http://dx.doi.org/10.1371/journal.pone.0018327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479171	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700047
J	Gouws, EJ; Gaston, KJ; Chown, SL				Gouws, E. Jeanne; Gaston, Kevin J.; Chown, Steven L.			Intraspecific Body Size Frequency Distributions of Insects	PLOS ONE			English	Article							INDIVIDUAL-LEVEL SELECTION; WORKER CASTE POLYMORPHISM; EVOLUTION; ECOLOGY; ANT; DIMORPHISM; ALLOMETRIES; PERFORMANCE; PHYSIOLOGY; ONTOGENY	Although interspecific body size frequency distributions are well documented for many taxa, including the insects, intraspecific body size frequency distributions (IaBSFDs) are more poorly known, and their variation among mass-based and linear estimates of size has not been widely explored. Here we provide IaBSFDs for 16 species of insects based on both mass and linear estimates and large sample sizes (n >= 100). In addition, we review the published IaBSFDs for insects, though doing so is complicated by their under-emphasis in the literature. The form of IaBSFDs can differ substantially between mass-based and linear measures. Nonetheless, in non-social insects they tend to be normally distributed (18 of 27 species) or in fewer instances positively skewed. Negatively skewed distributions are infrequently reported and log transformation readily removes the positive skew. Sexual size dimorphism does not generally cause bimodality in IaBSFDs. The available information on IaBSFDs in the social insects suggests that these distributions are usually positively skewed or bimodal (24 of 30 species). However, only c. 15% of ant genera are polymorphic, suggesting that normal distributions are probably more common, but less frequently investigated. Although only 57 species, representing seven of the 29 orders of insects, have been considered here, it appears that whilst IaBSFDs are usually normal, other distribution shapes can be found in several species, though most notably among the social insects. By contrast, the interspecific body size frequency distribution is typically right-skewed in insects and in most other taxa.	[Gouws, E. Jeanne; Chown, Steven L.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa; [Gaston, Kevin J.] Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	Stellenbosch University; University of Sheffield	Gouws, EJ (corresponding author), Sci Serv, Western Cape Nat Conservat Board, Stellenbosch, South Africa.	slchown@sun.ac.za	Chown, Steven/ABD-7646-2021; Chown, Steven L/H-3347-2011	Chown, Steven L/0000-0001-6069-5105; Gaston, Kevin J./0000-0002-7235-7928	National Research Foundation of South Africa; Royal Society	National Research Foundation of South Africa(National Research Foundation - South Africa); Royal Society(Royal Society of London)	EJG and SLC were supported by the National Research Foundation of South Africa via a grant to the DST-NRF Centre of Excellence for Invasion Biology. KJG holds a Royal Society-Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1984, EVOLUTION, V38, P220, DOI [10.2307/2408560, 10.1111/j.1558-5646.1984.tb00274.x]; Babin-Fenske J, 2008, ECOL ENTOMOL, V33, P646, DOI 10.1111/j.1365-2311.2008.01018.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billick I, 2007, INSECT SOC, V54, P113, DOI 10.1007/s00040-007-0918-9; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; Chown SL, 1997, FUNCT ECOL, V11, P365, DOI 10.1046/j.1365-2435.1997.00096.x; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; CHOWN SL, 1993, OECOLOGIA, V96, P508, DOI 10.1007/BF00320508; Chown SL, 2001, POLAR BIOL, V24, P706, DOI 10.1007/s003000100281; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; COOPER WE, 1989, AM NAT, V133, P729, DOI 10.1086/284948; Couvillon MJ, 2010, ECOL ENTOMOL, V35, P424, DOI 10.1111/j.1365-2311.2010.01198.x; de Jong Gerdien, 2008, P523; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Feener DH, 1988, FUNCT ECOL, V2, P509, DOI 10.2307/2389394; Fraser VS, 2000, BEHAV ECOL SOCIOBIOL, V47, P188, DOI 10.1007/s002650050010; FRUMHOFF PC, 1992, AM NAT, V139, P559, DOI 10.1086/285344; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Greve M, 2008, GLOBAL ECOL BIOGEOGR, V17, P514, DOI 10.1111/j.1466-8238.2008.00388.x; Hanks LM, 2005, ENTOMOL EXP APPL, V114, P25, DOI 10.1111/j.0013-8703.2005.00225.x; Hughes WOH, 2003, P NATL ACAD SCI USA, V100, P9394, DOI 10.1073/pnas.1633701100; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Koons DN, 2009, HERPETOL CONSERV BIO, V4, P221; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Kozlowski J, 1997, AM NAT, V149, P352; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Loder N, 1997, OIKOS, V78, P195, DOI 10.2307/3545817; LOUNIBOS LP, 1994, ECOL ENTOMOL, V19, P138, DOI 10.1111/j.1365-2311.1994.tb00403.x; MACHIN J, 1991, J EXP BIOL, V161, P439; May RM, 1981, THEORETICAL ECOLOGY, P5; Mercer RD, 2001, ANTARCT SCI, V13, P135, DOI 10.1017/S0954102001000219; Moczek Armin P., 2008, P81; Osmundson DB, 2006, J FISH BIOL, V68, P1563, DOI 10.1111/j.0022-1112.2006.001043.x; Oster G.F., 1978, Monographs in Population Biology, pi; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; PIELOU E C, 1969, P286; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Powell S, 2006, FUNCT ECOL, V20, P1105, DOI 10.1111/j.1365-2435.2006.01184.x; Roulston TH, 2000, J KANSAS ENTOMOL SOC, V73, P129; Schoning C, 2005, OIKOS, V110, P231, DOI 10.1111/j.0030-1299.2005.13672.x; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; Stergiou KI, 1999, ENVIRON BIOL FISH, V54, P151, DOI 10.1023/A:1007594719450; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Strobbe F, 2004, BIOL J LINN SOC, V83, P187, DOI 10.1111/j.1095-8312.2004.00379.x; Teder T, 2008, AM NAT, V172, P223, DOI 10.1086/589896; TSCHINKEL WR, 1988, BEHAV ECOL SOCIOBIOL, V22, P103, DOI 10.1007/BF00303545; WADDINGTON KD, 1986, J KANSAS ENTOMOL SOC, V59, P95; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512; Yang AS, 2004, CURR BIOL, V14, P514, DOI 10.1016/j.cub.2004.03.005	55	41	41	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e16606	10.1371/journal.pone.0016606	http://dx.doi.org/10.1371/journal.pone.0016606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479214	Green Published, gold			2022-12-25	WOS:000289055700005
J	Leonard, H; Glasson, E; Nassar, N; Whitehouse, A; Bebbington, A; Bourke, J; Jacoby, P; Dixon, G; Malacova, E; Bower, C; Stanley, F				Leonard, Helen; Glasson, Emma; Nassar, Natasha; Whitehouse, Andrew; Bebbington, Ami; Bourke, Jenny; Jacoby, Peter; Dixon, Glenys; Malacova, Eva; Bower, Carol; Stanley, Fiona			Autism and Intellectual Disability Are Differentially Related to Sociodemographic Background at Birth	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; OLDER REPRODUCTIVE AGE; MENTAL-RETARDATION; PATERNAL AGE; WESTERN-AUSTRALIA; SPECTRUM DISORDERS; SOCIOECONOMIC-STATUS; INFANTILE-AUTISM; CHILDREN; POPULATION	Background: Research findings investigating the sociodemographics of autism spectrum disorder (ASD) have been inconsistent and rarely considered the presence of intellectual disability (ID). Methods: We used population data on Western Australian singletons born from 1984 to 1999 (n = 398,353) to examine the sociodemographic characteristics of children diagnosed with ASD with or without ID, or ID without ASD compared with non-affected children. Results: The profiles for the four categories examined, mild-moderate ID, severe ID, ASD without ID and ASD with ID varied considerably and we often identified a gradient effect where the risk factors for mild-moderate ID and ASD without ID were at opposite extremes while those for ASD with ID were intermediary. This was demonstrated clearly with increased odds of ASD without ID amongst older mothers aged 35 years and over (odds ratio (OR) = 1.69 [CI: 1.18, 2.43]), first born infants (OR = 2.78; [CI: 1.67, 4.54]), male infants (OR = 6.57 [CI: 4.87, 8.87]) and increasing socioeconomic advantage. In contrast, mild-moderate ID was associated with younger mothers aged less than 20 years (OR = 1.88 [CI: 1.57, 2.25]), paternal age greater than 40 years (OR = 1.59 [CI: 1.36, 1.86]), Australian-born and Aboriginal mothers (OR = 1.60 [CI: 1.41, 1.82]), increasing birth order and increasing social disadvantage (OR = 2.56 [CI: 2.27, 2.97]). Mothers of infants residing in regional or remote areas had consistently lower risk of ASD or ID and may be linked to reduced access to services or under-ascertainment rather than a protective effect of location. Conclusions: The different risk profiles observed between groups may be related to aetiological differences or ascertainment factors or both. Untangling these pathways is challenging but an urgent public health priority in view of the supposed autism epidemic.	[Leonard, Helen; Glasson, Emma; Nassar, Natasha; Whitehouse, Andrew; Bebbington, Ami; Bourke, Jenny; Jacoby, Peter; Dixon, Glenys; Malacova, Eva; Bower, Carol; Stanley, Fiona] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA, Australia; [Glasson, Emma] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Nassar, Natasha] Univ Sydney, Kolling Inst Med Res, Perinatal Res, Sydney, NSW 2006, Australia; [Malacova, Eva] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Sydney; Kolling Institute of Medical Research; Curtin University	Leonard, H (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA, Australia.	hleonard@ichr.uwa.edu.au	Dixon, Glenys/J-2144-2015; Glasson, Emma/H-5339-2013; Whitehouse, Andrew J.O./AGJ-2519-2022; Nassar, Natasha/K-3918-2019; Leonard, Helen/A-1010-2013	Dixon, Glenys/0000-0002-1716-076X; Glasson, Emma/0000-0003-3996-9049; Whitehouse, Andrew J.O./0000-0001-8722-1575; Leonard, Helen/0000-0001-6405-5834; , Emma/0000-0001-5547-8595; Nassar, Natasha/0000-0002-3720-9655	Australian National Health and Medical Research Council (NHMRC) [353514, 572742]; NHMRC [353628, 572568, 632955]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033123, R01NS058500] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the Australian National Health and Medical Research Council (NHMRC, http://www.nhmrc.gov.au/) Program Grants (353514 and 572742), NHMRC Research Fellowship (353628 to CB), NHMRC Research Fellowship (572568) (to HL) and NHMRC Career Development Fellowship (632955 to NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anello A, 2009, J AUTISM DEV DISORD, V39, P1487, DOI 10.1007/s10803-009-0755-y; *AUSTR BUR STAT, 1998, INF PAP 1996 CENS SO; Australian Bureau of Statistics, 2008, STAND AUSTR CLASS CO; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Begeer S, 2009, J AUTISM DEV DISORD, V39, P142, DOI 10.1007/s10803-008-0611-5; Bhasin TK, 2007, J AUTISM DEV DISORD, V37, P667, DOI 10.1007/s10803-006-0194-y; Blair Eve M, 2005, BMC Pediatr, V5, P13, DOI 10.1186/1471-2431-5-13; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Chapman DA, 2002, AM J MENT RETARD, V107, P46, DOI 10.1352/0895-8017(2002)107<0046:ERFFMR>2.0.CO;2; Coo H, 2008, J AUTISM DEV DISORD, V38, P1036, DOI 10.1007/s10803-007-0478-x; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Currenti SA, 2010, CELL MOL NEUROBIOL, V30, P161, DOI 10.1007/s10571-009-9453-8; Decoufle Pierre, 1995, Annals of Epidemiology, V5, P347, DOI 10.1016/1047-2797(95)00031-2; DREWS CD, 1995, AM J PUBLIC HEALTH, V85, P329, DOI 10.2105/AJPH.85.3.329; Durkin MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011551; Durkin MS, 2010, AM J PUBLIC HEALTH, V100, P389, DOI 10.2105/AJPH.2009.184101; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Eaton WW, 2001, J AUTISM DEV DISORD, V31, P279, DOI 10.1023/A:1010743203048; Eyles DW, 2010, ACTA PAEDIATR, V99, P645, DOI 10.1111/j.1651-2227.2010.01797.x; Fernell E, 2010, ACTA PAEDIATR, V99, P743, DOI 10.1111/j.1651-2227.2010.01755.x; Gee A, 2010, LANCET, V376, P1451, DOI 10.1016/S0140-6736(10)61977-0; GILLBERG C, 1995, J INTELL DISABIL RES, V39, P141, DOI 10.1111/j.1365-2788.1995.tb00482.x; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Glasson EJ, 2008, MED J AUSTRALIA, V188, P288, DOI 10.5694/j.1326-5377.2008.tb01623.x; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; HEBER R, 1961, AM J MENT DEFIC, V64; Herbert MR, 2006, NEUROTOXICOLOGY, V27, P671, DOI 10.1016/j.neuro.2006.03.017; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Hultman CM, 2010, MOL PSYCHIAT; Keen DV, 2010, BRIT J PSYCHIAT, V196, P274, DOI 10.1192/bjp.bp.109.065490; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; King MD, 2009, AM J PUBLIC HEALTH, V99, P1673, DOI 10.2105/AJPH.2008.149021; Kinney DK, 2010, MED HYPOTHESES, V74, P102, DOI 10.1016/j.mehy.2009.07.052; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Leonard H, 2005, SOC SCI MED, V60, P1499, DOI 10.1016/j.socscimed.2004.08.014; Leonard H, 2008, AM J EPIDEMIOL, V167, P103, DOI 10.1093/aje/kwm245; Leonard H, 2010, RES AUTISM SPECT DIS, V4, P548, DOI 10.1016/j.rasd.2010.01.003; Liu KY, 2010, AM J SOCIOL, V115, P1387, DOI 10.1086/651448; Liu K, 2010, DEMOGRAPHY, V47, P327, DOI 10.1353/dem.0.0101; Loesch DZ, 2000, AM J PHYS ANTHROPOL, V111, P545, DOI 10.1002/(SICI)1096-8644(200004)111:4<545::AID-AJPA9>3.0.CO;2-X; Maimburg RD, 2006, ACTA PSYCHIAT SCAND, V114, P257, DOI 10.1111/j.1600-0447.2006.00805.x; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; Moraine C, 2009, WORLD J BIOL PSYCHIA, V10, P1030, DOI 10.1080/15622970802627455; Nassar N, 2009, INT J EPIDEMIOL, V38, P1245, DOI 10.1093/ije/dyp260; Palmer RF, 2010, AM J PUBLIC HEALTH, V100, P270, DOI 10.2105/AJPH.2008.150565; Petterson B, 2005, ANN HUM BIOL, V32, P237, DOI 10.1080/03014460500075035; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rutter M, 2009, INT J EPIDEMIOL, V38, P1238, DOI 10.1093/ije/dyp257; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; StataCorp, 2007, STAT STAT SOFTW REL; Statistics Canada, 2020, IND REM; Stromme P, 2000, SOC PSYCH PSYCH EPID, V35, P12, DOI 10.1007/s001270050003; Tanner JM., 1986, HUMAN GROWTH MULTIDI, P3; Tsuchiya KJ, 2008, BRIT J PSYCHIAT, V193, P316, DOI 10.1192/bjp.bp.107.045120; YearginAllsopp M, 1997, DEV MED CHILD NEUROL, V39, P142	62	79	81	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17875	10.1371/journal.pone.0017875	http://dx.doi.org/10.1371/journal.pone.0017875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479223	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700017
J	Mulrooney, TJ; Marsh, J; Urits, I; Seyfried, TN; Mukherjee, P				Mulrooney, Tiernan J.; Marsh, Jeremy; Urits, Ivan; Seyfried, Thomas N.; Mukherjee, Purna			Influence of Caloric Restriction on Constitutive Expression of NF-kappa B in an Experimental Mouse Astrocytoma	PLOS ONE			English	Article							INFLAMMATORY FACTOR-I; ENDOTHELIAL-GROWTH-FACTOR; DIETARY RESTRICTION; MALIGNANT GLIOMAS; GENE-EXPRESSION; KETOGENIC DIET; MESSENGER-RNA; KETONE-BODIES; UP-REGULATION; BRAIN-TUMORS	Background: Many of the current standard therapies employed for the management of primary malignant brain cancers are largely viewed as palliative, ultimately because these conventional strategies have been shown, in many instances, to decrease patient quality of life while only offering a modest increase in the length of survival. We propose that caloric restriction (CR) is an alternative metabolic therapy for brain cancer management that will not only improve survival but also reduce the morbidity associated with disease. Although we have shown that CR manages tumor growth and improves survival through multiple molecular and biochemical mechanisms, little information is known about the role that CR plays in modulating inflammation in brain tumor tissue. Methodology/Principal Findings: Phosphorylation and activation of nuclear factor kappa B (NF-kappa B) results in the transactivation of many genes including those encoding cycloxygenase-2 (COX-2) and allograft inflammatory factor-1 (AIF-1), both of which are proteins that are primarily expressed by inflammatory and malignant cancer cells. COX-2 has been shown to enhance inflammation and promote tumor cell survival in both in vitro and in vivo studies. In the current report, we demonstrate that the p65 subunit of NF-kappa B was expressed constitutively in the CT-2A tumor compared with contra-lateral normal brain tissue, and we also show that CR reduces (i) the phosphorylation and degree of transcriptional activation of the NF-kappa B-dependent genes COX-2 and AIF-1 in tumor tissue, as well as (ii) the expression of proinflammatory markers lying downstream of NF-kappa B in the CT-2A malignant mouse astrocytoma, [e. g. macrophage inflammatory protein-2 (MIP-2)]. On the whole, our date indicate that the NF-kappa B inflammatory pathway is constitutively activated in the CT-2A astrocytoma and that CR targets this pathway and inflammation. Conclusion: CR could be effective in reducing malignant brain tumor growth in part by inhibiting inflammation in the primary brain tumor.	[Mulrooney, Tiernan J.] Georgetown Univ, Med Ctr, Tumor Biol Program, Washington, DC 20007 USA; [Marsh, Jeremy] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Urits, Ivan; Seyfried, Thomas N.; Mukherjee, Purna] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Georgetown University; Yeshiva University; Albert Einstein College of Medicine; Boston College	Mulrooney, TJ (corresponding author), Georgetown Univ, Med Ctr, Tumor Biol Program, Washington, DC 20007 USA.	mukherjp@bc.edu		Seyfried, Thomas/0000-0003-1491-3989	National Institutes of Health [NS 055195, CA102135]; Boston College; NATIONAL CANCER INSTITUTE [R01CA102135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS055195, R01NS055195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS 055195 and CA102135 and the Boston College research expense fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370; Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Autieri MV, 1996, BIOCHEM BIOPH RES CO, V228, P29, DOI 10.1006/bbrc.1996.1612; Badie B, 2003, CLIN CANCER RES, V9, P872; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carlson MRJ, 2007, CLIN CANCER RES, V13, P2592, DOI 10.1158/1078-0432.CCR-06-2772; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004; Derr RL, 2009, J CLIN ONCOL, V27, P1082, DOI 10.1200/JCO.2008.19.1098; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dong WM, 1998, AM J RESP CELL MOL, V19, P462, DOI 10.1165/ajrcmb.19.3.3114; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Fisher PG, 2005, JAMA-J AM MED ASSOC, V293, P615, DOI 10.1001/jama.293.5.615; FLAVIN HJ, 1991, J NEUROCHEM, V56, P1007, DOI 10.1111/j.1471-4159.1991.tb02021.x; GUSTAFSON MP, NEURO ONCOL; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; HARVEY AE, 2010, CANC PREVENTION RE S, V3, pB54; Hayashi S, 2001, NEUROL MED-CHIR, V41, P187, DOI 10.2176/nmc.41.187; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; HOLNESS CL, 1993, BLOOD, V81, P1607; HUANG S, 1992, AM J PATHOL, V141, P981; Hursting SD, 2007, CANCER RES, V67, P2391, DOI 10.1158/0008-5472.CAN-06-4237; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Ikeda S, 2001, ARCH SURG-CHICAGO, V136, P297, DOI 10.1001/archsurg.136.3.297; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; JENKS S, J NATL CANC I, V102, P519; Jia J, 2010, PEDIATR RES, V67, P29, DOI 10.1203/PDR.0b013e3181bf572b; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Jukich PJ, 2001, NEURO-ONCOLOGY, V3, P141, DOI 10.1093/neuonc/3.3.141; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kimura M, 2007, J IMMUNOL, V178, P3316, DOI 10.4049/jimmunol.178.5.3316; Kobayashi Hanako, 2009, V511, P185, DOI 10.1007/978-1-59745-447-6_8; Korkolopoulou P, 2008, HUM PATHOL, V39, P1143, DOI 10.1016/j.humpath.2008.01.020; Krebs H.A., 1971, ADV ENZYME REGUL, V9, P387, DOI [10.1016/S0065-2571(71)80055-9, DOI 10.1016/S0065-2571(71)80055-9]; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Lowry JK, 1998, ARCH NEUROL-CHICAGO, V55, P922, DOI 10.1001/archneur.55.7.922; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Ludwig HC, 2000, ANTICANCER RES, V20, P299; Lukins MB, 2005, ANESTH ANALG, V100, P1129, DOI 10.1213/01.ANE.0000146943.45445.55; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mancardi S, 2003, IMMUNOLOGY, V108, P523, DOI 10.1046/j.1365-2567.2003.01613.x; MANCINO A, CLIN CANC RES, V16, P784; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marsh J, 2008, CLIN CANCER RES, V14, P7751, DOI 10.1158/1078-0432.CCR-08-0213; Martinez-Murillo R, 2007, HISTOL HISTOPATHOL, V22, P1309, DOI 10.14670/HH-22.1309; Matzer SP, 2004, INT IMMUNOL, V16, P1675, DOI 10.1093/intimm/dxh169; McMillan DC, 2006, BRIT MED J, V333, P1109, DOI 10.1136/bmj.39042.565035.BE1; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Mukherjee P, 1999, JNCI-J NATL CANCER I, V91, P512, DOI 10.1093/jnci/91.6.512; Mukherjee P, 2004, CLIN CANCER RES, V10, P5622, DOI 10.1158/1078-0432.CCR-04-0308; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Mukherjee P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-37; NABEL GJ, 1993, GENE DEV, V7, P2063, DOI 10.1101/gad.7.11.2063; Nicholson HS, 2007, CANCER, V110, P1542, DOI 10.1002/cncr.22961; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Pashenkov M, 2000, SCAND J IMMUNOL, V52, P117; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Portnow J, 2002, NEURO-ONCOLOGY, V4, P22, DOI 10.1093/neuonc/4.1.22; Ranes MK, 2001, BRIT J CANCER, V84, P1107, DOI 10.1054/bjoc.2000.1713; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; Rutz HP, 2005, CANCER BIOL THER, V4, P1186, DOI 10.4161/cbt.4.11.2232; Rutz HP, 2005, CANCER, V103, P2656, DOI 10.1002/cncr.21067; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Seyfried TN, 2001, PERSPECT BIOL MED, V44, P263, DOI 10.1353/pbm.2001.0035; SEYFRIED TN, 1992, MOL CHEM NEUROPATHOL, V17, P147, DOI 10.1007/BF03159989; SEYFRIED TN, NUTR METAB LOND, V7, P7; SEYFRIED TN, BIOCH BIOPHYS ACTA; Shelton LM, 2010, ASN NEURO, V2, DOI 10.1042/AN20100002; SHELTON LM, J NEUROONCOL; Shono T, 2001, CANCER RES, V61, P4375; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; STAUDT LM, COLD SPRING HARB PER, V2; Temel SG, 2009, J MOL HISTOL, V40, P369, DOI 10.1007/s10735-009-9250-1; Tsunoda Keishi, 2005, Brain Tumor Pathol, V22, P79, DOI 10.1007/s10014-005-0186-1; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; WANG H, CURR CANC DRUG TARGE; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Yang ZF, 2005, INT IMMUNOL, V17, P1391, DOI 10.1093/intimm/dxh316; Zampetaki A, 2004, FASEB J, V18, P1090, DOI 10.1096/fj.03-0991fje; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5	103	46	49	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18085	10.1371/journal.pone.0018085	http://dx.doi.org/10.1371/journal.pone.0018085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479220	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700024
J	Delogu, G; Chiacchio, T; Vanini, V; Butera, O; Cuzzi, G; Bua, A; Molicotti, P; Zanetti, S; Lauria, FN; Grisetti, S; Magnavita, N; Fadda, G; Girardi, E; Goletti, D				Delogu, Giovanni; Chiacchio, Teresa; Vanini, Valentina; Butera, Ornella; Cuzzi, Gilda; Bua, Alessandra; Molicotti, Paola; Zanetti, Stefania; Lauria, Francesco Nicola; Grisetti, Susanna; Magnavita, Nicola; Fadda, Giovanni; Girardi, Enrico; Goletti, Delia			Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; T-CELL; IMMUNE-RESPONSES; INFECTION; ANTIGENS; SPECTRUM	Background: A challenge in tuberculosis (TB) research is to develop a new immunological test that can help distinguish, among subjects responsive to QuantiFERON TB Gold In tube (QFT-IT), those who are able to control Mtb replication (remote LTBI, recent infection and past TB) from those who cannot (active TB disease). IFN-gamma response to the Heparin-binding-hemagglutinin (HBHA) of Mtb has been associated with LTBI, but the cumbersome procedures of purifying the methylated and immunological active form of the protein from Mtb or M. bovis Bacillus Calmette et Guerin (BCG) have prevented its implementation in a diagnostic test. Therefore, the aim of the present study was to evaluate the IFN-gamma response to methylated HBHA of Mtb produced in M. smegmatis (rHBHAms) in individuals at different stages of TB who scored positive to QFT-IT. Methodology/Principal Findings: 87 individuals at different stages of TB who scored positive to QFT-IT were selected. IFN-gamma response to in vitro whole blood stimulation with rHBHAms was evaluated by short-term and long-term tests and detected by ELISA or flow cytometry. We demonstrated that the IFN-gamma response to rHBHAms is mediated by CD4(+) T-cells with an effector-memory phenotype. This response, evaluated by short-term-tests, is significantly lower in active TB than in remote LTBI (p=0.0010) and past TB (p=0.0152). These results were confirmed by long-term tests. The qualitative data confirmed that IFN-gamma responses higher than the cut-off point identified by ROC analysis are associated with the status of non-active disease. Conclusions: In this study we show that the T-cell response to a recombinant and methylated HBHA of Mtb produced in M. smegmatis is useful to discriminate between active and non-active TB disease among those responsive to QFT-IT in a whole blood system. Further studies are needed to improve the accuracy of the assay.	[Delogu, Giovanni; Fadda, Giovanni] Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy; [Chiacchio, Teresa; Vanini, Valentina; Butera, Ornella; Cuzzi, Gilda; Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Translat Res Unit, Dept Epidemiol & Preclin Res, Rome, Italy; [Bua, Alessandra; Molicotti, Paola; Zanetti, Stefania] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Lauria, Francesco Nicola] INMI, Div Infect Dis Resp Tract, Dept Clin Res, Rome, Italy; [Grisetti, Susanna] INMI, Div Clin 3, Dept Clin Res, Rome, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Ist Med Lavoro, Rome, Italy; [Girardi, Enrico] INMI, Dept Epidemiol & Preclin Res, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Lazzaro Spallanzani; University of Sassari; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Lazzaro Spallanzani	Delogu, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy.	delia.goletti@inmi.it	molicotti, Paola/AAB-3217-2019; Delogu, Giovanni/I-3701-2012; goletti, delia/AAM-6577-2020; Vanini, Valentina/K-4475-2016; Magnavita, Nicola/J-6074-2014; Fadda, Giovanni/K-6224-2012	Delogu, Giovanni/0000-0003-0182-8267; Vanini, Valentina/0000-0001-8476-964X; Magnavita, Nicola/0000-0002-0988-7344; Goletti, Delia/0000-0001-8360-4376; MOLICOTTI, PAOLA/0000-0001-8127-1627; Girardi, Enrico/0000-0001-8182-5896	Italian Ministry of Health [06.76.1, 07.103]	Italian Ministry of Health(Ministry of Health, Italy)	The study was supported by grants from the Italian Ministry of Health "Ricerca Corrente" and "Ricerca Finalizzata" 06.76.1 and 07.103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Delogu G, 2006, INFECT IMMUN, V74, P3006, DOI 10.1128/IAI.74.5.3006-3011.2006; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-99; Lawn SD, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/980594; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Menozzi FD, 1998, P NATL ACAD SCI USA, V95, P12625, DOI 10.1073/pnas.95.21.12625; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Pethe K, 2002, P NATL ACAD SCI USA, V99, P10759, DOI 10.1073/pnas.162246899; Place S, 2010, AM J RESP CRIT CARE, V182, P848, DOI 10.1164/rccm.201001-0083OC; Savolainen L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003272; Shin AR, 2006, CLIN VACCINE IMMUNOL, V13, P869, DOI 10.1128/CVI.00103-06; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; World Health Organization, 2010, GLOB TUB CONTR SURV; Yang CS, 2008, RESP MED, V102, P280, DOI 10.1016/j.rmed.2007.08.016; Zanetti S, 2005, CLIN DIAGN LAB IMMUN, V12, P1135, DOI 10.1128/CDLI.12.9.1135-1138.2005	30	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18315	10.1371/journal.pone.0018315	http://dx.doi.org/10.1371/journal.pone.0018315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479248	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600044
J	Markwardt, ML; Kremers, GJ; Kraft, CA; Ray, K; Cranfill, PJC; Wilson, KA; Day, RN; Wachter, RM; Davidson, MW; Rizzo, MA				Markwardt, Michele L.; Kremers, Gert-Jan; Kraft, Catherine A.; Ray, Krishanu; Cranfill, Paula J. C.; Wilson, Korey A.; Day, Richard N.; Wachter, Rebekka M.; Davidson, Michael W.; Rizzo, Mark A.			An Improved Cerulean Fluorescent Protein with Enhanced Brightness and Reduced Reversible Photoswitching	PLOS ONE			English	Article							GREEN; FRET; CYAN; CHROMOPHORE; GFP; ACQUISITION; DYNAMICS; VARIANT	Cyan fluorescent proteins (CFPs), such as Cerulean, are widely used as donor fluorophores in Forster resonance energy transfer (FRET) experiments. Nonetheless, the most widely used variants suffer from drawbacks that include low quantum yields and unstable flurorescence. To improve the fluorescence properties of Cerulean, we used the X-ray structure to rationally target specific amino acids for optimization by site-directed mutagenesis. Optimization of residues in strands 7 and 8 of the beta-barrel improved the quantum yield of Cerulean from 0.48 to 0.60. Further optimization by incorporating the wild-type T65S mutation in the chromophore improved the quantum yield to 0.87. This variant, mCerulean3, is 20% brighter and shows greatly reduced fluorescence photoswitching behavior compared to the recently described mTurquoise fluorescent protein in vitro and in living cells. The fluorescence lifetime of mCerulean3 also fits to a single exponential time constant, making mCerulean3 a suitable choice for fluorescence lifetime microscopy experiments. Furthermore, inclusion of mCerulean3 in a fusion protein with mVenus produced FRET ratios with less variance than mTurquoise-containing fusions in living cells. Thus, mCerulean3 is a bright, photostable cyan fluorescent protein which possesses several characteristics that are highly desirable for FRET experiments.	[Markwardt, Michele L.; Kraft, Catherine A.; Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kremers, Gert-Jan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ray, Krishanu] Univ Maryland, Sch Med, Ctr Fluorescence Spect, Baltimore, MD 21201 USA; [Ray, Krishanu] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Cranfill, Paula J. C.; Wilson, Korey A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cranfill, Paula J. C.; Wilson, Korey A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Day, Richard N.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Wachter, Rebekka M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	University System of Maryland; University of Maryland Baltimore; Vanderbilt University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Indiana University System; Indiana University Bloomington; Arizona State University; Arizona State University-Tempe	Markwardt, ML (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mrizz001@umaryland.edu			National Science Foundation [MCB-061593]; National Institutes of Health [GM72048, DK47301, DK47301-15S2, DK077140, DK077140-02S1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK077140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072048] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation grant to R. M. W. (MCB-061593), and National Institutes of Health grants GM72048, which provided support to G.J.K. (D. W. Piston, PI), DK47301 and DK47301-15S2 to R.N.D., and DK077140 and DK077140-02S1 to M. A. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; Demachy I, 2005, J PHYS CHEM B, V109, P24121, DOI 10.1021/jp054656w; Dickinson ME, 2001, BIOTECHNIQUES, V31, P1272, DOI 10.2144/01316bt01; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Forster T., 1948, ANN PHYS, V6, P54; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lelimousin M, 2009, BIOCHEMISTRY-US, V48, P10038, DOI 10.1021/bi901093w; LEW D, 1993, GENE DEV, V7, P683, DOI 10.1101/gad.7.4.683; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Rizzo Mark A, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.top64; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vallverdu G, 2010, PROTEINS, V78, P1040, DOI 10.1002/prot.22628; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Wachter RM, 2007, ACCOUNTS CHEM RES, V40, P120, DOI 10.1021/ar040086r; Wachter RM, 2010, BIOCHEMISTRY-US, V49, P7417, DOI 10.1021/bi100901h; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zal T, 2004, CURR OPIN IMMUNOL, V16, P418, DOI 10.1016/j.coi.2004.05.019; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	49	190	202	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17896	10.1371/journal.pone.0017896	http://dx.doi.org/10.1371/journal.pone.0017896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479270	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600019
J	Bose, K; Meinke, G; Bohm, A; Baleja, JD				Bose, Kakoli; Meinke, Gretchen; Bohm, Andrew; Baleja, James D.			Design and characterization of an enhanced repressor of human papillomavirus E2 protein	FASEB JOURNAL			English	Article						crystallography; protein-DNA interaction; subunit interface; transactivation	DNA-BINDING DOMAIN; BOVINE PAPILLOMAVIRUS; TRANSCRIPTIONAL ACTIVATION; TRANSFORMED CELLS; CRYSTAL-STRUCTURE; TYPE-16; STABILITY; CHROMATIN; TRANSACTIVATOR; DISCRIMINATION	Papillomaviruses are causative agents of cervical and anogenital cancers. The viral E2 protein mediates viral DNA replication and transactivation of viral oncogenes and thus represents a specific target for therapeutic intervention. Short forms of E2, E2R, contain only the C-terminal dimerization domain, and repress the normal function of E2 due to formation of an inactive heterodimer. Using structure-guided design, we replaced conserved residues at the dimer interface to design a heterodimer with increased stability. One E2R mutant in which histidine was replaced by a glutamate residue showed preferential heterodimer formation in vitro, as well as an increase in plasticity at the interface, as a result of histidine-glutamate pair formation, as observed spectroscopically and in the crystal structure, determined to 2.2-angstrom resolution. In addition, the enhanced E2R showed greater repression of transcription from E2-responsive reporter plasmids in mammalian cell culture. Recent advances in protein delivery into the cell raise the possibility of using exogenously added proteins as therapeutic agents. More generally, this approach may be used to target the subunit interfaces of any multisubunit protein having a similar mechanism of action.-Bose, K., Meinke, G., Bohm, A., Baleja, J. D. Design and characterization of an enhanced repressor of human papillomavirus E2 protein. FASEB J. 25, 2354-2361 (2011). www.fasebj.org	[Bose, Kakoli; Meinke, Gretchen; Bohm, Andrew; Baleja, James D.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Bose, Kakoli] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, India	Tufts University; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Baleja, JD (corresponding author), Tufts Univ, Sch Med, Dept Biochem, 136 Harrison Ave, Boston, MA 02111 USA.	jim.baleja@tufts.edu			U.S. National Institutes of Health (NIH) [CA97992]; Lifespan/Tufts/Brown Center for AIDS Research [NIH P30AI042853]; NATIONAL CANCER INSTITUTE [K07CA097992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan/Tufts/Brown Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Drs. Brian Schaffhausen and Shaida Andrabi (Tufts University School of Medicine, Boston, MA, USA) for providing space, reagents, and advice for mammalian cell culture studies and Drs. Elliot Androphy and Xiaoyu Wang (University of Massachusetts Medical School, Worcester, MA, USA) for plasmids and protocols. This project was funded by U.S. National Institutes of Health (NIH) grant CA97992 and the Lifespan/Tufts/Brown Center for AIDS Research (NIH P30AI042853).	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Abroi A, 2004, J VIROL, V78, P2100, DOI 10.1128/JVI.78.4.2100-2113.2004; Alloul N, 1999, J GEN VIROL, V80, P2461, DOI 10.1099/0022-1317-80-9-2461; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; BARSOUM J, 1992, J VIROL, V66, P3941, DOI 10.1128/JVI.66.6.3941-3945.1992; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Bose K, 2005, PROTEIN SCI, V14, P24; Bose K, 2007, BIOCHEMISTRY-US, V46, P1402, DOI 10.1021/bi0611255; Bussiere DE, 1998, ACTA CRYSTALLOGR D, V54, P1367, DOI 10.1107/S0907444998005587; Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827; Dell G, 2003, J MOL BIOL, V334, P979, DOI 10.1016/j.jmb.2003.10.009; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eliseo T, 2009, J MOL BIOL, V388, P327, DOI 10.1016/j.jmb.2009.03.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Grossel MJ, 1996, VIROLOGY, V217, P301, DOI 10.1006/viro.1996.0117; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; HUBBERT NL, 1988, P NATL ACAD SCI USA, V85, P5864, DOI 10.1073/pnas.85.16.5864; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Kumar RA, 2007, J VIROL, V81, P2213, DOI 10.1128/JVI.01746-06; LAMBERT PF, 1987, CELL, V50, P69, DOI 10.1016/0092-8674(87)90663-5; LAMBERT PF, 1989, J VIROL, V63, P3151, DOI 10.1128/JVI.63.7.3151-3154.1989; Liang H, 1996, BIOCHEMISTRY-US, V35, P2095, DOI 10.1021/bi951932w; McLaughlin-Drubin ME, 2004, VIROLOGY, V321, P173, DOI 10.1016/j.virol.2003.12.019; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; MEISLER M, 2004, THESIS TUFTS U BOSTO, P34; Mok YK, 1996, PROTEIN SCI, V5, P310; MONINI P, 1991, J VIROL, V65, P2124, DOI 10.1128/JVI.65.4.2124-2130.1991; NADRA A, 2006, J BIOMOL NMR, V30, P211; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; PEPINSKY RB, 1994, DNA CELL BIOL, V13, P1011, DOI 10.1089/dna.1994.13.1011; Pepinsky RB, 1997, J VIROL, V71, P828, DOI 10.1128/JVI.71.1.828-831.1997; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; SANDERS CM, 1995, VIROLOGY, V211, P418, DOI 10.1006/viro.1995.1424; Skiadopoulos MH, 1998, J VIROL, V72, P2079, DOI 10.1128/JVI.72.3.2079-2088.1998; Soeda E, 2006, VIROLOGY, V351, P29, DOI 10.1016/j.virol.2006.03.016; Speck L M, 2006, Skin Therapy Lett, V11, P1; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TANAKA M, 1988, GENE DEV, V2, P1764, DOI 10.1101/gad.2.12b.1764; Veeraraghavan S, 1998, J BIOMOL NMR, V11, P457, DOI 10.1023/A:1008237029912; Veeraraghavan S, 1999, BIOCHEMISTRY-US, V38, P16115, DOI 10.1021/bi991633x; Wang XY, 2009, J VIROL, V83, P2274, DOI 10.1128/JVI.01791-08; Xi LF, 2009, CANCER EPIDEM BIOMAR, V18, P2507, DOI 10.1158/1055-9965.EPI-09-0482; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09	49	1	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2354	2361		10.1096/fj.10-176461	http://dx.doi.org/10.1096/fj.10-176461			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21482558	Green Published			2022-12-25	WOS:000292242200027
J	Hoff, M; Balfanz, S; Ehling, P; Gensch, T; Baumann, A				Hoff, Max; Balfanz, Sabine; Ehling, Petra; Gensch, Thomas; Baumann, Arnd			A single amino acid residue controls Ca2+ signaling by an octopamine receptor from Drosophila melanogaster	FASEB JOURNAL			English	Article						biogenic amine; G-protein-coupled receptor; inositol-1,4,5-trisphosphate; learning and memory; oscillation	PROTEIN-COUPLED RECEPTORS; CALCIUM OSCILLATIONS; LOCUST FLIGHT; PHOSPHORYLATION; DESENSITIZATION; TRAFFICKING; MECHANISMS; SEQUENCES; BEHAVIOR; FAMILY	Rhythmic activity of cells and cellular networks plays an important role in physiology. In the nervous system oscillations of electrical activity and/or second messenger concentrations are important to synchronize neuronal activity. At the molecular level, rhythmic activity can be initiated by different routes. We have recently shown that an octopamine-activated G-protein-coupled receptor (GPCR; DmOct alpha 1Rb, CG3856) from Drosophila initiates Ca2+ oscillations. Here, we have unraveled the molecular basis of cellular Ca2+ signaling controlled by the DmOct alpha 1Rb receptor using a combination of pharmacological intervention, site-directed mutagenesis, and functional cellular Ca2+ imaging on heterologously expressed receptors. Phosphorylation of a single amino acid residue in the third intracellular loop of the GPCR by PKC is necessary and sufficient to desensitize the receptor. From its desensitized state, DmOct alpha 1Rb is resensitized by dephosphorylation, and a new Ca2+ signal occurs on octopamine stimulation. Our findings show that transient changes of the receptor's surface profile have a strong effect on its physiological signaling properties. We expect that the detailed knowledge of DmOct alpha 1Rb-dependent signal transduction fosters the identification of specific drugs that can be used for GPCR-mediated pest control, since octopamine serves important physiological and behavioral functions in arthropods.-Hoff M., Balfanz, S., Ehling, P., Gensch, T., Baumann, A. A single amino acid residue controls Ca2+ signaling by an octopamine receptor from Drosophila melanogaster. FASEB J. 25, 2484-2491 (2011). www.fasebj.org	[Hoff, Max; Balfanz, Sabine; Gensch, Thomas; Baumann, Arnd] Inst Complex Syst, Julich, Germany; [Ehling, Petra] Univ Munster, Inst Phys, D-4400 Munster, Germany	University of Munster	Baumann, A (corresponding author), Forschungszentrum Juelich, Inst Complex Syst Zellulaere Biophys ICS 4, D-52425 Julich, Germany.	a.baumann@fz-juelich.de	Baumann, Arnd/I-7941-2013	Baumann, Arnd/0000-0001-9456-7275; Balfanz, Sabine/0000-0002-7082-3999	Deutsche Forschungsgemeinschaft [Ba 1541/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors gratefully acknowledge the assistance of Joachim Schmitz in the cell culture and Dr. M. Krahling during the initial phases of pharmacological tests on DmOct alpha 1Rb. The authors also thank Dr. D. Kaschuba and A. Meisenberg for comments on the manuscript. The work was supported in part by a Deutsche Forschungsgemeinschaft grant to A. B. (Ba 1541/3-1).	Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Burchett SA, 2006, PROG NEUROBIOL, V79, P223, DOI 10.1016/j.pneurobio.2006.07.003; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Gehret AU, 2010, BIOCHEM J, V428, P235, DOI 10.1042/BJ20100139; Han KA, 1998, J NEUROSCI, V18, P3650; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; MALAMUD JG, 1988, J COMP PHYSIOL A, V162, P827, DOI 10.1007/BF00610971; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Nakahara K, 1997, J NEUROCHEM, V69, P1467; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sambrook J, 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scheiner R, 2006, CURR NEUROPHARMACOL, V4, P259, DOI 10.2174/157015906778520791; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322	39	19	19	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2484	2491		10.1096/fj.11-180703	http://dx.doi.org/10.1096/fj.11-180703			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21478261	Green Published			2022-12-25	WOS:000292242200038
J	Jo, YH; Donier, E; Martinez, A; Garret, M; Toulme, E; Boue-Grabot, E				Jo, Young-Hwan; Donier, Emmanuelle; Martinez, Audrey; Garret, Maurice; Toulme, Estelle; Boue-Grabot, Eric			Cross-talk between P2X4 and gamma-Aminobutyric Acid, Type A Receptors Determines Synaptic Efficacy at a Central Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; ATP; TRAFFICKING; RELEASE; NEURONS; CHANNEL; HYPOTHALAMUS; TRANSMISSION; MODULATION; CALCIUM	The essence of neuronal function is to generate outputs in response to synaptic potentials. Synaptic integration at postsynaptic sites determines neuronal outputs in the CNS. Using immunohistochemical and electrophysiological approaches, we first reveal that steroidogenic factor 1 (SF-1) green fluorescent protein (GFP)-positive neurons in the ventromedial nucleus of the hypothalamus express P2X4 subunits that are activated by exogenous ATP. Increased membrane expression of P2X4 channels by using a peptide competing with P2X4 intracellular endocytosis motif enhances neuronal excitability of SF-1 GFP-positive neurons. This increased excitability is inhibited by a P2X receptor antagonist. Furthermore, increased surface P2X4 receptor expression significantly decreases the frequency and the amplitude of GABAergic postsynaptic currents of SF-1 GFP-positive neurons. Co-immunopurification and pulldown assays reveal that P2X4 receptors complex with aminobutyric acid, type A (GABA(A)) receptors and demonstrate that two amino acids in the carboxyl tail of the P2X4 subunit are crucial for its physical association with GABA(A) receptors. Mutation of these two residues prevents the physical association, thereby blocking cross-inhibition between P2X4 and GABA(A) receptors. Moreover, disruption of the physical coupling using competitive peptides containing the identified motif abolishes current inhibition between P2X4 and GABA(A) receptors in recombinant system and P2X4 receptor-mediated GABAergic depression in SF-1 GFP-positive neurons. Our present work thus provides evidence for cross-talk between excitatory and inhibitory receptors that appears to be crucial in determining GABAergic synaptic strength at a central synapse.	[Jo, Young-Hwan] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Donier, Emmanuelle; Martinez, Audrey; Garret, Maurice; Toulme, Estelle; Boue-Grabot, Eric] Univ Bordeaux, F-33000 Bordeaux, France; [Donier, Emmanuelle; Martinez, Audrey; Toulme, Estelle; Boue-Grabot, Eric] CNRS, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Garret, Maurice] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, F-33000 Bordeaux, France	Yeshiva University; Albert Einstein College of Medicine; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10467 USA.	young-hwan.jo@einstein.yu.edu; eric.boue-grabot@u-bordeaux2.fr	Boué-Grabot, Eric/AAQ-2061-2020	Boué-Grabot, Eric/0000-0003-2187-9037; Jo, Young-Hwan/0000-0001-6939-8000	CNRS; Conseil Regional Aquitaine; Agence Nationale de la Recherche [ANR-JC-05-0057]; American Diabetes Association	CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche(French National Research Agency (ANR)); American Diabetes Association(American Diabetes Association)	This work was supported by CNRS, Conseil Regional Aquitaine, Agence Nationale de la Recherche Grant ANR-JC-05-0057), and a junior faculty award from the American Diabetes Association (to Y.-H.J.).	Aguayo LG, 1998, PFLUG ARCH EUR J PHY, V435, P382, DOI 10.1007/s004240050527; Barajas-Lopez C, 1998, J PHYSIOL-LONDON, V513, P671, DOI 10.1111/j.1469-7793.1998.671ba.x; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Boue-Grabot E, 2004, J BIOL CHEM, V279, P52517, DOI 10.1074/jbc.M410223200; Boue-Grabot E, 2004, J BIOL CHEM, V279, P6967, DOI 10.1074/jbc.M307772200; Boue-Grabot E, 2003, J NEUROSCI, V23, P1246, DOI 10.1523/JNEUROSCI.23-04-01246.2003; Burnstock G, 2004, CURR OPIN PHARMACOL, V4, P47, DOI 10.1016/j.coph.2003.08.001; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353, DOI 10.1113/jphysiol.1995.sp020522; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Hugel S, 2000, J NEUROSCI, V20, P2121; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jo YH, 2002, J NEUROSCI, V22, P4794, DOI 10.1523/JNEUROSCI.22-12-04794.2002; Jo YH, 2002, J NEUROPHYSIOL, V88, P2501, DOI 10.1152/jn.00352.2002; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Karanjia R, 2006, EUR J NEUROSCI, V23, P3259, DOI 10.1111/j.1460-9568.2006.04861.x; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Rodrigues RJ, 2006, J MOL NEUROSCI, V30, P173, DOI 10.1385/JMN:30:1:173; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Rubio ME, 2001, J NEUROSCI, V21, P641, DOI 10.1523/JNEUROSCI.21-02-00641.2001; Seguela P, 1996, J NEUROSCI, V16, P448; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Sokolova E, 2001, J NEUROSCI, V21, P4958, DOI 10.1523/JNEUROSCI.21-14-04958.2001; Stallings NR, 2002, ENDOCR RES, V28, P497, DOI 10.1081/ERC-120016829; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Tobet SA, 1999, J COMP NEUROL, V405, P88, DOI 10.1002/(SICI)1096-9861(19990301)405:1<88::AID-CNE7>3.0.CO;2-0; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Toulme E, 2006, MOL PHARMACOL, V69, P576, DOI 10.1124/mol.105.018812; Toulme E, 2007, J NEUROCHEM, V102, P1357, DOI 10.1111/j.1471-4159.2007.04640.x; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	39	44	45	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19993	20004		10.1074/jbc.M111.231324	http://dx.doi.org/10.1074/jbc.M111.231324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482824	hybrid, Green Published			2022-12-25	WOS:000291027700077
J	Miyazawa, M; Tashiro, E; Kitaura, H; Maita, H; Suto, H; Iguchi-Ariga, SMM; Ariga, H				Miyazawa, Makoto; Tashiro, Erika; Kitaura, Hirotake; Maita, Hiroshi; Suto, Hiroo; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Prefoldin Subunits Are Protected from Ubiquitin-Proteasome System-mediated Degradation by Forming Complex with Other Constituent Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN L23; MYC-BINDING PROTEIN; FUNCTION IN-VIVO; TUMOR-SUPPRESSOR; C-MYC; EUKARYOTIC PREFOLDIN; CYTOSOLIC CHAPERONIN; UNFOLDED PROTEINS; ACTIN; MM-1	The molecular chaperone prefoldin (PFD) is a complex comprised of six different subunits, PFD1-PFD6, and delivers newly synthesized unfolded proteins to cytosolic chaperonin TRiC/CCT to facilitate the folding of proteins. PFD subunits also have functions different from the function of the PFD complex. We previously identified MM-1 alpha/PFD5 as a novel c-Myc-binding protein and found that MM-1 alpha suppresses transformation activity of c-Myc. However, it remains unclear how cells regulate protein levels of individual subunits and what mechanisms alter the ratio of their activities between subunits and their complex. In this study, we found that knockdown of one subunit decreased protein levels of other subunits and that transfection of five subunits other than MM-1 alpha into cells increased the level of endogenous MM-1 alpha. We also found that treatment of cells with MG132, a proteasome inhibitor, increased the level of transfected/overexpressed MM-1 alpha but not that of endogenous MM-1 alpha, indicating that overexpressed MM-1 alpha, but not endogenous MM-1 alpha, was degraded by the ubiquitin proteasome system (UPS). Experiments using other PFD subunits showed that the UPS degraded a monomer of PFD subunits, though extents of degradation varied among subunits. Furthermore, the level of one subunit was increased after cotransfection with the respective subunit, indicating that there are specific combinations between subunits to be stabilized. These results suggest mutual regulation of protein levels among PFD subunits and show how individual subunits form the PFD complex without degradation.	[Miyazawa, Makoto; Tashiro, Erika; Kitaura, Hirotake; Maita, Hiroshi; Suto, Hiroo; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Miyazawa, Makoto; Tashiro, Erika; Suto, Hiroo] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Ariga, Sanae/H-9647-2013; Maita, Hiroshi/D-5495-2012	Ariga, Hiroyoshi/0000-0001-7384-2143; 	Ministry of Education, Science, Culture and Sports; National Institute of Biomedical Innovation (NIBIO) of Japan; Grants-in-Aid for Scientific Research [21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture and Sports and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan.	Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; CHEN XY, 1994, P NATL ACAD SCI USA, V91, P9111, DOI 10.1073/pnas.91.19.9111; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Drose S, 1997, J EXP BIOL, V200, P1; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Her C, 2003, CANCER RES, V63, P865; Herberg JA, 1998, J MOL BIOL, V277, P839, DOI 10.1006/jmbi.1998.1637; Hirai I, 2004, ONCOGENE, V23, P5124, DOI 10.1038/sj.onc.1207658; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kim SY, 2008, BMB REP, V41, P158, DOI 10.5483/BMBRep.2008.41.2.158; Leroux MR, 1999, EMBO J, V18, P6730, DOI 10.1093/emboj/18.23.6730; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Rodgers KJ, 2003, INT J BIOCHEM CELL B, V35, P716, DOI 10.1016/S1357-2725(02)00391-6; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tsuchiya H, 1996, CANCER RES, V56, P2881; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	36	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19191	19203		10.1074/jbc.M110.216259	http://dx.doi.org/10.1074/jbc.M110.216259			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478150	Green Published, hybrid			2022-12-25	WOS:000291027700002
J	Taxman, DJ; Holley-Guthrie, EA; Huang, MTH; Moore, CB; Bergstralh, DT; Allen, IC; Lei, Y; Gris, D; Ting, JPY				Taxman, Debra J.; Holley-Guthrie, Elizabeth A.; Huang, Max Tze-Han; Moore, Chris B.; Bergstralh, Daniel T.; Allen, Irving C.; Lei, Yu; Gris, Denis; Ting, Jenny Pan-Yun			The NLR Adaptor ASC/PYCARD Regulates DUSP10, Mitogen-activated Protein Kinase (MAPK), and Chemokine Induction Independent of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SPECK-LIKE PROTEIN; PORPHYROMONAS-GINGIVALIS; IMMUNE-RESPONSES; ANTIINFLAMMATORY CYTOKINES; DIFFERENTIAL ACTIVATION; PERIODONTAL PATHOGENS; SIGNALING PATHWAYS; INDUCED ARTHRITIS; GENE-EXPRESSION	ASC/PYCARD is a common adaptor for a diverse set of inflammasomes that activate caspase-1, most prominently the NLR-based inflammasome. Mounting evidence indicates that ASC and these NLRs also elicit non-overlapping functions, but the molecular basis for this difference is unclear. To address this, we performed microarray and network analysis of ASC shRNA knockdown cells. In pathogen-infected cells, an ASC-dependent interactome is centered on the mitogen-activated protein kinase (MAPK) ERK and on multiple chemokines. ASC did not affect the expression of MAPK but affected its phosphorylation by pathogens and Toll-like receptor agonists via suppression of the dual-specificity phosphatase, DUSP10/MKP5. Chemokine induction, DUSP function, and MAPK phosphorylation were independent of caspase-1 and IL-1 beta. MAPK activation by pathogen was abrogated in Asc(-/-) but not Nlrp3(-/-), Nlrc4(-/-), or Casp1(-/-) macrophages. These results demonstrate a function for ASC that is distinct from the inflammasome in modulating MAPK activity and chemokine expression and further identify DUSP10 as a novel ASC target.	[Taxman, Debra J.; Holley-Guthrie, Elizabeth A.; Huang, Max Tze-Han; Moore, Chris B.; Bergstralh, Daniel T.; Allen, Irving C.; Gris, Denis; Ting, Jenny Pan-Yun] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lei, Yu] Univ N Carolina, N Carolina Oral Hlth Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	panyun@med.unc.edu	Gris, Denis/AGA-1192-2022; Gris, Denis/ABE-5229-2021; Lei, Yu Leo/ABF-1293-2020	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434; Lei, Yu Leo/0000-0002-9868-9824; Bergstralh, Dan/0000-0003-1689-3715; Allen, Irving/0000-0001-9573-5250	National Institutes of Health [RO1-DE016326]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DE016326 (to J. P.- Y. T.).	Argast GM, 2005, MOL CELL BIOCHEM, V268, P129, DOI 10.1007/s11010-005-3701-0; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Conway KE, 2000, CANCER RES, V60, P6236; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gibson FC, 2007, CURR PHARM DESIGN, V13, P3665, DOI 10.2174/138161207783018554; Hasegawa M, 2009, J IMMUNOL, V182, P7655, DOI 10.4049/jimmunol.0800448; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Huang MTH, 2009, J IMMUNOL, V182, P2395, DOI 10.4049/jimmunol.0800909; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lin DM, 2007, J PERIODONTOL, V78, P833, DOI 10.1902/jop.2007.060201; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Milward MR, 2007, CLIN EXP IMMUNOL, V148, P307, DOI 10.1111/j.1365-2249.2007.03342.x; Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	43	57	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19605	19616		10.1074/jbc.M111.221077	http://dx.doi.org/10.1074/jbc.M111.221077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487011	Green Published, hybrid			2022-12-25	WOS:000291027700044
J	Zomot, E; Bahar, I				Zomot, Elia; Bahar, Ivet			Protonation of Glutamate 208 Induces the Release of Agmatine in an Outward-facing Conformation of an Arginine/Agmatine Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ACID RESISTANCE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; PK(A) VALUES; TRANSPORTER; MECHANISM; SUPERFAMILY; ARGININE; RATIONALIZATION	Virulent enteric pathogens have developed several systems that maintain intracellular pH to survive extreme acidic conditions. One such mechanism is the exchange of arginine (Arg(+)) from the extracellular region with its intracellular decarboxylated form, agmatine (Agm(2+)). The net result of this process is the export of a virtual proton from the cytoplasm per antiport cycle. Crystal structures of the arginine/agmatine antiporter from Escherichia coli, AdiC, have been recently resolved in both the apo and Arg(+)-bound outward-facing conformations, which permit us to assess for the first time the time-resolved mechanisms of interactions that enable the specific antiporter functionality of AdiC. Using data from similar to 1 mu s of molecular dynamics simulations, we show that the protonation of Glu-208 selectively causes the dissociation and release of Agm(2+), but not Arg(+), to the cell exterior. The impact of Glu-208 protonation is transmitted to the substrate binding pocket via the reorientation of Ile-205 carbonyl group at the irregular portion of transmembrane (TM) helix 6. This effect, which takes place only in the subunits where Agm(2+) is released, invites attention to the functional role of the unwound portion of TM helices (TM6 Trp-202-Glu-208 in AdiC) in facilitating substrate translocation, reminiscent of the behavior observed in structurally similar Na+-coupled transporters.	[Zomot, Elia; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST3,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020		National Institutes of Health [1R01GM086238-01, 1U54GM087519-01A1]; National Science Foundation [TG-MCB100108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM086238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 1R01GM086238-01 and 1U54GM087519-01A1. This work was also supported by the National Science Foundation through TeraGrid resources provided by Kraken (National Institute for Computational Sciences) and Ranger (Texas Advanced Computing Center) under Grant TG-MCB100108.	Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FOSTER JW, 1994, MICROBIOL-SGM, V140, P341, DOI 10.1099/13500872-140-2-341; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POOLMAN B, 1990, MOL MICROBIOL, V4, P1629, DOI 10.1111/j.1365-2958.1990.tb00539.x; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	28	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19693	19701		10.1074/jbc.M110.202085	http://dx.doi.org/10.1074/jbc.M110.202085			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487006	Green Published, hybrid			2022-12-25	WOS:000291027700052
J	Beristain, AG; Zhu, H; Leung, PCK				Beristain, Alexander G.; Zhu, Hua; Leung, Peter C. K.			Regulated Expression of ADAMTS-12 in Human Trophoblastic Cells: A Role for ADAMTS-12 in Epithelial Cell Invasion?	PLOS ONE			English	Article							HUMAN EXTRAVILLOUS CYTOTROPHOBLASTS; VASCULAR INTEGRIN ALPHA(V)BETA(3); SMOOTH-MUSCLE-CELLS; GROWTH; METALLOPROTEINASES; DIFFERENTIATION; DISINTEGRIN; ADHESION; MATRIX; IMPLANTATION	Metastatic carcinoma cells exploit the same molecular machinery that allows human placental cytotrophoblasts to develop an invasive phenotype. As altered expression levels of ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin repeats) subtypes have been associated with cancer progression, we have examined the function and regulation of members of this gene family in epithelial cell invasion using cultures of highly invasive extravillous cytotrophoblasts and the poorly invasive JEG-3 cytotrophoblast cell line as model systems. Of the multiple ADAMTS subtypes identified in first trimester human placenta and these two trophoblastic cell types, only ADAMTS-12 was preferentially expressed by extravillous cytotrophoblasts. Transforming growth factor-beta 1 and interleukin-1 beta, two cytokines that promote and restrain cytotrophoblast invasion in vitro, were also found to differentially regulate trophoblastic ADAMTS-12 mRNA levels. Loss-or gain-of-function studies confirmed that ADAMTS-12, independent of its proteolytic activity, plays a specific, non-redundant role in trophoblast invasion. Furthermore, we demonstrated that ADAMTS-12 regulated cell-extracellular matrix adhesion and invasion through a mechanism involving the alpha v beta 3 integrin heterodimer. This study identifies a novel biological role for ADAMTS-12, and highlights the importance and complexity of its non-proteolytic domain(s) pertaining to its function.	[Beristain, Alexander G.] Ontario Canc Inst, Div Cell Signaling Biol, Toronto, ON M4X 1K9, Canada; [Beristain, Alexander G.; Zhu, Hua; Leung, Peter C. K.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia	Beristain, AG (corresponding author), Ontario Canc Inst, Div Cell Signaling Biol, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	aberista@uhnres.utoronto.ca		Leung, Peter/0000-0003-3152-3800; Beristain, Alexander/0000-0002-1117-6242	Canadian Institutes for Health Research [MOP-102578]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a research grant (#MOP-102578) to Dr. Colin D. MacCalman and PCKL from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; APLIN JD, 1991, J CELL SCI, V99, P681; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Bai XH, 2009, CELL MOL LIFE SCI, V66, P667, DOI 10.1007/s00018-008-8633-x; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Chou CS, 2002, J CLIN ENDOCR METAB, V87, P5594, DOI 10.1210/jc.2002-020883; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Eyre DR, 2004, CLIN ORTHOP RELAT R, pS118, DOI 10.1097/01.blo.0000144855.48640.b9; Farina A, 2006, PRENATAL DIAG, V26, P128, DOI 10.1002/pd.1373; Gasparini G, 1998, CLIN CANCER RES, V4, P2625; Getsios S, 1998, J REPROD FERTIL, V114, P357; GOSPODAROWICZ D, 1981, J CELL BIOL, V89, P568, DOI 10.1083/jcb.89.3.568; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; GRAHAM CH, 1993, TROPHOBLAST RES, V7, P237; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hamel MG, 2008, EXP NEUROL, V210, P428, DOI 10.1016/j.expneurol.2007.11.014; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Iwahashi M, 1996, J REPROD FERTIL, V108, P147; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kabir-Salmani M, 2003, ENDOCRINOLOGY, V144, P1620, DOI 10.1210/en.2002-220886; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Knofler M, 2008, PLACENTA, V29, pS26, DOI 10.1016/j.placenta.2007.11.008; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 2004, BIOCHEM BIOPH RES CO, V319, P1327, DOI 10.1016/j.bbrc.2004.05.105; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; LaMarca HL, 2005, PLACENTA, V26, P709, DOI 10.1016/j.placenta.2004.11.003; Lessey BA, 2002, J REPROD IMMUNOL, V55, P101, DOI 10.1016/S0165-0378(01)00139-5; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; MacCalman CD, 1996, DEV DYNAM, V206, P201; MacCalman CD, 1998, AM J REPROD IMMUNOL, V39, P96; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; Masui T, 2001, CLIN CANCER RES, V7, P3437; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moncada-Pazos A, 2009, J CELL SCI, V122, P2906, DOI 10.1242/jcs.050468; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Poehlmann TG, 2005, PLACENTA, V26, pS37, DOI 10.1016/j.placenta.2005.01.007; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Porter S, 2006, INT J CANCER, V118, P1241, DOI 10.1002/ijc.21476; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xu GX, 2002, BIOL REPROD, V67, P681, DOI 10.1095/biolreprod67.2.681; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; ZHOU Y, 1993, J CLIN INVEST, V89, P210	62	41	42	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18473	10.1371/journal.pone.0018473	http://dx.doi.org/10.1371/journal.pone.0018473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494557	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100015
J	Sormo, CG; Brembu, T; Winge, P; Bones, AM				Sormo, Christopher G.; Brembu, Tore; Winge, Per; Bones, Atle M.			Arabidopsis thaliana MIRO1 and MIRO2 GTPases Are Unequally Redundant in Pollen Tube Growth and Fusion of Polar Nuclei during Female Gametogenesis	PLOS ONE			English	Article							GAMETOPHYTE DEVELOPMENT; MITOCHONDRIAL MORPHOLOGY; EMBRYO DEVELOPMENT; AXONAL-TRANSPORT; RHO GTPASES; GENES; IDENTIFICATION; EMBRYOGENESIS; MUTAGENESIS; MUTATIONS	MIRO GTPases have evolved to regulate mitochondrial trafficking and morphology in eukaryotic organisms. A previous study showed that T-DNA insertion in the Arabidopsis MIRO1 gene is lethal during embryogenesis and affects pollen tube growth and mitochondrial morphology in pollen, whereas T-DNA insertion in MIRO2 does not affect plant development visibly. Phylogenetic analysis of MIRO from plants revealed that MIRO 1 and 2 orthologs in dicots cluster in two separate groups due to a gene/genome duplication event, suggesting that functional redundancy may exists between the two MIRO genes. To investigate this possibility, we generated miro1((+/-))/miro2-2((-/-)) plants. Compared to miro1((+/-)) plants, the miro1((+/-))/miro2-2((-/-)) plants showed increased segregation distortion. miro1((+/-))/miro2-2((-/-)) siliques contained less aborted seeds, but more than 3 times the number of undeveloped ovules. In addition, reciprocal crosses showed that co-transmission through the male gametes was nearly absent, whereas co-transmission through the female gametes was severely reduced in miro1((+/-))/miro2-2((-/-)) plants. Further investigations revealed that loss of MIRO2 (miro2((-/-))) function in the miro1((+/-)) background enhanced pollen tube growth defects. In developing miro1((+/-))/miro2((-/-)) embryo sacs, fusion of polar nuclei was further delayed or impaired compared to miro1 plants. This phenotype has not been reported previously for miro1 plants and coincides with studies showing that defects in some mitochondria-targeted genes results in the same phenotype. Our observations show that loss of function in MIRO2 in a miro1((+/-)) background enhances the miro1((+/-)) phenotype significantly, even though miro2((-/-)) plants alone does not display any phenotypes. Based on these findings, we conclude that MIRO1 and MIRO2 are unequally redundant and that a proportion of the miro1((+/-))/miro2((-/-)) plants haploid gametes displays the complete null phenotype of MIRO GTPase function at key developmental stages.	[Sormo, Christopher G.; Brembu, Tore; Winge, Per; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Sormo, CG (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	atle.bones@bio.ntnu.no	Brembu, Tore/J-7166-2015; Bones, Atle M/C-6202-2014	Brembu, Tore/0000-0001-5622-8037; Bones, Atle M/0000-0003-0544-7437	Norwegian Research Council [164583/V40, 184146/S10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council (grants #164583/V40 and 184146/S10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, METH MOL B, V236, P177; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Briggs GC, 2006, TRENDS PLANT SCI, V11, P492, DOI 10.1016/j.tplants.2006.08.005; Christensen CA, 2002, PLANT CELL, V14, P2215, DOI 10.1105/tpc.002170; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Force A, 1999, GENETICS, V151, P1531; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Fujimoto M, 2009, PLANT J, V58, P388, DOI 10.1111/j.1365-313X.2009.03786.x; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Jayasekaran K, 2006, PLANT CELL REP, V25, P1255, DOI 10.1007/s00299-006-0195-5; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Kagi C, 2010, P NATL ACAD SCI USA, V107, P22350, DOI 10.1073/pnas.1012795108; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Liu XG, 2009, INT J BIOCHEM CELL B, V41, P1972, DOI 10.1016/j.biocel.2009.05.013; Logan DC, 2006, BBA-MOL CELL RES, V1763, P430, DOI 10.1016/j.bbamcr.2006.01.003; Logan DC, 2010, BIOCHEM SOC T, V38, P789, DOI 10.1042/BST0380789; Logan DC, 2006, J EXP BOT, V57, P1225, DOI 10.1093/jxb/erj151; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; McElver J, 2001, GENETICS, V159, P1751; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Portereiko MF, 2006, PLANT PHYSIOL, V141, P957, DOI 10.1104/pp.106.079319; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; SAOTOME M, 2008, CONTROL, V105, P20728; Tadege M, 1997, PLANT MOL BIOL, V35, P343, DOI 10.1023/A:1005837112653; Tan XY, 2010, PLANT CELL PHYSIOL, V51, P635, DOI 10.1093/pcp/pcq029; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Van Gestel K, 2002, J EXP BOT, V53, P659, DOI 10.1093/jexbot/53.369.659; Weinig C, 2003, GENETICS, V165, P321; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; WINGE P, 2002, EVOLUTION SMALL GTP; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Yamaoka S, 2011, PLANT CELL REP, V30, P239, DOI 10.1007/s00299-010-0926-5	44	15	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18530	10.1371/journal.pone.0018530	http://dx.doi.org/10.1371/journal.pone.0018530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494602	Green Published, Green Submitted, gold			2022-12-25	WOS:000289354100018
J	Cerchietti, L; Damm-Welk, C; Vater, I; Klapper, W; Harder, L; Pott, C; Yang, SN; Reiter, A; Siebert, R; Melnick, A; Woessmann, W				Cerchietti, Leandro; Damm-Welk, Christine; Vater, Inga; Klapper, Wolfram; Harder, Lana; Pott, Christiane; Yang, Shao Ning; Reiter, Alfred; Siebert, Reiner; Melnick, Ari; Woessmann, Willi			Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas	PLOS ONE			English	Article							NPM-ALK; FUSION; STAT3; TRANSFORMATION; PROTEINS; CHILDREN; CANCER	ALK positive diffuse large B-cell lymphomas (DLBCL) are a distinct lymphoma subtype associated with a poor outcome. Most of them feature a t(2;17) encoding a clathrin (CLTC)-ALK fusion protein. The contribution of deregulated ALK-activity in the pathogenesis and maintenance of these DLBCLs is not yet known. We established and characterized the first CLTC-ALK positive DLBCL cell line (LM1). LM1 formed tumors in NOD-SCID mice. The selective ALK inhibitor NVP-TAE684 inhibited growth of LM1 cells in vitro at nanomolar concentrations. NVP-TAE684 repressed ALK-activated signalling pathways and induced apoptosis of LM1 DLBCL cells. Inhibition of ALK-activity resulted in sustained tumor regression in the xenotransplant tumor model. These data indicate a role of CLTC-ALK in the maintenance of the malignant phenotype thereby providing a rationale therapeutic target for these otherwise refractory tumors.	[Cerchietti, Leandro; Yang, Shao Ning; Melnick, Ari] Cornell Univ, Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY 10021 USA; [Cerchietti, Leandro; Yang, Shao Ning; Melnick, Ari] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Damm-Welk, Christine; Reiter, Alfred; Woessmann, Willi] Univ Giessen, Dept Pediat Hematol & Oncol, Giessen, Germany; [Vater, Inga; Harder, Lana] Univ Kiel, Inst Human Genet, Kiel, Germany; [Klapper, Wolfram; Siebert, Reiner] Univ Hosp Schleswig Holstein, Dept Pathol, Hematopathol Sect, Kiel, Germany; [Klapper, Wolfram; Siebert, Reiner] Univ Hosp Schleswig Holstein, Lymph Node Registry, Kiel, Germany; [Pott, Christiane] Univ Kiel, Dept Med 2, Kiel, Germany	Cornell University; Cornell University; Justus Liebig University Giessen; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Cerchietti, L (corresponding author), Cornell Univ, Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY 10021 USA.	lec2010@med.cornell.edu; wilhelm.woessmann@paediat.med.uni-giessen.de	Siebert, Reiner/A-8049-2010; Klapper, Wolfram/S-6314-2016; Melnick, Ari/AAA-5763-2020	Cerchietti, Leandro/0000-0003-0608-1350	Forschungshilfe Peiper; Deutsche Jose-Carreras Leukamiestiftung [DJCLS R 08/09]; Leukemia and Lymphoma Society [SCOR 7017-09]; Kinderkrebsinitiative Buchholz; Holm-Seppensen	Forschungshilfe Peiper; Deutsche Jose-Carreras Leukamiestiftung; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Kinderkrebsinitiative Buchholz; Holm-Seppensen	C.D., A.R. and W.W. were supported by the Forschungshilfe Peiper, W.K. and R.S. by the Kinderkrebsinitiative Buchholz, Holm-Seppensen. A. M. is a Scholar of the Leukemia and Lymphoma Society and a Burroughs Wellcome Clinical Translational Scientist. This work was supported in part by a grant from the Deutsche Jose-Carreras Leukamiestiftung (DJCLS R 08/09) and by Leukemia and Lymphoma Society (SCOR 7017-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Beltran B, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-11; Brugieres L, 1998, BLOOD, V92, P3591; Brugieres L, 2009, J CLIN ONCOL, V27, P897, DOI 10.1200/JCO.2008.18.1487; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cussac D, 2004, BLOOD, V103, P1464; Damm-Welk C, 2009, BRIT J HAEMATOL, V146, P306, DOI 10.1111/j.1365-2141.2009.07754.x; De Paepe P, 2003, BLOOD, V102, P2638, DOI 10.1182/blood-2003-04-1050; Delsol G, 1997, BLOOD, V89, P1483, DOI 10.1182/blood.V89.5.1483.1483_1483_1490; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gascoyne RD, 2003, BLOOD, V102, P2568, DOI 10.1182/blood-2003-03-0786; Gesk S, 2005, LEUKEMIA, V19, P1839, DOI 10.1038/sj.leu.2403921; Laurent C, 2009, J CLIN ONCOL, V27, P4211, DOI 10.1200/JCO.2008.21.5020; Marzec M, 2007, ONCOGENE, V26, P813, DOI 10.1038/sj.onc.1209843; Momose S, 2009, HUM PATHOL, V40, P75, DOI 10.1016/j.humpath.2008.06.009; Nieborowska-Skorska M, 2001, CANCER RES, V61, P6517; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Swerdlow E., 2008, WHO CLASSIFICATION T; Turner SD, 2005, LEUKEMIA, V19, P1128, DOI 10.1038/sj.leu.2403797; Woessmann W, 2006, BRIT J HAEMATOL, V133, P176, DOI 10.1111/j.1365-2141.2006.06004.x; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152	23	36	40	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18436	10.1371/journal.pone.0018436	http://dx.doi.org/10.1371/journal.pone.0018436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494621	Green Published, Green Submitted, gold			2022-12-25	WOS:000289292800017
J	Krstic, G				Krstic, Goran			Asthma Prevalence Associated with Geographical Latitude and Regional Insolation in the United States of America and Australia	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; EMERGENCY-DEPARTMENT VISITS; RESPIRATORY SYMPTOMS; ALLERGIC RHINITIS; VARIABILITY; PREGNANCY; CHILDREN; CLIMATE; IL-10; BLOOD	Background: It has been proposed that vitamin D deficiency may be responsible for an increase in the prevalence of allergic diseases and asthma worldwide. Human ability to generate physiologically required quantities of vitamin D through sun exposure is decreasing with increasing geographical latitude. Objectives: Considering that vitamin D deficiency is usually due to lack of outdoor sun exposure, this study is designed to test the hypothesis that a higher prevalence of asthma should be expected at high relative to low geographical latitudes. Methods: Linear regression analyses are performed on asthma prevalence in the U. S. adult population vs. geographical latitude, insolation, air temperature, and air pollution (PM2.5) for 97 major metropolitan/micropolitan statistical areas of the continental United States of America and on general population asthma prevalence vs. geographical latitude in eight metropolitan areas of Australia. Results: A 10 degrees change in geographical latitude from southern to northern regions of the Eastern Seaboard is associated with a 2% increase in adult asthma prevalence (p < 0.001). Total insolation in winter months is almost as strong as latitude in its ability to explain the observed spatial variation in the prevalence of asthma (r(2) = 0.43; p < 0.001). Similar results are obtained using the Australian data (r(2) = 0.73; p < 0.01), suggesting a consistent association between the latitude/insolation and asthma prevalence worldwide. Conclusions: The results of this study suggest that, as a known modulator of the immune response closely linked with the geographical latitude and erythemal UV irradiation, vitamin D may play an important role in the development/exacerbation of asthma.	Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada		Krstic, G (corresponding author), Fraser Hlth, Environm Hlth Serv, New Westminster, BC, Canada.	Goran.Krstic@fraserhealth.ca						Aiba Setsuya, 2007, Allergol Int, V56, P201, DOI 10.2332/allergolint.R-07-147; Akinbami L., 2006, ADV DATA VITAL HLTH; Allan K, 2010, P NUTR SOC, V69, pE475, DOI 10.1017/S0029665110003381; [Anonymous], 2008, BEH RISK FACT SURV S; Bharadwaj AS, 2007, CAN J PHYSIOL PHARM, V85, P686, DOI 10.1139/Y07-062; *C STURT U, 1996, GUID AUSTR LAT LONG; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cutolo M, 2009, RHEUMATOLOGY, V48, P210, DOI 10.1093/rheumatology/ken394; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Fioletov VE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004820; Franco JM, 2009, ALLERGOL IMMUNOPATH, V37, P116, DOI 10.1016/S0301-0546(09)71722-7; Freishtat RJ, 2010, J PEDIATR-US, V156, P948, DOI 10.1016/j.jpeds.2009.12.033; Genuis SJ, 2009, INT J ENV RES PUB HE, V6, P151, DOI 10.3390/ijerph6010151; George R B, 1991, Dis Mon, V37, P137; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; Grant EN, 2000, AM J PUBLIC HEALTH, V90, P1923, DOI 10.2105/AJPH.90.12.1923; Grant WB, 2007, EXPERT REV DERMATOL, V2, P563; Hintzpeter B, 2008, J NUTR, V138, P1482, DOI 10.1093/jn/138.8.1482; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; Koskela HO, 2007, INT J CIRCUMPOL HEAL, V66, P91, DOI 10.3402/ijch.v66i2.18237; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Matsumoto K, 2004, INT ARCH ALLERGY IMM, V134, P295, DOI 10.1159/000079167; Mead MN, 2008, ENVIRON HEALTH PERSP, V116, pA22, DOI 10.1289/ehp.116-a22b; Meng Ying-Ying, 2007, Policy Brief UCLA Cent Health Policy Res, P1; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Murillo W, 2003, RENEW ENERG, V28, P409, DOI 10.1016/S0960-1481(02)00039-3; *NASA ATM SCI DAT, SURF MET SOL EN INT; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; *PUBL HLTH INF DEV, 2010, SOC HLTH ATL AUSTR L; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rudders SA, 2010, ANN ALLERG ASTHMA IM, V104, P413, DOI 10.1016/j.anai.2010.01.022; Schauber J, 2008, J ALLERGY CLIN IMMUN, V121, P782, DOI 10.1016/j.jaci.2007.12.1170; Staples JA, 2003, ENVIRON HEALTH PERSP, V111, P518, DOI 10.1289/ehp.5941; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Tomita K, 2002, CLIN IMMUNOL, V102, P258, DOI 10.1006/clim.2001.5176; Trabea A. A., 2001, Egyptian Journal of Solids, V24, P123; *US EPA, 2009, AIR TRENDS AIR QUAL; *USGS, 2010, MICR RES MSR MAPS; Wang XL, 2007, P SOC PHOTO-OPT INS, V6679, P67903, DOI 10.1117/12.735284; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Wjst M, 1999, ALLERGY, V54, P757, DOI 10.1034/j.1398-9995.1999.00193.x; Wjst M, 2006, PEDIAT ALLERG IMM-UK, V17, P477, DOI 10.1111/j.1399-3038.2006.00456.x; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Zanolin ME, 2004, ALLERGY, V59, P306, DOI 10.1046/j.1398-9995.2003.00391.x	49	53	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18492	10.1371/journal.pone.0018492	http://dx.doi.org/10.1371/journal.pone.0018492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	747AP	21494627	Green Published, Green Submitted, gold			2022-12-25	WOS:000289292800025
J	Dechartres, A; Albaladejo, P; Mantz, J; Samama, CM; Collet, JP; Steg, PG; Ravaud, P; Tubach, F				Dechartres, Agnes; Albaladejo, Pierre; Mantz, Jean; Samama, Charles Marc; Collet, Jean-Philippe; Steg, Philippe Gabriel; Ravaud, Philippe; Tubach, Florence			Delphi-Consensus Weights for Ischemic and Bleeding Events to Be Included in a Composite Outcome for RCTs in Thrombosis Prevention	PLOS ONE			English	Article							END-POINTS; CARDIOVASCULAR TRIALS; THROMBOLYTIC THERAPY; SELECTION; BENEFITS	Background and Objectives: To weight ischemic and bleeding events according to their severity to be used in a composite outcome in RCTs in the field of thrombosis prevention. Method: Using a Delphi consensus method, a panel of anaesthesiology and cardiology experts rated the severity of thrombotic and bleeding clinical events. The ratings were expressed on a 10-point scale. The median and quartiles of the ratings of each item were returned to the experts. Then, the panel members evaluated the events a second time with knowledge of the group responses from the first round. Cronbach's a was used as a measure of homogeneity for the ratings. The final rating for each event corresponded to the median rating obtained at the last Delphi round. Results: Of 70 experts invited, 32 (46%) accepted to participate. Consensus was reached at the second round as indicated by Cronbach's a value (0.99 (95% CI 0.98-1.00)) so the Delphi was stopped. Severity ranged from under-popliteal venous thrombosis (median = 3, Q1 = 2; Q3 = 3) to ischemic stroke or intracerebral hemorrhage with severe disability at 7 days and massive pulmonary embolism (median = 9, Q1 = 9; Q3 = 9). Ratings did not differ according to the medical specialty of experts. Conclusions: These ratings could be used to weight ischemic and bleeding events of various severity comprising a composite outcome in the field of thrombosis prevention.	[Dechartres, Agnes; Ravaud, Philippe; Tubach, Florence] INSERM, UMR S 738, Paris, France; [Dechartres, Agnes; Ravaud, Philippe; Tubach, Florence] Univ Paris Diderot, UMR S 738, Paris, France; [Dechartres, Agnes; Samama, Charles Marc; Ravaud, Philippe] Univ Paris 05, Paris, France; [Dechartres, Agnes; Ravaud, Philippe] Hop Hotel Dieu, APHP, Ctr Epidemiol Clin, F-75181 Paris, France; [Albaladejo, Pierre] Ctr Hosp Univ, Grenoble, France; [Albaladejo, Pierre] Univ Grenoble 1, Grenoble, France; [Mantz, Jean] Hop Beaujon, APHP, Serv Anesthesie Reanimat & SMUR, Clichy, France; [Mantz, Jean; Steg, Philippe Gabriel; Tubach, Florence] Univ Paris Diderot, Paris, France; [Samama, Charles Marc] Hop Hotel Dieu, APHP, Serv Anesthesie Reanimat, F-75181 Paris, France; [Collet, Jean-Philippe] Hop La Pitie Salpetriere, Serv Cardiol, Paris, France; [Collet, Jean-Philippe] Univ Paris 06, F-75252 Paris 05, France; [Steg, Philippe Gabriel] INSERM, U 698, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, APHP, Serv Cardiol, F-75877 Paris 18, France; [Tubach, Florence] INSERM, CIE 801, Paris, France; [Tubach, Florence] Hop Bichat Claude Bernard, APHP, Dept Biostat Epidemiol, F-75877 Paris 18, France; [Tubach, Florence] Hop Bichat Claude Bernard, APHP, Rech Clin, F-75877 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Dechartres, A (corresponding author), INSERM, UMR S 738, Paris, France.	florence.tubach@bch.aphp.fr	albaladejo, pierre/M-6901-2014; STEG, Philippe Gabriel/Z-1567-2019; ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; STEG, Philippe Gabriel/0000-0001-6896-2941	Bristol Myers Squibb; Pfizer; Daiichi Sankyo; Eli-Lilly; Boehringer Ingelheim; LFB; Bayer; Bristol-Myers Squibb; Daichi-Sankyo; Pall Medical; Orionpharma; NovoNordisk; CSL Behring; AstraZeneca; GSK; Abbott Vascular; Boston Scientific; Cordis; Federation Francaise de Cardiologie; Fondation de France; Guerbet Medical; INSERM; Medtronic; Societe Francaise de Cardiologie; Zsra-Zeneca; Servier; Schering Plough	Bristol Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli-Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); LFB; Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daichi-Sankyo; Pall Medical; Orionpharma; NovoNordisk(Novo Nordisk); CSL Behring; AstraZeneca(AstraZeneca); GSK(GlaxoSmithKline); Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis; Federation Francaise de Cardiologie; Fondation de France(Fondation de France); Guerbet Medical; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Medtronic(Medtronic); Societe Francaise de Cardiologie; Zsra-Zeneca; Servier(Servier); Schering Plough(Merck & CompanySchering Plough Corporation)	P. Albaladejo: Research grants (to the institution) from Bristol Myers Squibb, Pfizer, Daiichi Sankyo, Eli-Lilly, Boehringer Ingelheim, LFB, consulting or lecture fees from Bayer, Bristol-Myers Squibb, Pfizer, Daichi-Sankyo, Eli-Lilly, Boehringer Ingelheim, Sanofi-Aventis, LFB, and Vifor. J. Mantz: Consulting fees from Baxter, Pall Medical and Orionpharma. C. M. Samama: Research grants (to the institution) from LFB, NovoNordisk, CSL Behring, SanofiAventis, Bayer, consulting or lecture fees from AstraZeneca, Bayer, Bristol-Myers Squibb, Daichi-Sankyo, Eli-Lilly, Sanofi-Aventis Group, Pfizer, Boehringer-Ingelheim, and GSK. J. P. Collet: Research grants (to the institution) from Abbott Vascular, Bristol-Myers Squibb, Boston Scientific, Cordis, Eli-Lilly, Federation Francaise de Cardiologie, Fondation de France, Guerbet Medical, INSERM, Medtronic, Sanofi-Aventis Group, Societe Francaise de Cardiologie, consulting or lecture fees from Zsra-Zeneca, Bayer, Bristol-Myers Squibb, Daichi-Sankyo, Eli-Lilly, Sanofi-Aventis Group, and Servier. P. G. Steg: Hamilton Health Services Astellas, AstraZeneca, Boerhinger-Ingelheim, Bristol-Myers Squibb, GSK, Daiichi-Sankyio/Eli-Lilly Alliance, Medtronic, Merck Sharpe Dohme, Roche, Sanofi-Aventis, Servier, The Medicines Company, and Aterovax. P. Ravaud: None. F. Tubach: Research grants (to the institution) from Abbott, AstraZeneca, Pfizer, and Schering Plough.	Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; BRAUNWALD E, 1992, CIRCULATION, V86, P683, DOI 10.1161/01.CIR.86.2.683; BRAVO G, 1991, J CLIN EPIDEMIOL, V44, P381, DOI 10.1016/0895-4356(91)90076-L; CALIFF RM, 1990, CIRCULATION, V82, P1847, DOI 10.1161/01.CIR.82.5.1847; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Dalkey N., 1963, MANAGE SCI; Dalkey NC, 1969, DELPHI METHOD EXPT S; Delbecq AL, 1975, J HUMAN SCI; Felker GM, 2008, J CARD FAIL, V14, P368, DOI 10.1016/j.cardfail.2008.01.009; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Ferreira-Gonzalez I, 2007, J CLIN EPIDEMIOL, V60, P651, DOI 10.1016/j.jclinepi.2006.10.020; Ferreira-Gonzalez I, 2009, ANN INTERN MED, V150, P566, DOI 10.7326/0003-4819-150-8-200904210-00016; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Freemantle N, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3529; Kraemer HC, 2010, JAMA-J AM MED ASSOC, V304, P683, DOI 10.1001/jama.2010.1133; Lim E, 2008, ANN INTERN MED, V149, P612, DOI 10.7326/0003-4819-149-9-200811040-00004; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Neaton JD, 2005, J CARD FAIL, V11, P567, DOI 10.1016/j.cardfail.2005.08.350; PILL J, 1971, SOCIO ECON PLAN SCI, V5, P57, DOI 10.1016/0038-0121(71)90041-3; Pogue J, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-49; Program CTE, 2006, COMM TERM CRIT ADV E; R Development Core Team, 2009, R FDN STAT COMP; Rahimi K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5707; ROSS S, 2007, AM J OBSTET GYNECOL, V196; Sampson UKA, 2010, J CLIN EPIDEMIOL, V63, P1156, DOI 10.1016/j.jclinepi.2010.01.019; Tugwell P, 2005, J CLIN EPIDEMIOL, V58, P785, DOI 10.1016/j.jclinepi.2004.11.028	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18461	10.1371/journal.pone.0018461	http://dx.doi.org/10.1371/journal.pone.0018461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490920	gold, Green Published, Green Submitted			2022-12-25	WOS:000289238700015
J	Hendrickson, ML; Rao, AJ; Demerdash, ONA; Kalil, RE				Hendrickson, Michael L.; Rao, Abigail J.; Demerdash, Omar N. A.; Kalil, Ronald E.			Expression of Nestin by Neural Cells in the Adult Rat and Human Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INTERMEDIATE-FILAMENT PROTEIN; CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; BASAL FOREBRAIN; STEM-CELLS; IMMUNOREACTIVE NEURONS; PURKINJE-CELLS; NEUROGENESIS; PHOSPHORYLATION	Neurons and glial cells in the developing brain arise from neural progenitor cells (NPCs). Nestin, an intermediate filament protein, is thought to be expressed exclusively by NPCs in the normal brain, and is replaced by the expression of proteins specific for neurons or glia in differentiated cells. Nestin expressing NPCs are found in the adult brain in the subventricular zone (SVZ) of the lateral ventricle and the subgranular zone (SGZ) of the dentate gyrus. While significant attention has been paid to studying NPCs in the SVZ and SGZ in the adult brain, relatively little attention has been paid to determining whether nestin-expressing neural cells (NECs) exist outside of the SVZ and SGZ. We therefore stained sections immunocytochemically from the adult rat and human brain for NECs, observed four distinct classes of these cells, and present here the first comprehensive report on these cells. Class I cells are among the smallest neural cells in the brain and are widely distributed. Class II cells are located in the walls of the aqueduct and third ventricle. Class IV cells are found throughout the forebrain and typically reside immediately adjacent to a neuron. Class III cells are observed only in the basal forebrain and closely related areas such as the hippocampus and corpus striatum. Class III cells resemble neurons structurally and co-express markers associated exclusively with neurons. Cell proliferation experiments demonstrate that Class III cells are not recently born. Instead, these cells appear to be mature neurons in the adult brain that express nestin. Neurons that express nestin are not supposed to exist in the brain at any stage of development. That these unique neurons are found only in brain regions involved in higher order cognitive function suggests that they may be remodeling their cytoskeleton in supporting the neural plasticity required for these functions.	[Hendrickson, Michael L.] Univ Wisconsin, WM Keck Lab Biol Imaging, Madison, WI 53706 USA; [Rao, Abigail J.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Demerdash, Omar N. A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Kalil, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hendrickson, ML (corresponding author), Univ Wisconsin, WM Keck Lab Biol Imaging, Madison, WI 53706 USA.	rekalil@wisc.edu		Hendrickson, Michael/0000-0002-4555-765X	University of Wisconsin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	University of Wisconsin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the University of Wisconsin Foundation (http://www.supportuw.org/) and by various intramural awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot F, 1999, J NEUROSCI RES, V58, P367; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; BRAAK H, 1994, NEURODEGENER DIS, P585; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; Chouaf-Lakhdar L, 2003, NEUROREPORT, V14, P633, DOI 10.1097/00001756-200303240-00022; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duggal N, 2001, J NEUROSURG, V95, P459, DOI 10.3171/jns.2001.95.3.0459; Ernst C, 2006, NEUROSCIENCE, V138, P183, DOI 10.1016/j.neuroscience.2005.10.065; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Gu HY, 2002, BRAIN RES, V943, P174, DOI 10.1016/S0006-8993(02)02615-X; Guo KH, 2010, NEUROCHEM INT, V56, P694, DOI 10.1016/j.neuint.2010.02.005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Krupkova O, 2010, NEOPLASMA, V57, P291, DOI 10.4149/neo_2010_04_291; LEHERICY S, 1993, J COMP NEUROL, V330, P15, DOI 10.1002/cne.903300103; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li DP, 2008, NEUROCHEM INT, V53, P270, DOI 10.1016/j.neuint.2008.08.006; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Mai JK., 2007, ATLAS HUMAN BRAIN; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizuno Y, 2006, J NEUROL SCI, V246, P131, DOI 10.1016/j.jns.2006.02.019; Mizuno Y, 2004, NEUROSCI LETT, V366, P144, DOI 10.1016/j.neulet.2004.05.033; Mizuno Y, 2003, NEUROSCI LETT, V352, P109, DOI 10.1016/j.neulet.2003.08.056; Muir JL, 1997, PHARMACOL BIOCHEM BE, V56, P687, DOI 10.1016/S0091-3057(96)00431-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Rao MS, 1999, ANAT RECORD, V257, P137; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Takamori Y, 2009, BRAIN RES, V1270, P10, DOI 10.1016/j.brainres.2009.03.014; VINORES SA, 1985, NEUROPATH APPL NEURO, V11, P349, DOI 10.1111/j.1365-2990.1985.tb00031.x; Wang S, 2006, NEUROSCIENCE, V142, P1209, DOI 10.1016/j.neuroscience.2006.07.059; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	51	105	120	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18535	10.1371/journal.pone.0018535	http://dx.doi.org/10.1371/journal.pone.0018535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490921	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700021
J	de Boer, OJ; Teeling, P; Jansen, M; Ploegmakers, H; van der Loos, CM; Kummer, JA; Florquin, S; van der Wal, AC				de Boer, Onno J.; Teeling, Peter; Jansen, Marcel; Ploegmakers, Hanneke; van der Loos, Chris M.; Kummer, J. Alain; Florquin, Sandrine; van der Wal, Allard C.			Spatial Differences in the Presence of FOXP3(+) and GranzymeB(+) T Cells between the Intra- and Extravascular Compartments in Renal Allograft Vasculopathy	PLOS ONE			English	Article							ATHEROSCLEROSIS; DISEASE; ARTERIOSCLEROSIS; TRANSPLANTATION; EXPRESSION; REJECTION; CLASSIFICATION; INFLAMMATION; ASSOCIATION; LYMPHOCYTES	Background: Allograft vasculopathy (AV) and native atherosclerosis (NA) share the presence of a T-cell mediated inflammatory response, but differ in overall plaque morphology and growth rate. We studied the distribution and frequency of regulatory-and cytotoxic T cells in the arterial intima lesions in both conditions. Methodology/Principal Findings: The study is based on vessels of 15 explanted human renal allografts with AV and 10 carotid artery plaques obtained at surgery. Distribution and frequency of cytotoxic-and regulatory T cells, as identified by the expression of Granzyme B (GrB) and FOXP3 was established in NA and AV. Furthermore, we compared the distribution of these cells in AV with the perivascular, interstitial renal tissue using immunohistochemistry. The total number of T cells was much higher in AV than in NA lesions (711 +/- 135 and 37 +/- 8 CD3/mm(2) respectively, p<0.005, mean, +/- SEM). Total numbers of FOXP3(+) regulatory cells were also significantly increased in AV (36 +/- 10 and 0.9 +/- 0.3 FOXP3(+)/mm(2) p<0.05), but relative numbers, expressed as a percentage of the total number of CD3(+) T cells ((FOXP3(+)/CD3(+)) 6100), were not significantly different (4.6%+/- 0.9 and 2.7%+/- 0.6). GrB(+) cells were rare in NA, but significantly increased numbers of GrB(+) cells were found in AV lesions (85 +/- 24 and 0.2 +/- 0.1 GrB(+)/mm(2), p<0.05). Perivascular tissues in the allografts showed a higher relative frequency of FOXP3(+) cells than adjacent intimal lesions (14.0%+/- 2.7 and 4.6%+/- 0.9, respectively, p<0.05), but a lower frequency of GrB(+) cytotoxic T cells (16.1%+/- 2.7 and 22.6%+/- 3.6, p<0.05). Conclusions: Similar to NA, AV is characterized by a low frequency of intimal FOXP3+ regulatory T cells. Moreover, significant spatial differences exist in the distribution of functional T cell subsets between the intra-and extravascular micro-environments of the graft.	[de Boer, Onno J.; Teeling, Peter; Jansen, Marcel; Ploegmakers, Hanneke; van der Loos, Chris M.; Florquin, Sandrine; van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Kummer, J. Alain] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; St. Antonius Hospital Utrecht	de Boer, OJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	o.j.deboer@amc.uva.nl	Florquin, Sandrine/B-8242-2012	van der Wal, Allard/0000-0001-5590-3758; de Boer, Onno/0000-0001-8844-1326; Florquin, Sandrine/0000-0002-9676-1722	Academic Medical Center	Academic Medical Center	This work was supported by the Academic Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton-Chess J, 2009, J AM SOC NEPHROL, V20, P1113, DOI 10.1681/ASN.2008050450; Boros P, 2009, AM J TRANSPLANT, V9, P1719, DOI 10.1111/j.1600-6143.2009.02704.x; Choy JC, 2003, MODERN PATHOL, V16, P460, DOI 10.1097/01.MP.0000067424.12280.BC; Colvin RB, 1996, KIDNEY INT, V50, P1069, DOI 10.1038/ki.1996.410; de Boer OJ, 2003, CARDIOVASC RES, V60, P78, DOI 10.1016/S0008-6363(03)00341-9; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; de Boer OJ, 2007, J HISTOCHEM CYTOCHEM, V55, P891, DOI 10.1369/jhc.6A7119.2007; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Dong CM, 1996, LAB INVEST, V74, P921; FOX WM, 1993, HUM PATHOL, V24, P477, DOI 10.1016/0046-8177(93)90159-E; Hagemeijer MC, 2008, AM J TRANSPLANT, V8, P1040, DOI 10.1111/j.1600-6143.2008.02198.x; Hosono M, 2003, ATHEROSCLEROSIS, V168, P73, DOI 10.1016/S0021-9150(03)00024-8; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Kobashigawa JA, 1997, TRANSPLANTATION, V63, P331, DOI 10.1097/00007890-199702150-00001; KUMMER JA, 1993, J IMMUNOL METHODS, V163, P77, DOI 10.1016/0022-1759(93)90241-X; Maggi E, 2005, AUTOIMMUN REV, V4, P579, DOI 10.1016/j.autrev.2005.04.010; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; PAUL LC, 1993, TRANSPLANT P, V25, P2024; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Ronday HK, 2001, RHEUMATOLOGY, V40, P55, DOI 10.1093/rheumatology/40.1.55; SHARPLES LD, 1991, TRANSPLANTATION, V52, P244, DOI 10.1097/00007890-199108000-00012; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Waltner-Romen M, 1998, J HISTOCHEM CYTOCHEM, V46, P1347, DOI 10.1177/002215549804601202; Yapici U, 2009, TRANSPLANTATION, V87, P1377, DOI 10.1097/TP.0b013e3181a24a4b	27	0	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18656	10.1371/journal.pone.0018656	http://dx.doi.org/10.1371/journal.pone.0018656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494640	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400042
J	Ebefors, K; Granqvist, A; Ingelsten, M; Molne, J; Haraldsson, B; Nystrom, J				Ebefors, Kerstin; Granqvist, Anna; Ingelsten, Madeleine; Molne, Johan; Haraldsson, Borje; Nystrom, Jenny			Role of Glomerular Proteoglycans in IgA Nephropathy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FOOT PROCESS EFFACEMENT; HEPARAN-SULFATE; OXFORD CLASSIFICATION; EXTRACELLULAR-MATRIX; NEPHROTIC SYNDROME; BASEMENT-MEMBRANE; MESANGIAL CELLS; FILTRATION-RATE; RENAL-DISEASE	Mesangial matrix expansion is a prominent feature of the most common form of glomerulonephritis, IgA nephropathy (IgAN). To find molecular markers and improve the understanding of the disease, the gene and protein expression of proteoglycans were investigated in biopsies from IgAN patients and correlated to clinical and morphological data. We collected and microdissected renal biopsies from IgAN patients (n = 19) and from healthy kidney donors (n = 14). Patients were followed for an average time of 4 years and blood pressure was according to target guidelines. Distinct patterns of gene expression were seen in glomerular and tubulo-interstitial cells. Three of the proteoglycans investigated were found to be of special interest and upregulated in glomeruli: perlecan, decorin and biglycan. Perlecan gene expression negatively correlated to albumin excretion and progress of the disease. Abundant decorin protein expression was found in sclerotic glomeruli, but not in unaffected glomeruli from IgAN patients or in controls. Transforming growth factor beta (TGF-beta), known to interact with perlecan, decorin and biglycan, were upregulated both on gene and protein level in the glomeruli. This study provides further insight into the molecular mechanisms involved in mesangial matrix expansion in IgAN. We conclude that perlecan is a possible prognostic marker for patients with IgAN. In addition, the up-regulation of biglycan and decorin, as well as TGF-beta itself, indicate that regulation of TGF-beta, and other profibrotic markers plays a role in IgAN pathology.	[Ebefors, Kerstin; Granqvist, Anna; Haraldsson, Borje] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden; [Ingelsten, Madeleine] Univ Gothenburg, Inst Biomed, Dept Infect Med, Sahlgrenska Acad, Gothenburg, Sweden; [Molne, Johan] Univ Gothenburg, Inst Biomed, Dept Pathol, Sahlgrenska Acad, Gothenburg, Sweden; [Nystrom, Jenny] Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	Ebefors, K (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden.	kerstin.ebefors@wlab.gu.se	Haraldsson, Borje/B-3871-2010	Haraldsson, Borje/0000-0002-7536-973X; Molne, Johan/0000-0001-6241-7117	Swedish Medical Research Council [9898, 14764]; VINNOVA; National Association for Kidney Diseases; Inga Britt and Arne Lundberg Research Foundation; Wennerstrom Foundation; Sahlgrenska University Hospital [LUA-7545]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); VINNOVA(Vinnova); National Association for Kidney Diseases; Inga Britt and Arne Lundberg Research Foundation; Wennerstrom Foundation; Sahlgrenska University Hospital	This study was supported by the Swedish Medical Research Council 9898 and 14764, VINNOVA, the National Association for Kidney Diseases, the Inga Britt and Arne Lundberg Research Foundation, Wennerstrom Foundation and the Sahlgrenska University Hospital Grant LUA-7545. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Amore A, 2000, AM J KIDNEY DIS, V36, P1242, DOI 10.1053/ajkd.2000.19840; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; BORDER WA, 1990, KIDNEY INT, V37, P689, DOI 10.1038/ki.1990.35; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Celie JWAM, 2008, AM J PHYSIOL-RENAL, V294, pF253, DOI 10.1152/ajprenal.00429.2007; Chihara Y, 2006, CLIN NEPHROL, V65, P385; Choi SY, 2010, ULTRASTRUCT PATHOL, V34, P195, DOI 10.3109/01913121003648402; Coppo R, 2010, CLIN EXP IMMUNOL, V159, P73, DOI 10.1111/j.1365-2249.2009.04045.x; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Gambichler T, 2009, AM J CLIN PATHOL, V132, P139, DOI 10.1309/AJCPGB55YDURJXZC; Goldberg S, 2009, NEPHROL DIAL TRANSPL, V24, P2044, DOI 10.1093/ndt/gfn758; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harvey SJ, 2008, CURR OPIN NEPHROL HY, V17, P393, DOI 10.1097/MNH.0b013e32830464de; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Jeansson M, 2006, DIABETOLOGIA, V49, P2200, DOI 10.1007/s00125-006-0319-z; Jeansson M, 2003, J AM SOC NEPHROL, V14, P1756, DOI 10.1097/01.ASN.0000072742.02714.6E; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Jones GRD, 2009, PATHOLOGY, V41, P379, DOI 10.1080/00313020902884980; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; KANWAR YS, 1979, P NATL ACAD SCI USA, V76, P1303, DOI 10.1073/pnas.76.3.1303; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Morita H, 2005, J AM SOC NEPHROL, V16, P1703, DOI 10.1681/ASN.2004050387; NAKAMURA T, 1992, KIDNEY INT, V41, P1213, DOI 10.1038/ki.1992.183; OKADA K, 1989, CLIN NEPHROL, V31, P96; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Rupprecht HD, 1996, KIDNEY INT, V49, P1575, DOI 10.1038/ki.1996.228; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Sharma K, 1997, DIABETES, V46, P854, DOI 10.2337/diabetes.46.5.854; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Stokes MB, 2000, KIDNEY INT, V57, P487, DOI 10.1046/j.1523-1755.2000.00868.x; TOMINO Y, 1989, J CLIN LAB ANAL, V3, P101, DOI 10.1002/jcla.1860030207; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; Waga I, 2003, KIDNEY INT, V64, P1253, DOI 10.1046/j.1523-1755.2003.00220.x; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; Xu L, 2010, MODERN PATHOL, V23, P1241, DOI 10.1038/modpathol.2010.110; Yung S, 2001, FASEB J, V15, P1631, DOI 10.1096/fj.00-0794fje	50	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18575	10.1371/journal.pone.0018575	http://dx.doi.org/10.1371/journal.pone.0018575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494642	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400040
J	Cattepoel, S; Hanenberg, M; Kulic, L; Nitsch, RM				Cattepoel, Susann; Hanenberg, Michael; Kulic, Luka; Nitsch, Roger M.			Chronic Intranasal Treatment with an Anti-A beta(30-42) scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHAIN VARIABLE FRAGMENTS; BLOOD-BRAIN-BARRIER; A-BETA BURDEN; COGNITIVE DEFICITS; PRECURSOR-PROTEIN; IN-VIVO; MEMORY DEFICITS; INTERFERON-BETA; PEPTIDE	Amyloid-beta peptide (A beta)-directed active and passive immunization therapeutic strategies reduce brain levels of A beta, decrease the severity of beta-amyloid plaque pathology and reverse cognitive deficits in mouse models of Alzheimer's disease (AD). As an alternative approach to passive immunization with full IgG molecules, single-chain variable fragment (scFv) antibodies can modulate or neutralize A beta-related neurotoxicity and inhibit its aggregation in vitro. In this study, we characterized a scFv derived from a full IgG antibody raised against the C-terminus of A beta, and studied its passage into the brains of APP transgenic mice, as well as its potential to reduce A beta-related pathology. We found that the scFv entered the brain after intranasal application, and that it bound to beta-amyloid plaques in the cortex and hippocampus of APP transgenic mice. Moreover, the scFv inhibited A beta fibril formation and A beta-mediated neurotoxicity in vitro. In a preventative therapeutic approach chronic intranasal treatment with scFv reduced congophilic amyloid angiopathy (CAA) and beta-amyloid plaque numbers in the cortex of APPswe/PS1dE9 mice. This reduction of CAA and plaque pathology was associated with a redistribution of brain A beta from the insoluble fraction to the soluble peptide pool. Due to their lack of the effector domain of full IgG, scFv may represent an alternative tool for the treatment of A beta-related pathology without triggering Fc-mediated effector functions. Additionally, our observations support the possibility that A beta-directed immunotherapy can reduce A beta deposition in brain vessels in transgenic mice.	[Cattepoel, Susann; Hanenberg, Michael; Kulic, Luka; Nitsch, Roger M.] Univ Zurich, Div Psychiat Res, Zurich, Switzerland	University of Zurich	Cattepoel, S (corresponding author), Univ Zurich, Div Psychiat Res, Zurich, Switzerland.	nitsch@bli.uzh.ch			Swiss National Science Foundation [3200B-112626/1]; Swiss Commission of Technology and Innovation; Swiss National Center for Competence in Research (NCCR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Commission of Technology and Innovation; Swiss National Center for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation Grant 3200B-112626/1, the Swiss Commission of Technology and Innovation and the Swiss National Center for Competence in Research (NCCR) on "Neural Plasticity and Repair". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; BRODY DL, ANN REV NEUROSCI, V31, P175; Burmester J, 2001, J MOL BIOL, V309, P671, DOI 10.1006/jmbi.2001.4663; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; Deadwyler SA, 2007, J NEUROSCI, V27, P14239, DOI 10.1523/JNEUROSCI.3878-07.2007; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; der Maur AA, 2001, FEBS LETT, V508, P407, DOI 10.1016/S0014-5793(01)03101-5; Dhuria SV, 2009, J PHARM SCI-US, V98, P2501, DOI 10.1002/jps.21604; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Frenkel D, 2000, J NEUROIMMUNOL, V106, P23, DOI 10.1016/S0165-5728(99)00232-5; Fu HJ, 2010, CNS NEUROL DISORD-DR, V9, P197, DOI 10.2174/187152710791012017; Fukuchi KI, 2006, BIOCHEM BIOPH RES CO, V344, P79, DOI 10.1016/j.bbrc.2006.03.145; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gaugler MNM, 2005, FEBS LETT, V579, P753, DOI 10.1016/j.febslet.2005.01.002; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Graff CL, 2005, J PHARM SCI-US, V94, P1187, DOI 10.1002/jps.20318; Graff CL, 2005, PHARM RES-DORDR, V22, P235, DOI 10.1007/s11095-004-1191-5; HANSON LR, 2004, DRUG DELIVERY TECHNO, V4, P66; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Illum L, 2004, J PHARM PHARMACOL, V56, P3, DOI 10.1211/0022357022539; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; Lawrence D, 2002, LANCET, V359, P1674, DOI 10.1016/S0140-6736(02)08601-4; Lemere CA, 2001, DNA CELL BIOL, V20, P705, DOI 10.1089/10445490152717569; Levites Y, 2006, FASEB J, V20, P2576, DOI 10.1096/fj.06-6463fje; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Maur AAD, 2002, J BIOL CHEM, V277, P45075, DOI 10.1074/jbc.M205264200; Mohajeri MH, 2004, NEURODEGENER DIS, V1, P160, DOI 10.1159/000080981; Mohajeri MH, 2002, J BIOL CHEM, V277, P33012, DOI 10.1074/jbc.M203193200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nitsch RM, 2008, NEUROTHERAPEUTICS, V5, P415, DOI 10.1016/j.nurt.2008.05.013; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Prada CM, 2007, J NEUROSCI, V27, P1973, DOI 10.1523/JNEUROSCI.5426-06.2007; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Ross TM, 2004, J NEUROIMMUNOL, V151, P66, DOI 10.1016/j.jneuroim.2004.02.011; ROZGA M, BIOCH BIOPHYS RES CO, V364, P714; SAKANE T, 1995, J PHARM PHARMACOL, V47, P379, DOI 10.1111/j.2042-7158.1995.tb05814.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schroeter S, 2008, J NEUROSCI, V28, P6787, DOI 10.1523/JNEUROSCI.2377-07.2008; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Solorzano-Vargas RS, 2008, MOL IMMUNOL, V45, P881, DOI 10.1016/j.molimm.2007.08.008; Thorne RG, 2008, NEUROSCIENCE, V152, P785, DOI 10.1016/j.neuroscience.2008.01.013; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Town T, 2009, CNS NEUROL DISORD-DR, V8, P114, DOI 10.2174/187152709787847306; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Yue S, 2008, LIFE SCI, V82, P1249, DOI 10.1016/j.lfs.2008.04.009; Zameer A, 2006, BIOCHEMISTRY-US, V45, P11532, DOI 10.1021/bi060601o	69	57	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18296	10.1371/journal.pone.0018296	http://dx.doi.org/10.1371/journal.pone.0018296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483675	gold, Green Submitted, Green Published			2022-12-25	WOS:000289191300017
J	Deeds, JR; Handy, SM; White, KD; Reimer, JD				Deeds, Jonathan R.; Handy, Sara M.; White, Kevin D.; Reimer, James D.			Palytoxin Found in Palythoa sp Zoanthids (Anthozoa, Hexacorallia) Sold in the Home Aquarium Trade	PLOS ONE			English	Article							PUTATIVE PALYTOXIN; MOLECULAR EVIDENCE; OSTREOPSIS-OVATA; PHYLOGENIES; SKIN	Zoanthids (Anthozoa, Hexacorallia) are colonial anemones that contain one of the deadliest toxins ever discovered, palytoxin (LD50 in mice 300 ng/kg), but it is generally believed that highly toxic species are not sold in the home aquarium trade. We previously showed that an unintentionally introduced zoanthid in a home aquarium contained high concentrations of palytoxin and was likely responsible for a severe respiratory reaction when an individual attempted to eliminate the contaminant colonies using boiling water. To assess the availability and potential exposure of palytoxin to marine aquarium hobbyists, we analyzed zoanthid samples collected from local aquarium stores for palytoxin using liquid chromatography and high resolution mass spectrometry and attempted to identify the specimens through genetic analysis of 16S and cytochrome c oxidase 1 (COI) markers. We found four specimens of the same apparent species of zoanthid, that we described previously to be responsible for a severe respiratory reaction in a home aquarium, to be available in three aquarium stores in the Washington D. C. area. We found all of these specimens (n = 4) to be highly toxic with palytoxin or palytoxin-like compounds (range 0.5-3.5 mg crude toxin/g zoanthid). One of the most potent non-protein compounds ever discovered is present in dangerous quantities in a select species of zoanthid commonly sold in the home aquarium trade.	[Deeds, Jonathan R.; Handy, Sara M.; White, Kevin D.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Reimer, James D.] Univ Ryukyus, Dept Chem Biol & Marine Sci, Okinawa, Japan	US Food & Drug Administration (FDA); University of the Ryukyus	Deeds, JR (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	jonathan.deeds@fda.hhs.gov	Reimer, James Davis/AAP-1331-2020; Handy, Sara/C-6195-2008		United States Food and Drug Administration Center for Food Safety and Applied Nutrition	United States Food and Drug Administration Center for Food Safety and Applied Nutrition	This study was funded by the United States Food and Drug Administration Center for Food Safety and Applied Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORNEMAN EH, 2004, AQUARIUM CORALS SELE, P464; Burnett WJ, 1997, CORAL REEFS, V16, P55, DOI 10.1007/s003380050060; Ciminiello P, 2008, J AM SOC MASS SPECTR, V19, P111, DOI 10.1016/j.jasms.2007.11.001; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2010, RAPID COMMUN MASS SP, V24, P2735, DOI 10.1002/rcm.4696; Ciminiello P, 2009, CHEM RES TOXICOL, V22, P1851, DOI 10.1021/tx900259v; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; Deeds JR, 2010, TOXICON, V56, P150, DOI 10.1016/j.toxicon.2009.05.035; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halstead B.W., 1988, POISONOUS VENOMOUS M; Hoffmann K, 2008, TOXICON, V51, P1535, DOI 10.1016/j.toxicon.2008.03.009; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; MAJLESI N, 2008, CLIN TOXICOL, V46, P637; MOORE RE, 1971, SCIENCE, V172, P495, DOI 10.1126/science.172.3982.495; MOORE RE, 1982, OCEANUS, V25, P54; MOORE RE, 1981, J AM CHEM SOC, V103, P2491, DOI 10.1021/ja00399a093; MURATA M, 1994, J AM CHEM SOC, V116, P7098, DOI 10.1021/ja00095a013; Nordt SP, 2011, J EMERG MED, V40, P397, DOI 10.1016/j.jemermed.2009.05.004; Reimer JD, 2007, ZOOL SCI, V24, P346, DOI 10.2108/zsj.24.346; Reimer James Davis, 2010, Marine Biodiversity, V40, P237, DOI 10.1007/s12526-010-0044-1; Reimer JD, 2004, ZOOL SCI, V21, P517, DOI 10.2108/zsj.21.517; Riobo P, 2008, FOOD CHEM TOXICOL, V46, P2639, DOI 10.1016/j.fct.2008.04.020; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rossi R, 2010, TOXICON, V56, P1381, DOI 10.1016/j.toxicon.2010.08.003; Ryland JS, 2003, INVERTEBR SYST, V17, P407, DOI 10.1071/IS02008; Sinniger F, 2005, MAR BIOL, V147, P1121, DOI 10.1007/s00227-005-0016-3; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; UEMURA D, 1981, TETRAHEDRON LETT, V22, P2781, DOI 10.1016/S0040-4039(01)90551-9; UEMURA D, 1985, TETRAHEDRON, V41, P1007, DOI 10.1016/S0040-4020(01)96468-3; Ukena T, 2001, BIOSCI BIOTECH BIOCH, V65, P2585, DOI 10.1271/bbb.65.2585; WALSH GE, 1971, ZOOL J LINN SOC-LOND, V50, P161, DOI 10.1111/j.1096-3642.1971.tb00757.x; WILES JS, 1974, TOXICON, V12, P427, DOI 10.1016/0041-0101(74)90011-7	39	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18235	10.1371/journal.pone.0018235	http://dx.doi.org/10.1371/journal.pone.0018235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483745	Green Submitted, Green Published, gold			2022-12-25	WOS:000289058700015
J	Schneider, KA; Peischl, S				Schneider, Kristan A.; Peischl, Stephan			Evolution of Assortative Mating in a Population Expressing Dominance	PLOS ONE			English	Article							DEPENDENT INTRASPECIFIC COMPETITION; AFRICAN FINCH PYRENESTES; BILL SIZE POLYMORPHISM; LONG-TERM EVOLUTION; DISRUPTIVE SELECTION; SYMPATRIC SPECIATION; REPRODUCTIVE ISOLATION; ADAPTIVE-DYNAMICS; NICHE WIDTH; MODEL	In this article, we study the influence of dominance on the evolution of assortative mating. We perform a population-genetic analysis of a two-locus two-allele model. We consider a quantitative trait that is under a mixture of frequency-independent stabilizing selection and density-and frequency-dependent selection caused by intraspecific competition for a continuum of resources. The trait is determined by a single (ecological) locus and expresses intermediate dominance. The second (modifier) locus determines the degree of assortative mating, which is expressed in females only. Assortative mating is based on similarities in the quantitative trait ('magic trait' model). Analytical conditions for the invasion of assortment modifiers are derived in the limit of weak selection and weak assortment. For the full model, extensive numerical iterations are performed to study the global dynamics. This allows us to gain a better understanding of the interaction of the different selective forces. Remarkably, depending on the size of modifier effects, dominance can have different effects on the evolution of assortment. We show that dominance hinders the evolution of assortment if modifier effects are small, but promotes it if modifier effects are large. These findings differ from those in previous work based on adaptive dynamics.	[Schneider, Kristan A.; Peischl, Stephan] Univ Vienna, Dept Math, Vienna, Austria	University of Vienna	Schneider, KA (corresponding author), Univ Vienna, Dept Math, Vienna, Austria.	kristan.schneider@univie.ac.at	Peischl, Stephan/AAT-3078-2020	Peischl, Stephan/0000-0002-0474-6104; Schneider, Kristan/0000-0003-4138-1180	Austrian Science Foundation (FWF) [P21305-N13]; Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF) [P 21305] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants of the Austrian Science Foundation (FWF) (P21305-N13) to R. Burger and the Vienna Science and Technology Fund (WWTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2004, EVOLUTION, V58, P2599; Barton NH, 2009, EVOLUTION, V63, P1171, DOI 10.1111/j.1558-5646.2009.00622.x; Bolnick DI, 2006, J THEOR BIOL, V241, P734, DOI 10.1016/j.jtbi.2006.01.009; Burger R, 2006, EVOLUTION, V60, P2185; BULMER MG, 1974, AM NAT, V108, P45, DOI 10.1086/282884; Bulmer MG, 1980, MATH THEORY QUANTITA; Burger R, 2005, J MATH BIOL, V50, P355, DOI 10.1007/s00285-004-0294-2; Burger R, 2006, AM NAT, V167, P190, DOI 10.1086/499375; CHRISTIANSEN FB, 1980, THEOR POPUL BIOL, V18, P297, DOI 10.1016/0040-5809(80)90056-8; CROSBY JL, 1970, HEREDITY, V25, P253, DOI 10.1038/hdy.1970.30; De Cara MAR, 2008, AM NAT, V171, P580, DOI 10.1086/587062; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Doebeli M, 1996, J EVOLUTION BIOL, V9, P893, DOI 10.1046/j.1420-9101.1996.9060893.x; Doebeli M, 2005, J EVOLUTION BIOL, V18, P1194, DOI 10.1111/j.1420-9101.2005.00912.x; Doebeli M, 2007, P ROY SOC B-BIOL SCI, V274, P347, DOI 10.1098/rspb.2006.3725; DURINX M, 2008, ASSORTATIVE MATE CHO; EPSTEIN E, 1984, SOC BIOL, V31, P243; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; GARRISON RJ, 1968, EUGEN QUART, V15, P113, DOI 10.1080/19485565.1968.9987762; Gavrilets S, 1998, AM NAT, V152, P706, DOI 10.1086/286201; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; HO HZ, 1986, SOC BIOL, V33, P77; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Kopp M, 2008, J EVOLUTION BIOL, V21, P1005, DOI 10.1111/j.1420-9101.2008.01547.x; Kopp M, 2006, EVOLUTION, V60, P1537; Leimar O, 2005, AM NAT, V165, P669, DOI 10.1086/429566; Matessi C, 2006, THEOR POPUL BIOL, V69, P283, DOI 10.1016/j.tpb.2005.08.007; Matessi C, 2001, SELECTION, V2, P41, DOI DOI 10.1556/SELECT.2.2001.1-2.4); MOORE WS, 1979, HEREDITY, V42, P173, DOI 10.1038/hdy.1979.21; O'DONALD P., 1960, HEREDITY, V15, P389, DOI 10.1038/hdy.1960.104; Otto SP, 2008, GENETICS, V179, P2091, DOI 10.1534/genetics.107.084418; Peischl S, 2008, J THEOR BIOL, V251, P210, DOI 10.1016/j.jtbi.2007.11.014; Peischl S, 2010, EVOLUTION, V64, P561, DOI 10.1111/j.1558-5646.2009.00839.x; Pennings PS, 2008, AM NAT, V171, pE44, DOI 10.1086/523952; RETTELBACH A, 2010, THEORETICAL IN PRESS; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Schneider KA, 2006, J EVOLUTION BIOL, V19, P570, DOI 10.1111/j.1420-9101.2005.01001.x; Schneider KA, 2006, J MATH BIOL, V52, P483, DOI 10.1007/s00285-005-0355-1; Schneider KA, 2007, THEOR POPUL BIOL, V71, P342, DOI 10.1016/j.tpb.2006.11.003; Slabbekoorn H, 2000, BIOL J LINN SOC, V71, P737, DOI 10.1006/bijl.2000.0472; SLATKIN M, 1979, GENETICS, V93, P755; SMITH TB, 1993, NATURE, V363, P618, DOI 10.1038/363618a0; SMITH TB, 1990, ECOLOGY, V71, P1246, DOI 10.2307/1938261; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; UDOVIC D, 1980, AM NAT, V116, P621, DOI 10.1086/283654; Van Dooren TJM, 2004, EVOL ECOL RES, V6, P857; Van Doorn GS, 2006, EVOLUTION, V60, P2226, DOI 10.1554/06-291.1; Waxman D, 2005, J EVOLUTION BIOL, V18, P1214, DOI 10.1111/j.1420-9101.2005.00953.x; WILSON DS, 1986, AM NAT, V127, P835, DOI 10.1086/284528	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e16821	10.1371/journal.pone.0016821	http://dx.doi.org/10.1371/journal.pone.0016821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483775	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058300001
J	Blakely, BD; Bye, CR; Fernando, CV; Horne, MK; Macheda, ML; Stacker, SA; Arenas, E; Parish, CL				Blakely, Brette D.; Bye, Christopher R.; Fernando, Chathurini V.; Horne, Malcolm K.; Macheda, Maria L.; Stacker, Steven A.; Arenas, Ernest; Parish, Clare L.			Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance	PLOS ONE			English	Article							UNBIASED STEREOLOGICAL ESTIMATION; NEURAL STEM-CELLS; INT-1 PROTOONCOGENE; NEURITE OUTGROWTH; BETA-CATENIN; TOTAL NUMBER; NEURONS; RECEPTOR; POLARITY; MICE	During development, precise temporal and spatial gradients are responsible for guiding axons to their appropriate targets. Within the developing ventral midbrain (VM) the cues that guide dopaminergic (DA) axons to their forebrain targets remain to be fully elucidated. Wnts are morphogens that have been identified as axon guidance molecules. Several Wnts are expressed in the VM where they regulate the birth of DA neurons. Here, we describe that a precise temporo-spatial expression of Wnt5a accompanies the development of nigrostriatal projections by VM DA neurons. In mice at E11.5, Wnt5a is expressed in the VM where it was found to promote DA neurite and axonal growth in VM primary cultures. By E14.5, when DA axons are approaching their striatal target, Wnt5a causes DA neurite retraction in primary cultures. Co-culture of VM explants with Wnt5a-overexpressing cell aggregates revealed that Wnt5a is capable of repelling DA neurites. Antagonism experiments revealed that the effects of Wnt5a are mediated by the Frizzled receptors and by the small GTPase, Rac1 (a component of the non-canonical Wnt planar cell polarity pathway). Moreover, the effects were specific as they could be blocked by Wnt5a antibody, sFRPs and RYK-Fc. The importance of Wnt5a in DA axon morphogenesis was further verified in Wnt5a(-/-) mice, where fasciculation of the medial forebrain bundle (MFB) as well as the density of DA neurites in the MFB and striatal terminals were disrupted. Thus, our results identify a novel role of Wnt5a in DA axon growth and guidance.	[Blakely, Brette D.; Bye, Christopher R.; Fernando, Chathurini V.; Horne, Malcolm K.; Parish, Clare L.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Blakely, Brette D.; Horne, Malcolm K.; Parish, Clare L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Horne, Malcolm K.] St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Macheda, Maria L.; Stacker, Steven A.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Arenas, Ernest] Karolinska Inst, Mol Neurobiol Lab, Dept Biochem & Biophys, Stockholm, Sweden	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Karolinska Institutet	Blakely, BD (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.	clare.parish@florey.edu.au	Horne, Malcolm/AAL-5214-2020; Bye, Chris R/D-6406-2011; Parish, Clare/A-3380-2014; Arenas, Ernest/AAO-5231-2020	Horne, Malcolm/0000-0001-9427-2100; Bye, Chris R/0000-0003-1714-5954; Arenas, Ernest/0000-0003-0197-6577; Stacker, Steven/0000-0003-4096-9273; Parish, Clare/0000-0001-8212-9884; Blakely, Brette/0000-0002-8420-7396; Macheda, Maria/0000-0002-8460-2046	Australian National Health and Medical Research Council (NHMRC) [566740]; Bethlehem Griffith Research Foundation (BGRF), Australia; Human Frontiers Science Program; NHMRC; Australian Postgraduate Award; Swedish Research Council [VR2008:2811]; Norwegian Research Council; Karolinska Institutet	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Bethlehem Griffith Research Foundation (BGRF), Australia; Human Frontiers Science Program(Human Frontier Science Program); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC #566740) and the Bethlehem Griffith Research Foundation (BGRF), Australia. C. L. P. was supported by a Human Frontiers Science Program Long-Term Training Fellowship, NHMRC CJ Martin Fellowship, and NHMRC Career Development Award. B. D. B. is supported by an Australian Postgraduate Award. S. A. S. is supported by an NHMRC Senior Research Fellowship. The work of E. A. was supported by grants from the Swedish Research Council (VR2008:2811 and DBRM), Norwegian Research Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; BJORKLUND A, 1984, DOPAMINE CONTAINING, P55; Bodmer D, 2009, J NEUROSCI, V29, P7569, DOI 10.1523/JNEUROSCI.1445-09.2009; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; BRAENDGAARD H, 1990, J MICROSC-OXFORD, V157, P285, DOI 10.1111/j.1365-2818.1990.tb02967.x; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Castelo-Branco GA, 2006, MOL CELL NEUROSCI, V31, P251, DOI 10.1016/j.mcn.2005.09.014; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Castelo-Branco G, 2006, NEURODEGENER DIS, V3, P5, DOI 10.1159/000092086; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fuentes EO, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-19; Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JC134508, 10.1172/JCI34508]; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hammond R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007007; HERNANDEZ CMA, 2007, REV ALERG MEX, V54, P162; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Kawano H, 2003, EXP NEUROL, V182, P103, DOI 10.1016/S0014-4886(03)00030-X; Keeble TR, 2006, INT J BIOCHEM CELL B, V38, P2011, DOI 10.1016/j.biocel.2006.07.005; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lin L, 2005, MOL CELL NEUROSCI, V28, P547, DOI 10.1016/j.mcn.2004.11.009; Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nakamura S, 2000, J NEUROSCI, V20, P4112; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x; SANCHEZCAMACHO C, 2009, BIOESSAYS; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; STUEBNER S, 2009, DEV DYN; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wang YS, 2002, J NEUROSCI, V22, P8563; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yue Y, 1999, J NEUROSCI, V19, P2090; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	66	75	78	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18373	10.1371/journal.pone.0018373	http://dx.doi.org/10.1371/journal.pone.0018373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483795	Green Published, gold			2022-12-25	WOS:000289057200066
J	Chazenbalk, G; Bertolotto, C; Heneidi, S; Jumabay, M; Trivax, B; Aronowitz, J; Yoshimura, K; Simmons, CF; Dumesic, DA; Azziz, R				Chazenbalk, Gregorio; Bertolotto, Cristina; Heneidi, Saleh; Jumabay, Medet; Trivax, Bradley; Aronowitz, Joel; Yoshimura, Kotaro; Simmons, Charles F.; Dumesic, Daniel A.; Azziz, Ricardo			Novel Pathway of Adipogenesis through Cross-Talk between Adipose Tissue Macrophages, Adipose Stem Cells and Adipocytes: Evidence of Cell Plasticity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; S-100 PROTEIN; STROMAL CELLS; FAT-CELLS; DIFFERENTIATION; EXPRESSION; OBESITY; PREADIPOCYTES; REQUIRES	Introduction: Previous studies highlight a complex relationship between lineage and phenotype for adipose tissue macrophages (ATMs), adipose stem cells (ASCs), and adipocytes, suggesting a high degree of plasticity of these cells. In the present study, using a novel co-culture system, we further characterized the interaction between ATMs, ASCs and adipocytes. Research Design and Methods: Human adipocytes and the stromal vascular fraction containing ATMs and ASCs were isolated from human adipose tissue and co-cultured for 24 hours. FACS was used to characterize ATMs and ASCs before and after co-culture. Preadipocytes generated after co-culture were characterized by immunostaining for DLK (preadipocytes), CD14 and CD68 (ATMs), CD34 (ASCs), and Nile Red staining for lipid drops. qRT-PCR was used to quantify adipogenic markers such as C/EBP alpha and PPAR gamma. A novel fluorescent nanobead lineage tracing method was utilized before co-culture where fluorescent nanobeads were internalized by CD68 (+) ATMs. Results: Co-culture of adipocytes with ATMs and ASCs increased the formation of new preadipocytes, thereby increasing lipid accumulation and C/EBP alpha and PPAR gamma gene expression. Preadipocytes originating after co-culture were positive for markers of preadipocytes, ATMs and ASCs. Moreover, fluorescent nanobeads were internalized by ATMs before co-culture and the new preadipocytes formed after co-culture also contained fluorescent nanobeads, suggesting that new preadipocytes originated in part from ATMs. The formation of CD34(+)/CD68(+)/DLK(+) cell spheres supported the interaction of ATMs, ASCs and preadipocytes. Conclusions: Cross-talk between adipocytes, ATMs and ASCs promotes preadipocyte formation. The regulation of this novel adipogenic pathway involves differentiation of ATMs to preadipocytes. The presence of CD34(+)/CD68(+)/DLK(+) cells grouped in spheres suggest that paracrine interactions between these cell types plays an important role in the generation and proliferation of new preadipocytes. This phenomenon may reflect the in vivo plasticity of adipose tissue in which ATMs play an additional role during inflammation and other disease states. Understanding this novel pathway could influence adipogenesis, leading to new treatments for obesity, inflammation, and type 2 diabetes.	[Chazenbalk, Gregorio; Trivax, Bradley; Dumesic, Daniel A.] Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Bertolotto, Cristina; Simmons, Charles F.] Cedars Sinai Med Ctr, Dept Pediat, Div Neonatol, Los Angeles, CA 90048 USA; [Bertolotto, Cristina; Simmons, Charles F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neonatol, Los Angeles, CA 90095 USA; [Heneidi, Saleh; Azziz, Ricardo] Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Jumabay, Medet] Univ Calif Los Angeles, David Geffen Sch Med, Dept Cardiol, Los Angeles, CA 90095 USA; [Aronowitz, Joel] Cedars Sinai Med Ctr, Dept Surg, Div Plast Surg, Los Angeles, CA 90048 USA; [Aronowitz, Joel] Univ So Calif, Los Angeles, CA USA; [Yoshimura, Kotaro] Univ Tokyo, Dept Plast Surg, Tokyo, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Georgia; Augusta University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of Southern California; University of Tokyo	Chazenbalk, G (corresponding author), Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90024 USA.	gchazenbalk@mednet.ucla.edu	Bertolotto, Corine/AAF-6634-2021; Azziz, Ricardo/N-7229-2014	Bertolotto, Corine/0000-0001-6971-7753; Azziz, Ricardo/0000-0002-3917-0483; Yoshimura, Kotaro/0000-0002-7152-5475; Dumesic, Daniel/0000-0003-0387-1277	Helping Hand of Los Angeles; Ruth and Harry Roman Chair in Neonatology; National Institutes of Health [R01-DK073632]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073632] Funding Source: NIH RePORTER	Helping Hand of Los Angeles; Ruth and Harry Roman Chair in Neonatology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Helping Hand of Los Angeles, by the Ruth and Harry Roman Chair in Neonatology, and by the National Institutes of Health grant R01-DK073632 (to RA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova P, 2001, CELLS TISSUES ORGANS, V169, P355, DOI 10.1159/000047902; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Charriere GM, 2006, EXP CELL RES, V312, P3205, DOI 10.1016/j.yexcr.2006.06.034; CINTI S, 1989, ANAT REC, V224, P466, DOI 10.1002/ar.1092240403; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Festy F, 2005, HISTOCHEM CELL BIOL, V124, P113, DOI 10.1007/s00418-005-0014-z; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jumabay M, 2010, CARDIOVASC RES, V85, P17, DOI 10.1093/cvr/cvp267; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Kuwana M, 2006, STEM CELLS, V24, P2733, DOI 10.1634/stemcells.2006-0026; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Seta Noriyuki, 2007, Keio Journal of Medicine, V56, P41, DOI 10.2302/kjm.56.41; SIMMONS PJ, 1992, BLOOD, V80, P388; Soilleux EJ, 2002, J PATHOL, V198, P511, DOI 10.1002/path.1205; Sonoda E, 2008, ENDOCRINOLOGY, V149, P4794, DOI 10.1210/en.2008-0525; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; VADAS MA, 1979, J IMMUNOL, V122, P1228; Vakkila J, 2005, PEDIATR DEVEL PATHOL, V8, P43, DOI 10.1007/s10024-004-5045-2; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055; Yoshimura K, 2009, REGEN MED, V4, P265, DOI 10.2217/17460751.4.2.265; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	44	67	73	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17834	10.1371/journal.pone.0017834	http://dx.doi.org/10.1371/journal.pone.0017834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483855	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200011
J	Rizvi, F; Heimann, T; Herrnreiter, A; O'Brien, WJ				Rizvi, Farhan; Heimann, Tom; Herrnreiter, Anja; O'Brien, William J.			Mitochondrial Dysfunction Links Ceramide Activated HRK Expression and Cell Death	PLOS ONE			English	Article							APOPTOSIS; MEMBRANE; STRESS; OXIDASE; PROTEIN; BCL-2; BAX; SPHINGOMYELINASE; SUPEROXIDE; SURVIVAL	Purpose: Cell death is an essential process in normal development and homeostasis. In eyes, corneal epithelial injury leads to the death of cells in underlying stroma, an event believed to initiate corneal wound healing. The molecular basis of wound induced corneal stromal cell death is not understood in detail. Studies of others have indicated that ceramide may play significant role in stromal cell death following LASIK surgery. We have undertaken the present study to investigate the mechanism of death induced by C6 ceramide in cultures of human corneal stromal (HCSF) fibroblasts. Methods: Cultures of HCSF were established from freshly excised corneas. Cell death was induced in low passage (p<4) cultures of HCSF by treating the cells with C6 ceramide or C6 dihydroceramide as a control. Cell death was assessed by Live/Dead cell staining with calcein AM and ethidium homodimer-1 as well as Annexin V staining, caspase activation and TUNEL staining Mitochondrial dysfunction was assessed by Mito Sox Red, JC-1 and cytochrome C release Gene expression was examined by qPCR and western blotting. Results: Our data demonstrate ceramide caused mitochondrial dysfunction as evident from reduced MTT staining, cyto c release from mitochondria, enhanced generation of ROS, and loss in mitochondrial membrane potential (Delta Psi(m)). Cell death was evident from Live -Dead Cell staining and the inability to reestablish cultures from detached cells. Ceramide induced the expression of the harikari gene(HRK) and up-regulated JNK phosphorylation. In ceramide treated cells HRK was translocated to mitochondria, where it was found to interact with mitochondrial protein p32. The data also demonstrated HRK, p32 and BAD interaction. Ceramide-induced expression of HRK, mitochondrial dysfunction and cell death were reduced by HRK knockdown with HRK siRNA. Conclusion: Our data document that ceramide is capable of inducing death of corneal stromal fibroblasts through the induction of HRK mediated mitochondria dysfunction.	[Rizvi, Farhan; Heimann, Tom; Herrnreiter, Anja; O'Brien, William J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [O'Brien, William J.] Med Coll Wisconsin, Dept Microbiol Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Rizvi, F (corresponding author), Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA.	frizvi@mcw.edu; wjob@mcw.edu			National Institutes of Health (NIH) [R01-EY017079, P30-EY01931, C06-RR016511]; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016511] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017079, P30EY001931] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by National Institutes of Health (NIH) Grants R01-EY017079 and P30-EY01931 and an unrestricted grant from Research to Prevent Blindness. Research was conducted in facilities constructed in part by Construction Grant C06-RR016511 from NIH. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basu S, 1998, J BIOL CHEM, V273, P30419, DOI 10.1074/jbc.273.46.30419; Basu S, 1998, ONCOGENE, V17, P3277, DOI 10.1038/sj.onc.1202570; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Chen SW, 2006, J NEUROCHEM, V97, P631, DOI 10.1111/j.1471-4159.2006.03774.x; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Freimoser FM, 1999, APPL ENVIRON MICROB, V65, P3727; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim TI, 2005, CORNEA, V24, P72, DOI 10.1097/01.ico.0000134000.52886.c3; Loughlin DT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011093; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Nakamura M, 2008, ONCOGENE, V27, pS105, DOI 10.1038/onc.2009.48; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; O'Brien WJ, 2009, MOL VIS, V15, P2535; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; PNG E, 2010, J CELL PHYSL; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Ruvolo PP, 2001, J BIOL CHEM, V276, P11754, DOI 10.1074/jbc.M011400200; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Wei MC, 2000, GENE DEV, V14, P2060; Yi F, 2004, KIDNEY INT, V66, P1977, DOI 10.1111/j.1523-1755.2004.00968.x; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	43	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18137	10.1371/journal.pone.0018137	http://dx.doi.org/10.1371/journal.pone.0018137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483866	gold, Green Submitted, Green Published			2022-12-25	WOS:000289057200031
J	Watkins, JD; Siddappa, NB; Lakhashe, SK; Humbert, M; Sholukh, A; Hemashettar, G; Wong, YL; Yoon, JK; Wang, W; Novembre, FJ; Villinger, F; Ibegbu, C; Patel, K; Corti, D; Agatic, G; Vanzetta, F; Bianchi, S; Heeney, JL; Sallusto, F; Lanzavecchia, A; Ruprecht, RM				Watkins, Jennifer D.; Siddappa, Nagadenahalli B.; Lakhashe, Samir K.; Humbert, Michael; Sholukh, Anton; Hemashettar, Girish; Wong, Yin Ling; Yoon, John K.; Wang, Wendy; Novembre, Francis J.; Villinger, Francois; Ibegbu, Chris; Patel, Kalpana; Corti, Davide; Agatic, Gloria; Vanzetta, Fabrizia; Bianchi, Siro; Heeney, Jonathan L.; Sallusto, Federica; Lanzavecchia, Antonio; Ruprecht, Ruth M.			An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; CHIMERIC VIRUS; HIV-1 VACCINE; TRANSMISSION; IMMUNIZATION; INFECTION; GP120; TRIAL	Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetically diverse HIV-1 clades have evolved, and a key question left unanswered is whether neutralizing antibodies can confer cross-clade protection in vivo. The novel human monoclonal antibody HGN194 was isolated from an individual infected with an HIV-1 clade AG recombinant circulating recombinant form (CRF). HGN194 targets an epitope in the third hypervariable loop (V3) of HIV-1 gp120 and neutralizes a range of relatively neutralization-sensitive and resistant viruses. We evaluated the potential of HGN194 to protect infant rhesus monkeys against a SHIV encoding a primary CCR5-tropic HIV-1 clade C envelope. After high-dose mucosal challenge, all untreated controls became highly viremic while all HGN194-treated animals (50 mg/kg) were completely protected. When HGN194 was given at 1 mg/kg, one out of two monkeys remained aviremic, whereas the other had delayed, lower peak viremia. Interestingly, all protected monkeys given high-dose HGN194 developed Gagspecific proliferative responses of both CD4+ and CD8+ T cells. To test whether generation of the latter involved cryptic infection, we ablated CD8+ cells after HGN194 clearance. No viremia was detected in any protected monkeys, thus ruling out virus reservoirs. Thus, induction of CD8 T-cell immunity may have resulted from transient `` Hit and Run'' infection or cross priming via Ag-Ab-mediated cross-presentation. Together, our data identified the HGN194 epitope as protective and provide proof-of-concept that this anti-V3 loop mAb can prevent infection with sterilizing immunity after challenge with virus of a different clade, implying that V3 is a potential vaccine target.	[Watkins, Jennifer D.; Siddappa, Nagadenahalli B.; Lakhashe, Samir K.; Humbert, Michael; Sholukh, Anton; Hemashettar, Girish; Wong, Yin Ling; Yoon, John K.; Wang, Wendy; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Watkins, Jennifer D.; Siddappa, Nagadenahalli B.; Lakhashe, Samir K.; Humbert, Michael; Sholukh, Anton; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Novembre, Francis J.; Villinger, Francois; Ibegbu, Chris; Patel, Kalpana] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Novembre, Francis J.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Villinger, Francois] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Corti, Davide; Agatic, Gloria; Vanzetta, Fabrizia; Bianchi, Siro] Humabs SAGL, Bellinzona, Switzerland; [Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sallusto, Federica; Lanzavecchia, Antonio] Inst Res Biomed, Bellinzona, Switzerland	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Emory University; Emory University; Emory University; University of Cambridge; Universita della Svizzera Italiana	Watkins, JD (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu	Sholukh, Anton/AAU-2338-2021; Lakhashe, Samir/F-1150-2014	Sholukh, Anton/0000-0003-0498-9162; Bianchi, Siro/0000-0002-5100-8905; Byrareddy, Siddappa/0000-0002-7423-1763; Heeney, Jonathan/0000-0003-2702-1621; Zatta, Fabrizia/0000-0003-4945-8058	National Institutes of Health [R37 AI34266, P01 AI48240]; Bill and Melinda Gates Foundation [38637]; Center For AIDS Research Immunology Core [P30 A01050409];  [RR-00165]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034266, P01AI048240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center For AIDS Research Immunology Core; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grant R37 AI34266 and P01 AI48240 to RMR, by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) UCL-VDC (Weiss) grant 38637, and by Center For AIDS Research Immunology Core P30 A01050409. Base grant RR-00165 provided support to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Brady LJ, 2005, INFECT IMMUN, V73, P671, DOI 10.1128/IAI.73.2.671-678.2005; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Kitabwalla M, 2003, AIDS RES HUM RETROV, V19, P125, DOI 10.1089/088922203762688630; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	26	67	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18207	10.1371/journal.pone.0018207	http://dx.doi.org/10.1371/journal.pone.0018207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483815	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200043
J	Sankey, C; Henry, S; Andre, N; Richard-Yris, MA; Hausberger, M				Sankey, Carol; Henry, Severine; Andre, Nicolas; Richard-Yris, Marie-Annick; Hausberger, Martine			Do Horses Have a Concept of Person?	PLOS ONE			English	Article							DOGS CANIS-FAMILIARIS; BEHAVIOR; HEARING; FACE; ME	Background: Animals' ability for cross-modal recognition has recently received much interest. Captive or domestic animals seem able to perceive cues of human attention and appear to have a multisensory perception of humans. Methodology/Principal Findings: Here, we used a task where horses have to remain immobile under a vocal order to test whether they are sensitive to the attentional state of the experimenter, but also whether they behave and respond differently to the familiar order when tested by a familiar or an unknown person. Horses' response varied according to the person's attentional state when the order was given by an unknown person: obedience levels were higher when the person giving the order was looking at the horse than when he was not attentive. More interesting is the finding that whatever the condition, horses monitored much more and for longer times the unknown person, as if they were surprised to hear the familiar order given by an unknown voice. Conclusion/Significance: These results suggest that recognition of humans may lie in a global, integrated, multisensory representation of specific individuals, that includes visual and vocal identity, but also expectations on the individual's behaviour in a familiar situation.	[Sankey, Carol; Henry, Severine; Andre, Nicolas; Richard-Yris, Marie-Annick; Hausberger, Martine] Univ Rennes 1, CNRS, Lab Eethol Anim & Humaine, Biol Stn,UMR 6552, Paimpont, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Sankey, C (corresponding author), Univ Rennes 1, CNRS, Lab Eethol Anim & Humaine, Biol Stn,UMR 6552, Paimpont, France.	carol.sankey@univ-rennes1.fr		Sankey, Carol/0000-0001-9890-9287	COST of the "Haras Nationaux"; region Bretagne	COST of the "Haras Nationaux"; region Bretagne(Region Bretagne)	This work was supported by the COST of the "Haras Nationaux" and the region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Castellan NJ, 1988, NONPARAMETRIC STAT B; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Hare B., 1998, EVOL COMMUN, V2, P137; Hattori Y, 2007, ANIM COGN, V10, P141, DOI 10.1007/s10071-006-0049-0; Hinde R., 1979, UNDERSTANDING RELATI; Kaminski J, 2004, ANIM COGN, V7, P216, DOI 10.1007/s10071-004-0214-2; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Seyfarth RM, 2009, P NATL ACAD SCI USA, V106, P669, DOI 10.1073/pnas.0811894106; Waring G.H., 2003, HORSE BEHAV, V2; Xitco MJ, 2004, ANIM COGN, V7, P231, DOI 10.1007/s10071-004-0217-z; [No title captured]	19	42	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18331	10.1371/journal.pone.0018331	http://dx.doi.org/10.1371/journal.pone.0018331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479184	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700048
J	Yang, WY; Cheng, TC; Ye, MQ; Deng, XJ; Yi, HY; Huang, YD; Tan, XA; Han, D; Wang, B; Xiang, ZH; Cao, Y; Xia, QY				Yang, Wanying; Cheng, Tingcai; Ye, Mingqiang; Deng, Xiaojuan; Yi, Huiyu; Huang, Yadong; Tan, Xiang; Han, Dong; Wang, Bo; Xiang, Zhonghuai; Cao, Yang; Xia, Qingyou			Functional Divergence among Silkworm Antimicrobial Peptide Paralogs by the Activities of Recombinant Proteins and the Induced Expression Profiles	PLOS ONE			English	Article							DROSOPHILA IMMUNE-RESPONSE; GENOME-WIDE ANALYSIS; ANTIBACTERIAL PEPTIDE; GENE-EXPRESSION; INSECT IMMUNITY; DIFFERENTIAL DISPLAY; ANTIFUNGAL PEPTIDE; HOST-DEFENSE; EVOLUTION; GLOVERIN	Antimicrobial peptides are small-molecule proteins that are usually encoded by multiple-gene families. They play crucial roles in the innate immune response, but reports on the functional divergence of antimicrobial peptide gene families are rare. In this study, 14 paralogs of antimicrobial peptides belonging to cecropin, moricin and gloverin families were recombinantly expressed in pET expression systems. By antimicrobial activity tests, peptides representing paralogs in the same family of cecropin and moricin families, displayed remarkable differences against 10 tested bacteria. The evolutionary rates were relatively fast in the two families, which presented obvious functional divergence among paralogs of each family. Four peptides of gloverin family had similar antimicrobial spectrum and activity against tested bacteria. The gloverin family showed similar antimicrobial function and slow evolutionary rates. By induced transcriptional activity, genes encoding active antimicrobial peptides were upregulated at obviously different levels when silkworm pupae were infected by three types of microbes. Association analysis of antimicrobial activities and induced transcriptional activities indicated that the antimicrobial activities might be positively correlated with induced transcriptional activities in the cecropin and moricin families. These results suggest that representative BmcecB6, BmcecD and Bmmor as the major effector genes have broad antimicrobial spectrum, strong antimicrobial activity and high microbe-induced expression among each family and maybe play crucial roles in eliminating microbial infection.	[Yang, Wanying; Ye, Mingqiang; Deng, Xiaojuan; Yi, Huiyu; Han, Dong; Cao, Yang] S China Agr Univ, Lab Insect Mol Biol & Biotechnol, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Cheng, Tingcai; Xia, Qingyou] Chongqing Univ, Inst Agr & Life Sci, Chongqing 630044, Peoples R China; [Tan, Xiang; Wang, Bo; Xiang, Zhonghuai; Xia, Qingyou] Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China; [Huang, Yadong] Jinan Univ, Biopharmaceut Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China; [Ye, Mingqiang] Guangdong Acad Agr Sci, Sericulture & Agri Food Res Inst, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chongqing University; Southwest University - China; Jinan University; Guangdong Academy of Agricultural Sciences	Yang, WY (corresponding author), S China Agr Univ, Lab Insect Mol Biol & Biotechnol, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China.	caoyang@scau.edu.cn; xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	Fund for Foreign Scholars in University Research and Teaching programs [B07045]; National Basic Research Program of China [2005CB121002]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0750]; National Natural Science Foundation [31001034]; Chongqing Natural Science Foundation [2009BB1368]	Fund for Foreign Scholars in University Research and Teaching programs; National Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work was supported by grants from the Fund for Foreign Scholars in University Research and Teaching programs (No. B07045, to ZX), the National Basic Research Program of China (No. 2005CB121002, to YC), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT0750, to QX), National Natural Science Foundation (No. 31001034, to TC), and the Chongqing Natural Science Foundation (2009BB1368, to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLING B, 1995, INSECT BIOCHEM MOLEC, V25, P511, DOI 10.1016/0965-1748(94)00091-C; Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; BULET P, 1993, J BIOL CHEM, V268, P14893; Cheng TC, 2006, GENOMICS, V87, P356, DOI 10.1016/j.ygeno.2005.11.018; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Dai HE, 2008, J PEPT SCI, V14, P855, DOI 10.1002/psc.1016; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Deng XJ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/315423; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; Duda TF, 2002, MOL BIOL EVOL, V19, P858, DOI 10.1093/oxfordjournals.molbev.a004143; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Furukawa S, 1999, BIOCHEM J, V340, P265, DOI 10.1042/0264-6021:3400265; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Hemmi H, 2002, FEBS LETT, V518, P33, DOI 10.1016/S0014-5793(02)02637-6; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Kang C, 2008, J MICROBIOL, V46, P656, DOI 10.1007/s12275-008-0214-z; KATO Y, 1993, INSECT BIOCHEM MOLEC, V23, P285, DOI 10.1016/0965-1748(93)90009-H; Kawaoka S, 2008, ARCH INSECT BIOCHEM, V67, P87, DOI 10.1002/arch.20223; Kuimelis R G, 1997, Nucleic Acids Symp Ser, P255; Lee WH, 2005, EUR J IMMUNOL, V35, P1220, DOI 10.1002/eji.200425615; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Mackintosh JA, 1998, DEV COMP IMMUNOL, V22, P387, DOI 10.1016/S0145-305X(98)00025-1; MORISHIMA I, 1990, COMP BIOCHEM PHYS B, V95, P551, DOI 10.1016/0305-0491(90)90019-P; Mrinal N, 2008, J BIOL CHEM, V283, P23376, DOI 10.1074/jbc.M801080200; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Oizumi Y, 2005, BBA-PROTEINS PROTEOM, V1752, P83, DOI 10.1016/j.bbapap.2005.07.013; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Seitz V, 2003, DEV COMP IMMUNOL, V27, P207, DOI 10.1016/S0145-305X(02)00097-6; Silva JLC, 2010, BRAZ J MED BIOL RES, V43, P431, DOI 10.1590/S0100-879X2010005000010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tennessen JA, 2005, J MOL EVOL, V61, P445, DOI 10.1007/s00239-004-0330-2; Tennessen JA, 2007, J MOL EVOL, V65, P605, DOI 10.1007/s00239-007-9045-5; Tian CH, 2008, MOL IMMUNOL, V45, P3909, DOI 10.1016/j.molimm.2008.06.025; Uttenweiler-Joseph S, 1998, P NATL ACAD SCI USA, V95, P11342, DOI 10.1073/pnas.95.19.11342; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; WICKER C, 1990, J BIOL CHEM, V265, P22493; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yang J, 1999, COMP BIOCHEM PHYS B, V122, P409, DOI 10.1016/S0305-0491(99)00015-2; Yang WY, 2006, GENE, V379, P26, DOI 10.1016/j.gene.2006.03.017; Zhu Y, 2003, INSECT BIOCHEM MOLEC, V33, P541, DOI 10.1016/S0965-1748(03)00028-6	48	24	35	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18109	10.1371/journal.pone.0018109	http://dx.doi.org/10.1371/journal.pone.0018109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479226	gold, Green Submitted, Green Published			2022-12-25	WOS:000289054600028
J	Mangano, C; Paino, F; d'Aquino, R; De Rosa, A; Iezzi, G; Piattelli, A; Laino, L; Mitsiadis, T; Desiderio, V; Mangano, F; Papaccio, G; Tirino, V				Mangano, Carlo; Paino, Francesca; d'Aquino, Riccardo; De Rosa, Alfredo; Iezzi, Giovanna; Piattelli, Adriano; Laino, Luigi; Mitsiadis, Thimios; Desiderio, Vincenzo; Mangano, Francesco; Papaccio, Gianpaolo; Tirino, Virginia			Human Dental Pulp Stem Cells Hook into Biocoral Scaffold Forming an Engineered Biocomplex	PLOS ONE			English	Article							BONE; DIFFERENTIATION; REGENERATION; POROSITY; REPAIR	The aim of this study was to evaluate the behavior of human Dental Pulp Stem Cells (DPSCs), as well as human osteoblasts, when challenged on a Biocoral scaffold, which is a porous natural hydroxyapatite. For this purpose, human DPSCs were seeded onto a three-dimensional (3D) Biocoral scaffold or on flask surface (control). Either normal or rotative (3D) cultures were performed. Scanning electron microscopic analyses, at 8, 24 and 48 h of culture showed that cells did not adhere on the external surface, but moved into the cavities inside the Biocoral structure. After 7, 15 and 30 days of culture, morphological and molecular analyses suggested that the Biocoral scaffold leads DPSCs to hook into the cavities where these cells quickly start to secrete the extra cellular matrix (ECM) and differentiate into osteoblasts. Control human osteoblasts also moved into the internal cavities where they secreted the ECM. Histological sections revealed a diffuse bone formation inside the Biocoral samples seeded with DPSCs or human osteoblasts, where the original scaffold and the new secreted biomaterial were completely integrated and cells were found within the remaining cavities. In addition, RT-PCR analyses showed a significant increase of osteoblast-related gene expression and, above all, of those genes highly expressed in mineralized tissues, including osteocalcin, OPN and BSP. Furthermore, the effects on the interaction between osteogenesis and angiogenesis were observed and substantiated by ELISA assays. Taken together, our results provide clear evidence that DPSCs differentiated into osteoblasts, forming a biocomplex made of Biocoral, ECM and differentiated cells.	[Mangano, Carlo; Mangano, Francesco] Univ Insubria, Dept Biomat Sci, Varese, Italy; [Paino, Francesca; d'Aquino, Riccardo; Desiderio, Vincenzo; Papaccio, Gianpaolo; Tirino, Virginia] Univ Naples 2, Dept Expt Med, Sect Histol & Embryol, Tissue Engn & Regenerat Med TERM Div, Naples, Italy; [De Rosa, Alfredo; Laino, Luigi] Univ Naples 2, Dept Odontol, Naples, Italy; [Iezzi, Giovanna; Piattelli, Adriano] Univ G dAnnunzio, Dept Odontol, Chieti, Italy; [Mitsiadis, Thimios] Univ Zurich, Inst Oral Biol, Zurich, Switzerland	University of Insubria; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; G d'Annunzio University of Chieti-Pescara; University of Zurich	Mangano, C (corresponding author), Univ Insubria, Dept Biomat Sci, Varese, Italy.	gianpaolo.papaccio@unina2.it	Mitsiadis, Thimios/B-5564-2016; desiderio, vincenzo/K-4244-2018; paino, francesca/AAC-8150-2019; LAINO, LUIGI/AAB-8203-2022; Mitsiadis, Thimios A/B-9249-2008; Iezzi, Giovanna/K-9403-2016; Mangano, Francesco/AAG-6184-2019; Papaccio, Gianpaolo/B-7150-2014	Mitsiadis, Thimios/0000-0002-9812-9982; paino, francesca/0000-0002-3186-1888; LAINO, LUIGI/0000-0003-2372-7109; Iezzi, Giovanna/0000-0002-2391-6594; Tirino, Virginia/0000-0003-2731-5718; desiderio, vincenzo/0000-0003-1819-6083; Papaccio, Gianpaolo/0000-0002-4014-5306; Mangano, Francesco/0000-0001-5488-4268	Leader Italia (Cinisello Balsamo, Milan, Italy)	Leader Italia (Cinisello Balsamo, Milan, Italy)	The authors kindly acknowledge Leader Italia (Cinisello Balsamo, Milan, Italy) for funding (to GP) and assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07; Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.0.CO;2-C; Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x; Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1; Mangano C, 2010, BIOMATERIALS, V31, P3543, DOI 10.1016/j.biomaterials.2010.01.056; Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Spath L, 2010, J CELL MOL MED, V14, P1635, DOI 10.1111/j.1582-4934.2009.00848.x; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; Zhang YF, 2007, BIOMATERIALS, V28, P1515, DOI 10.1016/j.biomaterials.2006.11.040; Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017	21	49	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18721	10.1371/journal.pone.0018721	http://dx.doi.org/10.1371/journal.pone.0018721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494568	Green Published, Green Accepted, gold			2022-12-25	WOS:000289354100034
J	Matthews, LT; Giddy, J; Ghebremichael, M; Hampton, J; Guarino, AJ; Ewusi, A; Carver, E; Axten, K; Geary, MC; Gandhi, RT; Bangsberg, DR				Matthews, Lynn T.; Giddy, Janet; Ghebremichael, Musie; Hampton, Jane; Guarino, Anthony J.; Ewusi, Aba; Carver, Emma; Axten, Karen; Geary, Meghan C.; Gandhi, Rajesh T.; Bangsberg, David R.			A Risk-Factor Guided Approach to Reducing Lactic Acidosis and Hyperlactatemia in Patients on Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SYMPTOMATIC HYPERLACTATEMIA; COMPLICATIONS; MANAGEMENT; STAVUDINE; LACTATE; WOMEN	Background: Stavudine continues to be used in antiretroviral treatment (ART) regimens in many resource-limited settings. The use of zidovudine instead of stavudine in higher-risk patients to reduce the likelihood of lactic acidosis and hyperlactatemia (LAHL) has not been examined. Methods: Antiretroviral-naive, HIV-infected adults initiating ART between 2004 and 2007 were divided into cohorts of those initiated on stavudine- or zidovudine-containing therapy. We evaluated stavudine or zidovudine use, age, sex, body mass index (BMI), baseline CD4 cell count, creatinine, hemoglobin, alanine aminotransferase, and albumin as predictors of time to LAHL with Cox Proportional Hazards (PH) regression models. Results: Among 2062 patients contributing 2747 patient years (PY), the combined incidence of LAHL was 3.2/100 PY in those initiating stavudine- and 0.34/100 PY in those initiating zidovudine-containing ART (RR 9.26, 95% CI: 1.28-66.93). In multivariable Cox PH analysis, stavudine exposure (HR 14.31, 95% CI: 5.79-35.30), female sex (HR 3.41, 95% CI: 1.89-6.19), higher BMI (HR 3.21, 95% CI: 2.16-4.77), higher creatinine (1.63, 95% CI: 1.12-2.36), higher albumin (HR 1.04, 95% CI: 1.011.07), and lower CD4 cell count (HR 0.96, 95% CI: 0.92-1.0) at baseline were associated with higher LAHL rates. Among participants who started on stavudine, switching to zidovudine was associated with lower LAHL rates (HR 0.15, 95% CI: 0.06-0.35). Subgroup analysis limited to women with higher BMI >= 25 kg/m(2) initiated on stavudine also showed that switch to zidovudine was protective when controlling for other risk factors (HR 0.21, 95% CI.07-0.64). Conclusions: Stavudine exposure, female sex, and higher BMI are strong, independent predictors for developing LAHL. Patients with risk factors for lactic acidosis have less LAHL while on zidovudine-rather than stavudine-containing ART. Switching patients from stavudine to zidovudine is protective. Countries continuing to use stavudine should avoid this drug in women and patients with higher BMI.	[Matthews, Lynn T.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Giddy, Janet; Hampton, Jane] McCord Hosp, HIV Program, Durban, South Africa; [Ghebremichael, Musie; Axten, Karen; Gandhi, Rajesh T.; Bangsberg, David R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA; [Guarino, Anthony J.] Massachusetts Gen Hosp, Inst Hlth Profess, Boston, MA 02114 USA; [Ewusi, Aba] Harvard Vanguard Med Associates, Div Internal Med, Boston, MA USA; [Carver, Emma] Univ Wales Hosp, Dept Emergency Med, Cardiff CF4 4XW, S Glam, Wales; [Geary, Meghan C.] Albany Med Coll, Albany, NY 12208 USA; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; Harvard Vanguard Medical Associates; Cardiff University; Albany Medical College; Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital	Matthews, LT (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	ltmatthe@bidmc.harvard.edu			Mark and Lisa Schwartz Family Foundation; Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene; NIH [R01 AI066992-04A1, NIH G08LM008830-01, MH K-24 87227]; Harvard University Center for AIDS Research [NIH 2P30 AI06035406];  [NIH U01 AI 694722]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066992, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM008830] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Family Foundation; Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Center for AIDS Research; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. Matthews' work was supported by the Mark and Lisa Schwartz Family Foundation and by a postdoctoral fellowship in tropical infectious diseases from the Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene. Dr. Gandhi is supported by NIH R01 AI066992-04A1 and NIH G08LM008830-01 and by grants to the AIDS Clinical Trials Group (NIH U01 AI 694722) and the Harvard University Center for AIDS Research (NIH 2P30 AI06035406). Dr. Bangsberg was supported by NIH grant MH K-24 87227. The authors are also grateful to Dr. Heather Ribaudo of the Harvard University Center for AIDS Research Biostatistical Core (NIH #AI060354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AD AIDS CLIN TRIA, 2003, AACTG TOX EV GROUP C; Arenas-Pinto A, 2007, AIDS, V21, P2455, DOI 10.1097/QAD.0b013e3282f08cdc; Bellomo R, 2002, CRIT CARE, V6, P322; Bolhaar MG, 2007, CLIN INFECT DIS, V45, P254, DOI 10.1086/518976; Bonnet F, 2003, CLIN INFECT DIS, V36, P1324, DOI 10.1086/374601; Boubaker K, 2001, CLIN INFECT DIS, V33, P1931, DOI 10.1086/324353; Boulle A, 2007, ANTIVIR THER, V12, P753; Cox DR., 1989, ANAL BINARY DATA; Fabian J, 2008, SAMJ S AFR MED J, V98, P795; Geddes R, 2006, SAMJ S AFR MED J, V96, P722; Harrell FE, 2001, REGRESSION MODELING; HILL A, 2007, EXPERT OPINION PHAMA, V8; Ivers LC, 2006, AIDS, V20, P779, DOI 10.1097/01.aids.0000216382.37679.b2; Kiragga AK, 2008, JAIDS-J ACQ IMM DEF, V49, P564, DOI 10.1097/QAI.0b013e31817e6391; Kumarasamy N, 2008, J WOMENS HEALTH, V17, P1471, DOI 10.1089/jwh.2007.0670; Lonergan JT, 2003, AIDS, V17, P2495, DOI 10.1097/00002030-200311210-00012; Moyle GJ, 2002, AIDS, V16, P1341, DOI 10.1097/00002030-200207050-00005; Murphy RA, 2007, J INFECT DIS, V196, pS449, DOI 10.1086/521112; Osler M, 2010, HIV MED, V11, P121, DOI 10.1111/j.1468-1293.2009.00754.x; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Shibuyama S, 2006, CURR PHARM DESIGN, V12, P1075, DOI 10.2174/138161206776055796; South Africa National AIDS Council, 2010, S AFR ANT TREATM GUI; SPAULDING A, COCHRANE DATABASE SY; Stead D, 2008, ANTIVIR THER, V13, P937; Stenzel MS, 2000, INFECT DIS CLIN N AM, V14, P851, DOI 10.1016/S0891-5520(05)70137-9; VANGRIENSVEN J, T R SOC TROP MED HYG, V104, P148; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f; WHO, 2010, ANT THER HIV INF AD; Wohl DA, 2006, CLIN INFECT DIS, V43, P645, DOI 10.1086/507333	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18736	10.1371/journal.pone.0018736	http://dx.doi.org/10.1371/journal.pone.0018736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494566	Green Submitted, gold, Green Published			2022-12-25	WOS:000289354100037
J	Panneels, V; Kock, I; Krijnse-Locker, J; Rezgaoui, M; Sinning, I				Panneels, Valerie; Kock, Ines; Krijnse-Locker, Jacomine; Rezgaoui, Meriem; Sinning, Irmgard			Drosophila Photoreceptor Cells Exploited for the Production of Eukaryotic Membrane Proteins: Receptors, Transporters and Channels	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LARGE-SCALE PRODUCTION; DNA-BINDING PROTEIN; ALLOSTERIC MODULATORS; SEROTONIN TRANSPORTER; EXPRESSION SYSTEM; NEUROTRANSMITTER TRANSPORTERS; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; GENE	Membrane proteins (MPs) play key roles in signal transduction. However, understanding their function at a molecular level is mostly hampered by the lack of protein in suitable amount and quality. Despite impressive developments in the expression of prokaryotic MPs, eukaryotic MP production has lagged behind and there is a need for new expression strategies. In a pilot study, we produced a Drosophila glutamate receptor specifically in the eyes of transgenic flies, exploiting the naturally abundant membrane stacks in the photoreceptor cells (PRCs). Now we address the question whether the PRCs also process different classes of medically relevant target MPs which were so far notoriously difficult to handle with conventional expression strategies. Principal Findings: We describe the homologous and heterologous expression of 10 different targets from the three major MP classes - G protein-coupled receptors (GPCRs), transporters and channels in Drosophila eyes. PRCs offered an extraordinary capacity to produce, fold and accommodate massive amounts of MPs. The expression of some MPs reached similar levels as the endogenous rhodopsin, indicating that the PRC membranes were almost unsaturable. Expression of endogenous rhodopsin was not affected by the target MPs and both could coexist in the membrane stacks. Heterologous expression levels reached about 270 to 500 pmol/mg total MP, resulting in 0.2-0.4 mg purified target MP from 1 g of fly heads. The metabotropic glutamate receptor and human serotonin transporter - both involved in synaptic transmission showed native pharmacological characteristics and could be purified to homogeneity as a prerequisite for further studies. Significance: We demonstrate expression in Drosophila PRCs as an efficient and inexpensive tool for the large scale production of functional eukaryotic MPs. The fly eye system offers a number of advantages over conventional expression systems and paves the way for in-depth analyses of eukaryotic MPs that have so far not been accessible to biochemical and biophysical studies.	[Panneels, Valerie; Kock, Ines; Rezgaoui, Meriem; Sinning, Irmgard] Univ Heidelberg, Biochem Ctr BZH, Dept Biol Struct, Heidelberg, Germany; [Krijnse-Locker, Jacomine] Univ Heidelberg, Dept Infect Dis, Heidelberg, Germany; [Krijnse-Locker, Jacomine] Univ Heidelberg, Core Facil Electron Microscopy EMCF, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Panneels, V (corresponding author), Univ Heidelberg, Biochem Ctr BZH, Dept Biol Struct, Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Locker, Jacomine Krijnse/AAX-1185-2020; Locker, Jacomine Krijnse/E-1009-2016	Panneels, Valerie/0000-0001-8899-3366	European Community [FP6-2003-LifeSciHealth 513770]	European Community(European Commission)	This work was supported by the European Community Specific Targeted Research Project grant IMPS (FP6-2003-LifeSciHealth 513770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ST, 2006, INVEST OPHTH VIS SCI, V47, P3722, DOI 10.1167/iovs.06-0281; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Bartesaghi A, 2009, CURR OPIN STRUC BIOL, V19, P402, DOI 10.1016/j.sbi.2009.06.005; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Eroglu C, 2002, EMBO REP, V3, P491, DOI 10.1093/embo-reports/kvf088; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fraley ME, 2009, EXPERT OPIN THER PAT, V19, P1259, DOI 10.1517/13543770903045009; Gasparini F, 2002, CURR OPIN PHARMACOL, V2, P43, DOI 10.1016/S1471-4892(01)00119-9; Griffith DA, 2003, FEBS LETT, V553, P45, DOI 10.1016/S0014-5793(03)00952-9; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2001, J EXP BIOL, V204, P3403; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Klaassen CHW, 1999, BIOCHEM J, V342, P293, DOI 10.1042/0264-6021:3420293; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; KOENIG J, 1977, DROS INF SERV, V42, P50; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MISMER D, 1987, GENETICS, V116, P565; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674; NICHOLS R, 1985, J BIOL CHEM, V260, P12670; NISWENDER CM, ANN REV PHARM TOXICO, V50, P295; Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X; Oksche A, 1998, J MOL MED, V76, P326, DOI 10.1007/s001090050224; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Panneels V, 2003, PROTEIN EXPRES PURIF, V30, P275, DOI 10.1016/S1046-5928(03)00100-1; Panneels V, 2010, METHODS MOL BIOL, V601, P135, DOI 10.1007/978-1-60761-344-2_9; PAULSEN R, 1983, EUR J BIOCHEM, V137, P609, DOI 10.1111/j.1432-1033.1983.tb07869.x; Pichaud F, 2001, DEVELOPMENT, V128, P815; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; SCHEURING S, 2009, PHOTOSYNTH RES; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Voie AM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P510; Vought BW, 2000, BIOCHEMISTRY-US, V39, P14128, DOI 10.1021/bi001135k; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAO KM, 1994, J NEUROCHEM, V63, P41; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18478	10.1371/journal.pone.0018478	http://dx.doi.org/10.1371/journal.pone.0018478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494623	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800022
J	Ennes-Vidal, V; Menna-Barreto, RFS; Santos, ALS; Branquinha, MH; d'Avila-Levy, CM				Ennes-Vidal, Vitor; Menna-Barreto, Rubem F. S.; Santos, Andre L. S.; Branquinha, Marta H.; d'Avila-Levy, Claudia M.			MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut	PLOS ONE			English	Article							CYSTEINE PROTEINASE; KINETOPLASTID PARASITES; EPIMASTIGOTE FORMS; IN-VITRO; DIFFERENTIATION; MEMBRANE; DISEASE; LOCALIZATION; RESERVOSOMES; DROSOPHILA	Background: Trypanosoma cruzi is the etiological agent of Chagas' disease. During the parasite life cycle, many molecules are involved in the differentiation process and infectivity. Peptidases are relevant for crucial steps of T. cruzi life cycle; as such, it is conceivable that they may participate in the metacyclogenesis and interaction with the invertebrate host. Methodology/Principal Findings: In this paper, we have investigated the effect of the calpain inhibitor MDL28170 on the attachment of T. cruzi epimastigotes to the luminal midgut surface of Rhodnius prolixus, as well as on the metacyclogenesis process and ultrastructure. MDL28170 treatment was capable of significantly reducing the number of bound epimastigotes to the luminal surface midgut of the insect. Once the cross-reactivity of the anti-Dm-calpain was assessed, it was possible to block calpain molecules by the antibody, leading to a significant reduction in the capacity of adhesion to the insect guts by T. cruzi. However, the antibodies were unable to interfere in metacyclogenesis, which was impaired by the calpain inhibitor presenting a significant reduction in the number of metacyclic trypomastigotes. The calpain inhibitor also promoted a direct effect against bloodstream trypomastigotes. Ultrastructural analysis of epimastigotes treated with the calpain inhibitor revealed disorganization in the reservosomes, Golgi and plasma membrane disruption. Conclusions/Significance: The presence of calpain and calpain-like molecules in a wide range of organisms suggests that these proteins could be necessary for basic cellular functions. Herein, we demonstrated the effects of MDL28170 in crucial steps of the T. cruzi life cycle, such as attachment to the insect midgut and metacyclogenesis, as well as in parasite viability and morphology. Together with our previous findings, these results help to shed some light on the functions of T. cruzi calpains. Considering the potential roles of these molecules on the interaction with both invertebrate and vertebrate hosts, it is interesting to improve knowledge on these molecules in T. cruzi.	[Ennes-Vidal, Vitor; d'Avila-Levy, Claudia M.] Fundacao Oswaldo Cruz Fiocruz, Lab Biol Mol & Doencas Endem, IOC, Rio De Janeiro, Brazil; [Menna-Barreto, Rubem F. S.] Fiocruz MS, Lab Biol Celular, IOC, BR-21045900 Rio De Janeiro, Brazil; [Santos, Andre L. S.] Univ Fed Rio de Janeiro, Lab Estudos Integrados Bioquim Microbiana, Dept Microbiol Geral, IMPPG, Rio de Janeiro, Brazil; [Branquinha, Marta H.] Univ Fed Rio de Janeiro, Lab Bioquim Proteases, Dept Microbiol Geral, IMPPG, Rio de Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ennes-Vidal, V (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Lab Biol Mol & Doencas Endem, IOC, Rio De Janeiro, Brazil.	davila.levy@ioc.fiocruz.br	Santos, André/Z-5853-2019; Menna-Barreto, Rubem/O-7325-2019; Branquinha, Marta/AAA-3084-2019; d'Avila-Levy, Claudia M/O-7192-2014	Santos, André/0000-0003-0821-8592; Menna-Barreto, Rubem/0000-0002-1352-0641; d'Avila-Levy, Claudia M/0000-0001-8042-4695	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FUJB (Fundacao Universitaria Jose Bonifacio); CEPG/UFRJ; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro); Fundacao Oswaldo Cruz (FIOCRUZ)	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FUJB (Fundacao Universitaria Jose Bonifacio); CEPG/UFRJ; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ)	This study was supported by MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FUJB (Fundacao Universitaria Jose Bonifacio), CEPG/UFRJ, FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azambuja P, 2005, AN ACAD BRAS CIENC, V77, P397, DOI 10.1590/S0001-37652005000300004; Azambuja P. de, 1997, The molecular biology of insect disease vectors: a methods manual., P56; Beyette JR, 1997, ARCH BIOCHEM BIOPHYS, V337, P232, DOI 10.1006/abbi.1996.9758; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; Couto LA, 2004, J NEUROSCI RES, V77, P410, DOI 10.1002/jnr.20170; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cunha-e-Silva N, 2006, PARASITOL RES, V99, P325, DOI 10.1007/s00436-006-0190-3; d'Avila-Levy CM, 2006, INT J ANTIMICROB AG, V28, P138, DOI 10.1016/j.ijantimicag.2006.03.021; d'Avila-Levy CM, 2003, ARCH BIOCHEM BIOPHYS, V420, P1, DOI 10.1016/j.abb.2003.09.033; de Souza W, 2009, PROG HISTOCHEM CYTO, V44, P67, DOI 10.1016/j.proghi.2009.01.001; DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1; Drugs for Neglected Diseases initiative, 2010, NEW AGR SIGN JOIN FO; Duschak VG, 2006, PARASITOLOGY, V132, P345, DOI 10.1017/S0031182005009030; EMORI Y, 1994, J BIOL CHEM, V269, P25137; Engel JC, 1998, J CELL SCI, V111, P597; Ennes-Vidal V, 2010, J ANTIMICROB CHEMOTH, V65, P1395, DOI 10.1093/jac/dkq154; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; FIGUEIREDO RCBQ, 1994, PARASITOL RES, V80, P517, DOI 10.1007/BF00932700; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Giese V, 2008, MEM I OSWALDO CRUZ, V103, P598, DOI 10.1590/S0074-02762008000600015; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Kumagai T, 2005, EXP PARASITOL, V109, P53, DOI 10.1016/j.exppara.2004.11.001; Lescop C, 2005, BIOORG MED CHEM LETT, V15, P5176, DOI 10.1016/j.bmcl.2005.08.064; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; MEIRELLES RMS, 2001, ACTA MICROSC, V10, P19; Mellgren RL, 2010, J BIOL CHEM, V285, P36597, DOI 10.1074/jbc.M110.110015; Nogueira NFS, 2007, EXP PARASITOL, V116, P120, DOI 10.1016/j.exppara.2006.12.014; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Pereira FM, 2009, PARASITOLOGY, V136, P45, DOI 10.1017/S0031182008005209; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sangenito LS, 2009, PARASITOLOGY, V136, P433, DOI 10.1017/S0031182009005629; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; Santos ALS, 2006, AN ACAD BRAS CIENC, V78, P687, DOI 10.1590/S0001-37652006000400006; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Vermelrio A.B., 2007, CURR ENZYME INHIB, V3, P19; Yu XL, 2003, J EXP BIOL, V206, P561, DOI 10.1242/jeb.00097	46	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18371	10.1371/journal.pone.0018371	http://dx.doi.org/10.1371/journal.pone.0018371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483751	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058700021
J	Herman-Roloff, A; Llewellyn, E; Obiero, W; Agot, K; Ndinya-Achola, J; Muraguri, N; Bailey, RC				Herman-Roloff, Amy; Llewellyn, Emma; Obiero, Walter; Agot, Kawango; Ndinya-Achola, Jeckoniah; Muraguri, Nicholas; Bailey, Robert C.			Implementing Voluntary Medical Male Circumcision for HIV Prevention in Nyanza Province, Kenya: Lessons Learned during the First Year	PLOS ONE			English	Article								Background: In 2007, the World Health Organization endorsed male circumcision as an effective HIV prevention strategy. In 2008, the Government of Kenya (GoK) launched the national voluntary medical male circumcision (VMMC) program in Nyanza Province, the geographic home to the Luo, the largest non-circumcising ethnic group in Kenya. Currently, several other African countries are in the early stages of implementing this intervention. Methods and Results: This paper uses data from a health facility needs assessment (n = 81 facilities) and a study to evaluate the implementation of VMMC services in 16 GoK facilities (n = 2,675 VMMC clients) to describe Kenya's experience in implementing the national program. The needs assessment revealed that no health facility was prepared to offer the minimum package of services as outlined by the national guidelines, and partner organizations were called upon to fill this gap. The findings concerning human resource shortages facilitated the GoK's decision to endorse trained nurses to provide VMMCs, enabling more facilities to offer the service. Findings from the evaluation study resulted in replacing voluntary counseling and testing (VCT) with provider-initiated testing and counseling (PITC) and subsequently doubling the proportion of VMMC clients tested for HIV. Conclusions: This paper outlines how certain challenges, like human resource shortages and low HIV test rates, were addressed through national policy changes, while other challenges, like large fluctuations in demand, were addressed locally. Currently, the program requires significant support from partner organizations, but a strategic plan is under development to continue to build capacity in GoK staff and facilities. Coordination between all parties was essential and was facilitated through the formation of national, provincial, and district VMMC task forces. The lessons learned from Kenya's VMMC implementation experience are likely generalizable to other African countries.	[Herman-Roloff, Amy; Bailey, Robert C.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60637 USA; [Herman-Roloff, Amy; Llewellyn, Emma; Obiero, Walter; Bailey, Robert C.] Nyanza Reprod Hlth Soc, Kisumu, Kenya; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Ndinya-Achola, Jeckoniah] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Muraguri, Nicholas] Natl AIDS & STI Control Programme, Nairobi, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi	Herman-Roloff, A (corresponding author), Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60637 USA.	aherma2@uic.edu			Bill & Melinda Gates Foundation; President's Emergency Plan for AIDS Relief [U62PS024508]; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS024508] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support for this study was provided by a grant to Family Health International (FHI) from the Bill & Melinda Gates Foundation to support the Male Circumcision Consortium (MCC), a partnership between FHI, University of Illinois at Chicago working closely with the Nyanza Reproductive Health Society, and EngenderHealth. The views expressed in this publication do not necessarily reflect those of the Bill & Melinda Gates Foundation or the MCC partners Grant number: 47394; (http://www.gatesfoundation.org/Pages/home.aspx). Additional funding for service provision came from Impact Research and Development Organization, which received funding from the President's Emergency Plan for AIDS Relief, administered through the Centers for Disease Control and Prevention (Cooperative Agreement U62PS024508; http://www.pepfar.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; *MIN HLTH NAT AIDS, 2008, GUID SAF VOL MED MAL; *MIN PUBL HLTH SAN, 2009, NAT STRAT VOL MED MA; National AIDS and STI Programme Ministry of Health Kenya, 2008, KEN AIDS IND SURV 20; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; *WHO UN JOINT PROG, 2007, NEW DAT MAL CIRC HIV	9	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18299	10.1371/journal.pone.0018299	http://dx.doi.org/10.1371/journal.pone.0018299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483697	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058700017
J	Kaspersen, MD; Larsen, PB; Ingerslev, HJ; Fedder, J; Petersen, GB; Bonde, J; Hollsberg, P				Kaspersen, Maja D.; Larsen, Peter B.; Ingerslev, Hans Jakob; Fedder, Jens; Petersen, Gert Bruun; Bonde, Jesper; Hollsberg, Per			Identification of Multiple HPV Types on Spermatozoa from Human Sperm Donors	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; DEOXYRIBONUCLEIC-ACID; SEMEN; MEN; PREVALENCE; INFECTION; ASSOCIATION; VIRUS; WOMEN	Human papillomaviruses (HPV) may cause sexually transmitted disease. High-risk types of HPV are involved in the development of cervical cell dysplasia, whereas low-risk types may cause genital condyloma. Despite the association between HPV and cancer, donor sperm need not be tested for HPV according to European regulations. Consequently, the potential health risk of HPV transmission by donor bank sperm has not been elucidated, nor is it known how HPV is associated with sperm. The presence of 35 types of HPV was examined on DNA from semen samples of 188 Danish sperm donors using a sensitive HPV array. To examine whether HPV was associated with the sperm, in situ hybridization were performed with HPV-6, HPV-16 and -18, and HPV-31-specific probes. The prevalence of HPV-positive sperm donors was 16.0% and in 66.7% of these individuals high-risk types of HPV were detected. In 5.3% of sperm donors, two or more HPV types were detected. Among all identified HPV types, 61.9% were high-risk types. In situ hybridization experiments identified HPV genomes particularly protruding from the equatorial segment and the tail of the sperm. Semen samples from more than one in seven healthy Danish donors contain HPV, most of them of high-risk types binding to the equatorial segment of the sperm cell. Most HPV-positive sperm showed decreased staining with DAPI, indicative of reduced content of DNA. Our data demonstrate that oncogenic HPV types are frequent in men.	[Kaspersen, Maja D.; Hollsberg, Per] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Larsen, Peter B.; Petersen, Gert Bruun] Cryos Int Sperm Bank, Aarhus, Denmark; [Ingerslev, Hans Jakob] Aarhus Univ Hosp, Fertil Clin, DK-8000 Aarhus, Denmark; [Fedder, Jens] Reg Hosp Horsens, Reprod Biol Lab, Sci Unit, Horsens, Denmark; [Fedder, Jens] Reg Hosp Horsens, Fertil Clin, Horsens, Denmark; [Bonde, Jesper] Univ Copenhagen, Hvidovre Hosp, Div Pathol, Clin Res Ctr, DK-2650 Hvidovre, Denmark	Aarhus University; Aarhus University; University of Copenhagen	Kaspersen, MD (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	ph@microbiology.au.dk	Bonde, Jesper/AAN-5930-2020; Bonde, Jesper H/F-1478-2013	Bonde, Jesper/0000-0003-4853-6747	University Hospital of Aarhus; Lundbeck Foundation; Faculty of Health Sciences, Aarhus University	University Hospital of Aarhus; Lundbeck Foundation(Lundbeckfonden); Faculty of Health Sciences, Aarhus University	This study was supported by The University Hospital of Aarhus; The Lundbeck Foundation; The Faculty of Health Sciences, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; Brossfield JE, 1999, J ASSIST REPROD GEN, V16, P325, DOI 10.1023/A:1020458100382; CHAN PJ, 1994, FERTIL STERIL, V61, P982; Chan PJ, 1996, J ASSIST REPROD GEN, V13, P516, DOI 10.1007/BF02066536; Connelly DA, 2001, AM J OBSTET GYNECOL, V184, P1068, DOI 10.1067/mob.2001.115226; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Didelot-Rousseau MN, 2007, J CLIN VIROL, V39, P153, DOI 10.1016/j.jcv.2007.03.003; FORESTA C, 2010, INT J ANDROL; Giatromanolaki A, 2007, Infect Dis Obstet Gynecol, V2007, P60549, DOI 10.1155/2007/60549; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; Goodman A, 2000, CURR OPIN OBSTET GYN, V12, P11, DOI 10.1097/00001703-200002000-00002; GREEN J, 1991, GENITOURIN MED, V67, P207; Hernandez BY, 2008, J INFECT DIS, V197, P787, DOI 10.1086/528379; Kapranos N, 2003, FERTIL STERIL, V79, P1566, DOI 10.1016/S0015-0282(03)00370-4; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; KYO S, 1994, J INFECT DIS, V170, P682, DOI 10.1093/infdis/170.3.682; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Lai YM, 1996, FERTIL STERIL, V65, P1026, DOI 10.1016/S0015-0282(16)58281-8; Lee CA, 2002, GYNECOL ONCOL, V85, P511, DOI 10.1006/gyno.2002.6662; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Olatunbosun O, 2001, OBSTET GYNECOL, V97, P357, DOI 10.1016/S0029-7844(00)01183-2; OSTROW RS, 1986, SCIENCE, V231, P731, DOI 10.1126/science.3003908; Perez-Andino J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005847; Rintala MAM, 2004, INT J STD AIDS, V15, P740, DOI 10.1258/0956462042395122; Rohde V, 1999, FERTIL STERIL, V72, P814, DOI 10.1016/S0015-0282(99)00363-5; Sherwood JB, 1997, GYNECOL ONCOL, V66, P141, DOI 10.1006/gyno.1997.4731; Spandorfer SD, 2006, FERTIL STERIL, V86, P765, DOI 10.1016/j.fertnstert.2006.01.051; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	28	47	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18095	10.1371/journal.pone.0018095	http://dx.doi.org/10.1371/journal.pone.0018095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479232	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600027
J	Smit, MA; Peeper, DS				Smit, M. A.; Peeper, D. S.			Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis	ONCOGENE			English	Article						Zeb1; TrkB; EMT; anoikis; metastasis	NEUROTROPHIC RECEPTOR TRKB; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; CANCER-CELLS; TUMOR PROGRESSION; MIR-200 FAMILY; PROMOTES METASTASIS; GENE-EXPRESSION; REPRESSORS ZEB1; BREAST-CANCER	Anoikis (detachment-induced apoptosis) prevents the survival of cells at inappropriate sites of the body and can therefore act as a barrier to metastasis. In a function-based genome-wide screen, we have previously identified the neurotrophic tyrosine kinase receptor TrkB as a potent suppressor of anoikis. Consistently, activated TrkB oncogenically transforms non-malignant epithelial cells and causes them to invade and produce metastatic tumors in vivo. Overexpression of activated TrkB also results in morphological transformation, resembling epithelial-mesenchymal transition (EMT). E-cadherin, an important EMT regulator, and two E-cadherin repressors, Twist and Snail, are critical for these TrkB functions. As Snail has been shown to induce Zeb1, another E-cadherin repressor, we hypothesized that Zeb1 could be a TrkB target, too. We show here that Zeb1 is required for TrkB-induced EMT in epithelial cells, as RNAi-mediated knockdown of Zeb1 reverted the morphological changes induced by TrkB. Furthermore, Zeb1 is involved in TrkB-induced anoikis resistance, migration and invasion. In vivo, knockdown of Zeb1 strongly reduced TrkB-induced metastasis. Finally, epistasis experiments showed that Zeb1 acts downstream of Twist and Snail. We conclude that Zeb1 is required for several TrkB-induced effects in vitro and in vivo, including metastasis. Oncogene (2011) 30, 3735-3744; doi:10.1038/onc.2011.96; published online 11 April 2011	[Smit, M. A.; Peeper, D. S.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Peeper, DS (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121,Room P1-011, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020		Dutch Cancer Society; European Union	Dutch Cancer Society(KWF Kankerbestrijding); European Union(European Commission)	We thank M Voetel, S Greven, H Grimminck and all other animal caretakers for their excellent technical help with the in vivo experiments, JY Song and the animal pathology department for help with the pathological analysis and performing IHC stainings, L Brocks and L Oomen for help with the confocal images, F Van Diepen and A Pfauth for fluorescence-activated cell sorting, M Heimerikx, M Nieuwland, J de Ronde, D Sie, A Velds, I de Rink and R Kerkhoven for performing the microarray analysis and ML Yurda for statistical analysis. We thank Dr Nakshatri for providing the Zeb1 plasmid, R Weinberg for the Twist plasmid, A Munoz for the Snail plasmid and K Becker for the Snail antibody. We thank all members of the Peeper laboratory for their valuable input and T Geiger for useful discussions and help with the microarray experiments. This work was supported by grants from MAS and DSP from the Dutch Cancer Society (KWF) and a European Union FP6 grant.	Adachi Y, 2009, FEBS LETT, V583, P430, DOI 10.1016/j.febslet.2008.12.042; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Dionne CA, 1998, CLIN CANCER RES, V4, P1887; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Miknyoczki SJ, 1999, INT J CANCER, V81, P417, DOI 10.1002/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Rosivatz E, 2006, VIRCHOWS ARCH, V448, P277, DOI 10.1007/s00428-005-0118-9; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Singh M, 2008, MODERN PATHOL, V21, P912, DOI 10.1038/modpathol.2008.82; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027	57	67	68	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	35					3735	3744		10.1038/onc.2011.96	http://dx.doi.org/10.1038/onc.2011.96			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21478908				2022-12-25	WOS:000294481400001
J	Beigneux, AP; Davies, BSJ; Tat, S; Chen, J; Gin, P; Voss, CV; Weinstein, MM; Bensadoun, A; Pullinger, CR; Fong, LG; Young, SG				Beigneux, Anne P.; Davies, Brandon S. J.; Tat, Shelly; Chen, Jenny; Gin, Peter; Voss, Constance V.; Weinstein, Michael M.; Bensadoun, Andre; Pullinger, Clive R.; Fong, Loren G.; Young, Stephen G.			Assessing the Role of the Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1) Three-finger Domain in Binding Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; SITE-DIRECTED MUTAGENESIS; PLASMINOGEN-ACTIVATOR; FUNCTIONAL EPITOPE; HEPARIN-BINDING; CHYLOMICRONS; RECEPTOR; IDENTIFICATION; RESIDUES; MELEDA	Glycosylphosphatidylinositol-anchored high density lipoprotein- binding protein 1 (GPIHBP1) is an endothelial cell protein that transports lipoprotein lipase (LPL) from the subendothelial spaces to the capillary lumen. GPIHBP1 contains two main structural motifs, an amino-terminal acidic domain enriched in aspartates and glutamates and a lymphocyte antigen 6 (Ly6) motif containing 10 cysteines. All of the cysteines in the Ly6 domain are disulfide-bonded, causing the protein to assume a three-fingered structure. The acidic domain of GPIHBP1 is known to be important for LPL binding, but the involvement of the Ly6 domain in LPL binding requires further study. To assess the importance of the Ly6 domain, we created a series of GPIHBP1 mutants in which each residue of the Ly6 domain was changed to alanine. The mutant proteins were expressed in Chinese hamster ovary (CHO) cells, and their expression level on the cell surface and their ability to bind LPL were assessed with an immunofluorescence microscopy assay and a Western blot assay. We identified 12 amino acids within GPIHBP1, aside from the conserved cysteines, that are important for LPL binding; nine of those were clustered in finger 2 of the GPIHBP1 three-fingered motif. The defective GPIHBP1 proteins also lacked the ability to transport LPL from the basolateral to the apical surface of endothelial cells. Our studies demonstrate that the Ly6 domain of GPIHBP1 is important for the ability of GPIHBP1 to bind and transport LPL.	[Beigneux, Anne P.; Davies, Brandon S. J.; Tat, Shelly; Gin, Peter; Voss, Constance V.; Weinstein, Michael M.; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Chen, Jenny; Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94158 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Beigneux, AP (corresponding author), 675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	abeigneux@mednet.ucla.edu		Davies, Brandon/0000-0002-7168-8522; Young, Stephen/0000-0001-7270-3176	National Institutes of Health [R01 HL094732, P01 HL090553, R01 HL087228]; American Heart Association, National Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, R01HL094732, R01HL087228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, National Office(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL094732 (to A. P. B.), P01 HL090553 (to S. G. Y.), and R01 HL087228 (to S. G. Y.). This work was also supported by a Scientist Development Award from the American Heart Association, National Office (to A. P. B.).	Beigneux AP, 2008, J LIPID RES, V49, P1312, DOI 10.1194/jlr.M700593-JLR200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; COCAPRIETO I, 2011, J INTERN ME IN PRESS; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Favre B, 2007, J INVEST DERMATOL, V127, P301, DOI 10.1038/sj.jid.5700551; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Gin P, 2007, BBA-MOL CELL BIOL L, V1771, P1464, DOI 10.1016/j.bbalip.2007.10.005; HATA A, 1993, J BIOL CHEM, V268, P8447; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; MA YH, 1994, J LIPID RES, V35, P2049; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Sendak RA, 1998, J LIPID RES, V39, P1310; Yerebakan O, 2003, CLIN EXP DERMATOL, V28, P542, DOI 10.1046/j.1365-2230.2003.01342.x; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	22	44	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19735	19743		10.1074/jbc.M111.242024	http://dx.doi.org/10.1074/jbc.M111.242024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478160	hybrid, Green Published			2022-12-25	WOS:000291027700056
J	De Francesco, MA; Baronio, M; Poiesi, C				De Francesco, Maria A.; Baronio, Manuela; Poiesi, Claudio			HIV-1 p17 Matrix Protein Interacts with Heparan Sulfate Side Chain of CD44v3, Syndecan-2, and Syndecan-4 Proteoglycans Expressed on Human Activated CD4(+) T Cells Affecting Tumor Necrosis Factor alpha and Interleukin 2 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HOMING RECEPTOR CD44; BINDING; REPLICATION; LYMPHOCYTES; RANTES; ASSOCIATION; APOPTOSIS; MEMBRANE; TURNOVER	HIV-1 p17 contains C-and N-terminal sequences with positively charged residues and a consensus cluster for heparin binding. We have previously demonstrated by affinity chromatography that HIV-1 p17 binds strongly to heparin-agarose at physiological pH and to human activated CD4(+) T cells. In this study we demonstrated that the viral protein binds to heparan sulfate side chains of syndecan-2, syndecan-4, and CD44v3 purified from HeLa cells and that these heparan sulfate proteoglycans (HSPGs) co-localize with HIV-1 p17 on activated human CD4(+) T cells by confocal fluorescence analysis. Moreover, we observed a stimulatory or inhibitory activity when CD4(+) T cells were activated with mitogens together with nanomolar or micromolar concentrations of the matrix protein.	[Poiesi, Claudio] Spedali Civil Brescia, Inst Microbiol & Virol, Lab Microbiol & Virol, I-25123 Brescia, Italy; [De Francesco, Maria A.] Univ Brescia, Sch Med, Inst Microbiol, I-25123 Brescia, Italy; [Baronio, Manuela] Osped St Orsola, Dept Intens Care Unit, I-27 Brescia, Italy	Hospital Spedali Civili Brescia; University of Brescia	Poiesi, C (corresponding author), Spedali Civil Brescia, Inst Microbiol & Virol, Lab Microbiol & Virol, Piazzale Spedali Civili 1, I-25123 Brescia, Italy.	claudio.poiesi@tiscali.it	De Francesco, M.A./H-3456-2019	De Francesco, M.A./0000-0003-2221-6286	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica.	Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Appay V, 2000, INT IMMUNOL, V12, P1173, DOI 10.1093/intimm/12.8.1173; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Borland G, 1998, IMMUNOLOGY, V93, P139; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Cannon PM, 1997, J VIROL, V71, P3474, DOI 10.1128/JVI.71.5.3474-3483.1997; Carey DJ, 1997, BIOCHEM J, V327, P1; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Conte MR, 1998, VIROLOGY, V246, P191, DOI 10.1006/viro.1998.9206; COSTES S, 2002, P MICROSC MICROANAL, V8; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; Forster-Horvath C, 2001, EUR J IMMUNOL, V31, P600, DOI 10.1002/1521-4141(200102)31:2<600::AID-IMMU600>3.0.CO;2-8; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; LASKIN JD, 1991, LEUKEMIA RES, V15, P515, DOI 10.1016/0145-2126(91)90063-Y; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; LORIES V, 1986, EUR J BIOCHEM, V158, P351, DOI 10.1111/j.1432-1033.1986.tb09758.x; LU W, 1995, NAT MED, V1, P386, DOI 10.1038/nm0595-386b; Poiesi C, 2008, VIRUS RES, V132, P25, DOI 10.1016/j.virusres.2007.10.006; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; Schacker TW, 2006, CLIN VACCINE IMMUNOL, V13, P556, DOI 10.1128/CVI.13.5.556-560.2006; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Seddon B, 2003, CURR OPIN IMMUNOL, V15, P321, DOI 10.1016/S0952-7915(03)00049-9; Sieg SF, 2005, J INFECT DIS, V192, P62, DOI 10.1086/430620; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; Teixe T, 2008, MOL IMMUNOL, V45, P2905, DOI 10.1016/j.molimm.2008.01.033; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Verli H, 2007, J MOL GRAPH MODEL, V26, P62, DOI 10.1016/j.jmgm.2006.09.009; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	47	20	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19541	19548		10.1074/jbc.M110.191270	http://dx.doi.org/10.1074/jbc.M110.191270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482826	Green Published, hybrid			2022-12-25	WOS:000291027700037
J	Rakovich, T; Boland, C; Bernstein, I; Chikwana, VM; Iwata-Reuyl, D; Kelly, VP				Rakovich, Tatsiana; Boland, Coilin; Bernstein, Ilana; Chikwana, Vimbai M.; Iwata-Reuyl, Dirk; Kelly, Vincent P.			Queuosine Deficiency in Eukaryotes Compromises Tyrosine Production through Increased Tetrahydrobiopterin Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLALANINE-HYDROXYLASE ACTIVITY; TRANSFER-RNA; ENDOTHELIAL DYSFUNCTION; HELA-CELLS; DIHYDROFOLATE-REDUCTASE; IN-VIVO; QUEUINE; GENE; BASE; MICE	Queuosine is a modified pyrrolopyrimidine nucleoside found in the anticodon loop of transfer RNA acceptors for the amino acids tyrosine, asparagine, aspartic acid, and histidine. Because it is exclusively synthesized by bacteria, higher eukaryotes must salvage queuosine or its nucleobase queuine from food and the gut microflora. Previously, animals made deficient in queuine died within 18 days of withdrawing tyrosine, a nonessential amino acid, from the diet (Marks, T., and Farkas, W. R. (1997) Biochem. Biophys. Res. Commun. 230, 233-237). Here, we show that human HepG2 cells deficient in queuine and mice made deficient in queuosine-modified transfer RNA, by disruption of the tRNA guanine transglycosylase enzyme, are compromised in their ability to produce tyrosine from phenylalanine. This has similarities to the disease phenylketonuria, which arises from mutation in the enzyme phenylalanine hydroxylase or from a decrease in the supply of its cofactor tetrahydrobiopterin (BH4). Immunoblot and kinetic analysis of liver from tRNA guanine transglycosylase-deficient animals indicates normal expression and activity of phenylalanine hydroxylase. By contrast, BH4 levels are significantly decreased in the plasma, and both plasma and urine show a clear elevation in dihydrobiopterin, an oxidation product of BH4, despite normal activity of the salvage enzyme dihydrofolate reductase. Our data suggest that queuosine modification limits BH4 oxidation in vivo and thereby potentially impacts on numerous physiological processes in eukaryotes.	[Rakovich, Tatsiana; Boland, Coilin; Kelly, Vincent P.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Bernstein, Ilana] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Chikwana, Vimbai M.; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Trinity College Dublin; University of Newcastle; Portland State University	Kelly, VP (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	kellyvp@tcd.ie	Kelly, Vincent P/I-2151-2017; Rakovich, Tatsiana/H-5087-2018	Kelly, Vincent P/0000-0001-7067-5407; Rakovich, Tatsiana/0000-0001-7903-9968; Boland, Coilin/0000-0001-6763-3767	Science Foundation Ireland [05-IN3-I761]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Programme Grant 05-IN3-I761 from Science Foundation Ireland.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Boland C, 2009, J BIOL CHEM, V284, P18218, DOI 10.1074/jbc.M109.002477; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Chen YC, 2010, RNA, V16, P958, DOI 10.1261/rna.1997610; Christensen R, 2002, MOL GENET METAB, V76, P313, DOI 10.1016/S1096-7192(02)00101-4; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Darlington G J, 1987, Methods Enzymol, V151, P19, DOI 10.1016/S0076-6879(87)51006-0; Du YH, 2008, CIRCULATION, V117, P1045, DOI 10.1161/CIRCULATIONAHA.107.748236; Durand JMB, 2000, MOL MICROBIOL, V35, P924, DOI 10.1046/j.1365-2958.2000.01767.x; FARKAS WR, 1984, BIOCHIM BIOPHYS ACTA, V781, P64, DOI 10.1016/0167-4781(84)90124-6; FARKAS WR, 1980, J BIOL CHEM, V255, P6832; Gaur R, 2007, J BIOSCIENCES, V32, P747, DOI 10.1007/s12038-007-0074-4; Gersting SW, 2010, J BIOL CHEM, V285, P30686, DOI 10.1074/jbc.M110.124016; HAGGERTY DF, 1975, J BIOL CHEM, V250, P8428; Hasegawa H, 2005, MOL GENET METAB, V86, pS2, DOI 10.1016/j.ymgme.2005.09.002; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Iino T, 2003, ARCH BIOCHEM BIOPHYS, V416, P180, DOI 10.1016/S0003-9861(03)00295-9; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; Iwata-Reuyl D., 2009, DNA RNA MODIFICATION; KATZE JR, 1982, SCIENCE, V216, P55; KAUFMAN S, 1991, NEUROCHEM RES, V16, P1031, DOI 10.1007/BF00965847; Kelly VP, 2005, MOL CELL BIOL, V25, P3658, DOI 10.1128/MCB.25.9.3658-3669.2005; Kirsch M, 2003, J BIOL CHEM, V278, P24481, DOI 10.1074/jbc.M211779200; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016; LANGGUT W, 1990, FEBS LETT, V265, P33, DOI 10.1016/0014-5793(90)80877-L; LANGGUT W, 1995, BIOCHEM BIOPH RES CO, V207, P306, DOI 10.1006/bbrc.1995.1188; Lichter-Konecki U, 1999, MOL GENET METAB, V67, P308, DOI 10.1006/mgme.1999.2880; MAHR U, 1990, Biofactors, V2, P185; Marks T, 1997, BIOCHEM BIOPH RES CO, V230, P233, DOI 10.1006/bbrc.1996.5768; MEIER F, 1985, EMBO J, V4, P823, DOI 10.1002/j.1460-2075.1985.tb03704.x; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; Morris RC, 1999, J BIOMOL STRUCT DYN, V16, P757, DOI 10.1080/07391102.1999.10508291; MURALIDHAR G, 1988, ANAL BIOCHEM, V171, P346, DOI 10.1016/0003-2697(88)90496-4; NICOSIA A, 1992, NUCLEIC ACIDS RES, V20, P5321, DOI 10.1093/nar/20.20.5321; NISHIMURA S, 1983, PROG NUCLEIC ACID RE, V28, P49, DOI 10.1016/S0079-6603(08)60082-3; OTT G, 1982, FEBS LETT, V146, P311, DOI 10.1016/0014-5793(82)80941-1; Pathak C, 2005, MOL BIOL REP, V32, P191, DOI 10.1007/s11033-004-6941-2; Pathak C, 2008, BIOSCIENCE REP, V28, P73, DOI 10.1042/BSR20070011; Pey AL, 2006, FASEB J, V20, P2130, DOI 10.1096/fj.06-5835fje; Phillips G, 2010, J BIOL CHEM, V285, P12706, DOI 10.1074/jbc.M110.102236; REISSER T, 1994, EUR J BIOCHEM, V221, P979, DOI 10.1111/j.1432-1033.1994.tb18814.x; REYNIERS JP, 1981, J BIOL CHEM, V256, P1591; Sawabe K, 2004, J PHARMACOL SCI, V96, P124, DOI 10.1254/jphs.FP0040280; SHIMAN R, 1980, J BIOL CHEM, V255, P4793; Shinozaki K, 2000, CIRC RES, V87, P566, DOI 10.1161/01.RES.87.7.566; SIARD TJ, 1991, BIOFACTORS, V3, P41; SZABO L, 1988, Biofactors, V1, P241; Takeda M, 2009, CIRC J, V73, P955, DOI 10.1253/circj.CJ-08-0850; Thony B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; WEBBER S, 1985, ARCH BIOCHEM BIOPHYS, V236, P681, DOI 10.1016/0003-9861(85)90674-5; XIA T, 1994, J BIOL CHEM, V269, P24657; Yang W. K., 1971, METHOD ENZYMOL, V20, P44	56	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19354	19363		10.1074/jbc.M111.219576	http://dx.doi.org/10.1074/jbc.M111.219576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487017	Green Published, hybrid			2022-12-25	WOS:000291027700017
J	Ekstrom, EJ; Sherwood, V; Andersson, T				Ekstrom, Elin J.; Sherwood, Victoria; Andersson, Tommy			Methylation and Loss of Secreted Frizzled-Related Protein 3 Enhances Melanoma Cell Migration and Invasion	PLOS ONE			English	Article							WNT ANTAGONIST; EPIGENETIC INACTIVATION; BETA-CATENIN; EXPRESSION; GENES; INHIBITION; PATHWAY; GROWTH; TRANSCRIPTION; PROGRESSION	Background: Wnt signaling is important in development and can also contribute to the initiation and progression of cancer. The Secreted Frizzled Related Proteins (SFRPs) constitute a family of Wnt modulators, crucial for controlling Wnt signaling. Here we investigate the expression and role of SFRP3 in melanoma. Methodology/Principal Findings: We show that SFRP3 mRNA is down-regulated in malignant melanoma tumors as compared to normal/benign tissue. Furthermore, we found that SFRP3 expression was lost in the malignant melanoma cell lines, A2058, HTB63 and A375, but not in the non-transformed melanocyte cell line, Hermes 3A. Methylated CpG rich areas were detected in the SFRP3 gene in melanoma cell lines and their SFRP3 expression could be restored using the demethylating agent, 5'aza-deoxycytidine. Addition of recombinant SFRP3 to melanoma cells had no effect on viable cell numbers, but decreased cell migration and invasion. Wnt5a signaling has been shown to increase the migration and invasion of malignant melanoma cells, and high expression of Wnt5a in melanoma tumors has been connected to a poor prognosis. We found that recombinant SFRP3 could inhibit Wnt5a signaling, and that it inhibited melanoma cell migration and invasion in a Wnt5a-dependent manner. Conclusion/Significance: We conclude that SFRP3 functions as a melanoma migration and invasion suppressor by interfering with Wnt5a signaling.	[Ekstrom, Elin J.; Sherwood, Victoria; Andersson, Tommy] Lund Univ, Skane Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden	Lund University; Skane University Hospital	Ekstrom, EJ (corresponding author), Lund Univ, Skane Univ Hosp, Clin Res Ctr, Dept Lab Med, Malmo, Sweden.	Tommy.Andersson@med.lu.se		Sherwood, Victoria/0000-0001-6193-2571; Andersson, Tommy/0000-0003-4032-5769; Pietras, Elin Josefina/0000-0003-1645-8916	Swedish Cancer Foundation; Swedish Research Council; Soderberg foundations; Malmo University Hospital Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society; Knut & Alice Wallenberg Foundation; Wellcome Trust Cell Bank	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg foundations; Malmo University Hospital Research Foundations; Gunnar Nilsson's Cancer Foundation; Royal Physiographic Society; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Wellcome Trust Cell Bank(Wellcome Trust)	This work was supported by the Swedish Cancer Foundation, the Swedish Research Council, the Soderberg foundations, Malmo University Hospital Research Foundations, the Gunnar Nilsson's Cancer Foundation (to TA), the Royal Physiographic Society (to EE and VS), the Knut & Alice Wallenberg Foundation, and the Wellcome Trust Cell Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Jonsson M, 2002, CANCER RES, V62, P409; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Larue L, 2003, PIGM CELL RES, V16, P312, DOI 10.1034/j.1600-0749.2003.00050.x; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu W, 2008, GROWTH FACTORS, V26, P343, DOI 10.1080/08977190802442013; Mandal D, 2007, GENE, V386, P131, DOI 10.1016/j.gene.2006.08.030; Marsit CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012334; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	44	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18674	10.1371/journal.pone.0018674	http://dx.doi.org/10.1371/journal.pone.0018674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494614	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800035
J	Nunez, F; Bravo, S; Cruzat, F; Montecino, M; De Ferrari, GV				Nunez, Felipe; Bravo, Soraya; Cruzat, Fernando; Montecino, Martin; De Ferrari, Giancarlo V.			Wnt/beta-Catenin Signaling Enhances Cyclooxygenase-2 (COX2) Transcriptional Activity in Gastric Cancer Cells	PLOS ONE			English	Article							PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE-2; BETA-CATENIN; TARGET GENES; COLON-CARCINOMA; EXPRESSION; WNT; ACTIVATION; PATHWAY; APC; LINES	Background: Increased expression of the cyclooxygenase-2 enzyme (COX2) is one of the main characteristics of gastric cancer (GC), which is a leading cause of death in the world, particularly in Asia and South America. Although the Wnt/beta-catenin signaling pathway has been involved in the transcriptional activation of the COX2 gene, the precise mechanism modulating this response is still unknown. Methodology/Principal Findings: Here we studied the transcriptional regulation of the COX2 gene in GC cell lines and assessed whether this phenomenon is modulated by Wnt/beta-catenin signaling. We first examined the expression of COX2 mRNA in GC cells and found that there is a differential expression pattern consistent with high levels of nuclear-localized beta-catenin. Pharmacological treatment with either lithium or valproic acid and molecular induction with purified canonical Wnt3a significantly enhanced COX2 mRNA expression in a dose-and time-dependent manner. Serial deletion of a 1.6 Kbp COX2 promoter fragment and gain-or loss-of-function experiments allowed us to identify a minimal Wnt/beta-catenin responsive region consisting of 0.8 Kbp of the COX2 promoter (pCOX2-0.8), which showed maximal response in gene-reporter assays. The activity of this pCOX2-0.8 promoter region was further confirmed by site-directed mutagenesis and DNA-protein binding assays. Conclusions/Significance: We conclude that the pCOX2-0.8 minimal promoter contains a novel functional T-cell factor/lymphoid enhancer factor (TCF/LEF)-response element (TBE Site II; -689/-684) that responds directly to enhanced Wnt/beta-catenin signaling and which may be important for the onset/progression of GC.	[Nunez, Felipe; Bravo, Soraya; Cruzat, Fernando; Montecino, Martin; De Ferrari, Giancarlo V.] Univ Concepcion, Fac Biol Sci, Dept Biochem & Mol Biol, Ctr Tecnol & Innovac Canc, Concepcion, Chile; [Montecino, Martin; De Ferrari, Giancarlo V.] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago, Chile; [Montecino, Martin; De Ferrari, Giancarlo V.] Univ Andres Bello, Fac Med, Santiago, Chile	Universidad de Concepcion; Universidad Andres Bello; Universidad Andres Bello	Nunez, F (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Biochem & Mol Biol, Ctr Tecnol & Innovac Canc, Concepcion, Chile.	gdeferrari@unab.cl		Nunez, Felipe J/0000-0002-4962-3642; De Ferrari, Giancarlo/0000-0003-0932-125X	CTI-Cancer; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) from the Chilean government [PBCT-6]	CTI-Cancer; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) from the Chilean government(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by CTI-Cancer, Programa Bicentenario en Ciencia y Tecnologia (PBCT) - Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) grant number PBCT-6 from the Chilean government (M. M. and G. V. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ackerman VE, 2004, BIOL REPROD, V71, P2079, DOI 10.1095/biolreprod.104.030841; Araki Y, 2003, CANCER RES, V63, P728; Avila ME, 2010, J BIOL CHEM, V285, P18939, DOI 10.1074/jbc.M110.103028; BARRANCO SC, 1983, CANCER RES, V43, P1703; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Carlson Mary L, 2003, Mol Cancer, V2, P42, DOI 10.1186/1476-4598-2-42; Chen G, 1999, J NEUROCHEM, V72, P1327, DOI 10.1046/j.1471-4159.2000.0721327.x; Cho SJ, 2007, DIGEST DIS SCI, V52, P1713, DOI 10.1007/s10620-007-9787-3; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Clements WM, 2002, CANCER RES, V62, P3503; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Han SW, 2003, CLIN CANCER RES, V9, P4627; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; INOUE H, 1994, FEBS LETT, V350, P51, DOI 10.1016/0014-5793(94)00731-4; Katoh M, 2001, INT J ONCOL, V19, P1003; Kim B, 2006, CLIN CANCER RES, V12, P3541, DOI 10.1158/1078-0432.CCR-05-2440; Kim H, 2001, SCAND J GASTROENTERO, V36, P706, DOI 10.1080/003655201300191969; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Konturek PC, 2006, J PHYSIOL PHARMACOL, V57, P51; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KOSAKA T, 1994, EUR J BIOCHEM, V221, P889, DOI 10.1111/j.1432-1033.1994.tb18804.x; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; Lee JH, 2002, AM J PATHOL, V161, P611, DOI 10.1016/S0002-9440(10)64216-2; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; PARK JG, 1990, CANCER RES, V50, P2773; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Ristimaki A, 1997, CANCER RES, V57, P1276; Satiroglu-Tufan NL, 2006, WORLD J GASTROENTERO, V12, P3283, DOI 10.3748/wjg.v12.i20.3283; Saukkonen K, 2003, APMIS, V111, P915, DOI 10.1034/j.1600-0463.2003.1111001.x; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiel A, 2006, J BIOL CHEM, V281, P4564, DOI 10.1074/jbc.M512722200; Tsuji S, 1996, PROSTAG LEUKOTR ESS, V55, P179, DOI 10.1016/S0952-3278(96)90095-2; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838	54	86	87	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18562	10.1371/journal.pone.0018562	http://dx.doi.org/10.1371/journal.pone.0018562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494638	Green Submitted, Green Published, gold			2022-12-25	WOS:000289192400038
J	Streb, JW; Long, XC; Lee, TH; Sun, QA; Kitchen, CM; Georger, MA; Slivano, OJ; Blaner, WS; Carr, DW; Gelman, IH; Miano, JM				Streb, Jeffrey W.; Long, Xiaochun; Lee, Ting-Hein; Sun, Qiang; Kitchen, Chad M.; Georger, Mary A.; Slivano, Orazio J.; Blaner, William S.; Carr, Daniel W.; Gelman, Irwin H.; Miano, Joseph M.			Retinoid-Induced Expression and Activity of an Immediate Early Tumor Suppressor Gene in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; SERUM RESPONSE FACTOR; KINASE-C SUBSTRATE; PROTEIN-KINASE; INTIMAL HYPERPLASIA; NEOINTIMA FORMATION; ANGIOTENSIN-II; CYTOSKELETAL ARCHITECTURE; BALLOON ANGIOPLASTY; NUCLEAR RECEPTORS	Retinoids are used clinically to treat a number of hyper-proliferative disorders and have been shown in experimental animals to attenuate vascular occlusive diseases, presumably through nuclear receptors bound to retinoic acid response elements (RARE) located in target genes. Here, we show that natural or synthetic retinoids rapidly induce mRNA and protein expression of a specific isoform of A-Kinase Anchoring Protein 12 (AKAP12 beta) in cultured smooth muscle cells (SMC) as well as the intact vessel wall. Expression kinetics and actinomycin D studies indicate Akap12 beta is a retinoid-induced, immediate-early gene. Akap12 beta promoter analyses reveal a conserved RARE mildly induced with atRA in a region that exhibits hyperacetylation. Immunofluorescence microscopy and protein kinase A (PKA) regulatory subunit overlay assays in SMC suggest a physical association between AKAP12 beta and PKA following retinoid treatment. Consistent with its designation as a tumor suppressor, inducible expression of AKAP12 beta attenuates SMC growth in vitro. Further, immunohistochemistry studies establish marked decreases in AKAP12 expression in experimentally-injured vessels of mice as well as atheromatous lesions in humans. Collectively, these results demonstrate a novel role for retinoids in the induction of an AKAP tumor suppressor that blocks vascular SMC growth thus providing new molecular insight into how retiniods may exert their anti-proliferative effects in the injured vessel wall.	[Streb, Jeffrey W.; Long, Xiaochun; Lee, Ting-Hein; Sun, Qiang; Kitchen, Chad M.; Georger, Mary A.; Slivano, Orazio J.; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA; [Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY USA; [Carr, Daniel W.] Portland VA Med Ctr, Portland, OR USA; [Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of Rochester; University of Rochester; Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Roswell Park Cancer Institute	Streb, JW (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA.	j.m.miano@rochester.edu	; Miano, Joseph/L-5634-2018	Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	National Institutes of Health [HL070077, CA094108, DK079221, DK068437, T32HL07949]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Service; NATIONAL CANCER INSTITUTE [R01CA094108, R55CA094108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070077, T32HL007949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, R01DK079221, R56DK068437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants HL070077 to JMM; CA094108 to IHG; DK079221 and DK068437 to WSB; and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Service to DWC. JWS was funded through an NIH training grant (#T32HL07949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2008, CANCER RES, V68, P5096, DOI 10.1158/0008-5472.CAN-07-5619; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen JY, 1999, CHINESE MED J-PEKING, V112, P121; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen JY, 2001, BIOCHEM BIOPH RES CO, V281, P475, DOI 10.1006/bbrc.2001.4362; Choi MC, 2004, ONCOGENE, V23, P7095, DOI 10.1038/sj.onc.1207932; Coats SR, 2000, J MOL CELL CARDIOL, V32, P2207, DOI 10.1006/jmcc.2000.1246; DeRose JJ, 1999, CARDIOVASC SURG, V7, P633, DOI 10.1016/S0967-2109(99)00041-1; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Flotho C, 2007, BRIT J HAEMATOL, V138, P644, DOI 10.1111/j.1365-2141.2007.06709.x; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Gelman IH, 2000, HISTOCHEM J, V32, P13, DOI 10.1023/A:1003950027529; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Goeppert B, 2010, HEPATOLOGY, V52, P2023, DOI 10.1002/hep.23939; GORDON T, 1992, J CLIN INVEST, V90, P992, DOI 10.1172/JCI115976; Haraguchi G, 2006, J MOL CELL CARDIOL, V41, P885, DOI 10.1016/j.yjmcc.2006.07.022; Haxsen V, 2001, CIRC RES, V88, P637, DOI 10.1161/01.RES.88.6.637; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Indolfi C, 2001, CIRC RES, V88, P319, DOI 10.1161/01.RES.88.3.319; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Indolfi C, 2000, J AM COLL CARDIOL, V36, P288, DOI 10.1016/S0735-1097(00)00679-3; Jo Ukhyun, 2006, Cancer Res Treat, V38, P144, DOI 10.4143/crt.2006.38.3.144; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Kosaka C, 2001, HYPERTENS RES, V24, P579, DOI 10.1291/hypres.24.579; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Leville CD, 2000, J SURG RES, V90, P183, DOI 10.1006/jsre.2000.5887; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; LIPPMAN SM, 1995, J CELL BIOCHEM, P1; Liu HO, 2009, BRAIN RES, V1265, P1, DOI 10.1016/j.brainres.2009.01.050; Liu YZ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-105; Long XC, 2007, J BIOL CHEM, V282, P15941, DOI 10.1074/jbc.R700010200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miano JM, 2000, CIRC RES, V87, P355; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; Miano JM, 1998, CIRCULATION, V98, P1219, DOI 10.1161/01.CIR.98.12.1219; Nagpal S, 2004, J INVEST DERMATOL, V123, pXX, DOI 10.1111/j.0022-202X.2004.23533.x; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Neuville P, 1999, ARTERIOSCL THROM VAS, V19, P1430, DOI 10.1161/01.ATV.19.6.1430; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pakala R, 2000, J CARDIOVASC PHARM, V35, P302, DOI 10.1097/00005344-200002000-00019; Quelo I, 2000, BIOCHEM BIOPH RES CO, V271, P481, DOI 10.1006/bbrc.2000.2654; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stolle K, 2004, J HISTOCHEM CYTOCHEM, V52, P1511, DOI 10.1369/jhc.4A6289.2004; Streb Jeffrey W., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P31, DOI 10.2174/1568006033337393; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; VENANCE SL, 1993, CAN J PHYSIOL PHARM, V71, P800, DOI 10.1139/y93-119; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; Wang S, 1997, PFLUG ARCH EUR J PHY, V434, P669, DOI 10.1007/s004240050450; Wiegman PJ, 2000, ARTERIOSCL THROM VAS, V20, P89, DOI 10.1161/01.ATV.20.1.89; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wright G, 1996, AM J PHYSIOL-HEART C, V270, pH1363, DOI 10.1152/ajpheart.1996.270.4.H1363; Xia W, 2001, CANCER RES, V61, P5644; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026	60	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18538	10.1371/journal.pone.0018538	http://dx.doi.org/10.1371/journal.pone.0018538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483686	gold, Green Published, Green Submitted			2022-12-25	WOS:000289191300028
J	Fiamegos, YC; Kastritis, PL; Exarchou, V; Han, H; Bonvin, AMJJ; Vervoort, J; Lewis, K; Hamblin, MR; Tegos, GP				Fiamegos, Yiannis C.; Kastritis, Panagiotis L.; Exarchou, Vassiliki; Han, Haley; Bonvin, Alexandre M. J. J.; Vervoort, Jacques; Lewis, Kim; Hamblin, Michael R.; Tegos, George P.			Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ANTIBIOTIC-ACTIVITY; CHLOROGENIC ACID; NORA; TRANSPORTER; DERIVATIVES; BERBERINE; ANALOGS; PLANT; IDENTIFICATION	Background: Traditional antibiotics are increasingly suffering from the emergence of multidrug resistance amongst pathogenic bacteria leading to a range of novel approaches to control microbial infections being investigated as potential alternative treatments. One plausible antimicrobial alternative could be the combination of conventional antimicrobial agents/antibiotics with small molecules which block multidrug efflux systems known as efflux pump inhibitors. Bioassay-driven purification and structural determination of compounds from plant sources have yielded a number of pump inhibitors which acted against gram positive bacteria. Methodology/Principal Findings: In this study we report the identification and characterization of 4',5'-O-dicaffeoylquinic acid (4',5'-ODCQA) from Artemisia absinthium as a pump inhibitor with a potential of targeting efflux systems in a wide panel of Gram-positive human pathogenic bacteria. Separation and identification of phenolic compounds (chlorogenic acid, 3',5'-ODCQA, 4',5'-ODCQA) was based on hyphenated chromatographic techniques such as liquid chromatography with post column solid-phase extraction coupled with nuclear magnetic resonance spectroscopy and mass spectroscopy. Microbial susceptibility testing and potentiation of well know pump substrates revealed at least two active compounds; chlorogenic acid with weak antimicrobial activity and 4',5'-ODCQA with pump inhibitory activity whereas 3',5'-ODCQA was ineffective. These intitial findings were further validated with checkerboard, berberine accumulation efflux assays using efflux-related phenotypes and clinical isolates as well as molecular modeling methodology. Conclusions/Significance: These techniques facilitated the direct analysis of the active components from plant extracts, as well as dramatically reduced the time needed to analyze the compounds, without the need for prior isolation. The calculated energetics of the docking poses supported the biological information for the inhibitory capabilities of 4',5'-ODCQA and furthermore contributed evidence that CQAs show a preferential binding to Major Facilitator Super family efflux systems, a key multidrug resistance determinant in gram-positive bacteria.	[Fiamegos, Yiannis C.] Univ Ioannina, Analyt Chem Lab, GR-45110 Ioannina, Greece; [Kastritis, Panagiotis L.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, Utrecht, Netherlands; [Exarchou, Vassiliki] Univ Ioannina, NMR Ctr, GR-45110 Ioannina, Greece; [Han, Haley; Hamblin, Michael R.; Tegos, George P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Vervoort, Jacques] Wageningen NMR Ctr, Biophys Lab, Wageningen, Netherlands; [Lewis, Kim] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Lewis, Kim] Northeastern Univ, Antimicrobial Drug Discovery Ctr, Boston, MA 02115 USA; [Hamblin, Michael R.; Tegos, George P.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	University of Ioannina; Utrecht University; University of Ioannina; Harvard University; Massachusetts General Hospital; Wageningen University & Research; Northeastern University; Northeastern University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Fiamegos, YC (corresponding author), Univ Ioannina, Analyt Chem Lab, GR-45110 Ioannina, Greece.	gtegos@salud.unm.edu	Bonvin, Alexandre M.J.J./A-5420-2009; Hamblin, Michael R/H-2758-2019; Kastritis, Panagiotis L/F-2498-2010; Tegos, George/C-8830-2011; Han, Hye Sung/AAQ-3621-2021; Hamblin, Mike/AAB-2511-2022; Kastritis, Panagiotis/AAL-7029-2021	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Hamblin, Michael R/0000-0001-6431-4605; Kastritis, Panagiotis L/0000-0002-1463-8422; Han, Hye Sung/0000-0002-3556-0740; Kastritis, Panagiotis/0000-0002-1463-8422	E.U. [HPRI-CT-2001-00178, 2002-31, 2003-011]; National Institutes of Health (NIH) [5U54MH084690-02, R01GM59903R01AI050875]; Massachusetts Technology Transfer Center (MTTC); Netherlands Organization for Scientific Research [700.56.442]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	E.U.(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Technology Transfer Center (MTTC); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for Y. Fiamegos was provided by E.U. Large Scale Facilities program, contracts HPRI-CT-2001-00178, 'LC-NMR analysis of traditional herbal pharmaceuticals' (project no 2002-31) and 'On line LC-SPE-NMR system in analyzing the bioactive constituents of Artemisia extract', (Project no 2003-011) of the Wageningen NMR center. Funding was provided for G. Tegos by the National Institutes of Health (NIH, 5U54MH084690-02, Center Driven Initiative 1) and Massachusetts Technology Transfer Center (MTTC), by the National Institutes of Health for K. Lewis (NIH, R01GM59903) and M. R. Hamblin (NIH, R01AI050875). Funding for P. Kastritis was provided by the Netherlands Organization for Scientific Research through a VICI grant (700.56.442) to A. Bonvin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Azuma K, 1999, J AGR FOOD CHEM, V47, P3963, DOI 10.1021/jf990347p; Ball AR, 2006, ACS CHEM BIOL, V1, P594, DOI 10.1021/cb600238x; Bandyopadhyay G, 2004, BLOOD, V104, P2514, DOI 10.1182/blood-2003-11-4065; Belofsky G, 2006, J NAT PROD, V69, P261, DOI 10.1021/np058057s; Belofsky G, 2004, J NAT PROD, V67, P481, DOI 10.1021/np030409c; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherigo L, 2008, J NAT PROD, V71, P1037, DOI 10.1021/np800148w; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q; *CLIN LAB STAND I, 2008, M39A329 CLSI; CLSI, 1908, M27A3 CLSI; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliopoulos G.M., 1991, ANTIBIOTICS LAB MED, V3rd Edn, P432; Exarchou V, 2003, ANAL CHEM, V75, P6288, DOI 10.1021/ac0347819; Falcao-Silva VS, 2009, PHYTOTHER RES, V23, P1367, DOI 10.1002/ptr.2695; German N, 2008, EUR J MED CHEM, V43, P2453, DOI 10.1016/j.ejmech.2008.01.042; Gibbons S, 2004, PLANTA MED, V70, P1240, DOI 10.1055/s-2004-835860; Hisamoto M, 2003, J AGR FOOD CHEM, V51, P5255, DOI 10.1021/jf0262458; [黄象艳 Huang Xiangyan], 2003, [中国抗生素杂志, Chinese Journal of Antibiotics], V28, P718; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jonas BM, 2001, ANTIMICROB AGENTS CH, V45, P3574, DOI 10.1128/AAC.45.12.3574-3579.2001; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Juteau F, 2003, PLANTA MED, V69, P158, DOI 10.1055/s-2003-37714; Kaatz GW, 2000, ANTIMICROB AGENTS CH, V44, P1404, DOI 10.1128/AAC.44.5.1404-1406.2000; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; Lechner D, 2008, J ANTIMICROB CHEMOTH, V62, P345, DOI 10.1093/jac/dkn178; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Lomovskaya O, 2001, J MOL MICROB BIOTECH, V3, P225; Lomovskaya O, 2007, NAT REV DRUG DISCOV, V6, P56, DOI 10.1038/nrd2200; Markham PN, 1999, ANTIMICROB AGENTS CH, V43, P2404, DOI 10.1128/AAC.43.10.2404; Michalet S, 2007, BIOORG MED CHEM LETT, V17, P1755, DOI 10.1016/j.bmcl.2006.12.059; Mohtar M, 2009, CURR MICROBIOL, V59, P181, DOI 10.1007/s00284-009-9416-9; Morel C, 2003, J AGR FOOD CHEM, V51, P5677, DOI 10.1021/jf0302714; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OHNISHI M, 1994, PHYTOCHEMISTRY, V36, P579, DOI 10.1016/S0031-9422(00)89778-2; PAULSEN IT, 2002, MICROBIAL MULTIDRUG, P5; Pereda-Miranda R, 2006, J NAT PROD, V69, P406, DOI 10.1021/np050227d; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Reinke RA, 2002, J MED CHEM, V45, P3669, DOI 10.1021/jm010359d; Rodrigues L, 2008, J ANTIMICROB CHEMOTH, V61, P1076, DOI 10.1093/jac/dkn070; Sabatini S, 2008, J MED CHEM, V51, P4321, DOI 10.1021/jm701623q; Samosorn S, 2006, BIOORGAN MED CHEM, V14, P857, DOI 10.1016/j.bmc.2005.09.019; Sangwan PL, 2008, BIOORGAN MED CHEM, V16, P9847, DOI 10.1016/j.bmc.2008.09.042; Schram K, 2004, J MASS SPECTROM, V39, P384, DOI 10.1002/jms.600; Singh N, 2008, CHEM-BIOL INTERACT, V173, P97, DOI 10.1016/j.cbi.2008.03.008; Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Stermitz FR, 2002, PLANTA MED, V68, P1140, DOI 10.1055/s-2002-36347; Stermitz FR, 2003, BIOORG MED CHEM LETT, V13, P1915, DOI 10.1016/S0960-894X(03)00316-0; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; TEGOS G, 2006, SUBSTRATES INHIBITOR; Thota N, 2008, BIOORGAN MED CHEM, V16, P6535, DOI 10.1016/j.bmc.2008.05.030; Truong-Bolduc QC, 2003, J BACTERIOL, V185, P3127, DOI 10.1128/JB.185.10.3127-3138.2003; Tsuchiya T, 1996, BIOSCI BIOTECH BIOCH, V60, P765, DOI 10.1271/bbb.60.765; Wei P, 2004, BIOORG MED CHEM LETT, V14, P3093, DOI 10.1016/j.bmcl.2004.04.018	62	114	120	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18127	10.1371/journal.pone.0018127	http://dx.doi.org/10.1371/journal.pone.0018127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483731	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058700009
J	Archer, SK; Inchaustegui, D; Queiroz, R; Clayton, C				Archer, Stuart K.; Inchaustegui, Diana; Queiroz, Rafael; Clayton, Christine			The Cell Cycle Regulated Transcriptome of Trypanosoma brucei	PLOS ONE			English	Article							MESSENGER-RNA ABUNDANCE; POLO-LIKE KINASE; CRITHIDIA-FASCICULATA; CHROMATIN IMMUNOPRECIPITATION; LEISHMANIA-MEXICANA; BINDING-PROTEINS; DNA-REPLICATION; EXPRESSED GENES; AURORA KINASE; IDENTIFICATION	Progression of the eukaryotic cell cycle requires the regulation of hundreds of genes to ensure that they are expressed at the required times. Integral to cell cycle progression in yeast and animal cells are temporally controlled, progressive waves of transcription mediated by cell cycle-regulated transcription factors. However, in the kinetoplastids, a group of early-branching eukaryotes including many important pathogens, transcriptional regulation is almost completely absent, raising questions about the extent of cell-cycle regulation in these organisms and the mechanisms whereby regulation is achieved. Here, we analyse gene expression over the Trypanosoma brucei cell cycle, measuring changes in mRNA abundance on a transcriptome-wide scale. We developed a "double-cut" elutriation procedure to select unperturbed, highly synchronous cell populations from log-phase cultures, and compared this to synchronization by starvation. Transcriptome profiling over the cell cycle revealed the regulation of at least 430 genes. While only a minority were homologous to known cell cycle regulated transcripts in yeast or human, their functions correlated with the cellular processes occurring at the time of peak expression. We searched for potential target sites of RNA-binding proteins in these transcripts, which might earmark them for selective degradation or stabilization. Over-represented sequence motifs were found in several co-regulated transcript groups and were conserved in other kinetoplastids. Furthermore, we found evidence for cell-cycle regulation of a flagellar protein regulon with a highly conserved sequence motif, bearing similarity to consensus PUF-protein binding motifs. RNA sequence motifs that are functional in cell-cycle regulation were more widespread than previously expected and conserved within kinetoplastids. These findings highlight the central importance of post-transcriptional regulation in the proliferation of parasitic kinetoplastids.	[Archer, Stuart K.; Inchaustegui, Diana; Clayton, Christine] DKFZ ZMBH Allianz, Zentrum Mol Biol Heidelberg, Heidelberg, Germany; [Queiroz, Rafael] DKFZ ZMBH Allianz, Deutsch Krebsforschungszentrum, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Archer, SK (corresponding author), DKFZ ZMBH Allianz, Zentrum Mol Biol Heidelberg, Heidelberg, Germany.	s.archer@victorchang.edu.au	Clayton, Christine/K-7700-2019	Archer, Stuart/0000-0003-0450-1243; Clayton, Christine/0000-0002-6384-0731	DFG [CL112/14-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant CL112/14-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; ARCHER SK, 2008, MOL BIOCH PARASITOL; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Avliyakulov NK, 2003, EUKARYOT CELL, V2, P671, DOI 10.1128/EC.2.4.671-677.2003; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; Brown LM, 1997, NUCLEIC ACIDS RES, V25, P3281, DOI 10.1093/nar/25.16.3281; Bucerius F, 2011, MOL BIOCHEM PARASIT, V175, P205, DOI 10.1016/j.molbiopara.2010.10.001; BULLARD J, GENOMINATOR ANAL GEN; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chowdhury AR, 2008, EUKARYOT CELL, V7, P425, DOI 10.1128/EC.00369-07; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; de Lichtenberg U, 2005, YEAST, V22, P1191, DOI 10.1002/yea.1302; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; Ersfeld K, 1996, MOL BIOCHEM PARASIT, V81, P201, DOI 10.1016/0166-6851(96)02709-0; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Forsythe GR, 2009, MOL BIOCHEM PARASIT, V164, P131, DOI 10.1016/j.molbiopara.2008.12.008; GALANTI N, 1994, EXP CELL RES, V214, P225, DOI 10.1006/excr.1994.1252; GALE M, 1994, J CELL SCI, V107, P1825; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; Haudry Y, 2010, NAT PROTOC, V5, P323, DOI 10.1038/nprot.2009.158; Hines JC, 2010, MOL CELL BIOL, V30, P1319, DOI 10.1128/MCB.01231-09; Ho HH, 2006, P NATL ACAD SCI USA, V103, P7676, DOI 10.1073/pnas.0602595103; Holzer TR, 2008, MOL BIOCHEM PARASIT, V157, P54, DOI 10.1016/j.molbiopara.2007.10.001; Kabani S, 2010, MOL BIOCHEM PARASIT, V169, P59, DOI 10.1016/j.molbiopara.2009.08.008; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Mahmood R, 2001, MOL CELL BIOL, V21, P4453, DOI 10.1128/MCB.21.14.4453-4459.2001; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Mishra KK, 2003, EUKARYOT CELL, V2, P1009, DOI 10.1128/EC.2.5.1009-1017.2003; Mittra B, 2004, EUKARYOT CELL, V3, P1185, DOI 10.1128/EC.3.5.1185-1197.2004; Mittra B, 2003, J BIOL CHEM, V278, P26564, DOI 10.1074/jbc.M304322200; Pasion SG, 1996, MOL CELL BIOL, V16, P6724; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2010, NUCL ACIDS RES; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; URBANI L, 1995, EXP CELL RES, V219, P159, DOI 10.1006/excr.1995.1216; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Vaughan PS, 1998, J BIOL CHEM, V273, P194, DOI 10.1074/jbc.273.1.194; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660; Zick A, 2005, NUCLEIC ACIDS RES, V33, P4235, DOI 10.1093/nar/gki742	65	72	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18425	10.1371/journal.pone.0018425	http://dx.doi.org/10.1371/journal.pone.0018425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483801	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200074
J	Dembele, L; Gego, A; Zeeman, AM; Franetich, JF; Silvie, O; Rametti, A; Le Grand, R; Dereuddre-Bosquet, N; Sauerwein, R; van Gemert, GJ; Vaillant, JC; Thomas, AW; Snounou, G; Kocken, CHM; Mazier, D				Dembele, Laurent; Gego, Audrey; Zeeman, Anne-Marie; Franetich, Jean-Francois; Silvie, Olivier; Rametti, Armelle; Le Grand, Roger; Dereuddre-Bosquet, Nathalie; Sauerwein, Robert; van Gemert, Geert-Jan; Vaillant, Jean-Christophe; Thomas, Alan W.; Snounou, Georges; Kocken, Clemens H. M.; Mazier, Dominique			Towards an In Vitro Model of Plasmodium Hypnozoites Suitable for Drug Discovery	PLOS ONE			English	Article							TROPHOZOITE-INDUCED INFECTIONS; VIVAX MALARIA; EXOERYTHROCYTIC PARASITES; CYNOMOLGI-BASTIANELLI; ANTIMALARIAL-DRUGS; HUMAN HEPATOCYTES; INVITRO CULTURE; PRIMAQUINE; SCHIZONTS; FORMS	Background: Amongst the Plasmodium species in humans, only P. vivax and P. ovale produce latent hepatic stages called hypnozoites, which are responsible for malaria episodes long after a mosquito bite. Relapses contribute to increased morbidity, and complicate malaria elimination programs. A single drug effective against hypnozoites, primaquine, is available, but its deployment is curtailed by its haemolytic potential in glucose-6-phosphate dehydrogenase deficient persons. Novel compounds are thus urgently needed to replace primaquine. Discovery of compounds active against hypnozoites is restricted to the in vivo P. cynomolgi-rhesus monkey model. Slow growing hepatic parasites reminiscent of hypnozoites had been noted in cultured P. vivax-infected hepatoma cells, but similar forms are also observed in vitro by other species including P. falciparum that do not produce hypnozoites. Methodology: P. falciparum or P. cynomolgi sporozoites were used to infect human or Macaca fascicularis primary hepatocytes, respectively. The susceptibility of the slow and normally growing hepatic forms obtained in vitro to three antimalarial drugs, one active against hepatic forms including hypnozoites and two only against the growing forms, was measured. Results: The non-dividing slow growing P. cynomolgi hepatic forms, observed in vitro in primary hepatocytes from the natural host Macaca fascicularis, can be distinguished from similar forms seen in P. falciparum-infected human primary hepatocytes by the differential action of selected anti-malarial drugs. Whereas atovaquone and pyrimethamine are active on all the dividing hepatic forms observed, the P. cynomolgi slow growing forms are highly resistant to treatment by these drugs, but remain susceptible to primaquine. Conclusion: Resistance of the non-dividing P. cynomolgi forms to atovaquone and pyrimethamine, which do not prevent relapses, strongly suggests that these slow growing forms are hypnozoites. This represents a first step towards the development of a practical medium-throughput in vitro screening assay for novel hypnozoiticidal drugs.	[Dembele, Laurent; Gego, Audrey; Franetich, Jean-Francois; Silvie, Olivier; Rametti, Armelle; Snounou, Georges; Mazier, Dominique] Univ Paris 06, UMR S945, Paris, France; [Dembele, Laurent; Gego, Audrey; Franetich, Jean-Francois; Silvie, Olivier; Rametti, Armelle; Snounou, Georges; Mazier, Dominique] INSERM, U945, Paris, France; [Zeeman, Anne-Marie; Thomas, Alan W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] CEA, Div Immunovirol, Inst Emerging Dis & Innovat Therapies IMETI, Fontenay Aux Roses, France; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] Univ Paris 11, UMR E01, Orsay, France; [Sauerwein, Robert; van Gemert, Geert-Jan] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vaillant, Jean-Christophe] Hop La Pitie Salpetriere, Serv Chirurg Digest Hepatobiliopancreat & Transpl, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Dembele, L (corresponding author), Univ Paris 06, UMR S945, Paris, France.	dominique.mazier@upmc.fr	Snounou, Georges/F-3352-2011; Sauerwein, Robert/C-8519-2013; Silvie, Olivier/AAF-5437-2021; Franetich, Jean-François/GZA-9674-2022; Silvie, Olivier/K-7290-2017	Snounou, Georges/0000-0002-6133-6398; Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; DEMBELE, LAURENT/0000-0001-9087-8439; Zeeman, Anne-Marie/0000-0002-0157-4669; Kocken, Clemens/0000-0002-4784-1734	Medicines for Malaria Venture; Wellcome Trust [WT078285]; Biomedical Primates Research Center; Universite Pierre et Marie Curie	Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Primates Research Center; Universite Pierre et Marie Curie	This work was supported by a grant from the Medicines for Malaria Venture and a translational research grant (WT078285) from the Wellcome Trust to the Novartis Institute for Tropical Diseases, the Biomedical Primates Research Center and the Universite Pierre et Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Chattopadhyay R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014275; Coatney G.R., 1971, PRIMATE MALARIAS, P1; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; GARNHAM PCC, 1966, MALARIA PARASITES OT, P1; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; HOLLINGDALE MR, 1986, AM J TROP MED HYG, V35, P275, DOI 10.4269/ajtmh.1986.35.275; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; JIANG JB, 1988, T ROY SOC TROP MED H, V82, P56, DOI 10.1016/0035-9203(88)90262-3; Jimenez BC, 2006, J TRAVEL MED, V13, P373, DOI 10.1111/j.1708-8305.2006.00073.x; Kocken CHM, 2009, ANTIMICROB AGENTS CH, V53, P421, DOI 10.1128/AAC.00576-08; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; Maguire JD, 2007, J TRAVEL MED, V14, P411, DOI 10.1111/j.1708-8305.2007.00153.x; MATTEI D, 1989, EUR J IMMUNOL, V19, P1823, DOI 10.1002/eji.1830191010; MAZIER D, 1983, ANN PARASIT HUM COMP, V58, P405, DOI 10.1051/parasite/1983584405; MAZIER D, 1984, NATURE, V307, P367, DOI 10.1038/307367a0; Mazier D, 2009, NAT REV DRUG DISCOV, V8, P854, DOI 10.1038/nrd2960; MILLET P, 1987, ANN PARASIT HUM COMP, V62, P5, DOI 10.1051/parasite/19876215; MILLET P, 1988, AM J TROP MED HYG, V39, P529, DOI 10.4269/ajtmh.1988.39.529; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Povinelli L, 2003, J TRAVEL MED, V10, P353, DOI 10.2310/7060.2003.9318; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P646, DOI 10.4269/ajtmh.1982.31.646; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P609, DOI 10.4269/ajtmh.1982.31.609; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P612, DOI 10.4269/ajtmh.1982.31.612; Shu H, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P185; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240	27	102	104	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18162	10.1371/journal.pone.0018162	http://dx.doi.org/10.1371/journal.pone.0018162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483865	gold, Green Published, Green Submitted			2022-12-25	WOS:000289057200036
J	Zamudio, NM; Scott, HS; Wolski, K; Lo, CY; Law, C; Leong, D; Kinkel, SA; Chong, SY; Jolley, D; Smyth, GK; de Kretser, D; Whitelaw, E; O'Bryan, MK				Zamudio, Natasha M.; Scott, Hamish S.; Wolski, Katja; Lo, Chi-Yi; Law, Charity; Leong, Dillon; Kinkel, Sarah A.; Chong, Suyinn; Jolley, Damien; Smyth, Gordon K.; de Kretser, David; Whitelaw, Emma; O'Bryan, Moira K.			DNMT3L Is a Regulator of X Chromosome Compaction and Post-Meiotic Gene Transcription	PLOS ONE			English	Article							NOVO DNA METHYLTRANSFERASES; PESTICIDE FACTORY-WORKERS; HUMAN SPERM; KLINEFELTER-SYNDROME; SPERMATOGENIC CELLS; TURNER-SYNDROME; INFERTILE MEN; GERM-CELLS; MOUSE; ANEUPLOIDY	Previous studies on the epigenetic regulator DNA methyltransferase 3-Like (DNMT3L), have demonstrated it is an essential regulator of paternal imprinting and early male meiosis. Dnmt3L is also a paternal effect gene, i. e., wild type offspring of heterozygous mutant sires display abnormal phenotypes suggesting the inheritance of aberrant epigenetic marks on the paternal chromosomes. In order to reveal the mechanisms underlying these paternal effects, we have assessed X chromosome meiotic compaction, XY chromosome aneuploidy rates and global transcription in meiotic and haploid germ cells from male mice heterozygous for Dnmt3L. XY bodies from Dnmt3L heterozygous males were significantly longer than those from wild types, and were associated with a three-fold increase in XY bearing sperm. Loss of a Dnmt3L allele resulted in deregulated expression of a large number of both X-linked and autosomal genes within meiotic cells, but more prominently in haploid germ cells. Data demonstrate that similar to embryonic stem cells, DNMT3L is involved in an autoregulatory loop in germ cells wherein the loss of a Dnmt3L allele resulted in increased transcription from the remaining wild type allele. In contrast, however, within round spermatids, this auto-regulatory loop incorporated the alternative noncoding alternative transcripts. Consistent with the mRNA data, we have localized DNMT3L within spermatids and sperm and shown that the loss of a Dnmt3L allele results in a decreased DNMT3L content within sperm. These data demonstrate previously unrecognised roles for DNMT3L in late meiosis and in the transcriptional regulation of meiotic and post-meiotic germ cells. These data provide a potential mechanism for some cases of human Klinefelter's and Turner's syndromes.	[Zamudio, Natasha M.; Wolski, Katja; Lo, Chi-Yi; de Kretser, David; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Zamudio, Natasha M.; O'Bryan, Moira K.] Monash Univ, Australian Res Council Ctr Excellence Biotechnol, Clayton, Vic 3800, Australia; [Jolley, Damien] Monash Univ, Monash Inst Hlth Serv Res, Clayton, Vic 3800, Australia; [Scott, Hamish S.] Univ Adelaide, Inst Med & Vet Sci, Adelaide, SA, Australia; [Law, Charity; Leong, Dillon; Kinkel, Sarah A.; Smyth, Gordon K.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Law, Charity; Chong, Suyinn; Whitelaw, Emma] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Kinkel, Sarah A.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	Monash University; Monash University; Monash University; Institute Medical & Veterinary Science Australia; University of Adelaide; Royal Melbourne Hospital; Walter & Eliza Hall Institute; QIMR Berghofer Medical Research Institute; University of Melbourne	Zamudio, NM (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	Moira.O'Bryan@monash.edu	O'Bryan, Moira K/F-8256-2012; Scott, Hamish/B-2122-2009; Chong, Suyinn/B-6715-2012; Smyth, Gordon/B-5276-2008	O'Bryan, Moira K/0000-0001-7298-4940; Scott, Hamish/0000-0002-5813-631X; Chong, Suyinn/0000-0001-8062-7281; Smyth, Gordon/0000-0001-9221-2892; Law, Charity W/0000-0001-6082-6814; Zamudio, Natasha/0000-0002-2532-5931	National Health and Medical Research Council of Australia; Australian Postgraduate Awards	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards(Australian Government)	This study was supported by National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) grants and fellowships to Moira O'Bryan, Emma Whitelaw, David de Kretser, Hamish Scott, Damien Jolley; an Australian Research Council (http://www.arc.gov.au/) grant to Moira O'Bryan. Natasha Zamudio and Charity Law and Sarah Kinkel were supported by Australian Postgraduate Awards. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; COCKWELL A, 1991, J MED GENET, V28, P151, DOI 10.1136/jmg.28.3.151; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Frias S, 2003, CANCER RES, V63, P44; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guttenbach M, 1997, HUM GENET, V100, P1, DOI 10.1007/s004390050459; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Hassold T, 1990, Birth Defects Orig Artic Ser, V26, P297; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Hata K, 2002, DEVELOPMENT, V129, P1983; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Hu YG, 2008, HUM MOL GENET, V17, P2654, DOI 10.1093/hmg/ddn165; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Hubert FX, 2009, J IMMUNOL, V182, P3902, DOI 10.4049/jimmunol.0802124; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; Jamsai D, 2008, REPRODUCTION, V135, P751, DOI 10.1530/REP-07-0485; La Salle S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-104; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Martin RH, 2003, BIOL REPROD, V69, P535, DOI 10.1095/biolreprod.102.015149; Martinez-Pasarell O, 1999, HUM GENET, V104, P345, DOI 10.1007/s004390050964; MEISTRICH ML, 1981, BIOL REPROD, V25, P1065, DOI 10.1095/biolreprod25.5.1065; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Morris JK, 2008, EUR J HUM GENET, V16, P163, DOI 10.1038/sj.ejhg.5201956; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Oppedisano L, 2002, HUM REPROD, V17, P710, DOI 10.1093/humrep/17.3.710; Paduch DA, 2009, SEMIN REPROD MED, V27, P137, DOI 10.1055/s-0029-1202302; Padungtod C, 1999, AM J IND MED, V36, P230, DOI 10.1002/(SICI)1097-0274(199908)36:2&lt;230::AID-AJIM2&gt;3.0.CO;2-6; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Schaller CE, 2008, J IMMUNOL, V180, P1338, DOI 10.4049/jimmunol.180.3.1338; Shovlin TC, 2007, HUM REPROD, V22, P457, DOI 10.1093/humrep/del379; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Templado C, 2002, MOL REPROD DEV, V61, P200, DOI 10.1002/mrd.1148; TRES LL, 1977, J CELL SCI, V25, P1; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Uchida K, 2000, BIOL REPROD, V63, P993, DOI 10.1095/biolreprod63.4.993; van der Laan R, 2004, J CELL SCI, V117, P5023, DOI 10.1242/jcs.01368; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Whyte JJ, 2007, THERIOGENOLOGY, V67, P1022, DOI 10.1016/j.theriogenology.2006.11.014; Xia YK, 2004, TOXICOLOGY, V203, P49, DOI 10.1016/j.tox.2004.05.018	52	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18276	10.1371/journal.pone.0018276	http://dx.doi.org/10.1371/journal.pone.0018276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483837	Green Published, gold			2022-12-25	WOS:000289057200050
J	de Paula, MR; Ravetti, MG; Berretta, R; Moscato, P				de Paula, Mateus Rocha; Ravetti, Martin Gomez; Berretta, Regina; Moscato, Pablo			Differences in Abundances of Cell-Signalling Proteins in Blood Reveal Novel Biomarkers for Early Detection Of Clinical Alzheimer's Disease	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; MITOCHONDRIAL-FUNCTION; CEREBROSPINAL-FLUID; FAS ANTIGEN; BETA; BRAIN; EXPRESSION; GENE; APOPTOSIS	Background: In November 2007 a study published in Nature Medicine proposed a simple test based on the abundance of 18 proteins in blood to predict the onset of clinical symptoms of Alzheimer's Disease (AD) two to six years before these symptoms manifest. Later, another study, published in PLoS ONE, showed that only five proteins (IL-1 alpha, IL-3, EGF, TNF-alpha and G-CSF) have overall better prediction accuracy. These classifiers are based on the abundance of 120 proteins. Such values were standardised by a Z-score transformation, which means that their values are relative to the average of all others. Methodology: The original datasets from the Nature Medicine paper are further studied using methods from combinatorial optimisation and Information Theory. We expand the original dataset by also including all pair-wise differences of z-score values of the original dataset ("metafeatures"). Using an exact algorithm to solve the resulting (alpha, beta)-k Feature Set problem, used to tackle the feature selection problem, we found signatures that contain either only features, metafeatures or both, and evaluated their predictive performance on the independent test set. Conclusions: It was possible to show that a specific pattern of cell signalling imbalance in blood plasma has valuable information to distinguish between NDC and AD samples. The obtained signatures were able to predict AD in patients that already had a Mild Cognitive Impairment (MCI) with up to 84% of sensitivity, while maintaining also a strong prediction accuracy of 90% on a independent dataset with Non Demented Controls (NDC) and AD samples. The novel biomarkers uncovered with this method now confirms ANG-2, IL-11, PDGF-BB, CCL15/MIP-1 delta; and supports the joint measurement of other signalling proteins not previously discussed: GM-CSF, NT-3, IGFBP-2 and VEGF-B.	[de Paula, Mateus Rocha; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Ravetti, Martin Gomez] Univ Fed Minas Gerais UFMG, Dept Engn Prod, Belo Horizonte, MG, Brazil	University of Newcastle; Universidade Federal de Minas Gerais	de Paula, MR (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Ravetti, Martin/K-1108-2012	Ravetti, Martin/0000-0001-7781-0034; Moscato, Pablo/0000-0003-2570-5966; Berretta, Regina/0000-0002-4420-3446	Australian Research Council (ARC) Centre for Bioinformatics, Australia	Australian Research Council (ARC) Centre for Bioinformatics, Australia(Australian Research Council)	The authors acknowledge partial support from the Australian Research Council (ARC) Centre for Bioinformatics, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED A, 2009, CIRC RES, P1333; Andreoli V, 2007, NEUROCHEM RES, V32, P1445, DOI 10.1007/s11064-007-9329-6; Angelova A, 2005, PROC CVPR IEEE, P494; ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Bengoechea TG, 2009, P NATL ACAD SCI USA, V106, P7870, DOI 10.1073/pnas.0901533106; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Cao CH, 2009, NEUROBIOL DIS, V34, P63, DOI 10.1016/j.nbd.2008.12.015; CHENPLOTKIN A, 2009, ANN NEUROLOGY; Chiappelli M, 2006, DEMENT GERIATR COGN, V22, P296, DOI 10.1159/000095160; Chiarini Anna, 2006, Italian Journal of Anatomy and Embryology, V111, P221; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; Cotta C, 2003, J COMPUT SYST SCI, V67, P686, DOI 10.1016/S0022-0000(03)00081-3; COTTA C, 2007, HDB APPROXIMATION AL; Coulson EJ, 2009, NEUROSCIENTIST, V15, P317, DOI 10.1177/1073858408331376; Coulson EJ, 2006, J NEUROCHEM, V98, P654, DOI 10.1111/j.1471-4159.2006.03905.x; DANIELVAN L, 2010, REJUV RES, P541; de la Monte SM, 2003, LAB INVEST, V83, P287, DOI 10.1097/01.LAB.0000056995.07053.C0; de la Monte SM, 2001, J NEUROPATH EXP NEUR, V60, P195, DOI 10.1093/jnen/60.2.195; Diarra Adama, 2009, Biochem Biophys Res Commun, V390, P352, DOI 10.1016/j.bbrc.2009.09.116; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Falk T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-49; FAYYAD UM, 1993, 13 INT JOINT C ART I; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; Feuk L, 2000, HUM GENET, V107, P391, DOI 10.1007/s004390000383; FEUK L, 2002, HUM MUTAT, V21, P53; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Frey C, 2006, J NEURAL TRANSM, V113, P1753, DOI 10.1007/s00702-006-0481-y; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; He XM, 2006, BRAIN RES, V1082, P192, DOI 10.1016/j.brainres.2006.01.086; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hock C, 2000, MOL PSYCHIATR, V5, P510, DOI 10.1038/sj.mp.4000743; Hourani Mou'ath, 2008, V453, P379, DOI 10.1007/978-1-60327-429-6_20; Iarlori C, 2005, EXP GERONTOL, V40, P605, DOI 10.1016/j.exger.2005.04.007; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Lesne S, 2005, J BIOL CHEM, V280, P24941, DOI 10.1074/jbc.M413495200; Lombardi VRM, 2004, METHOD FIND EXP CLIN, V26, P523, DOI 10.1358/mf.2004.26.7.863735; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Manczak M, 2009, HUM MOL GENET, V18, P3876, DOI 10.1093/hmg/ddp331; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Mirnics ZK, 2005, NEUROBIOL DIS, V20, P969, DOI 10.1016/j.nbd.2005.06.004; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Moscato P., 2005, ACSC 05, P371; Murphy GM, 1998, J BIOL CHEM, V273, P20967, DOI 10.1074/jbc.273.33.20967; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Poesen K, 2008, J NEUROSCI, V28, P10451, DOI 10.1523/JNEUROSCI.1092-08.2008; POON WW, 2009, NEUROBIOLOG IN PRESS; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; RAVETTI MG, 2009, FDN COMPUTATIONAL IN, V4, P149; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reale M, 2008, J ALZHEIMERS DIS, V14, P147; Richartz E, 2002, DEMENT GERIATR COGN, V13, P178, DOI 10.1159/000048650; Riemer C, 2000, J VIROL, V74, P10245, DOI 10.1128/JVI.74.21.10245-10248.2000; Rosenmann H, 2004, DEMENT GERIATR COGN, V17, P143, DOI 10.1159/000076347; Rosso OA, 2009, J NEUROSCI METH, V181, P257, DOI 10.1016/j.jneumeth.2009.04.028; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Schulte-Herbruggen O, 2008, CURR ALZHEIMER RES, V5, P38; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Su JH, 2003, NEUROBIOL DIS, V12, P182, DOI 10.1016/S0969-9961(02)00019-0; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Thirumangalakudi L, 2006, J ALZHEIMERS DIS, V10, P111; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tripathy D, 2010, NEUROBIOL AGING, V31, P8, DOI 10.1016/j.neurobiolaging.2008.03.009; Vezhnevets A, 2007, LECT NOTES ARTIF INT, V4701, P430; WALKER JM, 2008, METHODS MOL MED, V141, P131; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Witten I. H., 2005, DATA MINING PRACTICA; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Xiyang YB, 2009, J NEUROTRAUM, V26, P275, DOI 10.1089/neu.2007.0374; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yew DT, 2004, NEUROSCI LETT, V367, P113, DOI 10.1016/j.neulet.2004.05.091	82	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e17481	10.1371/journal.pone.0017481	http://dx.doi.org/10.1371/journal.pone.0017481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21479255	Green Submitted, Green Published, gold			2022-12-25	WOS:000288811500004
J	Lo Buono, N; Parrotta, R; Morone, S; Bovino, P; Nacci, G; Ortolan, E; Horenstein, AL; Inzhutova, A; Ferrero, E; Funaro, A				Lo Buono, Nicola; Parrotta, Rossella; Morone, Simona; Bovino, Paola; Nacci, Giulia; Ortolan, Erika; Horenstein, Alberto L.; Inzhutova, Alona; Ferrero, Enza; Funaro, Ada			The CD157-Integrin Partnership Controls Transendothelial Migration and Adhesion of Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; CELL-ADHESION; EXTRACELLULAR-MATRIX; LEUKOCYTE ADHESION; UROKINASE RECEPTOR; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; MEMBRANE RAFTS; HUMAN CD38; CD157	CD157, a member of the CD38 gene family, is an NAD-metabolizing ectoenzyme and a signaling molecule whose role in polarization, migration, and diapedesis of human granulocytes has been documented; however, the molecular events underpinning this role remain to be elucidated. This study focused on the role exerted by CD157 in monocyte migration across the endothelial lining and adhesion to extracellular matrix proteins. The results demonstrated that anti-CD157 antibodies block monocyte transmigration and adhesion to fibronectin and fibrinogen but that CD157 cross-linking is sufficient to overcome the block, suggesting an active signaling role for the molecule. Consistent with this is the observation that CD157 is prevalently located within the detergent-resistant membrane microdomains to which, upon clustering, it promotes the recruitment of beta(1) and beta(2) integrin, which, in turn, leads to the formation of a multimolecular complex favoring signal transduction. This functional cross-talk with integrins allows CD157 to act as a receptor despite its intrinsic structural inability to do so on its own. Intracellular signals mediated by CD157 rely on the integrin/Src/FAK (focal adhesion kinase) pathway, resulting in increased activity of the MAPK/ERK1/2 and the PI3K/Akt downstream signaling pathways, which are crucial in the control of monocyte transendothelial migration. Collectively, these findings indicate that CD157 acts as a molecular organizer of signaling-competent membrane microdomains and that it forms part of a larger molecular machine ruled by integrins. The CD157-integrin partnership provides optimal adhesion and transmigration of human monocytes.	[Lo Buono, Nicola; Parrotta, Rossella; Morone, Simona; Bovino, Paola; Nacci, Giulia; Ortolan, Erika; Horenstein, Alberto L.; Inzhutova, Alona; Ferrero, Enza; Funaro, Ada] Univ Turin, Immunogenet Lab, Dept Genet Biol & Biochem, Sch Med, I-10126 Turin, Italy; [Ortolan, Erika; Horenstein, Alberto L.; Ferrero, Enza; Funaro, Ada] Univ Turin, Res Ctr Expt Med CeRMS, Sch Med, I-10126 Turin, Italy	University of Turin; University of Turin	Funaro, A (corresponding author), Univ Turin, Immunogenet Lab, Dept Genet Biol & Biochem, Sch Med, Via Santena 19, I-10126 Turin, Italy.	ada.funaro@unito.it	Lo Buono, Nicola/F-4817-2013; Funaro, Ada/AAC-3203-2019	Lo Buono, Nicola/0000-0001-5538-6869; ORTOLAN, Erika/0000-0003-2287-9020; Funaro, Ada/0000-0001-6341-1817	Italian Ministry for University and Scientific Research [PRIN 2008]; University of Torino; Ricerca Sanitaria Finalizzata (Regione Piemonte); Italian Association for Cancer Research [MFAG 6312]; Fondazione Internazionale Ricerche Medicina Sperimentale (FIRMS); Ricerca Sanitaria Finalizzata	Italian Ministry for University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Torino; Ricerca Sanitaria Finalizzata (Regione Piemonte)(Regione Piemonte); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Internazionale Ricerche Medicina Sperimentale (FIRMS); Ricerca Sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was supported by grants from the Italian Ministry for University and Scientific Research (PRIN 2008 to A. F.) and from the University of Torino (to A. F.), Ricerca Sanitaria Finalizzata (Regione Piemonte 2008-2009 to A. F.), and the Italian Association for Cancer Research (MFAG 6312 to E. O.). The Fondazione Internazionale Ricerche Medicina Sperimentale (FIRMS) provided financial and administrative assistance.; Supported by a Regione Piemonte fellowship (Ricerca Sanitaria Finalizzata 2009).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Airas L, 2000, J IMMUNOL, V165, P5411, DOI 10.4049/jimmunol.165.10.5411; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Deaglio S, 2002, BLOOD, V99, P2490, DOI 10.1182/blood.V99.7.2490; Ferrero E, 1999, J LEUKOCYTE BIOL, V65, P151, DOI 10.1002/jlb.65.2.151; Florey O, 2010, J IMMUNOL, V185, P1878, DOI 10.4049/jimmunol.1001305; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Funaro A, 2004, BLOOD, V104, P4269, DOI 10.1182/blood-2004-06-2129; FUNARO A, 1993, EUR J IMMUNOL, V23, P2407, DOI 10.1002/eji.1830231005; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Holleran BJ, 2003, J LEUKOCYTE BIOL, V73, P243, DOI 10.1189/jlb.0902439; Ishihara K, 2000, CHEM IMMUNOL, V75, P235; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; JIANG YL, 1992, J IMMUNOL, V148, P2423; Kamei M, 2010, CURR OPIN HEMATOL, V17, P43, DOI 10.1097/MOH.0b013e3283333949; Korpos E, 2009, CURR PHARM DESIGN, V15, P1349, DOI 10.2174/138161209787846685; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5; Leitinger B, 2002, J CELL SCI, V115, P963; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liang F, 2001, FEBS LETT, V506, P207, DOI 10.1016/S0014-5793(01)02912-X; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Luzzatto L, 2006, CURR OPIN GENET DEV, V16, P317, DOI 10.1016/j.gde.2006.04.015; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Ortolan E, 2002, CELL BIOCHEM FUNCT, V20, P309, DOI 10.1002/cbf.978; Ortolan E, 2006, BLOOD, V108, P4214, DOI 10.1182/blood-2006-04-017160; Ortolan E, 2010, JNCI-J NATL CANCER I, V102, P1160, DOI 10.1093/jnci/djq256; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; RANDOLPH GJ, 1995, J IMMUNOL, V155, P3610; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; SHEN JK, 1995, MICROVASC RES, V50, P360, DOI 10.1006/mvre.1995.1064; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sitrin RG, 2004, AM J RESP CELL MOL, V30, P233, DOI 10.1165/rcmb.2003-0079OC; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80	52	39	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18681	18691		10.1074/jbc.M111.227876	http://dx.doi.org/10.1074/jbc.M111.227876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478153	Green Published, hybrid			2022-12-25	WOS:000290785700041
J	Britos, L; Abeliuk, E; Taverner, T; Lipton, M; McAdams, H; Shapiro, L				Britos, Leticia; Abeliuk, Eduardo; Taverner, Thomas; Lipton, Mary; McAdams, Harley; Shapiro, Lucy			Regulatory Response to Carbon Starvation in Caulobacter crescentus	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; HIGH-THROUGHPUT IDENTIFICATION; CELL-CYCLE REGULATION; ESCHERICHIA-COLI; PROTEOMIC ANALYSIS; BACILLUS-SUBTILIS; 2-DIMENSIONAL ELECTROPHORESIS; MEMBRANE PROTEOME; STATIONARY-PHASE; OXIDATIVE STRESS	Bacteria adapt to shifts from rapid to slow growth, and have developed strategies for long-term survival during prolonged starvation and stress conditions. We report the regulatory response of C. crescentus to carbon starvation, based on combined high-throughput proteome and transcriptome analyses. Our results identify cell cycle changes in gene expression in response to carbon starvation that involve the prominent role of the FixK FNR/CAP family transcription factor and the CtrA cell cycle regulator. Notably, the SigT ECF sigma factor mediates the carbon starvation-induced degradation of CtrA, while activating a core set of general starvation-stress genes that respond to carbon starvation, osmotic stress, and exposure to heavy metals. Comparison of the response of swarmer cells and stalked cells to carbon starvation revealed four groups of genes that exhibit different expression profiles. Also, cell pole morphogenesis and initiation of chromosome replication normally occurring at the swarmer-to-stalked cell transition are uncoupled in carbon-starved cells.	[Britos, Leticia; Abeliuk, Eduardo; McAdams, Harley; Shapiro, Lucy] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Abeliuk, Eduardo] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Taverner, Thomas; Lipton, Mary] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Britos, L (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	shapiro@cmgm.stanford.edu	Lipton, Mary S/H-3913-2012		National Institutes of Health (NIH) [GM32506]; Department of Energy (DOE) [DE-FG02ER64136, DE-AC05-76RL01830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R01GM032506] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH - http://nih.gov/) grant GM32506 to LS and by Department of Energy (DOE - http://www.energy.gov/) grant DE-FG02ER64136 to LS and HM. Proteomic analyses were performed in the Environmental Molecular Sciences Laboratory, a Department of Energy/Office of Biological and Environmental Research (DOE/BER) national scientific user facility on the Pacific Northwest National Laboratory (PNNL) campus in Richland, Washington. PNNL is a multiprogram national laboratory operated by Battelle for the DOE under Contract DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Alvarez-Martinez CE, 2006, J BACTERIOL, V188, P1835, DOI 10.1128/JB.188.5.1835-1846.2006; Alvarez-Martinez CE, 2007, MOL MICROBIOL, V66, P1240, DOI 10.1111/j.1365-2958.2007.06005.x; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Bowman GR, 2010, MOL MICROBIOL, V76, P173, DOI 10.1111/j.1365-2958.2010.07088.x; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Chiang SM, 2010, J MOL EVOL, V70, P557, DOI 10.1007/s00239-010-9352-0; Christen B, 2010, P NATL ACAD SCI USA, V107, P4681, DOI 10.1073/pnas.1000846107; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Crosson S, 2005, P NATL ACAD SCI USA, V102, P8018, DOI 10.1073/pnas.0503022102; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; da Rocha RP, 2008, J BACTERIOL, V190, P1209, DOI 10.1128/JB.01419-07; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Du X, 2008, J PROTEOME RES, V7, P2595, DOI 10.1021/pr0704837; England JC, 2010, J BACTERIOL, V192, P819, DOI 10.1128/JB.01240-09; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fischer B, 2002, MOL MICROBIOL, V44, P461, DOI 10.1046/j.1365-2958.2002.02887.x; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Gorbatyuk B, 2005, MOL MICROBIOL, V55, P1233, DOI 10.1111/j.1365-2958.2004.04459.x; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; Hecker M, 2001, ADV MICROB PHYSIOL, V44, P35, DOI 10.1016/S0065-2911(01)44011-2; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Herrou J, 2010, MOL MICROBIOL, V78, P290, DOI 10.1111/j.1365-2958.2010.07323.x; Holtzendorff J, 2006, BIOESSAYS, V28, P355, DOI 10.1002/bies.20384; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs-Wagner C, 2004, MOL MICROBIOL, V51, P7, DOI 10.1046/j.1365-2958.2003.03828.x; JENKINS DE, 1990, J BACTERIOL, V172, P2779, DOI 10.1128/jb.172.5.2779-2781.1990; JENKINS DE, 1991, J BACTERIOL, V173, P1992, DOI 10.1128/jb.173.6.1992-1996.1991; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; KIM SK, 1993, J BACTERIOL, V175, P1316, DOI 10.1128/JB.175.5.1316-1324.1993; Landt Stephen G, 2010, J Bacteriol, V192, P4763, DOI 10.1128/JB.00343-10; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lee PS, 2003, BIOTECHNOL BIOENG, V84, P834, DOI 10.1002/bit.10841; Lesley JA, 2008, J BACTERIOL, V190, P6867, DOI 10.1128/JB.00700-08; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; MALAKOOTI J, 1995, J BACTERIOL, V177, P4372, DOI 10.1128/jb.177.15.4372-4376.1995; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Miller J.H, 1972, EXPT MOL GENETICS, pxvi; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; Molloy MP, 2002, PROTEOMICS, V2, P899, DOI 10.1002/1615-9861(200207)2:7<899::AID-PROT899>3.0.CO;2-Y; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Phadke ND, 2001, PROTEOMICS, V1, P705, DOI 10.1002/1615-9861(200104)1:5<705::AID-PROT705>3.3.CO;2-E; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Quardokus E, 1996, P NATL ACAD SCI USA, V93, P6314, DOI 10.1073/pnas.93.13.6314; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Sauviac L, 2007, J BACTERIOL, V189, P4204, DOI 10.1128/JB.00175-07; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volker U, 1999, J BACTERIOL, V181, P3942; Wortinger MA, 1998, MOL MICROBIOL, V29, P963, DOI 10.1046/j.1365-2958.1998.00959.x	79	46	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18179	10.1371/journal.pone.0018179	http://dx.doi.org/10.1371/journal.pone.0018179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494595	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100006
J	Simoes, MR; Ribeiro, RF; Vescovi, MVA; de Jesus, HC; Padilha, AS; Stefanon, I; Vassallo, DV; Salaices, M; Fioresi, M				Simoes, Maylla Ronacher; Ribeiro Junior, Rogerio F.; Vescovi, Marcos Vinicius A.; de Jesus, Honerio C.; Padilha, Alessandra S.; Stefanon, Ivanita; Vassallo, Dalton V.; Salaices, Mercedes; Fioresi, Mirian			Acute Lead Exposure Increases Arterial Pressure: Role of the Renin-Angiotensin System	PLOS ONE			English	Article							K+-ATPASE ACTIVITY; INDUCED HYPERTENSION; BLOOD-PRESSURE; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; CONVERTING ENZYME; RATS; ASSOCIATION; SUPEROXIDE	Background: Chronic lead exposure causes hypertension and cardiovascular disease. Our purpose was to evaluate the effects of acute exposure to lead on arterial pressure and elucidate the early mechanisms involved in the development of lead-induced hypertension. Methodology/Principal Findings: Wistar rats were treated with lead acetate (i.v. bolus dose of 320 mu g/Kg), and systolic arterial pressure, diastolic arterial pressure and heart rate were measured during 120 min. An increase in arterial pressure was found, and potential roles of the renin-angiotensin system, Na+, K+-ATPase and the autonomic reflexes in this change in the increase of arterial pressure found were evaluated. In anesthetized rats, lead exposure: 1) produced blood lead levels of 37 +/- 1.7 mu g/dL, which is below the reference blood concentration (60 mu g/dL); 2) increased systolic arterial pressure (Ct: 109 +/- 3 mmHg vs Pb: 120 +/- 4 mmHg); 3) increased ACE activity (27% compared to Ct) and Na+, K+-ATPase activity (125% compared to Ct); and 4) did not change the protein expression of the alpha 1-subunit of Na+, K+-ATPase, AT(1) and AT(2). Pretreatment with an AT(1) receptor blocker (losartan, 10 mg/Kg) or an ACE inhibitor (enalapril, 5 mg/Kg) blocked the lead-induced increase of arterial pressure. However, a ganglionic blockade (hexamethonium, 20 mg/Kg) did not prevent lead's hypertensive effect. Conclusion: Acute exposure to lead below the reference blood concentration increases systolic arterial pressure by increasing angiotensin II levels due to ACE activation. These findings offer further evidence that acute exposure to lead can trigger early mechanisms of hypertension development and might be an environmental risk factor for cardiovascular disease.	[Simoes, Maylla Ronacher; Ribeiro Junior, Rogerio F.; Padilha, Alessandra S.; Stefanon, Ivanita; Vassallo, Dalton V.; Fioresi, Mirian] Univ Fed Espirito Santo, Physiol Sci Postgrad Program, Vitoria, ES, Brazil; [Vescovi, Marcos Vinicius A.; de Jesus, Honerio C.] Univ Fed Espirito Santo, Dept Chem, Vitoria, ES, Brazil; [Fioresi, Mirian] Univ Fed Espirito Santo, Dept Nursing, Vitoria, ES, Brazil; [Vassallo, Dalton V.] Hlth Sci Ctr Vitoria EMESCAM, Vitoria, ES, Brazil; [Salaices, Mercedes] Univ Autonoma Madrid, Dept Pharmacol, Madrid, Spain	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Autonomous University of Madrid	Simoes, MR (corresponding author), Univ Fed Espirito Santo, Physiol Sci Postgrad Program, Vitoria, ES, Brazil.	daltonv2@terra.com.br	Fioresi, Mirian/O-6625-2019; Ribeiro, Rogerio/F-7116-2012; Stefanon, Ivanita/J-4729-2014; Vassallo, Dalton/K-8289-2016	Ribeiro, Rogerio/0000-0002-9725-3869; Stefanon, Ivanita/0000-0003-2638-5183; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Vassallo, Dalton/0000-0002-4463-4174	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia), Brazil [39767531/07]; MCINN (Ministerio de Ciencia e Innovacion) [SAF 2009-07201]; ISCIII (Instituto de Salud Carlos III) (Red RECAVA- Red Tematica de Investigacion en Enfermedades Cardiovasculares del Instituto de Salud Carlos III, Spain [RD06/0014/0011]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII (Instituto de Salud Carlos III) (Red RECAVA- Red Tematica de Investigacion en Enfermedades Cardiovasculares del Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This study was supported by grants from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Amparo a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia)(39767531/07), Brazil and from MCINN (Ministerio de Ciencia e Innovacion) (SAF 2009-07201) and ISCIII (Instituto de Salud Carlos III) (Red RECAVA- Red Tematica de Investigacion en Enfermedades Cardiovasculares del Instituto de Salud Carlos III, RD06/0014/0011), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrzejak Ryszard, 2004, Medycyna Pracy, V55, P139; *ATSDR, 2005, TOX PROF LEAD, V78, P101; BOSCOLO P, 1988, ENVIRON HEALTH PERSP, V78, P101, DOI 10.2307/3430508; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCK TA, 1982, P NATL ACAD SCI-BIOL, V79, P1438, DOI 10.1073/pnas.79.5.1438; Carmignani M, 2000, LIFE SCI, V68, P401, DOI 10.1016/S0024-3205(00)00954-1; Carmignani M, 1999, IMMUNOPHARMACOLOGY, V44, P105, DOI 10.1016/S0162-3109(99)00115-0; Cheng YW, 1998, AM J CARDIOL, V82, P594, DOI 10.1016/S0002-9149(98)00402-0; Farmand F, 2005, ENVIRON RES, V98, P33, DOI 10.1016/j.envres.2004.05.016; FIORESI M, 2009, BIOL RES SA, V42, pR104; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Fujiwara Y, 1998, TOXICOL LETT, V94, P181, DOI 10.1016/S0378-4274(98)00004-6; GELBAND H, 1975, CIRC RES, V37, P542, DOI 10.1161/01.RES.37.5.542; GOLDSTEIN GW, 1993, NEUROTOXICOLOGY, V14, P97; Gonick HC, 1997, HYPERTENSION, V30, P1487, DOI 10.1161/01.HYP.30.6.1487; Grizzo LT, 2008, TOXICOL SCI, V103, P207, DOI 10.1093/toxsci/kfn018; KARAI I, 1982, BRIT J IND MED, V39, P290; KHALILMANESH F, 1993, AM J HYPERTENS, V6, P723, DOI 10.1093/ajh/6.9.723; Kosnett MJ, 2007, ENVIRON HEALTH PERSP, V115, P463, DOI 10.1289/ehp.9784; Lee DI, 2009, MOL PHARMACOL, V75, P774, DOI 10.1124/mol.108.052597; Levin SM, 2000, AM J IND MED, V37, P23, DOI 10.1002/(SICI)1097-0274(200001)37:1<23::AID-AJIM4>3.0.CO;2-U; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; MAHESWARAN R, 1993, AM J EPIDEMIOL, V137, P645, DOI 10.1093/oxfordjournals.aje.a116722; Malvezzi CK, 2001, BRAZ J MED BIOL RES, V34, P1341, DOI 10.1590/S0100-879X2001001000016; MOLLER L, 1992, AM J EPIDEMIOL, V136, P1091, DOI 10.1093/oxfordjournals.aje.a116574; Muscella A, 1997, J ENDOCRINOL, V155, P587, DOI 10.1677/joe.0.1550587; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Oliveira EM, 2000, BRAZ J MED BIOL RES, V33, P755, DOI 10.1590/S0100-879X2000000700005; Patrick L, 2006, ALTERN MED REV, V11, P2; Renner R, 2009, ENVIRON HEALTH PERSP, V117, pA542, DOI 10.1289/ehp.117-a542; Roncal C, 2007, AM J PHYSIOL-RENAL, V293, pF1391, DOI 10.1152/ajprenal.00216.2007; SCHWARTZ J, 1991, ENVIRON HEALTH PERSP, V91, P71, DOI 10.2307/3430985; Sharifi AM, 2004, TOXICOL LETT, V153, P233, DOI 10.1016/j.toxlet.2004.04.013; Silveira EA, 2010, BRAZ J MED BIOL RES, V43, P492, DOI 10.1590/S0100-879X2010007500027; Stefanon I, 2009, BRAZ J MED BIOL RES, V42, P902, DOI 10.1590/S0100-879X2009005000015; SYSALOVA JK, 1997, BIOL TRACE ELEM RES, V56, P321; Tsao DA, 2000, TOXICOL APPL PHARM, V164, P127, DOI 10.1006/taap.1999.8871; VANDER AJ, 1988, ENVIRON HEALTH PERSP, V78, P77, DOI 10.2307/3430505; Vassallo DV, 2008, BRAZ J MED BIOL RES, V41, P789, DOI 10.1590/S0100-879X2008000900008; Vaziri ND, 2001, HYPERTENSION, V37, P223, DOI 10.1161/01.HYP.37.2.223; Vaziri ND, 2008, AM J PHYSIOL-HEART C, V295, pH454, DOI 10.1152/ajpheart.00158.2008; WATTS SW, 1995, TOXICOLOGY, V99, P55, DOI 10.1016/0300-483X(94)03003-K; WEILER E, 1990, CLIN SCI, V79, P185, DOI 10.1042/cs0790185; Xie YX, 1998, IND HEALTH, V36, P234, DOI 10.2486/indhealth.36.234; Zhang CJ, 2001, AM J PHYSIOL-RENAL, V280, pF474, DOI 10.1152/ajprenal.2001.280.3.F474	46	43	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18730	10.1371/journal.pone.0018730	http://dx.doi.org/10.1371/journal.pone.0018730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494558	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100036
J	Banerjee, N; Sengupta, S; Roy, A; Ghosh, P; Das, K; Das, S				Banerjee, Nilanjana; Sengupta, Subhadipa; Roy, Amit; Ghosh, Prithwi; Das, Kalipada; Das, Sampa			Functional Alteration of a Dimeric Insecticidal Lectin to a Monomeric Antifungal Protein Correlated to Its Oligomeric Status	PLOS ONE			English	Article							SATIVUM LEAF AGGLUTININ; MANNOSE-BINDING LECTIN; PLANT-LECTINS; SWISS-MODEL; ASAL; EXPRESSION; RESISTANCE; SEQUENCE	Background Allium sativum leaf agglutinin (ASAL) is a 25-kDa homodimeric, insecticidal, mannose binding lectin whose subunits are assembled by the C-terminal exchange process. An attempt was made to convert dimeric ASAL into a monomeric form to correlate the relevance of quaternary association of subunits and their functional specificity. Using SWISS-MODEL program a stable monomer was designed by altering five amino acid residues near the C-terminus of ASAL. Methodology/Principal Findings: By introduction of 5 site-specific mutations (-DNSNN-), a beta turn was incorporated between the 11(th) and 12(th) b strands of subunits of ASAL, resulting in a stable monomeric mutant ASAL (mASAL). mASAL was cloned and subsequently purified from a pMAL-c2X system. CD spectroscopic analysis confirmed the conservation of secondary structure in mASAL. Mannose binding assay confirmed that molecular mannose binds efficiently to both mASAL and ASAL. In contrast to ASAL, the hemagglutination activity of purified mASAL against rabbit erythrocytes was lost. An artificial diet bioassay of Lipaphis erysimi with mASAL displayed an insignificant level of insecticidal activity compared to ASAL. Fascinatingly, mASAL exhibited strong antifungal activity against the pathogenic fungi Fusarium oxysporum, Rhizoctonia solani and Alternaria brassicicola in a disc diffusion assay. A propidium iodide uptake assay suggested that the inhibitory activity of mASAL might be associated with the alteration of the membrane permeability of the fungus. Furthermore, a ligand blot assay of the membrane subproteome of R. solani with mASAL detected a glycoprotein receptor having interaction with mASAL. Conclusions/Significance: Conversion of ASAL into a stable monomer resulted in antifungal activity. From an evolutionary aspect, these data implied that variable quaternary organization of lectins might be the outcome of defense-related adaptations to diverse situations in plants. Incorporation of mASAL into agronomically-important crops could be an alternative method to protect them from dramatic yield losses from pathogenic fungi in an effective manner.	[Banerjee, Nilanjana; Sengupta, Subhadipa; Roy, Amit; Ghosh, Prithwi; Das, Sampa] Bose Inst, Div Plant Biol, Kolkata, India; [Das, Kalipada] Bose Inst, Dept Chem, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Banerjee, N (corresponding author), Bose Inst, Div Plant Biol, Kolkata, India.	sampa@bic.boseinst.ernet.in	Roy, Amit/N-4761-2015; Roy, Amit/X-7485-2019; Ghosh, Prithwi/I-6450-2019	Roy, Amit/0000-0003-3237-3525; Roy, Amit/0000-0003-3237-3525; Ghosh, Prithwi/0000-0001-5243-751X; Das, Kali/0000-0001-7686-9077	Bose Institute	Bose Institute(Department of Science & Technology (India))	Bose Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Asif AR, 2006, J PROTEOME RES, V5, P954, DOI 10.1021/pr0504586; Bachhawat K, 2001, BIOCHEMISTRY-US, V40, P7291, DOI 10.1021/bi0027783; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Bandyopadhyay S, 2001, PLANT SCI, V161, P1025, DOI 10.1016/S0168-9452(01)00507-6; Banerjee S, 2004, J BIOL CHEM, V279, P23782, DOI 10.1074/jbc.M401405200; Barre A, 1996, PLANT PHYSIOL, V112, P1531, DOI 10.1104/pp.112.4.1531; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakraborti D, 2009, TRANSGENIC RES, V18, P529, DOI 10.1007/s11248-009-9242-7; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Chandra NR, 2001, PROTEIN ENG, V14, P857, DOI 10.1093/protein/14.11.857; Chi H, 1997, COMPUTER PROGRAM PRO; Dam TK, 1998, J BIOL CHEM, V273, P5528, DOI 10.1074/jbc.273.10.5528; de Beer A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-75; Dutta I, 2005, PLANT SCI, V169, P996, DOI 10.1016/j.plantsci.2005.05.016; Dutta I, 2005, PLANT BIOTECHNOL J, V3, P601, DOI 10.1111/j.1467-7652.2005.00151.x; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gangwar M, 2006, MYCOPATHOLOGIA, V162, P103, DOI 10.1007/s11046-006-0040-y; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; Jiang SY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-79; Kim Y, 2007, TRENDS BIOTECHNOL, V25, P395, DOI 10.1016/j.tibtech.2007.07.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu W, 2005, J BIOL CHEM, V280, P14865, DOI 10.1074/jbc.M411634200; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1348, DOI 10.1094/MPMI-19-1348; Natarajan S, 2005, ANAL BIOCHEM, V342, P214, DOI 10.1016/j.ab.2005.04.046; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Roy A, 2002, J AGR FOOD CHEM, V50, P6775, DOI 10.1021/jf025660x; Saha P, 2006, PLANTA, V223, P1329, DOI 10.1007/s00425-005-0182-z; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; Van Damme EJM, 2007, BIOCHEM J, V404, P51, DOI 10.1042/BJ20061819; VANPARIJS J, 1991, PLANTA, V183, P258, DOI 10.1007/BF00197797; VANPARIJS J, 1992, ARCH MICROBIOL, V158, P19, DOI 10.1007/BF00249060; VIGERS AJ, 1991, MOL PLANT MICROBE IN, V4, P315, DOI 10.1094/MPMI-4-315; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2	42	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18593	10.1371/journal.pone.0018593	http://dx.doi.org/10.1371/journal.pone.0018593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490929	Green Published, Green Submitted, gold			2022-12-25	WOS:000289238700026
J	Esguerra, JLS; Bolmeson, C; Cilio, CM; Eliasson, L				Esguerra, Jonathan Lou S.; Bolmeson, Caroline; Cilio, Corrado M.; Eliasson, Lena			Differential Glucose-Regulation of MicroRNAs in Pancreatic Islets of Non-Obese Type 2 Diabetes Model Goto-Kakizaki Rat	PLOS ONE			English	Article							INSULIN-SECRETION; GENE-EXPRESSION; BETA-CELLS; PROTEINS; IDENTIFICATION; SYNTAXIN; TARGETS; RNAS	Background: The Goto-Kakizaki (GK) rat is a well-studied non-obese spontaneous type 2 diabetes (T2D) animal model characterized by impaired glucose-stimulated insulin secretion (GSIS) in the pancreatic beta cells. MicroRNAs (miRNAs) are short regulatory RNAs involved in many fundamental biological processes. We aim to identify miRNAs that are differentially-expressed in the pancreatic islets of the GK rats and investigate both their short-and long term glucose-dependence during glucose-stimulatory conditions. Methodology/Principal Findings: Global profiling of 348 miRNAs in the islets of GK rats and Wistar controls (females, 60 days, N = 6 for both sets) using locked nucleic acid (LNA)-based microarrays allowed for the clear separation of the two groups. Significant analysis of microarrays (SAM) identified 30 differentially-expressed miRNAs, 24 of which are predominantly upregulated in the GK rat islets. Monitoring of qPCR-validated miRNAs during GSIS experiments on isolated islets showed disparate expression trajectories between GK and controls indicating distinct short-and long-term glucose dependence. We specifically found expression of rno-miR-130a, rno-miR-132, rno-miR-212 and rno-miR-335 to be regulated by hyperglycaemia. The putative targets of upregulated miRNAs in the GK, filtered with glucose-regulated mRNAs, were found to be enriched for insulin-secretion genes known to be downregulated in T2D patients. Finally, the binding of rno-miR-335 to a fragment of the 3'UTR of one of known down-regulated exocytotic genes in GK islets, Stxbp1 was shown by luciferase assay. Conclusions/Significance: The perturbed miRNA network found in the GK rat islets is indicative of a system-wide impairment in the regulation of genes important for the normal functions of pancreatic islets, particularly in processes involving insulin secretion during glucose stimulatory conditions. Our findings suggest that the reduced insulin secretion observed in the GK rat may be partly due to upregulated miRNA expression leading to decreased production of key proteins of the insulin exocytotic machinery.	[Esguerra, Jonathan Lou S.; Bolmeson, Caroline; Cilio, Corrado M.] Lund Univ, Dept Clin Sci Malmo, Cellular Autoimmun Unit, Malmo, Sweden	Lund University	Esguerra, JLS (corresponding author), Lund Univ, Dept Clin Sci Malmo, Cellular Autoimmun Unit, Malmo, Sweden.	jonathan.esguerra@med.lu.se	Eliasson, Lena/E-9294-2012; Esguerra, Jonathan/M-2366-2014	Eliasson, Lena/0000-0002-6467-5029; Esguerra, Jonathan/0000-0001-8454-6606	Albert Pahlsson's Foundation; Knut and Alice Wallenberg Foundation; Swedish Medical Research Council; Novo Nordisk Foundation; Swedish Diabetes Association; Lund University Diabetes Centre	Albert Pahlsson's Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Lund University Diabetes Centre	This work was supported by Albert Pahlsson's Foundation, Knut and Alice Wallenberg Foundation, Swedish Medical Research Council, Novo Nordisk Foundation and Swedish Diabetes Association. J.L.S. Esguerra is funded through Lund University Diabetes Centre Linnaeus grant. L. Eliasson is a senior researcher at the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dong YM, 2007, BIOCHEM BIOPH RES CO, V360, P609, DOI 10.1016/j.bbrc.2007.06.107; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Rose T, 2007, J GEN PHYSIOL, V129, P493, DOI 10.1085/jgp.200609604; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; WILLENBROCK H, 2009, QUANTITATIVE MIRNA E; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang W, 2002, BIOCHEM BIOPH RES CO, V291, P1038, DOI 10.1006/bbrc.2002.6555; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	44	130	137	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18613	10.1371/journal.pone.0018613	http://dx.doi.org/10.1371/journal.pone.0018613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490936	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700029
J	Malkani, N; Schmid, JA				Malkani, Naila; Schmid, Johannes A.			Some Secrets of Fluorescent Proteins: Distinct Bleaching in Various Mounting Fluids and Photoactivation of Cyan Fluorescent Proteins at YFP-Excitation	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; NF-KAPPA-B; IMAGING MICROSCOPY; FRET; RECEPTOR; PHOTOCONVERSION; OLIGOMERIZATION; VARIANT; RED	Background: The use of spectrally distinct variants of green fluorescent protein (GFP) such as cyan or yellow mutants (CFP and YFP, respectively) is very common in all different fields of life sciences, e. g. for marking specific proteins or cells or to determine protein interactions. In the latter case, the quantum physical phenomenon of fluorescence resonance energy transfer (FRET) is exploited by specific microscopy techniques to visualize proximity of proteins. Methodology/Principal Findings: When we applied a commonly used FRET microscopy technique - the increase in donor (CFP)-fluorescence after bleaching of acceptor fluorophores (YFP), we obtained good signals in live cells, but very weak signals for the same samples after fixation and mounting in commercial microscopy mounting fluids. This observation could be traced back to much faster bleaching of CFP in these mounting media. Strikingly, the opposite effect of the mounting fluid was observed for YFP and also for other proteins such as Cerulean, TFP or Venus. The changes in photostability of CFP and YFP were not caused by the fixation but directly dependent on the mounting fluid. Furthermore we made the interesting observation that the CFP-fluorescence intensity increases by about 10 - 15% after illumination at the YFP-excitation wavelength - a phenomenon, which was also observed for Cerulean. This photoactivation of cyan fluorescent proteins at the YFP-excitation can cause false-positive signals in the FRET-microscopy technique that is based on bleaching of a yellow FRET acceptor. Conclusions/Significance: Our results show that photostability of fluorescent proteins differs significantly for various media and that CFP bleaches significantly faster in commercial mounting fluids, while the opposite is observed for YFP and some other proteins. Moreover, we show that the FRET microscopy technique that is based on bleaching of the YFP is prone to artifacts due to photoactivation of cyan fluorescent proteins under these conditions.	[Malkani, Naila; Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Malkani, N (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	Johannes.Schmid@meduniwien.ac.at	Malkani, Naila/AAA-9224-2022; Schmid, Johannes A./C-7659-2009	Malkani, Naila/0000-0001-6454-1525; Schmid, Johannes A./0000-0002-6586-3507	Medical University Vienna, Austria	Medical University Vienna, Austria	The work was funded by the Medical University Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMI L, 1995, PFLUG ARCH EUR J PHY, V430, P447, DOI 10.1007/BF00373921; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; Fradkov AF, 2002, BIOCHEM J, V368, P17, DOI 10.1042/BJ20021191; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Harpur AG, 2001, NAT BIOTECHNOL, V19, P167, DOI 10.1038/84443; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Karpova Tatiana, 2006, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1207s35; Kirber MT, 2007, NAT METHODS, V4, P767, DOI 10.1038/nmeth1007-767; LINGBECK JM, 2008, FASEB J; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; MEVRWVABH CCD, 2008, J MICROSCOPY, V231, P97; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PISTON DW, 2007, TRENDS BIOCH SCI; Raarup MK, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103338; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schmid JA, 2003, CURR OPIN ONCOL, V15, P55, DOI 10.1097/00001622-200301000-00008; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Thaler C, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491A; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Verrier SE, 2006, NAT METHODS, V3, P491, DOI 10.1038/NMETH0706-491B; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; WOUTERS FS, 2006, CURR PROTOC NEUROSCI, pCH5	31	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18586	10.1371/journal.pone.0018586	http://dx.doi.org/10.1371/journal.pone.0018586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490932	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700025
J	Elling, L; Steinberg, C; Brockelmann, AK; Dobel, C; Bolte, J; Junghofer, M				Elling, Ludger; Steinberg, Christian; Broeckelmann, Ann-Kathrin; Dobel, Christan; Boelte, Jens; Junghofer, Markus			Acute Stress Alters Auditory Selective Attention in Humans Independent of HPA: A Study of Evoked Potentials	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; CORTICOTROPIN-RELEASING-FACTOR; MESOLIMBIC DOPAMINE NEURONS; WORKING-MEMORY; PREFRONTAL CORTEX; LOCUS-COERULEUS; NUCLEUS-ACCUMBENS; PERCEPTUAL LOAD; DISCHARGE RATE; ACTH 4-10	Background: Acute stress is a stereotypical, but multimodal response to a present or imminent challenge overcharging an organism. Among the different branches of this multimodal response, the consequences of glucocorticoid secretion have been extensively investigated, mostly in connection with long-term memory (LTM). However, stress responses comprise other endocrine signaling and altered neuronal activity wholly independent of pituitary regulation. To date, knowledge of the impact of such "paracorticoidal" stress responses on higher cognitive functions is scarce. We investigated the impact of an ecological stressor on the ability to direct selective attention using event-related potentials in humans. Based on research in rodents, we assumed that a stress-induced imbalance of catecholaminergic transmission would impair this ability. Methodology/Principal Findings: The stressor consisted of a single cold pressor test. Auditory negative difference (Nd) and mismatch negativity (MMN) were recorded in a tonal dichotic listening task. A time series of such tasks confirmed an increased distractibility occuring 4-7 minutes after onset of the stressor as reflected by an attenuated Nd. Salivary cortisol began to rise 8-11 minutes after onset when no further modulations in the event-related potentials (ERP) occurred, thus precluding a causal relationship. This effect may be attributed to a stress-induced activation of mesofrontal dopaminergic projections. It may also be attributed to an activation of noradrenergic projections. Known characteristics of the modulation of ERP by different stress-related ligands were used for further disambiguation of causality. The conjuncture of an attenuated Nd and an increased MMN might be interpreted as indicating a dopaminergic influence. The selective effect on the late portion of the Nd provides another tentative clue for this. Conclusions/Significance: Prior studies have deliberately tracked the adrenocortical influence on cognition, as it has proven most influential with respect to LTM. However, current cortisol-optimized study designs would have failed to detect the present findings regarding attention.	[Elling, Ludger; Steinberg, Christian; Broeckelmann, Ann-Kathrin; Dobel, Christan; Junghofer, Markus] Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Boelte, Jens] Univ Munster, Inst Psychol, Munster, Germany	University of Munster; University of Munster	Elling, L (corresponding author), Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	ellingl@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986; Bolte, Jens/0000-0002-8128-0520	Deutsche Forschungsgemeinschaft [FOR 751]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft, grant number FOR 751 (http://gepris.dfg.de/gepris/octopus/gepris/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Ahveninen J, 2003, NEUROSCI LETT, V340, P181, DOI 10.1016/S0304-3940(03)00102-2; Al'Absi M, 2002, PSYCHOPHYSIOLOGY, V39, P95, DOI 10.1017/S0048577202001543; Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BARTLETT EJ, 1994, AM J PSYCHIAT, V151, P681; BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X; Biondi M, 1999, PSYCHOTHER PSYCHOSOM, V68, P114, DOI 10.1159/000012323; BORN J, 1987, EXP BRAIN RES, V67, P85, DOI 10.1007/BF00269456; BORN J, 1987, PSYCHOPHYSIOLOGY, V24, P286, DOI 10.1111/j.1469-8986.1987.tb00297.x; BORN J, 1990, NEUROENDOCRINOLOGY, V52, P169, DOI 10.1159/000125569; BORN J, 1985, LIFE SCI, V36, P2117, DOI 10.1016/0024-3205(85)90308-X; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Braunstein-Bercovitz H, 2003, ANXIETY STRESS COPIN, V16, P345, DOI 10.1080/10615800310000112560; Braunstein-Bercovitz H, 2001, EMOTION, V1, P182, DOI 10.1037//1528-3542.1.2.182; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; CENCI MA, 1992, BRAIN RES, V581, P217, DOI 10.1016/0006-8993(92)90711-H; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cook CJ, 2004, PHYSIOL BEHAV, V82, P751, DOI 10.1016/j.physbeh.2004.06.013; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; COX T, 1985, ERGONOMICS, V28, P1155, DOI 10.1080/00140138508963238; Curtis AL, 1997, J PHARMACOL EXP THER, V281, P163; de Kloet ER, 2008, EUR J PHARMACOL, V585, P473, DOI 10.1016/j.ejphar.2008.03.011; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DEUTCH AY, 1990, BRAIN RES, V521, P311, DOI 10.1016/0006-8993(90)91557-W; DEWIED D, 1980, P ROY SOC LOND B BIO, P183; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Elzinga BM, 2005, BEHAV NEUROSCI, V119, P98, DOI 10.1037/0735-7044.119.1.98; Erickson K, 2003, NEUROSCI BIOBEHAV R, V27, P233, DOI 10.1016/S0149-7634(03)00033-2; Finlay JM, 1997, NEUROCHEM RES, V22, P1387, DOI 10.1023/A:1022075324164; GOLDMANRACIC PS, 1999, PRIMATE NERVOUS SYST, V15, P403; GRESCH PJ, 1994, J NEUROCHEM, V63, P575; HERD JA, 1991, PHYSIOL REV, V71, P305, DOI 10.1152/physrev.1991.71.1.305; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hoffman R, 2004, ARCH CLIN NEUROPSYCH, V19, P497, DOI 10.1016/j.acn.2003.07.005; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jemel B, 2003, BRAIN TOPOGR, V15, P249, DOI 10.1023/A:1023915730566; Joels M, 1997, FRONT NEUROENDOCRIN, V18, P2, DOI 10.1006/frne.1996.0144; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kahkonen S, 2002, METHOD FIND EXP CLIN, V24, P27; Kahkonen S, 2001, NEUROPSYCHOPHARMACOL, V25, P498, DOI 10.1016/S0893-133X(01)00255-X; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kok A, 2000, BIOL PSYCHOL, V54, P107, DOI 10.1016/S0301-0511(00)00054-5; Koob GF, 1999, BIOL PSYCHIAT, V46, P1167, DOI 10.1016/S0006-3223(99)00164-X; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Lightman SL, 2008, J NEUROENDOCRINOL, V20, P880, DOI 10.1111/j.1365-2826.2008.01711.x; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Martins JM, 1996, NEUROENDOCRINOLOGY, V63, P338; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Molle M, 1997, PSYCHOSOM MED, V59, P497, DOI 10.1097/00006842-199709000-00006; Morrow BA, 2000, BRAIN RES BULL, V52, P519, DOI 10.1016/S0361-9230(00)00290-2; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Robbins TW, 2005, HAND CHEM N, V21, P395; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Shelley AM, 1997, NEUROPSYCHOPHARMACOL, V16, P202, DOI 10.1016/S0893-133X(96)00190-X; Simoens VL, 2007, PSYCHOPHYSIOLOGY, V44, P30, DOI 10.1111/j.1469-8986.2006.00476.x; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Smolnik R, 1999, NEUROENDOCRINOLOGY, V70, P63, DOI 10.1159/000054460; Steciuk M, 2000, Stress, V3, P195, DOI 10.3109/10253890009001123; Strahler J, 2010, PSYCHOPHYSIOLOGY, V47, P587, DOI 10.1111/j.1469-8986.2009.00957.x; Streff A, 2010, EUR J PAIN, V14, P266, DOI 10.1016/j.ejpain.2009.05.011; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; van Marle HJF, 2009, BIOL PSYCHIAT, V66, P649, DOI 10.1016/j.biopsych.2009.05.014; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yoshioka M, 1996, NEUROSCI LETT, V209, P201, DOI 10.1016/0304-3940(96)12631-8; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8	88	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18009	10.1371/journal.pone.0018009	http://dx.doi.org/10.1371/journal.pone.0018009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UD	21483666	Green Published, gold, Green Submitted			2022-12-25	WOS:000289191300005
J	Al-Daghri, NM; Al-Attas, OS; Alokail, MS; Alkharfy, KM; Yakout, SM; Sabico, SB; Gibson, GC; Chrousos, GP; Kumar, S				Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Yakout, Sobhy M.; Sabico, Shaun B.; Gibson, Greg C.; Chrousos, George P.; Kumar, Sudhesh			Parent-Offspring Transmission of Adipocytokine Levels and Their Associations with Metabolic Traits	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; CHILDHOOD OVERWEIGHT; INSULIN-RESISTANCE; OBESITY; ADIPONECTIN; CHILDREN; PREVALENCE; TRENDS; HERITABILITY; ADOLESCENTS	Adipose tissue secreted cytokines (adipocytokines) have significant effects on the physiology and pathology of human metabolism relevant to diabetes and cardiovascular disease. We determined the relationship of the pattern of these circulating hormones with obesity-related phenotypes and whether such pattern is transmitted from parent to offspring. A combined total of 403 individuals from 156 consenting Saudi families divided into initial (119 families with 123 adults and 131 children) and replication (37 families with 58 adults and 91 children) cohorts were randomly selected from the RIYADH Cohort study. Anthropometrics were evaluated and metabolic measures such as fasting serum glucose, lipid profiles, insulin, leptin, adiponectin, resistin, tumor necrosis factor alpha (TNF alpha), activated plasminogen activator inhibitor 1 (aPAI1), high sensitivity C-reactive protein (hsCRP) and angiotensin II were also assessed. Parent-offspring regressions revealed that with the exception of hsCRP, all hormones measured showed evidence for significant inheritance. Principal component (PC) analysis of standardized hormone levels demonstrated surprising heritability of the three most common axes of variation. PC1, which explained 21% of the variation, was most strongly loaded on levels of leptin, TNF alpha, insulin, and aPAI1, and inversely with adiponectin. It was significantly associated with body mass index (BMI) and phenotypically stronger in children, and showed a heritability of similar to 50%, after adjustment for age, gender and generational effects. We conclude that adipocytokines are highly heritable and their pattern of co-variation significantly influences BMI as early as the pre-teen years. Investigation at the genomic scale is required to determine the variants affecting the regulation of the hormones studied.	[Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Yakout, Sobhy M.; Sabico, Shaun B.; Chrousos, George P.] King Saud Univ, Coll Med, Biomarkers Res Program, Dept Biochem, Riyadh 11461, Saudi Arabia; [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh 11461, Saudi Arabia; [Gibson, Greg C.] Georgia Inst Technol, Sch Biol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Chrousos, George P.] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet, GR-11527 Athens, Greece; [Kumar, Sudhesh] Univ Warwick, Diabet & Metab Unit, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	King Saud University; King Saud University; University System of Georgia; Georgia Institute of Technology; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; University of Warwick	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Med, Biomarkers Res Program, Dept Biochem, Riyadh 11461, Saudi Arabia.	ndaghri@ksu.edu.sa	Sabico, Shaun/C-9086-2011; Al-okail, Majed S/E-5565-2016; Al-Daghri, Nasser/A-8360-2011; yakout, sobhy/E-7509-2019; Al-Daghri, Nasser/G-7736-2011; kumar, sudhesh/D-6945-2013	Sabico, Shaun/0000-0002-5248-2350; Al-okail, Majed S/0000-0001-8147-3499; Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; kumar, sudhesh/0000-0003-4326-5941	King Saud University, Riyadh, KSA	King Saud University, Riyadh, KSA(King Saud University)	The study was funded internally by King Saud University, Riyadh, KSA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri N, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-10; Al-Daghri NM, 2010, EUR J CLIN INVEST, V40, P1063, DOI 10.1111/j.1365-2362.2010.02341.x; Al-Daghri NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012159; Alvarez-Aguilar C, 2007, EXP MOL MED, V39, P327, DOI 10.1038/emm.2007.36; Ayatollahi SMT, 2010, OBES REV, V11, P335, DOI 10.1111/j.1467-789X.2010.00725.x; Beardsall K, 2009, J CLIN ENDOCR METAB, V94, P3708, DOI 10.1210/jc.2009-0757; Benson L, 2009, PEDIATRICS, V123, pE153, DOI 10.1542/peds.2008-1408; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; COOPER R, AM J CLIN NUTR, V92, P946; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Davis MM, 2008, J AM BOARD FAM MED, V21, P549, DOI 10.3122/jabfm.2008.06.070140; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; de Luis DA, 2010, DIABETES RES CLIN PR, V89, P110, DOI 10.1016/j.diabres.2010.03.031; El Mouzan MI, 2010, ANN SAUDI MED, V30, P203, DOI 10.4103/0256-4947.62833; Elhadd TA, 2007, ANN SAUDI MED, V27, P241; Friedlander Y, 2009, OBESITY, V17, P1458, DOI 10.1038/oby.2008.672; Gilardini L, 2006, ATHEROSCLEROSIS, V189, P401, DOI 10.1016/j.atherosclerosis.2005.12.021; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; Haworth CMA, 2008, OBESITY, V16, P1585, DOI 10.1038/oby.2008.240; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Kaprio J, 2001, INT J OBESITY, V25, P132, DOI 10.1038/sj.ijo.0801526; Lim Lynette Ly, 2009, Popul Health Metr, V7, P15, DOI 10.1186/1478-7954-7-15; Lissner L, 2010, OBES REV, V11, P553, DOI 10.1111/j.1467-789X.2009.00696.x; Luo BF, 2010, J MED GENET, V47, P415, DOI 10.1136/jmg.2009.068932; Martin LJ, 2010, OBESITY, V18, P1378, DOI 10.1038/oby.2009.394; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Menzaghi C, 2010, J INTERN MED, V267, P287, DOI 10.1111/j.1365-2796.2009.02141.x; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Olds TS, 2010, INT J OBESITY, V34, P57, DOI 10.1038/ijo.2009.211; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schnabel RB, 2009, CIRC-CARDIOVASC GENE, V2, P229, DOI 10.1161/CIRCGENETICS.108.804245; Schoppen S, 2010, CLIN CHEM LAB MED, V48, P707, DOI 10.1515/CCLM.2010.142; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Tejero ME, 2007, INT J OBESITY, V31, P535, DOI 10.1038/sj.ijo.0803436; Umeda M, 2001, AM J HYPERTENS, V14, P206, DOI 10.1016/S0895-7061(00)01253-X; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1340, DOI 10.1161/ATVBAHA.106.136382; Zhang LX, 2010, J AM SOC NEPHROL, V21, P1185, DOI 10.1681/ASN.2009101053	41	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18182	10.1371/journal.pone.0018182	http://dx.doi.org/10.1371/journal.pone.0018182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483749	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058700012
J	Ganesh, BS; Chintala, SK				Ganesh, Bhagyalaxmi S.; Chintala, Shravan K.			Inhibition of Reactive Gliosis Attenuates Excitotoxicity-Mediated Death of Retinal Ganglion Cells	PLOS ONE			English	Article							OPTIC-NERVE HEAD; ELEVATED INTRAOCULAR-PRESSURE; MOUSE MODEL; ASTROCYTES; GLAUCOMA; RESPONSES; DAMAGE; EXPRESSION; NEUROPATHY; LIGATION	Reactive gliosis is a hallmark of many retinal neurodegenerative conditions, including glaucoma. Although a majority of studies to date have concentrated on reactive gliosis in the optic nerve head, very few studies have been initiated to investigate the role of reactive gliosis in the retina. We have previously shown that reactive glial cells synthesize elevated levels of proteases, and these proteases, in turn, promote the death of retinal ganglion cells (RGCs). In this investigation, we have used two glial toxins to inhibit reactive gliosis and have evaluated their effect on protease-mediated death of RGCs. Kainic acid was injected into the vitreous humor of C57BL/6 mice to induce reactive gliosis and death of RGCs. C57BL/6 mice were also treated with glial toxins, alpha-aminoadipic acid (AAA) or Neurostatin, along with KA. Reactive gliosis was assessed by immunostaining of retinal cross sections and retinal flat-mounts with glial fibrillary acidic protein (GFAP) and vimentin antibodies. Apoptotic cell death was assessed by TUNEL assays. Loss of RGCs was determined by immunostaining of flat-mounted retinas with Brn3a antibodies. Proteolytic activities of matrix metalloproteinase-9 (MMP-9), tissue plasminogen activator (tPA), and urokinase plasminogen activator (uPA) were assessed by zymography assays. GFAP-immunoreactivity indicated that KA induced reactive gliosis in both retinal astrocytes and in Muller cells. AAA alone or in combination with KA decreased GFAP and vimentin-immunoreactivity in Mller cells, but not in astrocytes. In addition AAA failed to decrease KA-mediated protease levels and apoptotic death of RGCs. In contrast, Neurostatin either alone or in combination with KA, decreased reactive gliosis in both astrocytes and Mller cells. Furthermore, Neurostatin decreased protease levels and prevented apoptotic death of RGCs. Our findings, for the first time, indicate that inhibition of reactive gliosis decreases protease levels in the retina, prevents apoptotic death of retinal neurons, and provides substantial neuroprotection.	[Ganesh, Bhagyalaxmi S.; Chintala, Shravan K.] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA	Oakland University	Ganesh, BS (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.	Chintala@oakland.edu			National Eye Institutes [EY017853-01A2]; Vision Research Infrastructure Development Grant [EY014803]; NATIONAL EYE INSTITUTE [R24EY014803, R01EY017853] Funding Source: NIH RePORTER	National Eye Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vision Research Infrastructure Development Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in part, by National Eye Institutes Project grant EY017853-01A2 (to SKC) and Vision Research Infrastructure Development Grant EY014803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Rodriguez J, 2000, J NEUROCHEM, V74, P2547, DOI 10.1046/j.1471-4159.2000.0742547.x; Anderson D R, 1967, Trans Am Ophthalmol Soc, V65, P275; BELLIVEAU DJ, 1994, GLIA, V12, P24, DOI 10.1002/glia.440120104; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; HEFTI F, 1985, J NEUROSCI, V5, P2086; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; ISHIKAWA Y, 1983, JPN J OPHTHALMOL, V27, P107; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; Kumada M, 2004, TOXICOL APPL PHARM, V200, P48, DOI 10.1016/j.taap.2004.03.017; Mali RS, 2005, FASEB J, V19, P1280, DOI 10.1096/fj.04-3403com; MILLER RH, 1989, EUR J NEUROSCI, V1, P172, DOI 10.1111/j.1460-9568.1989.tb00785.x; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nakazawa T, 2006, MOL VIS, V12, P867; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Prasanna G, 2002, INVEST OPHTH VIS SCI, V43, P2704; RADANY EH, 1992, P NATL ACAD SCI USA, V89, P6467, DOI 10.1073/pnas.89.14.6467; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang X, 2004, NEUROSCI LETT, V356, P140, DOI 10.1016/j.neulet.2003.10.084; Zhang X, 2003, MOL VIS, V9, P238	33	63	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18305	10.1371/journal.pone.0018305	http://dx.doi.org/10.1371/journal.pone.0018305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483783	gold, Green Published, Green Submitted			2022-12-25	WOS:000289057200055
J	Haefeli, RH; Erb, M; Gemperli, AC; Robay, D; Fruh, IC; Anklin, C; Dallmann, R; Gueven, N				Haefeli, Roman H.; Erb, Michael; Gemperli, Anja C.; Robay, Dimitri; Fruh, Isabelle Courdier; Anklin, Corinne; Dallmann, Robert; Gueven, Nuri			NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels	PLOS ONE			English	Article							NAD(P)H QUINONE OXIDOREDUCTASE; BRAIN MITOCHONDRIA; LIPID-PEROXIDATION; FRIEDREICH ATAXIA; DT-DIAPHORASE; COENZYME-Q; RESPIRATORY-CHAIN; INHIBITION; CYTOTOXICITY; ANTIOXIDANT	Short-chain quinones are described as potent antioxidants and in the case of idebenone have already been under clinical investigation for the treatment of neuromuscular disorders. Due to their analogy to coenzyme Q(10) (CoQ(10)), a long-chain quinone, they are widely regarded as a substitute for CoQ(10). However, apart from their antioxidant function, this provides no clear rationale for their use in disorders with normal CoQ(10) levels. Using recombinant NAD(P)H:quinone oxidoreductase (NQO) enzymes, we observed that contrary to CoQ(10) short-chain quinones such as idebenone are good substrates for both NQO1 and NQO2. Furthermore, the reduction of short-chain quinones by NQOs enabled an antimycin A-sensitive transfer of electrons from cytosolic NAD(P) H to the mitochondrial respiratory chain in both human hepatoma cells (HepG2) and freshly isolated mouse hepatocytes. Consistent with the substrate selectivity of NQOs, both idebenone and CoQ(1), but not CoQ(10), partially restored cellular ATP levels under conditions of impaired complex I function. The observed cytosolic-mitochondrial shuttling of idebenone and CoQ(1) was also associated with reduced lactate production by cybrid cells from mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) patients. Thus, the observed activities separate the effectiveness of short-chain quinones from the related long-chain CoQ(10) and provide the rationale for the use of short-chain quinones such as idebenone for the treatment of mitochondrial disorders.	[Haefeli, Roman H.; Erb, Michael; Robay, Dimitri; Anklin, Corinne; Gueven, Nuri] Santhera Pharmaceut, Liestal, Switzerland; [Haefeli, Roman H.] Univ Basel, Biozentrum, Basel, Switzerland; [Gemperli, Anja C.] Inst Straumann AG, Basel, Switzerland; [Fruh, Isabelle Courdier] Novartis Pharma AG, Basel, Switzerland; [Dallmann, Robert] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Basel; Institut Straumann AG; Novartis; University of Zurich	Haefeli, RH (corresponding author), Santhera Pharmaceut, Liestal, Switzerland.	nuri.gueven@santhera.com	Dallmann, Bob/AAA-4929-2022	Dallmann, Robert/0000-0002-7490-0218; Guven, Nuri/0000-0003-3782-767X	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd.	Santhera Pharmaceuticals (Switzerland) Ltd. (www.santhera.com) funded and approved the publication of this work.	Adikesavan AK, 2007, CANCER RES, V67, P7966, DOI 10.1158/0008-5472.CAN-06-4480; Audi SH, 2003, FREE RADICAL BIO MED, V34, P892, DOI 10.1016/S0891-5849(03)00025-X; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; Boutin JA, 2005, CHEM-BIOL INTERACT, V151, P213, DOI 10.1016/j.cbi.2005.01.002; Briere JJ, 2004, BIOCHEM BIOPH RES CO, V316, P1138, DOI 10.1016/j.bbrc.2004.03.002; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; Chapela SP, 2008, CELL BIOL INT, V32, P146, DOI 10.1016/j.cellbi.2007.08.003; CIVENNI G, 2009, EUR J PHARMACOL, V370, P161; Colucci MA, 2008, ORG BIOMOL CHEM, V6, P637, DOI 10.1039/b715270a; Degli Esposti Mauro, 1996, Archives of Biochemistry and Biophysics, V330, P395; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dragan M, 2006, BRAIN RES, V1078, P9, DOI 10.1016/j.brainres.2006.01.068; ERNSTER L, 1962, BIOCHIM BIOPHYS ACTA, V58, P171, DOI 10.1016/0006-3002(62)90997-6; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; FATO R, 2008, BIOCHIM BIOPHYS ACTA, V1787, P384; GASDASKA PY, 1995, CANCER RES, V55, P2542; Haginoya K, 2009, J NEUROL SCI, V278, P112, DOI 10.1016/j.jns.2008.11.008; HOUCHI H, 1991, JPN J PHARMACOL, V57, P553, DOI 10.1254/jjp.57.553; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Knox RJ, 2000, CANCER RES, V60, P4179; Kutz K, 2009, J NEUROL, V256, P31, DOI 10.1007/s00415-009-1006-z; Lenaz G, 2001, FEBS LETT, V509, P151, DOI 10.1016/S0014-5793(01)03172-6; Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Myers L, 2008, J NEUROL SCI, V267, P174, DOI 10.1016/j.jns.2007.10.008; Napolitano A, 2000, NEUROL SCI, V21, pS981, DOI 10.1007/s100720070015; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; OKAMOTO K, 1998, CHEM PHARM BULL, V36, P178; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Paolino D, 2004, J PHARM SCI-US, V93, P1815, DOI 10.1002/jps.20088; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Rauchova H, 2008, J BIOENERG BIOMEMBR, V40, P85, DOI 10.1007/s10863-008-9134-1; Rauchova H, 2006, BIOCHEM BIOPH RES CO, V339, P362, DOI 10.1016/j.bbrc.2005.11.035; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; SUGIYAMA Y, 1985, J PHARMACOBIO-DYNAM, V8, P1006; SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5; SUNO M, 1989, ARCH GERONTOL GERIAT, V8, P291, DOI 10.1016/0167-4943(89)90010-1; Takuma K, 2000, EUR J PHARMACOL, V406, P333, DOI 10.1016/S0014-2999(00)00701-9; Tan AS, 2010, FREE RADICAL BIO MED, V48, P421, DOI 10.1016/j.freeradbiomed.2009.11.016; Tonon C, 2008, EXPERT OPIN PHARMACO, V9, P2327, DOI 10.1517/14656566.9.13.2327 ; Villalba JM, 2010, EXPERT OPIN INV DRUG, V19, P535, DOI 10.1517/13543781003727495; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344	49	122	127	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17963	10.1371/journal.pone.0017963	http://dx.doi.org/10.1371/journal.pone.0017963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483849	Green Accepted, gold, Green Published			2022-12-25	WOS:000289057200014
J	Thompson, JD; Linard, B; Lecompte, O; Poch, O				Thompson, Julie D.; Linard, Benjamin; Lecompte, Odile; Poch, Olivier			A Comprehensive Benchmark Study of Multiple Sequence Alignment Methods: Current Challenges and Future Perspectives	PLOS ONE			English	Article							DISTANTLY RELATED PROTEINS; FUNCTIONAL SPECIFICITY; PHYLOGENETIC TREES; DATABASE SEARCHES; HIGH-THROUGHPUT; T-COFFEE; ACCURACY; INFORMATION; PROGRAMS; IDENTIFICATION	Multiple comparison or alignment of protein sequences has become a fundamental tool in many different domains in modern molecular biology, from evolutionary studies to prediction of 2D/3D structure, molecular function and intermolecular interactions etc. By placing the sequence in the framework of the overall family, multiple alignments can be used to identify conserved features and to highlight differences or specificities. In this paper, we describe a comprehensive evaluation of many of the most popular methods for multiple sequence alignment (MSA), based on a new benchmark test set. The benchmark is designed to represent typical problems encountered when aligning the large protein sequence sets that result from today's high throughput biotechnologies. We show that alignment methods have significantly progressed and can now identify most of the shared sequence features that determine the broad molecular function(s) of a protein family, even for divergent sequences. However, we have identified a number of important challenges. First, the locally conserved regions, that reflect functional specificities or that modulate a protein's function in a given cellular context, are less well aligned. Second, motifs in natively disordered regions are often misaligned. Third, the badly predicted or fragmentary protein sequences, which make up a large proportion of today's databases, lead to a significant number of alignment errors. Based on this study, we demonstrate that the existing MSA methods can be exploited in combination to improve alignment accuracy, although novel approaches will still be needed to fully explore the most difficult regions. We then propose knowledge-enabled, dynamic solutions that will hopefully pave the way to enhanced alignment construction and exploitation in future evolutionary systems biology studies.	[Thompson, Julie D.; Linard, Benjamin; Lecompte, Odile; Poch, Olivier] Univ Strasbourg, CNRS, INSERM, Dept Biol Struct & Genom,IGBMC, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Thompson, JD (corresponding author), Univ Strasbourg, CNRS, INSERM, Dept Biol Struct & Genom,IGBMC, Illkirch Graffenstaden, France.	julie@igbmc.fr	Lecompte, Odile/F-4741-2011; linard, benjamin/B-7985-2014; Thompson, Julie D/F-3208-2010; Lecompte, Odile/N-7992-2019	Lecompte, Odile/0000-0002-2005-460X; Lecompte, Odile/0000-0002-2005-460X; Linard, Benjamin/0000-0002-5555-898X	Agence Nationale de la Recherche [EvolHHuPro: BLAN07-1-198915]; Association Francaise contre les Myopathies [DDC/KBM: 14390]; IGBMC; CNRS; INSERM; Universite de Strasbourg	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); IGBMC; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg	This work was funded by the Agence Nationale de la Recherche (EvolHHuPro: BLAN07-1-198915) project, the Association Francaise contre les Myopathies (DDC/KBM: 14390) project and Institute funds from the IGBMC, CNRS, INSERM, and the Universite de Strasbourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Aniba MR, 2010, NUCLEIC ACIDS RES, V38, P7353, DOI 10.1093/nar/gkq625; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Bianchetti Laurent, 2005, Journal of Bioinformatics and Computational Biology, V3, P929, DOI 10.1142/S0219720005001326; Blackshields Gordon, 2006, In Silico Biol, V6, P321; Brandt BW, 2010, NUCLEIC ACIDS RES, V38, pW35, DOI 10.1093/nar/gkq415; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Chakrabarti S, 2006, NUCLEIC ACIDS RES, V34, P2598, DOI 10.1093/nar/gkl274; Chica C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-229; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eaton MJ, 2009, MOL PHYLOGENET EVOL, V50, P496, DOI 10.1016/j.ympev.2008.11.009; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GUIGO R, 2006, GENOME BIOL S1, V7, pNIL4; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Keller O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-278; Koh YS., 2009, RARE ASS RULE MINING; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Krause L, 2006, BIOINFORMATICS, V22, pE281, DOI 10.1093/bioinformatics/btl247; Kuipers RK, 2010, PROTEINS, V78, P2101, DOI 10.1002/prot.22725; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Levasseur A, 2008, EVOL BIOINFORM, V4, P121; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Notredame C, 1996, NUCLEIC ACIDS RES, V24, P1515, DOI 10.1093/nar/24.8.1515; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Plewniak F, 2000, BIOINFORMATICS, V16, P750, DOI 10.1093/bioinformatics/16.9.750; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Raghava GPS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-47; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh S, 2009, HUM GENET, V125, P95, DOI 10.1007/s00439-008-0599-0; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Taylor WR, 2000, METH MOL B, V143, P19; Thompson JD, 1999, BIOINFORMATICS, V15, P87, DOI 10.1093/bioinformatics/15.1.87; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Thompson JD, 2005, NUCLEIC ACIDS RES, V33, P4164, DOI 10.1093/nar/gki735; Thompson JD, 2004, NUCLEIC ACIDS RES, V32, P1298, DOI 10.1093/nar/gkh294; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Thompson JD, 2001, J MOL BIOL, V314, P937, DOI 10.1006/jmbi.2001.5187; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson JD, 2000, NUCLEIC ACIDS RES, V28, P2919, DOI 10.1093/nar/28.15.2919; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Thompson JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-318; *UNIPROT CONS, 2009, NUCL ACIDS IN PRESS; VINGRON M, 1993, P NATL ACAD SCI USA, V90, P8777, DOI 10.1073/pnas.90.19.8777; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Wong WC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000867; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347	71	134	134	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18093	10.1371/journal.pone.0018093	http://dx.doi.org/10.1371/journal.pone.0018093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483869	gold, Green Published, Green Submitted			2022-12-25	WOS:000289057200027
J	Chu, T; Lingelbach, K; Przyborski, JM				Trang Chu; Lingelbach, Klaus; Przyborski, Jude M.			Genetic Evidence Strongly Support an Essential Role for PfPV1 in Intra-Erythrocytic Growth of P. falciparum	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA PARASITES; PARASITOPHOROUS VACUOLE; INFECTED ERYTHROCYTES; PROTEINS; VIRULENCE; TRANSFECTION; PROTEASES; REVEALS; SIGNAL	Upon invading the host erythrocyte, the human malaria parasite P. falciparum lives and replicates within a membrane bound compartment referred to as the parasitophorous vacuole. Recently, interest in this compartment and its protein content has grown, due to the important roles these play in parasite egress and protein traffic to the host cell. Surprisingly, the function of many proteins within this compartment has not been experimentally addressed. Here, we study the importance of one of these proteins, termed PfPV1, for intra-erythrocytic parasite survival. Despite numerous attempts to inactivate the gene encoding PfPV1, we were unable to recover deletion mutants. Control experiments verified that the pv1 gene locus was per se open for gene targeting experiments, allowing us to exclude technical limitations in our experimental strategy. Our data provide strong genetic evidence that PfPV1 is essential for survival of blood stage P. falciparum, and further highlight the importance of parasitophorous vacuole proteins in this part of the parasite's life cycle.	[Trang Chu; Lingelbach, Klaus; Przyborski, Jude M.] Univ Marburg, Dept Parasitol, Fac Biol, Marburg, Germany	Philipps University Marburg	Chu, T (corresponding author), Univ Marburg, Dept Parasitol, Fac Biol, Marburg, Germany.	przybors@staff.uni-marburg.de	Przyborski, Jude/ABC-9498-2021	Przyborski, Jude/0000-0002-3494-7767	SFB [SFB 593]; International Max Planck Research School (IMPRS)	SFB(Austrian Science Fund (FWF)); International Max Planck Research School (IMPRS)	K.L. and T.C. are supported by the SFB 593. T. C was the recipient of a Doctoral Scholarship of the International Max Planck Research School (IMPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Cowman A F, 1984, Mol Biol Med, V2, P207; Crabb BS, 2004, METH MOL B, V270, P263; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; GUNTHER K, 1991, MOL BIOCHEM PARASIT, V46, P149, DOI 10.1016/0166-6851(91)90208-N; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; Lingelbach K, 1998, J CELL SCI, V111, P1467; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Nyalwidhe J, 2006, PROTEOMICS, V6, P1563, DOI 10.1002/pmic.200500379; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; RAGGE K, 1990, MOL BIOCHEM PARASIT, V42, P93, DOI 10.1016/0166-6851(90)90116-4; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840	21	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18396	10.1371/journal.pone.0018396	http://dx.doi.org/10.1371/journal.pone.0018396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483790	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200068
J	Wu, ZQ; Li, YZ; Li, XL; Ti, DD; Zhao, YL; Si, YL; Mei, QA; Zhao, P; Fu, XB; Han, WD				Wu, Zhiqiang; Li, Yazhuo; Li, Xiaolei; Ti, Dongdong; Zhao, Yali; Si, Yiling; Mei, Qian; Zhao, Po; Fu, Xiaobing; Han, Weidong			LRP16 Integrates into NF-kappa B Transcriptional Complex and Is Required for Its Functional Activation	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DEPENDENT GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; BREAST-CANCER; CLINICOPATHOLOGICAL SIGNIFICANCE; GASTRIC-CARCINOMA; ANDROGEN RECEPTOR; PROGNOSTIC VALUE; PROSTATE-CANCER; MACRO DOMAIN	Background: Nuclear factor kappa B (NF-kappa B)-mediated pathways have been widely implicated in cell survival, development and tumor progression. Although the molecular events of determining NF-kappa B translocation from cytoplasm to nucleus have been extensively documented, the regulatory mechanisms of NF-kappa B activity inside the nucleus are still poorly understood. Being a special member of macro domain proteins, LRP16 was previously identified as a coactivator of both estrogen receptor and androgen receptor, and as an interactor of NF-kappa B coactivator UXT. Here, we investigated the regulatory role of LRP16 on NF-kappa B activation. Methodology: GST pull-down and coimmunoprecipitation (CoIP) assays assessed protein-protein interactions. The functional activity of NF-kappa B was assessed by luciferase assays, changes in expression of its target genes, and its DNA binding ability. Annexin V staining and flow cytometry analysis were used to evaluate cell apoptosis. Immunohistochemical staining of LRP16 and enzyme-linked immunosorbent assay-based evaluation of active NF-kappa B were performed on primary human gastric carcinoma samples. Results: We demonstrate that LRP16 integrates into NF-kappa B transcriptional complex through associating with its p65 component. RNA interference knockdown of the endogenous LRP16 in cells leads to impaired NF-kappa B activity and significantly attenuated NF-kappa B-dependent gene expression. Mechanistic analysis revealed that knockdown of LRP16 did not affect tumor necrosis factor a (TNF-alpha)-induced nuclear translocation of NF-kappa B, but blunted the formation or stabilization of functional NF-kappa B/p300/CREB-binding protein transcription complex in the nucleus. In addition, knockdown of LRP16 also sensitizes cells to apoptosis induced by TNF-alpha. Finally, a positive link between LRP16 expression intensity in nuclei of tumor cells and NF-kappa B activity was preliminarily established in human gastric carcinoma specimens. Conclusions: Our findings not only indicate that LRP16 is a crucial regulator for NF-kappa B activation inside the nucleus, but also suggest that LRP16 may be an important contributor to the aberrant activation of NF-kappa B in tumors.	[Wu, Zhiqiang; Li, Xiaolei; Ti, Dongdong; Zhao, Yali; Si, Yiling; Mei, Qian; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Dept Mol Biol, Inst Basic Med, Beijing, Peoples R China; [Li, Yazhuo; Zhao, Po] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Wu, ZQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Mol Biol, Inst Basic Med, Beijing, Peoples R China.	hanwdrsw69@yahoo.com	li, Xiaolei/V-1383-2019	li, Xiaolei/0000-0002-2697-6496	National Natural Science Foundation of China [81071617, 81001184, 81072109]; Ministry of Science and Technology of China [2010CB912802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work is supported by the grants from the National Natural Science Foundation of China (website is http://www.nsfc.gov.cn/Portal0/default124.htm) (No. 81071617, 81001184 and 81072109) and is partially supported by the grant from the Ministry of Science and Technology of China (the website is http://www.most.gov.cn/) (No. 2010CB912802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Allen MD, 2003, J MOL BIOL, V330, P503, DOI 10.1016/S0022-2836(03)00473-X; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Han WD, 2007, ENDOCR-RELAT CANCER, V14, P741, DOI 10.1677/ERC-06-0082; Han WD, 2003, ENDOCR-RELAT CANCER, V10, P217, DOI 10.1677/erc.0.0100217; Han WD, 2008, J STEROID BIOCHEM, V109, P47, DOI 10.1016/j.jsbmb.2007.12.009; Han WD, 2009, NUCLEIC ACIDS RES, V37, P3996, DOI 10.1093/nar/gkp332; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Isaacs W, 2002, CANCER CELL, V2, P113, DOI 10.1016/S1535-6108(02)00103-4; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li YZ, 2009, WORLD J GASTROENTERO, V15, P4833, DOI 10.3748/wjg.15.4833; Meng YG, 2007, CELL RES, V17, P869, DOI 10.1038/cr.2007.79; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; O'Malley BW, 2008, CURR OPIN CELL BIOL, V20, P310, DOI 10.1016/j.ceb.2008.04.005; PEHRSON JR, 1992, SCIENCE, V257, P1398; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tian LY, 2009, J ENDOCRINOL, V202, P167, DOI 10.1677/JOE-09-0054; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xi HQ, 2010, WORLD J GASTROENTERO, V16, P1644, DOI 10.3748/wjg.v16.i13.1644; Yamanaka N, 2004, ANTICANCER RES, V24, P1071; Yang J, 2009, ENDOCR-RELAT CANCER, V16, P139, DOI 10.1677/ERC-08-0150; Zhao P, 2010, CANCER SCI, V101, P2262, DOI 10.1111/j.1349-7006.2010.01658.x; Zhao YL, 2005, J MOL ENDOCRINOL, V34, P77, DOI 10.1677/jme.1.01628; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	53	31	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18157	10.1371/journal.pone.0018157	http://dx.doi.org/10.1371/journal.pone.0018157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483817	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200034
J	Davis, CJ; Bowers, JS; Memon, A				Davis, Colin J.; Bowers, Jeffrey S.; Memon, Amina			Social Influence in Televised Election Debates: A Potential Distortion of Democracy	PLOS ONE			English	Article							CAMPAIGN; SUSCEPTIBILITY; IMPACT	A recent innovation in televised election debates is a continuous response measure (commonly referred to as the "worm") that allows viewers to track the response of a sample of undecided voters in real-time. A potential danger of presenting such data is that it may prevent people from making independent evaluations. We report an experiment with 150 participants in which we manipulated the worm and superimposed it on a live broadcast of a UK election debate. The majority of viewers were unaware that the worm had been manipulated, and yet we were able to influence their perception of who won the debate, their choice of preferred prime minister, and their voting intentions. We argue that there is an urgent need to reconsider the simultaneous broadcast of average response data with televised election debates.	[Davis, Colin J.; Memon, Amina] Royal Holloway Univ London, Dept Psychol, London, England; [Bowers, Jeffrey S.] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England	University of London; Royal Holloway University London; University of Bristol	Davis, CJ (corresponding author), Royal Holloway Univ London, Dept Psychol, London, England.	c.davis@rhul.ac.uk		Bowers, Jeffrey/0000-0001-9558-5010; Davis, Colin/0000-0001-5814-5104				ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Benoit WL, 2002, J COMMUN, V52, P316, DOI 10.1111/j.1460-2466.2002.tb02547.x; Berger J, 2008, P NATL ACAD SCI USA, V105, P8846, DOI 10.1073/pnas.0711988105; Blais A, 1999, CAN PUBLIC POL, V25, P197, DOI 10.2307/3551888; Blais A, 1996, BRIT J POLIT SCI, V26, P143, DOI 10.1017/S0007123400000405; CHAKRABARTI R, 2010, TV ELECTION DEBATES; COOKE D, 2007, AGE             1022; DAVIES D, 2008, DONT SCRAP SQUIGGLE; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; DIVESTA FJ, 1959, J ABNORM SOC PSYCH, V59, P204, DOI 10.1037/h0042945; Fein S, 2007, POLIT PSYCHOL, V28, P165, DOI 10.1111/j.1467-9221.2007.00561.x; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FINKEL SE, 1995, BRIT J POLIT SCI, V25, P349, DOI 10.1017/S0007123400007249; Fournier P, 2004, ELECT STUD, V23, P661, DOI 10.1016/j.electstud.2003.09.001; Gabbert F, 2003, APPL COGNITIVE PSYCH, V17, P533, DOI 10.1002/acp.885; Hoffman HG, 2001, MEM COGNITION, V29, P394, DOI 10.3758/BF03196390; KROSNICK JA, 1994, POLIT COMMUN, V11, P391, DOI 10.1080/10584609.1994.9963047; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NOSANCHUK TA, 1974, J PERS SOC PSYCHOL, V29, P153, DOI 10.1037/h0035737; PENNY T, 2010, BUSINESS WEEK   0430; Petty R.E., 1986, ADV EXP SOC PSYCHOL, V19, P123, DOI [DOI 10.1086/AHR/88.3.760, 10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2]; SCHILL KR, 2009, REAL TIME RESPONSE M, P155; SCHROTT PR, 1990, PUBLIC OPIN QUART, V54, P567, DOI 10.1086/269228; Philip S, 2008, AUST J POLIT SCI, V43, P443, DOI 10.1080/10361140802267241; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Tormala ZL, 2002, J PERS SOC PSYCHOL, V83, P1298, DOI 10.1037//0022-3514.83.6.1298; Weaver JB, 2009, COMPUT HUM BEHAV, V25, P50, DOI 10.1016/j.chb.2008.06.004; Yawn M, 1998, POLIT BEHAV, V20, P155, DOI 10.1023/A:1024832830083; 1992, SUN             0411	30	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18154	10.1371/journal.pone.0018154	http://dx.doi.org/10.1371/journal.pone.0018154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479191	Green Published, gold			2022-12-25	WOS:000289055700034
J	Yin, A; Korzh, S; Winata, CL; Korzh, V; Gong, ZY				Yin, Ao; Korzh, Svitlana; Winata, Cecilia L.; Korzh, Vladimir; Gong, Zhiyuan			Wnt Signaling Is Required for Early Development of Zebrafish Swimbladder	PLOS ONE			English	Article							LUNG MORPHOGENESIS; BETA-CATENIN; SWIM BLADDER; DANIO-RERIO; EXPRESSION; GENE; HEDGEHOG; SPECIFICATION; PATHWAY; ROLES	Background: Wnt signaling plays critical roles in mammalian lung development. However, Wnt signaling in the development of the zebrafish swimbladder, which is considered as a counterpart of mammalian lungs, have not been explored. To investigate the potential conservation of signaling events in early development of the lung and swimbladder, we wish to address the question whether Wnt signaling plays a role in swimbladder development. Methodology/Principal Findings: For analysis of zebrafish swimbladder development, we first identified, by whole-mount in situ hybridization (WISH), has2 as a mesenchymal marker, sox2 as the earliest epithelial marker, as well as hprt1l and elovl1a as the earliest mesothelial markers. We also demonstrated that genes encoding Wnt signaling members Wnt5b, Fz2, Fz7b, Lef1, Tcf3 were expressed in different layers of swimbladder. Then we utilized the heat-shock inducible transgenic lines hs: Dkk1-GFP and hs: Delta Tcf-GFP to temporarily block canonical Wnt signaling. Inhibition of canonical Wnt signaling at various time points disturbed precursor cells specification, organization, anterioposterior patterning, and smooth muscle differentiation in all three tissue layers of swimbladder. These observations were also confirmed by using a chemical inhibitor (IWR-1) of Wnt signaling. In addition, we found that Hedgehog (Hh) signaling was activated by canonical Wnt signaling and imposed a negative feedback on the latter. Significance/Conclusion: We first provided a new set of gene markers for the three tissue layers of swimbladder in zebrafish and demonstrated the expression of several key genes of Wnt signaling pathway in developing swimbladder. Our functional analysis data indicated that Wnt/beta-catenin signaling is required for swimbladder early development and we also provided evidence for the crosstalk between Wnt and Hh signaling in early swimbladder development.	[Yin, Ao; Korzh, Svitlana; Winata, Cecilia L.; Korzh, Vladimir; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Korzh, Vladimir] Natl Univ Singapore, Inst Mol & Cell Biol, Lab Fish Dev Biol, Genes & Dev Div, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Yin, A (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	vlad@imcb.a-star.edu.sg; dbsgzy@nus.edu.sg	Korzh, Vladimir P/H-1596-2011; Gong, Zhiyuan/H-8794-2012	Korzh, Vladimir P/0000-0002-6580-7986; Gong, Zhiyuan/0000-0002-9660-5260; winata, cecilia/0000-0002-7718-5248	Ministry of Education of Singapore; Agency for Science, Technology and Research of Singapore	Ministry of Education of Singapore(Ministry of Education, Singapore); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by the Ministry of Education of Singapore. VK's lab in the IMCB was supported by the grant from the Agency for Science, Technology and Research of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Alexa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008261; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Burke ZD, 2006, CURR BIOL, V16, pR688, DOI 10.1016/j.cub.2006.08.011; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; Farber SA, 2003, GENOME RES, V13, P1082, DOI 10.1101/gr.479603; Finney JL, 2006, J COMP NEUROL, V495, P587, DOI 10.1002/cne.20948; Georgijevic S, 2007, DEV DYNAM, V236, P1623, DOI 10.1002/dvdy.21165; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003736; Jia LW, 2008, CELL BIOL INT, V32, P807, DOI 10.1016/j.cellbi.2008.03.011; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li YH, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011014, 10.1371/journal.pone.0015219]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Muller II, 2006, DEV DYNAM, V235, P2881, DOI 10.1002/dvdy.20925; Perry SF, 2001, COMP BIOCHEM PHYS A, V129, P37, DOI 10.1016/S1095-6433(01)00304-X; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Reiter JF, 2001, DEVELOPMENT, V128, P125; Roy S, 2001, CURR BIOL, V11, P1358, DOI 10.1016/S0960-9822(01)00402-X; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Teoh PH, 2010, DEV DYNAM, V239, P865, DOI 10.1002/dvdy.22221; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Yin A, 2010, GENE EXPR PATTERNS, V10, P338, DOI 10.1016/j.gep.2010.07.005; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009	41	57	60	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18431	10.1371/journal.pone.0018431	http://dx.doi.org/10.1371/journal.pone.0018431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479192	gold, Green Submitted, Green Published			2022-12-25	WOS:000289055700057
J	Locatelli, A; Lange, CA				Locatelli, Alessia; Lange, Carol A.			Met Receptors Induce Sam68-dependent Cell Migration by Activation of Alternate Extracellular Signal-regulated Kinase Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; BINDING PROTEIN SAM68; FACTOR SCATTER FACTOR; MAMMALIAN MAP KINASE; BREAST-TUMOR KINASE; CHRONIC LEG ULCERS; RNA-BINDING; C-MET; ADAPTER PROTEIN; CANCER CELLS	The hepatocyte growth factor (HGF)/Met receptor signaling pathway is deregulated in diverse human malignancies and plays a central role in oncogenesis, tumor progression, and invasive cancer growth. Similarly, altered expression and splicing (i.e. inclusion of variant exon 5, "v5") of the cell adhesion marker, CD44, is associated with advanced cancer phenotypes. We sought to further understand how HGF regulates CD44v5 expression. Immortalized nontumorigenic keratinocyte (HaCaT) cells abundantly express both Met receptors and CD44v5 transmembrane glycoproteins. HGF stimulated CD44v5 protein expression and HaCaT cell migration; these events required activation of the ERK1/2 MAPK module and Sam68, a protein involved in RNA processing, splicing, and v5 inclusion. Similar to HaCaT cells, highly migratory MDA-MB-231 breast cancer cells also required Sam68 expression for HGF-induced migration. However, MDA-MB-231 cell migration occurred independently of ERK1/2 and CD44v5 expression and instead required ERK5 signaling to Sam68. Phospho-mutant, but not WT-Sam68, blocked HGF-induced cell migration in both cell types; MDA-MB-435 cells behaved similarly. These results suggest that Sam68 acts as a convergence point for ERK signaling to cell migration; blockade of phospho-Sam68 may provide a new avenue for therapeutic inhibition of metastatic cancers.	[Lange, Carol A.] Univ Minnesota, Masonic Canc Ctr, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; Univ Minnesota, Masonic Canc Ctr, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lange, CA (corresponding author), Univ Minnesota, Masonic Canc Ctr, Dept Med, Div Hematol Oncol & Transplantat, 420 Delaware St SE,MMC 806, Minneapolis, MN 55455 USA.	lange047@umn.edu		Lange, Carol/0000-0003-2751-3976	National Institutes of Health from NCI [CA107547]; American Cancer Society [RSG TBE-107800]; NATIONAL CANCER INSTITUTE [R01CA107547] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107547 from NCI (to C. A. L.). This work was also supported by American Cancer Society RSG TBE-107800 (to C. A. L.).	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Borland G, 1998, IMMUNOLOGY, V93, P139; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Gunthert U, 1993, Curr Top Microbiol Immunol, V184, P47; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hong W, 2002, MOL CANCER RES, V1, P48; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Huot ME, 2009, J BIOL CHEM, V284, P31903, DOI 10.1074/jbc.M109.018465; Huot ME, 2009, MOL CELL BIOL, V29, P1933, DOI 10.1128/MCB.01707-08; Jabado N, 1998, J IMMUNOL, V161, P2798; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Jiang WG, 1997, HISTOL HISTOPATHOL, V12, P537; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Konig H, 1996, EMBO J, V15, P4030, DOI 10.1002/j.1460-2075.1996.tb00776.x; Lawe DC, 1997, ONCOGENE, V14, P223, DOI 10.1038/sj.onc.1200821; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu K, 2000, J BIOL CHEM, V275, P40195, DOI 10.1074/jbc.M006194200; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Nayeri F, 2005, J DERMATOL SCI, V37, P75, DOI 10.1016/j.jdermsci.2004.11.002; Nayeri F, 2002, J DERMATOL TREAT, V13, P81, DOI 10.1080/095466302317584449; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; NUSRAT A, 1994, J CLIN INVEST, V93, P2056, DOI 10.1172/JCI117200; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Paronetto MP, 2003, ONCOGENE, V22, P8707, DOI 10.1038/sj.onc.1207016; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Richard S, 2008, ONCOGENE, V27, P548, DOI 10.1038/sj.onc.1210652; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; RUSSELL WE, 1984, J CELL PHYSIOL, V119, P183, DOI 10.1002/jcp.1041190207; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Wu ST, 2003, J FORMOS MED ASSOC, V102, P229; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	63	19	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21062	21072		10.1074/jbc.M110.211409	http://dx.doi.org/10.1074/jbc.M110.211409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21489997	Green Published, hybrid			2022-12-25	WOS:000291464700005
J	Narula, G; Annamalai, T; Aedo, S; Cheng, B; Sorokin, E; Wong, A; Tse-Dinh, YC				Narula, Gagandeep; Annamalai, Thirunavukkarasu; Aedo, Sandra; Cheng, Bokun; Sorokin, Elena; Wong, Agnes; Tse-Dinh, Yuk-Ching			The Strictly Conserved Arg-321 Residue in the Active Site of Escherichia coli Topoisomerase I Plays a Critical Role in DNA Rejoining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DIVALENT METAL-IONS; BACTERIAL; CLEAVAGE; COMPLEX; BINDING; PROTEIN; IDENTIFICATION; PURIFICATION; INHIBITION	The strictly conserved arginine residue proximal to the active site tyrosine of type IA topoisomerases is required for the relaxation of supercoiled DNA and was hypothesized to be required for positioning of the scissile phosphate for DNA cleavage to take place. Mutants of recombinant Yersinia pestis topoisomerase I with hydrophobic substitutions at this position were found in genetic screening to exhibit a dominant lethal phenotype, resulting in drastic loss in Escherichia coli viability when over-expressed. In depth biochemical analysis of E. coli topoisomerase I with the corresponding Arg-321 mutation showed that DNA cleavage can still take place in the absence of this arginine function if Mg2+ is present to enhance the interaction of the enzyme with the scissile phosphate. However, DNA rejoining is inhibited in the absence of this conserved arginine, resulting in accumulation of the cleaved covalent intermediate and loss of relaxation activity. These new experimental results demonstrate that catalysis of DNA rejoining by type IA topoisomerases has a more stringent requirement than DNA cleavage. In addition to the divalent metal ions, the side chain of this arginine residue is required for the precise positioning of the phosphotyrosine linkage for nucleophilic attack by the 3'-OH end to result in DNA rejoining. Small molecules that can interfere or distort the enzyme-DNA interactions required for DNA rejoining by bacterial type IA topoisomerases could be developed into novel antibacterial drugs.	[Narula, Gagandeep; Annamalai, Thirunavukkarasu; Aedo, Sandra; Cheng, Bokun; Sorokin, Elena; Wong, Agnes; Tse-Dinh, Yuk-Ching] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	New York Medical College	Tse-Dinh, YC (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	yuk-ching_tse-dinh@nymc.edu			National Institutes of Health [R01 GM054226, AI069313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM054226 and AI069313.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Bradbury BJ, 2008, CURR OPIN PHARMACOL, V8, P574, DOI 10.1016/j.coph.2008.04.009; Caron PR, 1999, METH MOL B, V94, P279; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Chen SJ, 1998, J BIOL CHEM, V273, P6050, DOI 10.1074/jbc.273.11.6050; Cheng B, 2005, J BIOL CHEM, V280, P38489, DOI 10.1074/jbc.M509722200; Cheng B, 2008, NUCLEIC ACIDS RES, V36, P1017, DOI 10.1093/nar/gkm1126; Cheng BK, 2009, J MOL BIOL, V385, P558, DOI 10.1016/j.jmb.2008.10.073; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DEPEW RE, 1978, J BIOL CHEM, V253, P511; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P1862, DOI 10.1021/bi8023256; Doyle SA, 2005, METH MOL B, V310, P107; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; GOTO T, 1984, J BIOL CHEM, V259, P422; HEITMAN J, 1991, GENE, V103, P1, DOI 10.1016/0378-1119(91)90383-M; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Narula G, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-41; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; PHILLIPS I, 1987, J ANTIMICROB CHEMOTH, V20, P631, DOI 10.1093/jac/20.5.631; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Sorokin EP, 2008, NUCLEIC ACIDS RES, V36, P4788, DOI 10.1093/nar/gkn460; Stern JC, 2001, BIOCHEMISTRY-US, V40, P11586, DOI 10.1021/bi010877q; Strahs D, 2006, NUCLEIC ACIDS RES, V34, P1785, DOI 10.1093/nar/gkl109; TSE YC, 1980, J BIOL CHEM, V255, P5560; Tse-Dinh YC, 1998, BBA-GENE STRUCT EXPR, V1400, P19, DOI 10.1016/S0167-4781(98)00125-0; TSEDINH YC, 1986, J BIOL CHEM, V261, P931; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 2002, J BIOL CHEM, V277, P1203, DOI 10.1074/jbc.M109436200; Zhu CX, 1999, METH MOL B, V94, P145; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1998, J BIOL CHEM, V273, P8783, DOI 10.1074/jbc.273.15.8783	40	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18673	18680		10.1074/jbc.M111.229450	http://dx.doi.org/10.1074/jbc.M111.229450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478161	Green Published, hybrid			2022-12-25	WOS:000290785700040
J	Boelte, KC; Gordy, LE; Joyce, S; Thompson, MA; Yang, L; Lin, PC				Boelte, Kimberly C.; Gordy, Laura E.; Joyce, Sebastian; Thompson, Mary Ann; Yang, Li; Lin, P. Charles			Rgs2 Mediates Pro-Angiogenic Function of Myeloid Derived Suppressor Cells in the Tumor Microenvironment via Upregulation of MCP-1	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MESSENGER-RNA; EXPRESSION; FAMILY; GENE; LOCALIZATION; LYMPHOCYTES; CHEMOTAXIS; ACTIVATION; CHEMOKINES	Background: Tumor growth is intimately linked with stromal interactions. Myeloid derived suppressor cells (MDSCs) are dramatically elevated in cancer patients and tumor bearing mice. MDSCs modulate the tumor microenvironment through attenuating host immune response and increasing vascularization. Methodology/Principal Findings: In searching for molecular mediators responsible for pro-tumor functions, we found that regulator of G protein signaling-2 (Rgs2) is highly increased in tumor-derived MDSCs compared to control MDSCs. We further demonstrate that hypoxia, a common feature associated with solid tumors, upregulates the gene expression. Genetic deletion of Rgs2 in mice resulted in a significant retardation of tumor growth, and the tumors exhibit decreased vascular density and increased cell death. Interestingly, deletion of Rgs2 in MDSCs completely abolished their tumor promoting function, suggesting that Rgs2 signaling in MDSCs is responsible for the tumor promoting function. Cytokine array profiling identified that Rgs2-/- tumor MDSCs produce less MCP-1, leading to decreased angiogenesis, which could be restored with addition of recombinant MCP-1. Conclusion: Our data reveal Rgs2 as a critical regulator of the pro-angiogenic function of MDSCs in the tumor microenvironment, through regulating MCP-1 production.	[Boelte, Kimberly C.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Gordy, Laura E.; Joyce, Sebastian] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN USA; [Thompson, Mary Ann] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Yang, Li; Lin, P. Charles] NIH, Ctr Canc Res, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Boelte, KC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA.	p.lin@nih.gov		JOYCE, Sebastian/0000-0002-3183-1451	National Institutes of Health [CA108856, NS45888, AR053718, HL054977, AI061721, AI042284, T32CA009582, T32HL069765, T32AI007611]; NATIONAL CANCER INSTITUTE [ZIABC011390, R01CA108856, T32CA009582] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054977, T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042284, T32AI007611, R01AI061721, R21AI042284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from National Institutes of Health to PCL (CA108856, NS45888 and AR053718) and SJ (HL054977, AI061721 and AI042284) as well as training grants to KCB (T32CA009582) and LEG (T32HL069765 and T32AI007611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Huang YH, 2007, BLOOD, V110, P624, DOI 10.1182/blood-2007-01-065714; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; ROLLINS BJ, 1991, BLOOD, V78, P1112; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Schwable J, 2005, BLOOD, V105, P2107, DOI 10.1182/blood-2004-03-0940; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; SIDEROVSKI DP, 1994, DNA CELL BIOL, V13, P125, DOI 10.1089/dna.1994.13.125; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Song L, 2001, BIOCHEM BIOPH RES CO, V283, P102, DOI 10.1006/bbrc.2001.4742; Song L, 2006, NEUROSCI LETT, V402, P205, DOI 10.1016/j.neulet.2006.03.023; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zmijewski JW, 2001, ARCH BIOCHEM BIOPHYS, V392, P192, DOI 10.1006/abbi.2001.2430	33	51	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18534	10.1371/journal.pone.0018534	http://dx.doi.org/10.1371/journal.pone.0018534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494556	gold, Green Submitted, Green Published			2022-12-25	WOS:000289354100019
J	Liu, ZH; Naranjo, A; Thiele, CJ				Liu, Zhihui; Naranjo, Arlene; Thiele, Carol J.			CASZ1b, the Short Isoform of CASZ1 Gene, Coexpresses with CASZ1a during Neurogenesis and Suppresses Neuroblastoma Cell Growth	PLOS ONE			English	Article							CASTOR; EXPRESSION; IDENTITY	In Drosophila, the CASZ1 (castor) gene encodes a zinc finger transcription factor and is a neural fate-determination gene. In mammals, the CASZ1 gene encodes two major isoforms, CASZ1a with 11 zinc fingers and CASZ1b with 5 zinc fingers. CASZ1b is more evolutionally conserved since it is the only homologue found in drosophila and Xenopus. Our previous study showed that full length CASZ1 (CASZ1a) functions to suppress growth in neuroblastoma tumor. However, the function of CASZ1b isoform in mammals is unknown. In this study, realtime PCR analyses indicate that mouse CASZ1b (mCASZ1b) is dynamically expressed during neurogenesis. CASZ1b and CASZ1a co-exist in all the neuronal tissues but exhibit distinct expression patterns spatially and temporally during brain development. CASZ1b and CASZ1a expression is coordinately upregulated by the differentiation agent Retinoic Acid, as well as agents that modify the epigenome in neural crest derived neuroblastoma cell lines. In contrast CASZ1b is down regulated while CASZ1a is upregulated by agents that raise intracellular cAMP levels. CASZ1b and CASZ1a have no synergistic or antagonistic activities on the regulation of their target NGFR gene transcription. Specific restoration of CASZ1b in NB cells suppresses tumor growth in vitro and in vivo. Consistent with its function role, we find that low CASZ1b expression is significantly associated with decreased survival probability of neuroblastoma patients (p<0.02). This study indicates that although their mechanisms of regulation may be distinct, both CASZ1b and CASZ1a have largely redundant but critical roles in suppressing tumor cell growth.	[Liu, Zhihui; Thiele, Carol J.] NCI, Ctr Canc Res, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Naranjo, Arlene] Univ Florida, Childrens Oncol Grp Stat, Gainesville, FL USA; [Naranjo, Arlene] Univ Florida, Ctr Data, Gainesville, FL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Children's Oncology Group (COG); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Liu, ZH (corresponding author), NCI, Ctr Canc Res, Pediat Oncol Branch, Bethesda, MD 20892 USA.	ct47a@nih.gov			National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010788] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Cancer Institute intramural program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Christinel KS, 2008, DEV CELL, V14, P616, DOI 10.1016/j.devcel.2008.01.009; COX DR, 1972, J R STAT SOC B, V34, P187; CUI X, 1992, DEVELOPMENT, V116, P943; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kusy S, 2003, MOL CELL NEUROSCI, V24, P409, DOI 10.1016/S1044-7431(03)00197-0; Lin YC, 2007, ONCOGENE, V26, P7017, DOI 10.1038/sj.onc.1210507; LIU Z, 2011, CELL DEATH DIFFER; Liu ZH, 2006, BIOCHEM BIOPH RES CO, V344, P834, DOI 10.1016/j.bbrc.2006.03.207; Lovat PE, 2002, CANCER RES, V62, P5158; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Rosenbluth JM, 2008, GENE DEV, V22, P2591, DOI 10.1101/gad.1727408; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Vacalla CMH, 2002, MECH DEVELOP, V118, P265, DOI 10.1016/S0925-4773(02)00282-4; von Hilchen CM, 2008, MECH DEVELOP, V125, P337, DOI 10.1016/j.mod.2007.10.010; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Warner LR, 2009, BRAIN RES, V1288, P1, DOI 10.1016/j.brainres.2009.06.086; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18557	10.1371/journal.pone.0018557	http://dx.doi.org/10.1371/journal.pone.0018557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490919	Green Published, Green Submitted, gold			2022-12-25	WOS:000289238700023
J	Wu, LX; Shao, LJ; An, NF; Wang, JR; Pazhanisamy, S; Feng, W; Hauer-Jensen, M; Miyamoto, S; Zhou, DH				Wu, Lixian; Shao, Lijian; An, Ningfei; Wang, Junru; Pazhanisamy, Senthil; Feng, Wei; Hauer-Jensen, Martin; Miyamoto, Shigeki; Zhou, Daohong			IKK beta Regulates the Repair of DNA Double-Strand Breaks Induced by Ionizing Radiation in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; HIGHLY SELECTIVE INHIBITOR; COLLAGEN-INDUCED ARTHRITIS; KINASE ATM; BMS-345541; THERAPY; TARGET; PHOSPHORYLATION; ACTIVATION; PATHWAYS	Activation of the IKK-NF kappa B pathway increases the resistance of cancer cells to ionizing radiation (IR). This effect has been largely attributed to the induction of anti-apoptotic proteins by NF kappa B. Since efficient repair of DNA double strand breaks (DSBs) is required for the clonogenic survival of irradiated cells, we investigated if activation of the IKK-NF kappa B pathway also regulates DSB repair to promote cell survival after IR. We found that inhibition of the IKK-NF kappa B pathway with a specific IKK beta inhibitor significantly reduced the repair of IR-induced DSBs in MCF-7 cells. The repair of DSBs was also significantly inhibited by silencing IKK beta expression with IKK beta shRNA. However, down-regulation of IKK alpha expression with IKK alpha shRNA had no significant effect on the repair of IR-induced DSBs. Similar findings were also observed in IKK alpha and/or IKK beta knockout mouse embryonic fibroblasts (MEFs). More importantly, inhibition of IKK beta with an inhibitor or down-regulation of IKK beta with IKK beta shRNA sensitized MCF-7 cells to IR-induced clonogenic cell death. DSB repair function and resistance to IR were completely restored by IKK beta reconstitution in IKK beta-knockdown MCF-7 cells. These findings demonstrate that IKK beta can regulate the repair of DSBs, a previously undescribed and important IKK beta kinase function; and inhibition of DSB repair may contribute to cance cell radiosensitization induced by IKK beta inhibition. As such, specific inhibition of IKK beta may represents a more effective approach to sensitize cancer cells to radiotherapy.	[Wu, Lixian; Shao, Lijian; Wang, Junru; Pazhanisamy, Senthil; Feng, Wei; Hauer-Jensen, Martin; Zhou, Daohong] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Wu, Lixian] Fujian Med Univ, Dept Pharmacol, Fuzhou, Peoples R China; [An, Ningfei] Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Miyamoto, Shigeki] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Arkansas System; University of Arkansas Medical Sciences; Fujian Medical University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Wisconsin System; University of Wisconsin Madison	Zhou, DH (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.	dzhou@uams.edu	PAZHANISAMY, SENTHIL KUMAR/G-4359-2012; Shao, Lijian/AAA-1074-2020		National Institutes of Health [R01CA086688, CA102558, AI080421]; Winthrop W. Rockefeller Endowment for Leukemia Research; Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE [R01CA077474, R01CA086860, R01CA102558, R01CA122023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winthrop W. Rockefeller Endowment for Leukemia Research; Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by grants from the National Institutes of Health (R01CA086688, CA102558 and AI080421), the Winthrop W. Rockefeller Endowment for Leukemia Research and the Arkansas Research Alliance Scholarship from the Arkansas Science & Technology Authority to DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2007, CURR CANCER DRUG TAR, V7, P335; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bednarski BK, 2008, MOL CANCER THER, V7, P1827, DOI 10.1158/1535-7163.MCT-08-0321; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Gillooly KM, 2009, J PHARMACOL EXP THER, V331, P349, DOI 10.1124/jpet.109.156018; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Kenneth NS, 2010, EMBO J, V29, P2966, DOI 10.1038/emboj.2010.171; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Saeki T, 2009, INT J BIOL SCI, V5, P722; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Townsend RM, 2004, TRANSPLANTATION, V77, P1090, DOI 10.1097/01.TP.0000118407.05205.05; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9	30	27	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18447	10.1371/journal.pone.0018447	http://dx.doi.org/10.1371/journal.pone.0018447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490922	gold, Green Submitted, Green Published			2022-12-25	WOS:000289238700014
J	Ni, JG; Jiang, HH; Jin, YX; Chen, NH; Wang, JH; Wang, ZB; Luo, YJ; Ma, YY; Hu, XT				Ni, Jianguang; Jiang, Huihui; Jin, Yixiang; Chen, Nanhui; Wang, Jianhong; Wang, Zhengbo; Luo, Yuejia; Ma, Yuanye; Hu, Xintian			Dissociable Modulation of Overt Visual Attention in Valence and Arousal Revealed by Topology of Scan Path	PLOS ONE			English	Article							EMOTIONAL AROUSAL; HUMAN AMYGDALA; EYE-MOVEMENTS; SCENE PERCEPTION; POWER SPECTRA; PICTURES; ACTIVATION; INTENSITY; COGNITION; MEMORY	Emotional stimuli have evolutionary significance for the survival of organisms; therefore, they are attention-grabbing and are processed preferentially. The neural underpinnings of two principle emotional dimensions in affective space, valence (degree of pleasantness) and arousal (intensity of evoked emotion), have been shown to be dissociable in the olfactory, gustatory and memory systems. However, the separable roles of valence and arousal in scene perception are poorly understood. In this study, we asked how these two emotional dimensions modulate overt visual attention. Twenty-two healthy volunteers freely viewed images from the International Affective Picture System (IAPS) that were graded for affective levels of valence and arousal (high, medium, and low). Subjects' heads were immobilized and eye movements were recorded by camera to track overt shifts of visual attention. Algebraic graph-based approaches were introduced to model scan paths as weighted undirected path graphs, generating global topology metrics that characterize the algebraic connectivity of scan paths. Our data suggest that human subjects show different scanning patterns to stimuli with different affective ratings. Valence salient stimuli (with neutral arousal) elicited faster and larger shifts of attention, while arousal salient stimuli (with neutral valence) elicited local scanning, dense attention allocation and deep processing. Furthermore, our model revealed that the modulatory effect of valence was linearly related to the valence level, whereas the relation between the modulatory effect and the level of arousal was nonlinear. Hence, visual attention seems to be modulated by mechanisms that are separate for valence and arousal.	[Ni, Jianguang; Jiang, Huihui; Chen, Nanhui; Wang, Jianhong; Wang, Zhengbo; Ma, Yuanye; Hu, Xintian] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Ma, Yuanye; Hu, Xintian] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Ma, Yuanye; Hu, Xintian] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Ni, Jianguang; Jiang, Huihui; Jin, Yixiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Jin, Yixiang] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Luo, Yuejia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Beijing Normal University	Ni, JG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	yuanma0716@vip.sina.com; xthu@mail.kiz.ac.cn	Ni, Jiuangang/E-2956-2012; wang, jian/GVS-0711-2022	wang, zhengbo/0000-0002-4717-5137; Ni, Jianguang/0000-0003-2023-9230; Lauwereyns, Jan/0000-0003-0551-2550	National Science Foundation of China (NSFC) [30530270, 30670669, 31070965, 30870825, 31070963, 30921064, 30770700, 30930031]; 973 program [2007CB947703, S2010071114, 2011CB711001]; Major State Basic Research of China [NO2003CB716600]; CASC [KSCX1-YW-R-33, KSCX2-EW-J-23, KSCX2-EW-R-11, KSCX2-YW-R-261]; Yunnan Development and Reform Commission [2009-1988]; West Light Foundation of the Chinese Academy of Sciences [292008312D11035]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Major State Basic Research of China; CASC; Yunnan Development and Reform Commission; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Science Foundation of China (NSFC 30530270, 30670669, 31070965, 30870825, 31070963, 30921064, 30770700 and 30930031), 973 program (2007CB947703, S2010071114 and 2011CB711001), the Major State Basic Research of China (NO2003CB716600), Program of CASC (KSCX1-YW-R-33, KSCX2-EW-J-23, KSCX2-EW-R-11 and KSCX2-YW-R-261), Yunnan Development and Reform Commission No. 2009-1988 and West Light Foundation of the Chinese Academy of Sciences (292008312D11035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Anders S, 2008, SOC COGN AFFECT NEUR, V3, P233, DOI 10.1093/scan/nsn017; Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Arana FS, 2003, J NEUROSCI, V23, P9632; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Brockmann D, 1999, IEE CONF PUBL, P263, DOI 10.1049/cp:19991119; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cuthbert B. N, 2005, A6 U FLOR; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; FIEDLER M, 1973, CZECH MATH J, V23, P298; FIEDLER M, 1975, CZECH MATH J, V25, P619; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Findlay JM, 2009, PSYCHOL RES-PSYCH FO, V73, P127, DOI 10.1007/s00426-008-0201-3; Gianotti LRR, 2008, BRAIN TOPOGR, V20, P143, DOI 10.1007/s10548-007-0041-2; Glascher J, 2003, J NEUROSCI, V23, P10274; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Greene HH, 2001, VISION RES, V41, P3763, DOI 10.1016/S0042-6989(01)00154-7; Gronau N, 2003, J EXP PSYCHOL GEN, V132, P512, DOI 10.1037/0096-3445.132.4.512; Heilman KM, 1997, J NEUROPSYCH CLIN N, V9, P439, DOI 10.1176/jnp.9.3.439; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hsiao WH, 2005, J OPT SOC AM A, V22, P1789, DOI 10.1364/JOSAA.22.001789; Keil A, 2004, EMOTION, V4, P23, DOI 10.1037/1528-3542.4.1.23; Keil A, 2003, COGN AFFECT BEHAV NE, V3, P195, DOI 10.3758/CABN.3.3.195; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; KENSINGER E, 2006, J MEMO LANG; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Ludwig CJH, 2002, BEHAV RES METH INS C, V34, P618, DOI 10.3758/BF03195490; Maljkovic V, 2005, J VISION, V5, P215, DOI 10.1167/5.3.6; Mannan SK, 1997, PERCEPTION, V26, P1059, DOI 10.1068/p261059; MOHAR B, 1991, GRAPH COMBINATOR, V7, P53, DOI 10.1007/BF01789463; Mourao-Miranda J, 2003, NEUROIMAGE, V20, P1955, DOI 10.1016/j.neuroimage.2003.08.011; Ochsner KN, 2007, TRENDS COGN SCI, V11, P317, DOI 10.1016/j.tics.2007.06.008; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Privitera CM, 2006, P SOC PHOTO-OPT INS, V6057, pA570, DOI 10.1117/12.674146; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Sabatinelli D, 2005, NEUROIMAGE, V24, P1265, DOI 10.1016/j.neuroimage.2004.12.015; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Sharot T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002884; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; SMIT AC, 1987, VISION RES, V27, P1745, DOI 10.1016/0042-6989(87)90104-0; SMIT AC, 1990, EXP BRAIN RES, V81, P335, DOI 10.1007/BF00228124; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; van der Linde I, 2009, SPATIAL VISION, V22, P161, DOI 10.1163/156856809787465636; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wedel M, 2008, J EXP PSYCHOL-APPL, V14, P129, DOI 10.1037/1076-898X.14.2.129; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	73	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18262	10.1371/journal.pone.0018262	http://dx.doi.org/10.1371/journal.pone.0018262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494331	gold, Green Submitted, Green Published			2022-12-25	WOS:000289192400010
J	Hoogendijk, AJ; Diks, SH; van der Poll, T; Peppelenbosch, MP; Wieland, CW				Hoogendijk, Arie J.; Diks, Sander H.; van der Poll, Tom; Peppelenbosch, Maikel P.; Wieland, Catharina W.			Kinase Activity Profiling of Pneumococcal Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACTIVATED PROTEIN-KINASE; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; INFLAMMATORY RESPONSE; DOWN-REGULATION; R-ROSCOVITINE; INFECTION; INHIBITION; BETA	Background: Pneumonia represents a major health burden. Previous work demonstrated that although the induction of inflammation is important for adequate host defense against pneumonia, an inability to regulate the host's inflammatory response within the lung later during infection can be detrimental. Intracellular signaling pathways commonly rely on activation of kinases, and kinases play an essential role in the regulation of the inflammatory response of immune cells. Methodology/Principal Findings: Pneumonia was induced in mice via intranasal instillation of Streptococcus ( S.) pneumoniae. Kinomics peptide arrays, exhibiting 1024 specific consensus sequences for protein kinases, were used to produce a systems biology analysis of cellular kinase activity during the course of pneumonia. Several differences in kinase activity revealed by the arrays were validated in lung homogenates of individual mice using western blot. We identified cascades of activated kinases showing that chemotoxic stress and a T helper 1 response were induced during the course of pneumococcal pneumonia. In addition, our data point to a reduction in WNT activity in lungs of S. pneumoniae infected mice. Moreover, this study demonstrated a reduction in overall CDK activity implying alterations in cell cycle biology. Conclusions/Significance: This study utilizes systems biology to provide insight into the signaling events occurring during lung infection with the common cause of community acquired pneumonia, and may assist in identifying novel therapeutic targets in the treatment of bacterial pneumonia.	[Hoogendijk, Arie J.; van der Poll, Tom; Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Hoogendijk, Arie J.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Diks, Sander H.] Univ Med Ctr Groningen, Dept Cell Biol, Immunol Sect, Groningen, Netherlands; [Diks, Sander H.] Univ Groningen, Groningen, Netherlands; [Peppelenbosch, Maikel P.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Wieland, Catharina W.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Hoogendijk, AJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.j.hoogendijk@amc.uva.nl	Peppelenbosch, Maikel P./U-5304-2019	Peppelenbosch, Maikel/0000-0001-9112-6028	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from The Netherlands Organization for Scientific Research to C.W. Wieland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Duffin R, 2009, FEBS LETT, V583, P2540, DOI 10.1016/j.febslet.2009.07.017; Ferreira DM, 2009, MICROB PATHOGENESIS, V47, P157, DOI 10.1016/j.micpath.2009.05.005; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; Hammerlein A, 2005, CELL MOL LIFE SCI, V62, P606, DOI 10.1007/s00018-005-4507-7; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Ho PL, 2009, CHEST, V136, P1119, DOI 10.1378/chest.09-0285; Hu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006640; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kang MJ, 2008, FEBS J, V275, P5969, DOI 10.1111/j.1742-4658.2008.06725.x; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Liu L, 2008, J IMMUNOL, V180, P1808, DOI 10.4049/jimmunol.180.3.1808; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Parikh K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006440; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Ratner AJ, 2007, CELL MICROBIOL, V9, P1343, DOI 10.1111/j.1462-5822.2006.00878.x; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; RIETHER C, 2009, BRAIN BEHAV IN PRESS; Ripoll VM, 2010, J LEUKOCYTE BIOL, V87, P735, DOI 10.1189/jlb.0509359; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor AW, 2009, J LEUKOCYTE BIOL, V85, P29, DOI 10.1189/jlb.0708415; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; van den Blink B, 2001, J IMMUNOL, V166, P582, DOI 10.4049/jimmunol.166.1.582; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Yinnon AM, 1996, QJM-MON J ASSOC PHYS, V89, P933; YUSKAITIS CJ, 2008, CELLULAR SI IN PRESS; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang P, 2009, MOL IMMUNOL, V46, P677, DOI 10.1016/j.molimm.2008.08.281	50	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18519	10.1371/journal.pone.0018519	http://dx.doi.org/10.1371/journal.pone.0018519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483672	Green Published, gold, Green Submitted			2022-12-25	WOS:000289191300027
J	Kessels, RPC; van Doormaal, A; Janzen, G				Kessels, Roy P. C.; van Doormaal, Amy; Janzen, Gabriele			Landmark Recognition in Alzheimer's Dementia: Spared Implicit Memory for Objects Relevant for Navigation	PLOS ONE			English	Article							SPATIAL MEMORY; NEURAL REPRESENTATION; DISEASE; LOCATION; DISORIENTATION; ATTENTION; ATROPHY; TASK	Background: In spatial navigation, landmark recognition is crucial. Specifically, memory for objects placed at decision points on a route is relevant. Previous fMRI research in healthy adults showed higher medial-temporal lobe (MTL) activation for objects placed at decision points compared to non-decision points, even at an implicit level. Since there is evidence that implicit learning is intact in amnesic patients, the current study examined memory for objects relevant for navigation in patients with Alzheimer's dementia (AD). Methodology/Principal Findings: 21 AD patients participated with MTL atrophy assessed on MRI (mean MMSE=21.2, SD=4.0), as well as 20 age- and education-matched non-demented controls. All participants watched a 5-min video showing a route through a virtual museum with 20 objects placed at intersections (decision points) and 20 at simple turns (non-decision points). The instruction was to pay attention to the toys (half of the objects) for which they were supposedly tested later. Subsequently, a recognition test followed with the 40 previously presented objects among 40 distracter items (both toys and non-toys). Results showed a better performance for the non-toy objects placed at decision points than non-decision points, both for AD patients and controls. Conclusion/Significance: Our findings indicate that AD patients with MTL damage have implicit memory for object information relevant for navigation. No decision point effect was found for the attended items. Possibly, focusing attention on the items occurred at the cost of the context information in AD, whereas the controls performed at an optimal level due to intact memory function.	[Kessels, Roy P. C.; van Doormaal, Amy; Janzen, Gabriele] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, NL-6525 ED Nijmegen, Netherlands; [Janzen, Gabriele] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Kessels, RPC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	r.kessels@donders.ru.nl	Kessels, Roy P.C./D-1902-2010; Janzen, Gabriele/G-2058-2012	Kessels, Roy P.C./0000-0001-9500-9793; Kessels, Roy/0000-0002-7107-8900	Netherlands Organisation for Scientific Research (NWO) [452-08-005, 452-07-015]; ERC [204643]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	RPCK was funded by a VIDI innovational grant from the Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl; no. 452-08-005); GJ was supported by a VIDI innovational grant from NWO (no. 452-07-015) and by an ERC Starting Independent Researcher Grant (no. 204643; http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett V., 1994, OUTLIERS STAT DATA; Bird CM, 2010, HIPPOCAMPUS, V20, P1154, DOI 10.1002/hipo.20715; Bresciani L, 2005, AGING CLIN EXP RES, V17, P8, DOI 10.1007/BF03337714; Bucks RS, 1997, CLIN NEUROPSYCHOL, V11, P273, DOI 10.1080/13854049708400456; Cherrier MM, 2001, NEUROPSY NEUROPSY BE, V14, P159; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HANNAY HJ, 1986, EXPT TECHNIQUES HUMA, P45; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Holdstock JS, 1999, CORTEX, V35, P479, DOI 10.1016/S0010-9452(08)70814-1; Hort J, 2007, P NATL ACAD SCI USA, V104, P4042, DOI 10.1073/pnas.0611314104; Janzen G, 2006, Q J EXP PSYCHOL, V59, P493, DOI 10.1080/02724980443000746; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Janzen G, 2008, HIPPOCAMPUS, V18, P40, DOI 10.1002/hipo.20364; Janzen G, 2007, CEREB CORTEX, V17, P975, DOI 10.1093/cercor/bhl008; Janzen G, 2010, NEUROIMAGE, V52, P364, DOI 10.1016/j.neuroimage.2010.03.083; Jheng SS, 2009, BEHAV BRAIN RES, V200, P42, DOI 10.1016/j.bbr.2008.12.029; Kalova E, 2005, BEHAV BRAIN RES, V159, P175, DOI 10.1016/j.bbr.2004.10.016; Kavcic V, 2003, BRAIN, V126, P1173, DOI 10.1093/brain/awg105; Kessels RPC, 2010, J INT NEUROPSYCH SOC, V16, P200, DOI 10.1017/S1355617709990944; Kessels RPC, 2005, DEMENT GERIATR COGN, V20, P184, DOI 10.1159/000087233; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Kilb A, 2007, MEM COGNITION, V35, P1162, DOI 10.3758/BF03193486; Laczo J, 2009, BEHAV BRAIN RES, V202, P252, DOI 10.1016/j.bbr.2009.03.041; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Milner B, 1997, PHILOS T R SOC B, V352, P1469, DOI 10.1098/rstb.1997.0133; Monacelli AM, 2003, NEUROLOGY, V61, P1491, DOI 10.1212/WNL.61.11.1491; NEBES RD, 1992, J CLIN EXP NEUROPSYC, V14, P317, DOI 10.1080/01688639208402831; OKEEFE J, 1978, HIPPOCAMPUS COGNITIV, P584; Piekema C, 2006, NEUROIMAGE, V33, P374, DOI 10.1016/j.neuroimage.2006.06.035; Postle BR, 1996, LEARN MEMORY, V3, P305, DOI 10.1101/lm.3.4.305; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; Schinazi VR, 2010, NEUROIMAGE, V53, P725, DOI 10.1016/j.neuroimage.2010.06.065; Schmand B., 1992, NEDERLANDSE LEESTEST; Simone PM, 1997, ALZ DIS ASSOC DIS, V11, P140, DOI 10.1097/00002093-199709000-00006; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van De Pol LA, 2006, J NEUROL NEUROSUR PS, V77, P439, DOI 10.1136/jnnp.2005.075341; Zakzanis KK, 2009, MED SCI MONITOR, V15, pCR140	42	30	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18611	10.1371/journal.pone.0018611	http://dx.doi.org/10.1371/journal.pone.0018611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743ZC	21483699	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058700033
J	Hegde, VL; Nagarkatti, PS; Nagarkatti, M				Hegde, Venkatesh L.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol	PLOS ONE			English	Article							CONSTITUENT CANNABIDIOL; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; LIVER-INJURY; INFLAMMATION; IDENTIFICATION; INVOLVEMENT; SUBSETS; MICE; CANNABINOIDS	Background: Myeloid-derived suppressor cells (MDSCs) are getting increased attention as one of the main regulatory cells of the immune system. They are induced at sites of inflammation and can potently suppress T cell functions. In the current study, we demonstrate how activation of TRPV1 vanilloid receptors can trigger MDSCs, which in turn, can inhibit inflammation and hepatitis. Methodology/Principal Findings: Polyclonal activation of T cells, following injection of concanavalin A (ConA), in C57BL/6 mice caused acute hepatitis, characterized by significant increase in aspartate transaminase (AST), induction of inflammatory cytokines, and infiltration of mononuclear cells in the liver, leading to severe liver injury. Administration of cannabidiol (CBD), a natural non-psychoactive cannabinoid, after ConA challenge, inhibited hepatitis in a dose-dependent manner, along with all of the associated inflammation markers. Phenotypic analysis of liver infiltrating cells showed that CBD-mediated suppression of hepatitis was associated with increased induction of arginase-expressing CD11b(+)Gr-1(+) MDSCs. Purified CBD-induced MDSCs could effectively suppress T cell proliferation in vitro in arginase-dependent manner. Furthermore, adoptive transfer of purified MDSCs into naive mice conferred significant protection from ConA-induced hepatitis. CBD failed to induce MDSCs and suppress hepatitis in the livers of vanilloid receptor-deficient mice (TRPV1(-/-)) thereby suggesting that CBD primarily acted via this receptor to induce MDSCs and suppress hepatitis. While MDSCs induced by CBD in liver consisted of granulocytic and monocytic subsets at a ratio of similar to 2:1, the monocytic MDSCs were more immunosuppressive compared to granulocytic MDSCs. The ability of CBD to induce MDSCs and suppress hepatitis was also demonstrable in Staphylococcal enterotoxin B-induced liver injury. Conclusions/Significance: This study demonstrates for the first time that MDSCs play a critical role in attenuating acute inflammation in the liver, and that agents such as CBD, which trigger MDSCs through activation of TRPV1 vanilloid receptors may constitute a novel therapeutic modality to treat inflammatory diseases.	[Hegde, Venkatesh L.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hegde, VL (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mnagark@uscmed.sc.edu	Hegde, Venkatesh/E-8519-2014	Hegde, Venkatesh/0000-0002-0949-919X; Nagarkatti, Prakash/0000-0003-2663-0759	National Institutes of Health, USA [R01-DA016545, P01-AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016545] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was funded by National Institutes of Health, USA grant awards, R01-DA016545 and P01-AT003961 to MN and PSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; CONSROE P, 1991, PHARMACOL BIOCHEM BE, V40, P701, DOI 10.1016/0091-3057(91)90386-G; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Costa B, 2004, N-S ARCH PHARMACOL, V369, P294, DOI 10.1007/s00210-004-0871-3; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; De Wilde V, 2009, AM J TRANSPLANT, V9, P2034, DOI 10.1111/j.1600-6143.2009.02757.x; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; EGGINK HF, 1982, CLIN EXP IMMUNOL, V50, P17; Fushimi S, 2009, CLIN IMMUNOL, V133, P437, DOI 10.1016/j.clim.2009.08.015; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Knolle PA, 1996, HEPATOLOGY, V24, P824, DOI 10.1002/hep.510240413; Li BF, 2006, HEPATOLOGY, V43, P1211, DOI 10.1002/hep.21174; Liou GI, 2008, INVEST OPHTH VIS SCI, V49, P5526, DOI 10.1167/iovs.08-2196; Luxon Bruce A, 2006, Curr Gastroenterol Rep, V8, P83, DOI 10.1007/s11894-006-0068-7; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Mechoulam R, 2002, J CLIN PHARMACOL, V42, p11S, DOI 10.1002/j.1552-4604.2002.tb05998.x; Mechoulam R, 2002, CHEM PHYS LIPIDS, V121, P35, DOI 10.1016/S0009-3084(02)00144-5; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nakaya M, 2009, J IMMUNOL, V183, P7047, DOI 10.4049/jimmunol.0900547; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rog DJ, 2007, CLIN THER, V29, P2068, DOI 10.1016/j.clinthera.2007.09.013; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Satoh M, 1996, TOHOKU J EXP MED, V180, P139, DOI 10.1620/tjem.180.139; Scuderi C, 2009, PHYTOTHER RES, V23, P597, DOI 10.1002/ptr.2625; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tiegs G, 1997, ACTA GASTRO-ENT BELG, V60, P176; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tomihara K, 2010, J IMMUNOL, V184, P6151, DOI 10.4049/jimmunol.0903519; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Wahl C, 2009, J IMMUNOL, V182, P4521, DOI 10.4049/jimmunol.0802810; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zuardi AW, 2006, J PSYCHOPHARMACOL, V20, P683, DOI 10.1177/0269881106060967	54	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18281	10.1371/journal.pone.0018281	http://dx.doi.org/10.1371/journal.pone.0018281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483776	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058300010
J	Le Bert, N; Chain, BM; Rook, G; Noursadeghi, M				Le Bert, Nina; Chain, Benjamin M.; Rook, Graham; Noursadeghi, Mahdad			DC Priming by M. vaccae Inhibits Th2 Responses in Contrast to Specific TLR2 Priming and Is Associated with Selective Activation of the CREB Pathway	PLOS ONE			English	Article							KILLED MYCOBACTERIUM-VACCAE; CHRONIC INFLAMMATORY DISORDERS; TOLL-LIKE RECEPTOR-2; REGULATORY T-CELLS; DENDRITIC CELLS; ATOPIC-DERMATITIS; BINDING PROTEIN; MACROPHAGE ACTIVATION; IMMUNE-RESPONSES; MITE ALLERGEN	The environmental mycobacterium, M. vaccae has been used in mouse models to support the contemporary hygiene hypothesis that non-pathogenic microorganisms reduce allergy associated T helper (Th)2 responses and inflammatory diseases by augmenting regulatory T cells. However, data for human models and possible mechanisms are limited. We tested the effect of innate immune interactions between human DC and M. vaccae on DC-dependent T cell responses. M. vaccae activation of DC via Toll like receptor (TLR)2 was compared to a specific TLR2 ligand (Pam(3)CSK4) and alternative stimulation with a TLR4 ligand (LPS). M. vaccae induced DC dependent inhibition of Th2 responses, in contrast to Pam(3)CSK4, which had the opposite effect and LPS, which had no polarizing effect. DC maturation, gene expression and cytokine production, in response to each stimulus did not correlate with the specific functional effects. Comparable DC transcriptional responses to M. vaccae and Pam(3)CSK4 suggested that TLR2 mediated transcriptional regulation was not sufficient for inhibition of Th2 responses. Transcription factor enrichment analysis and assessment of signaling events, implicated a role for selective early activation of the CREB pathway by M. vaccae. Further study of the CREB pathway may provide novel insight into the molecular mechanisms of DC-dependent T cell polarization.	[Le Bert, Nina; Chain, Benjamin M.; Rook, Graham; Noursadeghi, Mahdad] UCL, London, England	University of London; University College London	Le Bert, N (corresponding author), UCL, London, England.	m.noursadeghi@ucl.ac.uk		Rook, Graham/0000-0002-8041-8110; Chain, Benny/0000-0002-7417-3970; Le Bert, Nina/0000-0003-0502-2527; Noursadeghi, Mahdad/0000-0002-4774-0853	EC [MEST-CT-2005-020524]; Wellcome Trust [WT077161MA]; National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre; Medical Research Council [G9721629, G0900950B, G0900950, G9721629B] Funding Source: researchfish; MRC [G0900950, G9721629] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by an EC grant through the Marie Curie Early Stage Training Site GALTRAIN (project MEST-CT-2005-020524), supported by a Wellcome Trust fellowship (WT077161MA) to MN and the National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VC, 2004, EUR J IMMUNOL, V34, P631, DOI 10.1002/eji.200324659; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Arkwright PD, 2003, BRIT J DERMATOL, V149, P1029, DOI 10.1111/j.1365-2133.2003.05557.x; Arkwright PD, 2001, J ALLERGY CLIN IMMUN, V107, P531, DOI 10.1067/mai.2001.113081; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Brothers S, 2009, CLIN EXP DERMATOL, V34, P770, DOI 10.1111/j.1365-2230.2008.03153.x; Camporota L, 2003, EUR RESPIR J, V21, P287, DOI 10.1183/09031936.03.00042103; Chain B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-344; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fukushima A, 2006, BIOCHEM BIOPH RES CO, V339, P1048, DOI 10.1016/j.bbrc.2005.11.114; Gutzwiller MER, 2007, VET DERMATOL, V18, P87, DOI 10.1111/j.1365-3164.2007.00579.x; Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P391, DOI 10.1046/j.1365-2567.2000.00054.x; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lombardi V, 2008, CLIN EXP ALLERGY, V38, P1819, DOI 10.1111/j.1365-2222.2008.03056.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Noursadeghi M, 2009, J IMMUNOL, V182, P319, DOI 10.4049/jimmunol.182.1.319; Ozdemir C, 2003, CLIN EXP ALLERGY, V33, P266, DOI 10.1046/j.1365-2222.2003.01595.x; PANDO RH, 2008, CLIN VACCIN IN PRESS; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Rasaiyaah J, 2009, IMMUNOLOGY, V127, P429, DOI 10.1111/j.1365-2567.2008.03018.x; Retra K, 2008, PARASITE IMMUNOL, V30, P39, DOI 10.1111/j.1365-3024.2007.01000.x; Roach SK, 2005, INFECT IMMUN, V73, P514, DOI 10.1128/IAI.73.1.514-522.2005; Rook GAW, 2010, CLIN EXP IMMUNOL, V160, P70, DOI 10.1111/j.1365-2249.2010.04133.x; Rook GAW, 2007, T ROY SOC TROP MED H, V101, P1072, DOI 10.1016/j.trstmh.2007.05.014; Samten B, 2005, J IMMUNOL, V174, P6357, DOI 10.4049/jimmunol.174.10.6357; Shirtcliffe PM, 2003, RESPIROLOGY, V8, P497, DOI 10.1046/j.1440-1843.2003.00510.x; Skinner MA, 1997, INFECT IMMUN, V65, P4525, DOI 10.1128/IAI.65.11.4525-4530.1997; Smit JJ, 2003, EUR J PHARMACOL, V470, P193, DOI 10.1016/S0014-2999(03)01794-1; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Sweet L, 2006, J LEUKOCYTE BIOL, V80, P415, DOI 10.1189/jlb.1205702; Taylor RC, 2006, J ALLERGY CLIN IMMUN, V117, P1148, DOI 10.1016/j.jaci.2006.02.014; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Wang CC, 1998, IMMUNOLOGY, V93, P307; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zhou C, 2008, J ZHEJIANG UNIV-SC B, V9, P279, DOI 10.1631/jzus.B0730029; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zuany-Amorim C, 2002, J IMMUNOL, V169, P1492, DOI 10.4049/jimmunol.169.3.1492; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	57	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18346	10.1371/journal.pone.0018346	http://dx.doi.org/10.1371/journal.pone.0018346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483768	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058300013
J	Luo, YZ; Spurlock, F; Deng, X; Gill, S; Goh, K				Luo, Yuzhou; Spurlock, Frank; Deng, Xin; Gill, Sheryl; Goh, Kean			Use-Exposure Relationships of Pesticides for Aquatic Risk Assessment	PLOS ONE			English	Article							SURFACE WATERS; TRANSPORT; BEHAVIOR; MODEL; FATE	Field-scale environmental models have been widely used in aquatic exposure assessments of pesticides. Those models usually require a large set of input parameters and separate simulations for each pesticide in evaluation. In this study, a simple use-exposure relationship is developed based on regression analysis of stochastic simulation results generated from the Pesticide Root-Zone Model (PRZM). The developed mathematical relationship estimates edge-of-field peak concentrations of pesticides from aerobic soil metabolism half-life (AERO), organic carbon-normalized soil sorption coefficient (KOC), and application rate (RATE). In a case study of California crop scenarios, the relationships explained 90-95% of the variances in the peak concentrations of dissolved pesticides as predicted by PRZM simulations for a 30-year period. KOC was identified as the governing parameter in determining the relative magnitudes of pesticide exposures in a given crop scenario. The results of model application also indicated that the effects of chemical fate processes such as partitioning and degradation on pesticide exposure were similar among crop scenarios, while the cross-scenario variations were mainly associated with the landscape characteristics, such as organic carbon contents and curve numbers. With a minimum set of input data, the use-exposure relationships proposed in this study could be used in screening procedures for potential water quality impacts from the off-site movement of pesticides.	[Luo, Yuzhou; Spurlock, Frank; Deng, Xin; Gill, Sheryl; Goh, Kean] Calif Environm Protect Agcy, Dept Pesticide Regulat, Sacramento, CA 95812 USA	California Environmental Protection Agency	Luo, YZ (corresponding author), Calif Environm Protect Agcy, Dept Pesticide Regulat, Sacramento, CA 95812 USA.	yluo@cdpr.ca.gov; xdeng@cdpr.ca.gov	Luo, Yuzhou/A-7223-2010	Luo, Yuzhou/0000-0003-0879-9622				AHUJA LR, ROOT ZONE WATER QUAL; [Anonymous], [No title captured]; Capel PD, 2001, ENVIRON SCI TECHNOL, V35, P648, DOI 10.1021/es001220f; Capel PD, 2001, HYDROL PROCESS, V15, P1251, DOI 10.1002/hyp.212; *CDWR, 2002, 2001 STAT IRR METH S; *CEPA, 2010, SURF WAT DAT; Chapra SC, 1997, SURFACE WATER QUALIT; Chen WL, 2002, ENVIRON TOXICOL CHEM, V21, P298, DOI [10.1897/1551-5028(2002)021&lt;0298:APSWMI&gt;2.0.CO;2, 10.1002/etc.5620210211]; Cryer SA, 2001, ENVIRON MODEL ASSESS, V6, P195, DOI 10.1023/A:1011978420760; Dasgupta S, 2008, SYNTHETIC PYRETHROID; DOMAGALSKI JL, 2003, 034088 US GEOL SURV; Domagalski JL, 2010, ENVIRON TOXICOL CHEM, V29, P813, DOI 10.1002/etc.106; DON DF, 1992, WEED TECHNOL, V6, P716; Dubrovsky N.M., 1998, US GEOLOGICAL SURVEY, V1159; FOCUS (Forum for the Co-ordination of Pesticide Fate Models and their Use), 2001, SANCO48022001REV2 FO; GOSS DW, 1992, WEED TECHNOL, V6, P701, DOI 10.1017/S0890037X00036083; Kellogg RL, 2000, ENV INDICATORS PESTI; KRATZER CR, 2002, 024103 US GEOL SURV; Luo YZ, 2007, CHEMOSPHERE, V66, P1396, DOI 10.1016/j.chemosphere.2006.09.026; Luo YZ, 2010, ENVIRON POLLUT, V158, P1629, DOI 10.1016/j.envpol.2009.12.008; Luo YZ, 2009, J ENVIRON QUAL, V38, P664, DOI 10.2134/jeq2008.0216; Nolan B. T., 2005, 20051196 US GEOL SUR; ROSS LJ, 1999, EH9901 CAL DEP PEST; Russell M, 2001, FINAL REPORT FIFRA E; Siepmann S, 2000, 003 CAL DEP FISH GAM; Singh P, 2002, ENVIRON TOXICOL CHEM, V21, P1545, DOI 10.1897/1551-5028(2002)021&lt;1545:COPRZM&gt;2.0.CO;2; Spurlock F, 2008, ENVIRON TOXICOL CHEM, V27, P1683, DOI 10.1897/07-600.1; United States Environmental Protection Agency (US EPA), 2006, ORG PEST REV CUM RIS; *USEPA, 2010, WAT EXP MOD US OFF P; *USEPA, 1999, EPA600R99064 OFF RES; *USEPA, 2006, EPA600R05111 CTR EXP; *USEPA, 2008, USEPA TIER 2 CROP SC; USEPA, 2005, EPA822R05006 OFF WAT; *USEPA, 2010, PEST ROOT ZON MOD PR; *USEPA, 2010, EFF DET CAL RED LEGG; [USEPA] US Environmental Protection Agency, 2002, GUID SEL INP PAR MOD; *USGS, 2005, 20051196 USGS; Villeneuve J. P., 1988, Journal of Contaminant Hydrology, V3, P77, DOI 10.1016/0169-7722(88)90018-6; Wolt J, 2002, ENVIRON TOXICOL CHEM, V21, P1558, DOI [10.1897/1551-5028(2002)021<1558:SAFVEO>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1558:SAFVEO&gt;2.0.CO;2]	39	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18234	10.1371/journal.pone.0018234	http://dx.doi.org/10.1371/journal.pone.0018234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483772	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058300008
J	Goel, A; Xu, LDW; Snyder, KP; Song, LH; Goenaga-Vazquez, Y; Megill, A; Takamiya, K; Huganir, RL; Lee, HK				Goel, Anubhuti; Xu, Linda W.; Snyder, Kevin P.; Song, Lihua; Goenaga-Vazquez, Yamila; Megill, Andrea; Takamiya, Kogo; Huganir, Richard L.; Lee, Hey-Kyoung			Phosphorylation of AMPA Receptors Is Required for Sensory Deprivation-Induced Homeostatic Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-A; VISUAL CORTICAL PLASTICITY; GLUTAMATE RECEPTORS; RETINOIC ACID; GLUR1 SUBUNIT; IN-VIVO; CA1 REGION; RAR-ALPHA; CORTEX	Sensory experience, and the lack thereof, can alter the function of excitatory synapses in the primary sensory cortices. Recent evidence suggests that changes in sensory experience can regulate the synaptic level of Ca(2+)-permeable AMPA receptors (CP-AMPARs). However, the molecular mechanisms underlying such a process have not been determined. We found that binocular visual deprivation, which is a well-established in vivo model to produce multiplicative synaptic scaling in visual cortex of juvenile rodents, is accompanied by an increase in the phosphorylation of AMPAR GluR1 (or GluA1) subunit at the serine 845 (S845) site and the appearance of CP-AMPARs at synapses. To address the role of GluR1-S845 in visual deprivation-induced homeostatic synaptic plasticity, we used mice lacking key phosphorylation sites on the GluR1 subunit. We found that mice specifically lacking the GluR1-S845 site (GluR1-S845A mutants), which is a substrate of cAMP-dependent kinase (PKA), show abnormal basal excitatory synaptic transmission and lack visual deprivation-induced homeostatic synaptic plasticity. We also found evidence that increasing GluR1-S845 phosphorylation alone is not sufficient to produce normal multiplicative synaptic scaling. Our study provides concrete evidence that a GluR1 dependent mechanism, especially S845 phosphorylation, is a necessary pre-requisite step for in vivo homeostatic synaptic plasticity.	[Goel, Anubhuti; Xu, Linda W.; Snyder, Kevin P.; Song, Lihua; Goenaga-Vazquez, Yamila; Megill, Andrea; Lee, Hey-Kyoung] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Goel, Anubhuti; Goenaga-Vazquez, Yamila; Lee, Hey-Kyoung] Univ Maryland, Neurosci & Cognit Sci NACS Program, College Pk, MD 20742 USA; [Megill, Andrea] Univ Maryland, Cell Biol & Mol Genet CBMG Program, College Pk, MD 20742 USA; [Takamiya, Kogo] Miyazaki Univ, Dept Integrat Physiol, Fac Med, Miyazaki, Japan; [Takamiya, Kogo; Huganir, Richard L.] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Miyazaki; Johns Hopkins University; Johns Hopkins Medicine	Goel, A (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	hlee21@umd.edu		Takamiya, Kogo/0000-0001-7240-6307; Snyder, Kevin/0000-0003-3029-4815; Lee, Hey-Kyoung/0000-0002-5554-983X	National Institutes of Health [R01-EY014882, R01-NS036715]; Howard Hughes Medical Institute (HHMI); University of Maryland Neuroscience and Cognitive Science (NACS); NATIONAL EYE INSTITUTE [R01EY014882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); University of Maryland Neuroscience and Cognitive Science (NACS); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grant (R01-EY014882) to H-KL, the National Institutes of Health Grant (R01-NS036715) and the Howard Hughes Medical Institute (HHMI) Investigator Award to RLH, the HHMI Undergraduate Research Fellowships to LWX and KPS, and the University of Maryland Neuroscience and Cognitive Science (NACS) Summer Internship to YG-V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Linden ML, 2009, NAT NEUROSCI, V12, P390, DOI 10.1038/nn.2284; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SL, 2003, CEREB CORTEX, V13, P864, DOI 10.1093/cercor/13.8.864; Liu Y, 2010, NAT NEUROSCI, V13, P223, DOI 10.1038/nn.2474; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Poon MM, 2008, P NATL ACAD SCI USA, V105, P20303, DOI 10.1073/pnas.0807740105; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005	62	71	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18264	10.1371/journal.pone.0018264	http://dx.doi.org/10.1371/journal.pone.0018264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483826	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200048
J	Goris, MGA; Wagenaar, JFP; Hartskeerl, RA; van Gorp, ECM; Schuller, S; Monahan, AM; Nally, JE; van der Poll, T; van 't Veer, C				Goris, Marga G. A.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.; van Gorp, Eric C. M.; Schuller, Simone; Monahan, Avril M.; Nally, Jarlath E.; van der Poll, Tom; van 't Veer, Cornelis			Potent Innate Immune Response to Pathogenic Leptospira in Human Whole Blood	PLOS ONE			English	Article							PULMONARY HEMORRHAGE; LETHAL INFECTION; INTERROGANS; COMPLEMENT; CELLS; LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN; INFLAMMATION; RECOGNITION; MACROPHAGES	Background: Leptospirosis is caused by pathogenic spirochetes of the genus Leptospira. The bacteria enter the human body via abraded skin or mucous membranes and may disseminate throughout. In general the clinical picture is mild but some patients develop rapidly progressive, severe disease with a high case fatality rate. Not much is known about the innate immune response to leptospires during haematogenous dissemination. Previous work showed that a human THP-1 cell line recognized heat-killed leptospires and leptospiral LPS through TLR2 instead of TLR4. The LPS of virulent leptospires displayed a lower potency to trigger TNF production by THP-1 cells compared to LPS of non-virulent leptospires. Methodology/Principal Findings: We investigated the host response and killing of virulent and non-virulent Leptospira of different serovars by human THP-1 cells, human PBMC's and human whole blood. Virulence of each leptospiral strain was tested in a well accepted standard guinea pig model. Virulent leptospires displayed complement resistance in human serum and whole blood while in-vitro attenuated non-virulent leptospires were rapidly killed in a complement dependent manner. In vitro stimulation of THP-1 and PBMC's with heat-killed and living leptospires showed differential serovar and cell type dependence of cytokine induction. However, at low, physiological, leptospiral dose, living virulent complement resistant strains were consistently more potent in whole blood stimulations than the corresponding non-virulent complement sensitive strains. At higher dose living virulent and non-virulent leptospires were equipotent in whole blood. Inhibition of different TLRs indicated that both TLR2 and TLR4 as well as TLR5 play a role in the whole blood cytokine response to living leptospires. Conclusions/Significance: Thus, in a minimally altered system as human whole blood, highly virulent Leptospira are potent inducers of the cytokine response.	[Goris, Marga G. A.; Hartskeerl, Rudy A.] KIT Biomed Res, Royal Trop Inst KIT, Amsterdam, Netherlands; [Wagenaar, Jiri F. P.; van Gorp, Eric C. M.] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands; [Schuller, Simone; Monahan, Avril M.; Nally, Jarlath E.] Univ Coll Dublin, Coll Life Sci, Vet Sci Ctr, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [van der Poll, Tom; van 't Veer, Cornelis] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands; [van der Poll, Tom; van 't Veer, Cornelis] Univ Amsterdam, CINIMA, Amsterdam, Netherlands; [van Gorp, Eric C. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Slotervaart Hospital; University College Dublin; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Goris, MGA (corresponding author), KIT Biomed Res, Royal Trop Inst KIT, Amsterdam, Netherlands.	m.goris@kit.nl						Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; ANDERSON DL, 1968, J BACTERIOL, V95, P2293, DOI 10.1128/JB.95.6.2293-2309.1968; AREAN VM, 1962, AM J PATHOL, V40, P393; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506; Chierakul W, 2004, CLIN IMMUNOL, V113, P140, DOI 10.1016/j.clim.2004.08.006; CINCO M, 1983, ZBL BAKT-INT J MED M, V254, P261; de Fost M, 2003, CLIN DIAGN LAB IMMUN, V10, P332, DOI 10.1128/CDLI.10.2.332-335.2003; DESOUZA L, 1992, CAN J MICROBIOL, V38, P284, DOI 10.1139/m92-047; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; FAINE S, 1982, GUIDELINES CONTROL L, P67; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; GOLDSTEIN SF, 1988, CELL MOTIL CYTOSKEL, V9, P101, DOI 10.1002/cm.970090202; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Hartskeerl R., 2003, NED TIJDSCHR MED MIC, V11, P94; Kmety E., 1993, CLASSIFICATION SPECI; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2005, INFECT IMMUN, V73, P7014, DOI 10.1128/IAI.73.10.7014-7017.2005; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Silva João José Pereira da, 2002, Rev. Soc. Bras. Med. Trop., V35, P395, DOI 10.1590/S0037-86822002000400017; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Truccolo J, 2001, FEMS MICROBIOL LETT, V204, P317, DOI 10.1111/j.1574-6968.2001.tb10904.x; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006; Wagenaar JFP, 2004, J TRAVEL MED, V11, P379, DOI 10.2310/7060.2004.19208; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; WANG B, 1984, INFECT IMMUN, V46, P809, DOI 10.1128/IAI.46.3.809-813.1984; WANG B, 1984, INFECT IMMUN, V44, P459, DOI 10.1128/IAI.44.2.459-464.1984; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119	42	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18279	10.1371/journal.pone.0018279	http://dx.doi.org/10.1371/journal.pone.0018279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483834	gold, Green Published, Green Submitted			2022-12-25	WOS:000289057200051
J	Chou, KC; Wu, ZC; Xiao, XA				Chou, Kuo-Chen; Wu, Zhi-Cheng; Xiao, Xuan			iLoc-Euk: A Multi-Label Classifier for Predicting the Subcellular Localization of Singleplex and Multiplex Eukaryotic Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; APOPTOSIS PROTEINS; GENE ONTOLOGY; LOCATION PREDICTION; HYBRID APPROACH; MARCH-INSIDE; SEQUENCES; NETWORKS; REPRESENTATION	Predicting protein subcellular localization is an important and difficult problem, particularly when query proteins may have the multiplex character, i.e., simultaneously exist at, or move between, two or more different subcellular location sites. Most of the existing protein subcellular location predictor can only be used to deal with the single-location or "singleplex" proteins. Actually, multiple-location or "multiplex" proteins should not be ignored because they usually posses some unique biological functions worthy of our special notice. By introducing the "multi-labeled learning" and "accumulation-layer scale", a new predictor, called iLoc-Euk, has been developed that can be used to deal with the systems containing both singleplex and multiplex proteins. As a demonstration, the jackknife cross-validation was performed with iLoc-Euk on a benchmark dataset of eukaryotic proteins classified into the following 22 location sites: (1) acrosome, (2) cell membrane, (3) cell wall, (4) centriole, (5) chloroplast, (6) cyanelle, (7) cytoplasm, (8) cytoskeleton, (9) endoplasmic reticulum, (10) endosome, (11) extracellular, (12) Golgi apparatus, (13) hydrogenosome, (14) lysosome, (15) melanosome, (16) microsome (17) mitochondrion, (18) nucleus, (19) peroxisome, (20) spindle pole body, (21) synapse, and (22) vacuole, where none of proteins included has >= 25% pairwise sequence identity to any other in a same subset. The overall success rate thus obtained by iLoc-Euk was 79%, which is significantly higher than that by any of the existing predictors that also have the capacity to deal with such a complicated and stringent system. As a user-friendly web-server, iLoc-Euk is freely accessible to the public at the web-site http://icpr.jci.edu.cn/bioinfo/iLoc-Euk. It is anticipated that iLoc-Euk may become a useful bioinformatics tool for Molecular Cell Biology, Proteomics, System Biology, and Drug Development Also, its novel approach will further stimulate the development of predicting other protein attributes.	[Chou, Kuo-Chen; Xiao, Xuan] Gordon Life Sci Inst, San Diego, CA 92130 USA; [Wu, Zhi-Cheng; Xiao, Xuan] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China	Jingdezhen Ceramic Institute	Chou, KC (corresponding author), Gordon Life Sci Inst, San Diego, CA 92130 USA.	kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of Jiangxi [2009GZS0064]; Department of Education of Jiangxi Province [GJJ09271]; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of Jiangxi; Department of Education of Jiangxi Province; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of Jiangxi (2009GZS0064), the Department of Education of Jiangxi Province (No. GJJ09271), and the plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Cai YD, 2010, PROTEIN PEPTIDE LETT, V17, P464, DOI 10.2174/092986610790963654; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen YL, 2007, J THEOR BIOL, V248, P377, DOI 10.1016/j.jtbi.2007.05.019; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 2003, BIOCHEM BIOPH RES CO, V311, P743, DOI 10.1016/j.bbrc.2003.10.062; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Feng Zhi-Ping, 2002, In Silico Biology, V2, P291; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gerstein M, 2003, CURR OPIN STRUC BIOL, V13, P341, DOI 10.1016/S0959-440X(03)00080-0; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771; Gonzalez-Diaz H, 2010, CURR DRUG METAB, V11, P379, DOI 10.2174/138920010791514225; Gonzalez-Diaz H, 2008, CURR TOP MED CHEM, V8, P1676, DOI 10.2174/156802608786786543; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Jahandideh S, 2009, J THEOR BIOL, V259, P517, DOI 10.1016/j.jtbi.2009.04.016; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Jin YH, 2008, PROTEIN PEPTIDE LETT, V15, P286; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Liu LJ, 2010, PROTEIN PEPTIDE LETT, V17, P246, DOI 10.2174/092986610790226085; Liu T, 2010, PROTEIN PEPTIDE LETT, V17, P1263, DOI 10.2174/092986610792231528; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mardia K.V., 1979, MULTIVARIATE ANAL, P322; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Mundra P, 2007, PATTERN RECOGN LETT, V28, P1610, DOI 10.1016/j.patrec.2007.04.001; Munteanu CR, 2009, J PROTEOME RES, V8, P5219, DOI 10.1021/pr900556g; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Pan YX, 2003, J PROTEIN CHEM, V22, P395, DOI 10.1023/A:1025350409648; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Rodriguez-Soca Y, 2010, J PROTEOME RES, V9, P1182, DOI 10.1021/pr900827b; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SMITH C, 2008, SUBCELLULAR TARGETIN; Tantoso E, 2008, AMINO ACIDS, V35, P345, DOI 10.1007/s00726-007-0616-y; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Xiao X, 2006, AMINO ACIDS, V30, P49, DOI 10.1007/s00726-005-0225-6; Yang XY, 2010, PROTEIN PEPTIDE LETT, V17, P899, DOI 10.2174/092986610791306670; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251	73	305	307	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18258	10.1371/journal.pone.0018258	http://dx.doi.org/10.1371/journal.pone.0018258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21483473	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700042
J	Mizuno, H; Nakamura, A; Aoki, Y; Ito, N; Kishi, S; Yamamoto, K; Sekiguchi, M; Takeda, S; Hashido, K				Mizuno, Hideya; Nakamura, Akinori; Aoki, Yoshitsugu; Ito, Naoki; Kishi, Soichiro; Yamamoto, Kazuhiro; Sekiguchi, Masayuki; Takeda, Shin'ichi; Hashido, Kazuo			Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy	PLOS ONE			English	Article							CREATINE-KINASE; CIRCULATING MICRORNAS; DIFFERENTIATION; REGENERATION; EXPRESSION; INJURY; FIBERS	Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder caused by mutations in the dystrophin gene, which encodes a cytoskeletal protein, dystrophin. Creatine kinase (CK) is generally used as a blood-based biomarker for muscular disease including DMD, but it is not always reliable since it is easily affected by stress to the body, such as exercise. Therefore, more reliable biomarkers of muscular dystrophy have long been desired. MicroRNAs (miRNAs) are small,,22 nucleotide, noncoding RNAs which play important roles in the regulation of gene expression at the post-transcriptional level. Recently, it has been reported that miRNAs exist in blood. In this study, we hypothesized that the expression levels of specific serum circulating miRNAs may be useful to monitor the pathological progression of muscular diseases, and therefore explored the possibility of these miRNAs as new biomarkers for muscular diseases. To confirm this hypothesis, we quantified the expression levels of miRNAs in serum of the dystrophin-deficient muscular dystrophy mouse model, mdx, and the canine X-linked muscular dystrophy in Japan dog model (CXMDJ), by real-time PCR. We found that the serum levels of several muscle-specific miRNAs (miR-1, miR-133a and miR-206) are increased in both mdx and CXMDJ. Interestingly, unlike CK levels, expression levels of these miRNAs in mdx serum are little influenced by exercise using treadmill. These results suggest that serum miRNAs are useful and reliable biomarkers for muscular dystrophy.	[Mizuno, Hideya; Kishi, Soichiro; Hashido, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Tokyo, Japan; [Nakamura, Akinori; Aoki, Yoshitsugu; Ito, Naoki; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan; [Yamamoto, Kazuhiro; Sekiguchi, Masayuki] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo, Japan; [Aoki, Yoshitsugu] Tokyo Med & Dent Sch Univ Grad Sch, Med Res Inst, Dept Syst Neurosci, Tokyo, Japan; [Ito, Naoki] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Tokyo Institute of Technology	Mizuno, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Tokyo, Japan.	hashido@ncnp.go.jp	Kishi, Soichiro/C-7712-2011; Ito, Naoki/K-9327-2018	Ito, Naoki/0000-0002-1884-8494; Aoki, MD, PhD, Yoshitsugu/0000-0002-9038-7506	ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [21300149] Funding Source: KAKEN	ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Health and Labour Sciences Research Grants for Translational research from the ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; CULLEN MJ, 1980, BRIT MED BULL, V36, P145, DOI 10.1093/oxfordjournals.bmb.a071630; EBASHI S, 1959, J BIOCHEM-TOKYO, V46, P103; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FLORENCE JM, 1985, NEUROLOGY, V35, P758, DOI 10.1212/WNL.35.5.758; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; NICHOLSON GA, 1986, MUSCLE NERVE, V9, P820, DOI 10.1002/mus.880090905; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Urasawa N, 2008, CIRCULATION, V117, P2437, DOI 10.1161/CIRCULATIONAHA.107.739326; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VASSELLA F, 1965, PEDIATRICS, V35, P322; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Yugeta Naoko, 2006, BMC Cardiovasc Disord, V6, P47, DOI 10.1186/1471-2261-6-47	25	136	146	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18388	10.1371/journal.pone.0018388	http://dx.doi.org/10.1371/journal.pone.0018388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479190	gold, Green Published, Green Submitted			2022-12-25	WOS:000289055700054
J	Velez, JM; Miriyala, S; Nithipongvanitch, R; Noel, T; Plabplueng, CD; Oberley, T; Jungsuwadee, P; Van Remmen, H; Vore, M; Clair, DKS				Velez, Joyce M.; Miriyala, Sumitra; Nithipongvanitch, Ramaneeya; Noel, Teresa; Plabplueng, Chotiros D.; Oberley, Terry; Jungsuwadee, Paiboon; Van Remmen, Holly; Vore, Mary; Clair, Daret K. St.			p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; GLUTATHIONE TRANSFERASE; LIPID-PEROXIDATION; NITRIC-OXIDE; CELL-DEATH; ACTIVATION; MICE; AUTOPHAGY; PROTEINS; HEART	The side effects of cancer therapy on normal tissues limit the success of therapy. Generation of reactive oxygen species (ROS) has been implicated for numerous chemotherapeutic agents including doxorubicin (DOX), a potent cancer chemotherapeutic drug. The production of ROS by DOX has been linked to DNA damage, nuclear translocation of p53, and mitochondrial injury; however, the causal relationship and molecular mechanisms underlying these events are unknown. The present study used wild-type (WT) and p53 homozygous knock-out (p53(-/-)) mice to investigate the role of p53 in the crosstalk between mitochondria and nucleus. Injecting mice with DOX (20 mg/kg) causes oxidative stress in cardiac tissue as demonstrated by immunogold analysis of the levels of 4-hydroxy-2'-nonenal (4HNE)-adducted protein, a lipid peroxidation product bound to proteins. 4HNE levels increased in both nuclei and mitochondria of WT DOX-treated mice but only in nuclei of DOX-treated p53((-/-)) mice, implicating a critical role for p53 in causing DOX-induced oxidative stress in mitochondria. The stress-activated protein c-Jun amino-terminal kinase (JNKs) was activated in response to increased 4HNE in WT mice but not p53((-/-)) mice receiving DOX treatment, as determined by co-immunoprecipitation of HNE and pJNK. The activation of JNK in DOX treated WT mice was accompanied by Bcl-2 dissociation from Beclin in mitochondria and induction of type II cell death (autophagic cell death), as evidenced by an increase in LC3-I/LC-3-II ratio and gamma-H2AX, a biomarker for DNA damage. The absence of p53 significantly reduces mitochondrial injury, assessed by quantitative morphology, and decline in cardiac function, assessed by left ventricular ejection fraction and fraction shortening. These results demonstrate that p53 plays a critical role in DOX-induced cardiac toxicity, in part, by the induction of oxidative stress mediated retrograde signaling.	[Velez, Joyce M.; Miriyala, Sumitra; Noel, Teresa; Jungsuwadee, Paiboon; Vore, Mary; Clair, Daret K. St.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40526 USA; [Oberley, Terry] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Oberley, Terry] Univ Wisconsin Hosp & Clin, William S Middleton Mem Vet Adm Hosp, Pathol & Lab Med Serv, Madison, WI 53792 USA; [Nithipongvanitch, Ramaneeya; Plabplueng, Chotiros D.] Mahidol Univ, Fac Med Technol, Bangkok 10700, Thailand; [Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Kentucky; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; Mahidol University; University of Texas System; University of Texas Health San Antonio	Velez, JM (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40526 USA.	DSTCL00@uky.edu	Jungsuwadee, Paiboon/AAE-4038-2020; Vore, Mary/E-2177-2012	Jungsuwadee, Paiboon/0000-0002-5430-6887; Miriyala, Sumitra/0000-0001-7158-9295	National Institutes of Health [CA 139483, CA 139484, T32 HL072743]; Interdisciplinary Cardiovascular Training Program; NATIONAL CANCER INSTITUTE [R01CA139843] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Cardiovascular Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health grants CA 139483, CA 139484 and T32 HL072743, Interdisciplinary Cardiovascular Training Program (Joyce M. Velez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; Awasthi YC, 2005, METHOD ENZYMOL, V401, P379, DOI 10.1016/S0076-6879(05)01024-4; BLOOM KR, 1978, CANCER, V41, P1265, DOI 10.1002/1097-0142(197804)41:4<1265::AID-CNCR2820410408>3.0.CO;2-R; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chaiswing L, 2005, MOL CANCER THER, V4, P1056, DOI 10.1158/1535-7163.MCT-04-0322; Chaiswing L, 2004, TOXICOL PATHOL, V32, P536, DOI 10.1080/01926230490502601; Cole MP, 2006, CARDIOVASC RES, V69, P186, DOI 10.1016/j.cardiores.2005.07.012; Daosukho C, 2007, FREE RADICAL BIO MED, V42, P1818, DOI 10.1016/j.freeradbiomed.2007.03.007; ISHIKAWA T, 1986, J BIOL CHEM, V261, P1576; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Jungsuwadee P, 2006, MOL CANCER THER, V5, P2851, DOI 10.1158/1535-7163.MCT-06-0297; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liu W, 2000, J CELL SCI, V113, P635; Liu W, 1999, J CELL SCI, V112, P2409; Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mela L, 1979, Methods Enzymol, V55, P39; Nedergaard J, 1979, Methods Enzymol, V55, P3; Nishida Kazuhiko, 2008, Circ J, V72 Suppl A, pA17, DOI 10.1253/circj.CJ-08-0669; NITHIPONGVANITC.R, 2007, J HISTOCHEM CYTOCHEM; Oberley TD, 2002, METHOD ENZYMOL, V352, P373; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Seimiya H, 1997, J BIOL CHEM, V272, P4631, DOI 10.1074/jbc.272.7.4631; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Yen HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P59, DOI 10.1006/abbi.1998.1011; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com; Zainal TA, 1999, FREE RADICAL BIO MED, V26, P1181, DOI 10.1016/S0891-5849(98)00312-8; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	37	52	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18005	10.1371/journal.pone.0018005	http://dx.doi.org/10.1371/journal.pone.0018005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479164	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700021
J	Vidwans, SJ; Flaherty, KT; Fisher, DE; Tenenbaum, JM; Travers, MD; Shrager, J				Vidwans, Smruti J.; Flaherty, Keith T.; Fisher, David E.; Tenenbaum, Jay M.; Travers, Michael D.; Shrager, Jeff			A Melanoma Molecular Disease Model	PLOS ONE			English	Article							P16 PROTEIN EXPRESSION; METASTATIC MELANOMA; SIGNALING PATHWAYS; BRAF MUTATIONS; CYCLIN D1; COMBINED INHIBITION; MALIGNANT-MELANOMA; COMPLETE RESPONSE; LINEAGE SURVIVAL; MUCOSAL MELANOMA	While advanced melanoma remains one of the most challenging cancers, recent developments in our understanding of the molecular drivers of this disease have uncovered exciting opportunities to guide personalized therapeutic decisions. Genetic analyses of melanoma have uncovered several key molecular pathways that are involved in disease onset and progression, as well as prognosis. These advances now make it possible to create a "Molecular Disease Model" (MDM) for melanoma that classifies individual tumors into molecular subtypes (in contrast to traditional histological subtypes), with proposed treatment guidelines for each subtype including specific assays, drugs, and clinical trials. This paper describes such a Melanoma Molecular Disease Model reflecting the latest scientific, clinical, and technological advances.	[Vidwans, Smruti J.; Tenenbaum, Jay M.; Travers, Michael D.; Shrager, Jeff] CollabRx Inc, Palo Alto, CA 94301 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Fisher, David E.] Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Fisher, David E.] Massachusetts Gen Hosp, Melanoma Program, Boston, MA 02114 USA; [Shrager, Jeff] Stanford Univ, Symbol Syst Program Consulting, Stanford, CA 94305 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Stanford University	Vidwans, SJ (corresponding author), CollabRx Inc, Palo Alto, CA 94301 USA.	jshrager@stanford.edu	Fisher, David/AAH-2878-2019		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR043369] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aziz SA, 2007, J CLIN ONCOL, V25; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Board RE, 2009, BRIT J CANCER, V101, P1724, DOI 10.1038/sj.bjc.6605371; Borner C, 1999, MELANOMA RES, V9, P347, DOI 10.1097/00008390-199908000-00002; BOS JL, 1989, CANCER RES, V49, P4682; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Carvajal RD, 2009, J CLIN ONCOL S, V27; Celebi JT, 2000, J MED GENET, V37, P653, DOI 10.1136/jmg.37.9.653; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Fisher D E, 2010, Pigment Cell Melanoma Res, V23, P14, DOI 10.1111/j.1755-148X.2009.00655.x; FLAHERTY K, 2009, J CLIN ONCOL S, V27, pNIL18; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gajewski TF, 2006, J CLIN ONCOL, V24, p456S; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gautschi O, 2001, J NATL CANCER I, V93, P463, DOI 10.1093/jnci/93.6.463; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Grover R, 1998, MELANOMA RES, V8, P267, DOI 10.1097/00008390-199806000-00010; Harland M, 2005, GENE CHROMOSOME CANC, V43, P128, DOI 10.1002/gcc.20177; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kefford R., 2010, J CLIN ONCOL S, V28; Keller-Melchior R, 1998, J INVEST DERMATOL, V110, P932, DOI 10.1046/j.1523-1747.1998.00211.x; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Lennartsson J., 2005, CANC THER, V3, P5; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; Li G, 1998, MELANOMA RES, V8, P17, DOI 10.1097/00008390-199802000-00004; Li G, 2000, J INVEST DERMATOL, V114, P514, DOI 10.1046/j.1523-1747.2000.00867.x; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marini A, 2006, J INVEST DERMATOL, V126, P422, DOI 10.1038/sj.jid.5700073; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Meier F, 2009, J AM ACAD DERMATOL, V60, P863, DOI 10.1016/j.jaad.2008.09.053; Mikhail M, 2005, CLIN CANCER RES, V11, P5153, DOI 10.1158/1078-0432.CCR-05-0397; Molhoek KR, 2008, CANCER RES, V68, P4392, DOI 10.1158/0008-5472.CAN-07-5844; OLA MS, 2011, MOL CELL BIOCH; Pavlick AC, 2009, J CLIN ONCOL, V27; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Przybojewska B, 2000, CANCER GENET CYTOGEN, V121, P73, DOI 10.1016/S0165-4608(00)00223-5; Quinlan MP, 2009, FUTURE ONCOL, V5, P105, DOI 10.2217/14796694.5.1.105; Quintas-Cardama A, 2008, NAT CLIN PRACT ONCOL, V5, P737, DOI 10.1038/ncponc1251; Rizos H, 2001, J BIOL CHEM, V276, P41424, DOI 10.1074/jbc.M105299200; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Satzger I, 2010, DERMATOLOGY, V220, P77, DOI 10.1159/000265558; Sauter ER, 2002, CANCER RES, V62, P3200; Schwartz GK, 2009, J CLIN ONCOL, V27; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Smalley KSM, 2008, MOL CANCER THER, V7, P2876, DOI 10.1158/1535-7163.MCT-08-0431; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Straume O, 2000, CLIN CANCER RES, V6, P1845; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Woodman SE, 2009, MOL CANCER THER, V8, P2079, DOI 10.1158/1535-7163.MCT-09-0459; WOODMAN SE, 2010, BIOCH PHARM     0508; Yokoyama S, 2008, PIGM CELL MELANOMA R, V21, P457, DOI 10.1111/j.1755-148X.2008.00480.x	92	66	70	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18257	10.1371/journal.pone.0018257	http://dx.doi.org/10.1371/journal.pone.0018257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479172	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700041
J	Li, C; Fan, S; Owonikoko, TK; Khuri, FR; Sun, SY; Li, R				Li, C.; Fan, S.; Owonikoko, T. K.; Khuri, F. R.; Sun, S-Y; Li, R.			Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway	ONCOGENE			English	Article						EAPII; MAPK-ERK pathway; NSCLC	RECEPTOR-ASSOCIATED FACTORS; NONSMALL CELL; CYCLIN D1; TTRAP; GENE; EXPRESSION; PROTEIN; ETS1; MYC; AMPLIFICATION	Cancer progression involves multiple complex and interdependent steps, including progressive proliferation, angiogenesis and metastases. The complexity of these processes requires a comprehensive elucidation of the integrated signaling networks for better understanding. EAPII interacts with multiple cancer-related proteins, but its biological significance in cancer development remains unknown. In this report we identified the elevated level of EAPII protein in non-small-cell lung carcinoma (NSCLC) patients and NSCLC cell lines in culture. The oncogenic role of EAPII in lung cancer development was demonstrated using NSCLC cells with genetic manipulations that influence EAPII expression: EAPII overexpression increases proliferation of NSCLC cells with an accelerated transition of cell cycle and facilitates xenograft tumor growth in vivo; EAPII knockdown results in apoptosis of NSCLC cells and reduces xenograft tumor formation. To further explore the mechanism of EAPII's oncogenic role in lung cancer development and to elucidate the potential signaling pathway(s) that EAPII may impact, we employed antibody array to investigate the alternation of the major signaling pathways in NSCLC cells with altered EAPII level. We found that EAPII overexpression significantly activated Raf1 and ERK1/2, but not c-Jun N-terminal kinase and p38 pathways. Consistently, the protein and mRNA levels of MYC and cyclin D1, which are targets of the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK-ERK) pathway, are significantly increased by EAPII overexpression. Taken together, we demonstrated that EAPII is an oncogenic factor and the activation of MAPK-ERK signaling pathway by EAPII may contribute to lung cancer development. Oncogene (2011) 30, 3802-3812; doi:10.1038/onc.2011.94; published online 11 April 2011	[Li, C.; Fan, S.; Owonikoko, T. K.; Khuri, F. R.; Sun, S-Y; Li, R.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University	Li, R (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Room 4090,1365C Clifton Rd, Atlanta, GA 30322 USA.	ssun@emory.edu; r.li@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Owonikoko, Taofeek/C-3012-2011	Khuri, Fadlo R./0000-0002-8638-7618; Owonikoko, Taofeek/0000-0002-7724-7728	National Institutes of Health [K22CA109577, RO1CA118450]; Department of Hematology and Medical Oncology, Emory University; NATIONAL CANCER INSTITUTE [K23CA164015, R01CA118450, K22CA109577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Hematology and Medical Oncology, Emory University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs JD Minna (University of Texas Southwestern Medical Center, Dallas) and R Lotan (University of Texas MD Anderson Cancer Center, Houston) for providing HBEC3KT and BEAS2B cell lines and Biomolecular Computing Resource (BIMCORE) at the Emory University School of Medicine for assistance with antibody array analysis. This work was supported in part by National Institutes of Health grants K22CA109577 (RL) and RO1CA118450 (SYS), a start-up fund from the Department of Hematology and Medical Oncology, Emory University (RL).	Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Blanco R, 2009, HUM MUTAT, V30, P1199, DOI 10.1002/humu.21028; Borczuk Alain C, 2009, Proc Am Thorac Soc, V6, P152, DOI 10.1513/pats.200807-076LC; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Hubner A, 2006, DEV CELL, V11, P752, DOI 10.1016/j.devcel.2006.11.006; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lee HY, 2008, ARTERIOSCL THROM VAS, V28, P112, DOI 10.1161/ATVBAHA.107.153304; Lee JT, 2010, CELL CYCLE, V9, P857, DOI 10.4161/cc.9.5.11175; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Li RH, 1999, P NATL ACAD SCI USA, V96, P3876, DOI 10.1073/pnas.96.7.3876; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mitani S, 2001, CLIN EXP MED, V1, P105, DOI 10.1007/s10238-001-8020-5; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Pei HP, 2005, CANCER RES, V65, P7205, DOI 10.1158/0008-5472.CAN-04-3566; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Salomoni P, 2009, CELL DEATH DIFFER, V16, P1083, DOI 10.1038/cdd.2009.63; Sanchez-Cespedes M, 2009, CLIN TRANSL ONCOL, V11, P263, DOI 10.1007/s12094-009-0353-7; SCHAUER IE, 1994, P NATL ACAD SCI USA, V91, P7827, DOI 10.1073/pnas.91.16.7827; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singhal S, 2008, LUNG CANCER, V60, P313, DOI 10.1016/j.lungcan.2008.03.007; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Xu GL, 2008, BIOCHEM BIOPH RES CO, V375, P395, DOI 10.1016/j.bbrc.2008.08.023; Zhang Zheng-Bin, 2007, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V25, P654; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	38	31	33	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	35					3802	3812		10.1038/onc.2011.94	http://dx.doi.org/10.1038/onc.2011.94			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21478903	Green Published, hybrid			2022-12-25	WOS:000294481400007
J	Farghaian, H; Chen, Y; Fu, AWY; Fu, AKY; Ip, JPK; Ip, NY; Turnley, AM; Cole, AR				Farghaian, Hovik; Chen, Yu; Fu, Ada W. Y.; Fu, Amy K. Y.; Ip, Jacque P. K.; Ip, Nancy Y.; Turnley, Ann M.; Cole, Adam R.			Scapinin-induced Inhibition of Axon Elongation Is Attenuated by Phosphorylation and Translocation to the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE INHIBITORS; SUBSTRATE SPECIFICITIES; CYTOCHALASIN-B; ACTIN; BINDING; FAMILY; GROWTH; PHOSPHATASE-1; UPDATE	Scapinin is an actin-and PP1-binding protein that is exclusively expressed in the brain; however, its function in neurons has not been investigated. Here we show that expression of scapinin in primary rat cortical neurons inhibits axon elongation without affecting axon branching, dendritic outgrowth, or polarity. This inhibitory effect was dependent on its ability to bind actin because a mutant form that does not bind actin had no effect on axon elongation. Immunofluorescence analysis showed that scapinin is predominantly located in the distal axon shaft, cell body, and nucleus of neurons and displays a reciprocal staining pattern to phalloidin, consistent with previous reports that it binds actin monomers to inhibit polymerization. We show that scapinin is phosphorylated at a highly conserved site in the central region of the protein (Ser-277) by Cdk5 in vitro. Expression of a scapinin phospho-mimetic mutant (S277D) restored normal axon elongation without affecting actin binding. Instead, phosphorylated scapinin was sequestered in the cytoplasm of neurons and away from the axon. Because its expression is highest in relatively plastic regions of the adult brain (cortex, hippocampus), scapinin is a new regulator of neurite outgrowth and neuroplasticity in the brain.	[Farghaian, Hovik; Cole, Adam R.] Garvan Inst Med Res, Neurosignalling Grp, Sydney, NSW 2010, Australia; [Chen, Yu; Fu, Ada W. Y.; Fu, Amy K. Y.; Ip, Jacque P. K.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Chen, Yu; Fu, Ada W. Y.; Fu, Amy K. Y.; Ip, Jacque P. K.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia	Garvan Institute of Medical Research; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Melbourne	Cole, AR (corresponding author), Garvan Inst Med Res, Neurosignalling Grp, 384 Victoria St, Sydney, NSW 2010, Australia.	a.cole@garvan.org.au	Turnley, Ann/A-8125-2010; Ip, Jacque Pak Kan/AAH-1744-2020	Ip, Jacque Pak Kan/0000-0003-4545-8261; Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Turnley, Ann/0000-0002-8442-127X	Australian National Health and Medical Research Council (NHMRC) [454886]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Supported by an Australian National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship (454886).	Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MORRIS JR, 1984, J CELL BIOL, V98, P2064, DOI 10.1083/jcb.98.6.2064; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Sagara J, 2003, J BIOL CHEM, V278, P45611, DOI 10.1074/jbc.M305227200; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Worch S, 2006, CYTOGENET GENOME RES, V115, P23, DOI 10.1159/000094797	18	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19724	19734		10.1074/jbc.M110.205781	http://dx.doi.org/10.1074/jbc.M110.205781			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487013	Green Published, hybrid			2022-12-25	WOS:000291027700055
J	Liu, SA; Piatigorsky, J				Liu, Shuang; Piatigorsky, Joram			Regulation of Mouse Small Heat Shock Protein alpha b-Crystallin Gene by Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							DIOXIN-RESPONSIVE ENHANCER; LIGANDED AH RECEPTOR; DEVELOPMENTAL EXPRESSION; TRANSCRIPTION FACTORS; DNA INTERACTIONS; 2 MEMBERS; LENS; IDENTIFICATION; PROMOTER; MICE	The stress-inducible small heat shock protein (shsp)/alpha B-crystallin gene is expressed highly in the lens and moderately in other tissues. Here we provide evidence that it is a target gene of the aryl hydrocarbon receptor (AhR) transcription factor. A sequence (-329/-323, CATGCGA) similar to the consensus xenobiotic responsive element (XRE), called here XRE-like, is present in the alpha BE2 region of alpha B-crystallin enhancer and can bind AhR in vitro and in vivo. alpha B-crystallin protein levels were reduced in retina, lens, cornea, heart, skeletal muscle and cultured muscle fibroblasts of AhR(-/-) mice; alpha B-crystallin mRNA levels were reduced in the eye, heart and skeletal muscle of AhR(-/-) mice. Increased AhR stimulated alpha B-crystallin expression in transfection experiments conducted in conjunction with the aryl hydrocarbon receptor nuclear translocator (ARNT) and decreased AhR reduced alpha B-crystallin expression. AhR effect on aB-crystallin promoter activity was cell-dependent in transfection experiments. AhR up-regulated alpha B-crystallin promoter activity in transfected HeLa, NIH3T3 and COS-7 cells in the absence of exogenously added ligand (TCDD), but had no effect on the alpha B-crystallin promoter in C2C12, CV-1 or Hepa-1 cells with or without TCDD. TCDD enhanced AhR-stimulated alpha B-crystallin promoter activity in transfected alpha TN4 cells. AhR could bind to an XRE-like site in the alpha B-crystallin enhancer in vitro and in vivo. Finally, site-specific mutagenesis experiments showed that the XRE-like motif was necessary for both basal and maximal AhR-induction of alpha B-crystallin promoter activity. Our data strongly suggest that AhR is a regulator of alpha B-crystallin gene expression and provide new avenues of research for the mechanism of tissue-specific alpha B-crystallin gene regulation under normal and physiologically stressed conditions.	[Liu, Shuang; Piatigorsky, Joram] NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Liu, Shuang] NCI, Expt Immunol Lab, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, SA (corresponding author), NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA.	liushuang1999@yahoo.com; joramp@nei.nih.gov			NIH, NEI	NIH, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Intramural Research Program of the NIH, NEI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BD, 1995, DEV DYNAM, V204, P144, DOI 10.1002/aja.1002040205; ABBOTT BD, 1995, DEV DYNAM, V204, P133, DOI 10.1002/aja.1002040204; Andreasen EA, 2002, TOXICOL SCI, V68, P403, DOI 10.1093/toxsci/68.2.403; ARRIGO AP, 2002, SMALL STRESS PROTEIN, pR15; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Boutros PC, 2004, BIOCHEM BIOPH RES CO, V321, P707, DOI 10.1016/j.bbrc.2004.06.177; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; DERETIC D, 1994, J BIOL CHEM, V269, P16853; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Duncan B, 2007, DNA CELL BIOL, V26, P745, DOI 10.1089/dna.2007.0629; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Gopal-Srivastava R, 1998, J BIOL CHEM, V273, P17954, DOI 10.1074/jbc.273.28.17954; GopalSrivastava R, 1996, J BIOL CHEM, V271, P23029, DOI 10.1074/jbc.271.38.23029; GOPALSRIVASTAVA R, 1993, MOL CELL BIOL, V13, P7144, DOI 10.1128/MCB.13.11.7144; Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; LUSSKA A, 1993, J BIOL CHEM, V268, P6575; Matsumura F, 2006, BIOL CHEM, V387, P1189, DOI 10.1515/BC.2006.146; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Piatigorsky J, 2007, GENE SHARING EVOLUTI, pxv; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; SHEN ES, 1992, J BIOL CHEM, V267, P6815; Shimauchi-Matsukawa Y, 2008, MOL VIS, V14, P358; Sogawa K, 2004, BIOCHEM BIOPH RES CO, V318, P746, DOI 10.1016/j.bbrc.2004.04.090; Swamynathan SK, 2007, INT J DEV BIOL, V51, P689, DOI 10.1387/ijdb.072302ss; Swamynathan SK, 2002, J BIOL CHEM, V277, P49700, DOI 10.1074/jbc.M209700200; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Xi JH, 2003, MOL VIS, V9, P410	40	12	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e17904	10.1371/journal.pone.0017904	http://dx.doi.org/10.1371/journal.pone.0017904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494593	gold, Green Published, Green Submitted			2022-12-25	WOS:000289354100003
J	Chen, Z; Buki, K; Vaaraniemi, J; Gu, GL; Vaananen, HK				Chen, Zhi; Buki, Kalman; Vaaraniemi, Jukka; Gu, Guoliang; Vaananen, H. Kalervo			The Critical Role of IL-34 in Osteoclastogenesis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BONE-RESORPTION; OSTEOPROTEGERIN LIGAND; OP/OP MICE; DIFFERENTIATION; CELLS; EXPRESSION; CYTOKINE; RECEPTOR; GENE	It has been widely believed that the cytokines required for osteoclast formation are M-CSF (also known as CSF-1) and RANKL. Recently, a novel cytokine, designated IL-34, has been identified as another ligand of CSF1R. This study was to explore the biological function, specifically osteoclastogenesis and bone metabolism, of the new cytokine. We produced recombinant mouse IL-34 and found that together with RANKL it induces the formation of osteoclasts both from splenocytes as well as dose-dependently from bone marrow cells in mouse and these cells also revealed bone resorption activity. It also promotes osteoclast differentiation from human peripheral blood mononucleated cells. Finally, we show that systemic administration of IL-34 to mice increases the proportion of CD11b+ cells and reduces trabecular bone mass. Our data indicate that IL-34 is another important player in osteoclastogenesis and thus may have a role in bone diseases. Strategies of targeting CSF1/CSF1R have been developed and some of them are already in preclinical and clinical studies for treatment of inflammatory diseases. Our results strongly suggest the need to revisit these strategies as they may provide a new potential pharmaceutical target for the regulation of bone metabolism in addition to their role in the treatment of inflammatory diseases.	[Chen, Zhi; Buki, Kalman; Vaaraniemi, Jukka; Gu, Guoliang] Univ Turku, Dept Cell Biol & Anat, Inst Biomed, Turku, Finland; [Vaananen, H. Kalervo] Univ Eastern Finland, Kuopio, Finland	University of Turku; University of Eastern Finland	Chen, Z (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	zchen@utu.fi		Chen, Zhi/0000-0002-4658-7463	Academy of Finland [122330]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by the Academy of Finland (www.aka.fi. Decision No. 122330) and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; SELANDER K, 1994, CALCIFIED TISSUE INT, V55, P368, DOI 10.1007/BF00299317; Sezer O, 2003, BLOOD, V101, P2094, DOI 10.1182/blood-2002-09-2684; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Van Wesenbeeck L, 2002, P NATL ACAD SCI USA, V99, P14303, DOI 10.1073/pnas.202332999; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	29	73	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18689	10.1371/journal.pone.0018689	http://dx.doi.org/10.1371/journal.pone.0018689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494622	gold, Green Published, Green Submitted			2022-12-25	WOS:000289292800037
J	D'Amato, FR; Zanettini, C; Lampis, V; Coccurello, R; Pascucci, T; Ventura, R; Puglisi-Allegra, S; Spatola, CAM; Pesenti-Gritti, P; Oddi, D; Moles, A; Battaglia, M				D'Amato, Francesca R.; Zanettini, Claudio; Lampis, Valentina; Coccurello, Roberto; Pascucci, Tiziana; Ventura, Rossella; Puglisi-Allegra, Stefano; Spatola, Chiara A. M.; Pesenti-Gritti, Paola; Oddi, Diego; Moles, Anna; Battaglia, Marco			Unstable Maternal Environment, Separation Anxiety, and Heightened CO2 Sensitivity Induced by Gene-by-Environment Interplay	PLOS ONE			English	Article							CARBON-DIOXIDE; PANIC DISORDER; VENTILATORY RESPONSE; INBRED STRAINS; BEHAVIOR; MICE; MOUSE; TWIN; PSYCHOPATHOLOGY; HYPERCAPNIA	Background: In man, many different events implying childhood separation from caregivers/unstable parental environment are associated with heightened risk for panic disorder in adulthood. Twin data show that the occurrence of such events in childhood contributes to explaining the covariation between separation anxiety disorder, panic, and the related psychobiological trait of CO2 hypersensitivity. We hypothesized that early interference with infant-mother interaction could moderate the interspecific trait of response to CO2 through genetic control of sensitivity to the environment. Methodology: Having spent the first 24 hours after birth with their biological mother, outbred NMRI mice were cross-fostered to adoptive mothers for the following 4 post-natal days. They were successively compared to normally-reared individuals for: number of ultrasonic vocalizations during isolation, respiratory physiology responses to normal air (20%O-2), CO2-enriched air (6% CO2), hypoxic air (10%O-2), and avoidance of CO2-enriched environments. Results: Cross-fostered pups showed significantly more ultrasonic vocalizations, more pronounced hyperventilatory responses (larger tidal volume and minute volume increments) to CO2-enriched air and heightened aversion towards CO2-enriched environments, than normally-reared individuals. Enhanced tidal volume increment response to 6% CO2 was present at 16-20, and 75-90 postnatal days, implying the trait's stability. Quantitative genetic analyses of unrelated individuals, sibs and half-sibs, showed that the genetic variance for tidal volume increment during 6% CO2 breathing was significantly higher (Bartlett chi = 8.3, p = 0.004) among the cross-fostered than the normally-reared individuals, yielding heritability of 0.37 and 0.21 respectively. These results support a stress-diathesis model whereby the genetic influences underlying the response to 6% CO2 increase their contribution in the presence of an environmental adversity. Maternal grooming/licking behaviour, and corticosterone basal levels were similar among cross-fostered and normally-reared individuals. Conclusions: A mechanism of gene-by-environment interplay connects this form of early perturbation of infant-mother interaction, heightened CO2 sensitivity and anxiety. Some non-inferential physiological measurements can enhance animal models of human neurodevelopmental anxiety disorders.	[Lampis, Valentina; Spatola, Chiara A. M.; Pesenti-Gritti, Paola; Battaglia, Marco] Univ Vita Salute San Raffaele, Acad Ctr Study Behav Plast, Milan, Italy; [Pascucci, Tiziana; Ventura, Rossella; Puglisi-Allegra, Stefano] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy; [Pascucci, Tiziana; Puglisi-Allegra, Stefano] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Ventura, Rossella] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy; [Moles, Anna] Genomnia, Lainate, Italy; [Battaglia, Marco] Ist Sci San Raffaele, Dept Clin Neurosci, Milan, Italy; [D'Amato, Francesca R.; Zanettini, Claudio; Coccurello, Roberto; Oddi, Diego; Moles, Anna] CNR, Cell Biol & Neurobiol Inst, Rome, Italy	Vita-Salute San Raffaele University; IRCCS Santa Lucia; Sapienza University Rome; University of L'Aquila; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR)	D'Amato, FR (corresponding author), CNR, Cell Biol & Neurobiol Inst, Rome, Italy.	marco.battaglia@unisr.it	Coccurello, Roberto/F-8460-2015; Lampis, Valentina/AAA-9001-2022; Puglisi-Allegra, Stefano/ABI-7468-2020; Pascucci, Tiziana/AAB-9706-2019; Ventura, Rossella/AAA-8816-2019	Lampis, Valentina/0000-0003-0895-7918; Puglisi-Allegra, Stefano/0000-0002-9433-2000; Ventura, Rossella/0000-0002-7601-8683; COCCURELLO, ROBERTO/0000-0001-7059-7015; D'Amato, Francesca/0000-0002-4577-4574; Spatola, Chiara/0000-0003-4807-9566; Pascucci, Tiziana/0000-0003-1520-7373; Moles, Anna/0000-0002-5805-5763	Italian Ministry of University; Fondazione Telethon Funding Source: Custom	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Fondazione Telethon(Fondazione Telethon)	Supported in part by grants from the Italian Ministry of University and Research PRIN 2008 grant (MB and FRD), from The Region Lombardy Grant Funding for Scientific and Technological Partnerships grant SAL-25/16848 (MB), and by an award granted by the Anna Villa & Felice Rusconi Foundation (MB). FRD, AM, CZ, RC and DO were supported by funds from Regione Lazio for "Sviluppo della Ricerca sul Cervello"; FRD and AM were also partially supported by Telethon, Italy (Grant no. GGP05220). VL, CAMS, and PP-G are in the San Raffaele University PhD Program in Developmental Psychopathology, supported in part by the CARIPLO Foundation "Human Talents" Grant for Academic Centres of Excellence in Post-Graduate Teaching (Dr. Battaglia, recipient). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANDERSON DJ, 1984, AM J PSYCHIAT, V141, P572; Barbazanges A, 1996, J NEUROSCI, V16, P7783; Bartolomucci A, 2004, GENES BRAIN BEHAV, V3, P115, DOI 10.1111/j.1601-183X.2003.00059.x; BATTAGLIA M, 1995, AM J PSYCHIAT, V152, P1362; Battaglia M, 2005, NEUROSCI BIOBEHAV R, V29, P169, DOI 10.1016/j.neubiorev.2004.06.013; Battaglia M, 2008, AM J MED GENET B, V147B, P586, DOI 10.1002/ajmg.b.30647; Battaglia M, 2007, J PSYCHIATR RES, V41, P906, DOI 10.1016/j.jpsychires.2006.12.002; Battaglia M, 2009, ARCH GEN PSYCHIAT, V66, P64, DOI 10.1001/archgenpsychiatry.2008.513; Bavis RW, 2008, J APPL PHYSIOL, V104, P1220, DOI 10.1152/japplphysiol.01086.2007; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Colasanti A, 2008, NEUROPSYCHOPHARMACOL, V33, P3103, DOI 10.1038/npp.2008.31; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Falconer D. S, 1996, INTRO QUANTITATIVE G; Forman EM, 2003, J CLIN CHILD ADOLESC, V32, P94, DOI 10.1207/S15374424JCCP3201_09; Fyer AJ, 1999, AM J MED GENET, V88, P173, DOI 10.1002/(SICI)1096-8628(19990416)88:2<173::AID-AJMG15>3.0.CO;2-#; Gaultier C, 2008, J APPL PHYSIOL, V104, P1522, DOI 10.1152/japplphysiol.01266.2007; Genest SE, 2004, J PHYSIOL-LONDON, V554, P543, DOI 10.1113/jphysiol.2003.052894; Genest SE, 2007, J APPL PHYSIOL, V102, P1416, DOI 10.1152/japplphysiol.00454.2006; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Griez EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000987; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Han F, 2000, RESP PHYSIOL, V121, P247, DOI 10.1016/S0034-5687(00)00132-8; Jacob RG, 1996, AM J PSYCHIAT, V153, P503; Kas MJH, 2007, MOL PSYCHIATR, V12, P324, DOI 10.1038/sj.mp.4001979; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P109; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Klein RG, 1995, CLIN NEUROPHARMACOL, V18, pS7; MACLEAN PD, 1985, ARCH GEN PSYCHIAT, V42, P405; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Mather K, 1982, BIOMETRICAL GENETICS; MILLHORN DE, 1986, J APPL PHYSIOL, V61, P1249, DOI 10.1152/jappl.1986.61.4.1249; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Ogliari A, 2010, PSYCHOTHER PSYCHOSOM, V79, P48, DOI 10.1159/000259417; Pine DS, 2000, ARCH GEN PSYCHIAT, V57, P960, DOI 10.1001/archpsyc.57.10.960; Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Ricceri L, 2007, BEHAV BRAIN RES, V176, P40, DOI 10.1016/j.bbr.2006.08.024; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Shoji H, 2006, PHYSIOL BEHAV, V89, P320, DOI 10.1016/j.physbeh.2006.06.012; Shoji H, 2009, DEV PSYCHOBIOL, V51, P345, DOI 10.1002/dev.20375; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Smoller JW, 1998, AM J PSYCHIAT, V155, P1152, DOI 10.1176/ajp.155.9.1152; Spatola CAM, 2011, AM J MED GENET B, V156B, P79, DOI 10.1002/ajmg.b.31144; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; TANKERSLEY CG, 1994, AM J PHYSIOL-REG I, V267, pR1371, DOI 10.1152/ajpregu.1994.267.5.R1371; Terleph TA, 2006, AM J PSYCHIAT, V163, P738, DOI 10.1176/appi.ajp.163.4.738; Upton KJ, 2010, DEV PSYCHOBIOL, V52, P453, DOI 10.1002/dev.20448; van Duinen MA, 2007, INT J NEUROPSYCHOPH, V10, P797; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769; WESTBERG P, 1991, BIOL PSYCHIAT, V30, P247, DOI 10.1016/0006-3223(91)90109-Y; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	59	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18637	10.1371/journal.pone.0018637	http://dx.doi.org/10.1371/journal.pone.0018637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494633	Green Published, gold, Green Accepted			2022-12-25	WOS:000289292800033
J	Duncan, DS; Miller, SD				Duncan, D'Anne S.; Miller, Stephen D.			CNS Expression of B7-H1 Regulates Pro-Inflammatory Cytokine Production and Alters Severity of Theiler's Virus-Induced Demyelinating Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ADAPTIVE IMMUNE-RESPONSES; SELF MYELIN EPITOPES; B7 FAMILY; MULTIPLE-SCLEROSIS; ENDOGENOUS PRESENTATION; CELL-PROLIFERATION; RESIDENT APCS; INFECTED MICE	The CNS is a unique organ due to its limited capacity for immune surveillance. As macrophages of the CNS, microglia represent a population originally known for the ability to assist neuronal stability, are now appreciated for their role in initiating and regulating immune responses in the brain. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease is a mouse model of multiple sclerosis ( MS). In response to TMEV infection in vitro, microglia produce high levels of inflammatory cytokines and chemokines, and are efficient antigen-presenting cells (APCs) for activating CD4(+) T cells. However, the regulatory function of microglia and other CNS-infiltrating APCs in response to TMEV in vivo remains unclear. Here we demonstrate that microglia increase expression of proliferating cell nuclear antigen ( PCNA), and phenotypically express high levels of major histocompatibility complex (MHC)-Class I and II in response to acute infection with TMEV in SJL/J mice. Microglia increase expression of the inhibitory co-stimulatory molecule, B7-H1 as early as day 5 post-infection, while CNS-infiltrating CD11b(+)CD11c(-)CD45(HIGH) monocytes/macrophages and CD11b(+)CD11c(+)CD45(HIGH) dendritic cells upregulate expression of B7-H1 by day 3 post-infection. Utilizing a neutralizing antibody, we demonstrate that B7-H1 negatively regulates TMEV-specific ex vivo production of interferon (IFN)-gamma, interleukin (IL)-17, IL-10, and IL-2 from CD4(+) and CD8(+) T cells. In vivo blockade of B7-H1 in SJL/J mice significantly exacerbates clinical disease symptoms during the chronic autoimmune stage of TMEV-IDD, but only has minimal effects on viral clearance. Collectively, these results suggest that CNS expression of B7-H1 regulates activation of TMEV-specific T cells, which affects protection against TMEV-IDD.	[Duncan, D'Anne S.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Duncan, DS (corresponding author), Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu			National Institutes of Health [NS-062365]; National Multiple Sclerosis Society [RG 4294A9/1]; Northwestern University [T32 AI060523-04]; NRSA [F31 NS061621]; Northwestern University Alliance for Graduate Education and the Professoriate (AGEP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062365, F31NS061621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Northwestern University; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Alliance for Graduate Education and the Professoriate (AGEP)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health R01 Grant NS-062365 and National Multiple Sclerosis Society Grant RG 4294A9/1. DSD was supported by Northwestern University Viral Replication Training Grant (T32 AI060523-04), NRSA Predoctoral Fellowship (F31 NS061621), and the Northwestern University Alliance for Graduate Education and the Professoriate (AGEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bowen JL, 2009, J IMMUNOL, V183, P6971, DOI 10.4049/jimmunol.0902193; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Carson MJ, 1999, J NEUROSCI RES, V55, P1; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Dong HD, 1999, NAT MED, V5, P1365; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hamo L, 2007, GLIA, V55, P1169, DOI 10.1002/glia.20538; Katz-Levy Y, 1999, J CLIN INVEST, V104, P599, DOI 10.1172/JCI7292; Katz-Levy Y, 2000, J IMMUNOL, V165, P5304, DOI 10.4049/jimmunol.165.9.5304; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Lafon M, 2008, J IMMUNOL, V180, P7506, DOI 10.4049/jimmunol.180.11.7506; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Mack CL, 2003, J NEUROIMMUNOL, V144, P68, DOI 10.1016/j.jneuroim.2003.08.032; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Miller SD, 2001, J AUTOIMMUN, V16, P219, DOI 10.1006/jaut.2000.0489; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Olson JK, 2001, J VIROL, V75, P9780, DOI 10.1128/JVI.75.20.9780-9789.2001; Phares TW, 2009, J IMMUNOL, V182, P5430, DOI 10.4049/jimmunol.0803557; Ponomarev ED, 2005, J IMMUNOL METHODS, V300, P32, DOI 10.1016/j.jim.2005.02.011; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; SCHREINER B, 2008, EUR J IMMUNOL; Williams K, 2002, AM J PATHOL, V161, P575, DOI 10.1016/S0002-9440(10)64213-7	30	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18548	10.1371/journal.pone.0018548	http://dx.doi.org/10.1371/journal.pone.0018548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494618	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800028
J	Chiang, J; Hodes, RJ				Chiang, Jeffrey; Hodes, Richard J.			Cbl Enforces Vav1 Dependence and a Restricted Pathway of T Cell Development	PLOS ONE			English	Article							ADAPTER PROTEIN SLP-76; C-CBL; DIFFERENTIAL REQUIREMENT; TYROSINE PHOSPHORYLATION; LYMPHOCYTE DEVELOPMENT; NEGATIVE REGULATION; RECEPTOR SIGNALS; ACTIVATION; ZAP-70; FAMILY	Extensive studies of pre-TCR- and TCR-dependent signaling have led to characterization of a pathway deemed essential for efficient T cell development, and comprised of a cascade of sequential events involving phosphorylation of Lck and ZAP-70, followed by phosphorylation of LAT and SLP-76, and subsequent additional downstream events. Of interest, however, reports from our lab as well as others have indicated that the requirements for ZAP-70, LAT, and SLP-76 are partially reversed by inactivation of c-Cbl (Cbl), an E3 ubiquitin ligase that targets multiple molecules for ubiquitination and degradation. Analysis of signaling events in these Cbl knockout models, including the recently reported analysis of SLP-76 transgenes defective in interaction with Vav1, suggested that activation of Vav1 might be a critical event in alternative pathways of T cell development. To extend the analysis of signaling requirements for thymic development, we have therefore assessed the effect of Cbl inactivation on the T cell developmental defects that occur in Vav1-deficient mice. The defects in Vav1-deficient thymic development, including a marked defect in DN3-DN4 transition, were completely reversed by Cbl inactivation, accompanied by enhanced phosphorylation of PLC-gamma 1 and ERKs in response to pre-TCR/TCR cross-linking of Vav1(-/-)Cbl(-/-)DP thymocytes. Taken together, these results suggest a substantially modified paradigm for pre-TCR/TCR signaling and T cell development. The observed consensus pathways of T cell development, including requirements for ZAP-70, LAT, SLP-76, and Vav1, appear to reflect the restriction by Cbl of an otherwise much broader set of molecular pathways capable of mediating T cell development.	[Chiang, Jeffrey; Hodes, Richard J.] NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; [Hodes, Richard J.] NIA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chiang, J (corresponding author), NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA.	chiangj@mail.nih.gov			National Institutes of Health (NIH), National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC009281] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; Chiang YJ, 2009, J BIOL CHEM, V284, P4429, DOI 10.1074/jbc.M808679200; Chiang YJ, 2004, J EXP MED, V200, P25, DOI 10.1084/jem.20040262; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; FitzerAttas CJ, 1997, J BIOL CHEM, V272, P8551, DOI 10.1074/jbc.272.13.8551; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Myung PS, 2001, IMMUNITY, V15, P1011, DOI 10.1016/S1074-7613(01)00253-9; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; QI Q, 2007, SCI STKE, pPE39; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; Thien CBF, 1999, J IMMUNOL, V162, P7133; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Vacchio MS, 2005, J IMMUNOL, V174, P4657, DOI 10.4049/jimmunol.174.8.4657; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18542	10.1371/journal.pone.0018542	http://dx.doi.org/10.1371/journal.pone.0018542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490975	Green Submitted, Green Published, gold			2022-12-25	WOS:000289238700022
J	Lenz, KM; Wright, CL; Martin, RC; McCarthy, MM				Lenz, Kathryn M.; Wright, Christopher L.; Martin, Ryan C.; McCarthy, Margaret M.			Prostaglandin E-2 Regulates AMPA Receptor Phosphorylation and Promotes Membrane Insertion in Preoptic Area Neurons and Glia during Sexual Differentiation	PLOS ONE			English	Article							PROTEIN-KINASE-A; DENDRITIC SPINE PROLIFERATION; SYNAPTIC-TRANSMISSION; PLASTICITY; BEHAVIOR; MASCULINIZATION; INDUCTION; ESTRADIOL; BRAIN; ASTROCYTES	Sexual differentiation of the rodent brain is dependent upon the organizing actions of the steroid hormone, estradiol. In the preoptic area, a brain region critical for the expression of adult reproductive behavior, there are twice as many dendritic spine synapses per unit length on newborn male neurons compared to female neurons and this sex difference correlates with the expression of adult male copulatory behavior. The sex difference in the POA is achieved via estradiol's upregulation of the membrane-derived lipid signaling molecule prostaglandin E-2 (PGE(2)); PGE(2) is necessary and sufficient to masculinize both dendritic spine density and adult sexual behavior in rats. We have previously shown that PGE(2) activates EP2 and EP4 receptors which increases protein kinase A (PKA) activity and that masculinized dendritic spine density and sex behavior are both dependent upon PKA as well as activation of AMPA type glutamate receptors. In the current experiments, we build upon this signaling cascade by determining that PGE(2) induces phosphorylation of the AMPA receptor subunit, GluR1, which leads to increased AMPA receptor insertion at the membrane. Treating female pups on the day of birth with PGE(2) induced the phosphorylation of GluR1 at the PKA-sensitive site within 2 hours of treatment, an effect that was blocked by co-administration of the PKA/AKAP inhibitor, HT31 with PGE(2). Brief treatment of mixed neuronal/glial POA cultures with PGE(2) or the cAMP/PKA stimulator, forskolin, increased membrane associated GluR1 in both neurons and glia. We speculate that PGE(2) induced increases in AMPA receptor associated with the membrane underlies our previously observed increase in dendritic spine density and is a critical component in the masculinization of rodent sex behavior.	[Lenz, Kathryn M.; Martin, Ryan C.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Lenz, Kathryn M.; Martin, Ryan C.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Wright, Christopher L.] Loyola Univ Maryland, Dept Biol, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Loyola University Maryland	Lenz, KM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	kmlenz@umaryland.edu	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726	U.S. National Institutes of Health [R01 MH052716, T32 NS007375]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the U.S. National Institutes of Health R01 MH052716 (MMM) and T32 NS007375. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Amateau SK, 2002, J NEUROSCI, V22, P8586; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; Dziedzic B, 2003, J NEUROSCI, V23, P915; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Koch H, 2010, J NEUROSCI, V30, P11678, DOI 10.1523/JNEUROSCI.4665-09.2010; Ma YJ, 1997, ENDOCRINOLOGY, V138, P19, DOI 10.1210/en.138.1.19; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Perrot-Sinal TS, 2001, BRAIN RES, V922, P201, DOI 10.1016/S0006-8993(01)03167-5; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; SEIL FJ, 1992, EXP NEUROL, V117, P85, DOI 10.1016/0014-4886(92)90114-6; Seil Fredrick J., 1997, Journal of Neural Transplantation and Plasticity, V6, P1; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Wright CL, 2008, DEV NEUROBIOL, V68, P1406, DOI 10.1002/dneu.20665; Wright CL, 2009, J NEUROSCI, V29, P13274, DOI 10.1523/JNEUROSCI.3603-09.2009; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	25	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18500	10.1371/journal.pone.0018500	http://dx.doi.org/10.1371/journal.pone.0018500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490976	Green Published, Green Submitted, gold			2022-12-25	WOS:000289238700017
J	Wang, R; Ahmed, J; Wang, GQ; Hassan, I; Strulovici-Barel, Y; Hackett, NR; Crystal, RG				Wang, Rui; Ahmed, Joumana; Wang, Guoqing; Hassan, Ibrahim; Strulovici-Barel, Yael; Hackett, Neil R.; Crystal, Ronald G.			Down-Regulation of the Canonical Wnt beta-Catenin Pathway in the Airway Epithelium of Healthy Smokers and Smokers with COPD	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEINS; STEM-CELLS; GENE-EXPRESSION; LUNG DEVELOPMENT; CIGARETTE-SMOKE; OVINE UTERUS; BASAL-CELLS; DIFFERENTIATION; ACTIVATION; INHIBITION	Background: The Wnt pathway mediates differentiation of epithelial tissues; depending on the tissue types, Wnt can either drive or inhibit the differentiation process. We hypothesized that key genes in the Wnt pathway are suppressed in the human airway epithelium under the stress of cigarette smoking, a stress associated with dysregulation of the epithelial differentiated state. Methodology/Principal Findings: Microarrays were used to assess the expression of Wnt-related genes in the small airway epithelium (SAE) obtained via bronchoscopy and brushing of healthy nonsmokers, healthy smokers, and smokers with COPD. Thirty-three of 56 known Wnt-related genes were expressed in the SAE. Wnt pathway downstream mediators beta-catenin and the transcription factor 7-like 1 were down-regulated in healthy smokers and smokers with COPD, as were many Wnt target genes. Among the extracellular regulators that suppress the Wnt pathway, secreted frizzled-related protein 2 (SFRP2), was up-regulated 4.3-fold in healthy smokers and 4.9-fold in COPD smokers, an observation confirmed by TaqMan Real-time PCR, Western analysis and immunohistochemistry. Finally, cigarette smoke extract mediated up-regulation of SFRP2 and down-regulation of Wnt target genes in airway epithelial cells in vitro. Conclusions/Significance: Smoking down-regulates the Wnt pathway in the human airway epithelium. In the context that Wnt pathway plays an important role in differentiation of epithelial tissues, the down-regulation of Wnt pathway may contribute to the dysregulation of airway epithelium differentiation observed in smoking-related airway disorders.	[Wang, Rui; Ahmed, Joumana; Wang, Guoqing; Hassan, Ibrahim; Strulovici-Barel, Yael; Hackett, Neil R.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University	Wang, R (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu	Hassan, Ibrahim/ABH-1285-2020	Hassan, Ibrahim/0000-0001-6863-4593	National Institutes of Health [R01 HL074326, P50 HL084936, UL1-RR024996, 1T32HL094284]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936, R01HL074326, T32HL094284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by National Institutes of Health R01 HL074326, P50 HL084936; UL1-RR024996; and 1T32HL094284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bishop AE, 2004, CELL PROLIFERAT, V37, P89, DOI 10.1111/j.1365-2184.2004.00302.x; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; COSIO MG, 1980, AM REV RESPIR DIS, V122, P265; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Das AV, 2008, DEV NEUROSCI-BASEL, V30, P389, DOI 10.1159/000178017; De Langhe Stijn P, 2008, Organogenesis, V4, P100; Deb A, 2008, STEM CELLS, V26, P35, DOI 10.1634/stemcells.2007-0475; DEMOLY P, 1994, AM J RESP CRIT CARE, V150, P214, DOI 10.1164/ajrccm.150.1.7912988; Descamps S, 2008, CELL TISSUE RES, V332, P299, DOI 10.1007/s00441-008-0574-z; Esteve P, 2003, J CELL SCI, V116, P2471, DOI 10.1242/jcs.00452; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Hayashi K, 2006, BIOL REPROD, V74, P721, DOI 10.1095/biolreprod.105.049718; He B, 2006, Ernst Schering Found Symp Proc, P27; He B, 2005, CLIN LUNG CANCER, V7, P54, DOI 10.3816/CLC.2005.n.022; Heguy A, 2007, PHYSIOL GENOMICS, V29, P139, DOI 10.1152/physiolgenomics.00167.2006; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004; Imai K, 2002, CHEST, V121, p7S, DOI 10.1378/chest.121.3_suppl.7S; Jaluria P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-71; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kinnula VL, 2005, THORAX, V60, P693, DOI 10.1136/thx.2004.037473; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; KONIGSHOFF M, 2009, AM J RESP CELL MOL B; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee JL, 2006, BREAST CANCER RES TR, V100, P49, DOI 10.1007/s10549-006-9233-9; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Morello R, 2008, J CELL PHYSIOL, V217, P127, DOI 10.1002/jcp.21483; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rennard SI, 2007, EUR RESPIR REV, V16, P91, DOI 10.1183/09059180.00010502; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Takayasu H, 2007, J PEDIATR SURG, V42, P426, DOI 10.1016/j.jpedsurg.2006.10.018; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; Wagatsuma A, 2007, MOL CELL BIOCHEM, V304, P25, DOI 10.1007/s11010-007-9482-x; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	74	90	97	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e14793	10.1371/journal.pone.0014793	http://dx.doi.org/10.1371/journal.pone.0014793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490961	Green Published, Green Submitted, gold			2022-12-25	WOS:000289238700001
J	Elkan-Miller, T; Ulitsky, I; Hertzano, R; Rudnicki, A; Dror, AA; Lenz, DR; Elkon, R; Irmler, M; Beckers, J; Shamir, R; Avraham, KB				Elkan-Miller, Tal; Ulitsky, Igor; Hertzano, Ronna; Rudnicki, Anya; Dror, Amiel A.; Lenz, Danielle R.; Elkon, Ran; Irmler, Martin; Beckers, Johannes; Shamir, Ron; Avraham, Karen B.			Integration of Transcriptomics, Proteomics, and MicroRNA Analyses Reveals Novel MicroRNA Regulation of Targets in the Mammalian Inner Ear	PLOS ONE			English	Article							GROWTH-FACTOR LEDGF/P75; PROGRESSIVE HEARING-LOSS; GENE-EXPRESSION; SENSORY EPITHELIA; CANCER CELLS; HAIR-CELLS; MOUSE; IDENTIFICATION; ACTIVATION; MUTATIONS	We have employed a novel approach for the identification of functionally important microRNA (miRNA)-target interactions, integrating miRNA, transcriptome and proteome profiles and advanced in silico analysis using the FAME algorithm. Since miRNAs play a crucial role in the inner ear, demonstrated by the discovery of mutations in a miRNA leading to human and mouse deafness, we applied this approach to microdissected auditory and vestibular sensory epithelia. We detected the expression of 157 miRNAs in the inner ear sensory epithelia, with 53 miRNAs differentially expressed between the cochlea and vestibule. Functionally important miRNAs were determined by searching for enriched or depleted targets in the transcript and protein datasets with an expression consistent with the dogma of miRNA regulation. Importantly, quite a few of the targets were detected only in the protein datasets, attributable to regulation by translational suppression. We identified and experimentally validated the regulation of PSIP1-P75, a transcriptional co-activator previously unknown in the inner ear, by miR-135b, in vestibular hair cells. Our findings suggest that miR-135b serves as a cellular effector, involved in regulating some of the differences between the cochlear and vestibular hair cells.	[Elkan-Miller, Tal; Hertzano, Ronna; Rudnicki, Anya; Dror, Amiel A.; Lenz, Danielle R.; Elkon, Ran; Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Ulitsky, Igor; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Irmler, Martin; Beckers, Johannes] Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Expt Genet, Neuherberg, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-8050 Freising Weihenstephan, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Elkan-Miller, T (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	karena@post.tau.ac.il	Dror, Amiel/AAB-7522-2020; Ulitsky, Igor/HCH-7453-2022; Dror, Amiel/AAD-3348-2022; Irmler, Martin/B-3317-2013; Hertzano, Ronna P/Y-8304-2019; Beckers, Johannes/K-7237-2012	Ulitsky, Igor/0000-0003-0555-6561; Dror, Amiel/0000-0002-7178-6771; Irmler, Martin/0000-0003-3169-479X; Beckers, Johannes/0000-0001-7874-3822; Avraham, Karen B/0000-0002-4913-251X; Shamir, Ron/0000-0003-1889-9870	Israel Science Foundation [1486/07, 802/08]; European Commission [LSHG-CT-2004-512063, HEALTH-F4-2009-223575]; Eumodic [037188]; Helmholtz Alliance CoReNe; Tel Aviv University; Legacy Heritage Fund	Israel Science Foundation(Israel Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Eumodic; Helmholtz Alliance CoReNe; Tel Aviv University; Legacy Heritage Fund	This work was supported by the Israel Science Foundation (Grant number 1486/07), European Commission FP6 Integrated Projects EuroHear (Grant number LSHG-CT-2004-512063) and Eumodic (Grant number 037188) (to K.B.A.); Helmholtz Alliance CoReNe (to J.B.); Israel Science Foundation (Grant number 802/08) and the European Union 7th framework programme (project HEALTH-F4-2009-223575, TRIREME) (to R.S.). I.U. was supported in part by the Edmond J. Safra Bioinformatics program at Tel Aviv University and the Legacy Heritage Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen YR, 2006, J PROTEOME RES, V5, P2727, DOI 10.1021/pr060212g; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chylack LT, 2004, EXP EYE RES, V79, P941, DOI 10.1016/j.exer.2004.08.022; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Dror AA, 2010, J BIOL CHEM, V285, P21724, DOI 10.1074/jbc.M110.120188; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; GIOANNI J, 1990, BRIT J CANCER, V62, P8, DOI 10.1038/bjc.1990.219; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Grosshans H, 2008, CELL, V134, P560, DOI 10.1016/j.cell.2008.08.008; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hertzano R, 2010, JARO-J ASSOC RES OTO, V11, P407, DOI 10.1007/s10162-010-0211-x; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Irmler M, 2008, PROTEOMICS, V8, P1165, DOI 10.1002/pmic.200700741; Kawamoto K, 2009, HEARING RES, V247, P17, DOI 10.1016/j.heares.2008.08.010; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly M, 2007, INT J DEV BIOL, V51, P535, DOI 10.1387/ijdb.072344mk; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kubo E, 2003, HISTOCHEM CELL BIOL, V119, P289, DOI 10.1007/s00418-003-0518-3; Kubo E, 2002, J MOL BIOL, V320, P1053, DOI 10.1016/S0022-2836(02)00551-X; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; Nishizawa Y, 2001, CELL TISSUE RES, V305, P107, DOI 10.1007/s004410100398; Oshima A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034397; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takacs CM, 2010, SEMIN CELL DEV BIOL, V21, P760, DOI 10.1016/j.semcdb.2010.02.003; Tunnacliffe A, 1996, MAMM GENOME, V7, P784, DOI 10.1007/s003359900234; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Voorhoeve PM, 2007, ADV EXP MED BIOL, V604, P17, DOI 10.1007/978-0-387-69116-9_2; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Yang Y, 2010, MOL BIOSYST, V6, P1873, DOI 10.1039/c004401f; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551	60	63	69	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18195	10.1371/journal.pone.0018195	http://dx.doi.org/10.1371/journal.pone.0018195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483685	Green Published, gold			2022-12-25	WOS:000289191300010
J	Savas, S; Azorsa, DO; Jarjanazi, H; Ibrahim-Zada, I; Gonzales, IM; Arora, S; Henderson, MC; Choi, YH; Briollais, L; Ozcelik, H; Tuzmen, S				Savas, Sevtap; Azorsa, David O.; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Gonzales, Irma M.; Arora, Shilpi; Henderson, Meredith C.; Choi, Yun Hee; Briollais, Laurent; Ozcelik, Hilmi; Tuzmen, Sukru			NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells	PLOS ONE			English	Article							PROSTATE-CANCER; COLORECTAL-CANCER; STATINS INHIBIT; STEM-CELLS; PROTEIN; ADENOCARCINOMA; CHOLESTEROL; APOPTOSIS; SURVIVAL; PATHWAY	Simvastatin and lovastatin are statins traditionally used for lowering serum cholesterol levels. However, there exists evidence indicating their potential chemotherapeutic characteristics in cancer. In this study, we used bioinformatic analysis of publicly available data in order to systematically identify the genes involved in resistance to cytotoxic effects of these two drugs in the NCI60 cell line panel. We used the pharmacological data available for all the NCI60 cell lines to classify simvastatin or lovastatin resistant and sensitive cell lines, respectively. Next, we performed whole-genome single marker case-control association tests for the lovastatin and simvastatin resistant and sensitive cells using their publicly available Affymetrix 125K SNP genomic data. The results were then evaluated using RNAi methodology. After correction of the p-values for multiple testing using False Discovery Rate, our results identified three genes (NRP1, COL13A1, MRPS31) and six genes (EAF2, ANK2, AKAP7, STEAP2, LPIN2, PARVB) associated with resistance to simvastatin and lovastatin, respectively. Functional validation using RNAi confirmed that silencing of EAF2 expression modulated the response of HCT-116 colon cancer cells to both statins. In summary, we have successfully utilized the publicly available data on the NCI60 cell lines to perform whole-genome association studies for simvastatin and lovastatin. Our results indicated genes involved in the cellular response to these statins and siRNA studies confirmed the role of the EAF2 in response to these drugs in HCT-116 colon cancer cells.	[Savas, Sevtap; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Ozcelik, Hilmi] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Savas, Sevtap; Jarjanazi, Hamdi; Ibrahim-Zada, Irada; Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Azorsa, David O.; Gonzales, Irma M.; Arora, Shilpi; Henderson, Meredith C.; Tuzmen, Sukru] Translat Genom Res Inst TGen, Pharmaceut Genom Div, Scottsdale, AZ USA; [Azorsa, David O.; Gonzales, Irma M.; Henderson, Meredith C.] Translat Genom Res Inst TGen, Clin Translat Res Div, Scottsdale, AZ USA; [Choi, Yun Hee; Briollais, Laurent] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Translational Genomics Research Institute; Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Savas, S (corresponding author), Mem Univ, Discipline Genet, Fac Med, St John, NF, Canada.	dazorsa@tgen.org	Jarjanazi, Hamdi/B-6221-2011; Briollais, Laurent/A-2941-2013; Tüzmen, Şükrü/AAH-9916-2021; Tuzmen, Sukru/I-5663-2013	Jarjanazi, Hamdi/0000-0001-8652-2560; Tüzmen, Şükrü/0000-0003-4822-396X; Tuzmen, Sukru/0000-0003-4822-396X; Savas, Sevtap/0000-0002-7324-938X	Canadian Breast Cancer Foundation - Ontario Chapter; TGen institutional research funds; prostate cancer foundation	Canadian Breast Cancer Foundation - Ontario Chapter; TGen institutional research funds; prostate cancer foundation	This study was supported by TGen institutional research funds and a grant from the prostate cancer foundation (H. Ozcelik). Y.H. Choi is supported by a fellowship from the Canadian Breast Cancer Foundation - Ontario Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2006, BBA-REV CANCER, V1766, P168, DOI 10.1016/j.bbcan.2006.10.003; Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431; Arden SD, 1996, J CLIN INVEST, V97, P551, DOI 10.1172/JCI118448; Azorsa DO, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-43; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; Eng L, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-18; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Fuchs D, 2008, BIOCHEM BIOPH RES CO, V374, P309, DOI 10.1016/j.bbrc.2008.07.012; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Gauthaman K, 2009, J CELL BIOCHEM, V106, P975, DOI 10.1002/jcb.22092; Gbelcova H, 2008, INT J CANCER, V122, P1214, DOI 10.1002/ijc.23242; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Hahn J, 2007, PROSTATE, V67, P146, DOI 10.1002/pros.20481; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jarjanazi H, 2008, HUM MUTAT, V29, P461, DOI 10.1002/humu.20732; Kang S, 2009, ONCOL REP, V21, P1317, DOI 10.3892/or_00000357; Kim WS, 2001, INVEST NEW DRUG, V19, P81, DOI 10.1023/A:1006481423298; Kodach LL, 2007, GASTROENTEROLOGY, V133, P1272, DOI 10.1053/j.gastro.2007.08.021; Korenbaum E, 2001, GENE, V279, P69, DOI 10.1016/S0378-1119(01)00743-0; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Lewis KA, 2005, LEUKEMIA RES, V29, P527, DOI 10.1016/j.leukres.2004.10.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzi PL, 2006, MOL CANCER THER, V5, P2613, DOI 10.1158/1535-7163.MCT-06-0447; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mohler PJ, 2006, J CARDIOVASC ELECTR, V17, P1153, DOI 10.1111/j.1540-8167.2006.00540.x; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Porkka KP, 2002, LAB INVEST, V82, P1573, DOI 10.1097/01.LAB.0000038554.26102.C6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Savas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012601; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Tomiyama N, 2008, BIOL PHARM BULL, V31, P369, DOI 10.1248/bpb.31.369; Tuzmen Sukru, 2007, Methods Mol Biol, V353, P177; Vree Tom B, 2003, ScientificWorldJournal, V3, P1332; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Ylonen R, 2005, J BONE MINER RES, V20, P1381, DOI 10.1359/JBMR.050319; Zhuang LY, 2002, CANCER RES, V62, P2227	49	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18306	10.1371/journal.pone.0018306	http://dx.doi.org/10.1371/journal.pone.0018306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483694	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000289058700018
J	Petersen, TR; Sika-Paotonu, D; Knight, DA; Simkins, HMA; Hermans, IF				Petersen, Troels R.; Sika-Paotonu, Dianne; Knight, Deborah A.; Simkins, Helen M. A.; Hermans, Ian F.			Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+T Cells to Dendritic Cell-Based Vaccines	PLOS ONE			English	Article							KILLER T-CELLS; INNATE IMMUNE-SYSTEM; ANTIGEN IN-VIVO; ALPHA-GALACTOSYLCERAMIDE; CROSS-PRESENTATION; CUTTING EDGE; SOLUBLE-ANTIGEN; MARGINAL ZONE; STEADY-STATE; CD8(+)	Transfer of antigen between antigen-presenting cells (APCs) is potentially a physiologically relevant mechanism to spread antigen to cells with specialized stimulatory functions. Here we show that specific CD8(+) T cell responses induced in response to intravenous administration of antigen-loaded bone marrow-derived dendritic cells (BM-DCs), were ablated in mice selectively depleted of endogenous lymphoid-resident langerin(+) CD8 alpha(+) dendritic cells (DCs), suggesting that the antigen is transferred from the injected cells to resident APCs. In contrast, antigen-specific CD4(+) T cells were primed predominantly by the injected BM-DCs, with only very weak contribution of resident APCs. Crucially, resident langerin(+) CD8 alpha(+) DCs only contributed to the priming of CD8(+) T cells in the presence of maturation stimuli such as intravenous injection of TLR ligands, or by loading the BM-DCs with the glycolipid alpha-galactosylceramide (alpha-GalCer) to recruit the adjuvant activity of activated invariant natural killer-like T (iNKT) cells. In fact, injection of alpha-GalCer-loaded CD1d(-/-) BM-DCs resulted in potent iNKT cell activation, suggesting that this glycolipid antigen can also be transferred to resident CD1d(+) APCs. While iNKT cell activation per se was independent of langerin(+) CD8 alpha(+) DCs, some iNKT cell-mediated activities were reduced, notably release of IL-12p70 and transactivation of NK cells. We conclude that both protein and glycolipid antigens can be exchanged between distinct DC species. These data suggest that the efficacy of DC-based vaccination strategies may be improved by the incorporation of a systemic maturation signal aimed to engage resident APCs in CD8+ T cell priming, and a-GalCer may be particularly well suited to this purpose.	[Petersen, Troels R.; Sika-Paotonu, Dianne; Knight, Deborah A.; Simkins, Helen M. A.; Hermans, Ian F.] Malaghan Inst Med Res, Wellington, New Zealand; [Hermans, Ian F.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Victoria University Wellington	Petersen, TR (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	tpetersen@malaghan.org.nz	Hermans, Ian/I-3961-2013	Hermans, Ian/0000-0002-7584-887X; Sika-Paotonu, Dianne/0000-0003-1930-1551; Petersen, Troels/0000-0002-6378-352X	Health Research Council of New Zealand [06/316, 09/105D]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was funded by Health Research Council of New Zealand (http://www.hrc.govt.nz) project grants 06/316 and 09/105D. I.F.H. was supported by a New Zealand Health Research Council Sir Charles Hercus Fellowship and DSP was supported by a Health Research Council of New Zealand Pacific Health Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BARRAL P, 2010, NAT IMMUNOL, P1; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Farrand KJ, 2009, J IMMUNOL, V183, P7732, DOI 10.4049/jimmunol.0902707; Finkelman FD, 1996, J IMMUNOL, V157, P1406; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hermans IF, 2007, J IMMUNOL, V178, P2721, DOI 10.4049/jimmunol.178.5.2721; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hoshino K, 1999, J IMMUNOL, V162, P3749; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lee A, 2006, CARBOHYD RES, V341, P2785, DOI 10.1016/j.carres.2006.09.006; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Millrain M, 2005, J IMMUNOL, V175, P7209, DOI 10.4049/jimmunol.175.11.7209; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shimizu K, 2007, J EXP MED, V204, P2641, DOI 10.1084/jem.20070458; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Stober D, 2003, J IMMUNOL, V170, P2540, DOI 10.4049/jimmunol.170.5.2540; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Taraban VY, 2008, J IMMUNOL, V180, P4615, DOI 10.4049/jimmunol.180.7.4615; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Tomura M, 1999, J IMMUNOL, V163, P93; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; YEWDALL AW, PLOS ONE, V5	57	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17657	10.1371/journal.pone.0017657	http://dx.doi.org/10.1371/journal.pone.0017657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483862	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200009
J	Smith, ST; Chadwick, RS				Smith, Sonya T.; Chadwick, Richard S.			Simulation of the Response of the Inner Hair Cell Stereocilia Bundle to an Acoustical Stimulus	PLOS ONE			English	Article							IMMERSED BOUNDARY METHOD; MECHANOELECTRICAL TRANSDUCTION; CHANNELS; FORCES; MOTION; SPEED	Mammalian hearing relies on a cochlear hydrodynamic sensor embodied in the inner hair cell stereocilia bundle. It is presumed that acoustical stimuli induce a fluid shear-driven motion between the tectorial membrane and the reticular lamina to deflect the bundle. It is hypothesized that ion channels are opened by molecular gates that sense tension in tip-links, which connect adjacent stepped rows of stereocilia. Yet almost nothing is known about how the fluid and bundle interact. Here we show using our microfluidics model how each row of stereocilia and their associated tip links and gates move in response to an acoustical input that induces an orbital motion of the reticular lamina. The model confirms the crucial role of the positioning of the tectorial membrane in hearing, and explains how this membrane amplifies and synchronizes the timing of peak tension in the tip links. Both stereocilia rotation and length change are needed for synchronization of peak tip link tension. Stereocilia length change occurs in response to accelerations perpendicular to the oscillatory fluid shear flow. Simulations indicate that nanovortices form between rows to facilitate diffusion of ions into channels, showing how nature has devised a way to solve the diffusive mixing problem that persists in engineered microfluidic devices.	[Smith, Sonya T.] Howard Univ, Dept Mech Engn, Washington, DC 20059 USA; [Smith, Sonya T.; Chadwick, Richard S.] Natl Inst Deafness & Other Commun Disorders, Sect Auditory Mech, NIH, Bethesda, MD USA	Howard University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Smith, ST (corresponding author), Howard Univ, Dept Mech Engn, Washington, DC 20059 USA.	chadwick@helix.nih.gov			National Institute on Deafness and Other Communication Disorders [DC00033-15]; ORISE fellowship through the NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000033, Z01DC000033, ZIADC000033] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ORISE fellowship through the NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the intramural program project DC00033-15 in the National Institute on Deafness and Other Communication Disorders. STS' sabbatical was funded as an ORISE fellowship through the NIDCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; BILLONE M, 1973, J ACOUST SOC AM, V54, P1143, DOI 10.1121/1.1914361; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; CHORIN AJ, 1968, MATH COMPUT, V22, P745, DOI 10.2307/2004575; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; FREEMAN DM, 1990, HEARING RES, V48, P17, DOI 10.1016/0378-5955(90)90196-V; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Karavitaki KD, 2010, J NEUROSCI, V30, P9051, DOI 10.1523/JNEUROSCI.4864-09.2010; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; Rayleigh L, 1911, PHILOS MAG, V21, P697, DOI 10.1080/14786440608637084; Stockie JM, 1998, J COMPUT PHYS, V147, P147, DOI 10.1006/jcph.1998.6086	18	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18161	10.1371/journal.pone.0018161	http://dx.doi.org/10.1371/journal.pone.0018161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483823	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200035
J	Trevino, V; Tadesse, MG; Vannucci, M; Al-Shahrour, F; Antczak, P; Durant, S; Bikfalvi, A; Dopazo, J; Campbell, MJ; Falciani, F				Trevino, Victor; Tadesse, Mahlet G.; Vannucci, Marina; Al-Shahrour, Fatima; Antczak, Philipp; Durant, Sarah; Bikfalvi, Andreas; Dopazo, Joaquin; Campbell, Moray J.; Falciani, Francesco			Analysis of Normal-Tumour Tissue Interaction in Tumours: Prediction of Prostate Cancer Features from the Molecular Profile of Adjacent Normal Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; II RECEPTOR BLOCKER; NF-KAPPA-B; GENE-EXPRESSION; LYSYL OXIDASE; BREAST-CANCER; MICROARRAY ANALYSIS; SIGNALING PATHWAYS; VARIABLE SELECTION; METASTASIS	Statistical modelling, in combination with genome-wide expression profiling techniques, has demonstrated that the molecular state of the tumour is sufficient to infer its pathological state. These studies have been extremely important in diagnostics and have contributed to improving our understanding of tumour biology. However, their importance in in-depth understanding of cancer patho-physiology may be limited since they do not explicitly take into consideration the fundamental role of the tissue microenvironment in specifying tumour physiology. Because of the importance of normal cells in shaping the tissue microenvironment we formulate the hypothesis that molecular components of the profile of normal epithelial cells adjacent the tumour are predictive of tumour physiology. We addressed this hypothesis by developing statistical models that link gene expression profiles representing the molecular state of adjacent normal epithelial cells to tumour features in prostate cancer. Furthermore, network analysis showed that predictive genes are linked to the activity of important secreted factors, which have the potential to influence tumor biology, such as IL1, IGF1, PDGF BB, AGT, and TGF beta.	[Trevino, Victor; Antczak, Philipp; Durant, Sarah; Falciani, Francesco] Univ Birmingham, Sch Biosci, Edgbaston, England; [Trevino, Victor; Antczak, Philipp; Durant, Sarah; Falciani, Francesco] Univ Birmingham, IBR, Edgbaston, England; [Tadesse, Mahlet G.] Univ Penn, Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Vannucci, Marina] Rice Univ, Houston, TX USA; [Al-Shahrour, Fatima; Dopazo, Joaquin] Ctr Invest Principe Felipe, Bioinformat Dept, Valencia, Spain; [Campbell, Moray J.] Univ Birmingham, Sch Med, Inst Biomed Res, Birmingham, W Midlands, England; [Trevino, Victor] Inst Tecnol & Estudios Super Monterrey, Dept Comp Sci, Nuevo Leon, Mexico; [Trevino, Victor] Inst Tecnol & Estudios Super Monterrey, Biomed Engn Program, Nuevo Leon, Mexico; [Campbell, Moray J.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Bikfalvi, Andreas] INSERM, U920, Talence, France; [Bikfalvi, Andreas] Univ Bordeaux 1, F-33405 Talence, France	University of Birmingham; University of Birmingham; University of Pennsylvania; Rice University; Prince Felipe Research Center; University of Birmingham; Tecnologico de Monterrey; Tecnologico de Monterrey; Roswell Park Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Trevino, V (corresponding author), Univ Birmingham, Sch Biosci, Edgbaston, England.	ffalciani@googlemail.com	Antczak, Philipp/L-5879-2019; Trevino, Victor/C-9219-2009; Vannucci, Marina/I-8439-2014; Campbell, Moray/ABF-1264-2021; Dopazo, Joaquin/A-9270-2014; Campbell, Moray J/A-1311-2013	Antczak, Philipp/0000-0001-9600-7757; Trevino, Victor/0000-0002-7472-9844; Vannucci, Marina/0000-0002-7360-5321; Campbell, Moray/0000-0002-3355-0928; Dopazo, Joaquin/0000-0003-3318-120X; 	Darwin Trust; CONACyT; CRUK [C8504/A9488]; Spanish Ministry of Science and Innovation [BIO2008-04212]; GVA-FEDER [PROMETEO/2010/001]; National Institute of Bioinformatics; RTICC [RD06/0020/1019]; NIH-NHGRI [R01-HG003319]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003319] Funding Source: NIH RePORTER	Darwin Trust; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CRUK(Cancer Research UK); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); GVA-FEDER; National Institute of Bioinformatics; RTICC(Instituto de Salud Carlos III); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Victor Trevino was a recipient of a Darwin Trust Fellowship and CONACyT. This work is in part funded by grants from the CRUK (C8504/A9488), Spanish Ministry of Science and Innovation (BIO2008-04212), GVA-FEDER (PROMETEO/2010/001). The authors also thank the support of the National Institute of Bioinformatics (www.inab.org) and the RTICC (grant RD06/0020/1019) both initiatives of the Instituto de Salud Carlos III (MICINN). Marina Vannucci is partially supported by NIH-NHGRI R01-HG003319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2006, INT J BIOL MARKER, V21, P88, DOI 10.1177/172460080602100204; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Bose SK, 2009, PROSTATE, V69, P1334, DOI 10.1002/pros.20980; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Chow L, 2009, MOL CELL ENDOCRINOL, V302, P219, DOI 10.1016/j.mce.2008.08.032; Cianfrocca M, 2009, CA-CANCER J CLIN, V59, P303, DOI 10.3322/caac.20029; Ding Q, 2010, AM J MED SCI, V339, P425, DOI 10.1097/MAJ.0b013e3181d7c9db; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Ghadjar P, 2008, J CANCER RES CLIN, V134, P1181, DOI 10.1007/s00432-008-0403-5; Gonzalez-Moreno O, 2010, EXP CELL RES, V316, P554, DOI 10.1016/j.yexcr.2009.11.020; Gregg JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-165; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lindmark F, 2005, BRIT J CANCER, V93, P493, DOI 10.1038/sj.bjc.6602729; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ooi CH, 2003, BIOINFORMATICS, V19, P37, DOI 10.1093/bioinformatics/19.1.37; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; REDNER A, 1986, ANN NY ACAD SCI, V468, P241, DOI 10.1111/j.1749-6632.1986.tb42043.x; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakamoto S, 2004, PROSTATE, V61, P305, DOI 10.1002/pros.20098; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Schroder FH, 2009, J UROLOGY, V181, P69, DOI 10.1016/j.juro.2008.09.012; Sha NJ, 2004, BIOMETRICS, V60, P812, DOI 10.1111/j.0006-341X.2004.00233.x; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Uemura H, 2008, MOL CANCER RES, V6, P250, DOI 10.1158/1541-7786.MCR-07-0289; Uemura H, 2008, INT J UROL, V15, P19, DOI 10.1111/j.1442-2042.2007.01937.x; Uemura H, 2006, MINI-REV MED CHEM, V6, P835, DOI 10.2174/138955706777698633; VLAHOS CJ, 1993, J CELL BIOCHEM, V52, P404, DOI 10.1002/jcb.240520405; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961	57	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e16492	10.1371/journal.pone.0016492	http://dx.doi.org/10.1371/journal.pone.0016492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479216	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700004
J	Gilot, D; Le Meur, N; Giudicelli, F; Le Vee, M; Lagadic-Gossmann, D; Theret, N; Fardel, O				Gilot, David; Le Meur, Nolwenn; Giudicelli, Fanny; Le Vee, Marc; Lagadic-Gossmann, Dominique; Theret, Nathalie; Fardel, Olivier			RNAi-Based Screening Identifies Kinases Interfering with Dioxin-Mediated Up-Regulation of CYP1A1 Activity	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CELL-CYCLE PROGRESSION; BREAST-CANCER CELLS; AH RECEPTOR; PROTEIN-KINASE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; INOSITOL 1,4,5-TRISPHOSPHATE; ACTIVATION; PHOSPHORYLATION; INHIBITOR	Background: The aryl hydrocarbon receptor (AhR) is a transcription factor activated by several environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and involved in carcinogenesis and various physiological processes, including immune response and endocrine functions. Characterization of kinases-related AhR transduction pathway remains an important purpose. Results: We performed a kinome-wide siRNA screen in human mammary MCF-7 cells to identify non redundant protein kinases implicated in the up-regulation of cytochrome P-450 (CYP) 1A1 activity, an AhR referent target, in response to TCDD exposure. To this aim, we monitored CYP1A1-related ethoxyresorufin-O-deethylase (EROD) activity and quantified cell density. This normalization was crucial since it allowed us to focus only on siRNA affecting EROD activity and discard siRNA affecting cell density. Analyses of the cell density data allowed us to identify several hits already well-characterized as effectors of the cell cycle and original hits. Collectively, these data fully validated the protocol and the siRNA library. Next, 22 novel candidates were identified as kinases potentially implicated in the up-regulation of CYP1A1 in response to TCDD, without alteration of cell survival or cell proliferation. The siRNA library screen gave a limited number of hits (approximately 3%). Interestingly, four of them are able to bind calmodulin among which the IP3 kinase A (ITPKA) and pregnancy up-regulated non-ubiquitously expressed CaM kinase (PNCK, also named CaMKI beta). Remarkably, for both proteins, their kinase activity depends on the calmodulin binding. Involvement of ITPKA and PNCK in TCDD-mediated CYP1A1 up-regulation was further validated by screening-independent expression knock-down. PNCK was finally shown to regulate activation of CaMKI alpha, a CaMKI isoform previously reported to interplay with the AhR pathway. Conclusions: These data fully support a role for both IP3-related kinase and CaMK isoforms in the AhR signaling cascade. More generally, this study also highlights the interest of large scale loss-of-function screens for characterizing the molecular mechanism of action of environmental contaminants.	[Gilot, David; Le Meur, Nolwenn; Giudicelli, Fanny; Le Vee, Marc; Lagadic-Gossmann, Dominique; Theret, Nathalie; Fardel, Olivier] Univ Rennes 1, EA Signalisat & Reponse Agents Infectieux & Chim, Inst Rech Sante Environm & Travail, Rennes, France; [Gilot, David; Le Meur, Nolwenn; Giudicelli, Fanny; Le Vee, Marc; Lagadic-Gossmann, Dominique; Theret, Nathalie; Fardel, Olivier] Inst Federatif Rech 140, Rennes, France; [Fardel, Olivier] CHU Rennes, Dept Hematol Immunol & Therapie Cellulaire, Hop Pontchaillou, Rennes, France	Universite de Rennes; CHU Rennes	Gilot, D (corresponding author), Inst Genet & Dev Rennes, CNRS, UMR 6061, Equipe Regulat Transcript & Oncogenese, Rennes, France.	david.gilot@univ-rennes1.fr	Le Meur, Nolwenn/M-3039-2013; Theret, Nathalie/I-2871-2015; Le Vee, Marc/U-8843-2019; LAGADIC-GOSSMANN, Dominique/I-5079-2015; theret, nathalie/ABG-6780-2020; Fardel, Olivier/J-8560-2015; LE VÉE, Marc/AAP-6961-2020	Le Meur, Nolwenn/0000-0001-8451-4014; Theret, Nathalie/0000-0002-5857-7828; LAGADIC-GOSSMANN, Dominique/0000-0002-4888-236X; theret, nathalie/0000-0002-5857-7828; 	Ministere de l'Ecologie, de l'Energie, du Developpement Durable et de la Mer	Ministere de l'Ecologie, de l'Energie, du Developpement Durable et de la Mer	This work was supported by the Programme National de Recherche sur les Perturbateurs Endocriniens (PNRPE) from the Ministere de l'Ecologie, de l'Energie, du Developpement Durable et de la Mer (http://www.developpement-durable.gouv.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHULETA MM, 1993, P NATL ACAD SCI USA, V90, P6105, DOI 10.1073/pnas.90.13.6105; Barhoover MA, 2010, MOL PHARMACOL, V77, P195, DOI 10.1124/mol.109.059675; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1576, DOI 10.1124/dmd.109.027821; Chen SJ, 2005, J BIOL CHEM, V280, P4350, DOI 10.1074/jbc.M411554200; Condon JC, 2002, ENDOCRINOLOGY, V143, P3651, DOI 10.1210/en.2001-211359; Davila DR, 1999, J TOXICOL ENV HEAL A, V56, P249, DOI 10.1080/009841099158097; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gardner HP, 2000, GENOMICS, V63, P279, DOI 10.1006/geno.1999.6091; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; GILOT D, 2010, CHEM BIOL INTERACT; Han EH, 2009, TOXICOLOGY, V266, P38, DOI 10.1016/j.tox.2009.10.013; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Lin CH, 2008, J NEUROCHEM, V104, P1415, DOI 10.1111/j.1471-4159.2007.05098.x; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783; Monteiro P, 2008, MOL PHARMACOL, V73, P769, DOI 10.1124/mol.107.043125; Monteiro P, 2008, DRUG METAB DISPOS, V36, P2556, DOI 10.1124/dmd.108.023333; Mullenders J, 2009, ONCOGENE, V28, P4409, DOI 10.1038/onc.2009.295; N'Diaye M, 2006, J BIOL CHEM, V281, P19906, DOI 10.1074/jbc.M601192200; Naito Y, 1997, J BIOL CHEM, V272, P32704, DOI 10.1074/jbc.272.51.32704; Oesch-Bartlomowicz B, 2005, BIOCHEM BIOPH RES CO, V338, P446, DOI 10.1016/j.bbrc.2005.08.092; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; Pelz O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-185; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Schwarz M, 2005, REGUL TOXICOL PHARM, V43, P19, DOI 10.1016/j.yrtph.2005.05.008; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; Tan ZQ, 2004, TOXICOL SCI, V82, P80, DOI 10.1093/toxsci/kfh228; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18261	10.1371/journal.pone.0018261	http://dx.doi.org/10.1371/journal.pone.0018261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479225	Green Published, gold			2022-12-25	WOS:000289054600039
J	Gregory, MS; Hackett, CG; Abernathy, EF; Lee, KS; Saff, RR; Hohlbaum, AM; Moody, KSL; Hobson, MW; Jones, A; Kolovou, P; Karray, S; Giani, A; John, SWM; Chen, DF; Marshak-Rothstein, A; Ksander, BR				Gregory, Meredith S.; Hackett, Caroline G.; Abernathy, Emma F.; Lee, Karen S.; Saff, Rebecca R.; Hohlbaum, Andreas M.; Moody, Krishna-sulayman L.; Hobson, Maura W.; Jones, Alexander; Kolovou, Paraskevi; Karray, Saoussen; Giani, Andrea; John, Simon W. M.; Chen, Dong Feng; Marshak-Rothstein, Ann; Ksander, Bruce R.			Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell Death	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBER LAYER THICKNESS; OCULAR IMMUNE PRIVILEGE; OPEN-ANGLE GLAUCOMA; INFLAMMATORY RESPONSES; INDUCED APOPTOSIS; GENE-EXPRESSION; DBA/2J MICE; ALPHA; ACTIVATION	Glaucoma, the most frequent optic neuropathy, is a leading cause of blindness worldwide. Death of retinal ganglion cells (RGCs) occurs in all forms of glaucoma and accounts for the loss of vision, however the molecular mechanisms that cause RGC loss remain unclear. The pro-apoptotic molecule, Fas ligand, is a transmembrane protein that can be cleaved from the cell surface by metalloproteinases to release a soluble protein with antagonistic activity. Previous studies documented that constitutive ocular expression of FasL maintained immune privilege and prevented neoangeogenesis. We now show that FasL also plays a major role in retinal neurotoxicity. Importantly, in both TNF alpha triggered RGC death and a spontaneous model of glaucoma, gene-targeted mice that express only full-length FasL exhibit accelerated RGC death. By contrast, FasL-deficiency, or administration of soluble FasL, protected RGCs from cell death. These data identify membrane-bound FasL as a critical effector molecule and potential therapeutic target in glaucoma.	[Gregory, Meredith S.; Hackett, Caroline G.; Abernathy, Emma F.; Hobson, Maura W.; Jones, Alexander; Kolovou, Paraskevi; Chen, Dong Feng; Ksander, Bruce R.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02163 USA; [Lee, Karen S.; Hohlbaum, Andreas M.; Moody, Krishna-sulayman L.; Hobson, Maura W.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Saff, Rebecca R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Moody, Krishna-sulayman L.; Marshak-Rothstein, Ann] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Karray, Saoussen] Hop Necker Enfants Malad, INSERM, U580, Paris, France; [Giani, Andrea] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [John, Simon W. M.] Jackson Lab, Howard Hughes Med Inst, Bar Harbor, ME 04609 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Boston University; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Howard Hughes Medical Institute; Jackson Laboratory	Gregory, MS (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02163 USA.	ann.rothstein@umassmed.edu; bruce.ksander@schepens.harvard.edu	Gregory-Ksander, Meredith/AAG-1413-2019; Giani, Andrea/L-5926-2017	Gregory-Ksander, Meredith/0000-0002-7193-0032; Giani, Andrea/0000-0003-0682-1945; Karray, Saoussen/0000-0003-0107-4039	Lions Research Foundation; American Health Assistance Foundation; NEI [EY016486, EY016145]; NCI [CA90691]; Glaucoma Foundation;  [EY11721]; NATIONAL CANCER INSTITUTE [R01CA090691] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011721, R29EY011721, R01EY016145, R01EY016486] Funding Source: NIH RePORTER	Lions Research Foundation; American Health Assistance Foundation(BrightFocus Foundation); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Glaucoma Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding sources: Lions Research Foundation (BRK), American Health Assistance Foundation (MSG), NEI EY016486 (BRK), NEI EY016145 (MSG), NCI CA90691 (AMR), EY11721 (SWMJ), the Glaucoma Foundation (BRK) and SWMJ is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Dace DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007121; Ferguson TA, 2008, SEMIN IMMUNOPATHOL, V30, P111, DOI 10.1007/s00281-008-0113-8; Funayama T, 2004, INVEST OPHTH VIS SCI, V45, P4359, DOI 10.1167/iovs.03-1403; Gregory MS, 2002, J IMMUNOL, V169, P2727, DOI 10.4049/jimmunol.169.5.2727; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; He JS, 2007, J IMMUNOL, V179, P2339, DOI 10.4049/jimmunol.179.4.2339; Hohlbaum AM, 2001, J IMMUNOL, V167, P6217, DOI 10.4049/jimmunol.167.11.6217; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; Hu MS, 1999, INFECT IMMUN, V67, P928, DOI 10.1128/IAI.67.2.928-935.1999; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jodo S, 2001, J BIOL CHEM, V276, P39938, DOI 10.1074/jbc.M107005200; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; Kavurma MM, 2003, CELL DEATH DIFFER, V10, P36, DOI 10.1038/sj.cdd.4401179; Kim JS, 2009, BRIT J OPHTHALMOL, V93, P1057, DOI 10.1136/bjo.2009.157875; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lee HO, 2003, CYTOKINE GROWTH F R, V14, P325, DOI 10.1016/S1359-6101(03)00028-5; Lei Y, 2008, INVEST OPHTH VIS SCI, V49, P1940, DOI 10.1167/iovs.07-0735; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Lin HJ, 2003, EYE, V17, P31, DOI 10.1038/sj.eye.6700227; Martinez-Lorenzo MJ, 1998, EUR J IMMUNOL, V28, P2714, DOI 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9; McKinnon S J, 1997, Curr Opin Ophthalmol, V8, P28, DOI 10.1097/00055735-199704000-00006; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; NEMAZEE D, 1991, J IMMUNOL, V147, P2536; Ohta K, 2000, INVEST OPHTH VIS SCI, V41, P2591; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; Sano Y, 2002, EXP EYE RES, V75, P475, DOI 10.1006/exer.2002.2044; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; SHERRY B, 1988, J CELL BIOL, V107, P1269, DOI 10.1083/jcb.107.4.1269; Shudo K, 2001, EUR J IMMUNOL, V31, P2504, DOI 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO;2-C; Sotozono C, 2000, CURR EYE RES, V20, P54, DOI 10.1076/0271-3683(200001)20:1;1-H;FT054; Stuart PM, 2003, INVEST OPHTH VIS SCI, V44, P93, DOI 10.1167/iovs.02-0299; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Sugita S, 2000, BRIT J OPHTHALMOL, V84, P1130, DOI 10.1136/bjo.84.10.1130; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P2577, DOI 10.1167/iovs.07-1101; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; THEOFILOPOULOS AN, 1985, J EXP MED, V162, P1, DOI 10.1084/jem.162.1.1; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wollstein G, 2005, ARCH OPHTHALMOL-CHIC, V123, P464, DOI 10.1001/archopht.123.4.464; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542	61	81	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17659	10.1371/journal.pone.0017659	http://dx.doi.org/10.1371/journal.pone.0017659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479271	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600014
J	Held, N; Smits, BMG; Gockeln, R; Schubert, S; Nave, H; Northrup, E; Cuppen, E; Hedrich, HJ; Wedekind, D				Held, Nadine; Smits, Bart M. G.; Gockeln, Roland; Schubert, Stephanie; Nave, Heike; Northrup, Emily; Cuppen, Edwin; Hedrich, Hans J.; Wedekind, Dirk			A Mutation in Myo15 Leads to Usher-Like Symptoms in LEW/Ztm-ci2 Rats	PLOS ONE			English	Article							UNCONVENTIONAL MYOSIN; RETINITIS-PIGMENTOSA; HEARING-LOSS; CIRCLING BEHAVIOR; DEAFNESS DFNB3; HAIR-CELLS; GENE; WHIRLIN; MOUSE; MODEL	The LEW/Ztm-ci2 rat is an animal model for syndromal deafness that arose from a spontaneous mutation. Homozygous animals show locomotor abnormalities like lateralized circling behavior. Additionally, an impaired vision can be observed in some animals through behavioral studies. Syndromal deafness as well as retinal degeneration are features of the Usher syndrome in humans. In the present study, the mutation was identified as a base substitution (T->C) in exon 56 of Myo15, leading to an amino acid exchange from leucine (Leu) to proline (Pro) within the carboxy-terminal MyTH4 domain in the proteins' tail region. Myo15 mRNA was expressed in the retina as demonstrated for the first time with the help of in-situ hybridization and PCR. To characterize the visual phenotype, rats were examined by scotopic and photopic electroretinography and, additionally, histological analyses of the retinas were conducted. The complete loss of sight was detected along with a severe degeneration of photoreceptor cells. Interestingly, the manifestation of the disease does not solely depend on the mutation, but also on environmental factors. Since the LEW/Ztm-ci2 rat features the entire range of symptoms of the human Usher syndrome we think that this strain is an appropriate model for this disease. Our findings display that mutations in binding domains of myosin XV do not only cause non-syndromic hearing loss but can also lead to syndromic disorders including retinal dysfunction.	[Held, Nadine; Northrup, Emily; Hedrich, Hans J.; Wedekind, Dirk] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Smits, Bart M. G.; Cuppen, Edwin] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Smits, Bart M. G.; Cuppen, Edwin] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Gockeln, Roland] Hannover Med Sch, Clin Ophthalmol, D-3000 Hannover, Germany; [Schubert, Stephanie] Hannover Med Sch, Inst Human Genet, D-3000 Hannover, Germany; [Nave, Heike] Hannover Med Sch, Inst Funct & Appl Anat, D-3000 Hannover, Germany	Hannover Medical School; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Hannover Medical School; Hannover Medical School; Hannover Medical School	Held, N (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany.		Kielstein, Heike/GNW-4839-2022; Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Schubert, Stephanie/0000-0001-8634-7299	Deutsche Forschungsgemeinschaft (DFG) [GRK705-II]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG), GRK705-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Baker JP, 1998, CURR OPIN CELL BIOL, V10, P80, DOI 10.1016/S0955-0674(98)80089-6; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Chwalisz WT, 2003, MAMM GENOME, V14, P620, DOI 10.1007/s00335-003-3009-x; DAVENPORT SLH, 1977, MONTR 5 INT C BIRTH; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gockeln R, 2003, INVEST OPHTH VIS SCI, V44, pU431; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Kaiser A, 2001, EUR J NEUROSCI, V14, P1129, DOI 10.1046/j.0953-816x.2001.01726.x; Karl T, 2003, PHYSIOL BEHAV, V80, P123, DOI 10.1016/S0031-9384(03)00229-4; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Liu XZ, 1999, AM J HUM GENET, V64, P1221, DOI 10.1086/302332; Loscher W, 2010, NEUROMETHODS, V44, P33, DOI 10.1007/978-1-60761-474-6_3; Loscher W, 2010, NEUROSCI BIOBEHAV R, V34, P31, DOI 10.1016/j.neubiorev.2009.07.001; Loscher W, 1996, NEUROSCIENCE, V74, P1135; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu Philomena, 1997, Genes and Function, V1, P191; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Nal N, 2007, HUM MUTAT, V28, P1014, DOI 10.1002/humu.20556; NARAYAN O, 1983, J INFECT DIS, V148, P305, DOI 10.1093/infdis/148.2.305; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Noell W K, 1966, Invest Ophthalmol, V5, P450; Paige AJW, 2000, MAMM GENOME, V11, P51, DOI 10.1007/s003350010010; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Redowicz MJ, 2002, ACTA BIOCHIM POL, V49, P789; ROBBINS SG, 1990, LAB INVEST, V62, P417; Rogers MJC, 1999, MAMM GENOME, V10, P513, DOI 10.1007/s003359901032; Schwartz SB, 2005, INVEST OPHTH VIS SCI, V46, P734, DOI 10.1167/iovs.04-1136; Shearer AE, 2009, LARYNGOSCOPE, V119, P727, DOI 10.1002/lary.20116; Smits BMG, 2005, GENETICS, V170, P1887, DOI 10.1534/genetics.105.044222; Tlili Abdelaziz, 2005, Hum Mutat, V25, P503, DOI 10.1002/humu.9333; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; Urbach YK, 2010, METHODS MOL BIOL, V597, P333, DOI 10.1007/978-1-60327-389-3_24; Usher C. H., 1914, ROY LOND OPHTHAL HOS, V19, P130; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILLIAMS TP, 1983, INVEST OPHTH VIS SCI, V24, P285	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e15669	10.1371/journal.pone.0015669	http://dx.doi.org/10.1371/journal.pone.0015669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479269	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600006
J	Irving, AD; Connell, SD; Russell, BD				Irving, Andrew D.; Connell, Sean D.; Russell, Bayden D.			Restoring Coastal Plants to Improve Global Carbon Storage: Reaping What We Sow	PLOS ONE			English	Article							CLIMATE-CHANGE; CO2; IMPACTS	Long-term carbon capture and storage (CCS) is currently considered a viable strategy for mitigating rising levels of atmospheric CO2 and associated impacts of global climate change. Until recently, the significant below-ground CCS capacity of coastal vegetation such as seagrasses, salt marshes, and mangroves has largely gone unrecognized in models of global carbon transfer. However, this reservoir of natural, free, and sustainable carbon storage potential is increasingly jeopardized by alarming trends in coastal habitat loss, totalling 30-50% of global abundance over the last century alone. Human intervention to restore lost habitats is a potentially powerful solution to improve natural rates of global CCS, but data suggest this approach is unlikely to substantially improve long-term CCS unless current restoration efforts are increased to an industrial scale. Failure to do so raises the question of whether resources currently used for expensive and time-consuming restoration projects would be more wisely invested in arresting further habitat loss and encouraging natural recovery.	[Irving, Andrew D.; Connell, Sean D.; Russell, Bayden D.] Univ Adelaide, So Seas Ecol Labs, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of Adelaide	Irving, AD (corresponding author), Univ Adelaide, So Seas Ecol Labs, Sch Earth & Environm Sci, Adelaide, SA, Australia.	andrew.irving@adelaide.edu.au	Connell, Sean D/A-8874-2008; Russell, Bayden D./A-9942-2008; Russell, Bayden D./R-9325-2019	Connell, Sean D/0000-0002-5350-6852; Russell, Bayden D./0000-0003-1282-9978; Russell, Bayden D./0000-0003-1282-9978; Irving, Andrew/0000-0002-9763-2148	Australian Research Council	Australian Research Council(Australian Research Council)	Funding support was provided by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Bachu S, 2008, PROG ENERG COMBUST, V34, P254, DOI 10.1016/j.pecs.2007.10.001; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cebrian J, 2002, LIMNOL OCEANOGR, V47, P11, DOI 10.4319/lo.2002.47.1.0011; Chalmers H, 2010, P I MECH ENG C-J MEC, V224, P505, DOI 10.1243/09544062JMES1516; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Fonseca M.S., 1998, GUIDELINES CONSERVAT; Goldenheim W, 2008, OECOLOGIA, V158, P473, DOI 10.1007/s00442-008-1157-0; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Irving AD, 2010, J APPL ECOL, V47, P1119, DOI 10.1111/j.1365-2664.2010.01852.x; Kennedy D, 2005, SCIENCE, V309, P75, DOI 10.1126/science.309.5731.75; Kennish MJ, 2001, J COASTAL RES, V17, P731; KIRKMAN H, 1990, AQUAT BOT, V37, P367, DOI 10.1016/0304-3770(90)90022-D; Laffoley D., 2009, MANAGEMENT NATURAL C; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Mcalpine CA, 2009, GLOBAL CHANGE BIOL, V15, P2206, DOI 10.1111/j.1365-2486.2009.01939.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Orth RJ, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P111; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Pidgeon E., 2009, MANAGEMENT NATURAL C, P47; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rogelj J, 2010, NATURE, V464, P1126, DOI 10.1038/4641126a; Russell BD, 2010, SCIENCE, V327, P144, DOI 10.1126/science.327.5962.144-c; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WALSH B, 2009, CAN GEOENGINEERING H; Watzin M. C., 1992, FRAGILE FRINGE COAST; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wigley TML, 2006, SCIENCE, V314, P452, DOI 10.1126/science.1131728	34	58	64	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18311	10.1371/journal.pone.0018311	http://dx.doi.org/10.1371/journal.pone.0018311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479244	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600043
J	Silva, LP; Yu, RH; Calmettes, C; Yang, X; Moraes, TF; Schryvers, AB; Schriemer, DC				Silva, Leslie P.; Yu, Ronghua; Calmettes, Charles; Yang, Xue; Moraes, Trevor F.; Schryvers, Anthony B.; Schriemer, David C.			Conserved Interaction between Transferrin and Transferrin-binding Proteins from Porcine Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RECEPTOR PROTEIN; NEISSERIA-MENINGITIDIS; ACTINOBACILLUS-PLEUROPNEUMONIAE; SERUM TRANSFERRIN; IRON TRANSPORT; HAEMOPHILUS-INFLUENZAE; BOUND IRON; C-LOBE; IDENTIFICATION; GONORRHOEAE	Gram-negative porcine pathogens from the Pasteurellaceae family possess a surface receptor complex capable of acquiring iron from porcine transferrin (pTf). This receptor consists of transferrin-binding protein A (TbpA), a transmembrane iron transporter, and TbpB, a surface-exposed lipoprotein. Questions remain as to how the receptor complex engages pTf in such a way that iron is positioned for release, and whether divergent strains present distinct recognition sites on Tf. In this study, the TbpB-pTf interface was mapped using a combination of mass shift analysis and molecular docking simulations, localizing binding uniquely to the pTf Clobe for multiple divergent strains of Actinobacillus plueropneumoniae and suis. The interface was further characterized and validated with site-directed mutagenesis. Although targeting a common lobe, variants differ in preference for the two sublobes comprising the iron coordination site. Sublobes C1 and C2 participate in high affinity binding, but sublobe C1 contributes in a minor fashion to the overall affinity. Further, the TbpB-pTf complex does not release iron independent of other mediators, based on competitive iron binding studies. Together, our findings support a model whereby TbpB efficiently captures and presents iron-loaded pTf to other elements of the uptake pathway, even under low iron conditions.	[Silva, Leslie P.; Schryvers, Anthony B.; Schriemer, David C.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Yu, Ronghua; Yang, Xue; Schryvers, Anthony B.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Calmettes, Charles; Moraes, Trevor F.] Univ Toronto, Dept Biochem, Toronto, ON M5A 2N4, Canada	University of Calgary; University of Calgary; University of Toronto	Schryvers, AB (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada.	schryver@ucalgary.ca; dschriem@ucalgary.ca	Schryvers, Anthony B./AAF-3417-2020	calmettes, charles/0000-0002-2542-4382	Canadian Foundation for Innovation; Canada Research Chair program; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chair program(Canada Research Chairs); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Foundation for Innovation, the Canada Research Chair program, the Alberta Heritage Foundation for Medical Research, and the Canadian Institutes of Health Research.	ALCANTARA J, 1993, MOL MICROBIOL, V8, P1135, DOI 10.1111/j.1365-2958.1993.tb01658.x; BAILEY S, 1988, BIOCHEMISTRY-US, V27, P5804, DOI 10.1021/bi00415a061; Baltes N, 2002, FEMS MICROBIOL LETT, V209, P283, DOI 10.1111/j.1574-6968.2002.tb11145.x; Bennett MJ, 2010, CHEM BIOL, V17, P725, DOI 10.1016/j.chembiol.2010.05.019; Bobst CE, 2009, J MOL BIOL, V388, P954, DOI 10.1016/j.jmb.2009.03.044; Boulton IC, 1998, BIOCHEM J, V334, P269, DOI 10.1042/bj3340269; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Cornelissen CN, 1998, MOL MICROBIOL, V27, P611, DOI 10.1046/j.1365-2958.1998.00710.x; CRIADO MT, 1993, RES MICROBIOL, V144, P77, DOI 10.1016/0923-2508(93)90217-P; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; DeRocco AJ, 2007, INFECT IMMUN, V75, P3220, DOI 10.1128/IAI.00072-07; DYER DW, 1987, INFECT IMMUN, V55, P2171, DOI 10.1128/IAI.55.9.2171-2175.1987; Giannetti AM, 2005, STRUCTURE, V13, P1613, DOI 10.1016/j.str.2005.07.016; GRAYOWEN SD, 1995, INFECT IMMUN, V63, P3809, DOI 10.1128/IAI.63.10.3809-3815.1995; Halbrooks PJ, 2003, BIOCHEMISTRY-US, V42, P3701, DOI 10.1021/bi027071q; Hall DR, 2002, ACTA CRYSTALLOGR D, V58, P70, DOI 10.1107/S0907444901017309; Hirose M, 2000, BIOSCI BIOTECH BIOCH, V64, P1328, DOI 10.1271/bbb.64.1328; Jacques M, 2004, CAN J VET RES, V68, P81; Krell T, 2003, J BIOL CHEM, V278, P14712, DOI 10.1074/jbc.M204461200; LEE BC, 1988, MOL MICROBIOL, V2, P827, DOI 10.1111/j.1365-2958.1988.tb00095.x; Ling JML, 2010, MOL MICROBIOL, V77, P1301, DOI 10.1111/j.1365-2958.2010.07289.x; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; MICKELSEN PA, 1981, INFECT IMMUN, V33, P555, DOI 10.1128/IAI.33.2.555-564.1981; MICKELSEN PA, 1982, INFECT IMMUN, V35, P915, DOI 10.1128/IAI.35.3.915-920.1982; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Nemish U, 2003, BIOCHEM CELL BIOL, V81, P275, DOI 10.1139/O03-057; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Renauld-Mongenie G, 1998, FEMS MICROBIOL LETT, V169, P171; RENAULDMONGE NIEG, 2004, J INFECTION, V72, P3461; Retzer MD, 1999, MOL MICROBIOL, V32, P111, DOI 10.1046/j.1365-2958.1999.01331.x; SCHRYVERS AB, 1990, CAN J MICROBIOL, V36, P145, DOI 10.1139/m90-026; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P281, DOI 10.1111/j.1365-2958.1988.tb00029.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; SHEN ZM, 1992, PROTEIN SCI, V1, P1477, DOI 10.1002/pro.5560011109; Shouldice SR, 2003, J BIOL CHEM, V278, P11513, DOI 10.1074/jbc.M211780200; Siburt CJP, 2009, METALLOMICS, V1, P249, DOI 10.1039/b902860a; Slysz GW, 2008, ANAL CHEM, V80, P7004, DOI 10.1021/ac800897q; VOGEL W, 1989, KLIN WOCHENSCHR, V67, P538, DOI 10.1007/BF01719780; VONDERHAAR RA, 1994, J BACTERIOL, V176, P6207, DOI 10.1128/jb.176.20.6207-6213.1994; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WEST SEH, 1985, INFECT IMMUN, V47, P388, DOI 10.1128/IAI.47.2.388-394.1985; YU RH, 1993, MICROB PATHOGENESIS, V15, P433, DOI 10.1006/mpat.1993.1092	42	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21353	21360		10.1074/jbc.M111.226449	http://dx.doi.org/10.1074/jbc.M111.226449			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21487007	hybrid, Green Published			2022-12-25	WOS:000291464700034
J	Kemp, MG; Lindsey-Boltz, LA; Sancar, A				Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz			The DNA Damage Response Kinases DNA-dependent Protein Kinase (DNA-PK) and Ataxia Telangiectasia Mutated (ATM) Are Stimulated by Bulky Adduct-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-A; H2AX PHOSPHORYLATION; CHECKPOINT KINASE; UV-IRRADIATION; CELL-LINE; RADIOSENSITIZING AGENT; STRAND BREAKS; ACTIVATION; BINDING	A variety of environmental, carcinogenic, and chemotherapeutic agents form bulky lesions on DNA that activate DNA damage checkpoint signaling pathways in human cells. To identify the mechanisms by which bulky DNA adducts induce damage signaling, we developed an in vitro assay using mammalian cell nuclear extract and plasmid DNA containing bulky adducts formed by N-acetoxy-2-acetylaminofluorene or benzo(a) pyrene diol epoxide. Using this cell-free system together with a variety of pharmacological, genetic, and biochemical approaches, we identified the DNA damage response kinases DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM) as bulky DNA damage-stimulated kinases that phosphorylate physiologically important residues on the checkpoint proteins p53, Chk1, and RPA. Consistent with these results, purified DNA-PK and ATM were directly stimulated by bulky adduct-containing DNA and preferentially associated with damaged DNA in vitro. Because the DNA damage response kinase ATM and Rad3-related (ATR) is also stimulated by bulky DNA adducts, we conclude that a common biochemical mechanism exists for activation of DNA-PK, ATM, and ATR by bulky adduct-containing DNA.	[Kemp, Michael G.; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010; Kemp, Michael G./AAT-1545-2021	Lindsey-Boltz, Laura/0000-0001-6493-8194; Kemp, Michael G./0000-0001-8203-0745	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM32833 (to A. S.).	ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Block WD, 2004, NUCLEIC ACIDS RES, V32, P1967, DOI 10.1093/nar/gkh508; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Callegari AJ, 2006, P NATL ACAD SCI USA, V103, P15877, DOI 10.1073/pnas.0607343103; Callegari AJ, 2010, P NATL ACAD SCI USA, V107, P8219, DOI 10.1073/pnas.1003449107; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hess MT, 1996, NUCLEIC ACIDS RES, V24, P824, DOI 10.1093/nar/24.5.824; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoppe BS, 2000, RADIAT RES, V153, P125, DOI 10.1667/0033-7587(2000)153[0125:COTRMC]2.0.CO;2; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Kemp MG, 2010, J BIOL CHEM, V285, P4788, DOI 10.1074/jbc.M109.079418; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; LEVY DD, 1995, CARCINOGENESIS, V16, P1557, DOI 10.1093/carcin/16.7.1557; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Tsuchida R, 2002, RADIAT RES, V158, P195, DOI 10.1667/0033-7587(2002)158[0195:DOAGMI]2.0.CO;2; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	64	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19237	19246		10.1074/jbc.M111.235036	http://dx.doi.org/10.1074/jbc.M111.235036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487018	Green Published, hybrid			2022-12-25	WOS:000291027700006
J	Laederich, MB; Degnin, CR; Lunstrum, GP; Holden, P; Horton, WA				Laederich, Melanie B.; Degnin, Catherine R.; Lunstrum, Gregory P.; Holden, Paul; Horton, William A.			Fibroblast Growth Factor Receptor 3 (FGFR3) Is a Strong Heat Shock Protein 90 (Hsp90) Client IMPLICATIONS FOR THERAPEUTIC MANIPULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTANT BIOLOGIC ACTIVITIES; MULTIPLE-MYELOMA; ACTIVATING MUTATIONS; DEGRADATIVE PATHWAY; KINASE-ACTIVITY; IN-VITRO; CHAPERONE; INHIBITOR; CHIP; BINDING	Fibroblast growth factor receptor 3 (FGFR3) is a key regulator of growth and differentiation, whose aberrant activation causes a number of genetic diseases including achondroplasia and cancer. Hsp90 is a specialized molecular chaperone involved in stabilizing a select set of proteins termed clients. Here, we delineate the relationship of Hsp90 and co-chaperone Cdc37 with FGFR3 and the FGFR family. FGFR3 strongly associates with these chaperone complexes and depends on them for stability and function. Inhibition of Hsp90 function using the geldanamycin analog 17-AAG induces the ubiquitination and degradation of FGFR3 and reduces the signaling capacity of FGFR3. Other FGFRs weakly interact with these chaperones and are differentially influenced by Hsp90 inhibition. The Hsp90-related ubiquitin ligase CHIP is able to interact and destabilize FGFR3. Our results establish FGFR3 as a strong Hsp90 client and suggest that modulating Hsp90 chaperone complexes may beneficially influence the stability and function of FGFR3 in disease.	[Horton, William A.] Oregon Hlth & Sci Univ, Res Ctr, Shriners Hosp Children, Portland, OR 97239 USA; [Laederich, Melanie B.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Holden, Paul; Horton, William A.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Horton, WA (corresponding author), Oregon Hlth & Sci Univ, Res Ctr, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	wah@shcc.org			Shriners Hospitals for Children; PhRMA Foundation	Shriners Hospitals for Children; PhRMA Foundation	This work was supported by research and fellowship training grants from the Shriners Hospitals for Children.; Recipient of a predoctoral fellowship from the PhRMA Foundation.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Avantaggiati ML, 1996, EMBO J, V15, P2236, DOI 10.1002/j.1460-2075.1996.tb00577.x; Bae JH, 2010, P NATL ACAD SCI USA, V107, P2866, DOI 10.1073/pnas.0914157107; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chiosis G, 2003, MOL CANCER THER, V2, P123; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Germano S, 2006, J BIOL CHEM, V281, P21710, DOI 10.1074/jbc.M602014200; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Guo CS, 2008, CELL SIGNAL, V20, P1471, DOI 10.1016/j.cellsig.2008.04.001; Hikri E, 2009, CELL SIGNAL, V21, P588, DOI 10.1016/j.cellsig.2008.12.011; Jeong JH, 2008, J CELL BIOCHEM, V105, P585, DOI 10.1002/jcb.21859; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Laederich MB, 2010, CURR OPIN PEDIATR, V22, P516, DOI 10.1097/MOP.0b013e32833b7a69; Li R, 2006, FASEB J, V20, P1218, DOI 10.1096/fj.05-5258fje; Lievens PMJ, 2006, J MOL BIOL, V357, P783, DOI 10.1016/j.jmb.2006.01.058; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nakashima T, 2010, CLIN CANCER RES, V16, P2792, DOI 10.1158/1078-0432.CCR-09-3112; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Sun XP, 2010, P NATL ACAD SCI USA, V107, P3146, DOI 10.1073/pnas.0910717107; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Terry J, 2005, CLIN CANCER RES, V11, P5631, DOI 10.1158/1078-0432.CCR-05-0398; Theodoraki MA, 2007, EXP CELL RES, V313, P3851, DOI 10.1016/j.yexcr.2007.06.022; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	53	33	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19597	19604		10.1074/jbc.M110.206151	http://dx.doi.org/10.1074/jbc.M110.206151			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487019	Green Published, hybrid			2022-12-25	WOS:000291027700043
J	Li, X; Apel, D; Gaynor, EC; Tanner, ME				Li, Xu; Apel, Dmitry; Gaynor, Erin C.; Tanner, Martin E.			5 '-Methylthioadenosine Nucleosidase Is Implicated in Playing a Key Role in a Modified Futalosine Pathway for Menaquinone Biosynthesis in Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; TRANSITION-STATE ANALOGS; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; AUTOINDUCER-2; MICROORGANISMS; IDENTIFICATION; VITAMIN-K-2; SIMILARITY; INHIBITORS	Menaquinone (vitamin K(2)) serves as an electron carrier in the electron transport chain required for respiration in many pathogenic bacteria. Most bacteria utilize a common menaquinone biosynthetic pathway as exemplified by Escherichia coli. Recently, a novel biosynthetic pathway, the futalosine pathway, was discovered in Streptomyces. Bioinformatic analysis strongly suggests that this pathway is also operative in the human pathogens Campylobacter jejuni and Helicobacter pylori. Here, we provide compelling evidence that a modified futalosine pathway is operative in C. jejuni and that it utilizes 6-amino-6-deoxyfutalosine instead of futalosine. A key step in the Streptomyces pathway involves a nucleosidase called futalosine hydrolase. The closest homolog in C. jejuni has been annotated as a 5'-methylthioadenosine nucleosidase (MTAN). We have shown that this C. jejuni enzyme has MTAN activity but negligible futalosine hydrolase activity. However, the C. jejuni MTAN is able to hydrolyze 6-amino-6-deoxyfutalosine at a rate comparable with that of its known substrates. This suggests that the adenine-containing version of futalosine is the true biosynthetic intermediate in this organism. To demonstrate this in vivo, we constructed a C. jejuni mutant strain deleted for mqnA2, which is predicted to encode for the enzyme required to synthesize 6-amino-6-deoxyfutalosine. Growth of this mutant was readily rescued by the addition of 6-amino-6-deoxyfutalosine, but not futalosine. This provides the first direct evidence that a modified futalosine pathway is operative in C. jejuni. It also highlights the tremendous versatility of the C. jejuni MTAN, which plays key roles in S-adenosylmethionine recycling, the biosynthesis of autoinducer molecules, and the biosynthesis of menaquinone.	[Apel, Dmitry; Gaynor, Erin C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Li, Xu; Tanner, Martin E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Gaynor, EC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	egaynor@mail.ubc.ca; mtanner@chem.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Burroughs Wellcome Fund; Canada Research Chair Award; Canadian Institutes of Health Research [MOP-68981]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC; to M. E. T.) and by a Burroughs Wellcome Fund Career Development Award in the Biomedical Sciences, a Canada Research Chair Award, and Canadian Institutes of Health Research Operating Grant MOP-68981 (to E. C. G.).	Arai R, 2009, J STRUCT BIOL, V168, P575, DOI 10.1016/j.jsb.2009.07.007; Arakawa C, 2011, ANTIMICROB AGENTS CH, V55, P913, DOI 10.1128/AAC.01362-10; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; CARLONE GM, 1983, J GEN MICROBIOL, V129, P3385; Cloak OM, 2002, APPL ENVIRON MICROB, V68, P4666, DOI 10.1128/AEM.68.9.4666-4671.2002; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; COLLINS MD, 1984, ARCH MICROBIOL, V137, P168, DOI 10.1007/BF00414461; Cornell KA, 1998, BBA-GENE STRUCT EXPR, V1396, P8, DOI 10.1016/S0167-4781(97)00169-3; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; Dairi T, 2009, J ANTIBIOT, V62, P347, DOI 10.1038/ja.2009.46; Dhiman RK, 2009, MOL MICROBIOL, V72, P85, DOI 10.1111/j.1365-2958.2009.06625.x; DUERRE JA, 1962, J BIOL CHEM, V237, P3737; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; Evans GB, 2004, J MED CHEM, V47, P3275, DOI 10.1021/jm0306475; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Hiratsuka T, 2009, BIOSCI BIOTECH BIOCH, V73, P1137, DOI 10.1271/bbb.80906; Ikejiri M, 2008, BIOORG MED CHEM LETT, V18, P4638, DOI 10.1016/j.bmcl.2008.07.015; KALCKAR HM, 1947, J BIOL CHEM, V167, P429; KLENOW H, 1952, BIOCHEM J, V50, P404, DOI 10.1042/bj0500404; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; Lee JE, 2005, J MOL BIOL, V352, P559, DOI 10.1016/j.jmb.2005.07.027; Lee JE, 2005, BIOCHEMISTRY-US, V44, P11049, DOI 10.1021/bi050493q; Lee JE, 2005, J BIOL CHEM, V280, P18274, DOI 10.1074/jbc.M414471200; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Li X, 2010, TETRAHEDRON LETT, V51, P6463, DOI 10.1016/j.tetlet.2010.10.010; Marcelli SW, 1996, FEMS MICROBIOL LETT, V138, P59; MEDEIROS GC, 1971, BIOCHIM BIOPHYS ACTA, V238, P1, DOI 10.1016/0005-2787(71)90002-5; Meganathan R, 2001, VITAM HORM, V61, P173; MOSS CW, 1990, J CLIN MICROBIOL, V28, P395, DOI 10.1128/JCM.28.2.395-397.1990; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Quinones B, 2009, APPL ENVIRON MICROB, V75, P281, DOI 10.1128/AEM.01803-08; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Singh V, 2005, BIOCHEMISTRY-US, V44, P11647, DOI 10.1021/bi050863a; Singh V, 2005, J BIOL CHEM, V280, P18265, DOI 10.1074/jbc.M414472200; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x	42	40	44	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19392	19398		10.1074/jbc.M111.229781	http://dx.doi.org/10.1074/jbc.M111.229781			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489995	hybrid, Green Published			2022-12-25	WOS:000291027700021
J	Claser, C; Malleret, B; Gun, SY; Wong, AYW; Chang, ZW; Teo, P; See, PCE; Howland, SW; Ginhoux, F; Renia, L				Claser, Carla; Malleret, Benoit; Gun, Sin Yee; Wong, Alicia Yoke Wei; Chang, Zi Wei; Teo, Pearline; See, Peter Chi Ee; Howland, Shanshan Wu; Ginhoux, Florent; Renia, Laurent			CD8(+) T Cells and IFN-gamma Mediate the Time-Dependent Accumulation of Infected Red Blood Cells in Deep Organs during Experimental Cerebral Malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PARASITE SEQUESTRATION; C-FMS; BRAIN; PATHOGENESIS; RECEPTOR; PHAGOCYTOSIS; PATHOLOGY; IMMUNITY; ALPHA	Background: Infection with Plasmodium berghei ANKA (PbA) in susceptible mice induces a syndrome called experimental cerebral malaria (ECM) with severe pathologies occurring in various mouse organs. Immune mediators such as T cells or cytokines have been implicated in the pathogenesis of ECM. Red blood cells infected with PbA parasites have been shown to accumulate in the brain and other tissues during infection. This accumulation is thought to be involved in PbA-induced pathologies, which mechanisms are poorly understood. Methods and Findings: Using transgenic PbA parasites expressing the luciferase protein, we have assessed by real-time in vivo imaging the dynamic and temporal contribution of different immune factors in infected red blood cell (IRBC) accumulation and distribution in different organs during PbA infection. Using deficient mice or depleting antibodies, we observed that CD8(+) T cells and IFN-gamma drive the rapid increase in total parasite biomass and accumulation of IRBC in the brain and in different organs 6-12 days post-infection, at a time when mice develop ECM. Other cells types like CD4(+) T cells, monocytes or neutrophils or cytokines such as IL-12 and TNF-alpha did not influence the early increase of total parasite biomass and IRBC accumulation in different organs. Conclusions: CD8(+) T cells and IFN-gamma are the major immune mediators controlling the time-dependent accumulation of P. berghei-infected red blood cells in tissues.	[Claser, Carla; Malleret, Benoit; Gun, Sin Yee; Wong, Alicia Yoke Wei; Chang, Zi Wei; Teo, Pearline; See, Peter Chi Ee; Howland, Shanshan Wu; Ginhoux, Florent; Renia, Laurent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Claser, C (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	renia_laurent@immunol.a-star.edu.sg	Malleret, Benoit/E-9159-2011; Renia, Laurent/E-2117-2011; Claser, Carla/P-2736-2018; Howland, Shanshan W/I-2245-2014	Malleret, Benoit/0000-0001-9658-7528; Renia, Laurent/0000-0003-0349-1557; Claser, Carla/0000-0002-5395-9632; Howland, Shanshan W/0000-0003-4794-1564; See, Peter/0000-0003-4428-7763; Wong, Alicia Yoke Wei/0000-0003-1169-7766; Teo, Pearline/0000-0002-8283-6308; Gun, Sin Yee/0000-0001-6158-6293	A*STAR	A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by an intramural grant from A*STAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 1998, INFECT IMMUN, V66, P4093; Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; [Anonymous], REFORMA MED; Bagot S, 2004, INFECT IMMUN, V72, P2817, DOI 10.1128/IAI.72.5.2817-2826.2004; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BROSNAN CF, 1993, ADV NEUROL, V59, P349; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; CELADA A, 1983, J PARASITOL, V69, P49, DOI 10.2307/3281273; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Chen QJ, 2000, CLIN MICROBIOL REV, V13, P439, DOI 10.1128/CMR.13.3.439-450.2000; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Ewing J, 1901, J EXP MED, V6, P119; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hulier E, 1996, MOL BIOCHEM PARASIT, V77, P127, DOI 10.1016/0166-6851(96)02584-4; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Jose MD, 2003, AM J TRANSPLANT, V3, P294, DOI 10.1034/j.1600-6143.2003.00068.x; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1969, AM J TROP MED HYG, V18, P860, DOI 10.4269/ajtmh.1969.18.860; Murayama T, 1999, CIRCULATION, V99, P1740, DOI 10.1161/01.CIR.99.13.1740; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; SCHETTERS TPM, 1983, CELL BIOL INT REP, V7, P402, DOI 10.1016/0309-1651(83)90124-8; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Sudo T, 1995, ONCOGENE, V11, P2469; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Togbe D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002608; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Wang YQ, 1999, J NEUROSCI RES, V57, P616, DOI 10.1002/(SICI)1097-4547(19990901)57:5<616::AID-JNR4>3.0.CO;2-E; Yanez DM, 1996, J IMMUNOL, V157, P1620	53	111	114	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18720	10.1371/journal.pone.0018720	http://dx.doi.org/10.1371/journal.pone.0018720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494565	gold, Green Published, Green Submitted			2022-12-25	WOS:000289354100033
J	Wang, DV; Wang, F; Liu, J; Zhang, L; Wang, ZR; Lin, LN				Wang, Dong V.; Wang, Fang; Liu, Jun; Zhang, Lu; Wang, Zhiru; Lin, Longnian			Neurons in the Amygdala with Response-Selectivity for Anxiety in Two Ethologically Based Tests	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; OPEN-FIELD TEST; BASOLATERAL AMYGDALA; INDIVIDUAL-DIFFERENCES; RAT AMYGDALA; FEAR; BEHAVIOR; EXPOSURE; RECEPTORS; STRESS	The amygdala is a key area in the brain for detecting potential threats or dangers, and further mediating anxiety. However, the neuronal mechanisms of anxiety in the amygdala have not been well characterized. Here we report that in freely-behaving mice, a group of neurons in the basolateral amygdala (BLA) fires tonically under anxiety conditions in both open-field and elevated plus-maze tests. The firing patterns of these neurons displayed a characteristic slow onset and progressively increased firing rates. Specifically, these firing patterns were correlated to a gradual development of anxiety-like behaviors in the open-field test. Moreover, these neurons could be activated by any impoverished environment similar to an open-field; and introduction of both comfortable and uncomfortable stimuli temporarily suppressed the activity of these BLA neurons. Importantly, the excitability of these BLA neurons correlated well with levels of anxiety. These results demonstrate that this type of BLA neuron is likely to represent anxiety and/or emotional values of anxiety elicited by anxiogenic environmental stressors.	[Wang, Dong V.; Wang, Fang; Liu, Jun; Zhang, Lu; Wang, Zhiru; Lin, Longnian] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Inst Brain Funct Genom, Shanghai 200062, Peoples R China	East China Normal University	Wang, DV (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Inst Brain Funct Genom, Shanghai 200062, Peoples R China.	lnlin@brain.ecnu.edu.cn		Zhang, Lu/0000-0001-7300-1037	National Natural Science Foundation of China [30990262, 30570584]; Shanghai Municipal Education Commission [09ZZ44]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the National Natural Science Foundation of China (No. 30990262, 30570584) and the Innovation Program of Shanghai Municipal Education Commission (No. 09ZZ44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec RE, 1999, PHYSIOL BEHAV, V65, P723; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Clement Y, 1998, NEUROSCI BIOBEHAV R, V22, P623, DOI 10.1016/S0149-7634(97)00058-4; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Hale MW, 2006, BRAIN RES BULL, V71, P174, DOI 10.1016/j.brainresbull.2006.09.001; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Johnstone KA, 2004, BEHAV RES THER, V42, P249, DOI 10.1016/S0005-7967(03)00137-2; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kwekkeboom Kristine L, 2003, Oncol Nurs Forum, V30, P433, DOI 10.1188/03.ONF.433-440; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Mitra R, 2009, MOL PSYCHIATR, V14, P847, DOI 10.1038/mp.2009.9; NISHIJO H, 1988, J NEUROSCI, V8, P3570; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Sajdyk TJ, 1997, BRAIN RES, V764, P262, DOI 10.1016/S0006-8993(97)00594-5; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; Shearer SL, 2007, PRIMARY CARE, V34, P475, DOI 10.1016/j.pop.2007.05.002; SILVEIRA MCL, 1993, BEHAV BRAIN RES, V56, P115, DOI 10.1016/0166-4328(93)90028-O; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; WILSON FAW, 1993, EXP BRAIN RES, V93, P367; Wu LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000167; Wunderlich GR, 2002, PSYCHOPHARMACOLOGY, V164, P193, DOI 10.1007/s00213-002-1181-4	37	47	49	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18739	10.1371/journal.pone.0018739	http://dx.doi.org/10.1371/journal.pone.0018739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494567	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100038
J	Zhou, B; Xiao, L; Wang, ZH; Chang, ET; Chen, JJ; Hou, JL				Zhou, Bin; Xiao, Lei; Wang, Zhanhui; Chang, Ellen T.; Chen, Jinjun; Hou, Jinlin			Geographical and Ethnic Distribution of the HBV C/D Recombinant on the Qinghai-Tibet Plateau	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; E-ANTIGEN; HEPATOCELLULAR-CARCINOMA; CORE PROMOTER; GENOTYPE-A; VIROLOGICAL CHARACTERISTICS; NATURAL-HISTORY; MUTATIONS; SUBGENOTYPES; INFECTION	Two forms of hepatitis B virus (HBV) C/D recombinant have been identified in western China, but little is known about their geographical and ethnic distributions, and particularly the clinical significance and specific mutations in the pre-core region. To address these questions, a total of 624 chronic HBV carriers from four ethnic populations representing five provinces in western China were enrolled in this study. Genotypes were firstly determined by restriction fragment length polymorphism, and then confirmed by full or partial genome nucleotide sequencing. The distribution of HBV genotypes was as follows: HBV/B: 40 (6.4%); HBV/C: 221 (35.4%); HBV/D: 39 (6.3%); HBV/CD: 324 (51.9%). In the 324 HBV C/D recombinant infections, 244 (75.3%) were infected with the "CD1'' and 80 (24.7%) were infected with the "CD2.'' The distribution of HBV genotypes exhibited distinct patterns in different regions and ethnic populations. Geographically, the C/D recombinant was the most prevalent HBV strain on the Qinghai-Tibet Plateau. Ethnically, the C/D recombinant had a higher prevalence in Tibetan patients than in other populations. Clinically, patients with HBV/CD1 showed significantly lower levels of serum total bilirubin than patients with HBV/C2. The prevalence of HBeAg was comparable between patients with HBV/CD1 and HBV/C2 (63.3% vs 50.0%, P = 0.118) whether patients were taken together or stratified by age into three groups (65.6% vs 58.8% in < 30 years, P = 0.758; 61.9% vs 48.0% in 30-50 years, P = 0.244; 64.3% vs 33.3%, P = 0.336). Virologically HBV/CD1 had a significantly lower frequency of G1896A than HBV/C2. In conclusion, the HBV C/D recombinant is restricted to the Qinghai-Tibet Plateau in western China and is found predominantly in Tibetans. The predominance of the premature pre-core stop mutation G1896A in patients with the HBV C/D recombinant may account for the higher prevalence of HBeAg in these patients.	[Zhou, Bin; Xiao, Lei; Wang, Zhanhui; Chen, Jinjun; Hou, Jinlin] So Med Univ, Nanfang Hosp, Inst Hepatol, Guangzhou, Guangdong, Peoples R China; [Zhou, Bin; Xiao, Lei; Wang, Zhanhui; Chen, Jinjun; Hou, Jinlin] So Med Univ, Nanfang Hosp, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Xiao, Lei] Eighth Peoples Hosp Guangzhou, Dept Severe Hepatopathy, Guangzhou, Guangdong, Peoples R China; [Chang, Ellen T.] Stanford Univ, Asian Liver Ctr, Dept Surg, Sch Med, Stanford, CA 94305 USA	Southern Medical University - China; Southern Medical University - China; Stanford University	Zhou, B (corresponding author), So Med Univ, Nanfang Hosp, Inst Hepatol, Guangzhou, Guangdong, Peoples R China.	wangzhhsu@gmail.com; jlhousmu@yahoo.com.cn	Shen, Jianzhong/AAH-8184-2019		National eleven-five project of China [2008ZX10002-004]; Major 973 [2007CB512901]; National Natural Science Foundation of China [30730082]	National eleven-five project of China; Major 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National eleven-five project of China (2008ZX10002-004), the Major 973 (No. 2007CB512901) and National Natural Science Foundation of China (Grant number: 30730082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CS, 2009, J GASTROEN HEPATOL, V24, P569, DOI 10.1111/j.1440-1746.2008.05642.x; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Bartholomeusz A, 2004, REV MED VIROL, V14, P3, DOI 10.1002/rmv.400; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chattopadhyay S, 2006, HEPATOL RES, V35, P79, DOI 10.1016/j.hepres.2006.03.002; Chauhan R, 2008, WORLD J GASTROENTERO, V14, P6228, DOI 10.3748/wjg.14.6228; Chen S, 2006, INT J IMMUNOGENET, V33, P439, DOI 10.1111/j.1744-313X.2006.00637.x; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Davaalkham D, 2007, ARCH VIROL, V152, P575, DOI 10.1007/s00705-006-0863-3; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; GUNTHER S, 1995, J VIROL, V69, P5437; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Kato H, 2002, HEPATOLOGY, V35, P922, DOI 10.1053/jhep.2002.32096; Kato H, 2003, J VIROL METHODS, V110, P29, DOI 10.1016/S0166-0934(03)00095-8; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lai S P, 1999, Yi Chuan Xue Bao, V26, P447; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luo KX, 2004, VIRUS GENES, V29, P31, DOI 10.1023/B:VIRU.0000032787.77837.09; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Morozov V, 2000, GENE, V260, P55, DOI 10.1016/S0378-1119(00)00424-8; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Okwiredu WKBA, 2001, J MED VIROL, V65, P485, DOI 10.1002/jmv.2062; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Osiowy C, 2003, J CLIN MICROBIOL, V41, P5473, DOI 10.1128/JCM.41.12.5473-5477.2003; Osiowy C, 2008, J GEN VIROL, V89, P3009, DOI 10.1099/vir.0.2008/005124-0; Raimondi S, 2010, J HEPATOL, V52, P441, DOI 10.1016/j.jhep.2009.12.014; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Shrestha SM, 2007, J GASTROEN HEPATOL, V22, P1921, DOI 10.1111/j.1440-1746.2006.04611.x; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Sugauchi F, 2003, GASTROENTEROLOGY, V124, P925, DOI 10.1053/gast.2003.50140; Szmaragd C, 2007, MOL ECOL, V16, P4747, DOI 10.1111/j.1365-294X.2007.03564.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Tsatsralt-Od B, 2006, J MED VIROL, V78, P542, DOI 10.1002/jmv.20574; Wang Z, 2007, J VIRAL HEPATITIS, V14, P426, DOI 10.1111/j.1365-2893.2006.00813.x; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yano Y, 2007, HEPATOL RES, V37, P1095, DOI 10.1111/j.1872-034X.2007.00161.x; Yin JH, 2010, CANCER EPIDEM BIOMAR, V19, P777, DOI 10.1158/1055-9965.EPI-09-1001; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x; Zeng GB, 2004, WORLD J GASTROENTERO, V10, P3132	49	36	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18708	10.1371/journal.pone.0018708	http://dx.doi.org/10.1371/journal.pone.0018708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494570	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100032
J	Nazarenko, I; Hedren, A; Sjodin, H; Orrego, A; Andrae, J; Afink, GB; Nister, M; Lindstrom, MS				Nazarenko, Inga; Hedren, Anna; Sjodin, Hanna; Orrego, Abiel; Andrae, Johanna; Afink, Gijs B.; Nister, Monica; Lindstrom, Mikael S.			Brain Abnormalities and Glioma-Like Lesions in Mice Overexpressing the Long Isoform of PDGF-A in Astrocytic Cells	PLOS ONE			English	Article							GROWTH-FACTOR-A; NEURAL STEM-CELLS; RAT OPTIC-NERVE; IN-VIVO; OLIGODENDROCYTE DEVELOPMENT; SUBVENTRICULAR ZONE; PROGENITOR-CELL; B-CHAIN; GENE; EXPRESSION	Background: Deregulation of platelet-derived growth factor (PDGF) signaling is a hallmark of malignant glioma. Two alternatively spliced PDGF-A mRNAs have been described, corresponding to a long (L) and a short (S) isoform of PDGF-A. In contrast to PDGF-A(S), the PDGF-A(L) isoform has a lysine and arginine rich carboxy-terminal extension that acts as an extracellular matrix retention motif. However, the exact role of PDGF-A(L) and how it functionally differs from the shorter isoform is not well understood. Methodology/Principal Findings: We overexpressed PDGF-A(L) as a transgene under control of the glial fibrillary acidic protein (GFAP) promoter in the mouse brain. This directs expression of the transgene to astrocytic cells and GFAP expressing neural stem cells throughout the developing and adult central nervous system. Transgenic mice exhibited a phenotype with enlarged skull at approximately 6-16 weeks of age and they died between 1.5 months and 2 years of age. We detected an increased number of undifferentiated cells in all areas of transgene expression, such as in the subependymal zone around the lateral ventricle and in the cerebellar medulla. The cells stained positive for Pdgfr-alpha, Olig2 and NG2 but this population did only partially overlap with cells positive for Gfap and the transgene reporter. Interestingly, a few mice presented with overt neoplastic glioma-like lesions composed of both Olig2 and Gfap positive cell populations and with microvascular proliferation, in a wild-type p53 background. Conclusions: Our findings show that PDGF-A(L) can induce accumulation of immature cells in the mouse brain. The strong expression of NG2, Pdgfr-alpha and Olig2 in PDGF-A(L) brains suggests that a fraction of these cells are oligodendrocyte progenitors. In addition, accumulation of fluid in the subarachnoid space and skull enlargement indicate that an increased intracranial pressure contributed to the observed lethality.	[Nazarenko, Inga; Hedren, Anna; Orrego, Abiel; Nister, Monica; Lindstrom, Mikael S.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Sjodin, Hanna] Univ Pittsburgh, Pittsburgh, PA USA; [Andrae, Johanna] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Afink, Gijs B.] Univ Amsterdam, Acad Med Ctr, Reprod Biol Lab, NL-1105 AZ Amsterdam, Netherlands; [Andrae, Johanna] Karolinska Inst, Ludwig Inst Canc Res, Stockholm Branch, Stockholm, Sweden	Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Ludwig Institute for Cancer Research	Nazarenko, I (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	mikael.lindstrom@ki.se	Andrae, Johanna/L-3875-2014; Afink, Gijs/A-2025-2009; Lindström, Mikael S/AAA-1451-2019; Afink, Gijs/AAB-2832-2021	Afink, Gijs/0000-0002-2155-725X; Lindström, Mikael S/0000-0003-1148-8497; 	Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council (VR Medicine); Karolinska Institutet; Cancer Society in Stockholm; James S. McDonnell Foundation; Swedish Institute; Swedish Cancer Society (Cancerfonden); Ake Wiberg's foundation; Magnus Bergvall's foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council (VR Medicine)(Swedish Research Council); Karolinska Institutet(Karolinska Institutet); Cancer Society in Stockholm; James S. McDonnell Foundation; Swedish Institute; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Ake Wiberg's foundation; Magnus Bergvall's foundation	Financial support for this work was provided by the Swedish Cancer Society (M.N.), the Swedish Childhood Cancer Foundation (M.N.), the Swedish Research Council (VR Medicine) (M.N.), Karolinska Institutet (M.N.), the Cancer Society in Stockholm (M.N.), the James S. McDonnell Foundation (M.N., G. B. A.), and the Swedish Institute/Visby program (scholarship to I.N.). M. L. was supported by a fellowship from the Swedish Cancer Society (Cancerfonden), the Karolinska Institutet funds, Ake Wiberg's foundation and Magnus Bergvall's foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSSON M, 1994, J BIOL CHEM, V269, P926; Andrae J, 2001, MECH DEVELOP, V107, P181, DOI 10.1016/S0925-4773(01)00460-9; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Barami K, 2007, J CLIN NEUROSCI, V14, P1143, DOI 10.1016/j.jocn.2007.04.009; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BETSHOLTZ C, 1990, NATURE, V344, P299, DOI 10.1038/344299a0; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Calzolari F, 2010, BRAIN PATHOL, V20, P527, DOI 10.1111/j.1750-3639.2009.00335.x; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; Crews L, 2004, BRAIN PATHOL, V14, P312; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; DELBIGIO MR, DEV DISABIL RES REV, V16, P16; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Emerich DF, 2004, EXPERT OPIN BIOL TH, V4, P1191, DOI 10.1517/14712598.4.8.1191; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; HART IK, 1989, DEVELOPMENT, V105, P595; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Jackson EL, 2008, CELLS TISSUES ORGANS, V188, P212, DOI 10.1159/000114541; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; MAGLIONE D, 1993, ONCOGENE, V8, P925; MATOSKOVA B, 1989, MOL CELL BIOL, V9, P3148, DOI 10.1128/MCB.9.7.3148; MERCOLA M, 1988, SCIENCE, V241, P1223, DOI 10.1126/science.3413486; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Niklasson M, 2010, EXP CELL RES, V316, P2779, DOI 10.1016/j.yexcr.2010.07.009; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; Rorsman F, 1992, GROWTH FACTORS, V7, DOI 10.3109/08977199209046928; Uhrbom L, 1998, CANCER RES, V58, P5275; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; YOUNG RM, 1990, MOL CELL BIOL, V10, P6051, DOI 10.1128/MCB.10.11.6051; Zhang XQ, 1998, MECH DEVELOP, V70, P167, DOI 10.1016/S0925-4773(97)00190-1	50	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18303	10.1371/journal.pone.0018303	http://dx.doi.org/10.1371/journal.pone.0018303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490965	Green Accepted, Green Published, gold			2022-12-25	WOS:000289238700007
J	Lou, YQ; Liu, JL; Li, Y; Liu, Y; Wang, ZG; Liu, K; Wu, H; Niu, QL; Gu, W; Guo, YH; Li, ZZ; Wen, SJ				Lou, Yuqing; Liu, Jielin; Li, Yao; Liu, Ya; Wang, Zuoguang; Liu, Kuo; Wu, Hai; Niu, Qiuli; Gu, Wei; Guo, Yanhong; Li, Zhizhong; Wen, Shaojun			Association Study of the beta 2-Adrenergic Receptor Gene Polymorphisms and Hypertension in the Northern Han Chinese	PLOS ONE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; HAPLOTYPE INFERENCE; BLOOD-PRESSURE; ADRB2 GENE; OBESITY; COMBINATION; PREVALENCE; ALGORITHM; PROTEIN; ASTHMA	Background: The beta 2-adrenergic receptor (ADRB2) gene has been widely researched as a candidate gene for essential hypertension (EH), but no consensus has been reached in different ethnicities. The aim of the present study was to evaluate the possible association between the ADRB2 gene polymorphisms and the EH risk in the Northern Han Chinese population. Methodology/Principal Findings: This study included 747 hypertensive subjects and 390 healthy volunteers as control subjects in the Northern Han Chinese. Genotyping was performed to identify the C-47T, A46G and C79G polymorphisms of the ADRB2 gene. G allelic frequency of A46G polymorphism was significantly higher in hypertensive subjects (P = 0.011, OR = 1.287, 95% CI [1.059-1.565]) than that in controls. Significant association could also be found in dominant genetic model (GG+AG vs. AA, P = 0.006, OR = 1.497, 95% CI [1.121-1.998]), in homozygote comparison (GG vs. AA, P = 0.025, OR = 1.568, 95% CI [1.059-2.322]), and in additive genetic model (GG vs. AG vs. AA, P = 0.012, OR = 1.282, 95% CI [1.056-1.555]). Subgroup analyses performed by gender suggested that this association could be found in male, but not in female. Stratification analyses by obesity showed that A46G polymorphism was related to the prevalence of hypertension in the obese population (GG vs. AG vs. AA, P<0.001, OR = 1.645, 95% CI [1.258-2.151]). Significant interaction was found between A46G genotypes and body mass index on EH risk. No significant association could be found between C-47T or C79G polymorphism and EH risk. Linkage disequilibrium was detected between the C-47T, A46G and C79G polymorphisms. Haplotype analyses observed that the T-47-A46-C79 haplotype was a protective haplotype for EH, while the T-47-G46-C79 haplotype increased the risk. Conclusions/Significances: We revealed that the ADRB2 A46G polymorphism might increase the risk for EH in the Northern Han Chinese population.	[Lou, Yuqing; Liu, Jielin; Liu, Ya; Wang, Zuoguang; Liu, Kuo; Niu, Qiuli; Gu, Wei; Wen, Shaojun] Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens Res, Beijing, Peoples R China; [Lou, Yuqing; Liu, Jielin; Liu, Ya; Wang, Zuoguang; Liu, Kuo; Niu, Qiuli; Gu, Wei; Wen, Shaojun] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Li, Yao; Wu, Hai] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Guo, Yanhong] Peking Univ, Hosp 3, Dept Cardiol, Beijing 100871, Peoples R China; [Li, Zhizhong] Capital Med Univ, Beijing Anzhen Hosp, Emergency Ctr Heart Lung & Blood Vessel Dis, Beijing, Peoples R China	Capital Medical University; Fudan University; Peking University; Capital Medical University	Lou, YQ (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens Res, Beijing, Peoples R China.	dr_lizhizhong@yahoo.com.cn; wenshaojun@yahoo.com.cn	GUO, Yanhong/B-5325-2012; Guo, Yanhong/D-9764-2012	Liu, Ya/0000-0002-7816-684X; Wang, Zuoguang/0000-0002-0230-1611	National High Technology Research and Development Program [2008AA02Z441]; Ministry of Science and Technology of the People's Republic of China [2008BAI52B03]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was funded by grants 2008AA02Z441 of the National High Technology Research and Development Program (http://program.most.gov.cn/page/pds/mian1_AA.htm?planId=AA), and grants 2008BAI52B03 of the National Eleventh Five-year Plan Program from the Ministry of Science and Technology (http://program.most.gov.cn/page/pds/mian1_BA.htm?planId=BA) of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartels NK, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-1; Brodde OE, 2005, PHARMACOGENET GENOM, V15, P267, DOI 10.1097/01213011-200505000-00001; Busjahn A, 2000, HYPERTENSION, V35, P555, DOI 10.1161/01.HYP.35.2.555; Candy G, 2000, J HYPERTENS, V18, P167, DOI 10.1097/00004872-200018020-00006; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Feldman RD, 1998, TRENDS CARDIOVAS MED, V8, P297, DOI 10.1016/S1050-1738(98)00022-X; Ge D, 2005, ANN HUM GENET, V69, P36, DOI 10.1046/j.1529-8817.2003.00093.x; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2006, HYPERTENSION, V47, P1147, DOI 10.1161/01.HYP.0000219041.66702.45; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Herrmann SM, 2002, J HYPERTENS, V20, P229, DOI 10.1097/00004872-200202000-00012; Herrmann V, 2000, AM J HYPERTENS, V13, P1021, DOI 10.1016/S0895-7061(00)01188-2; Hu CJ, 2007, CLIN CHEM LAB MED, V45, P20, DOI 10.1515/CCLM.2007.014; Jia HY, 2000, J HYPERTENS, V18, P687, DOI 10.1097/00004872-200018060-00005; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kato N, 2001, HYPERTENSION, V37, P286, DOI 10.1161/01.HYP.37.2.286; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Leineweber K, 2004, N-S ARCH PHARMACOL, V369, P1, DOI 10.1007/s00210-003-0824-2; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lima JJ, 2007, METABOLISM, V56, P757, DOI 10.1016/j.metabol.2007.01.007; Lou YQ, 2010, HYPERTENS RES, V33, P1114, DOI 10.1038/hr.2010.151; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Misono M, 2009, J HYPERTENS, V27, P1377, DOI 10.1097/HJH.0b013e32832b7ead; Mo W, 2007, CLIN CHEM LAB MED, V45, P493, DOI 10.1515/CCLM.2007.089; Petrone A, 2006, EUR J HUM GENET, V14, P94, DOI 10.1038/sj.ejhg.5201521; Pojoga L, 2006, HYPERTENSION, V48, P892, DOI 10.1161/01.HYP.0000244688.45472.95; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Scott MGH, 1999, BRIT J PHARMACOL, V126, P841, DOI 10.1038/sj.bjp.0702385; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Smith SC, 2005, CIRCULATION, V111, pE134, DOI 10.1161/01.CIR.0000157743.54710.04; STEIN CM, 1995, J CLIN INVEST, V96, P579, DOI 10.1172/JCI118070; Szczepankiewicz A, 2009, J APPL GENET, V50, P275, DOI 10.1007/BF03195683; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; *WHO, 2000, WHO REG OFF W PAC IN; Wu HY, 2006, J HYPERTENS, V24, P1041, DOI 10.1097/01.hjh.0000226193.21311.e1; Xie HG, 2000, CLIN PHARMACOL THER, V67, P670, DOI 10.1067/mcp.2000.106293; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yu SF, 2008, BIOMED ENVIRON SCI, V21, P239, DOI 10.1016/S0895-3988(08)60036-7; Zhang HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008783	48	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18590	10.1371/journal.pone.0018590	http://dx.doi.org/10.1371/journal.pone.0018590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483652	gold, Green Published, Green Submitted			2022-12-25	WOS:000289191300031
J	Mine-Hattab, J; Fleury, G; Prevost, C; Dutreix, M; Viovy, JL				Mine-Hattab, Judith; Fleury, Genevieve; Prevost, Chantal; Dutreix, Marie; Viovy, Jean-Louis			Optimizing the Design of Oligonucleotides for Homology Directed Gene Targeting	PLOS ONE			English	Article							SINGLE-STRANDED OLIGONUCLEOTIDES; RECA-PROTEIN; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; NUCLEOPROTEIN FILAMENTS; MULTIPLE PATHWAYS; RAD51 PROTEIN; DNA; RECOMBINATION; EXCHANGE	Background: Gene targeting depends on the ability of cells to use homologous recombination to integrate exogenous DNA into their own genome. A robust mechanistic model of homologous recombination is necessary to fully exploit gene targeting for therapeutic benefit. Methodology/Principal Findings: In this work, our recently developed numerical simulation model for homology search is employed to develop rules for the design of oligonucleotides used in gene targeting. A Metropolis Monte-Carlo algorithm is used to predict the pairing dynamics of an oligonucleotide with the target double-stranded DNA. The model calculates the base-alignment between a long, target double-stranded DNA and a probe nucleoprotein filament comprised of homologous recombination proteins (Rad51 or RecA) polymerized on a single strand DNA. In this study, we considered different sizes of oligonucleotides containing 1 or 3 base heterologies with the target; different positions on the probe were tested to investigate the effect of the mismatch position on the pairing dynamics and stability. We show that the optimal design is a compromise between the mean time to reach a perfect alignment between the two molecules and the stability of the complex. Conclusion and Significance: A single heterology can be placed anywhere without significantly affecting the stability of the triplex. In the case of three consecutive heterologies, our modeling recommends using long oligonucleotides (at least 35 bases) in which the heterologous sequences are positioned at an intermediate position. Oligonucleotides should not contain more than 10% consecutive heterologies to guarantee a stable pairing with the target dsDNA. Theoretical modeling cannot replace experiments, but we believe that our model can considerably accelerate optimization of oligonucleotides for gene therapy by predicting their pairing dynamics with the target dsDNA.	[Mine-Hattab, Judith; Fleury, Genevieve; Viovy, Jean-Louis] Inst Curie, CNRS, Lab Phys Chim Curie, UMR 168, F-75231 Paris, France; [Dutreix, Marie] Hosp Orsay, Inst Curie, Translat Res Dept, Lab Recombinat Repair & Canc, Orsay, France; [Prevost, Chantal] CNRS, IBPC, Lab Biochim Theor, UMR 9080, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Mine-Hattab, J (corresponding author), Inst Curie, CNRS, Lab Phys Chim Curie, UMR 168, F-75231 Paris, France.	Jean-Louis.Viovy@curie.fr	Fleury, Geneviève/E-6184-2013	Viovy, Jean-Louis/0000-0002-8223-4040; Chantal, Prevost/0000-0003-3516-6687	IMPBio ANR; Institute Curie-PIC	IMPBio ANR(French National Research Agency (ANR)); Institute Curie-PIC	This work was partly supported by the IMPBio ANR programme, by the Institute Curie-PIC "Physics at the Cell Level". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzuma K, 1998, J BIOL CHEM, V273, P31565, DOI 10.1074/jbc.273.47.31565; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Bertucat G, 1998, J BIOMOL STRUCT DYN, V16, P535, DOI 10.1080/07391102.1998.10508268; Bertucat G, 1999, BIOPHYS J, V77, P1562, DOI 10.1016/S0006-3495(99)77004-9; BIANCHI ME, 1983, CELL, V35, P511, DOI 10.1016/0092-8674(83)90185-X; Biet E, 2003, PIGM CELL RES, V16, P133, DOI 10.1034/j.1600-0749.2003.00021.x; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cizeau P, 1997, BIOPOLYMERS, V42, P383, DOI 10.1002/(SICI)1097-0282(19971005)42:4<383::AID-BIP1>3.0.CO;2-M; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; DORFMAN K, 2004, PHYS REV LETT, V93, P1; DUTREIX D, 2003, COMPLEXUS, V1, P89; Fulconis R, 2005, BIOPHYS J, V88, P3770, DOI 10.1529/biophysj.104.055269; Gamper HB, 2000, BIOCHEMISTRY-US, V39, P5808, DOI 10.1021/bi9921891; Gendrel CG, 2000, GENE DEV, V14, P1261; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HONIGBERG SM, 1985, J BIOL CHEM, V260, P1845; Igoucheva O, 2001, GENE THER, V8, P391, DOI 10.1038/sj.gt.3301414; JWANG BR, 1992, P NATL ACAD SCI USA, V89, P7596, DOI 10.1073/pnas.89.16.7596; Klapstein K, 2004, BIOPHYS J, V87, P1466, DOI 10.1529/biophysj.104.039578; Lavery R, 1999, GENETICA, V106, P75, DOI 10.1023/A:1003776827836; Leger JF, 1998, P NATL ACAD SCI USA, V95, P12295, DOI 10.1073/pnas.95.21.12295; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu L, 2002, NUCLEIC ACIDS RES, V30, P2742, DOI 10.1093/nar/gkf397; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McLachlan J, 2009, DNA REPAIR, V8, P1424, DOI 10.1016/j.dnarep.2009.09.014; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mine J, 2007, NUCLEIC ACIDS RES, V35, P7171, DOI 10.1093/nar/gkm752; MOREL P, 1994, J BIOL CHEM, V269, P19830; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Ohbayashi F, 2005, P NATL ACAD SCI USA, V102, P13628, DOI 10.1073/pnas.0506598102; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Parekh-Olmedo H, 2007, GENE THER, V14, P1675, DOI 10.1038/sj.gt.3303053; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Savir Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000468; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; SHEN P, 1986, GENETICS, V112, P441; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; Xiao J, 2006, CHEMBIOCHEM, V7, P1265, DOI 10.1002/cbic.200600038; Yanez RJ, 1999, GENE THER, V6, P1282, DOI 10.1038/sj.gt.3300945; Yin WX, 2005, BIOCHEM BIOPH RES CO, V334, P1032, DOI 10.1016/j.bbrc.2005.06.193	49	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e14795	10.1371/journal.pone.0014795	http://dx.doi.org/10.1371/journal.pone.0014795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483664	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300003
J	Itzhaki, I; Rapoport, S; Huber, I; Mizrahi, I; Zwi-Dantsis, L; Arbel, G; Schiller, J; Gepstein, L				Itzhaki, Ilanit; Rapoport, Sophia; Huber, Irit; Mizrahi, Itzhak; Zwi-Dantsis, Limor; Arbel, Gil; Schiller, Jackie; Gepstein, Lior			Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; RELEASE; CONTRACTION; EXPRESSION; INDUCTION; CHANNELS	Background: The ability to establish human induced pluripotent stem cells (hiPSCs) by reprogramming of adult fibroblasts and to coax their differentiation into cardiomyocytes opens unique opportunities for cardiovascular regenerative and personalized medicine. In the current study, we investigated the Ca2+-handling properties of hiPSCs derived-cardiomyocytes (hiPSC-CMs). Methodology/Principal Findings: RT-PCR and immunocytochemistry experiments identified the expression of key Ca2+-handling proteins. Detailed laser confocal Ca2+ imaging demonstrated spontaneous whole-cell [Ca2+](i) transients. These transients required Ca2+ influx via L-type Ca2+ channels, as demonstrated by their elimination in the absence of extracellular Ca2+ or by administration of the L-type Ca2+ channel blocker nifedipine. The presence of a functional ryanodine receptor (RyR)-mediated sarcoplasmic reticulum (SR) Ca2+ store, contributing to [Ca2+](i) transients, was established by application of caffeine (triggering a rapid increase in cytosolic Ca2+) and ryanodine (decreasing [Ca2+](i)). Similarly, the importance of Ca2+ reuptake into the SR via the SR Ca2+ ATPase (SERCA) pump was demonstrated by the inhibiting effect of its blocker (thapsigargin), which led to [Ca2+](i) transients elimination. Finally, the presence of an IP3-releasable Ca2+ pool in hiPSC-CMs and its contribution to whole-cell [Ca2+](i) transients was demonstrated by the inhibitory effects induced by the IP3-receptor blocker 2-Aminoethoxydiphenyl borate (2-APB) and the phosopholipase C inhibitor U73122. Conclusions/Significance: Our study establishes the presence of a functional, SERCA-sequestering, RyR-mediated SR Ca2+ store in hiPSC-CMs. Furthermore, it demonstrates the dependency of whole-cell [Ca2+](i) transients in hiPSC-CMs on both sarcolemmal Ca2+ entry via L-type Ca2+ channels and intracellular store Ca2+ release.	[Itzhaki, Ilanit; Huber, Irit; Mizrahi, Itzhak; Zwi-Dantsis, Limor; Arbel, Gil; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, IL-31096 Haifa, Israel; [Rapoport, Sophia; Schiller, Jackie] Technion Israel Inst Technol, Dept Physiol Biophys, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Itzhaki, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, POB 9649, IL-31096 Haifa, Israel.	mdlior@tx.technion.ac.il	Gepstein, Lior/H-9458-2012		Israel Science Foundation [1781/07]; Legacy Heritage Foundation [1225/09]; European Research Council [ERC-2010-StG-260830-Cardio-iPS]; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Foundation; European Research Council(European Research Council (ERC)European Commission); Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	This study was supported in part by the Israel Science Foundation and Legacy Heritage Foundation (no. 1225/09), by the Israel Science Foundation Converging Technologies Program (1781/07), by the Ideas Program of the European Research Council (ERC-2010-StG-260830-Cardio-iPS), by the Lorry Lokey research fund, and by the Nancy and Stephen Grand Philanthropic Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Fu JD, 2005, FASEB J, V19, P181, DOI 10.1096/fj.05-4501fje; Fu JD, 2006, ACTA PHARMACOL SIN, V27, P901, DOI 10.1111/j.1745-7254.2006.00380.x; Galli GLJ, 2006, AM J PHYSIOL-REG I, V291, pR1781, DOI 10.1152/ajpregu.00421.2006; GERMANGUZ I, 2009, J CELL MOL MED; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; ITZHAKI I, 2011, NATURE; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Kapur N, 2007, J PHYSIOL-LONDON, V581, P1113, DOI 10.1113/jphysiol.2006.125955; Katz G, 2009, CURR PROB CARDIOLOGY, V34, P1, DOI 10.1016/j.cpcardiol.2008.09.002; Li J, 1997, AM J PHYSIOL-HEART C, V273, pH2481, DOI 10.1152/ajpheart.1997.273.5.H2481; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu WR, 2002, LIFE SCI, V71, P1279, DOI 10.1016/S0024-3205(02)01826-X; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Mery A, 2005, MOL BIOL CELL, V16, P2414, DOI 10.1091/mbc.E04-10-0883; MORAD M, 1983, NATURE, V304, P635, DOI 10.1038/304635a0; MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Poindexter BJ, 2001, CELL CALCIUM, V30, P373, DOI 10.1054/ceca.2001.0249; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Priori SG, 2005, CIRC RES, V97, P1077, DOI 10.1161/01.RES.0000194556.41865.e2; Rosemblit N, 1999, DEV BIOL, V206, P163, DOI 10.1006/dbio.1998.9120; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Sauer H, 2001, AM J PHYSIOL-HEART C, V281, pH411, DOI 10.1152/ajpheart.2001.281.1.H411; Sedan O, 2008, STEM CELLS, V26, P3130, DOI 10.1634/stemcells.2008-0777; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; WEBER A, 1968, J GEN PHYSIOL, V52, P750, DOI 10.1085/jgp.52.5.750; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhu WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005407; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	44	131	133	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18037	10.1371/journal.pone.0018037	http://dx.doi.org/10.1371/journal.pone.0018037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483779	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058300006
J	Santarelli, L; Strafella, E; Staffolani, S; Amati, M; Emanuelli, M; Sartini, D; Pozzi, V; Carbonari, D; Bracci, M; Pignotti, E; Mazzanti, P; Sabbatini, A; Ranaldi, R; Gasparini, S; Neuzil, J; Tomasetti, M				Santarelli, Lory; Strafella, Elisabetta; Staffolani, Sara; Amati, Monica; Emanuelli, Monica; Sartini, Davide; Pozzi, Valentina; Carbonari, Damiano; Bracci, Massimo; Pignotti, Elettra; Mazzanti, Paola; Sabbatini, Armando; Ranaldi, Renzo; Gasparini, Stefano; Neuzil, Jiri; Tomasetti, Marco			Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma	PLOS ONE			English	Article							PLEURAL MESOTHELIOMA; CIRCULATING MICRORNAS; HUMAN CANCERS; LUNG-CANCER; DIAGNOSIS; SERUM; DISEASES; BIOMARKERS; PROFILES; EXPOSURE	Background: Improved detection methods for diagnosis of malignant pleural mesothelioma (MPM) are essential for early and reliable detection as well as treatment. Since recent data point to abnormal levels of microRNAs (miRNAs) in tumors, we hypothesized that a profile of deregulated miRNAs may be a marker of MPM and that the levels of specific miRNAs may be used for monitoring its progress. Methods and Results: miRNAs isolated from fresh-frozen biopsies of MPM patients were tested for the expression of 88 types of miRNA involved in cancerogenesis. Most of the tested miRNAs were downregulated in the malignant tissues compared with the normal tissues. Of eight significantly downregulated, three miRNAs were assayed in cancerous tissue and adjacent non-cancerous tissue sample pairs collected from 27 formalin-fixed, paraffin-embedded MPM tissues by quantitative RT-PCR. Among the miRNAs tested, only miR-126 significantly remained downregulated in the malignant tissues. Furthermore, the performance of the selected miR-126 as biomarker was evaluated in serum samples of asbestos-exposed subjects and MPM patients and compared with controls. MiR-126 was not affected by asbestos exposure, whereas it was found strongly associated with VEGF serum levels. Levels of miR-126 in serum, and its levels in patients' serum in association with a specific marker of MPM, SMRPs, correlate with subjects at high risk to develop MPM. Conclusions and Significance: We propose miR-126, in association with SMRPs, as a marker for early detection of MPM. The identification of tumor biomarkers used alone or, in particular, in combination could greatly facilitate the surveillance procedure for cohorts of subjects exposed to asbestos.	[Santarelli, Lory; Strafella, Elisabetta; Staffolani, Sara; Amati, Monica; Carbonari, Damiano; Bracci, Massimo; Tomasetti, Marco] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Emanuelli, Monica; Sartini, Davide; Pozzi, Valentina] Polytech Univ Marche, Dept Biochem Biol & Genet, Ancona, Italy; [Pignotti, Elettra] Univ Bologna, Dept Stat Sci, Bologna, Italy; [Mazzanti, Paola] Hosp Univ Ancona, Dept Med Oncol, Ancona, Italy; [Sabbatini, Armando] Hosp Univ Ancona, Thorac Surg Unit, Ancona, Italy; [Ranaldi, Renzo] Hosp Univ Ancona, Anat Pathol Unit, Ancona, Italy; [Gasparini, Stefano] Hosp Univ Ancona, Pneumol Unit, Ancona, Italy; [Neuzil, Jiri] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld 4215, Australia; [Neuzil, Jiri] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Neuzil, Jiri] Acad Sci Czech Republic, Inst Biotechnol, Mol Therapy Grp, Prague, Czech Republic	Marche Polytechnic University; Marche Polytechnic University; University of Bologna; Griffith University; Griffith University; Menzies Health Institute Queensland; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	Santarelli, L (corresponding author), Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy.	m.tomasetti@univpm.it	Neuzil, Jiri/H-7204-2014; santarelli, lory/I-7429-2012; Bracci, Massimo/K-1192-2018; Santarelli, Lory/AAU-4494-2020	Neuzil, Jiri/0000-0002-2478-2460; Bracci, Massimo/0000-0003-3901-5376; santarelli, lory/0000-0003-1015-7098	National Institute against Occupational Injury Insurance (INAIL); Australian Research Council; Grant Agency of the Czech Republic [204/08/0811]	National Institute against Occupational Injury Insurance (INAIL); Australian Research Council(Australian Research Council); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The study was supported by a grant from the National Institute against Occupational Injury Insurance (INAIL) to L.S. and M.T. The INAIL is not a commercial company. J.N. was supported in part by grants from the Australian Research Council and the Grant Agency of the Czech Republic (204/08/0811). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	AISNER J, 1995, CHEST, V108, P1122; Amati M, 2008, CANCER EPIDEM BIOMAR, V17, P163, DOI 10.1158/1055-9965.EPI-07-0607; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Ellis P, 2006, J THORAC ONCOL, V1, P591, DOI 10.1097/01243894-200607000-00017; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; GEE GV, 2010, INT J CANC; Grigoriu BD, 2009, AM J RESP CRIT CARE, V179, P950, DOI 10.1164/rccm.200807-1125OC; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hansen J, 1998, AM J RESP CRIT CARE, V157, P69, DOI 10.1164/ajrccm.157.1.96-11086; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo L, 2010, RESP MED, V104, P149, DOI 10.1016/j.rmed.2009.05.017; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MURPHY RLH, 1971, NEW ENGL J MED, V285, P1271, DOI 10.1056/NEJM197112022852301; Ortholan C, 2009, CURR MED CHEM, V16, P1047, DOI 10.2174/092986709787581833; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Romero S, 1996, EUR RESPIR J, V9, P17, DOI 10.1183/09031936.96.09010017; Scagliotti GV, 2007, ONCOL REV, V1, P91, DOI 10.1007/s12156-007-0011-7; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Shah PP, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-11; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Waller DA, 2003, CURR OPIN ONCOL, V15, P139, DOI 10.1097/00001622-200303000-00004; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang CX, 2009, CELL CYCLE, V8, P3469, DOI 10.4161/cc.8.21.9837	42	76	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18232	10.1371/journal.pone.0018232	http://dx.doi.org/10.1371/journal.pone.0018232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483773	Green Published, gold			2022-12-25	WOS:000289058300007
J	Achenbach, JE; Bowen, RA				Achenbach, Jenna E.; Bowen, Richard A.			Transmission of Avian Influenza A Viruses among Species in an Artificial Barnyard	PLOS ONE			English	Article							WATERBORNE TRANSMISSION; COTTON RAT; HONG-KONG; H5N1; PATHOGENICITY; EVOLUTION; OUTBREAK; PIGEONS; DUCKS; PERSISTENCE	Waterfowl and shorebirds harbor and shed all hemagglutinin and neuraminidase subtypes of influenza A viruses and interact in nature with a broad range of other avian and mammalian species to which they might transmit such viruses. Estimating the efficiency and importance of such cross-species transmission using epidemiological approaches is difficult. We therefore addressed this question by studying transmission of low pathogenic H5 and H7 viruses from infected ducks to other common animals in a quasi-natural laboratory environment designed to mimic a common barnyard. Mallards (Anas platyrhynchos) recently infected with H5N2 or H7N3 viruses were introduced into a room housing other mallards plus chickens, blackbirds, rats and pigeons, and transmission was assessed by monitoring virus shedding (ducks) or seroconversion (other species) over the following 4 weeks. Additional animals of each species were directly inoculated with virus to characterize the effect of a known exposure. In both barnyard experiments, virus accumulated to high titers in the shared water pool. The H5N2 virus was transmitted from infected ducks to other ducks and chickens in the room either directly or through environmental contamination, but not to rats or blackbirds. Ducks infected with the H7N2 virus transmitted directly or indirectly to all other species present. Chickens and blackbirds directly inoculated with these viruses shed significant amounts of virus and seroconverted; rats and pigeons developed antiviral antibodies, but, except for one pigeon, failed to shed virus.	[Achenbach, Jenna E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Achenbach, JE (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	rbowen@colostate.edu		Achenbach, Jenna/0000-0002-5367-6413	Centers for Disease Control and Prevention [1 U19 CI00419-01]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U19CI000419] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	These studies were supported through cooperative agreement 1 U19 CI00419-01 from the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENAS A, 1990, AVIAN PATHOL, V19, P539, DOI 10.1080/03079459008418706; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brochet AL, 2009, ECOHEALTH, V6, P449, DOI 10.1007/s10393-010-0275-4; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Eichelberger MC, 2007, VIRAL IMMUNOL, V20, P243, DOI 10.1089/vim.2007.0017; Fang TH, 2006, AVIAN DIS, V50, P269, DOI 10.1637/7437-090905R.1; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Forrest HL, 2010, J VIROL, V84, P3718, DOI 10.1128/JVI.02017-09; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Jia BB, 2008, ARCH VIROL, V153, P1821, DOI 10.1007/s00705-008-0193-8; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; LATORREMARGALEF N, 2008, P ROY SOC LOND B BIO, V276, P1029; LAUDERT E, 1993, AVIAN DIS, V37, P793, DOI 10.2307/1592031; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagy A, 2009, VET MICROBIOL, V133, P257, DOI 10.1016/j.vetmic.2008.07.013; Niqueux E, 2010, AVIAN DIS, V54, P502, DOI 10.1637/8804-040109-ResNote.1; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Rice EW, 2007, EMERG INFECT DIS, V13, P1568, DOI 10.3201/eid1310.070323; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; SHORTRIDGE KF, 1982, B WORLD HEALTH ORGAN, V60, P129; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; TYRRELL DAJ, 1952, J IMMUNOL, V69, P563; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Werner O, 2007, J GEN VIROL, V88, P3089, DOI 10.1099/vir.0.83105-0	40	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17643	10.1371/journal.pone.0017643	http://dx.doi.org/10.1371/journal.pone.0017643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483843	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200008
J	Kelsen, J; Dige, A; Schwindt, H; D'Amore, F; Pedersen, FS; Agnholt, J; Christensen, LA; Dahlerup, JF; Hvas, CL				Kelsen, Jens; Dige, Anders; Schwindt, Heinrich; D'Amore, Francesco; Pedersen, Finn S.; Agnholt, Jorgen; Christensen, Lisbet A.; Dahlerup, Jens F.; Hvas, Christian L.			Infliximab Induces Clonal Expansion of gamma delta-T Cells in Crohn's Disease: A Predictor of Lymphoma Risk?	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THERAPY; AZATHIOPRINE; DIAGNOSIS; PATIENT; BLOOD; IBD	Background: Concominant with the widespread use of combined immunotherapy in the management of Crohn's disease (CD), the incidence of hepato-splenic gamma-delta (gamma delta)-T cell lymphoma has increased sharply in CD patients. Malignant transformation of lymphocytes is believed to be a multistep process resulting in the selection of malignant gamma delta-T cell clones. We hypothesised that repeated infusion of anti-TNF-alpha agents may induce clonal selection and that concurrent treatment with immunomodulators further predisposes patients to gamma delta-T cell expansion. Methodology/Principal Findings: We investigated dynamic changes in the gamma delta-T cells of patient with CD following treatment with infliximab (Remicade (R); n = 20) or adalimumab (Humira (R); n = 26) using flow cytometry. In patients with a high gamma delta-T cell level, the gamma delta-T cells were assessed for clonality. Of these 46 CD patients, 35 had a gamma delta-T cells level (mean 1.6%) comparable to healthy individuals (mean 2.2%), and 11 CD patients (24%) exhibited an increased level of gamma delta-T cells (5-15%). In the 18 patients also receiving thiopurines or methotrexate, the average baseline gamma delta-T cell level was 4.4%. In three male CD patients with a high baseline value, the gamma delta-T cell population increased dramatically following infliximab therapy. A fourth male patient also on infliximab monotherapy presented with 20% gamma delta-T cells, which increased to 25% shortly after treatment and was 36% between infusions. Clonality studies revealed an oligoclonal gamma delta-T cell pattern with dominant gamma delta-T cell clones. In support of our clinical findings, in vitro experiments showed a dose-dependent proliferative effect of anti-TNF-alpha agents on gamma delta-T cells. Conclusion/Significance: CD patients treated with immunomodulators had constitutively high levels of gamma delta-T cells. Infliximab exacerbated clonal gamma delta-T cell expansion in vivo and induced gamma delta-T cell proliferation in vitro. Overall, young, male CD patients with high baseline gamma delta-T cell levels may be at an increased risk of developing malignant gamma delta-T cell lymphomas following treatment with anti-TNF-alpha agents.	[Kelsen, Jens; Dige, Anders; Agnholt, Jorgen; Christensen, Lisbet A.; Dahlerup, Jens F.; Hvas, Christian L.] Aarhus Univ Hosp, Dept Med 5, GIRL, DK-8000 Aarhus, Denmark; [Schwindt, Heinrich; Pedersen, Finn S.] Aarhus Univ, Inst Mol Biol, Aarhus, Denmark; [D'Amore, Francesco] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kelsen, J (corresponding author), Aarhus Univ Hosp, Dept Med 5, GIRL, DK-8000 Aarhus, Denmark.	jenskels@rm.dk		Dahlerup, Jens Frederik/0000-0002-1587-7636; Agnholt, Jorgen/0000-0003-2822-6442	Karen Elise Jensen Foundation; Beckett Foundation; Desiree and Niels Ydes Foundation; Danish Colitis-Crohn Foundation; Toyota Foundation, Denmark; Abbott	Karen Elise Jensen Foundation; Beckett Foundation; Desiree and Niels Ydes Foundation; Danish Colitis-Crohn Foundation; Toyota Foundation, Denmark; Abbott(Abbott Laboratories)	The study was supported by research funding from the Karen Elise Jensen Foundation, the Beckett Foundation, the Desiree and Niels Ydes Foundation, the Danish Colitis-Crohn Foundation, and the Toyota Foundation, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Jorgen Agnholt is member of the Abbott Advisory Board, Denmark. Lisbet Ambrosius Christensen is a member of the MSD Advisory Board, Denmark. Anders Dige has received an unrestricted grant from Abbott. Abbott was not involved in the study design, collection, analysis and interpretation of data, writing of the paper, and/or decision to submit for publication. The authors declare full adherence to all the PLoS ONE policies on sharing data and materials.	Atreya I, 2009, GUT, V58, P325, DOI 10.1136/gut.2008.163485; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Belhadj K, 2003, BLOOD, V102, P4261, DOI 10.1182/blood-2003-05-1675; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Mackey AC, 2007, J PEDIATR GASTR NUTR, V44, P265, DOI 10.1097/MPG.0b013e31802f6424; D'Haens G, 2009, LANCET, V374, P1572, DOI 10.1016/S0140-6736(09)61487-2; Dige A, 2010, J IMMUNOL METHODS, V353, P141, DOI 10.1016/j.jim.2009.11.019; GIACOMELLI R, 1994, CLIN EXP IMMUNOL, V98, P83; HARVEY RF, 1980, LANCET, V1, P514; Holtmeier W, 2002, AM J PHYSIOL-GASTR L, V282, pG1024, DOI 10.1152/ajpgi.00224.2001; Hvas CL, 2010, AUTOIMMUNITY, V43, P325, DOI 10.3109/08916930903509064; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Iqbal J, 2009, BEST PRACT RES CL HA, V22, P191, DOI 10.1016/j.beha.2009.05.001; Mackey AC, 2009, J PEDIATR GASTR NUTR, V48, P386, DOI 10.1097/MPG.0b013e3181957a11; Miyazaki K, 2009, BLOOD, V113, P1071, DOI 10.1182/blood-2008-07-166363; Moran G, 2009, INFLAMM BOWEL DIS, V15, P1281, DOI 10.1002/ibd.20802; Navarro JT, 2003, LEUKEMIA LYMPHOMA, V44, P531, DOI 10.1080/1042819021000035662; Ochenrider MG, 2010, CL LYMPH MYELOM LEUK, V10, P144, DOI 10.3816/CLML.2010.n.021; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Rosh JR, 2007, INFLAMM BOWEL DIS, V13, P1024, DOI 10.1002/ibd.20169; Shale M, 2008, GUT, V57, P1639, DOI 10.1136/gut.2008.163279; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P1392, DOI 10.1002/ibd.20490; Soderstrom K, 1996, J IMMUNOL, V156, P2331; Sokol H, 2009, GUT, V58, P1427, DOI 10.1136/gut.2009.181982; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Thayu M, 2005, J PEDIATR GASTR NUTR, V40, P220, DOI 10.1097/00005176-200502000-00026; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202	28	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17890	10.1371/journal.pone.0017890	http://dx.doi.org/10.1371/journal.pone.0017890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483853	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200012
J	Matar-Merheb, R; Rhimi, M; Leydier, A; Huche, F; Galian, C; Desuzinges-Mandon, E; Ficheux, D; Flot, D; Aghajari, N; Kahn, R; Di Pietro, A; Jault, JM; Coleman, AW; Falson, P				Matar-Merheb, Rima; Rhimi, Moez; Leydier, Antoine; Huche, Frederic; Galian, Carmen; Desuzinges-Mandon, Elodie; Ficheux, Damien; Flot, David; Aghajari, Nushin; Kahn, Richard; Di Pietro, Attilio; Jault, Jean-Michel; Coleman, Anthony W.; Falson, Pierre			Structuring Detergents for Extracting and Stabilizing Functional Membrane Proteins	PLOS ONE			English	Article							MULTIDRUG ABC TRANSPORTER; BACILLUS-SUBTILIS; RESISTANCE; BINDING; ACID; ATP; CA2+-ATPASE; DERIVATIVES; EXPRESSION; AMPHIPOLS	Background: Membrane proteins are privileged pharmaceutical targets for which the development of structure-based drug design is challenging. One underlying reason is the fact that detergents do not stabilize membrane domains as efficiently as natural lipids in membranes, often leading to a partial to complete loss of activity/stability during protein extraction and purification and preventing crystallization in an active conformation. Methodology/Principal Findings: Anionic calix[4] arene based detergents (C4Cn, n = 1-12) were designed to structure the membrane domains through hydrophobic interactions and a network of salt bridges with the basic residues found at the cytosol-membrane interface of membrane proteins. These compounds behave as surfactants, forming micelles of 5-24 nm, with the critical micellar concentration (CMC) being as expected sensitive to pH ranging from 0.05 to 1.5 mM. Both by (1)H NMR titration and Surface Tension titration experiments, the interaction of these molecules with the basic amino acids was confirmed. They extract membrane proteins from different origins behaving as mild detergents, leading to partial extraction in some cases. They also retain protein functionality, as shown for BmrA (Bacillus multidrug resistance ATP protein), a membrane multidrug-transporting ATPase, which is particularly sensitive to detergent extraction. These new detergents allow BmrA to bind daunorubicin with a Kd of 12 mu M, a value similar to that observed after purification using dodecyl maltoside (DDM). They preserve the ATPase activity of BmrA (which resets the protein to its initial state after drug efflux) much more efficiently than SDS (sodium dodecyl sulphate), FC12 (Foscholine 12) or DDM. They also maintain in a functional state the C4Cn-extracted protein upon detergent exchange with FC12. Finally, they promote 3D-crystallization of the membrane protein. Conclusion/Significance: These compounds seem promising to extract in a functional state membrane proteins obeying the positive inside rule. In that context, they may contribute to the membrane protein crystallization field.	[Matar-Merheb, Rima; Rhimi, Moez; Huche, Frederic; Desuzinges-Mandon, Elodie; Ficheux, Damien; Di Pietro, Attilio; Falson, Pierre] CNRS, Drug Resistance Mech & Modulat Lab, Ligue Labeled Team 2009, Lyon, France; [Rhimi, Moez; Huche, Frederic; Aghajari, Nushin] Univ Lyon 1, Lab BioCristallog & Biol Struct Cibles Therapeut, CNRS, UMR 5086,IBCP, F-69365 Lyon, France; [Leydier, Antoine] CEA DEN DRCP SCPS LEPS, Bagnols Sur Ceze, France; [Galian, Carmen; Kahn, Richard; Jault, Jean-Michel] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, Grenoble, France; [Coleman, Anthony W.] Univ Lyon 1, CNRS, UMR 5615, Lab Multimat & Interfaces, F-69365 Lyon, France; [Flot, David] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF)	Matar-Merheb, R (corresponding author), CNRS, Drug Resistance Mech & Modulat Lab, Ligue Labeled Team 2009, Lyon, France.	anthony.coleman@univ-lyon1.fr; p.falson@ibcp.fr	Coleman, Anthony William/K-2208-2019; Kahn, Richard/ABD-2666-2020; Leydier, Antoine/AAK-1685-2020; Aghajari, Nushin B.H./P-1906-2016; jault, jean-michel/G-2086-2012	Kahn, Richard/0000-0002-0259-0601; Leydier, Antoine/0000-0002-1997-9664; Aghajari, Nushin B.H./0000-0002-2245-2679; jault, jean-michel/0000-0003-1743-2777; Falson, Pierre/0000-0002-9760-4577; RHIMI, Moez/0000-0001-8067-6526	CNRS (Centre National de la Recherche Scientifique); ANR (Agence Nationale de la Recherche) [ANR-06-PCVI-0019-01, ANR-09-PIRI-0002-01, ANR-06-BLANC-0420]; CIBLE [06 022966 01/02]; PRIME (Projets de Recherche Interne Multi-Equipes)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); CIBLE(Region Auvergne-Rhone-Alpes); PRIME (Projets de Recherche Interne Multi-Equipes)	This work was supported by CNRS (Centre National de la Recherche Scientifique, www.cnrs.fr); ANR (Agence Nationale de la Recherche, www.agence-nationale-recherche.fr) ANR-06-PCVI-0019-01, ANR-09-PIRI-0002-01, ANR-06-BLANC-0420; CIBLE (www.rhonealpes.fr) Cible no 06 022966 01/02; PRIME (Projets de Recherche Interne Multi-Equipes, www.ibcp.fr) IBCP-Prime 2006, IBCP Prime 2007; Ligue Nationale contre le Cancer (www.ligue-cancer.net), labelled team:"Laboratoire des Proteines de Resistance aux Agents Chimiotherapeutiques". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Boumendjel A, 2007, BIOORGAN MED CHEM, V15, P2892, DOI 10.1016/j.bmc.2007.02.017; CHAE PS, 2010, NAT METH; Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deniaud A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006214; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; DRUECKES P, 1995, ANAL BIOCHEM, V230, P173, DOI 10.1006/abio.1995.1453; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; FALSON P, 1993, BIOCHEMISTRY-US, V32, P10387, DOI 10.1021/bi00090a014; HAMADA H, 1988, CANCER RES, V48, P4926; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2; Kalchenko OI, 2001, J CHEM SOC PERK T 2, P258, DOI 10.1039/b005497f; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Litman T, 2000, J CELL SCI, V113, P2011; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; McDermott A, 2009, ANNU REV BIOPHYS, V38, P385, DOI 10.1146/annurev.biophys.050708.133719; MCGREGOR CL, 2003, NAT BIOTECHNOL; Montigny C, 2004, BBA-BIOMEMBRANES, V1660, P53, DOI 10.1016/j.bbamem.2003.10.013; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Suwinska K, 2008, NEW J CHEM, V32, P1988, DOI 10.1039/b806342g; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Trometer C, 2010, METHODS MOL BIOL, V601, P105, DOI 10.1007/978-1-60761-344-2_7; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; White S., 2009, MEMBRANE PROTEINS KN; Zhang QH, 2007, ANGEW CHEM INT EDIT, V46, P7023, DOI 10.1002/anie.200701556	38	65	67	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18036	10.1371/journal.pone.0018036	http://dx.doi.org/10.1371/journal.pone.0018036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483854	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200021
J	Zhou, GL; Isoe, J; Day, WA; Miesfeld, RL				Zhou, Guoli; Isoe, Jun; Day, W. Antony; Miesfeld, Roger L.			Alpha-COPI Coatomer Protein Is Required for Rough Endoplasmic Reticulum Whorl Formation in Mosquito Midgut Epithelial Cells	PLOS ONE			English	Article							AEDES-AEGYPTI L; BLOOD DIGESTION; L INSECTA; DIPTERA; TRYPSIN; ULTRASTRUCTURE; CULICIDAE; MEAL; P100	Background: One of the early events in midgut epithelial cells of Aedes aegypti mosquitoes is the dynamic reorganization of rough endoplasmic reticulum (RER) whorl structures coincident with the onset of blood meal digestion. Based on our previous studies showing that feeding on an amino acid meal induces TOR signaling in Ae. aegypti, we used proteomics and RNAi to functionally identify midgut epithelial cell proteins that contribute to RER whorl formation. Methodology/Principal Findings: Adult female Ae. aegypti mosquitoes were maintained on sugar alone (unfed), or fed an amino acid meal, and then midgut epithelial cells were analyzed by electron microscopy and protein biochemistry. The size and number of RER whorls in midgut epithelial cells were found to decrease significantly after feeding, and several KDEL-containing proteins were shown to have altered expression levels. LC-MS/MS mass spectrometry was used to analyze midgut microsomal proteins isolated from unfed and amino acid fed mosquitoes, and of the 127 proteins identified, 8 were chosen as candidate whorl forming proteins. Three candidate proteins were COPI coatomer subunits (alpha, beta, beta'), all of which appeared to be present at higher levels in microsomal fractions from unfed mosquitoes. Using RNAi to knockdown alpha-COPI expression, electron microscopy revealed that both the size and number of RER whorls were dramatically reduced in unfed mosquitoes, and moreover, that extended regions of swollen RER were prevalent in fed mosquitoes. Lastly, while a deficiency in alpha-COPI had no effect on early trypsin protein synthesis or secretion 3 hr post blood meal (PBM), expression of late phase proteases at 24 hr PBM was completely blocked. Conclusions: alpha-COPI was found to be required for the formation of RER whorls in midgut epithelial cells of unfed Aa. aegypti mosquitoes, as well as for the expression of late phase midgut proteases.	[Zhou, Guoli; Isoe, Jun; Miesfeld, Roger L.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Day, W. Antony] Univ Arizona, Arizona Res Labs, Tucson, AZ USA	University of Arizona; University of Arizona	Zhou, GL (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	rlm@email.arizona.edu			National Institutes of Health [R01AI31951]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant R01AI31951 to RLM (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Saraiva KLA, 2008, MICRON, V39, P580, DOI 10.1016/j.micron.2007.06.003; Andrade-Coelho CA, 2001, MEM I OSWALDO CRUZ, V96, P1141, DOI 10.1590/S0074-02762001000800020; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; BAUER P, 1977, CELL TISSUE RES, V177, P215, DOI 10.1007/BF00221082; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; BERTRAM D. S., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P404, DOI 10.1016/0035-9203(61)90085-2; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Briegel H, 2003, J VECTOR ECOL, V28, P1; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Dickhout JG, 2007, CIRCULATION, V116, P1214, DOI 10.1161/CIRCULATIONAHA.107.728378; Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002; GRAF R, 1986, CELL TISSUE RES, V245, P19, DOI 10.1007/BF00218082; Hecker H., 1971, Acta Tropica, V28, P80; HECKER H, 1977, CELL TISSUE RES, V184, P321, DOI 10.1007/BF00219894; HOUK EJ, 1977, TISSUE CELL, V9, P103, DOI 10.1016/0040-8166(77)90052-0; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; HWANG KM, 1974, J CELL BIOL, V62, P20, DOI 10.1083/jcb.62.1.20; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Marquardt W. C., 2005, BIOL DIS VECTORS; Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; Okuda K, 2005, J INSECT PHYSIOL, V51, P769, DOI 10.1016/j.jinsphys.2005.03.010; Okuda K, 2002, TISSUE CELL, V34, P210, DOI 10.1016/S0040-8166(02)00032-0; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; RUDIN W, 1976, TISSUE CELL, V8, P459, DOI 10.1016/0040-8166(76)90006-9; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003; Zhou Guoli, 2009, Open Access Insect Physiology, V1, P1; Zhou HX, 2010, J VIROL, V84, P3542, DOI 10.1128/JVI.02570-09	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18150	10.1371/journal.pone.0018150	http://dx.doi.org/10.1371/journal.pone.0018150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483820	gold, Green Published, Green Submitted			2022-12-25	WOS:000289057200033
J	Heidt, T; Deininger, F; Peter, K; Goldschmidt, J; Pethe, A; Hagemeyer, CE; Neudorfer, I; Zirlik, A; Weber, WA; Bode, C; Meyer, PT; Behe, M; von zur Muhlen, C				Heidt, Timo; Deininger, Friederike; Peter, Karlheinz; Goldschmidt, Juergen; Pethe, Annette; Hagemeyer, Christoph E.; Neudorfer, Irene; Zirlik, Andreas; Weber, Wolfgang A.; Bode, Christoph; Meyer, Philipp T.; Behe, Martin; von zur Muehlen, Constantin			Activated Platelets in Carotid Artery Thrombosis in Mice Can Be Selectively Targeted with a Radiolabeled Single-Chain Antibody	PLOS ONE			English	Article							MAGNETIC-RESONANCE; GLYCOPROTEIN IIB/IIIA; CONTRAST AGENT; ATHEROSCLEROTIC PLAQUES; VASCULAR INFLAMMATION; PULMONARY EMBOLI; GPIIB/IIIA; ATHEROGENESIS; ANTAGONIST; RESOLUTION	Background: Activated platelets can be found on the surface of inflamed, rupture-prone and ruptured plaques as well as in intravascular thrombosis. They are key players in thrombosis and atherosclerosis. In this study we describe the construction of a radiolabeled single-chain antibody targeting the LIBS-epitope of activated platelets to selectively depict platelet activation and wall-adherent non-occlusive thrombosis in a mouse model with nuclear imaging using in vitro and ex vivo autoradiography as well as small animal SPECT-CT for in vivo analysis. Methodology/Principal Findings: LIBS as well as an unspecific control single-chain antibody were labeled with (111)Indium ((111)In) via bifunctional DTPA (=(111)In-LIBS/(111)In-control). Autoradiography after incubation with (111)In-LIBS on activated platelets in vitro (mean 3866+/-28 DLU/mm(2), 4010+/-630 DLU/mm(2) and 4520+/-293 DLU/mm(2)) produced a significantly higher ligand uptake compared to (111)In-control (2101+/-76 DLU/mm(2), 1181+/-96 DLU/mm(2) and 1866+/-246 DLU/mm(2)) indicating a specific binding to activated platelets; P < 0.05. Applying these findings to an ex vivo mouse model of carotid artery thrombosis revealed a significant increase in ligand uptake after injection of (111)In-LIBS in the presence of small thrombi compared to the non-injured side, as confirmed by histology (49630+/-10650 DLU/mm(2) vs. 17390+/-7470 DLU/mm(2); P < 0.05). These findings could also be reproduced in vivo. SPECT-CT analysis of the injured carotid artery with (111)In-LIBS resulted in a significant increase of the target-to-background ratio compared to (111)In-control (1.99+/-0.36 vs. 1.1+/-0.24; P<0.01). Conclusions/Significance: Nuclear imaging with (111)In-LIBS allows the detection of platelet activation in vitro and ex vivo with high sensitivity. Using SPECT-CT, wall-adherent activated platelets in carotid arteries could be depicted in vivo. These results encourage further studies elucidating the role of activated platelets in plaque pathology and atherosclerosis and might be of interest for further developments towards clinical application.	[Heidt, Timo; Neudorfer, Irene; Zirlik, Andreas; Bode, Christoph; von zur Muehlen, Constantin] Univ Freiburg, Dept Cardiol & Angiol, Freiburg, Germany; [Deininger, Friederike; Weber, Wolfgang A.; Meyer, Philipp T.; Behe, Martin] Univ Freiburg, Dept Nucl Med, Freiburg, Germany; [Peter, Karlheinz; Hagemeyer, Christoph E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Goldschmidt, Juergen] Leibniz Inst Neurobiol, Magdeburg, Germany; [Pethe, Annette] Univ Magdeburg, Dept Nucl Med, D-39106 Magdeburg, Germany	University of Freiburg; University of Freiburg; Baker Heart and Diabetes Institute; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Heidt, T (corresponding author), Univ Freiburg, Dept Cardiol & Angiol, Freiburg, Germany.	timo.heidt@uniklinik-freiburg.de	Peter, Karlheinz/E-8772-2010; /S-2765-2019; Hagemeyer, Christoph/E-8958-2011; Zirlik, Andreas/A-6400-2011; Behe, Martin/E-2941-2013	Peter, Karlheinz/0000-0002-8040-2258; /0000-0002-8040-2258; Hagemeyer, Christoph/0000-0002-7114-4023; Zirlik, Andreas/0000-0001-6290-3297; 	German Research Foundation (DFG) [MU2727/3-1]; Australian National Health and Medical Research Council; Australian Research Council [FT0992210]; Australian National Health and Medical Research Council [472668]	German Research Foundation (DFG)(German Research Foundation (DFG)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the German Research Foundation (DFG, grant number MU2727/3-1: CvzM, DvE, IN) and by the Australian National Health and Medical Research Council (www.nhmrc.gov.au); Australian Research Council Future Fellowship FT0992210 to K. P. and Australian National Health and Medical Research Council Career Development Award 472668 to C. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates SM, 2003, ARCH INTERN MED, V163, P452, DOI 10.1001/archinte.163.4.452; BREITLING F, 1999, RECOMBINANT ANTIBODI; Choudhury RP, 2009, ARTERIOSCL THROM VAS, V29, P983, DOI 10.1161/ATVBAHA.108.165498; Choudhury RP, 2004, NAT REV DRUG DISCOV, V3, P913, DOI 10.1038/nrd1548; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Fujimoto S, 2008, J AM COLL CARDIOL, V52, P1847, DOI 10.1016/j.jacc.2008.08.048; Gawaz M, 2008, J THROMB HAEMOST, V6, P235, DOI 10.1111/j.1538-7836.2007.02867.x; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Haider N, 2009, J NUCL CARDIOL, V16, P753, DOI 10.1007/s12350-009-9107-8; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Klem JA, 2000, J NUCL CARDIOL, V7, P359, DOI 10.1067/mnc.2000.106967; LARSON SM, 1985, J NUCL MED, V26, P538; Li D, 2010, CIRC-CARDIOVASC IMAG, V3, P464, DOI 10.1161/CIRCIMAGING.109.896654; McAteer MA, 2010, ATHEROSCLEROSIS, V209, P18, DOI 10.1016/j.atherosclerosis.2009.10.009; Morris TA, 2010, SEMIN NUCL MED, V40, P474, DOI 10.1053/j.semnuclmed.2010.08.002; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Nahrendorf M, 2009, CIRC-CARDIOVASC IMAG, V2, P56, DOI 10.1161/CIRCIMAGING.108.839092; Rudd JHF, 2008, NAT CLIN PRACT CARD, V5, pS11, DOI 10.1038/ncpcardio1160; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Schmidt KC, 2005, NUCL MED BIOL, V32, P719, DOI 10.1016/j.nucmedbio.2005.04.020; Schwarz M, 2004, J PHARMACOL EXP THER, V308, P1002, DOI 10.1124/jpet.103.058883; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Sinusas AJ, 2008, CIRC-CARDIOVASC IMAG, V1, P244, DOI 10.1161/CIRCIMAGING.108.824359; Spuentrup E, 2005, CIRCULATION, V111, P1377, DOI 10.1161/01.CIR.0000158478.29668.9B; Stoll P, 2007, ARTERIOSCL THROM VAS, V27, P1206, DOI 10.1161/ATVBAHA.106.138875; von zur Muhlen C, 2008, CIRCULATION, V118, P258, DOI 10.1161/CIRCULATIONAHA.107.753657; von zur Muhlen C, 2008, MOL IMAGING, V7, P59, DOI 10.2310/7290.2008.0008; von zur Muhlen C, 2009, J VASC RES, V46, P6, DOI 10.1159/000135660; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810; Zhang JS, 2008, CIRCULATION, V118, P1953, DOI 10.1161/CIRCULATIONAHA.108.789743	32	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18446	10.1371/journal.pone.0018446	http://dx.doi.org/10.1371/journal.pone.0018446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479193	gold, Green Published, Green Submitted			2022-12-25	WOS:000289055700058
J	Nocchi, L; Tomasetti, M; Amati, M; Neuzil, J; Santarelli, L; Saccucci, F				Nocchi, Linda; Tomasetti, Marco; Amati, Monica; Neuzil, Jiri; Santarelli, Lory; Saccucci, Franca			Thrombomodulin Is Silenced in Malignant Mesothelioma by a Poly(ADP-ribose) Polymerase-1-mediated Epigenetic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; CHROMATIN MODIFICATIONS; UNMETHYLATED STATE; ADHESION MOLECULE; EXPRESSION; METHYLATION; CANCER; GENE; INVASIVENESS; EPITHELIUM	Malignant mesothelioma (MM) is often complicated by thromboembolic episodes, with thrombomodulin (TM) playing a critical role in the anticoagulant process. Heterogeneous expression of TM has been observed in cancer, and low or no TM expression in cancer cells is associated with poor prognosis. In this study, we analyzed TM expression in biopsies of MM patients and compared them with normal mesothelial tissue. The role of DNA methylation-associated gene silencing in TM expression was investigated. To evaluate poly(ADP-ribose) polymerase-1 (PARP1) as responsible for gene promoter epigenetic modifications, nonmalignant mesothelial cells (Met-5A) and MM cells (H28) were silenced for PARP1 and the DNA methylation/acetylation-associated TM expression evaluated. A correlation between low TM expression and high level of TM promoter methylation was found in MM biopsies. Low expression of TM was restored in MM cells by their treatment with 5-aza-2'-deoxycytidine and, to a lesser extent, with trichostatin, whereas the epigenetic agents did not affect TM expression in Met-5A cells. Silencing of PARP1 resulted in a strong down-regulation of TM expression in Met-5A cells, while restoring TM expression in H28 cells. PARP1 silencing induced TM promoter methylation in Met-5A cells and demethylation in MM cells, and this was paralleled by corresponding changes in the DNA methyltransferase activity. We propose that methylation of the TM promoter is responsible for silencing of TM expression in MM tissue, a process that is regulated by PARP1.	[Nocchi, Linda; Saccucci, Franca] Polytech Univ Marche, Dept Biochem Biol & Genet, I-60126 Ancona, Italy; [Tomasetti, Marco; Amati, Monica; Santarelli, Lory] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, I-60126 Ancona, Italy; [Neuzil, Jiri] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld 4222, Australia; [Neuzil, Jiri] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4222, Australia; [Neuzil, Jiri] Acad Sci Czech Republ, Mol Therapy Grp, Inst Biotechnol, Prague 14220, Czech Republic	Marche Polytechnic University; Marche Polytechnic University; Griffith University; Griffith University; Menzies Health Institute Queensland; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	Tomasetti, M (corresponding author), Tronto 10-A Torrette, I-60126 Ancona, Italy.	m.tomasetti@univpm.it	santarelli, lory/I-7429-2012; Santarelli, Lory/AAU-4494-2020; Neuzil, Jiri/H-7204-2014	Neuzil, Jiri/0000-0002-2478-2460; Saccucci, Franca/0000-0002-8407-2516; santarelli, lory/0000-0003-1015-7098; Nocchi, Linda/0000-0002-2113-9031	National Institute against Occupational Injury Insurance; Australian Research Council; Grant Agency of the Czech Republic [204/08/0811]	National Institute against Occupational Injury Insurance; Australian Research Council(Australian Research Council); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported in part by a grant from the National Institute against Occupational Injury Insurance (to L. S. and M. T.).; Supported in part by grants from the Australian Research Council and the Grant Agency of the Czech Republic (204/08/0811).	Ames PRJ, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-3; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; CHAHINIAN AP, 1982, ANN INTERN MED, V96, P746, DOI 10.7326/0003-4819-96-6-746; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; De Capoa A, 1999, FASEB J, V13, P89; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Faraone-Mennella MR, 2005, BIOCHEM CELL BIOL, V83, P396, DOI 10.1139/o05-042; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; FERRERO E, 2010, ANN VASC SURG, V24; Furuta J, 2005, MELANOMA RES, V15, P15, DOI 10.1097/00008390-200502000-00004; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; HILLERDAL G, 1983, BRIT J DIS CHEST, V77, P321, DOI 10.1016/S0007-0971(83)80069-2; Kaneda A, 2002, CANCER RES, V62, P6645; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; LAGER DJ, 1995, AM J PATHOL, V146, P933; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Matsushita Y, 1998, CANCER LETT, V127, P195, DOI 10.1016/S0304-3835(98)00038-X; Nguyen D, 2008, ANN THORAC SURG, V85, P1032, DOI 10.1016/j.athoracsur.2007.11.064; Niforas P, 1996, GENE, V176, P139, DOI 10.1016/0378-1119(96)00238-7; Noble S, 2010, BRIT J CANCER, V102, pS2, DOI 10.1038/sj.bjc.6605599; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Obama H, 1999, ANTICANCER RES, V19, P1143; Ogawa H, 2000, CANCER LETT, V149, P95, DOI 10.1016/S0304-3835(99)00348-1; Prandoni P, 1999, HAEMATOLOGICA, V84, P437; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; RUSCH VW, 1995, CHEST, V107, pS322, DOI 10.1378/chest.107.6_Supplement.322S; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; SIERO E, 2010, THROMB RES, V125, P71; Sperry JL, 2003, CIRC RES, V92, P41, DOI 10.1161/01.RES.0000048196.11060.A0; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; SUEHIRO T, 1995, HEPATOLOGY, V21, P1285, DOI 10.1002/hep.1840210511; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	42	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19478	19488		10.1074/jbc.M110.217331	http://dx.doi.org/10.1074/jbc.M110.217331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489980	hybrid, Green Published			2022-12-25	WOS:000291027700031
J	Razidlo, GL; Katafiasz, D; Taylor, GS				Razidlo, Gina L.; Katafiasz, Dawn; Taylor, Gregory S.			Myotubularin Regulates Akt-dependent Survival Signaling via Phosphatidylinositol 3-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; SKELETAL-MUSCLE ATROPHY; PHOSPHATASE MYOTUBULARIN; LIPID PHOSPHATASES; MAMMALIAN-CELLS; MYOPATHY; PROTEIN; PHOSPHOINOSITIDES; AUTOPHAGY; PATHWAY	Myotubularin is a 3-phosphoinositide phosphatase that is mutated in X-linked myotubular myopathy, a severe neonatal disorder in which skeletal muscle development and/or regeneration is impaired. In this report we provide evidence that siRNA-mediated silencing of myotubularin expression markedly inhibits growth factor-stimulated Akt phosphorylation, leading to activation of caspase-dependent pro-apoptotic signaling in HeLa cells and primary human skeletal muscle myotubes. Myotubularin silencing also inhibits Akt-dependent signaling through the mammalian target of rapamycin complex 1 as assessed by p70 S6-kinase and 4E-BP1 phosphorylation. Similarly, phosphorylation of FoxO transcription factors is also significantly reduced in myotubularin-deficient cells. Our data further suggest that inhibition of Akt activation and downstream survival signaling in myotubularin-deficient cells is caused by accumulation of the MTMR substrate lipid phosphatidylinositol 3-phosphate generated from the type II phosphatidylinositol 3-kinase PIK3C2B. Our findings are significant because they suggest that myotubularin regulates Akt activation via a cellular pool of phosphatidylinositol 3-phosphate that is distinct from that generated by the type III phosphatidylinositol 3-kinase hVps34. Because impaired Akt signaling has been tightly linked to skeletal muscle atrophy, we hypothesize that loss of Akt-dependent growth/survival cues due to impaired myotubularin function may be a critical factor underlying the severe skeletal muscle atrophy characteristic of muscle fibers in patients with X-linked myotubular myopathy.	[Taylor, Gregory S.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Taylor, GS (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, DRC7044,985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	gstaylor@unmc.edu		Razidlo, Gina/0000-0002-9042-2738	National Institutes of Health (National Center for Research Resources); Gladys Pearson Research Foundation in Pediatric Cancer and Genetics	National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gladys Pearson Research Foundation in Pediatric Cancer and Genetics	This work was supported, in whole or in part, by a National Institutes of Health CoBRe grant (National Center for Research Resources; to the Nebraska Center for Cellular Signaling (to G. S. T.).; Supported by a fellowship from the Gladys Pearson Research Foundation in Pediatric Cancer and Genetics. Present address: Dept. of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St. SW, Guggenheim 1637, Rochester, MN 55905.	Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Berger P, 2011, J CELL MOL MED, V15, P307, DOI 10.1111/j.1582-4934.2009.00967.x; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Botelho RJ, 2009, BIOESSAYS, V31, P1127, DOI 10.1002/bies.200900060; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; CHEEK DB, 1985, EARLY HUM DEV, V12, P211, DOI 10.1016/0378-3782(85)90144-6; Chojnowski A, 2007, NEUROBIOL DIS, V26, P323, DOI 10.1016/j.nbd.2006.12.018; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Deretic V, 2007, BIOCHEM SOC SYMP, V74, P141, DOI 10.1042/BSS2007c13; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Dove SK, 2007, BIOCHEM SOC SYMP, V74, P129, DOI 10.1042/BSS2007c12; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fritzius T, 2006, BIOCHEM J, V399, P9, DOI 10.1042/BJ20060511; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gurpur PB, 2009, AM J PATHOL, V174, P999, DOI 10.2353/ajpath.2009.080537; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Laporte J, 2001, ANN NEUROL, V50, P42, DOI 10.1002/ana.1033; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marino JS, 2008, AM J PHYSIOL-CELL PH, V295, pC1026, DOI 10.1152/ajpcell.212.2008; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; McLoughlin TJ, 2009, AM J PHYSIOL-CELL PH, V297, pC548, DOI 10.1152/ajpcell.00502.2008; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Previtali Stefano C., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000439; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ribeiro I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001295; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Shi XZ, 2010, STEM CELLS, V28, P462, DOI 10.1002/stem.274; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1, DOI 10.1001/archneur.1966.00470070005001; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Srivastava S, 2006, MOL BIOL CELL, V17, P146, DOI 10.1091/mbc.e05-08-0763; Suter U, 2007, CELL MOL LIFE SCI, V64, P3261, DOI 10.1007/s00018-007-7381-7; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; VANWIJNG.GK, 1969, NEUROLOGY, V19, P901, DOI 10.1212/WNL.19.9.901; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200	60	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20005	20019		10.1074/jbc.M110.197749	http://dx.doi.org/10.1074/jbc.M110.197749			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478156	hybrid, Green Published			2022-12-25	WOS:000291027700078
J	Solodova, E; Jablonska, J; Weiss, S; Lienenklaus, S				Solodova, Evgenia; Jablonska, Jadwiga; Weiss, Siegfried; Lienenklaus, Stefan			Production of IFN-beta during Listeria monocytogenes Infection Is Restricted to Monocyte/Macrophage Lineage	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; I INTERFERON RESPONSE; INTRACELLULAR PATHOGENS; BACTERIAL-INFECTION; MOUSE FIBROBLASTS; MICE; EXPRESSION; IMMUNITY; INNATE	The family of type I interferons (IFN), which consists of several IFN-alpha and one IFN-beta, are produced not only after stimulation by viruses, but also after infection with non-viral pathogens. In the course of bacterial infections, these cytokines could be beneficial or detrimental. IFN-beta is the primary member of type I IFN that initiates a cascade of IFN-alpha production. Here we addressed the question which cells are responsible for IFN-beta expression after infection with the intracellular pathogen Listeria monocytogenes by using a genetic approach. By means of newly established reporter mice, maximum of IFN-beta expression was observed at 24 hours post infection in spleen and, surprisingly, 48 hours post infection in colonized cervical and inguinal lymph nodes. Colonization of lymph nodes was independent of the type I IFN signaling, as well as bacterial dose and strain. Using cell specific reporter function and conditional deletions we could define cells expressing LysM as the major IFN-beta producers, with cells formerly defined as Tip-DCs being the highest. Neutrophilic granulocytes, dendritic cells and plasmacytoid dendritic cells did not significantly contribute to type I IFN production.	[Solodova, Evgenia; Jablonska, Jadwiga; Weiss, Siegfried; Lienenklaus, Stefan] Helmholtz Ctr Infect Res, Dept Mol Biotechnol, Braunschweig, ME, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Solodova, E (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Biotechnol, Braunschweig, ME, Germany.	eso07@helmholtz-hzi.de	Jablonska, Jadwiga/S-8278-2019; Lienenklaus, Stefan/HIK-0899-2022	Jablonska, Jadwiga/0000-0003-1490-2542; Lienenklaus, Stefan/0000-0003-4790-3445	German Research Council [SFB 566]; Hannover Biomedical Research School; DAAD	German Research Council(German Research Foundation (DFG)); Hannover Biomedical Research School; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by the German Research Council via SFB 566, the Hannover Biomedical Research School and the DAAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Banks TA, 2005, J IMMUNOL, V174, P7217, DOI 10.4049/jimmunol.174.11.7217; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COHEN MS, 1988, REV INFECT DIS, V10, P1088; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CORR SC, 2009, CELL MICROBIOL; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; CROSS M, 1990, EMBO J, V9, P1283, DOI 10.1002/j.1460-2075.1990.tb08237.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Deny P, 2010, PATHOL BIOL, V58, P245, DOI 10.1016/j.patbio.2010.05.002; Dresing P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015567; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gregory SH, 1996, J IMMUNOL, V157, P2514; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; HUME DA, 2010, J LEUKOC BIOL; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; ISAACS A, 1987, J INTERFERON RES, V7, P429, DOI 10.1089/jir.1987.7.429; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; KASAMA T, 1993, J EXP MED, V178, P63, DOI 10.1084/jem.178.1.63; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LEIMEISTERWACHTER M, 1989, INFECT IMMUN, V57, P2350; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Merrick JC, 1997, AM J PATHOL, V151, P785; Neuenhahn M, 2007, IMMUNOL LETT, V114, P66, DOI 10.1016/j.imlet.2007.09.007; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roche SM, 2003, INFECT IMMUN, V71, P3429, DOI 10.1128/IAI.71.6.3429-3436.2003; Rogers HW, 1996, J IMMUNOL, V156, P679; Samuelsson CV, 2005, BIOCHEM BIOPH RES CO, V335, P584, DOI 10.1016/j.bbrc.2005.07.124; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; SEEBACH J, 1995, J IMMUNOL, V155, P4367; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Smith D, 2009, J NEUROIMMUNOL, V215, P117, DOI 10.1016/j.jneuroim.2009.08.011; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Tam MA, 2006, CELL MICROBIOL, V8, P1172, DOI 10.1111/j.1462-5822.2006.00700.x; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; XING Z, 1994, AM J RESP CELL MOL, V10, P148, DOI 10.1165/ajrcmb.10.2.8110470; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008; Zwaferink H, 2008, J IMMUNOL, V180, P4116, DOI 10.4049/jimmunol.180.6.4116	66	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18543	10.1371/journal.pone.0018543	http://dx.doi.org/10.1371/journal.pone.0018543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494554	Green Published, Green Submitted, gold			2022-12-25	WOS:000289354100020
J	Jainta, S; Kapoula, Z				Jainta, Stephanie; Kapoula, Zoi			Dyslexic Children Are Confronted with Unstable Binocular Fixation while Reading	PLOS ONE			English	Article							DIFFERENT VIEWING DISTANCES; SACCADIC EYE-MOVEMENTS; VISUAL-DISPLAY; GAZE-SHIFTS; VERGENCE DYNAMICS; COORDINATION; DISPARITY; ADULTS; CONJUGATE	Reading requires three-dimensional motor control: saccades bring the eyes from left to right, fixating word after word; and oblique saccades bring the eyes to the next line of the text. The angle of vergence of the two optic axes should be adjusted to the depth of the book or screen and - most importantly - should be maintained in a sustained manner during saccades and fixations. Maintenance of vergence is important as it is a prerequisite for a single clear image of each word to be projected onto the fovea of the eyes. Deficits in the binocular control of saccades and of vergence in dyslexics have been reported previously but only for tasks using single targets. This study examines saccades and vergence control during real text reading. Thirteen dyslexic and seven non-dyslexic children read the French text "L'Allouette" in two viewing distances (40 cm vs. 100 cm), while binocular eye movements were measured with the Chronos Eye-tracking system. We found that the binocular yoking of reading saccades was poor in dyslexic children (relative to non-dyslexics) resulting in vergence errors; their disconjugate drift during fixations was not correlated with the disconjugacy during their saccades, causing considerable variability of vergence angle from fixation to fixation. Due to such poor oculomotor adjustments during reading, the overall fixation disparity was larger for dyslexic children, putting larger demand on their sensory fusion processes. Moreover, for dyslexics the standard deviation of fixation disparity was larger particularly when reading at near distance. We conclude that besides documented phoneme processing disorders, visual/ocular motor imperfections may exist in dyslexics that lead to fixation instability and thus, to instability of the letters or words during reading; such instability may perturb fusional processes and might - in part - complicate letter/word identification.	[Jainta, Stephanie; Kapoula, Zoi] AP HP, CNRS, IRIS Lab, Paris, France	Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS)	Jainta, S (corresponding author), AP HP, CNRS, IRIS Lab, Paris, France.	jainta@ifado.de; zoi.kapoula@egp-aphp.fr			Deutsche Forschungsgemeinschaft [DFG Ja 1921/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG Ja 1921/1-1). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; Collewijn H, 1997, VISION RES, V37, P1049, DOI 10.1016/S0042-6989(96)00245-3; Collewijn H, 1990, Rev Oculomot Res, V4, P213; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P183, DOI 10.1113/jphysiol.1988.sp017285; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; Collewijn H, 2001, VISION RES, V41, P3413, DOI 10.1016/S0042-6989(01)00047-5; CORNELISSEN P, 1993, DEV MED CHILD NEUROL, V35, P777; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Heller D, 1998, CURRENT OCULOMOTOR R; HOWARD IP, 2002, SEEING DEPTH DEPTH P, P92; Jainta S, 2002, HUM FACTORS, V44, P443, DOI 10.1518/0018720024497736; Jainta S, 2010, VISION RES, V50, P1775, DOI 10.1016/j.visres.2010.05.033; Jaschinski W, 2004, KLIN MONATSBL AUGENH, V221, P854, DOI 10.1055/s-2004-813712; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 1998, OPHTHAL PHYSL OPT, V18, P30, DOI 10.1016/S0275-5408(97)00039-2; Jaschinski W, 1998, ERGONOMICS, V41, P1034, DOI 10.1080/001401398186586; JASCHINSKIKRUZA W, 1993, OPHTHAL PHYSL OPT, V13, P27, DOI 10.1111/j.1475-1313.1993.tb00422.x; Kapoula Z, 2007, GRAEF ARCH CLIN EXP, V245, P931, DOI 10.1007/s00417-006-0490-4; Kapoula Z, 2009, DYSLEXIA, V15, P243, DOI 10.1002/dys.377; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Lefavrais P., 1967, TEST ALOUETTE; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; PAVLIDIS GT, 1981, NEUROPSYCHOLOGIA, V19, P57, DOI 10.1016/0028-3932(81)90044-0; R Core Team, 2022, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein JF., 1993, J RES READ, V16, P30, DOI [DOI 10.1111/J.1467-9817.1993.TB00033.X, 10.1111/j.1467-9817.1993.tb00033.x]; StuddertKennedy M, 1995, PSYCHON B REV, V2, P508, DOI 10.3758/BF03210986; Sylvestre PA, 2002, J NEUROPHYSIOL, V87, P257, DOI 10.1152/jn.00919.2000; Vernet M, 2009, J VISION, V9, DOI 10.1167/9.7.2; Yang Q, 2003, J VISION, V3, P554, DOI 10.1167/3.8.3; Yang Q, 2004, EXP BRAIN RES, V156, P212, DOI 10.1007/s00221-003-1773-1	39	60	61	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18694	10.1371/journal.pone.0018694	http://dx.doi.org/10.1371/journal.pone.0018694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494641	gold, Green Published, Green Submitted			2022-12-25	WOS:000289192400044
J	Buechel, HM; Popovic, J; Searcy, JL; Porter, NM; Thibault, O; Blalock, EM				Buechel, Heather M.; Popovic, Jelena; Searcy, James L.; Porter, Nada M.; Thibault, Olivier; Blalock, Eric M.			Deep Sleep and Parietal Cortex Gene Expression Changes Are Related to Cognitive Deficits with Age	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; DAYTIME SLEEPINESS; GLUCOSE-METABOLISM; HIPPOCAMPAL; BRAIN; MEMORY; IMPAIRMENT; CALCIUM; RATS	Background: Age-related cognitive deficits negatively affect quality of life and can presage serious neurodegenerative disorders. Despite sleep disruption's well-recognized negative influence on cognition, and its prevalence with age, surprisingly few studies have tested sleep's relationship to cognitive aging. Methodology: We measured sleep stages in young adult and aged F344 rats during inactive (enhanced sleep) and active (enhanced wake) periods. Animals were behaviorally characterized on the Morris water maze and gene expression profiles of their parietal cortices were taken. Principal Findings: Water maze performance was impaired, and inactive period deep sleep was decreased with age. However, increased deep sleep during the active period was most strongly correlated to maze performance. Transcriptional profiles were strongly associated with behavior and age, and were validated against prior studies. Bioinformatic analysis revealed increased translation and decreased myelin/neuronal pathways. Conclusions: The F344 rat appears to serve as a reasonable model for some common sleep architecture and cognitive changes seen with age in humans, including the cognitively disrupting influence of active period deep sleep. Microarray analysis suggests that the processes engaged by this sleep are consistent with its function. Thus, active period deep sleep appears temporally misaligned but mechanistically intact, leading to the following: first, aged brain tissue appears capable of generating the slow waves necessary for deep sleep, albeit at a weaker intensity than in young. Second, this activity, presented during the active period, seems disruptive rather than beneficial to cognition. Third, this active period deep sleep may be a cognitively pathologic attempt to recover age-related loss of inactive period deep sleep. Finally, therapeutic strategies aimed at reducing active period deep sleep (e.g., by promoting active period wakefulness and/or inactive period deep sleep) may be highly relevant to cognitive function in the aging community.	[Buechel, Heather M.; Popovic, Jelena; Searcy, James L.; Porter, Nada M.; Thibault, Olivier; Blalock, Eric M.] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40526 USA	University of Kentucky	Buechel, HM (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40526 USA.	emblal@uky.edu	Thibault, Olivier/AAY-7614-2020	Thibault, Olivier/0000-0002-3548-3466	University of Kentucky College of Medicine; National Institute on Aging, National Institutes of Health (NIA NIH) [1R01AG037868]; NATIONAL INSTITUTE ON AGING [R01AG037868] Funding Source: NIH RePORTER	University of Kentucky College of Medicine; National Institute on Aging, National Institutes of Health (NIA NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by start-up funding from the University of Kentucky College of Medicine as well as the National Institute on Aging, National Institutes of Health (NIA NIH) 1R01AG037868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2005, NEUROLOGY, V65, P1442, DOI 10.1212/01.wnl.0000183056.89590.0d; Ancoli-Israel S, 2006, AM J GERIAT PSYCHIAT, V14, P95, DOI 10.1097/01.JGP.0000196627.12010.d1; Ancoli-Israel S, 2006, J CLIN SLEEP MED, V2, P333; ARMSTRONG DM, 1993, NEUROBIOL AGING, V14, P457, DOI 10.1016/0197-4580(93)90104-J; Avidan Alon Y, 2003, Clin Cornerstone, V5, P51, DOI 10.1016/S1098-3597(03)90035-4; Banks S, 2007, J CLIN SLEEP MED, V3, P519; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2003, J NEUROSCI, V23, P3807; Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405; Blalock EM, 2010, J NEUROSCI, V30, P6058, DOI 10.1523/JNEUROSCI.3956-09.2010; BOLSTAD B, 2005, BIOINFORMATICS COMPU; BORBELY AA, 1975, BRAIN RES, V95, P89, DOI 10.1016/0006-8993(75)90209-7; Boric K, 2008, J NEUROSCI, V28, P8034, DOI 10.1523/JNEUROSCI.2036-08.2008; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Born J, 2010, WORLD J BIOL PSYCHIA, V11, P16, DOI 10.3109/15622971003637637; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Cajochen C, 2006, CHRONOBIOL INT, V23, P461, DOI 10.1080/07420520500545813; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; d'Hellencourt CL, 2005, J NEUROCHEM, V93, P206, DOI 10.1111/j.1471-4159.2004.03017.x; DETOLEDOMORRELL L, 1988, NEUROBIOL AGING, V9, P581, DOI 10.1016/S0197-4580(88)80117-9; Di Stefano G, 2010, REJUV RES, V13, P224, DOI 10.1089/rej.2009.0965; Diekelmann S, 2011, NAT NEUROSCI; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Foley D, 2001, J AM GERIATR SOC, V49, P1628, DOI 10.1111/j.1532-5415.2001.49271.x; Foster TC, 1997, HIPPOCAMPUS, V7, P602, DOI 10.1002/(SICI)1098-1063(1997)7:6<602::AID-HIPO3>3.0.CO;2-G; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; GAGE FH, 1988, NEUROBIOL AGING, V9, P645, DOI 10.1016/S0197-4580(88)80129-5; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GINSBERG SD, 2010, BIOL PSYCHIAT; Ginsberg Stephen D, 2006, NeuroRx, V3, P302, DOI 10.1016/j.nurx.2006.05.007; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Imeri L, 2004, BRAIN BEHAV IMMUN, V18, P399, DOI 10.1016/j.bbi.2003.12.003; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Khachaturian Z S, 1989, Aging (Milano), V1, P17; Kirov R, 2002, NEUROSCI LETT, V322, P134, DOI 10.1016/S0304-3940(02)00096-4; Kryger M, 2004, GERIATRICS-US, V59, P24; LANDFIELD PW, 1984, SCIENCE, V226, P1089, DOI 10.1126/science.6494926; LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1; Mackiewicz M, 2008, ANN NY ACAD SCI, V1129, P335, DOI 10.1196/annals.1417.030; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Mariani E, 2007, J ALZHEIMERS DIS, V12, P23; MARKOWSKA AL, 1989, NEUROBIOL AGING, V10, P31, DOI 10.1016/S0197-4580(89)80008-9; Masliah E, 2006, J ALZHEIMERS DIS, V9, P91; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison JH, 2007, INT REV NEUROBIOL, V81, P41, DOI 10.1016/S0074-7742(06)81004-4; Naylor E, 1998, SLEEP, V21, P687, DOI 10.1093/sleep/21.7.687; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299; Reid KJ, 2006, AM J GERIAT PSYCHIAT, V14, P860, DOI 10.1097/01.JGP.0000206164.56404.ba; RONCAGLIOLO M, 1991, BRAIN RES BULL, V27, P573, DOI 10.1016/0361-9230(91)90029-J; ROSENBERG RS, 1979, J GERONTOL, V34, P525, DOI 10.1093/geronj/34.4.525; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarvari M, 2010, ENDOCRINOLOGY, V151, P3847, DOI 10.1210/en.2010-0375; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shiromani PJ, 2000, AM J PHYSIOL-REG I, V278, pR125, DOI 10.1152/ajpregu.2000.278.1.R125; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stone WS, 1997, EXP AGING RES, V23, P287, DOI 10.1080/03610739708254285; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toescu EC, 2010, CELL CALCIUM, V47, P158, DOI 10.1016/j.ceca.2009.11.013; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Tornatore Jane B, 2003, Am J Alzheimers Dis Other Demen, V18, P240, DOI 10.1177/153331750301800413; Tractenberg RE, 2005, J SLEEP RES, V14, P177, DOI 10.1111/j.1365-2869.2005.00445.x; Van Cauter E, 1998, HORM RES, V49, P147, DOI 10.1159/000023162; VANGOOL WA, 1986, SLEEP, V9, P335, DOI 10.1093/sleep/9.2.335; VANGOOL WA, 1983, BRAIN RES, V279, P394, DOI 10.1016/0006-8993(83)90217-2; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Weinert D, 2000, CHRONOBIOL INT, V17, P261, DOI 10.1081/CBI-100101048; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	91	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18387	10.1371/journal.pone.0018387	http://dx.doi.org/10.1371/journal.pone.0018387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483696	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058700023
J	Chen, JJ; Nag, S; Vidi, PA; Irudayaraj, J				Chen, Jiji; Nag, Suman; Vidi, Pierre-Alexandre; Irudayaraj, Joseph			Single Molecule In Vivo Analysis of Toll-Like Receptor 9 and CpG DNA Interaction	PLOS ONE			English	Article							FLUORESCENCE FLUCTUATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; PHOTON-COUNTING HISTOGRAM; NUCLEIC-ACIDS; LIVING CELLS; ACTIVATION; TLR9; TOLL-LIKE-RECEPTOR-9; BACTERIAL; LIFETIME	Toll-like receptor 9 (TLR9) activates the innate immune system in response to oligonucleotides rich in CpG whereas DNA lacking CpG could inhibit its activation. However, the mechanism of how TLR9 interacts with nucleic acid and becomes activated in live cells is not well understood. Here, we report on the successful implementation of single molecule tools, constituting fluorescence correlation/cross-correlation spectroscopy (FCS and FCCS) and photon count histogram (PCH) with fluorescence lifetime imaging (FLIM) to study the interaction of TLR9-GFP with Cy5 labeled oligonucleotide containing CpG or lacking CpG in live HEK 293 cells. Our findings show that i) TLR9 predominantly forms homodimers (80%) before binding to a ligand and further addition of CpG or non CpG DNA does not necessarily increase the proportion of TLR9 dimers, ii) CpG DNA has a lower dissociation constant (62 nM +/- 9 nM) compared to non CpG DNA (153 nM +/- 26 nM) upon binding to TLR9, suggesting that a motif specific binding affinity of TLR9 could be an important factor in instituting a conformational change-dependant activation, and iii) both CpG and non CpG DNA binds to TLR9 with a 1: 2 stoichiometry in vivo. Collectively, through our findings we establish an in vivo model of TLR9 binding and activation by CpG DNA using single molecule fluorescence techniques for single cell studies.	[Chen, Jiji; Irudayaraj, Joseph] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Chen, Jiji; Irudayaraj, Joseph] Purdue Univ, Birck Nanotechnol Ctr, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Nag, Suman] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Vidi, Pierre-Alexandre] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tata Institute of Fundamental Research (TIFR); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chen, JJ (corresponding author), Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.	josephi@purdue.edu	Chen, Jiji/K-5551-2012	Irudayaraj, Joseph/0000-0002-0630-1520; Vidi, Pierre-Alexandre/0000-0002-9117-8896	Purdue University; Purdue Center for Cancer Research Innovation; National Science Foundation [NSF 0945771]	Purdue University; Purdue Center for Cancer Research Innovation; National Science Foundation(National Science Foundation (NSF))	Blisland Fellowship from Purdue University is acknowledged. Partial funding from the Purdue Center for Cancer Research Innovation grant, Vice President for Research (Purdue University), and National Science Foundation (NSF 0945771) is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Caspi A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011916; Chen JJ, 2010, ANAL CHEM, V82, P6415, DOI 10.1021/ac101236t; Chen JJ, 2009, ACS NANO, V3, P4071, DOI 10.1021/nn900743v; Chen Y, 2005, BIOPHYS J, V88, P2177, DOI 10.1529/biophysj.104.048413; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gannot I, 2004, LASER SURG MED, V35, P342, DOI 10.1002/lsm.20101; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kindrachuk J, 2008, MINI-REV MED CHEM, V8, P590, DOI 10.2174/138955708784534481; Kindrachuk J, 2007, J BIOL CHEM, V282, P13944, DOI 10.1074/jbc.M608089200; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Rigler R., 2001, FLUORESCENCE CORRELA; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Sengupta P, 2003, BIOPHYS J, V84, P1977, DOI 10.1016/S0006-3495(03)75006-1; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Slaughter BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001931; Takeda K, 2002, J ENDOTOXIN RES, V8, P459, DOI 10.1179/096805102125001073; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; van Manen HJ, 2008, BIOPHYS J, V94, pL67, DOI 10.1529/biophysj.107.127837; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210	39	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17991	10.1371/journal.pone.0017991	http://dx.doi.org/10.1371/journal.pone.0017991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483736	gold, Green Submitted, Green Published			2022-12-25	WOS:000289058700007
J	Hirata, K; Kataoka, S; Furutani, S; Hayashi, H; Matsuda, K				Hirata, Koichi; Kataoka, Saori; Furutani, Shogo; Hayashi, Hideo; Matsuda, Kazuhiko			A Fungal Metabolite Asperparaline A Strongly and Selectively Blocks Insect Nicotinic Acetylcholine Receptors: The First Report on the Mode of Action	PLOS ONE			English	Article							ASPERGILLUS-JAPONICUS JV-23; COCKROACH NEURONS; LOOP-D; NEONICOTINOIDS; SENSITIVITY; FIPRONIL; CHANNEL	Asperparalines produced by Aspergillus japonicus JV-23 induce paralysis in silkworm (Bombyx mori) larvae, but the target underlying insect toxicity remains unknown. In the present study, we have investigated the actions of asperparaline A on ligand-gated ion channels expressed in cultured larval brain neurons of the silkworm using patch-clamp electrophysiology. Bath-application of asperparaline A (10 mu M) had no effect on the membrane current, but when delivered for 1 min prior to co-application with 10 mu M acetylcholine (ACh), it blocked completely the ACh-induced current that was sensitive to mecamylamine, a nicotinic acetylcholine receptor (nAChR)-selective antaogonist. In contrast, 10 mu M asperparaline A was ineffective on the c-aminobutyric acid-and L-glutamate-induced responses of the Bombyx larval neurons. The fungal alkaloid showed no-use dependency in blocking the ACh-induced response with distinct affinity for the peak and slowly-desensitizing current amplitudes of the response to 10 mM ACh in terms of IC50 values of 20.2 and 39.6 nM, respectively. Asperparaline A (100 nM) reduced the maximum neuron response to ACh with a minimal shift in EC50, suggesting that the alkaloid is non-competitive with ACh. In contrast to showing marked blocking action on the insect nAChRs, it exhibited only a weak blocking action on chicken alpha 3 beta 4, alpha 4 beta 2 and alpha 7 nAChRs expressed in Xenopus laevis oocytes, suggesting a high selectivity for insect over certain vertebrate nAChRs.	[Hirata, Koichi; Kataoka, Saori; Furutani, Shogo; Matsuda, Kazuhiko] Kinki Univ, Fac Agr, Dept Appl Biol Chem, Nara 631, Japan; [Hayashi, Hideo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Osaka, Japan	Kindai University (Kinki University)	Hirata, K (corresponding author), Nippon Soda Co Ltd, Kanagawa, Japan.	kmatsuda@nara.kindai.ac.jp	Matsuda, Kazuhiko/AAX-4926-2020; Hayashi, Hideo/AAI-1910-2020		Ministry of Agriculture, Forestry and Fisheries of Japan [1302]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	KM was supported in part by the Integrated Research Project for Plant, Insect and Animal using Genome Technology from the Ministry of Agriculture, Forestry and Fisheries of Japan (Grant: 1302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hayashi H, 2000, BIOSCI BIOTECH BIOCH, V64, P111, DOI 10.1271/bbb.64.111; Hayashi H, 1997, TETRAHEDRON LETT, V38, P5655, DOI 10.1016/S0040-4039(97)01231-8; Hirata K, 2008, INSECT MOL BIOL, V17, P341, DOI 10.1111/j.1365-2583.2008.00806.x; Ikeda T, 2003, NEUROTOXICOLOGY, V24, P807, DOI 10.1016/S0161-813X(03)00041-X; Matsuda K, 2000, BRIT J PHARMACOL, V130, P981, DOI 10.1038/sj.bjp.0703374; Matsuda K, 1998, BRIT J PHARMACOL, V123, P518, DOI 10.1038/sj.bjp.0701618; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Stromgaard K, 2005, TOXICON, V45, P249, DOI 10.1016/j.toxicon.2004.11.013; Williams RM, 2003, ACCOUNTS CHEM RES, V36, P127, DOI 10.1021/ar020229e; Zhao XL, 2004, J PHARMACOL EXP THER, V310, P192, DOI 10.1124/jpet.104.065516	14	22	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18354	10.1371/journal.pone.0018354	http://dx.doi.org/10.1371/journal.pone.0018354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483774	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058300014
J	Chen, Y; Yang, PZ; Li, FZ; Kijlstra, A				Chen, Ying; Yang, Peizeng; Li, Fuzhen; Kijlstra, Aize			The Effects of Th17 Cytokines on the Inflammatory Mediator Production and Barrier Function of ARPE-19 Cells	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; T-CELLS; RHEUMATOID-ARTHRITIS; IL-17 RECEPTOR; EXPRESSION; KERATINOCYTES; DISTINCT; LINEAGE; UVEITIS; IL-23	Th17 cells have emerged as a key factor in the pathogenesis of uveitis as well as other autoimmune disorders. They secrete a number of cytokines including IL-17A, IL-17F and IL-22 and until now the effects of these cytokines on resident cells of the eye were not yet clear. The purpose of this study was to investigate the effects of Interleukin (IL)-17A, IL-17F and IL-22 on the production of inflammatory mediators and barrier function of retinal pigment epithelium cells. We showed that ARPE-19 cells, a spontaneously arisen cell line of retinal pigment epithelium (RPE), constitutively expressed IL-17RC and IL-22R, but not IL-17RA. IL-17A significantly enhanced the production of CXCL8, CCL2, CCL20 and IL-6 by these cells. IL-17F had a similar effect on the production of CXCL8, CCL2 and IL-6 by ARPE-19 cells, but did not influence the expression of CCL20. Both IL-17A and IL-17F significantly decreased the transepithelial electrical resistance (TER) of the ARPE-19 monolayer and increased the diffusion rate of fluorescein isothiocyanate (FITC)-dextran. They also disrupted the distribution of the junction proteins zonula occludens (ZO)-1 and occludin at the interface of adjacent cells. IL-22 did not have a detectable effect on the production of the tested inflammatory mediators by ARPE-19 cells, TER of the ARPE-19 monolayer, the diffusion rate of FITC-dextran or the distribution of ZO-1 and occludin. This study demonstrates that IL-17A and IL-17F, but not IL-22, significantly promoted ARPE-19 cells to secrete inflammatory mediators and compromised the ARPE-19 monolayer barrier function in association with a disrupted distribution of ZO-1 and occludin. These results suggest that both IL-17A and IL-17F may play a role in posterior segment inflammation of the eye.	[Chen, Ying; Yang, Peizeng; Li, Fuzhen] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Chen, Ying] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Eye Res Inst Maastricht, Dept Ophthalmol, Maastricht, Netherlands	Chongqing Medical University; Sun Yat Sen University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013		Natural Science Foundation [30630064, 30910103912]; National Natural Science Foundation [30973242]; National supporting project of P.R. China [2007BAI18B10]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing [2008115]; Medical Science and Technology of Chongqing [2008-1-15]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Fund for Liangjiang Scholar; National Basic Research Program of China (973 program) [2011CB510200]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National supporting project of P.R. China; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Health Bureau of Chongqing; Medical Science and Technology of Chongqing; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Fund for Liangjiang Scholar; National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by Key Project of Natural Science Foundation (30630064, URL: http://159.226.244.15/portal/proj_search.asp), Natural Science Foundation Major International (Regional) Joint Research Project (30910103912, URL: http://159.226.244.15/portal/proj_search.asp), National Natural Science Foundation Project (30973242, URL: http://159.226.244.15/portal/proj_search.asp), National supporting project of P.R. China (2007BAI18B10, URL: http://www.most.gov.cn/cxfw/index.htm), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality (URL: http://www.ctin.ac.cn/Class.aspx?clsId=413), Key Project of Health Bureau of Chongqing (2008115, URL: http://www.cqwsj.gov.cn/News.asp), Project of Medical Science and Technology of Chongqing (2008-1-15, URL: http://www.cqwsj.gov.cn/News.asp), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037, URL: http://www.ctin.ac.cn/Class.aspx?clsId=413), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003, URL: http://www.ctin.ac.cn/Class.aspx?clsId=413), Fund for Liangjiang Scholar and National Basic Research Program of China (973 program, 2011CB510200, URL: http://www.973.gov.cn/AreaItem.aspx?fid=05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, INVEST OPHTH VIS SCI, V44, P4097, DOI 10.1167/iovs.02-0867; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Caspi R, 2008, IMMUNOL RES, V42, P41, DOI 10.1007/s12026-008-8031-3; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Ke Y, 2009, J LEUKOCYTE BIOL, V86, P1377, DOI 10.1189/jlb.0409237; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kerr EC, 2008, PROG RETIN EYE RES, V27, P527, DOI 10.1016/j.preteyeres.2008.07.001; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Leung KW, 2009, MOL IMMUNOL, V46, P1374, DOI 10.1016/j.molimm.2008.12.001; Li ZQ, 2008, J IMMUNOL, V181, P5147, DOI 10.4049/jimmunol.181.7.5147; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; MIURA Y, 2010, INVEST OPHTHALMOL VI; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zech JC, 1998, INVEST OPHTH VIS SCI, V39, P1600; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	31	62	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18139	10.1371/journal.pone.0018139	http://dx.doi.org/10.1371/journal.pone.0018139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479174	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700030
J	Hart, JP; Matson, RG; Thompson, RG; Blake, M				Hart, John P.; Matson, R. G.; Thompson, Robert G.; Blake, Michael			Teosinte Inflorescence Phytolith Assemblages Mirror Zea Taxonomy	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; NEW-YORK; MAIZE; MAYS; DOMESTICATION; EVOLUTION; POACEAE; ORIGIN	Molecular DNA analyses of the New World grass (Poaceae) genus Zea, comprising five species, has resolved taxonomic issues including the most likely teosinte progenitor (Zea mays ssp. parviglumis) of maize (Zea mays ssp. mays). However, archaeologically, little is known about the use of teosinte by humans both prior to and after the domestication of maize. One potential line of evidence to explore these relationships is opaline phytoliths produced in teosinte fruit cases. Here we use multidimensional scaling and multiple discriminant analyses to determine if rondel phytolith assemblages from teosinte fruitcases reflect teosinte taxonomy. Our results indicate that rondel phytolith assemblages from the various taxa, including subspecies, can be statistically discriminated. This indicates that it will be possible to investigate the archaeological histories of teosinte use pending the recovery of appropriate samples.	[Hart, John P.] New York State Museum & Sci Serv, Albany, NY 12230 USA; [Matson, R. G.; Blake, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada; [Thompson, Robert G.] Univ Minnesota, Dept Anthropol, Minneapolis, MN USA	University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Hart, JP (corresponding author), New York State Museum & Sci Serv, Albany, NY 12230 USA.	tmichaelblake@gmail.com	Hart, John/H-7419-2014	Hart, John/0000-0003-2009-0624				Callen E.O., 1967, PREHISTORY TEHUACAN, VVolume 1, P261; Chavez S. J., 2006, HIST MAIZE MULTIDISC, P415; DOEBLEY JF, 1980, AM J BOT, V67, P982, DOI 10.2307/2442441; Dorweiler JE, 1997, AM J BOT, V84, P1313, DOI 10.2307/2446130; Flannery K., 1986, GUILA NAQUITZ ARCHAI; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; GOWER JC, 1967, J ROY STAT SOC D-STA, V17, P13; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hart JP, 2009, J ARCHAEOL SCI, V36, P74, DOI 10.1016/j.jas.2008.07.011; Hart JP, 2007, AM ANTIQUITY, V72, P563, DOI 10.2307/40035861; Hart JP, 2003, AM ANTIQUITY, V68, P619, DOI 10.2307/3557065; ILTIS HH, 1980, AM J BOT, V67, P994, DOI 10.2307/2442442; Iltis HH, 2000, ECON BOT, V54, P7, DOI 10.1007/BF02866598; Klecka W. R., 1980, DISCRIMINANT ANAL; MACNEISH RS, 1958, T AM PHIL SOC, V48; Mangelsdorf PC., 1967, PREHISTORY TEHUACAN, P178; MATSON RG, 1974, AM ANTIQUITY, V39, P51, DOI 10.2307/279218; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mulholland S.C., 1992, PHYTOLITH SYSTEMATIC, P65, DOI DOI 10.1007/978-1-4899-1155-1_4; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; Pearsall DM, 2003, J ARCHAEOL SCI, V30, P611, DOI 10.1016/S0305-4403(02)00237-6; Piperno D. R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1998, ORIGINS AGR LOWLAND; PIPERNO DR, 1993, J ARCHAEOL SCI, V20, P337, DOI 10.1006/jasc.1993.1021; Smalley J, 2003, CURR ANTHROPOL, V44, P675, DOI 10.1086/377664; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Thompson RG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P82; TORGERSON W, 1958, THEORY METHODS SCALI; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863	32	8	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18349	10.1371/journal.pone.0018349	http://dx.doi.org/10.1371/journal.pone.0018349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479186	gold, Green Published, Green Submitted			2022-12-25	WOS:000289055700051
J	Kiernan, UA; Phillips, DA; Trenchevska, O; Nedelkov, D				Kiernan, Urban A.; Phillips, David A.; Trenchevska, Olgica; Nedelkov, Dobrin			Quantitative Mass Spectrometry Evaluation of Human Retinol Binding Protein 4 and Related Variants	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; PARATHYROID-HORMONE; ALTERED RATIOS; HUMAN PLASMA; IMMUNOASSAY; QUANTIFICATION; DIVERSITY	Background: Retinol Binding Protein 4 (RBP4) is an exciting new biomarker for the determination of insulin resistance and type 2 diabetes. It is known that circulating RBP4 resides in multiple variants which may provide enhanced clinical utility, but conventional immunoassay methods are blind to such differences. A Mass Spectrometric immunoassay (MSIA) technology that can quantitate total RBP4 as well as individual isoforms may provide an enhanced analysis for this biomarker. Methods: RBP4 was isolated and detected from 0.5 uL of human plasma using MSIA technology, for the simultaneous quantification and differentiation of endogenous human RBP4 and its variants. Results: The linear range of the assay was 7.81-500 ug/mL, and the limit of detection and limit of quantification were 3.36 ug/mL and 6.52 ug/mL, respectively. The intra-assay CVs were determined to be 5.1% and the inter-assay CVs were 9.6%. The percent recovery of the RBP4-MSIA ranged from 95 - 105%. Method comparison of the RBP4 MSIA vs the Immun Diagnostik ELISA yielded a Passing & Bablok fit of MSIA = 1.05 x ELISA - 3.09, while the Cusum linearity p-value was > 0.1 and the mean bias determined by the Altman Bland test was 1.2%. Conclusion: The novel RBP4 MSIA provided a fast, accurate and precise quantitative protein measurement as compared to the standard commercially available ELISA. Moreover, this method also allowed for the detection of RBP4 variants that are present in each sample, which may in the future provide a new dimension in the clinical utility of this biomarker.	[Kiernan, Urban A.; Phillips, David A.; Trenchevska, Olgica; Nedelkov, Dobrin] Intrins Bioprobes Inc, Tempe, AZ 85284 USA		Kiernan, UA (corresponding author), Intrins Bioprobes Inc, Tempe, AZ 85284 USA.	ukiernan@intrinsicbio.com	Nedelkov, Dobrin/I-3603-2013		National Institutes of Health (NIH);  [R43RR025701]; NATIONAL CENTER FOR RESEARCH RESOURCES [R43RR025701] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was soley funded under grant no. R43RR025701. Even though the research took place at a commercial institution, it was fully supported by National Institutes of Health (NIH) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Bobbert P, 2009, EUR J HEART FAIL, V11, P1163, DOI 10.1093/eurjhf/hfp153; Duncan Mark W., 2008, Briefings in Functional Genomics & Proteomics, V7, P355, DOI 10.1093/bfgp/eln041; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Henze A, 2010, BIOCHEM BIOPH RES CO, V393, P79, DOI 10.1016/j.bbrc.2010.01.082; JACONI S, 1995, J LIPID RES, V36, P1247; Jaconi S, 1996, EUR J ENDOCRINOL, V134, P576, DOI 10.1530/eje.0.1340576; Kierman Urbana, 2002, American Biotechnology Laboratory, V20, P28; Kiernan UA, 2002, BIOCHEM BIOPH RES CO, V297, P401, DOI 10.1016/S0006-291X(02)02212-X; Kiernan UA, 2002, ANAL BIOCHEM, V301, P49, DOI 10.1006/abio.2001.5478; Kiernan UA, 2006, J PROTEOME RES, V5, P1682, DOI 10.1021/pr0601133; Kiernan Urban A, 2008, Expert Opin Med Diagn, V2, P1391, DOI 10.1517/17530050802566488; Klein K, 2010, J WOMENS HEALTH, V19, P517, DOI 10.1089/jwh.2009.1615; Kumar V, 2010, CLIN CHEM, V56, P306, DOI 10.1373/clinchem.2009.134643; Lopez MF, 2010, CLIN CHEM, V56, P281, DOI 10.1373/clinchem.2009.137323; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nedelkov D, 2008, PROTEOMICS, V8, P779, DOI 10.1002/pmic.200700501; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; Niederkofler EE, 2003, J LIPID RES, V44, P630, DOI 10.1194/jlr.D200034-JLR200; Niederkofler EE, 2001, ANAL CHEM, V73, P3294, DOI 10.1021/ac010143j; Niederkofler EE, 2008, CIRC-HEART FAIL, V1, P258, DOI 10.1161/CIRCHEARTFAILURE.108.790774; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Stuck BJ, 2009, AM J HYPERTENS, V22, P948, DOI 10.1038/ajh.2009.124; Tubbs KA, 2001, ANAL BIOCHEM, V289, P26, DOI 10.1006/abio.2000.4921; VANWEEME.BK, 1971, FEBS LETT, V15, P232, DOI 10.1016/0014-5793(71)80319-8	27	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17282	10.1371/journal.pone.0017282	http://dx.doi.org/10.1371/journal.pone.0017282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479165	gold, Green Published, Green Submitted			2022-12-25	WOS:000289055700009
J	Liu, J; Yin, DC; Guo, YZ; Wang, XK; Xie, SX; Lu, QQ; Liu, YM				Liu, Jun; Yin, Da-Chuan; Guo, Yun-Zhu; Wang, Xi-Kai; Xie, Si-Xiao; Lu, Qin-Qin; Liu, Yong-Ming			Selecting Temperature for Protein Crystallization Screens Using the Temperature Dependence of the Second Virial Coefficient	PLOS ONE			English	Article							DYNAMIC LIGHT-SCATTERING; CRYSTAL-GROWTH; SOLUBILITY; EQUILIBRIUM; LYSOZYME; PHASE; MODEL	Protein crystals usually grow at a preferable temperature which is however not known for a new protein. This paper reports a new approach for determination of favorable crystallization temperature, which can be adopted to facilitate the crystallization screening process. By taking advantage of the correlation between the temperature dependence of the second virial coefficient (B(22)) and the solubility of protein, we measured the temperature dependence of B(22) to predict the temperature dependence of the solubility. Using information about solubility versus temperature, a preferred crystallization temperature can be proposed. If B(22) is a positive function of the temperature, a lower crystallization temperature is recommended; if B(22) shows opposite behavior with respect to the temperature, a higher crystallization temperature is preferred. Otherwise, any temperature in the tested range can be used.	[Liu, Jun; Yin, Da-Chuan; Guo, Yun-Zhu; Wang, Xi-Kai; Xie, Si-Xiao; Lu, Qin-Qin; Liu, Yong-Ming] NW Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China	Northwestern Polytechnical University	Liu, J (corresponding author), NW Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China.	yindc@nwpu.edu.cn	Liu, Yong-Ming/AAI-4692-2020; Liu, Jun/AAS-9772-2020; Liu, Yong-Ming/T-5279-2019	Liu, Jun/0000-0003-4094-8974; Liu, Yong-Ming/0000-0001-9606-6570	National Natural Science Foundation of China [10772150]; Ministry of Education of China [200806990011]; National High Technology Research and Development Program of China [2008AA12A220]; National Program on Key Basic Research Project [2011CB710900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Program on Key Basic Research Project(National Basic Research Program of China)	These studies were partly funded by Grant 10772150 from the National Natural Science Foundation of China (www.nsfc.gov.cn), Grant 200806990011 from the Ph.D. Programs Foundation of the Ministry of Education of China (www.cutech.edu.cn), Grant 2008AA12A220 from the National High Technology Research and Development Program of China (www.863.gov.cn) and Grant 2011CB710900 from the National Program on Key Basic Research Project (www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JR, 2008, ANAL BIOCHEM, V377, P128, DOI 10.1016/j.ab.2008.03.032; Andersson M, 2003, ANAL CHEM, V75, P4279, DOI 10.1021/ac030128+; Annunziata O, 2008, J AM CHEM SOC, V130, P13347, DOI 10.1021/ja804304e; Bajaj H, 2006, PHARM RES-DORDR, V23, P1382, DOI 10.1007/s11095-006-0018-y; BALDWIN ET, 1986, BIOPHYS J, V49, P47, DOI 10.1016/S0006-3495(86)83587-1; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BULL HB, 1972, ARCH BIOCHEM BIOPHYS, V149, P164, DOI 10.1016/0003-9861(72)90310-4; Cherezov V, 2002, BIOPHYS J, V83, P3393, DOI 10.1016/S0006-3495(02)75339-3; Christopher GK, 1998, J CRYST GROWTH, V191, P820, DOI 10.1016/S0022-0248(98)00355-8; Deszczynski M, 2006, BIOPHYS CHEM, V120, P106, DOI 10.1016/j.bpc.2005.10.003; Dierks K, 2008, CRYST GROWTH DES, V8, P1628, DOI 10.1021/cg701067r; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; George A, 1997, METHOD ENZYMOL, V276, P100, DOI 10.1016/S0076-6879(97)76052-X; Grabe M, 2003, BIOPHYS J, V84, P854, DOI 10.1016/S0006-3495(03)74904-2; Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2; Haas C, 1999, J PHYS CHEM B, V103, P2808, DOI 10.1021/jp984035l; Hanlon AD, 2010, BIOPHYS J, V98, P297, DOI 10.1016/j.bpj.2009.09.061; Helliwell JR, 2007, NATURE, V448, P658, DOI 10.1038/448658a; Huglin M. B., 1972, LIGHT SCATTERING POL; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kratochvil P., 1987, CLASSICAL LIGHT SCAT; Kuiper MJ, 2002, J PEPT RES, V59, P1, DOI 10.1046/j.1397-002x.2001.00001.x; Leinala EK, 2002, ACTA CRYSTALLOGR D, V58, P1081, DOI 10.1107/S0907444902005334; Lin YB, 2008, CRYST GROWTH DES, V8, P4277, DOI 10.1021/cg800698p; LIU XY, 1995, NATURE, V374, P342, DOI 10.1038/374342a0; McPherson A, 2009, INTRO MACROMOLECULAR; Sasaki T, 2008, J CRYST GROWTH, V310, P1288, DOI 10.1016/j.jcrysgro.2007.11.228; Song XJ, 2007, BIOPHYS J, V92, pL43, DOI 10.1529/biophysj.106.102160; Tanaka S, 2003, BIOPHYS J, V84, P3299, DOI 10.1016/S0006-3495(03)70054-X; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Wang XK, 2010, CRYST RES TECHNOL, V45, P479, DOI 10.1002/crat.201000097; Wilson WW, 2003, J STRUCT BIOL, V142, P56, DOI 10.1016/S1047-8477(03)00038-8; Wingren C, 2003, PROTEIN ENG, V16, P255, DOI 10.1093/proeng/gzg038; Yin DC, 2008, CRYST RES TECHNOL, V43, P447, DOI 10.1002/crat.200710998; Zhang CY, 2008, CRYST GROWTH DES, V8, P4227, DOI 10.1021/cg800689j	35	6	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17950	10.1371/journal.pone.0017950	http://dx.doi.org/10.1371/journal.pone.0017950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479212	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700019
J	Stefanovski, D; Richey, JM; Woolcott, O; Lottati, M; Zheng, D; Harrison, LN; Ionut, V; Kim, SP; Hsu, I; Bergman, RN				Stefanovski, Darko; Richey, Joyce M.; Woolcott, Orison; Lottati, Maya; Zheng, Dan; Harrison, Lisa N.; Ionut, Viorica; Kim, Stella P.; Hsu, Isabel; Bergman, Richard N.			Consistency of the Disposition Index in the Face of Diet Induced Insulin Resistance: Potential Role of FFA	PLOS ONE			English	Article							FREE FATTY-ACIDS; IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL; INTRAVENOUS GLUCOSE; PERIPHERAL INSULIN; METABOLIC SYNDROME; FASTING GLUCOSE; SECRETION; SENSITIVITY; LINK	Objective: Insulin resistance induces hyperinsulinemic compensation, which in turn maintains almost a constant disposition index. However, the signal that gives rise to the hyperinsulinemic compensation for insulin resistance remains unknown. Methods: In a dog model of obesity we examined the possibility that potential early-week changes in plasma FFA, glucose, or both could be part of a cascade of signals that lead to compensatory hyperinsulinemia induced by insulin resistance. Results: Hypercaloric high fat feeding in dogs resulted in modest weight gain, and an increase in adipose tissue with no change in the non-adipose tissue size. To compensate for the drop in insulin sensitivity, there was a significant rise in plasma insulin, which can be attributed in part to a decrease in the metabolic clearance rate of insulin and increased insulin secretion. In this study we observed complete compensation for high fat diet induced insulin resistance as measured by the disposition index. The compensatory hyperinsulinemia was coupled with significant changes in plasma FFAs and no change in plasma glucose. Conclusions: We postulate that early in the development of diet induced insulin resistance, a change in plasma FFAs may directly, through signaling at the level of beta-cell, or indirectly, by decreasing hepatic insulin clearance, result in the observed hyperinsulinemic compensation.	[Stefanovski, Darko; Richey, Joyce M.; Woolcott, Orison; Lottati, Maya; Zheng, Dan; Harrison, Lisa N.; Ionut, Viorica; Kim, Stella P.; Hsu, Isabel; Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Southern California	Stefanovski, D (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.	stefanov@usc.edu	Woolcott, Orison O./AAQ-3440-2020	Woolcott, Orison O./0000-0003-2905-972X; Bergman, Richard/0000-0003-1539-4471	National Institutes of Health [DK27619, DK29867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027619, R37DK027619, R01DK029867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (DK27619 and DK29867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Carpentier A, 2000, DIABETES, V49, P399, DOI 10.2337/diabetes.49.3.399; Dai T, 2004, J BIOL CHEM, V279, P45155, DOI 10.1074/jbc.M404764200; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Julius Stevo, 1998, Blood Pressure, V7, P5; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1590, DOI 10.1152/ajpendo.00669.2006; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1581, DOI 10.1152/ajpendo.00351.2006; MAHEUX P, 1994, HYPERTENSION, V24, P695, DOI 10.1161/01.HYP.24.6.695; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Morgan LM, 1999, ANN CLIN BIOCHEM, V36, P447, DOI 10.1177/000456329903600407; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; POLONSKY KS, 1984, J CLIN INVEST, V74, P1821, DOI 10.1172/JCI111601; REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038; Richey JM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1311, DOI 10.1152/ajpendo.90972.2008; Rocchini AP, 1997, AM J PHYSIOL-ENDOC M, V272, pE147, DOI 10.1152/ajpendo.1997.272.1.E147; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Stumvoll M, 2005, DIABETOLOGIA, V48, P207, DOI 10.1007/s00125-004-1657-3; Tasali E, 2002, AM J RESP CRIT CARE, V165, P562, DOI 10.1164/ajrccm.165.5.2201001b; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x	34	24	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18134	10.1371/journal.pone.0018134	http://dx.doi.org/10.1371/journal.pone.0018134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479217	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700029
J	van der Ploeg, R; Mader, U; Homuth, G; Schaffer, M; Denham, EL; Monteferrante, CG; Miethke, M; Marahiel, MA; Harwood, CR; Winter, T; Hecker, M; Antelmann, H; van Dijl, JM				van der Ploeg, Rene; Maeder, Ulrike; Homuth, Georg; Schaffer, Marc; Denham, Emma L.; Monteferrante, Carmine G.; Miethke, Marcus; Marahiel, Mohamed A.; Harwood, Colin R.; Winter, Theresa; Hecker, Michael; Antelmann, Haike; van Dijl, Jan Maarten			Environmental Salinity Determines the Specificity and Need for Tat-Dependent Secretion of the YwbN Protein in Bacillus subtilis	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; BACTERIAL CYTOPLASMIC MEMBRANE; FERROUS IRON-UPTAKE; ESCHERICHIA-COLI; SIGNAL PEPTIDE; TRANSPORT-SYSTEM; EXPORT PATHWAY; ADAPTATION; PRECURSOR; COMPLEX	Twin-arginine protein translocation (Tat) pathways are required for transport of folded proteins across bacterial, archaeal and chloroplast membranes. Recent studies indicate that Tat has evolved into a mainstream pathway for protein secretion in certain halophilic archaea, which thrive in highly saline environments. Here, we investigated the effects of environmental salinity on Tat-dependent protein secretion by the Gram-positive soil bacterium Bacillus subtilis, which encounters widely differing salt concentrations in its natural habitats. The results show that environmental salinity determines the specificity and need for Tat-dependent secretion of the Dyp-type peroxidase YwbN in B. subtilis. Under high salinity growth conditions, at least three Tat translocase subunits, namely TatAd, TatAy and TatCy, are involved in the secretion of YwbN. Yet, a significant level of Tat-independent YwbN secretion is also observed under these conditions. When B. subtilis is grown in medium with 1% NaCl or without NaCl, the secretion of YwbN depends strictly on the previously described "minimal Tat translocase" consisting of the TatAy and TatCy subunits. Notably, in medium without NaCl, both tatAyCy and ywbN mutants display significantly reduced exponential growth rates and severe cell lysis. This is due to a critical role of secreted YwbN in the acquisition of iron under these conditions. Taken together, our findings show that environmental conditions, such as salinity, can determine the specificity and need for the secretion of a bacterial Tat substrate.	[van der Ploeg, Rene; Denham, Emma L.; Monteferrante, Carmine G.; van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [van der Ploeg, Rene; Denham, Emma L.; Monteferrante, Carmine G.; van Dijl, Jan Maarten] Univ Groningen, Groningen, Netherlands; [Maeder, Ulrike; Homuth, Georg; Schaffer, Marc] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Miethke, Marcus; Marahiel, Mohamed A.] Univ Marburg, Dept Chem Biochem, Marburg, Germany; [Harwood, Colin R.] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Winter, Theresa; Hecker, Michael; Antelmann, Haike] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol & Mol Biol, Greifswald, Germany	University of Groningen; University of Groningen; Ernst Moritz Arndt Universitat Greifswald; Philipps University Marburg; Newcastle University - UK; Ernst Moritz Arndt Universitat Greifswald	van der Ploeg, R (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands.	j.m.van.dijl@med.umcg.nl	Harwood, Colin/AGF-0120-2022; van Dijl, Jan Maarten/G-1205-2013; Antelmann, Haike/I-3129-2019; Denham, Emma/P-3979-2014	Antelmann, Haike/0000-0002-1766-4386; van der Ploeg, Rene/0000-0003-2490-9262; Denham, Emma/0000-0002-5123-4099; Harwood, Colin/0000-0002-3624-0001	Commission of the European Union (CEU) [LSHG-CT-2004-503468, LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469, PITN-GA-2008-215524]; transnational Systems Biology of Microorganisms (SysMO) initiative [BACELL SysMO1, BACELL SysMO2]; European Science Foundation; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research [04-EScope 01-011]; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Bundesministerium fur Bildung und Forschung [03ZIK012]	Commission of the European Union (CEU)(European Commission); transnational Systems Biology of Microorganisms (SysMO) initiative; European Science Foundation(European Science Foundation (ESF)European Commission); Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This research was supported by the Commission of the European Union (CEU) projects LSHG-CT-2004-503468, LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469 and PITN-GA-2008-215524, the transnational Systems Biology of Microorganisms (SysMO) initiative through projects BACELL SysMO1 and 2, the European Science Foundation under the EUROCORES Programme EuroSCOPE, and grant 04-EScope 01-011 from the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research, the "Deutsche Forschungsgemeinschaft", the "Fonds der Chemischen Industrie" and the "Bundesministerium fur Bildung und Forschung" (03ZIK012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Askwith C, 1997, J BIOL CHEM, V272, P401; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2002, MICROBIOL-SGM, V148, P3335, DOI 10.1099/00221287-148-11-3335; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Darmon E, 2006, APPL ENVIRON MICROB, V72, P6876, DOI 10.1128/AEM.01176-06; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eijlander RT, 2009, J BACTERIOL, V191, P196, DOI 10.1128/JB.01264-08; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Hantke K, 1997, J BACTERIOL, V179, P6201, DOI 10.1128/jb.179.19.6201-6204.1997; Hoffmann T, 2002, J BACTERIOL, V184, P718, DOI 10.1128/JB.184.3.718-727.2002; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Hutcheon GW, 2003, BIOCHEM SOC T, V31, P686, DOI 10.1042/bst0310686; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; KOUWEN TR, 2009, PROTEOMICS; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Thomas JR, 2006, FEMS MICROBIOL LETT, V256, P44, DOI 10.1111/j.1574-6968.2006.00107.x; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X; WIDDICK DA, 2007, J MOL BIOL; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	57	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18140	10.1371/journal.pone.0018140	http://dx.doi.org/10.1371/journal.pone.0018140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479178	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700031
J	Erler, S; Popp, M; Lattorff, HMG				Erler, Silvio; Popp, Mario; Lattorff, H. Michael G.			Dynamics of Immune System Gene Expression upon Bacterial Challenge and Wounding in a Social Insect (Bombus terrestris)	PLOS ONE			English	Article							APIS-MELLIFERA; PEPTIDE GENES; DROSOPHILA; DEFENSE; INFECTION; PATHWAY; INJURY; MEMORY; ANTS	The innate immune system which helps individuals to combat pathogens comprises a set of genes representing four immune system pathways (Toll, Imd, JNK and JAK/STAT). There is a lack of immune genes in social insects (e. g. honeybees) when compared to Diptera. Potentially, this might be compensated by an advanced system of social immunity (synergistic action of several individuals). The bumble bee, Bombus terrestris, is a primitively eusocial species with an annual life cycle and colonies headed by a single queen. We used this key pollinator to study the temporal dynamics of immune system gene expression in response to wounding and bacterial challenge. Antimicrobial peptides (AMP) (abaecin, defensin 1, hymenoptaecin) were strongly up-regulated by wounding and bacterial challenge, the latter showing a higher impact on the gene expression level. Sterile wounding down-regulated TEP A, an effector gene of the JAK/STAT pathway, and bacterial infection influenced genes of the Imd (relish) and JNK pathway (basket). Relish was up-regulated within the first hour after bacterial challenge, but decreased strongly afterwards. AMP expression following wounding and bacterial challenge correlates with the expression pattern of relish whereas correlated expression with dorsal was absent. Although expression of AMPs was high, continuous bacterial growth was observed throughout the experiment. Here we demonstrate for the first time the temporal dynamics of immune system gene expression in a social insect. Wounding and bacterial challenge affected the innate immune system significantly. Induction of AMP expression due to wounding might comprise a pre-adaptation to accompanying bacterial infections. Compared with solitary species this social insect exhibits reduced immune system efficiency, as bacterial growth could not be inhibited. A negative feedback loop regulating the Imd-pathway is suggested. AMPs, the end product of the Imd-pathway, inhibited the up-regulation of the transcription factor relish, which is necessary for effector gene expression.	[Erler, Silvio; Popp, Mario; Lattorff, H. Michael G.] Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Erler, S (corresponding author), Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany.	silvio.erler@zoologie.uni-halle.de	Lattorff, Michael/F-6287-2010; Erler, Silvio/B-4162-2012	Lattorff, Michael/0000-0002-8603-6332; Erler, Silvio/0000-0002-9425-8103	BMBF [FKZ: 0315126]	BMBF(Federal Ministry of Education & Research (BMBF))	This project was supported by a grant from the BMBF program FUGATO-Plus (FKZ: 0315126) to HMGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Choi YS, 2008, COMP BIOCHEM PHYS B, V150, P141, DOI 10.1016/j.cbpb.2008.02.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kube M, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-110, 10.1186/1471-2164-11-393]; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Viljakainen L, 2008, J MOL EVOL, V67, P643, DOI 10.1007/s00239-008-9173-6; Welchman David P, 2009, Cell Host Microbe, V6, P107, DOI 10.1016/j.chom.2009.07.008; Wilfert L, 2009, INSECT SOC, V56, P44, DOI 10.1007/s00040-008-1034-1; Xu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004239; Yoon Hyung Joo, 2009, Journal of Asia-Pacific Entomology, V12, P27, DOI 10.1016/j.aspen.2008.11.003	32	74	76	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18126	10.1371/journal.pone.0018126	http://dx.doi.org/10.1371/journal.pone.0018126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479237	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600029
J	Morello, V; Cabodi, S; Sigismund, S; Camacho-Leal, MP; Repetto, D; Volante, M; Papotti, M; Turco, E; Defilippi, P				Morello, V.; Cabodi, S.; Sigismund, S.; Camacho-Leal, M. P.; Repetto, D.; Volante, M.; Papotti, M.; Turco, E.; Defilippi, P.			beta 1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells	ONCOGENE			English	Article						EGFR; beta 1 integrin; lung cancer	GROWTH-FACTOR-RECEPTOR; IN-VIVO; TUMOR PROGRESSION; INTEGRIN; KINASE; EXPRESSION; PATHWAY; PHOSPHORYLATION; ACTIVATION; MIGRATION	Lung cancer is the leading cause of cancer death worldwide. The epidermal growth factor receptor (EGFR) represents the main target for non-small cell lung cancer (NSCLC) therapy, as its overexpression or constitutive activation contributes to malignancy and correlates with poor prognosis. Our previous work demonstrated that in epithelial cells beta 1 integrin is required for propagating EGFR signaling from the plasma membrane to the nucleus. In this study, we silenced beta 1 integrin in human NSCLC A549 cells. The beta 1 integrin-silenced cells show a defective activation of the EGFR signaling cascade, leading to decreased in vitro proliferation, enhanced sensitivity to cisplatin and Gefitinib, impaired migration and invasive behavior. Inhibitory effects on tumor growth and on the EGFR pathway were also observed in in vivo experiments. Moreover, beta 1 integrin silencing increases the amount of EGFR on the cell surface, suggesting that beta 1 integrin is required for efficient constitutive EGFR turnover at the cell membrane. Although the rate of EGF internalization and recycling is not affected in silenced cells, EGFR signaling is recovered only by expression of the Rab-coupling protein RCP, indicating that beta 1 integrin sustains the endocytic machinery required for EGFR signaling. Overall, these results show that beta 1 integrin is an essential regulator of EGFR signaling and tumorigenic properties of lung cancer cells, and that its silencing might represent an adjuvant approach to anti-EGFR therapy. Oncogene (2011) 30, 4087-4096; doi:10.1038/onc.2011.107; published online 11 April 2011	[Morello, V.; Cabodi, S.; Camacho-Leal, M. P.; Repetto, D.; Turco, E.; Defilippi, P.] Univ Turin, Ctr Mol Biotechnol, I-10125 Turin, Italy; [Sigismund, S.] Ist FIRC Oncol Mol, Milan, Italy; [Volante, M.; Papotti, M.] Univ Turin, Orbassano, TO, Italy	University of Turin; IFOM - FIRC Institute of Molecular Oncology; University of Turin	Defilippi, P (corresponding author), Univ Turin, Ctr Mol Biotechnol, Via Nizza 52, I-10125 Turin, Italy.	paola.defilippi@unito.it	DEFILIPPI, Paola/L-2232-2014; Sigismund, Sara/H-3687-2017	Sigismund, Sara/0000-0002-1396-4453; Morello, Virginia/0000-0002-3001-0993	AIRC; AICR; EU; MUR; Regione Piemonte-Progetti Sanita; Oncoprot; PiSTEM; Druidi and CIPE; Compagnia San Paolo, Torino	AIRC(Fondazione AIRC per la ricerca sul cancro); AICR; EU(European Commission); MUR(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte-Progetti Sanita; Oncoprot; PiSTEM; Druidi and CIPE; Compagnia San Paolo, Torino(Compagnia di San Paolo)	We thank Dr Jim Norman (The Beatson Institute for Cancer Research, Glasgow, UK) for kindly providing the RCP construct. We also thank Elona Saraci for initial experiments and Giusy Tornillo for the 3D invasion assays. This work was supported by AIRC, AICR, EU FP7 Metafight, MUR (PRIN, ex-60%), Regione Piemonte-Progetti Sanita, Oncoprot, PiSTEM, Druidi and CIPE, Compagnia San Paolo, Torino.	Adachi M, 2000, CLIN CANCER RES, V6, P96; Arteaga CL, 2001, CURR OPIN ONCOL, V13, P491, DOI 10.1097/00001622-200111000-00012; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Cordes N, 2007, INT J RADIAT BIOL, V83, P753, DOI 10.1080/09553000701639694; Cusinato F, 1999, BBA-MOL CELL RES, V1451, P35, DOI 10.1016/S0167-4889(99)00092-0; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Erba EB, 2005, MOL CELL PROTEOMICS, V4, P1107, DOI 10.1074/mcp.M500070-MCP200; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Maione P, 2010, EXPERT OPIN PHARMACO, V11, P2997, DOI 10.1517/14656566.2010.511615; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Okamura M, 2007, HUM PATHOL, V38, P1081, DOI 10.1016/j.humpath.2007.01.003; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yoshida T, 2010, BIOCHEM PHARMACOL, V80, P613, DOI 10.1016/j.bcp.2010.05.014	42	107	110	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	39					4087	4096		10.1038/onc.2011.107	http://dx.doi.org/10.1038/onc.2011.107			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	826ME	21478906	Green Submitted			2022-12-25	WOS:000295357500004
J	Neves, AA; Stockmann, H; Harmston, RR; Pryor, HJ; Alam, IS; Ireland-Zecchini, H; Lewis, DY; Lyons, SK; Leeper, FJ; Brindle, KM				Neves, Andre A.; Stoeckmann, Henning; Harmston, Rebecca R.; Pryor, Helen J.; Alam, Israt S.; Ireland-Zecchini, Heather; Lewis, David Y.; Lyons, Scott K.; Leeper, Finian J.; Brindle, Kevin M.			Imaging sialylated tumor cell glycans in vivo	FASEB JOURNAL			English	Article						sialic acid; metabolic labeling; fluorescence imaging; SPECT	FREE CLICK CHEMISTRY; SIALIC-ACID; LIVING ANIMALS; CANCER METASTASIS; BREAST-CANCER; GLYCOSYLATION; EXPRESSION; CARCINOMA; SURVIVAL; ADENOCARCINOMA	Cell surface glycans are involved in numerous physiological processes that involve cell-cell interactions and migration, including lymphocyte trafficking and cancer metastasis. We have used a bioorthogonal metabolic labeling strategy to detect cell surface glycans and demonstrate, for the first time, fluorescence and radionuclide imaging of sialylated glycans in a murine tumor model in vivo. Peracetylated azido-labeled N-acetyl-mannosamine, injected intraperitoneally, was used as the metabolic precursor for the biosynthesis of 5-azidoneuraminic, or azidosialic acid. Azidosialic acid-labeled cell surface glycans were then reacted, by Staudinger ligation, with a biotinylated phosphine injected intraperitoneally, and the biotin was detected by subsequent intravenous injection of a fluorescent or radiolabeled avidin derivative. At 24 h after administration of NeutrAvidin, labeled with either a far-red fluorophore or (111)In, there was a significant azido-labeled N-acetyl-mannosamine-dependent increase in tumor-to-tissue contrast, which was detected using optical imaging or single-photon-emission computed tomography (SPECT), respectively. The technique has the potential to translate to the clinic, where, given the prognostic relevance of altered sialic acid expression in cancer, it could be used to monitor disease progression.-Neves, A. A., Stockmann, H., Harmston, R. R., Pryor, H. J., Alam, I. S., Ireland-Zecchini, H., Lewis, D. Y., Lyons, S. K., Leeper, F. J., Brindle, K. M. Imaging sialylated tumor cell glycans in vivo. FASEB J. 25, 2528-2537 (2011). www.fasebj.org	[Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Stoeckmann, Henning; Leeper, Finian J.] Univ Cambridge, Dept Chem, Cambridge CB2 1GA, England; [Neves, Andre A.; Stoeckmann, Henning; Harmston, Rebecca R.; Pryor, Helen J.; Alam, Israt S.; Ireland-Zecchini, Heather; Lewis, David Y.; Lyons, Scott K.; Brindle, Kevin M.] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge, England	University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Brindle, KM (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	kmb1001@cam.ac.uk	Lewis, David/AAN-9235-2021; Leeper, Finian/B-4842-2012; Neves, Andre/B-8397-2011; Stockmann, Henning/A-1891-2012	Neves, Andre/0000-0003-2740-5166; Lyons, Scott/0000-0003-0139-6054; Lewis, David/0000-0001-9329-1326; Leeper, Finian James/0000-0003-3408-5199; Stockmann, Henning/0000-0002-2409-5476	Cancer Research UK; Cancer Research UK [6934] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	H.S. and I.S.A. were recipients of Cancer Research UK Ph.D. studentships. A.A.N. thanks Kwasi Agyei-Owusu, James Kelly, and Hiral Bhalara for advice on synthetic methods. The authors thank De-En Hu and Sarah Fawcett for support with animal procedures, Mikko Kettunen for advice on imaging, and Joan Boren for support on flow cytometric imaging. The authors acknowledge Kishor Solanki, Chandra Solanki, and Sarah Heard (Nuclear Medicine Department, Addenbrooke's Hospital, Cambridge, UK) for kind logistical support in the SPECT studies. This work was supported by a Cancer Research UK program grant to K.M.B. The authors declare no competing financial interests.	Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Becker A, 2000, PHOTOCHEM PHOTOBIOL, V72, P234, DOI 10.1562/0031-8655(2000)072<0234:MCAFOI>2.0.CO;2; BERNACKI RJ, 1977, SCIENCE, V195, P577, DOI 10.1126/science.835014; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; BRENNAN MJ, 1986, INFECT IMMUN, V52, P840, DOI 10.1128/IAI.52.3.840-845.1986; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Fukuda M, 1996, CANCER RES, V56, P2237; Goetz M, 2010, GASTROENTEROLOGY, V138, P828, DOI 10.1053/j.gastro.2010.01.009; Gold DV, 2007, CLIN CANCER RES, V13, P7380, DOI 10.1158/1078-0432.CCR-07-1488; Granovsky M, 2000, NAT MED, V6, P306; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Igarashi Y, 2010, J BIOCHEM, V147, P3, DOI 10.1093/jb/mvp195; INOKUCHI J, 1990, CANCER RES, V50, P6731; Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13; Kobayashi H, 2004, CLIN CANCER RES, V10, P7712, DOI 10.1158/1078-0432.CCR-04-1175; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laughlin ST, 2009, ACS CHEM BIOL, V4, P1068, DOI 10.1021/cb900254y; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Lemieux GA, 1999, J AM CHEM SOC, V121, P4278, DOI 10.1021/ja984228m; Leroy X, 2006, ANN PATHOL, V26, P257, DOI 10.1016/S0242-6498(06)70718-0; Luchansky SJ, 2004, BIOCHEMISTRY-US, V43, P12358, DOI 10.1021/bi049274f; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; Medina LA, 2004, NUCL MED BIOL, V31, P41, DOI 10.1016/S0969-8051(03)00122-7; MILES DW, 1994, BRIT J CANCER, V70, P1272, DOI 10.1038/bjc.1994.486; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; MURAYAMA K, 1986, CANCER RES, V46, P1395; NAKAMORI S, 1993, CANCER RES, V53, P3632; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Satoh H, 1997, CLIN CANCER RES, V3, P495; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schneider F, 2001, CANCER RES, V61, P4605; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Stockmann H, 2011, CHEM SCI, V2, P932, DOI 10.1039/c0sc00631a; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; TAKANO R, 1994, GLYCOBIOLOGY, V4, P665, DOI 10.1093/glycob/4.5.665; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wahrenbrock MG, 2006, CANCER RES, V66, P2433, DOI 10.1158/0008-5472.CAN-05-3851; Yu CJ, 1996, ONCOLOGY, V53, P118	54	64	65	0	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2528	2537		10.1096/fj.10-178590	http://dx.doi.org/10.1096/fj.10-178590			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21493886				2022-12-25	WOS:000293337800004
J	Atefi, G; Zetoune, FS; Herron, TJ; Jalife, J; Bosmann, M; Al-Aref, R; Sarma, JV; Ward, PA				Atefi, Gelareh; Zetoune, Firas S.; Herron, Todd J.; Jalife, Jose; Bosmann, Markus; Al-Aref, Rami; Sarma, J. Vidya; Ward, Peter A.			Complement dependency of cardiomyocyte release of mediators during sepsis	FASEB JOURNAL			English	Article						cytokines; cytokine receptors; C5a; IL-17A; cardiomyopathy	NECROSIS-FACTOR-ALPHA; SEPTIC SHOCK; MITOCHONDRIAL DYSFUNCTION; TNF-ALPHA; CALCIUM; C5A; INTERLEUKIN-1-BETA; PATHOGENESIS; ACTIVATION	We have recently shown that antibody-induced blockade of C5a, C5a receptors, or IL-17A greatly reduced the harmful outcomes of sepsis. In the current study, normal cardiomyocytes from young (300 g) male Sprague-Dawley rats responded in vitro to C5a (ED50 = 55 nM) with release of IL-6 and TNF alpha, peaking between 2 to 8 h. Neutralizing antibodies to mouse C5a or IL-17A (ED50 = 40 mu g for each, based on improved survival) reduced spontaneous in vitro release of cardiosuppressive cytokines and chemokines in cardiomyocytes obtained from mice with polymicrobial sepsis. A non-neutralizing C5a antibody had no such effects. Cardiomyocytes from septic mice (C57B1/6) showed increased mRNA for TNFR1, IL-6 (gp80), and C5aR at 6 h after sepsis. Cardiomyocytes from septic C5aR(-/-) or C5L2(-/-) mice did not show spontaneous in vitro release of cytokines and chemokines. These data suggest that cardiomyocytes from septic mice release suppressive cytokines in a C5a-, C5aR-, and IL-17A-dependent manner, followed by mediator reactivity with receptors on cardiomyocytes, resulting in defective contractility and relaxation. These data may be relevant to a strategy for the treatment of heart dysfunction developing during sepsis.-Atefi, G., Zetoune, F. S., Herron, T. J., Jalife, J., Bosmann, M., Chen, A., Al-Aref, R., Sarma, J. V., Ward, P. A. Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB J. 25, 2500-2508 (2011). www.fasebj.org	[Atefi, Gelareh; Zetoune, Firas S.; Bosmann, Markus; Al-Aref, Rami; Sarma, J. Vidya; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Herron, Todd J.; Jalife, Jose] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Herron, Todd J.; Jalife, Jose] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,Box 5602, Ann Arbor, MI 48109 USA.	pward@umich.edu	Jalife, Jose/L-4833-2015; Jalife, Jose/AAJ-9156-2021	Jalife, Jose/0000-0003-0080-3500; Jalife, Jose/0000-0003-0080-3500; Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health [GM-61656, GM-29507, HL-31963, NHLBI-T32-HL007517-28]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963, T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was sponsored by U.S. National Institutes of Health grants GM-61656, GM-29507, and HL-31963 to P. A. W. and NHLBI-T32-HL007517-28 to G. A.	Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Ballard-Croft C, 2004, J APPL PHYSIOL, V97, P1470, DOI 10.1152/japplphysiol.01149.2003; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Buras JA, 2004, IMMUNOBIOLOGY, V209, P629, DOI 10.1016/j.imbio.2004.09.004; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; CLOWES GHA, 1966, ANN SURG, V163, P866, DOI 10.1097/00000658-196606000-00008; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; Flierl MA, 2008, MOL MED, V14, P327, DOI 10.2119/2007-00130.Flierl; Gellerich FN, 2002, BIOSCIENCE REP, V22, P99, DOI 10.1023/A:1016017224003; Harrois A, 2009, CURR OPIN ANESTHESIO, V22, P143, DOI 10.1097/ACO.0b013e328328d1cc; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Huber-Lang MS, 2001, FASEB J, V15, P568; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Joulin O, 2007, PHYSIOL RES, V56, P291, DOI 10.33549/physiolres.930946; Kumar A, 2007, CRIT CARE MED, V35, P358, DOI 10.1097/01.CCM.0000254341.87098.A4; Maass DL, 2002, SHOCK, V18, P360, DOI 10.1097/00024382-200210000-00012; Maass DL, 2002, SHOCK, V17, P293, DOI 10.1097/00024382-200204000-00009; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; Rabuel C, 2006, INTENS CARE MED, V32, P799, DOI 10.1007/s00134-006-0142-5; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Soriano FG, 2006, CRIT CARE MED, V34, P1073, DOI 10.1097/01.CCM.0000206470.47721.8D; Thompson M, 2000, PEDIATR RES, V47, P669, DOI 10.1203/00006450-200005000-00019; Ward PA, 2009, NAT MED, V15, P497, DOI 10.1038/nm0509-497	30	42	43	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2500	2508		10.1096/fj.11-183236	http://dx.doi.org/10.1096/fj.11-183236			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21478262	Green Submitted, Green Published			2022-12-25	WOS:000292242200040
J	Barthel, SR; Antonopoulos, A; Cedeno-Laurent, F; Schaffer, L; Hernandez, G; Patil, SA; North, SJ; Dell, A; Matta, KL; Neelamegham, S; Haslam, SM; Dimitroff, CJ				Barthel, Steven R.; Antonopoulos, Aristotelis; Cedeno-Laurent, Filiberto; Schaffer, Lana; Hernandez, Gilberto; Patil, Shilpa A.; North, Simon J.; Dell, Anne; Matta, Khushi L.; Neelamegham, Sriram; Haslam, Stuart M.; Dimitroff, Charles J.			Peracetylated 4-Fluoro-glucosamine Reduces the Content and Repertoire of N- and O-Glycans without Direct Incorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGAND; LYMPHOCYTE-ASSOCIATED ANTIGEN; SKIN-HOMING RECEPTORS; PROSTATE TUMOR-CELLS; MAJOR E-SELECTIN; SIALYL-LEWIS-X; P-SELECTIN; PLASMA-MEMBRANE; CANCER CELLS; EXPRESSION	Prior studies have shown that treatment with the peracetylated 4-fluorinated analog of glucosamine (4-F-GlcNAc) elicits anti-skin inflammatory activity by ablating N-acetyllactosamine (LacNAc), sialyl Lewis X (sLe(X)), and related lectin ligands on effector leukocytes. Based on anti-sLe(X) antibody and lectin probing experiments on 4-F-GlcNAc-treated leukocytes, it was hypothesized that 4-F-GlcNAc inhibited sLe(X) formation by incorporating into LacNAc and blocking the addition of galactose or fucose at the carbon 4-position of 4-F-GlcNAc. To test this hypothesis, we determined whether 4-F-GlcNAc is directly incorporated into N- and O-glycans released from 4-F-GlcNAc-treated human sLe(X) (+) T cells and leukemic KG1a cells. At concentrations that abrogated galectin-1 (Gal-1) ligand and E-selectin ligand expression and related LacNAc and sLe(X) structures, MALDI-TOF and MALDI-TOF/TOF mass spectrometry analyses showed that 4-F-GlcNAc 1) reduced content and structural diversity of tri- and tetra-antennary N-glycans and of O-glycans, 2) increased biantennary N-glycans, and 3) reduced LacNAc and sLe(X) on N-glycans and on core 2 O-glycans. Moreover, MALDI-TOF MS did not reveal any m/z ratios relating to the presence of fluorine atoms, indicating that 4-F-GlcNAc did not incorporate into glycans. Further analysis showed that 4-F-GlcNAc treatment had minimal effect on expression of 1200 glycome-related genes and did not alter the activity of LacNAc-synthesizing enzymes. However, 4-F-GlcNAc dramatically reduced intracellular levels of uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc), a key precursor of LacNAc synthesis. These data show that Gal-1 and E-selectin ligand reduction by 4-F-GlcNAc is not caused by direct 4-F-GlcNAc glycan incorporation and consequent chain termination but rather by interference with UDP-GlcNAc synthesis.	[Barthel, Steven R.; Cedeno-Laurent, Filiberto; Dimitroff, Charles J.] Harvard Univ, Sch Med, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Barthel, Steven R.; Cedeno-Laurent, Filiberto; Dimitroff, Charles J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Antonopoulos, Aristotelis; North, Simon J.; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; [Schaffer, Lana; Hernandez, Gilberto] Scripps Res Inst, La Jolla, CA 92037 USA; [Patil, Shilpa A.; Neelamegham, Sriram] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Matta, Khushi L.] Roswell Pk Canc Inst, Dept Canc Biol, Buffalo, NY 14263 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Imperial College London; Scripps Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Dimitroff, CJ (corresponding author), HIM, Rm 662,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cdimitroff@rics.bwh.harvard.edu		Neelamegham, Sriram/0000-0002-1371-8500	National Institutes of Health (NIH), NCI [RO1 CA118124]; NIH, NCCAM [RO1 AT004268]; NIH Analytical Glycotechnology Core [62116]; Biotechnology and Biological Sciences Research Council [BBF0083091, B19088]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA118124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004628] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH Analytical Glycotechnology Core; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant RO1 CA118124 (to C. J. D.); NIH, NCCAM, Grant RO1 AT004268 (to C. J. D.); and NIH Analytical Glycotechnology Core (Core C) of the Consortium for Functional Glycomics Grant GM 62116. This work was also supported by Biotechnology and Biological Sciences Research Council Grants BBF0083091 and B19088 and the Wellcome Trust (to S. M. H. and A. D.).	Barthel SR, 2008, GLYCOBIOLOGY, V18, P806, DOI 10.1093/glycob/cwn070; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bernacki R, 1977, Adv Enzyme Regul, V16, P217, DOI 10.1016/0065-2571(78)90075-4; BERNACKI RJ, 1977, J SUPRAMOL STR CELL, V7, P235, DOI 10.1002/jss.400070208; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown JR, 2009, J BIOL CHEM, V284, P4952, DOI 10.1074/jbc.M805782200; Brown JR, 2003, J BIOL CHEM, V278, P23352, DOI 10.1074/jbc.M303093200; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; BURGHARDT C, 2007, Patent No. 1431397; Cedeno-Laurent F, 2010, J IMMUNOL, V185, P4659, DOI 10.4049/jimmunol.1000715; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Dell Anne, 1993, Current Opinion in Biotechnology, V4, P52, DOI 10.1016/0958-1669(93)90032-R; Descheny L, 2006, J INVEST DERMATOL, V126, P2065, DOI 10.1038/sj.jid.5700364; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Dimitroff CJ, 2005, CANCER RES, V65, P5750, DOI 10.1158/0008-5472.CAN-04-4653; Dimitroff CJ, 2004, CANCER RES, V64, P5261, DOI 10.1158/0008-5472.CAN-04-0691; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Dimitroff CJ, 2003, BLOOD, V101, P602, DOI 10.1182/blood-2002-06-1736; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Dimitroff CJ, 1999, BIOCHEM BIOPH RES CO, V256, P631, DOI 10.1006/bbrc.1999.0388; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Foster MM, 2003, CANCER RES, V63, P2775; Gainers ME, 2007, J IMMUNOL, V179, P8509, DOI 10.4049/jimmunol.179.12.8509; Hou YM, 1996, BIOCHEMISTRY-US, V35, P3963, DOI 10.1021/bi9524575; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Rabinovich GA, 2009, IMMUNOL REV, V230, P144, DOI 10.1111/j.1600-065X.2009.00787.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; Salatino M, 2008, EXPERT OPIN BIOL TH, V8, P45, DOI 10.1517/14712598.8.1.45; SHARMA M, 1990, CARBOHYD RES, V198, P205, DOI 10.1016/0008-6215(90)84293-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; WOOD TC, 1994, BIOCHEM BIOPH RES CO, V198, P1119, DOI 10.1006/bbrc.1994.1159; WOYNAROWSKA B, 1994, J BIOL CHEM, V269, P22797; Woynarowska B, 1996, GLYCOCONJUGATE J, V13, P663, DOI 10.1007/BF00731455; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	51	52	52	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21717	21731		10.1074/jbc.M110.194597	http://dx.doi.org/10.1074/jbc.M110.194597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21493714	hybrid, Green Published			2022-12-25	WOS:000291464700068
J	Lu, YF; Li, T; Qureshi, HY; Han, D; Paudel, HK				Lu, Yifan; Li, Tong; Qureshi, Hamid Y.; Han, Dong; Paudel, Hemant K.			Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR EGR-1; CYCLIN-DEPENDENT PROTEIN-KINASE-5; NEURONAL CDC2-LIKE KINASE; NF-KAPPA-B; ALZHEIMERS-DISEASE; MOUSE MODEL; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO	In the normal brain, tau protein is phosphorylated at a number of proline-and non-proline directed sites, which reduce tau microtubule binding and thus regulate microtubule dynamics. In Alzheimer disease (AD), tau is abnormally hyperphosphorylated, leading to neurofibrillary tangle formation and microtubule disruption, suggesting a loss of regulatory mechanisms controlling tau phosphorylation. Early growth response 1 (Egr-1) is a transcription factor that is significantly up-regulated in AD brain. The pathological significance of this up-regulation is not known. In this study, we found that lentivirus-mediated overexpression of Egr-1 in rat brain hippocampus and primary neurons in culture activates proline-directed kinase Cdk5, inactivates PP1, promotes tau phosphorylation at both proline-directed Ser(396/404) and non-proline-directed Ser(262) sites, and destabilizes microtubules. Furthermore, in Egr-1(-/-) mouse brain, Cdk5 activity was decreased, PP1 activity was increased, and tau phosphorylation was reduced at both proline-directed and non-proline-directed sites. By using nerve growth factor-exposed PC12 cells, we determined that Egr-1 activates Cdk5 to promote phosphorylation of tau and inactivates PP1 via phosphorylation. When Cdk5 was inhibited, tau phosphorylation at both proline-and non-proline directed sites and PP1 phosphorylation were blocked, indicating that Egr-1 acts through Cdk5. By using an in vitro kinase assay and HEK-293 cells transfected with tau, PP1, and Cdk5, we found that Cdk5 phosphorylates Ser(396/404) directly. In addition, by phosphorylating and inactivating PP1, Cdk5 promotes tau phosphorylation at Ser(262) indirectly. Our results indicate that Egr-1 is an in vivo regulator of tau phosphorylation and suggest that in AD brain increased levels of Egr-1 aberrantly activate an Egr-1/Cdk5/PP1 pathway, leading to accumulation of hyperphosphorylated tau, thus destabilizing the microtubule cytoskeleton.	[Lu, Yifan; Li, Tong; Qureshi, Hamid Y.; Han, Dong; Paudel, Hemant K.] Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer's Society of Canada; Natural Sciences and Engineering Research Council of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Canadian Institute for Health Research, Alzheimer's Society of Canada, and Natural Sciences and Engineering Research Council of Canada.	ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Broussau S, 2008, MOL THER, V16, P500, DOI 10.1038/sj.mt.6300383; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P20, DOI 10.1097/01.wad.0000155068.23937.9b; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Giri RK, 2005, AM J PHYSIOL-CELL PH, V289, pC264, DOI 10.1152/ajpcell.00461.2004; Giri RK, 2004, J NEUROCHEM, V91, P1199, DOI 10.1111/j.1471-4159.2004.02800.x; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Han SS, 1999, CLIN IMMUNOL, V93, P152, DOI 10.1006/clim.1999.4769; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Huang RP, 1998, INT J CANCER, V77, P880, DOI 10.1002/(SICI)1097-0215(19980911)77:6<880::AID-IJC14>3.0.CO;2-5; Ishrat T, 2009, EUR NEUROPSYCHOPHARM, V19, P636, DOI 10.1016/j.euroneuro.2009.02.002; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Krones-Herzig A, 2003, P NATL ACAD SCI USA, V100, P3233, DOI 10.1073/pnas.2628034100; Kudo T, 2000, NEUROBIOL AGING, V21, P215, DOI 10.1016/S0197-4580(00)00129-9; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu CT, 1996, P NATL ACAD SCI USA, V93, P11831, DOI 10.1073/pnas.93.21.11831; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Liu J, 2001, INT J ONCOL, V18, P863; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; Masliah E, 1998, J NEUROPATH EXP NEUR, V57, P1041, DOI 10.1097/00005072-199811000-00007; Merrick SE, 1997, J NEUROSCI, V17, P5726; Moon Y, 2005, J PHARMACOL EXP THER, V315, P788, DOI 10.1124/jpet.105.084434; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Paudel HK, 1997, J BIOL CHEM, V272, P28328, DOI 10.1074/jbc.272.45.28328; Paudel HK, 1997, J BIOL CHEM, V272, P1777; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P3406, DOI 10.1161/01.ATV.17.12.3406; Pendurthi UR, 2000, THROMB RES, V97, P179, DOI 10.1016/S0049-3848(99)00148-6; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rohn TT, 2008, J NEUROSCI, V28, P3051, DOI 10.1523/JNEUROSCI.5620-07.2008; Schipper HM, 1999, NEUROSCIENCE, V93, P585, DOI 10.1016/S0306-4522(99)00120-7; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; VANDERWAL EA, 1993, NEUROREPORT, V4, P69, DOI 10.1097/00001756-199301000-00018; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461	75	42	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20569	20581		10.1074/jbc.M111.220962	http://dx.doi.org/10.1074/jbc.M111.220962			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489990	Green Published, hybrid			2022-12-25	WOS:000291267600043
J	Blanco, MA; Aleckovic, M; Hua, YL; Li, T; Wei, Y; Xu, Z; Cristea, IM; Kang, YB				Blanco, Mario Andres; Aleckovic, Masa; Hua, Yuling; Li, Tuo; Wei, Yong; Xu, Zhen; Cristea, Ileana M.; Kang, Yibin			Identification of Staphylococcal Nuclease Domain-containing 1 (SND1) as a Metadherin-interacting Protein with Metastasis-promoting Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE-ELEVATED GENE-1; BREAST-CANCER METASTASIS; TUDOR-SN; TUMOR PROGRESSION; SUPPRESSOR GENE; P100; RNA; COACTIVATOR; ACTIVATION; RESISTANCE	Metastasis is the deadliest and most poorly understood feature of malignant diseases. Recent work has shown that Metadherin (MTDH) is overexpressed in over 40% of breast cancer patients and promotes metastasis and chemoresistance in experimental models of breast cancer progression. Here we applied mass spectrometry-based screen to identify staphylococcal nuclease domain-containing 1 (SND1) as a candidate MTDH-interacting protein. After confirming the interaction between SND1 and MTDH, we tested the role of SND1 in breast cancer and found that it strongly promotes lung metastasis. SND1 was further shown to promote resistance to apoptosis and to regulate the expression of genes associated with metastasis and chemoresistance. Analyses of breast cancer clinical microarray data indicated that high expression of SND1 in primary tumors is strongly associated with reduced metastasis-free survival in multiple large scale data sets. Thus, we have uncovered SND1 as a novel MTDH-interacting protein and shown that it is a functionally and clinically significant mediator of metastasis.	[Blanco, Mario Andres; Aleckovic, Masa; Hua, Yuling; Li, Tuo; Wei, Yong; Xu, Zhen; Cristea, Ileana M.; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, LTL255 Washington Rd, Princeton, NJ 08544 USA.	ykang@princeton.edu	Li, Tuo/L-6958-2015; Xu, Zhen/P-3029-2014	Xu, Zhen/0000-0002-2190-3861; Kang, Yibin/0000-0002-1626-6730; Blanco, M. Andres/0000-0003-4404-2301; Aleckovic, Masa/0000-0001-5653-8502	National Institutes of Health [R01CA134519]; National Research Service Award; United States Department of Defense; Brewster Foundation; NATIONAL CANCER INSTITUTE [R01CA134519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Brewster Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134519 (to Y. K.) and a National Research Service Award predoctoral fellowship (to M. A. B.). This work was also supported by grants from the United States Department of Defense and the Brewster Foundation.	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Bhutia SK, 2010, P NATL ACAD SCI USA, V107, P22243, DOI 10.1073/pnas.1009479107; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Luo Y, 2010, J AM SOC MASS SPECTR, V21, P34, DOI 10.1016/j.jasms.2009.08.026; Makri A, 2008, CANCER TREAT REV, V34, P682, DOI 10.1016/j.ctrv.2008.05.007; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Sarkar D, 2009, CANCER RES, V69, P8529, DOI 10.1158/0008-5472.CAN-09-1846; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; TONG X, 1995, MOL CELL BIOL, V15, P4735; Townsend AJ, 2001, CHEM-BIOL INTERACT, V130, P261, DOI 10.1016/S0009-2797(00)00270-2; Wei Y, 2009, CELL CYCLE, V8, P2132; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460	59	89	94	2	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19982	19992		10.1074/jbc.M111.240077	http://dx.doi.org/10.1074/jbc.M111.240077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478147	Green Published, hybrid			2022-12-25	WOS:000291027700076
J	Kuhnle, S; Kogel, U; Glockzin, S; Marquardt, A; Ciechanover, A; Matentzoglu, K; Scheffner, M				Kuehnle, Simone; Kogel, Ulrike; Glockzin, Sandra; Marquardt, Andreas; Ciechanover, Aaron; Matentzoglu, Konstantin; Scheffner, Martin			Physical and Functional Interaction of the HECT Ubiquitin-protein Ligases E6AP and HERC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS TYPE-16 E6; ANGELMAN SYNDROME; E6-ASSOCIATED PROTEIN; SELF-UBIQUITINATION; CERVICAL-CANCER; HUMAN-DISEASE; GENE UBE3A; E6-AP; DEGRADATION; MICE	Deregulation of the ubiquitin-protein ligase E6AP contributes to the development of the Angelman syndrome and to cervical carcinogenesis suggesting that the activity of E6AP needs to be under tight control. However, how E6AP activity is regulated at the post-translational level under non-pathologic conditions is poorly understood. In this study, we report that the giant protein HERC2, which is like E6AP a member of the HECT family of ubiquitin-protein ligases, binds to E6AP. The interaction is mediated by the RCC1-like domain 2 of HERC2 and a region spanning amino acid residues 150-200 of E6AP. Furthermore, we provide evidence that HERC2 stimulates the ubiquitin-protein ligase activity of E6AP in vitro and within cells and that this stimulatory effect does not depend on the ubiquitin-protein ligase activity of HERC2. Thus, the data obtained indicate that HERC2 acts as a regulator of E6AP.	[Kuehnle, Simone; Kogel, Ulrike; Glockzin, Sandra; Matentzoglu, Konstantin; Scheffner, Martin] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Kuehnle, Simone; Kogel, Ulrike; Glockzin, Sandra; Matentzoglu, Konstantin; Scheffner, Martin] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Marquardt, Andreas] Univ Konstanz, Prote Facil, D-78457 Constance, Germany; [Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	University of Konstanz; University of Konstanz; University of Konstanz; Technion Israel Institute of Technology	Scheffner, M (corresponding author), Univ Konstanz, Dept Biol, Box 642, D-78457 Constance, Germany.	martin.scheffner@uni-konstanz.de	Scheffner, Martin/K-2940-2012; Ciechanover, Aaron J/C-9166-2017	Scheffner, Martin/0000-0003-2229-0128; Kuhnle, Simone/0000-0001-9382-3142	Deutsche Forschungsgemeinschaft; German-Israeli Foundation for Scientific Research and Development; European Union Network of Excellence RUBICON	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); European Union Network of Excellence RUBICON(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the German-Israeli Foundation for Scientific Research and Development, and the European Union Network of Excellence RUBICON.	Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; Matentzoglu K, 2008, BIOCHEM SOC T, V36, P797, DOI 10.1042/BST0360797; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mulherkar SA, 2009, J NEUROCHEM, V110, P1955, DOI 10.1111/j.1471-4159.2009.06293.x; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shai A, 2010, CANCER RES, V70, P5064, DOI 10.1158/0008-5472.CAN-09-3307; Vos RM, 2009, J VIROL, V83, P8885, DOI 10.1128/JVI.00605-09; Walkowicz M, 1999, MAMM GENOME, V10, P870, DOI 10.1007/s003359901106; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107	37	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19410	19416		10.1074/jbc.M110.205211	http://dx.doi.org/10.1074/jbc.M110.205211			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21493713	Green Published, hybrid			2022-12-25	WOS:000291027700023
J	Le, YL; Peng, JJ; Wu, HW; Sun, JZ; Shao, WL				Le, Yilin; Peng, Jingjing; Wu, Huawei; Sun, Jianzhong; Shao, Weilan			An Approach to the Production of Soluble Protein from a Fungal Gene Encoding an Aggregation-Prone Xylanase in Escherichia coli	PLOS ONE			English	Article							INCLUSION-BODY FORMATION; HIGH-LEVEL EXPRESSION; HEAT-SHOCK PROTEINS; THERMOANAEROBACTER-ETHANOLICUS; THERMOMYCES-LANUGINOSUS; CHAPERONE ACTIVITY; PERIPLASM; OVEREXPRESSION; XYLOSIDASE; ISOMERASE	The development of new procedures and protocols that allow researchers to obtain recombinant proteins is of fundamental importance in the biotechnology field. A strategy was explored to overcome inclusion-body formation observed when expressing an aggregation-prone fungal xylanase in Escherichia coli. pHsh is an expression plasmid that uses a synthetic heat-shock (Hsh) promoter, in which gene expression is regulated by an alternative sigma factor (sigma(32)). A derivative of pHsh was constructed by fusing a signal peptide to xynA2 gene to facilitate export of the recombinant protein to the periplasm. The xylanase was produced in a soluble form. Three factors were essential to achieving such soluble expression of the xylanase: 1) the target gene was under the control of the Hsh promoter, 2) the gene product was exported into the periplasm, and 3) gene expression was induced by a temperature upshift. For the first time we report the expression of periplasmic proteins under the control of an Hsh promoter regulated by sigma(32). One unique feature of this approach was that over 200 copies of the Hsh promoter in an E. coli cell significantly increased the concentration of sigma(32). The growth inhibition of the recombinant cells corresponded to an increase in the levels of soluble periplasmic protein. Therefore, an alternative protocol was designed to induce gene expression from pHsh-ex to obtain high levels of active soluble enzymes.	[Le, Yilin; Peng, Jingjing; Wu, Huawei; Shao, Weilan] Nanjing Normal Univ, Res Ctr Biotechnol & Biomass Energy, Nanjing, Jiangsu, Peoples R China; [Le, Yilin; Peng, Jingjing; Wu, Huawei; Shao, Weilan] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Sun, Jianzhong] Jiangsu Univ, Sch Environm, Biofuels Inst, Zhenjiang, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Jiangsu University	Le, YL (corresponding author), Nanjing Normal Univ, Res Ctr Biotechnol & Biomass Energy, Nanjing, Jiangsu, Peoples R China.	shaoweilan@njnu.edu.cn		le, yilin/0000-0002-1620-007X; Shao, Weilan/0000-0001-8067-3755	"973" of China [2004CB719600]; National Natural Science Foundation of China [30770061]	"973" of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from a sub-project of "973" of China (2004CB719600), and the National Natural Science Foundation of China (30770061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; GOMES J, 1993, J BIOTECHNOL, V30, P283, DOI 10.1016/0168-1656(93)90145-D; Hunke S, 2003, MOL MICROBIOL, V50, P1579, DOI 10.1046/j.1365-2958.2003.03785.x; Kadokura H, 2001, J GEN APPL MICROBIOL, V47, P133, DOI 10.2323/jgam.47.133; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Mai V, 2000, GENE, V247, P137, DOI 10.1016/S0378-1119(00)00106-2; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; Missiakas D, 1997, TRENDS BIOCHEM SCI, V22, P59, DOI 10.1016/S0968-0004(96)10072-4; Pan KL, 2003, J BACTERIOL, V185, P3020, DOI 10.1128/JB.185.10.3020-3030.2003; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Sambrook J., MOL CLONING LAB MANU; Sevastsyanovich YR, 2010, BIOTECHNOL APPL BIOC, V55, P9, DOI 10.1042/BA20090174; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; SHAO WL, 1992, J BACTERIOL, V174, P5848, DOI 10.1128/jb.174.18.5848-5853.1992; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; SKELLY S, 1987, P NATL ACAD SCI USA, V84, P8365, DOI 10.1073/pnas.84.23.8365; STRANDBERG L, 1991, APPL ENVIRON MICROB, V57, P1669, DOI 10.1128/AEM.57.6.1669-1674.1991; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Thomas JG, 1996, MOL MICROBIOL, V21, P1185, DOI 10.1046/j.1365-2958.1996.651436.x; Thorstenson YR, 1997, J BACTERIOL, V179, P5333, DOI 10.1128/jb.179.17.5333-5339.1997; TILLY K, 1989, J BACTERIOL, V171, P1585, DOI 10.1128/jb.171.3.1585-1589.1989; Wu HW, 2008, ENZYME MICROB TECH, V42, P230, DOI 10.1016/j.enzmictec.2007.09.013; Wu HW, 2010, BIOTECHNOL LETT, V32, P795, DOI 10.1007/s10529-010-0223-y; Yin E, 2008, WORLD J MICROB BIOT, V24, P275, DOI 10.1007/s11274-007-9469-5; Zhang Z, 2003, BIOTECHNIQUES, V35, P1032, DOI 10.2144/03355rr03	35	17	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18489	10.1371/journal.pone.0018489	http://dx.doi.org/10.1371/journal.pone.0018489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494625	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800024
J	Krenn, BM; Egorov, A; Romanovskaya-Romanko, E; Wolschek, M; Nakowitsch, S; Ruthsatz, T; Kiefmann, B; Morokutti, A; Humer, J; Geiler, J; Cinatl, J; Michaelis, M; Wressnigg, N; Sturlan, S; Ferko, B; Batishchev, OV; Indenbom, AV; Zhu, R; Kastner, M; Hinterdorfer, P; Kiselev, O; Muster, T; Romanova, J				Krenn, Brigitte M.; Egorov, Andrej; Romanovskaya-Romanko, Ekaterina; Wolschek, Markus; Nakowitsch, Sabine; Ruthsatz, Tanja; Kiefmann, Bettina; Morokutti, Alexander; Humer, Johannes; Geiler, Janina; Cinatl, Jindrich; Michaelis, Martin; Wressnigg, Nina; Sturlan, Sanda; Ferko, Boris; Batishchev, Oleg V.; Indenbom, Andrey V.; Zhu, Rong; Kastner, Markus; Hinterdorfer, Peter; Kiselev, Oleg; Muster, Thomas; Romanova, Julia			Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1	PLOS ONE			English	Article							A VIRUSES; NASAL PH; HEMAGGLUTININ; SAFETY; ACID; CONDUCTANCE; REASSORTANT; STABILITY; SECRETION; TRIVALENT	Background: H5N1 influenza vaccines, including live intranasal, appear to be relatively less immunogenic compared to seasonal analogs. The main influenza virus surface glycoprotein hemagglutinin (HA) of highly pathogenic avian influenza viruses (HPAIV) was shown to be more susceptible to acidic pH treatment than that of human or low pathogenic avian influenza viruses. The acidification machinery of the human nasal passageway in response to different irritation factors starts to release protons acidifying the mucosal surface (down to pH of 5.2). We hypothesized that the sensitivity of H5 HA to the acidic environment might be the reason for the low infectivity and immunogenicity of intranasal H5N1 vaccines for mammals. Methodology/Principal Findings: We demonstrate that original human influenza viruses infect primary human nasal epithelial cells at acidic pH (down to 5.4), whereas H5N1 HPAIVs lose infectivity at pH <= 5.6. The HA of A/Vietnam/1203/04 was modified by introducing the single substitution HA2 58K -> I, decreasing the pH of the HA conformational change. The H5N1 reassortants containing the indicated mutation displayed an increased resistance to acidic pH and high temperature treatment compared to those lacking modification. The mutation ensured a higher viral uptake as shown by immunohistochemistry in the respiratory tract of mice and 25 times lower mouse infectious dose(50). Moreover, the reassortants keeping 58K -> I mutation designed as a live attenuated vaccine candidate lacking an NS1 gene induced superior systemic and local antibody response after the intranasal immunization of mice. Conclusion/Significance: Our finding suggests that an efficient intranasal vaccination with a live attenuated H5N1 virus may require a certain level of pH and temperature stability of HA in order to achieve an optimal virus uptake by the nasal epithelial cells and induce a sufficient immune response. The pH of the activation of the H5 HA protein may play a substantial role in the infectivity of HPAIVs for mammals.	[Krenn, Brigitte M.; Egorov, Andrej; Wolschek, Markus; Nakowitsch, Sabine; Ruthsatz, Tanja; Kiefmann, Bettina; Morokutti, Alexander; Humer, Johannes; Wressnigg, Nina; Sturlan, Sanda; Ferko, Boris; Muster, Thomas; Romanova, Julia] Avir Green Hills Biotechnol AG, Vienna, Austria; [Romanovskaya-Romanko, Ekaterina; Kiselev, Oleg] Russian Acad Med Sci, Influenza Res Inst, St Petersburg, Russia; [Batishchev, Oleg V.; Indenbom, Andrey V.] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow, Russia; [Zhu, Rong; Kastner, Markus; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, Christian Doppler Lab Nanoscop Methods Biophys, A-4040 Linz, Austria; [Geiler, Janina; Cinatl, Jindrich] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany	Russian Academy of Medical Sciences; Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Johannes Kepler University Linz; Goethe University Frankfurt	Krenn, BM (corresponding author), Avir Green Hills Biotechnol AG, Vienna, Austria.	a.egorov@greenhillsbiotech.com	Indenbom, Andrey V/J-8208-2018; Romanova, Julia R/M-9490-2016; Romanovskaya-Romanko, Ekaterina/J-1022-2018; Batishchev, Oleg V/L-1976-2013; Hinterdorfer, Peter/C-4235-2013	Romanova, Julia R/0000-0002-8114-4262; Romanovskaya-Romanko, Ekaterina/0000-0001-7560-398X; Batishchev, Oleg V/0000-0002-9581-2233; FERKO, Boris/0000-0001-5340-4437; Hinterdorfer, Peter/0000-0003-2583-1305; Kastner, Markus/0000-0003-2662-9344; Michaelis, Martin/0000-0002-5710-5888	European Commission [SP5B-CT-2007-044512, LSHB-CT-2005-518281]; AVIR Green Hills Biotechnology AG (AGHB); Russian Foundation for Basic Researches [08-03-00971]; Presidium of RAS [P337]; Austrian Institute for Biophysics, Christian Doppler Laboratory of Nanoscopic Methods in Biophysics (Johannes Kepler University Linz)	European Commission(European CommissionEuropean Commission Joint Research Centre); AVIR Green Hills Biotechnology AG (AGHB); Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Presidium of RAS(Russian Academy of Sciences); Austrian Institute for Biophysics, Christian Doppler Laboratory of Nanoscopic Methods in Biophysics (Johannes Kepler University Linz)	This work has been partially funded by the European Commission's 6th Framework Program projects "Intranasal H5 Vaccine'' (SP5B-CT-2007-044512) and "FLUVACC'' (LSHB-CT-2005-518281). Costs not covered by the European Grants are funded by AVIR Green Hills Biotechnology AG (AGHB) and in part by Russian Foundation for Basic Researches (project #08-03-00971), Program of Presidium of RAS "Molecular and Cell Biology,'' Federal Task Program "Scientific and Scientific-Pedagogic Personnel of Innovative Russia'' for 2009-2013 (state contract #P337) and Austrian Institute for Biophysics, Christian Doppler Laboratory of Nanoscopic Methods in Biophysics (Johannes Kepler University Linz). No additional external funding was received for this study. AGHB performed the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Cyranoski D, 2005, NATURE, V435, P1009, DOI 10.1038/4351009a; Desheva JA, 2006, VACCINE, V24, P6859, DOI 10.1016/j.vaccine.2006.06.023; Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39; England RJA, 1999, CLIN OTOLARYNGOL, V24, P67, DOI 10.1046/j.1365-2273.1999.00223.x; Ferko B, 2006, J VIROL, V80, P11621, DOI 10.1128/JVI.01645-06; Fischer H, 2002, AM J PHYSIOL-CELL PH, V282, pC736, DOI 10.1152/ajpcell.00369.2001; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hehar SS, 1999, CLIN OTOLARYNGOL, V24, P24, DOI 10.1046/j.1365-2273.1999.00190.x; Horimoto T, 2006, VACCINE, V24, P3669, DOI 10.1016/j.vaccine.2005.07.005; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Karron RA, 2009, VACCINE, V27, P4953, DOI 10.1016/j.vaccine.2009.05.099; Limberis M, 2002, HUM GENE THER, V13, P1961, DOI 10.1089/10430340260355365; Lin YP, 1997, VIROLOGY, V233, P402, DOI 10.1006/viro.1997.8626; Lorenz R. J., 1973, Laboratory techniques in rabies. WHO Monograph Series No.23., P321; McShane D, 2003, EUR RESPIR J, V21, P37, DOI 10.1183/09031936.03.00027603; MUSTER T, 1995, J VIROL, V69, P6678, DOI 10.1128/JVI.69.11.6678-6686.1995; NAKOWITSCH SWM, 2011, VACCINE IN PRESS; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Romanova J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005984; Rudenko L, 2008, INFLUENZA OTHER RESP, V2, P203, DOI 10.1111/j.1750-2659.2008.00064.x; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SCHOLTISSEK C, 1985, ARCH VIROL, V85, P1, DOI 10.1007/BF01317001; SCHOLTISSEK C, 1985, VACCINE, V3, P215, DOI 10.1016/0264-410X(85)90109-4; Scull MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000424; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; TAKEUCHI K, 1994, J VIROL, V68, P911, DOI 10.1128/JVI.68.2.911-919.1994; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Wacheck V, 2010, J INFECT DIS, V201, P354, DOI 10.1086/649428; Washington N, 2000, INT J PHARM, V198, P139, DOI 10.1016/S0378-5173(99)00442-1; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	49	61	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18577	10.1371/journal.pone.0018577	http://dx.doi.org/10.1371/journal.pone.0018577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490925	Green Submitted, Green Published, gold			2022-12-25	WOS:000289238700024
J	Fang, F; Kasperzyk, JL; Shui, I; Hendrickson, W; Hollis, BW; Fall, K; Ma, J; Gaziano, JM; Stampfer, MJ; Mucci, LA; Giovannucci, E				Fang, Fang; Kasperzyk, Julie L.; Shui, Irene; Hendrickson, Whitney; Hollis, Bruce W.; Fall, Katja; Ma, Jing; Gaziano, J. Michael; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward			Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer	PLOS ONE			English	Article							SUBSEQUENT DEVELOPMENT; D-RECEPTOR; RISK; 1,25-DIHYDROXYVITAMIN-D; 25-HYDROXYVITAMIN-D; RADIOIMMUNOASSAY; CALCITRIOL; DIAGNOSIS; VARIANTS; SUNLIGHT	Background: Laboratory evidence suggests that vitamin D might influence prostate cancer prognosis. Methodology/Principal Findings: We examined the associations between prediagnostic plasma levels of 25(OH) vitamin D [25(OH)D] and 1,25(OH)(2)vitamin D [1,25(OH)(2)D] and mortality among 1822 participants of the Health Professionals Follow-up Study and Physicians' Health Study who were diagnosed with prostate cancer. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of total mortality (n = 595) and lethal prostate cancer (death from prostate cancer or development of bone metastases; n = 202). In models adjusted for age at diagnosis, BMI, physical activity, and smoking, we observed a HR of 1.22 (95% CI: 0.97, 1.54) for total mortality, comparing men in the lowest to the highest quartile of 25(OH) D. There was no association between 1,25(OH) 2D and total mortality. Men with the lowest 25(OH) D quartile were more likely to die of their cancer (HR: 1.59; 95% CI: 1.06, 2.39) compared to those in the highest quartile (P-trend = 0.006). This association was largely explained by the association between low 25(OH) D levels and advanced cancer stage and higher Gleason score, suggesting that these variables may mediate the influence of 25(OH) D on prognosis. The association also tended to be stronger among patients with samples collected within five years of cancer diagnosis. 1,25(OH)(2)D levels were not associated with lethal prostate cancer. Conclusions/Significance: Although potential bias of less advanced disease due to more screening activity among men with high 25(OH) D levels cannot be ruled out, higher prediagnostic plasma 25(OH) D might be associated with improved prostate cancer prognosis.	[Fang, Fang; Kasperzyk, Julie L.; Hendrickson, Whitney; Ma, Jing; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Fang, Fang; Kasperzyk, Julie L.; Hendrickson, Whitney; Ma, Jing; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA; [Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kasperzyk, Julie L.; Shui, Irene; Hendrickson, Whitney; Fall, Katja; Stampfer, Meir J.; Mucci, Lorelei A.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hollis, Bruce W.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Fall, Katja] Orebro Univ Hosp, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Medical University of South Carolina; Orebro University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard T.H. Chan School of Public Health	Fang, F (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	fang.fang@channing.harvard.edu	Fall, Katja/AAE-1876-2021; H, W/AAM-2887-2020	Fall, Katja/0000-0002-3649-2639; Fang, Fang/0000-0002-3310-6456; Hendrickson, Whitney/0000-0003-4603-2879	National Institutes of Health [CA133891, CA141298, CA34933, CA40360, CA091793, CA055075, CA42182, HL26490, HL34595]; Prostate Cancer Foundation, Santa Monica, CA, USA; National Cancer Institute National Research Service [T32 CA09001]; NATIONAL CANCER INSTITUTE [R01CA042182, R01CA133891, R01CA040360, T32CA009001, R01CA141298, P01CA055075, R01CA097193] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation, Santa Monica, CA, USA; National Cancer Institute National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health research grants CA133891, CA141298, CA34933, CA40360, CA091793, CA055075, CA42182, HL26490 and HL34595; Prostate Cancer Foundation, Santa Monica, CA, USA and National Cancer Institute National Research Service Award T32 CA09001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Beer TM, 2006, ANTICANCER RES, V26, P2647; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795; Chen L, 2009, CANCER EPIDEM BIOMAR, V18, P2874, DOI 10.1158/1055-9965.EPI-09-0544; CORDER EH, 1993, CANCER EPIDEM BIOMAR, V2, P467; Cowen ME, 1996, CANCER, V78, P1952, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1952::AID-CNCR16>3.0.CO;2-X; Dunlap N, 2003, BRIT J CANCER, V89, P746, DOI 10.1038/sj.bjc.6601161; Gann PH, 1996, CANCER EPIDEM BIOMAR, V5, P121; GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P1767, DOI 10.1093/jnci/87.23.1767; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; HENDRICKSON WK, J CLIN ONCO IN PRESS; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hollis BW, 1996, CLIN CHEM, V42, P586; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Holmberg L, 2009, CANCER CAUSE CONTROL, V20, P663, DOI 10.1007/s10552-008-9279-6; Holt SK, 2010, PROSTATE, V70, P1448, DOI 10.1002/pros.21180; Jacobs ET, 2004, J STEROID BIOCHEM, V89-90, P533, DOI 10.1016/j.jsbmb.2004.03.063; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Lim HS, 2006, INT J CANCER, V119, P1530, DOI 10.1002/ijc.22052; Mikhak B, 2007, PROSTATE, V67, P911, DOI 10.1002/pros.20570; Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Robsahm TE, 2004, CANCER CAUSE CONTROL, V15, P149, DOI 10.1023/B:CACO.0000019494.34403.09; Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348; Schwartz GG, 2009, ANN EPIDEMIOL, V19, P96, DOI 10.1016/j.annepidem.2008.03.007; SCHWARTZ GG, 1990, ANTICANCER RES, V10, P1307; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Tretli S, 2009, BRIT J CANCER, V100, P450, DOI 10.1038/sj.bjc.6604865; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375	29	78	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18625	10.1371/journal.pone.0018625	http://dx.doi.org/10.1371/journal.pone.0018625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494639	Green Submitted, gold, Green Published			2022-12-25	WOS:000289192400041
J	Saha, P; Bhattacharjee, S; Sarkar, A; Manna, A; Majumder, S; Chatterjee, M				Saha, Piu; Bhattacharjee, Surajit; Sarkar, Avijit; Manna, Alak; Majumder, Subrata; Chatterjee, Mitali			Berberine Chloride Mediates Its Anti-Leishmanial Activity via Differential Regulation of the Mitogen Activated Protein Kinase Pathway in Macrophages	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; NITRIC-OXIDE; SIGNAL-TRANSDUCTION; MURINE MACROPHAGES; MOUSE MACROPHAGES; INDUCTION; INTERLEUKIN-10; INFECTION; CYTOKINES; DONOVANI	Background: A complex interplay between Leishmania and macrophages influences parasite survival and necessitates disruption of signaling molecules, eventually resulting in impairment of macrophage function. In this study, we demonstrate the immunomodulatory activity of Berberine chloride in Leishmania infected macrophages. Principal Findings: The IC50 of Berberine chloride, a quaternary isoquinoline alkaloid was tested in an amastigote macrophage model and its safety index measured by a cell viability assay. It eliminated intracellular amastigotes, the IC50 being 2.8 fold lower than its IC50 in promastigotes (7.10 mu M vs. 2.54 mu M) and showed a safety index >16. Levels of intracellular and extracellular nitric oxide (NO) as measured by flow cytometry and Griess assay respectively showed that Berberine chloride in Leishmania infected macrophages increased production of NO. Measurement of the mRNA expression of iNOS, IL-12 and IL-10 by RT-PCR along with levels of IL-12p40 and IL-10 by ELISA showed that in infected macrophages, Berberine chloride enhanced expression of iNOS and IL-12p40, concomitant with a downregulation of IL-10. The phosphorylation status of extracellular signal related kinase (ERK1/2) and p38 mitogen activated protein kinase (p38 MAPK) was studied by western blotting. In infected macrophages, Berberine chloride caused a time dependent activation of p38 MAPK along with deactivation of ERK1/2; addition of a p38 MAPK inhibitor SB203580 inhibited the increased generation of NO and IL-12p40 by Berberine chloride as also prevented its decrease of IL-10. Conclusions: Berberine chloride modulated macrophage effector responses via the mitogen activated protein kinase (MAPK) pathway, highlighting the importance of MAPKs as an antiparasite target.	[Saha, Piu; Sarkar, Avijit; Manna, Alak; Chatterjee, Mitali] Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, India; [Bhattacharjee, Surajit; Majumder, Subrata] Bose Inst, Div Mol Med, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Department of Science & Technology (India); Bose Institute	Saha, P (corresponding author), Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, India.	ilatim@vsnl.net	Chatterjee, Mitali/AAV-2129-2021; Bhattacharjee, Surajit/B-5979-2012; Manna, Alak/AAY-1248-2021; Manna, Alak/AAE-7308-2021	Bhattacharjee, Surajit/0000-0001-9233-4777; Manna, Alak/0000-0003-3894-3277; 	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study received no direct funding. However, the corresponding author received funding from the Department of Science and Technology, Government of India for a project entitled "Targetting of thiol mediated anti-oxidant pathways as a potential chemotherapeutic modality in Indian Leishmaniasis." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Bhattacharjee S, 2009, J ANTIMICROB CHEMOTH, V63, P317, DOI 10.1093/jac/dkn479; Bhattacharyya S, 2001, INFECT IMMUN, V69, P1499, DOI 10.1128/IAI.69.3.1499-1507.2001; BUCHMULLERROUILLER Y, 1987, INFECT IMMUN, V55, P587; CHATTERJEE A, 1994, TREATISE INDIAN MED, V1, P129; Chatton JY, 2002, METHOD ENZYMOL, V359, P134; da Luz RI, 2009, ANTIMICROB AGENTS CH, V53, P5197, DOI 10.1128/AAC.00866-09; Feng GJ, 1999, J IMMUNOL, V163, P6403; Ganguly S, 2007, J PHARM PHARMACOL, V59, P711, DOI 10.1211/jpp.59.5.0012; Ganguly S, 2006, J MICROBIOL METH, V66, P79, DOI 10.1016/j.mimet.2005.10.011; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Ghazanfari T, 2000, SCAND J IMMUNOL, V52, P491, DOI 10.1046/j.1365-3083.2000.00803.x; GHOSH AK, 1985, EXP PARASITOL, V60, P404, DOI 10.1016/0014-4894(85)90047-5; GHOSH AK, 1983, INDIAN J MED RES, V78, P407; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kang BY, 2002, BIOCHEM PHARMACOL, V63, P1901, DOI 10.1016/S0006-2952(02)00982-6; KAYE PM, 1991, J IMMUNOL, V146, P2763; Kim TS, 2003, IMMUNOLOGY, V109, P407, DOI 10.1046/j.1365-2567.2003.01673.x; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Roberts MTM, 2005, BRIT MED BULL, V75-76, P115, DOI 10.1093/bmb/ldl003; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Saha P, 2009, FREE RADICAL RES, V43, P1101, DOI 10.1080/10715760903186124; Sarkar A, 2011, CYTOM PART A, V79A, P35, DOI 10.1002/cyto.a.21001; Sarkar D, 2008, INT IMMUNOPHARMACOL, V8, P1264, DOI 10.1016/j.intimp.2008.05.003; Sen R, 2010, INT J ANTIMICROB AG, V36, P43, DOI 10.1016/j.ijantimicag.2010.03.008; Tiscornia A, 2009, J IMMUNOL METHODS, V342, P49, DOI 10.1016/j.jim.2008.11.014; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; Ukil A, 2005, J IMMUNOL, V175, P1161, DOI 10.4049/jimmunol.175.2.1161; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	38	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18467	10.1371/journal.pone.0018467	http://dx.doi.org/10.1371/journal.pone.0018467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483684	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300024
J	Vijay, S; Rawat, M; Adak, T; Dixit, R; Nanda, N; Srivastava, H; Sharma, JK; Prasad, GBKS; Sharma, A				Vijay, Sonam; Rawat, Manmeet; Adak, Tridibes; Dixit, Rajnikant; Nanda, Nutan; Srivastava, Harish; Sharma, Joginder K.; Prasad, Godavarthi B. K. S.; Sharma, Arun			Parasite Killing in Malaria Non-Vector Mosquito Anopheles culicifacies Species B: Implication of Nitric Oxide Synthase Upregulation	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TIME BOMB; GAMBIAE; STEPHENSI; IMMUNITY; SUSCEPTIBILITY; MIDGUT; INSECTS; VIVAX; REFRACTORINESS	Background: Anopheles culicifacies, the main vector of human malaria in rural India, is a complex of five sibling species. Despite being phylogenetically related, a naturally selected subgroup species B of this sibling species complex is found to be a poor vector of malaria. We have attempted to understand the differences between vector and non-vector Anopheles culicifacies mosquitoes in terms of transcriptionally activated nitric oxide synthase (AcNOS) physiologies to elucidate the mechanism of refractoriness. Identification of the differences between genes and gene products that may impart refractory phenotype can facilitate development of novel malaria transmission blocking strategies. Methodology/Principal Findings: We conducted a study on phylogenetically related susceptible (species A) and refractory (species B) sibling species of An. culicifacies mosquitoes to characterize biochemical and molecular differences in AcNOS gene and gene elements and their ability to inhibit oocyst growth. We demonstrate that in species B, AcNOS specific activity and nitrite/nitrates in mid-guts and haemolymph were higher as compared to species A after invasion of the mid-gut by P. vivax at the beginning and during the course of blood feeding. Semiquantitative RT-PCR and real time PCR data of AcNOS concluded that this gene is more abundantly expressed in midgut of species B than in species A and is transcriptionally upregulated post blood meals. Dietary feeding of L-NAME along with blood meals significantly inhibited midgut AcNOS activity leading to an increase in oocyst production in An. culicifacies species B. Conclusions/Significance: We hypothesize that upregulation of mosquito innate cytotoxicity due to NOS in refractory strain to Plasmodium vivax infection may contribute to natural refractoriness in An. culicifacies mosquito population. This innate capacity of refractory mosquitoes could represent the ancestral function of the mosquito immune system against the parasite and could be utilized to understand the molecular basis of refractoriness in planning effective vector control strategies.	[Vijay, Sonam; Rawat, Manmeet; Sharma, Arun] Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Lab, New Delhi, India; [Adak, Tridibes] Natl Inst Malaria Res ICMR, Vector Biol Lab, New Delhi, India; [Dixit, Rajnikant] Natl Inst Malaria Res ICMR, Host Parasite Interact Grp, New Delhi, India; [Nanda, Nutan] Natl Inst Malaria Res ICMR, Mol Entomol Lab, New Delhi, India; [Srivastava, Harish] Civil Hosp, Entomol Lab, Natl Inst Malaria Res ICMR, Field Unit, Nadiad, Gujarat, India; [Sharma, Joginder K.] Inst Cytol & Prevent Oncol ICMR, Mol Diagnost Lab, Noida, India; [Prasad, Godavarthi B. K. S.] Jiwaji Univ, Dept Biotechnol, Gwalior, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Jiwaji University Gwalior	Vijay, S (corresponding author), Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Lab, New Delhi, India.	arushar@gmail.com	Dixit, Rajnikant/D-2566-2009; Adak, Tridibes/C-2501-2011; Manmeet, Rawat/AAE-5057-2021	Dixit, Rajnikant/0000-0002-3536-8329; Rawat, Manmeet/0000-0002-8325-3390	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Financial support to the work was provided by Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 1999, T ROY SOC TROP MED H, V93, P573, DOI 10.1016/S0035-9203(99)90052-4; Adak T, 2006, TROP MED INT HEALTH, V2, P1; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Ali M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012634; Ascenzi P, 2002, IUBMB LIFE, V53, P121, DOI [10.1080/10399710290039016, 10.1080/15216540211472]; Atkinson PW, 2002, GENESIS, V32, P42, DOI 10.1002/gene.10026; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; CURTIS CF, 1994, PARASITOL TODAY, V10, P371, DOI 10.1016/0169-4758(94)90222-4; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dixit R, 2008, ACTA TROP, V106, P75, DOI 10.1016/j.actatropica.2008.01.001; EYLES DE, 1950, J PARASITOL, V36, P501, DOI 10.2307/3273188; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; HENRY JM, 1990, ANAL BIOCHEM, V185, P147, DOI 10.1016/0003-2697(90)90270-J; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Jacobs-Lorena Marcelo, 2003, Journal of Vector Borne Diseases, V40, P73; James AA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P461; Kaur S, 2000, J PARASITOL, V86, P1345, DOI 10.1645/0022-3395(2000)086[1345:SOSABA]2.0.CO;2; Kim KM, 2002, J BIOCHEM MOL BIOL, V35, P127; Kumar S, 2005, INSECT BIOCHEM MOLEC, V35, P721, DOI 10.1016/j.ibmb.2005.02.014; LACKIE AM, 1988, PARASITOL TODAY, V4, P98, DOI 10.1016/0169-4758(88)90035-X; Lanz-Mendoza H, 2002, J PARASITOL, V88, P702, DOI 10.1645/0022-3395(2002)088[0702:SAIAAH]2.0.CO;2; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; MARTINEZ A, 1995, HISTOCHEM J, V27, P770; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; NAOTUNNE TD, 1993, IMMUNOLOGY, V78, P555; NATHAN C, 1995, CELL, V82, P873, DOI 10.1016/0092-8674(95)90019-5; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; Rodrigues J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-33; Schwartz A, 2002, J MED ENTOMOL, V39, P84, DOI 10.1603/0022-2585-39.1.84; Sharma A, 2004, J BIOCHEM, V136, P329, DOI 10.1093/jb/mvh128; Sharma A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-71; Sharma VP, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P349; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SUBBARAO SK, 1988, MED VET ENTOMOL, V2, P219, DOI 10.1111/j.1365-2915.1988.tb00186.x; SUBBARAO SK, 1988, T ROY SOC TROP MED H, V82, P394, DOI 10.1016/0035-9203(88)90132-0; SUBBARAO SK, 1988, J AM MOSQUITO CONTR, V4, P29; SUBBARAO SK, 1998, TECHNICAL PUBLICATIO, V18; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	62	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18400	10.1371/journal.pone.0018400	http://dx.doi.org/10.1371/journal.pone.0018400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483693	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058700024
J	Wuolikainen, A; Moritz, T; Marklund, SL; Antti, H; Andersen, PM				Wuolikainen, Anna; Moritz, Thomas; Marklund, Stefan L.; Antti, Henrik; Andersen, Peter Munch			Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; MUTATIONS; ALS; PLS; PHENOTYPES; PLASMA; TDP-43; BLOOD; RISK	Background/Aim: The changes in the cerebrospinal fluid (CSF) metabolome associated with the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) are poorly understood and earlier smaller studies have shown conflicting results. The metabolomic methodology is suitable for screening large cohorts of samples. Global metabolomics can be used for detecting changes of metabolite concentrations in samples of fluids such as CSF. Methodology: Using gas chromatography coupled to mass spectrometry (GC/TOFMS) and multivariate statistical modeling, we simultaneously studied the metabolome signature of similar to 120 small metabolites in the CSF of patients with ALS, stratified according to hereditary disposition and clinical subtypes of ALS in relation to controls. Principal Findings: The study is the first to report data validated over two sub-sets of ALS vs. control patients for a large set of metabolites analyzed by GC/TOFMS. We find that patients with sporadic amyotrophic lateral sclerosis (SALS) have a heterogeneous metabolite signature in the cerebrospinal fluid, in some patients being almost identical to controls. However, familial amyotrophic lateral sclerosis (FALS) without superoxide dismutase-1 gene (SOD1) mutation is less heterogeneous than SALS. The metabolome of the cerebrospinal fluid of 17 ALS patients with a SOD1 gene mutation was found to form a separate homogeneous group. Analysis of metabolites revealed that glutamate and glutamine were reduced, in particular in patients with a familial predisposition. There are significant differences in the metabolite profile and composition among patients with FALS, SALS and patients carrying a mutation in the SOD1 gene suggesting that the neurodegenerative process in different subtypes of ALS may be partially dissimilar. Conclusions/Significance: Patients with a genetic predisposition to amyotrophic lateral sclerosis have a more distinct and homogeneous signature than patients with a sporadic disease.	[Wuolikainen, Anna; Andersen, Peter Munch] Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden; [Wuolikainen, Anna; Antti, Henrik] Umea Univ, Dept Chem, Umea, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Marklund, Stefan L.] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University; Umea University	Wuolikainen, A (corresponding author), Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden.	Peter.Andersen@neuro.umu.se		Wuolikainen, Anna/0000-0003-0838-5526	Swedish Research Council; Swedish Brain Power Consortium; Hallstens Research Foundation; Swedish Brain Foundation; Swedish Medical Society; Ulla-Carin Lindquist Foundation for ALS Research; Kempe Foundation; Swedish Association for Persons with Neurological Disabilities	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power Consortium; Hallstens Research Foundation; Swedish Brain Foundation; Swedish Medical Society; Ulla-Carin Lindquist Foundation for ALS Research; Kempe Foundation; Swedish Association for Persons with Neurological Disabilities	This work was supported by the Swedish Research Council; the Swedish Brain Power Consortium; the Hallstens Research Foundation; the Swedish Brain Foundation; the Swedish Medical Society; the Ulla-Carin Lindquist Foundation for ALS Research; the Kempe Foundation and the Swedish Association for Persons with Neurological Disabilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2002, J NEUROL NEUROSUR PS, V73, P199, DOI 10.1136/jnnp.73.2.199; Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Brouns R, 2010, NEUROCHEM INT, V56, P865, DOI 10.1016/j.neuint.2009.12.014; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; FELBECKER A, 2001, J NEUROL NEUROSUR PS, V81, P572; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gros-Louis F, 2009, P NATL ACAD SCI USA, V106, P21777, DOI 10.1073/pnas.0902174106; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; LI TM, 1988, J NEUROL NEUROSUR PS, V51, P778, DOI 10.1136/jnnp.51.6.778; Maekawa S, 2009, NEUROPATHOLOGY, V29, P672, DOI 10.1111/j.1440-1789.2009.01029.x; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Paraskevas GP, 1997, ACTA NEUROL SCAND, V96, P88; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; PERRY TL, 1990, ANN NEUROL, V28, P12, DOI 10.1002/ana.410280105; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Spreux-Varoquaux O, 2002, J NEUROL SCI, V193, P73, DOI 10.1016/S0022-510X(01)00661-X; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tachikawa M, 2008, J NEUROCHEM, V107, P432, DOI 10.1111/j.1471-4159.2008.05641.x; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wilson ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015133; Wuolikainen A, 2009, AMYOTROPH LATERAL SC, V10, P229, DOI 10.1080/17482960902871009; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhou JY, 2010, J PROTEOME RES, V9, P5133, DOI 10.1021/pr100409r; Zoccolella S, 2008, NEUROLOGY, V70, P222, DOI 10.1212/01.wnl.0000297193.53986.6f	34	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17947	10.1371/journal.pone.0017947	http://dx.doi.org/10.1371/journal.pone.0017947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483737	Green Submitted, Green Published, gold			2022-12-25	WOS:000289058700005
J	Ohsugi, T; Kumasaka, T				Ohsugi, Takeo; Kumasaka, Toshio			Low CD4/CD8 T-Cell Ratio Associated with Inflammatory Arthropathy in Human T-Cell Leukemia Virus Type I Tax Transgenic Mice	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; RESEMBLING RHEUMATOID-ARTHRITIS; HTLV-I; MOLECULAR-MECHANISMS; ADOPTIVE TRANSFER; PERIPHERAL-BLOOD; INDUCTION; EXPRESSION; GENE; TRANSFORMATION	Background: Human T-cell leukemia virus type I (HTLV-1) can cause an aggressive malignancy known as adult T-cell leukemia/lymphoma (ATL) as well as inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). A transgenic mouse that expresses HTLV-1 Tax also develops T-cell leukemia/lymphoma and an inflammatory arthropathy that resembles rheumatoid arthritis. The aim of this study was to identify the primary T-cell subsets involved in the development of arthropathy in Tax transgenic mice. Principal Findings: By 24 months of age, Tax transgenic mice developed severe arthropathy with a cumulative incidence of 22.8%. The pathological findings of arthropathy in Tax transgenic mice were similar to those seen in human rheumatoid arthritis or mouse models of rheumatoid arthritis, with synovial proliferation and a positive rheumatoid factor. Before the onset of spontaneous arthropathy, young and old Tax transgenic mice were not sensitive to collagen and did not develop arthritis after immunization with type II collagen. The arthropathic Tax transgenic mice showed a significantly decreased proportion of splenic CD4(+) T cells, whereas the proportion of splenic CD8(+) T cells was increased. Regulatory T cells (CD4(+)CD25(+)Foxp3(+)) were significantly decreased and CD8(+) T cells that expressed the chemokine receptor CCR4 (CD8(+)CCR4(+)) were significantly increased in arthropathic Tax transgenic mice. The expression of tax mRNA was strong in the spleen and joints of arthropathic mice, with a 40-fold increase compared with healthy transgenic mice. Conclusions: Our findings reveal that Tax transgenic mice develop rheumatoid-like arthritis with proliferating synovial cells in the joints; however, the proportion of different splenic T-cell subsets in these mice was completely different from other commonly used animal models of rheumatoid arthritis. The crucial T-cell subsets in arthropathic Tax transgenic mice appear to resemble those in HAM/TSP patients rather than those in rheumatoid arthritis patients.	[Ohsugi, Takeo] Kumamoto Univ, Div Microbiol & Genet, Ctr Anim Resources & Dev, Inst Resource Dev & Anal, Kumamoto, Japan; [Kumasaka, Toshio] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan	Kumamoto University; Japanese Red Cross Medical Center; University of Tokyo	Ohsugi, T (corresponding author), Kumamoto Univ, Div Microbiol & Genet, Ctr Anim Resources & Dev, Inst Resource Dev & Anal, Kumamoto, Japan.	ohsugi@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science [21500390]; Japan Leukaemia Research Fund; Kumamoto University's Centers of Excellence (COE)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Leukaemia Research Fund; Kumamoto University's Centers of Excellence (COE)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 21500390), the Japan Leukaemia Research Fund (http://www.flrf.gr.jp), and Kumamoto University's Centers of Excellence (COE) Programs (http://sendou.kuma-u.jp/en/research/research1.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino T, 2007, EUR J PHARMACOL, V558, P199, DOI 10.1016/j.ejphar.2006.11.072; Benito MJ, 2004, ARTHRITIS RHEUM-US, V50, P1781, DOI 10.1002/art.20260; Cao D, 2006, SCAND J IMMUNOL, V63, P444, DOI 10.1111/j.1365-3083.2006.001755.x; CHIOCCHIA G, 1993, CLIN EXP RHEUMATOL, V11, pS15; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; Doncarli A, 1999, EUR J IMMUNOL, V29, P3636; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Furukawa Y, 2003, JAIDS-J ACQ IMM DEF, V32, P328, DOI 10.1097/00126334-200303010-00013; Gonzalez-Rey E, 2007, ARTHRITIS RHEUM-US, V56, P531, DOI 10.1002/art.22394; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Habu K, 1999, J IMMUNOL, V162, P2956; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Inaoki M, 2003, J CLIN IMMUNOL, V23, P269, DOI 10.1023/A:1024584732614; IWAKURA Y, 1991, SCIENCE, V253, P1026, DOI 10.1126/science.1887217; IWAKURA Y, 1995, J IMMUNOL, V155, P1588; Iwakura Y, 1998, J IMMUNOL, V161, P6592; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; Kondo T, 2009, INT IMMUNOL, V21, P523, DOI 10.1093/intimm/dxp019; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kotani M, 1999, EUR J IMMUNOL, V29, P54, DOI 10.1002/(SICI)1521-4141(199901)29:01<54::AID-IMMU54>3.0.CO;2-M; Lairmore MD, 2005, ONCOGENE, V24, P6005, DOI 10.1038/sj.onc.1208974; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; LESLIE CA, 1985, J EXP MED, V162, P1336, DOI 10.1084/jem.162.4.1336; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Luross JA, 2001, IMMUNOLOGY, V103, P407, DOI 10.1046/j.1365-2567.2001.01267.x; MarinovaMutafchieva L, 1997, CLIN EXP IMMUNOL, V107, P507, DOI 10.1046/j.1365-2249.1997.2901181.x; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Ohata J, 2007, ARTHRITIS RHEUM, V56, P2947, DOI 10.1002/art.22846; Ohsugi T, 2006, LEUKEMIA RES, V30, P90, DOI 10.1016/j.leukres.2005.06.001; Ohsugi Takeo, 1993, Kurume Medical Journal, V40, P89, DOI 10.2739/kurumemedj.40.89; Ohsugi T, 2007, NAT MED, V13, P527, DOI 10.1038/nm0507-527; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; OTSUKA A, 2010, J EUR ACAD IN PRESS; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Saggioro D, 1997, J ACQ IMMUN DEF SYND, V14, P272, DOI 10.1097/00042560-199703010-00012; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKURAI M, 1992, INT J CANCER, V52, P323, DOI 10.1002/ijc.2910520228; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SEKI N, 1988, J IMMUNOL, V140, P1477; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Tartar DM, 2010, J IMMUNOL, V184, P3377, DOI 10.4049/jimmunol.0903324; TAYLOR PC, 1995, EUR J IMMUNOL, V25, P763, DOI 10.1002/eji.1830250321; TENDLER CL, 1991, J CELL BIOCHEM, V46, P302, DOI 10.1002/jcb.240460405; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Watanabe T, 1997, INT J HEMATOL, V66, P257; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WILDIN RS, 1995, J IMMUNOL, V155, P1286; WILLIAMS RO, 1994, P NATL ACAD SCI USA, V91, P2762, DOI 10.1073/pnas.91.7.2762; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; Yamano Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006517; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yoshino S, 1998, BRIT J PHARMACOL, V123, P237, DOI 10.1038/sj.bjp.0701607; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	64	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18518	10.1371/journal.pone.0018518	http://dx.doi.org/10.1371/journal.pone.0018518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483764	Green Submitted, gold, Green Published			2022-12-25	WOS:000289058300018
J	Yang, XH; Gong, Y; Friesel, R				Yang, Xuehui; Gong, Yan; Friesel, Robert			Spry1 Is Expressed in Hemangioblasts and Negatively Regulates Primitive Hematopoiesis and Endothelial Cell Function	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; AORTIC ENDOTHELIUM; SPROUTY PROTEINS; GENE-EXPRESSION; TRANSGENIC MICE; MOUSE EMBRYO; IN-VIVO; LINEAGE; VEGF; FGF	Background: Development of the hematopoietic and endothelial lineages derives from a common mesodermal precursor, the Flk1(+) hemangioblast. However, the signaling pathways that regulate the development of hematopoietic and endothelial cells from this common progenitor cell remains incompletely understood. Using mouse models with a conditional Spry1 transgene, and a Spry1 knockout mouse, we investigated the role of Spry1 in the development of the endothelial and hematopoietic lineages during development. Methodology/Principal Findings: Quantitative RT-PCR analysis demonstrates that Spry1, Spry2, and Spry4 are expressed in Flk1(+) hemangioblasts in vivo, and decline significantly in c-Kit(+) and CD41(+) hematopoietic progenitors, while expression is maintained in developing endothelial cells. Tie2-Cre-mediated over-expression of Spry1 results in embryonic lethality. At E9.5 Spry1;Tie2-Cre embryos show near normal endothelial cell development and vessel patterning but have reduced hematopoiesis. FACS analysis shows a reduction of primitive hematopoietic progenitors and erythroblastic cells in Spry1; Tie2-Cre embryos compared to controls. Colony forming assays confirm the hematopoietic defects in Spry1; Tie2-Cre transgenic embryos. Immunostaining shows a significant reduction of CD41 or CD71 and dpERK co-stained cells in Spry1; Tie2-Cre embryos compared to controls, whereas the number of VEC(+) and dpERK co-stained cells is comparable. Compared to controls, Spry1; Tie2-Cre embryos also show a decrease in proliferation and an increase in apoptosis. Furthermore, loss of Spry1 results in an increase of CD41(+) and CD71(+) cells at E9.5 compared with controls. Conclusions/Significance: These data indicate that primitive hematopoietic cells derive from Tie2-expressing hemangioblasts and that Spry1 over expression inhibits primitive hematopoietic progenitor and erythroblastic cell development and expansion while having no obvious effect on endothelial cell development.	[Yang, Xuehui; Gong, Yan; Friesel, Robert] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	Maine Medical Center	Yang, XH (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.	friesr@mmc.org		Gong, Yan/0000-0002-4805-0459	NIH [R01 HL65301, P20 RR15555]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789, P20RR015555, P30RR030927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01 HL65301 and P20 RR15555 to RF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2009, NAT CELL BIOL, V11, P106, DOI 10.1038/ncb1820; He C, 2008, DEVELOPMENT, V135, P2467, DOI 10.1242/dev.020131; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee SJ, 2010, MOL CELL BIOCHEM, V338, P255, DOI 10.1007/s11010-009-0359-z; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Magnusson PU, 2005, ARTERIOSCL THROM VAS, V25, P944, DOI 10.1161/01.ATV.0000163182.73190.f9; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; Okamoto R, 2005, BLOOD, V105, P2757, DOI 10.1182/blood-2004-08-3317; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIGEMATSU A, 2010, STEM CELLS DEV; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Taniguchi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005467; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Zhang Y, 2007, BLOOD, V110, P116, DOI 10.1182/blood-2006-11-060707; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18374	10.1371/journal.pone.0018374	http://dx.doi.org/10.1371/journal.pone.0018374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483770	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058300015
J	Baker, A; Pearson, T; Price, EP; Dale, J; Keim, P; Hornstra, H; Greenhill, A; Padilla, G; Warner, J				Baker, Anthony; Pearson, Talima; Price, Erin P.; Dale, Julia; Keim, Paul; Hornstra, Heidie; Greenhill, Andrew; Padilla, Gabriel; Warner, Jeffrey			Molecular Phylogeny of Burkholderia pseudomallei from a Remote Region of Papua New Guinea	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; GENETIC DIVERSITY; AUSTRALIA; MELIOIDOSIS; MAXIMUM	Background: The island of New Guinea is located midway between the world's two major melioidosis endemic regions of Australia and Southeast Asia. Previous studies in Papua New Guinea have demonstrated autochthonous melioidosis in Balimo, Western province. In contrast to other regions of endemicity, isolates recovered from both environmental and clinical sources demonstrate narrow genetic diversity over large spatial and temporal scales. Methodology/Principal Findings: We employed molecular typing techniques to determine the phylogenetic relationships of these isolates to each other and to others worldwide to aid in understanding the origins of the Papua New Guinean isolates. Multi-locus sequence typing of the 39 isolates resolved three unique sequence types. Phylogenetic reconstruction and Structure analysis determined that all isolates were genetically closer to those from Australia than those from Southeast Asia. Gene cluster analysis however, identified a Yersinia-like fimbrial gene cluster predominantly found among Burkholderia pseudomallei derived from Southeast Asia. Higher resolution VNTR typing and phylogenetic reconstruction of the Balimo isolates resolved 24 genotypes with long branch lengths. These findings are congruent with long term persistence in the region and a high level of environmental stability. Conclusions/Significance: Given that anthropogenic influence has been hypothesized as a mechanism for the dispersal of B. pseudomallei, these findings correlate with limited movement of the indigenous people in the region. The palaeogeographical and anthropogenic history of Australasia and the results from this study indicate that New Guinea is an important region for the further study of B. pseudomallei origins and dissemination.	[Baker, Anthony; Greenhill, Andrew; Padilla, Gabriel; Warner, Jeffrey] James Cook Univ, Sch Vet & Biomed Sci, Environm & Publ Hlth Microbiol Res Grp, Townsville, Qld 4811, Australia; [Pearson, Talima; Price, Erin P.; Dale, Julia; Keim, Paul; Hornstra, Heidie] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Greenhill, Andrew] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea	James Cook University; Northern Arizona University; PNG Institute Of Medical Research	Baker, A (corresponding author), James Cook Univ, Sch Vet & Biomed Sci, Environm & Publ Hlth Microbiol Res Grp, Townsville, Qld 4811, Australia.	Anthony.Baker@jcu.edu.au	Pearson, Talima/O-7840-2019; Anderson, Julia/W-6122-2019; Price, Erin/N-2336-2013; Keim, Paul S/A-2269-2010; Padilla, Gabriel/C-6491-2012; Baker, Anthony/C-2433-2014; Padilla, Gabriel/M-2183-2016	Pearson, Talima/0000-0003-3696-041X; Anderson, Julia/0000-0001-5582-7206; Price, Erin/0000-0002-1079-4882; Baker, Anthony/0000-0001-5455-2271; Warner, Jeffrey/0000-0002-5869-8283; Greenhill, Andrew/0000-0001-5831-8714; Padilla, Gabriel/0000-0001-8086-3065	U.S. Department of Homeland Security S&T CB Division Bioforensics	U.S. Department of Homeland Security S&T CB Division Bioforensics(United States Department of Homeland Security (DHS))	This work was supported by the U.S. Department of Homeland Security S&T CB Division Bioforensics R&D Program. Use of products/names does not constitute endorsement by the DHS or USG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN B, 1983, J HUM EVOL, V12, P3, DOI 10.1016/S0047-2484(83)80010-4; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; Bird MI, 2004, QUATERN INT, V118, P145, DOI 10.1016/S1040-6182(03)00135-6; Cheng AC, 2008, J CLIN MICROBIOL, V46, P249, DOI 10.1128/JCM.01725-07; CURRIE B, 1994, EPIDEMIOL INFECT, V113, P307, DOI 10.1017/S0950268800051736; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Ouadah AHE, 2007, INTERNET J VET MED, V2; Pearson T, 2007, INFECT GENET EVOL, V7, P416, DOI 10.1016/j.meegid.2006.12.002; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Pritchard JK, 2000, GENETICS, V155, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; U'Ren JM, 2007, APPL ENVIRON MICROB, V73, P6678, DOI 10.1128/AEM.00986-07; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Warner JM, 2007, T ROY SOC TROP MED H, V101, P809, DOI 10.1016/j.trstmh.2007.02.024; Warner JM, 2007, EPIDEMIOL INFECT, P1; WUTHIEKANUN V, 1990, J MED MICROBIOL, V33, P121, DOI 10.1099/00222615-33-2-121; Yap E. H., 1995, Singapore Medical Journal, V36, P60; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	26	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18343	10.1371/journal.pone.0018343	http://dx.doi.org/10.1371/journal.pone.0018343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483841	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000289057200063
J	Immecke, SN; Baal, N; Wilhelm, J; Bechtel, J; Knoche, A; Bein, G; Hackstein, H				Immecke, Sabrina N.; Baal, Nelli; Wilhelm, Jochen; Bechtel, Juliane; Knoche, Angela; Bein, Gregor; Hackstein, Holger			The Cyclophilin-Binding Agent Sanglifehrin A Is a Dendritic Cell Chemokine and Migration Inhibitor	PLOS ONE			English	Article							STREPTOMYCES SP A92-308110; IN-VIVO; TOLERANCE; INDUCTION; CD38; TRANSPLANTATION; EXPRESSION; RECEPTORS; MECHANISM; COMPOUND	Sanglifehrin A (SFA) is a cyclophilin-binding immunosuppressant but the immunobiology of action is poorly understood. We and others have reported that SFA inhibits IL-12 production and antigen uptake in dendritic cells (DC) and exhibits lower activity against lymphocytes. Here we show that SFA suppresses DC chemokine production and migration. Gene expression analysis and subsequent protein level confirmation revealed that SFA suppressed CCL5, CCL17, CCL19, CXCL9 and CXCL10 expression in human monocyte-derived DC (moDC). A systems biology analysis, Onto Express, confirmed that SFA interferes with chemokine-chemokine receptor gene expression with the highest impact. Direct comparison with the related agent cyclosporine A (CsA) and dexamethasone indicated that SFA uniquely suppresses moDC chemokine expression. Competitive experiments with a 100-fold molar excess of CsA and with N-Methyl-Val-4-cyclosporin, representing a nonimmunosuppressive derivative of CsA indicated chemokine suppression through a cyclophilin-A independent pathway. Functional assays confirmed reduced migration of CD4+ Tcells and moDCs to supernatant of SFA-exposed moDCs. Vice versa, SFA-exposed moDC exhibited reduced migration against CCL19. Moreover, SFA suppressed expression of the ectoenzyme CD38 that was reported to regulate DC migration and cytokine production. These results identify SFA as a DC chemokine and migration inhibitor and provide novel insight into the immunobiology of SFA.	[Immecke, Sabrina N.; Baal, Nelli; Bechtel, Juliane; Knoche, Angela; Bein, Gregor; Hackstein, Holger] Univ Giessen, Inst Clin Immunol & Transfus Med, D-6300 Giessen, Germany; [Wilhelm, Jochen] Univ Giessen, Dept Pathol, D-6300 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Immecke, SN (corresponding author), Univ Giessen, Inst Clin Immunol & Transfus Med, Langhansstr 7, D-6300 Giessen, Germany.	Holger.Hackstein@immunologie.med.uni-giessen.de	Wilhelm, Jochen/AAX-4302-2021	Wilhelm, Jochen/0000-0001-5544-9647	Excellence Center Cardiopulmonary System (ECCPS, DFG, German Research Foundation); University of Giessen and Marburg Lung Center (UGMLC); Current Collaborative Research Centre, DFG Transregio [84, B3]	Excellence Center Cardiopulmonary System (ECCPS, DFG, German Research Foundation)(German Research Foundation (DFG)); University of Giessen and Marburg Lung Center (UGMLC); Current Collaborative Research Centre, DFG Transregio(German Research Foundation (DFG))	The study was supported by the Excellence Center Cardiopulmonary System (ECCPS, DFG, German Research Foundation), the University of Giessen and Marburg Lung Center (UGMLC) and the Current Collaborative Research Centre, DFG Transregio 84 (Project B3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2004, J IMMUNOL, V172, P4797, DOI 10.4049/jimmunol.172.8.4797; Banchereau J, 2009, ANN NY ACAD SCI, V1174, P24, DOI 10.1111/j.1749-6632.2009.04999.x; Belperio JA, 2008, CIRC RES, V103, P454, DOI 10.1161/CIRCRESAHA.108.182865; Colvin BL, 2002, TRANSPLANTATION, V74, P149, DOI 10.1097/00007890-200207270-00001; Colvin BL, 2008, CLIN LAB MED, V28, P375, DOI 10.1016/j.cll.2008.07.003; Fedele G, 2004, EUR J IMMUNOL, V34, P1342, DOI 10.1002/eji.200324728; Fehr T, 1999, J ANTIBIOT, V52, P474, DOI 10.7164/antibiotics.52.474; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hackstein H, 2007, AM J TRANSPLANT, V7, P789, DOI 10.1111/j.1600-6143.2006.01729.x; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hackstein H, 2002, BLOOD, V100, P1084, DOI 10.1182/blood.V100.3.1084; Hornick P, 2006, METH MOL B, V333, P131; Kallen J, 2005, J BIOL CHEM, V280, P21965, DOI 10.1074/jbc.M501623200; Khatri P, 2005, NUCLEIC ACIDS RES, V33, pW762, DOI 10.1093/nar/gki472; Ko H, 2008, TRANSPL IMMUNOL, V20, P99, DOI 10.1016/j.trim.2008.07.001; Lukacs-Kornek V, 2008, FRONT BIOSCI-LANDMRK, V13, P2238, DOI 10.2741/2838; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Pemberton TJ, 2003, FEBS LETT, V555, P335, DOI 10.1016/S0014-5793(03)01270-5; Powell JD, 2006, CURR OPIN INVESTIG D, V7, P1002; RAIMONDI G, 2009, J IMMUNOL; Raimondi Giorgio, 2007, Methods Mol Biol, V380, P1; Sanglier JJ, 1999, J ANTIBIOT, V52, P466, DOI 10.7164/antibiotics.52.466; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Sedrani R, 2003, J AM CHEM SOC, V125, P3849, DOI 10.1021/ja021327y; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinschulte C, 2003, J IMMUNOL, V171, P542, DOI 10.4049/jimmunol.171.2.542; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Turnquist HR, 2010, METHODS MOL BIOL, V595, P135, DOI 10.1007/978-1-60761-421-0_8; Woltman AM, 2004, J IMMUNOL, V172, P6482, DOI 10.4049/jimmunol.172.10.6482; Zenke G, 2001, J IMMUNOL, V166, P7165, DOI 10.4049/jimmunol.166.12.7165	37	8	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18406	10.1371/journal.pone.0018406	http://dx.doi.org/10.1371/journal.pone.0018406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483789	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200071
J	Mansiaux, Y; Joseph, AP; Gelly, JC; de Brevern, AG				Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.			Assignment of PolyProline II Conformation and Analysis of Sequence - Structure Relationship	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; BETA-SHEET; HOMOLOGOUS PROTEINS; MOLECULAR-DYNAMICS; GLOBULAR-PROTEINS; AMINO-ACIDS; SH3 DOMAINS; HELIX; ALPHABET; PROLINE	Background: Secondary structures are elements of great importance in structural biology, biochemistry and bioinformatics. They are broadly composed of two repetitive structures namely alpha-helices and beta-sheets, apart from turns, and the rest is associated to coil. These repetitive secondary structures have specific and conserved biophysical and geometric properties. PolyProline II (PPII) helix is yet another interesting repetitive structure which is less frequent and not usually associated with stabilizing interactions. Recent studies have shown that PPII frequency is higher than expected, and they could have an important role in protein - protein interactions. Methodology/Principal Findings: A major factor that limits the study of PPII is that its assignment cannot be carried out with the most commonly used secondary structure assignment methods (SSAMs). The purpose of this work is to propose a PPII assignment methodology that can be defined in the frame of DSSP secondary structure assignment. Considering the ambiguity in PPII assignments by different methods, a consensus assignment strategy was utilized. To define the most consensual rule of PPII assignment, three SSAMs that can assign PPII, were compared and analyzed. The assignment rule was defined to have a maximum coverage of all assignments made by these SSAMs. Not many constraints were added to the assignment and only PPII helices of at least 2 residues length are defined. Conclusions/Significance: The simple rules designed in this study for characterizing PPII conformation, lead to the assignment of 5% of all amino as PPII. Sequence - structure relationships associated with PPII, defined by the different SSAMs, underline few striking differences. A specific study of amino acid preferences in their N and C-cap regions was carried out as their solvent accessibility and contact patterns. Thus the assignment of PPII can be coupled with DSSP and thus opens a simple way for further analysis in this field.	[Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.] INSERM, UMR S 665, Paris, France; [Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.] Univ Paris 07, Paris, France; [Mansiaux, Yohann; Joseph, Agnel Praveen; Gelly, Jean-Christophe; de Brevern, Alexandre G.] INTS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mansiaux, Y (corresponding author), INSERM, UMR S 665, Paris, France.	alexandre.debrevern@univ-paris-diderot.fr	de Brevern, Alexandre G./B-4788-2009; Gelly, Jean-Christophe/A-9321-2010	de Brevern, Alexandre G./0000-0001-7112-5626; Gelly, Jean-Christophe/0000-0001-5138-361X	Ministere de la Recherche, Universite Paris Diderot - Paris; National Institute for Blood Transfusion (INTS); Institute for Health and Medical Research (INSERM); CEFIPRA [3903-E]	Ministere de la Recherche, Universite Paris Diderot - Paris(Ministry of Research, France); National Institute for Blood Transfusion (INTS); Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CEFIPRA	This work was supported by grants from the Ministere de la Recherche, Universite Paris Diderot - Paris 7, National Institute for Blood Transfusion (INTS) and the Institute for Health and Medical Research (INSERM). APJ has a grant from CEFIPRA number 3903-E. AdB acknowledges CEFIPRA for collaborative grant (number 3903-E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZHUBEI AA, 1994, PROTEIN SCI, V3, P2395, DOI 10.1002/pro.5560031223; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; ARNOTT S, 1968, ACTA CRYSTALL B-STRU, VB 24, P599, DOI 10.1107/S056774086800289X; Avbelj F, 2009, P NATL ACAD SCI USA, V106, P3137, DOI 10.1073/pnas.0813018106; Banks GB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000958; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; Beck DAC, 2008, P NATL ACAD SCI USA, V105, P12259, DOI 10.1073/pnas.0706527105; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berisio R, 2006, PROTEIN PEPTIDE LETT, V13, P847, DOI 10.2174/092986606777841154; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; Bornot A, 2006, BIOINFORMATION, V1, P153, DOI 10.6026/97320630001153; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chellgren BW, 2006, J MOL BIOL, V361, P362, DOI 10.1016/j.jmb.2006.06.044; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Chen K, 2005, J AM CHEM SOC, V127, P10146, DOI 10.1021/ja052094o; COLLOCH N, 1993, PROTEIN ENG, V6, P377, DOI 10.1093/protein/6.4.377; COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0; Creamer TP, 2002, ADV PROTEIN CHEM, V62, P263; Creamer TP, 1998, PROTEINS, V33, P218, DOI 10.1002/(SICI)1097-0134(19981101)33:2<218::AID-PROT6>3.0.CO;2-E; Cubellis MV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S8; Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern AG, 2003, BIOINFORMATICS, V19, P345, DOI 10.1093/bioinformatics/btf859; de Brevern AG, 2002, PROTEIN SCI, V11, P2871, DOI 10.1110/ps.0220502; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; de Brevern Alexandre G, 2004, In Silico Biol, V4, P381; DEBREVERN AG, 2011, J THEOR BIO IN PRESS; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Eisenberg D, 2003, P NATL ACAD SCI USA, V100, P11207, DOI 10.1073/pnas.2034522100; Eker F, 2004, BIOCHEMISTRY-US, V43, P6893, DOI 10.1021/bi049542+; ESQUE J, 2011, J CHEM INF MODEL; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Faure G, 2008, BIOCHIMIE, V90, P626, DOI 10.1016/j.biochi.2007.11.007; Faure G, 2009, BIOCHIMIE, V91, P876, DOI 10.1016/j.biochi.2009.04.008; Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005; Fourrier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-58; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hicks JM, 2004, PROTEINS, V55, P330, DOI 10.1002/prot.10630; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; Jha AK, 2005, BIOCHEMISTRY-US, V44, P9691, DOI 10.1021/bi0474822; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Joseph A.P., 2010, PROTEIN STRUCTURE PR, P75; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; Jun S, 2006, BIOCHEMISTRY-US, V45, P11666, DOI 10.1021/bi061195b; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kameda T, 2006, P NATL ACAD SCI USA, V103, P17765, DOI 10.1073/pnas.0602632103; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kentsis A, 2004, PROTEINS, V55, P493, DOI 10.1002/prot.20051; King SM, 1999, PROTEINS, V35, P313, DOI 10.1002/(SICI)1097-0134(19990515)35:3<313::AID-PROT5>3.3.CO;2-T; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kuemin M, 2009, J AM CHEM SOC, V131, P15474, DOI 10.1021/ja906466q; Kutter S, 2009, J BIOL CHEM, V284, P12136, DOI 10.1074/jbc.M806228200; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu ZG, 2004, J AM CHEM SOC, V126, P15141, DOI 10.1021/ja047594g; Makowska J, 2006, P NATL ACAD SCI USA, V103, P1744, DOI 10.1073/pnas.0510549103; Martin J, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-17; Martin J, 2008, PROTEINS, V71, P92, DOI 10.1002/prot.21659; Mezei M, 2004, PROTEINS, V55, P502, DOI 10.1002/prot.20050; Obuchowski PL, 2008, J BACTERIOL, V190, P1718, DOI 10.1128/JB.01706-07; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Pappu RV, 2002, PROTEIN SCI, V11, P2437, DOI 10.1110/ps.0217402; PAULING L, 1950, J AM CHEM SOC, V72, P5349, DOI 10.1021/ja01167a545; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAULING L, 1951, P NATL ACAD SCI USA, V37, P272, DOI 10.1073/pnas.37.5.272; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Perskie LL, 2010, PROTEIN SCI, V19, P1127, DOI 10.1002/pro.399; Peterson FC, 2009, FRONT BIOSCI-LANDMRK, V14, P833, DOI 10.2741/3281; Polverini E, 2008, BIOCHEMISTRY-US, V47, P267, DOI 10.1021/bi701336n; Porter LL, 2011, P NATL ACAD SCI USA, V108, P109, DOI 10.1073/pnas.1014674107; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; ROSE GD, 1978, NATURE, V272, P586, DOI 10.1038/272586a0; SASISEKHARAN V, 1959, ACTA CRYSTALLOGR, V12, P897, DOI 10.1107/S0365110X59002535; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Shi ZS, 2011, P NATL ACAD SCI USA, V108, P3, DOI 10.1073/pnas.1017021108; Shi ZS, 2005, P NATL ACAD SCI USA, V102, P17964, DOI 10.1073/pnas.0507124102; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163; Sreerama N, 1999, PROTEINS, V36, P400, DOI 10.1002/(SICI)1097-0134(19990901)36:4<400::AID-PROT3>3.0.CO;2-B; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Stapley BJ, 1999, PROTEIN SCI, V8, P587; SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596; Thompson EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010056; TIFFANY ML, 1968, BIOPOLYMERS, V6, P1379, DOI 10.1002/bip.1968.360060911; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, NUCLEIC ACIDS RES, V34, pW119, DOI 10.1093/nar/gkl199; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; Tyagi M, 2009, PROTEIN SCI, V18, P1869, DOI 10.1002/pro.198; Tyagi M, 2009, COMPUT BIOL CHEM, V33, P329, DOI 10.1016/j.compbiolchem.2009.06.002; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006; Vlasov PK, 2001, BIOFIZIKA+, V46, P573; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Watanabe Y, 2006, COMPUT BIOL CHEM, V30, P303, DOI 10.1016/j.compbiolchem.2006.04.004; Whittington SJ, 2003, BIOCHEMISTRY-US, V42, P14690, DOI 10.1021/bi035565x; Wu CY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq478; Zagrovic B, 2005, P NATL ACAD SCI USA, V102, P11698, DOI 10.1073/pnas.0409693102	109	72	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18401	10.1371/journal.pone.0018401	http://dx.doi.org/10.1371/journal.pone.0018401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483785	gold, Green Published, Green Submitted			2022-12-25	WOS:000289057200070
J	McLaren, CE; Garner, CP; Constantine, CC; McLachlan, S; Vulpe, CD; Snively, BM; Gordeuk, VR; Nickerson, DA; Cook, JD; Leiendecker-Foster, C; Beckman, KB; Eckfeldt, JH; Barcellos, LF; Murray, JA; Adams, PC; Acton, RT; Killeen, AA; McLaren, GD				McLaren, Christine E.; Garner, Chad P.; Constantine, Clare C.; McLachlan, Stela; Vulpe, Chris D.; Snively, Beverly M.; Gordeuk, Victor R.; Nickerson, Debbie A.; Cook, James D.; Leiendecker-Foster, Catherine; Beckman, Kenneth B.; Eckfeldt, John H.; Barcellos, Lisa F.; Murray, Joseph A.; Adams, Paul C.; Acton, Ronald T.; Killeen, Anthony A.; McLaren, Gordon D.			Genome-Wide Association Study Identifies Genetic Loci Associated with Iron Deficiency	PLOS ONE			English	Article							OVERLOAD SCREENING HEIRS; SERUM FERRITIN; TRANSFERRIN SATURATION; HFE HEMOCHROMATOSIS; BINDING-CAPACITY; COMMON VARIANTS; G277S MUTATION; TMPRSS6 GENE; METABOLISM; ANEMIA	The existence of multiple inherited disorders of iron metabolism in man, rodents and other vertebrates suggests genetic contributions to iron deficiency. To identify new genomic locations associated with iron deficiency, a genome-wide association study (GWAS) was performed using DNA collected from white men aged >= 25 y and women >= 50 y in the Hemochromatosis and Iron Overload Screening (HEIRS) Study with serum ferritin (SF) <= 12 mu g/L (cases) and iron replete controls (SF > 100 mu g/L in men, SF > 50 mu g/L in women). Regression analysis was used to examine the association between case-control status (336 cases, 343 controls) and quantitative serum iron measures and 331,060 single nucleotide polymorphism (SNP) genotypes, with replication analyses performed in a sample of 71 cases and 161 controls from a population of white male and female veterans screened at a US Veterans Affairs (VA) medical center. Five SNPs identified in the GWAS met genome-wide statistical significance for association with at least one iron measure, rs2698530 on chr. 2p14; rs3811647 on chr. 3q22, a known SNP in the transferrin (TF) gene region; rs1800562 on chr. 6p22, the C282Y mutation in the HFE gene; rs7787204 on chr. 7p21; and rs987710 on chr. 22q11 (GWAS observed P < 1.51x10(-7) for all). An association between total iron binding capacity and SNP rs3811647 in the TF gene (GWAS observed P = 7.0x10(-9), corrected P = 0.012) was replicated within the VA samples (observed P = 0.012). Associations with the C282Y mutation in the HFE gene also were replicated. The joint analysis of the HEIRS and VA samples revealed strong associations between rs2698530 on chr. 2p14 and iron status outcomes. These results confirm a previously-described TF polymorphism and implicate one potential new locus as a target for gene identification.	[McLaren, Christine E.; Garner, Chad P.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA; [Constantine, Clare C.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Snively, Beverly M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27103 USA; [Gordeuk, Victor R.] Howard Univ, Dept Med, Washington, DC 20059 USA; [Nickerson, Debbie A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Cook, James D.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Leiendecker-Foster, Catherine; Eckfeldt, John H.; Killeen, Anthony A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Beckman, Kenneth B.] Univ Minnesota, Dept Genet Cell Biol & Dev Biol, Minneapolis, MN USA; [Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Murray, Joseph A.] Mayo Clin, Coll Med, Div Gastroenterol Hepatol, Rochester, MN USA; [Adams, Paul C.] London Hlth Sci Ctr, London, ON, Canada; [Acton, Ronald T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [McLaren, Gordon D.] Long Beach Healthcare Syst, Dept Vet Affairs, Long Beach, CA USA; [McLaren, Gordon D.] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of Melbourne; Wake Forest University; Wake Forest Baptist Medical Center; Howard University; University of Washington; University of Washington Seattle; University of Kansas; University of Kansas Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; Mayo Clinic; London Health Sciences Centre; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	McLaren, CE (corresponding author), Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA.	cmclaren@uci.edu	Vulpe, Chris/AAF-9170-2020; Gordeuk, Victor/AAG-6577-2019	Vulpe, Chris/0000-0001-5134-8929; murray, joseph/0000-0003-1941-9090; Adams, Paul/0000-0002-9921-2956	National Heart, Lung, and Blood Institute (NHLBI) [R01 HL083328, UH1-HL03679-05]; Department of Veterans Affairs; National Human Genome Research Institute (NHGRI); University of Minnesota [N01-HC-05185]; Howard University [N01-HC-05186]; University of Alabama at Birmingham [N01-HC-05188]; Kaiser Permanente Center for Health Research [N01-HC-05189]; University of California, Irvine [N01-HC-05190]; London Health Sciences Centre [N01-HC-05191]; Wake Forest University [N01-HC-05192]; University of Alabama at Birmingham General Clinical Research Center (GCRC) [M01-RR00032]; Southern Iron Disorders Center; Howard University GCRC [M01-RR10284]; Office of Research on Minority Health; National Center for Research Resources National Institutes of Health [UC Irvine M01RR 00827-29]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005189, N01HC005190, N01HC005188, N01HC005192, N01HC005191, N01HC005185, N01HC005186] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032, M01RR000827, M01RR010284] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL003679, R01HL083328] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Minnesota(University of Minnesota System); Howard University; University of Alabama at Birmingham; Kaiser Permanente Center for Health Research; University of California, Irvine(University of California System); London Health Sciences Centre; Wake Forest University; University of Alabama at Birmingham General Clinical Research Center (GCRC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Southern Iron Disorders Center; Howard University GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by grant R01 HL083328 from the National Heart, Lung, and Blood Institute (NHLBI) (C.E.M.) and by a Merit Review award from the Department of Veterans Affairs (G.D.M.). The HEIRS Study was initiated and funded by NHLBI, in conjunction with National Human Genome Research Institute (NHGRI). Data collection for this study was supported by contracts N01-HC-05185 (University of Minnesota), N01-HC-05186 (Howard University), N01-HC-05188 (University of Alabama at Birmingham), N01-HC-05189 (Kaiser Permanente Center for Health Research), N01-HC-05190 (University of California, Irvine), N01-HC-05191 (London Health Sciences Centre), and N01-HC-05192 (Wake Forest University). Additional funding was provided by the University of Alabama at Birmingham General Clinical Research Center (GCRC) grant M01-RR00032, Southern Iron Disorders Center (J.C.B.), Howard University GCRC grant M01-RR10284, Howard University Research Scientist Award UH1-HL03679-05 from the NHLBI and the Office of Research on Minority Health (V.R.G.), and grant UC Irvine M01RR 00827-29 from the General Clinical Research Centers Program of the National Center for Research Resources National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Aisen P, 2003, BRIT J HAEMATOL, V121, P674, DOI 10.1046/j.1365-2141.2003.04347.x; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BALLAS SK, 1979, AM J CLIN PATHOL, V71, P401, DOI 10.1093/ajcp/71.4.401; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Beutler E, 2003, BRIT J HAEMATOL, V120, P887, DOI 10.1046/j.1365-2141.2003.04215.x; Bleackley MR, 2009, TRANSFUS MED REV, V23, P103, DOI 10.1016/j.tmrv.2008.12.001; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; Camaschella C, 2009, NAT GENET, V41, P386, DOI 10.1038/ng0409-386; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Constantine CC, 2009, BRIT J HAEMATOL, V147, P140, DOI 10.1111/j.1365-2141.2009.07843.x; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; CUSTER EM, 1995, J LAB CLIN MED, V126, P88; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Datz C, 1998, CLIN CHEM, V44, P2429; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; FLOWERS CA, 1986, AM J HEMATOL, V23, P141, DOI 10.1002/ajh.2830230209; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Lee P, 2009, ACTA HAEMATOL-BASEL, V122, P87, DOI 10.1159/000243792; Lee PL, 2001, BRIT J HAEMATOL, V115, P329, DOI 10.1046/j.1365-2141.2001.03096.x; Lee PL, 2001, BLOOD CELL MOL DIS, V27, P539, DOI 10.1006/bcmd.2001.0418; Lee PL, 1999, BLOOD CELL MOL DIS, V25, P374, DOI 10.1006/bcmd.1999.0267; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; McLaren CE, 2003, BLOOD, V102, P4563, DOI 10.1182/blood-2003-04-1278; McLaren CE, 2003, AM J MED SCI, V325, P53, DOI 10.1097/00000441-200302000-00001; McLaren CE, 2010, AM J HEMATOL, V85, P101, DOI 10.1002/ajh.21585; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Milet J, 2007, AM J HUM GENET, V81, P799, DOI 10.1086/520001; MILMAN N, 1983, DAN MED BULL, V30, P115; Morse AC, 1999, P SOC EXP BIOL MED, V220, P147, DOI 10.1046/j.1525-1373.1999.d01-22.x; Pfeiffer CM, 2007, CLIN CHIM ACTA, V382, P112, DOI 10.1016/j.cca.2007.04.008; Raddatz D, 2003, Z GASTROENTEROL, V41, P1069; Sarria B, 2007, EUR J NUTR, V46, P57, DOI 10.1007/s00394-006-0631-x; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Wallace DF, 2007, WORLD J GASTROENTERO, V13, P4690, DOI 10.3748/wjg.v13.i35.4690; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; World Health Organization, 2000, WHONHD007	44	49	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17390	10.1371/journal.pone.0017390	http://dx.doi.org/10.1371/journal.pone.0017390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483845	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200005
J	Steinstraesser, L; Hauk, J; Schubert, C; Al-Benna, S; Stricker, I; Hatt, H; Shai, Y; Steinau, HU; Jacobsen, F				Steinstraesser, Lars; Hauk, Jennifer; Schubert, Cornelius; Al-Benna, Sammy; Stricker, Ingo; Hatt, Hanns; Shai, Yechiel; Steinau, Hans-Ulrich; Jacobsen, Frank			Suppression of Soft Tissue Sarcoma Growth by a Host Defense-Like Lytic Peptide	PLOS ONE			English	Article							D-AMINO-ACID; ANTIMICROBIAL PEPTIDES; ANGIOGENESIS INHIBITOR; INNATE IMMUNITY; TUMOR-GROWTH; CELLS; CHEMOTHERAPY; RESISTANCE; MICE; EXPRESSION	Background: Soft tissue sarcoma (STS) is an anatomically and histologically heterogeneous neoplasia that shares a putative mesenchymal cell origin. The treatment with common chemotherapeutics is still unsatisfying because of association with poor response rates. Although evidence is accumulating for potent oncolytic activity of host defense peptides (HDPs), their potential therapeutic use is often limited by poor bioavailability and inactivation in serum. Therefore, we tested the designer host defense-like lytic D, L-amino acid peptide [D]-K3H3L9 on two STS cell lines in vitro and also in an athymic and syngeneic mouse model. In recent studies the peptide could show selectivity against prostate carcinoma cells and also an active state in serum. Methods: In vitro the human synovial sarcoma cell line SW982, the murine fibrosarcoma cell line BFS-1 and primary human fibroblasts as a control were exposed to [D]-K3H3L9, a 15mer D, L-amino acid designer HDP. Cell vitality in physiological and acidic conditions (MTT-assay), cell growth (BrdU) and DNA-fragmentation (TUNEL) were investigated. Membrane damage at different time points could be analyzed with LDH assay. An antibody against the tested peptide and recordings using scanning electron microscopy could give an inside in the mode of action. In vivo [D]-K3H3L9 was administered intratumorally in an athymic and syngeneic (immunocompetent) mouse model with SW982 and BFS-1 cells, respectively. After three weeks tumor sections were histologically analyzed. Results: The peptide exerts rapid and high significant cytotoxicity and antiproliferating activity against the malignant cell lines, apparently via a membrane disrupting mode of action. The local intratumoral administration of [D]-K3H3L9 in the athymic and syngeneic mice models significantly inhibited tumor progression. The histological analyses of the tumor sections revealed a significant antiproliferative, antiangiogenic activity of the treatment group. Conclusion: These findings demonstrate the in vitro and in vivo oncolytic activity of [D]-K3H3L9 in athymic and syngeneic mouse models.	[Steinstraesser, Lars; Hauk, Jennifer; Schubert, Cornelius; Al-Benna, Sammy; Steinau, Hans-Ulrich; Jacobsen, Frank] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Lab Wound Healing & Mol Oncol, Bochum, N Rhine Westpha, Germany; [Stricker, Ingo] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Pathol, Bochum, N Rhine Westpha, Germany; [Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, N Rhine Westpha, Germany; [Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Weizmann Institute of Science	Steinstraesser, L (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Lab Wound Healing & Mol Oncol, Bochum, N Rhine Westpha, Germany.	Lars.Steinstraesser@rub.de	Al-Benna, Sammy/AAG-1463-2019; Al-Benna, Sammy/G-1245-2013	Al-Benna, Sammy/0000-0003-4079-9286	German Research Foundation (DFG) [STE 1099/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG, reference number: STE 1099/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2009, PLAST RECONSTR SURG, V124, p463E, DOI 10.1097/PRS.0b013e3181bf7fe3; BAKER MA, 1993, CANCER RES, V53, P3052; BENKIRANE N, 1993, J BIOL CHEM, V268, P26279; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Billingsley KG, 1999, ANN SURG, V229, P602, DOI 10.1097/00000658-199905000-00002; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Chao Celia, 2002, J Ky Med Assoc, V100, P10; Cormier JN, 2004, J CLIN ONCOL, V22, P4567, DOI 10.1200/JCO.2004.02.057; Dennison SR, 2006, CURR PROTEIN PEPT SC, V7, P487, DOI 10.2174/138920306779025611; Eilber FC, 2004, ANN SURG, V240, P686, DOI 10.1109/01.sla.0000141710.74073.0d; Hirsch T, 2006, MOL MED, V12, P199, DOI 10.2119/2006-00031.Hirsch; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; Kuenen BC, 2003, CLIN CANCER RES, V9, P1648; Lehmann J, 2006, EUR UROL, V50, P141, DOI 10.1016/j.eururo.2005.12.043; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lins L, 2006, BIOPHYS J, V90, P470, DOI 10.1529/biophysj.105.068213; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Moscow JA, 1997, CANCER CHEMOTHER BIO, V17, P139; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; PAN JG, 2007, SCI STKE, pPE14, DOI DOI 10.1126/STKE.3812007PE14; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2004, CANCER RES, V64, P5779, DOI 10.1158/0008-5472.CAN-04-1438; Papo N, 2003, J BIOL CHEM, V278, P21018, DOI 10.1074/jbc.M211204200; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Reichardt P, 2002, CRIT REV ONCOL HEMAT, V41, P157, DOI 10.1016/S1040-8428(01)00153-6; Saenz NC, 1998, ANN SURG ONCOL, V5, P48, DOI 10.1007/BF02303764; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Steinau HU, 2001, CHIRURG, V72, P501, DOI 10.1007/s001040051339; STEINSTRAESSER L, HUM CELL IN PRESS; STEINSTRAESSER L, IMMUNOBIOLO IN PRESS; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; TANNOCK IF, 1989, CANCER RES, V49, P4373; UTSUGI T, 1991, CANCER RES, V51, P3062; VAUPEL P, 1989, CANCER RES, V49, P6449; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18321	10.1371/journal.pone.0018321	http://dx.doi.org/10.1371/journal.pone.0018321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483840	Green Submitted, gold, Green Published			2022-12-25	WOS:000289057200058
J	Carvalho, G; Poalas, K; Demian, C; Hatchi, E; Vazquez, A; Bidere, N				Carvalho, Gabrielle; Poalas, Konstantinos; Demian, Catherine; Hatchi, Emeline; Vazquez, Aime; Bidere, Nicolas			Participation of the Cell Polarity Protein PALS1 to T-Cell Receptor-Mediated NF-kappa B Activation	PLOS ONE			English	Article							MAMMALIAN EPITHELIAL-CELLS; TIGHT JUNCTION FORMATION; DLGH1; COMPLEXES; LEUKEMIA; MALT1	Background: Beside their established function in shaping cell architecture, some cell polarity proteins were proposed to participate to lymphocyte migration, homing, scanning, as well as activation following antigen receptor stimulation. Although PALS1 is a central component of the cell polarity network, its expression and function in lymphocytes remains unknown. Here we investigated whether PALS1 is present in T cells and whether it contributes to T Cell-Receptor (TCR)-mediated activation. Methodology/Principal Findings: By combining RT-PCR and immunoblot assays, we found that PALS1 is constitutively expressed in human T lymphocytes as well as in Jurkat T cells. siRNA-based knockdown of PALS1 hampered TCR-induced activation and optimal proliferation of lymphocyte. We further provide evidence that PALS1 depletion selectively hindered TCR-driven activation of the transcription factor NF-kappa B. Conclusions: The cell polarity protein PALS1 is expressed in T lymphocytes and participates to the optimal activation of NFkB following TCR stimulation.	[Carvalho, Gabrielle; Poalas, Konstantinos; Demian, Catherine; Hatchi, Emeline; Vazquez, Aime; Bidere, Nicolas] Hop Paul Brousse, INSERM, UMR S 1014, F-94800 Villejuif, France; [Carvalho, Gabrielle; Poalas, Konstantinos; Demian, Catherine; Hatchi, Emeline; Vazquez, Aime; Bidere, Nicolas] Univ Paris 11, F-91400 Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Carvalho, G (corresponding author), Hop Paul Brousse, INSERM, UMR S 1014, F-94800 Villejuif, France.	nicolas.bidere@inserm.fr	Bidère, Nicolas/K-8887-2015	Bidère, Nicolas/0000-0001-9177-0008	ANR; Fondation de France; Association pour la Recherche contre le Cancer; Universite Paris Sud; Ligue Nationale contre le Cancer (Equipe Labellisee); la Ligue contre le Cancer	ANR(French National Research Agency (ANR)); Fondation de France(Fondation de France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Universite Paris Sud; Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); la Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from ANR, Fondation de France, Association pour la Recherche contre le Cancer, Universite Paris Sud, and Ligue Nationale contre le Cancer (Equipe Labellisee). GC is supported by a post-doctoral fellowship from la Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin-Andre C, 2007, J BIOL CHEM, V282, P33132, DOI 10.1074/jbc.M702279200; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Carvalho G, 2010, J CELL SCI, V123, P2375, DOI 10.1242/jcs.069476; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Hawkins ED, 2008, ONCOGENE, V27, P7003, DOI 10.1038/onc.2008.350; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Real E, 2007, J IMMUNOL, V179, P5649, DOI 10.4049/jimmunol.179.9.5649; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Stephenson LM, 2007, MOL CELL BIOL, V27, P7574, DOI 10.1128/MCB.00439-07; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044	23	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18159	10.1371/journal.pone.0018159	http://dx.doi.org/10.1371/journal.pone.0018159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479189	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700036
J	Kodali, VK; Gannon, SA; Paramasivam, S; Raje, S; Polenova, T; Thorpe, C				Kodali, Vamsi K.; Gannon, Shawn A.; Paramasivam, Sivakumar; Raje, Sonali; Polenova, Tatyana; Thorpe, Colin			A Novel Disulfide-Rich Protein Motif from Avian Eggshell Membranes	PLOS ONE			English	Article							KERATIN-ASSOCIATED PROTEINS; SULFHYDRYL OXIDASE; CHEMICAL-SHIFT; BOND FORMATION; GENE DOMAIN; EGG-WHITE; MATRIX; MINERALIZATION; IDENTIFICATION; DICTYOSTELIUM	Under the shell of a chicken egg are two opposed proteinaceous disulfide-rich membranes. They are fabricated in the avian oviduct using fibers formed from proteins that are extensively coupled by irreversible lysine-derived crosslinks. The intractability of these eggshell membranes (ESM) has slowed their characterization and their protein composition remains uncertain. In this work, reductive alkylation of ESM followed by proteolytic digestion led to the identification of a cysteine rich ESM protein (abbreviated CREMP) that was similar to spore coat protein SP75 from cellular slime molds. Analysis of the cysteine repeats in partial sequences of CREMP reveals runs of remarkably repetitive patterns. Module a contains a C-X(4)-C-X(5)-C-X(8)-C-X(6) pattern (where X represents intervening non-cysteine residues). These inter-cysteine amino acid residues are also strikingly conserved. The evolutionarily-related module b has the same cysteine spacing as a, but has 11 amino acid residues at its C-terminus. Different stretches of CREMP sequences in chicken genomic DNA fragments show diverse repeat patterns: e. g. all a modules; an alternation of a-b modules; or an a-b-b arrangement. Comparable CREMP proteins are found in contigs of the zebra finch (Taeniopygia guttata) and in the oviparous green anole lizard (Anolis carolinensis). In all these cases the long runs of highly conserved modular repeats have evidently led to difficulties in the assembly of full length DNA sequences. Hence the number, and the amino acid lengths, of CREMP proteins are currently unknown. A 118 amino acid fragment (representing an a-b-a-b pattern) from a chicken oviduct EST library expressed in Escherichia coli is a well folded, highly anisotropic, protein with a large chemical shift dispersion in 2D solution NMR spectra. Structure is completely lost on reduction of the 8 disulfide bonds of this protein fragment. Finally, solid state NMR spectra suggest a surprising degree of order in intact ESM fibers.	[Kodali, Vamsi K.; Gannon, Shawn A.; Paramasivam, Sivakumar; Polenova, Tatyana; Thorpe, Colin] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Raje, Sonali] Towson Univ, Dept Chem, Towson, MD USA	University of Delaware; University System of Maryland; Towson University	Kodali, VK (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	cthorpe@udel.edu	Kodali, Vamsi/A-8530-2010	Kodali, Vamsi/0000-0001-8941-9761	National Institutes of Health (NIH) [GM26643]; NCRR, NIH [NIH P20RR017716-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026643] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM26643 (CT) and NIH P20RR017716-08 from NCRR (TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JL, 1997, CONNECT TISSUE RES, V36, P21, DOI 10.3109/03008209709160211; ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162; BELLAIRS R, 1969, Z ZELLFORSCH MIK ANA, V96, P237, DOI 10.1007/BF00338771; Benitez BAS, 2000, PROTEINS, V40, P168, DOI 10.1002/(SICI)1097-0134(20000701)40:1<168::AID-PROT180>3.0.CO;2-N; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Burley R., 1989, AVIAN EGG CHEM BIOL; CARMON A, PLOS ONE, V5; Case ST, 1997, J MOL EVOL, V44, P452, DOI 10.1007/PL00006165; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; CHOWDHURY SD, 1990, WORLD POULTRY SCI J, V46, P153, DOI 10.1079/WPS19900018; CROMBIE G, 1981, BIOCHIM BIOPHYS ACTA, V640, P365, DOI 10.1016/0005-2736(81)90560-5; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gregg KY, 2000, DEV BIOL, V224, P81, DOI 10.1006/dbio.2000.9768; GUILLETTE LJ, 1989, J MORPHOL, V201, P145, DOI 10.1002/jmor.1052010205; Hawthorne SK, 2006, GENOMICS, V87, P382, DOI 10.1016/j.ygeno.2005.09.010; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; HOFFER AP, 1971, AM J ANAT, V131, P253, DOI 10.1002/aja.1001310302; Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; IATROU K, 1984, P NATL ACAD SCI-BIOL, V81, P4452, DOI 10.1073/pnas.81.14.4452; KALKHOF S, BIOCHEMISTRY; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3; KAWASAKI H, 1971, INSECT BIOCHEM, V1, P130, DOI 10.1016/0020-1790(71)90067-9; Kumar Manish, 2008, In Silico Biology, V8, P121; LEACH RM, 1982, POULTRY SCI, V61, P2040, DOI 10.3382/ps.0612040; LEACH RM, 1981, ARCH BIOCHEM BIOPHYS, V207, P353, DOI 10.1016/0003-9861(81)90042-4; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Meier S, 2007, J MOL BIOL, V368, P718, DOI 10.1016/j.jmb.2007.02.026; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Neue G, 1997, SOLID STATE NUCL MAG, V7, P333, DOI 10.1016/S0926-2040(96)01291-X; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Rogers MA, 2004, J INVEST DERMATOL, V122, P147, DOI 10.1046/j.0022-202X.2003.22128.x; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; SMITH SV, 1995, PROTEIN SCI, V4, P945; STARCHER BC, 1980, CONNECT TISSUE RES, V8, P53, DOI 10.3109/03008208009152122; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; TORRES FG, ACTA BIOMATER, V6, P3687; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; West CM, 1996, MICROBIOL-UK, V142, P2227, DOI 10.1099/13500872-142-8-2227; West CM, 2003, INT REV CYTOL, V222, P237; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Wong JL, 2004, EVOL DEV, V6, P134, DOI 10.1111/j.1525-142X.2004.04019.x; WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2	50	49	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18187	10.1371/journal.pone.0018187	http://dx.doi.org/10.1371/journal.pone.0018187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479176	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700037
J	Banerjee, S; Oldridge, D; Poptsova, M; Hussain, WM; Chakravarty, D; Demichelis, F				Banerjee, Samprit; Oldridge, Derek; Poptsova, Maria; Hussain, Wasay M.; Chakravarty, Dimple; Demichelis, Francesca			A Computational Framework Discovers New Copy Number Variants with Functional Importance	PLOS ONE			English	Article							HUMAN BLEOMYCIN HYDROLASE; HIDDEN-MARKOV MODEL; GENE-EXPRESSION; MECHANISMS; CANCER; GENOME; IMPACT	Structural variants which cause changes in copy numbers constitute an important component of genomic variability. They account for 0.7% of genomic differences in two individual genomes, of which copy number variants (CNVs) are the largest component. A recent population-based CNV study revealed the need of better characterization of CNVs, especially the small ones (<500 bp). We propose a three step computational framework (Identification of germline Changes in Copy Number or IgC2N) to discover and genotype germline CNVs. First, we detect candidate CNV loci by combining information across multiple samples without imposing restrictions to the number of coverage markers or to the variant size. Secondly, we fine tune the detection of rare variants and infer the putative copy number classes for each locus. Last, for each variant we combine the relative distance between consecutive copy number classes with genetic information in a novel attempt to estimate the reference model bias. This computational approach is applied to genome-wide data from 1250 HapMap individuals. Novel variants were discovered and characterized in terms of size, minor allele frequency, type of polymorphism (gains, losses or both), and mechanism of formation. Using data generated for a subset of individuals by a 42 million marker platform, we validated the majority of the variants with the highest validation rate (66.7%) was for variants of size larger than 1 kb. Finally, we queried transcriptomic data from 129 individuals determined by RNA-sequencing as further validation and to assess the functional role of the new variants. We investigated the possible enrichment for variant's regulatory effect and found that smaller variants (<1 Kb) are more likely to regulate gene transcript than larger variants (p-value = 2.04e-08). Our results support the validity of the computational framework to detect novel variants relevant to disease susceptibility studies and provide evidence of the importance of genetic variants in regulatory network studies.	[Banerjee, Samprit] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA; [Oldridge, Derek; Poptsova, Maria; Hussain, Wasay M.; Chakravarty, Dimple; Demichelis, Francesca] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Demichelis, Francesca] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA	Cornell University; Cornell University; Cornell University	Banerjee, S (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA.	francesca.demichelis@gmail.com	Poptsova, Maria/G-6985-2014; Demichelis, Francesca/J-9829-2016; Chakravarty, Dimple/N-3325-2014	Poptsova, Maria/0000-0002-7198-8234; Demichelis, Francesca/0000-0002-8266-8631; Chakravarty, Dimple/0000-0002-8588-8461	Starr Cancer Consortium; Department of Defense; National Cancer Institute [R01-CA116337]; NATIONAL CANCER INSTITUTE [R01CA116337] Funding Source: NIH RePORTER	Starr Cancer Consortium; Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Starr Cancer Consortium (S. B., F. D.), the Department of Defense (F. D.), and the National Cancer Institute (R01-CA116337, S. B., F. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DIJKSTRA T, OPTIMIZATION ALGORIT, P74; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ferrando AA, 1996, CANCER RES, V56, P1746; Gokcumen O, 2009, METHODS, V49, P18, DOI 10.1016/j.ymeth.2009.06.001; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Habegger L, 2011, BIOINFORMATICS, V27, P281, DOI 10.1093/bioinformatics/btq643; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hayashi R, 2007, DNA CELL BIOL, V26, P91, DOI 10.1089/dna.2006.0515; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LAM HY, NAT BIOTECHNOL, V28, P47; Lee C, 2008, NEW ENGL J MED, V358, P740, DOI 10.1056/NEJMcibr0708452; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Li B, 2009, MOL VIS, V15, P861; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Montoya SE, 1998, NAT GENET, V18, P211, DOI 10.1038/ng0398-211; OLDRIDGE DA, NUCL ACIDS RES, V38, P3275; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TOMIMARU Y, BR J CANC, V102, P1483; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; YAVAS G, PAC S BIOCOMPUT, P371	41	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17539	10.1371/journal.pone.0017539	http://dx.doi.org/10.1371/journal.pone.0017539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479260	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600012
J	Munkacsi, AB; Chen, FW; Brinkman, MA; Higaki, K; Gutierrez, GD; Chaudhari, J; Layer, JV; Tong, A; Bard, M; Boone, C; Ioannou, YA; Sturley, SL				Munkacsi, Andrew B.; Chen, Fannie W.; Brinkman, Matthew A.; Higaki, Katsumi; Gutierrez, Giselle Dominguez; Chaudhari, Jagruti; Layer, Jacob V.; Tong, Amy; Bard, Martin; Boone, Charles; Ioannou, Yiannis A.; Sturley, Stephen L.			An "Exacerbate-reverse" Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in Human Niemann-Pick Type C Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-ANALYSIS; MOUSE MODEL; PROTEIN; REVEALS; BINDING; EXPRESSION; MUTATIONS; HOMOLOG; DOMAIN; CELLS	Niemann-Pick type C (NP-C) disease is a fatal lysosomal lipid storage disorder for which no effective therapy exists. A genome-wide, conditional synthetic lethality screen was performed using the yeast model of NP-C disease during anaerobiosis, an auxotrophic condition that requires yeast to utilize exogenous sterol. We identified 12 pathways and 13 genes as modifiers of the absence of the yeast NPC1 ortholog (NCR1) and quantified the impact of loss of these genes on sterol metabolism in ncr1 Delta strains grown under viable aerobic conditions. Deletion of components of the yeast NuA4 histone acetyltransferase complex in ncr1 Delta strains conferred anaerobic inviability and accumulation of multiple sterol intermediates. Thus, we hypothesize an imbalance in histone acetylation in human NP-C disease. Accordingly, we show that the majority of the 11 histone deacetylase (HDAC) genes are transcriptionally up-regulated in three genetically distinct fibroblast lines derived from patients with NP-C disease. A clinically approved HDAC inhibitor (suberoylanilide hydroxamic acid) reverses the dysregulation of the majority of the HDAC genes. Consequently, three key cellular diagnostic criteria of NP-C disease are dramatically ameliorated as follows: lysosomal accumulation of both cholesterol and sphingolipids and defective esterification of LDL-derived cholesterol. These data suggest HDAC inhibition as a candidate therapy for NP-C disease. We conclude that pathways that exacerbate lethality in a model organism can be reversed in human cells as a novel therapeutic strategy. This "exacerbate-reverse" approach can potentially be utilized in any model organism for any disease.	[Gutierrez, Giselle Dominguez; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Munkacsi, Andrew B.; Brinkman, Matthew A.; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Chen, Fannie W.; Chaudhari, Jagruti; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Higaki, Katsumi] Tottori Univ, Res Ctr Biosci & Technol, Div Funct Genom, Yonago, Tottori 6838503, Japan; [Layer, Jacob V.; Bard, Martin] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; [Tong, Amy; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Tong, Amy; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet & Microbiol, Toronto, ON M5S 3E1, Canada	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Tottori University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; University of Toronto	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Munkacsi, Andrew/0000-0003-3033-395X	National Institutes of Health [DK54320, T32 HL07343, DK082712, GM62104]; Ara Parseghian Medical Research Foundation; Dana Angels Research Trust; Irving Institute for Clinical and Translational Science; Ministry of Education, Culture, Science, Sports and Technology of Japan [20790728]; Genome Canada through Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health Research [GSP-41567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082712, R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; Dana Angels Research Trust; Irving Institute for Clinical and Translational Science; Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genome Canada through Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54320 (to S. L. S.). This work was also supported by the Ara Parseghian Medical Research Foundation and the Dana Angels Research Trust.; Supported by National Institutes of Health Postdoctoral Fellow in Arteriosclerosis Grant T32 HL07343, as a Charles H. Revson Senior Fellow in the Biomedical Sciences, and by the Irving Institute for Clinical and Translational Science.; Supported by National Institutes of Health Grant DK082712.; Supported by Ministry of Education, Culture, Science, Sports and Technology of Japan Grant 20790728.; Supported by National Institutes of Health Grant GM62104.; Supported by Genome Canada through Ontario Genomics Institute Grant 2004-OGI-3-01 and Canadian Institutes of Health Research Grant GSP-41567.	ALMANZARPARAMIO D, 2006, THESIS COLUMBIA U NE; Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Berger AC, 2005, EUKARYOT CELL, V4, P1851, DOI 10.1128/EC.4.11.1851-1862.2005; Bhuiyan MSA, 1999, BIOSCI BIOTECH BIOCH, V63, P1075, DOI 10.1271/bbb.63.1075; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bu BT, 2002, J NEUROSCI, V22, P6515; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dittmar JC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-353; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Garver WS, 2002, J LIPID RES, V43, P579; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Heinicke S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000766; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madra M, 2010, CLIN LIPIDOL, V5, P387, DOI 10.2217/CLP.10.19; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Munkacsi AB, 2007, FUTURE LIPIDOL, V2, P357, DOI 10.2217/17460875.2.3.357; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Park JH, 2010, MOL CELL BIOL, V30, P2750, DOI 10.1128/MCB.00804-09; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PIPALIA NH, 2011, P NATL ACA IN PRESS; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Sullivan DP, 2009, EUKARYOT CELL, V8, P161, DOI 10.1128/EC.00135-08; Taniguchi M, 2001, BRAIN DEV-JPN, V23, P414, DOI 10.1016/S0387-7604(01)00252-2; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Walter M, 2003, J LIPID RES, V44, P243, DOI 10.1194/jlr.M200230-JLR200; Yamamoto T, 1999, HUM GENET, V105, P10, DOI 10.1007/s004390051057; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966	44	55	58	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23842	23851		10.1074/jbc.M111.227645	http://dx.doi.org/10.1074/jbc.M111.227645			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21489983	Green Published, hybrid			2022-12-25	WOS:000292294900027
J	Kasaikina, MV; Kravtsova, MA; Lee, BC; Seravalli, J; Peterson, DA; Walter, J; Legge, R; Benson, AK; Hatfield, DL; Gladyshev, VN				Kasaikina, Marina V.; Kravtsova, Marina A.; Lee, Byung Cheon; Seravalli, Javier; Peterson, Daniel A.; Walter, Jens; Legge, Ryan; Benson, Andrew K.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Dietary selenium affects host selenoproteome expression by influencing the gut microbiota	FASEB JOURNAL			English	Article						selenoproteins; germ-free mice; high-throughput sequencing	HUMAN HEALTH; DISEASE; MICE; BACTERIA; METABOLISM; MODULATION; OBESITY; COLON	Colonization of the gastrointestinal tract and composition of the microbiota may be influenced by components of the diet, including trace elements. To understand how selenium regulates the intestinal microflora, we used high-throughput sequencing to examine the composition of gut microbiota of mice maintained on selenium-deficient, selenium-sufficient, and selenium-enriched diets. The microbiota diversity increased as a result of selenium in the diet. Specific phylotypes showed differential effects of selenium, even within a genus, implying that selenium had unique effects across microbial taxa. Conventionalized germfree mice subjected to selenium diets gave similar results and showed an increased diversity of the bacterial population in animals fed with higher levels of selenium. Germ-free mice fed selenium diets modified their selenoproteome expression similar to control mice but showed higher levels and activity of glutathione peroxidase 1 and methionine-R-sulfoxide reductase 1 in the liver, suggesting partial sequestration of selenium by the gut microorganisms, limiting its availability for the host. These changes in the selenium status were independent of the levels of other trace elements. The data show that dietary selenium affects both composition of the intestinal microflora and colonization of the gastrointestinal tract, which, in turn, influence the host selenium status and selenoproteome expression.-Kasaikina, M. V., Kravtsova, M. A., Lee, B. C., Seravalli, J., Peterson, D. A., Walter, J., Legge, R., Benson, A. K., Hatfield, D. L., Gladyshev, V. N. Dietary selenium affects host selenoproteome expression by influencing the gut microbiota. FASEB J. 25, 2492-2499 (2011). www.fasebj.org	[Kasaikina, Marina V.; Lee, Byung Cheon; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kasaikina, Marina V.; Lee, Byung Cheon; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kasaikina, Marina V.; Kravtsova, Marina A.; Lee, Byung Cheon; Seravalli, Javier; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Kasaikina, Marina V.; Kravtsova, Marina A.; Lee, Byung Cheon; Seravalli, Javier; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68583 USA; [Peterson, Daniel A.; Walter, Jens; Legge, Ryan; Benson, Andrew K.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, New Res Bldg,Rm 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Walter, Jens/AAA-7636-2020; Gladyshev, Vadim N/J-6187-2013	Walter, Jens/0000-0003-1754-172X; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940; Benson, Andrew/0000-0001-6330-0252	U.S. National Institutes of Health (NIH) [GM061603, AG021518]; Center for Cancer Research, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by U.S. National Institutes of Health (NIH) grants GM061603 and AG021518 (to V.N.G.) and the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH (to D.L.H.).	Baesman SA, 2007, APPL ENVIRON MICROB, V73, P2135, DOI 10.1128/AEM.02558-06; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Fava F, 2006, CURR MED CHEM, V13, P3005, DOI 10.2174/092986706778521814; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Fukushima K, 2003, SCAND J GASTROENTERO, V38, P626, DOI 10.1080/00365510310000376; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Hrdina J, 2009, J NUTR BIOCHEM, V20, P638, DOI 10.1016/j.jnutbio.2008.06.009; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mostert V, 2001, BIOFACTORS, V14, P135, DOI 10.1002/biof.5520140118; Novoselov SV, 2010, ANTIOXID REDOX SIGN, V12, P829, DOI 10.1089/ars.2009.2895; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Possemiers S, 2009, CURR PHARM DESIGN, V15, P2051, DOI 10.2174/138161209788489159; Rock C, 2009, BIOMETALS, V22, P995, DOI 10.1007/s10534-009-9251-2; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Tannock GW, 2008, TRENDS MICROBIOL, V16, P488, DOI 10.1016/j.tim.2008.07.005; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yi YS, 2003, BBA-MOL BASIS DIS, V1638, P249, DOI 10.1016/S0925-4439(03)00090-5	27	128	130	10	76	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2492	2499		10.1096/fj.11-181990	http://dx.doi.org/10.1096/fj.11-181990			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21493887	Green Published, Green Submitted			2022-12-25	WOS:000292242200039
J	Skjorringe, T; Tumer, Z; Moller, LB				Skjorringe, Tina; Tumer, Zeynep; Moller, Lisbeth Birk			Splice Site Mutations in the ATP7A Gene	PLOS ONE			English	Article							OCCIPITAL-HORN-SYNDROME; CLASSICAL MENKES-DISEASE; JAPANESE PATIENTS; MESSENGER-RNA; IDENTIFICATION; PHENOTYPE; DIAGNOSIS; LEAD	Menkes disease (MD) is caused by mutations in the ATP7A gene. We describe 33 novel splice site mutations detected in patients with MD or the milder phenotypic form, Occipital Horn Syndrome. We review these 33 mutations together with 28 previously published splice site mutations. We investigate 12 mutations for their effect on the mRNA transcript in vivo. Transcriptional data from another 16 mutations were collected from the literature. The theoretical consequences of splice site mutations, predicted with the bioinformatics tool Human Splice Finder, were investigated and evaluated in relation to in vivo results. Ninety-six percent of the mutations identified in 45 patients with classical MD were predicted to have a significant effect on splicing, which concurs with the absence of any detectable wild-type transcript in all 19 patients investigated in vivo. Sixty-seven percent of the mutations identified in 12 patients with milder phenotypes were predicted to have no significant effect on splicing, which concurs with the presence of wild-type transcript in 7 out of 9 patients investigated in vivo. Both the in silico predictions and the in vivo results support the hypothesis previously suggested by us and others, that the presence of some wild-type transcript is correlated to a milder phenotype.	[Skjorringe, Tina; Tumer, Zeynep; Moller, Lisbeth Birk] Kennedy Ctr, Dept Appl Funct Human Genet, Glostrup, Denmark		Skjorringe, T (corresponding author), Kennedy Ctr, Dept Appl Funct Human Genet, Glostrup, Denmark.	lbm@kennedy.dk	Tumer, Zeynep/AAF-8501-2019; Tümer, Zeynep/C-4235-2014	Tumer, Zeynep/0000-0002-4777-5802; Moller, Lisbeth/0000-0002-9524-4301				BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Grange DK, 2005, AM J MED GENET A, V139A, P151, DOI 10.1002/ajmg.a.31001; Gu YH, 2001, AM J MED GENET, V99, P217, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1167>3.0.CO;2-R; Hubner CA, 2005, NEUROSCIENCE, V132, P697, DOI 10.1016/j.neuroscience.2005.01.042; Kaler SG, 1995, ANN NEUROL, V38, P921, DOI 10.1002/ana.410380613; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2008, NEW ENGL J MED, V358, P605, DOI 10.1056/NEJMoa070613; Moller LB, 2005, HUM MUTAT, V26, P84, DOI 10.1002/humu.20190; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Noordzij JG, 2002, J CLIN IMMUNOL, V22, P306, DOI 10.1023/A:1019982206951; Ogawa A, 1999, J HUM GENET, V44, P206, DOI 10.1007/s100380050144; Qi M, 1998, HUM MOL GENET, V7, P465, DOI 10.1093/hmg/7.3.465; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tumer Z, 1997, AM J HUM GENET, V60, P63; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Varon R, 2006, HUM MOL GENET, V15, P679, DOI 10.1093/hmg/ddi482; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Watanabe A, 2005, PEDIATR INT, V47, P1, DOI 10.1111/j.1442-200x.2004.02012.x	27	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18599	10.1371/journal.pone.0018599	http://dx.doi.org/10.1371/journal.pone.0018599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494555	Green Submitted, Green Published, gold			2022-12-25	WOS:000289354100025
J	Hardiess, G; Basten, K; Mallot, HA				Hardiess, Gregor; Basten, Kai; Mallot, Hanspeter A.			Acquisition vs. Memorization Trade-Offs Are Modulated by Walking Distance and Pattern Complexity in a Large-Scale Copying Paradigm	PLOS ONE			English	Article							SHORT-TERM-MEMORY; VISUAL WORKING-MEMORY; INTERACTIVE BEHAVIOR; SOFT CONSTRAINTS; CAPACITY; INFORMATION; STORAGE; EYE; COORDINATION; CONJUNCTIONS	In a "block-copying paradigm", subjects were required to copy a configuration of colored blocks from a model area to a distant work area, using additional blocks provided at an equally distant resource area. Experimental conditions varied between the inter-area separation (walking distance) and the complexity of the block patterns to be copied. Two major behavioral strategies were identified: in the memory-intensive strategy, subjects memorize large parts of the pattern and rebuild them without intermediate visits at the model area. In the acquisition-intensive strategy, subjects memorize one block at a time and return to the model after having placed this block. Results show that the frequency of the memory-intensive strategy is increased for larger inter-area separations (larger walking distances) and for simpler block patterns. This strategy-shift can be interpreted as the result of an optimization process or trade-off, minimizing combined, condition-dependent costs of the two strategies. Combined costs correlate with overall response time. We present evidence that for the memory-intensive strategy, costs correlate with model visit duration, while for the acquisition-intensive strategy, costs correlate with inter-area transition (i.e., walking) times.	[Hardiess, Gregor] Univ Tubingen, Dept Biol, Tubingen, Germany; Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hardiess, G (corresponding author), Univ Tubingen, Dept Biol, Tubingen, Germany.	gregor.hardiess@uni-tuebingen.de	Mallot, Hanspeter A/H-7888-2016		Werner Reichardt Center for Integrative Neuroscience (CIN)	Werner Reichardt Center for Integrative Neuroscience (CIN)	This research was partially supported by the Deutsche Forschungsgemeinschaft within the Werner Reichardt Center for Integrative Neuroscience (CIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Ardila A, 2008, BRAIN COGNITION, V68, P92, DOI 10.1016/j.bandc.2008.03.003; Baddeley AD, 1974, RECENT ADV LEARNING, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Barrouillet P, 2009, TRENDS COGN SCI, V13, P145, DOI 10.1016/j.tics.2009.01.002; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Carpenter RHS, 1988, MOVEMENTS EYES; Cary M, 1999, J EXP PSYCHOL LEARN, V25, P1053, DOI 10.1037/0278-7393.25.4.1053; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Droll JA, 2007, J EXP PSYCHOL HUMAN, V33, P1352, DOI 10.1037/0096-1523.33.6.1352; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Gray WD, 2005, COGN SYST RES, V6, P27, DOI 10.1016/j.cogsys.2004.09.004; Gray WD, 2004, COGNITIVE SCI, V28, P359, DOI 10.1016/j.cogsci.2003.12.001; Hardiess G, 2008, J VISION, V8, DOI 10.1167/8.1.7; Haxby JV, 2000, NEUROIMAGE, V11, P380, DOI 10.1006/nimg.2000.0592; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Inamdar S, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P599; Irwin DE., 1996, ATTENTION PERFORM, P125; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria A. R., 2012, HIGHER CORTICAL FUNC; Luria A.R., 1966, HUMAN BRAIN PSYCHOL; MAGNUSSEN S, 1991, VISION RES, V31, P1213, DOI 10.1016/0042-6989(91)90046-8; McAfoose J, 2009, NEUROPSYCHOL REV, V19, P130, DOI 10.1007/s11065-008-9063-0; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Montojo CA, 2008, NEURON, V59, P173, DOI 10.1016/j.neuron.2008.05.012; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Ploner CJ, 1998, EUR J NEUROSCI, V10, P794, DOI 10.1046/j.1460-9568.1998.00101.x; RAYNER K, 1995, STUD VIS INFORM PROC, V6, P3; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; SIMON HA, 1974, SCIENCE, V183, P482, DOI 10.1126/science.183.4124.482; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Xu YD, 2002, PERCEPT PSYCHOPHYS, V64, P1260, DOI 10.3758/BF03194770; Zhang WW, 2009, PSYCHOL SCI, V20, P423, DOI 10.1111/j.1467-9280.2009.02322.x	42	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18494	10.1371/journal.pone.0018494	http://dx.doi.org/10.1371/journal.pone.0018494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	747AP	21494620	gold, Green Published, Green Submitted			2022-12-25	WOS:000289292800026
J	Van Raay, TJ; Fortino, NJ; Miller, BW; Ma, HT; Lau, G; Li, CX; Franklin, JL; Attisano, L; Solnica-Krezel, L; Coffey, RJ				Van Raay, Terence J.; Fortino, Nicholas J.; Miller, Bryan W.; Ma, Haiting; Lau, Garnet; Li, Cunxi; Franklin, Jeffery L.; Attisano, Liliana; Solnica-Krezel, Lilianna; Coffey, Robert J.			Naked1 Antagonizes Wnt Signaling by Preventing Nuclear Accumulation of beta-Catenin	PLOS ONE			English	Article							PLASMA-MEMBRANE; STEM-CELLS; IN-VIVO; EXOCYTIC VESICLES; CUTICLE NKD; ZEBRAFISH; PROTEINS; PATHWAY; DEGRADATION; EXPRESSION	Cyto-nuclear shuttling of beta-catenin is at the epicenter of the canonical Wnt pathway and mutations in genes that result in excessive nuclear accumulation of beta-catenin are the driving force behind the initiation of many cancers. Recently, Naked Cuticle homolog 1 (Nkd1) has been identified as a Wnt-induced intracellular negative regulator of canonical Wnt signaling. The current model suggests that Nkd1 acts between Disheveled (Dvl) and beta-catenin. Here, we employ the zebrafish embryo to characterize the cellular and biochemical role of Nkd1 in vivo. We demonstrate that Nkd1 binds to beta-catenin and prevents its nuclear accumulation. We also show that this interaction is conserved in mammalian cultured cells. Further, we demonstrate that Nkd1 function is dependent on its interaction with the cell membrane. Given the conserved nature of Nkd1, our results shed light on the negative feedback regulation of Wnt signaling through the Nkd1-mediated negative control of nuclear accumulation of beta-catenin.	[Van Raay, Terence J.; Li, Cunxi; Franklin, Jeffery L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Van Raay, Terence J.; Ma, Haiting; Solnica-Krezel, Lilianna] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Van Raay, Terence J.; Fortino, Nicholas J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Miller, Bryan W.; Lau, Garnet; Attisano, Liliana] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Miller, Bryan W.; Lau, Garnet; Attisano, Liliana] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Franklin, Jeffery L.; Solnica-Krezel, Lilianna; Coffey, Robert J.] Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN USA; [Solnica-Krezel, Lilianna] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; University of Guelph; University of Toronto; University of Toronto; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Van Raay, TJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	tvanraay@uoguelph.ca; robert.coffey@vanderbilt.edu	Van Raay, Terry/AAA-7342-2021	Van Raay, Terence/0000-0003-0196-1041	University of Guelph; Canadian Foundation for Innovation; Canadian Cancer Society; National Institutes of Health (NIH) [GM55101]; NCI [CA46413]; Solnica-Krezel; Coffey; Attisano; Attisano and Van Raay labs; NATIONAL CANCER INSTITUTE [R01CA046413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055101] Funding Source: NIH RePORTER	University of Guelph; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Solnica-Krezel; Coffey; Attisano; Attisano and Van Raay labs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TVR acknowledges support from the University of Guelph and the Canadian Foundation for Innovation; LA acknowledges support from the Canadian Cancer Society; LSK acknowledges the support of National Institutes of Health (NIH) RO1 grant GM55101; RJC acknowledges the support of NCI CA46413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank members of the Solnica-Krezel, Coffey, Attisano and Van Raay labs for support and valuable comments.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; Chan CC, 2007, DEV BIOL, V311, P538, DOI 10.1016/j.ydbio.2007.09.002; Chang JL, 2008, DEV BIOL, V321, P446, DOI 10.1016/j.ydbio.2008.05.551; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Ding W, 2008, P NATL ACAD SCI USA, V105, P13433, DOI 10.1073/pnas.0806298105; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fan LC, 2006, METHOD ENZYMOL, V418, P64, DOI 10.1016/S0076-6879(06)18004-0; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Guo JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007982; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; KANE DA, 1993, DEVELOPMENT, V119, P447; Katoh M, 2001, INT J ONCOL, V19, P963; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Lei HY, 2007, J EXP ZOOL PART A, V307A, P1, DOI 10.1002/jez.a.327; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li CX, 2004, P NATL ACAD SCI USA, V101, P5571, DOI 10.1073/pnas.0401294101; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Miller BW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.72; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rousset R, 2002, J BIOL CHEM, V277, P49019, DOI 10.1074/jbc.M203246200; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Schmidt C, 2006, ANAT EMBRYOL, V211, P525, DOI 10.1007/s00429-006-0102-4; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018; Waldrop S, 2006, GENETICS, V174, P331, DOI 10.1534/genetics.106.061853; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zhang S, 2007, MOL CELL BIOL, V27, P4454, DOI 10.1128/MCB.00133-07	56	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18650	10.1371/journal.pone.0018650	http://dx.doi.org/10.1371/journal.pone.0018650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490931	Green Published, Green Submitted, gold			2022-12-25	WOS:000289238700033
J	Majumder, R; Nayak, AR; Pandit, R				Majumder, Rupamanjari; Nayak, Alok Ranjan; Pandit, Rahul			Scroll-Wave Dynamics in Human Cardiac Tissue: Lessons from a Mathematical Model with Inhomogeneities and Fiber Architecture	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; SPIRAL WAVES; FILAMENT INSTABILITY; ACTION-POTENTIALS; HUMAN HEARTS; OBSTACLE; REENTRY; DEFIBRILLATION; MECHANISMS; ROTATION	Cardiac arrhythmias, such as ventricular tachycardia (VT) and ventricular fibrillation (VF), are among the leading causes of death in the industrialized world. These are associated with the formation of spiral and scroll waves of electrical activation in cardiac tissue; single spiral and scroll waves are believed to be associated with VT whereas their turbulent analogs are associated with VF. Thus, the study of these waves is an important biophysical problem. We present a systematic study of the combined effects of muscle-fiber rotation and inhomogeneities on scroll-wave dynamics in the TNNP (ten Tusscher Noble Noble Panfilov) model for human cardiac tissue. In particular, we use the three-dimensional TNNP model with fiber rotation and consider both conduction and ionic inhomogeneities. We find that, in addition to displaying a sensitive dependence on the positions, sizes, and types of inhomogeneities, scroll-wave dynamics also depends delicately upon the degree of fiber rotation. We find that the tendency of scroll waves to anchor to cylindrical conduction inhomogeneities increases with the radius of the inhomogeneity. Furthermore, the filament of the scroll wave can exhibit drift or meandering, transmural bending, twisting, and break-up. If the scroll-wave filament exhibits weak meandering, then there is a fine balance between the anchoring of this wave at the inhomogeneity and a disruption of wave-pinning by fiber rotation. If this filament displays strong meandering, then again the anchoring is suppressed by fiber rotation; also, the scroll wave can be eliminated from most of the layers only to be regenerated by a seed wave. Ionic inhomogeneities can also lead to an anchoring of the scroll wave; scroll waves can now enter the region inside an ionic inhomogeneity and can display a coexistence of spatiotemporal chaos and quasi-periodic behavior in different parts of the simulation domain. We discuss the experimental implications of our study.	[Majumder, Rupamanjari; Nayak, Alok Ranjan; Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India; [Pandit, Rahul] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Majumder, R (corresponding author), Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India.	rupamanjari@physics.iisc.ernet.in	Nayak, Alok Ranjan/AAF-1119-2020; Nayak, Alok/E-2979-2016	Nayak, Alok/0000-0003-0102-0778; Breakspear, Michael/0000-0003-4943-3969	Department of Science and Technology (India); University Grants Commission (India); Microsoft Research Corporation (India); Council for Scientific and Industrial Research (India)	Department of Science and Technology (India)(Department of Science & Technology (India)); University Grants Commission (India)(University Grants Commission, India); Microsoft Research Corporation (India); Council for Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by research grants from the Department of Science and Technology (India), University Grants Commission (India), and Microsoft Research Corporation (India). ARN was supported by fellowships from the Council for Scientific and Industrial Research (India) and Microsoft Research Corporation (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AP, 2007, LECT NOTES COMPUT SC, V4466, P200; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; BRUGADA J, 1991, CIRCULATION, V84, P1296, DOI 10.1161/01.CIR.84.3.1296; Bub G, 1998, P NATL ACAD SCI USA, V95, P10283, DOI 10.1073/pnas.95.17.10283; Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Bursac N, 2004, P NATL ACAD SCI USA, V101, P15530, DOI 10.1073/pnas.0400984101; Chen JX, 2008, CENT EUR J PHYS, V6, P427, DOI 10.2478/s11534-008-0068-3; Cherry EM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125016; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; CLUSIN WT, 1982, CIRC RES, V50, P518, DOI 10.1161/01.RES.50.4.518; DAVIDENKO JM, 1990, P NATL ACAD SCI USA, V87, P8785, DOI 10.1073/pnas.87.22.8785; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; DILLON SM, 1988, CIRC RES, V63, P182, DOI 10.1161/01.RES.63.1.182; EFIMOV IR, 2004, CIRC RES        0721; Fenton F, 1998, PHYS REV LETT, V81, P481, DOI 10.1103/PhysRevLett.81.481; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Ferencik M, 2004, AM J CARDIOLOGY, V93, P1; Gillis AM, 2000, CIRCULATION, V101, P2438, DOI 10.1161/01.CIR.101.20.2438; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Gullberg GT, 2001, MAGN RESON IMAGING, V19, P233, DOI 10.1016/S0730-725X(01)00232-6; Hwang SM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198103; Hwang SM, 2005, P NATL ACAD SCI USA, V102, P10363, DOI 10.1073/pnas.0501539102; Ikeda T, 1997, CIRC RES, V81, P753; Iravanian S, 2003, AM J PHYSIOL-HEART C, V285, pH449, DOI 10.1152/ajpheart.00896.2002; Jalife J, 1998, CHAOS, V8, P79, DOI 10.1063/1.166289; Kim YH, 1999, CIRCULATION, V100, P1450, DOI 10.1161/01.CIR.100.13.1450; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kuijpers NHL, 2005, EUROPACE, V7, pS166, DOI 10.1016/j.eupc.2005.03.021; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Lim ZY, 2006, CIRCULATION, V114, P2113, DOI 10.1161/CIRCULATIONAHA.105.598631; LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; Nearing BD, 1996, J CARDIOVASC PHARM, V27, P777, DOI 10.1097/00005344-199606000-00003; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; PANFILOV AV, 2007, PROCS NAT ACD SCI, V104; PERTSOV AM, 1993, CIRCULATION RES, V72; Peters NS, 1996, CLIN SCI, V90, P447, DOI 10.1042/cs0900447; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Pumir A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.010901; QU Z, 2000, ANN BIOMED ENG, V28; Qu ZL, 2000, BIOPHYS J, V78, P2761, DOI 10.1016/S0006-3495(00)76821-4; Rappel WJ, 2001, CHAOS, V11, P71, DOI 10.1063/1.1338128; Remy-Jardin M, 2009, MED RADIOL DIAGN IMA, P161, DOI 10.1007/978-3-540-72387-5_10; Roth BJ, 2001, PHYSICA D, V150, P127, DOI 10.1016/S0167-2789(01)00145-2; Rusakov A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.022902; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Sinha S, 2002, CHAOS, V12, P893, DOI 10.1063/1.1501176; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; SINHA S, 2008, EPL, V81, P50002; Starobin JM, 1996, PHYS REV E, V54, P430, DOI 10.1103/PhysRevE.54.430; ten Tusscher KHWJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.062902; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; TENTUSSCHER KHW, 2006, PROGR BIOPHYSICS MOL, V90; Valderrabano M, 2000, J AM COLL CARDIOL, V36, P2000, DOI 10.1016/S0735-1097(00)00941-4; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2001, MED BIOL ENG COMPUT, V39, P455, DOI 10.1007/BF02345368; WINSLOW SDF, 2000, ANNU REV BIOMED ENG, V2; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Wu TJ, 2002, CIRCULATION, V106, P1859, DOI 10.1161/01.CIR.0000031334.49170.FB; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134; Zhang H, 2008, PROG BIOPHYS MOL BIO, V96, P112, DOI 10.1016/j.pbiomolbio.2007.07.020; Zhang HG, 2004, BIOCHEM BIOPH RES CO, V322, P693, DOI 10.1016/j.bbrc.2004.07.176	69	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18052	10.1371/journal.pone.0018052	http://dx.doi.org/10.1371/journal.pone.0018052			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483682	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000289191300006
J	Auld, AF; Mbofana, F; Shiraishi, RW; Sanchez, M; Alfredo, C; Nelson, LJ; Ellerbrock, T				Auld, Andrew F.; Mbofana, Francisco; Shiraishi, Ray W.; Sanchez, Mauro; Alfredo, Charity; Nelson, Lisa J.; Ellerbrock, Tedd			Four-Year Treatment Outcomes of Adult Patients Enrolled in Mozambique's Rapidly Expanding Antiretroviral Therapy Program	PLOS ONE			English	Article							HIV-INFECTED ADULTS; SUB-SAHARAN AFRICA; EARLY MORTALITY; FOLLOW-UP; SCALE-UP; PREVENTION INTERVENTIONS; MULTIPLE IMPUTATION; SEXUAL-BEHAVIOR; SOUTH-AFRICA; COTRIMOXAZOLE PROPHYLAXIS	Background: In Mozambique during 2004-2007 numbers of adult patients (>= 15 years old) enrolled on antiretroviral therapy (ART) increased about 16-fold, from <5,000 to 79,500. All ART patients were eligible for co-trimoxazole. ART program outcomes, and determinants of outcomes, have not yet been reported. Methodology/Principal Findings: In a retrospective cohort study, we investigated rates of mortality, attrition (death, loss to follow-up, or treatment cessation), immunologic treatment failure, and regimen-switch, as well as determinants of selected outcomes, among a nationally representative sample of 2,596 adults initiating ART during 2004-2007. At ART initiation, median age of patients was 34 and 62% were female. Malnutrition and advanced disease were common; 18% of patients weighed,45 kilograms, and 15% were WHO stage IV. Median baseline CD4(+) T-cell count was 153/mu L and was lower for males than females (139/mu L vs. 159/mu L, p<0.01). Stavudine, lamivudine, and nevirapine or efavirenz were prescribed to 88% of patients; only 31% were prescribed co-trimoxazole. Mortality and attrition rates were 3.4 deaths and 19.8 attritions per 100 patient-years overall, and 12.9 deaths and 57.2 attritions per 100 patient-years in the first 90 days. Predictors of attrition included male sex [adjusted hazard ratio (AHR) 1.5; 95% confidence interval (CI), 1.3-1.8], weight,45 kg (AHR 2.1; 95% CI, 1.6-2.9, reference group >60 kg), WHO stage IV (AHR 1.7; 95% CI, 1.3-2.4, reference group WHO stage I/II), lack of cotrimoxazole prescription (AHR 1.4; 95% CI, 1.0-1.8), and later calendar year of ART initiation (AHR 1.5; 95% CI, 1.2-1.8). Rates of immunologic treatment failure and regimen-switch were 14.0 and 0.6 events per 100-patient years, respectively. Conclusions: ART initiation at earlier disease stages and scale-up of co-trimoxazole among ART patients could improve outcomes. Research to determine reasons for low regimen-switch rates and increasing rates of attrition during program expansion is needed.	[Auld, Andrew F.; Shiraishi, Ray W.; Ellerbrock, Tedd] Ctr Dis Control & Prevent CDC, Div Global AIDS, Atlanta, GA 30333 USA; [Mbofana, Francisco] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Sanchez, Mauro; Alfredo, Charity; Nelson, Lisa J.] Ctr Dis Control & Prevent CDC, Div Global AIDS, Maputo, Mozambique	Centers for Disease Control & Prevention - USA	Auld, AF (corresponding author), Ctr Dis Control & Prevent CDC, Div Global AIDS, Atlanta, GA 30333 USA.	aauld@cdc.gov	Sanchez, Mauro/AAU-2404-2020	Sanchez, Mauro/0000-0002-0472-1804; Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163	U.S. Centers for Disease Control and Prevention (CDC)	U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All parts of this study were funded by the United States President's Emergency Plan for AIDS Relief (PEPFAR, http://www.pepfar.gov/) through the U.S. Centers for Disease Control and Prevention (CDC). Authors employed by the CDC (Drs Auld, Shiraishi, Sanchez, Alfredo, Nelson, and Ellerbrock) contributed substantially to all parts of the study and writing of the manuscript.	Alemu AW, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5398; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boerma JT, 2006, B WORLD HEALTH ORGAN, V84, P145, DOI 10.2471/BLT.05.025189; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brentlinger PE, 2010, JAIDS-J ACQ IMM DEF, V55, P351, DOI 10.1097/QAI.0b013e3181e3a4cd; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Coyne-Meyers Kristen, 2004, Nutr Clin Pract, V19, P340, DOI 10.1177/0115426504019004340; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Donovan C, 2007, FOOD NUTR BULL, V28, pS331, DOI 10.1177/15648265070282S212; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; GENG EH, 2009, J ACQ IMMUN DEF SYND, V53, P405; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Gordon CM, 2005, AIDS EDUC PREV, V17, P6, DOI 10.1521/aeap.17.2.6.58697; Gordon CM, 2004, JAIDS-J ACQ IMM DEF, V37, pS53, DOI 10.1097/01.qai.0000142321.27136.8b; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hoffmann CJ, 2010, AIDS, V24, P1709, DOI 10.1097/QAD.0b013e32833ac6bc; Janssen RS, 2004, JAIDS-J ACQ IMM DEF, V37, pS119, DOI 10.1097/01.qai.0000140610.82134.e3; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Makombe SD, 2007, INT J TUBERC LUNG D, V11, P412; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; *MULT TECHN GROUP, IMP DEM HIV SIDA MOZ; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2010.02512.x; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Seyler C, 2003, ANTIVIR THER, V8, P385; Sherr K, 2009, JAIDS-J ACQ IMM DEF, V52, pS20, DOI 10.1097/QAI.0b013e3181bbc9c0; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; *US CDCP, 2003, JAMA-J AM MED ASSOC, V289, P2493; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO, 2010, ANT THER HIV INF AD; WHO, ANT THER HIV INF AD; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhou J, 2007, HIV MED, V8, P8, DOI 10.1111/j.1468-1293.2007.00417.x	76	74	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18453	10.1371/journal.pone.0018453	http://dx.doi.org/10.1371/journal.pone.0018453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483703	Green Published, gold			2022-12-25	WOS:000289058700029
J	Zanello, G; Berri, M; Dupont, J; Sizaret, PY; D'Inca, R; Salmon, H; Meurens, F				Zanello, Galliano; Berri, Mustapha; Dupont, Joelle; Sizaret, Pierre-Yves; D'Inca, Romain; Salmon, Henri; Meurens, Francois			Saccharomyces cerevisiae Modulates Immune Gene Expressions and Inhibits ETEC-Mediated ERK1/2 and p38 Signaling Pathways in Intestinal Epithelial Cells	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; INFECTED T84 CELLS; DIFFICILE TOXIN-A; NF-KAPPA-B; IN-VITRO; ANTIMICROBIAL RESISTANCE; TRANSCRIPTION FACTORS; VIRULENCE FACTORS; COLONIC-MUCOSA; BOULARDII	Background: Enterotoxigenic Escherichia coli (ETEC) infections result in large economic losses in the swine industry worldwide. ETEC infections cause pro-inflammatory responses in intestinal epithelial cells and subsequent diarrhea in pigs, leading to reduced growth rate and mortality. Administration of probiotics as feed additives displayed health benefits against intestinal infections. Saccharomyces cerevisiae (Sc) is non-commensal and non-pathogenic yeast used as probiotic in gastrointestinal diseases. However, the immuno-modulatory effects of Sc in differentiated porcine intestinal epithelial cells exposed to ETEC were not investigated. Methodology/Principal Findings: We reported that the yeast Sc (strain CNCM I-3856) modulates transcript and protein expressions involved in inflammation, recruitment and activation of immune cells in differentiated porcine intestinal epithelial IPEC-1 cells. We demonstrated that viable Sc inhibits the ETEC-induced expression of pro-inflammatory transcripts (IL-6, IL-8, CCL20, CXCL2, CXCL10) and proteins (IL-6, IL-8). This inhibition was associated to a decrease of ERK1/2 and p38 MAPK phosphorylation, an agglutination of ETEC by Sc and an increase of the anti-inflammatory PPAR-c nuclear receptor mRNA level. In addition, Sc up-regulates the mRNA levels of both IL-12p35 and CCL25. However, measurement of transepithelial electrical resistance displayed that Sc failed to maintain the barrier integrity in monolayer exposed to ETEC suggesting that Sc does not inhibit ETEC enterotoxin activity. Conclusions: Sc (strain CNCM I-3856) displays multiple immuno-modulatory effects at the molecular level in IPEC-1 cells suggesting that Sc may influence intestinal inflammatory reaction.	[Zanello, Galliano; D'Inca, Romain] Soc Ind Lesaffre, Marcq En Baroeul, France; [Zanello, Galliano; Berri, Mustapha; Salmon, Henri; Meurens, Francois] INRA, UR1282, Tours, France; [Dupont, Joelle] INRA, UMR85, Tours, France; [Sizaret, Pierre-Yves] Univ Tours, Dept Microscopies, Plate Forme RIO Microscopie Elect, Tours, France	INRAE; INRAE; Universite de Tours	Zanello, G (corresponding author), Soc Ind Lesaffre, Marcq En Baroeul, France.	meurens@tours.inra.fr	Meurens, Francois JMA/J-3829-2019; salmon, henri/B-2605-2010	Meurens, Francois JMA/0000-0002-0353-4871; 	Lesaffre company; INRA; French government	Lesaffre company; INRA; French government	The study has been funded mostly by Lesaffre company and partially by INRA (<10%). GZ received a CIFRE PhD grant from Lesaffre company and the French government (50/50). GZ performed all the study at INRA under the supervision of HS and FM (INRA employees). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Bandyopadhaya A, 2009, CAN J MICROBIOL, V55, P1310, DOI [10.1139/W09-093, 10.1139/w09-093]; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Bridger PS, 2010, VET IMMUNOL IMMUNOP, V137, P54, DOI 10.1016/j.vetimm.2010.04.010; Bruel T, 2010, DEV COMP IMMUNOL, V34, P562, DOI 10.1016/j.dci.2009.12.017; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Castagliuolo I, 1999, INFECT IMMUN, V67, P302, DOI 10.1128/IAI.67.1.302-307.1999; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chen XH, 2009, GASTROENTEROLOGY, V137, P914, DOI 10.1053/j.gastro.2009.05.050; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Czerucka D, 2000, INFECT IMMUN, V68, P5998, DOI 10.1128/IAI.68.10.5998-6004.2000; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; Dahan S, 2002, INFECT IMMUN, V70, P2304, DOI 10.1128/IAI.70.5.2304-2310.2002; Dalmasso G, 2006, RES MICROBIOL, V157, P456, DOI 10.1016/j.resmic.2005.11.007; DESREUMAUX P, 2010, SACCHAROMYCES CEREVI; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Docic M, 2003, J VET MED B, V50, P27, DOI 10.1046/j.1439-0450.2003.00609.x; Dommisch H, 2010, INNATE IMMUN-LONDON, V16, P226, DOI 10.1177/1753425909339237; Edwards-Ingram L, 2007, APPL ENVIRON MICROB, V73, P2458, DOI 10.1128/AEM.02201-06; Ericsson A, 2006, J IMMUNOL, V176, P3642, DOI 10.4049/jimmunol.176.6.3642; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; ETIENNEMESMIN L, 2010, APPL ENV MICROBIOL; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fang L, 2000, INFECT IMMUN, V68, P564, DOI 10.1128/IAI.68.2.564-569.2000; Fietto JLR, 2004, CAN J MICROBIOL, V50, P615, DOI [10.1139/w04-050, 10.1139/W04-050]; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; GonzalezVallina R, 1996, AM J PHYSIOL-GASTR L, V271, pG249, DOI 10.1152/ajpgi.1996.271.2.G249; Hennequin C, 2001, J CLIN MICROBIOL, V39, P551, DOI 10.1128/JCM.39.2.551-559.2001; Huang FC, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/103890; Jin LZ, 2000, APPL MICROBIOL BIOT, V54, P311, DOI 10.1007/s002530000404; JOHNSON AM, 2009, VET MICROBIOL; Jurczyluk J, 2003, CELL BIOL INT, V27, P997, DOI 10.1016/j.cellbi.2003.09.002; Jurgens MH, 1997, J ANIM SCI, V75, P593; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kaplan JM, 2010, MOL MED, V16, P491, DOI 10.2119/molmed.2010.00063; Koh SY, 2008, VET MICROBIOL, V130, P191, DOI 10.1016/j.vetmic.2007.12.018; Konstantinov SR, 2008, FEMS MICROBIOL ECOL, V66, P599, DOI 10.1111/j.1574-6941.2008.00517.x; Kuhle AVDA, 2005, INT J FOOD MICROBIOL, V101, P29, DOI 10.1016/j.ijfoodmicro.2004.10.039; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; Lee Sang Kil, 2005, Korean J Gastroenterol, V45, P328; Lessard M, 2009, J ANIM SCI, V87, P922, DOI 10.2527/jas.2008-0919; Levine M M, 1981, Ciba Found Symp, V80, P142; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; Meurens F, 2006, VET IMMUNOL IMMUNOP, V113, P313, DOI 10.1016/j.vetimm.2006.05.014; Moeser AJ, 2008, WORLD J GASTROENTERO, V14, P6012, DOI 10.3748/wjg.14.6012; MUMY KL, 2007, AM J PHYSL GASTROINT; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nighot PK, 2009, EXP CELL RES, V315, P110, DOI 10.1016/j.yexcr.2008.10.001; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Perez-Sotelo Luis Salvador, 2005, Rev Latinoam Microbiol, V47, P70; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Roselli M, 2007, TOXICOL IN VITRO, V21, P224, DOI 10.1016/j.tiv.2006.09.012; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Saegusa S, 2009, BIOSCI BIOTECH BIOCH, V73, P2600, DOI 10.1271/bbb.90410; Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Valledor AF, 2008, J IMMUNOL, V180, P4523, DOI 10.4049/jimmunol.180.7.4523; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEIGUO Z, 2009, IMMUNOL CELL BIOL, V88, P305; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007; ZANELLO G, VET IMMUNOL IN PRESS; Zanello G, 2009, CURR ISSUES MOL BIOL, V11, P47; Zhou YJ, 2009, MOL CELL BIOCHEM, V325, P131, DOI 10.1007/s11010-009-0027-3	78	98	101	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18573	10.1371/journal.pone.0018573	http://dx.doi.org/10.1371/journal.pone.0018573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483702	Green Published, gold			2022-12-25	WOS:000289058700032
J	Bruno, L; Salierno, M; Wetzler, DE; Desposito, MA; Levi, V				Bruno, Luciana; Salierno, Marcelo; Wetzler, Diana E.; Desposito, Marcelo A.; Levi, Valeria			Mechanical Properties of Organelles Driven by Microtubule-Dependent Molecular Motors in Living Cells	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; XENOPUS-LAEVIS MELANOPHORES; CYTOPLASMIC DYNEIN; INTRACELLULAR-TRANSPORT; MYOSIN-V; BIDIRECTIONAL MOTILITY; PARTICLE TRACKING; DYNACTIN; PROTEIN; MELANOSOMES	The organization of the cytoplasm is regulated by molecular motors which transport organelles and other cargoes along cytoskeleton tracks. Melanophores have pigment organelles or melanosomes that move along microtubules toward their minus and plus end by the action of cytoplasmic dynein and kinesin-2, respectively. In this work, we used single particle tracking to characterize the mechanical properties of motor-driven organelles during transport along microtubules. We tracked organelles with high temporal and spatial resolutions and characterized their dynamics perpendicular to the cytoskeleton track. The quantitative analysis of these data showed that the dynamics is due to a spring-like interaction between melanosomes and microtubules in a viscoelastic microenvironment. A model based on a generalized Langevin equation explained these observations and predicted that the stiffness measured for the motor complex acting as a linker between organelles and microtubules is, one order smaller than that determined for motor proteins in vitro. This result suggests that other biomolecules involved in the interaction between motors and organelles contribute to the mechanical properties of the motor complex. We hypothesise that the high flexibility observed for the motor linker may be required to improve the efficiency of the transport driven by multiple copies of motor molecules.	[Bruno, Luciana; Desposito, Marcelo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Salierno, Marcelo; Wetzler, Diana E.; Levi, Valeria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Bruno, L (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Pabellon 1,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.	vlevi@df.uba.ar	Salierno, Marcelo J/E-5557-2016; Salierno, Marcelo/AAA-7198-2021	Salierno, Marcelo J/0000-0003-3897-3177; Levi, Valeria/0000-0002-1666-4675; Wetzler, Diana Elena/0000-0003-2231-6690	ANPCyT [PICT 2008-1104]; UBACyT [20020090200201]	ANPCyT(ANPCyT); UBACyT	This research was supported by ANPCyT (PICT 2008-1104) and UBACyT (20020090200201). LB, MAD, DW and VL are members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albet-Torres N, 2007, LANGMUIR, V23, P11147, DOI 10.1021/la7008682; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BERLINER E, 1994, J BIOL CHEM, V269, P8610; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Bruno L, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011912; Bruno L, 2008, CELL BIOCHEM BIOPHYS, V52, P191, DOI 10.1007/s12013-008-9034-3; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Desposito MA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021111; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; Ishii Y., 2003, MOL MOTORS; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Kashina AS, 2004, CURR BIOL, V14, P1877, DOI 10.1016/j.cub.2004.10.003; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kubo R., 1991, STAT PHYS; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Levi V, 2006, BIOPHYS J, V90, pL7, DOI 10.1529/biophysj.105.075556; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Martin DS, 2002, BIOPHYS J, V83, P2109, DOI 10.1016/S0006-3495(02)73971-4; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Nilsson H, 1997, CELL MOTIL CYTOSKEL, V38, P397, DOI 10.1002/(SICI)1097-0169(1997)38:4<397::AID-CM9>3.3.CO;2-5; Olesen OF, 2002, GENE, V283, P299, DOI 10.1016/S0378-1119(01)00869-1; Raupach C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011918; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tolic-Norrelykke IM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.078102; Toyabe S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041403; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vinales AD, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016111; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Wong IY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178101	56	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18332	10.1371/journal.pone.0018332	http://dx.doi.org/10.1371/journal.pone.0018332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483765	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058300011
J	Yang, JR; Lin, YC; Huang, YP; Su, CH; Lo, J; Ho, YL; Yao, CY; Hsu, LC; Wu, HS; Liu, MT				Yang, Ji-Rong; Lin, Yu-Cheng; Huang, Yuan-Pin; Su, Chun-Hui; Lo, Je; Ho, Yu-Lin; Yao, Ching-Yuan; Hsu, Li-Ching; Wu, Ho-Sheng; Liu, Ming-Tsan			Reassortment and Mutations Associated with Emergence and Spread of Oseltamivir-Resistant Seasonal Influenza A/H1N1 Viruses in 2005-2009	PLOS ONE			English	Article							A(H1N1) VIRUSES; A VIRUS; SURVEILLANCE; EVOLUTION; H1N1	A dramatic increase in the frequency of the H275Y mutation in the neuraminidase (NA), conferring resistance to oseltamivir, has been detected in human seasonal influenza A/H1N1 viruses since the influenza season of 2007-2008. The resistant viruses emerged in the ratio of 14.3% and quickly reached 100% in Taiwan from September to December 2008. To explore the mechanisms responsible for emergence and spread of the resistant viruses, we analyzed the complete genome sequences of 25 viruses collected during 2005-2009 in Taiwan, which were chosen from various clade viruses, 1, 2A, 2B-1, 2B-2, 2C-1 and 2C-2 by the classification of hemagglutinin (HA) sequences. Our data revealed that the dominant variant, clade 2B-1, in the 2007-2008 influenza emerged through an intra-subtype 4+ 4 reassortment between clade 1 and 2 viruses. The dominant variant acquired additional substitutions, including A206T in HA, H275Y and D354G in NA, L30R and H41P in PB1-F2, and V411I and P453S in basic polymerase 2 (PB2) proteins and subsequently caused the 2008-2009 influenza epidemic in Taiwan, accompanying the widespread oseltamivir-resistant viruses. We also characterized another 3+ 5 reassortant virus which became double resistant to oseltamivir and amantadine. Comparison of oseltamivir-resistant influenza A/H1N1 viruses belonging to various clades in our study highlighted that both reassortment and mutations were associated with emergence and spread of these viruses and the specific mutation, H275Y, conferring to antiviral resistance, was acquired in a hitch-hiking mechanism during the viral evolutionary processes.	[Yang, Ji-Rong; Lin, Yu-Cheng; Huang, Yuan-Pin; Su, Chun-Hui; Lo, Je; Ho, Yu-Lin; Yao, Ching-Yuan; Hsu, Li-Ching; Wu, Ho-Sheng; Liu, Ming-Tsan] Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University	Yang, JR (corresponding author), Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan.	wuhs@cdc.gov.tw; mtliu@cdc.gov.tw			National Science Council [98-0324-01-F-20, 99-0324-01-F-12]; Centers for Disease Control, Department of Health, Taiwan [DOH98-DC-2011, DOH99-DC-2027]	National Science Council(Ministry of Science and Technology, Taiwan); Centers for Disease Control, Department of Health, Taiwan	This study was supported by grants from the National Science Council (National Research Program for Genome Medicine 98-0324-01-F-20 and 99-0324-01-F-12) and Centers for Disease Control, Department of Health, Taiwan (DOH98-DC-2011 and DOH99-DC-2027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon A, 2009, EUROSURVEILLANCE, V14; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Casalegno JS, 2010, ANTIVIR RES, V87, P242, DOI 10.1016/j.antiviral.2010.05.010; Cheng PKC, 2010, EMERG INFECT DIS, V16, P155, DOI 10.3201/eid1601.091304; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gooskens J, 2009, JAMA-J AM MED ASSOC, V301, P1042, DOI 10.1001/jama.2009.297; HALL CB, 1987, PEDIATRICS, V80, P275; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; HAYDEN FG, 1991, ANTIMICROB AGENTS CH, V35, P1741, DOI 10.1128/AAC.35.9.1741; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Lackenby A., 2008, Eurosurveillance, V13, P8026; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ward Penelope, 2005, J Antimicrob Chemother, V55 Suppl 1, pi5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; *WHO, 2009, INFL A H1N1 VIR RES; *WHO, 2009, INFL VIR RES OS OTH; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	37	29	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18177	10.1371/journal.pone.0018177	http://dx.doi.org/10.1371/journal.pone.0018177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483816	gold, Green Published			2022-12-25	WOS:000289057200039
J	Bansal, V; Tewhey, R; LeProust, EM; Schork, NJ				Bansal, Vikas; Tewhey, Ryan; LeProust, Emily M.; Schork, Nicholas J.			Efficient and Cost Effective Population Resequencing by Pooling and In-Solution Hybridization	PLOS ONE			English	Article							RARE VARIANTS; GENETIC-VARIATION; COMPLEX DISEASES; DNA; ASSOCIATION	High-throughput sequencing of targeted genomic loci in large populations is an effective approach for evaluating the contribution of rare variants to disease risk. We evaluated the feasibility of using in-solution hybridization-based target capture on pooled DNA samples to enable cost-efficient population sequencing studies. For this, we performed pooled ;sequencing of 100 HapMap samples across similar to 600 kb of DNA sequence using the Illumina GAIIx. Using our accurate variant calling method for pooled sequence data, we were able to not only identify single nucleotide variants with a low false discovery rate (<1%) but also accurately detect short insertion/deletion variants. In addition, with sufficient coverage per individual in each pool (30-fold) we detected 97.2% of the total variants and 93.6% of variants below 5% in frequency. Finally, allele frequencies for single nucleotide variants (SNVs) estimated from the pooled data and the HapMap genotype data were tightly correlated (correlation coefficient >= 0.995).	[Bansal, Vikas; Tewhey, Ryan; Schork, Nicholas J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Tewhey, Ryan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [LeProust, Emily M.] Agilent Technol LLSU, Genom, Santa Clara, CA USA; [Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; University of California System; University of California San Diego; Agilent Technologies; Scripps Research Institute	Bansal, V (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	vbansal@scripps.edu; rtewhey@ucsd.edu; nschork@scripps.edu		Schork, Nicholas/0000-0003-0920-5013	Price Foundation; Scripps Genomic Medicine;  [U19 AG023122-01];  [R01 MH078151-01A1];  [N01 MH22005];  [U01 DA024417-01];  [P50 MH081755-01];  [UL1 RR025774]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755, R01MH078151, N01MH022005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG023122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA024417] Funding Source: NIH RePORTER	Price Foundation; Scripps Genomic Medicine; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the following research grants: U19 AG023122-01, R01 MH078151-01A1, N01 MH22005, U01 DA024417-01, P50 MH081755-01, UL1 RR025774, the Price Foundation and Scripps Genomic Medicine. This work is the authors' sole responsibility and does not necessarily represent funding agencies' views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502	18	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18353	10.1371/journal.pone.0018353	http://dx.doi.org/10.1371/journal.pone.0018353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479135	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700052
J	Liedtke, HC; Abjornsson, K; Harraca, V; Knudsen, JT; Wallin, EA; Hedenstrom, E; Ryne, C				Liedtke, H. Christoph; Abjornsson, Kajsa; Harraca, Vincent; Knudsen, Jette T.; Wallin, Erika A.; Hedenstrom, Erik; Ryne, Camilla			Alarm Pheromones and Chemical Communication in Nymphs of the Tropical Bed Bug Cimex hemipterus (Hemiptera: Cimicidae)	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; LECTULARIUS; COMPONENTS; BEHAVIOR; BEDBUGS	The recent resurge of bed bug infestations (Cimex spp.; Cimicidae) and their resistance to commonly used pesticides calls for alternative methods of control. Pheromones play an important role in environmentally sustainable methods for the management of many pest insects and may therefore be applicable for the control of bed bugs. The tropical bed bug, Cimex hemipterus, is a temporary ectoparasite on humans and causes severe discomfort. Compared to the common bed bug, Cimex lectularius, little is known about the chemical signalling and pheromone-based behaviour of the tropical species. Here, we show that the antennal morphology and volatile emission of C. hemipterus closely resembles those of C. lectularius and we test their behavioural responses to conspecific odour emissions. Two major volatiles are emitted by male, female and nymph C. hemipterus under stress, (E)-2-hexenal and (E)-2-octenal. Notably, nymph emissions show contrasting ratios of these compounds to adults and are further characterized by the addition of 4-oxo-(E)-2-hexenal and 4-oxo-(E)-2-octenal. The discovery of this nymph pheromone in C. hemipterus is potentially the cause of a repellent effect observed in the biotests, where nymph odours induce a significantly stronger repellent reaction in conspecifics than adult odours. Our results suggest that pheromone-based pest control methods developed for C. lectularius could be applicable to C. hemipterus, with the unique nymph blend showing promising practical properties.	[Liedtke, H. Christoph; Abjornsson, Kajsa; Harraca, Vincent; Knudsen, Jette T.; Wallin, Erika A.; Hedenstrom, Erik; Ryne, Camilla] Lund Univ, Dept Ecol, S-22362 Lund, Sweden; [Wallin, Erika A.; Hedenstrom, Erik] Engn & Math Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden	Lund University	Liedtke, HC (corresponding author), Lund Univ, Dept Ecol, S-22362 Lund, Sweden.	jette.knudsen@ekol.lu.se	Liedtke, H. Christoph/K-2253-2015	Liedtke, H. Christoph/0000-0002-6221-8043; Harraca, Vincent/0000-0002-9506-0895	Swedish International Development Agency [SWE 2005-340]; Crafoord Foundation [20080561]; Carl Trygger Foundation [CTS 03:278]; LU; EU Foundation; Lanstyrelsen i Vasternorrlands lan	Swedish International Development Agency; Crafoord Foundation; Carl Trygger Foundation; LU; EU Foundation; Lanstyrelsen i Vasternorrlands lan	Swedish International Development Agency (SWE 2005-340); Crafoord Foundation (20080561); Carl Trygger Foundation (CTS 03:278); LU travel stipend for CR; EU Foundation, and Lanstyrelsen i Vasternorrlands lan for EW and EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; Benoit JB, 2009, J MED ENTOMOL, V46, P572, DOI 10.1603/033.046.0323; Blum M.S., 1985, P193; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; BOASE C, 2007, BED BUGS RES RESURGE, P261; Boase Clive J., 2004, Biologist (London), V51, P9; Burgess I., 2003, PROFESSIONAL PEST CO, V32, P16; CARAYON J, 1971, ANN SOC ENTOMOL FR, V7, P737; Cleary Carmen J, 2004, Nurse Pract, V29, P46, DOI 10.1097/00006205-200406000-00009; DOGGETT SL, 2003, ENV HLTH, P80; DOGGETT SL, 2004, ENV HLTH, P30; Feldlaufer MF, 2010, J MED ENTOMOL, V47, P140, DOI 10.1603/ME09210; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; GEBHARDT H, 1953, ZOOL JB PHYSL, P558; Harraca V, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-121; Harraca V, 2010, CHEM SENSES, V35, P195, DOI 10.1093/chemse/bjp096; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P102, DOI 10.1016/j.pestbp.2006.09.006; LEVINSON HZ, 1974, NATURWISSENSCHAFTEN, V61, P684, DOI 10.1007/BF00606522; LEVINSON HZ, 1974, J INSECT PHYSIOL, V20, P1231, DOI 10.1016/0022-1910(74)90229-7; LEVINSON HZ, 1971, EXPERIENTIA, V27, P102, DOI 10.1007/BF02137766; MCIVER SB, 1987, INSECT SCI APPL, V8, P627, DOI 10.1017/S1742758400022712; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Moreira JA, 2005, J CHEM ECOL, V31, P965, DOI 10.1007/s10886-004-1978-1; Myamba J, 2002, MED VET ENTOMOL, V16, P448, DOI 10.1046/j.1365-2915.2002.00389.x; NEWBERRY K, 1989, MED VET ENTOMOL, V3, P407, DOI 10.1111/j.1365-2915.1989.tb00248.x; Olson JF, 2009, J INSECT PHYSIOL, V55, P580, DOI 10.1016/j.jinsphys.2009.03.001; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Singh RN, 1996, INT J INSECT MORPHOL, V25, P183, DOI 10.1016/0020-7322(95)00016-X; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Staddon B.W., 1979, Advances in Insect Physiology, V14, P351, DOI 10.1016/S0065-2806(08)60055-7; STEINBRECHT RA, 1976, TISSUE CELL, V8, P615, DOI 10.1016/0040-8166(76)90035-5; Usinger RL, 1966, MONOGRAPH CIMICIDAE; Valeur PG, 1999, PHYSIOL ENTOMOL, V24, P240, DOI 10.1046/j.1365-3032.1999.00138.x	36	17	18	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18156	10.1371/journal.pone.0018156	http://dx.doi.org/10.1371/journal.pone.0018156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479180	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700035
J	Konstantinopoulos, PA; Cannistra, SA; Fountzilas, H; Culhane, A; Pillay, K; Rueda, B; Cramer, D; Seiden, M; Birrer, M; Coukos, G; Zhang, L; Quackenbush, J; Spentzos, D				Konstantinopoulos, Panagiotis A.; Cannistra, Stephen A.; Fountzilas, Helen; Culhane, Aedin; Pillay, Kamana; Rueda, Bo; Cramer, Daniel; Seiden, Michael; Birrer, Michael; Coukos, George; Zhang, Lin; Quackenbush, John; Spentzos, Dimitrios			Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; GENOMIC SIGNATURES; STAGE-III; PACLITAXEL; CISPLATIN; PATTERNS; PATHWAY; CELL; CARBOPLATIN; CARCINOMA	Background: Public data integration may help overcome challenges in clinical implementation of microarray profiles. We integrated several ovarian cancer datasets to identify a reproducible predictor of survival. Methodology/Principal Findings: Four microarray datasets from different institutions comprising 265 advanced stage tumors were uniformly reprocessed into a single training dataset, also adjusting for inter-laboratory variation ("batcheffect"). Supervised principal component survival analysis was employed to identify prognostic models. Models were independently validated in a 61-patient cohort using a custom array genechip and a publicly available 229-array dataset. Molecular correspondence of high-and low-risk outcome groups between training and validation datasets was demonstrated using Subclass Mapping. Previously established molecular phenotypes in the 2(nd) validation set were correlated with high and low-risk outcome groups. Functional representational and pathway analysis was used to explore gene networks associated with high and low risk phenotypes. A 19-gene model showed optimal performance in the training set (median OS 31 and 78 months, p < 0.01), 1(st) validation set (median OS 32 months versus not-yet-reached, p=0.026) and 2(nd) validation set (median OS 43 versus 61 months, p=0.013) maintaining independent prognostic power in multivariate analysis. There was strong molecular correspondence of the respective high-and low-risk tumors between training and 1(st) validation set. Low and high-risk tumors were enriched for favorable and unfavorable molecular subtypes and pathways, previously defined in the public 2(nd) validation set. Conclusions/Significance: Integration of previously generated cancer microarray datasets may lead to robust and widely applicable survival predictors. These predictors are not simply a compilation of prognostic genes but appear to track true molecular phenotypes of good-and poor-outcome.	[Konstantinopoulos, Panagiotis A.; Cannistra, Stephen A.; Fountzilas, Helen; Pillay, Kamana; Spentzos, Dimitrios] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Boston, MA 02215 USA; [Culhane, Aedin; Quackenbush, John] Harvard Univ, Dept Biostat & Computat Biol, Dana Farber Canc Inst, Dept Biostat,Sch Publ Hlth, Boston, MA 02215 USA; [Rueda, Bo] Harvard Univ, Dept Obstet Gynecol & Reprod Biol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA; [Cramer, Daniel] Harvard Univ, Dept Obstet Gynecol & Reprod Biol, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA; [Seiden, Michael] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Birrer, Michael] Harvard Univ, Div Gynecol Med Oncol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Gynecol Oncol, Philadelphia, PA 19104 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fox Chase Cancer Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute	Konstantinopoulos, PA (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Boston, MA 02215 USA.	dspentzo@bidmc.harvard.edu	Coukos, George/ABG-7389-2020; Culhane, Aedin/AAG-8490-2019; Zhang, Lin/K-8478-2012	Culhane, Aedin/0000-0002-1395-9734; Quackenbush, John/0000-0002-2702-5879; Coukos, George/0000-0001-8813-7367	NIH/NCI [P50CA105009]; Clinical Investigation Training Program; Beth Israel Deaconess Medical Center; Harvard-MIT Division of Health Sciences and Technology, Boston; Bernice Shopkin Weisman Fund; Ovarian Cancer Research Fund in memory of Amy Sachs Simon; LeAnn's Fund; Sisters Against Ovarian Cancer; NATIONAL CANCER INSTITUTE [P50CA105009] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical Investigation Training Program; Beth Israel Deaconess Medical Center; Harvard-MIT Division of Health Sciences and Technology, Boston; Bernice Shopkin Weisman Fund; Ovarian Cancer Research Fund in memory of Amy Sachs Simon; LeAnn's Fund; Sisters Against Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported via the NIH/NCI P50CA105009 Ovarian Cancer SPORE (Career Development Award to Dimitrios Spentzos, and Project 4 to Daniel Cramer/Stephen Cannistra), the Clinical Investigation Training Program, Beth Israel Deaconess Medical Center and Harvard-MIT Division of Health Sciences and Technology, Boston, to Panagiotis Konstantinopoulos, the Bernice Shopkin Weisman Fund, the Ovarian Cancer Research Fund in memory of Amy Sachs Simon, LeAnn's Fund, and the Sisters Against Ovarian Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Baggerly KA, 2008, J CLIN ONCOL, V26, P1186, DOI 10.1200/JCO.2007.15.1951; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Culhane AC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-59; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Konstantinopoulos PA, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-59; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Schwartz DR, 2002, CANCER RES, V62, P4722; Selvakumaran M, 2003, CANCER RES, V63, P1311; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Smith S, 2007, J CLIN ONCOL, V25, P5172, DOI 10.1200/JCO.2007.11.8547; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THIGPEN T, 1993, CANCER-AM CANCER SOC, V71, P606; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	34	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18202	10.1371/journal.pone.0018202	http://dx.doi.org/10.1371/journal.pone.0018202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479231	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600033
J	Roy, R; Rodig, S; Bielenberg, D; Zurakowski, D; Moses, MA				Roy, Roopali; Rodig, Scott; Bielenberg, Diane; Zurakowski, David; Moses, Marsha A.			ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth A DISTINCT ROLE FOR ADAM12-S PROTEIN IN TUMOR METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							12 MELTRIN ALPHA; CELL-PROLIFERATION; FAMILY-MEMBERS; CANCER; METALLOPROTEINASES; DISINTEGRIN; PROGRESSION; EXPRESSION; APOPTOSIS; STAGE	Increased levels of ADAM12 have been reported in a variety of human cancers. We have previously reported that urinary ADAM12 is predictive of disease status in breast cancer patients and that ADAM12 protein levels in urine increase with progression of disease. On the basis of these findings, the goal of this study was to elucidate the contribution of ADAM12 in breast tumor growth and progression. Overexpression of both the ADAM12-L (transmembrane) and ADAM12-S (secreted) isoforms in human breast tumor cells resulted in a significantly higher rate of tumor take and increased tumor size. Cells expressing the enzymatically inactive form of the secreted isoform, ADAM12-S, had tumor take rates and tumor volumes similar to those of wild-type cells, suggesting that the tumor-promoting activity of ADAM12-S was a function of its proteolytic activity. Of the two isoforms, only the secreted isoform, ADAM12-S, enhanced the ability of tumor cells to migrate and invade in vitro and resulted in a higher incidence of local and distant metastasis in vivo. This stimulatory effect of ADAM12-S on migration and invasion was dependent on its catalytic activity. Expression of both ADAM12 isoforms was found to be significantly elevated in human malignant breast tissue. Taken together, our results suggest that ADAM12 overexpression results in increased tumor take, tumor size, and metastasis in vivo. These findings suggest that ADAM12 may represent a potential therapeutic target in breast cancer.	[Moses, Marsha A.] Childrens Hosp Boston, Karp Family Res Labs, Program Vasc Biol, Boston, MA 02115 USA; Childrens Hosp Boston, Dept Surg, Boston, MA 02115 USA; [Zurakowski, David] Childrens Hosp Boston, Dept Orthoped, Boston, MA 02115 USA; [Rodig, Scott] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Roy, Roopali; Rodig, Scott; Bielenberg, Diane; Zurakowski, David; Moses, Marsha A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Moses, MA (corresponding author), Childrens Hosp Boston, Karp Family Res Labs, Program Vasc Biol, 300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu	Rodig, Scott/Y-3889-2019		National Institutes of Health [PO1 CA45548, R01 CA118764]; Breast Cancer Research Foundation; JoAnn Webb Fund for Angiogenesis Research; Ellison Foundation; Fortin Foundation; NATIONAL CANCER INSTITUTE [P01CA045548, R01CA118764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; JoAnn Webb Fund for Angiogenesis Research; Ellison Foundation(Lawrence Ellison Foundation); Fortin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 CA45548 and R01 CA118764. This work was also supported by The Breast Cancer Research Foundation, The JoAnn Webb Fund for Angiogenesis Research, The Ellison Foundation, and The Fortin Foundation.	Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Ito N, 2004, BIOCHEM BIOPH RES CO, V314, P1008, DOI 10.1016/j.bbrc.2003.12.183; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Kveiborg M, 2010, BIOCHEM J, V430, P79, DOI 10.1042/BJ20100649; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Markowski J, 2009, J PHYSIOL PHARMACOL, V60, P57; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Okada A, 2008, ARTHRITIS RHEUM-US, V58, P778, DOI 10.1002/art.23262; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; PERROTTE P, 1997, MOL UROL, V1, P299; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Rocks N, 2008, CELL PROLIFERAT, V41, P988, DOI 10.1111/j.1365-2184.2008.00557.x; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; ROY R, 2011, BREAST CANC IN PRESS; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106	29	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20758	20768		10.1074/jbc.M110.216036	http://dx.doi.org/10.1074/jbc.M110.216036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21493715	Green Published, hybrid			2022-12-25	WOS:000291267600061
J	Boubekeur, S; Boute, N; Pagesy, P; Zilberfarb, V; Christeff, N; Issad, T				Boubekeur, Samira; Boute, Nicolas; Pagesy, Patrick; Zilberfarb, Vladimir; Christeff, Nevena; Issad, Tarik			A New Highly Efficient Substrate-trapping Mutant of Protein Tyrosine Phosphatase 1B (PTP1B) Reveals Full Autoactivation of the Insulin Receptor Precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; GROWTH-FACTOR RECEPTOR; LIVING CELLS; IN-VIVO; SIGNAL-TRANSDUCTION; ENDOPLASMIC-RETICULUM; NEGATIVE REGULATOR; ACTIVATION STATE; KINASE-ACTIVITY; BREAST-CANCER	PTP1B is a protein tyrosine-phosphatase located on the cytosolic side of the endoplasmic reticulum that plays an important role in the regulation of the insulin receptor (IR). Replacement of the conserved Asp-181 by alanine is known to convert PTP1B into a substrate-trapping protein that binds to but cannot dephosphorylate its substrates. In this work, we have studied the effect of an additional mutation (Y46F) on the substrate-trapping efficiency of PTP1B-D181A. We observed that this mutation converts PTP1B-D181A into a highly efficient substrate-trapping mutant, resulting in much higher recovery of tyrosine-phosphorylated proteins coimmunoprecipitated with PTP1B. Bioluminescence resonance energy transfer (BRET) experiments were also performed to compare the dynamics of interaction of the IR with these mutants. Basal BRET, which mainly reflects the interaction of PTP1B with the IR precursor during its biosynthesis in the endoplasmic reticulum, was markedly increased with the PTP1B-D181A-Y46F mutant. In contrast, insulin-induced BRET was markedly reduced with PTP1B-D181A-Y46F. I-125 insulin binding experiments indicated that PTP1B-D181-Y46F reduced the expression of IR at the plasma membrane. Reduced expression at the cell surface was associated with higher amounts of the uncleaved IR precursor in the cell. Moreover, we observed that substantial amounts of the uncleaved IR precursor reached the Tris-phosphorylated, fully activated form in an insulin independent fashion. These results support the notion that PTP1B plays a crucial role in the control of the activity of the IR precursor during its biosynthesis. In addition, this new substrate-trapping mutant may be a valuable tool for the identification of new PTP1B substrates.	INSERM, U1016, F-75014 Paris, France; CNRS, UMR8104, F-75014 Paris, France; Univ Paris 05, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Issad, T (corresponding author), Inst Cochin, Dept Endocrinol Metab & Canc, 22 Rue Mechain, F-75014 Paris, France.	tarik.issad@inserm.fr	Pagesy, Patrick/GLN-4814-2022; Pagesy, Patrick/M-9345-2017	Pagesy, Patrick/0000-0002-6153-8926; Issad, Tarik/0000-0002-2638-6330	Institut de Recherche Servier; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer and the Ligue contre le Cancer, Comite de Paris	Institut de Recherche Servier; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer and the Ligue contre le Cancer, Comite de Paris	This work was supported by the Institut de Recherche Servier, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, and the Association pour la Recherche sur le Cancer and the Ligue contre le Cancer, Comite de Paris.	AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Blanquart C, 2006, MOL PHARMACOL, V70, P1802, DOI 10.1124/mol.106.026989; Blanquart C, 2009, BIOCHEM BIOPH RES CO, V387, P748, DOI 10.1016/j.bbrc.2009.07.105; Blanquart C, 2010, BIOCHEM BIOPH RES CO, V392, P83, DOI 10.1016/j.bbrc.2009.12.176; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; CICIRELLI MF, 1990, P NATL ACAD SCI USA, V87, P5514, DOI 10.1073/pnas.87.14.5514; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; Dadke S, 2001, MOL CELL BIOCHEM, V221, P147, DOI 10.1023/A:1010909031310; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; ISSAD T, 1989, BIOCHEM J, V264, P217, DOI 10.1042/bj2640217; ISSAD T, 1995, EUR J BIOCHEM, V234, P108, DOI 10.1111/j.1432-1033.1995.108_c.x; Issad T, 2005, BIOCHIMIE, V87, P111, DOI 10.1016/j.biochi.2004.12.008; Issad T, 2003, DIABETES METAB, V29, P111, DOI 10.1016/S1262-3636(07)70016-2; Issad T, 2002, BIOCHEM PHARMACOL, V64, P813, DOI 10.1016/S0006-2952(02)01143-7; ISSAD T, 1992, FEBS LETT, V296, P41, DOI 10.1016/0014-5793(92)80399-2; Issad T, 2007, EXPERT OPIN THER TAR, V11, P541, DOI 10.1517/14728222.11.4.541; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; KING MJ, 1991, BIOCHEM J, V275, P413, DOI 10.1042/bj2750413; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lacasa D, 2005, MOL PHARMACOL, V67, P1206, DOI 10.1124/mol.104.009514; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Nouaille S, 2006, BIOCHEM PHARMACOL, V72, P1355, DOI 10.1016/j.bcp.2006.07.018; PASHMFOROUSH M, 1994, J BIOL CHEM, V269, P32639; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tao JC, 2001, J BIOL CHEM, V276, P29520, DOI 10.1074/jbc.M103721200; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	53	21	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19373	19380		10.1074/jbc.M111.222984	http://dx.doi.org/10.1074/jbc.M111.222984			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487008	hybrid, Green Published			2022-12-25	WOS:000291027700019
J	Amiel, JJ; Tingley, R; Shine, R				Amiel, Joshua J.; Tingley, Reid; Shine, Richard			Smart Moves: Effects of Relative Brain Size on Establishment Success of Invasive Amphibians and Reptiles	PLOS ONE			English	Article							FEEDING INNOVATIONS; REPRODUCTIVE RATES; FOREBRAIN SIZE; LIFE-HISTORY; EVOLUTION; BEHAVIOR; BIRDS; PATTERNS; ANURANS	Brain size relative to body size varies considerably among animals, but the ecological consequences of that variation remain poorly understood. Plausibly, larger brains confer increased behavioural flexibility, and an ability to respond to novel challenges. In keeping with that hypothesis, successful invasive species of birds and mammals that flourish after translocation to a new area tend to have larger brains than do unsuccessful invaders. We found the same pattern in ectothermic terrestrial vertebrates. Brain size relative to body size was larger in species of amphibians and reptiles reported to be successful invaders, compared to species that failed to thrive after translocation to new sites. This pattern was found in six of seven global biogeographic realms; the exception (where relatively larger brains did not facilitate invasion success) was Australasia. Establishment success was also higher in amphibian and reptile families with larger relative brain sizes. Future work could usefully explore whether invasion success is differentially associated with enlargement of specific parts of the brain (as predicted by the functional role of the forebrain in promoting behavioural flexibility), or with a general size increase (suggesting that invasion success is facilitated by enhanced perceptual and motor skills, as well as cognitive ability).	[Amiel, Joshua J.; Tingley, Reid; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Amiel, JJ (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	jami3107@uni.sydney.edu.au	Tingley, Reid/D-7388-2011	Tingley, Reid/0000-0002-7630-7434	Richard Shine's Federation; University of Sydney; Australian Department of Education, Employment and Workplace Relations	Richard Shine's Federation; University of Sydney(University of Sydney); Australian Department of Education, Employment and Workplace Relations(Australian Government)	Funding was provided by Richard Shine's Federation Fellowship grant. Joshua Amiel and Reid Tingley are funded by IPA scholarships through the University of Sydney and EIPRS scholarships through the Australian Department of Education, Employment and Workplace Relations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; BAUCHOT R, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P383; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Byrne R., 1988, MACHIAVELLIAN INTELL; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Cassey P, 2002, BIOL J LINN SOC, V76, P465, DOI 10.1046/j.1095-8312.2002.00086.x; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Dechmann DKN, 2009, BIOL REV, V84, P161, DOI 10.1111/j.1469-185X.2008.00067.x; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Ewert JP, 2001, COMP BIOCHEM PHYS A, V128, P417, DOI 10.1016/S1095-6433(00)00333-0; Flannery T, 1994, FUTURE EATERS ECOLOG; FOX SF, LIZARD SOCIAL BEHAV; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Hurlburt G.R., 1996, THESIS U TORONTO; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; JERISON HJ, 1985, PHILOS T ROY SOC B, V308, P21, DOI 10.1098/rstb.1985.0007; Kraus Fred, 2009, V4, P1; KREBS JR, 1989, P NATL ACAD SCI USA, V86, P1388, DOI 10.1073/pnas.86.4.1388; LASHLEY KS, 1949, Q REV BIOL, V24, P28, DOI 10.1086/396806; Lefebvre L, 1998, BEHAVIOUR, V135, P1077, DOI 10.1163/156853998792913492; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Lindenfors P, 2005, BIOL LETT-UK, V1, P407, DOI 10.1098/rsbl.2005.0362; Long JL, 2003, INTRO MAMMALS WORLD; MARTIN RD, 1981, NATURE, V293, P57, DOI 10.1038/293057a0; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Northcutt R.G., 1978, P11; Nunn CL, 2000, AM NAT, V156, P519, DOI 10.1086/303405; PAGEL MD, 1988, AM NAT, V132, P344, DOI 10.1086/284857; Platel R., 1976, Journal fuer Hirnforschung, V17, P513; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; TAYLOR GM, 1995, BRAIN BEHAV EVOLUT, V45, P96, DOI 10.1159/000113543; THIREAU M, 1975, I B MUS NAT HIST NAT, V207, P467; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Watters JV, 2007, APPL ANIM BEHAV SCI, V102, P364, DOI 10.1016/j.applanim.2006.05.036; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; WYLES JS, 1983, P NATL ACAD SCI-BIOL, V80, P4394, DOI 10.1073/pnas.80.14.4394; YOMTOV Y, 1985, OECOLOGIA, V66, P250, DOI 10.1007/BF00379862; YOMTOV Y, 1987, AUST WILDLIFE RES, V14, P319, DOI 10.1071/WR9870319	44	106	106	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18277	10.1371/journal.pone.0018277	http://dx.doi.org/10.1371/journal.pone.0018277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494328	Green Published, gold			2022-12-25	WOS:000289192400014
J	Hill, SE; Miti, T; Richmond, T; Muschol, M				Hill, Shannon E.; Miti, Tatiana; Richmond, Tyson; Muschol, Martin			Spatial Extent of Charge Repulsion Regulates Assembly Pathways for Lysozyme Amyloid Fibrils	PLOS ONE			English	Article							PROTEIN AGGREGATION; COMMON MECHANISM; SCATTERING; LIGHT; FIBRILLATION; OLIGOMERS; IMPLIES	Formation of large protein fibrils with a characteristic cross beta-sheet architecture is the key indicator for a wide variety of systemic and neurodegenerative amyloid diseases. Recent experiments have strongly implicated oligomeric intermediates, transiently formed during fibril assembly, as critical contributors to cellular toxicity in amyloid diseases. At the same time, amyloid fibril assembly can proceed along different assembly pathways that might or might not involve such oligomeric intermediates. Elucidating the mechanisms that determine whether fibril formation proceeds along non-oligomeric or oligomeric pathways, therefore, is important not just for understanding amyloid fibril assembly at the molecular level but also for developing new targets for intervening with fibril formation. We have investigated fibril formation by hen egg white lysozyme, an enzyme for which human variants underlie non-neuropathic amyloidosis. Using a combination of static and dynamic light scattering, atomic force microscopy and circular dichroism, we find that amyloidogenic lysozyme monomers switch between three different assembly pathways: from monomeric to oligomeric fibril assembly and, eventually, disordered precipitation as the ionic strength of the solution increases. Fibril assembly only occurred under conditions of net repulsion among the amyloidogenic monomers while net attraction caused precipitation. The transition from monomeric to oligomeric fibril assembly, in turn, occurred as salt-mediated charge screening reduced repulsion among individual charged residues on the same monomer. We suggest a model of amyloid fibril formation in which repulsive charge interactions are a prerequisite for ordered fibril assembly. Furthermore, the spatial extent of non-specific charge screening selects between monomeric and oligomeric assembly pathways by affecting which subset of denatured states can form suitable intermolecular bonds and by altering the energetic and entropic requirements for the initial intermediates emerging along the monomeric vs. oligomeric assembly path.	[Hill, Shannon E.; Miti, Tatiana; Richmond, Tyson; Muschol, Martin] Univ S Florida, Dept Phys, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Hill, SE (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	mmuschol@usf.edu		Muschol, Martin/0000-0002-6488-0049	National Science Foundation; Office of Undergraduate Research at USF; Byrd Alzheimer's Institute [ARG-2007-22]; USF BITT Florida Center of Excellence; USF	National Science Foundation(National Science Foundation (NSF)); Office of Undergraduate Research at USF; Byrd Alzheimer's Institute; USF BITT Florida Center of Excellence; USF	This work was supported, in part, by a National Science Foundation IGERT fellowship (S.H.), the Office of Undergraduate Research at USF (T.M.) and funding from the Byrd Alzheimer's Institute (ARG-2007-22), the USF BITT Florida Center of Excellence and the USF Neuroscience Collaborative (M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; Dobson CM, 2004, SCIENCE, V304, P1259, DOI 10.1126/science.1093078; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2; HAGEN MHJ, 1994, J CHEM PHYS, V101, P4093, DOI 10.1063/1.467526; Hess S, 2007, EMBO REP, V8, P1196, DOI 10.1038/sj.embor.7401096; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Hunter R. J., 1987, FDN COLLOIDAL SCI; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kuehner DE, 1997, BIOPHYS J, V73, P3211, DOI 10.1016/S0006-3495(97)78346-2; Kuehner DE, 1999, J PHYS CHEM B, V103, P1368, DOI 10.1021/jp983852i; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Muschol M, 1995, J CHEM PHYS, V103, P10424, DOI 10.1063/1.469891; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Parmar AS, 2009, BIOPHYS J, V97, P590, DOI 10.1016/j.bpj.2009.04.045; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; PTITSYN OB, 1994, FEBS LETT, V341, P15, DOI 10.1016/0014-5793(94)80231-9; Rosenbaum DF, 1996, J CRYST GROWTH, V169, P752, DOI 10.1016/S0022-0248(96)00455-1; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SOPHIANOPOULOS AJ, 1962, J BIOL CHEM, V237, P1107; tenWolde PR, 1996, J CHEM PHYS, V104, P9932, DOI 10.1063/1.471721; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Velev OD, 1998, BIOPHYS J, V75, P2682, DOI 10.1016/S0006-3495(98)77713-6	42	68	68	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18171	10.1371/journal.pone.0018171	http://dx.doi.org/10.1371/journal.pone.0018171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483680	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300008
J	Costantini, M; Committeri, G; Sinigaglia, C				Costantini, Marcello; Committeri, Giorgia; Sinigaglia, Corrado			Ready Both to Your and to My Hands: Mapping the Action Space of Others	PLOS ONE			English	Article							AREA F5; OBJECTS; REPRESENTATION; CORTEX; BODY; RECOGNITION; PERSPECTIVE; MECHANISMS; GAZE	To date, mutual interaction between action and perception has been investigated mainly by focusing on single individuals. However, we perceive affording objects and acts upon them in a surrounding world inhabited by other perceiving and acting bodies. Thus, the issue arises as to whether our action-oriented object perception might be modulated by the presence of another potential actor. To tackle this issue we used the spatial alignment effect paradigm and systematically examined this effect when a visually presented handled object was located close either to the perceiver or to another individual (a virtual avatar). We found that the spatial alignment effect occurred whenever the object was presented within the reaching space of a potential actor, regardless of whether it was the participant's own or the other's reaching space. These findings show that objects may afford a suitable motor act when they are ready not only to our own hand but also, and most importantly, to the other's hand. Our proposal is that this effect is likely to be due to a mapping of our own and the other's reaching space and we posit that such mapping could play a critical role in joining our own and the other's action.	[Costantini, Marcello; Committeri, Giorgia] Univ G DAnnunzio, Lab Neuropsychol & Cognit Neurosci, Dept Neurosci & Imaging, Chieti, Italy; [Costantini, Marcello; Committeri, Giorgia] Fdn Univ G dAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Sinigaglia, Corrado] Univ Milan, Dept Philosophy, Milan, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Milan	Costantini, M (corresponding author), Univ G DAnnunzio, Lab Neuropsychol & Cognit Neurosci, Dept Neurosci & Imaging, Chieti, Italy.	marcello.costantini@unich.it	Committeri, Giorgia/AAC-1035-2022; Costantini, Marcello/F-7083-2011; sinigaglia, corrado/AAI-2220-2021; SINIGAGLIA, CORRADO/AGY-7196-2022	SINIGAGLIA, CORRADO/0000-0002-3365-7522; Costantini, Marcello/0000-0002-0504-1296	MIUR [2008PBT985]	MIUR(Ministry of Education, Universities and Research (MIUR))	GC was supported by a grant from MIUR, no. 2008PBT985 (www.miur.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MA, 2003, VIS COGN, V10, P157, DOI 10.1080/13506280244000078; Becchio C, 2008, TRENDS COGN SCI, V12, P254, DOI 10.1016/j.tics.2008.04.005; Bub DN, 2010, J EXP PSYCHOL HUMAN, V36, P341, DOI 10.1037/a0017606; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; CARDINI F, 2010, J COGN NEUROSCI; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; COSTANTINI M, 2011, JOINT ATTEN IN PRESS; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Lambrey S, 2008, BRAIN, V131, P523, DOI 10.1093/brain/awm317; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Pierno AC, 2006, J COGNITIVE NEUROSCI, V18, P2130, DOI 10.1162/jocn.2006.18.12.2130; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Richardson MJ, 2007, J EXP PSYCHOL HUMAN, V33, P845, DOI 10.1037/0096-1523.33.4.845; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; SIRIGU A, 1991, BRAIN, V114, P2555, DOI 10.1093/brain/114.6.2555; Thomas R, 2006, ACTA PSYCHOL, V121, P317, DOI 10.1016/j.actpsy.2005.08.002; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; Vainio L, 2007, BRAIN COGNITION, V65, P195, DOI 10.1016/j.bandc.2007.07.004; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799	29	74	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17923	10.1371/journal.pone.0017923	http://dx.doi.org/10.1371/journal.pone.0017923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743ZC	21483734	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058700004
J	Pham, M; Helluy, X; Kleinschnitz, C; Kraft, P; Bartsch, AJ; Jakob, P; Nieswandt, B; Bendszus, M; Stoll, G				Pham, Mirko; Helluy, Xavier; Kleinschnitz, Christoph; Kraft, Peter; Bartsch, Andreas J.; Jakob, Peter; Nieswandt, Bernhard; Bendszus, Martin; Stoll, Guido			Sustained Reperfusion after Blockade of Glycoprotein-Receptor-Ib in Focal Cerebral Ischemia: An MRI Study at 17.6 Tesla	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; EXPERIMENTAL STROKE; MAGNETIC-RESONANCE; ARTERIAL WATER; BRAIN; PERFUSION; MICE; INFLAMMATION; COEFFICIENT; MECHANISMS	Background: Inhibition of early platelet adhesion by blockade of glycoprotein-IB (GPIb) protects mice from ischemic stroke. To elucidate underlying mechanisms in-vivo, infarct development was followed by ultra-high field MRI at 17.6 Tesla. Methods: Cerebral infarction was induced by transient-middle-cerebral-artery-occlusion (tMCAO) for 1 hour in C57/BL6 control mice (N = 10) and mice treated with 100 mg Fab-fragments of the GPIb blocking antibody p0p/B 1 h after tMCAO (N = 10). To control for the effect of reperfusion, additional mice underwent permanent occlusion and received anti-GPIb treatment (N = 6; pMCAO) or remained without treatment (N = 3; pMCAO). MRI 2 h and 24 h after MCAO measured cerebral-blood-flow (CBF) by continuous arterial-spin labelling, the apparent-diffusion-coefficient (ADC), quantitative-T2 and T2-weighted imaging. All images were registered to a standard mouse brain MRI atlas and statistically analysed voxel-wise, and by cortico-subcortical ROI analysis. Results: Anti-GPIb treatment led to a relative increase of postischemic CBF vs. controls in the cortical territory of the MCA (2 h: 44.2 +/- 6.9 ml/100g/min versus 24 h: 60.5 +/- 8.4; p = 0.0012, F-(1,F-18) = 14.63) after tMCAO. Subcortical CBF 2 h after tMCAO was higher in anti-GPIb treated animals (45.3 +/- 5.9 vs. controls: 33.6 +/- 4.3; p = 0.04). In both regions, CBF findings were clearly related to a lower probability of infarction (Cortex/Subcortex of treated group: 35%/65% vs. controls: 95%/100%) and improved quantitative-T2 and ADC. After pMCAO, anti-GPIb treated mice developed similar infarcts preceded by severe irreversible hypoperfusion as controls after tMCAO indicating dependency of stroke protection on reperfusion. Conclusion: Blockade of platelet adhesion by anti-GPIb-Fab-fragments results in substantially improved CBF early during reperfusion. This finding was in exact spatial correspondence with the prevention of cerebral infarction and indicates in-vivo an increased patency of the microcirculation. Thus, progression of infarction during early ischemia and reperfusion can be mitigated by anti-platelet treatment.	[Pham, Mirko; Bartsch, Andreas J.; Bendszus, Martin] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Helluy, Xavier; Jakob, Peter] Univ Wurzburg, Dept Expt Phys, Sect 5, Wurzburg, Germany; [Kleinschnitz, Christoph; Kraft, Peter; Stoll, Guido] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Chair Expt Med, Wurzburg, Germany	Ruprecht Karls University Heidelberg; University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg	Pham, M (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	mirko.pham@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020	Jakob, Peter/0000-0002-3481-5545	Medical Faculty of the University of Heidelberg, Germany; Deutsche Forschungsgemeinschaft [SFB 688]	Medical Faculty of the University of Heidelberg, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Postdoctoral Fellowship granted to MP from the Medical Faculty of the University of Heidelberg, Germany (www.medizinische-fakultaet-hd.uni-heidelberg.de) and by the Deutsche Forschungsgemeinschaft (www.dfg.de), SFB 688 (TP B1 granted to BN and GS, TP A13 granted to CK and Z2 to PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2005, NEUROSCI LETT, V388, P54, DOI 10.1016/j.neulet.2005.06.067; Coutts SB, 2009, STROKE, V40, P2661, DOI 10.1161/STROKEAHA.109.557447; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; De Meyer SF, 2010, ARTERIOSCL THROM VAS, V30, P1949, DOI 10.1161/ATVBAHA.110.208918; DEMEYER SF, 2010, ARTERIOSCLER THROMB; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaur J, 2009, INT J STROKE, V4, P159, DOI 10.1111/j.1747-4949.2009.00288.x; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P1821, DOI 10.1038/jcbfm.2010.160; Maccotta L, 1997, NMR BIOMED, V10, P216, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<216::AID-NBM468>3.0.CO;2-U; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Pham M, 2010, NEUROIMAGE, V49, P2907, DOI 10.1016/j.neuroimage.2009.11.061; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; STOLL G, ANN NY ACAD IN PRESS; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1998, MAGNET RESON MED, V40, P348, DOI 10.1002/mrm.1910400303; ZHANG WG, 1993, MAGNET RESON MED, V29, P416, DOI 10.1002/mrm.1910290323	34	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18386	10.1371/journal.pone.0018386	http://dx.doi.org/10.1371/journal.pone.0018386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483769	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058300016
J	Adekambi, T; Butler, RW; Hanrahan, F; Delcher, AL; Drancourt, M; Shinnick, TM				Adekambi, Toidi; Butler, Ray W.; Hanrahan, Finnian; Delcher, Arthur L.; Drancourt, Michel; Shinnick, Thomas M.			Core Gene Set As the Basis of Multilocus Sequence Analysis of the Subclass Actinobacteridae	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ET-AL. 2000; SP NOV.; EMENDED DESCRIPTION; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; GENOME; MYCOBACTERIUM; EVOLUTION; RPOB	Comparative genomic sequencing is shedding new light on bacterial identification, taxonomy and phylogeny. An in silico assessment of a core gene set necessary for cellular functioning was made to determine a consensus set of genes that would be useful for the identification, taxonomy and phylogeny of the species belonging to the subclass Actinobacteridae which contained two orders Actinomycetales and Bifidobacteriales. The subclass Actinobacteridae comprised about 85% of the actinobacteria families. The following recommended criteria were used to establish a comprehensive gene set; the gene should (i) be long enough to contain phylogenetically useful information, (ii) not be subject to horizontal gene transfer, (iii) be a single copy (iv) have at least two regions sufficiently conserved that allow the design of amplification and sequencing primers and (v) predict whole-genome relationships. We applied these constraints to 50 different Actinobacteridae genomes and made 1,224 pairwise comparisons of the genome conserved regions and gene fragments obtained by using Sequence VARiability Analysis Program (SVARAP), which allow designing the primers. Following a comparative statistical modeling phase, 3 gene fragments were selected, ychF, rpoB, and secY with R-2 > 0.85. Selected sets of broad range primers were tested from the 3 gene fragments and were demonstrated to be useful for amplification and sequencing of 25 species belonging to 9 genera of Actinobacteridae. The intraspecies similarities were 96.3-100% for ychF, 97.8-100% for rpoB and 96.9-100% for secY among 73 strains belonging to 15 species of the subclass Actinobacteridae compare to 99.4-100% for 16S rRNA. The phylogenetic topology obtained from the combined datasets ychF+rpoB+secY was globally similar to that inferred from the 16S rRNA but with higher confidence. It was concluded that multi-locus sequence analysis using core gene set might represent the first consensus and valid approach for investigating the bacterial identification, phylogeny and taxonomy.	[Adekambi, Toidi; Butler, Ray W.; Shinnick, Thomas M.] Ctr Dis Control & Prevent, Mycobacteriol Lab Branch, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Hanrahan, Finnian; Delcher, Arthur L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Drancourt, Michel] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, CNRS, UMR 6236,IRD 198,IFR 48,Fac Med, Marseille, France	Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland College Park; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Adekambi, T (corresponding author), Ctr Dis Control & Prevent, Mycobacteriol Lab Branch, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	tadekambi@gmail.com			ASM/CCID	ASM/CCID	Toidi Adekambi was supported by ASM/CCID postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Adekambi T, 2006, J CLIN MICROBIOL, V44, P3493, DOI 10.1128/JCM.00724-06; Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Ara I, 2008, INT J SYST EVOL MICR, V58, P1950, DOI 10.1099/ijs.0.65548-0; Atlas R., 1997, PRINCIPLES MICROBIOL; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Butler WR, 2005, INT J SYST EVOL MICR, V55, P1615, DOI 10.1099/ijs.0.63465-0; Chun J, 1997, INT J SYST BACTERIOL, V47, P127, DOI 10.1099/00207713-47-1-127; Coenye T, 2005, FEMS MICROBIOL REV, V29, P147, DOI 10.1016/j.femsre.2004.11.004; Colson P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-21; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; Gao B, 2006, ANTON LEEUW INT J G, V90, P69, DOI 10.1007/s10482-006-9061-2; Gao BL, 2005, INT J SYST EVOL MICR, V55, P2401, DOI 10.1099/ijs.0.63785-0; GARRITY GM, 2004, BERGERYS MANUAL SYST; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kampfer P, 1999, INT J SYST BACTERIOL, V49, P681, DOI 10.1099/00207713-49-2-681; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lee SD, 2006, INT J SYST EVOL MICR, V56, P2391, DOI 10.1099/ijs.0.64268-0; Lehnen A, 2006, INT J SYST EVOL MICR, V56, P861, DOI 10.1099/ijs.0.63923-0; McKenzie CM, 2006, INT J SYST EVOL MICR, V56, P2279, DOI 10.1099/ijs.0.63978-0; Mignard S, 2008, INT J SYST EVOL MICR, V58, P1432, DOI 10.1099/ijs.0.65658-0; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Ninet B, 1996, J CLIN MICROBIOL, V34, P2531, DOI 10.1128/JCM.34.10.2531-2536.1996; Novichkov PS, 2004, J BACTERIOL, V186, P6575, DOI 10.1128/JB.186.19.6575-6585.2004; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; RAINEY FA, 1995, INT J SYST BACTERIOL, V45, P32, DOI 10.1099/00207713-45-1-32; Richert K, 2007, SYST APPL MICROBIOL, V30, P102, DOI 10.1016/j.syapm.2006.04.001; ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323; ROLLER C, 1992, J GEN MICROBIOL, V138, P1167, DOI 10.1099/00221287-138-6-1167; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Soddell JA, 2006, INT J SYST EVOL MICR, V56, P739, DOI 10.1099/ijs.0.63855-0; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Stackebrandt E, 2007, CURR MICROBIOL, V55, P42, DOI 10.1007/s00284-006-0569-5; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueda K, 1999, J BACTERIOL, V181, P78, DOI 10.1128/JB.181.1.78-82.1999; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ventura M, 2006, INT J SYST EVOL MICR, V56, P2783, DOI 10.1099/ijs.0.64233-0; Wang Y, 2000, MICROBIOL-UK, V146, P2845, DOI 10.1099/00221287-146-11-2845; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wertz JE, 2003, J EVOLUTION BIOL, V16, P1236, DOI 10.1046/j.1420-9101.2003.00612.x; Yamamoto S, 1996, INT J SYST BACTERIOL, V46, P506, DOI 10.1099/00207713-46-2-506; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0	65	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e14792	10.1371/journal.pone.0014792	http://dx.doi.org/10.1371/journal.pone.0014792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483493	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200003
J	Goergen, EM; Leger, EA; Espeland, EK				Goergen, Erin M.; Leger, Elizabeth A.; Espeland, Erin K.			Native Perennial Grasses Show Evolutionary Response to Bromus tectorum (Cheatgrass) Invasion	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; NATURAL-SELECTION; PLANT; COMPETITION; PLASTICITY; RESISTANCE; TRAITS; WATER; RESTORATION; COMMUNITIES	Invasive species can change selective pressures on native plants by altering biotic and abiotic conditions in invaded habitats. Although invasions can lead to native species extirpation, they may also induce rapid evolutionary changes in remnant native plants. We investigated whether adult plants of five native perennial grasses exhibited trait shifts consistent with evolution in response to invasion by the introduced annual grass Bromus tectorum L. (cheatgrass), and asked how much variation there was among species and populations in the ability to grow successfully with the invader. Three hundred and twenty adult plants were collected from invaded and uninvaded communities from four locations near Reno, Nevada, USA. Each plant was divided in two and transplanted into the greenhouse. One clone was grown with B. tectorum while the other was grown alone, and we measured tolerance (ability to maintain size) and the ability to reduce size of B. tectorum for each plant. Plants from invaded populations consistently had earlier phenology than those from uninvaded populations, and in two out of four sites, invaded populations were more tolerant of B. tectorum competition than uninvaded populations. Poa secunda and one population of E. multisetus had the strongest suppressive effect on B. tectorum, and these two species were the only ones that flowered in competition with B. tectorum. Our study indicates that response to B. tectorum is a function of both location and species identity, with some, but not all, populations of native grasses showing trait shifts consistent with evolution in response to B. tectorum invasion within the Great Basin.	[Goergen, Erin M.; Leger, Elizabeth A.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Espeland, Erin K.] Agr Res Serv ARS Sidney, NPARL, USDA, Sidney, MT USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of Agriculture (USDA)	Goergen, EM (corresponding author), Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA.	erin.goergen@gmail.com		Leger, Elizabeth/0000-0003-0308-9496; Espeland, Erin/0000-0001-8541-3610	USDA CSREES; Great Basin Native Plant Selection and Increase Project	USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Great Basin Native Plant Selection and Increase Project	This research was funded by a USDA CSREES Seed Grant to E. Leger and E. Espeland and The Great Basin Native Plant Selection and Increase Project. The funders had no role in study design, data collection, analysis, or manuscript preparation.	Arredondo JT, 1998, J RANGE MANAGE, V51, P584, DOI 10.2307/4003380; Beckstead J, 2004, BIOL INVASIONS, V6, P417, DOI 10.1023/B:BINV.0000041557.92285.43; Blank RR, 2008, INVAS PLANT SCI MANA, V1, P226, DOI 10.1614/IPSM-07-026.1; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Booth MS, 2003, J ECOL, V91, P36, DOI 10.1046/j.1365-2745.2003.00739.x; Bradley BA, 2006, ECOL APPL, V16, P1132, DOI 10.1890/1051-0761(2006)016[1132:CTLDOA]2.0.CO;2; Callaway RM, 2005, J ECOL, V93, P576, DOI 10.1111/j.1365-2745.2005.00994.x; Carroll SP, 2007, ECOL RES, V22, P892, DOI 10.1007/s11284-007-0352-5; CHEPLICK GP, 1995, INT J PLANT SCI, V156, P522, DOI 10.1086/297275; Cipollini KA, 2008, OHIO J SCI, V108, P47; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dyer AR, 2000, ECOL LETT, V3, P523, DOI 10.1046/j.1461-0248.2000.00187.x; Ferrero-Serrano A, 2011, RESTOR ECOL, V19, P545, DOI 10.1111/j.1526-100X.2009.00611.x; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; Gonzalez A, 2008, OIKOS, V117, P1247, DOI 10.1111/j.0030-1299.2008.16419.x; Hangelbroek HH, 2004, EVOL ECOL RES, V6, P147; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HuberSannwald E, 1996, AM J BOT, V83, P919, DOI 10.2307/2446270; Humphrey LD, 2004, J ARID ENVIRON, V58, P405, DOI 10.1016/j.jaridenv.2003.11.008; Jones T.A., 2010, RANGELANDS, V32, P38, DOI DOI 10.2111/RANGELANDS-D-09-00011.1; Jones TA, 2009, FRONT ECOL ENVIRON, V7, P541, DOI 10.1890/080028; Keddy P, 1998, J VEG SCI, V9, P777, DOI 10.2307/3237043; KEDDY PA, 1994, J ECOL, V82, P635, DOI 10.2307/2261270; Kulmatiski A, 2006, PLANT SOIL, V288, P271, DOI 10.1007/s11104-006-9115-2; Lau JA, 2008, ECOLOGY, V89, P1023, DOI 10.1890/06-1999.1; Leger EA, 2008, ECOL APPL, V18, P1226, DOI 10.1890/07-1598.1; Leger EA, 2010, EVOL APPL, V3, P169, DOI 10.1111/j.1752-4571.2009.00105.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Mealor BA, 2007, OIKOS, V116, P1493, DOI 10.1111/j.0030-1299.2007.15781.x; MELGOZA G, 1990, OECOLOGIA, V83, P7, DOI 10.1007/BF00324626; Murren CJ, 2006, ECOLOGY, V87, P2591, DOI 10.1890/0012-9658(2006)87[2591:IACEOM]2.0.CO;2; Nord EA, 2009, J EXP BOT, V60, P1927, DOI 10.1093/jxb/erp018; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Van Kleunen M, 2003, J EVOLUTION BIOL, V16, P474, DOI 10.1046/j.1420-9101.2003.00532.x; WALKER LR, 1991, ECOLOGY, V72, P1449, DOI 10.2307/1941117; Willis CG, 2010, J EVOLUTION BIOL, V23, P1412, DOI 10.1111/j.1420-9101.2010.02003.x	41	57	60	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18145	10.1371/journal.pone.0018145	http://dx.doi.org/10.1371/journal.pone.0018145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479185	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700033
J	Lin, CY; Chen, JY; Lin, TN; Jeng, WJ; Huang, CH; Huang, CW; Chang, SW; Sheen, IS				Lin, Chun-Yen; Chen, Ji-Yih; Lin, Tsung-Nan; Jeng, Wen-Juei; Huang, Chien-Hao; Huang, Chang-Wen; Chang, Su-Wei; Sheen, I-Shyan			IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; GENETIC-VARIATION; SPONTANEOUS CLEARANCE; TREATMENT DURATION; POLYMORPHISM; INTERFERON; GENOMICS; EFFICACY	Background: Single nucleotide polymorphisms (SNPs) of interleukin-28B (IL28B) have received considerable interest for their association with sustained virological response (SVR) when treating patients of genotype-1 hepatitis C virus (GT1-HCV) chronic infection with pegylated interferon and ribavirin (PegIFN/RBV). This study was to investigate the predictive power of IL28B SNPs for on-treatment responses and SVR in treatment-naive patients with GT1-HCV chronic infection. Methodology/Principal Findings: We analyzed ten SNPs of IL28B in 191 treatment-naive patients with GT1-HCV chronic infection who received PegIFN/RBV. In these patients, rapid virological response (RVR), early virological response (EVR) and SVR were achieved in 69.6%, 95.8% and 68.6% of the patients, respectively. Multivariate analysis (odds ratio; 95% confidence interval; P value) indicated age (0.96; 0.93-0.99; 0.012), low baseline viral load (4.65; 2.23-9.66; < 0.001) and CC genotype of rs12979860 (7.74; 2.55-23.53; < 0.001) but no other SNPs were independent predictors for SVR. In addition, none of the ten SNPs examined were associated with baseline viral load and stages of liver fibrosis. Regarding RVR, low baseline viral load (2.83; 1.40-5.73; 0.004) and CC genotype of rs12979860 (10.52; 3.45-32.04; < 0.001) were two critical predictors. As for EVR, only CC genotype of rs12979860 (36.21; 6.68-196.38; < 0.001) was the predictor. Similarly, for end of treatment response (ETR), CC genotype of rs12979860 (15.42; 4.62-51.18; < 0.001) was the only predictor. For patients with RVR, only low baseline viral load (3.90; 1.57-9.68; 0.003) could predict the SVR. For patients without RVR, only rs12979860 (4.60; 1.13-18.65; 0.033) was the predictor for SVR. Conclusions/ Significance: rs12979860 is the critical predictor for RVR, EVR, ETR and SVR in treatment-naive patients of GT1-HCV chronic infection. Furthermore, this SNP is the only predictor for SVR in patients without RVR. These results have provided evidence that rs12979860 is the ideal IL28B SNP for genetic testing in treating patients of GT1-HCV chronic infection.	[Lin, Chun-Yen; Lin, Tsung-Nan; Jeng, Wen-Juei; Huang, Chien-Hao; Huang, Chang-Wen; Sheen, I-Shyan] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Tao Yuan, Taiwan; [Chen, Ji-Yih] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Rheumatol Allergy & Immunol, Tao Yuan, Taiwan; [Lin, Chun-Yen; Chen, Ji-Yih; Sheen, I-Shyan] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chang, Su-Wei] Acad Sinica, Inst Biomed Sci, Div Biostat, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan	Lin, CY (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Tao Yuan, Taiwan.	issheen.jks@gmail.com		Huang, Chien-Hao/0000-0003-1689-3221; LIN, TSUNGNAN/0000-0001-5659-1194; Lin, Chun-Yen/0000-0003-3007-3190	National Science Council, Taiwan; Chang Gung Memorial Hospital [CMRPG 390682, 37542, 360463]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by National Science Council, Taiwan, and CMRPG 390682, 37542, 360463 from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 2010, J HEPATOLOG IN PRESS; Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; BALAGOPAL A, 2010, GASTROENTEROLOGY, DOI DOI 10.1053/J.GASTRO.2010.1010.1004; Chen JY, 2006, ARTHRITIS RHEUM-US, V54, P3908, DOI 10.1002/art.22220; Dalgard O, 2004, HEPATOLOGY, V40, P1260, DOI 10.1002/hep.20467; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Ferenci P, 2008, GASTROENTEROLOGY, V135, P451, DOI 10.1053/j.gastro.2008.04.015; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gheorghe L, 2007, J GASTROINTEST LIVER, V16, P23; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Iadonato SP, 2009, NATURE, V461, P357, DOI 10.1038/461357a; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kamal SM, 2007, HEPATOLOGY, V46, P1732, DOI 10.1002/hep.21917; Kuboki M, 2007, J GASTROEN HEPATOL, V22, P645, DOI 10.1111/j.1440-1746.2007.04834.x; LANGHANS B, 2010, J HEPATOLOG IN PRESS; Lee Hyuk, 2006, Korean J Hepatol, V12, P31; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu CJ, 2009, GASTROENTEROLOGY, V136, P496, DOI 10.1053/j.gastro.2008.10.049; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2008, HEPATOLOGY, V47, P43, DOI 10.1002/hep.22061; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Rauch A, 2010, EUR J CLIN INVEST, V40, P950, DOI 10.1111/j.1365-2362.2010.02337.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; STATTERMAYER AF, 2010, CLIN GASTRO IN PRESS; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Yu ML, 2006, LIVER INT, V26, P73, DOI 10.1111/j.1478-3231.2005.01196.x; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; ZHANG L, 2010, J HEPATOL IN PRESS	43	48	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18322	10.1371/journal.pone.0018322	http://dx.doi.org/10.1371/journal.pone.0018322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479134	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700046
J	Dias-Santagata, D; Lam, Q; Vernovsky, K; Vena, N; Lennerz, JK; Borger, DR; Batchelor, TT; Ligon, KL; Iafrate, AJ; Ligon, AH; Louis, DN; Santagata, S				Dias-Santagata, Dora; Lam, Quynh; Vernovsky, Kathy; Vena, Natalie; Lennerz, Jochen K.; Borger, Darrell R.; Batchelor, Tracy T.; Ligon, Keith L.; Iafrate, A. John; Ligon, Azra H.; Louis, David N.; Santagata, Sandro			BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications	PLOS ONE			English	Article							ANAPLASTIC FEATURES; GENETIC ALTERATIONS; MAPK PATHWAY; EXPRESSION; DUPLICATION; FUSION; IDH1; CLASSIFICATION; GANGLIOGLIOMA; ACTIVATION	Pleomorphic xanthoastrocytoma (PXA) is low-grade glial neoplasm principally affecting children and young adults. Approximately 40% of PXA are reported to recur within 10 years of primary resection. Upon recurrence, patients receive radiation therapy and conventional chemotherapeutics designed for high-grade gliomas. Genetic changes that can be targeted by selective therapeutics have not been extensively evaluated in PXA and ancillary diagnostic tests to help discriminate PXA from other pleomorphic and often more aggressive astrocytic malignancies are limited. In this study, we apply the SNaPshot multiplexed targeted sequencing platform in the analysis of brain tumors to interrogate 60 genetic loci that are frequently mutated in 15 cancer genes. In our analysis we detect BRAF V600E mutations in 12 of 20 (60%) WHO grade II PXA, in 1 of 6 (17%) PXA with anaplasia and in 1 glioblastoma arising in a PXA. Phospho-ERK was detected in all tumors independent of the BRAF mutation status. BRAF duplication was not detected in any of the PXA cases. BRAF V600E mutations were identified in only 2 of 71 (2.8%) glioblastoma (GBM) analyzed, including 1 of 9 (11.1%) giant cell GBM (gcGBM). The finding that BRAF V600E mutations are common in the majority of PXA has important therapeutic implications and may help in differentiating less aggressive PXAs from lethal gcGBMs and GBMs.	[Dias-Santagata, Dora; Lam, Quynh; Lennerz, Jochen K.; Iafrate, A. John; Louis, David N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dias-Santagata, Dora; Lam, Quynh; Lennerz, Jochen K.; Iafrate, A. John; Louis, David N.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Vernovsky, Kathy; Borger, Darrell R.; Batchelor, Tracy T.] Massachusetts Gen Hosp, Ctr Canc, Div Hematol Oncol, Boston, MA USA; [Dias-Santagata, Dora; Lam, Quynh; Vernovsky, Kathy; Lennerz, Jochen K.; Borger, Darrell R.; Batchelor, Tracy T.; Ligon, Keith L.; Iafrate, A. John; Ligon, Azra H.; Louis, David N.; Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA USA; [Vena, Natalie; Ligon, Keith L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Vena, Natalie; Ligon, Keith L.; Ligon, Azra H.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Batchelor, Tracy T.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Batchelor, Tracy T.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Ligon, Keith L.; Santagata, Sandro] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.; Ligon, Azra H.; Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Dias-Santagata, D (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	ssantagata@partners.org		Santagata, Sandro/0000-0002-7528-9668; Ligon, Keith/0000-0002-7733-600X	Aid for Cancer Research Foundation; PLGA Foundation; National Institutes of Health (NIH) [CA095616, CA57683, K08NS064168]; Sontag Foundation; Goldhirsh Foundation; V Foundation for Cancer Research; Brain Science Foundation; NATIONAL CANCER INSTITUTE [R01CA057683, P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Aid for Cancer Research Foundation; PLGA Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation; Goldhirsh Foundation; V Foundation for Cancer Research; Brain Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Aid for Cancer Research Foundation and from an anonymous donor (to MGH) and the PLGA Foundation. KLL is supported by National Institutes of Health (NIH) grant CA095616, the Sontag Foundation, and the Goldhirsh Foundation. DNL is supported by NIH grant CA57683. SS is supported by NIH grant K08NS064168, the V Foundation for Cancer Research and the Brain Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Basto D, 2005, ACTA NEUROPATHOL, V109, P207, DOI 10.1007/s00401-004-0936-x; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bruger P., 2002, SURG PATHOLOGY NERVO, P405; Camelo-Piragua S, 2010, ACTA NEUROPATHOL, V119, P509, DOI 10.1007/s00401-009-0632-y; Cartmill M, 2001, CHILD NERV SYST, V17, P563; Chang HT, 2006, CHILD NERV SYST, V22, P609, DOI 10.1007/s00381-005-0005-3; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; DOUGHERTY MJ, 2010, NEURO ONCOL, V12; Flaherty KT, 2010, ANN INTERN MED, V153, P587, DOI 10.7326/0003-4819-153-9-201011020-00008; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fletcher CD, 2007, DIAGNOSTIC HISTOPATH; Forshew T, 2009, J PATHOL, V218, P172, DOI 10.1002/path.2558; Giannini C, 1997, BRAIN PATHOL, V7, P785, DOI 10.1111/j.1750-3639.1997.tb01064.x; Giannini C, 2001, NEUROGENETICS, V3, P159, DOI 10.1007/s100480100116; Giannini C, 1999, CANCER, V85, P2033, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2033::AID-CNCR22>3.3.CO;2-Q; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hagemann C, 2009, INT J MOL MED, V23, P17, DOI 10.3892/ijmm_00000097; Horbinski C, 2011, BRAIN PATHOL, V21, P57, DOI 10.1111/j.1750-3639.2010.00453.x; Ironside JW, 2002, DIAGNOSTIC PATHOLOGY; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kaulich K, 2002, J NEUROPATH EXP NEUR, V61, P1092, DOI 10.1093/jnen/61.12.1092; KEPES JJ, 1993, BRAIN PATHOL, V3, P269, DOI 10.1111/j.1750-3639.1993.tb00753.x; KEPES JJ, 1979, CANCER, V44, P1839, DOI 10.1002/1097-0142(197911)44:5<1839::AID-CNCR2820440543>3.0.CO;2-0; KEPES JJ, 1973, ACTA NEUROPATHOL, V23, P187, DOI 10.1007/BF00687875; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Knobbe CB, 2004, ACTA NEUROPATHOL, V108, P467, DOI 10.1007/s00401-004-0929-9; Koga T, 2009, NEURO-ONCOLOGY, V11, P446, DOI 10.1215/15228517-2008-112; KROS JM, 1991, HUM PATHOL, V22, P1128, DOI 10.1016/0046-8177(91)90265-Q; Louis DN, 2007, WHO HISTOLOGICAL CLA; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; MeyerPuttlitz B, 1997, AM J PATHOL, V151, P853; Munoz EL, 1996, J NEUROPATHOL EXP NE, V55, P606; MURRAY JC, 2010, J NEUROONCOL; Pahapill PA, 1996, NEUROSURGERY, V38, P822, DOI 10.1227/00006123-199604000-00038; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paulus W, 1996, ACTA NEUROPATHOL, V91, P293, DOI 10.1007/s004010050428; Peraud A, 1997, J NEUROPATH EXP NEUR, V56, P1236, DOI 10.1097/00005072-199711000-00008; Peraud A, 1999, LAB INVEST, V79, P123; Perry A, 1997, AM J SURG PATHOL, V21, P763, DOI 10.1097/00000478-199707000-00004; Perry A., 2010, PRACTICAL SURG NEURO; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Rao AAN, 2010, PEDIATR BLOOD CANCER, V55, P290, DOI 10.1002/pbc.22490; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Sievert AJ, 2009, BRAIN PATHOL, V19, P449, DOI 10.1111/j.1750-3639.2008.00225.x; Sugita Y, 2009, BRAIN TUMOR PATHOL, V26, P31, DOI 10.1007/s10014-009-0244-1; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Weber RG, 2007, ONCOGENE, V26, P1088, DOI 10.1038/sj.onc.1209851; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	56	209	225	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17948	10.1371/journal.pone.0017948	http://dx.doi.org/10.1371/journal.pone.0017948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479234	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600021
J	Toivari, E; Manninen, T; Nahata, AK; Jalonen, TO; Linne, ML				Toivari, Eeva; Manninen, Tiina; Nahata, Amit K.; Jalonen, Tuula O.; Linne, Marja-Leena			Effects of Transmitters and Amyloid-Beta Peptide on Calcium Signals in Rat Cortical Astrocytes: Fura-2AM Measurements and Stochastic Model Simulations	PLOS ONE			English	Article							COUPLED CHEMICAL-REACTIONS; ALZHEIMERS-DISEASE; A-BETA; IN-VITRO; DEPRESSION; NEURONS; EQUATION; PATHWAYS; WAVES; DYSREGULATION	Background: To better understand the complex molecular level interactions seen in the pathogenesis of Alzheimer's disease, the results of the wet-lab and clinical studies can be complemented by mathematical models. Astrocytes are known to become reactive in Alzheimer's disease and their ionic equilibrium can be disturbed by interaction of the released and accumulated transmitters, such as serotonin, and peptides, including amyloid-beta peptides (A beta). We have here studied the effects of small amounts of A beta 25-35 fragments on the transmitter-induced calcium signals in astrocytes by Fura-2AM fluorescence measurements and running simulations of the detected calcium signals. Methodology/Principal Findings: Intracellular calcium signals were measured in cultured rat cortical astrocytes following additions of serotonin and glutamate, or either of these transmitters together with A beta 25-35. A beta 25-35 increased the number of astrocytes responding to glutamate and exceedingly increased the magnitude of the serotonin-induced calcium signals. In addition to A beta 25-35-induced effects, the contribution of intracellular calcium stores to calcium signaling was tested. When using higher stimulus frequency, the subsequent calcium peaks after the initial peak were of lower amplitude. This may indicate inadequate filling of the intracellular calcium stores between the stimuli. In order to reproduce the experimental findings, a stochastic computational model was introduced. The model takes into account the major mechanisms known to be involved in calcium signaling in astrocytes. Model simulations confirm the principal experimental findings and show the variability typical for experimental measurements. Conclusions/Significance: Nanomolar A beta 25-35 alone does not cause persistent change in the basal level of calcium in astrocytes. However, even small amounts of A beta 25-35, together with transmitters, can have substantial synergistic effects on intracellular calcium signals. Computational modeling further helps in understanding the mechanisms associated with intracellular calcium oscillations. Modeling the mechanisms is important, as astrocytes have an essential role in regulating the neuronal microenvironment of the central nervous system.	[Toivari, Eeva; Manninen, Tiina; Linne, Marja-Leena] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Nahata, Amit K.] DCI, Kidney Care Ctr, Steubenville, OH USA; [Jalonen, Tuula O.] St Georges Univ, Sch Med, Dept Physiol & Neurosci, St Georges, Grenada	Tampere University	Toivari, E (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	eeva.toivari@tut.fi; marja-leena.linne@tut.fi		Linne, Marja-Leena/0000-0003-2577-7329; Manninen, Tiina/0000-0002-0456-1185	Tampere University of Technology Doctoral Programme; Tampere Doctoral Programme in Information Science and Engineering (TISE); Academy of Finland [213462, 129657, 106030, 107694, 124615, 126556]; Emil Aaltonen Foundation; Finnish Concordia Fund	Tampere University of Technology Doctoral Programme; Tampere Doctoral Programme in Information Science and Engineering (TISE); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Concordia Fund	This work was supported in part by Tampere University of Technology Doctoral Programme (www.tut.fi), Tampere Doctoral Programme in Information Science and Engineering (TISE) (www.cs.tut.fi/tise/), the Academy of Finland, No. 213462, and 129657 (Finnish 320 Programme for Centres of Excellence in Research 2006-2011), 106030, 107694, 124615, and 126556 (www.aka.fi), Emil Aaltonen Foundation (www.emilaaltonen.fi), and Finnish Concordia Fund (www.konkordia-liitto.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Alberts B, 2002, MOL BIOL CELL; [Anonymous], [No title captured]; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Blankenfeld G.v, 1995, NEUROGLIA, P335; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Branden C., 1999, INTRO PROTEIN STRUCT; Charles A, 1998, GLIA, V24, P39, DOI 10.1002/(SICI)1098-1136(199809)24:1<39::AID-GLIA5>3.0.CO;2-W; Cheng L, 2009, SYNAPSE, V63, P206, DOI 10.1002/syn.20599; D'Ursi AM, 2004, J MED CHEM, V47, P4231, DOI 10.1021/jm040773o; Di Garbo A, 2007, BIOSYSTEMS, V89, P74, DOI 10.1016/j.biosystems.2006.05.013; Di Garbo A, 2009, J BIOL PHYS, V35, P361, DOI 10.1007/s10867-009-9143-2; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; FRANGAKIS MV, 1984, NEUROCHEM RES, V9, P1689, DOI 10.1007/BF00968079; Freir DB, 2003, J NEUROPHYSIOL, V89, P3061, DOI 10.1152/jn.00992.2002; Galoyan AA, 2008, ALZHEIMERS DEMENT, V4, P332, DOI 10.1016/j.jalz.2007.10.019; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hofer T, 2002, J NEUROSCI, V22, P4850, DOI 10.1523/JNEUROSCI.22-12-04850.2002; Jalonen TO, 1997, BRAIN RES, V746, P85, DOI 10.1016/S0006-8993(96)01189-4; Jalonen TO, 1997, BRAIN RES, V758, P69, DOI 10.1016/S0006-8993(97)00163-7; JALONEN TO, 1997, THESIS U TAMPERE CIT; Khachaturian ZS, 2006, J ALZHEIMERS DIS, V9, P409; Kimelberg H. K., 1992, V94, P57; Kimelberg HK, 1997, J NEUROCHEM, V68, P1088; KIMELBERG HK, 1997, GLIAL CELLS THEIR RO, P107; Kita Y, 2009, PSYCHOGERIATRICS, V9, P180, DOI 10.1111/j.1479-8301.2009.00293.x; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Lavrentovich M, 2008, J THEOR BIOL, V251, P553, DOI 10.1016/j.jtbi.2007.12.011; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; MAKIRAATIKKA E, 2007, P 5 IEEE INT WORKSH; Manninen T, 2006, COMPUT BIOL CHEM, V30, P280, DOI 10.1016/j.compbiolchem.2006.04.002; Marhl M, 2010, BIOPHYS CHEM, V148, P42, DOI 10.1016/j.bpc.2010.02.006; Matrisciano F, 2007, MOL PSYCHIATR, V12, P704, DOI 10.1038/sj.mp.4002005; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; Nie BM, 2008, NEUROPHARMACOLOGY, V54, P845, DOI 10.1016/j.neuropharm.2008.01.003; Paradisi S, 2004, GLIA, V46, P252, DOI 10.1002/glia.20005; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2009, CHAOS, V19, DOI 10.1063/1.3160017; Perea G, 2005, J NEURAL TRANSM, V112, P127, DOI 10.1007/s00702-004-0170-7; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; Saarinen A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000004; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Vesce S, 1999, CELL MOL LIFE SCI, V56, P991, DOI 10.1007/s000180050488; Wilkinso D.J., 2006, STOCHASTIC MODELLING	62	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17914	10.1371/journal.pone.0017914	http://dx.doi.org/10.1371/journal.pone.0017914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21483471	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600020
J	Burnier, JV; Wang, N; Michel, RP; Hassanain, M; Li, S; Lu, Y; Metrakos, P; Antecka, E; Burnier, MN; Ponton, A; Gallinger, S; Brodt, P				Burnier, J. V.; Wang, N.; Michel, R. P.; Hassanain, M.; Li, S.; Lu, Y.; Metrakos, P.; Antecka, E.; Burnier, M. N.; Ponton, A.; Gallinger, S.; Brodt, P.			Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis	ONCOGENE			English	Article						metastasis; liver; extracellular matrix; collagen IV; anoikis	FOCAL ADHESION KINASE; PANCREATIC ADENOCARCINOMA CELLS; MEMBRANE PROTEINS PLAY; VON-HIPPEL-LINDAU; BASEMENT-MEMBRANE; FACTOR RECEPTOR; EXTRACELLULAR-MATRIX; COLORECTAL-CANCER; CARCINOMA-CELLS; TUMOR-METASTASIS	The liver is a major site of metastasis for human malignancies, yet the factors that regulate tumor cell survival and growth in this organ remain elusive. Previously, we reported that M-27(IGF-IR) murine lung carcinoma cells with ectopic insulin-like growth factor-1 (IGF-I) receptor overexpression acquired a site-specific, liver-metastasizing potential. Gene expression profiling and subsequent RNA and protein analyses revealed that this was associated with major changes to the expression of extracellular matrix (ECM) protein-encoding genes including type III, IV and XVIII collagen genes, and these changes were also observed in the respective tumors in vivo. Because type IV collagen was the most prominently altered ECM protein in this model, we further analyzed its functional relevance to liver metastasis. M-27 cells stably overexpressing type IV collagen alpha 1 and alpha 2 chains were generated and their growth and metastatic properties investigated. We found that these cells acquired a site-selective growth advantage in the liver and this was associated with cell rescue from anoikis in a collagen IV/alpha 2 integrin/FAK-dependent manner and increased responsiveness to IGF-I. Conversely, collagen IV or focal adhesion kinase (FAK) silencing by small-interfering RNA in highly metastatic tumor cells enhanced anoikis and decreased liver metastases formation. Moreover, analysis of human surgical specimens revealed uniformly high collagen IV expression in 65/65 hepatic metastases analyzed, regardless of tissue of origin, whereas it was variable and generally low in 50/50 primary colorectal carcinoma specimens examined. The results suggest that collagen IV-conveyed signals are essential cues for liver metastasis in diverse tumor types and identify mediators of collagen IV signaling as potential therapeutic targets in the management of hepatic metastases. Oncogene (2011) 30, 3766-3783; doi:10.1038/onc.2011.89; published online 11 April 2011	[Burnier, J. V.; Wang, N.; Hassanain, M.; Li, S.; Lu, Y.; Metrakos, P.; Burnier, M. N.; Brodt, P.] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Wang, N.; Hassanain, M.; Lu, Y.; Metrakos, P.; Brodt, P.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Michel, R. P.; Antecka, E.; Burnier, M. N.] McGill Univ, Dept Surg, Montreal, PQ H3A 1A1, Canada; [Michel, R. P.; Burnier, M. N.; Brodt, P.] McGill Univ, Dept Pathol, Montreal, PQ H3A 1A1, Canada; [Burnier, M. N.] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Ponton, A.] McGill Univ, Dept Ophthalmol, Montreal, PQ H3A 1A1, Canada; [Gallinger, S.] Univ Hlth Network Toronto, Mt Sinai Hosp, Dept Surg, Toronto, ON, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto	Brodt, P (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Room H6-25,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	pnina.brodt@mcgill.ca	Gallinger, Steven/E-4575-2013; metrakos, peter/D-3726-2013; Hassanain, Mazen/C-7256-2011	Hassanain, Mazen/0000-0002-2441-5142; burnier, julia/0000-0002-2184-2157	Canadian Institute for Health Research [MOP-81201]; Research Institute of the McGill University Health Center; Stewart family award for Cancer Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Center; Stewart family award for Cancer Research	We thank Dr Zelia Correa (Department of Ophthalmology, University of Cincinnati) for the kind gift of the uveal melanoma specimens, Dr Yoshihiko Yamada for collagen IV alpha 1 and alpha 2 plasmids, Dr Taina Pihlajaniemi for antibodies to collagen XVIII and Ms Boram Ham for her help with the submission. This work was supported by Grant MOP-81201 from the Canadian Institute for Health Research (to PB). JVB was supported by a doctoral fellowship from the Research Institute of the McGill University Health Center and PB is a recipient of the Stewart family award for Cancer Research.	All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1; Andersson S, 2009, BIOCHEM BIOPH RES CO, V387, P36, DOI 10.1016/j.bbrc.2009.06.088; BARSKY SH, 1983, LANCET, V1, P296; Beattie J, 2010, J CELL PHYSIOL, V224, P605, DOI 10.1002/jcp.22183; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Brodt P, 2001, J BIOL CHEM, V276, P33608, DOI 10.1074/jbc.M102754200; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Catusse C, 2000, J HISTOCHEM CYTOCHEM, V48, P663, DOI 10.1177/002215540004800510; Clark RAF, 2008, J INVEST DERMATOL, V128, P1354, DOI 10.1038/jid.2008.75; Clemmons DR, 2003, ENDOCRINOLOGY, V144, P1664, DOI 10.1210/en.2002-221102; Decker NK, 2008, AM J PATHOL, V173, P1002, DOI 10.2353/ajpath.2008.080158; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Enns AE, 2004, J GASTROINTEST SURG, V8, P1049, DOI 10.1016/j.gassur.2004.08.016; ERIN N, 2009, INT J CANCER, V124, P14; Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355; FENYVESI A, 2003, ARCH ONCOL, V11, P15; Furukawa M, 2005, CLIN CANCER RES, V11, P3233, DOI 10.1158/1078-0432.CCR-04-1915; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Goel HL, 2005, CANCER RES, V65, P6692, DOI 10.1158/0008-5472.CAN-04-4315; Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Gulubova MV, 2004, CLIN EXP METASTAS, V21, P485, DOI 10.1007/s10585-004-3171-x; Gydee H, 2004, PEDIATR RES, V55, P709, DOI 10.1203/01.PDR.0000111282.98401.93; Habeck M, 2001, DRUG DISCOV TODAY, V6, P1077, DOI 10.1016/S1359-6446(01)02023-2; HAVENITH MG, 1988, CANCER-AM CANCER SOC, V62, P2207, DOI 10.1002/1097-0142(19881115)62:10<2207::AID-CNCR2820621023>3.0.CO;2-L; Hiki Y, 2002, PATHOL INT, V52, P224, DOI 10.1046/j.1440-1827.2002.01341.x; Iglesias-de la Cruz MC, 2002, KIDNEY INT, V62, P901, DOI 10.1046/j.1523-1755.2002.00528.x; Ikeda K, 2006, AM J PATHOL, V168, P856, DOI 10.2353/ajpath.2006.050384; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeschke MG, 2005, WOUND REPAIR REGEN, V13, P269, DOI 10.1111/j.1067-1927.2005.130309.x; Kahana O, 2002, ONCOGENE, V21, P3969, DOI 10.1038/sj.onc.1205472; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Krensel K, 1999, INT J CANCER, V80, P546, DOI 10.1002/(SICI)1097-0215(19990209)80:4<546::AID-IJC11>3.0.CO;2-9; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Liu GY, 2008, CELL BIOL INT, V32, P663, DOI 10.1016/j.cellbi.2008.01.292; Liu WG, 2008, CARCINOGENESIS, V29, P1096, DOI 10.1093/carcin/bgn026; LONG L, 1995, CANCER RES, V55, P1006; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8; Meir T, 2007, INVEST OPHTH VIS SCI, V48, P4890, DOI 10.1167/iovs.07-0215; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Miyamoto S, 2008, ADV EXP MED BIOL, V622, P281, DOI 10.1007/978-0-387-68969-2_23; Nadal C, 2007, WORLD J GASTROENTERO, V13, P5832, DOI 10.3748/wjg.v13.i44.5832; Nakano S, 1999, LAB INVEST, V79, P281; Neubauer K, 2001, CAN J GASTROENTEROL, V15, P187, DOI 10.1155/2001/870205; Oshima T, 2008, ONCOL REP, V20, P359, DOI 10.3892/or_00000015; PAGET S, 1989, CANCER METAST REV, V8, P98; Polette M, 2004, CRIT REV ONCOL HEMAT, V49, P179, DOI 10.1016/j.critrevonc.2003.10.008; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samani AA, 2004, CANCER RES, V64, P3380, DOI 10.1158/0008-5472.CAN-03-3780; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Sawai H, 2008, J SURG RES, V144, P117, DOI 10.1016/j.jss.2007.03.023; SCHAPERS RFM, 1990, CANCER, V66, P2583, DOI 10.1002/1097-0142(19901215)66:12<2583::AID-CNCR2820661222>3.0.CO;2-S; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steenhard BM, 2010, AM J PATHOL, V177, P84, DOI 10.2353/ajpath.2010.090767; Tanaka K, 1997, HISTOCHEM J, V29, P563, DOI 10.1023/A:1026428010104; Tang YC, 2003, CANCER RES, V63, P1166; Theret N, 2001, HEPATOLOGY, V34, P82, DOI 10.1053/jhep.2001.25758; Tian B, 2005, J CANCER RES CLIN, V131, P80, DOI 10.1007/s00432-004-0614-3; Ueda S, 2006, MODERN PATHOL, V19, P788, DOI 10.1038/modpathol.3800582; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; Vidal-Vanaclocha F, 2008, CANCER MICROENVIRON, V1, P113, DOI 10.1007/s12307-008-0011-6; Wang JY, 2006, J NEUROSCI RES, V83, P7, DOI 10.1002/jnr.20712; Wang N, 2006, CANCER RES, V66, P3062, DOI 10.1158/0008-5472.CAN-05-2638; Wang N, 2009, MOL THER, V17, P1241, DOI 10.1038/mt.2009.82; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xie YT, 1999, CANCER RES, V59, P3588; Yakar S, 2006, ENDOCRINOLOGY, V147, P5826, DOI 10.1210/en.2006-0311; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; Zeisberg M, 2006, MOL CELL BIOCHEM, V283, P181, DOI 10.1007/s11010-006-2677-8; Zha JP, 2010, CLIN CANCER RES, V16, P2512, DOI 10.1158/1078-0432.CCR-09-2232; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197	83	70	73	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	35					3766	3783		10.1038/onc.2011.89	http://dx.doi.org/10.1038/onc.2011.89			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21478904				2022-12-25	WOS:000294481400004
J	Manthey, HD; Thomas, AC; Shiels, IA; Zernecke, A; Woodruff, TM; Rolfe, B; Taylor, SM				Manthey, Helga D.; Thomas, Anita C.; Shiels, Ian A.; Zernecke, Alma; Woodruff, Trent M.; Rolfe, Barbara; Taylor, Stephen M.			Complement C5a inhibition reduces atherosclerosis in ApoE(-/-) mice	FASEB JOURNAL			English	Article						macrophage; C5a receptor; PMX53	E-DEFICIENT MICE; GENE-EXPRESSION; IN-VIVO; DIETARY-CHOLESTEROL; ENDOTHELIAL-CELLS; REGULATOR CD59; COMPONENT C5A; RECEPTOR; LESIONS; C5L2	The complement C5a receptor, CD88, is present on many of the cells found within human atherosclerotic plaques, but little is known about the role of C5a in atherogenesis. Using real-time PCR, we determined that ApoE(-/-) mice fed a normal diet express more aortic CD88 mRNA compared with controls, and this increase coincides with atherosclerotic lesion development (P<0.001 for 3- vs. 25-wk-old animals). Conversely, mRNA expression of the alternative C5a receptor, C5L2, in aortas of ApoE(-/-) mice, was lower than controls at all time points. Using immunohistochemistry, we confirmed the presence of CD88 on macrophages, smooth muscle cells, and activated endothelial cells in plaques from brachiocephalic arteries. Treatment of ApoE(-/-) mice with a CD88 antagonist (PMX53; 3 mg/kg s.c. 3 x /wk plus 1 mg/kg/d p.o.) for 25 wk reduced lesion size and lipid content in the plaque by similar to 40% (P<0.05). Our study provides evidence for a proatherogenic role for C5a and identifies the CD88 antagonist PMX53 as a potential antiatherosclerotic drug.-Manthey, H. D., Thomas, A. C., Shiels, I. A., Zernecke, A., Woodruff, T. M., Rolfe, B., Taylor, S. M. Complement C5a inhibition reduces atherosclerosis in ApoE(-/-) mice. FASEB J. 25, 2447-2455 (2011). www.fasebj.org	[Manthey, Helga D.; Zernecke, Alma; Rolfe, Barbara] Univ Wurzburg, Rudolf Virchow Zentrum, DFG Forschungszentrum Experimentelle Biomed, D-97080 Wurzburg, Germany; [Manthey, Helga D.; Shiels, Ian A.; Woodruff, Trent M.; Taylor, Stephen M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Thomas, Anita C.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Thomas, Anita C.] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England	University of Wurzburg; University of Queensland; University of Queensland; University of Bristol	Manthey, HD (corresponding author), Univ Wurzburg, Rudolf Virchow Zentrum, DFG Forschungszentrum Experimentelle Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	helga.manthey@uni-wuerzburg.de	Woodruff, Trent/AAS-4629-2020; Thomas, Anita C/E-1743-2011; Woodruff, Trent M/B-4861-2009	Woodruff, Trent/0000-0003-1382-911X; Thomas, Anita C/0000-0002-3792-2653; Woodruff, Trent M/0000-0003-1382-911X; Rolfe, Barbara/0000-0002-0468-1371	Australia National Health and Medical Research Council; British Heart Foundation; Deutsche Forschungsgemeinschaft [ZE827/4-1]	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Australia National Health and Medical Research Council. A. C. T. is supported by funding from the British Heart Foundation and A.Z. by the Deutsche Forschungsgemeinschaft (ZE827/4-1). The authors thank Tyson Moore, Michael Morgan, Jackie Costello, and Mike Wu for technical assistance with dosing mice and Bob Simpson and Johanna Barclay for technical assistance with real-time PCR experiments. The authors also thank Dr. Peter Monk (University of Sheffield, Sheffield, UK) for supplying the anti-mouse C5L2 antibody and Promics Ltd (Brisbane, QLD, Australia) for supplying the CD88 antagonist, PMX53, used in these studies.	Albrecht EA, 2004, AM J PATHOL, V164, P849, DOI 10.1016/S0002-9440(10)63173-2; Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; DENIS C, 1993, ARTERIOSCLER THROMB, V13, P398, DOI 10.1161/01.ATV.13.3.398; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Haskard DO, 2008, CURR OPIN LIPIDOL, V19, P478, DOI 10.1097/MOL.0b013e32830f4a06; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Koehl J, 2006, CURR OPIN MOL THER, V8, P529; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; LI H, 1993, ARTERIOSCLER THROMB, V13, P197, DOI 10.1161/01.ATV.13.2.197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Niculescu F, 1999, MOL IMMUNOL, V36, P949, DOI 10.1016/S0161-5890(99)00117-0; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Oksjoki R, 2007, ATHEROSCLEROSIS, V195, P90, DOI 10.1016/j.atherosclerosis.2006.12.016; Patel S, 2001, BIOCHEM BIOPH RES CO, V286, P164, DOI 10.1006/bbrc.2001.5276; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Schmiedt W, 1998, ARTERIOSCL THROM VAS, V18, P1790, DOI 10.1161/01.ATV.18.11.1790; SEIFERT PS, 1990, J EXP MED, V172, P547, DOI 10.1084/jem.172.2.547; SEIFERT PS, 1989, LAB INVEST, V60, P747; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Shagdarsuren E, 2010, CIRCULATION, V122, P1026, DOI 10.1161/CIRCULATIONAHA.110.954370; Speidl WS, 2011, FASEB J, V25, P35, DOI 10.1096/fj.10-156083; Speidl WS, 2005, EUR HEART J, V26, P2294, DOI 10.1093/eurheartj/ehi339; Thomas AC, 2010, J VASC RES, V47, P299, DOI 10.1159/000265564; Tous M, 2006, BIOCHEM BIOPH RES CO, V340, P1078, DOI 10.1016/j.bbrc.2005.12.109; Vischer UM, 1998, THROMB HAEMOSTASIS, V80, P1002; VLAICU R, 1985, ATHEROSCLEROSIS, V55, P35, DOI 10.1016/0021-9150(85)90164-9; VLAICU R, 1985, ATHEROSCLEROSIS, V57, P163, DOI 10.1016/0021-9150(85)90030-9; Woodruff TM, 2006, DRUG FUTURE, V31, P325, DOI 10.1358/dof.2006.031.04.980656; Woodruff TM, 2008, J IMMUNOL, V181, P8727, DOI 10.4049/jimmunol.181.12.8727; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wu GX, 2009, CIRC RES, V104, P550, DOI 10.1161/CIRCRESAHA.108.191361; Yasojima K, 2001, AM J PATHOL, V158, P1039, DOI 10.1016/S0002-9440(10)64051-5; Yun S, 2008, ARTERIOSCL THROM VAS, V28, P1714, DOI 10.1161/ATVBAHA.108.169912	48	69	70	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2447	2455		10.1096/fj.10-174284	http://dx.doi.org/10.1096/fj.10-174284			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21490292				2022-12-25	WOS:000292242200035
J	Kurotani, R; Okumura, S; Matsubara, T; Yokoyama, U; Buckley, JR; Tomita, T; Kezuka, K; Nagano, T; Esposito, D; Taylor, TE; Gillette, WK; Ishikawa, Y; Abe, H; Ward, JM; Kimura, S				Kurotani, Reiko; Okumura, Satoshi; Matsubara, Tsutomu; Yokoyama, Utako; Buckley, John R.; Tomita, Takeshi; Kezuka, Kyohei; Nagano, Tomokazu; Esposito, Dominic; Taylor, Troy E.; Gillette, William K.; Ishikawa, Yoshihiro; Abe, Hiroyuki; Ward, Jerrold M.; Kimura, Shioko			Secretoglobin 3A2 Suppresses Bleomycin-induced Pulmonary Fibrosis by Transforming Growth Factor beta Signaling Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTEROGLOBIN-RELATED PROTEIN-1; ALLERGIC AIRWAY INFLAMMATION; INDUCED LUNG FIBROSIS; INTERFERON-GAMMA; IFN-GAMMA; GENE-EXPRESSION; BREAST-CANCER; MOUSE; INHIBITION; RECEPTOR	With increasing worldwide rates of morbidity and mortality of pulmonary fibrosis, the development of effective therapeutics for this disease is of great interest. Secretoglobin (SCGB) 3A2, a novel cytokine-like molecule predominantly expressed in pulmonary airways epithelium, exhibits anti-inflammatory and growth factor activities. In the current study SCGB3A2 was found to inhibit TGF beta-induced differentiation of fibroblasts to myofibroblasts, a hallmark of the fibrogenic process, using pulmonary fibroblasts isolated from adult mice. This induction was through increased phosphorylation of STAT1 and expression of SMAD7 and decreased phosphorylation of SMAD2 and SMAD3. To demonstrate the effect of SCGB3A2 on the TGF beta signaling in vivo, a bleomycin-induced pulmonary fibrosis mouse model was used. Mice were administered bleomycin intratracheally followed by intravenous injection of recombinant SCGB3A2. Histological examination in conjunction with inflammatory cell counts in bronchoalveolar lavage fluids demonstrated that SCGB3A2 suppressed bleomycin-induced pulmonary fibrosis. Microarray analysis was carried out using RNAs from lungs of bleomycin-treated mice with or without SCGB3A2 and normal mice treated with SCGB3A2. The results demonstrated that SCGB3A2 affects TGF beta signaling and reduces the expression of genes involved in fibrosis. This study suggests the potential utility of SCGB3A2 for targeting TGF beta signaling in the treatment of pulmonary fibrosis.	[Kurotani, Reiko; Matsubara, Tsutomu; Buckley, John R.; Tomita, Takeshi; Nagano, Tomokazu; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kurotani, Reiko; Okumura, Satoshi; Yokoyama, Utako; Kezuka, Kyohei; Ishikawa, Yoshihiro] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan; [Kurotani, Reiko; Abe, Hiroyuki] Yamagata Univ, Fac Engn, Yamagata 9928510, Japan; [Esposito, Dominic; Taylor, Troy E.; Gillette, William K.] NCI, Prot Express Lab, Adv Technol Program, SAIC Frederick Inc,NIH, Frederick, MD 21701 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med & Med Cardiol, Newark, NJ 07103 USA; [Ward, Jerrold M.] Global VetPathol, Montgomery Village, MD 20866 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yokohama City University; Yamagata University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kimura, S (corresponding author), NCI, Lab Metab, NIH, Bldg 37,Rm 3106, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov	Yokoyama, Utako/AAD-1404-2022	Yokoyama, Utako/0000-0003-1803-0155; Esposito, Dominic/0000-0002-9987-1687; Gillette, William/0000-0002-8592-3642; Tomita, Takeshi/0000-0001-6815-2244	National Institutes of Health, Center for Cancer Research (NCI; NIH) [0010190305, Z01 BC010449-06];  [21790207]; NATIONAL CANCER INSTITUTE [ZIABC010449, Z01BC010449] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590936, 21380171] Funding Source: KAKEN	National Institutes of Health, Center for Cancer Research (NCI; NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Institutes of Health, Center for Cancer Research (Intramural Research Program of the NCI; NIH 0010190305 and Z01 BC010449-06, to S. K.). This work was also supported by Grant-in-aid for Young Scientists (B) (21790207, to R. K.).	Asazuma-Nakamura Y, 2009, EXP CELL RES, V315, P1190, DOI 10.1016/j.yexcr.2008.12.021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma A, 2005, AM J RESP CELL MOL, V32, P93, DOI 10.1165/rcmb.2003-0374OC; Bin LH, 2003, J IMMUNOL, V171, P924, DOI 10.4049/jimmunol.171.2.924; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Chiba Y, 2006, AM J RESP CRIT CARE, V173, P958, DOI 10.1164/rccm.200503-456OC; Chiba Y, 2005, IMMUNOL LETT, V97, P123, DOI 10.1016/j.imlet.2004.10.013; Chiba Y, 2004, AM J PHYSIOL-LUNG C, V287, pL1193, DOI 10.1152/ajplung.00263.2004; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Culleton J, 2007, INT J CANCER, V120, P1087, DOI 10.1002/ijc.22471; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Inoue Keiichi, 2008, Allergol Int, V57, P57, DOI 10.2332/allergolint.O-07-493; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Kurotani R, 2002, J ENDOCRINOL, V172, P477, DOI 10.1677/joe.0.1720477; Kurotani R, 2008, AM J RESP CRIT CARE, V178, P389, DOI 10.1164/rccm.200707-1104OC; Lee YJ, 1996, J IMMUNOL, V157, P1559; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Luppi F, 2009, SARCOIDOSIS VASC DIF, V26, P64; Maeng HG, 2009, IMMUNOBIOLOGY, V214, P311, DOI 10.1016/j.imbio.2008.09.003; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Miele L, 2000, ANN NY ACAD SCI, V923, P128; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mukherjee AB, 1999, CELL MOL LIFE SCI, V55, P771, DOI 10.1007/s000180050331; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; Papatheodoridis GV, 2005, J VIRAL HEPATITIS, V12, P199, DOI 10.1111/j.1365-2893.2005.00582.x; Puente Napoleon A, 2007, Med Health R I, V90, P43; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2003, AM J RESP CRIT CARE, V167, P945, DOI 10.1164/rccm.2301004; Senft AP, 2010, AM J RESP CELL MOL, V42, P404, DOI 10.1165/rcmb.2008-0229OC; Seo JY, 2009, CYTOKINE, V46, P51, DOI 10.1016/j.cyto.2008.12.008; Shijubo N, 2003, CURR PHARM DESIGN, V9, P1139, DOI 10.2174/1381612033455026; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Tamai M, 2006, J LAB CLIN MED, V147, P182, DOI 10.1016/j.lab.2005.12.001; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tomita T, 2008, J BIOL CHEM, V283, P25617, DOI 10.1074/jbc.M805140200; Tzortzaki EG, 2007, RESP MED, V101, P1821, DOI 10.1016/j.rmed.2007.02.006; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Watson MA, 1996, CANCER RES, V56, P860; Weng HL, 2007, J HEPATOL, V46, P295, DOI 10.1016/j.jhep.2006.09.014; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	50	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19682	19692		10.1074/jbc.M111.239046	http://dx.doi.org/10.1074/jbc.M111.239046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478551	Green Published, hybrid			2022-12-25	WOS:000291027700051
J	Wethkamp, N; Hanenberg, H; Funke, S; Suschek, CV; Wetzel, W; Heikaus, S; Grinstein, E; Ramp, U; Engers, R; Gabbert, HE; Mahotka, C				Wethkamp, Nils; Hanenberg, Helmut; Funke, Sarah; Suschek, Christoph V.; Wetzel, Wiebke; Heikaus, Sebastian; Grinstein, Edgar; Ramp, Uwe; Engers, Rainer; Gabbert, Helmut E.; Mahotka, Csaba			Daxx-beta and Daxx-gamma, Two Novel Splice Variants of the Transcriptional Co-repressor Daxx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENIC DOMAINS PODS; LEUKEMIA PROTEIN PML; INDUCED APOPTOSIS; P53-DEPENDENT APOPTOSIS; INTERACTING PROTEIN; NUCLEAR-BODIES; JNK ACTIVATION; P53 ACTIVITY; CELL-DEATH; RECEPTOR	Daxx is involved in transcriptional control and apoptosis. It comprises several domains, including a regulatory C terminus that is responsible for the interaction with numerous proteins such as p53, promyelocytic leukemia protein (PML), and Hsp27. Here, we describe the identification and characterization of two novel variants of Daxx termed Daxx-beta and Daxx-gamma, which are generated by alternative splicing. Alternative splicing results in a truncated regulatory C terminus in both proteins. As a consequence, Daxx-beta and Daxx-gamma show a markedly decreased affinity to PML, which in turn is associated with a different subnuclear localization of these proteins compared with Daxx. Although Daxx is localized mainly in PML-oncogenic domains (PODs) Daxx-beta and Daxx-gamma display a distinct distribution pattern. Furthermore, Daxx-beta and Daxx-gamma show a decreased affinity to p53 also due to the truncated C terminus. We provide evidence that the p53 recruitment into PODs is Daxx isoform-dependent. The decreased affinity of Daxx-beta/-gamma to p53 and PML results in a diffuse localization of p53 throughout the nucleus. In contrast to Daxx, Daxx-beta and Daxx-gamma are unable to repress p53-mediated transcription. Therefore, alternative splicing of Daxx might indicate an additional level in the cellular apoptosis network.	[Wethkamp, Nils; Funke, Sarah; Heikaus, Sebastian; Ramp, Uwe; Engers, Rainer; Gabbert, Helmut E.; Mahotka, Csaba] Univ Dusseldorf, Fac Med, Inst Pathol, Univ Hosp, D-40225 Dusseldorf, Germany; [Hanenberg, Helmut] Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Hanenberg, Helmut] Univ Dusseldorf, Sch Med, Dept Otorhinolaryngol, D-40225 Dusseldorf, Germany; [Suschek, Christoph V.; Wetzel, Wiebke] Univ Dusseldorf, Inst Mol Biol & Biochem 2, Fac Med, D-40225 Dusseldorf, Germany; [Grinstein, Edgar] Univ Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Fac Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Mahotka, C (corresponding author), Univ Dusseldorf, Fac Med, Inst Pathol, Moorenstr 5, D-40225 Dusseldorf, Germany.	mahotka@uni-duesseldorf.de			Dr. Mildred-Scheel-Stiftung fur Krebsforschung	Dr. Mildred-Scheel-Stiftung fur Krebsforschung(Deutsche Krebshilfe)	This work was supported in part by a grant from the Dr. Mildred-Scheel-Stiftung fur Krebsforschung.	Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Chang HY, 1999, P NATL ACAD SCI USA, V96, P1252, DOI 10.1073/pnas.96.4.1252; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Doucas V, 1996, BBA-REV CANCER, V1288, pM25, DOI 10.1016/S0304-419X(96)00028-5; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; HUGHES DPM, 1995, J EXP MED, V182, P1395, DOI 10.1084/jem.182.5.1395; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kim YY, 2003, BIOCHEM BIOPH RES CO, V312, P426, DOI 10.1016/j.bbrc.2003.10.144; Kiriakidou M, 1997, DNA CELL BIOL, V16, P1289, DOI 10.1089/dna.1997.16.1289; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Mahotka C, 1999, CANCER RES, V59, P6097; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Salomoni P, 2006, CELL DEATH DIFFER, V13, P672, DOI 10.1038/sj.cdd.4401820; Shkreta L, 2011, J BIOL CHEM, V286, P331, DOI 10.1074/jbc.M110.162644; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	43	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19576	19588		10.1074/jbc.M110.196311	http://dx.doi.org/10.1074/jbc.M110.196311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482821	Green Published, hybrid			2022-12-25	WOS:000291027700041
J	Laczy, B; Fulop, N; Onay-Besikci, A; Rosiers, CD; Chatham, JC				Laczy, Boglarka; Fueloep, Norbert; Onay-Besikci, Arzu; Rosiers, Christine Des; Chatham, John C.			Acute Regulation of Cardiac Metabolism by the Hexosamine Biosynthesis Pathway and Protein O-GlcNAcylation	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; FATTY-ACID TRANSLOCASE/CD36; NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; DIABETIC CARDIOMYOPATHY; CARDIOVASCULAR-SYSTEM; SUBSTRATE METABOLISM; ENDOTHELIAL-CELLS; RAT HEARTS; GLUCOSAMINE	Objective: The hexosamine biosynthesis pathway (HBP) flux and protein O-linked N-acetyl-glucosamine (O-GlcNAc) levels have been implicated in mediating the adverse effects of diabetes in the cardiovascular system. Activation of these pathways with glucosamine has been shown to mimic some of the diabetes-induced functional and structural changes in the heart; however, the effect on cardiac metabolism is not known. Therefore, the primary goal of this study was to determine the effects of glucosamine on cardiac substrate utilization. Methods: Isolated rat hearts were perfused with glucosamine (0-10 mM) to increase HBP flux under normoxic conditions. Metabolic fluxes were determined by C-13-NMR isotopomer analysis; UDP-GlcNAc a precursor of O-GlcNAc synthesis was assessed by HPLC and immunoblot analysis was used to determine O-GlcNAc levels, phospho-and total levels of AMPK and ACC, and membrane levels of FAT/CD36. Results: Glucosamine caused a dose dependent increase in both UDP-GlcNAc and O-GlcNAc levels, which was associated with a significant increase in palmitate oxidation with a concomitant decrease in lactate and pyruvate oxidation. There was no effect of glucosamine on AMPK or ACC phosphorylation; however, membrane levels of the fatty acid transport protein FAT/CD36 were increased and preliminary studies suggest that FAT/CD36 is a potential target for O-GlcNAcylation. Conclusion/Interpretation: These data demonstrate that acute modulation of HBP and protein O-GlcNAcylation in the heart stimulates fatty acid oxidation, possibly by increasing plasma membrane levels of FAT/CD36, raising the intriguing possibility that the HBP and O-GlcNAc turnover represent a novel, glucose dependent mechanism for regulating cardiac metabolism.	[Laczy, Boglarka; Fueloep, Norbert; Chatham, John C.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Fueloep, Norbert] Kaposi Mor Cty Hosp, Dept Nephrol, Kaposvar, Hungary; [Onay-Besikci, Arzu] Ankara Univ, Dept Pharmacol, TR-06100 Ankara, Turkey; [Rosiers, Christine Des] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Rosiers, Christine Des] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada	University of Alabama System; University of Alabama Birmingham; Ankara University; Universite de Montreal; Universite de Montreal	Laczy, B (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	jchatham@uab.edu	Onay-Besikci, Arzu/AAH-1413-2020; Rosiers, Christine Des/O-6285-2014	Onay-Besikci, Arzu/0000-0001-6883-1757; Chatham, John/0000-0001-7180-9948	National Institutes of Health [HL079364, HL067464, HL101192]; Canadian Institutes of Health Research (CIHR) [9575]; Scientific and Technological Research Council of Turkey (TUBITAK) [2219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067464, R01HL079364, R01HL101192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL079364, HL067464 and HL101192, JCC), Canadian Institutes of Health Research (CIHR Grants 9575 to CDR.) and The Scientific and Technological Research Council of Turkey (TUBITAK)-2219 (AOB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Arreola R, 2003, FEBS LETT, V551, P63, DOI 10.1016/S0014-5793(03)00896-2; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Chatham JC, 1999, AM J PHYSIOL-ENDOC M, V277, pE342, DOI 10.1152/ajpendo.1999.277.2.E342; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; COMB DG, 1958, J BIOL CHEM, V232, P807; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Coort SLM, 2007, MOL CELL BIOCHEM, V299, P5, DOI 10.1007/s11010-005-9030-5; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gross BJ, 2008, J AM CHEM SOC, V130, P440, DOI 10.1021/ja078125s; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Kuang M, 2004, CIRCULATION, V109, P1550, DOI 10.1161/01.CIR.0000121730.41801.12; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Lloyd SG, 2004, AM J PHYSIOL-HEART C, V287, pH351, DOI 10.1152/ajpheart.00983.2003; Lloyd SG, 2004, MAGN RESON MED, V51, P1279, DOI 10.1002/mrm.20075; LOPASCHUK GD, 1996, HEART DIABETES, P215; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Luo B, 2008, ARTERIOSCL THROM VAS, V28, P651, DOI 10.1161/ATVBAHA.107.159533; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; MARSH SA, AMINO ACIDS IN PRESS; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Onay-Besikci A, 2007, BASIC RES CARDIOL, V102, P436, DOI 10.1007/s00395-007-0661-4; Pang Y, 2004, DIABETES, V53, P1074, DOI 10.2337/diabetes.53.4.1074; RANDLE PJ, 1963, LANCET, V1, P785; Stanley WC, 1997, CARDIOVASC RES, V34, P25, DOI 10.1016/S0008-6363(97)00047-3; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Virkamaki A, 1999, DIABETES, V48, P1101, DOI 10.2337/diabetes.48.5.1101; Wang PP, 2005, AM J PHYSIOL-HEART C, V288, pH2102, DOI 10.1152/ajpheart.00935.2004; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	52	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18417	10.1371/journal.pone.0018417	http://dx.doi.org/10.1371/journal.pone.0018417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494549	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100013
J	Li, XQ; Zhang, TL; Donnelly, D				Li, Xiu-Qing; Zhang, Tieling; Donnelly, Danielle			Selective Loss of Cysteine Residues and Disulphide Bonds in a Potato Proteinase Inhibitor II Family	PLOS ONE			English	Article							GENE; RECEPTOR; DATABASE; COMPLEX; BINDING; TRANSCRIPTS; EXPRESSION; GENERATION; EVOLUTION; PLANTS	Disulphide bonds between cysteine residues in proteins play a key role in protein folding, stability, and function. Loss of a disulphide bond is often associated with functional differentiation of the protein. The evolution of disulphide bonds is still actively debated; analysis of naturally occurring variants can promote understanding of the protein evolutionary process. One of the disulphide bond-containing protein families is the potato proteinase inhibitor II (PI-II, or Pin2, for short) superfamily, which is found in most solanaceous plants and participates in plant development, stress response, and defence. Each PI-II domain contains eight cysteine residues (8C), and two similar PI-II domains form a functional protein that has eight disulphide bonds and two non-identical reaction centres. It is still unclear which patterns and processes affect cysteine residue loss in PI-II. Through cDNA sequencing and data mining, we found six natural variants missing cysteine residues involved in one or two disulphide bonds at the first reaction centre. We named these variants Pi7C and Pi6C for the proteins missing one or two pairs of cysteine residues, respectively. This PI-II-7C/6C family was found exclusively in potato. The missing cysteine residues were in bonding pairs but distant from one another at the nucleotide/protein sequence level. The non-synonymous/synonymous substitution (Ka/Ks) ratio analysis suggested a positive evolutionary gene selection for Pi6C and various Pi7C. The selective deletion of the first reaction centre cysteine residues that are structure-level-paired but sequence-level-distant in PI-II illustrates the flexibility of PI-II domains and suggests the functionality of their transient gene versions during evolution.	[Li, Xiu-Qing; Zhang, Tieling] Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada; [Zhang, Tieling; Donnelly, Danielle] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP); McGill University	Li, XQ (corresponding author), Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada.	xiu-qing.li@agr.gc.ca		Li, Xiu-Qing/0000-0002-7308-0596	Agriculture and Agri-Food Canada	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	The research was supported by the Agriculture and Agri-Food Canada A-base grant to XQL on plant molecular genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2005, PLANT MOL BIOL, V57, P189, DOI 10.1007/s11103-004-6959-9; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2007, HEREDITY, V99, P567, DOI 10.1038/sj.hdy.6801052; Barrette-Ng IH, 2003, J BIOL CHEM, V278, P24062, DOI 10.1074/jbc.M302020200; Barta E, 2002, TRENDS GENET, V18, P600, DOI 10.1016/S0168-9525(02)02771-3; Beekwilder J, 2000, EUR J BIOCHEM, V267, P1975, DOI 10.1046/j.1432-1327.2000.01201.x; Behe MJ, 2004, PROTEIN SCI, V13, P2651, DOI 10.1110/ps.04802904; Belville C, 2009, HUM MOL GENET, V18, P3002, DOI 10.1093/hmg/ddp238; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Fahnoe DC, 2000, ARCH BIOCHEM BIOPHYS, V373, P385, DOI 10.1006/abbi.1999.1586; Fitton HL, 1997, BLOOD COAGUL FIBRIN, V8, P145, DOI 10.1097/00001721-199703000-00009; Flinn B, 2005, PLANT MOL BIOL, V59, P407, DOI 10.1007/s11103-005-0185-y; GREENBLATT HM, 1989, J MOL BIOL, V205, P201, DOI 10.1016/0022-2836(89)90376-8; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hawkes J. G., 1988, Kulturpflanze, V36, P189; JONGSMA MA, 1995, MOL BREEDING, V1, P181, DOI 10.1007/BF01249702; Knudsen SM, 1997, FEBS LETT, V412, P141, DOI 10.1016/S0014-5793(97)00714-X; KRYSTEK S, 1993, J MOL BIOL, V234, P661, DOI 10.1006/jmbi.1993.1619; Li XQ, 1998, P NATL ACAD SCI USA, V95, P10032, DOI 10.1073/pnas.95.17.10032; Li XQ, 2005, THEOR APPL GENET, V110, P1068, DOI 10.1007/s00122-005-1927-6; Li XQ, 1996, PLANT CELL, V8, P1961, DOI 10.1105/tpc.8.11.1961; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; Lynch M, 2005, PROTEIN SCI, V14, P2217, DOI 10.1110/ps.041171805; MIYATA T, 1981, P NATL ACAD SCI-BIOL, V78, P450, DOI 10.1073/pnas.78.1.450; PENACORTES H, 1992, PLANTA, V186, P495, DOI 10.1007/BF00198028; PERLMAN JH, 1995, J BIOL CHEM, V270, P24682, DOI 10.1074/jbc.270.42.24682; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Schirra HJ, 2010, J MOL BIOL, V395, P609, DOI 10.1016/j.jmb.2009.11.031; Sin SF, 2006, PLANT J, V45, P58, DOI 10.1111/j.1365-313X.2005.02597.x; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thangudu RR, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-55; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van Vlijmen HWT, 2004, J MOL BIOL, V335, P1083, DOI 10.1016/j.jmb.2003.10.077; YOUNG RJ, 1994, PLANT PHYSIOL, V104, P811, DOI 10.1104/pp.104.2.811; ZHANG T, 2008, J HUAZHONG AGR U, V27, P10	38	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18615	10.1371/journal.pone.0018615	http://dx.doi.org/10.1371/journal.pone.0018615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494600	gold, Green Submitted, Green Published			2022-12-25	WOS:000289354100026
J	Dorr, J; Wernecke, KD; Bock, M; Gaede, G; Wuerfel, JT; Pfueller, CF; Bellmann-Strobl, J; Freing, A; Brandt, AU; Friedemann, P				Doerr, Jan; Wernecke, Klaus D.; Bock, Markus; Gaede, Gunnar; Wuerfel, Jens T.; Pfueller, Caspar F.; Bellmann-Strobl, Judith; Freing, Alina; Brandt, Alexander U.; Friedemann, Paul			Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; AXONAL DAMAGE; NEURONAL LOSS; DISABILITY; MS; ROBUST; ACCURATE; IMAGES; OPTIMIZATION	Neuroaxonal degeneration in the central nervous system contributes substantially to the long term disability in multiple sclerosis (MS) patients. However, in vivo determination and monitoring of neurodegeneration remain difficult. As the widely used MRI-based approaches, including the brain parenchymal fraction (BPF) have some limitations, complementary in vivo measures for neurodegeneration are necessary. Optical coherence tomography (OCT) is a potent tool for the detection of MS-related retinal neurodegeneration. However, crucial aspects including the association between OCT- and MRI-based atrophy measures or the impact of MS-related parameters on OCT parameters are still unclear. In this large prospective cross-sectional study on 104 relapsing remitting multiple sclerosis (RRMS) patients we evaluated the associations of retinal nerve fiber layer thickness (RNFLT) and total macular volume (TMV) with BPF and addressed the impact of disease-determining parameters on RNFLT, TMV or BPF. BPF, normalized for subject head size, was estimated with SIENAX. Relations were analyzed primarily by Generalized Estimating Equation (GEE) models considering within-patient inter-eye relations. We found that both RNFLT (p = 0.019, GEE) and TMV (p = 0.004, GEE) associate with BPF. RNFLT was furthermore linked to the disease duration (p<0.001, GEE) but neither to disease severity nor patients' age. Contrarily, BPF was rather associated with severity (p<0.001, GEE) than disease duration and was confounded by age (p<0.001, GEE). TMV was not associated with any of these parameters. Thus, we conclude that in RRMS patients with relatively short disease duration and rather mild disability RNFLT and TMV reflect brain atrophy and are thus promising parameters to evaluate neurodegeneration in MS. Furthermore, our data suggest that RNFLT and BPF reflect different aspects of MS. Whereas BPF best reflects disease severity, RNFLT might be the better parameter for monitoring axonal damage longitudinally. Longitudinal studies are necessary for validation of data and to further clarify the relevance of TMV.	[Doerr, Jan; Bock, Markus; Gaede, Gunnar; Pfueller, Caspar F.; Bellmann-Strobl, Judith; Freing, Alina; Brandt, Alexander U.; Friedemann, Paul] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Wernecke, Klaus D.] Sophisticated Stat Anal GmbH, Berlin, Germany; [Wuerfel, Jens T.] Med Univ Lubeck, Inst Neuroradiol, D-23538 Lubeck, Germany; [Bellmann-Strobl, Judith; Friedemann, Paul] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Bellmann-Strobl, Judith; Friedemann, Paul] Max Delbruck Ctr Mol Med, Berlin, Germany; [Brandt, Alexander U.] Gfnmediber GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Dorr, J (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	jan-markus.doerr@charite.de		paul, friedemann/0000-0002-6378-0070; Wuerfel, Jens/0000-0002-0034-8053; Bellmann-Strobl, Judith/0000-0003-2615-1643	German Research Foundation; German Ministry of Economics to NeuroCure Clinical Research Center [KF2286101FO9]; gfnmediber GmbH; TEVA Pharma GmbH, Germany; German Ministry of Economics [KF2286101FO9]	German Research Foundation(German Research Foundation (DFG)); German Ministry of Economics to NeuroCure Clinical Research Center; gfnmediber GmbH; TEVA Pharma GmbH, Germany; German Ministry of Economics	This work was supported by grants from the Excellence Cluster 257 of the German Research Foundation to NeuroCure Clinical Research Center, grant KF2286101FO9 from the German Ministry of Economics to NeuroCure Clinical Research Center and gfnmediber GmbH (www.gfnmediber.de) and a limited research grant by TEVA Pharma GmbH, Germany (www.teva-deutschland.de). These funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Besides their scientific affiliation at the Charite, Alexander U. Brandt and Klaus-Dieter Wernecke are employed by gfnmediber (AU Brandt) and SoStAna (KD Wernecke, www.sostana.com). Alexander U. Brandt contributed to this project (study design, statistical analysis and preparation of the manuscript) in his role as scientist and not as employee of gfnmediber GmbH. Apart from partial funding (grant KF2286101FO9 from the German Ministry of Economics) the company gfnmediber GmbH had no further role in this project. Klaus-Dieter Wernecke contributed to this project (study design, statistical analysis) in his role as scientist at the Charite and not as CEO of SoStAna. The company SoStAna itself had no role in this project.	Audoin B, 2007, MULT SCLER J, V13, P483, DOI 10.1177/1352458506070450; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; BOCK M, 2010, CLIN NEUROL NEUROSUR; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalkers NF, 2001, NEUROLOGY, V57, P1253, DOI 10.1212/WNL.57.7.1253; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pueyo V, 2008, MULT SCLER J, V14, P609, DOI 10.1177/1352458507087326; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Schirmer L, 2009, ANN NEUROL, V66, P698, DOI 10.1002/ana.21799; Sergott RC, 2007, J NEUROL SCI, V263, P3, DOI 10.1016/j.jns.2007.05.024; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	35	107	107	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18132	10.1371/journal.pone.0018132	http://dx.doi.org/10.1371/journal.pone.0018132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494659	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000289292800004
J	Liang, XD; Hall, JW; Yang, JS; Yan, MY; Doll, K; Bey, R; Ji, YD				Liang, Xudong; Hall, Jeffrey W.; Yang, Junshu; Yan, Meiying; Doll, Katherine; Bey, Russell; Ji, Yinduo			Identification of Single Nucleotide Polymorphisms Associated with Hyperproduction of Alpha-Toxin in Staphylococcus aureus	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; IN-VITRO; VIRULENCE DETERMINANTS; EPITHELIAL-CELLS; GENE-EXPRESSION; BETA-TOXIN; HEMOLYSIN; REGULATOR; APOPTOSIS; SARA	The virulence factor alpha-toxin (hla) is needed by Staphylococcus aureus in order to cause infections in both animals and humans. Although the complicated regulation of hla expression has been well studied in human S. aureus isolates, the mechanisms of of hla regulation in bovine S. aureus isolates remain undefined. In this study, we found that many bovine S. aureus isolates, including the RF122 strain, generate dramatic amounts of alpha-toxin in vitro compared with human clinical S. aureus isolates, including MRSA WCUH29 and MRSA USA300. To elucidate potential regulatory mechanisms, we analyzed the hla promoter regions and identified predominant single nucleotide polymorphisms (SNPs) at positions -376, -483, and -484 from the start codon in a-toxin hyper-producing isolates. Using site-directed mutagenesis and hla promoter-gfp-luxABCDE dual reporter approaches, we demonstrated that the SNPs contribute to the differential control of hla expression among bovine and human S. aureus isolates. Using a DNA affinity assay, gel-shift assays and a null mutant, we identified and revealed that an hla positive regulator, SarZ, contributes to the involvement of the SNPs in mediating hla expression. In addition, we found that the bovine S. aureus isolate RF122 exhibits higher transcription levels of hla positive regulators, including agrA, saeR, arlR and sarZ, but a lower expression level of hla repressor rot compared to the human S. aureus isolate WCUH29. Our results indicate alpha-toxin hyperproduction in bovine S. aureus is a multifactorial process, influenced at both the genomic and transcriptional levels. Moreover, the identification of predominant SNPs in the hla promoter region may provide a novel method for genotyping the S. aureus isolates.	[Liang, Xudong; Hall, Jeffrey W.; Yang, Junshu; Yan, Meiying; Doll, Katherine; Bey, Russell; Ji, Yinduo] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Liang, XD (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	jixxx002@umn.edu		Hall, Jeffrey/0000-0002-0214-4062	MAES Competitive Grants; NIH [AI057451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057451] Funding Source: NIH RePORTER	MAES Competitive Grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the MAES Competitive Grants and partially by NIH grant AI057451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Bayer AS, 1997, INFECT IMMUN, V65, P4652, DOI 10.1128/IAI.65.11.4652-4660.1997; Bonnstetter KK, 2007, J CLIN MICROBIOL, V45, P141, DOI 10.1128/JCM.01228-06; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; da Silva MCA, 2004, AM J PHYSIOL-LUNG C, V287, pL543, DOI 10.1152/ajplung.00256.2003; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Guinane CM, 2008, J INFECT DIS, V197, P205, DOI 10.1086/524689; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; JONSSON P, 1985, INFECT IMMUN, V49, P765, DOI 10.1128/IAI.49.3.765-769.1985; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Karlsson-Kanth A, 2006, INT J MED MICROBIOL, V296, P229, DOI 10.1016/j.ijmm.2006.01.067; KENNY K, 1992, CAN J VET RES, V56, P265; Kernodle DS, 1997, INFECT IMMUN, V65, P179, DOI 10.1128/IAI.65.1.179-184.1997; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kovacikova G, 2000, J BACTERIOL, V182, P3228, DOI 10.1128/JB.182.11.3228-3238.2000; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Larsen HD, 2002, VET MICROBIOL, V85, P61, DOI 10.1016/S0378-1135(01)00478-3; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Liang XD, 2007, CELL MICROBIOL, V9, P1809, DOI 10.1111/j.1462-5822.2007.00917.x; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; LOEFFLER DA, 1987, VET IMMUNOL IMMUNOP, V14, P145, DOI 10.1016/0165-2427(87)90049-3; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Nascimento JD, 2002, VET MICROBIOL, V85, P133, DOI 10.1016/S0378-1135(01)00476-X; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; Ohlsen K, 1997, INFECT IMMUN, V65, P3606, DOI 10.1128/IAI.65.9.3606-3614.1997; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Patel D, 2006, INFECT IMMUN, V74, P2849, DOI 10.1128/IAI.74.5.2849-2855.2006; Qazi SNA, 2004, J BACTERIOL, V186, P1065, DOI 10.1128/JB.186.4.1065-1077.2004; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stermann M, 2004, J BACTERIOL, V186, P2856, DOI 10.1128/JB.186.9.2856-2861.2004; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Sun JS, 2005, J BACTERIOL, V187, P7876, DOI 10.1128/JB.187.22.7876-7880.2005; Takeuchi S, 2001, VET MICROBIOL, V79, P267, DOI 10.1016/S0378-1135(00)00354-0; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210	56	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18428	10.1371/journal.pone.0018428	http://dx.doi.org/10.1371/journal.pone.0018428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494631	gold, Green Published, Green Submitted			2022-12-25	WOS:000289292800016
J	Lin, FPY; Lan, RT; Sintchenko, V; Gilbert, GL; Kong, FR; Coiera, E				Lin, Frank Po-Yen; Lan, Ruiting; Sintchenko, Vitali; Gilbert, Gwendolyn L.; Kong, Fanrong; Coiera, Enrico			Computational Bacterial Genome-Wide Analysis of Phylogenetic Profiles Reveals Potential Virulence Genes of Streptococcus agalactiae	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; NEISSERIA-MENINGITIDIS; STAPHYLOCOCCUS-AUREUS; PROTEIN; SEQUENCE; IDENTIFICATION; INFECTION; AFFINITY; ADHESIN; ISLANDS	The phylogenetic profile of a gene is a reflection of its evolutionary history and can be defined as the differential presence or absence of a gene in a set of reference genomes. It has been employed to facilitate the prediction of gene functions. However, the hypothesis that the application of this concept can also facilitate the discovery of bacterial virulence factors has not been fully examined. In this paper, we test this hypothesis and report a computational pipeline designed to identify previously unknown bacterial virulence genes using group B streptococcus (GBS) as an example. Phylogenetic profiles of all GBS genes across 467 bacterial reference genomes were determined by candidate-against-all BLAST searches, which were then used to identify candidate virulence genes by machine learning models. Evaluation experiments with known GBS virulence genes suggested good functional and model consistency in cross-validation analyses (areas under ROC curve, 0.80 and 0.98 respectively). Inspection of the top-10 genes in each of the 15 virulence functional groups revealed at least 15 (of 119) homologous genes implicated in virulence in other human pathogens but previously unrecognized as potential virulence genes in GBS. Among these highly-ranked genes, many encode hypothetical proteins with possible roles in GBS virulence. Thus, our approach has led to the identification of a set of genes potentially affecting the virulence potential of GBS, which are potential candidates for further in vitro and in vivo investigations. This computational pipeline can also be extended to in silico analysis of virulence determinants of other bacterial pathogens.	[Lin, Frank Po-Yen; Sintchenko, Vitali; Coiera, Enrico] Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Sintchenko, Vitali; Gilbert, Gwendolyn L.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW 2006, Australia; [Sintchenko, Vitali; Gilbert, Gwendolyn L.; Kong, Fanrong] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Lin, FPY (corresponding author), Univ New S Wales, Ctr Hlth Informat, Sydney, NSW, Australia.	f.lin@unsw.edu.au	Gilbert, Gwendolyn/B-7733-2013; Lin, Frank/R-1275-2019	Gilbert, Gwendolyn/0000-0001-7490-6727; Lin, Frank/0000-0001-9250-6874; Coiera, Enrico/0000-0002-6444-6584; Lan, Ruiting/0000-0001-9834-5258; Sintchenko, Vitali/0000-0002-9261-3650	Australian National Health & Medical Research Council (NHMRC)	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This research is supported by Australian National Health & Medical Research Council (NH&MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Franken C, 2001, MOL MICROBIOL, V41, P925, DOI 10.1046/j.1365-2958.2001.02563.x; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Haas W, 2005, J BACTERIOL, V187, P8205, DOI 10.1128/JB.187.23.8205-8210.2005; Haas W, 2004, J BACTERIOL, V186, P8463, DOI 10.1128/JB.186.24.8463-8471.2004; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KATO T, 1992, J BACTERIOL, V174, P3889, DOI 10.1128/jb.174.12.3889-3895.1992; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lin FPY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-86; Marcotte EM, 2000, P NATL ACAD SCI USA, V97, P12115, DOI 10.1073/pnas.220399497; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perrin A, 2002, INFECT IMMUN, V70, P7063, DOI 10.1128/IAI.70.12.7063-7072.2002; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Witten I. H., 2005, DATA MINING PRACTICA; Wu J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-80; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Yamanishi Y, 2004, BIOINFORMATICS, V20, P363, DOI 10.1093/bioinformatics/bth910; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790; Zheng Y, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-243	48	14	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e17964	10.1371/journal.pone.0017964	http://dx.doi.org/10.1371/journal.pone.0017964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483735	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058700006
J	Real, C; Remedio, L; Caiado, F; Igreja, C; Borges, C; Trindade, A; Pinto-do-O, P; Yagita, H; Duarte, A; Dias, S				Real, Carla; Remedio, Leonor; Caiado, Francisco; Igreja, Catia; Borges, Cristina; Trindade, Alexandre; Pinto-do-O, Perpetua; Yagita, Hideo; Duarte, Antonio; Dias, Sergio			Bone Marrow-Derived Endothelial Progenitors Expressing Delta-Like 4 (Dll4) Regulate Tumor Angiogenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM; UP-REGULATION; CELLS; GROWTH; VEGF; RECRUITMENT; INHIBITION; LETHALITY; DEFECTS; THERAPY	Neo-blood vessel growth (angiogenesis), which may involve the activation of pre-existing endothelial cells (EC) and/or the recruitment of bone marrow-derived vascular precursor cells (BM-VPC), is essential for tumor growth. Molecularly, besides the well established roles for Vascular endothelial growth factor (VEGF), recent findings show the Notch signalling pathway, in particular the ligand Delta-like 4 (Dll4), is also essential for adequate tumor angiogenesis; Dll4 inhibition results in impaired, non-functional, angiogenesis and reduced tumor growth. However, the role of BM-VPC in the setting of Notch pathway modulation was not addressed and is the subject of the present report. Here we show that SDF-1 and VEGF, which are produced by tumors, increase Dll4 expression on recruited BM-VPC. Mechanistically, BM-VPC activated, in a Dll4-dependent manner, a transcriptional program on mature EC suggestive of EC activation and stabilization. BM-VPC induced ICAM-2 and Fibronectin expression on EC, an effect that was blocked by a Dll4-specific neutralizing antibody. In vivo, transplantation of BM-VPC with decreased Dll4 into tumor-bearing mice resulted in the formation of microvessels with decreased pericyte coverage and reduced fibronectin expression. Consequently, transplantation of BM-VPC with decreased Dll4 resulted in impaired tumor angiogenesis, increased tumor hypoxia and apoptosis, and decreased tumor growth. Taken together, our data suggests that Dll4 expression by BM-VPC affects their communication with tumor vessel endothelial cells, thereby modulating tumor angiogenesis by affecting vascular stability.	[Real, Carla; Remedio, Leonor; Caiado, Francisco; Igreja, Catia; Dias, Sergio] CIPM Portuguese Inst Oncol, Angiogenesis Lab, Lisbon, Portugal; [Real, Carla; Remedio, Leonor; Caiado, Francisco; Igreja, Catia; Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Real, Carla] Univ Univ Lisboa, Ctr Quim & Bioquim, Fac Ciencias, Lisbon, Portugal; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Dias, Sergio] Univ Nova Lisboa, CEDOC, Fac Ciencias Med, P-1200 Lisbon, Portugal; [Borges, Cristina; Trindade, Alexandre; Duarte, Antonio] Univ Tecn Lisboa, CIISA, Fac Med Vet, Lisbon, Portugal; [Pinto-do-O, Perpetua] Univ Porto, Div Biomat, INEB Inst Engn Biomed, P-4100 Oporto, Portugal	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Juntendo University; Universidade Nova de Lisboa; Universidade de Lisboa; Universidade do Porto	Real, C (corresponding author), CIPM Portuguese Inst Oncol, Angiogenesis Lab, Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Dias, Sergio/L-1250-2014; Trindade, Alexandre/AAC-9726-2019; Trindade, Alexandre/J-3606-2013; Pinto-do-Ó, Perpetua/ABD-7205-2020; Real, Carla/D-5444-2009; Pinto-do-Ó, Perpetua/K-3742-2012; Igreja, Catia/I-8902-2018; Igreja, Catia/J-3674-2017; Duarte, Antonio/V-1178-2018	Dias, Sergio/0000-0002-7603-4616; Trindade, Alexandre/0000-0002-3104-9259; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Real, Carla/0000-0001-8067-2023; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Duarte, Antonio/0000-0002-9255-3635; Caiado, Francisco/0000-0003-4096-4448; Igreja, Catia/0000-0003-3563-1788; Borges, Ana/0000-0002-2572-6823	Fundacao para a Ciencia e Tecnologia (FCT)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Fundacao para a Ciencia e Tecnologia (FCT) grants (AD and PPdoO) and by individual FCT fellowships (CR, LR, FC, CI, CB, AT). The funders had no role in the design or orientation of the project, or in the preparation of the manuscript.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Caiado F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003752; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Deutsch U, 2008, EXP CELL RES, V314, P1202, DOI 10.1016/j.yexcr.2007.12.026; Dias S, 1998, INT J CANCER, V75, P151, DOI 10.1002/(SICI)1097-0215(19980105)75:1<151::AID-IJC23>3.0.CO;2-I; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dudley AC, 2010, BLOOD, V116, P3367, DOI 10.1182/blood-2010-02-271122; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Krebs LT, 2000, GENE DEV, V14, P1343; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Pasquier E, 2010, CURR CANCER DRUG TAR, V10, P914, DOI 10.2174/156800910793358041; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Scott KA, 2000, BRIT J CANCER, V83, P1538, DOI 10.1054/bjoc.2000.1487; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	32	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18323	10.1371/journal.pone.0018323	http://dx.doi.org/10.1371/journal.pone.0018323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483741	gold, Green Submitted, Green Published			2022-12-25	WOS:000289058700019
J	To, A; Bai, Y; Shen, A; Gong, H; Umamoto, S; Lu, SW; Liu, FY				To, Aaron; Bai, Yong; Shen, Ao; Gong, Hao; Umamoto, Sean; Lu, Sangwei; Liu, Fenyong			Yeast Two Hybrid Analyses Reveal Novel Binary Interactions between Human Cytomegalovirus-Encoded Virion Proteins	PLOS ONE			English	Article							SMALLEST CAPSID PROTEIN; SIMPLEX-VIRUS TYPE-1; TEGUMENT PROTEINS; INTERACTION MAP; RNASE P; HERPESVIRUS; GENOME; REPLICATION; RECRUITMENT; INHIBITION	Human cytomegalovirus (HCMV) is the largest human herpesvirus and its virion contains many viral encoded proteins found in the capsid, tegument, and envelope. In this study, we carried out a yeast two-hybrid (YTH) analysis to study potential binary interactions among 56 HCMV-encoded virion proteins. We have tested more than 3,500 pairwise combinations for binary interactions in the YTH analysis, and identified 79 potential interactions that involve 37 proteins. Forty five of the 79 interactions were also identified in human cells expressing the viral proteins by co-immunoprecipitation (co-IP) experiments. To our knowledge, 58 of the 79 interactions revealed by YTH analysis, including those 24 that were also identified in co-IP experiments, have not been reported before. Novel potential interactions were found between viral capsid proteins and tegument proteins, between tegument proteins, between tegument proteins and envelope proteins, and between envelope proteins. Furthermore, both the YTH and co-IP experiments have identified 9, 7, and 5 interactions that were involved with UL25, UL24, and UL89, respectively, suggesting that these "hub" proteins may function as the organizing centers for connecting multiple virion proteins in the mature virion and for recruiting other virion proteins during virion maturation and assembly. Our study provides a framework to study potential interactions between HCMV proteins and investigate the roles of protein-protein interactions in HCMV virion formation or maturation process.	[To, Aaron; Shen, Ao; Gong, Hao; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Bai, Yong; Umamoto, Sean; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	To, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	liu_fy@uclink4.berkeley.edu		SHEN, AO/0000-0002-1559-3895	NIH [T32AI007620, AI050468, DE014145, DE014842, DE016813]; University of California-Berkeley; State of California AIDS research program [D07-B-414]; Chinese Ministry of Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050468, T32AI007620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014145, R01DE016813, R01DE014842] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Berkeley(University of California System); State of California AIDS research program; Chinese Ministry of Education(Ministry of Education, China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	A.T. acknowledges support from NIH (T32AI007620) and Y.B. was partially supported by a Block Grant Graduate Fellowship (University of California-Berkeley). S.U. was a recipient of the predoctoral dissertation fellowship of the State of California AIDS research program (D07-B-414). A. S. was a visiting graduate student from State Key Laboratory of Virology, Wuhan University (P.R. China) and a recipient of a China Graduate Student Scholarship from the Chinese Ministry of Education. This research was, in part, supported by NIH (AI050468, DE014145, DE014842, and DE016813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adair R, 2002, J GEN VIROL, V83, P1315, DOI 10.1099/0022-1317-83-6-1315; Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; BRITT WJ, 1999, SEXUALLY TRANSMITTED, P269; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; Chen DH, 1999, VIROLOGY, V260, P10, DOI 10.1006/viro.1999.9791; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Desai P, 1996, VIROLOGY, V220, P516, DOI 10.1006/viro.1996.0341; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dunn W, 2005, CELL MICROBIOL, V7, P1684, DOI 10.1111/j.1462-5822.2005.00598.x; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Dunn W, 2001, P NATL ACAD SCI USA, V98, P14831, DOI 10.1073/pnas.261560598; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Gibson W, 1996, INTERVIROLOGY, V39, P389, DOI 10.1159/000150509; Gibson W, 1996, J VIROL, V70, P7454, DOI 10.1128/JVI.70.11.7454-7461.1996; Gibson W, 1996, J VIROL, V70, P5680, DOI 10.1128/JVI.70.8.5680-5683.1996; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GREIS KD, 1994, J VIROL, V68, P8339, DOI 10.1128/JVI.68.12.8339-8349.1994; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P75, DOI 10.1001/archopht.1989.01070010077031; Klupp BG, 2002, J VIROL, V76, P3065, DOI 10.1128/JVI.76.6.3065-3071.2002; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lai LL, 2003, J VIROL, V77, P2730, DOI 10.1128/JVI.77.4.2730-2735.2003; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lischka P, 2007, J GEN VIROL, V88, P405, DOI 10.1099/vir.0.82480-0; LIU F, 2007, COMP VIRION STRUCTUR, P27; Loveland AN, 2007, J VIROL, V81, P620, DOI 10.1128/JVI.01903-06; Mackay JP, 2007, TRENDS BIOCHEM SCI, V32, P530, DOI 10.1016/j.tibs.2007.09.006; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Moorman AC, 1999, ANN EPIDEMIOL, V9, P349, DOI 10.1016/S1047-2797(99)00005-8; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Okoye ME, 2006, J VIROL, V80, P929, DOI 10.1128/JVI.80.2.929-940.2006; Park MY, 2006, J VIROL, V80, P2718, DOI 10.1128/JVI.80.6.2718-2727.2006; PHILLIPS SL, 2010, J VIROL IN PRESS; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Schierling K, 2004, J VIROL, V78, P9512, DOI 10.1128/JVI.78.17.9512-9523.2004; Schnee M, 2006, J VIROL, V80, P11658, DOI 10.1128/JVI.01662-06; Spaderna S, 2005, J VIROL, V79, P11837, DOI 10.1128/JVI.79.18.11837-11847.2005; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Trus BL, 1999, J VIROL, V73, P2181, DOI 10.1128/JVI.73.3.2181-2192.1999; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vittone V, 2005, J VIROL, V79, P9566, DOI 10.1128/JVI.79.15.9566-9571.2005; Wang D, 2004, P NATL ACAD SCI USA, V101, P16642, DOI 10.1073/pnas.0407233101; Wood LJ, 1997, J VIROL, V71, P179, DOI 10.1128/JVI.71.1.179-190.1997; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; Yu XK, 2005, P NATL ACAD SCI USA, V102, P7103, DOI 10.1073/pnas.0408826102	53	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17796	10.1371/journal.pone.0017796	http://dx.doi.org/10.1371/journal.pone.0017796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483780	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058300004
J	Ghosh, S; Tan, F; Yu, TW; Li, YH; Adisa, O; Mosunjac, M; Ofori-Acquah, SF				Ghosh, Samit; Tan, Fang; Yu, Tianwei; Li, Yuhua; Adisa, Olufolake; Mosunjac, Mario; Ofori-Acquah, Solomon F.			Global Gene Expression Profiling of Endothelium Exposed to Heme Reveals an Organ-Specific Induction of Cytoprotective Enzymes in Sickle Cell Disease	PLOS ONE			English	Article							NAD(P)H-QUINONE OXIDOREDUCTASE-1; OXYGENASE-1 DEFICIENCY; SUPEROXIDE SCAVENGER; SKIN CARCINOGENESIS; MICROVASCULAR FLOW; OXIDATIVE STRESS; BREAST-CANCER; LUNG INJURY; MICE; VASOOCCLUSION	Background: Sickle cell disease (SCD) is characterized by hemolysis, vaso-occlusion and ischemia reperfusion injury. These events cause endothelial dysfunction and vasculopathies in multiple systems. However, the lack of atherosclerotic lesions has led to the idea that there are adaptive mechanisms that protect the endothelium from major vascular insults in SCD patients. The molecular bases for this phenomenon are poorly defined. This study was designed to identify the global profile of genes induced by heme in the endothelium, and assess expression of the heme-inducible cytoprotective enzymes in major organs impacted by SCD. Methods and Findings: Total RNA isolated from heme-treated endothelial monolayers was screened with the Affymetrix U133 Plus 2.0 chip, and the microarray data analyzed using multiple bioinformatics software. Hierarchical cluster analysis of significantly differentially expressed genes successfully segregated heme and vehicle-treated endothelium. Validation studies showed that the induction of cytoprotective enzymes by heme was influenced by the origin of endothelial cells, the duration of treatment, as well as the magnitude of induction of individual enzymes. In agreement with these heterogeneities, we found that induction of two major Nrf2-regulated cytoprotective enzymes, heme oxygenase-1 and NAD(P)H:quinone oxidoreductase-1 is organ-specific in two transgenic mouse models of SCD. This data was confirmed in the endothelium of post-mortem lung tissues of SCD patients. Conclusions: Individual organ systems induce unique profiles of cytoprotective enzymes to neutralize heme in SCD. Understanding this heterogeneity may help to develop effective therapies to manage vasculopathies of individual systems.	[Ghosh, Samit; Tan, Fang; Adisa, Olufolake; Ofori-Acquah, Solomon F.] Emory Univ Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Ghosh, Samit; Tan, Fang; Adisa, Olufolake; Ofori-Acquah, Solomon F.] Emory Univ Sch Med, Dept Pediat, Blood Disorders Serv, Atlanta, GA USA; [Yu, Tianwei] Emory Univ Sch Med, Dept Biostat & Bioinformat, Atlanta, GA USA; [Li, Yuhua] Emory Univ Sch Med, Winship Canc Ctr, Atlanta, GA USA; [Mosunjac, Mario] Emory Univ Sch Med, Dept Pathol & Lab Med, Atlanta, GA USA; [Ofori-Acquah, Solomon F.] Childrens Healthcare Atlanta, Ctr Endothelial Biol, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA)	Ghosh, S (corresponding author), Emory Univ Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA.	soforia@emory.edu	Mosunjac, Marina/A-4150-2012; Ghosh, Samit/F-1772-2015	Ghosh, Samit/0000-0002-3536-3077; Yu, Tianwei/0000-0003-2502-1628; Ofori-Acquah, Solomon/0000-0001-5000-3048	National Institutes of Health (NIH) [K02HL088026]; Emory Center for AIDS Research, NIH [P30-AI-50409]; Emory's Clinical Research (CTSI) [1 UL1RR025008-03]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL088026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Center for AIDS Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory's Clinical Research (CTSI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant # K02HL088026 awarded to SFOA. The gene expression studies were carried out in part with resources from the Emory Center for AIDS Research, NIH grant # P30-AI-50409. The microarray study was supported by Emory's Clinical Research grant (CTSI grant # 1 UL1RR025008-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; BALLA J, 1993, T ASSOC AM PHYSICIAN, V106, P128; Beckman JD, 2009, AM J PHYSIOL-HEART C, V297, pH1243, DOI 10.1152/ajpheart.00327.2009; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Belcher JD, 2010, J MOL MED, V88, P665, DOI 10.1007/s00109-010-0613-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENSINGER TA, 1974, ARCH INTERN MED, V133, P624, DOI 10.1001/archinte.133.4.624; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Embury S, 1995, SICKLE CELL DIS BASI; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; FOIDART M, 1983, J LAB CLIN MED, V102, P838; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graham JK, 2007, AM J FOREN MED PATH, V28, P168, DOI 10.1097/01.paf.0000257397.92466.50; Han SJ, 2009, MOL GENET METAB, V97, P85, DOI 10.1016/j.ymgme.2009.01.012; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Kaul DK, 2004, AM J PHYSIOL-HEART C, V287, pH293, DOI 10.1152/ajpheart.01150.2003; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Long DJ, 2000, CANCER RES, V60, P5913; Mahaseth H, 2005, J LAB CLIN MED, V145, P204, DOI 10.1016/j.lab.2005.02.008; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Maines MD, 2001, ADV EXP MED BIOL, V502, P249; Manci EA, 2006, BLOOD, V107, P1651, DOI 10.1182/blood-2005-07-2839; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; Ohta K, 2000, AM J KIDNEY DIS, V35, P863, DOI 10.1016/S0272-6386(00)70256-3; Park SJ, 2003, MUTAT RES-GEN TOX EN, V536, P131, DOI 10.1016/S1383-5718(03)00041-X; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Shen J, 2010, CANCER RES, V70, P1006, DOI 10.1158/0008-5472.CAN-09-2938; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zhang JH, 2003, CARCINOGENESIS, V24, P905, DOI 10.1093/carcin/bgg019; Zhu H, 2007, CARDIOVASC TOXICOL, V7, P202, DOI 10.1007/s12012-007-9001-z	50	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18399	10.1371/journal.pone.0018399	http://dx.doi.org/10.1371/journal.pone.0018399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483798	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200069
J	Molnar, F; Sigueiro, R; Sato, Y; Araujo, C; Schuster, I; Antony, P; Peluso, J; Muller, C; Mourino, A; Moras, D; Rochel, N				Molnar, Ferdinand; Sigueeiro, Rita; Sato, Yoshiteru; Araujo, Clarisse; Schuster, Inge; Antony, Pierre; Peluso, Jean; Muller, Christian; Mourino, Antonio; Moras, Dino; Rochel, Natacha			1 alpha,25(OH)(2)-3-Epi-Vitamin D-3, a Natural Physiological Metabolite of Vitamin D-3: Its Synthesis, Biological Activity and Crystal Structure with Its Receptor	PLOS ONE			English	Article							C-3 EPIMERIZATION PATHWAY; C-24 OXIDATION PATHWAY; A-RING DIASTEREOMERS; D-NUCLEAR-RECEPTOR; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1-ALPHA,25-DIHYDROXY-3-EPI-VITAMIN D-3; CALCIUM-TRANSPORT; ORGANIC-CHEMISTRY; PHOSPHINE OXIDE; GENE PROMOTER	Background: The 1 alpha,25-dihydroxy-3-epi-vitamin-D-3 (1 alpha,25(OH)(2)-3-epi-D-3), a natural metabolite of the seco-steroid vitamin D-3, exerts its biological activity through binding to its cognate vitamin D nuclear receptor (VDR), a ligand dependent transcription regulator. In vivo action of 1 alpha,25(OH)(2)-3-epi-D-3 is tissue-specific and exhibits lowest calcemic effect compared to that induced by 1 alpha,25(OH)(2)D-3. To further unveil the structural mechanism and structure-activity relationships of 1 alpha,25(OH)(2)-3-epi-D3 and its receptor complex, we characterized some of its in vitro biological properties and solved its crystal structure complexed with human VDR ligand-binding domain (LBD). Methodology/Principal Findings: In the present study, we report the more effective synthesis with fewer steps that provides higher yield of the 3-epimer of the 1 alpha,25(OH)(2)D-3. We solved the crystal structure of its complex with the human VDR-LBD and found that this natural metabolite displays specific adaptation of the ligand-binding pocket, as the 3-epimer maintains the number of hydrogen bonds by an alternative water-mediated interaction to compensate the abolished interaction with Ser278. In addition, the biological activity of the 1 alpha,25(OH)(2)-3-epi-D-3 in primary human keratinocytes and biochemical properties are comparable to 1 alpha,25(OH)(2)D-3. Conclusions/Significance: The physiological role of this pathway as the specific biological action of the 3-epimer remains unclear. However, its high metabolic stability together with its significant biologic activity makes this natural metabolite an interesting ligand for clinical applications. Our new findings contribute to a better understanding at molecular level how natural metabolites of 1 alpha,25(OH)(2)D-3 lead to significant activity in biological systems and we conclude that the C3-epimerization pathway produces an active metabolite with similar biochemical and biological properties to those of the 1 alpha,25(OH)(2)D-3.	[Molnar, Ferdinand; Sato, Yoshiteru; Antony, Pierre; Moras, Dino; Rochel, Natacha] Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR 7104, Illkirch Graffenstaden, France; [Molnar, Ferdinand] Univ Eastern Finland, Sch Pharm, Fac Hlth Sci, Kuopio, Finland; [Sigueeiro, Rita; Araujo, Clarisse; Mourino, Antonio] Univ Santiago de Compostela, Dept Quim Organ, Santiago De Compostela, Spain; [Sigueeiro, Rita; Araujo, Clarisse; Mourino, Antonio] CSIC, Unidad Asociada, Santiago De Compostela, Spain; [Schuster, Inge] Univ Vienna, Inst Pharmaceut Chem, A-1090 Vienna, Austria; [Peluso, Jean; Muller, Christian] Univ Strasbourg, CNRS, Fac Pharm, Inst Gilbert Laustriat,UMR 7175, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Eastern Finland; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); University of Vienna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Molnar, F (corresponding author), Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR 7104, Illkirch Graffenstaden, France.	rochel@igbmc.fr	Molnár, Ferdinand/E-2290-2011; Rochel, Natacha/A-5718-2016; schuster, inge/B-5304-2013; MULLER, Christian D./F-8399-2010	Molnár, Ferdinand/0000-0001-9008-4233; Rochel, Natacha/0000-0002-3573-5889; MULLER, Christian D./0000-0002-3463-1025; Mourino, Antonio/0000-0003-4803-3883	CNRS; INSERM; ULP; European Commission [LSHG-CT-2006-031220]; Spanish Ministry of Education and Science [SAF2007-67205]; Xunta de Galicia [INCITE08PXIB-209130PR, ACEUIC-2006/XA050]; Spanish MEC; Academy of Finland [128226]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ULP; European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Education and Science(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Spanish MEC(Spanish Government); Academy of Finland(Academy of Finland)	This study received financial support from CNRS, INSERM, ULP, the European Commission as SPINE2-complexes (contract no. LSHG-CT-2006-031220) under the RDT programme 'Quality of Life and Management of Living Resources', the Spanish Ministry of Education and Science (Grant SAF2007-67205) and Xunta de Galicia (Projects INCITE08PXIB-209130PR and ACEUIC-2006/XA050). Dishman-Netherlands provided the gift of vitamin D2. R. S. thanks the Spanish MEC for a predoctoral fellowship. F. M. thanks the Academy of Finland for a postdoctoral fellowship (128226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; BIKLE DD, 1986, BIOCHEMISTRY-US, V25, P1545, DOI 10.1021/bi00355a013; Bischof MG, 1998, EXP CELL RES, V241, P194, DOI 10.1006/excr.1998.4044; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Brown AJ, 1999, J CELL BIOCHEM, V73, P106, DOI 10.1002/(SICI)1097-4644(19990401)73:1&lt;106::AID-JCB12&gt;3.0.CO;2-Q; Campbell MJ, 2006, EXPERT OPIN THER TAR, V10, P735, DOI 10.1517/14728222.10.5.735; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Choi MW, 2001, BIOORGAN MED CHEM, V9, P1721, DOI 10.1016/S0968-0896(01)00060-8; COREY EJ, 1972, TETRAHEDRON LETT, V13, P3769, DOI DOI 10.1016/S0040-4039(01)94157-7; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Daniewski AR, 2002, J ORG CHEM, V67, P1580, DOI 10.1021/jo0161577; DeLuca HF, 2008, NUTR REV, V66, pS73, DOI 10.1111/j.1753-4887.2008.00105.x; Eelen G, 2008, CHEM BIOL, V15, P1029, DOI 10.1016/j.chembiol.2008.08.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleet JC, 1996, ARCH BIOCHEM BIOPHYS, V329, P228, DOI 10.1006/abbi.1996.0213; GARABEDIAN M, 1978, CLIN ORTHOP RELAT R, P241; Gogoi P, 2010, CHEM-EUR J, V16, P1432, DOI 10.1002/chem.200902972; Gomez-Reino C, 2005, ORG LETT, V7, P5885, DOI 10.1021/ol052489c; Harant H, 2000, J CELL BIOCHEM, V78, P112, DOI 10.1002/(SICI)1097-4644(20000701)78:1<112::AID-JCB10>3.0.CO;2-7; HOLICK MF, 1972, BIOCHEMISTRY-US, V11, P4251, DOI 10.1021/bi00773a009; HORST RL, 1979, BIOCHEM BIOPH RES CO, V89, P286, DOI 10.1016/0006-291X(79)90976-8; Hourai S, 2008, CHEM BIOL, V15, P383, DOI 10.1016/j.chembiol.2008.03.016; Hourai S, 2006, J MED CHEM, V49, P5199, DOI 10.1021/jm0604070; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; HYLEMON PB, 1985, COMPREHENSIVE BIOCH, V12, P331; ISHIZUKA S, 1987, J BIOL CHEM, V262, P7165; JONES G, 1987, Steroids, V49, P29, DOI 10.1016/0039-128X(87)90078-X; Kamao M, 2004, J BIOL CHEM, V279, P15897, DOI 10.1074/jbc.M311473200; Krause S., 2000, ORGANIC SYNTHESIS HI, P212; KUMAR R, 1978, J BIOL CHEM, V253, P3804; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LUCHE JL, 1978, J AM CHEM SOC, V100, P2226, DOI 10.1021/ja00475a040; Molnar F, 2006, J BIOL CHEM, V281, P10516, DOI 10.1074/jbc.M513609200; MORRISON NA, 1991, J BONE MINER RES, V6, P893; Mourino A, 1997, TETRAHEDRON LETT, V38, P4713, DOI 10.1016/S0040-4039(97)01005-8; MURALIDHARAN KR, 1993, J ORG CHEM, V58, P1895, DOI 10.1021/jo00059a048; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nakagawa K, 2001, STEROIDS, V66, P327, DOI 10.1016/S0039-128X(00)00142-2; NORMAN AW, 1993, J BIOL CHEM, V268, P20022; Penning TM, 1997, STEROIDS, V62, P101, DOI 10.1016/S0039-128X(96)00167-5; Pinette KV, 2003, MINI-REV MED CHEM, V3, P193, DOI 10.2174/1389557033488204; Posner GH, 2003, EUR J ORG CHEM, V2003, P3889, DOI 10.1002/ejoc.200300264; Reddy G.S., 2000, VITAMIN D ENDOCRINE, P139; Reddy GS, 2000, ARCH BIOCHEM BIOPHYS, V383, P197, DOI 10.1006/abbi.2000.2074; REDDY GS, 1994, VITAMIN D, P172; Reddy GS, 1997, VITAMIN D CHEM BIOL, P139; Reddy MD, 2007, J STEROID BIOCHEM, V103, P347, DOI 10.1016/j.jsbmb.2006.12.045; Rehan VK, 2002, MOL GENET METAB, V76, P46, DOI 10.1016/S1096-7192(02)00022-7; REINHARDT TA, 1981, BIOCHEMISTRY-US, V20, P6230, DOI 10.1021/bi00524a050; Rochel N, 2001, EUR J BIOCHEM, V268, P971, DOI 10.1046/j.1432-1327.2001.01953.x; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Sekimoto H, 1999, FEBS LETT, V448, P278, DOI 10.1016/S0014-5793(99)00377-4; SHARPLES.KB, 1973, J AM CHEM SOC, V95, P6136, DOI 10.1021/ja00799a061; Siu-Caldera ML, 1999, BONE, V24, P457, DOI 10.1016/S8756-3282(99)00019-8; SUDA T, 1970, BIOCHEMISTRY-US, V9, P4776, DOI 10.1021/bi00826a022; Takeyama KI, 1999, MOL CELL BIOL, V19, P1049; Tocchini-Valentini G, 2001, P NATL ACAD SCI USA, V98, P5491, DOI 10.1073/pnas.091018698; TROST BM, 1992, J AM CHEM SOC, V114, P9836, DOI 10.1021/ja00051a016; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; WICHMANN JK, 1979, BIOCHEMISTRY-US, V18, P4775, DOI 10.1021/bi00589a002; ZHU GD, 1995, CHEM REV, V95, P1877, DOI 10.1021/cr00038a007	65	67	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18124	10.1371/journal.pone.0018124	http://dx.doi.org/10.1371/journal.pone.0018124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483824	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200030
J	Nallaparaju, KC; Yu, JJ; Rodriguez, SA; Zogaj, X; Manam, S; Guentzel, MN; Seshu, J; Murthy, AK; Chambers, JP; Klose, KE; Arulanandam, BP				Nallaparaju, Kalyan C.; Yu, Jieh-Juen; Rodriguez, Stephen A.; Zogaj, Xhavit; Manam, Srikanth; Guentzel, M. Neal; Seshu, Janakiram; Murthy, Ashlesh K.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.			Evasion of IFN-gamma Signaling by Francisella novicida Is Dependent upon Francisella Outer Membrane Protein C	PLOS ONE			English	Article							LIVE VACCINE STRAIN; T-CELLS; INTRAMACROPHAGE SURVIVAL; CHLAMYDIA-TRACHOMATIS; PROTECTIVE IMMUNITY; MURINE MACROPHAGES; VIRULENCE FACTORS; EPITHELIAL-CELLS; TULARENSIS LVS; INFECTION	Background: Francisella tularensis is a Gram-negative facultative intracellular bacterium and the causative agent of the lethal disease tularemia. An outer membrane protein (FTT0918) of F. tularensis subsp. tularensis has been identified as a virulence factor. We generated a F. novicida (F. tularensis subsp. novicida) FTN_0444 (homolog of FTT0918) fopC mutant to study the virulence-associated mechanism(s) of FTT0918. Methods and Findings: The DfopC strain phenotype was characterized using immunological and biochemical assays. Attenuated virulence via the pulmonary route in wildtype C57BL/6 and BALB/c mice, as well as in knockout (KO) mice, including MHC I, MHC II, and mmT (B cell deficient), but not in IFN-gamma or IFN-gamma R KO mice was observed. Primary bone marrow derived macrophages (BMDM) prepared from C57BL/6 mice treated with rIFN-gamma exhibited greater inhibition of intracellular DfopC than wildtype U112 strain replication; whereas, IFN-gamma R KO macrophages showed no IFN-gamma-dependent inhibition of DfopC replication. Moreover, phosphorylation of STAT1 was downregulated by the wildtype strain, but not the fopC mutant, in rIFN-gamma treated macrophages. Addition of N G -monomethyl-L-arginine, an NOS inhibitor, led to an increase of DfopC replication to that seen in the BMDM unstimulated with rIFN-gamma. Enzymatic screening of DfopC revealed aberrant acid phosphatase activity and localization. Furthermore, a greater abundance of different proteins in the culture supernatants of DfopC than that in the wildtype U112 strain was observed. Conclusions: F. novicida FopC protein facilitates evasion of IFN-gamma-mediated immune defense(s) by down-regulation of STAT1 phosphorylation and nitric oxide production, thereby promoting virulence. Additionally, the FopC protein also may play a role in maintaining outer membrane stability (integrity) facilitating the activity and localization of acid phosphatases and other F. novicida cell components.	[Nallaparaju, Kalyan C.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Nallaparaju, KC (corresponding author), Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.	Bernard.arulanandam@utsa.edu	Arulanandam, Bernard P/O-9501-2014; Manam, Srikanth/K-6265-2019	Manam, Srikanth/0000-0001-5682-1957	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [PO1 AI057986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986] Funding Source: NIH RePORTER	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part with federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Grant PO1 AI057986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aragon V, 2000, INFECT IMMUN, V68, P1855, DOI 10.1128/IAI.68.4.1855-1863.2000; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; Ekchariyawat P, 2005, INFECT IMMUN, V73, P7332, DOI 10.1128/IAI.73.11.7332-7339.2005; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Forsberg A, 2007, ANN NY ACAD SCI, V1105, P187, DOI 10.1196/annals.1409.016; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Frirdich E, 2005, J BIOL CHEM, V280, P27604, DOI 10.1074/jbc.M504987200; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Henry T, 2007, CELL MICROBIOL, V9, P2543, DOI 10.1111/j.1462-5822.2007.01022.x; Hrstka R, 2005, MICROBES INFECT, V7, P619, DOI 10.1016/j.micinf.2004.12.020; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Powell HJ, 2008, IMMUNOL CELL BIOL, V86, P515, DOI 10.1038/icb.2008.31; Ray M, 2000, J INFECT DIS, V181, P1121, DOI 10.1086/315330; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Roth KM, 2009, INT IMMUNOL, V21, P19, DOI 10.1093/intimm/dxn119; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Sju┬stedt A.B., 2005, BERGEYS MANUAL SYSTE, P200; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Titball RW, 2003, TRENDS MICROBIOL, V11, P118, DOI 10.1016/S0966-842X(03)00020-9; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x	55	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18201	10.1371/journal.pone.0018201	http://dx.doi.org/10.1371/journal.pone.0018201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483828	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200042
J	Schaber, J; Flottmann, M; Li, J; Tiger, CF; Hohmann, S; Klipp, E				Schaber, Joerg; Floettmann, Max; Li, Jian; Tiger, Carl-Fredrik; Hohmann, Stefan; Klipp, Edda			Automated Ensemble Modeling with modelMaGe: Analyzing Feedback Mechanisms in the Sho1 Branch of the HOG Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BIOLOGY MARKUP LANGUAGE; SACCHAROMYCES-CEREVISIAE; YEAST OSMOREGULATION; PERFECT ADAPTATION; BIOCHEMICAL-MODELS; NEGATIVE FEEDBACK; SYSTEMS; ACCUMULATION; INHIBITION	In systems biology uncertainty about biological processes translates into alternative mathematical model candidates. Here, the goal is to generate, fit and discriminate several candidate models that represent different hypotheses for feedback mechanisms responsible for downregulating the response of the Sho1 branch of the yeast high osmolarity glycerol (HOG) signaling pathway after initial stimulation. Implementing and testing these candidate models by hand is a tedious and error-prone task. Therefore, we automatically generated a set of candidate models of the Sho1 branch with the tool modelMaGe. These candidate models are automatically documented, can readily be simulated and fitted automatically to data. A ranking of the models with respect to parsimonious data representation is provided, enabling discrimination between candidate models and the biological hypotheses underlying them. We conclude that a previously published model fitted spurious effects in the data. Moreover, the discrimination analysis suggests that the reported data does not support the conclusion that a desensitization mechanism leads to the rapid attenuation of Hog1 signaling in the Sho1 branch of the HOG pathway. The data rather supports a model where an integrator feedback shuts down the pathway. This conclusion is also supported by dedicated experiments that can exclusively be predicted by those models including an integrator feedback. modelMaGe is an open source project and is distributed under the Gnu General Public License (GPL) and is available from http://modelmage.org.	[Schaber, Joerg] Otto Von Guericke Univ, Fac Med, Inst Expt Internal Med, Magdeburg, Germany; [Schaber, Joerg; Floettmann, Max; Li, Jian; Klipp, Edda] Humboldt Univ, Dept Biol, D-1040 Berlin, Germany; [Tiger, Carl-Fredrik; Hohmann, Stefan] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden	Otto von Guericke University; Humboldt University of Berlin; University of Gothenburg	Schaber, J (corresponding author), Otto Von Guericke Univ, Fac Med, Inst Expt Internal Med, Magdeburg, Germany.	schaber@med.ovgu.de	Hohmann, Stefan/K-9895-2013	Hohmann, Stefan/0000-0002-0809-1985; Schaber, Jorg/0000-0001-6971-2530	Max Planck Society; German Academic Exchange Service (DAAD); European Commission [043310]; Vinnova, Sweden; DAAD [PPP D/05/50405]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); European Commission(European CommissionEuropean Commission Joint Research Centre); Vinnova, Sweden(Vinnova); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	MF was supported by the Max Planck Society and the German Academic Exchange Service (DAAD). This work was supported by the European Commission via the CELLCOMPUT project (Contract No. 043310 to EK and SK), Vinnova, Sweden (Multidisciplinary BIO to SH), and the DAAD (PPP D/05/50405 to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Bhalla US, 2003, PROG BIOPHYS MOL BIO, V81, P45, DOI 10.1016/S0079-6107(02)00046-9; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; DIBROV BF, 1982, J MATH BIOL, V15, P51, DOI 10.1007/BF00275788; Finney A, 2003, BIOCHEM SOC T, V31, P1472; Flottmann Max, 2008, Genome Inform, V20, P52; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Klipp E, 2007, NAT BIOTECHNOL, V25, P390, DOI 10.1038/nbt0407-390; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Schaber J, 2009, IET SYST BIOL, V3, P1, DOI 10.1049/iet-syb:20070042; Schaber J, 2010, EUR BIOPHYS J BIOPHY, V39, P1547, DOI 10.1007/s00249-010-0612-0; Schulz Marvin, 2006, Genome Inform, V17, P62; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	32	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e14791	10.1371/journal.pone.0014791	http://dx.doi.org/10.1371/journal.pone.0014791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21483474	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700003
J	Obata, H; Manabe, A; Nakamura, N; Onishi, T; Senba, Y				Obata, Hiroki; Manabe, Aya; Nakamura, Naoko; Onishi, Tomokazu; Senba, Yasuko			A New Light on the Evolution and Propagation of Prehistoric Grain Pests: The World's Oldest Maize Weevils Found in Jomon Potteries, Japan	PLOS ONE			English	Article							RICE WEEVIL; CURCULIONIDAE; COLEOPTERA; REPLACEMENT	Three Sitophilus species (S. granarius L., S. oryzae L., and S. zeamais Mots.) are closely related based on DNA analysis of their endosymbionts. All are seed parasites of cereal crops and important economic pest species in stored grain. The Sitophilus species that currently exist, including these three species, are generally believed to be endemic to Asia's forested areas, suggesting that the first infestations of stored grain must have taken place near the forested mountains of southwestern Asia. Previous archaeological data and historical records suggest that the three species may have been diffused by the spread of Neolithic agriculture, but this hypothesis has only been established for granary weevils in European and southwestern Asian archaeological records. There was little archeological evidence for grain pests in East Asia before the discovery of maize weevil impressions in Jomon pottery in 2004 using the "impression replica" method. Our research on Jomon agriculture based on seed and insect impressions in pottery continued to seek additional evidence. In 2010, we discovered older weevil impressions in Jomon pottery dating to ca. 10 500 BP. These specimens are the oldest harmful insects in the world discovered at archaeological sites. Our results provide evidence of harmful insects living in the villages from the Earliest Jomon, when no cereals were cultivated. This suggests we must reconsider previous scenarios for the evolution and propagation of grain pest weevils, especially in eastern Asia. Although details of their biology or the foods they infested remain unclear, we hope future interdisciplinary collaborations among geneticists, entomologists, and archaeologists will provide the missing details.	[Obata, Hiroki; Manabe, Aya] Kumamoto Univ, Fac Letters, Kumamoto, Japan; [Nakamura, Naoko] Kagoshima Univ, Fac Law & Letters, Kagoshima 890, Japan; [Onishi, Tomokazu] Int Univ Kagoshima, Fac Intercultural Studies, Kagoshima, Japan; [Senba, Yasuko] Kumamoto Univ, Project Seed Impress Studies, Kumamoto, Japan	Kumamoto University; Kagoshima University; International University Kagoshima; Kumamoto University	Obata, H (corresponding author), Kumamoto Univ, Fac Letters, Kumamoto, Japan.	totori@kumamoto-u.ac.jp			Japan Society for Promotion of Science	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aid for Scientific Research on Areas A ( subject number: 20242022) by Japan Society for Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAKI N, 1982, JPN J APPL ENTOMOL Z, V26, P166, DOI 10.1303/jjaez.26.166; Campbell JF, 2002, J INSECT BEHAV, V15, P429, DOI 10.1023/A:1016225427886; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; DELOBEL B, 1993, J STORED PROD RES, V29, P7, DOI 10.1016/0022-474X(93)90014-U; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Hara T., 1971, ECOLOGY CONTROL FOOD; HAYASHI N, 1999, ENV ENT BEHAV PHYSL, P321; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; Longstaff B.C., 1981, PROT ECOL, V2, P83; MIYAMOTO K, 2003, CULTURA ANTIQUE, V55, P1; MORI Y, 2001, HOUSE HOUSEHOLD INSE, V23, P23; MORIMOTO K, 1980, HOUSE HOUSEHOLD INSE, V7, P65; Nakayama S., 2008, B YAMANASHI MUSEUM, V2, P1; NAKAYAMA S, 2009, ANCIENT CULTURE, V61, P40; Obata H., 2008, CEREALS PREHISTORIC, V3, P43; OBATA H, 2006, UTILIZATION ACORNS P, P31; OBATA H, 2010, PREHISTORY ARCHAEOL, V5, P239; OMEARA B, 2001, THESIS HARVARD U; ONBE S, 2009, NEWSLETTER JOMON STU, V20, P114; *PALC RES I, 2006, SANKAKUYAMA SITES, V3, P252; Plarre R, 2010, EUR J ENTOMOL, V107, P1, DOI 10.14411/eje.2010.001; SATO Y, 2002, HIST RICE CULTIVATIO; SHINTO K, 2008, HDB JOMON POTTERY, P186; SUGIYAMA S, 2001, MONTHLY J EARTH, V23, P645; TAKAMIYA H, 1999, JPN J ETHNOL, V63, P283; UDATSU T, 2004, SUBSTANTIAL STUDY DI; YAMADA G, 2009, B HIST MUSEUM HOKKAI, V37, P13; Yamasaki S, 2005, ISSUES AGR NEOLITHIC, P33; Yasue Y., 1976, INSECTA, V13, P182; Yasue Y., 1959, NEW INSECTS, V12, P25; YASUTOMI K, 2000, ILLUSTRATED ENCY HOU; YOSHIDA T, 2001, ILLUSTRATIONS PESTS; YOSHIDA T, 1956, B FAC FINE ARTS LIT, V1, P137	33	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14785	10.1371/journal.pone.0014785	http://dx.doi.org/10.1371/journal.pone.0014785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479261	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600004
J	Yung, LM; Wong, WT; Tian, XY; Leung, FP; Yung, LH; Chen, ZY; Yao, XQ; Lau, CW; Huang, Y				Yung, Lai Ming; Wong, Wing Tak; Tian, Xiao Yu; Leung, Fung Ping; Yung, Lai Hang; Chen, Zhen Yu; Yao, Xiaoqiang; Lau, Chi Wai; Huang, Yu			Inhibition of Renin-Angiotensin System Reverses Endothelial Dysfunction and Oxidative Stress in Estrogen Deficient Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; ESSENTIAL-HYPERTENSION; SMOOTH-MUSCLE; RECEPTOR; CANDESARTAN; EXPRESSION; BRADYKININ; CELLS	Background: Estrogen deficiency increases the cardiovascular risks in postmenopausal women. Inhibition of the renin-angiotensin system (RAS) and associated oxidative stress confers a cardiovascular protection, but the role of RAS in estrogen deficiency-related vascular dysfunction is unclear. The present study investigates whether the up-regulation of RAS and associated oxidative stress contributes to the development of endothelial dysfunction during estrogen deficiency in ovariectomized (OVX) rats. Methodology/Principal Findings: Adult female rats were ovariectomized with and without chronic treatment with valsartan and enalapril. Isometric force measurement was performed in isolated aortae. The expression of RAS components was determined by immunohistochemistry and Western blotting method while ROS accumulation in the vascular wall was evaluated by dihydroethidium fluorescence. Ovariectomy increased the expression of angiotensin-converting enzyme (ACE), angiotensin II type 1 receptor (AT(1)R), NAD(P)H oxidase, and nitrotyrosine in the rat aorta. An over-production of angiotensin II and ROS was accompanied by decreased phosphorylation of eNOS at Ser(1177) in OVX rat aortae. These pathophysiological changes were closely coupled with increased oxidative stress and decreased nitric oxide bioavailability, culminating in markedly impaired endothelium-dependent relaxations. Furthermore, endothelial dysfunction and increased oxidative stress in aortae of OVX rats were inhibited or reversed by chronic RAS inhibition with enalapril or valsartan. Conclusions/Significance: The novel findings highlight a significant therapeutic benefit of RAS blockade in the treatment of endothelial dysfunction-related vascular complications in postmenopausal states.	[Yung, Lai Ming; Wong, Wing Tak; Tian, Xiao Yu; Leung, Fung Ping; Yung, Lai Hang; Yao, Xiaoqiang; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Zhen Yu] Chinese Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yung, LM (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China.	yu-huang@cuhk.edu.hk	Huang, Yu/K-2866-2017; Yao, Xiaoqiang/I-5413-2016; Tian, Xiao Yu/P-1092-2016; Wong, Wing Tak Jack/Q-4512-2018	Huang, Yu/0000-0002-1277-6784; Yao, Xiaoqiang/0000-0002-0687-8186; Tian, Xiao Yu/0000-0003-3472-9898; Wong, Wing Tak Jack/0000-0002-4514-3780	Hong Kong GRF [465308]; CUHK; Li Ka Shing Institute of Health Sciences	Hong Kong GRF(Hong Kong Research Grants Council); CUHK(Chinese University of Hong Kong); Li Ka Shing Institute of Health Sciences	This study was supported by Hong Kong GRF (465308), CUHK Focused Investment Scheme and Li Ka Shing Institute of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI 10.1359/JBMR.081006; Elesber AA, 2007, AM HEART J, V153, P1081, DOI 10.1016/j.ahj.2007.03.007; Ginnan R, 2008, FREE RADICAL BIO MED, V44, P1232, DOI 10.1016/j.freeradbiomed.2007.12.025; Gragasin FS, 2003, ARTERIOSCL THROM VAS, V23, P38, DOI 10.1161/01.ATV.0000047868.93732.B7; Halligan SC, 2004, MAYO CLIN PROC, V79, P1514, DOI 10.4065/79.12.1514; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hinojosa-Laborde C, 2004, HYPERTENSION, V44, P405, DOI 10.1161/01.HYP.0000142893.08655.96; Hodgin JB, 2002, J CLIN INVEST, V109, P541, DOI 10.1172/JCI200214066; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Imanishi T, 2006, HYPERTENSION, V48, P1058, DOI 10.1161/01.HYP.0000248920.16956.d8; Lavi S, 2007, CIRCULATION, V115, P2715, DOI 10.1161/CIRCULATIONAHA.106.671420; Li YQ, 2009, CAN J PHYSIOL PHARM, V87, P51, DOI 10.1139/Y08-097; Malmqvist K, 2000, AM J HYPERTENS, V13, P504, DOI 10.1016/S0895-7061(99)00264-2; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Nogawa N, 2001, MENOPAUSE, V8, P210, DOI 10.1097/00042192-200105000-00011; Ono H, 2008, HYPERTENS RES, V31, P271, DOI 10.1291/hypres.31.271; Phoon S, 2002, J RENIN-ANGIO-ALDO S, V3, P36, DOI 10.3317/jraas.2002.006; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Sumino H, 1999, AM J HYPERTENS, V12, P1044, DOI 10.1016/S0895-7061(99)00094-1; Tran D, 2001, J RENIN-ANGIO-ALDO S, V2, P199, DOI 10.3317/jraas.2001.028; Ungvari Z, 2006, ANTIOXID REDOX SIGN, V8, P1121, DOI 10.1089/ars.2006.8.1121; Vitale C, 2008, ARTERIOSCL THROM VAS, V28, P348, DOI 10.1161/ATVBAHA.107.158634; Wassmann K, 2006, MATURITAS, V53, P176, DOI 10.1016/j.maturitas.2005.04.002; Wassmann S, 2001, CIRCULATION, V103, P435; Wassmann S, 2004, HYPERTENSION, V44, P381, DOI 10.1161/01.HYP.0000142232.29764.a7; WENGER NK, 1993, NEW ENGL J MED, V329, P247, DOI 10.1056/NEJM199307223290406; Wong CM, 2006, VASC PHARMACOL, V44, P290, DOI 10.1016/j.vph.2005.12.005; Yoshida K, 2007, J HYPERTENS, V25, P1633, DOI 10.1097/HJH.0b013e32814db89f; Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1	31	58	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17437	10.1371/journal.pone.0017437	http://dx.doi.org/10.1371/journal.pone.0017437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479266	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600011
J	Liu, G; Gramling, S; Munoz, D; Cheng, D; Azad, AK; Mirshams, M; Chen, Z; Xu, W; Roberts, H; Shepherd, FA; Tsao, MS; Reisman, D				Liu, G.; Gramling, S.; Munoz, D.; Cheng, D.; Azad, A. K.; Mirshams, M.; Chen, Z.; Xu, W.; Roberts, H.; Shepherd, F. A.; Tsao, M. S.; Reisman, D.			Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk	ONCOGENE			English	Article						genetic polymorphism; BRG1; SWI/SNF; chromatin remodeling; lung cancer	SMALL-CELL-LUNG; CHROMATIN REMODELING COMPLEXES; SWI/SNF COMPLEX; BREAST-CANCER; SUSCEPTIBILITY LOCUS; PROTEIN EXPRESSION; CYCLE ARREST; DNA-DAMAGE; GENE; BRG1	SWI/SNF (SWItch/sucrose non-fermentable) complexes are ATP-dependent chromatin remodeling enzymes critically involved in the regulation of multiple functions, including gene expression, differentiation, development, DNA repair, cell adhesion and cell cycle control. BRM, a key SWI/SNF complex subunit, is silenced in 15-20% of many solid tumors. As BRM-deficient mice develop 10-fold more tumors when exposed to carcinogens, BRM is a strong candidate for a cancer susceptibility gene. In this paper, we show that BRM is regulated by transcription, thus demonstrating that the promoter region is important for BRM expression. We sequenced the BRM promoter region, finding two novel promoter indel polymorphisms, BRM -741 and BRM -1321, that are in linkage disequilibrium (D'>= 0.83). The variant insertion alleles of both polymorphisms produce sequence variants that are highly homologous to myocyte enhancer factor-2 (MEF2) transcription factor-binding sites; MEF2 is known to recruit histone deacetylases that silence BRM expression. Each polymorphic BRM insertion variant is found in similar to 20% of Caucasians, and each correlates strongly with the loss of protein expression of BRM, both in cancer cell lines (P = 0.009) and in primary human lung tumor specimens (P = 0.015). With such strong functional evidence, we conducted a case-control study of 1199 smokers. We found an increased risk of lung cancer when both BRM homozygous promoter insertion variants were present: adjusted odds ratio of 2.19 (95% confidence interval, 1.40-3.43). Thus, we here demonstrate a strong functional association between these polymorphisms and loss of BRM expression. These polymorphisms thus have the potential to identify a sub-population of smokers at greater lung cancer risk, wherein this risk could be driven by an aberrant SWI/SNF chromatin-remodeling pathway. Oncogene (2011) 30, 3295-3304; doi:10.1038/onc.2011.81; published online 11 April 2011	[Gramling, S.; Munoz, D.; Reisman, D.] Univ Florida, Dept Med, Div Hematol Oncol, Gainesville, FL 32611 USA; [Liu, G.; Shepherd, F. A.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Ontario Canc Inst,Div Med Oncol & Hematol,Dept Me, Toronto, ON, Canada; [Liu, G.; Cheng, D.; Azad, A. K.; Mirshams, M.; Chen, Z.; Tsao, M. S.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Ontario Canc Inst,Dept Med Biophys, Toronto, ON, Canada; [Xu, W.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Ontario Canc Inst,Biostat Dept, Toronto, ON, Canada; [Roberts, H.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Radiol, Toronto, ON, Canada; [Tsao, M. S.] Univ Toronto, Univ Hlth Network, Dept Pathol & Lab Med, Toronto, ON, Canada	State University System of Florida; University of Florida; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Reisman, D (corresponding author), Univ Florida, Dept Med, Div Hematol Oncol, Canc Genet Bldg Off 290,Off 294,2033 Mowry Rd, Gainesville, FL 32611 USA.	dnreisman@ufl.edu	Azad, Abul Kalam/G-3729-2010; Tsao, Ming-Sound/M-3503-2017; Liu, Geoffrey/N-4421-2016; Tsao, Ming Sound/AFQ-7332-2022	Azad, Abul Kalam/0000-0002-9236-9598; Tsao, Ming Sound/0000-0002-9160-5405; Liu, Geoffrey/0000-0002-2603-7296	Alan B Brown Chair in Molecular Genomics; CCO Chair in Experimental Therapeutics and Population Studies; Posluns Family Foundation; Ontario Ministry of Health and Long Term Care (OMHLTC); Lucy Wong Fund; NCI [7R03CA128038-02]; NATIONAL CANCER INSTITUTE [R03CA128038, T32CA009126] Funding Source: NIH RePORTER	Alan B Brown Chair in Molecular Genomics; CCO Chair in Experimental Therapeutics and Population Studies; Posluns Family Foundation; Ontario Ministry of Health and Long Term Care (OMHLTC)(Ministry of Health and Long-Term Care, Ontario); Lucy Wong Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GL is funded by the Alan B Brown Chair in Molecular Genomics, CCO Chair in Experimental Therapeutics and Population Studies, and Posluns Family Foundation; FAS holds the Scott Taylor Chair in Lung Cancer Research; MST holds the M Qasim Chair in Lung Cancer Translational Research; Supported by the Ontario Ministry of Health and Long Term Care (OMHLTC) and the Lucy Wong Fund. The results presented do not necessarily reflect the views of OMHLTC. Reisman lab funding is from NCI:7R03CA128038-02.	An HX, 1999, CANCER RES, V59, P3941; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; BARTLETT C, 2010, J CELL PHYSL; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fickett JW, 1996, MOL CELL BIOL, V16, P437; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gaillard H, 2003, J BIOL CHEM, V278, P17655, DOI 10.1074/jbc.M300770200; Gazdar AF, 2010, J NATL CANCER I, V102, P920, DOI 10.1093/jnci/djq220; Girard L, 2000, CANCER RES, V60, P4894; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Gramling S, 2011, ONCOGENE, V30, P3289, DOI 10.1038/onc.2011.80; Gramling S, 2011, LETT DRUG DES DISCOV, V8, P93, DOI 10.2174/157018011793663840; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gunduz E, 2009, CANCER INVEST, V27, P661, DOI 10.1080/07357900802563010; Hill DA, 2004, J CELL BIOCHEM, V91, P987, DOI 10.1002/jcb.20003; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; Liu G, 2005, SEMIN RESP CRIT CARE, V26, P265, DOI 10.1055/s-2005-871983; Morrison AJ, 2006, RES PRO CEL, V41, P109, DOI 10.1007/008; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Naidu SR, 2009, ONCOGENE, V28, P2492, DOI 10.1038/onc.2009.121; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Otsuki T, 2001, HUM MOL GENET, V10, P2651, DOI 10.1093/hmg/10.23.2651; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reisman DN, 2003, CANCER RES, V63, P560; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Sabah M, 2005, VIRCHOWS ARCH, V446, P251, DOI 10.1007/s00428-004-1190-2; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Solomon B, 2009, J THORAC ONCOL, V4, P1450, DOI 10.1097/JTO.0b013e3181c4dedb; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Tripathi A, 2003, J EXP CLIN CANC RES, V22, P289; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wang M, 2007, J BIOCHEM, V142, P613, DOI 10.1093/jb/mvm176; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yue JM, 2006, CANCER BIOL THER, V5, P573, DOI 10.4161/cbt.5.6.2872	51	40	41	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	29					3295	3304		10.1038/onc.2011.81	http://dx.doi.org/10.1038/onc.2011.81			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21478907	Green Accepted			2022-12-25	WOS:000293006800008
J	Vaneycken, I; Devoogdt, N; Van Gassen, N; Vincke, C; Xavier, C; Wernery, U; Muyldermans, S; Lahoutte, T; Caveliers, V				Vaneycken, Ilse; Devoogdt, Nick; Van Gassen, Naomi; Vincke, Cecile; Xavier, Catarina; Wernery, Ulrich; Muyldermans, Serge; Lahoutte, Tony; Caveliers, Vicky			Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer	FASEB JOURNAL			English	Article						tracer development; SPECT	SINGLE-CHAIN FV; ANKYRIN REPEAT PROTEINS; PINHOLE SPECT/MICRO-CT; ANTIBODY FRAGMENTS; HER-2 OVEREXPRESSION; AFFIBODY MOLECULE; METASTATIC SITES; AFFINITY; THERAPY; MICE	Accurate determination of tumor human epidermal growth factor receptor 2 (HER2)-status in breast cancer patients is possible via noninvasive imaging, provided adequate tracers are used. In this study, we describe the generation of a panel of 38 nanobodies, small HER2-binding fragments that are derived from heavy-chain-only antibodies raised in an immunized dromedary. In search of a lead compound, a subset of nanobodies was biochemically characterized in depth and preclinically tested for use as tracers for imaging of xenografted tumors. The selected compound, 2Rs15d, was found to be stable and to interact specifically with HER2 recombinant protein and HER2-expressing cells in ELISA, surface plasmon resonance, flow cytometry, and radioligand binding studies with low nanomolar affinities, and did not compete with anti-HER2 therapeutic antibodies trastuzumab and pertuzumab. Single-photon-emission computed tomography (SPECT) imaging quantification and biodistribution analyses showed that Tc-99m-labeled 2Rs15d has a high tumor uptake in 2 HER2(+) tumor models, fast blood clearance, low accumulation in nontarget organs except kidneys, and high concomitant tumor-to-blood and tumor-to-muscle ratios at 1 h after intravenous injection. These values were dramatically lower for an irrelevant control Tc-99m-nanobody and for Tc-99m-2Rs15d targeting a HER2(-) tumor.-Vaneycken, I., Devoogdt, N., Van Gassen, N., Vincke, C., Xavier, C., Wernery, U., Muyldermans, S., Lahoutte, T., Caveliers, V. Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer. FASEB J. 25, 2433-2446 (2011). www.fasebj.org	[Vaneycken, Ilse; Devoogdt, Nick; Xavier, Catarina; Lahoutte, Tony; Caveliers, Vicky] Vrije Univ Brussel, In Vivo Cellular & Mol Imaging ICMI Lab, B-1090 Brussels, Belgium; [Van Gassen, Naomi; Vincke, Cecile; Muyldermans, Serge] Vrije Univ Brussel, Lab Cellular & Mol Immunol, B-1090 Brussels, Belgium; [Lahoutte, Tony; Caveliers, Vicky] Univ Ziekenhuis St Rafael, Dept Nucl Med, Brussels, Belgium; [Van Gassen, Naomi; Vincke, Cecile; Muyldermans, Serge] VIB, Dept Mol & Cellular Interact, Brussels, Belgium; [Wernery, Ulrich] Cent Vet Res Lab, Dubai, U Arab Emirates	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Vaneycken, I (corresponding author), Vrije Univ Brussel, In Vivo Cellular & Mol Imaging Lab, Laarbeeklaan 103, B-1090 Brussels, Belgium.	ilse.vaneycken@gmail.com	Lahoutte, Tony/O-6381-2016; Muyldermans, Serge V/C-6418-2016; Devoogdt, Nick/H-5156-2013; Muyldermans, Serge/AAC-7374-2019; Xavier, Catarina/D-8080-2015; Vincke, Cecile/C-6590-2016	Muyldermans, Serge V/0000-0002-3678-3575; Devoogdt, Nick/0000-0001-9220-4833; Muyldermans, Serge/0000-0002-3678-3575; Xavier, Catarina/0000-0001-9006-1074; Vincke, Cecile/0000-0003-0681-7444; Lahoutte, Tony/0000-0002-1773-8664; Caveliers, Vicky/0000-0002-4301-5902	Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy	Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office)	The authors thank Cindy Peleman and Isabel Remory for their technical assistance with the small-animal pinhole SPECT/microCT and the cell culturing. The research at ICMI is funded by the Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy. T. L. is a Senior Clinical Investigator of the Research Foundation, Flanders (FWO), Belgium.	Adams GP, 2001, CANCER RES, V61, P4750; Agus DB, 2005, J CLIN ONCOL, V23, P2534, DOI 10.1200/JCO.2005.03.184; Ahlgren S, 2010, J NUCL MED, V51, P1131, DOI 10.2967/jnumed.109.073346; Behr TM, 2001, EUR J NUCL MED, V28, P976; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Cortez-Retamozo V, 2008, CURR RADIOPHARM, V1, P37, DOI 10.2174/1874471010801010037; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; Gainkam LOT, 2008, J NUCL MED, V49, P788, DOI 10.2967/jnumed.107.048538; Gainkam LOT, 2011, CONTRAST MEDIA MOL I, V6, P85, DOI 10.1002/cmmi.408; Gancberg D, 2002, ANN ONCOL, V13, P1036, DOI 10.1093/annonc/mdf252; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Hait W.N., 2008, MOL BASIS CANC, V3rd ed., P571; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanna W, 2007, BREAST J, V13, P122, DOI 10.1111/j.1524-4741.2007.00396.x; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hicks DG, 2008, AM J CLIN PATHOL, V129, P263, DOI 10.1309/99AE032R9FM8WND1; Huang L, 2008, MOL IMAGING BIOL, V10, P167, DOI 10.1007/s11307-008-0133-8; McLarty K, 2009, J NUCL MED, V50, P1848, DOI 10.2967/jnumed.109.067231; Nielsen UB, 2000, CANCER RES, V60, P6434; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Orlova A, 2009, J NUCL MED, V50, P417, DOI 10.2967/jnumed.108.057919; Robinson MK, 2005, CANCER RES, V65, P1471, DOI 10.1158/0008-5472.CAN-04-2008; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Tang Y, 2005, NUCL MED COMMUN, V26, P427, DOI 10.1097/00006231-200505000-00006; Tolmachev V, 2008, CURR PHARM DESIGN, V14, P2999, DOI 10.2174/138161208786404290; Vaneycken I, 2010, J NUCL MED, V51, P1099, DOI 10.2967/jnumed.109.069823; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Willuda J, 1999, CANCER RES, V59, P5758; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396; Zahnd C, 2006, J BIOL CHEM, V281, P35167, DOI 10.1074/jbc.M602547200; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zidan J, 2005, BRIT J CANCER, V93, P552, DOI 10.1038/sj.bjc.6602738	34	198	223	4	112	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2433	2446		10.1096/fj.10-180331	http://dx.doi.org/10.1096/fj.10-180331			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21478264				2022-12-25	WOS:000292242200034
J	Kim, S; Brandon, S; Zhou, Z; Cobb, CE; Edwards, SJ; Moth, CW; Parry, CS; Smith, JA; Lybrand, TP; Hustedt, EJ; Beth, AH				Kim, Sunghoon; Brandon, Suzanne; Zhou, Zheng; Cobb, Charles E.; Edwards, Sarah J.; Moth, Christopher W.; Parry, Christian S.; Smith, Jarrod A.; Lybrand, Terry P.; Hustedt, Eric J.; Beth, Albert H.			Determination of Structural Models of the Complex between the Cytoplasmic Domain of Erythrocyte Band 3 and Ankyrin-R Repeats 13-24	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOMA CELLS; INTERNAL CA2+ RELEASE; ANION-EXCHANGER; MEMBRANE BAND-3; SPIN LABELS; DISTANCE CONSTRAINTS; CRYSTAL-STRUCTURE; OLIGOMERIC STATE; PROTEIN DOCKING; BINDING SITE	The adaptor protein ankyrin-R interacts via its membrane binding domain with the cytoplasmic domain of the anion exchange protein (AE1) and via its spectrin binding domain with the spectrin-based membrane skeleton in human erythrocytes. This set of interactions provides a bridge between the lipid bilayer and the membrane skeleton, thereby stabilizing the membrane. Crystal structures for the dimeric cytoplasmic domain of AE1 (cdb3) and for a 12-ankyrin repeat segment (repeats 13-24) from the membrane binding domain of ankyrin-R (AnkD34) have been reported. However, structural data on how these proteins assemble to form a stable complex have not been reported. In the current studies, site-directed spin labeling, in combination with electron paramagnetic resonance (EPR) and double electron-electron resonance, has been utilized to map the binding interfaces of the two proteins in the complex and to obtain inter-protein distance constraints. These data have been utilized to construct a family of structural models that are consistent with the full range of experimental data. These models indicate that an extensive area on the peripheral domain of cdb3 binds to ankyrin repeats 18-20 on the top loop surface of AnkD34 primarily through hydrophobic interactions. This is a previously uncharacterized surface for binding of cdb3 to AnkD34. Because a second dimer of cdb3 is known to bind to ankyrin repeats 7-12 of the membrane binding domain of ankyrin-R, the current models have significant implications regarding the structural nature of a tetrameric form of AE1 that is hypothesized to be involved in binding to full-length ankyrin-R in the erythrocyte membrane.	[Beth, Albert H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Edwards, Sarah J.; Moth, Christopher W.; Parry, Christian S.; Lybrand, Terry P.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Smith, Jarrod A.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Beth, AH (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 727 Light Hall, Nashville, TN 37232 USA.	al.beth@vanderbilt.edu		kim, sunghoon/0000-0002-1570-3230	National Institutes of Health [P01 GM080513]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065086, P01GM080513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM080513 (to A. H. B.).	Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bhatnagar J, 2010, BIOCHEMISTRY-US, V49, P3824, DOI 10.1021/bi100055m; Blackman SM, 1998, BIOPHYS J, V75, P1117, DOI 10.1016/S0006-3495(98)77601-5; Borbat PP, 2002, J AM CHEM SOC, V124, P5304, DOI 10.1021/ja020040y; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P17917, DOI 10.1074/jbc.270.30.17917; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; CASEY JR, 1991, J BIOL CHEM, V266, P15726; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Che A, 1997, BIOCHEMISTRY-US, V36, P9588, DOI 10.1021/bi971074z; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, SEMIN CELL DEV BIOL, V22, P166, DOI 10.1016/j.semcdb.2010.09.013; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DAVIS L, 1989, J BIOL CHEM, V264, P9665; DAVIS LH, 1991, J BIOL CHEM, V266, P11163; Delaunay J, 2002, ACTA HAEMATOL-BASEL, V108, P210, DOI 10.1159/000065657; Ding Y, 1996, J BIOL CHEM, V271, P22494, DOI 10.1074/jbc.271.37.22494; DING Y, 1994, J BIOL CHEM, V269, P32201; Fajer MI, 2007, J AM CHEM SOC, V129, P13840, DOI 10.1021/ja071404v; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hanspal M, 1998, BLOOD, V92, P329, DOI 10.1182/blood.V92.1.329.413k20_329_338; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; KALOMIRIS EL, 1988, J CELL BIOL, V106, P319, DOI 10.1083/jcb.106.2.319; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; LI ZP, 1993, J BIOL CHEM, V268, P11489; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Nilsson KR, 2009, J CARDIOVASC PHARM, V54, P106, DOI 10.1097/FJC.0b013e3181b2b6ed; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Sale K, 2005, J AM CHEM SOC, V127, P9334, DOI 10.1021/ja051652w; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Stefanovic M, 2007, P NATL ACAD SCI USA, V104, P13972, DOI 10.1073/pnas.0706266104; THEVENIN BJM, 1990, J BIOL CHEM, V265, P16166; WANG CC, 1995, J BIOL CHEM, V270, P17892, DOI 10.1074/jbc.270.30.17892; WILLARDSON BM, 1989, J BIOL CHEM, V264, P15893; Zhang DC, 2000, BLOOD, V96, P2925; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t; ZHOU Z, 2006, THESIS VANDERBILT U; Zhou Z, 2007, BIOCHEMISTRY-US, V46, P10248, DOI 10.1021/bi700948p	49	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20746	20757		10.1074/jbc.M111.230326	http://dx.doi.org/10.1074/jbc.M111.230326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21493712	Green Published, hybrid			2022-12-25	WOS:000291267600060
J	Larabee, JL; Shakir, SM; Hightower, L; Ballard, JD				Larabee, Jason L.; Shakir, Salika M.; Hightower, Logan; Ballard, Jimmy D.			Adenomatous Polyposis Coli Protein Associates with C/EBP beta and Increases Bacillus anthracis Edema Toxin-stimulated Gene Expression in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; KINASE-A; PHOSPHORYLATION; TRANSCRIPTION; CATENIN; BINDING; CREB; DIFFERENTIATION; LOCALIZATION; INACTIVATION	The production of cAMP from Bacillus anthracis edema toxin (ET) activates gene expression in macrophages through a complex array of signaling pathways, most of which remain poorly defined. In this study, the tumor suppressor protein adenomatous polyposis coli (APC) was found to be important for the up-regulation of previously defined ET-stimulated genes (Vegfa, Ptgs2, Arg2, Cxcl2, Sdc1, and Cebpb). A reduction in the expression of these genes after ET exposure was observed when APC was disrupted in macrophages using siRNA or in bone marrow-derived macrophages obtained from C57BL/6J-Apc(Min) mice, which are heterozygous for a truncated form of APC. In line with this observation, ET increased the expression of APC at the transcriptional level, leading to increased amounts of APC in the nucleus. The mechanism utilized by APC to increase ET-induced gene expression was determined to depend on the ability of APC to interact with C/EBP beta, which is a transcription factor activated by cAMP. Coimmunoprecipitation experiments found that APC associated with C/EBP beta and that levels of this complex increase after ET exposure. A further connection was uncovered when silencing APC was determined to reduce the ET-induced phosphorylation of C/EBP beta at Thr-188. This ET-mediated phosphorylation of C/EBP beta was blocked by glycogen synthase kinase 3 (GSK-3) inhibitors, suggesting that GSK-3 is involved in the activation of C/EBP beta and supporting the idea of APC helping direct interactions between GSK-3 and C/EBP beta. These results indicate that ET stimulates gene expression by promoting the formation of an inducible protein complex consisting of APC and C/EBP beta.	[Larabee, Jason L.; Shakir, Salika M.; Hightower, Logan; Ballard, Jimmy D.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Larabee, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BRC-358,975 NE 10th St, Oklahoma City, OK 73104 USA.	jason-larabee@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	NIAID National Institutes of Health [U19 AI062629-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER	NIAID National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NIAID National Institutes of Health Grant U19 AI062629-6 (to J. D. B.).	BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Comer JE, 2006, MICROB PATHOGENESIS, V41, P96, DOI 10.1016/j.micpath.2006.05.001; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gorgoni B, 2001, J BIOL CHEM, V276, P40769, DOI 10.1074/jbc.M106865200; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kouzmenko AP, 2008, ONCOGENE, V27, P4888, DOI 10.1038/onc.2008.127; Kouzmenko AP, 2008, GENES CELLS, V13, P723, DOI 10.1111/j.1365-2443.2008.01200.x; Larabee JL, 2008, INFECT IMMUN, V76, P4895, DOI 10.1128/IAI.00889-08; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu XD, 2001, AM J PHYSIOL-RENAL, V281, pF649, DOI 10.1152/ajprenal.2001.281.4.F649; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Orellana D, 2010, J BIOL CHEM, V285, P23442, DOI 10.1074/jbc.M110.129825; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Raymond B, 2007, PLOS PATHOG, V3, P1907, DOI 10.1371/journal.ppat.0030187; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Strom A, 2007, DEVELOPMENT, V134, P2719, DOI 10.1242/dev.02875; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Yeager LA, 2009, INFECT IMMUN, V77, P2530, DOI 10.1128/IAI.00905-08; Zhang F, 2000, P NATL ACAD SCI USA, V97, P12577, DOI 10.1073/pnas.230435597; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001	35	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19364	19372		10.1074/jbc.M111.224543	http://dx.doi.org/10.1074/jbc.M111.224543			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487015	hybrid, Green Published			2022-12-25	WOS:000291027700018
J	Thompson, S; Pearson, AN; Ashley, MD; Jessick, V; Murphy, BM; Gafken, P; Henshall, DC; Morris, KT; Simon, RP; Meller, R				Thompson, Simon; Pearson, Andrea N.; Ashley, Michelle D.; Jessick, Veronica; Murphy, Brona M.; Gafken, Philip; Henshall, David C.; Morris, Kate T.; Simon, Roger P.; Meller, Robert			Identification of a Novel Bcl-2-interacting Mediator of Cell Death (Bim) E3 Ligase, Tripartite Motif-containing Protein 2 (TRIM2), and Its Role in Rapid Ischemic Tolerance-induced Neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED KINASES 1/2; BH3-ONLY PROTEIN; DEPENDENT APOPTOSIS; UBIQUITIN LIGASES; PHOSPHORYLATION; DEGRADATION; BIM(EL); ADENOSINE; FAMILY; CHAIN	We have previously shown that the cell death-promoting protein Bcl-2-interacting mediator of cell death (Bim) is ubiquitinated and degraded following a neuroprotection-conferring episode of brief ischemia (preconditioning). Here, we identify the E3 ligase that ubiquitinates Bim in this model, using a proteomics approach. Using phosphorylated GST-Bim as bait, we precipitated and identified by mass spectrometry tripartite motif protein 2 (TRIM2), a RING (really interesting new gene) domain-containing protein. The reaction between TRIM2 and Bim was confirmed using co-immunoprecipitation followed by immunoblotting. We show that TRIM2 binds to Bim when it is phosphorylated by p42/p44 MAPK but does not interact with a nonphosphorylatable Bim mutant (3ABim). 12-O-tetradecanoylphorbol-13-acetate activation of p42/p44 MAPK drives Bim ubiquitination in mouse embryonic fibroblast cells and is associated with an increased interaction between TRIM2 and Bim. One hour following preconditioning ischemia, the binding of Bim to TRIM2 increased, consistent with the time window of enhanced Bim degradation. Blocking p42/p44 MAPK activation following preconditioning ischemia with U0126 or using the nonphosphorylatable 3ABim reduced the binding between Bim and TRIM2. Immunodepletion of TRIM2 from cell lysates prepared from preconditioned cells reduced Bim ubiquitination. Finally, suppression of TRIM2 expression, using lentivirus transduction of shRNAmir, stabilized Bim protein levels and blocked neuroprotection observed in rapid ischemic tolerance. Taken together, these data support a role for TRIM2 in mediating the p42/p44 MAPK-dependent ubiquitination of Bim in rapid ischemic tolerance.	[Pearson, Andrea N.; Simon, Roger P.; Meller, Robert] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; [Thompson, Simon; Pearson, Andrea N.; Ashley, Michelle D.; Jessick, Veronica; Simon, Roger P.; Meller, Robert] Legacy Res, Robert S Dow Neurobiol Labs, Portland, OR 97208 USA; [Gafken, Philip] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98109 USA; [Murphy, Brona M.; Henshall, David C.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Morris, Kate T.; Meller, Robert] Legacy Res, Canc Res Labs, Portland, OR 97210 USA	Morehouse School of Medicine; Fred Hutchinson Cancer Center; Royal College of Surgeons - Ireland	Meller, R (corresponding author), Morehouse Sch Med, Inst Neurosci, 720 Westview Dr SW, Atlanta, GA 30310 USA.	rmeller@msm.edu	Murphy, Brona/P-2544-2019; Henshall, David/C-3364-2012; Murphy, Brona/D-4873-2012	Murphy, Brona/0000-0002-6740-8858; Murphy, Brona/0000-0002-6740-8858; Henshall, David/0000-0001-6237-9632; Thompson, Simon/0000-0003-0769-8555	National Institutes of Health [NS50669, NS59588, NS24728, NS39016]; National Institutes of Health/National Center for Research Resources/Research Centers at Minority Institutes [G12-RR03034, U54 NS060659]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024728, U54NS060659, R01NS039016, R01NS059588, R21NS050669] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Research Resources/Research Centers at Minority Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants NS50669 and NS59588 (to R. M.) and NS24728 and NS39016 (to R. P. S.). This work was also supported by National Institutes of Health/National Center for Research Resources/Research Centers at Minority Institutes Grants G12-RR03034 and U54 NS060659 (to Morehouse School of Medicine).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Cleary SP, 2002, J BIOL CHEM, V277, P5562, DOI 10.1074/jbc.M106532200; El Chami N, 2005, J CELL BIOL, V171, P651, DOI 10.1083/jcb.200507076; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Ley R, 2005, J BIOL CHEM, V280, P17657, DOI 10.1074/jbc.M412342200; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miyatake T, 2007, INT J CANCER, V120, P2068, DOI 10.1002/ijc.22264; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Nakamura M, 2002, J CEREBR BLOOD F MET, V22, P161, DOI 10.1097/00004647-200202000-00004; Ohkawa N, 2001, J NEUROCHEM, V78, P75, DOI 10.1046/j.1471-4159.2001.00373.x; Ordonez Andrea Nicole, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P36; Perez-Pinzon MA, 1999, NEUROSCIENCE, V89, P453, DOI 10.1016/S0306-4522(98)00560-0; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Reshef A, 2000, ADV EXP MED BIOL, V486, P217; Reshef A, 2000, NEUROREPORT, V11, P463, DOI 10.1097/00001756-200002280-00007; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinoda S, 2004, J CLIN INVEST, V113, P1059, DOI 10.1172/JCI200419971; Wiggins CM, 2007, CELL SIGNAL, V19, P2605, DOI 10.1016/j.cellsig.2007.08.008; Zhang WZ, 2008, J BIOL CHEM, V283, P16416, DOI 10.1074/jbc.M802360200	31	39	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19331	19339		10.1074/jbc.M110.197707	http://dx.doi.org/10.1074/jbc.M110.197707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478148	Green Published, hybrid			2022-12-25	WOS:000291027700015
J	Donninger, H; Allen, N; Henson, A; Pogue, J; Williams, A; Gordon, L; Kassler, S; Dunwell, T; Latif, F; Clark, GJ				Donninger, Howard; Allen, Nadia; Henson, Adrianna; Pogue, Jennifer; Williams, Andrew; Gordon, Laura; Kassler, Susannah; Dunwell, Thomas; Latif, Farida; Clark, Geoffrey J.			Salvador Protein Is a Tumor Suppressor Effector of RASSF1A with Hippo Pathway-independent Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; RAS TRANSFORMATION; SIGNALING PATHWAY; KINASE MST2; ORGAN SIZE; APOPTOSIS; CANCER; P73; YAP; PROLIFERATION	The RASSF1A tumor suppressor binds and activates proapoptotic MST kinases. The Salvador adaptor protein couples MST kinases to the LATS kinases to form the hippo pathway. Upon activation by RASSF1A, LATS1 phosphorylates the transcriptional regulator YAP, which binds to p73 and activates its proapoptotic effects. However, although serving as an adaptor for MST and LATS, Salvador can also bind RASSF1A. The functional role of the RASSF1A/Salvador interaction is unclear. Although Salvador is a novel tumor suppressor in Drosophila and mice, its role in human systems remains largely unknown. Here we show that Salvador promotes apoptosis in human cells and that Salvador inactivation deregulates the cell cycle and enhances the transformed phenotype. Moreover, we show that although the salvador gene is seldom mutated or epigenetically inactivated in human cancers, it is frequently down-regulated posttranscriptionally. Surprisingly, we also find that although RASSF1A requires the presence of Salvador for full apoptotic activity and to activate p73, this effect does not require a direct interaction of RASSF1A with MST kinases or the activation of the hippo pathway. Thus, we confirm a role for Salvador as a human tumor suppressor and RASSF1A effector and show that Salvador allows RASSF1A to modulate p73 independently of the hippo pathway.	[Donninger, Howard; Henson, Adrianna; Pogue, Jennifer; Williams, Andrew; Gordon, Laura; Kassler, Susannah; Clark, Geoffrey J.] Univ Louisville, Mol Targets Program, JG Brown Canc Ctr, Dept Med, Louisville, KY 40202 USA; [Allen, Nadia] QIAGEN, Gaithersburg, MD 20878 USA; [Dunwell, Thomas; Latif, Farida] Univ Birmingham, Sect Med & Mol Genet, Edgbaston B15 2TT, W Midlands, England	University of Louisville; University of Birmingham	Clark, GJ (corresponding author), 505 S Hancock St,Rm 417, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660; Dunwell, Thomas/0000-0001-9985-3828	National Institutes of Health [RR18733]; NCI, National Institutes of Health; Cancer Research UK; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR18733 and NCI, National Institutes of Health intramural funds (to G. J. C.). F. L. was supported by Cancer Research UK.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Antonsson A, 2009, ANTICANCER RES, V29, P2893; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hergovich A, 2009, BIOFACTORS, V35, P338, DOI 10.1002/biof.47; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tomkova K, 2004, CANCER RES, V64, P6390, DOI 10.1158/0008-5472.CAN-04-2176; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Vos MD, 2006, METHOD ENZYMOL, V407, P311, DOI 10.1016/S0076-6879(05)07026-6; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	45	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18483	18491		10.1074/jbc.M110.214874	http://dx.doi.org/10.1074/jbc.M110.214874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21489991	hybrid, Green Published			2022-12-25	WOS:000290785700021
J	Wang, JF; Chou, KC				Wang, Jing-Fang; Chou, Kuo-Chen			Insights from Modeling the 3D Structure of New Delhi Metallo-beta-Lactamse and Its Binding Interactions with Antibiotic Drugs	PLOS ONE			English	Article							M2 PROTON CHANNEL; PSEUDOMONAS-AERUGINOSA; MOLECULAR-DYNAMICS; XYLOSE REDUCTASE; PICHIA-STIPITIS; MECHANISM; RECEPTOR; BIOINFORMATICS; PREDICTION; RESISTANCE	New Delhi metallo-beta-lactamase (NDM-1) is an enzyme that makes bacteria resistant to a broad range of beta-lactam antibiotic drugs. This is because it can inactivate most beta-lactam antibiotic drugs by hydrolyzing them. For in-depth understanding of the hydrolysis mechanism, the three-dimensional structure of NDM-1 was developed. With such a structural frame, two enzyme-ligand complexes were derived by respectively docking Imipenem and Meropenem (two typical beta-lactam antibiotic drugs) to the NDM-1 receptor. It was revealed from the NDM-1/Imipenem complex that the antibiotic drug was hydrolyzed while sitting in a binding pocket of NDM-1 formed by nine residues. And for the case of NDM-1/Meropenem complex, the antibiotic drug was hydrolyzed in a binding pocket formed by twelve residues. All these constituent residues of the two binding pockets were explicitly defined and graphically labeled. It is anticipated that the findings reported here may provide useful insights for developing new antibiotic drugs to overcome the resistance problem.	[Wang, Jing-Fang] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Wang, Jing-Fang; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University; Chinese Academy of Sciences	Wang, JF (corresponding author), Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China.	jfwang8113@sjtu.edu.cn; kcchou@gordonlifescience.org	Wang, Jingfang/Q-2597-2018; Chou, Kuo-Chen/A-8340-2009	Wang, Jingfang/0000-0002-1355-5481; 				Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; Chou KC, 2005, J PROTEOME RES, V4, P1681, DOI 10.1021/pr050145a; Chou KC, 2004, J PROTEOME RES, V3, P1284, DOI 10.1021/pr049849v; CHOU KC, 1991, PROTEIN ENG, V4, P661, DOI 10.1093/protein/4.6.661; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 2004, BIOCHEM BIOPH RES CO, V316, P636, DOI 10.1016/j.bbrc.2004.02.098; Chou KC, 1999, BIOCHEM BIOPH RES CO, V259, P420, DOI 10.1006/bbrc.1999.0792; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2006, CURR MED CHEM, V13, P3263, DOI 10.2174/092986706778773077; Colotta V, 2009, BIOORGAN MED CHEM, V17, P401, DOI 10.1016/j.bmc.2008.10.018; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009388; Du QS, 2009, J THEOR BIOL, V259, P159, DOI 10.1016/j.jtbi.2009.03.003; Garcia-Saez I, 2008, J MOL BIOL, V375, P604, DOI 10.1016/j.jmb.2007.11.012; Giamarellou H, 2009, DRUGS, V69, P1879, DOI 10.2165/11315690-000000000-00000; Gong K, 2009, MED CHEM, V5, P242, DOI 10.2174/157340609788185936; Gu H, 2010, CHINESE SCI BULL, V55, P2677, DOI 10.1007/s11434-010-3257-6; Gu RX, 2009, MED CHEM, V5, P250, DOI 10.2174/157340609788185909; Guo XL, 2010, CURR COMPUT-AID DRUG, V6, P139, DOI 10.2174/157340910791202487; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li L, 2007, BIOCHEM BIOPH RES CO, V358, P1102, DOI 10.1016/j.bbrc.2007.05.053; Livermore DM, 2009, CURR PROTEIN PEPT SC, V10, P397, DOI 10.2174/138920309789351994; Magdziarz T, 2009, J MOL MODEL, V15, P41, DOI 10.1007/s00894-008-0373-1; Maltezou HC, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.09.003; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; POIREL L, 2010, ANTIMICROB AGENTS CH; Ricchiuto P, 2008, J MOL RECOGNIT, V21, P347, DOI 10.1002/jmr.908; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Tamilselvi A, 2006, CHEM-EUR J, V12, P7797, DOI 10.1002/chem.200600629; Tang B, 2010, CHINESE SCI BULL, V55, P1619, DOI 10.1007/s11434-009-3700-8; Wang JF, 2009, PHARMACOGENOMICS, V10, P1213, DOI 10.2217/PGS.09.81; WANG JF, 2008, OPEN BIOINFORMATICS, V2, P72; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V359, P323, DOI 10.1016/j.bbrc.2007.05.101; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2009, INTERDISCIP SCI, V1, P214, DOI 10.1007/s12539-009-0047-4; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2010, CURR DRUG METAB, V11, P342, DOI 10.2174/138920010791514180; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, MED CHEM, V5, P263, DOI 10.2174/157340609788185954; Wang JF, 2009, PROTEIN ENG DES SEL, V22, P349, DOI 10.1093/protein/gzp012; Wang JF, 2009, CURR MED CHEM, V16, P232, DOI 10.2174/092986709787002727; Wang JF, 2008, CURR TOP MED CHEM, V8, P1573, DOI 10.2174/156802608786786534; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zeng QK, 2009, BIOTECHNOL LETT, V31, P1025, DOI 10.1007/s10529-009-9980-x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	58	70	73	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18414	10.1371/journal.pone.0018414	http://dx.doi.org/10.1371/journal.pone.0018414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494599	Green Submitted, Green Published, gold			2022-12-25	WOS:000289354100012
J	Monecke, S; Coombs, G; Shore, AC; Coleman, DC; Akpaka, P; Borg, M; Chow, H; Ip, M; Jatzwauk, L; Jonas, D; Kadlec, K; Kearns, A; Laurent, F; O'Brien, FG; Pearson, J; Ruppelt, A; Schwarz, S; Scicluna, E; Slickers, P; Tan, HL; Weber, S; Ehricht, R				Monecke, Stefan; Coombs, Geoffrey; Shore, Anna C.; Coleman, David C.; Akpaka, Patrick; Borg, Michael; Chow, Henry; Ip, Margaret; Jatzwauk, Lutz; Jonas, Daniel; Kadlec, Kristina; Kearns, Angela; Laurent, Frederic; O'Brien, Frances G.; Pearson, Julie; Ruppelt, Antje; Schwarz, Stefan; Scicluna, Elizabeth; Slickers, Peter; Tan, Hui-Leen; Weber, Stefan; Ehricht, Ralf			A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; CASSETTE CHROMOSOME MEC; MOLECULAR EPIDEMIOLOGY; ANTIMICROBIAL RESISTANCE; VIRULENCE DETERMINANTS; RAPID IDENTIFICATION; COMPARATIVE GENOMICS; GENETIC DIVERSITY; ANIMAL ORIGIN; FITNESS COST	In recent years, methicillin-resistant Staphylococcus aureus (MRSA) have become a truly global challenge. In addition to the long-known healthcare-associated clones, novel strains have also emerged outside of the hospital settings, in the community as well as in livestock. The emergence and spread of virulent clones expressing Panton-Valentine leukocidin (PVL) is an additional cause for concern. In order to provide an overview of pandemic, epidemic and sporadic strains, more than 3,000 clinical and veterinary isolates of MRSA mainly from Germany, the United Kingdom, Ireland, France, Malta, Abu Dhabi, Hong Kong, Australia, Trinidad & Tobago as well as some reference strains from the United States have been genotyped by DNA microarray analysis. This technique allowed the assignment of the MRSA isolates to 34 distinct lineages which can be clearly defined based on non-mobile genes. The results were in accordance with data from multilocus sequence typing. More than 100 different strains were distinguished based on affiliation to these lineages, SCCmec type and the presence or absence of PVL. These strains are described here mainly with regard to clinically relevant antimicrobial resistance-and virulence-associated markers, but also in relation to epidemiology and geographic distribution. The findings of the study show a high level of biodiversity among MRSA, especially among strains harbouring SCCmec IV and V elements. The data also indicate a high rate of genetic recombination in MRSA involving SCC elements, bacteriophages or other mobile genetic elements and large-scale chromosomal replacements.	[Monecke, Stefan; Ruppelt, Antje] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Coombs, Geoffrey; Pearson, Julie; Tan, Hui-Leen] Royal Perth Hosp, PathW Lab Med WA, Dept Microbiol & Infect Dis, Perth, WA, Australia; [Shore, Anna C.; Coleman, David C.] Univ Dublin, Trinity Coll, Dublin Dent Univ Hosp, Microbiol Res Unit, Dublin 2, Ireland; [Akpaka, Patrick] Univ W Indies, Dept Para Clin Sci, St Augustine, Trinidad Tobago; [Borg, Michael; Scicluna, Elizabeth] Mater Dei Hosp, Infect Control Unit, Msida, Malta; [Chow, Henry; Ip, Margaret] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Jatzwauk, Lutz] Dresden Univ Hosp, Infect Control Unit, Dresden, Germany; [Jonas, Daniel] Univ Freiburg, Med Ctr, Dept Environm Hlth Sci, D-7800 Freiburg, Germany; [Kadlec, Kristina; Schwarz, Stefan] FLI, Inst Farm Anim Genet, Neustadt, Germany; [Kearns, Angela] Hlth Protect Agcy, Ctr Infect, Staphylococcus Reference Unit, London, England; [Laurent, Frederic] Univ Lyon, Ctr Natl Reference Staphylocoques, Lyon, France; [O'Brien, Frances G.] Curtin Univ Technol, Sch Biomed Sci, Perth, WA, Australia; [Monecke, Stefan; Slickers, Peter; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Weber, Stefan] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates	Technische Universitat Dresden; Royal Perth Hospital; University of Western Australia; Trinity College Dublin; University West Indies Mona Jamaica; University West Indies Saint Augustine; Chinese University of Hong Kong; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Freiburg; Friedrich Loeffler Institute; Health Protection Agency; Curtin University; Alere	Monecke, S (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany.	monecke@rocketmail.com	Ip, Margaret/K-1096-2013; Laurent, Frederic/M-4719-2014; Coleman, David C./C-2008-2009; LAURENT, Frederic/AGM-0706-2022	Ip, Margaret/0000-0003-1291-6537; Coleman, David C./0000-0003-1797-2888; Coombs, Geoffrey/0000-0003-1635-6506; Shore, Anna/0000-0002-6667-0918; laurent, frederic/0000-0003-0609-9091; Akpaka, Patrick Eberechi/0000-0001-9895-3077	Vice-Rectorate for Research of the Medical Faculty Dresden	Vice-Rectorate for Research of the Medical Faculty Dresden	R. Ehricht and P. Slickers are employees of Alere Technologies GmbH. The Vice-Rectorate for Research of the Medical Faculty Dresden partially financed this work. Each of the participating institutions regularly purchased test kits and reagents form commercial providers, which included Alere Technologies GmbH, and covered the costs of experiments performed in the respective institutions, as well as granting the time needed to perform this study. Decisions on study design, data collection and analysis, publication or preparation of the manuscript were agreed upon by the authors involved without influence by the funding institutions.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Akpaka PE, 2007, INT J INFECT DIS, V11, P544, DOI 10.1016/j.ijid.2007.03.004; Alp E, 2009, J INFECTION, V58, P433, DOI 10.1016/j.jinf.2009.04.006; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; [Anonymous], 1999, JAMA, V282, P1123; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Aspiroz C, 2010, ENFERM INFEC MICR CL, V28, P70, DOI 10.1016/j.eimc.2009.01.016; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baranovich T, 2010, CLIN MICROBIOL INFEC, V16, P575, DOI 10.1111/j.1469-0691.2009.02891.x; BASSET P, 2010, INT S STAPH STAPH IN; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; BEISSER P, 2009, CLIN MICROBIOL INFEC, V15, pS22; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Berglund C, 2005, J CLIN MICROBIOL, V43, P4448, DOI 10.1128/JCM.43.9.4448-4454.2005; Berglund C, 2008, ANTIMICROB AGENTS CH, V52, P3512, DOI 10.1128/AAC.00087-08; Blanc DS, 2007, J CLIN MICROBIOL, V45, P3729, DOI 10.1128/JCM.00511-07; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; BUDIMIR A, 2009, CLIN MICROBIOL INFEC; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Chaberny IF, 2005, INT J HYG ENVIR HEAL, V208, P447, DOI 10.1016/j.ijheh.2005.08.004; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Chua T, 2008, J CLIN MICROBIOL, V46, P2345, DOI 10.1128/JCM.00154-08; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Coombs GW, 2007, INFECT CONT HOSP EP, V28, P845, DOI 10.1086/518726; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Cooper JE, 2006, MICROBIOL-SGM, V152, P1297, DOI 10.1099/mic.0.28620-0; Cuevas O, 2007, CLIN MICROBIOL INFEC, V13, P250, DOI 10.1111/j.1469-0691.2006.01672.x; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; DAWKINS R, 1994, EGOISTISCHE GEN; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; De Sousa MA, 2001, J CLIN MICROBIOL, V39, P2197, DOI 10.1128/JCM.39.6.2197-2205.2001; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Dijkshoorn L, 2000, J Med Microbiol, V49, P397, DOI 10.1099/0022-1317-49-5-397; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; DOMINGUEZ MA, 1994, J CLIN MICROBIOL, V32, P2081, DOI 10.1128/JCM.32.9.2081-2087.1994; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; El Solh A, 2009, EXPERT OPIN PHARMACO, V10, P1675, DOI 10.1517/14656560903048967; Ellington MJ, 2010, CLIN MICROBIOL INFEC, V16, P1009, DOI 10.1111/j.1469-0691.2009.02994.x; Ellington MJ, 2009, EUR J CLIN MICROBIOL, V28, P1113, DOI 10.1007/s10096-009-0757-x; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V60, P402, DOI 10.1093/jac/dkm206; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; ELLINGTON MJ, 2008, 18 EUR C CLIN MICR I; ENANY S, 2007, EUROSURVEILLANCE, V12; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fang H, 2008, CLIN MICROBIOL INFEC, V14, P370, DOI 10.1111/j.1469-0691.2007.01941.x; Faria NA, 2005, J CLIN MICROBIOL, V43, P1836, DOI 10.1128/JCM.43.4.1836-1842.2005; Fatholahzadeh B, 2009, JPN J INFECT DIS, V62, P309; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fessler AT, 2011, ANTIMICROB AGENTS CH, V55, P373, DOI 10.1128/AAC.01124-10; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Francois P, 2008, EMERG INFECT DIS, V14, P304, DOI 10.3201/eid1402.070229; GARNIER F, 2006, EMERG INFECT DIS; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Ghebremedhin B, 2005, EUR J CLIN MICROBIOL, V24, P388, DOI 10.1007/s10096-005-1339-1; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gosbell IB, 2006, PATHOLOGY, V38, P239, DOI 10.1080/00313020600699227; Gould SWJ, 2008, J MED MICROBIOL, V57, P1394, DOI 10.1099/jmm.0.2008/003509-0; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Heusser R, 2007, ANTIMICROB AGENTS CH, V51, P390, DOI 10.1128/AAC.00921-06; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Ho PL, 2008, DIAGN MICR INFEC DIS, V61, P135, DOI 10.1016/j.diagmicrobio.2007.12.017; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; HOLDEN MTG, 2009, J BACTERIOL; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; HOWDEN BP, 2010, J BACTERIOL; Hsu LY, 2007, J MED MICROBIOL, V56, P376, DOI 10.1099/jmm.0.46950-0; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Hulten KG, 2010, INFECT CONT HOSP EP, V31, P183, DOI 10.1086/649793; HUMPHREYS H, 1990, J HOSP INFECT, V15, P127, DOI 10.1016/0195-6701(90)90121-4; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ip M, 2005, J CLIN MICROBIOL, V43, P5069, DOI 10.1128/JCM.43.10.5069-5073.2005; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; *IWG SCC, 2009, ANTIMICROB AGENTS CH, V53; JEVONS MP, 1961, BRIT MED J, P1924; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P915, DOI 10.1128/AAC.01091-09; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P3589, DOI 10.1128/AAC.00570-09; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P776, DOI 10.1128/AAC.01128-08; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kanerva M, 2007, J HOSP INFECT, V66, P22, DOI 10.1016/j.jhin.2007.02.014; Kehrenberg C, 2009, ANTIMICROB AGENTS CH, V53, P779, DOI 10.1128/AAC.01376-08; Kerttula AM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-94; KINNEVEY P, 2010, ECCMID VIENN; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Krziwanek K, 2008, CLIN MICROBIOL INFEC, V14, P250, DOI 10.1111/j.1469-0691.2007.01896.x; Krziwanek K, 2007, EUR J CLIN MICROBIOL, V26, P931, DOI 10.1007/s10096-007-0391-4; Krziwanek K, 2009, EMERG INFECT DIS, V15, P766, DOI 10.3201/eid1505.080326; KUPFER M, 2009, THESIS TU DRESDEN; Kwon NH, 2006, VET MICROBIOL, V117, P304, DOI 10.1016/j.vetmic.2006.05.006; LAYER F, 2010, DGHM HANN; Lee SM, 2007, ANTIMICROB AGENTS CH, V51, P1497, DOI 10.1128/AAC.01239-06; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lo WT, 2006, EMERG INFECT DIS, V12, P1267, DOI 10.3201/eid1708.051570; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Lozano C, 2009, J ANTIMICROB CHEMOTH, V64, P1325, DOI 10.1093/jac/dkp378; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; Mato R, 2004, MICROB DRUG RESIST, V10, P106, DOI 10.1089/1076629041310109; Mayor L, 2007, J CLIN MICROBIOL, V45, P2298, DOI 10.1128/JCM.00040-07; McDonald M, 2006, J CLIN MICROBIOL, V44, P3720, DOI 10.1128/JCM.00836-06; Melter O, 1999, J CLIN MICROBIOL, V37, P2798, DOI 10.1128/JCM.37.9.2798-2803.1999; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Meyer E, 2006, INFECTION, V34, P303, DOI 10.1007/s15010-006-6619-x; Miklasevics E, 2004, Euro Surveill, V9, P29, DOI 10.2807/esm.09.11.00485-en; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; MOLINOS S, 2009, 13 REUN SEIMC SEV; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1383, DOI 10.1007/s10096-009-0796-3; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2009, CLIN MICROBIOL INFEC, V15, P770, DOI 10.1111/j.1469-0691.2009.02792.x; MONECKE S, 2008, ISSSI PERTH; Monecke S, 2003, GENOME LETT, V2, P106; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Monecke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014025; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Murchan S, 2004, J CLIN MICROBIOL, V42, P5154, DOI 10.1128/JCM.42.11.5154-5160.2004; Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; NEJMA MB, 2008, DIAGN MICROBIOL INFE; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Nienhoff U, 2009, J ANTIMICROB CHEMOTH, V64, P660, DOI 10.1093/jac/dkp243; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; Nowak MA, 2002, Z PHYS CHEM, V216, P5, DOI 10.1524/zpch.2002.216.1.005; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Oliveira DC, 2000, ANTIMICROB AGENTS CH, V44, P1906, DOI 10.1128/AAC.44.7.1906-1910.2000; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Orth D, 2006, EUR J CLIN MICROBIOL, V25, P104, DOI 10.1007/s10096-006-0102-6; Otter JA, 2008, CLIN MICROBIOL INFEC, V14, P670, DOI 10.1111/j.1469-0691.2008.02017.x; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Ozaki K, 2009, J INFECT CHEMOTHER, V15, P84, DOI 10.1007/s10156-009-0668-x; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Panton PN, 1932, LANCET, V1, P506; Peck KR, 2009, J KOREAN MED SCI, V24, P585, DOI 10.3346/jkms.2009.24.4.585; Perez-Vazquez M, 2009, J ANTIMICROB CHEMOTH, V63, P21, DOI 10.1093/jac/dkn430; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Potel C, 2010, EUR J CLIN MICROBIOL, V29, P351, DOI 10.1007/s10096-009-0860-z; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Rolain JM, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-1; ROSSNEY A, 2005, EUROSURVEILLANCE, V10; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; Rossney AS, 2003, EUR J CLIN MICROBIOL, V22, P379, DOI 10.1007/s10096-003-0917-3; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; SCHAEFLER S, 1981, J CLIN MICROBIOL, V13, P754, DOI 10.1128/JCM.13.4.754-759.1981; Schefold Joerg C, 2007, J Med Case Rep, V1, P165; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Schwarz S, 2008, J ANTIMICROB CHEMOTH, V61, P282, DOI 10.1093/jac/dkm487; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shittu A, 2009, J MED MICROBIOL, V58, P1219, DOI 10.1099/jmm.0.011452-0; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; SHORE A, 2010, INT S STAPH STAPH IN; SHORE AC, 2010, ANTIMICROB AGENTS CH; Shore AC, 2008, ANTIMICROB AGENTS CH, V52, P4407, DOI 10.1128/AAC.00447-08; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; Smith Tara C, 2009, PLoS One, V4, pe4258, DOI 10.1371/journal.pone.0004258; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Soavi L, 2010, EMERG INFECT DIS, V16, P346, DOI 10.3201/eid1602.091478; Stam-Bolink EM, 2007, EUR J CLIN MICROBIOL, V26, P723, DOI 10.1007/s10096-007-0352-y; Stefani S, 2009, DIAGN MICR INFEC DIS, V63, P100, DOI 10.1016/j.diagmicrobio.2008.09.012; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2007, MICROBIOL IMMUNOL, V51, P627, DOI 10.1111/j.1348-0421.2007.tb03949.x; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; Udo EE, 2010, J MED MICROBIOL, V59, P193, DOI 10.1099/jmm.0.013268-0; Udo EE, 2006, CLIN MICROBIOL INFEC, V12, P262, DOI 10.1111/j.1469-0691.2005.01350.x; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vanderhaeghen W, 2010, VET MICROBIOL, V144, P166, DOI 10.1016/j.vetmic.2009.12.044; VANDEVELDE H, 1894, CELLULE, V10, P401; VANRENSBURG MJ, 2010, CLIN MICROBIOL INFEC; Vindel A, 2006, J CLIN MICROBIOL, V44, P266, DOI 10.1128/JCM.44.1.266-270.2006; Vivoni AM, 2006, J CLIN MICROBIOL, V44, P1686, DOI 10.1128/JCM.44.5.1686-1691.2006; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Vourli S, 2005, Euro Surveill, V10, P78; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Ward John M., 2009, American Fisheries Society Annual Meeting; WEBER S, 2010, ECCMID VIENN; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; Welinder-Olsson C, 2008, EMERG INFECT DIS, V14, P1271, DOI 10.3201/eid1408.071427; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P466, DOI 10.1111/j.1469-0691.2005.01153.x; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; WITTE W, 2000, BUNDESGESUNDHEITSBLA, V43, P633; Wolter DJ, 2008, J CLIN MICROBIOL, V46, P3548, DOI 10.1128/JCM.00985-08; Wulf M, 2006, EMERG INFECT DIS, V12, P1939; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zafar A, 2011, J MED MICROBIOL, V60, P56, DOI 10.1099/jmm.0.022707-0; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	244	584	596	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e17936	10.1371/journal.pone.0017936	http://dx.doi.org/10.1371/journal.pone.0017936			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494333	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400005
J	Zaravinos, A; Lambrou, GI; Boulalas, I; Delakas, D; Spandidos, DA				Zaravinos, Apostolos; Lambrou, George I.; Boulalas, Ioannis; Delakas, Dimitris; Spandidos, Demetrios A.			Identification of Common Differentially Expressed Genes in Urinary Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; NF-KAPPA-B; YIN YANG 1; CDNA MICROARRAYS; HEPATOCELLULAR-CARCINOMA; COMPUTATIONAL ANALYSIS; CHROMOSOMAL DOMAINS; EXPERIMENTAL-DESIGN; PITUITARY-ADENOMAS; HYDROGEN-PEROXIDE	Background: Current diagnosis and treatment of urinary bladder cancer (BC) has shown great progress with the utilization of microarrays. Purpose: Our goal was to identify common differentially expressed (DE) genes among clinically relevant subclasses of BC using microarrays. Methodology/Principal Findings: BC samples and controls, both experimental and publicly available datasets, were analyzed by whole genome microarrays. We grouped the samples according to their histology and defined the DE genes in each sample individually, as well as in each tumor group. A dual analysis strategy was followed. First, experimental samples were analyzed and conclusions were formulated; and second, experimental sets were combined with publicly available microarray datasets and were further analyzed in search of common DE genes. The experimental dataset identified 831 genes that were DE in all tumor samples, simultaneously. Moreover, 33 genes were up-regulated and 85 genes were down-regulated in all 10 BC samples compared to the 5 normal tissues, simultaneously. Hierarchical clustering partitioned tumor groups in accordance to their histology. K-means clustering of all genes and all samples, as well as clustering of tumor groups, presented 49 clusters. K-means clustering of common DE genes in all samples revealed 24 clusters. Genes manifested various differential patterns of expression, based on PCA. YY1 and NF kappa B were among the most common transcription factors that regulated the expression of the identified DE genes. Chromosome 1 contained 32 DE genes, followed by chromosomes 2 and 11, which contained 25 and 23 DE genes, respectively. Chromosome 21 had the least number of DE genes. GO analysis revealed the prevalence of transport and binding genes in the common down-regulated DE genes; the prevalence of RNA metabolism and processing genes in the up-regulated DE genes; as well as the prevalence of genes responsible for cell communication and signal transduction in the DE genes that were down-regulated in T1-Grade III tumors and up-regulated in T2/T3-Grade III tumors. Combination of samples from all microarray platforms revealed 17 common DE genes, (BMP4, CRYGD, DBH, GJB1, KRT83, MPZ, NHLH1, TACR3, ACTC1, MFAP4, SPARCL1, TAGLN, TPM2, CDC20, LHCGR, TM9SF1 and HCCS) 4 of which participate in numerous pathways. Conclusions/Significance: The identification of the common DE genes among BC samples of different histology can provide further insight into the discovery of new putative markers.	[Zaravinos, Apostolos; Boulalas, Ioannis; Spandidos, Demetrios A.] Univ Crete, Virol Lab, Sch Med, Iraklion, Greece; [Lambrou, George I.] Univ Athens, Choremeio Res Lab, Dept Pediat 1, Athens, Greece; [Boulalas, Ioannis; Delakas, Dimitris] Asklipieio Gen Hosp, Dept Urol, Athens, Greece	University of Crete; National & Kapodistrian University of Athens	Zaravinos, A (corresponding author), Univ Crete, Virol Lab, Sch Med, Iraklion, Greece.	spandidos@spandidos.gr	Zaravinos, Apostolos/B-2528-2019; Lambrou, George/F-9674-2011	Zaravinos, Apostolos/0000-0003-4625-5562; Lambrou, George/0000-0001-8389-1360; Spandidos, Demetrios/0000-0002-1146-931X	Department of Urology, Asklipieio General Hospital, Athens, Greece	Department of Urology, Asklipieio General Hospital, Athens, Greece	The Department of Urology, Asklipieio General Hospital, 16673 Voula, Athens, Greece funded the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin SA, 2009, CARCINOGENESIS, V30, P449, DOI 10.1093/carcin/bgp005; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altman NS, 2006, GENET RES, V88, P153, DOI 10.1017/S0016672307008476; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Bohgaki M, 2008, BBA-MOL CELL RES, V1783, P826, DOI 10.1016/j.bbamcr.2007.09.006; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang TS, 2004, FREE RADICAL BIO MED, V37, P521, DOI 10.1016/j.freeradbiomed.2004.05.006; Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cole SW, 2005, BIOINFORMATICS, V21, P803, DOI 10.1093/bioinformatics/bti038; Czerniak B, 1999, ONCOGENE, V18, P1185, DOI 10.1038/sj.onc.1202385; Diez D, 2007, BIOINFORMATICS, V23, P1168, DOI 10.1093/bioinformatics/btm072; Do Kim J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-85; Duggan BJ, 2003, CLIN CANCER RES, V9, P1240; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Dyrskjot L, 2003, EXPERT REV MOL DIAGN, V3, P635, DOI 10.1586/14737159.3.5.635; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Halleck M, 2009, TOXICOLOGY, V258, P116, DOI 10.1016/j.tox.2009.01.017; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Jiang C, 2004, J BIOL CHEM, V279, P27781, DOI 10.1074/jbc.M401809200; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kakar S, 2003, AM J CLIN PATHOL, V119, P361, DOI 10.1309/8L872RPHEJRKF5JJ; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kim IY, 2004, CANCER RES, V64, P7355, DOI 10.1158/0008-5472.CAN-04-0154; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Klonisch T, 2007, ADV EXP MED BIOL, V612, P104; KOLLEGAL M, 2005, COMP SYST BIOINF C W, P101; Kraemer K, 2006, INT J CANCER, V119, P1276, DOI 10.1002/ijc.21975; Langat DL, 2008, AM J PATHOL, V172, P1303, DOI 10.2353/ajpath.2008.071139; Li YH, 2001, CANCER RES, V61, P6428; Li Z, 2009, ANN NY ACAD SCI, V1160, P374, DOI 10.1111/j.1749-6632.2008.03803.x; Liu JP, 2006, FEBS LETT, V580, P245, DOI 10.1016/j.febslet.2005.12.005; Lopez-Beltran A, 2004, EUR UROL, V46, P170, DOI 10.1016/j.eururo.2004.03.017; Mansure J. J., 2009, CANCER BIOL THER, V8, P6, DOI DOI 10.4161/CBT.8.7.7853; Marks Friedrich, 2007, V174, P37; Matsumoto M, 2010, INT J MOL MED, V26, P241, DOI 10.3892/ijmm_00000458; Mengual L, 2009, J UROLOGY, V182, P741, DOI 10.1016/j.juro.2009.03.084; Modlich O, 2004, CLIN CANCER RES, V10, P3410, DOI 10.1158/1078-0432.CCR-03-0134; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Mor O, 2003, ONCOGENE, V22, P7702, DOI 10.1038/sj.onc.1207039; Nishioka H, 2005, ACTA NEUROPATHOL, V109, P598, DOI 10.1007/s00401-005-1008-6; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; REESE DH, 1979, MED HYPOTHESES, V5, P1007, DOI 10.1016/0306-9877(79)90049-5; Reyal F, 2005, CANCER RES, V65, P1376, DOI 10.1158/0008-5472.CAN-04-2706; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rotondo F, 2009, APPL IMMUNOHISTO M M, V17, P185, DOI 10.1097/PAI.0b013e31818fa0ed; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Seligson D, 2005, INT J ONCOL, V27, P131; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Sirbu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013822; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sun YH, 2002, UROL ONCOL, V7, P207, DOI 10.1016/S1078-1439(02)00192-8; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thykjaer T, 2001, CANCER RES, V61, P2492; Townsend JP, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-41; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Yauk CL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh123; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037; Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648	88	72	78	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18135	10.1371/journal.pone.0018135	http://dx.doi.org/10.1371/journal.pone.0018135			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483740	Green Published, gold			2022-12-25	WOS:000289058700010
J	Canonici, A; Siret, C; Pellegrino, E; Pontier-Bres, R; Pouyet, L; Montero, MP; Colin, C; Czerucka, D; Rigot, V; Andre, F				Canonici, Alexandra; Siret, Carole; Pellegrino, Emilie; Pontier-Bres, Rodolphe; Pouyet, Laurent; Montero, Marie Pierre; Colin, Carole; Czerucka, Dorota; Rigot, Veronique; Andre, Frederic			Saccharomyces boulardii Improves Intestinal Cell Restitution through Activation of the alpha 2 beta 1 Integrin Collagen Receptor	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE ACTIVATION; GROWTH-FACTOR; EPITHELIAL-CELLS; ALPHA-CATENIN; CANCER CELLS; CROHNS-DISEASE; E-CADHERIN; RAT COLON; IN-VITRO	Intestinal epithelial cell damage is frequently seen in the mucosal lesions of inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. Complete remission of these diseases requires both the cessation of inflammation and the migration of enterocytes to repair the damaged epithelium. Lyophilized Saccharomyces boulardii (Sb, Biocodex) is a nonpathogenic yeast widely used as a therapeutic agent for the treatment and prevention of diarrhea and other gastrointestinal disorders. In this study, we determined whether Sb could accelerate enterocyte migration. Cell migration was determined in Sb force-fed C57BL6J mice and in an in vitro wound model. The impact on alpha 2 beta 1 integrin activity was assessed using adhesion assays and the analysis of alpha 2 beta 1 mediated signaling pathways both in vitro and in vivo. We demonstrated that Sb secretes compounds that enhance the migration of enterocytes independently of cell proliferation. This enhanced migration was associated with the ability of Sb to favor cell-extracellular matrix interaction. Indeed, the yeast activates alpha 2 beta 1 integrin collagen receptors. This leads to an increase in tyrosine phosphorylation of cytoplasmic molecules, including focal adhesion kinase and paxillin, involved in the integrin signaling pathway. These changes are associated with the reorganization of focal adhesion structures. In conclusion Sb secretes motogenic factors that enhance cell restitution through the dynamic regulation of alpha 2 beta 1 integrin activity. This could be of major importance in the development of novel therapies targeting diseases characterized by severe mucosal injury, such as inflammatory and infectious bowel diseases.	[Canonici, Alexandra; Siret, Carole; Pellegrino, Emilie; Montero, Marie Pierre; Colin, Carole; Rigot, Veronique; Andre, Frederic] Ctr Rech Oncol & Oncopharmacol, INSERM, UMR 911, Marseille, France; [Canonici, Alexandra; Siret, Carole; Pellegrino, Emilie; Montero, Marie Pierre; Colin, Carole; Rigot, Veronique; Andre, Frederic] Aix Marseille Univ, UMR 911, Marseille, France; [Pontier-Bres, Rodolphe; Czerucka, Dorota] Ctr Mediterraneen Med Mol C3M, INSERM, U895, Team Inflammat 4, Nice, France; [Pouyet, Laurent] INSERM, U624, F-13258 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm)	Canonici, A (corresponding author), Ctr Rech Oncol & Oncopharmacol, INSERM, UMR 911, Marseille, France.	frederic.andre@univmed.fr		PONTIER-BRES, Rodolphe/0000-0002-4139-5913; Montero, Marie-Pierre/0000-0003-4280-0674	Institut National du Cancer (InCa, Canceropole PACA); Fondation pour la Recherche Medicale	Institut National du Cancer (InCa, Canceropole PACA)(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was financed in part by an institutional grant from Institut National du Cancer (InCa, Canceropole PACA). L. Pouyet is recipient of a postdoctoral fellowship award from Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 1999, INT J CANCER, V83, P497, DOI 10.1002/(SICI)1097-0215(19991112)83:4<497::AID-IJC11>3.3.CO;2-4; Andre F, 2004, ONCOGENE, V23, P1177, DOI 10.1038/sj.onc.1207238; Andre F, 1999, GASTROENTEROLOGY, V116, P64, DOI 10.1016/S0016-5085(99)70230-1; ARROYO AG, 1993, J BIOL CHEM, V268, P9863; Basson MD, 2001, LIFE SCI, V69, P3005, DOI 10.1016/S0024-3205(01)01408-4; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; BRASKEN P, 1990, ANN CHIR GYNAECOL FE, V79, P65; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Buts JP, 2009, DIGEST DIS SCI, V54, P15, DOI 10.1007/s10620-008-0322-y; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; CHANTRET I, 1994, J CELL SCI, V107, P213; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Dalmasso G, 2006, RES MICROBIOL, V157, P456, DOI 10.1016/j.resmic.2005.11.007; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; FANTINI J, 1986, J CELL SCI, V83, P235; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Girard P, 2005, DIGEST DIS SCI, V50, P2183, DOI 10.1007/s10620-005-3029-3; Goke M, 1998, GASTROENTEROLOGY, V114, P697, DOI 10.1016/S0016-5085(98)70583-9; Grzesiak JJ, 2008, INT J CANCER, V122, P2199, DOI 10.1002/ijc.23368; Guslandi M, 2000, DIGEST DIS SCI, V45, P1462, DOI 10.1023/A:1005588911207; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; Ido A, 2005, J GASTROENTEROL, V40, P925, DOI 10.1007/s00535-005-1705-x; Lee Sang Kil, 2005, Korean J Gastroenterol, V45, P328; MANSKE M, 1994, INT REV CYTOL, V155, P49, DOI 10.1016/S0074-7696(08)62096-3; Martins FS, 2009, LETT APPL MICROBIOL, V49, P738, DOI 10.1111/j.1472-765X.2009.02732.x; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; PLEIN K, 1993, Z GASTROENTEROL, V31, P129; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Qureshi FG, 2005, GASTROENTEROLOGY, V128, P1012, DOI 10.1053/j.gastro.2005.01.052; Rigot V, 1998, J CELL SCI, V111, P3119; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zanello G, 2009, CURR ISSUES MOL BIOL, V11, P47; Zeeh JM, 1996, GASTROENTEROLOGY, V110, P1077, DOI 10.1053/gast.1996.v110.pm8612996; Zhang JH, 2006, GASTROENTEROLOGY, V131, P1179, DOI 10.1053/j.gastro.2006.08.007	41	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18427	10.1371/journal.pone.0018427	http://dx.doi.org/10.1371/journal.pone.0018427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483797	Green Submitted, gold, Green Published			2022-12-25	WOS:000289057200076
J	Jespersen, JG; Nedergaard, A; Reitelseder, S; Mikkelsen, UR; Dideriksen, KJ; Agergaard, J; Kreiner, F; Pott, FC; Schjerling, P; Kjaer, M				Jespersen, Jakob G.; Nedergaard, Anders; Reitelseder, Soren; Mikkelsen, Ulla R.; Dideriksen, Kasper J.; Agergaard, Jakob; Kreiner, Frederik; Pott, Frank C.; Schjerling, Peter; Kjaer, Michael			Activated Protein Synthesis and Suppressed Protein Breakdown Signaling in Skeletal Muscle of Critically Ill Patients	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; GROWTH-FACTOR-I; UBIQUITIN LIGASES; AMINO-ACID; IGF-I; BODY-COMPOSITION; GENE-EXPRESSION; SEVERE SEPSIS; CARE PATIENTS; ATROPHY	Background: Skeletal muscle mass is controlled by myostatin and Akt-dependent signaling on mammalian target of rapamycin (mTOR), glycogen synthase kinase 3 beta (GSK3 beta) and forkhead box O (FoxO) pathways, but it is unknown how these pathways are regulated in critically ill human muscle. To describe factors involved in muscle mass regulation, we investigated the phosphorylation and expression of key factors in these protein synthesis and breakdown signaling pathways in thigh skeletal muscle of critically ill intensive care unit (ICU) patients compared with healthy controls. Methodology/Principal Findings: ICU patients were systemically inflamed, moderately hyperglycemic, received insulin therapy, and showed a tendency to lower plasma branched chain amino acids compared with controls. Using Western blotting we measured Akt, GSK3 beta, mTOR, ribosomal protein S6 kinase (S6k), eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), and muscle ring finger protein 1 (MuRF1); and by RT-PCR we determined mRNA expression of, among others, insulin-like growth factor 1 (IGF-1), FoxO 1, 3 and 4, atrogin1, MuRF1, interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and myostatin. Unexpectedly, in critically ill ICU patients Akt-mTOR-S6k signaling was substantially higher compared with controls. FoxO1 mRNA was higher in patients, whereas FoxO3, atrogin1 and myostatin mRNAs and MuRF1 protein were lower compared with controls. A moderate correlation (r(2) = 0.36, p < 0.05) between insulin infusion dose and phosphorylated Akt was demonstrated. Conclusions/Significance: We present for the first time muscle protein turnover signaling in critically ill ICU patients, and we show signaling pathway activity towards a stimulation of muscle protein synthesis and a somewhat inhibited proteolysis.	[Jespersen, Jakob G.; Nedergaard, Anders; Reitelseder, Soren; Mikkelsen, Ulla R.; Dideriksen, Kasper J.; Agergaard, Jakob; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark; [Jespersen, Jakob G.; Nedergaard, Anders; Reitelseder, Soren; Mikkelsen, Ulla R.; Dideriksen, Kasper J.; Agergaard, Jakob; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth Sci, Copenhagen, Denmark; [Kreiner, Frederik] Rigshosp, Dept Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Pott, Frank C.] Bispebjerg Hosp, Dept Anesthesiol, DK-2400 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Jespersen, JG (corresponding author), Univ Copenhagen, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark.	jespersen.jakob@gmail.com	Kjaer, Michael/W-6842-2019; Schjerling, Peter/F-6194-2011; Agergaard, Jakob/ABF-2729-2020	Kjaer, Michael/0000-0002-4582-8755; Schjerling, Peter/0000-0001-7138-3211; Flindt Kreiner, Frederik/0000-0001-8296-453X; Agergaard, Jakob/0000-0003-3401-3144	Copenhagen Graduate School of Health Sciences; Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; Gigtforeningen; Nordea Foundation	Copenhagen Graduate School of Health Sciences; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Gigtforeningen; Nordea Foundation	This study was supported by a PhD fellowship from the Copenhagen Graduate School of Health Sciences (to JGJ) and grants from Danish Medical Research Council, The Novo Nordisk Foundation, The Lundbeck Foundation, Gigtforeningen and The Nordea Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Biolo G, 2002, J CLIN ENDOCR METAB, V87, P3378, DOI 10.1210/jc.87.7.3378; Biolo G, 2008, CRIT CARE MED, V36, P1768, DOI 10.1097/CCM.0b013e318174de32; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Cho JE, 2010, J APPL PHYSIOL, V108, P137, DOI 10.1152/japplphysiol.00704.2009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crossland H, 2008, J PHYSIOL-LONDON, V586, P5589, DOI 10.1113/jphysiol.2008.160150; Dehoux M, 2004, ENDOCRINOLOGY, V145, P4806, DOI 10.1210/en.2004-0406; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Druml W, 2001, AM J CLIN NUTR, V73, P908; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fang CH, 2007, AM J PHYSIOL-REG I, V293, pR1545, DOI 10.1152/ajpregu.00244.2007; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Frystyk J, 1995, GROWTH REGULAT, V5, P169; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Gamrin L, 1996, CRIT CARE MED, V24, P575, DOI 10.1097/00003246-199604000-00005; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gore DC, 2004, AM J PHYSIOL-ENDOC M, V286, pE529, DOI 10.1152/ajpendo.00258.2003; Grander W, 2010, CHEST, V138, P856, DOI 10.1378/chest.09-1677; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gruther W, 2008, J REHABIL MED, V40, P185, DOI 10.2340/16501977-0139; HASSELGREN PO, 1987, ARCH SURG-CHICAGO, V122, P228; Helliwell TR, 1998, NEUROPATH APPL NEURO, V24, P507; HELLIWELL TR, 1991, J PATHOL, V164, P307, DOI 10.1002/path.1711640406; Ho KM, 2008, INTENS CARE MED, V34, P481, DOI 10.1007/s00134-007-0928-0; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jespersen J, 2006, SCAND J MED SCI SPOR, V16, P74, DOI 10.1111/j.1600-0838.2005.00498.x; JESPERSEN JG, 2009, SCAND J MED IN PRESS; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE234, DOI 10.1152/ajpendo.00274.2003; Lang CH, 2005, INT J BIOCHEM CELL B, V37, P2180, DOI 10.1016/j.biocel.2005.04.013; Lang CH, 2005, J CELL PHYSIOL, V203, P144, DOI 10.1002/jcp.20207; Lang CH, 2004, AM J PHYSIOL-ENDOC M, V287, pE721, DOI 10.1152/ajpendo.00132.2004; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Lang CH, 2007, METABOLISM, V56, P49, DOI 10.1016/j.metabol.2006.08.025; Langouche L, 2007, J CLIN ENDOCR METAB, V92, P3890, DOI 10.1210/jc.2007-0813; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McLoughlin TJ, 2009, AM J PHYSIOL-CELL PH, V297, pC548, DOI 10.1152/ajpcell.00502.2008; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; Mikura M, 2009, ANESTHESIOLOGY, V110, P81, DOI 10.1097/ALN.0b013e318190b6c1; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Plank LD, 2000, ANN NY ACAD SCI, V904, P592, DOI 10.1111/j.1749-6632.2000.tb06521.x; Plank LD, 2000, WORLD J SURG, V24, P630, DOI 10.1007/s002689910104; POULSEN JB, 2010, CRIT CARE M IN PRESS; Rabuel C, 2004, ANESTHESIOLOGY, V101, P583, DOI 10.1097/00000542-200409000-00006; Reitelseder S, 2011, AM J PHYSIOL-ENDOC M, V300, pE231, DOI 10.1152/ajpendo.00513.2010; ROTH E, 1985, CLIN CHEM, V31, P1305; Saberi F, 2008, JPEN-PARENTER ENTER, V32, P227, DOI 10.1177/0148607108316195; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Schulze PC, 2005, CIRC RES, V97, P418, DOI 10.1161/01.RES.0000179580.72375.c2; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Smith IJ, 2010, INT J BIOCHEM CELL B, V42, P701, DOI 10.1016/j.biocel.2010.01.006; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Timmerman KL, 2010, J CLIN ENDOCR METAB, V95, P3848, DOI 10.1210/jc.2009-2696; TISCHLER ME, 1983, METABOLISM, V32, P853, DOI 10.1016/0026-0495(83)90198-1; Tjader I, 2004, INTENS CARE MED, V30, P266, DOI 10.1007/s00134-003-2048-9; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vary TC, 1998, AM J PHYSIOL-ENDOC M, V275, pE584, DOI 10.1152/ajpendo.1998.275.4.E584; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	83	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18090	10.1371/journal.pone.0018090	http://dx.doi.org/10.1371/journal.pone.0018090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483870	gold, Green Submitted, Green Published			2022-12-25	WOS:000289057200025
J	Sommi, P; Cheerambathur, D; Brust-Mascher, I; Mogilner, A				Sommi, Patrizia; Cheerambathur, Dhanya; Brust-Mascher, Ingrid; Mogilner, Alex			Actomyosin-Dependent Cortical Dynamics Contributes to the Prophase Force-Balance in the Early Drosophila Embryo	PLOS ONE			English	Article							NONMUSCLE MYOSIN-II; CENTROSOME SEPARATION; CHROMOSOME MOVEMENT; SPINDLE ORIENTATION; FURROW FORMATION; CLEAVAGE FURROW; ACTIN; CYTOKINESIS; MICROTUBULES; RECRUITMENT	Background: The assembly of the Drosophila embryo mitotic spindle during prophase depends upon a balance of outward forces generated by cortical dynein and inward forces generated by kinesin-14 and nuclear elasticity. Myosin II is known to contribute to the dynamics of the cell cortex but how this influences the prophase force-balance is unclear. Principal Findings: Here we investigated this question by injecting the myosin II inhibitor, Y27632, into early Drosophila embryos. We observed a significant increase in both the area of the dense cortical actin caps and in the spacing of the spindle poles. Tracking of microtubule plus ends marked by EB1-GFP and of actin at the cortex revealed that astral microtubules can interact with all regions of these expanded caps, presumably via their interaction with cortical dynein. In Scrambled mutants displaying abnormally small actin caps but normal prophase spindle length in late prophase, myosin II inhibition produced very short spindles. Conclusions: These results suggest that two complementary outward forces are exerted on the prophase spindle by the overlying cortex. Specifically, dynein localized on the mechanically firm actin caps and the actomyosin-driven contraction of the deformable soft patches of the actin cortex, cooperate to pull astral microtubules outward. Thus, myosin II controls the size and dynamic properties of the actin-based cortex to influence the spacing of the poles of the underlying spindle during prophase.	[Sommi, Patrizia] Univ Pavia, Human Physiol Sect, Dept Physiol, I-27100 Pavia, Italy; [Cheerambathur, Dhanya] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Brust-Mascher, Ingrid] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Mogilner, Alex] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of Pavia; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Sommi, P (corresponding author), Univ Pavia, Human Physiol Sect, Dept Physiol, Via Palestro 3, I-27100 Pavia, Italy.	mogilner@math.ucdavis.edu	Mogilner, Alex/A-3135-2008	Cheerambathur, Dhanya/0000-0001-8525-8366	National Institutes of Health [GM 55507, GM068952, GM 068952]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health grants GM 55507 to Jonathan Scholey, GM068952 to Alex Mogilner, and GM 068952 to Alex Mogilner and Jonathan Scholey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; Brust-Mascher Ingrid, 2009, J Vis Exp, DOI 10.3791/1382; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Cytrynbaum EN, 2005, MOL BIOL CELL, V16, P4967, DOI 10.1091/mbc.E05-02-0154; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Fabian L, 2007, PROTOPLASMA, V231, P201, DOI 10.1007/s00709-007-0262-y; Foe VE, 2000, DEVELOPMENT, V127, P1767; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Glover DM, 2005, ONCOGENE, V24, P230, DOI 10.1038/sj.onc.1208279; Halsell SR, 1998, GENETICS, V148, P1845; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; KIEHART DP, 1982, J CELL BIOL, V94, P165, DOI 10.1083/jcb.94.1.165; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Redemann S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012301; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589; Stevenson VA, 2001, NAT CELL BIOL, V3, P68, DOI 10.1038/35050579; SULLIVAN W, 1993, DEVELOPMENT, V118, P1245; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; WHEATLEY S, 1995, DEVELOPMENT, V121, P1937; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wollman R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.23; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18366	10.1371/journal.pone.0018366	http://dx.doi.org/10.1371/journal.pone.0018366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483831	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200064
J	Um, JH; Pendergast, JS; Springer, DA; Foretz, M; Viollet, B; Brown, A; Kim, MK; Yamazaki, S; Chung, JH				Um, Jee-Hyun; Pendergast, Julie S.; Springer, Danielle A.; Foretz, Marc; Viollet, Benoit; Brown, Alexandra; Kim, Myung K.; Yamazaki, Shin; Chung, Jay H.			AMPK Regulates Circadian Rhythms in a Tissue- and Isoform-Specific Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; PPAR-GAMMA; SUPRACHIASMATIC NUCLEUS; MITOCHONDRIAL BIOGENESIS; CALORIE RESTRICTION; PERIPHERAL-TISSUES; CLOCK GENES; FOOD-INTAKE; SIRT1	Background: AMP protein kinase (AMPK) plays an important role in food intake and energy metabolism, which are synchronized to the light-dark cycle. In vitro, AMPK affects the circadian rhythm by regulating at least two clock components, CKI alpha and CRY1, via direct phosphorylation. However, it is not known whether the catalytic activity of AMPK actually regulates circadian rhythm in vivo. Methodology/Principal Finding: The catalytic subunit of AMPK has two isoforms: alpha 1 and alpha 2. We investigate the circadian rhythm of behavior, physiology and gene expression in AMPK alpha 1-/- and AMPK alpha 2-/- mice. We found that both alpha 1-/- and alpha 2-/- mice are able to maintain a circadian rhythm of activity in dark-dark (DD) cycle, but alpha 1-/- mice have a shorter circadian period whereas alpha 2-/- mice showed a tendency toward a slightly longer circadian period. Furthermore, the circadian rhythm of body temperature was dampened in alpha 1-/- mice, but not in alpha 2-/- mice. The circadian pattern of core clock gene expression was severely disrupted in fat in alpha 1-/- mice, but it was severely disrupted in the heart and skeletal muscle of alpha 2-/- mice. Interestingly, other genes that showed circadian pattern of expression were dysreguated in both alpha 1-/- and alpha 2-/- mice. The circadian rhythm of nicotinamide phosphoryl-transferase (NAMPT) activity, which converts nicotinamide (NAM) to NAD(+), is an important regulator of the circadian clock. We found that the NAMPT rhythm was absent in AMPK-deficient tissues and cells. Conclusion/Significance: This study demonstrates that the catalytic activity of AMPK regulates circadian rhythm of behavior, energy metabolism and gene expression in isoform-and tissue-specific manners.	[Um, Jee-Hyun; Brown, Alexandra; Kim, Myung K.; Chung, Jay H.] NHLBI, Lab Obes & Aging Res, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Pendergast, Julie S.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Springer, Danielle A.] NHLBI, Mouse Phenotyping Core Facil, NIH, Bethesda, MD 20892 USA; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Foretz, Marc; Viollet, Benoit] INSERM, U567, Paris, France	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Um, JH (corresponding author), NHLBI, Lab Obes & Aging Res, Genet & Dev Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	chungj@nhlbi.nih.gov	Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Yamazaki, Shin/0000-0002-6691-1531	National Heart Lung and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002243, ZIGHL006020, ZIAHL006118] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program, National Heart Lung and Blood Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Goh BC, 2007, BIOCHEM BIOPH RES CO, V360, P828, DOI 10.1016/j.bbrc.2007.06.136; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ibuka N, 1980, Waking Sleeping, V4, P167; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lihn A, 2004, BIOCHEM BIOPH RES CO, V316, P853, DOI 10.1016/j.bbrc.2004.02.139; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; OKAMURA H, 2007, COLD SPRING HARB SYM, V72, P551; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Vieira E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1032, DOI 10.1152/ajpendo.90510.2008; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; WELSH DK, 1988, PHYSIOL BEHAV, V43, P771, DOI 10.1016/0031-9384(88)90375-7; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yang ST, 2009, ENDOCRINOLOGY, V150, P2153, DOI 10.1210/en.2008-0705; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	61	80	85	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18450	10.1371/journal.pone.0018450	http://dx.doi.org/10.1371/journal.pone.0018450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483791	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200081
J	Crockett, DK; Piccolo, SR; Ridge, PG; Margraf, RL; Lyon, E; Williams, MS; Mitchell, JA				Crockett, David K.; Piccolo, Stephen R.; Ridge, Perry G.; Margraf, Rebecca L.; Lyon, Elaine; Williams, Marc S.; Mitchell, Joyce A.			Predicting Phenotypic Severity of Uncertain Gene Variants in the RET Proto-Oncogene	PLOS ONE			English	Article							ENDOCRINE NEOPLASIA TYPE-2; MEDULLARY-THYROID CANCER; AMINO-ACID SUBSTITUTIONS; AFFECT PROTEIN FUNCTION; CLINICAL GENETICS; MUTATIONS; DISEASE; DATABASE; SIFT	Although reported gene variants in the RET oncogene have been directly associated with multiple endocrine neoplasia type 2 and hereditary medullary thyroid carcinoma, other mutations are classified as variants of uncertain significance (VUS) until the associated clinical phenotype is made clear. Currently, some 46 non-synonymous VUS entries exist in curated archives. In the absence of a gold standard method for predicting phenotype outcomes, this follow up study applies feature selected amino acid physical and chemical properties feeding a Bayes classifier to predict disease association of uncertain gene variants into categories of benign and pathogenic. Algorithm performance and VUS predictions were compared to established phylogenetic based mutation prediction algorithms. Curated outcomes and unpublished RET gene variants with known disease association were used to benchmark predictor performance. Reliable classification of RET uncertain gene variants will augment current clinical information of RET mutations and assist in improving prediction algorithms as knowledge increases.	[Crockett, David K.; Piccolo, Stephen R.; Williams, Marc S.; Mitchell, Joyce A.] Univ Utah Sch Med, Salt Lake City, UT 84132 USA; [Crockett, David K.; Ridge, Perry G.; Margraf, Rebecca L.; Lyon, Elaine] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Williams, Marc S.] Intermt Healthcare Clin Genet Inst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Intermountain Healthcare	Crockett, DK (corresponding author), Univ Utah Sch Med, Salt Lake City, UT 84132 USA.	david.crockett@aruplab.com		Williams, Marc/0000-0001-6165-8701	University of Utah School of Medicine; Department of Pathology and ARUP Institute for Clinical and Experimental Pathology; NLM [LM007124]; NCRR [1KL2RR025763 01]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025763] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007124] Funding Source: NIH RePORTER	University of Utah School of Medicine; Department of Pathology and ARUP Institute for Clinical and Experimental Pathology; NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the University of Utah School of Medicine, Department of Pathology and ARUP Institute for Clinical and Experimental Pathology, NLM training grant LM007124 and NCRR translational science award 1KL2RR025763 01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Crockett DK, 2010, J DATA MINING GENOM, V1, P1; Dorfman R, 2010, CLIN GENET, V77, P464, DOI 10.1111/j.1399-0004.2009.01351.x; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Ensenauer RE, 2005, MAYO CLIN PROC, V80, P63; Ferreira-Gonzalez A, 2008, PERS MED, V5, P521, DOI 10.2217/17410541.5.5.521; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Kang HH, 2006, BRIT J CANCER, V95, P914, DOI 10.1038/sj.bjc.6603358; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403; Kouvaraki MA, 2005, THYROID, V15, P531, DOI 10.1089/thy.2005.15.531; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Machens A, 2001, J CLIN ENDOCR METAB, V86, P1104, DOI 10.1210/jc.86.3.1104; Margraf RL, 2009, HUM MUTAT, V30, P548, DOI 10.1002/humu.20928; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; NOWAK R, 1994, SCIENCE, V265, P464, DOI 10.1126/science.8036486; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Spencer DS, 1996, J MOL BIOL, V257, P497, DOI 10.1006/jmbi.1996.0180; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Weinstein Neil D., 1999, Journal of the National Cancer Institute Monographs, P15; Williams MS, 2009, AM J MED GENET C, V151C, P175, DOI 10.1002/ajmg.c.30216	28	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18380	10.1371/journal.pone.0018380	http://dx.doi.org/10.1371/journal.pone.0018380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479187	Green Submitted, gold, Green Published			2022-12-25	WOS:000289055700053
J	Girard-Buttoz, C; Higham, JP; Heistermann, M; Wedegartner, S; Maestripieri, D; Engelhardt, A				Girard-Buttoz, Cedric; Higham, James P.; Heistermann, Michael; Wedegaertner, Stefan; Maestripieri, Dario; Engelhardt, Antje			Urinary C-Peptide Measurement as a Marker of Nutritional Status in Macaques	PLOS ONE			English	Article							RHESUS-MONKEYS; ENERGY-BALANCE; BODY-MASS; TESTOSTERONE; INSULIN; PRIMATE; WEIGHT; GROWTH; SIZE; AVAILABILITY	Studies of the nutritional status of wild animals are important in a wide range of research areas such as ecology, behavioural ecology and reproductive biology. However, they have so far been strongly limited by the indirect nature of the available non-invasive tools for the measurement of individual energetic status. The measurement of urinary C-peptide (UCP), which in humans and great apes shows a close link to individual nutritional status, may be a more direct, non-invasive tool for such studies in other primates as well and possibly even in non-primate mammals. Here, we test the suitability of UCPs as markers of nutritional status in non-hominid primates, investigating relationships between UCPs and body-mass-index (BMI), skinfold fatness, and plasma C-peptide levels in captive and free-ranging macaques. We also conducted a food reduction experiment, with daily monitoring of body weight and UCP levels. UCP levels showed significant positive correlations with BMI and skinfold fatness in both captive and free-ranging animals and with plasma C-peptide levels in captive ones. In the feeding experiment, UCP levels were positively correlated with changes in body mass and were significantly lower during food reduction than during re-feeding and the pre-experimental control condition. We conclude that UCPs may be used as reliable biomarkers of body condition and nutritional status in studies of free-ranging catarrhines. Our results open exciting opportunities for energetic studies on free-ranging primates and possibly also other mammals.	[Girard-Buttoz, Cedric; Wedegaertner, Stefan; Engelhardt, Antje] German Primate Ctr, Reprod Biol Unit, Jr Res Grp Primate Sexual Select, Gottingen, Germany; [Girard-Buttoz, Cedric; Engelhardt, Antje] Univ Gottingen, Gottingen, Germany; [Higham, James P.; Maestripieri, Dario] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA	Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Chicago	Girard-Buttoz, C (corresponding author), German Primate Ctr, Reprod Biol Unit, Jr Res Grp Primate Sexual Select, Gottingen, Germany.	cgirard-buttoz@dpz.eu	Engelhardt, Antje/A-2660-2013; Girard-Buttoz, Cedric/J-6285-2019	Engelhardt, Antje/0000-0003-2704-7493	German Research Council (DFG) [DFG EN 719/2]; Volkswagen Foundation, on Cayo Santiago; National Institutes of Health [R21-AG029862]; NIH National Center for Research Resources (NCRR) [CM-5-P40RR003640]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067175] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR003640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029862] Funding Source: NIH RePORTER	German Research Council (DFG)(German Research Foundation (DFG)); Volkswagen Foundation, on Cayo Santiago(Volkswagen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research at DPZ was supported by the German Research Council (DFG EN 719/2) and the Volkswagen Foundation, on Cayo Santiago, This research was supported by the National Institutes of Health (grant number R21-AG029862 to DM). This publication was made possible by grant number CM-5-P40RR003640 from the NIH National Center for Research Resources (NCRR) to the Caribbean Primate Research Center of the University of Puerto Rico. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1987, OECOLOGIA, V72, P15, DOI 10.1007/BF00385038; ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; ALTMANN J, 1992, BEHAV ECOL SOCIOBIOL, V29, P391; Altmann S.A., 1998, FORAGING SURVIVAL, DOI University of Chicago Press; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; BARTON RA, 1993, FOLIA PRIMATOL, V61, P1, DOI 10.1159/000156722; BERMAN CM, 1988, AM J PRIMATOL, V14, P53, DOI 10.1002/ajp.1350140105; BERNSTEIN IS, 1989, AM J PRIMATOL, V18, P251, DOI 10.1002/ajp.1350180309; Blanc S, 2005, J MED PRIMATOL, V34, P130, DOI 10.1111/j.1600-0684.2005.00106.x; Bronson FH, 1989, MAMMALIAN REPROD BIO; Campbell BC, 2004, J MED PRIMATOL, V33, P70, DOI 10.1111/j.1600-0684.2004.00055.x; Chivers DJ, 1998, P NUTR SOC, V57, P321, DOI 10.1079/PNS19980047; Cooper MA, 2004, INT J PRIMATOL, V25, P165, DOI 10.1023/B:IJOP.0000014648.12402.b6; Cuthill Innes C., 1997, P97; Deschner T, 2008, HORM BEHAV, V54, P620, DOI 10.1016/j.yhbeh.2008.06.005; GLICK BB, 1979, FOLIA PRIMATOL, V32, P268; GOLDIZEN AW, 1988, J ANIM ECOL, V57, P893, DOI 10.2307/5099; Hamada Y, 1999, PRIMATES, V40, P439, DOI 10.1007/BF02557580; Harris TR, 2010, BEHAV ECOL, V21, P46, DOI 10.1093/beheco/arp150; Harrison T, 2007, AM J PHYS ANTHROPOL, P126; Hoffman CL, 2008, BEHAV ECOL SOCIOBIOL, V62, P1711, DOI 10.1007/s00265-008-0599-z; HOOGWERF BJ, 1986, AM J CLIN NUTR, V43, P350, DOI 10.1093/ajcn/43.3.350; JURGENS KD, 1991, COMP BIOCHEM PHYS A, V100, P703, DOI 10.1016/0300-9629(91)90393-Q; KARASOV WH, 1986, TRENDS ECOL EVOL, V1, P101, DOI 10.1016/0169-5347(86)90034-0; Kelly TR, 2004, VET REC, V154, P729, DOI 10.1136/vr.154.23.729; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Knott CD, 2005, CAM S BIO EVOL ANTHR, V44, P351, DOI 10.1017/CBO9780511542343.013; Koenig A, 1997, J ZOOL, V243, P215, DOI 10.1111/j.1469-7998.1997.tb02778.x; Krebs JR, 1993, INTRO BEHAV ECOLOGY; KRUSZYNSKA YT, 1987, DIABETOLOGIA, V30, P16, DOI 10.1007/BF01788901; LIFSON N, 1966, J THEOR BIOL, V12, P46, DOI 10.1016/0022-5193(66)90185-8; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Marriott B.M., 1989, Puerto Rico Health Sciences Journal, V8, P87; MEISTAS MT, 1982, METABOLISM, V31, P1224, DOI 10.1016/0026-0495(82)90008-7; MORI A, 1979, Primates, V20, P371, DOI 10.1007/BF02373390; Muehlenbein MP, 2005, AM J PHYS ANTHROPOL, V127, P335, DOI 10.1002/ajpa.20071; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; PURI CP, 1981, ACTA ENDOCRINOL-COP, V97, P118, DOI 10.1530/acta.0.0970118; Rawlins RG., 1986, CAYO SANTIAGO MACAQU; RUBENSTEIN AH, 1969, NATURE, V224, P697, DOI 10.1038/224697a0; SAPOLSKY RM, 1982, HORM BEHAV, V16, P279, DOI 10.1016/0018-506X(82)90027-7; SAPOLSKY RM, 1986, ENDOCRINOLOGY, V118, P1630, DOI 10.1210/endo-118-4-1630; SAPOLSKY RM, 1985, ENDOCRINOLOGY, V116, P2273, DOI 10.1210/endo-116-6-2273; Schlulke O, 2006, AM J PRIMATOL, V68, P951, DOI 10.1002/ajp.20300; Sherry DS, 2007, AM J PHYS ANTHROPOL, V133, P771, DOI 10.1002/ajpa.20562; Thompson ME, 2008, HORM BEHAV, V53, P526, DOI 10.1016/j.yhbeh.2007.12.005; Thompson ME, 2009, HORM BEHAV, V55, P299, DOI 10.1016/j.yhbeh.2008.11.005; Wich SA, 2006, INT J PRIMATOL, V27, P1535, DOI 10.1007/s10764-006-9093-5; Wolden-Hanson T, 1993, Obes Res, V1, P5; Yoshida N, 2006, J PSYCHOSOM RES, V61, P571, DOI 10.1016/j.jpsychores.2006.02.009	50	44	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18042	10.1371/journal.pone.0018042	http://dx.doi.org/10.1371/journal.pone.0018042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479215	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000289055700023
J	Koshimizu, E; Imamura, S; Qi, J; Toure, J; Valdez, DM; Carr, CE; Hanai, J; Kishi, S				Koshimizu, Eriko; Imamura, Shintaro; Qi, Jie; Toure, Jamal; Valdez, Delgado M., Jr.; Carr, Christopher E.; Hanai, Jun-ichi; Kishi, Shuji			Embryonic Senescence and Laminopathies in a Progeroid Zebrafish Model	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; A-TYPE LAMINS; NUCLEAR-ENVELOPE; PRELAMIN-A; CELL-DIFFERENTIATION; GRADUAL SENESCENCE; STEM-CELLS; INHIBITING FARNESYLATION; RETINOBLASTOMA PROTEIN; RESTRICTIVE DERMOPATHY	Background: Mutations that disrupt the conversion of prelamin A to mature lamin A cause the rare genetic disorder Hutchinson-Gilford progeria syndrome and a group of laminopathies. Our understanding of how A-type lamins function in vivo during early vertebrate development through aging remains limited, and would benefit from a suitable experimental model. The zebrafish has proven to be a tractable model organism for studying both development and aging at the molecular genetic level. Zebrafish show an array of senescence symptoms resembling those in humans, which can be targeted to specific aging pathways conserved in vertebrates. However, no zebrafish models bearing human premature senescence currently exist. Principal Findings: We describe the induction of embryonic senescence and laminopathies in zebrafish harboring disturbed expressions of the lamin A gene (LMNA). Impairments in these fish arise in the skin, muscle and adipose tissue, and sometimes in the cartilage. Reduced function of lamin A/C by translational blocking of the LMNA gene induced apoptosis, cell-cycle arrest, and craniofacial abnormalities/cartilage defects. By contrast, induced cryptic splicing of LMNA, which generates the deletion of 8 amino acid residues lamin A (zlamin A-Delta 8), showed embryonic senescence and S-phase accumulation/arrest. Interestingly, the abnormal muscle and lipodystrophic phenotypes were common in both cases. Hence, both decrease-of-function of lamin A/C and gain-of-function of aberrant lamin A protein induced laminopathies that are associated with mesenchymal cell lineages during zebrafish early development. Visualization of individual cells expressing zebrafish progerin (zProgerin/zlamin A-Delta 37) fused to green fluorescent protein further revealed misshapen nuclear membrane. A farnesyltransferase inhibitor reduced these nuclear abnormalities and significantly prevented embryonic senescence and muscle fiber damage induced by zProgerin. Importantly, the adult Progerin fish survived and remained fertile with relatively mild phenotypes only, but had shortened lifespan with obvious distortion of body shape. Conclusion: We generated new zebrafish models for a human premature aging disorder, and further demonstrated the utility for studying laminopathies. Premature aging could also be modeled in zebrafish embryos. This genetic model may thus provide a new platform for future drug screening as well as genetic analyses aimed at identifying modifier genes that influence not only progeria and laminopathies but also other age-associated human diseases common in vertebrates.	[Koshimizu, Eriko; Imamura, Shintaro; Qi, Jie; Toure, Jamal; Kishi, Shuji] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02163 USA; [Koshimizu, Eriko] Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan; [Carr, Christopher E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Hanai, Jun-ichi] Harvard Univ, Sch Med, Div Nephrol Interdisciplinary Med & Biotechnol, Dept Med,Beth Israel Deaconess Med Ctr, Boston, MA USA; [Qi, Jie; Valdez, Delgado M., Jr.; Kishi, Shuji] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA	Harvard University; Harvard Medical School; Tokyo University of Marine Science & Technology; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Scripps Research Institute	Koshimizu, E (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02163 USA.	kishi@scripps.edu		Carr, Christopher/0000-0002-7946-5622	Ellison Medical Foundation; Glenn Foundation for Medical Research	Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research	This study was supported by The Ellison Medical Foundation and The Glenn Foundation for Medical Research (S.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati F, 2004, GENE EXPRESSION, V12, P39, DOI 10.3727/000000004783992189; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Candelario J, 2008, AGING CELL, V7, P355, DOI 10.1111/j.1474-9726.2008.00393.x; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; Davies BSJ, 2010, HUM MOL GENET, V19, P2682, DOI 10.1093/hmg/ddq158; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Sandre-Giovannoli A, 2006, PROG MOLEC, V44, P199; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dialynas G, 2010, DEVELOPMENT, V137, P3067, DOI 10.1242/dev.048231; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domingo DL, 2009, ORAL DIS, V15, P187, DOI 10.1111/j.1601-0825.2009.01521.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108; Foster HA, 2007, CHROMOSOME RES, V15, P163, DOI 10.1007/s10577-006-1088-8; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gotic I, 2010, STEM CELLS, V28, P480, DOI 10.1002/stem.292; Grabher C, 2004, METHOD CELL BIOL, V77, P381; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Hofemeister H, 2002, EUR J CELL BIOL, V81, P51, DOI 10.1078/0171-9335-00229; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; LEHNER CF, 1987, J CELL BIOL, V105, P577, DOI 10.1083/jcb.105.1.577; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Mariappan I, 2007, BIOCHEM BIOPH RES CO, V355, P981, DOI 10.1016/j.bbrc.2007.02.060; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Meng A, 1999, METHOD CELL BIOL, V60, P133; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Peter A, 2008, EUR J CELL BIOL, V87, P879, DOI 10.1016/j.ejcb.2008.06.001; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; PRATHER RS, 1989, BIOL REPROD, V41, P123, DOI 10.1095/biolreprod41.1.123; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Raharjo WH, 2001, J CELL SCI, V114, P4447; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rodriguez JI, 1999, AM J MED GENET, V82, P242, DOI 10.1002/(SICI)1096-8628(19990129)82:3<242::AID-AJMG9>3.3.CO;2-5; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Schulze SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007564; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; SINENSKY M, 1994, J CELL SCI, V107, P61; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; van Engelen BGM, 2005, NEUROLOGY, V64, P374, DOI 10.1212/01.WNL.0000149763.15180.00; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhdanova IV, 2008, BRAIN RES BULL, V75, P433, DOI 10.1016/j.brainresbull.2007.10.053	90	38	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17688	10.1371/journal.pone.0017688	http://dx.doi.org/10.1371/journal.pone.0017688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479207	gold, Green Published, Green Submitted			2022-12-25	WOS:000289055700015
J	Rother, F; Shmidt, T; Popova, E; Krivokharchenko, A; Hugel, S; Vilianovich, L; Ridders, M; Tenner, K; Alenina, N; Kohler, M; Hartmann, E; Bader, M				Rother, Franziska; Shmidt, Tatiana; Popova, Elena; Krivokharchenko, Alexander; Huegel, Stefanie; Vilianovich, Larissa; Ridders, Michael; Tenner, Katja; Alenina, Natalia; Koehler, Matthias; Hartmann, Enno; Bader, Michael			Importin alpha 7 Is Essential for Zygotic Genome Activation and Early Mouse Development	PLOS ONE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; PORE-TARGETING COMPLEX; GENE ACTIVATION; NUCLEAR; TRANSPORT; FAMILY; MICE; TRANSITION; EXPRESSION; SUBUNIT	Importin alpha is involved in the nuclear import of proteins. It also contributes to spindle assembly and nuclear membrane formation, however, the underlying mechanisms are poorly understood. Here, we studied the function of importin alpha 7 by gene targeting in mice and show that it is essential for early embryonic development. Embryos lacking importin alpha 7 display a reduced ability for the first cleavage and arrest completely at the two-cell stage. We show that the zygotic genome activation is severely disturbed in these embryos. Our findings indicate that importin alpha 7 is a new member of the small group of maternal effect genes.	[Rother, Franziska; Shmidt, Tatiana; Popova, Elena; Krivokharchenko, Alexander; Huegel, Stefanie; Vilianovich, Larissa; Ridders, Michael; Tenner, Katja; Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Koehler, Matthias] Univ Kiel, Dept Hypertens & Nephrol, Kiel, Germany; [Koehler, Matthias] Ctr Nephrol & Hypertens, Ostsee Clin, Damp, Germany; [Koehler, Matthias] Reha Clin Damp, Damp, Germany; [Rother, Franziska; Hartmann, Enno] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biol, Lubeck, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; University of Lubeck	Rother, F (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	mbader@mdc-berlin.de	Bader, Michael/K-2124-2013; Hartmann, Enno/C-5687-2013	Bader, Michael/0000-0003-4780-4164; Popova, Elena/0000-0002-3043-9650	Deutsche Forschungsgemeinschaft [KO 1950/3-1]; European Union [NEST 12702]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants of the Deutsche Forschungsgemeinschaft (KO 1950/3-1; www.dfg.de) and the European Union (NEST 12702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorjanacz M, 2006, J STRUCT BIOL, V154, P27, DOI 10.1016/j.jsb.2005.12.007; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; HU J, 2010, J BIOL CHEM; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Krivokharchenko A, 2003, BIOL REPROD, V68, P829, DOI 10.1095/biolreprod.102.006494; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Mason DA, 2003, GENETICS, V165, P1943; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Popova E, 2005, METH MOLEC MED, V108, P33; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shmidt T, 2007, NAT CELL BIOL, V9, P1337, DOI 10.1038/ncb1207-1337; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tsuji L, 1997, FEBS LETT, V416, P30, DOI 10.1016/S0014-5793(97)01092-2; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038	28	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18310	10.1371/journal.pone.0018310	http://dx.doi.org/10.1371/journal.pone.0018310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479251	Green Published, Green Accepted, gold			2022-12-25	WOS:000289054600042
J	Wu, N; Castel, D; Debily, MA; Vigano, MA; Alibert, O; Mantovani, R; Iljin, K; Romeo, PH; Gidrol, X				Wu, Ning; Castel, David; Debily, Marie-Anne; Vigano, Maria Alessandra; Alibert, Olivier; Mantovani, Roberto; Iljin, Kristina; Romeo, Paul-Henri; Gidrol, Xavier			Large Scale RNAi Screen Reveals That the Inhibitor of DNA Binding 2 (ID2) Protein Is Repressed by p53 Family Member p63 and Functions in Human Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; CELL-CYCLE; GENE-EXPRESSION; CANCER-CELLS; REGULATES PROLIFERATION; CHROMATID COHESION; GROWTH; IDENTIFICATION; PATHWAY; TARGETS	The inhibitor of DNA binding 2, dominant negative helix-loop-helix protein, ID2, acts as an oncogene and elevated levels of ID2 have been reported in several malignancies. Whereas some inducers of the ID2 gene have been characterized, little is known regarding the proteins capable to repress its expression. We developed siRNA microarrays to perform a large scale loss-of-function screen in human adult keratinocytes engineered to express GFP under the control of the upstream region of ID2 gene. We screened the effect of siRNA-dependent inhibition of 220 cancer-associated genes on the expression of the ID2:: GFP reporter construct. Three genes NBN, RAD21, and p63 lead to a repression of ID2 promoter activity. Strikingly NBN and RAD21 are playing on major role in cell cycle progression and mitosis arrest. These results underline the pregnant need to silence ID2 expression at transcript level to promote cell cycle exit. Central to this inhibitory mechanism we find p63, a key transcription factor in epithelial development and differentiation, which binds specific cis-acting sequence within the ID2 gene promoter both in vitro and in vivo. P63 would not suppress ID2 expression, but would rather prevent excessive expression of that protein to enable the onset of keratinocyte differentiation.	[Wu, Ning; Castel, David; Gidrol, Xavier] CEA, IRTSV, Lab Biopuces, F-38054 Grenoble 9, France; [Wu, Ning; Debily, Marie-Anne; Alibert, Olivier; Romeo, Paul-Henri; Gidrol, Xavier] CEA, IRCM, Lab Explorat Fonct Genomes, F-91057 Evry, France; [Debily, Marie-Anne] Univ Evry Val dEssonne, F-91025 Evry, France; [Vigano, Maria Alessandra; Mantovani, Roberto] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Iljin, Kristina] Univ Turku, Turku, Finland; [Iljin, Kristina] VTT Tech Res Ctr, Turku, Finland	CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Milan; University of Turku; VTT Technical Research Center Finland	Gidrol, X (corresponding author), CEA, IRTSV, Lab Biopuces, 17 Rue Martyrs, F-38054 Grenoble 9, France.	xavier.gidrol@cea.fr	Romeo, Paul-Henri/L-5989-2017; Debily, Marie-Anne/X-7697-2018; Castel, David/D-5353-2018	Romeo, Paul-Henri/0000-0002-8294-0367; Debily, Marie-Anne/0000-0002-8509-6165; Castel, David/0000-0003-0247-080X; Iljin, Kristiina/0000-0002-5161-0584; Gidrol, Xavier/0000-0002-4233-3749; vigano, maria alessandra/0000-0003-2009-0384	Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer (ARC); CEA	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); CEA(French Atomic Energy Commission)	This work was funded by CEA (to N. W. and D. C.), a fellowship from the "Fondation pour la Recherche Medicale" (to N. W.), and an Association pour la Recherche sur le Cancer (ARC) Fellowship (to D. C.).	Alaminos M, 2005, PEDIATR BLOOD CANCER, V45, P909, DOI 10.1002/pbc.20505; Asirvatharn AJ, 2007, PROSTATE, V67, P1411, DOI 10.1002/pros.20633; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Baghdoyan S, 2005, J BIOL CHEM, V280, P15836, DOI 10.1074/jbc.M414216200; Baghdoyan S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh074; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Belletti B, 2001, J BIOL CHEM, V276, P13867, DOI 10.1074/jbc.M010509200; Beretta C, 2005, CELL CYCLE, V4, P1625, DOI 10.4161/cc.4.11.2135; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Drewelus I, 2010, CELL CYCLE, V9, P580, DOI 10.4161/cc.9.3.10593; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kleeff J, 1998, CANCER RES, V58, P3769; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Memezawa A, 2007, ONCOGENE, V26, P5038, DOI 10.1038/sj.onc.1210320; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Rotzer D, 2006, ONCOGENE, V25, P2070, DOI 10.1038/sj.onc.1209230; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Scobey MJ, 2004, J BIOL CHEM, V279, P16064, DOI 10.1074/jbc.M309298200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Simbulan-Rosenthal CM, 2005, ONCOGENE, V24, P5443, DOI 10.1038/sj.onc.1208709; Stighall M, 2005, INT J CANCER, V115, P403, DOI 10.1002/ijc.20875; Tokuriki A, 2009, CARCINOGENESIS, V30, P1645, DOI 10.1093/carcin/bgp172; Toyoda Y, 2002, CURR BIOL, V12, P347, DOI 10.1016/S0960-9822(02)00692-9; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vigano MA, 2007, CELL CYCLE, V6, P233, DOI 10.4161/cc.6.3.3802; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zhang Y, 2006, CELL RES, V16, P45, DOI 10.1038/sj.cr.7310007	57	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20870	20879		10.1074/jbc.M110.169433	http://dx.doi.org/10.1074/jbc.M110.169433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21478550	hybrid, Green Published			2022-12-25	WOS:000291267600071
J	Alves, MS; Reis, PAB; Dadalto, SP; Faria, JAQA; Fontes, EPB; Fietto, LG				Alves, Murilo S.; Reis, Pedro A. B.; Dadalto, Silvana P.; Faria, Jerusa A. Q. A.; Fontes, Elizabeth P. B.; Fietto, Luciano G.			A Novel Transcription Factor, ERD15 (Early Responsive to Dehydration 15), Connects Endoplasmic Reticulum Stress with an Osmotic Stress-induced Cell Death Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; C-MYC; DOMAIN; NUCLEAR; GENE; EXPRESSION; PROMOTER; ER; IDENTIFICATION	As in all other eukaryotic organisms, endoplasmic reticulum (ER) stress triggers the evolutionarily conserved unfolded protein response in soybean, but it also communicates with other adaptive signaling responses, such as osmotic stress-induced and ER stress-induced programmed cell death. These two signaling pathways converge at the level of gene transcription to activate an integrated cascade that is mediated by N-rich proteins (NRPs). Here, we describe a novel transcription factor, GmERD15 (Glycine max Early Responsive to Dehydration 15), which is induced by ER stress and osmotic stress to activate the expression of NRP genes. GmERD15 was isolated because of its capacity to stably associate with the NRP-B promoter in yeast. It specifically binds to a 187-bp fragment of the NRP-B promoter in vitro and activates the transcription of a reporter gene in yeast. Furthermore, GmERD15 was found in both the cytoplasm and the nucleus, and a ChIP assay revealed that it binds to the NRP-B promoter in vivo. Expression of GmERD15 in soybean protoplasts activated the NRP-B promoter and induced expression of the NRP-B gene. Collectively, these results support the interpretation that GmERD15 functions as an upstream component of stress-induced NRP-B-mediated signaling to connect stress in the ER to an osmotic stress-induced cell death signal.	[Alves, Murilo S.; Reis, Pedro A. B.; Dadalto, Silvana P.; Faria, Jerusa A. Q. A.; Fontes, Elizabeth P. B.; Fietto, Luciano G.] Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil; [Alves, Murilo S.; Reis, Pedro A. B.; Fontes, Elizabeth P. B.; Fietto, Luciano G.] Univ Fed Vicosa, Natl Inst Sci & Technol Plant Pest Interact, BR-36571000 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Fontes, EPB (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil.	bbfontes@ufv.br; lgfietto@ufv.br	Alves, Murilo/X-9772-2018; Alves, Murilo/H-9891-2013; Fietto, Luciano G/F-9908-2012; Reis, Pedro Augusto Braga/U-4103-2019; Faria, Jerusa Araujo Quintao Arantes/AAB-5215-2020; Fontes, Elizabeth/K-3159-2012	Reis, Pedro Augusto Braga/0000-0003-2396-3662; Faria, Jerusa Araujo Quintao Arantes/0000-0001-7974-0295; Fontes, Elizabeth/0000-0002-7986-1369; Fietto, Luciano/0000-0002-2674-6471	Brazilian Government Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [559602/2009-0, 573600/2008-2, 470878/2006-1]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CBB-APQ-00070-09]; Financiadora de Estudos e Projetos (FINEP) [01.09.0625.00]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Brazilian Government Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian Government Agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 559602/2009-0, 573600/2008-2, and 470878/2006-1 (to E. P. B. F.), as well as by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Grant CBB-APQ-00070-09 and Financiadora de Estudos e Projetos (FINEP) Grant 01.09.0625.00 (to E. P. B. F.).; Supported by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) graduate fellowship.; Supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) graduate fellowship.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; Amberg D. C., 2005, METHODS YEAST GENETI, P135; Brandsen J, 1997, NAT STRUCT BIOL, V4, P900, DOI 10.1038/nsb1197-900; Buzeli RAA, 2002, PLANT MOL BIOL, V50, P757, DOI 10.1023/A:1019994721545; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Carvalho CM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000247; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Chekanova JA, 2003, RNA, V9, P1476, DOI 10.1261/rna.5128903; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Cormack RS, 1998, PLANT J, V14, P685, DOI 10.1046/j.1365-313x.1998.00169.x; Costa MDL, 2008, J BIOL CHEM, V283, P20209, DOI 10.1074/jbc.M802654200; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Delu-Filho N, 2000, PLANT PHYSIOL BIOCH, V38, P353, DOI 10.1016/S0981-9428(00)00752-X; Desveaux D, 2000, PLANT CELL, V12, P1477, DOI 10.1105/tpc.12.8.1477; Desveaux D, 2002, NAT STRUCT BIOL, V9, P512, DOI 10.1038/nsb814; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; GEITZ RD, 1993, MOL GENETICS YEAST P, P121; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; KAMADA S, 1992, GENE, V119, P229, DOI 10.1016/0378-1119(92)90276-U; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; KIYOSUE T, 1994, PLANT PHYSIOL, V106, P1707, DOI 10.1104/pp.106.4.1707; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Ludwig AA, 2001, EUR J PLANT PATHOL, V107, P323, DOI 10.1023/A:1011202225323; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Saleh A, 2006, PLANT J, V46, P747, DOI 10.1111/j.1365-313X.2006.02742.x; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SMIDT MP, 1995, NUCLEIC ACIDS RES, V23, P2389, DOI 10.1093/nar/23.13.2389; Sridhar VV, 2004, P NATL ACAD SCI USA, V101, P11494, DOI 10.1073/pnas.0403055101; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tenhaken R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-169; Urade R, 2009, BIOFACTORS, V35, P326, DOI 10.1002/biof.45; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Wang XF, 2004, PLANT MOL BIOL, V54, P85, DOI 10.1023/B:PLAN.0000028771.70969.6b; Wang ZR, 2000, MOL CELL BIOL, V20, P6334, DOI 10.1128/MCB.20.17.6334-6341.2000; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188	45	45	52	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20020	20030		10.1074/jbc.M111.233494	http://dx.doi.org/10.1074/jbc.M111.233494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21482825	Green Published, hybrid			2022-12-25	WOS:000291027700079
J	Nakagawa, S; Gong, XQ; Maeda, S; Dong, YH; Misumi, Y; Tsukihara, T; Bai, DL				Nakagawa, So; Gong, Xiang-Qun; Maeda, Shoji; Dong, Yuhua; Misumi, Yuko; Tsukihara, Tomitake; Bai, Donglin			Asparagine 175 of Connexin32 Is a Critical Residue for Docking and Forming Functional Heterotypic Gap Junction Channels with Connexin26	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; EXTRACELLULAR LOOP; SELECTIVE INTERACTIONS; MISSENSE MUTATION; PLASMA-MEMBRANE; TRAFFICKING; DOMAINS; PROTEIN; DETERMINANT; MUTANTS	The gap junction channel is formed by proper docking of two hemichannels. Depending on the connexin(s) in the hemichannels, homotypic and heterotypic gap junction channels can be formed. Previous studies suggest that the extracellular loop 2 (E2) is an important molecular domain for heterotypic compatibility. Based on the crystal structure of the Cx26 gap junction channel and homology models of heterotypic channels, we analyzed docking selectivity for several hemichannel pairs and found that the hydrogen bonds between E2 domains are conserved in a group of heterotypically compatible hemichannels, including Cx26 and Cx32 hemichannels. According to our model analysis, Cx32N175Y mutant destroys three hydrogen bonds in the E2-E2 interactions due to steric hindrance at the heterotypic docking interface, which makes it unlikely to dock with the Cx26 hemichannel properly. Our experimental data showed that Cx26-red fluorescent protein (RFP) and Cx32-GFP were able to traffic to cell-cell interfaces forming gap junction plaques and functional channels in transfected HeLa/N2A cells. However, Cx32N175Y-GFP exhibited mostly intracellular distribution and was occasionally observed in cell-cell junctions. Double patch clamp analysis demonstrated that Cx32N175Y did not form functional homotypic channels, and dye uptake assay indicated that Cx32N175Y could form hemichannels on the cell surface similar to wild-type Cx32. When Cx32N175Y-GFP- and Cx26-RFP-transfected cells were co-cultured, no colocalization was found at the cell-cell junctions between Cx32N175YGFP- and Cx26-RFP-expressing cells; also, no functional Cx32N175Y-GFP/Cx26-RFP heterotypic channels were identified. Both our modeling and experimental data suggest that Asn(175) of Cx32 is a critical residue for heterotypic docking and functional gap junction channel formation between the Cx32 and Cx26 hemichannels.	[Gong, Xiang-Qun; Dong, Yuhua; Bai, Donglin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Nakagawa, So; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Maeda, Shoji] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Misumi, Yuko; Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Western University (University of Western Ontario); Osaka University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Hyogo	Bai, DL (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	donglin.bai@schulich.uwo.ca	Bai, Donglin/A-5799-2008; Bai, Donglin/ABB-9924-2021	Bai, Donglin/0000-0003-1112-6947; Bai, Donglin/0000-0003-1112-6947; Maeda, Shoji/0000-0002-7762-9793; Misumi, Yuko/0000-0003-3434-6678	Japan Society for the Promotion of Science; Osaka University; Institutional Program for Young Researcher Overseas Visits; Ministry of Education, Culture, Sports, Science and Technology of Japan [10188101, 10179101, 16087206, 18207006]; Canadian Institutes of Health Research; government of Ontario	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka University; Institutional Program for Young Researcher Overseas Visits; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); government of Ontario	This work was supported by a grant-in-aid for Japan Society for the Promotion of Science Fellow, the Global Centers of Excellence Program "Global Education and Research Center for Bio-Environmental Chemistry" of Osaka University; Institutional Program for Young Researcher Overseas Visits (to S.N.); Grants-in-aid for Scientific Research 10188101, 10179101, 16087206, and 18207006 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. T.); a grant from the Canadian Institutes of Health Research (to D. B.); and an Early Researcher Award from the government of Ontario (to D. B.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUZZONE R, 1994, J CELL SCI, V107, P955; DAHL G, 1994, BIOPHYS J, V67, P1816, DOI 10.1016/S0006-3495(94)80663-0; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falk MM, 2000, J CELL SCI, V113, P4109; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; GHOSHROY S, 1995, J MEMBRANE BIOL, V146, P15; Gong XQ, 2007, J BIOL CHEM, V282, P19190, DOI 10.1074/jbc.M609653200; Gong XQ, 2006, J BIOL CHEM, V281, P31801, DOI 10.1074/jbc.M605961200; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOH JH, 1993, BIOPHYS J, V65, P149, DOI 10.1016/S0006-3495(93)81074-9; Iwai M, 2000, J HEPATOL, V32, P11, DOI 10.1016/S0168-8278(00)80184-1; JOHN SA, 1991, BIOCHEM BIOPH RES CO, V178, P1312, DOI 10.1016/0006-291X(91)91037-D; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kochanski Andrzej, 2004, Journal of Applied Genetics, V45, P95; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martin PEM, 2001, CELL COMMUN ADHES, V8, P243, DOI 10.3109/15419060109080731; Martin PEM, 2001, J CELL SCI, V114, P3845; Musa H, 2004, J PHYSIOL-LONDON, V557, P863, DOI 10.1113/jphysiol.2003.059386; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Primignani P, 2003, CLIN GENET, V63, P516, DOI 10.1034/j.1399-0004.2003.00079.x; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Silander K, 1998, HUM MUTAT, V12, P59, DOI 10.1002/(SICI)1098-1004(1998)12:1<59::AID-HUMU9>3.3.CO;2-1; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; SOSINSKY G, 1995, P NATL ACAD SCI USA, V92, P9210, DOI 10.1073/pnas.92.20.9210; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Suchyna TM, 1999, BIOPHYS J, V77, P2968, DOI 10.1016/S0006-3495(99)77129-8; Suga M, 2009, ACTA CRYSTALLOGR D, V65, P758, DOI 10.1107/S0907444909014711; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Unger VM, 1997, NAT STRUCT BIOL, V4, P39, DOI 10.1038/nsb0197-39; WHITE TW, 1995, MOL BIOL CELL, V6, P459, DOI 10.1091/mbc.6.4.459; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; Yeager C. M., 2000, GAP JUNCTIONS ADV MO, P31; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545	54	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19672	19681		10.1074/jbc.M110.204958	http://dx.doi.org/10.1074/jbc.M110.204958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478159	hybrid, Green Published			2022-12-25	WOS:000291027700050
J	Patterson, AD; Bonzo, JA; Li, F; Krausz, KW; Eichler, GS; Aslam, S; Tigno, X; Weinstein, JN; Hansen, BC; Idle, JR; Gonzalez, FJ				Patterson, Andrew D.; Bonzo, Jessica A.; Li, Fei; Krausz, Kristopher W.; Eichler, Gabriel S.; Aslam, Sadaf; Tigno, Xenia; Weinstein, John N.; Hansen, Barbara C.; Idle, Jeffrey R.; Gonzalez, Frank J.			Metabolomics Reveals Attenuation of the SLC6A20 Kidney Transporter in Nonhuman Primate and Mouse Models of Type 2 Diabetes Mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE-CARBOXYKINASE GENE; NUCLEAR-MAGNETIC-RESONANCE; GLYCINE BETAINE EXCRETION; METABONOMIC ANALYSIS; PIPECOLIC ACID; PLASMA; RAT; EXPRESSION; MONKEY; METABOLISM	To enhance understanding of the metabolic indicators of type 2 diabetes mellitus (T2DM) disease pathogenesis and progression, the urinary metabolomes of well characterized rhesus macaques (normal or spontaneously and naturally diabetic) were examined. High-resolution ultra-performance liquid chromatography coupled with the accurate mass determination of time-of-flight mass spectrometry was used to analyze spot urine samples from normal (n = 10) and T2DM (n = 11) male monkeys. The machine-learning algorithm random forests classified urine samples as either from normal or T2DM monkeys. The metabolites important for developing the classifier were further examined for their biological significance. Random forests models had a misclassification error of less than 5%. Metabolites were identified based on accurate masses (<10 ppm) and confirmed by tandem mass spectrometry of authentic compounds. Urinary compounds significantly increased (p < 0.05) in the T2DM when compared with the normal group included glycine betaine (9-fold), citric acid (2.8-fold), kynurenic acid (1.8-fold), glucose (68-fold), and pipecolic acid (6.5-fold). When compared with the conventional definition of T2DM, the metabolites were also useful in defining the T2DM condition, and the urinary elevations in glycine betaine and pipecolic acid (as well as proline) indicated defective re-absorption in the kidney proximal tubules by SLC6A20, a Na+-dependent transporter. The mRNA levels of SLC6A20 were significantly reduced in the kidneys of monkeys with T2DM. These observations were validated in the db/db mouse model of T2DM. This study provides convincing evidence of the power of metabolomics for identifying functional changes at many levels in the omics pipeline.	[Patterson, Andrew D.; Bonzo, Jessica A.; Li, Fei; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Eichler, Gabriel S.; Weinstein, John N.] NCI, Genom & Bioinformat Grp, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Aslam, Sadaf; Tigno, Xenia; Hansen, Barbara C.] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA; [Aslam, Sadaf; Tigno, Xenia; Hansen, Barbara C.] Univ S Florida, Dept Pediat, Tampa, FL 33612 USA; [Idle, Jeffrey R.] Univ Bern, Dept Clin Pharmacol, CH-3010 Bern, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Bern	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	fjgonz@helix.nih.gov	Patterson, Andrew/ABF-1575-2020; Hansen, Barbara C/J-8723-2012; Patterson, Andrew/G-3852-2012; Li, Fei/F-6849-2013; Idle, Jeff/B-1152-2012	Patterson, Andrew/0000-0003-2073-0070; Hansen, Barbara C/0000-0001-9646-3525; Patterson, Andrew/0000-0003-2073-0070; Idle, Jeff/0000-0002-6143-1520; Weinstein, John/0000-0001-9401-6908	National Institutes of Health [NO1-AG-3-1012, AG-42100, HHSN26300800022C]; National Cancer Institute; NIGMS, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG042100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NO1-AG-3-1012 (to B. C. H.), AG-42100 (to B. C. H.), and HHSN26300800022C and the National Cancer Institute, Intramural Research Program.; Supported by Pharmacology Research Associate in Training Fellowships from the NIGMS, National Institutes of Health.	Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Baas JCM, 2002, J INHERIT METAB DIS, V25, P699; BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Bonzo JA, 2010, MOL ENDOCRINOL, V24, P2343, DOI 10.1210/me.2010-0130; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broer A, 2006, PFLUG ARCH EUR J PHY, V451, P511, DOI 10.1007/s00424-005-1481-8; Cassuto H, 1997, FEBS LETT, V412, P597, DOI 10.1016/S0014-5793(97)00867-3; Cassuto H, 2003, GENE, V318, P177, DOI 10.1016/S0378-1119(03)00775-3; Cusumano AM, 2002, AM J KIDNEY DIS, V40, P1075, DOI 10.1053/ajkd.2002.36348; D'Amato E, 2008, PEDIATR NEPHROL, V23, P137, DOI 10.1007/s00467-007-0609-9; Dellow WJ, 1999, DIABETES RES CLIN PR, V43, P91, DOI 10.1016/S0168-8227(98)00115-6; Dellow WJ, 2001, DIABETES RES CLIN PR, V52, P165, DOI 10.1016/S0168-8227(01)00237-6; Ding SY, 2007, METABOLISM, V56, P838, DOI 10.1016/j.metabol.2007.01.015; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fardet A, 2008, J PROTEOME RES, V7, P2388, DOI 10.1021/pr800034h; Frank S, 1998, DNA CELL BIOL, V17, P679, DOI 10.1089/dna.1998.17.679; Freitas HS, 2009, MOL CELL ENDOCRINOL, V305, P63, DOI 10.1016/j.mce.2009.02.014; GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595, DOI 10.1161/01.HYP.16.6.595; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095; GROSSMAN EB, 1989, AM J PHYSIOL, V256, pF107; HANSEN BC, 2004, DIABETES MELLITUS FU, P1059; Hodavance MS, 2007, ANAL BIOANAL CHEM, V387, P533, DOI 10.1007/s00216-006-0979-z; Idle JR, 2007, CELL METAB, V6, P348, DOI 10.1016/j.cmet.2007.10.005; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Johnson MA, 2005, EXP EYE RES, V80, P37, DOI 10.1016/j.exer.2004.08.006; Khalifah RG, 1996, BIOCHEMISTRY-US, V35, P4645, DOI 10.1021/bi9525942; Kikuchi R, 2010, KIDNEY INT, V78, P569, DOI 10.1038/ki.2010.176; Kim SY, 2005, DIABETES, V54, P1534, DOI 10.2337/diabetes.54.5.1534; Kim SY, 2004, INVEST OPHTH VIS SCI, V45, P4543, DOI 10.1167/iovs.04-0519; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; KORNER A, 1994, DIABETES, V43, P629, DOI 10.2337/diabetes.43.5.629; LAM S, 1986, BIOCHIM BIOPHYS ACTA, V882, P254, DOI 10.1016/0304-4165(86)90162-5; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; LEVER M, 1994, CLIN CHIM ACTA, V230, P69, DOI 10.1016/0009-8981(94)90090-6; LEVER M, 1994, BBA-GEN SUBJECTS, V1200, P259, DOI 10.1016/0304-4165(94)90165-1; LOHR J, 1990, J PHARMACOL EXP THER, V252, P154; Mache CJ, 2002, PEDIATR NEPHROL, V17, P1021, DOI 10.1007/s00467-002-0975-2; Major HJ, 2006, RAPID COMMUN MASS SP, V20, P3295, DOI 10.1002/rcm.2732; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Misener S., 2000, BIOINFORMATICS METHO; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Nadeau KJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE90, DOI 10.1152/ajpendo.00543.2005; NUMA S, 1972, BIOCH SOC S, V35, P27; Ortmeyer HK, 2005, AM J PHYSIOL-REG I, V288, pR1509, DOI 10.1152/ajpregu.00692.2004; Otsuji T, 2002, EXP EYE RES, V75, P201, DOI 10.1006/exer.2002.2020; Pare M, 2007, J COMP NEUROL, V501, P543, DOI 10.1002/cne.21262; Peduto A, 2004, MOL GENET METAB, V82, P224, DOI 10.1016/j.ymgme.2004.04.010; Pennisi E, 2007, SCIENCE, V316, P218, DOI 10.1126/science.316.5822.218; Pennisi E, 2007, SCIENCE, V316, P216, DOI 10.1126/science.316.5822.216; Rashed MS, 2001, CLIN CHEM, V47, P2124; Ringeissen S, 2003, BIOMARKERS, V8, P240, DOI 10.1080/1354750031000149124; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Standaert ML, 2002, DIABETES, V51, P2936, DOI 10.2337/diabetes.51.10.2936; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Takanaga H, 2005, J BIOL CHEM, V280, P8974, DOI 10.1074/jbc.M413027200; TAKEUCHI F, 1989, J NUTR SCI VITAMINOL, V35, P111, DOI 10.3177/jnsv.35.111; Tanimoto M, 2007, METABOLISM, V56, P160, DOI 10.1016/j.metabol.2006.08.026; Tigno XT, 2006, CLIN HEMORHEOL MICRO, V34, P273; Tigno XT, 2004, J GERONTOL A-BIOL, V59, P1081, DOI 10.1093/gerona/59.11.1081; TIGNO XT, 2007, HDB EXPT ANIMALS, P451; Verrey F, 2009, PFLUG ARCH EUR J PHY, V458, P53, DOI 10.1007/s00424-009-0638-2; Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955; Wang C, 2005, ANAL CHEM, V77, P4108, DOI 10.1021/ac0481001; Williams R, 2006, MOL BIOSYST, V2, P174, DOI 10.1039/b516356k; Williams RE, 2005, J PHARMACEUT BIOMED, V38, P465, DOI 10.1016/j.jpba.2005.01.013; Zhang J, 2009, ANAL CHIM ACTA, V650, P16, DOI 10.1016/j.aca.2009.02.027; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhen Y, 2007, MOL ENDOCRINOL, V21, P2136, DOI 10.1210/me.2007-0150; 2005, J AM SOC NEPHROL, V16, P1886	75	54	57	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19511	19522		10.1074/jbc.M111.221739	http://dx.doi.org/10.1074/jbc.M111.221739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487016	hybrid, Green Published			2022-12-25	WOS:000291027700034
J	Battista, J; Badcock, DR; McKendrick, AM				Battista, Josephine; Badcock, David R.; McKendrick, Allison M.			Migraine Increases Centre-Surround Suppression for Drifting Visual Stimuli	PLOS ONE			English	Article							PARVOCELLULAR PATHWAYS; CONTRAST SENSITIVITY; CORTICAL INHIBITION; MOTION PERCEPTION; FIELD LOSS; DEFICITS; EPIDEMIOLOGY; DYSFUNCTION; ADAPTATION; ANTAGONISM	Background: The pathophysiology of migraine is incompletely understood, but evidence points to hyper-responsivity of cortical neurons being a key feature. The basis of hyper-responsiveness is not clear, with an excitability imbalance potentially arising from either reduced inhibition or increased excitation. In this study, we measure centre-surround contrast suppression in people with migraine as a perceptual analogue of the interplay between inhibition and excitation in cortical areas responsible for vision. We predicted that reduced inhibitory function in migraine would reduce perceptual surround suppression. Recent models of neuronal surround suppression incorporate excitatory feedback that drives surround inhibition. Consequently, an increase in excitation predicts an increase in perceptual surround suppression. Methods and Findings: Twenty-six people with migraine and twenty approximately age-and gender-matched non-headache controls participated. The perceived contrast of a central sinusoidal grating patch (4 c/deg stationary grating, or 2 c/deg drifting at 2 deg/sec, 40% contrast) was measured in the presence and absence of a 95% contrast annular grating (same orientation, spatial frequency, and drift rate). For the static grating, similar surround suppression strength was present in control and migraine groups with the presence of the surround resulting in the central patch appearing to be 72% and 65% of its true contrast for control and migraine groups respectively (t(44) = 0.81, p = 0.42). For the drifting stimulus, the migraine group showed significantly increased surround suppression (t(44) = 2.86, p < 0.01), with perceived contrast being on average 53% of actual contrast for the migraine group and 68% for non-headache controls. Conclusions: In between migraines, when asymptomatic, visual surround suppression for drifting stimuli is greater in individuals with migraine than in controls. The data provides evidence for a behaviourally measurable imbalance in inhibitory and excitatory visual processes in migraine and is incompatible with a simple model of reduced cortical inhibitory function within the visual system.	[Battista, Josephine; McKendrick, Allison M.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Badcock, David R.] Univ Western Australia, Sch Psychol, Nedlands, WA 6009, Australia	University of Melbourne; University of Western Australia	Battista, J (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	allisonm@unimelb.edu.au	McKendrick, Allison M/A-2114-2008; Badcock, David R/A-4913-2008	Badcock, David R/0000-0002-4517-435X; McKendrick, Allison/0000-0003-1972-1222	Australian National Health and Medical Research Council [509208]; Australian Research Council [FT0990930]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This project was supported by an Australian National Health and Medical Research Council Project Grant #509208 to authors AMM and DRB. Author AMM is supported by an Australian Research Council Future Fellowship #FT0990930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Antal A, 2005, CEPHALALGIA, V25, P788, DOI 10.1111/j.1468-2982.2005.00949.x; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; Aurora SK, 2005, HEADACHE, V45, P546, DOI 10.1111/j.1526-4610.2005.05108.x; Battelli L, 2002, NEUROLOGY, V58, P1066, DOI 10.1212/WNL.58.7.1066; Battista J, 2010, INVEST OPHTH VIS SCI, V51, P6070, DOI 10.1167/iovs.10-5290; Benedek K, 2002, CEPHALALGIA, V22, P142, DOI 10.1046/j.1468-2982.2002.00351.x; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Betts LR, 2005, NEURON, V45, P361, DOI 10.1016/j.neuron.2004.12.041; Brighina F, 2007, CEPHALALGIA, V27, P187, DOI 10.1111/j.1468-2982.2007.01276_1.x; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; COLESTON DM, 1995, CEPHALALGIA, V15, P396, DOI 10.1046/j.1468-2982.1995.1505396.x; Comoglu S, 2003, J NEUROL, V250, P201, DOI 10.1007/s00415-003-0975-6; Coppola G, 2007, Cephalalgia, V27, P1427, DOI 10.1111/j.1468-2982.2007.01500.x; Cuomo-Granston A, 2010, PROG NEUROBIOL, V91, P300, DOI 10.1016/j.pneurobio.2010.04.001; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; Ditchfield JA, 2006, VISION RES, V46, P141, DOI 10.1016/j.visres.2005.09.014; DRUMMOND PD, 1992, CEPHALALGIA, V12, P349, DOI 10.1111/j.1468-2982.1992.00349.x; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Friedman DI, 2009, HEADACHE, V49, P941, DOI 10.1111/j.1526-4610.2009.01443.x; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; *INT HEAD SOC, 2004, CEPHALALGIA, V24; Kaplan E., 1990, Progress in Retinal Research, V9, P273, DOI 10.1016/0278-4327(90)90009-7; Karas R, 2009, J VISION, V9, DOI 10.1167/9.5.11; Kowacs PA, 2005, CEPHALALGIA, V25, P339, DOI 10.1111/j.1468-2982.2004.00861.x; Lambert GA, 2009, HEADACHE, V49, P253, DOI 10.1111/j.1526-4610.2008.01230.x; LAMME VAF, 2000, NEW COGNITIVE NEUROS, P279; LEWIS RA, 1989, OPHTHALMOLOGY, V96, P321, DOI 10.1016/S0161-6420(89)33069-7; Lipton RB, 2001, HEADACHE, V41, P854; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; MARCUS DA, 1989, ARCH NEUROL-CHICAGO, V46, P1129, DOI 10.1001/archneur.1989.00520460125024; McColl SL, 2000, CEPHALALGIA, V20, P74, DOI 10.1046/j.1468-2982.2000.00033.x; McKendrick AM, 2009, CEPHALALGIA, V29, P539, DOI 10.1111/j.1468-2982.2008.01817.x; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1846, DOI 10.1167/iovs.03-1225; McKendrick AM, 2004, CEPHALALGIA, V24, P389, DOI 10.1111/j.1468-2982.2004.00682.x; McKendrick AM, 2004, CEPHALALGIA, V24, P363, DOI 10.1111/j.1468-2982.2004.00679.x; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1061, DOI 10.1167/iovs.03-0936; McKendrick AM, 2003, INVEST OPHTH VIS SCI, V44, P442, DOI 10.1167/iovs.02-0630; McKendrick AM, 2001, INVEST OPHTH VIS SCI, V42, P626; Mulleners WM, 2001, NEUROLOGY, V56, P178, DOI 10.1212/WNL.56.2.178; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Pastor MA, 2003, J NEUROSCI, V23, P11621; Pietrobon D, 2010, J PHYSIOL-LONDON, V588, P1871, DOI 10.1113/jphysiol.2010.188003; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Sanchez-del-Rio M, 2006, CURR OPIN NEUROL, V19, P294, DOI 10.1097/01.wco.0000227041.23694.5c; Schoenen J, 2003, CLIN NEUROPHYSIOL, V114, P955, DOI 10.1016/S1388-2457(03)00024-5; Schwabe L, 2010, NEUROIMAGE, V52, P777, DOI 10.1016/j.neuroimage.2010.01.032; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; Shepherd AJ, 2006, BRAIN, V129, P1833, DOI 10.1093/brain/awl124; Shepherd AJ, 2000, CEPHALALGIA, V20, P865, DOI 10.1046/j.1468-2982.2000.00119.x; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tadin D, 2003, NATURE, V424, P312, DOI 10.1038/nature01800; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Takeuchi T, 2000, VISION RES, V40, P2697, DOI 10.1016/S0042-6989(00)00129-2; Wagner D, 2010, INVEST OPHTH VIS SCI, V51, P2294, DOI 10.1167/iovs.09-4318; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilkinson F, 2008, CEPHALALGIA, V28, P1327, DOI 10.1111/j.1468-2982.2008.01696.x; Xing J, 2001, VISION RES, V41, P571, DOI 10.1016/S0042-6989(00)00270-4; Yu C, 2001, J VISION, V1, P18, DOI 10.1167/1.1.3	63	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18211	10.1371/journal.pone.0018211	http://dx.doi.org/10.1371/journal.pone.0018211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494594	Green Published, gold			2022-12-25	WOS:000289354100007
J	Heupink, TH; Huynen, L; Lambert, DM				Heupink, Tim H.; Huynen, Leon; Lambert, David M.			Ancient DNA Suggests Dwarf and 'Giant' Emu Are Conspecific	PLOS ONE			English	Article							EVOLUTION; INSIGHTS; BROWN; MC1R	Background: The King Island Emu (Dromaius ater) of Australia is one of several extinct emu taxa whose taxonomic relationship to the modern Emu (D. novaehollandiae) is unclear. King Island Emu were mainly distinguished by their much smaller size and a reported darker colour compared to modern Emu. Methodology and Results: We investigated the evolutionary relationships between the King Island and modern Emu by the recovery of both nuclear and mitochondrial DNA sequences from sub-fossil remains. The complete mitochondrial control (1,094 bp) and cytochrome c oxidase subunit I (COI) region (1,544 bp), as well as a region of the melanocortin 1 receptor gene (57 bp) were sequenced using a multiplex PCR approach. The results show that haplotypes for King Island Emu fall within the diversity of modern Emu. Conclusions: These data show the close relationship of these emu when compared to other congeneric bird species and indicate that the King Island and modern Emu share a recent common ancestor. King Island emu possibly underwent insular dwarfism as a result of phenotypic plasticity. The close relationship between the King Island and the modern Emu suggests it is most appropriate that the former should be considered a subspecies of the latter. Although both taxa show a close genetic relationship they differ drastically in size. This study also suggests that rates of morphological and neutral molecular evolution are decoupled.	[Heupink, Tim H.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Heupink, TH (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au	Heupink, Tim/B-3609-2014	Heupink, Tim/0000-0001-6237-3898; Lambert, David/0000-0002-5821-3637	Griffith University	Griffith University(Griffith University)	This research was funded by Griffith University and specifically THH was supported by a PhD scholarship from Griffith University (www.griffith.edu.au). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER W, 1922, EMU, V21, P318; BALOUET JC, 1990, OISEAU REV FRANCAISE, P314; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; EDWARDS MM, 1899, B MUSEUM HIST NATURE, V5, P206; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Ho SYW, 2007, MOL BIOL EVOL, V24, P1416, DOI 10.1093/molbev/msm062; HOPE J H, 1973, Proceedings of the Royal Society of Victoria, V85, P163; JOUANIN C, 1960, P 12 INT ORN C HELS, P363; Jouanin C., 1959, OISEAU REV FRANCAISE, V29, P168; Keogh JS, 2005, EVOLUTION, V59, P226; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; KUMAR S, 2008, MEGA BIOL CENTRIC SO; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Leonard JA, 2005, BIOL LETTERS, V1, P291, DOI 10.1098/rsbl.2005.0323; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; MORGAN A. M., 1928, EMU, V28, P1; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nadeau NJ, 2006, ANIM GENET, V37, P287, DOI 10.1111/j.1365-2052.2006.01442.x; Parker S.A., 1984, Bulletin of the British Ornithologists' Club, V104, P19; PATTERSON C, 1987, Records of the South Australian Museum (Adelaide), V21, P85; Pfennigwerth S, 2010, ARCH NAT HIST, V37, P74, DOI 10.3366/E0260954109001661; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; ROWLEY MJ, 1986, NATURWISSENSCHAFTEN, V73, P620, DOI 10.1007/BF00368777; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Spencer B., 1910, Melbourne Mem Nat Mus, V3; Strachan Rob, 1995, P1; Subramanian S, 2009, TRENDS GENET, V25, P16, DOI 10.1016/j.tig.2008.11.001; Templeton AR, 2008, BIOESSAYS, V30, P470, DOI 10.1002/bies.20745; Wilson S. K., 1988, AUSTRALIAS REPTILES	37	14	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18728	10.1371/journal.pone.0018728	http://dx.doi.org/10.1371/journal.pone.0018728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494561	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100035
J	Ohno, T; Oboki, K; Morita, H; Kajiwara, N; Arae, K; Tanaka, S; Ikeda, M; Iikura, M; Akiyama, T; Inoue, J; Matsumoto, K; Sudo, K; Azuma, M; Okumura, K; Kamradt, T; Saito, H; Nakae, S				Ohno, Tatsukuni; Oboki, Keisuke; Morita, Hideaki; Kajiwara, Naoki; Arae, Ken; Tanaka, Shizuko; Ikeda, Masako; Iikura, Motoyasu; Akiyama, Taishin; Inoue, Jun-ichiro; Matsumoto, Kenji; Sudo, Katsuko; Azuma, Miyuki; Okumura, Ko; Kamradt, Thomas; Saito, Hirohisa; Nakae, Susumu			Paracrine IL-33 Stimulation Enhances Lipopolysaccharide-Mediated Macrophage Activation	PLOS ONE			English	Article							RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN-1 RECEPTOR; CYTOKINE PRODUCTION; MAST-CELLS; T-CELLS; ALLERGIC INFLAMMATION; T1/ST2 EXPRESSION; INDUCED ARTHRITIS; HUMAN BASOPHILS; CUTTING EDGE	Background: IL-33, a member of the IL-1 family of cytokines, provokes Th2-type inflammation accompanied by accumulation of eosinophils through IL-33R, which consists of ST2 and IL-1RAcP. We previously demonstrated that macrophages produce IL-33 in response to LPS. Some immune responses were shown to differ between ST2-deficient mice and soluble ST2-Fc fusion protein-treated mice. Even in anti-ST2 antibody (Ab)-treated mice, the phenotypes differed between distinct Ab clones, because the characterization of such Abs (i.e., depletion, agonistic or blocking Abs) was unclear in some cases. Methodology/Principal Findings: To elucidate the precise role of IL-33, we newly generated neutralizing monoclonal Abs for IL-33. Exogenous IL-33 potentiated LPS-mediated cytokine production by macrophages. That LPS-mediated cytokine production by macrophages was suppressed by inhibition of endogenous IL-33 by the anti-IL-33 neutralizing mAbs. Conclusions/Significance: Our findings suggest that LPS-mediated macrophage activation is accelerated by macrophage-derived paracrine IL-33 stimulation.	[Ohno, Tatsukuni; Oboki, Keisuke; Morita, Hideaki; Kajiwara, Naoki; Arae, Ken; Matsumoto, Kenji; Saito, Hirohisa; Nakae, Susumu] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Ohno, Tatsukuni; Azuma, Miyuki] Tokyo Med & Dent Univ, Dept Mol Immunol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Kajiwara, Naoki; Okumura, Ko; Saito, Hirohisa; Nakae, Susumu] Juntendo Univ, Atopy Res Ctr, Tokyo, Japan; [Tanaka, Shizuko; Ikeda, Masako] Med & Biol Labs Co Ltd, Ina Lab, Tech & Res Dept, Nagano, Japan; [Iikura, Motoyasu] Int Med Ctr Japan, Dept Resp Med, Tokyo, Japan; [Akiyama, Taishin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Frontier Res Initiat, Tokyo, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Lab Syst Biol, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo, Japan; [Kamradt, Thomas] Univ Klinikum Jena, Inst Immunol, Jena, Germany	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Juntendo University; National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical University; Friedrich Schiller University of Jena	Ohno, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan.	snakae@ims.u-tokyo.ac.jp	Kamradt, Thomas/E-9971-2018; Morita, Hideaki/ADL-2008-2022; Azuma, Miyuki/AAT-8928-2021; Oboki, Keisuke/AAR-1813-2020; Morita, Hideaki/S-2214-2016	Azuma, Miyuki/0000-0002-3529-4585; Morita, Hideaki/0000-0003-0928-8322; Kamradt, Thomas/0000-0001-8443-5893; Saito, Hirohisa/0000-0002-6630-8337; Akiyama, Taishin/0000-0002-0341-6154	Japan Chemical Industry Association; Program for Improvement of Research Environment for Young Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [23590475, 22659094, 21390148, 23390262] Funding Source: KAKEN	Japan Chemical Industry Association; Program for Improvement of Research Environment for Young Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Chemical Industry Association, Grants-in-Aid for Young Scientists (B) (T.O., K. Oboki. and S.N.), the Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology (S.N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant from the National Institute of Biomedical Innovation (H.S.). S.T. and M.I., who are the researchers in Medical & Biological Laboratories Co., Ltd., generated the anti-IL-33 mAb in the submitted manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2009, TISSUE ANTIGENS, V73, P206, DOI 10.1111/j.1399-0039.2008.01185.x; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Castano R, 2009, AMJ RHINOL ALLERGY, V23, P377, DOI 10.2500/ajra.2009.23.3303; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; KAWAKAMI T, 2005, NOVART FDN SYMP, V271, P108; Kawakami T., 2005, NOVARTIS FDN S, V271, P145, DOI [10.1002/9780470033449.ch8, DOI 10.1002/9780470033449.CH8]; Kawakami Toshiaki, 2005, Novartis Found Symp, V271, P100; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kuroiwa K, 2000, HYBRIDOMA, V19, P151, DOI 10.1089/02724570050031194; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Leung BP, 2004, J IMMUNOL, V173, P145, DOI 10.4049/jimmunol.173.1.145; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lin HS, 2001, J BIOL CHEM, V276, P20597, DOI 10.1074/jbc.M010095200; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Mangan NE, 2007, EUR J IMMUNOL, V37, P1302, DOI 10.1002/eji.200636520; Matsuda A, 2009, INVEST OPHTH VIS SCI, V50, P4646, DOI 10.1167/iovs.08-3365; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Moritz DR, 1998, HYBRIDOMA, V17, P107, DOI 10.1089/hyb.1998.17.107; Moritz DR, 1998, J IMMUNOL, V161, P4866; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Reijmerink NE, 2008, J ALLERGY CLIN IMMUN, V122, P651, DOI 10.1016/j.jaci.2008.06.030; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Umetsu DT, 2006, NAT REV IMMUNOL, V6, P953, DOI 10.1038/nri1968; Walzl G, 2001, J EXP MED, V193, P785, DOI 10.1084/jem.193.7.785; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	71	45	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18404	10.1371/journal.pone.0018404	http://dx.doi.org/10.1371/journal.pone.0018404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494550	Green Published, Green Submitted, gold			2022-12-25	WOS:000289354100010
J	Santini, S; Claverie, JM; Mouz, N; Rousselle, T; Maza, C; Monchois, V; Abergel, C				Santini, Sebastien; Claverie, Jean-Michel; Mouz, Nicolas; Rousselle, Tristan; Maza, Caroline; Monchois, Vincent; Abergel, Chantal			The Conserved Candida albicans CA3427 Gene Product Defines a New Family of Proteins Exhibiting the Generic Periplasmic Binding Protein Structural Fold	PLOS ONE			English	Article							FUNGAL-INFECTIONS; VENUS-FLYTRAP; WEB SERVER; EPIDEMIOLOGY; DIFFRACTION; DATABASE	Nosocomial diseases due to Candida albicans infections are in constant rise in hospitals, where they cause serious complications to already fragile intensive care patients. Antifungal drug resistance is fast becoming a serious issue due to the emergence of strains resistant to currently available antifungal agents. Thus the urgency to identify new potential protein targets, the function and structure of which may guide the development of new antifungal drugs. In this context, we initiated a comparative genomics study in search of promising protein coding genes among the most conserved ones in reference fungal genomes. The CA3427 gene was selected on the basis of its presence among pathogenic fungi contrasting with its absence in the non pathogenic Saccharomyces cerevisiae. We report the crystal 3D-structure of the Candida albicans CA3427 protein at 2.1 angstrom resolution. The combined analysis of its sequence and structure reveals a structural fold originally associated with periplasmic binding proteins. The CA3427 structure highlights a binding site located between the two protein domains, corresponding to a sequence segment conserved among fungi. Two crystal forms of CA3427 were found, suggesting that the presence or absence of a ligand at the proposed binding site might trigger a "Venus flytrap'' motion, coupled to the previously described activity of bacterial periplasmic binding proteins. The conserved binding site defines a new subfamily of periplasmic binding proteins also found in many bacteria of the bacteroidetes division, in a choanoflagellate (a free-living unicellular and colonial flagellate eukaryote) and in a placozoan (the closest multicellular relative of animals). A phylogenetic analysis suggests that this gene family originated in bacteria before its horizontal transfer to an ancestral eukaryote prior to the radiation of fungi. It was then lost by the Saccharomycetales which include Saccharomyces cerevisiae.	[Santini, Sebastien; Claverie, Jean-Michel; Maza, Caroline; Abergel, Chantal] Aix Marseille Univ, CNRS UPR2589, Mediterranean Inst Microbiol, Marseille, France; [Mouz, Nicolas; Rousselle, Tristan; Monchois, Vincent] PXTherapeut, Grenoble, France	UDICE-French Research Universities; Aix-Marseille Universite	Santini, S (corresponding author), Aix Marseille Univ, CNRS UPR2589, Mediterranean Inst Microbiol, Parc Sci Luminy, Marseille, France.	chantal.abergel@igs.cnrs-mrs.fr	Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; Abergel, Chantal/0000-0003-1875-4049; Santini, Sebastien/0000-0001-7087-1950	French ministry of research and education; Centre National de la Recherche Scientifique (CNRS)	French ministry of research and education; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	The PROFUN project was supported by a grant from the French ministry of research and education and by Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALEGADO RA, J BACTERIOL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BODEY G, 1992, EUR J CLIN MICROBIOL, V11, P99, DOI 10.1007/BF01967060; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Chen PE, 2006, BRIT J PHARMACOL, V147, P839, DOI 10.1038/sj.bjp.0706689; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felder CB, 1999, AAPS PHARMSCI, V1; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 1998, CURR OPIN STRUC BIOL, V8, P372, DOI 10.1016/S0959-440X(98)80072-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, PROTEIN CRYSTALLOGRA, V26; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; MAO B, 1982, J BIOL CHEM, V257, P1131; OH BH, 1994, J BIOL CHEM, V269, P4135; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1592, DOI 10.1128/JCM.02445-09; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Santini S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-33; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vanden Bossche H, 1998, MED MYCOL, V36, P119; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; PROFUN PROJECT	39	1	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18528	10.1371/journal.pone.0018528	http://dx.doi.org/10.1371/journal.pone.0018528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494601	gold, Green Submitted, Green Published			2022-12-25	WOS:000289354100017
J	Bernabe-Ortiz, A; Carcamo, CP; Sanchez, JF; Rios, J				Bernabe-Ortiz, Antonio; Carcamo, Cesar P.; Sanchez, Juan F.; Rios, Julia			Weight Variation over Time and Its Association with Tuberculosis Treatment Outcome: A Longitudinal Analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; COURSE CHEMOTHERAPY PROGRAMS; PULMONARY TUBERCULOSIS; TREATMENT FAILURE; NUTRITIONAL-STATUS; IDENTIFY PATIENTS; HIV-INFECTION; RISK-FACTOR; GAIN; PERU	Objective: Weight variation during therapy has been described as a useful marker to predict TB treatment outcome. No previous study has used longitudinal analysis to corroborate this finding. The goal of this study was to evaluate change and trends of patients' bodyweight over time depending on TB treatment outcome. Methods and Findings: A retrospective cohort study with all TB cases diagnosed from 2000 to 2006 was carried out. Information from 5 public tuberculosis treatment facilities at Pampas de San Juan de Miraflores, Lima, Peru was analyzed. Poor outcome was defined as failure or death during TB therapy, and compared to good outcome defined as cured. Longitudinal analysis with a pre-specified marginal model was fitted using Generalized Estimating Equations to compare weight trends for patients with good and poor outcome adjusting for potential confounders. A total of 460 patients (55.4% males, mean age: 31.6 years) were included in the analysis: 42 (9.1%) had a poor outcome (17 failed and 25 died). Weight at baseline was not different comparing outcome groups (p = 0.17). After adjusting for age, gender, type of TB, scheme of treatment, HIV status and sputum variation during follow-up, after the first month of treatment, patients with good outcome gained, on average, almost 1 kg compared to their baseline weight (p < 0.001), whereas those with poor outcome lost 1 kg (p = 0.003). Similarly, after 4 months, a patient with good outcome increased 3 kg on average (p < 0.001), while those with poor outcome only gained 0.2 kg (p = 0.02). Conclusions: Weight variation during tuberculosis therapy follow-up can predict treatment outcome. Patients losing weight during TB treatment, especially in the first month, should be more closely followed as they are at risk of failure or death.	[Bernabe-Ortiz, Antonio; Carcamo, Cesar P.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol Unit, Lima, Peru; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Ctr Excellence Chron Dis, CRONICAS, Lima, Peru; [Sanchez, Juan F.] US Naval Med Res Unit 6, Dept Parasitol, Lima, Peru; [Rios, Julia] DISA II, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol Unit, Lima, Peru.	antonio.bernabe@upch.pe		Bernabe-Ortiz, Antonio/0000-0002-6834-1376				Asencios Luis, 2009, Rev. perú. med. exp. salud publica, V26, P278; Balding DJ, 2004, APPL LONGITUDINAL AN; Baldwin MR, 2004, INT J TUBERC LUNG D, V8, P1484; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P108; Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI /S0716-10182008000300002; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Gillespie SH, 1998, INT J TUBERC LUNG D, V2, P522; Gupta R, 2000, INT J TUBERC LUNG D, V4, P1089; Hardin J., 2003, GEN ESTIMATING EQUAT; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kennedy N, 1996, T ROY SOC TROP MED H, V90, P162, DOI 10.1016/S0035-9203(96)90123-6; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Krapp F, 2008, INT J TUBERC LUNG D, V12, P1153; Ministerio de Salud, 2006, ESTR SAN NAC PREV CO; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Pachas AMC, 2004, INT J TUBERC LUNG D, V8, P52; Salaniponi FML, 1999, INT J TUBERC LUNG D, V3, P1047; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Schwenk A, 2004, AM J CLIN NUTR, V79, P1006; Schwenk A, 2000, Curr Opin Clin Nutr Metab Care, V3, P285, DOI 10.1097/00075197-200007000-00008; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721; Swaminathan S, 2008, CLIN INFECT DIS, V46, P946, DOI 10.1086/528860; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Vasantha M, 2009, Indian J Tuberc, V56, P5; Warmelink I, 2011, BRIT J NUTR, V105, P400, DOI 10.1017/S0007114510003636; World Health Organization, 2010, GLOB TUB CONTR; Yew WW, 2006, AM J RESP CRIT CARE, V174, P236, DOI 10.1164/rccm.200605-669ED; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; Zhao FZ, 1997, INT J TUBERC LUNG D, V1, P570	30	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18474	10.1371/journal.pone.0018474	http://dx.doi.org/10.1371/journal.pone.0018474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494617	Green Submitted, Green Published, gold			2022-12-25	WOS:000289292800021
J	Zhang, ZP; Wang, YL; Wang, SH; Liu, JT; Warren, W; Mitreva, M; Walter, RB				Zhang, Ziping; Wang, Yilei; Wang, Shuhong; Liu, Jingtao; Warren, Wesley; Mitreva, Makedonka; Walter, Ronald B.			Transcriptome Analysis of Female and Male Xiphophorus maculatus Jp 163 A	PLOS ONE			English	Article							SEX DETERMINATION; DIFFERENTIAL DISPLAY; GENE-EXPRESSION; VITELLOGENIN GENE; RAINBOW-TROUT; EVOLUTION; PROTEIN; GENOME; FISH; SRY	Background: Xiphophorus models are important for melanoma, sex determination and differentiation, ovoviviparity and evolution. To gain a global view of the molecular mechanism(s) whereby gene expression may influence sexual dimorphism in Xiphophorus and to develop a database for future studies, we performed a large-scale transcriptome study. Methodology/Principal Findings: The 454-FLX massively parallel DNA sequencing platform was employed to obtain 742,771 and 721,543 reads from 2 normalized cDNA libraries generated from whole adult female and male X. maculatus Jp 163 A, respectively. The reads assembled into 45,538 contigs (here, a "contig" is a set of contiguous sequences), of which, 11,918 shared homology to existing protein sequences. These numbers estimate that the contigs may cover 53% of the total number of Xiphophorus transcriptome. Putative translations were obtained for 11,918 cDNA contigs, of which, 3,049 amino acid sequences contain Pfam domains and 11,064 contigs encode secretory proteins. A total of 3,898 contigs were associated with 2,781 InterPro (IPR) entries and 5,411 contigs with 132 KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways. There were 10,446 contigs annotated with 69,778 gene ontology (GO) terms and the three corresponding organizing principles. Fifty-four potential sex differentially expressed genes have been identified from these contigs. Eight and nine of these contigs were confirmed by real-time PCR as female and male predominantly expressed genes respectively. Based on annotation results, 34 contigs were predicted to be differentially expressed in male and female and 17 of them were also confirmed by real-time PCR. Conclusions/Significance: This is the first report of an annotated overview of the transcriptome of X. maculatus and identification of sex differentially expressed genes. These data will be of interest to researchers using the Xiphophorus model. This work also provides an archive for future studies in molecular mechanisms of sexual dimorphism and evolution, and can be used in comparative studies of other fish.	[Zhang, Ziping; Liu, Jingtao; Walter, Ronald B.] Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA; [Wang, Yilei; Wang, Shuhong] Jimei Univ, Fujian Prov Univ, Key Lab Sci & Technol Aquaculture & Food Safety, Fisheries Biotechnol Inst,Fisheries Coll, Xiamen, Peoples R China; [Warren, Wesley; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA	Texas State University System; Texas State University San Marcos; Fuzhou University; Jimei University; Washington University (WUSTL)	Zhang, ZP (corresponding author), Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA.	RWalter@txstate.edu	Zhang, Ziping/AAH-2392-2021; Walter, Ronald/AAI-5522-2020	Zhang, Ziping/0000-0003-2802-1586; Mitreva, Makedonka/0000-0001-9572-3436	NIH, National Center for Research Resources [R24-RR024790]; National Cancer Institute [R15CA147871]; NATIONAL CANCER INSTITUTE [R15CA147871] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR024790] Funding Source: NIH RePORTER	NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH, National Center for Research Resources (R24-RR024790), National Cancer Institute (R15CA147871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2005, NATURE, V435, P134, DOI 10.1038/435134a; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BIDWELL CA, 1995, J MOL EVOL, V41, P104, DOI 10.1007/BF00174046; Boswell MG, 2009, COMP BIOCHEM PHYS C, V149, P258, DOI 10.1016/j.cbpc.2008.11.005; Brawand D, 2008, PLOS BIOL, V6, P507, DOI 10.1371/journal.pbio.0060063; Breyne P, 2003, MOL GENET GENOMICS, V269, P173, DOI 10.1007/s00438-003-0830-6; CHEN TT, 1983, CAN J BIOCHEM CELL B, V61, P802, DOI 10.1139/o83-102; CHENCHIK A, 1998, GENE CLONING ANAL RT, P305; Chiriva-Internati M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-61; DEBOUCK C, 1995, CURR OPIN BIOTECH, V6, P597, DOI 10.1016/0958-1669(95)80098-0; Deng XN, 2000, J ANDROL, V21, P822; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; KALLMAN KD, 1983, COPEIA, P755; KALLMAN KD, 1984, NEW LOOK SEX DETERMI, P95; KAZIANIS S, 2005, SEX DETERMINATION PL, P381; King V, 2007, GENETICS, V175, P1855, DOI 10.1534/genetics.106.066779; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Macgregor PF, 2002, CLIN CHEM, V48, P1170; MCCLELLAND M, 1995, TRENDS GENET, V11, P242, DOI 10.1016/S0168-9525(00)89058-7; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Miracle A, 2006, ECOTOX ENVIRON SAFE, V63, P337, DOI 10.1016/j.ecoenv.2005.12.002; Mouchel N, 1997, GENE, V197, P147, DOI 10.1016/S0378-1119(97)00253-9; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Richardson RT, 2001, GENE, V274, P67, DOI 10.1016/S0378-1119(01)00605-9; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sawaguchi S, 2006, MOL REPROD DEV, V73, P719, DOI 10.1002/mrd.20446; Schartl M, 2004, MECH DEVELOP, V121, P639, DOI 10.1016/j.mod.2004.03.001; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; STEVANOVIC M, 1993, HUM MOL GENET, V2, P2013, DOI 10.1093/hmg/2.12.2013; Trichet V, 2000, MOL GEN GENET, V263, P828, DOI 10.1007/s004380000247; Volff JN, 2007, SEX DEV, V1, P85, DOI 10.1159/000100030; Volff JN, 2001, GENETICA, V111, P101, DOI 10.1023/A:1013795415808; Walter R B, 2001, ILAR J, V42, P299; WALTER RB, 2006, XIPHOPHORUS GENETIC, P1; Wang H, 2000, GENE, V256, P303, DOI 10.1016/S0378-1119(00)00376-0; Zarkower D, 2001, NAT REV GENET, V2, P175, DOI 10.1038/35056032; Zhang ZP, 2007, COMP BIOCHEM PHYS B, V147, P466, DOI 10.1016/j.cbpb.2007.02.013; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	46	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18379	10.1371/journal.pone.0018379	http://dx.doi.org/10.1371/journal.pone.0018379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483681	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000289191300019
J	de Boer, MGJ; Jolink, H; Halkes, CJM; van der Heiden, PLJ; Kremer, D; Falkenburg, JHF; van de Vosse, E; van Dissel, JT				de Boer, Mark G. J.; Jolink, Hetty; Halkes, Constantijn J. M.; van der Heiden, Pim L. J.; Kremer, Dennis; Falkenburg, J. H. Frederik; van de Vosse, Esther; van Dissel, Jaap T.			Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PULMONARY ASPERGILLOSIS; RISK-FACTORS; FUNGAL-INFECTIONS; MYELOID-LEUKEMIA; GAMMA GENE; FUMIGATUS; INTERLEUKIN-10; TUBERCULOSIS; RECIPIENTS	The innate immune system plays a pivotal role in the primary defence against invasive fungal infection. Genetic variation in genes that regulate this response, initiated by pulmonary macrophages, may influence susceptibility to invasive aspergillosis in patients at risk. We investigated in a clinical setting whether common polymorphisms in Toll-like receptor (TLR) and cytokine genes involved in macrophage regulation are associated with susceptibility to invasive aspergillosis. Forty-four allogeneic stem cell transplantation recipients diagnosed with probable or proven IA according to the criteria of the European Organization for Research and Treatment of Cancer/Mycoses Study Group, were enrolled. The control group consisted of 64 allogeneic stem cell transplantation recipients without invasive aspergillosis. The TLR4 1063A>G single nucleotide polymorphism was associated with invasive aspergillosis when present in donors of allogeneic stem cell transplantation recipients (unadjusted OR 3.77 95% CI 1.08-13.2, p=0.03). In a multivariate analysis, adjusted for occurrence of graft-versus-host-disease, Cytomegalovirus serostatus and duration of neutropenia, paired presence of the TLR4 1063A>G and IFNG 874T>A single nucleotide polymorphisms showed a trend towards increased susceptibility to invasive aspergillosis (p=0.04). These findings point to the relevant immunological pathway involved in resistance to invasive aspergillosis and warrant further study of the effects of TLR and cytokine polymorphisms and their interaction, which may occur on different levels of the complex biological interplay between the immunocompromised host and Aspergillus sp.	[de Boer, Mark G. J.; Jolink, Hetty; van de Vosse, Esther; van Dissel, Jaap T.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Jolink, Hetty; Halkes, Constantijn J. M.; van der Heiden, Pim L. J.; Falkenburg, J. H. Frederik] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Kremer, Dennis] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Boer, MGJ (corresponding author), Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands.	M.G.J.de_Boer@lumc.nl	van de Vosse, Esther/HDO-0723-2022; de Boer, mark/AGE-5167-2022; van de Vosse, Esther/B-7285-2009	de Boer, mark/0000-0002-5009-6499; van de Vosse, Esther/0000-0001-5199-3426				ABDI J, 2011, CRIT REV ONCOL HEMAT; Avery Robin K, 2009, Curr Infect Dis Rep, V11, P223, DOI 10.1007/s11908-009-0033-3; Bjorklund A, 2007, BONE MARROW TRANSPL, V40, P1055, DOI 10.1038/sj.bmt.1705856; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Brieland JK, 2001, INFECT IMMUN, V69, P1554, DOI 10.1128/IAI.69.3.1554-1560.2001; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Cenci E, 1998, J INFECT DIS, V178, P1750, DOI 10.1086/314493; Chai LYA, 2009, MED MYCOL, V47, P227, DOI 10.1080/13693780802209082; Chai LYA, 2009, INFECT IMMUN, V77, P2184, DOI 10.1128/IAI.01455-08; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dickinson AM, 2010, HAEMATOL-HEMATOL J, V95, P922, DOI 10.3324/haematol.2009.016220; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Lasker MV, 2006, J IMMUNOL, V177, P11, DOI 10.4049/jimmunol.177.1.11; Liang XY, 2009, BRIT J HAEMATOL, V146, P418, DOI 10.1111/j.1365-2141.2009.07790.x; Luther K, 2008, MICROBES INFECT, V10, P175, DOI 10.1016/j.micinf.2007.11.001; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Netea MG, 2004, EUR J CLIN MICROBIOL, V23, P672, DOI 10.1007/s10096-004-1192-7; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Nieters A, 2006, GENES IMMUN, V7, P615, DOI 10.1038/sj.gene.6364337; Pagano L, 2010, HAEMATOL-HEMATOL J, V95, P644, DOI 10.3324/haematol.2009.012054; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Sainz J, 2007, IMMUNOL LETT, V109, P76, DOI 10.1016/j.imlet.2007.01.005; Seo KW, 2005, BONE MARROW TRANSPL, V36, P1089, DOI 10.1038/sj.bmt.1705181; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863	36	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18403	10.1371/journal.pone.0018403	http://dx.doi.org/10.1371/journal.pone.0018403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483748	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058700025
J	Arnold, L; Tyagi, RK; Meija, P; Swetman, C; Gleeson, J; Perignon, JL; Druilhe, P				Arnold, Ludovic; Tyagi, Rajeev Kumar; Meija, Pedro; Swetman, Claire; Gleeson, James; Perignon, Jean-Louis; Druilhe, Pierre			Further Improvements of the P. falciparum Humanized Mouse Model	PLOS ONE			English	Article							ACUTE LUNG INJURY; RED-BLOOD-CELLS; IN-VIVO MODEL; PLASMODIUM-FALCIPARUM; HUMAN MALARIA; MURINE MODEL; IMMUNOCOMPROMISED MICE; CYTOKINE PRODUCTION; INNATE IMMUNITY; AOTUS MONKEYS	Background: It has been shown previously that it is possible to obtain growth of Plasmodium falciparum in human erythrocytes grafted in mice lacking adaptive immune responses by controlling, to a certain extent, innate defences with liposomes containing clodronate (clo-lip). However, the reproducibility of those models is limited, with only a proportion of animals supporting longstanding parasitemia, due to strong inflammation induced by P. falciparum. Optimisation of the model is much needed for the study of new anti-malarial drugs, drug combinations, and candidate vaccines. Materials/Methods: We investigated the possibility of improving previous models by employing the intravenous route (IV) for delivery of both human erythrocytes (huRBC) and P. falciparum, instead of the intraperitoneal route (IP), by testing various immunosuppressive drugs that might help to control innate mouse defences, and by exploring the potential benefits of using immunodeficient mice with additional genetic defects, such as those with IL-2R gamma deficiency (NSG mice). Results: We demonstrate here the role of aging, of inosine and of the IL-2 receptor gamma mutation in controlling P. falciparum induced inflammation. IV delivery of huRBC and P. falciparum in clo-lip treated NSG mice led to successful infection in 100% of inoculated mice, rapid rise of parasitemia to high levels (up to 40%), long-lasting parasitemia, and consistent results from mouse-to-mouse. Characteristics were closer to human infection than in previous models, with evidence of synchronisation, partial sequestration, and receptivity to various P. falciparum strains without preliminary adaptation. However, results show that a major IL-12p70 inflammatory response remains prevalent. Conclusion: The combination of the NSG mouse, clodronate loaded liposomes, and IV delivery of huRBC has produced a reliable and more relevant model that better meets the needs of Malaria research.	[Arnold, Ludovic; Tyagi, Rajeev Kumar; Meija, Pedro; Swetman, Claire; Gleeson, James; Perignon, Jean-Louis; Druilhe, Pierre] Inst Pasteur, Malaria Vaccine Dev Lab, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Arnold, L (corresponding author), Univ Paris 06, INSERM, Fac Med, UMR S 945, Paris, France.	druilhe@pasteur.fr	arnold, ludovic/ABI-1244-2020		French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was funded, in part, by a grant from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Arnold L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-197; BADELL E, 1995, PARASITOL TODAY, V11, P235, DOI 10.1016/0169-4758(95)80088-3; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; BARANKIEWICZ J, 1985, EUR J IMMUNOL, V15, P627, DOI 10.1002/eji.1830150618; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; BRUCE-CHWATT L. J., 1963, W AFRICAN MED JOUR, V12, P199; Chelvarajan RL, 2006, J LEUKOCYTE BIOL, V79, P1314, DOI 10.1189/jlb.0106024; Chelvarajan RL, 2005, J LEUKOCYTE BIOL, V77, P503, DOI 10.1189/jlb.0804449; Collins WE, 1997, J PARASITOL, V83, P1174, DOI 10.2307/3284381; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Druilhe P, 2002, TRENDS MICROBIOL, V10, pS38, DOI 10.1016/S0966-842X(02)02437-X; Druilhe P, 2007, CURR OPIN MICROBIOL, V10, P371, DOI 10.1016/j.mib.2007.07.009; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Hasko G, 1998, EUR J PHARMACOL, V358, P261, DOI 10.1016/S0014-2999(98)00619-0; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; INAMIZU T, 1985, IMMUNOLOGY, V55, P447; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; King M, 2007, ANN NY ACAD SCI, V1103, P90, DOI 10.1196/annals.1394.011; Liaudet L, 2002, ANN SURG, V235, P568, DOI 10.1097/00000658-200204000-00016; Liaudet L, 2001, AM J RESP CRIT CARE, V164, P1213, DOI 10.1164/ajrccm.164.7.2101013; Mabley JG, 2003, AM J PHYSIOL-GASTR L, V284, pG138, DOI 10.1152/ajpgi.00060.2002; Mabley JG, 2009, SHOCK, V32, P258, DOI 10.1097/SHK.0b013e31819c3414; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marton A, 2001, INT J MOL MED, V8, P617; Moreno A, 2006, INT J PARASITOL, V36, P361, DOI 10.1016/j.ijpara.2005.10.012; Moreno A, 2001, ANTIMICROB AGENTS CH, V45, P1847, DOI 10.1128/AAC.45.6.1847-1853.2001; Morosan S, 2006, J INFECT DIS, V193, P996, DOI 10.1086/500840; Nomellini Vanessa, 2008, V15, P188, DOI 10.1159/000136358; Obaldia N, 2009, AM J TROP MED HYG, V81, P587, DOI 10.4269/ajtmh.2009.08-0445; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; PUKRITTAYAKAMEE S, 1992, T ROY SOC TROP MED H, V86, P598, DOI 10.1016/0035-9203(92)90143-Z; PYE D, 1994, J PARASITOL, V80, P558, DOI 10.2307/3283191; ROWE AW, 1968, CRYOBIOLOGY, V5, P119, DOI 10.1016/S0011-2240(68)80154-3; SCHRIER DJ, 1990, J IMMUNOL, V145, P1874; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Shanks GD, 2006, J POSTGRAD MED, V52, P277; SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; VANROOIJEN N, 1992, RES IMMUNOL, V143, P215; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; WAYMACK JP, 1987, ARCH SURG-CHICAGO, V122, P56; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHITE NJ, 2008, HARRISONS PRINCIPLES	53	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18045	10.1371/journal.pone.0018045	http://dx.doi.org/10.1371/journal.pone.0018045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483851	gold, Green Submitted, Green Published			2022-12-25	WOS:000289057200022
J	Chiu, YHC; Ong, J; Walker, S; Kumalawati, J; Gartinah, T; McPhee, DA; Dax, EM				Chiu, Yu-Ho C.; Ong, Joanna; Walker, Sandy; Kumalawati, July; Gartinah, Tintin; McPhee, Dale A.; Dax, Elizabeth M.			Photographed Rapid HIV Test Results Pilot Novel Quality Assessment and Training Schemes	PLOS ONE			English	Article							ASSAYS; SETTINGS	HIV rapid diagnostic tests (RDTs) are now used widely in non-laboratory settings by non-laboratory-trained operators. Quality assurance programmes are essential in ensuring the quality of HIV RDT outcomes. However, there is no cost-effective means of supplying the many operators of RDTs with suitable quality assurance schemes. Therefore, it was examined whether photograph-based RDT results could be used and correctly interpreted in the non-laboratory setting. Further it was investigated if a single training session improved the interpretation skills of RDT operators. The photographs were interpreted, a 10-minute tutorial given and then a second interpretation session was held. It was established that the results could be read with accuracy. The participants (n = 75) with a range of skills interpreted results (> 80% concordance with reference results) from a panel of 10 samples (three negative and seven positive) using four RDTs. Differences in accuracy of interpretation before and after the tutorial were marked in some cases. Training was more effective for improving the accurate interpretation of more complex results, e. g. results with faint test lines or for multiple test lines, and especially for improving interpretation skills of inexperienced participants. It was demonstrated that interpretation of RDTs was improved using photographed results allied to a 10-minute training session. It is anticipated that this method could be used for training but also for quality assessment of RDT operators without access to conventional quality assurance or training schemes requiring wet samples.	[Chiu, Yu-Ho C.; Ong, Joanna; Walker, Sandy; McPhee, Dale A.; Dax, Elizabeth M.] St Vincents Inst, NRL, Melbourne, Vic, Australia; [Kumalawati, July] Univ Indonesia, Dept Clin Pathol, Fac Med, Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Gartinah, Tintin] W Java Hlth Off, W Java Prov Hlth Lab, Bandung, Indonesia; [McPhee, Dale A.; Dax, Elizabeth M.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	St. Vincent's Institute of Medical Research; University of Indonesia; University of Melbourne	Chiu, YHC (corresponding author), St Vincents Inst, NRL, Melbourne, Vic, Australia.	liz@nrl.gov.au	McPhee, Dale A/D-1825-2011	Chiu, Yu Ho Chris/0000-0002-5380-1114	AusAID	AusAID(Australian Aid (AusAID))	HIV Consortium for Partnerships in Asia and the Pacific funded by AusAID supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; Bowles KE, 2008, PUBLIC HEALTH REP, V123, P78, DOI 10.1177/00333549081230S310; Chappel RJ, 2009, FUTURE MICROBIOL, V4, P963, DOI 10.2217/FMB.09.77; Everett DB, 2009, J CLIN MICROBIOL, V47, P1058, DOI 10.1128/JCM.01998-08; Ferreira Junior Orlando C, 2005, AIDS, V19 Suppl 4, pS70, DOI 10.1097/01.aids.0000191494.51489.75; Huebner DM, 2010, AIDS BEHAV, V14, P688, DOI 10.1007/s10461-008-9442-9; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; Pai NP, 2008, PLOS MED, V5, P768, DOI 10.1371/journal.pmed.0050092; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Respess RA, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200104003-00007; Tao GY, 1999, J ACQ IMMUN DEF SYND, V22, P395; *WHO, 2003, GUID APPR EV HIV TES; *WHO, 2009, HIV ASS OP CHAR RAP	15	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18294	10.1371/journal.pone.0018294	http://dx.doi.org/10.1371/journal.pone.0018294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483842	Green Published, gold			2022-12-25	WOS:000289057200052
J	Lv, L; Pan, K; Li, XD; She, KL; Zhao, JJ; Wang, W; Chen, JG; Chen, YB; Yun, JP; Xia, JC				Lv, Lin; Pan, Ke; Li, Xiao-dong; She, Ke-lin; Zhao, Jing-jing; Wang, Wei; Chen, Ju-gao; Chen, Yi-bin; Yun, Jing-ping; Xia, Jian-chuan			The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							DELTA T-CELLS; TH17 CELLS; IL-17-PRODUCING CELLS; OVARIAN-CANCER; IMMUNITY; GROWTH; METASTASIS; EXPRESSION; SURVIVAL; PROTUMOR	Background: The role of IL-17 producing cells in tumors is controversial. In the present study, we investigated the prognostic value of measuring tumor-infiltrating IL-17 producing cell levels in human esophageal squamous cell carcinoma (ESCC). Methodology/Principal Findings: Immunohistochemical staining was performed to investigate the levels of IL-17+ tumor infiltrating lymphocytes (TILs), as well as CD8+ cytotoxic T lymphocytes (CTLs) and CD57+ natural killer (NK) cells from 181 ESCC patients. The prognostic value of measuring the densities of IL-17+ TILs and the correlation with CTLs and NK was evaluated. IL-17 producing cells were detected in esophageal squamous cell carcinoma tissues. The IL-17 producing cells were major CD4 positive, but Foxp3 negative. The median level of IL-17+ TILs was 3.90 cells/high power microscopic field (HPF). The density of IL-17 producing cells correlated negatively with T stage (P = 0.042). The higher densities of tumor infiltrating IL-17+ lymphocytes were associated with better overall survival (P = 0.031). Furthermore, we found that there were positive correlations between levels of IL-17 producing cells and the densities of CD8+ cells, as well as CD57+ cells (r = 0.198, P = 0.008 for CD8+ cells and r = 0.261, P, 0.001 for CD57+ cells, respectively). The prognosis analysis also showed that the higher levels of CD8+ CTLs and CD57+ NK cells correlated with better overall survival of ESCC patients. Conclusions: Our study suggests that tumor infiltrating IL-17 producing cells in ESCC patients may have protective roles in the tumor microenvironment and may be treated as a prognostic marker for ESCC patients.	[Lv, Lin; Pan, Ke; Li, Xiao-dong; She, Ke-lin; Zhao, Jing-jing; Wang, Wei; Chen, Ju-gao; Chen, Yi-bin; Yun, Jing-ping; Xia, Jian-chuan] Sun Yat Sen Univ, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Lin; Pan, Ke; Li, Xiao-dong; She, Ke-lin; Zhao, Jing-jing; Wang, Wei; Chen, Ju-gao; Chen, Yi-bin; Yun, Jing-ping; Xia, Jian-chuan] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiao-dong; She, Ke-lin] Sun Yat Sen Univ, Dept Thorac Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Jing-ping] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lv, L (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	yunjp@mail.sysu.edu.cn; xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [u0772002, 30700985, 30973398]; Guangdong Natural Science Foundation [925100890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (u0772002, 30700985, 30973398) and Guangdong Natural Science Foundation (925100890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Cho Y, 2003, CANCER RES, V63, P1555; Couzin J, 2006, SCIENCE, V313, P1868; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong GF, 2003, CHINESE MED J-PEKING, V116, P543; Dunn Gavin P, 2007, Cancer Immun, V7, P12; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Hsia Jiun-Yi, 2005, Chang Gung Med J, V28, P335; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P735, DOI 10.1006/bbrc.2001.4618; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; LEE JJ, 2010, HEAD NECK; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; LIU J, 2010, PATHOL RES PRACT; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; O'Brien RL, 2009, INVEST OPHTH VIS SCI, V50, P3266, DOI 10.1167/iovs.08-2982; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Oukka M, 2008, ANN RHEUM DIS, V67, P26, DOI 10.1136/ard.2008.098004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Simonian PL, 2009, TRANSL RES, V154, P222, DOI 10.1016/j.trsl.2009.08.006; Taghavi N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-138; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Traves SL, 2008, CURR MOL MED, V8, P416, DOI 10.2174/156652408785160998; Xue L, 2010, DIS ESOPHAGUS, V23, P340, DOI 10.1111/j.1442-2050.2009.01013.x; Yamada Hisakata, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P249; Yoshioka T, 2008, BRIT J CANCER, V98, P1258, DOI 10.1038/sj.bjc.6604294; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	40	89	95	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18219	10.1371/journal.pone.0018219	http://dx.doi.org/10.1371/journal.pone.0018219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483813	Green Submitted, gold, Green Published			2022-12-25	WOS:000289057200044
J	Mihic, A; Chauhan, VS; Gao, XD; Oudit, GY; Tsushima, RG				Mihic, Anton; Chauhan, Vijay S.; Gao, Xiaodong; Oudit, Gavin Y.; Tsushima, Robert G.			Trafficking Defect and Proteasomal Degradation Contribute to the Phenotype of a Novel KCNH2 Long QT Syndrome Mutation	PLOS ONE			English	Article							HERG POTASSIUM CHANNEL; C-TERMINUS; PHARMACOLOGICAL RESCUE; MUTANT CHANNELS; K+ CHANNEL; WILD-TYPE; PROTEIN TRAFFICKING; EXTRACELLULAR K+; GENE HERG; I-KR	The Kv11.1 (hERG) K+ channel plays a fundamental role in cardiac repolarization. Missense mutations in KCNH2, the gene encoding Kv11.1, cause long QT syndrome (LQTS) and frequently cause channel trafficking-deficiencies. This study characterized the properties of a novel KCNH2 mutation discovered in a LQT2 patient resuscitated from a ventricular fibrillation arrest. Proband genotyping was performed by SSCP and DNA sequencing. The electrophysiological and biochemical properties of the mutant channel were investigated after expression in HEK293 cells. The proband manifested a QTc of 554 ms prior to electrolyte normalization. Mutation analysis revealed an autosomal dominant frameshift mutation at proline 1086 (P1086fs+32X; 3256InsG). Co-immunoprecipitation demonstrated that wild-type Kv11.1 and mutant channels coassemble. Western blot showed that the mutation did not produce mature complex-glycosylated Kv11.1 channels and coexpression resulted in reduced channel maturation. Electrophysiological recordings revealed mutant channel peak currents to be similar to untransfected cells. Co-expression of channels in a 1: 1 ratio demonstrated dominant negative suppression of peak Kv11.1 currents. Immunocytochemistry confirmed that mutant channels were not present at the plasma membrane. Mutant channel trafficking rescue was attempted by incubation at reduced temperature or with the pharmacological agents E-4031. These treatments did not significantly increase peak mutant currents or induce the formation of mature complex-glycosylated channels. The proteasomal inhibitor lactacystin increased the protein levels of the mutant channels demonstrating proteasomal degradation, but failed to induce mutant Kv11.1 protein trafficking. Our study demonstrates a novel dominant-negative Kv11.1 mutation, which results in degraded non-functional channels leading to a LQT2 phenotype.	[Mihic, Anton] Univ Toronto, Dept Med, Toronto, ON, Canada; [Mihic, Anton] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Chauhan, Vijay S.] Univ Hlth Network, Div Cardiol, Toronto, ON, Canada; [Oudit, Gavin Y.] Univ Alberta, Dept Med, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Oudit, Gavin Y.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Gao, Xiaodong; Tsushima, Robert G.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta; University of Alberta; York University - Canada	Mihic, A (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	gavin.oudit@ualberta.ca; tsushima@yorku.ca	Chauhan, Vijay/AAA-9872-2020		Heart and Stroke/Richard Lewar Centre of Excellence at the University of Toronto; Heart and Stroke Foundation of Ontario [T5903]; Canadian Institutes of Health Research [86602]; Alberta Heritage Foundation for Medical Research	Heart and Stroke/Richard Lewar Centre of Excellence at the University of Toronto; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	AM received a studentship from the Heart and Stroke/Richard Lewar Centre of Excellence at the University of Toronto. VSC is a Clinician Scientist Scholar of the Heart and Stroke Foundation of Ontario. GYO is a Clinician-Investigator Scholar of the Alberta Heritage Medical Research Foundation and RGT is a Career Investigator of the Heart and Stroke Foundation of Ontario. This work was supported by grants from the Heart and Stroke Foundation of Ontario T5903 to RGT) and the Canadian Institutes of Health Research (Grant 86602 to GYO). This work was also supported by a grant to GYO from the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Chapman H, 2005, J CELL SCI, V118, P5325, DOI 10.1242/jcs.02635; Chen MX, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-93; Christe G, 2008, HEART RHYTHM, V5, P1577, DOI 10.1016/j.hrthm.2008.08.031; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gong QM, 2004, J MOL CELL CARDIOL, V37, P1225, DOI 10.1016/j.yjmcc.2004.10.002; Gong QM, 2004, AM J PHYSIOL-HEART C, V287, pH652, DOI 10.1152/ajpheart.00052.2004; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; Kapa S, 2009, CIRCULATION, V120, P1752, DOI 10.1161/CIRCULATIONAHA.109.863076; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Marr N, 2002, HUM MOL GENET, V11, P779, DOI 10.1093/hmg/11.7.779; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Moss AJ, 2003, JAMA-J AM MED ASSOC, V289, P2041, DOI 10.1001/jama.289.16.2041; Robertson GA, 2006, HANDB EXP PHARMACOL, V171, P349; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sasano T, 2004, J MOL CELL CARDIOL, V37, P1205, DOI 10.1016/j.yjmcc.2004.09.010; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Teng SY, 2004, J MOL MED, V82, P189, DOI 10.1007/s00109-003-0504-1; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; Verkerk AO, 2005, CARDIOVASC RES, V68, P441, DOI 10.1016/j.cardiores.2005.06.027; Vyas H, 2006, CIRCULATION, V113, P1385, DOI 10.1161/CIRCULATIONAHA.105.600445; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wu ZY, 2008, ENDOCRINOLOGY, V149, P5061, DOI 10.1210/en.2007-1802; Yao Y, 2009, HEART RHYTHM, V6, P553, DOI 10.1016/j.hrthm.2009.01.017; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18273	10.1371/journal.pone.0018273	http://dx.doi.org/10.1371/journal.pone.0018273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483829	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200049
J	Frampton, D; Kerr, J; Harrison, TJ; Kellam, P				Frampton, Daniel; Kerr, Jonathan; Harrison, Tim J.; Kellam, Paul			Assessment of a 44 Gene Classifier for the Evaluation of Chronic Fatigue Syndrome from Peripheral Blood Mononuclear Cell Gene Expression	PLOS ONE			English	Article							EXPLORATION	Chronic fatigue syndrome (CFS) is a clinically defined illness estimated to affect millions of people worldwide causing significant morbidity and an annual cost of billions of dollars. Currently there are no laboratory-based diagnostic methods for CFS. However, differences in gene expression profiles between CFS patients and healthy persons have been reported in the literature. Using mRNA relative quantities for 44 previously identified reporter genes taken from a large dataset comprising both CFS patients and healthy volunteers, we derived a gene profile scoring metric to accurately classify CFS and healthy samples. This metric out-performed any of the reporter genes used individually as a classifier of CFS. To determine whether the reporter genes were robust across populations, we applied this metric to classify a separate blind dataset of mRNA relative quantities from a new population of CFS patients and healthy persons with limited success. Although the metric was able to successfully classify roughly two-thirds of both CFS and healthy samples correctly, the level of misclassification was high. We conclude many of the previously identified reporter genes are study-specific and thus cannot be used as a broad CFS diagnostic.	[Frampton, Daniel; Kellam, Paul] UCL, Div Infect & Immun, Dept Infect, London, England; [Kerr, Jonathan] Univ London St Georges Hosp, Div Clin Sci, London, England; [Harrison, Tim J.] UCL, Sch Med, Dept Internal Med, London W1N 8AA, England; [Kellam, Paul] Wellcome Trust Sanger Inst, Cambridge, England	University of London; University College London; St Georges University London; University of London; University College London; UCL Medical School; Wellcome Trust Sanger Institute	Frampton, D (corresponding author), UCL, Div Infect & Immun, Dept Infect, London, England.	pk5@sanger.ac.uk		Kellam, Paul/0000-0003-3166-4734; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	Chronic Fatigue Syndrome Research Foundation	Chronic Fatigue Syndrome Research Foundation	This study was funded by a research grant from the Chronic Fatigue Syndrome Research Foundation (http://www.cfsrf.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Fang H, 2006, PHARMACOGENOMICS, V7, P429, DOI 10.2217/14622416.7.3.429; Fostel J, 2006, PHARMACOGENOMICS, V7, P441, DOI 10.2217/14622416.7.3.441; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gow JW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-38; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saiki T, 2008, MOL MED, V14, P599, DOI 10.2119/2007-00059.Saiki; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vinciotti Veronica, 2006, Appl Bioinformatics, V5, P1, DOI 10.2165/00822942-200605010-00001; Xu Y, 2002, CANCER RES, V62, P3493	18	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e16872	10.1371/journal.pone.0016872	http://dx.doi.org/10.1371/journal.pone.0016872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479222	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700007
J	Giorgio, C; Mohamed, IH; Flammini, L; Barocelli, E; Incerti, M; Lodola, A; Tognolini, M				Giorgio, Carmine; Mohamed, Iftiin Hassan; Flammini, Lisa; Barocelli, Elisabetta; Incerti, Matteo; Lodola, Alessio; Tognolini, Massimiliano			Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation	PLOS ONE			English	Article							RECEPTOR-TYROSINE KINASE; BILE-ACIDS; COLON-CANCER; MELANOMA-CELLS; EXPRESSION; ANGIOGENESIS; ANTAGONISTS; CARCINOMA; SURVIVAL; BEHAVIOR	Eph-ephrin system plays a central role in a large variety of human cancers. In fact, alterated expression and/or de-regulated function of Eph-ephrin system promotes tumorigenesis and development of a more aggressive and metastatic tumour phenotype. In particular EphA2 upregulation is correlated with tumour stage and progression and the expression of EphA2 in non-trasformed cells induces malignant transformation and confers tumorigenic potential. Based on these evidences our aim was to identify small molecules able to modulate EphA2-ephrinA1 activity through an ELISA-based binding screening. We identified lithocholic acid (LCA) as a competitive and reversible ligand inhibiting EphA2-ephrinA1 interaction (Ki = 49 mu M). Since each ephrin binds many Eph receptors, also LCA does not discriminate between different Eph-ephrin binding suggesting an interaction with a highly conserved region of Eph receptor family. Structurally related bile acids neither inhibited Eph-ephrin binding nor affected Eph phosphorylation. Conversely, LCA inhibited EphA2 phosphorylation induced by ephrinA1-Fc in PC3 and HT29 human prostate and colon adenocarcinoma cell lines (IC50 = 48 and 66 mM, respectively) without affecting cell viability or other receptor tyrosine-kinase (EGFR, VEGFR, IGFR1 beta, IRK beta) activity. LCA did not inhibit the enzymatic kinase activity of EphA2 at 100 mu M (LANCE method) confirming to target the Eph-ephrin protein-protein interaction. Finally, LCA inhibited cell rounding and retraction induced by EphA2 activation in PC3 cells. In conclusion, our findings identified a hit compound useful for the development of molecules targeting ephrin system. Moreover, as ephrin signalling is a key player in the intestinal cell renewal, our work could provide an interesting starting point for further investigations about the role of LCA in the intestinal homeostasis.	[Giorgio, Carmine; Mohamed, Iftiin Hassan; Flammini, Lisa; Barocelli, Elisabetta; Tognolini, Massimiliano] Univ Parma, Dipartimento Sci Farmacol Biol & Chim Applicate, I-43100 Parma, Italy; [Incerti, Matteo; Lodola, Alessio] Univ Parma, Dipartimento Farmaceut, I-43100 Parma, Italy	University of Parma; University of Parma	Giorgio, C (corresponding author), Univ Parma, Dipartimento Sci Farmacol Biol & Chim Applicate, I-43100 Parma, Italy.	massimiliano.tognolini@unipr.it	Lodola, Alessio/H-9078-2013; giorgio, carmine/A-6840-2018; tognolini, massimiliano/B-5768-2012; Incerti, Matteo/M-3896-2017	Lodola, Alessio/0000-0002-8675-1002; giorgio, carmine/0000-0001-6414-8221; Tognolini, Massimiliano/0000-0002-4715-0407	"Associazione Italiana Ricerca sul Cancro" (AIRC) [6181]	"Associazione Italiana Ricerca sul Cancro" (AIRC)(Fondazione AIRC per la ricerca sul cancro)	"My First AIRC Grant" number 6181 of the "Associazione Italiana Ricerca sul Cancro" (AIRC) supported this work (www.airc.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford SC, 2007, EXP CELL RES, V313, P4170, DOI 10.1016/j.yexcr.2007.07.019; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Chang Q, 2008, BRIT J CANCER, V99, P1074, DOI 10.1038/sj.bjc.6604676; CHEAH PY, 1990, NUTR CANCER, V14, P5, DOI 10.1080/01635589009514073; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Herrem CJ, 2005, CLIN CANCER RES, V11, P226; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; HILL MJ, 1990, MUTAT RES, V238, P313, DOI 10.1016/0165-1110(90)90023-5; HILL MJ, 1971, LANCET, V1, P95; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Katona BW, 2007, J MED CHEM, V50, P6048, DOI 10.1021/jm0707931; Katona BW, 2009, J BIOL CHEM, V284, P3354, DOI 10.1074/jbc.M805804200; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kinch MS, 2003, CLIN CANCER RES, V9, P613; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Olive DM, 2004, EXPERT REV PROTEOMIC, V1, P327, DOI 10.1586/14789450.1.3.327; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; REDDY BS, 1977, CANCER RES, V37, P1697; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Zelinski DP, 2001, CANCER RES, V61, P2301	40	58	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18128	10.1371/journal.pone.0018128	http://dx.doi.org/10.1371/journal.pone.0018128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479221	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700028
J	Hashimoto, T; Kikkawa, U; Kamada, S				Hashimoto, Toshiaki; Kikkawa, Ushio; Kamada, Shinji			Contribution of Caspase(s) to the Cell Cycle Regulation at Mitotic Phase	PLOS ONE			English	Article							X-LINKED INHIBITOR; UBIQUITIN-PROTEIN LIGASE; SPINDLE CHECKPOINT; APOPTOSIS; ACTIVATION; CANCER; XIAP; MITOSIS; DEGRADATION; PROGRESSION	Caspases have been suggested to contribute to not only apoptosis regulation but also non-apoptotic cellular phenomena. Recently, we have reported the involvement of caspase-7 to the cell cycle progression at mitotic phase by knockdown of caspase-7 using small interfering RNAs and short hairpin RNA. Here we showed that chemically synthesized broad-spectrum caspase inhibitors, which have been used to suppress apoptosis, prevented the cell proliferation in a dose-dependent manner, and that the subtype-specific peptide-based caspase inhibitor for caspase-3 and -7, but not for caspase-9, inhibited cell proliferation. It was also indicated that the BIR2 domain of X-linked inhibitor of apoptosis protein, functioning as an inhibitor for caspase-3 and -7, but not the BIR3 domain which plays as a caspase-9 inhibitor, induced cell cycle arrest. Furthermore, flow cytometry revealed that the cells treated with caspase inhibitors arrested at G(2)/M phase. By using HeLa. S-Fucci (fluorescent ubiquitination-based cell cycle indicator) cells, the prevention of the cell proliferation by caspase inhibitors induced cell cycle arrest at mitotic phase accompanying the accumulation of the substrates for APC/C, suggesting the impairment of the APC/C activity at the transition from M to G(1) phases. These results indicate that caspase(s) contribute to the cell cycle regulation at mitotic phase.	[Hashimoto, Toshiaki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 657, Japan	Kobe University	Hashimoto, T (corresponding author), Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 657, Japan.	skamada@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Grant-in-Aid for Scientific Research (B) of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Broemer M, 2010, MOL CELL, V40, P810, DOI 10.1016/j.molcel.2010.11.011; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Faragher AJ, 2007, MOL BIOL CELL, V18, P1337, DOI 10.1091/mbc.E06-05-0409; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Galvan V, 2004, FEBS LETT, V558, P57, DOI 10.1016/S0014-5793(03)01488-1; Hashimoto T, 2008, GENES CELLS, V13, P609, DOI 10.1111/j.1365-2443.2008.01192.x; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Hsu SL, 2006, APOPTOSIS, V11, P765, DOI 10.1007/s10495-006-5880-x; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Misaghi S, 2006, CELL DEATH DIFFER, V13, P163, DOI 10.1038/sj.cdd.4401716; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakopoulou L, 2001, PATHOBIOLOGY, V69, P266, DOI 10.1159/000064337; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuel T, 2005, CANCER RES, V65, P210; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Swe M, 2000, APOPTOSIS, V5, P29, DOI 10.1023/A:1009681408367; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vakkala M, 1999, BRIT J CANCER, V81, P592, DOI 10.1038/sj.bjc.6690735; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Yang L, 2003, CANCER RES, V63, P6815; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	50	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18449	10.1371/journal.pone.0018449	http://dx.doi.org/10.1371/journal.pone.0018449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479177	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700059
J	Tracy, JL; Hart, J; Martens, JP				Tracy, Jessica L.; Hart, Joshua; Martens, Jason P.			Death and Science: The Existential Underpinnings of Belief in Intelligent Design and Discomfort with Evolution	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; MORTALITY SALIENCE; WORLDVIEW DEFENSE; BIOLOGY TEACHERS; ACCESSIBILITY; THOUGHTS; CREATURELINESS; CONSERVATISM; UNCERTAINTY; DISGUST	The present research examined the psychological motives underlying widespread support for intelligent design theory (IDT), a purportedly scientific theory that lacks any scientific evidence; and antagonism toward evolutionary theory (ET), a theory supported by a large body of scientific evidence. We tested whether these attitudes are influenced by IDT's provision of an explanation of life's origins that better addresses existential concerns than ET. In four studies, existential threat (induced via reminders of participants' own mortality) increased acceptance of IDT and/or rejection of ET, regardless of participants' religion, religiosity, educational background, or preexisting attitude toward evolution. Effects were reversed by teaching participants that naturalism can be a source of existential meaning (Study 4), and among natural-science students for whom ET may already provide existential meaning (Study 5). These reversals suggest that the effect of heightened mortality awareness on attitudes toward ET and IDT is due to a desire to find greater meaning and purpose in science when existential threats are activated.	[Tracy, Jessica L.; Martens, Jason P.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Hart, Joshua] Union Coll, Dept Psychol, Schenectady, NY 12308 USA	University of British Columbia; Union College	Tracy, JL (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jltracy@psych.ubc.ca			Social Sciences and Humanities Research Council of Canada [410-2009-2458]; Michael Smith Foundation [CI-SCH-01862(07-1)]; Union College; Social Science and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Union College; Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This project was supported by the Social Sciences and Humanities Research Council of Canada, Standard Research Grant #410-2009-2458, a Michael Smith Foundation for Health Research Scholar Award [CI-SCH-01862(07-1)] to the first author, a Faculty Research Fund Grant from Union College, and a Social Science and Humanities Research Council of Canada Graduate Scholarship to the third author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAAS, 2006, STAT TEACH EV; Altemeyer B., 2004, INT J PSYCHOL RELIG, V14, P47, DOI DOI 10.1207/S15327582IJPR1401_4; [Anonymous], 2009, ENCY BRITANNICA; BEHE MJ, 2000, SCI EVIDENCE DESIGN; BEHE MJ, 1996, NY TIMES        1029; Behe MJ., 1996, DARWINS BLACK BOX BI; Berkman MB, 2008, PLOS BIOL, V6, P920, DOI 10.1371/journal.pbio.0060124; Brem SK, 2003, SCI EDUC, V87, P181, DOI 10.1002/sce.10105; Bumiller Elisabeth, 2005, NY TIMES; Cohen F, 2004, PSYCHOL SCI, V15, P846, DOI 10.1111/j.0956-7976.2004.00765.x; Cox CR, 2007, EUR J SOC PSYCHOL, V37, P494, DOI 10.1002/ejsp.370; DAWKINS R, 1998, UNWEAVING RAINBOW; Dawkins R., 2006, SELFISH GENE, P360; DeWall CN, 2007, PSYCHOL SCI, V18, P984, DOI 10.1111/j.1467-9280.2007.02013.x; Druyan Ann, 2006, VARIETIES SCI EXPERI, pix; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Fritsche I, 2008, J PERS SOC PSYCHOL, V95, P524, DOI 10.1037/a0012666; Gewin V, 2005, NATURE, V436, P761, DOI 10.1038/436761a; Goldenberg JL, 2001, J EXP PSYCHOL GEN, V130, P427, DOI 10.1037//0096-3445.130.3.427; GORSUCH RL, 1989, J SCI STUD RELIG, V28, P348, DOI 10.2307/1386745; Greenberg J, 2003, PSYCHOL SCI, V14, P516, DOI 10.1111/1467-9280.03454; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Hart J, 2005, J PERS SOC PSYCHOL, V88, P999, DOI 10.1037/0022-3514.88.6.999; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Hoag H, 2006, NATURE, V440, P720, DOI 10.1038/440720b; Jonas E, 2006, J PERS SOC PSYCHOL, V91, P553, DOI 10.1037/0022-3514.91.3.553; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Landau MJ, 2006, J PERS SOC PSYCHOL, V90, P879, DOI 10.1037/0022-3514.90.6.879; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; Lifton R.J., 1983, BROKEN CONNECTION DE; Lombrozo T., 2008, EVOL EDUC OUTREACH, V1, P290, DOI [10.1007/s12052-008-0061-8, DOI 10.1007/S12052-008-0061-8]; Lombrozo T, 2007, PSYCHOL SCI, V18, P999, DOI 10.1111/j.1467-9280.2007.02015.x; Martin JD, 2006, J MEDIA RELIG, V5, P49, DOI 10.1207/s15328415jmr0501_3; Martin LL, 1999, PSYCHOL INQ, V10, P195, DOI 10.1207/S15327965PLI1003_1; McCann SJH, 2008, J PERS SOC PSYCHOL, V94, P913, DOI 10.1037/0022-3514.94.5.913; McGregor I, 2001, J PERS SOC PSYCHOL, V80, P472, DOI 10.1037//0022-3514.80.3.472; Meyer S. C., 2005, TEACH CONTROVERSY; Nehm RH, 2009, SCI EDUC, V93, P1122, DOI 10.1002/sce.20340; Norenzayan A, 2006, PERS SOC PSYCHOL B, V32, P174, DOI 10.1177/0146167205280251; OSARCHUK M, 1973, J PERS SOC PSYCHOL, V27, P256, DOI 10.1037/h0034769; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T, 2006, PERS SOC PSYCHOL B, V32, P525, DOI 10.1177/0146167205282157; Pyszczynski T., 2003, WAKE 9 11 PSYCHOL TE; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Rutjens BT, 2009, PERS SOC PSYCHOL B, V35, P535, DOI 10.1177/0146167208331252; Rutledge ML, 2000, AM BIOL TEACH, V62, P23, DOI 10.1662/0002-7685(2000)062[0023:ETTNOS]2.0.CO;2; Schimel J, 2007, J PERS SOC PSYCHOL, V92, P789, DOI 10.1037/0022-3514.92.5.789; Shtulman A, 2008, COGNITIVE SCI, V32, P1049, DOI 10.1080/03640210801897864; Sinatra GM, 2003, J RES SCI TEACH, V40, P510, DOI 10.1002/tea.10087; van den Bos K, 2005, J EXP SOC PSYCHOL, V41, P91, DOI 10.1016/j.jesp.2004.06.001; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	52	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17349	10.1371/journal.pone.0017349	http://dx.doi.org/10.1371/journal.pone.0017349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479169	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700010
J	de Andrade, ACV; Luz, PM; Velasque, L; Veloso, VG; Moreira, RI; Russomano, F; Chicarino-Coelho, J; Pires, E; Levi, JE; Grinsztejn, B; Friedman, RK				Vasconcelos de Andrade, Angela Cristina; Luz, Paula Mendes; Velasque, Luciane; Veloso, Valdilea Goncalves; Moreira, Ronaldo I.; Russomano, Fabio; Chicarino-Coelho, Janice; Pires, Elaine; Levi, Jose Eduardo; Grinsztejn, Beatriz; Friedman, Ruth Khalili			Factors Associated with Colposcopy-Histopathology Confirmed Cervical Intraepithelial Neoplasia among HIV-Infected Women from Rio De Janeiro, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-PAPILLOMAVIRUS; CANCER-RISK; AIDS; PREVALENCE; TERMINOLOGY; PREDICTORS; MANAGEMENT; PEOPLE	Introduction: Despite the availability of preventive strategies (screening tests and vaccines), cervical cancer continues to impose a significant health burden in low- and medium-resourced countries. HIV-infected women are at increased risk for infection with human papillomavirus (HPV) and thus development of cervical squamous intraepithelial neoplasia (CIN). Methods: Study participants included HIV-infected women enrolling the prospective open cohort of Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation (IPEC/FIOCRUZ). At cohort entry, women were subjected to conventional Papanicolaou test, HPV-DNA test and colposcopy; lesions suspicious for CIN were biopsied. Histopathology report was based on directed biopsy or on specimens obtained by excision of the transformation zone or cervical conization. Poisson regression modeling was used to assess factors associated with CIN2+ diagnosis. Results: The median age of the 366 HIV-infected women included in the study was 34 years (interquartile range: 28-41 years). The prevalence of CIN1, CIN2 and CIN3 were 20.0%, 3.5%, and 2.2%, respectively. One woman was found to have cervical cancer. The prevalence of CIN2+ was 6.0%. Factors associated with CIN2+ diagnosis in the multivariate model were age < years compared to >= 35 years (aPR = 3.22 95% CI 1.23-8.39), current tobacco use (aPR = 3.69 95% CI 1.54-8.78), nadir CD4 T-cell count < 350 cells/mm3 when compared to >= 350 cells/mm3 (aPR = 6.03 95% CI 1.50-24.3) and concomitant diagnosis of vulvar and/or vaginal intraepithelial lesion (aPR = 2.68 95% CI 0.99-7.24). Discussion: Increased survival through wide-spread use of highly active antiretroviral therapy might allow for the development of cervical cancer. In Brazil, limited cytology screening and gynecological care adds further complexity to the HIV-HPV co-infection problem. Integrated HIV care and cervical cancer prevention programs are needed for the prevention of cervical cancer mortality in this group of women.	[Vasconcelos de Andrade, Angela Cristina; Luz, Paula Mendes; Velasque, Luciane; Veloso, Valdilea Goncalves; Moreira, Ronaldo I.; Chicarino-Coelho, Janice; Pires, Elaine; Grinsztejn, Beatriz; Friedman, Ruth Khalili] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro, Dept Matemat & Estat, Rio De Janeiro, Brazil; [Russomano, Fabio] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil; [Levi, Jose Eduardo] Univ Sao Paulo, Inst Trop Med, Virol Lab, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	de Andrade, ACV (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	gbeatriz@ipec.fiocruz.br	Veloso, Valdilea Gonçalves/J-6189-2012	Luz, Paula/0000-0001-9746-719X				Anastos K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013525; Arrossi S, 2003, SALUD PUBLICA MEXICO, V45, pS306; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Behrens T, 2004, METHOD INFORM MED, V43, P505; Bollen LJM, 2006, SEX TRANSM DIS, V33, P259; Brasil. Ministerio da Saude (MS). Secretaria de Vigilancia em Saude. Programa Nacional de DST/Aids, 2006, MAN CONTR DOENC SEX; Campos DP, 2005, AIDS, V19, pS22, DOI 10.1097/01.aids.0000191486.92285.1c; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Conley LJ, 2002, LANCET, V359, P108, DOI 10.1016/S0140-6736(02)07368-3; Dexeus S, 2002, EUR J GYNAECOL ONCOL, V23, P269; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Franceschi S, 2003, JAIDS-J ACQ IMM DEF, V34, P84, DOI 10.1097/00126334-200309010-00013; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Heard I, 2002, AIDS, V16, P1799, DOI 10.1097/00002030-200209060-00013; *INCA, 2009, EST 2010 INC CANC BR; INCA, 2006, NOM BRAS LAUD CERV C; Jamieson DJ, 2006, OBSTET GYNECOL, V107, P1023, DOI 10.1097/01.AOG.0000210237.80211.ff; Massad LS, 1999, J ACQ IMMUN DEF SYND, V21, P33, DOI 10.1097/00126334-199905010-00005; Massad LS, 2004, AM J OBSTET GYNECOL, V190, P1241, DOI 10.1016/j.ajog.2003.12.037; Orem J, 2004, CURR OPIN ONCOL, V16, P468, DOI 10.1097/00001622-200409000-00010; Palefsky JM, 2003, CURR OPIN ONCOL, V15, P382, DOI 10.1097/00001622-200309000-00007; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; PRENDIVILLE W, 1989, BRIT J OBSTET GYNAEC, V96, P1054, DOI 10.1111/j.1471-0528.1989.tb03380.x; RICHART RM, 1990, OBSTET GYNECOL, V75, P131; Sahasrabuddhe VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008634; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; UNAIDS, 2010, AIDS EP UPD 2009; Walker P, 2003, OBSTET GYNECOL, V101, P175, DOI 10.1016/S0029-7844(02)02581-4; Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719; Zimmermmann JB, 2006, REV BRAS GINECOL OBS, V28, P345, DOI 10.1590/S0100-72032006000600005	33	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18297	10.1371/journal.pone.0018297	http://dx.doi.org/10.1371/journal.pone.0018297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479179	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700045
J	Congiu, L; Pujolar, JM; Forlani, A; Cenadelli, S; Dupanloup, I; Barbisan, F; Galli, A; Fontana, F				Congiu, Leonardo; Pujolar, Jose Martin; Forlani, Anna; Cenadelli, Silvia; Dupanloup, Isabelle; Barbisan, Federica; Galli, Andrea; Fontana, Francesco			Managing Polyploidy in Ex Situ Conservation Genetics: The Case of the Critically Endangered Adriatic Sturgeon (Acipenser naccarii)	PLOS ONE			English	Article							POPULATION; IDENTIFICATION; MANAGEMENT; DIVERSITY	While the current expansion of conservation genetics enables to address more efficiently the management of threatened species, alternative methods for genetic relatedness data analysis in polyploid species are necessary. Within this framework, we present a standardized and simple protocol specifically designed for polyploid species that can facilitate management of genetic diversity, as exemplified by the ex situ conservation program for the tetraploid Adriatic sturgeon Acipenser naccarii. A critically endangered endemic species of the Adriatic Sea tributaries, its persistence is strictly linked to the ex situ conservation of a single captive broodstock currently decimated to about 25 individuals, which represents the last remaining population of Adriatic sturgeon of certain wild origin. The genetic variability of three F1 broodstocks available as future breeders was estimated based on mitochondrial and microsatellite information and compared with the variability of the parental generation. Genetic data showed that the F1 stocks have only retained part of the genetic variation present in the original stock due to the few parent pairs used as founders. This prompts for the urgent improvement of the current F1 stocks by incorporating new founders that better represent the genetic diversity available. Following parental allocation based on band sharing values, we set up a user-friendly tool for selection of candidate breeders according to relatedness between all possible parent-pairs that secures the use of non-related individuals. The approach developed here could also be applied to other endangered tetraploid sturgeon species overexploited for caviar production, particularly in regions lacking proper infrastructure and/or expertise.	[Congiu, Leonardo; Pujolar, Jose Martin; Forlani, Anna; Barbisan, Federica] Univ Padua, Dipartimento Biol, Padua, Italy; [Cenadelli, Silvia; Galli, Andrea] Ist Sperimentale Lazzaro Spallanzani, Rivolta Dadda, Italy; [Dupanloup, Isabelle] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Fontana, Francesco] Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy	University of Padua; University of Bern; University of Ferrara	Congiu, L (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	leonardo.congiu@unipd.it	Dupanloup, Isabelle/AAD-5372-2020; Congiu, Leonardo/G-7967-2011; Galli, Andrea/AAC-1623-2019; Dupanloup, Isabelle/O-8609-2017	Dupanloup, Isabelle/0000-0002-9258-6963; pujolar, marti/0000-0002-5037-8840; CONGIU, LEONARDO/0000-0002-9293-9837	EU [04NAT/IT/00126]; University of Padova [CPDA087543/08]	EU(European Commission); University of Padova	This work was supported by the EU Life project "Cobice" 04NAT/IT/00126 and by the University of Padova grant CPDA087543/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlati G., 1988, RIV ITAL ACQUACOL, V23, P94; BRONZI P, 1994, INT C STURG BIOD CON; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Fontana F, 2001, GENETICA, V111, P359, DOI 10.1023/A:1013711919443; Forlani A, 2008, CONSERV GENET, V9, P461, DOI 10.1007/s10592-007-9335-x; GIOVANNINI G, 1991, ACIPENSER, P401; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; GULYAS T, 2000, PUBLICATIONES ESTACI, V1999, P61; Henderson-Arzapalo A, 2002, MOL ECOL NOTES, V2, P437, DOI 10.1046/j.1471-8286.2002.00262.x; Jenneckens I, 2001, J APPL ICHTHYOL, V17, P39, DOI 10.1046/j.1439-0426.2001.00234.x; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Ludwig A, 2000, GENETICS, V156, P1933; Ludwig A, 2008, J APPL ICHTHYOL, V24, P2, DOI 10.1111/j.1439-0426.2008.01085.x; Ludwig A, 2003, MOL ECOL, V12, P3253, DOI 10.1046/j.1365-294X.2003.01999.x; Ludwig A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-221; May B, 1997, CAN J FISH AQUAT SCI, V54, P1542, DOI 10.1139/cjfas-54-7-1542; McQuown EC, 2000, T AM FISH SOC, V129, P1380, DOI 10.1577/1548-8659(2000)129&lt;1380:MAOGVI&gt;2.0.CO;2; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Pourkazemi M, 2006, J APPL ICHTHYOL, V22, P12, DOI 10.1111/j.1439-0426.2007.00923.x; *RAMS DECL GLOB SU, 2005, J APPL ICHTHYOL, V22, P5; Russello MA, 2004, MOL ECOL, V13, P2829, DOI 10.1111/j.1365-294X.2004.02266.x; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tortonese E., 1989, FRESHWATER FISHES EU, V1, P285; Welsh AB, 2003, MOL ECOL NOTES, V3, P47, DOI 10.1046/j.1471-8286.2003.00346.x; Zane L, 2002, MOL ECOL NOTES, V2, P586, DOI 10.1046/j.1471-8286.2002.00328.x	30	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18249	10.1371/journal.pone.0018249	http://dx.doi.org/10.1371/journal.pone.0018249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21483472	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600038
J	Fournier, G; Cabaud, O; Josselin, E; Chaix, A; Adelaide, J; Isnardon, D; Restouin, A; Castellano, R; Dubreuil, P; Chaffanet, M; Birnbaum, D; Lopez, M				Fournier, G.; Cabaud, O.; Josselin, E.; Chaix, A.; Adelaide, J.; Isnardon, D.; Restouin, A.; Castellano, R.; Dubreuil, P.; Chaffanet, M.; Birnbaum, D.; Lopez, M.			Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth	ONCOGENE			English	Article						afadin; breast cancer; migration; invasion; tumorigenicity; SRC and MAPK	ACTIVATED PROTEIN-KINASE; PDZ DOMAIN; ACTIN CYTOSKELETON; ADHERENS JUNCTIONS; NEGATIVE REGULATOR; ADHESION MOLECULE; AF-6; DROSOPHILA; BINDING; AFADIN	Afadin/AF6, an F-actin-binding protein, is ubiquitously expressed in epithelia and has a key role during development, through its regulatory role in cell-cell junction organization. Afadin loss of expression in 15% of breast carcinoma is associated with adverse prognosis and increased risk of metastatic relapse. To determine the role of afadin in breast cancer, we studied the functional consequences of afadin protein extinction using in vitro and in vivo models. Three different breast cancer cell lines representative of the major molecular subtypes were stably repressed for afadin expression (knockdown of afadin (afadin KD)) using RNA interference. Collective and individual migrations as well as Matrigel invasion were markedly increased in afadin KD cells. Heregulin-beta 1 (HRG-beta 1)-induced migration and invasion were increased by twofold in afadin KD cells. Conversely, ectopic expression of afadin in the afadin-negative T47D cell line inhibited spontaneous and HRG-beta 1-induced migrations. RAS/MAPK and SRC kinase pathways were activated in afadin KD cells. Activation levels positively correlated with migration and invasion strength. Use of MEK1/2 (U0126) and SRC kinases (SU6656) inhibitors reduced afadin-dependent migration and invasion. Afadin extinction in the SK-BR-3 cell line markedly accelerated tumor growth development in mouse mammary gland and lung metastasis formation. These results may explain why the loss of afadin expression in tumors correlates with high tumor size and poor metastasis-free survival in patients. Oncogene (2011) 30, 3862-3874; doi:10.1038/onc.2011.106; published online 11 April 2011	[Fournier, G.; Cabaud, O.; Josselin, E.; Chaffanet, M.; Birnbaum, D.; Lopez, M.] INSERM, Oncol Mol Lab, UMR 891, CRCM, F-13009 Marseille, France; [Chaix, A.; Dubreuil, P.] INSERM, Lab Hematopoiese Fonct & Mol, UMR 891, CRCM, F-13009 Marseille, France; [Restouin, A.; Castellano, R.] INSERM, Plateforme TrGET Essais Preclin, UMR 891, CRCM, F-13009 Marseille, France; [Fournier, G.; Cabaud, O.; Josselin, E.; Chaix, A.; Adelaide, J.; Isnardon, D.; Restouin, A.; Castellano, R.; Dubreuil, P.; Chaffanet, M.; Lopez, M.] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Fournier, G.; Cabaud, O.; Josselin, E.; Chaix, A.; Adelaide, J.; Isnardon, D.; Restouin, A.; Castellano, R.; Dubreuil, P.; Chaffanet, M.; Lopez, M.] Univ Aix Marseille 2, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	Lopez, M (corresponding author), INSERM, Oncol Mol Lab, UMR891, 27 Bd Lei Roure, F-13009 Marseille, France.	marc.lopez@inserm.fr	CHAFFANET, Max/AAU-5743-2020; Dubreuil, Patrice/V-4816-2019; ADELAIDE, José JA/O-4390-2017; dubreuil, patrice/F-5346-2011	Dubreuil, Patrice/0000-0003-1155-1150; ADELAIDE, José JA/0000-0003-4364-9857; dubreuil, patrice/0000-0003-1155-1150; Birnbaum, Daniel/0000-0001-7920-9883; CHAFFANET, Max/0000-0002-2344-1488	INSERM; Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC); Institut National du Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France)	We thank F Birg for helpful discussions. We are grateful of M Buchert for providing us with the pCDNA3-FLAG-L-AF6 vector. This work was supported by INSERM, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (LNCC) (Label 2009-2011) and Institut National du Cancer (AO translationnelle). In 2009-2010, GF has been supported by a fellowship from LNCC.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Buchert M, 2007, J CELL PHYSIOL, V210, P212, DOI 10.1002/jcp.20853; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Gaengel K, 2003, DEVELOPMENT, V130, P5413, DOI 10.1242/dev.00759; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Letessier A, 2007, ONCOGENE, V26, P298, DOI 10.1038/sj.onc.1209772; Liedtke M, 2010, BLOOD, V116, P63, DOI 10.1182/blood-2009-09-243386; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Lorger M, 2006, J CELL SCI, V119, P3385, DOI 10.1242/jcs.03027; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Martuszewska D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004350; Matsuo T, 1999, CELL TISSUE RES, V298, P397, DOI 10.1007/s004419900107; MIYAMOTO H, 1995, GENE DEV, V9, P612, DOI 10.1101/gad.9.5.612; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P265, DOI 10.1016/S0968-0004(00)89040-4; PRASAD R, 1993, CANCER RES, V53, P5624; Radziwill G, 2003, MOL CELL BIOL, V23, P4663, DOI 10.1128/MCB.23.13.4663-4672.2003; Radziwill G, 2007, EMBO J, V26, P2633, DOI 10.1038/sj.emboj.7601706; SAHA V, 1995, GENE CHROMOSOME CANC, V14, P220, DOI 10.1002/gcc.2870140311; Saito S, 1998, DNA Res, V5, P115, DOI 10.1093/dnares/5.2.115; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Speicher S, 2008, CURR BIOL, V18, P831, DOI 10.1016/j.cub.2008.04.072; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; TANAKA M, 1995, CANCER RES, V55, P3228; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Yamamoto T, 1999, BIOCHEM BIOPH RES CO, V259, P103, DOI 10.1006/bbrc.1999.0731; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	43	39	39	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	36					3862	3874		10.1038/onc.2011.106	http://dx.doi.org/10.1038/onc.2011.106			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	817PV	21478912				2022-12-25	WOS:000294687200004
J	Yang, FL; Yang, YL; Liao, PC; Chou, JC; Tsai, KC; Yang, AS; Sheu, F; Lin, TL; Hsieh, PF; Wang, JT; Hua, KF; Wu, SH				Yang, Feng-Ling; Yang, Yu-Liang; Liao, Pei-Chun; Chou, Ju-Ching; Tsai, Keng-Chang; Yang, An-Suei; Sheu, Fuu; Lin, Tzu-Lung; Hsieh, Pei-Fang; Wang, Jin-Town; Hua, Kuo-Feng; Wu, Shih-Hsiung			Structure and Immunological Characterization of the Capsular Polysaccharide of a Pyrogenic Liver Abscess Caused by Klebsiella pneumoniae ACTIVATION OF MACROPHAGES THROUGH TOLL-LIKE RECEPTOR 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE STRAINS; NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; NF-KAPPA-B; NADPH PHAGOCYTE OXIDASE; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; SIGNALING PATHWAYS; LIPOPOLYSACCHARIDE RECOGNITION; EXPERIMENTAL SALMONELLOSIS	The active components of a primary pyrogenic liver abscess (PLA) Klebsiella pneumoniae in stimulating cytokine expression in macrophages are still unclear. The capsular polysaccharide (CPS) of PLA K. pneumoniae is important in determining clinical manifestations, and we have shown that it consists of repeating units of the trisaccharide (-> 3)-beta-D-Glc-(1 -> 4)-[2,3-(S)-pyruvate]-beta-D-GlcA-(1 -> 4)-alpha-L-Fuc-(1 ->) and has the unusual feature of extensive pyruvation of glucuronic acid and acetylation of C-2-OH or C-3-OH of fucose. We demonstrated that PLAK. pneumoniae CPS induces secretion of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by macrophages through Toll-like receptor 4 (TLR4) and that this effect was lost when pyruvation and O-acetylation were chemically destroyed. Furthermore, expression of TNF-alpha and IL-6 in PLA K. pneumoniae CPS-stimulated macrophages was shown to be regulated by the TLR4/ROS/PKC-delta/NF-kappa B, TLR4/PI3-kinase/AKT/NF-kappa B, and TLR4/MAPK signaling pathways.	[Yang, Feng-Ling; Yang, Yu-Liang; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Liao, Pei-Chun; Chou, Ju-Ching; Hua, Kuo-Feng] Natl Ilan Univ, Inst Biotechnol, Ilan 260, Taiwan; [Tsai, Keng-Chang; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Sheu, Fuu] Natl Taiwan Univ, Dept Hort, Taipei 106, Taiwan; [Lin, Tzu-Lung; Hsieh, Pei-Fang; Wang, Jin-Town] Natl Taiwan Univ, Dept Microbiol, Taipei 100, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; National Ilan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hua, KF (corresponding author), 1,Sect 1,Shen Lung Rd, Ilan 260, Taiwan.	kfhua@niu.edu.tw; shwu@gate.sinica.edu.tw		Yang, An-Suei/0000-0002-4699-873X; Tsai, Keng-Chang/0000-0001-8277-9174; Sheu, Fuu/0000-0001-9794-3483	National Science Council of Taiwan [NSC 92-2321-B-001-019, 94-2311-B-001-045, 98-2320-B-197-003-MY2, 098-2811-B-197-001, NRPGM 96IDP003-2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan Grants NSC 92-2321-B-001-019, 94-2311-B-001-045, 98-2320-B-197-003-MY2, 098-2811-B-197-001, and NRPGM 96IDP003-2.	Anthon GE, 2003, J SCI FOOD AGR, V83, P1210, DOI 10.1002/jsfa.1525; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Chaurasia B, 2010, MOL CELL BIOL, V30, P4354, DOI 10.1128/MCB.00069-10; CHENG D-L, 1991, Archives of Internal Medicine, V151, P1557, DOI 10.1001/archinte.151.8.1557; Choy YM, 1996, LIFE SCI, V58, pPL153, DOI 10.1016/0024-3205(95)02361-5; Chuang HC, 2009, J MICROBIOL IMMUNOL, V42, P385; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Cook CH, 2006, J VIROL, V80, P9151, DOI 10.1128/JVI.00216-06; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; CRYZ SJ, 1986, INFECT IMMUN, V54, P403, DOI 10.1128/IAI.54.2.403-407.1986; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Fusco PC, 2007, CLIN VACCINE IMMUNOL, V14, P577, DOI 10.1128/CVI.00009-07; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; HESTRIN H, 1949, J BIOL CHEM, V180, P249; Ho CY, 2000, IMMUNOPHARMACOLOGY, V46, P1, DOI 10.1016/S0162-3109(99)00124-1; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Keck S, 2010, J IMMUNOL, V184, P5809, DOI 10.4049/jimmunol.0901423; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lee CH, 2005, SCAND J INFECT DIS, V37, P905, DOI 10.1080/00365540500333624; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lin MH, 2009, MOL CELL PROTEOMICS, V8, P2613, DOI 10.1074/mcp.M900276-MCP200; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MARSILI M, 1980, CROAT CHEM ACTA, V53, P601; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; NOWAK TP, 1975, BIOCHIM BIOPHYS ACTA, V393, P115, DOI 10.1016/0005-2795(75)90221-4; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PREHM P, 1980, CARBOHYD RES, V78, P372, DOI 10.1016/0008-6215(80)90018-X; PURCELL WP, 1967, J CHEM ENG DATA, V12, P235, DOI 10.1021/je60033a020; RAY AK, 1987, CARBOHYD RES, V165, P77, DOI 10.1016/0008-6215(87)80079-4; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thomsen RW, 2007, CLIN INFECT DIS, V44, P1194, DOI 10.1086/513201; TOMAS JM, 1991, INFECT IMMUN, V59, P2006; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Verhoef R, 2002, CARBOHYD RES, V337, P1821, DOI 10.1016/S0008-6215(02)00280-X; WAEGHE TJ, 1983, CARBOHYD RES, V123, P281, DOI 10.1016/0008-6215(83)88484-5; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Williams P., 1990, Reviews in Medical Microbiology, V1, P196; Wu JH, 2006, CELL MICROBIOL, V8, P1467, DOI 10.1111/j.1462-5822.2006.00725.x; Wu JH, 2008, EXP BIOL MED, V233, P64, DOI 10.3181/0706-RM-170; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yang Ching-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P176; Yang FL, 2004, EUR J BIOCHEM, V271, P4545, DOI 10.1111/j.1432-1033.2004.04415.x; Yeh KM, 2006, J INFECT DIS, V194, P403, DOI 10.1086/505153; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	71	42	47	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21041	21051		10.1074/jbc.M111.222091	http://dx.doi.org/10.1074/jbc.M111.222091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21478151	Green Published, hybrid			2022-12-25	WOS:000291464700003
J	Nakamura, K; Nemani, VM; Azarbal, F; Skibinski, G; Levy, JM; Egami, K; Munishkina, L; Zhang, J; Gardner, B; Wakabayashi, J; Sesaki, H; Cheng, YF; Finkbeiner, S; Nussbaum, RL; Masliah, E; Edwards, RH				Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Skibinski, Gaia; Levy, Jon M.; Egami, Kiyoshi; Munishkina, Larissa; Zhang, Jue; Gardner, Brooke; Wakabayashi, Junko; Sesaki, Hiromi; Cheng, Yifan; Finkbeiner, Steven; Nussbaum, Robert L.; Masliah, Eliezer; Edwards, Robert H.			Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN FRAGMENT; TRANSGENIC MICE; COMPLEX-I; SACCHAROMYCES-CEREVISIAE; GAMMA-SYNUCLEIN; KNOCKOUT MICE; LEWY BODIES; AGGREGATION; MUTATION; DYSFUNCTION	The protein alpha-synuclein has a central role in Parkinson disease, but the mechanism by which it contributes to neural degeneration remains unknown. We now show that the expression of alpha-synuclein in mammalian cells, including neurons in vitro and in vivo, causes the fragmentation of mitochondria. The effect is specific for synuclein, with more fragmentation by alpha- than beta- or gamma-isoforms, and it is not accompanied by changes in the morphology of other organelles or in mitochondrial membrane potential. However, mitochondrial fragmentation is eventually followed by a decline in respiration and neuronal death. The fragmentation does not require the mitochondrial fission protein Drp1 and involves a direct interaction of synuclein with mitochondrial membranes. In vitro, synuclein fragments artificial membranes containing the mitochondrial lipid cardiolipin, and this effect is specific for the small oligomeric forms of synuclein. alpha-Synuclein thus exerts a primary and direct effect on the morphology of an organelle long implicated in the pathogenesis of Parkinson disease.	[Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Biomed Sci, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Cell Biol, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Neurosci, Dept Physiol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Biomed Sci, Dept Physiol, San Francisco, CA 94158 USA; [Nakamura, Ken; Nemani, Venu M.; Azarbal, Farnaz; Levy, Jon M.; Zhang, Jue; Gardner, Brooke; Finkbeiner, Steven; Edwards, Robert H.] Univ Calif San Francisco, Grad Program Cell Biol, Dept Physiol, San Francisco, CA 94158 USA; [Nakamura, Ken; Skibinski, Gaia; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Skibinski, Gaia; Finkbeiner, Steven] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA 94158 USA; [Skibinski, Gaia; Finkbeiner, Steven] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Egami, Kiyoshi; Cheng, Yifan] Univ Calif San Francisco, Grad Program Biophys, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Munishkina, Larissa] Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA; [Wakabayashi, Junko; Sesaki, Hiromi] Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21205 USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Dept Med, Div Med Genet, San Francisco, CA 94143 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Diego	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, 600 16th St,Genentech Hall N272B, San Francisco, CA 94158 USA.	robert.edwards@ucsf.edu		Cheng, Yifan/0000-0001-9535-0369; Nakamura, Ken/0000-0002-9192-182X; Nemani, Venu/0000-0001-8895-7090	National Institutes of Health [GM089853]; NINDS [2R01NS39074, 1KO8NS062954-01A1, NS057096]; NIA [P01AG022074, AG18440, AG022074]; NIDA [DA10154]; Hillblom Foundation; Alzheimer's Disease Research Center; Burroughs-Wellcome Medical Scientist Fund Carrer Award; University of California San Francisco; Taube-Koret Center; McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039074, R01NS062715, P30NS057096, K08NS062954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG018440, P01AG022074, R01AG018440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Hillblom Foundation; Alzheimer's Disease Research Center; Burroughs-Wellcome Medical Scientist Fund Carrer Award(Burroughs Wellcome Fund); University of California San Francisco(University of California System); Taube-Koret Center; McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by Grant GM089853 from the National Institutes of Health (to H. S.), Grant 2R01NS39074 from NINDS and Grants 1KO8NS062954-01A1 (to K. N.), and NS057096 from NINDS (to E. M.), Grants P01AG022074, AG18440, and AG022074 from NIA, and Grant DA10154 from NIDA. This work was also supported by a postdoctoral fellowship from the Hillblom Foundation, an Alzheimer's Disease Research Center pilot grant, and a Burroughs-Wellcome Medical Scientist Fund Career Award (to K. N.), the University of California San Francisco Medical Scientist Training Program and a predoctoral fellowship from the Hillblom Foundation (to V. M. N.), postdoctoral fellowships from the Hillblom Foundation (to G. S.) and the Taube-Koret Center (to S. F.), and a Brain Disorders Award from the McKnight Foundation (to R. H. E.).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; HOVIUS R, 1993, FEBS LETT, V330, P71, DOI 10.1016/0014-5793(93)80922-H; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kruger R, 2001, NEUROLOGY, V56, P1355, DOI 10.1212/WNL.56.10.1355; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Liu JH, 2003, MOL CANCER RES, V1, P892; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Nakamura K, 2001, J BIOL CHEM, V276, P34402, DOI 10.1074/jbc.M103766200; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soper JH, 2008, MOL BIOL CELL, V19, P1093, DOI 10.1091/mbc.E07-08-0827; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Ward MW, 2000, J NEUROSCI, V20, P7208; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	102	414	418	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20710	20726		10.1074/jbc.M110.213538	http://dx.doi.org/10.1074/jbc.M110.213538			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489994	Green Published, hybrid			2022-12-25	WOS:000291267600057
J	Ali, YO; McCormack, R; Darr, A; Zhai, RG				Ali, Yousuf O.; McCormack, Ryan; Darr, Andrew; Zhai, R. Grace			Nicotinamide Mononucleotide Adenylyltransferase Is a Stress Response Protein Regulated by the Heat Shock Factor/Hypoxia-inducible Factor 1 alpha Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; LIFE-SPAN; OXIDATIVE STRESS; IN-VIVO; DROSOPHILA-MELANOGASTER; CHAPERONE SUPPRESSION; HYPOXIA REQUIRES; HSP70 GENE; NEURODEGENERATION	Stress responses are cellular processes essential for maintenance of cellular integrity and defense against environmental and intracellular insults. Neurodegenerative conditions are linked with inadequate stress responses. Several stress-responsive genes encoding neuroprotective proteins have been identified, and among them, the heat shock proteins comprise an important group of molecular chaperones that have neuroprotective functions. However, evidence for other critical stress-responsive genes is lacking. Recent studies on the NAD synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT) have uncovered a novel neuronal maintenance and protective function against activity-, injury-, or misfolded protein-induced degeneration in Drosophila and in mammalian neurons. Here, we show that NMNAT is also a novel stress response protein required for thermotolerance and mitigation of oxidative stress-induced shortened lifespan. NMNATis transcriptionally regulated during various stress conditions including heat shock and hypoxia through heat shock factor (HSF) and hypoxia-inducible factor 1 alpha in vivo. HSF binds to nmnat promoter and induces NMNAT expression under heat shock. In contrast, under hypoxia, HIF1 alpha up-regulates NMNAT indirectly through the induction of HSF. Our studies provide an in vivo mechanism for transcriptional regulation of NMNAT under stress and establish an essential role for this neuroprotective factor in cellular stress response.	[Ali, Yousuf O.; McCormack, Ryan; Zhai, R. Grace] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Darr, Andrew] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Darr, Andrew; Zhai, R. Grace] Univ Miami, Miller Sch Med, Grad Program Neurosci, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Zhai, RG (corresponding author), 1600 NW 10th Ave,RMSB 6069, Miami, FL 33136 USA.	gzhai@med.miami.edu	Zhai, R. Grace/AGZ-3936-2022	Zhai, Rong/0000-0002-7599-1430	American Heart Association; Miami Project Buoniconti Fund; National Institute for Neurological Disorder and Stroke [R01NS64269]; Pew Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS064269, R01NS064269] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Miami Project Buoniconti Fund; National Institute for Neurological Disorder and Stroke; Pew Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an American Heart Association Predoctoral Fellowship (to Y. O. A.), funds from the Miami Project Buoniconti Fund (to A. D.), National Institute for Neurological Disorder and Stroke Grant R01NS64269 (to R. G. Z.), and funds from the Pew Charitable Trust (to R. G. Z.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ali YO, 2010, MOLECULES, V15, P6859, DOI 10.3390/molecules15106859; Appenzeller O, 2006, J NEUROL SCI, V247, P93, DOI 10.1016/j.jns.2006.03.021; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; BANERJI SS, 1984, MOL CELL BIOL, V4, P2437, DOI 10.1128/MCB.4.11.2437; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bruder ED, 2007, PHYSIOL GENOMICS, V29, P193, DOI 10.1152/physiolgenomics.00245.2006; Camenisch G, 2001, PFLUG ARCH EUR J PHY, V443, P240, DOI 10.1007/s004240100679; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chan K, 2008, EUKARYOT CELL, V7, P1795, DOI 10.1128/EC.00160-08; CHOMYN A, 1979, DEV GENET, V1, P77, DOI 10.1002/dvg.1020010109; Cramer C T, 1995, J Biochem Toxicol, V10, P293, DOI 10.1002/jbt.2570100603; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Dougherty CJ, 2008, MOL VIS, V14, P471; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; Kim SY, 2006, GENE EXPR PATTERNS, V6, P504, DOI 10.1016/j.modgep.2005.10.009; Laifenfeld D, 2010, TOXICOL SCI, V113, P254, DOI 10.1093/toxsci/kfp213; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; Lee YJ, 1998, J BIOL CHEM, V273, P29857, DOI 10.1074/jbc.273.45.29857; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; MORIMOTO RI, 1998, ANNU REV BIOCHEM, V16, P959; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Romero NM, 2008, MOL CELL BIOL, V28, P3410, DOI 10.1128/MCB.01027-07; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; SCHILLER P, 1988, J MOL BIOL, V203, P97, DOI 10.1016/0022-2836(88)90094-0; Sittipunt Chanchai, 2005, Respir Care, V50, P383; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x	64	26	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					19089	19099		10.1074/jbc.M111.219295	http://dx.doi.org/10.1074/jbc.M111.219295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478149	Green Published, hybrid			2022-12-25	WOS:000290785700078
J	Kang, S; Chemaly, ER; Hajjar, RJ; Lebeche, D				Kang, Soojeong; Chemaly, Elie R.; Hajjar, Roger J.; Lebeche, Djamel			Resistin Promotes Cardiac Hypertrophy via the AMP-activated Protein Kinase/Mammalian Target of Rapamycin (AMPK/mTOR) and c-Jun N-terminal Kinase/Insulin Receptor Substrate 1 (JNK/IRS1) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; INSULIN-RECEPTOR; HEART-FAILURE; DIABETIC CARDIOMYOPATHY; THERAPEUTIC TARGET; MAMMALIAN TARGET; PHOSPHORYLATION; GLUCOSE; OBESITY; MTOR	Resistin has been suggested to be involved in the development of diabetes and insulin resistance. We recently reported that resistin is expressed in diabetic hearts and promotes cardiac hypertrophy; however, the mechanisms underlying this process are currently unknown. Therefore, we wanted to elucidate the mechanisms associated with resistin-induced cardiac hypertrophy and myocardial insulin resistance. Overexpression of resistin using adenoviral vector in neonatal rat ventricular myocytes was associated with inhibition of AMP-activated protein kinase (AMPK) activity, activation of tuberous sclerosis complex 2/mammalian target of rapamycin (mTOR) pathway, and increased cell size, [H-3]leucine incorporation (i.e. protein synthesis) and mRNA expression of the hypertrophic marker genes, atrial natriuretic factor, brain natriuretic peptide, and beta-myosin heavy chain. Activation of AMPK with 5-aminoimidazole-4-carbozamide-1-beta-D-ribifuranoside or inhibition of mTOR with rapamycin or mTOR siRNA attenuated these resistin-induced changes. Furthermore, resistin increased serine phosphorylation of insulin receptor substrate (IRS1) through the activation of the apoptosis signal-regulating kinase 1/c-Jun N-terminal Kinase (JNK) pathway, a module known to stimulate insulin resistance. Inhibition of JNK (with JNK inhibitor SP600125 or using dominant-negative JNK) reduced serine 307 phosphorylation of IRS1. Resistin also stimulated the activation of p70(S6K), a downstream kinase target of mTOR, and increased phosphorylation of the IRS1 serine 636/639 residues, whereas treatment with rapamycin reduced the phosphorylation of these residues. Interestingly, these in vitro signaling pathways were also operative in vivo in ventricular tissues from adult rat hearts overexpressing resistin. These data demonstrate that resistin induces cardiac hypertrophy and myocardial insulin resistance, possibly via the AMPK/mTOR/p70(S6K) and apoptosis signal-regulating kinase 1/JNK/IRS1 pathways.	[Kang, Soojeong; Chemaly, Elie R.; Hajjar, Roger J.; Lebeche, Djamel] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Lebeche, D (corresponding author), Mt Sinai Sch Med, Cardiovasc Res Ctr, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	djamel.lebeche@mssm.edu			NHLBI National Institutes of Health; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by an NHLBI National Institutes of Health grant (to D. L. and R. J. H.) and a National Institutes of Health training grant (to E. R. C.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chemaly ER, 2008, CIRCULATION, V118, pS487; Del Monte F, 2002, PHYSIOL GENOMICS, V9, P49, DOI 10.1152/physiolgenomics.00035.2001; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; McGaffin KR, 2011, CARDIOVASC RES, V89, P60, DOI 10.1093/cvr/cvq288; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wang BW, 2007, AM J PHYSIOL-HEART C, V293, pH2305, DOI 10.1152/ajpheart.00361.2007; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066	43	87	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18465	18473		10.1074/jbc.M110.200022	http://dx.doi.org/10.1074/jbc.M110.200022			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21478152	Green Published, hybrid			2022-12-25	WOS:000290785700019
J	Lee, SB; Warthaka, M; Yan, CL; Kaoud, TS; Piserchio, A; Ghose, R; Ren, PY; Dalby, KN				Lee, Sunbae; Warthaka, Mangalika; Yan, Chunli; Kaoud, Tamer S.; Piserchio, Andrea; Ghose, Ranajeet; Ren, Pengyu; Dalby, Kevin N.			A Model of a MAPK center dot Substrate Complex in an Active Conformation: A Computational and Experimental Approach	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SIGNAL-REGULATED KINASE; TRANSCRIPTION FACTOR; DOCKING INTERACTIONS; KINETIC MECHANISM; POINTED DOMAIN; ERK2; PHOSPHORYLATION; BINDING; SITES	The mechanisms by which MAP kinases recognize and phosphorylate substrates are not completely understood. Efforts to understand the mechanisms have been compromised by the lack of MAPK-substrate structures. While MAPK-substrate docking is well established as a viable mechanism for bringing MAPKs and substrates into close proximity the molecular details of how such docking promotes phosphorylation is an unresolved issue. In the present study computer modeling approaches, with restraints derived from experimentally known interactions, were used to predict how the N-terminus of Ets-1 associates with ERK2. Interestingly, the N-terminus does not contain a consensus-docking site ((R/K)(2-3)-X2-6-Phi(A)-X-Phi(B), where Phi is aliphatic hydrophobic) for ERK2. The modeling predicts that the N-terminus of Ets-1 makes important contributions to the stabilization of the complex, but remains largely disordered. The computer-generated model was used to guide mutagenesis experiments, which support the notion that Leu-11 and possibly Ile-13 and Ile-14 of Ets-1 1-138 (Ets) make contributions through binding to the hydrophobic groove of the ERK2 D-recruiting site (DRS). Based on the modeling, a consensus-docking site was introduced through the introduction of an arginine at residue 7, to give the consensus (RK)-R-7-X-2-Phi(A)-X-Phi(13)(B). This results in a 2-fold increase in k(cat)/K-m for the phosphorylation of Ets by ERK2. Similarly, the substitution of the N-terminus for two different consensus docking sites derived from Elk-1 and MKK1 also improves k(cat)/K-m by two-fold compared to Ets. Disruption of the N-terminal docking through deletion of residues 1-23 of Ets results in a 14-fold decrease in k(cat)/K-m, with little apparent change in k(cat). A peptide that binds to the DRS of ERK2 affects K-m, but not k(cat). Our kinetic analysis suggests that the unstructured N-terminus provides 10-fold uniform stabilization of the ground state ERK2 center dot Ets center dot MgATP complex and intermediates of the enzymatic reaction.	[Lee, Sunbae; Warthaka, Mangalika; Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA; [Yan, Chunli; Ren, Pengyu] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Pharm, Austin, TX 78712 USA; [Piserchio, Andrea; Ghose, Ranajeet] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Ghose, Ranajeet] CUNY, Grad Ctr, New York, NY USA; [Ren, Pengyu; Dalby, Kevin N.] Univ Texas Austin, Grad Program Biomed Engn, Austin, TX 78712 USA; [Dalby, Kevin N.] Univ Texas Austin, Grad Program Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, SB (corresponding author), Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA.	pren@mail.utexas.edu; kinases@me.com	Kaoud, Tamer S/C-3618-2019; Dalby, Kevin N/A-1905-2013; Ren, Pengyu/Q-6872-2017; Yan, Chunli/E-5292-2012	Kaoud, Tamer S/0000-0003-1298-8725; Dalby, Kevin N/0000-0001-9272-5129; Ren, Pengyu/0000-0002-5613-1910; Yan, Chunli/0000-0001-5742-120X	National Institute of General Medical Sciences [R01GM059802, R01 GM079686, R01 GM084278]; Welch Foundation [F-1390]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802, R01GM079686, R01GM084278] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was from grants from the National Institute of General Medical Sciences to KND (R01GM059802) 2) to PR (R01 GM079686) and to RG (R01 GM084278). The Welch Foundation also supported KND (F-1390). Computing resources were provided by TeraGrid (MCB100057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramczyk O, 2007, BIOCHEMISTRY-US, V46, P9174, DOI 10.1021/bi7002058; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Callaway K, 2010, BIOCHEMISTRY-US, V49, P3619, DOI 10.1021/bi100199q; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hobeika M, 2009, J BIOL CHEM, V284, P17575, DOI 10.1074/jbc.M109.004374; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Waas WF, 2003, BIOCHEMISTRY-US, V42, P12273, DOI 10.1021/bi0348617; Waas WF, 2002, J BIOL CHEM, V277, P12532, DOI 10.1074/jbc.M110523200; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	36	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18594	10.1371/journal.pone.0018594	http://dx.doi.org/10.1371/journal.pone.0018594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494553	gold, Green Published			2022-12-25	WOS:000289354100024
J	Fu, JL; Reinhold, J; Woodbury, NW				Fu, Jinglin; Reinhold, Jeremy; Woodbury, Neal W.			Peptide-Modified Surfaces for Enzyme Immobilization	PLOS ONE			English	Article							ORIENTATION; PROTEINS	Background: Chemistry and particularly enzymology at surfaces is a topic of rapidly growing interest, both in terms of its role in biological systems and its application in biocatalysis. Existing protein immobilization approaches, including noncovalent or covalent attachments to solid supports, have difficulties in controlling protein orientation, reducing nonspecific absorption and preventing protein denaturation. New strategies for enzyme immobilization are needed that allow the precise control over orientation and position and thereby provide optimized activity. Methodology/Principal Findings: A method is presented for utilizing peptide ligands to immobilize enzymes on surfaces with improved enzyme activity and stability. The appropriate peptide ligands have been rapidly selected from high-density arrays and when desirable, the peptide sequences were further optimized by single-point variant screening to enhance both the affinity and activity of the bound enzyme. For proof of concept, the peptides that bound to beta-galactosidase and optimized its activity were covalently attached to surfaces for the purpose of capturing target enzymes. Compared to conventional methods, enzymes immobilized on peptide-modified surfaces exhibited higher specific activity and stability, as well as controlled protein orientation. Conclusions/Significance: A simple method for immobilizing enzymes through specific interactions with peptides anchored on surfaces has been developed. This approach will be applicable to the immobilization of a wide variety of enzymes on surfaces with optimized orientation, location and performance, and provides a potential mechanism for the patterned self-assembly of multiple enzymes on surfaces.	[Fu, Jinglin; Reinhold, Jeremy; Woodbury, Neal W.] Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA; [Fu, Jinglin] Arizona State Univ, Biodesign Inst, Ctr Innovat Med, Tempe, AZ USA; [Fu, Jinglin; Reinhold, Jeremy; Woodbury, Neal W.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Fu, JL (corresponding author), Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA.	nwoodbury@asu.edu	Fu, Jinglin/F-3589-2012		Technology and Research Initiative Funds (TRIF); National Science Foundation [SKS0045]	Technology and Research Initiative Funds (TRIF); National Science Foundation(National Science Foundation (NSF))	This work was supported by Technology and Research Initiative Funds (TRIF) provided to Dr. Neal Woodbury by ASU, the Edson Student Entrepreneur Initiative provided to Dr. Jinglin Fu at ASU, and the National Science Foundation (SKS0045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIODUPONT M, 1988, FEBS LETT, V240, P181, DOI 10.1016/0014-5793(88)80364-8; Boltz KW, 2009, ANALYST, V134, P650, DOI 10.1039/b823156g; Cha T, 2005, PROTEOMICS, V5, P416, DOI 10.1002/pmic.200400948; Clarizia LJ, 2009, ANAL BIOANAL CHEM, V393, P1531, DOI 10.1007/s00216-008-2567-x; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Fu JL, 2010, J AM CHEM SOC, V132, P6419, DOI 10.1021/ja100403a; GREVING MP, 2010, PLOS ONE IN PRESS; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jung YW, 2008, ANAL BIOCHEM, V374, P99, DOI 10.1016/j.ab.2007.10.022; Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006; Laurent N, 2008, TRENDS BIOTECHNOL, V26, P328, DOI 10.1016/j.tibtech.2008.03.003; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Naffin JL, 2003, CHEM BIOL, V10, P251, DOI 10.1016/S1074-5521(03)00049-8; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735	18	39	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18692	10.1371/journal.pone.0018692	http://dx.doi.org/10.1371/journal.pone.0018692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494577	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800038
J	Kolatsi-Joannou, M; Price, KL; Winyard, PJ; Long, DA				Kolatsi-Joannou, Maria; Price, Karen L.; Winyard, Paul J.; Long, David A.			Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; PROSTATE-CANCER CELLS; FOLIC-ACID; GROWTH-FACTOR; MOUSE KIDNEY; RAT; APOPTOSIS; INHIBITION; FIBROSIS; PROLIFERATION	Galectin-3 is a beta-galactoside binding lectin with roles in diverse processes including proliferation, apoptosis, inflammation and fibrosis which are dependent on different domains of the molecule and subcellular distribution. Although galectin-3 is known to be upregulated in acute kidney injury, the relative importance of its different domains and functions are poorly understood in the underlying pathogenesis. Therefore we experimentally modulated galectin-3 in folic acid (FA)-induced acute kidney injury utilising modified citrus pectin (MCP), a derivative of pectin which can bind to the galectin-3 carbohydrate recognition domain thereby predominantly antagonising functions linked to this role. Mice were pre-treated with normal or 1% MCP-supplemented drinking water one week before FA injection. During the initial injury phase, all FA-treated mice lost weight whilst their kidneys enlarged secondary to the renal insult; these gross changes were significantly lessened in the MCP group but this was not associated with significant changes in galectin-3 expression. At a histological level, MCP clearly reduced renal cell proliferation but did not affect apoptosis. Later, during the recovery phase at two weeks, MCP-treated mice demonstrated reduced galectin-3 in association with decreased renal fibrosis, macrophages, proinflammatory cytokine expression and apoptosis. Other renal galectins, galectin-1 and -9, were unchanged. Our data indicates that MCP is protective in experimental nephropathy with modulation of early proliferation and later galectin-3 expression, apoptosis and fibrosis. This raises the possibility that MCP may be a novel strategy to reduce renal injury in the long term, perhaps via carbohydrate binding-related functions of galectin-3.	[Kolatsi-Joannou, Maria; Price, Karen L.; Winyard, Paul J.; Long, David A.] UCL, Inst Child Hlth, Nephrourol Unit, London, England	University of London; University College London	Kolatsi-Joannou, M (corresponding author), UCL, Inst Child Hlth, Nephrourol Unit, London, England.	d.long@ich.ucl.ac.uk	Price, Karen L/A-5323-2009; Long, David/I-3254-2019	Long, David/0000-0001-6580-3435; Price, Karen/0000-0002-8113-1461	Kidney Research UK [RP33/2008]; Senior Non-Clinical Fellowship [SF1/2008]; Kids Kidney Research; Kidney Research UK [SF1/2008] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Senior Non-Clinical Fellowship; Kids Kidney Research(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK))	This work was funded by Kidney Research UK (project grant to PJW and DAL (RP33/2008) and a Senior Non-Clinical Fellowship (to DAL, SF1/2008)) and Kids Kidney Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahani S, 1997, CANCER RES, V57, P5272; Baba M, 2005, J AM SOC NEPHROL, V16, P3222, DOI 10.1681/ASN.2004110915; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BASERGA R, 1968, LAB INVEST, V19, P92; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; Bullock SL, 2001, J AM SOC NEPHROL, V12, P515, DOI 10.1681/ASN.V123515; Chiu MG, 2006, AM J PATHOL, V169, P1925, DOI 10.2353/ajpath.2006.060245; COLES HSR, 1993, DEVELOPMENT, V118, P777; Davidson PJ, 2002, GLYCOBIOLOGY, V12, P329, DOI 10.1093/glycob/12.5.329; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Bertocchi APF, 2008, TRANSPL INT, V21, P999, DOI 10.1111/j.1432-2277.2008.00705.x; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Gunning AP, 2009, FASEB J, V23, P415, DOI 10.1096/fj.08-106617; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; INOHARA H, 1994, GLYCOCONJUGATE J, V11, P527, DOI 10.1007/BF00731303; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; JENG KCG, 1994, IMMUNOL LETT, V42, P113, DOI 10.1016/0165-2478(94)90072-8; Johnson KD, 2007, NEOPLASIA, V9, P662, DOI 10.1593/neo.07433; Kang EH, 2009, LUPUS, V18, P22, DOI 10.1177/0961203308094361; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Lin HM, 2002, ONCOGENE, V21, P8001, DOI 10.1038/sj.onc.1205820; LIU FT, 1995, AM J PATHOL, V147, P1016; LIU FT, 2002, BIOCHIM BIOPHYS ACTA, V19, P263; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Long DA, 2008, KIDNEY INT, V74, P300, DOI 10.1038/ki.2008.179; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Morris VJ, 2011, FOOD HYDROCOLLOID, V25, P230, DOI 10.1016/j.foodhyd.2009.11.015; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nishiyama J, 2000, AM J PATHOL, V157, P815, DOI 10.1016/S0002-9440(10)64595-6; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Okamura DM, 2011, AM J PHYSIOL-RENAL, V300, pF245, DOI 10.1152/ajprenal.00326.2010; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; Price KL, 2009, J UROLOGY, V181, P2366, DOI 10.1016/j.juro.2009.01.001; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sasaki S, 1999, J PATHOL, V187, P481, DOI 10.1002/(SICI)1096-9896(199903)187:4<481::AID-PATH263>3.0.CO;2-2; Sathisha UV, 2007, GLYCOCONJUGATE J, V24, P497, DOI 10.1007/s10719-007-9042-3; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Shimizu M, 2009, LAB INVEST, V89, P178, DOI 10.1038/labinvest.2008.125; Tsuchiyama Y, 2000, KIDNEY INT, V58, P1941, DOI 10.1111/j.1523-1755.2000.00366.x; Winyard PJD, 1997, J AM SOC NEPHROL, V8, P1647; Yan J, 2010, INTEGR CANCER THER, V9, P197, DOI 10.1177/1534735410369672; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; ZIMMERMANN HD, 1977, VIRCHOWS ARCH A, V376, P47, DOI 10.1007/BF00433084	50	104	118	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18683	10.1371/journal.pone.0018683	http://dx.doi.org/10.1371/journal.pone.0018683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494626	Green Published, gold			2022-12-25	WOS:000289292800036
J	Lugo, JE; Doti, R; Faubert, J				Lugo, Jesus Eduardo; Doti, Rafael; Faubert, Jocelyn			Negative Refraction Angular Characterization in One-Dimensional Photonic Crystals	PLOS ONE			English	Article							POROUS SILICON; BLOCH WAVES; MULTILAYERS; LIGHT	Background: Photonic crystals are artificial structures that have periodic dielectric components with different refractive indices. Under certain conditions, they abnormally refract the light, a phenomenon called negative refraction. Here we experimentally characterize negative refraction in a one dimensional photonic crystal structure; near the low frequency edge of the fourth photonic bandgap. We compare the experimental results with current theory and a theory based on the group velocity developed here. We also analytically derived the negative refraction correctness condition that gives the angular region where negative refraction occurs. Methodology/Principal Findings: By using standard photonic techniques we experimentally determined the relationship between incidence and negative refraction angles and found the negative refraction range by applying the correctness condition. In order to compare both theories with experimental results an output refraction correction was utilized. The correction uses Snell's law and an effective refractive index based on two effective dielectric constants. We found good agreement between experiment and both theories in the negative refraction zone. Conclusions/Significance: Since both theories and the experimental observations agreed well in the negative refraction region, we can use both negative refraction theories plus the output correction to predict negative refraction angles. This can be very useful from a practical point of view for space filtering applications such as a photonic demultiplexer or for sensing applications.	[Lugo, Jesus Eduardo; Doti, Rafael; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada	Universite de Montreal	Lugo, JE (corresponding author), Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada.	je.lugo.arce@umontreal.ca	Faubert, Jocelyn/E-2207-2011		NSERC-Essilor Research Chair; NSERC	NSERC-Essilor Research Chair(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC-Essilor Research Chair and an NSERC operating grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, MRS BULL, V33, P927, DOI 10.1557/mrs2008.201; Boedecker G, 2003, OPT EXPRESS, V11, P1590, DOI 10.1364/OE.11.001590; Foteinopoulou S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.165112; Gerken M, 2003, IEEE PHOTONIC TECH L, V15, P1097, DOI 10.1109/LPT.2003.815318; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Kavokin AV, 2005, PHYS LETT A, V339, P387, DOI 10.1016/j.physleta.2005.02.077; Kosaka H, 1999, APPL PHYS LETT, V74, P1212, DOI 10.1063/1.123502; Kosaka H, 1998, PHYS REV B, V58, P10096, DOI 10.1103/PhysRevB.58.R10096; Lugo J. E., 2009, OPT EXPRESS, V17, P3036; Nava R, 2009, PHYS STATUS SOLIDI C, V6, P1721, DOI 10.1002/pssc.200881090; Notomi M, 2002, OPT QUANT ELECTRON, V34, P133, DOI 10.1023/A:1013300825612; Pavesi L, 1997, RIV NUOVO CIMENTO, V20, P1, DOI 10.1007/BF02877374; Russell PS, 1996, NATO ADV SCI INST SE, V315, P71; RUSSELL PSJ, 1986, PHYS REV A, V33, P3232, DOI 10.1103/PhysRevA.33.3232; RUSSELL PSJ, 1995, NATO ADV SCI I B-PHY, V340, P585; Russell PStJ, 1986, APPL PHYS B, V39, P23; Srivastava R, 2008, SOLID STATE COMMUN, V147, P157, DOI 10.1016/j.ssc.2008.04.036; YUAN YC, 2007, CHINESE PHYS, V16, P173; Zeng Y, 2006, SOLID STATE COMMUN, V138, P205, DOI 10.1016/j.ssc.2006.02.019; ZENGERLE R, 1987, J MOD OPTIC, V34, P1589, DOI 10.1080/09500348714551531	20	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e17188	10.1371/journal.pone.0017188	http://dx.doi.org/10.1371/journal.pone.0017188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494332	gold, Green Submitted, Green Published			2022-12-25	WOS:000289192400003
J	Kovochich, M; Marsden, MD; Zack, JA				Kovochich, Michael; Marsden, Matthew D.; Zack, Jerome A.			Activation of Latent HIV Using Drug-Loaded Nanoparticles	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IMMUNODEFICIENCY-VIRUS TYPE-1; NON-HODGKINS-LYMPHOMA; CELLS-IN-VITRO; BRYOSTATIN 1; PHASE-II; T-CELLS; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; LIPOSOMES	Antiretroviral therapy is currently only capable of controlling HIV replication rather than completely eradicating virus from patients. This is due in part to the establishment of a latent virus reservoir in resting CD4(+) T cells, which persists even in the presence of HAART. It is thought that forced activation of latently infected cells could induce virus production, allowing targeting of the cell by the immune response. A variety of molecules are able to stimulate HIV from latency. However no tested purging strategy has proven capable of eliminating the infection completely or preventing viral rebound if therapy is stopped. Hence novel latency activation approaches are required. Nanoparticles can offer several advantages over more traditional drug delivery methods, including improved drug solubility, stability, and the ability to simultaneously target multiple different molecules to particular cell or tissue types. Here we describe the development of a novel lipid nanoparticle with the protein kinase C activator bryostatin-2 incorporated (LNP-Bry). These particles can target and activate primary human CD4(+) T-cells and stimulate latent virus production from human T-cell lines in vitro and from latently infected cells in a humanized mouse model ex vivo. This activation was synergistically enhanced by the HDAC inhibitor sodium butyrate. Furthermore, LNP-Bry can also be loaded with the protease inhibitor nelfinavir (LNP-Bry-Nel), producing a particle capable of both activating latent virus and inhibiting viral spread. Taken together these data demonstrate the ability of nanotechnological approaches to provide improved methods for activating latent HIV and provide key proof-of-principle experiments showing how novel delivery systems may enhance future HIV therapy.	[Kovochich, Michael; Zack, Jerome A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kovochich, M (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	jzack@ucla.edu			NIH [AI070010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI070010 and by the UCLA CFAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlen PA, 2006, J VIROL, V80, P1599, DOI 10.1128/JVI.80.3.1599-1603.2006; Baert L, 2009, EUR J PHARM BIOPHARM, V72, P502, DOI 10.1016/j.ejpb.2009.03.006; Brooks DG, 2002, J VIROL, V76, P1673, DOI 10.1128/JVI.76.4.1673-1681.2002; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Brooks DG, 2003, P NATL ACAD SCI USA, V100, P12955, DOI 10.1073/pnas.2233345100; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; CAGDAS FM, PHARM DEV TECHNOL; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Desormeaux A, 2005, METHOD ENZYMOL, V391, P330, DOI 10.1016/S0076-6879(05)91019-7; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; Dutta T, 2008, EUR J PHARM SCI, V34, P181, DOI 10.1016/j.ejps.2008.04.002; Dutta T, 2007, J DRUG TARGET, V15, P89, DOI 10.1080/10611860600965914; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; GABIZON A, 1994, CANCER RES, V54, P987; GABIZON A, 1994, ACTA ONCOL, V33, P779, DOI 10.3109/02841869409083948; Gagne JF, 2002, BBA-BIOMEMBRANES, V1558, P198, DOI 10.1016/S0005-2736(01)00432-1; Garg M, 2006, J PHARM PHARMACOL, V58, P605, DOI 10.1211/jpp.58.5.0005; HANSEN CB, 1995, BBA-BIOMEMBRANES, V1239, P133, DOI 10.1016/0005-2736(95)00138-S; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kaur CD, 2008, J DRUG TARGET, V16, P798, DOI 10.1080/10611860802475688 ; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; LAUGHLIN MA, 1993, VIROLOGY, V196, P496, DOI 10.1006/viro.1993.1505; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Levchenko TS, 2002, INT J PHARMACEUT, V240, P95, DOI 10.1016/S0378-5173(02)00129-1; Lindkvist Annica, 2009, AIDS Res Ther, V6, P15, DOI 10.1186/1742-6405-6-15; MEHLA R, PLOS ONE, V5; Mohammad RM, 1998, CLIN CANCER RES, V4, P445; Mutter R, 2000, BIOORGAN MED CHEM, V8, P1841, DOI 10.1016/S0968-0896(00)00150-4; Oussoren C, 2001, ADV DRUG DELIVER REV, V50, P143, DOI 10.1016/S0169-409X(01)00154-5; PEREZ M, CURR HIV RES; PETROS RA, NAT REV DRUG DISCOV, V9, P615; Pollock S, 2008, AIDS, V22, P1961, DOI 10.1097/QAD.0b013e32830efd96; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Propper DJ, 1998, BRIT J CANCER, V78, P1337, DOI 10.1038/bjc.1998.680; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; Varterasian ML, 2000, CLIN CANCER RES, V6, P825; Varterasian ML, 2001, INVEST NEW DRUG, V19, P245, DOI 10.1023/A:1010676719178; Varterasian ML, 1998, J CLIN ONCOL, V16, P56, DOI 10.1200/JCO.1998.16.1.56; VLACH J, 1992, VIROLOGY, V187, P63, DOI 10.1016/0042-6822(92)90295-Z; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400	49	69	74	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18270	10.1371/journal.pone.0018270	http://dx.doi.org/10.1371/journal.pone.0018270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483687	Green Submitted, gold, Green Published			2022-12-25	WOS:000289191300015
J	Melby, ES; Soldat, DJ; Barak, P				Melby, Eric S.; Soldat, Douglas J.; Barak, Phillip			Synthesis and Detection of Oxygen-18 Labeled Phosphate	PLOS ONE			English	Article							OXYGEN ISOTOPIC COMPOSITION; PHOSPHORUS; WATER	Phosphorus (P) has only one stable isotope and therefore tracking P dynamics in ecosystems and inferring sources of P loading to water bodies have been difficult. Researchers have recently employed the natural abundance of the ratio of O-18/O-16 of phosphate to elucidate P dynamics. In addition, phosphate highly enriched in oxygen-18 also has potential to be an effective tool for tracking specific sources of P in the environment, but has so far been used sparingly, possibly due to unavailability of oxygen-18 labeled phosphate (OLP) and uncertainty in synthesis and detection. One objective of this research was to develop a simple procedure to synthesize highly enriched OLP. Synthesized OLP is made up of a collection of species that contain between zero and four oxygen-18 atoms and, as a result, the second objective of this research was to develop a method to detect and quantify each OLP species. OLP was synthesized by reacting either PCl5 or POCl3 with water enriched with 97 atom % oxygen-18 in ambient atmosphere under a fume hood. Unlike previous reports, we observed no loss of oxygen-18 enrichment during synthesis. Electrospray ionization mass spectrometertry (ESI-MS) was used to detect and quantify each species present in OLP. OLP synthesized from POCl3 contained 1.2% (PO16O3)-O-18, 18.2% (PO2O2)-O-18-O-16, 67.7% (PO3O)-O-18-O-16, and 12.9% (PO4)-O-18, and OLP synthesized from PCl5 contained 0.7% (PO4)-O-16, 9.3% (PO3O)-O-18-O-16, and 90.0% (PO4)-O-18. We found that OLP can be synthesized using a simple procedure in ambient atmosphere without the loss of oxygen-18 enrichment and ESI-MS is an effective tool to detect and quantify OLP that sheds light on the dynamics of synthesis in ways that standard detection methods cannot.	[Melby, Eric S.; Soldat, Douglas J.; Barak, Phillip] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Melby, ES (corresponding author), Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA.	djsoldat@wisc.edu	Melby, Eric/Z-2879-2019	Barak, Phillip/0000-0002-1033-3795; Soldat, Douglas/0000-0002-2323-7786	University of Wisconsin-Madison Graduate School	University of Wisconsin-Madison Graduate School	This research was funded by the University of Wisconsin-Madison Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2000, INT J MASS SPECTROM, V203, P177, DOI 10.1016/S1387-3806(00)00297-9; Blake RE, 2005, AM J SCI, V305, P596, DOI 10.2475/ajs.305.6-8.596; Blumenthal E, 1937, T FARADAY SOC, V33, P0849, DOI 10.1039/tf9373300849; Colman AS, 2005, P NATL ACAD SCI USA, V102, P13023, DOI 10.1073/pnas.0506455102; Elsbury KE, 2009, ENVIRON SCI TECHNOL, V43, P3108, DOI 10.1021/es8034126; Gruau G, 2005, WATER RES, V39, P232, DOI 10.1016/j.watres.2004.08.035; JOHANSEN HS, 1989, APPL RADIAT ISOTOPES, V40, P641; JOHANSEN HS, 1988, APPL RADIAT ISOTOPES, V39, P1059, DOI 10.1016/0883-2889(88)90141-4; LARSEN S, 1989, PLANT SOIL, V117, P143, DOI 10.1007/BF02206267; Markel Doron, 1994, Israel Journal of Earth Sciences, V43, P165; McLaughlin K, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000079; McLaughlin K, 2006, ESTUAR COAST SHELF S, V70, P499, DOI 10.1016/j.ecss.2006.06.030; MIDDELBOE V, 1992, APPL RADIAT ISOTOPES, V43, P1167; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; RAY WJ, 1992, J LABELLED COMPD RAD, V31, P637, DOI 10.1002/jlcr.2580310810; RISLEY JM, 1978, J LABELLED COMPD RAD, V15, P533, DOI 10.1002/jlcr.2580150162; Young MB, 2009, ENVIRON SCI TECHNOL, V43, P5190, DOI 10.1021/es900337q	17	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18420	10.1371/journal.pone.0018420	http://dx.doi.org/10.1371/journal.pone.0018420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483747	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058700026
J	Daus, ML; Breyer, J; Wagenfuehr, K; Wemheuer, WM; Thomzig, A; Schulz-Schaeffer, WJ; Beekes, M				Daus, Martin L.; Breyer, Johanna; Wagenfuehr, Katja; Wemheuer, Wiebke M.; Thomzig, Achim; Schulz-Schaeffer, Walter J.; Beekes, Michael			Presence and Seeding Activity of Pathological Prion Protein (PrPTSE) in Skeletal Muscles of White-Tailed Deer Infected with Chronic Wasting Disease	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; CREUTZFELDT-JAKOB-DISEASE; CERVUS-ELAPHUS-NELSONI; ODOCOILEUS-VIRGINIANUS; PRPSC ACCUMULATION; TRANSGENIC MICE; MULE DEER; SCRAPIE; HAMSTERS; AGGREGATION	Chronic wasting disease (CWD) is a contagious, rapidly spreading transmissible spongiform encephalopathy (TSE), or prion disease, occurring in cervids such as white tailed-deer (WTD), mule deer or elk in North America. Despite efficient horizontal transmission of CWD among cervids natural transmission of the disease to other species has not yet been observed. Here, we report for the first time a direct biochemical demonstration of pathological prion protein PrPTSE and of PrPTSE-associated seeding activity, the static and dynamic biochemical markers for biological prion infectivity, respectively, in skeletal muscles of CWD-infected cervids, i.e. WTD for which no clinical signs of CWD had been recognized. The presence of PrPTSE was detected by Western-and postfixed frozen tissue blotting, while the seeding activity of PrPTSE was revealed by protein misfolding cyclic amplification (PMCA). Semi-quantitative Western blotting indicated that the concentration of PrPTSE in skeletal muscles of CWD-infected WTD was approximately 2000-10000 - fold lower than in brain tissue. Tissue-blot-analyses revealed that PrPTSE was located in muscle-associated nerve fascicles but not, in detectable amounts, in myocytes. The presence and seeding activity of PrPTSE in skeletal muscle from CWD-infected cervids suggests prevention of such tissue in the human diet as a precautionary measure for food safety, pending on further clarification of whether CWD may be transmissible to humans.	[Daus, Martin L.; Wagenfuehr, Katja; Thomzig, Achim; Beekes, Michael] Robert Koch Inst, D-1000 Berlin, Germany; [Breyer, Johanna; Wemheuer, Wiebke M.; Schulz-Schaeffer, Walter J.] Univ Med Ctr Gottingen, Dept Neuropathol, Prion & Dementia Res Unit, Gottingen, Germany	Robert Koch Institute; University of Gottingen	Daus, ML (corresponding author), Robert Koch Inst, D-1000 Berlin, Germany.	BeekesM@rki.de	Beekes, Michael/S-1975-2018	Beekes, Michael/0000-0002-6454-6657; Jurgens-Wemheuer, Wiebke/0000-0002-1234-3321	Alberta Prion Research Institute (APRI)	Alberta Prion Research Institute (APRI)	The study was sponsored by the Alberta Prion Research Institute (APRI, www.prioninstitute.ca), and the study was carried out within the APRI-sponsored research project "Comprehensive risk assessment of Chronic Wasting Disease (CWD) transmission to humans using non-human primates". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Balachandran A, 2010, CAN VET J, V51, P169; BEEKES M, 1995, J GEN VIROL, V76, P2567, DOI 10.1099/0022-1317-76-10-2567; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Brown P, 2005, LANCET, V365, P122, DOI 10.1016/S0140-6736(05)17700-9; Caughey B, 1997, J VIROL, V71, P4107, DOI 10.1128/JVI.71.5.4107-4110.1997; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Hamir AN, 2008, VET PATHOL, V45, P297, DOI 10.1354/vp.45-3-297; Hamir AN, 2004, VET PATHOL, V41, P78, DOI 10.1354/vp.41-1-78; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Wemheuer WM, 2009, VET REC, V164, P677, DOI 10.1136/vr.164.22.677; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530	34	20	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e18345	10.1371/journal.pone.0018345	http://dx.doi.org/10.1371/journal.pone.0018345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483771	gold, Green Submitted, Green Published			2022-12-25	WOS:000289058300012
J	Kurita, S; Mott, JL; Cazanave, SC; Fingas, CD; Guicciardi, ME; Bronk, SF; Roberts, LR; Fernandez-Zapico, ME; Gores, GJ				Kurita, Satoshi; Mott, Justin L.; Cazanave, Sophie C.; Fingas, Christian D.; Guicciardi, Maria E.; Bronk, Steve F.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.; Gores, Gregory J.			Hedgehog Inhibition Promotes a Switch from Type II to Type I Cell Death Receptor Signaling in Cancer Cells	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; CHOLANGIOCARCINOMA CELLS; CYTOCHROME-C; RESISTANCE; PATHWAY; BAX; EXPRESSION; CARCINOMA; MCL-1; MITOCHONDRIA	TRAIL is a promising therapeutic agent for human malignancies. TRAIL often requires mitochondrial dysfunction, referred to as the Type II death receptor pathway, to promote cytotoxicity. However, numerous malignant cells are TRAIL resistant due to inhibition of this mitochondrial pathway. Using cholangiocarcinoma cells as a model of TRAIL resistance, we found that Hedgehog signaling blockade sensitized these cancer cells to TRAIL cytotoxicity independent of mitochondrial dysfunction, referred to as Type I death receptor signaling. This switch in TRAIL requirement from Type II to Type I death receptor signaling was demonstrated by the lack of functional dependence on Bid/Bim and Bax/Bak, proapoptotic components of the mitochondrial pathway. Hedgehog signaling modulated expression of X-linked inhibitor of apoptosis (XIAP), which serves to repress the Type I death receptor pathway. siRNA targeted knockdown of XIAP mimics sensitization to mitochondria-independent TRAIL killing achieved by Hedgehog inhibition. Regulation of XIAP expression by Hedgehog signaling is mediated by the glioma-associated oncogene 2 (GLI2), a downstream transcription factor of Hedgehog. In conclusion, these data provide additional mechanisms modulating cell death by TRAIL and suggest Hedgehog inhibition as a therapeutic approach for TRAIL-resistant neoplasms.	[Kurita, Satoshi; Mott, Justin L.; Cazanave, Sophie C.; Fingas, Christian D.; Guicciardi, Maria E.; Bronk, Steve F.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Kurita, S (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	gores.gregory@mayo.edu		Roberts, Lewis/0000-0001-7885-8574; Mott, Justin/0000-0002-2927-6962	National Institutes of Health [DK59427]; Division of Oncology Research, Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology NIDDK [P30 DK084567]; Mayo Foundation; NATIONAL CANCER INSTITUTE [P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059427, P30DK084567, K01DK079875, R56DK059427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Oncology Research, Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE; Mayo Clinic Center for Cell Signaling in Gastroenterology NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01 Grants DK59427 (GJG), Division of Oncology Research, Mayo Clinic Cancer Center, Mayo Clinic Pancreatic SPORE P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology NIDDK P30 DK084567 (MEF-Z) and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Becattini B, 2004, CHEM BIOL, V11, P1107, DOI 10.1016/j.chembiol.2004.05.022; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Eggert A, 2001, CANCER RES, V61, P1314; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Kurita S, 2010, ONCOGENE, V29, P4848, DOI 10.1038/onc.2010.235; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Qiao L, 2009, DRUG RESIST UPDATE, V12, P55, DOI 10.1016/j.drup.2009.02.002; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; RUDIN CM, 2009, N ENGL J MED; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Varfolomeev E, 2009, J BIOL CHEM, V284, P34553, DOI 10.1074/jbc.M109.040139; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730	40	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18330	10.1371/journal.pone.0018330	http://dx.doi.org/10.1371/journal.pone.0018330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483830	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200060
J	Nepomnaschy, PA; Altman, RM; Watterson, R; Co, C; McConnell, DS; England, BG				Nepomnaschy, Pablo A.; Altman, Rachel M.; Watterson, Rita; Co, Caroll; McConnell, Daniel S.; England, Barry G.			Is Cortisol Excretion Independent of Menstrual Cycle Day? A Longitudinal Evaluation of First Morning Urinary Specimens	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GROWTH-HORMONE RESPONSES; PSYCHOLOGICAL STRESS; SALIVARY CORTISOL; SEX-DIFFERENCES; WOMEN; PHASE; EXERCISE; REACTIVITY; MOOD	Background: Cortisol is frequently used as a marker of physiologic stress levels. Using cortisol for that purpose, however, requires a thorough understanding of its normal longitudinal variability. The current understanding of longitudinal variability of basal cortisol secretion in women is very limited. It is often assumed, for example, that basal cortisol profiles do not vary across the menstrual cycle. This is a critical assumption: if cortisol were to follow a time dependent pattern during the menstrual cycle, then ignoring this cyclic variation could lead to erroneous imputation of physiologic stress. Yet, the assumption that basal cortisol levels are stable across the menstrual cycle rests on partial and contradictory evidence. Here we conduct a thorough test of that assumption using data collected for up to a year from 25 women living in rural Guatemala. Methodology: We apply a linear mixed model to describe longitudinal first morning urinary cortisol profiles, accounting for differences in both mean and standard deviation of cortisol among women. To that aim we evaluate the fit of two alternative models. The first model assumes that cortisol does not vary with menstrual cycle day. The second assumes that cortisol mean varies across the menstrual cycle. Menstrual cycles are aligned on ovulation day (day 0). Follicular days are assigned negative numbers and luteal days positive numbers. When we compared Models 1 and 2 restricting our analysis to days between 214 (follicular) and day 14 (luteal) then day of the menstrual cycle did not emerge as a predictor of urinary cortisol levels (p-value >0.05). Yet, when we extended our analyses beyond that central 28-day-period then day of the menstrual cycle become a statistically significant predictor of cortisol levels. Significance: The observed trend suggests that studies including cycling women should account for day dependent variation in cortisol in cycles with long follicular and luteal phases.	[Nepomnaschy, Pablo A.; Watterson, Rita] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Altman, Rachel M.; Co, Caroll] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada; [McConnell, Daniel S.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [England, Barry G.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Simon Fraser University; Simon Fraser University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nepomnaschy, PA (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	pablo_nepomnaschy@sfu.ca		Nepomnaschy, Pablo/0000-0002-8989-7381	Rackham Graduate School, the Department of Anthropology, and the School of Natural Resources and Environment at the University of Michigan; Simon Fraser University; CIHR [106705]; NSERC [RGPIN293140]	Rackham Graduate School, the Department of Anthropology, and the School of Natural Resources and Environment at the University of Michigan; Simon Fraser University; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The original data collection phase of this study was funded by grants to P.A.N. from Rackham Graduate School, the Department of Anthropology, and the School of Natural Resources and Environment at the University of Michigan. The data analysis phase was funded by a President's Research Start-up Grant from Simon Fraser University and a CIHR Operational Grant #106705 to P.A.N., and a NSERC Discovery Grant RGPIN293140 to R. M. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABPLANALP JM, 1977, PSYCHOSOM MED, V39, P158, DOI 10.1097/00006842-197705000-00002; Altemus M, 1997, NEUROPSYCHOPHARMACOL, V17, P100; Altemus M, 2001, PSYCHOSOM MED, V63, P814, DOI 10.1097/00006842-200109000-00015; ATKINSON HC, 1997, ENDOCRINOLOGY, V86, P220; Baerwald AR, 2004, ULTRASOUND OBST GYN, V24, P453, DOI 10.1002/uog.1123; Baerwald AR, 2003, FERTIL STERIL, V80, P116, DOI 10.1016/S0015-0282(03)00544-2; Baerwald AR, 2003, BIOL REPROD, V69, P1023, DOI 10.1095/biolreprod.103.017772; BAIRD DD, 1991, STAT MED, V10, P255, DOI 10.1002/sim.4780100209; BECK RP, 1972, AM J OBSTET GYNECOL, V112, P364, DOI 10.1016/0002-9378(72)90478-4; BONEN A, 1976, J APPL PHYSIOL, V40, P155, DOI 10.1152/jappl.1976.40.2.155; BUCKINGHAM JC, 1978, J ENDOCRINOL, V78, P359, DOI 10.1677/joe.0.0780359; CARR BR, 1979, J CLIN ENDOCR METAB, V49, P346, DOI 10.1210/jcem-49-3-346; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; COLLINS A, 1985, PSYCHOSOM MED, V47, P512, DOI 10.1097/00006842-198511000-00002; Critchley HOD, 2001, CLIN ENDOCRINOL, V55, P701, DOI 10.1046/j.1365-2265.2001.01432.x; CRITCHLOW V, 1963, AM J PHYSIOL, V205, P807, DOI 10.1152/ajplegacy.1963.205.5.807; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; FLINN MV, 1995, CURR ANTHROPOL, V36, P854, DOI 10.1086/204444; GENAZZANI AR, 1975, J CLIN ENDOCR METAB, V41, P431, DOI 10.1210/jcem-41-3-431; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; KAJANTIE, 2008, ASS PSYCHOL SCI, V17, P348; KANALEY JA, 1992, INT J SPORTS MED, V13, P332, DOI 10.1055/s-2007-1021276; Kanaley JA, 2002, ENDOCRINOLOGIST, V12, P421, DOI 10.1097/00019616-200209000-00010; Kanaley JA, 2001, J CLIN ENDOCR METAB, V86, P2881, DOI 10.1210/jc.86.6.2881; Kassam A, 1996, ENVIRON HEALTH PERSP, V104, P408, DOI 10.2307/3432685; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KUBO C, 2003, JMAJ, V46, P50; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Kudielka BM, 2003, PSYCHOSOM MED, V65, P313, DOI 10.1097/01.PSY.0000058374.50240.BF; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kunz-Ebrecht SR, 2004, PSYCHONEUROENDOCRINO, V29, P516, DOI 10.1016/S0306-4530(03)00072-6; Lightman S L, 2001, Prog Brain Res, V133, P111; MALENDOWICZ LK, 1982, ENDOKRINOLOGIE, V79, P292; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; McCormick CM, 2001, HORM BEHAV, V39, P29, DOI 10.1006/hbeh.2000.1636; McLean M, 1999, TRENDS ENDOCRIN MET, V10, P174, DOI 10.1016/S1043-2760(98)00146-5; MEULENBERG EPMM, 1990, J CLIN CHEM CLIN BIO, V28, P923; Negrao AB, 2000, BIOMED PHARMACOTHER, V54, P122, DOI 10.1016/S0753-3322(00)89044-7; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Nepomnaschy PA, 2004, AM J HUM BIOL, V16, P523, DOI 10.1002/ajhb.20057; Nepomnaschy PA, 2007, ANN NY ACAD SCI, V1113, P350, DOI 10.1196/annals.1391.028; Odber J, 1998, J PSYCHOSOM RES, V45, P557, DOI 10.1016/S0022-3999(98)00061-0; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; SAXENA BN, 1974, J OBSTET GYN BR COMM, V81, P563; Seale JV, 2004, J NEUROENDOCRINOL, V16, P516, DOI 10.1111/j.1365-2826.2004.01195.x; SELYE H, 1970, AM J CARDIOL, V26, P289, DOI 10.1016/0002-9149(70)90796-4; Shanks N, 1999, J NEUROENDOCRINOL, V11, P857; Symonds CS, 2004, PSYCHOL MED, V34, P93, DOI 10.1017/S0033291703008535; Tu MT, 2006, J NEUROENDOCRINOL, V18, P494, DOI 10.1111/j.1365-2826.2006.01441.x; Walker CD, 2004, J PSYCHIATR NEUROSCI, V29, P364; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259; Xiao EN, 1998, J CLIN ENDOCR METAB, V83, P2454, DOI 10.1210/jc.83.7.2454	57	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18242	10.1371/journal.pone.0018242	http://dx.doi.org/10.1371/journal.pone.0018242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483825	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200047
J	Sjowall, J; Fryland, L; Nordberg, M; Sjogren, F; Garpmo, U; Jansson, C; Carlsson, SA; Bergstrom, S; Ernerudh, J; Nyman, D; Forsberg, P; Ekerfelt, C				Sjowall, Johanna; Fryland, Linda; Nordberg, Marika; Sjogren, Florence; Garpmo, Ulf; Jansson, Christian; Carlsson, Sten-Anders; Bergstrom, Sven; Ernerudh, Jan; Nyman, Dag; Forsberg, Pia; Ekerfelt, Christina			Decreased Th1-Type Inflammatory Cytokine Expression in the Skin Is Associated with Persisting Symptoms after Treatment of Erythema Migrans	PLOS ONE			English	Article							EARLY LYME-DISEASE; BORRELIA-BURGDORFERI; CEREBROSPINAL-FLUID; ANTIBIOTIC-TREATMENT; PERIPHERAL-BLOOD; INTERFERON-GAMMA; MESSENGER-RNA; UP-REGULATION; FOLLOW-UP; NEUROBORRELIOSIS	Background: Despite the good prognosis of erythema migrans (EM), some patients have persisting symptoms of various character and duration post-treatment. Several factors may affect the clinical outcome of EM, e. g. the early interaction between Borrelia (B.) burgdorferi and the host immune response, the B. burgdorferi genotype, antibiotic treatment as well as other clinical circumstances. Our study was designed to determine whether early cytokine expression in the skin and in peripheral blood in patients with EM is associated with the clinical outcome. Methods: A prospective follow-up study of 109 patients with EM was conducted at the A land Islands, Finland. Symptoms were evaluated at 3, 6, 12 and 24 months post-treatment. Skin biopsies from the EM and healthy skin were immunohistochemically analysed for expression of interleukin (IL)-4, IL-10, IL-12p70 and interferon (IFN)-gamma, as well as for B. burgdorferi DNA. Blood samples were analysed for B. burgdorferi antibodies, allergic predisposition and levels of systemic cytokines. Findings: None of the patients developed late manifestations of Lyme borreliosis. However, at the 6-month follow-up, 7 of 88 patients reported persisting symptoms of diverse character. Compared to asymptomatic patients, these 7 patients showed decreased expression of the Th1-associated cytokine IFN-gamma in the EM biopsies (p = 0.003). B. afzelii DNA was found in 48%, B. garinii in 15% and B. burgdorferi sensu stricto in 1% of the EM biopsies, and species distribution was the same in patients with and without post-treatment symptoms. The two groups did not differ regarding baseline patient characteristics, B. burgdorferi antibodies, allergic predisposition or systemic cytokine levels. Conclusion: Patients with persisting symptoms following an EM show a decreased Th1-type inflammatory response in infected skin early during the infection, which might reflect a dysregulation of the early immune response. This finding supports the importance of an early, local Th1-type response for optimal resolution of LB.	[Sjowall, Johanna; Nordberg, Marika; Forsberg, Pia] Linkoping Univ, Fac Hlth Sci, Div Infect Dis, Dept Clin & Expt Med, Linkoping, Sweden; [Sjowall, Johanna; Fryland, Linda; Ernerudh, Jan; Ekerfelt, Christina] Linkoping Univ, Fac Hlth Sci, Div Clin Immunol, Dept Clin & Expt Med, Linkoping, Sweden; [Sjogren, Florence] Linkoping Univ, Fac Hlth Sci, Div Dermatol, Dept Clin & Expt Med, Linkoping, Sweden; [Garpmo, Ulf] Kalmar Hosp, Dept Clin Microbiol, Kalmar, Sweden; [Bergstrom, Sven] Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; [Nordberg, Marika; Jansson, Christian; Carlsson, Sten-Anders; Nyman, Dag] Aland Borrelia Grp, The Aland Isl, Finland	Linkoping University; Linkoping University; Linkoping University; Umea University	Sjowall, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Infect Dis, Dept Clin & Expt Med, Linkoping, Sweden.	linda.fryland@liu.se	Nordberg, Markus/L-4255-2017	Sjowall, Johanna/0000-0001-5622-866X	Swedish Research Council (Medicine); Health Research Council in South-East Sweden (FORSS); Ostergotland County Council; A land Foundation for Medical Research; Wilhelm and Else Stockmann Foundation	Swedish Research Council (Medicine)(Swedish Research Council); Health Research Council in South-East Sweden (FORSS); Ostergotland County Council; A land Foundation for Medical Research; Wilhelm and Else Stockmann Foundation	This work was supported by grants from The Swedish Research Council (Medicine), the Health Research Council in South-East Sweden (FORSS), ALF grants from the Ostergotland County Council, grants from the A land Foundation for Medical Research, and the Wilhelm and Else Stockmann Foundation. The funding sources had no involvement in the study design, the data analysis or in the writing of the report.	ANDERSSON J, 1994, IMMUNOLOGY, V83, P16; Auvinen JP, 2009, SPINE, V34, P1192, DOI 10.1097/BRS.0b013e3181a401df; Auwaerter PG, 2007, CLIN INFECT DIS, V45, P143, DOI 10.1086/518854; Bennet L, 2003, SCAND J INFECT DIS, V35, P129, DOI 10.1080/0036554021000027009; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; Borish L, 1998, J ALLERGY CLIN IMMUN, V101, P293, DOI 10.1016/S0091-6749(98)70238-6; Cerar T, 2008, CLIN MICROBIOL INFEC, V14, P653, DOI 10.1111/j.1469-0691.2008.02013.x; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; Ekerfelt C, 2007, CLIN EXP IMMUNOL, V150, P189, DOI 10.1111/j.1365-2249.2007.03474.x; Ekerfelt C, 1997, J NEUROIMMUNOL, V79, P155, DOI 10.1016/S0165-5728(97)00118-5; Ekerfelt C, 1999, CLIN EXP IMMUNOL, V115, P498; Gross DM, 1998, J IMMUNOL, V160, P1022; Grusell M, 2002, J NEUROIMMUNOL, V131, P173, DOI 10.1016/S0165-5728(02)00255-2; Henningsson AJ, 2010, CLIN MICROBIOL INFEC, V16, P1245, DOI 10.1111/j.1469-0691.2009.03059.x; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Kang IS, 1997, INFECT IMMUN, V65, P3107, DOI 10.1128/IAI.65.8.3107-3111.1997; Kowalski TJ, 2010, CLIN INFECT DIS, V50, P512, DOI 10.1086/649920; Lipsker D, 2002, BRIT J DERMATOL, V146, P872, DOI 10.1046/j.1365-2133.2002.04628.x; LJOSTAD U, 2009, EUR J NEUROL; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; LUGER SW, 1995, ANTIMICROB AGENTS CH, V39, P661, DOI 10.1128/AAC.39.3.661; MASSAROTTI EM, 1992, AM J MED, V92, P396, DOI 10.1016/0002-9343(92)90270-L; Mullegger RR, 2000, J INVEST DERMATOL, V115, P1115, DOI 10.1046/j.1523-1747.2000.00198.x; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Oksi J, 1996, INFECT IMMUN, V64, P3620, DOI 10.1128/IAI.64.9.3620-3623.1996; Ornstein K, 2001, J CLIN MICROBIOL, V39, P1294, DOI 10.1128/JCM.39.4.1294-1298.2001; Picha D, 2006, SCAND J INFECT DIS, V38, P747, DOI 10.1080/00365540600810000; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Sjowall J, 2005, CLIN EXP IMMUNOL, V141, P89, DOI 10.1111/j.1365-2249.2005.02820.x; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stanek G, 2009, CURR OPIN INFECT DIS, V22, P450, DOI 10.1097/QCO.0b013e32832ee880; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Vrethem M, 2002, ACTA NEUROL SCAND, V106, P205, DOI 10.1034/j.1600-0404.2002.01358.x; Wang WZ, 1995, SCAND J IMMUNOL, V42, P694, DOI 10.1111/j.1365-3083.1995.tb03713.x; Widhe M, 2005, INT IMMUNOL, V17, P1283, DOI 10.1093/intimm/dxh304; Widhe M, 2004, J INFECT DIS, V189, P1881, DOI 10.1086/382893; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2009, CLIN MICROBIOL REV, V22, P387, DOI 10.1128/CMR.00004-09; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Yin ZN, 1997, ARTHRITIS RHEUM, V40, P69, DOI 10.1002/art.1780400111	43	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18220	10.1371/journal.pone.0018220	http://dx.doi.org/10.1371/journal.pone.0018220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483819	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200045
J	Almeida, C; Azevedo, NF; Santos, S; Keevil, CW; Vieira, MJ				Almeida, Carina; Azevedo, Nuno F.; Santos, Silvio; Keevil, Charles W.; Vieira, Maria J.			Discriminating Multi-Species Populations in Biofilms with Peptide Nucleic Acid Fluorescence In Situ Hybridization (PNA FISH)	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; HELICOBACTER-PYLORI; BACTERIAL BIOFILMS; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; INFECTIOUS-DISEASES; MICROBIAL BIOFILMS; CYSTIC-FIBROSIS; WATER BIOFILMS	Background: Our current understanding of biofilms indicates that these structures are typically composed of many different microbial species. However, the lack of reliable techniques for the discrimination of each population has meant that studies focusing on multi-species biofilms are scarce and typically generate qualitative rather than quantitative data. Methodology/Principal Findings: We employ peptide nucleic acid fluorescence in situ hybridization (PNA FISH) methods to quantify and visualize mixed biofilm populations. As a case study, we present the characterization of Salmonella enterica/Listeria monocytogenes/Escherichia coli single, dual and tri-species biofilms in seven different support materials. Ex-situ, we were able to monitor quantitatively the populations of,56 mixed species biofilms up to 48 h, regardless of the support material. In situ, a correct quantification remained more elusive, but a qualitative understanding of biofilm structure and composition is clearly possible by confocal laser scanning microscopy (CLSM) at least up to 192 h. Combining the data obtained from PNA FISH/CLSM with data from other established techniques and from calculated microbial parameters, we were able to develop a model for this tri-species biofilm. The higher growth rate and exopolymer production ability of E. coli probably led this microorganism to outcompete the other two [average cell numbers (cells/cm(2)) for 48 h biofilm: E. coli 2,1x10(8) (+/-2,4x10(7)); L. monocytogenes 6,8x10(7) (+/-9,4x10(6)); and S. enterica 1,4x10(6) (+/-4,1x10(5))]. This overgrowth was confirmed by CSLM, with two well-defined layers being easily identified: the top one with E. coli, and the bottom one with mixed regions of L. monocytogenes and S. enterica. Significance: While PNA FISH has been described previously for the qualitative study of biofilm populations, the present investigation demonstrates that it can also be used for the accurate quantification and spatial distribution of species in polymicrobial communities. Thus, it facilitates the understanding of interspecies interactions and how these are affected by changes in the surrounding environment.	[Almeida, Carina; Santos, Silvio; Vieira, Maria J.] Univ Minho, Ctr Biol Engn, IBB, Braga, Portugal; [Almeida, Carina; Keevil, Charles W.] Univ Southampton, Sch Biol Sci, Environm Healthcare Unit, Southampton, Hants, England; [Azevedo, Nuno F.] Univ Porto, Dept Chem Engn, Fac Engn, P-4100 Oporto, Portugal	Universidade do Minho; University of Southampton; Universidade do Porto	Almeida, C (corresponding author), Univ Minho, Ctr Biol Engn, IBB, Campus Gualta, Braga, Portugal.	mjv@deb.uminho.pt	Azevedo, Nuno/I-4915-2013; Santos, Silvio/O-5491-2015; Guimarães, Nuno/J-6879-2013	Santos, Silvio/0000-0003-0801-8080; Guimarães, Nuno/0000-0002-7623-3877; Keevil, Charles/0000-0003-1917-7706; Vieira, Maria Joao/0000-0002-1379-890X; Almeida, Carina/0000-0002-0175-1119; Almeida, Carina/0000-0003-0613-8855; Azevedo, Nuno/0000-0001-5864-3250	Portuguese Institute Fundacao para a Ciencia e Tecnologia [SFRH/BD/29297/2006]	Portuguese Institute Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Institute Fundacao para a Ciencia e Tecnologia, PhD Fellowship SFRH/BD/29297/2006 (http://alfa.fct.mctes.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Almeida C, 2010, APPL ENVIRON MICROB, V76, P4476, DOI 10.1128/AEM.01678-09; Almeida C, 2009, APPL ENVIRON MICROB, V75, P2925, DOI 10.1128/AEM.02470-08; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Azevedo NF, 2008, APPL ENVIRON MICROB, V74, P1805, DOI 10.1128/AEM.02241-07; Azevedo NF, 2007, APPL ENVIRON MICROB, V73, P3423, DOI 10.1128/AEM.00047-07; Azevedo NF, 2006, J APPL MICROBIOL, V101, P718, DOI 10.1111/j.1365-2672.2006.03029.x; Azevedo NF, 2003, WATER SCI TECHNOL, V47, P155, DOI 10.2166/wst.2003.0307; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Braganca SM, 2007, WATER SCI TECHNOL, V55, P387, DOI 10.2166/wst.2007.282; Bremer PJ, 2001, J FOOD PROTECT, V64, P1369, DOI 10.4315/0362-028X-64.9.1369; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Carlson G, 1998, WATER RES, V32, P1580, DOI 10.1016/S0043-1354(97)00354-0; Carpentier B, 2004, INT J FOOD MICROBIOL, V97, P111, DOI 10.1016/j.ijfoodmicro.2004.03.031; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Coetser SE, 2005, CRIT REV MICROBIOL, V31, P213, DOI 10.1080/10408410500304074; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2007, APPL MICROBIOL BIOT, V75, P237, DOI 10.1007/s00253-007-0886-z; Delatolla R, 2009, WATER RES, V43, P1775, DOI 10.1016/j.watres.2009.01.009; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, ORAL MICROBIOL IMMUN, V24, P69, DOI 10.1111/j.1399-302X.2008.00482.x; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Garner MR, 2006, APPL ENVIRON MICROB, V72, P5384, DOI 10.1128/AEM.00764-06; GILBERT P, 1991, J APPL BACTERIOL, V71, P72; Gu F, 2005, J MICROBIOL METH, V62, P145, DOI 10.1016/j.mimet.2005.02.013; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Harrison JJ, 2008, ANTIMICROB AGENTS CH, V52, P2870, DOI 10.1128/AAC.00203-08; Hood SK, 1997, J FOOD PROTECT, V60, P1135, DOI 10.4315/0362-028X-60.9.1135; Hoshino T, 2008, APPL ENVIRON MICROB, V74, P5068, DOI 10.1128/AEM.00208-08; KRAMER JG, 1992, APPL ENVIRON MICROB, V58, P201, DOI 10.1128/AEM.58.1.201-207.1992; Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LERICHE V, 1995, J FOOD PROTECT, V58, P1186, DOI 10.4315/0362-028X-58.11.1186; MacDonald R, 2000, WATER RES, V34, P2439, DOI 10.1016/S0043-1354(99)00409-1; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Molteni C, 2010, APPL ENVIRON MICROB, V76, P4099, DOI 10.1128/AEM.00424-10; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; Naves P, 2008, MICROB PATHOGENESIS, V45, P86, DOI 10.1016/j.micpath.2008.03.003; Neu TR, 2010, FEMS MICROBIOL ECOL, V72, P1, DOI 10.1111/j.1574-6941.2010.00837.x; Norhana MNW, 2010, FOOD CONTROL, V21, P343, DOI 10.1016/j.foodcont.2009.06.020; Oulahal N, 2007, INNOV FOOD SCI EMERG, V8, P192, DOI 10.1016/j.ifset.2006.10.001; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pavlekovic M, 2009, J MICROBIOL METH, V78, P119, DOI 10.1016/j.mimet.2009.04.003; Perry-O'Keefe H, 2001, J MICROBIOL METH, V47, P281, DOI 10.1016/S0167-7012(01)00303-7; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Rodrigues AC, 2003, WATER SCI TECHNOL, V47, P139, DOI 10.2166/wst.2003.0302; Rosche B, 2009, TRENDS BIOTECHNOL, V27, P636, DOI 10.1016/j.tibtech.2009.08.001; Schaudinn C, 2009, J MICROSC-OXFORD, V235, P124, DOI 10.1111/j.1365-2818.2009.03201.x; Stender H, 2003, EXPERT REV MOL DIAGN, V3, P649, DOI 10.1586/14737159.3.5.649; Stender H, 2002, J MICROBIOL METH, V48, P1, DOI 10.1016/S0167-7012(01)00340-2; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stewart PS, 1997, MICROBIAL ECOL, V33, P2, DOI 10.1007/s002489900002; Thimm T, 2003, APPL ENVIRON MICROB, V69, P2875, DOI 10.1128/AEM.69.5.2875-2878.2003; Thurnheer T, 2004, J MICROBIOL METH, V56, P37, DOI 10.1016/j.mimet.2003.09.003; Turner K, 2000, J APPL MICROBIOL, V89, P90, DOI 10.1046/j.1365-2672.2000.01086.x; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; VANDERVLIET GME, 1994, ANTIMICROB AGENTS CH, V38, P1959, DOI 10.1128/AAC.38.9.1959; Wang ZW, 2009, APPL MICROBIOL BIOT, V83, P1, DOI 10.1007/s00253-009-1940-9; Warnes SL, 2010, APPL ENVIRON MICROB, V76, P5390, DOI 10.1128/AEM.03050-09; WEAVER L, 2010, J APPL MICR IN PRESS; Wellinghausen N, 2005, J CLIN MICROBIOL, V43, P4070, DOI 10.1128/JCM.43.8.4070-4075.2005; Zhu L, 2004, APPL ENVIRON MICROB, V70, P597, DOI 10.1128/AEM.70.1.597-598.2004	72	107	114	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14786	10.1371/journal.pone.0014786	http://dx.doi.org/10.1371/journal.pone.0014786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479268	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000289054600005
J	Jeanes, AI; Maya-Mendoza, A; Streuli, CH				Jeanes, Alexa I.; Maya-Mendoza, Apolinar; Streuli, Charles H.			Cellular Microenvironment Influences the Ability of Mammary Epithelia to Undergo Cell Cycle	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; IN-VITRO; BASEMENT-MEMBRANE; BREAST-CANCER; GROWTH-FACTOR; PROLIFERATION; DIFFERENTIATION; MORPHOGENESIS; GLAND; CULTURE	The use of cell culture models is a principal and fundamental technology used in understanding how mammalian cells work. However, for some cell types such as mammary epithelia, the lines selected for extended culture are often transformed or have chromosomal abnormalities, while primary cultures have such a curtailed lifespan that their use is restricted. For example, mammary luminal epithelial cells (MECs) are used to study mechanisms of breast cancer, but the proliferation of primary cell cultures is highly limited. Here we describe the establishment of a new culture system to allow extended analysis of cultures of primary mouse MECs. In 2D monolayer culture, primary MECs showed a burst of proliferation 2-3 days post isolation, after which cell cycle decreased substantially. Addition of mammary epithelial growth factors, such as Epidermal Growth Factor, Fibroblast Growth Factor-2, Hepatocyte Growth Factor, and Receptor Activator for Nuclear Factor kappa B Ligand, or extracellular matrix proteins did not maintain their proliferation potential, neither did replating the cells to increase the mitogenic response. However, culturing MECs directly after tissue extraction in a 3D microenvironment consisting of basement membrane proteins, extended the time in culture in which the cells could proliferate. Our data reveal that the cellular microenvironment has profound effects on the proliferative properties of the mammary epithelia and is dominant over growth factors. Moreover, manipulating the cellular environment using this novel method can maintain the proliferative potential of primary MECs, thus enabling cell cycle to be studied as an endpoint after gene transfer or gene deletion experiments.	[Jeanes, Alexa I.; Maya-Mendoza, Apolinar; Streuli, Charles H.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Jeanes, AI (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England.	cstreuli@manchester.ac.uk		Maya-Mendoza, Apolinar/0000-0001-7452-9896	Wellcome Trust [081203/Z/06/Z]; Breast Cancer campaign [2006NovPHD12]	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer campaign	This work was funded by the Wellcome Trust (081203/Z/06/Z), wellcome.ac.uk, and Breast Cancer campaign (2006NovPHD12), breastcancercampaign.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGELER J, 1991, J CELL SCI, V99, P407; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; CHAMMAS R, 1994, J CELL SCI, V107, P1031; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Ehmann UK, 2003, CELL PROLIFERAT, V36, P177, DOI 10.1046/j.1365-2184.2003.00265.x; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Gache C, 1998, IN VITRO CELL DEV-AN, V34, P347; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Gordon KE, 2000, BREAST CANCER RES, V2, P222, DOI 10.1186/bcr57; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gudjonsson T, 2003, METHODS, V30, P247, DOI 10.1016/S1046-2023(03)00031-8; Hopfer U, 1996, AM J PHYSIOL-CELL PH, V270, pC1, DOI 10.1152/ajpcell.1996.270.1.C1; Hovey RC, 1998, IN VITRO CELL DEV-AN, V34, P385; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; IMAGAWA W, 1990, ENDOCR REV, V11, P494, DOI 10.1210/edrv-11-4-494; IMAGAWA W, 1982, P NATL ACAD SCI-BIOL, V79, P4074, DOI 10.1073/pnas.79.13.4074; JEANES A, 2010, BETA INTEGRIN UNPUB; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; KITTRELL FS, 1992, CANCER RES, V52, P1924; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; Pullan S, 1996, J CELL SCI, V109, P631; Pullan Shirley E., 1996, P97; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; SMALLEY MJ, 2010, ISOLATION CULTURE AN, P139; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Stoker AW, 1990, CURR OPIN CELL BIOL, V2, P864, DOI 10.1016/0955-0674(90)90085-S; Streuli CH, 1998, J MAMMARY GLAND BIOL, V3, P107, DOI 10.1023/A:1018734620748; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sunil N, 2002, ENDOCRINOLOGY, V143, P2953, DOI 10.1210/en.143.8.2953; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; WHITE MT, 1978, IN VITRO CELL DEV B, V14, P271; Woodward TL, 2000, ENDOCRINOLOGY, V141, P3578, DOI 10.1210/en.141.10.3578; YANG J, 1981, CANCER RES, V41, P1021	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18144	10.1371/journal.pone.0018144	http://dx.doi.org/10.1371/journal.pone.0018144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479230	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600031
J	Zhang, L; Yokoi, F; Jin, YH; DeAndrade, MP; Hashimoto, K; Standaert, DG; Li, YQ				Zhang, Lin; Yokoi, Fumiaki; Jin, Yuan-Hu; DeAndrade, Mark P.; Hashimoto, Kenji; Standaert, David G.; Li, Yuqing			Altered Dendritic Morphology of Purkinje cells in Dyt1 Delta GAG Knock-In and Purkinje Cell-Specific Dyt1 Conditional Knockout Mice	PLOS ONE			English	Article							ONSET TORSION DYSTONIA; SYNAPTIC PLASTICITY; MUTANT TORSINA; GENE DYT1; EXPRESSION; PROTEIN; MODEL; SUPPRESSION; IMPAIRMENT; CEREBELLUM	Background: DYT1 early-onset generalized dystonia is a neurological movement disorder characterized by involuntary muscle contractions. It is caused by a trinucleotide deletion of a GAG (Delta GAG) in the DYT1 (TOR1A) gene encoding torsinA; the mouse homolog of this gene is Dyt1 (Tor1a). Although structural and functional alterations in the cerebellum have been reported in DYT1 dystonia, neuronal morphology has not been examined in vivo. Methodology/Principal Findings: In this study, we examined the morphology of the cerebellum in Dyt1 Delta GAG knock-in (KI) mice. Golgi staining of the cerebellum revealed a reduction in the length of primary dendrites and a decrease in the number of spines on the distal dendrites of Purkinje cells. To determine if this phenomenon was cell autonomous and mediated by a loss of torsinA function in Purkinje cells, we created a knockout of the Dyt1 gene only in Purkinje cells of mice. We found the Purkinje-cell specific Dyt1 conditional knockout (Dyt1 pKO) mice have similar alterations in Purkinje cell morphology, with shortened primary dendrites and decreased spines on the distal dendrites. Conclusion/Significance: These results suggest that the torsinA is important for the proper development of the cerebellum and a loss of this function in the Purkinje cells results in an alteration in dendritic structure.	[Zhang, Lin; Yokoi, Fumiaki; Jin, Yuan-Hu; DeAndrade, Mark P.; Standaert, David G.; Li, Yuqing] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Sch Med, Birmingham, AL 35294 USA; [Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	University of Alabama System; University of Alabama Birmingham; Chiba University	Li, YQ (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Sch Med, Birmingham, AL 35294 USA.	yuqing.li@neurology.ufl.edu	ZHANG, LIN/F-9873-2011; Li, Yuqing/AAR-9383-2021; Li, Yuqing/G-1596-2011; DeAndrade, Mark/G-4930-2011; Hashimoto, Kenji/I-5800-2015	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; DeAndrade, Mark/0000-0003-3610-6459; Standaert, David/0000-0003-2921-8348; Hashimoto, Kenji/0000-0002-8892-0439	National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, NS74423]; Department of Neurology (UAB); Tyler's Hope for a Dystonia Cure, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, P50NS037409, R21NS047692, P30NS057098, R21NS072872, P01NS037409, R21NS065273, R03NS074423, R01NS054246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurology (UAB); Tyler's Hope for a Dystonia Cure, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants (NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72872, and NS74423), the Department of Neurology (UAB), and Tyler's Hope for a Dystonia Cure, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Augood SJ, 2003, BRAIN RES, V986, P12, DOI 10.1016/S0006-8993(03)03164-0; Augood SJ, 1998, ANN NEUROL, V43, P669, DOI 10.1002/ana.410430518; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Blazquez PM, 2004, CEREBELLUM, V3, P188, DOI 10.1080/14734220410018120; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Campos VE, 2004, BIOCHEM BIOPH RES CO, V320, P606, DOI 10.1016/j.bbrc.2004.05.204; CAO S, DIS MODEL MECH, V3, P386; Carbon M, 2009, NEUROSCIENCE, V164, P220, DOI 10.1016/j.neuroscience.2008.12.041; Carbon M, 2008, BRAIN, V131, P146, DOI 10.1093/brain/awm243; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Draganski B, 2003, NEUROLOGY, V61, P1228, DOI 10.1212/01.WNL.0000094240.93745.83; Fahn S, 1988, Adv Neurol, V50, P1; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Koh YH, 2004, HUM MOL GENET, V13, P2019, DOI 10.1093/hmg/ddh208; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50; LEDOUX MS, 1995, BRAIN RES, V697, P91, DOI 10.1016/0006-8993(95)00792-O; LEDOUX MS, 1993, EXP NEUROL, V120, P302, DOI 10.1006/exnr.1993.1064; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Obermann M, 2007, MOVEMENT DISORD, V22, P1117, DOI 10.1002/mds.21495; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Rossi S, 2008, RESTOR NEUROL NEUROS, V26, P475; RUMBACH L, 1995, MOVEMENT DISORD, V10, P522, DOI 10.1002/mds.870100424; Shashidharan P, 2004, J NEUROCHEM, V88, P1019, DOI 10.1046/j.1471-4159.2003.02233.x; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Yokoi F, 2009, NEUROSCI RES, V65, P228, DOI 10.1016/j.neures.2009.07.004	47	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18357	10.1371/journal.pone.0018357	http://dx.doi.org/10.1371/journal.pone.0018357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479250	gold, Green Submitted, Green Published			2022-12-25	WOS:000289054600049
J	Gramling, S; Rogers, C; Liu, G; Reisman, D				Gramling, S.; Rogers, C.; Liu, G.; Reisman, D.			Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy	ONCOGENE			English	Article						SWI/SNF; epigenetic; tumor suppressor; target therapy; chromatin remodeling; cancer therapy	CANCER CELL-LINES; SWI-SNF COMPLEX; SWI/SNF COMPLEX; TRANSCRIPTIONAL ACTIVATORS; EXPRESSION; CHROMATIN; BRG1; GENE; ARREST; ATPASE	Tumor suppressor genes and oncogenes are both commonly altered during carcinogenesis. For oncogenes and other genes that drive growth, targeting mutated or activated forms (such as the EGFR-Her2/Nneu pathway) has been shown to be an effective anti-cancer approach. Pharmacologically targeting tumor suppressor genes has not been as fruitful, as many tumor suppressor genes are irreversibly silenced through somatic mutation or entirely deleted during carcinogenesis, thereby making it difficult to restore gene function. BRM, a key SWI/SNF complex subunit and a putative tumor suppressor gene, is inactivated in 15-20% of many solid tumor types. Unlike other tumor suppressor genes, the loss of BRM has been shown to be a reversible epigenetic change, rather than an irreversible genetic alteration. Using a high throughput drug screen, we identified a number of compounds that could effectively restore BRM expression and function. Two of these compounds, RH (RH02032) and GK (GK0037), were found to be such reactivating agents. Both compounds led to robust re-expression of BRM, induced downstream expression of BRM-dependent genes and inhibited BRM-dependent growth across a wide range of BRM-deficient cancer cell lines of different origins. We therefore show, for the first time, that pharmacologic reversal of epigenetic changes of the SWI/SNF chromatic remodeling complex subunit, BRM, is a potentially viable and novel therapeutic approach. Oncogene (2011) 30, 3289-3294; doi:10.1038/onc.2011.80; published online 11 April 2011	[Gramling, S.; Rogers, C.; Reisman, D.] Univ Florida, Dept Med, Div Hematol Oncol, Gainesville, FL 32610 USA; [Liu, G.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Ontario Canc Inst,Dept Med, Toronto, ON, Canada; [Liu, G.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Ontario Canc Inst,Dept Med Biophys, Toronto, ON, Canada	State University System of Florida; University of Florida; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Reisman, D (corresponding author), Univ Florida, Dept Med, Div Hematol Oncol, 2033 Mowry Rd,Off 294, Gainesville, FL 32610 USA.	dnreisman@ufl.edu	Liu, Geoffrey/N-4421-2016	Liu, Geoffrey/0000-0002-2603-7296	Alan B Brown Chair in Molecular Genomics; CCO Chair in Experimental Therapeutics and Population Studies; Posluns Family Foundation; NCI [R03CA128038-02, 1R01CA136683-01A1]; NATIONAL CANCER INSTITUTE [R01CA136683, T32CA009126, R03CA128038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA028854] Funding Source: NIH RePORTER	Alan B Brown Chair in Molecular Genomics; CCO Chair in Experimental Therapeutics and Population Studies; Posluns Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	GL is funded by the Alan B Brown Chair in Molecular Genomics, CCO Chair in Experimental Therapeutics and Population Studies, and the Posluns Family Foundation; Reisman lab funding for this paper is from NCI: R03CA128038-02 and 1R01CA136683-01A1.	Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Gramling S, 2011, LETT DRUG DES DISCOV, V8, P93, DOI 10.2174/157018011793663840; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Mizutani T, 2002, J BIOL CHEM, V277, P15859, DOI 10.1074/jbc.M112421200; Morrison AJ, 2006, RES PRO CEL, V41, P109, DOI 10.1007/008; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reisman DN, 2003, CANCER RES, V63, P560; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Sansam CG, 2006, CELL CYCLE, V5, P621, DOI 10.4161/cc.5.6.2579; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wong AKC, 2000, CANCER RES, V60, P6171; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601	30	33	33	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	29					3289	3294		10.1038/onc.2011.80	http://dx.doi.org/10.1038/onc.2011.80			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21478905	Green Accepted			2022-12-25	WOS:000293006800007
J	Terrinoni, A; Pagani, IS; Zucchi, I; Chiaravalli, AM; Serra, V; Rovera, F; Sirchia, S; Dionigi, G; Miozzo, M; Frattini, A; Ferrari, A; Capella, C; Pasquali, F; Curto, FL; Albertini, A; Melino, G; Porta, G				Terrinoni, A.; Pagani, I. S.; Zucchi, I.; Chiaravalli, A. M.; Serra, V.; Rovera, F.; Sirchia, S.; Dionigi, G.; Miozzo, M.; Frattini, A.; Ferrari, A.; Capella, C.; Pasquali, F.; Curto, F. L.; Albertini, A.; Melino, G.; Porta, G.			OTX1 expression in breast cancer is regulated by p53	ONCOGENE			English	Article						p53; OTX1; human breast cancer; cancer stem cells	HOMEOBOX GENES; MAMMARY-GLAND; STEM-CELLS; HOX GENES; DIFFERENTIATION; DIVISIONS; APOPTOSIS; FAMILY; P63	The p53 transcription factor has a critical role in cell stress response and in tumor suppression. Wild-type p53 protein is a growth modulator and its inactivation is a critical event in malignant transformation. It has been recently demonstrated that wild-type p53 has developmental and differentiation functions. Indeed an overexpression of p53 in tumor cells induces asymmetrical division avoiding self-renewal of cancer stem cells (CSCs) and instead promoting their differentiation. In this study, 28 human breast carcinomas have been analyzed for expression of wild-type p53 and of a pool of non-clustered homeobox genes. We demonstrated that orthodenticle homolog 1 gene (OTX1) is transcribed in breast cancer. We established that the p53 protein directly induces OTX1 expression by acting on its promoter. OTX1 has been described as a critical molecule for axon refinement in the developing cerebral cortex of mice, and its activity in breast cancer suggests a synergistic function with p53 in CSC differentiation. Wild-type p53 may regulate cellular differentiation by an alternative pathway controlling OTX1 signaling only in breast cancer cells and not in physiological conditions. Oncogene (2011) 30, 3096-3103; doi: 10.1038/onc.2011.31; published online 11 April 2011	[Pagani, I. S.; Pasquali, F.; Curto, F. L.; Porta, G.] Univ Insubria, Dept Expt & Clin Biomed Sci, I-21100 Varese, Italy; [Terrinoni, A.; Serra, V.; Melino, G.] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Biochem Lab, IDI IRCCS, I-00173 Rome, Italy; [Zucchi, I.; Frattini, A.; Albertini, A.] CNR, Inst Biomed Technol, Milan, Italy; [Chiaravalli, A. M.] Osped Circolo Varese, Dept Pathol, Varese, Italy; [Dionigi, G.] Univ Insubria, Dept Surg Sci, Endocrine Surg Res Ctr, I-21100 Varese, Italy; [Sirchia, S.; Miozzo, M.] Univ Milan, Dept Med Surg & Dent, Med Genet Unit, Milan, Italy; [Ferrari, A.] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Capella, C.] Univ Insubria, Osped Circolo, Ctr Insubre Biotecnol Salute Umana, Dept Human Morphol,Anat Pathol Unit, I-21100 Varese, Italy; [Melino, G.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England	University of Insubria; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Insubria; University of Milan; IRCCS Fondazione San Matteo; Ospedale Circolo & Fondazione Macchi; University of Insubria; University of Leicester	Porta, G (corresponding author), Univ Insubria, Dept Expt & Clin Biomed Sci, Via Dunant 5, I-21100 Varese, Italy.	giovanni.porta@uninsubria.it	Frattini, Annalisa/B-7684-2015; Miozzo, Monica Rosa/AAC-6401-2022; Chiaravalli, Anna Maria/AAC-4135-2022; Pagani, Ilaria Stefania/J-9856-2019; Sirchia, Silvia/AAB-2620-2019; CHIARAVALLI, Anna Maria/AAC-2679-2022; Dionigi, Gianlorenzo/R-4381-2017; TERRINONI, Alessandro/J-1533-2012	Frattini, Annalisa/0000-0002-1166-3091; Miozzo, Monica Rosa/0000-0002-6523-4575; Pagani, Ilaria Stefania/0000-0002-3216-2966; CHIARAVALLI, Anna Maria/0000-0002-3924-2117; Dionigi, Gianlorenzo/0000-0003-0864-6087; TERRINONI, Alessandro/0000-0002-7442-2252; Ferrari, Alberta/0000-0003-2525-3787; albertini, alberto/0000-0002-7989-649X; Sirchia, Silvia/0000-0002-6106-3721; porta, giovanni/0000-0001-5260-2415	Medical Research Council, UK; Alleanza contro il Cancro [ACC12-ACC6]; MIUR [RBIP06LCA9_0023]; AIRC [2008-2010_33-08]; Italian Human ProteomeNet [RBRN07BMCT_007]; Telethon [GGPO9133]; Ministero della Salute [RF06-RF07]; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alleanza contro il Cancro; MIUR(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Human ProteomeNet; Telethon(Fondazione Telethon); Ministero della Salute(Ministry of Health, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Centro Grandi Strumenti University of Insubria, Fondazione Comunitaria del Varesotto-ONLUS, Ministero dell'Istruzione, dell'Universita e della Ricerca DM25591 and Banca del Monte di Lombardia, Pavia, Italy to GP. This work has also been supported by the Medical Research Council, UK; 'Alleanza contro il Cancro' (ACC12-ACC6), MIUR/PRIN (RBIP06LCA9_0023), AIRC (2008-2010_33-08), Italian Human ProteomeNet RBRN07BMCT_007 and Telethon (GGPO9133) to GM, Ministero della Salute RF06-RF07 to GM. GP thanks to AIL Varese.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Blackburn AC, 2002, BREAST CANCER RES, V4, P98; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; CARBONE D, 1991, ONCOGENE, V6, P1691; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; Danilova N, 2008, MECH DEVELOP, V125, P919, DOI 10.1016/j.mod.2008.09.003; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; Ford HL, 1998, CELL BIOL INT, V22, P397, DOI 10.1006/cbir.1998.0329; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Levantini E, 2003, P NATL ACAD SCI USA, V100, P10299, DOI 10.1073/pnas.1734071100; Lewis MT, 2000, BREAST CANCER RES, V2, P158, DOI 10.1186/bcr49; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Omodei D, 2009, AM J PATHOL, V175, P2609, DOI 10.2353/ajpath.2009.090542; Papadakis E. N., 2000, Molecular Cell Biology Research Communications, V3, P389, DOI 10.1006/mcbr.2000.0241; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Zhang YA, 2002, MOL CELL NEUROSCI, V19, P430, DOI 10.1006/mcne.2001.1076; Zucchi I, 2008, P NATL ACAD SCI USA, V105, P16940, DOI 10.1073/pnas.0808978105; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	33	30	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	27					3096	3103		10.1038/onc.2011.31	http://dx.doi.org/10.1038/onc.2011.31			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21478910	Green Published			2022-12-25	WOS:000292510100009
J	Zetterstrom, P; Graffmo, KS; Andersen, PM; Brannstrom, T; Marklund, SL				Zetterstrom, Per; Graffmo, Karin S.; Andersen, Peter M.; Brannstrom, Thomas; Marklund, Stefan L.			Proteins That Bind to Misfolded Mutant Superoxide Dismutase-1 in Spinal Cords from Transgenic Amyotrophic Lateral Sclerosis (ALS) Model Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DISEASE; HEAT-SHOCK PROTEINS; FAMILIAL ALS; CHAPERONE; SOD1; AGGREGATION; DEGRADATION; ARIMOCLOMOL; MECHANISM; INTERACTS	Mutant superoxide dismutase-1 (SOD1) has an unidentified toxic property that provokes ALS. Several ALS-linked SOD1 mutations cause long C-terminal truncations, which suggests that common cytotoxic SOD1 conformational species should be misfolded and that the C-terminal end cannot be involved. The cytotoxicity may arise from interaction of cellular proteins with misfolded SOD1 species. Here we specifically immunocaptured misfolded SOD1 by the C-terminal end, from extracts of spinal cords from transgenic ALS model mice. Associated proteins were identified with proteomic techniques. Two transgenic models expressing SOD1s with contrasting molecular properties were examined: the stable G93A mutant, which is abundant in the spinal cord with only a tiny subfraction misfolded, and the scarce disordered truncation mutant G127ins TGGG. For comparison, proteins in spinal cord extracts with affinity for immobilized apo G93A mutant SOD1 were determined. Two-dimensional gel patterns with a limited number of bound proteins were found, which were similar for the two SOD1 mutants. Apart from neurofilament light, the proteins identified were all chaperones and by far most abundant was Hsc70. The immobilized apo G93A SOD1, which would populate a variety of conformations, was found to bind to a considerable number of additional proteins. A substantial proportion of the misfolded SOD1 in the spinal cord extracts appeared to be chaperone-associated. Still, only about 1% of the Hsc70 appeared to be associated with misfolded SOD1. The results argue against the notion that chaperone depletion is involved in ALS pathogenesis in the transgenic models and in humans carrying SOD1 mutations.	[Zetterstrom, Per; Marklund, Stefan L.] Umea Univ, Dept Med Biosci, SE-90185 Umea, Sweden; [Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden	Umea University; Umea University	Marklund, SL (corresponding author), Umea Univ, Dept Med Biosci, SE-90185 Umea, Sweden.	Stefan.Marklund@medbio.umu.se	Zetterström, Per/AAL-5018-2020	Zetterström, Per/0000-0001-8718-3249	Swedish Science Council; Swedish Brain Fund/Hallsten Fund; Swedish Medical Society; ALS Association; Swedish Association of Persons with Neurological Disabilities, Vasterbotten County Council; Kempe Foundations; King Gustaf V and Queen Victoria Foundation	Swedish Science Council; Swedish Brain Fund/Hallsten Fund; Swedish Medical Society; ALS Association; Swedish Association of Persons with Neurological Disabilities, Vasterbotten County Council; Kempe Foundations; King Gustaf V and Queen Victoria Foundation	This work was supported by the Swedish Science Council, the Swedish Brain Fund/Hallsten Fund, the Swedish Medical Society including the Bjorklund Fund for ALS Research, the ALS Association, the Swedish Association of Persons with Neurological Disabilities, Vasterbotten County Council, the Kempe Foundations, and the King Gustaf V and Queen Victoria Foundation.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Ahl IM, 2004, PROTEIN EXPRES PURIF, V37, P311, DOI 10.1016/j.pep.2004.06.006; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Bergemalm D, 2010, J NEUROCHEM, V114, P408, DOI 10.1111/j.1471-4159.2010.06753.x; Bergemalm D, 2009, MOL CELL PROTEOMICS, V8, P1306, DOI 10.1074/mcp.M900046-MCP200; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Choi JS, 2004, BIOCHEM BIOPH RES CO, V321, P574, DOI 10.1016/j.bbrc.2004.07.010; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabuta T, 2009, BIOCHEM BIOPH RES CO, V387, P121, DOI 10.1016/j.bbrc.2009.06.138; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lanka V, 2009, EXPERT OPIN INV DRUG, V18, P1907, DOI 10.1517/13543780903357486; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Manzerra P, 1997, J CELL PHYSIOL, V170, P130, DOI 10.1002/(SICI)1097-4652(199702)170:2<130::AID-JCP4>3.0.CO;2-P; Marks W, 2002, COMPUTATIONAL NEUROA; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Takamiya R, 2005, AM J PHYSIOL-CELL PH, V288, pC253, DOI 10.1152/ajpcell.00014.2004; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003497; Wroe R, 2008, AMYOTROPH LATERAL SC, V9, P249, DOI 10.1080/17482960802146106; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	35	35	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20130	20136		10.1074/jbc.M111.218842	http://dx.doi.org/10.1074/jbc.M111.218842			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21493711	Green Published, hybrid			2022-12-25	WOS:000291267600002
J	Polizio, AH; Chinchilla, P; Chen, XL; Kim, S; Manning, DR; Riobo, NA				Polizio, Ariel H.; Chinchilla, Pilar; Chen, Xiaole; Kim, Sangbumn; Manning, David R.; Riobo, Natalia A.			Heterotrimeric G(i) Proteins Link Hedgehog Signaling to Activation of Rho Small GTPases to Promote Fibroblast Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; CANCER; PATHWAYS; BINDING; RAC; MECHANISMS; RECEPTORS	Evidence supporting the functionality of Smoothened (SMO), an essential transducer in most pathways engaged by Hedgehog (Hh), as a G(i)-coupled receptor contrasts with the lack of an apparently consistent requirement for G(i) in Hh signal transduction. In the present study, we sought to evaluate the role of SMO-G(i) coupling in fibroblast migration induced by Sonic Hedgehog (Shh). Our results demonstrate an absolute requirement for G(i) in Shh-induced fibroblast migration. We found that Shh acutely stimulates the small Rho GTPases Rac1 and RhoA via SMO through a G(i) protein-and PI3K-dependent mechanism, and that these are required for cell migration. These responses were independent of transcription by Gli and of the C-terminal domain of SMO, as we show using a combination of molecular and genetic tools. Our findings provide a mechanistic model for fibroblast migration in response to Shh and underscore the role of SMO-Gi coupling in non-canonical Hh signaling.	[Polizio, Ariel H.; Chinchilla, Pilar; Chen, Xiaole; Kim, Sangbumn; Riobo, Natalia A.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Riobo, Natalia A.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Manning, David R.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; University of Pennsylvania	Riobo, NA (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Bluemle Life Sci Bldg,Room 922,233 S 10th St, Philadelphia, PA 19107 USA.	natalia.riobo@jefferson.edu	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Polizio, Ariel/0000-0001-5413-7238	National Institutes of Health [GM080396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088256, R01GM080396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080396.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bailey EC, 2002, J BIOL CHEM, V277, P33632, DOI 10.1074/jbc.M202203200; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Fanelli F, 2009, CURR PROTEIN PEPT SC, V10, P173, DOI 10.2174/138920309787847554; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Martinez-Chinchilla P, 2008, METHOD ENZYMOL, V446, P189, DOI 10.1016/S0076-6879(08)01611-X; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Meyer NP, 2003, DEV BIOL, V257, P343, DOI 10.1016/S0012-1606(03)00065-4; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Nakamura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008824; NOBES CD, 1995, J CELL SCI, V108, P225; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Togashi H., 1998, AM J PHYSIOL, V274, P803; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Woodard AS, 1998, J CELL SCI, V111, P469; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392	42	114	120	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19589	19596		10.1074/jbc.M110.197111	http://dx.doi.org/10.1074/jbc.M110.197111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21474452	Green Published, hybrid			2022-12-25	WOS:000291027700042
J	Shen, B; Kwan, HY; Ma, X; Wong, CO; Du, J; Huang, Y; Yao, XQ				Shen, Bing; Kwan, Hiu-Yee; Ma, Xin; Wong, Ching-On; Du, Juan; Huang, Yu; Yao, Xiaoqiang			cAMP Activates TRPC6 Channels via the Phosphatidylinositol 3-Kinase (PI3K)-Protein Kinase B (PKB)-Mitogen-activated Protein Kinase Kinase (MEK)-ERK1/2 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; ENDOTHELIAL-CELLS; DOWN-REGULATION; CALCIUM-ENTRY; HIGH GLUCOSE; EXPRESSION; PHOSPHORYLATION; GLOMERULOSCLEROSIS; TRANSLOCATION; OSCILLATIONS	cAMP is an important second messenger that executes diverse physiological function in living cells. In this study, we investigated the effect of cAMP on canonical TRPC6 (transient receptor potential channel 6) channels in TRPC6-expressing HEK293 cells and glomerular mesangial cells. The results showed that 500 mu M8-Br-cAMP, a cell-permeable analog of cAMP, elicited [Ca2+](i) increases and stimulated a cation current at the whole-cell level in TRPC6-expressing HEK293 cells. The effect of cAMP diminished in the presence of the PI3K inhibitors wortmannin and LY294002 or the MEK inhibitors PD98059, U0126, and MEK inhibitor I. 8-Br-cAMP also induced phosphorylation of MEK and ERK1/2. Conversion of serine to glycine at an ERK1/2 phosphorylation site (S281G) abolished the cAMP activation of TRPC6 as determined by whole-cell and cell-attached single-channel patch recordings. Experiments based on a panel of pharmacological inhibitors or activators suggested that the cAMP action on TRPC6 was not mediated by PKA, PKG, or EPAC (exchange protein activated by cAMP). Total internal fluorescence reflection microscopy showed that 8-Br-cAMP did not alter the trafficking of TRPC6 to the plasma membrane. We also found that, in glomerular mesangial cells, glucagon-induced [Ca2+](i) increases were mediated through the cAMP-PI3K-PKB-MEK-ERK1/2-TRPC6 signaling pathway. In summary, this study uncovered a novel TRPC6 activation mechanism in which cAMP activates TRPC6 via the PI3KPKB- MEK-ERK1/2 signaling pathway.	[Shen, Bing; Kwan, Hiu-Yee; Ma, Xin; Wong, Ching-On; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Shen, Bing; Kwan, Hiu-Yee; Ma, Xin; Wong, Ching-On; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Shen, Bing; Du, Juan] Anhui Med Univ, Dept Physiol, Hefei 230032, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Anhui Medical University	Yao, XQ (corresponding author), Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Ma, Xin/G-1297-2013; Huang, Yu/K-2866-2017; Huang, Yvonne/D-3808-2011; Yao, Xiaoqiang/I-5413-2016	Huang, Yu/0000-0002-1277-6784; Yao, Xiaoqiang/0000-0002-0687-8186; KWAN, Hiu Yee/0000-0002-6088-7323; Wong, Ching On/0000-0002-8602-2125	Hong Kong Research Grants Council [CUHK477408, CUHK479109, CUHK478710]; Focused Investment Scheme; Li Ka Shing Institute of Health Sciences	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences	This work was supported by Hong Kong Research Grants Council Grants CUHK477408, CUHK479109, and CUHK478710; the Focused Investment Scheme; and the Li Ka Shing Institute of Health Sciences.	Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dietrich A., 2007, V179, P125; Ding X, 2010, EXPERT OPIN THER TAR, V14, P513, DOI 10.1517/14728221003733602; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; FERDOWS M, 1989, KIDNEY INT, V35, P783, DOI 10.1038/ki.1989.53; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hostetter TH, 2003, SEMIN NEPHROL, V23, P194, DOI 10.1053/snep.2003.50017; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Li XC, 2006, HYPERTENSION, V47, P580, DOI 10.1161/01.HYP.0000197946.81754.0a; Li XC, 2006, BIOCHEM PHARMACOL, V71, P1711, DOI 10.1016/j.bcp.2006.03.018; LI YX, 1994, P NATL ACAD SCI USA, V91, P58, DOI 10.1073/pnas.91.1.58; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P2249, DOI 10.1161/ATVBAHA.110.212084; Mountian I, 1999, CELL CALCIUM, V25, P371, DOI 10.1054/ceca.1999.0034; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; RALL TW, 1958, J BIOL CHEM, V232, P1065; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schulte G, 2000, MOL PHARMACOL, V58, P477, DOI 10.1124/mol.58.3.477; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Schulte G, 2003, EXP CELL RES, V290, P168, DOI 10.1016/S0014-4827(03)00324-0; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Shah P, 2000, J CLIN ENDOCR METAB, V85, P4053, DOI 10.1210/jc.85.11.4053; Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Wang X, 2002, CELL CALCIUM, V31, P265, DOI 10.1016/S0143-4160(02)00075-1; Webster CRL, 1999, AM J PHYSIOL-GASTR L, V277, pG1165, DOI 10.1152/ajpgi.1999.277.6.G1165; Welling A, 2005, MOL PHARMACOL, V67, P541, DOI 10.1124/mol.104.006049; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhang XJ, 2006, J AM SOC NEPHROL, V17, P1532, DOI 10.1681/ASN.2005070776; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127	37	47	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19439	19445		10.1074/jbc.M110.210294	http://dx.doi.org/10.1074/jbc.M110.210294			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21487005	hybrid, Green Published			2022-12-25	WOS:000291027700027
J	Matthaus, F; Mommer, MS; Curk, T; Dobnikar, J				Matthaeus, Franziska; Mommer, Mario S.; Curk, Tine; Dobnikar, Jure			On the Origin and Characteristics of Noise-Induced Levy Walks of E. Coli	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; ESCHERICHIA-COLI; BEHAVIORAL VARIABILITY; WANDERING ALBATROSSES; GENE-EXPRESSION; SCALING LAWS; CHEMOTAXIS; TRACKING; CELLS	Levy walks as a random search strategy have recently attracted a lot of attention, and have been described in many animal species. However, very little is known about one of the most important issues, namely how Levy walks are generated by biological organisms. We study a model of the chemotaxis signaling pathway of E. coli, and demonstrate that stochastic fluctuations and the specific design of the signaling pathway in concert enable the generation of Levy walks. We show that Levy walks result from the superposition of an ensemble of exponential distributions, which occurs due to the shifts in the internal enzyme concentrations following the stochastic fluctuations. With our approach we derive the power-law analytically from a model of the chemotaxis signaling pathway, and obtain a power-law exponent mu approximate to 2:2, which coincides with experimental results. This work provides a means to confirm Levy walks as natural phenomenon by providing understanding on the process through which they emerge. Furthermore, our results give novel insights into the design aspects of biological systems that are capable of translating additive noise on the microscopic scale into beneficial macroscopic behavior.	[Matthaeus, Franziska] Univ Heidelberg, Ctr Modeling & Simulat Biosci BIOMS, Heidelberg, Germany; [Mommer, Mario S.] Univ Heidelberg, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Curk, Tine] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Curk, Tine; Dobnikar, Jure] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Dobnikar, Jure] Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Maribor; University of Cambridge; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Matthaus, F (corresponding author), Univ Heidelberg, Ctr Modeling & Simulat Biosci BIOMS, Heidelberg, Germany.	franziska.matthaeus@iwr.uni-heidelberg.de; jd489@cam.ac.uk	Dobnikar, Jure/C-8765-2011; Matthäus, Franziska/AAE-5523-2022	Dobnikar, Jure/0000-0002-1169-6619; Matthäus, Franziska/0000-0001-6042-1366	Center for Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg; German Ministry of Education and Research [03BOPAL1]; Slovenian Research Agency [P1-0055]; European Research Council [COLSTRUCTIION 227758]; 7th Framework Programme [ITN-COMPLOIDS 234810]	Center for Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Research Council(European Research Council (ERC)European Commission); 7th Framework Programme(European Commission)	This work was supported by the Center for Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg, the German Ministry of Education and Research (grant Nr. 03BOPAL1), the Slovenian Research Agency (P1-0055), the European Research Council (COLSTRUCTIION 227758), and the 7th Framework Programme (ITN-COMPLOIDS 234810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin A, 1998, GENETICS, V149, P1633; ASAKURA S, 1984, J MOL BIOL, V176, P349, DOI 10.1016/0022-2836(84)90494-7; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Beylkin G, 2005, APPL COMPUT HARMON A, V19, P17, DOI 10.1016/j.acha.2005.01.003; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Klafter J., 1990, LECT NOTES BIOMATHEM, VVolume 89; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Levin MD, 2003, FEBS LETT, V550, P135, DOI 10.1016/S0014-5793(03)00857-3; Matthaus F, 2009, BIOPHYS J, V97, P946, DOI 10.1016/j.bpj.2009.04.065; Mommer MS, 2009, SIAM J APPL MATH, V70, P112, DOI 10.1137/070681648; Park H, 2010, NATURE, V468, P819, DOI 10.1038/nature09551; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011906; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Wang JW, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-50; Wu MM, 2006, APPL ENVIRON MICROB, V72, P4987, DOI 10.1128/AEM.00158-06	28	40	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18623	10.1371/journal.pone.0018623	http://dx.doi.org/10.1371/journal.pone.0018623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494629	Green Submitted, Green Published, gold			2022-12-25	WOS:000289292800031
J	Planer, D; Metzger, S; Zcharia, E; Wexler, ID; Vlodavsky, I; Chajek-Shaul, T				Planer, David; Metzger, Shulamit; Zcharia, Eyal; Wexler, Isaiah D.; Vlodavsky, Israel; Chajek-Shaul, Tova			Role of Heparanase on Hepatic Uptake of Intestinal Derived Lipoprotein and Fatty Streak Formation in Mice	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; CORONARY-ARTERY-DISEASE; SULFATE PROTEOGLYCANS; LDL RECEPTOR; MAMMALIAN HEPARANASE; CHYLOMICRON REMNANTS; LIGAND CATABOLISM; DEFICIENT MICE; METABOLISM; CLEARANCE	Background: Heparanase modulates the level of heparan sulfate proteoglycans (HSPGs) which have an important role in multiple cellular processes. Recent studies indicate that HSPGs have an important function in hepatic lipoprotein handling and processes involving removal of lipoprotein particles. Principal Findings: To determine the effects of decreased HSPGs chain length on lipoprotein metabolism and atherosclerosis, transgenic mice over-expressing the human heparanase gene were studied. Hepatic lipid uptake in hpa-Tg mice were evaluated by giving transgenic mice oral fat loads and labeled retinol. Sections of aorta from mice over-expressing heparanase (hpa-Tg) and controls (C57/BL6) fed an atherogenic diet were examined for evidence of atherosclerosis. Heparanase over-expression results in reduced hepatic clearance of postprandial lipoproteins and higher levels of fasting and postprandial serum triglycerides. Heparanase over-expression also induces formation of fatty streaks in the aorta. The mean lesion cross-sectional area in heparanase over-expressing mice was almost 6 times higher when compared to control mice (23,984 mu m(2)+/-5,922 vs. 4,189 mu m(2)+/-1,130, p<0.001). Conclusions: Over-expression of heparanase demonstrates the importance of HSPGs for the uptake of intestinal derived lipoproteins and its role in the formation of fatty streaks.	[Planer, David; Metzger, Shulamit; Chajek-Shaul, Tova] Hadassah Hebrew Univ, Dept Med, Med Ctr, Jerusalem, Israel; [Zcharia, Eyal; Vlodavsky, Israel] Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, Jerusalem, Israel; [Wexler, Isaiah D.] Hadassah Hebrew Univ, Dept Pediat, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Planer, D (corresponding author), Hadassah Hebrew Univ, Dept Med, Med Ctr, Jerusalem, Israel.	chajek@hadassah.org.il						Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Boquist S, 1999, CIRCULATION, V100, P723, DOI 10.1161/01.CIR.100.7.723; CHANG SY, 1994, BBA-LIPID LIPID MET, V1215, P205, DOI 10.1016/0005-2760(94)90112-0; CHUNG BH, 1994, ARTERIOSCLER THROMB, V14, P622, DOI 10.1161/01.ATV.14.4.622; Ebara T, 2000, J CLIN INVEST, V105, P1807, DOI 10.1172/JCI8283; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; George J, 2001, CIRCULATION, V104, P1646, DOI 10.1161/hc3901.095772; GOLDBERG DM, 1990, BIOCHIM BIOPHYS ACTA, V1047, P103, DOI 10.1016/0005-2760(90)90035-V; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; JI ZS, 1995, J LIPID RES, V36, P583; Kudchadkar R, 2008, EXPERT OPIN INV DRUG, V17, P1769, DOI 10.1517/13543784.17.11.1769 ; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; Mero N, 2000, ATHEROSCLEROSIS, V150, P167, DOI 10.1016/S0021-9150(99)00364-0; Metzger S, 2001, AM J PHYSIOL-ENDOC M, V281, pE957, DOI 10.1152/ajpendo.2001.281.5.E957; Noto ATW, 2008, LIPIDS, V43, P353, DOI 10.1007/s11745-008-3159-4; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767; STANFORD KI, 2009, J CLIN INVEST; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; WEINSTEIN MM, ARTERIOSCLER THROMB, V30, P20; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Williams KJ, 2005, DIABETES, V54, P1116, DOI 10.2337/diabetes.54.4.1116; Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253; WILLIAMS KJ, CURR OPIN LIPIDOL, V21, P218; Zhang XH, 2008, CIRC RES, V102, P250, DOI 10.1161/CIRCRESAHA.107.156554; Zheng CY, 2006, ARTERIOSCL THROM VAS, V26, P891, DOI 10.1161/01.ATV.0000203512.01007.3d; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18370	10.1371/journal.pone.0018370	http://dx.doi.org/10.1371/journal.pone.0018370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483695	Green Submitted, Green Published, gold			2022-12-25	WOS:000289058700020
J	Siu, KY; Yu, MKE; Wu, XG; Zong, M; Roth, MG; Chan, HC; Yu, S				Siu, Ka Yu; Yu, Mei Kuen; Wu, Xinggang; Zong, Min; Roth, Michael G.; Chan, Hsiao Chang; Yu, Sidney			The Non-Catalytic Carboxyl-Terminal Domain of ARFGAP1 Regulates Actin Cytoskeleton Reorganization by Antagonizing the Activation of Rac1	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; BINDING PROTEIN; PHOSPHOLIPASE-D; SACCHAROMYCES-CEREVISIAE; DOWNSTREAM EFFECTOR; EXCHANGE FACTOR; GOLGI-COMPLEX; STRESS FIBERS; KDEL RECEPTOR; ARF	Background: The regulation of the actin cytoskeleton and membrane trafficking is coordinated in mammalian cells. One of the regulators of membrane traffic, the small GTP-binding protein ARF1, also activates phosphatidylinositol kinases that in turn affect actin polymerization. ARFGAP1 is a GTPase activating protein (GAP) for ARF1 that is found on Golgi membranes. We present evidence that ARFGAP1 not only serves as a GAP for ARF1, but also can affect the actin cytoskeleton. Principal Findings: As cells attach to a culture dish foci of actin appear prior to the cells flattening and spreading. We have observed that overexpression of a truncated ARFGAP1 that lacks catalytic activity for ARF, called GAP273, caused these foci to persist for much longer periods than non-transfected cells. This phenomenon was dependent on the level of GAP273 expression. Furthermore, cell spreading after re-plating or cell migration into a previously scraped area was inhibited in cells transfected with GAP273. Live cell imaging of such cells revealed that actin-rich membrane blebs formed that seldom made protrusions of actin spikes or membrane ruffles, suggesting that GAP273 interfered with the regulation of actin dynamics during cell spreading. The over-expression of constitutively active alleles of ARF6 and Rac1 suppressed the effect of GAP273 on actin. In addition, the activation of Rac1 by serum, but not that of RhoA or ARF6, was inhibited in cells over-expressing GAP273, suggesting that Rac1 is a likely downstream effector of ARFGAP1. The carboxyl terminal 65 residues of ARFGAP1 were sufficient to produce the effects on actin and cell spreading in transfected cells and co-localized with cortical actin foci. Conclusions: ARFGAP1 functions as an inhibitor upstream of Rac1 in regulating actin cytoskeleton. In addition to its GAP catalytic domain and Golgi binding domain, it also has an actin regulation domain in the carboxyl-terminal portion of the protein.	[Siu, Ka Yu; Yu, Mei Kuen; Wu, Xinggang; Zong, Min; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Yu, Mei Kuen; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas	Siu, KY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	Sidney.yu@cuhk.edu.hk	Zong, Min/B-6706-2016; Chan, Hsiao Chang/E-1507-2016; Bin Sidney Yu, Siu/R-4936-2018	Zong, Min/0000-0001-9381-5791; Bin Sidney Yu, Siu/0000-0001-9643-2729; Roth, Michael/0000-0002-9056-332X	NIH [GM37547]; School of Biomedical Sciences, CUHK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Biomedical Sciences, CUHK(Chinese University of Hong Kong); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM37547 from the NIH to MGR, and the One-line budget of the School of Biomedical Sciences, CUHK, to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoe T, 1999, J BIOL CHEM, V274, P20545, DOI 10.1074/jbc.274.29.20545; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Blader IJ, 1999, MOL BIOL CELL, V10, P581, DOI 10.1091/mbc.10.3.581; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fucini RV, 2000, J BIOL CHEM, V275, P18824, DOI 10.1074/jbc.M000024200; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859, DOI 10.1074/jbc.271.31.18859; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; HIROKI I, 2007, TRAFFIC, V8, P1465; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Lorra C, 1999, NAT CELL BIOL, V1, pE113, DOI 10.1038/12939; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Oshiro T, 2002, J BIOL CHEM, V277, P38618, DOI 10.1074/jbc.M203453200; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Pruyne D, 2000, J CELL SCI, V113, P571; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Roth MG, 2000, FR MOLEC B, V24, P176; Roth MG, 1999, CHEM PHYS LIPIDS, V98, P141, DOI 10.1016/S0009-3084(99)00026-2; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shin OH, 2005, METHOD ENZYMOL, V404, P359, DOI 10.1016/S0076-6879(05)04031-0; Shome K, 1998, J BIOL CHEM, V273, P30836, DOI 10.1074/jbc.273.46.30836; Song J, 1998, J CELL SCI, V111, P2257; Stow JL, 1998, TRENDS CELL BIOL, V8, P138, DOI 10.1016/S0962-8924(98)01238-0; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Valderrama F, 2000, P NATL ACAD SCI USA, V97, P1560, DOI 10.1073/pnas.97.4.1560; Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18458	10.1371/journal.pone.0018458	http://dx.doi.org/10.1371/journal.pone.0018458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483700	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058700030
J	Zolkipli, Z; Pedersen, CB; Lamhonwah, AM; Gregersen, N; Tein, I				Zolkipli, Zarazuela; Pedersen, Christina B.; Lamhonwah, Anne-Marie; Gregersen, Niels; Tein, Ingrid			Vulnerability to Oxidative Stress In Vitro in Pathophysiology of Mitochondrial Short-Chain Acyl-CoA Dehydrogenase Deficiency: Response to Antioxidants	PLOS ONE			English	Article							CREATINE-KINASE ACTIVITY; NEWBORN BLOOD SPOTS; ETHYLMALONIC ACID; SUPEROXIDE-DISMUTASE; RAT-BRAIN; HYDROGEN-PEROXIDE; SCAD DEFICIENCY; CEREBRAL-CORTEX; YOUNG-RATS; CELL-DEATH	Objective: To elucidate the pathophysiology of SCAD deficient patients who have a unique neurological phenotype, among fatty acid oxidation disorders, with early developmental delay, CNS malformations, intractable seizures, myopathy and clinical signs suggesting oxidative stress. Methods: We studied skin fibroblast cultures from patients homozygous for ACADS common variant c.625G > A (n = 10), compound heterozygous for c.625G > A/c.319C > T (n = 3) or homozygous for pathogenic c.319C > T (n = 2) and c.1138C > T (n = 2) mutations compared to fibroblasts from patients with carnitine palmitoyltransferase 2 (CPT2) (n = 5), mitochondrial trifunctional protein (MTP)/long-chain L-3-hydroxyacyl-CoA dehydrogenase (LCHAD) (n = 7), and medium-chain acyl-CoA dehydrogenase (MCAD) deficiencies (n = 4) and normal controls (n = 9). All were exposed to 50 mu M menadione at 37 degrees C. Additonal conditions included exposure to 39 degrees C and/or hypoglycemia. Time to 100% cell death was confirmed with trypan blue dye exclusion. Experiments were repeated with antioxidants (Vitamins C and E or N-acetylcysteine), Bezafibrate or glucose and temperature rescue. Results: The most significant risk factor for vulnerability to menadione-induced oxidative stress was the presence of a FAO defect. SCADD fibroblasts were the most vulnerable compared to other FAO disorders and controls, and were similarly affected, independent of genotype. Cell death was exacerbated by hyperthermia and/or hypoglycemia. Hyperthermia was a more significant independent risk factor than hypoglycemia. Rescue significantly prolonged survival. Incubation with antioxidants and Bezafibrate significantly increased viability of SCADD fibroblasts. Interpretation: Vulnerability to oxidative stress likely contributes to neurotoxicity of SCADD regardless of ACADS genotype and is significantly exacerbated by hyperthermia. We recommend rigorous temperature control in SCADD patients during acute illness. Antioxidants and Bezafibrate may also prove instrumental in their management.	[Zolkipli, Zarazuela; Lamhonwah, Anne-Marie; Tein, Ingrid] Univ Toronto, Hosp Sick Children, Dept Pediat, Neurometab Res Lab,Div Neurol, Toronto, ON M5G 1X8, Canada; [Zolkipli, Zarazuela; Lamhonwah, Anne-Marie; Tein, Ingrid] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Pedersen, Christina B.; Gregersen, Niels] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus N, Denmark	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Aarhus University	Zolkipli, Z (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Neurometab Res Lab,Div Neurol, Toronto, ON M5G 1X8, Canada.	Ingrid.tein@sickkids.ca			Physicians' Services Incorporated Foundation of Ontario; Danish Medical Research Council; Department of Pediatrics, Hospital for Sick Children, Toronto	Physicians' Services Incorporated Foundation of Ontario; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Pediatrics, Hospital for Sick Children, Toronto	This work was supported in part by an operating grant from the Physicians' Services Incorporated Foundation of Ontario as well as grants from the Danish Medical Research Council (no relevant grant numbers). ZZ was funded by the Department of Pediatrics, Hospital for Sick Children, Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, PLOS ONE, V4, pA57, DOI 10.1371/journal.pone.0007719; Barschak AG, 2006, METAB BRAIN DIS, V21, P11, DOI 10.1007/s11011-006-9000-y; Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Corydon MJ, 1996, PEDIATR RES, V39, P1059, DOI 10.1203/00006450-199606000-00021; Djouadi F, 2005, HUM MOL GENET, V14, P2695, DOI 10.1093/hmg/ddi303; DUEE ED, 1969, J BIOL CHEM, V244, P3932; DUTHIE SJ, 1989, BRIT J CANCER, V60, P566, DOI 10.1038/bjc.1989.314; FAZZONE H, 1993, J CLIN INVEST, V92, P1278, DOI 10.1172/JCI116700; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fridovich I, 1998, PROTEIN SCI, V7, P2688, DOI 10.1002/pro.5560071225; Gregersen N, 1998, HUM MOL GENET, V7, P619, DOI 10.1093/hmg/7.4.619; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Kelly G S, 1998, Altern Med Rev, V3, P114; Leipnitz G, 2003, NEUROCHEM RES, V28, P771, DOI 10.1023/A:1022874103630; Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021; MAK IT, 1986, J BIOL CHEM, V261, P1153; Nagan N, 2003, MOL GENET METAB, V78, P239, DOI 10.1016/S1096-7192(03)00034-9; PANDE SV, 1971, J BIOL CHEM, V246, P402; Pedersen CB, 2003, J BIOL CHEM, V278, P47449, DOI 10.1074/jbc.M309514200; Pedersen CB, 2008, HUM GENET, V124, P43, DOI 10.1007/s00439-008-0521-9; Pedersen CB, 2010, J INHERIT METAB DIS, V33, P211, DOI 10.1007/s10545-010-9086-6; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Schuck PF, 2009, NEUROCHEM INT, V54, P519, DOI 10.1016/j.neuint.2009.02.009; Schuck PF, 2010, NEUROCHEM RES, V35, P298, DOI 10.1007/s11064-009-0055-0; Schuck PF, 2009, BRAIN RES, V1296, P117, DOI 10.1016/j.brainres.2009.08.053; Schuck PF, 2002, NEUROCHEM RES, V27, P1633, DOI 10.1023/A:1021682910373; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129; Tein I, 1999, NEUROLOGY, V52, P366, DOI 10.1212/WNL.52.2.366; Tein I, 2008, MOL GENET METAB, V93, P179, DOI 10.1016/j.ymgme.2007.09.021; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van Maldegem B T, 2008, Ned Tijdschr Geneeskd, V152, P1678; van Maldegem BT, 2006, JAMA-J AM MED ASSOC, V296, P943, DOI 10.1001/jama.296.8.943; van Maldegem BT, 2005, J INHERIT METAB DIS, V28, P557, DOI 10.1007/s10545-005-0557-0; VIGNAIS PV, 1976, BIOCHIM BIOPHYS ACTA, V456, P1, DOI 10.1016/0304-4173(76)90007-0; Zolkipli Z, 2008, J INHERIT METAB DIS, V31, P31	42	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17534	10.1371/journal.pone.0017534	http://dx.doi.org/10.1371/journal.pone.0017534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483766	Green Published, Green Submitted, gold			2022-12-25	WOS:000289058300002
J	Gays, F; Koh, ASC; Mickiewicz, KM; Aust, JG; Brooks, CG				Gays, Frances; Koh, Alan S. C.; Mickiewicz, Katarzyna M.; Aust, Jonathan G.; Brooks, Colin G.			Comprehensive Analysis of Transcript Start Sites in Ly49 Genes Reveals an Unexpected Relationship with Gene Function and a Lack Of Upstream Promoters	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MHC CLASS-I; GENOME-WIDE ANALYSIS; NK CELLS; RECEPTOR REPERTOIRE; REGULATORY ELEMENT; CORE PROMOTER; RMA-S; EXPRESSION; IDENTIFICATION	Comprehensive analysis of the transcription start sites of the Ly49 genes of C57BL/6 mice using the oligo-capping 5'-RACE technique revealed that the genes encoding the "missing self" inhibitory receptors, Ly49A, C, G, and I, were transcribed from multiple broad regions in exon 1, in the intron1/exon2 region, and upstream of exon - 1b. Ly49E was also transcribed in this manner, and uniquely showed a transcriptional shift from exon1 to exon 2 when NK cells were activated in vitro with IL2. Remarkably, a large proportion of Ly49E transcripts was then initiated from downstream of the translational start codon. By contrast, the genes encoding Ly49B and Q in myeloid cells, the activating Ly49D and H receptors in NK cells, and Ly49F in activated T cells, were predominantly transcribed from a conserved site in a pyrimidine-rich region upstream of exon 1. An similar to 200 bp fragment from upstream of the Ly49B start site displayed tissue-specific promoter activity in dendritic cell lines, but the corresponding upstream fragments from all other Ly49 genes lacked detectable tissue-specific promoter activity. In particular, none displayed any significant activity in a newly developed adult NK cell line that expressed multiple Ly49 receptors. Similarly, no promoter activity could be found in fragments upstream of intron1/exon2. Collectively, these findings reveal a previously unrecognized relationship between the pattern of transcription and the expression/function of Ly49 receptors, and indicate that transcription of the Ly49 genes expressed in lymphoid cells is achieved in a manner that does not require classical upstream promoters.	[Gays, Frances; Koh, Alan S. C.; Mickiewicz, Katarzyna M.; Aust, Jonathan G.; Brooks, Colin G.] Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Gays, F (corresponding author), Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	colin.brooks@ncl.ac.uk	Koh, Alan/ABA-9226-2021	Koh, Alan/0000-0002-9267-455X; Mickiewicz, Katarzyna/0000-0001-9109-2120	Biotechnology and Biological Sciences Research Council, United Kingdom; Medical Research Council, United Kingdom; MRC [G0601166] Funding Source: UKRI; Medical Research Council [G0601166] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was generously supported by grants from the Biotechnology and Biological Sciences Research Council, United Kingdom, and Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Aust JG, 2011, J IMMUNOL, V186, P2013, DOI 10.4049/jimmunol.1003698; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BROOKS CG, 1993, J IMMUNOL, V151, P6645; Brooks CG, 2000, METH MOL B, V121, P13; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2007, CURR OPIN GENET DEV, V17, P139, DOI 10.1016/j.gde.2007.02.008; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Fraser KP, 2002, EUR J IMMUNOL, V32, P868, DOI 10.1002/1521-4141(200203)32:3<868::AID-IMMU868>3.0.CO;2-A; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gays F, 2005, J IMMUNOL, V175, P2938, DOI 10.4049/jimmunol.175.5.2938; Gays F, 2000, J IMMUNOL, V164, P5094, DOI 10.4049/jimmunol.164.10.5094; Gays F, 2006, J IMMUNOL, V177, P5840, DOI 10.4049/jimmunol.177.9.5840; Gosselin P, 2000, IMMUNOGENETICS, V51, P326, DOI 10.1007/s002510050626; Held W, 1998, EUR J IMMUNOL, V28, P2407, DOI 10.1002/(SICI)1521-4141(199808)28:08&lt;2407::AID-IMMU2407&gt;3.0.CO;2-D; Jin VX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-114; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; KUBO S, 1993, GENE, V136, P329; Kubo S, 1999, BBA-GENE STRUCT EXPR, V1444, P191, DOI 10.1016/S0167-4781(98)00284-X; Kunz B, 2001, J IMMUNOL, V166, P6181, DOI 10.4049/jimmunol.166.10.6181; LUTZ MB, 1994, J IMMUNOL METHODS, V174, P269, DOI 10.1016/0022-1759(94)90031-0; MARUYAMA K, 1994, GENE, V138, P171; Mazda O, 1997, J IMMUNOL METHODS, V204, P143, DOI 10.1016/S0022-1759(97)00036-7; McQueen KL, 2001, IMMUNOGENETICS, V52, P212; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Rouhi A, 2007, MOL IMMUNOL, V44, P821, DOI 10.1016/j.molimm.2006.04.006; Rouhi A, 2009, NUCLEIC ACIDS RES, V37, P5331, DOI 10.1093/nar/gkp592; Saleh A, 2004, IMMUNITY, V21, P55, DOI 10.1016/j.immuni.2004.06.005; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Takei F, 2001, IMMUNOL REV, V181, P90, DOI 10.1034/j.1600-065X.2001.1810107.x; Tanamachi DM, 2004, J IMMUNOL, V172, P1074, DOI 10.4049/jimmunol.172.2.1074; Toomey JA, 1998, EUR J IMMUNOL, V28, P47, DOI 10.1002/(SICI)1521-4141(199801)28:01<47::AID-IMMU47>3.0.CO;2-A; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Toyama-Sorimachi N, 2004, P NATL ACAD SCI USA, V101, P1016, DOI 10.1073/pnas.0305400101; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Van Beneden K, 2002, J IMMUNOL, V168, P3295, DOI 10.4049/jimmunol.168.7.3295; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wilhelm BT, 2001, IMMUNOGENETICS, V53, P215, DOI 10.1007/s002510100313; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18475	10.1371/journal.pone.0018475	http://dx.doi.org/10.1371/journal.pone.0018475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483805	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200085
J	Li, DS; Aaskov, J; Lott, WB				Li, Dongsheng; Aaskov, John; Lott, William B.			Identification of a Cryptic Prokaryotic Promoter within the cDNA Encoding the 5 ' End of Dengue Virus RNA Genome	PLOS ONE			English	Article							TRANSLATION INITIATION; INFECTIOUS CLONE; GENE-EXPRESSION; MESSENGER-RNA; TYPE-2; LOCALIZATION; CONSTRUCTION; DETERMINANT; SUBUNITS; STRAIN	Infectious cDNA clones of RNA viruses are important research tools, but flavivirus cDNA clones have proven difficult to assemble and propagate in bacteria. This has been attributed to genetic instability and/or host cell toxicity, however the mechanism leading to these difficulties has not been fully elucidated. Here we identify and characterize an efficient cryptic bacterial promoter in the cDNA encoding the dengue virus (DENV) 59 UTR. Following cryptic transcription in E. coli, protein expression initiated at a conserved in-frame AUG that is downstream from the authentic DENV initiation codon, yielding a DENV polyprotein fragment that was truncated at the N-terminus. A more complete understanding of constitutive viral protein expression in E. coli might help explain the cloning and propagation difficulties generally observed with flavivirus cDNA.	[Li, Dongsheng; Aaskov, John; Lott, William B.] Queensland Univ Technol, Program Infect Dis, IHBI, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Li, DS (corresponding author), Queensland Univ Technol, Program Infect Dis, IHBI, Brisbane, Qld 4001, Australia.	b.lott@qut.edu.au	Lott, William B/J-1062-2012	Lott, William B/0000-0001-7118-7560	National Health and Medical Research Council (NHMRC) of Australia [497203]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia (grant ID: 497203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONUCCI TK, 1989, J BIOL CHEM, V264, P17656; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; KOZAK M, 1978, J BIOL CHEM, V253, P6568; LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139; Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Pierro DJ, 2006, J GEN VIROL, V87, P2263, DOI 10.1099/vir.0.81958-0; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Moreno ACR, 2009, FEMS MICROBIOL LETT, V301, P156, DOI 10.1111/j.1574-6968.2009.01815.x; RICE C M, 1989, New Biologist, V1, P285; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rossi SL, 2005, VIROLOGY, V331, P457, DOI 10.1016/j.virol.2004.10.046; Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992; Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18197	10.1371/journal.pone.0018197	http://dx.doi.org/10.1371/journal.pone.0018197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483867	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200040
J	Washburn, LR; Zekzer, D; Eitan, S; Lu, YX; Dang, H; Middleton, B; Evans, CJ; Tian, JD; Kaufman, DL				Washburn, Lorraine R.; Zekzer, Dan; Eitan, Shoshana; Lu, Yuxin; Dang, Hoa; Middleton, Blake; Evans, Christopher J.; Tian, Jide; Kaufman, Daniel L.			A Potential Role for Shed Soluble Major Histocompatibility Class I Molecules as Modulators of Neurite Outgrowth	PLOS ONE			English	Article							MHC CLASS-I; CENTRAL-NERVOUS-SYSTEM; HUMAN-SERUM; COMPLEMENT COMPONENT-C1S; AXONAL REGENERATION; IMMUNE-RESPONSE; GENE-EXPRESSION; PROTEIN-KINASE; HEAVY-CHAIN; SPINAL-CORD	The neurobiological activities of classical major histocompatibility class I (MHCI) molecules are just beginning to be explored. To further examine MHCI's actions during the formation of neuronal connections, we cultured embryonic mouse retina explants a short distance from wildtype thalamic explants, or thalami from transgenic mice (termed "NSE-D-b") whose neurons express higher levels of MHCI. While retina neurites extended to form connections with wildtype thalami, we were surprised to find that retina neurite outgrowth was very stunted in regions proximal to NSE-D-b thalamic explants, suggesting that a diffusible factor from these thalami inhibited retina neurite outgrowth. It has been long known that MHCI-expressing cells release soluble forms of MHCI (sMHCI) due to the shedding of intact MHCI molecules, as well as the alternative exon splicing of its heavy chain or the action proteases which cleave off it's transmembrane anchor. We show that the diffusible inhibitory factor from the NSE-D-b thalami is sMHCI. We also show that COS cells programmed to express murine MHCI release sMHCI that inhibits neurite outgrowth from nearby neurons in vitro. The neuroinhibitory effect of sMHCI could be blocked by lowering cAMP levels, suggesting that the neuronal MHCI receptor's signaling mechanism involves a cyclic nucleotide-dependent pathway. Our results suggest that MHCI may not only have neurobiological activity in its membrane-bound form, it may also influence local neurons as a soluble molecule. We discuss the involvement of complement proteins in generating sMHCI and new theoretical models of MHCI's biological activities in the nervous system.	[Washburn, Lorraine R.; Zekzer, Dan; Lu, Yuxin; Dang, Hoa; Middleton, Blake; Tian, Jide; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Eitan, Shoshana; Evans, Christopher J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Washburn, LR (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	dkaufman@mednet.ucla.edu	Kaufman, Daniel/AAU-1228-2021	Kaufman, Daniel/0000-0002-9844-5918	National Institute of Health [R21NS053847, R21NS047383]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053847, R21NS047383] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health grants R21NS053847 and R21NS047383 to DLK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamashvili I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-13; ALLISON JP, 1977, J IMMUNOL, V118, P1004; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; AULITZKY WE, 1991, CLIN EXP IMMUNOL, V86, P236; BJORCK L, 1984, ACTA PATH MICRO IM C, V92, P19; Carbone E, 1996, EUR J IMMUNOL, V26, P683, DOI 10.1002/eji.1830260326; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; CHARLTON RK, 1970, SCIENCE, V170, P636, DOI 10.1126/science.170.3958.636; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; DOBBE LME, 1988, IMMUNOGENETICS, V27, P203, DOI 10.1007/BF00346587; Eriksson H, 1996, IMMUNOTECHNOLOGY, V2, P163, DOI 10.1016/S1380-2933(96)00050-4; ERIKSSON H, 1992, BIOCHEM BIOPH RES CO, V187, P832, DOI 10.1016/0006-291X(92)91272-R; ERIKSSON H, 1990, BIOCHIM BIOPHYS ACTA, V1037, P209, DOI 10.1016/0167-4838(90)90169-G; Escande-Beillard N, 2010, J IMMUNOL, V184, P816, DOI 10.4049/jimmunol.0902159; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Guido W, 1997, J NEUROPHYSIOL, V77, P511, DOI 10.1152/jn.1997.77.1.511; HAGA JA, 1991, J BIOL CHEM, V266, P3695; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Kambayashi T, 2001, J LEUKOCYTE BIOL, V70, P903; KAMMER GM, 1988, IMMUNOL TODAY, V9, P222, DOI 10.1016/0167-5699(88)91220-0; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; LAMPSON LA, 1995, MICROSC RES TECHNIQ, V32, P267, DOI 10.1002/jemt.1070320402; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LENSCHOW DJ, 1993, CURR OPIN IMMUNOL, V5, P747, DOI 10.1016/0952-7915(93)90132-C; MAIO M, 1989, CANCER RES, V49, P2980; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Natarajan K, 1999, Rev Immunogenet, V1, P32; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; PUPPO F, 1995, J CLIN IMMUNOL, V15, P179, DOI 10.1007/BF01541087; PUPPO F, 1995, IMMUNOL TODAY, V16, P124, DOI 10.1016/0167-5699(95)80127-8; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; SARIRIAN K, 1993, TISSUE ANTIGENS, V42, P9, DOI 10.1111/j.1399-0039.1993.tb02159.x; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; SMALHEISER NR, 1981, BRAIN RES, V204, P159, DOI 10.1016/0006-8993(81)90659-4; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Spaggiari GM, 2002, BLOOD, V100, P4098, DOI 10.1182/blood-2002-04-1284; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; TAKAYAMA H, 1989, J PHARM SCI, V78, P8, DOI 10.1002/jps.2600780104; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; Torres AR, 2006, HUM IMMUNOL, V67, P346, DOI 10.1016/j.humimm.2006.01.001; VANROOD JJ, 1970, NATURE, V226, P366, DOI 10.1038/226366a0; Viret C, 1999, Rev Immunogenet, V1, P91; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; Wu ZP, 2011, J NEUROIMMUNOL, V232, P8, DOI 10.1016/j.jneuroim.2010.09.009; Wu ZP, 2011, IMMUNOL LETT, V135, P118, DOI 10.1016/j.imlet.2010.10.011; Zanon RG, 2006, EXP NEUROL, V200, P521, DOI 10.1016/j.expneurol.2006.03.004; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005; Zavazava N, 1998, MOL MED TODAY, V4, P116, DOI 10.1016/S1357-4310(97)01185-4	62	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18439	10.1371/journal.pone.0018439	http://dx.doi.org/10.1371/journal.pone.0018439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483793	Green Published, gold			2022-12-25	WOS:000289057200079
J	Michaelsson, K; Byberg, L; Ahlbom, A; Melhus, H; Farahmand, BY				Michaelsson, Karl; Byberg, Liisa; Ahlbom, Anders; Melhus, Hakan; Farahmand, Bahman Y.			Risk of Severe Knee and Hip Osteoarthritis in Relation to Level of Physical Exercise: A Prospective Cohort Study of Long-Distance Skiers in Sweden	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; CARTILAGE THICKNESS; ARTICULAR-CARTILAGE; JOINT; MORTALITY; INJURIES; ADULTS	Background: To complete long-distance ski races, regular physical exercise is required. This includes not only cross-country skiing but also endurance exercise during the snow-free seasons. The aim of this study was to determine whether the level of physical exercise is associated with future risk of severe osteoarthritis independent of previous diseases and injuries. Methodology/Principal Findings: We used a cohort that consisted of 48 574 men and 5 409 women who participated in the 90 km ski race Vasaloppet at least once between 1989 and 1998. Number of performed races and finishing time were used as estimates of exercise level. By matching to the National Patient Register we identified participants with severe osteoarthritis, defined as arthroplasty of knee or hip due to osteoarthritis. With an average follow-up of 10 years, we identified 528 men and 42 women with incident osteoarthritis. The crude rate was 1.1/1000 person-years for men and 0.8/1000 person-years for women. Compared with racing once, participation in >= 5 races was associated with a 70% higher rate of osteoarthritis (multivariable-adjusted hazard ratio (HR) 1.72, 95% confidence interval (CI) 1.33 to 2.22). The association was dose-dependent with an adjusted HR of 1.09, 95% CI 1.05 to 1.13 for each completed race. A faster finishing time, in comparison with a slow finishing time, was also associated with an increased rate (adjusted HR 1.51, 95% CI 1.14 to 2.01). Contrasting those with 5 or more ski races and a fast finish time to those who only participated once with a slow finish time, the adjusted HR of osteoarthritis was 2.73, 95% CI 1.78 to 4.18. Conclusions/Significance: Participants with multiple and fast races have an increased risk of subsequent arthroplasty of knee and hip due to osteoarthritis, suggesting that intensive exercise may increase the risk.	[Michaelsson, Karl; Byberg, Liisa] Uppsala Univ, Sect Orthopaed, Dept Surg Sci, Uppsala, Sweden; [Michaelsson, Karl; Byberg, Liisa; Melhus, Hakan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Ahlbom, Anders; Farahmand, Bahman Y.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Melhus, Hakan] Uppsala Univ, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Uppsala University	Michaelsson, K (corresponding author), Uppsala Univ, Sect Orthopaed, Dept Surg Sci, Uppsala, Sweden.	karl.michaelsson@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council [K2006-73P-20267-01-4, K2009-52x-13511-10-3]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council (K2006-73P-20267-01-4 and K2009-52x-13511-10-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AROKOSKI J, 1994, INT J SPORTS MED, V15, P254, DOI 10.1055/s-2007-1021056; Astrand PO., 1986, TXB WORK PHYSL, P391; Buckwalter JA, 2004, CURR OPIN RHEUMATOL, V16, P634, DOI 10.1097/01.bor.0000132647.55056.a9; Byberg L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b688; Carlsson S, 2006, MED SCI SPORT EXER, V38, P1396, DOI 10.1249/01.mss.0000228941.17034.c1; Cheng YL, 2000, J CLIN EPIDEMIOL, V53, P315, DOI 10.1016/S0895-4356(99)00168-7; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Engstrom L, 1993, LIFESTYLE FUNCTION H; Farahmand BY, 2003, J INTERN MED, V253, P276, DOI 10.1046/j.1365-2796.2003.01122.x; Felson DT, 2007, ARTHRIT RHEUM-ARTHR, V57, P6, DOI 10.1002/art.22464; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Forsberg A, 2002, IMPROVE YOUR FITNESS; Fransen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub2; Garstang SV, 2006, AM J PHYS MED REHAB, V85, pS2, DOI 10.1097/01.phm.0000245568.69434.1a; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Hart DJ, 1999, ARTHRITIS RHEUM, V42, P17, DOI 10.1002/1529-0131(199901)42:1<17::AID-ANR2>3.0.CO;2-E; Hart LE, 2008, CLIN J SPORT MED, V18, P508, DOI 10.1097/JSM.0b013e3181865ed4; Hootman JM, 2003, PREV MED, V36, P636, DOI 10.1016/S0091-7435(03)00018-5; Hunter DJ, 2009, J ANAT, V214, P197, DOI 10.1111/j.1469-7580.2008.01013.x; KIVIRANTA I, 1992, CLIN ORTHOP RELAT R, P302; Lane NE, 1998, J RHEUMATOL, V25, P334; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lievense AM, 2003, ARTHRIT RHEUM-ARTHR, V49, P228, DOI 10.1002/art.11012; Lohmander LS, 2009, ANN RHEUM DIS, V68, P490, DOI 10.1136/ard.2008.089748; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McAlindon TE, 1999, AM J MED, V106, P151, DOI 10.1016/S0002-9343(98)00413-6; Muhlbauer R, 2000, AM J SPORT MED, V28, P541; Newton PM, 1997, AM J SPORT MED, V25, P282, DOI 10.1177/036354659702500302; Pollock M L, 1977, Ann N Y Acad Sci, V301, P310, DOI 10.1111/j.1749-6632.1977.tb38209.x; RENSTROM P, 1989, SPORTS MED, V8, P346, DOI 10.2165/00007256-198908060-00004; RUSKO HK, 1992, MED SCI SPORT EXER, V24, P1040; Soderman P, 2000, J ARTHROPLASTY, V15, P884, DOI 10.1054/arth.2000.8591; Spector Tim D, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS39; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Szoeke CEI, 2006, BONE, V39, P1149, DOI 10.1016/j.bone.2006.05.016; VENN G, 1995, ARTHRITIS RHEUM, V38, P525, DOI 10.1002/art.1780380410; Vignon E, 2006, JOINT BONE SPINE, V73, P442, DOI 10.1016/j.jbspin.2006.03.001	43	33	33	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18339	10.1371/journal.pone.0018339	http://dx.doi.org/10.1371/journal.pone.0018339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479136	gold, Green Submitted, Green Published			2022-12-25	WOS:000289055700050
J	Chai, YP; Zhang, DM; Lin, YF				Chai, Yongping; Zhang, Dai-Min; Lin, Yu-Fung			Activation of cGMP-Dependent Protein Kinase Stimulates Cardiac ATP-Sensitive Potassium Channels via a ROS/Calmodulin/CaMKII Signaling Cascade	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; RABBIT VENTRICULAR MYOCYTES; OXYGEN-FREE RADICALS; K+ CHANNELS; MEDIATED PHOSPHORYLATION; SKELETAL-MUSCLE; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; DOPAMINE RELEASE; MEMBRANE PATCHES	Background: Cyclic GMP (cGMP)-dependent protein kinase (PKG) is recognized as an important signaling component in diverse cell types. PKG may influence the function of cardiac ATP-sensitive potassium (K(ATP)) channels, an ion channel critical for stress adaptation in the heart; however, the underlying mechanism remains largely unknown. The present study was designed to address this issue. Methods and Findings: Single-channel recordings of cardiac K(ATP) channels were performed in both cell-attached and inside-out patch configurations using transfected human embryonic kidney (HEK) 293 cells and rabbit ventricular cardiomyocytes. We found that Kir6.2/SUR2A (the cardiac-type K(ATP)) channels were activated by cGMP-selective phosphodiesterase inhibitor zaprinast in a concentration-dependent manner in cell-attached patches obtained from HEK293 cells, an effect mimicked by the membrane-permeable cGMP analog 8-bromo-cGMP whereas abolished by selective PKG inhibitors. Intriguingly, direct application of PKG moderately reduced rather than augmented Kir6.2/SUR2A single-channel currents in excised, inside-out patches. Moreover, PKG stimulation of Kir6.2/SUR2A channels in intact cells was abrogated by ROS/H(2)O(2) scavenging, antagonism of calmodulin, and blockade of calcium/calmodulin-dependent protein kinase II (CaMKII), respectively. Exogenous H(2)O(2) also concentration-dependently stimulated Kir6.2/SUR2A channels in intact cells, and its effect was prevented by inhibition of calmodulin or CaMKII. PKG stimulation of K(ATP) channels was confirmed in intact ventricular cardiomyocytes, which was ROS- and CaMKII-dependent. Kinetically, PKG appeared to stimulate these channels by destabilizing the longest closed state while stabilizing the long open state and facilitating opening transitions. Conclusion: The present study provides novel evidence that PKG exerts dual regulation of cardiac K(ATP) channels, including marked stimulation resulting from intracellular signaling mediated by ROS (H(2)O(2) in particular), calmodulin and CaMKII, alongside of moderate channel suppression likely mediated by direct PKG phosphorylation of the channel or some closely associated proteins. The novel cGMP/PKG/ROS/calmodulin/CaMKII signaling pathway may regulate cardiomyocyte excitability by opening K(ATP) channels and contribute to cardiac protection against ischemia-reperfusion injury.	[Chai, Yongping; Zhang, Dai-Min; Lin, Yu-Fung] Univ Calif Davis, Dept Physiol, Davis, CA 95616 USA; [Chai, Yongping; Zhang, Dai-Min; Lin, Yu-Fung] Univ Calif Davis, Dept Membrane Biol, Davis, CA 95616 USA; [Lin, Yu-Fung] Univ Calif Davis, Dept Anesthesiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chai, YP (corresponding author), Univ Calif Davis, Dept Physiol, Davis, CA 95616 USA.	yu-fung.lin@ucdmc.ucdavis.edu	Zhang, Dai-Min/J-2765-2019	Zhang, Dai-Min/0000-0001-5251-3113; Lin, Yu-Fung/0000-0003-1471-949X	American Heart Association National Center [0730320N]; National Center for Research Resources, National Institutes of Health [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER	American Heart Association National Center(American Heart Association); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a grant (0730320N) from American Heart Association National Center (Y.F.L.), and was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Avshalumov MV, 2003, J NEUROSCI, V23, P2744; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Baines CP, 1997, J MOL CELL CARDIOL, V29, P207, DOI 10.1006/jmcc.1996.0265; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Chai Y, 2008, PFLUG ARCH EUR J PHY, V456, P897, DOI 10.1007/s00424-008-0447-z; Chai YP, 2010, AM J PHYSIOL-CELL PH, V298, pC875, DOI 10.1152/ajpcell.00196.2009; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COETZEE WA, 1995, AM J PHYSIOL-HEART C, V269, pH1625, DOI 10.1152/ajpheart.1995.269.5.H1625; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; GOLDHABER JI, 1989, J CLIN INVEST, V83, P1800, DOI 10.1172/JCI114085; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han J, 2002, AM J PHYSIOL-HEART C, V283, pH1545, DOI 10.1152/ajpheart.01052.2001; Han J, 2001, J BIOL CHEM, V276, P22140, DOI 10.1074/jbc.M010103200; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Hu K, 1999, AM J PHYSIOL-HEART C, V276, pH488, DOI 10.1152/ajpheart.1999.276.2.H488; Ichinari K, 1996, J MOL CELL CARDIOL, V28, P1867, DOI 10.1006/jmcc.1996.0179; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; ISLAM MS, 1993, FEBS LETT, V319, P128, DOI 10.1016/0014-5793(93)80051-U; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kane GC, 2006, HUM MOL GENET, V15, P2285, DOI 10.1093/hmg/ddl154; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; KUBO M, 1994, CIRC RES, V74, P471, DOI 10.1161/01.RES.74.3.471; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2008, NEUROSCIENCE, V152, P371, DOI 10.1016/j.neuroscience.2008.01.003; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Mao X, 2007, AM J PHYSIOL-CELL PH, V292, pC2239, DOI 10.1152/ajpcell.00326.2006; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; NAKAZAKI M, 1995, DIABETES, V44, P878, DOI 10.2337/diabetes.44.8.878; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Okuyama Y, 1998, PFLUG ARCH EUR J PHY, V435, P595, DOI 10.1007/s004240050559; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Olson TM, 2010, PFLUG ARCH EUR J PHY, V460, P295, DOI 10.1007/s00424-009-0771-y; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Tokube K, 1996, AM J PHYSIOL-HEART C, V271, pH478, DOI 10.1152/ajpheart.1996.271.2.H478; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Wagner S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P285, DOI 10.1161/CIRCEP.108.842799; Wang X, 1997, J NEUROCHEM, V68, P443; WEIK R, 1989, J MEMBRANE BIOL, V110, P217, DOI 10.1007/BF01869152; Wellman GC, 1998, J PHYSIOL-LONDON, V507, P117, DOI 10.1111/j.1469-7793.1998.117bu.x; Xu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1433, DOI 10.1152/ajpheart.00882.2003; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	62	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18191	10.1371/journal.pone.0018191	http://dx.doi.org/10.1371/journal.pone.0018191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479273	gold, Green Published			2022-12-25	WOS:000289054600032
J	Lorbeck, M; Pirooznia, K; Sarthi, J; Zhu, XM; Elefant, F				Lorbeck, Meridith; Pirooznia, Keerthy; Sarthi, Jessica; Zhu, Xianmin; Elefant, Felice			Microarray Analysis Uncovers a Role for Tip60 in Nervous System Function and General Metabolism	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; DOUBLE-STRAND BREAKS; RUBINSTEIN-TAYBI-SYNDROME; HISTONE ACETYLTRANSFERASE; DROSOPHILA-MELANOGASTER; SYNAPTIC PLASTICITY; CHROMATIN-STRUCTURE; CO-REPRESSOR; MYST FAMILY; GLIAL-CELLS	Background: Tip60 is a key histone acetyltransferase (HAT) enzyme that plays a central role in diverse biological processes critical for general cell function; however, the chromatin-mediated cell-type specific developmental pathways that are dependent exclusively upon the HAT activity of Tip60 remain to be explored. Methods and Findings: Here, we investigate the role of Tip60 HAT activity in transcriptional control during multicellular development in vivo by examining genome-wide changes in gene expression in a Drosophila model system specifically depleted for endogenous dTip60 HAT function. Conclusions: We show that amino acid residue E431 in the catalytic HAT domain of dTip60 is critical for the acetylation of endogenous histone H4 in our fly model in vivo, and demonstrate that dTip60 HAT activity is essential for multicellular development. Moreover, our results uncover a novel role for Tip60 HAT activity in controlling neuronal specific gene expression profiles essential for nervous system function as well as a central regulatory role for Tip60 HAT function in general metabolism.	[Lorbeck, Meridith; Pirooznia, Keerthy; Sarthi, Jessica; Zhu, Xianmin; Elefant, Felice] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University	Lorbeck, M (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	fe22@drexel.edu	Zhu, Xianmin/M-6437-2017	Zhu, Xianmin/0000-0003-1405-9700	National Institutes of Health [1R01HD057939]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a National Institutes of Health grant (www.nichd.nih.gov) 1R01HD057939 to FE. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2002, MECH DEVELOP, V113, P41, DOI 10.1016/S0925-4773(02)00010-2; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chailleux C, 2010, BIOCHEM J, V426, P365, DOI 10.1042/BJ20091329; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Clarke AS, 2006, MOL BIOL CELL, V17, P1744, DOI 10.1091/mbc.E05-07-0613; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gorski MM, 2004, DNA REPAIR, V3, P603, DOI 10.1016/j.dnarep.2004.02.001; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; MATHIS DJ, 1978, NUCLEIC ACIDS RES, V5, P3523, DOI 10.1093/nar/5.10.3523; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Park JH, 2010, MOL CELL BIOL, V30, P2750, DOI 10.1128/MCB.00804-09; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; POULSON DF, 1994, BIOL DROSOPHILA, P168; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schirling C, 2010, CHROMOSOMA, V119, P99, DOI 10.1007/s00412-009-0247-z; Shilova VY, 2006, GENETICS, V173, P809, DOI 10.1534/genetics.105.053959; Singh N, 2010, J NEUROCHEM, V115, P493, DOI 10.1111/j.1471-4159.2010.06892.x; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sweatt JD, 2010, SCIENCE, V328, P701, DOI 10.1126/science.1189968; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Todd PK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001240; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063; Zhu XM, 2007, GENETICS, V175, P1229, DOI 10.1534/genetics.106.063685	79	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18412	10.1371/journal.pone.0018412	http://dx.doi.org/10.1371/journal.pone.0018412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494552	gold, Green Submitted, Green Published			2022-12-25	WOS:000289354100011
J	Jiang, P; Li, JB; Han, F; Duan, GF; Lu, XZ; Gu, YC; Yu, WG				Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong			Antibiofilm Activity of an Exopolysaccharide from Marine Bacterium Vibrio sp QY101	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; STAPHYLOCOCCUS-EPIDERMIDIS; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; RESISTANCE; PROTECTS; ADHESION; AUREUS; IDENTIFICATION	Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides.	[Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong] Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Peoples R China; [Jiang, Peng; Li, Jingbao; Han, Feng; Duan, Gaofei; Lu, Xinzhi; Gu, Yuchao; Yu, Wengong] Ocean Univ China, Lab Glycobiol, Sch Med & Pharm, Qingdao, Peoples R China; [Li, Jingbao] Northwestern Polytech Univ, Fac Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Ocean University of China; Ocean University of China; Ocean University of China; Northwestern Polytechnical University	Jiang, P (corresponding author), Ocean Univ China, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China.	yuwg66@ouc.edu.cn	Han, Feng/AAX-3761-2021	Han, Feng/0000-0001-5706-7028	National High-tech RD Program [2007AA09Z418, 2007AA091506]; National ST Major Project [2009ZX09301-013]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0944]; Special Fund for Marine Scientific Research in the Public Interest [201005024]	National High-tech RD Program(National High Technology Research and Development Program of China); National ST Major Project; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Marine Scientific Research in the Public Interest	This work was supported by the National High-tech R&D Program, number 2007AA09Z418 and 2007AA091506, http://www.most.gov.cn/? the National S&T Major Project, number 2009ZX09301-013, http://www.nmp.gov.cn/; the Program for Changjiang Scholars and Innovative Research Team in University, number IRT0944, http://www.dost.moe.edu.cn/; the Special Fund for Marine Scientific Research in the Public Interest, number 201005024?http://www.soa.gov.cn/soa.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Antiporta MH, 2002, J BACTERIOL, V184, P1155, DOI 10.1128/jb.184.4.1155-1162.2002; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Bianciotto V, 2001, EUR J HISTOCHEM, V45, P39; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Carte Brad K., 1993, Current Opinion in Biotechnology, V4, P275, DOI 10.1016/0958-1669(93)90095-E; Coelho LR, 2008, MICROBIOL-SGM, V154, P3480, DOI 10.1099/mic.0.2007/016014-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Defives C, 1996, CURR MICROBIOL, V33, P371, DOI 10.1007/s002849900130; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FALCIERI E, 1987, J INFECT DIS, V155, P524, DOI 10.1093/infdis/155.3.524; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667; Gonzalez JE, 1996, GENE, V179, P141, DOI 10.1016/S0378-1119(96)00322-8; Greenberg EP, 2003, NATURE, V424, P134, DOI 10.1038/424134a; Guo SD, 2010, BIORESOURCE TECHNOL, V101, P4729, DOI 10.1016/j.biortech.2010.01.125; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoyle B D, 1991, Prog Drug Res, V37, P91; Hsieh YC, 2003, INFECT IMMUN, V71, P3329, DOI 10.1128/IAI.71.6.3329-3336.2003; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; JANN K, 1980, J BACTERIOL, V143, P1108, DOI 10.1128/JB.143.3.1108-1115.1980; JOHNSON MC, 1977, J BACTERIOL, V129, P351, DOI 10.1128/JB.129.1.351-357.1977; Joseph LA, 2004, J BACTERIOL, V186, P889, DOI 10.1128/JB.186.3.889-893.2004; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Kierek K, 2003, P NATL ACAD SCI USA, V100, P14357, DOI 10.1073/pnas.2334614100; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Langille SE, 2000, J IND MICROBIOL BIOT, V25, P81, DOI 10.1038/sj.jim.7000033; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007; Nemoto K, 2000, CHEMOTHERAPY, V46, P111, DOI 10.1159/000007264; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; PIER GB, 1994, INFECT IMMUN, V62, P3972, DOI 10.1128/IAI.62.9.3972-3979.1994; Pihl M, 2010, FEMS IMMUNOL MED MIC, V59, P439, DOI 10.1111/j.1574-695X.2010.00697.x; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; REDDY GP, 1993, ANAL BIOCHEM, V214, P106, DOI 10.1006/abio.1993.1463; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; Ruas-Madiedo P, 2006, J FOOD PROTECT, V69, P2011, DOI 10.4315/0362-028X-69.8.2011; Sahly H, 2008, INFECT IMMUN, V76, P1322, DOI 10.1128/IAI.00910-07; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Song K, 2003, ACTA BIOCH BIOPH SIN, V35, P473; Stapper AP, 2004, J MED MICROBIOL, V53, P679, DOI 10.1099/jmm.0.45539-0; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sun HH, 2009, CARBOHYD POLYM, V78, P117, DOI 10.1016/j.carbpol.2009.04.017; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yoshida Yasuo, 2006, BMC Oral Health, V6 Suppl 1, pS12, DOI 10.1186/1472-6831-6-S1-S12; You JL, 2007, APPL MICROBIOL BIOT, V76, P1137, DOI 10.1007/s00253-007-1074-x; ZAJAC E, 1983, J GEN MICROBIOL, V129, P3171	79	96	105	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18514	10.1371/journal.pone.0018514	http://dx.doi.org/10.1371/journal.pone.0018514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490923	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700018
J	Kelly, TR; Bloom, PH; Torres, SG; Hernandez, YZ; Poppenga, RH; Boyce, WM; Johnson, CK				Kelly, Terra R.; Bloom, Peter H.; Torres, Steve G.; Hernandez, Yvette Z.; Poppenga, Robert H.; Boyce, Walter M.; Johnson, Christine K.			Impact of the California Lead Ammunition Ban on Reducing Lead Exposure in Golden Eagles and Turkey Vultures	PLOS ONE			English	Article							BALD EAGLES; SHOT; INGESTION; CONDORS; HAZARDS; PELLETS; DUCKS	Predatory and scavenging birds may be exposed to high levels of lead when they ingest shot or bullet fragments embedded in the tissues of animals injured or killed with lead ammunition. Lead poisoning was a contributing factor in the decline of the endangered California condor population in the 1980s, and remains one of the primary factors threatening species recovery. In response to this threat, a ban on the use of lead ammunition for most hunting activities in the range of the condor in California was implemented in 2008. Monitoring of lead exposure in predatory and scavenging birds is essential for assessing the effectiveness of the lead ammunition ban in reducing lead exposure in these species. In this study, we assessed the effectiveness of the regulation in decreasing blood lead concentration in two avian sentinels, golden eagles and turkey vultures, within the condor range in California. We compared blood lead concentration in golden eagles and turkey vultures prior to the lead ammunition ban and one year following implementation of the ban. Lead exposure in both golden eagles and turkey vultures declined significantly post-ban. Our findings provide evidence that hunter compliance with lead ammunition regulations was sufficient to reduce lead exposure in predatory and scavenging birds at our study sites.	[Kelly, Terra R.; Hernandez, Yvette Z.; Boyce, Walter M.; Johnson, Christine K.] Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Bloom, Peter H.] Univ Idaho, Dept Fish & Wildlife, Moscow, ID 83843 USA; [Torres, Steve G.] Calif Dept Fish & Game, Wildlife Invest Lab, Rancho Cordova, CA 95670 USA	University of California System; University of California Davis; Idaho; University of Idaho	Kelly, TR (corresponding author), Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA.	trkelly@ucdavis.edu			California State Wildlife Grant [T-12-1]	California State Wildlife Grant	California State Wildlife Grant "Heavy Metal Contamination in Sentinel Wildlife Species," Grant # T-12-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WL, 2000, J WILDLIFE MANAGE, V64, P848, DOI 10.2307/3802755; BELLROSE FRANK C., 1959, ILLINOIS NAT HIST SURV BULL, V27, P235; Bloom P., 1987, NATL WILDL FED SCI T, V10, P99; Bloom Peter H., 2001, North American Bird Bander, V26, P97; *CA DEP FISH GAM, 2008, ATT HUNT ITS TIM GET; *CA DEP FISH GAM, 2007, REP 2007 GAM TAK HUN; *CA DEP FISH GAM, 2009, 2008 CAL DEER KILL R; *CA DEP FISH GAM, 2008, 2008 2009 WILD PIG H; *CA DEP FISH GAM, 2009, 2007 2008 WILD PIG T; *CA DEP FISH GAM, 2010, CERT NONL AMM; *CA DEP FISH GAM, 2008, 2007 CAL DEER KILL R; Cade TJ, 2007, J WILDLIFE MANAGE, V71, P2125, DOI 10.2193/2007-084; Carpenter JW, 2003, J WILDLIFE DIS, V39, P96, DOI 10.7589/0090-3558-39.1.96; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Clark AJ, 2003, ECOTOXICOLOGY, V12, P23, DOI 10.1023/A:1022576510445; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; ESKILDSEN J, 1984, TOXICOL LETT, V21, P225, DOI 10.1016/0378-4274(84)90211-X; FEIERABEND JS, 1983, NATL WILDLIFE FEDERA, V8; Franson J. Christian, 1996, P265; FRY M.D., 2003, ASSESSMENT LEAD CONT; GarciaFernandez AJ, 1997, ARCH ENVIRON CON TOX, V33, P76, DOI 10.1007/s002449900226; GILL CE, 1994, CAN VET J, V35, P303; HAAS G H, 1977, Wildlife Society Bulletin, V5, P123; Henckel E, 1981, N AM BIRD BANDER, V6, P106; HOFFMAN DJ, 1981, J WILDLIFE DIS, V17, P423, DOI 10.7589/0090-3558-17.3.423; HOSMER DW, 2000, WILEY PS TX, P1; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; JACKMAN RE, 1994, J RAPTOR RES, V28, P268; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Kenntner N, 2001, ENVIRON TOXICOL CHEM, V20, P1831, DOI [10.1897/1551-5028(2001)020&lt;1831:HMISTO&gt;2.0.CO;2, 10.1002/etc.5620200829]; Kirk David A., 1998, BIRDS N AM; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Kochert M. N., 2002, BIRDS N AM ONLINE; Kramer JL, 1997, J RAPTOR RES, V31, P327; Krone O, 2006, AMBIO, V35, P98, DOI 10.1579/0044-7447(2006)35[98:MFHBAC]2.0.CO;2; Krone Oliver, 2009, P289, DOI 10.4080/ilsa.2009.0207; Locke Louis N., 1996, P108; LOPAKA L, 2009, NADA NONDETECTS DATA; Miller MJR, 1998, J WILDLIFE DIS, V34, P704, DOI 10.7589/0090-3558-34.4.704; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PAIN DJ, 1993, BIOL CONSERV, V81, P1; Pattee O.H., 1983, Transactions of the North American Wildlife and Natural Resources Conference, V48, P230; PATTEE OH, 1990, CONDOR, V92, P931, DOI 10.2307/1368729; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Development Core Team, 2009, R FDN STAT COMP; Saito Keisuke, 2009, P302, DOI 10.4080/ilsa.2009.0304; Samuel MD, 2000, J WILDLIFE MANAGE, V64, P947, DOI 10.2307/3803203; Sanderson G.C., 1986, REV PROBLEM LEAD POI; Scheuhammer AM, 1996, ECOTOXICOLOGY, V5, P279, DOI 10.1007/BF00119051; SEIG R, 2009, INGESTION LEAD SPENT, P341, DOI DOI 10.4080/ILSA.2009.0309; Snyder NFR., 2000, CALIFORNIA CONDOR SA; STEPHENS R, 2009, INGESTION LEAD SPENT, P232, DOI DOI 10.4080/ILSA.2009.0212; *US FISH WILDL SER, 1986, US LEAD SHOT HUNT MI; *US FISH WILDL SER, 2009, NONT SHOT REG HUNT W; Wayland M, 1999, ENVIRON POLLUT, V104, P341, DOI 10.1016/S0269-7491(98)00201-2; Wayland M, 2003, J RAPTOR RES, V37, P8; 2009, SHOOTING SPORTS NEWS	58	42	42	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e17656	10.1371/journal.pone.0017656	http://dx.doi.org/10.1371/journal.pone.0017656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494329	Green Published, gold			2022-12-25	WOS:000289192400004
J	Santosuosso, M; Righi, E; Hill, ED; Leblanc, PR; Kodish, B; Mylvaganam, HN; Siddappa, NB; Stevceva, L; Hu, SL; Ghebremichael, M; Chenine, AL; Hovav, AH; Ruprecht, RM; Poznansky, MC				Santosuosso, Michael; Righi, Elda; Hill, E. David; Leblanc, Pierre R.; Kodish, Brett; Mylvaganam, Hari N.; Siddappa, Nagadenahalli B.; Stevceva, Liljana; Hu, Shiu-Lok; Ghebremichael, Musie; Chenine, Agnes-L.; Hovav, Avi-Hai; Ruprecht, Ruth M.; Poznansky, Mark C.			R5-SHIV Induces Multiple Defects in T Cell Function during Early Infection of Rhesus Macaques Including Accumulation of T Reg Cells in Lymph Nodes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE PROTEIN; INDUCED APOPTOSIS; IMMUNE-RESPONSES; DENDRITIC CELLS; HIV-INFECTION; GP120; ACTIVATION; CD4(+); TYPE-1	Background: HIV-1 is a pathogen that T cell responses fail to control. HIV-1gp120 is the surface viral envelope glycoprotein that interacts with CD4 T cells and mediates entry. HIV-1gp120 has been implicated in immune dysregulatory functions that may limit anti-HIV antigen-specific T cell responses. We hypothesized that in the context of early SHIV infection, immune dysregulation of antigen-specific T-effector cell and regulatory functions would be detectable and that these would be associated or correlated with measurable concentrations of HIV-1gp120 in lymphoid tissues. Methods: Rhesus macaques were intravaginally inoculated with a Clade C CCR5-tropic simian-human immunodeficiency virus, SHIV-1157ipd3N4. HIV-1gp120 levels, antigen-specificity, levels of apoptosis/anergy and frequency and function of Tregs were examined in lymph node and blood derived T cells at 5 and 12 weeks post inoculation. Results/Conclusions: We observed reduced responses to Gag in CD4 and gp120 in CD8 lymph node-derived T cells compared to the peripheral blood at 5 weeks post-inoculation. Reduced antigen-specific responses were associated with higher levels of PD-1 on lymph node-derived CD4 T cells as compared to peripheral blood and uninfected lymph node-derived CD4 T cells. Lymph nodes contained increased numbers of Tregs as compared to peripheral blood, which positively correlated with gp120 levels; T regulatory cell depletion restored CD8 T cell responses to Gag but not to gp120. HIV gp120 was also able to induce T regulatory cell chemotaxis in a dose-dependent, CCR5-mediated manner. These studies contribute to our broader understanding of the ways in which HIV-1 dysregulates T cell function and localization during early infection.	[Santosuosso, Michael; Righi, Elda; Hill, E. David; Leblanc, Pierre R.; Kodish, Brett; Mylvaganam, Hari N.; Stevceva, Liljana; Poznansky, Mark C.] Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Infect Dis Med Div, Charlestown, MA USA; [Siddappa, Nagadenahalli B.; Chenine, Agnes-L.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA; [Siddappa, Nagadenahalli B.; Chenine, Agnes-L.; Ruprecht, Ruth M.] Dana Farber Canc Inst, AIDS, Boston, MA 02115 USA; [Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Ghebremichael, Musie] Harvard Univ, Sch Publ Hlth, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Hovav, Avi-Hai] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Jerusalem, Israel	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Hebrew University of Jerusalem	Santosuosso, M (corresponding author), Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Infect Dis Med Div, Charlestown, MA USA.	mpoznansky@partners.org	Leblanc, Pierre/AAB-3554-2020; Poznansky, Mark C/M-4996-2015; Righi, Elda/Y-3558-2019	Leblanc, Pierre/0000-0001-8756-2396; Poznansky, Mark C/0000-0003-1344-7103; Righi, Elda/0000-0001-8718-1200; Byrareddy, Siddappa/0000-0002-7423-1763	National Institutes of Health (NIH) [RO1 AI49757, PO1 AI048240, RO1 DE016013]; Yerkes National Primate Research center [RR00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, R01AI049757, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016013] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes National Primate Research center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was completed via support of MCP (National Institutes of Health (NIH) RO1 AI49757), RMR (NIH grants PO1 AI048240 and RO1 DE016013) and Yerkes National Primate Research center (Grant #RR00165). MS is a research fellow of the Canadian Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero P, 1998, FEBS LETT, V436, P461, DOI 10.1016/S0014-5793(98)01127-2; Algeciras A, 1998, J EXP MED, V187, P711, DOI 10.1084/jem.187.5.711; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bachis A, 2004, J NEUROSCI RES, V75, P75, DOI 10.1002/jnr.10826; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; Brainard DM, 2004, J VIROL, V78, P5184, DOI 10.1128/JVI.78.10.5184-5193.2004; Chenine AL, 2010, J INFECT DIS, V201, P1155, DOI 10.1086/651274; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chougnet C, 2006, J LEUKOCYTE BIOL, V80, P994, DOI 10.1189/jlb.0306135; COOPER DA, 1988, J INFECT DIS, V157, P889, DOI 10.1093/infdis/157.5.889; CORBEIL J, 1995, J GEN VIROL, V76, P681, DOI 10.1099/0022-1317-76-3-681; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dunham RM, 2008, J IMMUNOL, V180, P5582, DOI 10.4049/jimmunol.180.8.5582; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Hovav AH, 2009, J VIROL, V83, P10941, DOI 10.1128/JVI.00394-09; Hu HT, 2008, J IMMUNOL, V180, P5593, DOI 10.4049/jimmunol.180.8.5593; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Ji JX, 2009, INT IMMUNOL, V21, P283, DOI 10.1093/intimm/dxn146; Kaufmann GR, 1998, J INFECT DIS, V178, P1812, DOI 10.1086/314480; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; Munier ML, 2007, IMMUNOL CELL BIOL, V85, P6, DOI 10.1038/sj.icb.7100015; Musey LK, 1999, J INFECT DIS, V180, P278, DOI 10.1086/314868; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Ronaldson PT, 2006, MOL PHARMACOL, V70, P1087, DOI 10.1124/mol.106.025973; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Stevceva L, 2008, J IMMUNOL, V181, P5510, DOI 10.4049/jimmunol.181.8.5510; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0	58	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18465	10.1371/journal.pone.0018465	http://dx.doi.org/10.1371/journal.pone.0018465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483689	gold, Green Submitted, Green Published			2022-12-25	WOS:000289191300023
J	Slattery, M; Ma, LJ; Negre, N; White, KP; Mann, RS				Slattery, Matthew; Ma, Lijia; Negre, Nicolas; White, Kevin P.; Mann, Richard S.			Genome-Wide Tissue-Specific Occupancy of the Hox Protein Ultrabithorax and Hox Cofactor Homothorax in Drosophila	PLOS ONE			English	Article							BITHORAX COMPLEX; GENE-FUNCTION; TARGET GENE; ORGAN SIZE; BODY; TRANSCRIPTION; WINGLESS; DNA; RECOGNITION; IDENTITY	The Hox genes are responsible for generating morphological diversity along the anterior-posterior axis during animal development. The Drosophila Hox gene Ultrabithorax (Ubx), for example, is required for specifying the identity of the third thoracic (T3) segment of the adult, which includes the dorsal haltere, an appendage required for flight, and the ventral T3 leg. Ubx mutants show homeotic transformations of the T3 leg towards the identity of the T2 leg and the haltere towards the wing. All Hox genes, including Ubx, encode homeodomain containing transcription factors, raising the question of what target genes Ubx regulates to generate these adult structures. To address this question, we carried out whole genome ChIP-chip studies to identify all of the Ubx bound regions in the haltere and T3 leg imaginal discs, which are the precursors to these adult structures. In addition, we used ChIP-chip to identify the sites bound by the Hox cofactor, Homothorax (Hth). In contrast to previous ChIP-chip studies carried out in Drosophila embryos, these binding studies reveal that there is a remarkable amount of tissue-and transcription factor-specific binding. Analyses of the putative target genes bound and regulated by these factors suggest that Ubx regulates many downstream transcription factors and developmental pathways in the haltere and T3 leg. Finally, we discovered additional DNA sequence motifs that in some cases are specific for individual data sets, arguing that Ubx and/or Hth work together with many regionally expressed transcription factors to execute their functions. Together, these data provide the first whole-genome analysis of the binding sites and target genes regulated by Ubx to specify the morphologies of the adult T3 segment of the fly.	[Slattery, Matthew; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Ma, Lijia; Negre, Nicolas; White, Kevin P.] Univ Chicago, Dept Ecol & Evolut, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA	Columbia University; University of Chicago	Slattery, M (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	rsm10@columbia.edu		Negre, Nicolas/0000-0001-9727-3416	NIH-NHGRI; NIH [5R01GM054510]; NIH NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510] Funding Source: NIH RePORTER	NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is funded by an NIH-NHGRI, modENCODE grant awarded to KPW, by NIH grant 5R01GM054510 awarded to RSM, and by an NIH NRSA grant awarded to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856; Ayers KL, 2010, DEV CELL, V18, P605, DOI 10.1016/j.devcel.2010.02.015; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Calleja M, 2000, DEVELOPMENT, V127, P3971; Crickmore MA, 2008, BIOESSAYS, V30, P843, DOI 10.1002/bies.20806; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Diez del Corral R, 1999, GENE DEV, V13, P1754, DOI 10.1101/gad.13.13.1754; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; Estella C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001001; Galant R, 2002, DEVELOPMENT, V129, P3115; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Hersh BM, 2007, DEV BIOL, V302, P717, DOI 10.1016/j.ydbio.2006.11.011; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; IRVINE KD, 1993, DEVELOPMENT, V117, P387; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Kozu S, 2006, DEV BIOL, V294, P497, DOI 10.1016/j.ydbio.2006.03.015; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; Miller DFB, 2001, MECH DEVELOP, V102, P3, DOI 10.1016/S0925-4773(01)00301-X; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mohit P, 2006, DEV BIOL, V291, P356, DOI 10.1016/j.ydbio.2005.12.022; Morata G, 2001, NAT REV MOL CELL BIO, V2, P89, DOI 10.1038/35052047; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pradel J, 1998, INT J DEV BIOL, V42, P417; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Spradling AC, 1999, GENETICS, V153, P135; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Zhang L, 2009, FLY, V3, P68, DOI 10.4161/fly.3.1.7788	81	62	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e14686	10.1371/journal.pone.0014686	http://dx.doi.org/10.1371/journal.pone.0014686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483663	Green Submitted, gold, Green Published			2022-12-25	WOS:000289191300001
J	Hubben, G; Bootsma, M; Luteijn, M; Glynn, D; Bishai, D; Bonten, M; Postma, M				Hubben, Gijs; Bootsma, Martin; Luteijn, Michiel; Glynn, Diarmuid; Bishai, David; Bonten, Marc; Postma, Maarten			Modelling the Costs and Effects of Selective and Universal Hospital Admission Screening for Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INFECTION-CONTROL; RISK-FACTORS; MRSA; IMPACT; STATES; TRANSMISSION; SPREAD; SURVEILLANCE; PREVALENCE	Background: Screening at hospital admission for carriage of methicillin-resistant Staphylococcus aureus (MRSA) has been proposed as a strategy to reduce nosocomial infections. The objective of this study was to determine the long-term costs and health benefits of selective and universal screening for MRSA at hospital admission, using both PCR-based and chromogenic media-based tests in various settings. Methodology/Principal Findings: A simulation model of MRSA transmission was used to determine costs and effects over 15 years from a US healthcare perspective. We compared admission screening together with isolation of identified carriers against a baseline policy without screening or isolation. Strategies included selective screening of high risk patients or universal admission screening, with PCR-based or chromogenic media-based tests, in medium (5%) or high nosocomial prevalence (15%) settings. The costs of screening and isolation per averted MRSA infection were lowest using selective chromogenic-based screening in high and medium prevalence settings, at $4,100 and $10,300, respectively. Replacing the chromogenic-based test with a PCR-based test costs $13,000 and $36,200 per additional infection averted, and subsequent extension to universal screening with PCR would cost $131,000 and $232,700 per additional infection averted, in high and medium prevalence settings respectively. Assuming $17,645 benefit per infection averted, the most cost-saving strategies in high and medium prevalence settings were selective screening with PCR and selective screening with chromogenic, respectively. Conclusions/ Significance: Admission screening costs $4,100-$21,200 per infection averted, depending on strategy and setting. Including financial benefits from averted infections, screening could well be cost saving.	[Hubben, Gijs; Postma, Maarten] Univ Groningen, Dept Pharm, Groningen, Netherlands; [Bootsma, Martin] Univ Utrecht, Fac Sci, Dept Math, Utrecht, Netherlands; [Bootsma, Martin; Bonten, Marc] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Med Microbiol, Utrecht, Netherlands; [Hubben, Gijs; Glynn, Diarmuid] BaseCase Software, Berlin, Germany; [Luteijn, Michiel] Univ Ulster, Sch Nursing, Belfast, Antrim, North Ireland; [Bishai, David] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Groningen; Utrecht University; Utrecht University; Utrecht University Medical Center; Ulster University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hubben, G (corresponding author), Univ Groningen, Dept Pharm, Groningen, Netherlands.	g.hubben@basecase.com	, David Bishai/GRO-4211-2022	Postma, Maarten/0000-0002-6306-3653; Bishai, David/0000-0003-0714-9062; Luteijn, Michiel/0000-0002-9526-9015	Becton Dickinson (San Diego, CA); 3M (Minneapolis, MI); Netherlands Organization for Scientific Research [916-05-041, 918.76.611]; BaseCase (Berlin, Germany); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Becton Dickinson (San Diego, CA); 3M (Minneapolis, MI)(3M); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BaseCase (Berlin, Germany); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was financially supported by Becton Dickinson (San Diego, CA; www.bd.com) and 3M (Minneapolis, MI; www.3m.com) through research grants without publication restrictions. The funders had no role in study design, data collection and analysis, data interpretation, decision to publish, or preparation of the manuscript. MCJB and MJMB are supported by the Netherlands Organization for Scientific Research (VENI NWO GRANT 916-05-041 and VICI NWO Grant 918.76.611 www.nwo.nl). GAAH, DMG, DB, MJP, and JML have no financial disclosures.; This study was financially supported by Becton Dickinson (San Diego, CA) and 3M (Minneapolis, MI), through research grants without publication restrictions. This did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. GAAH and DMG are financially supported by BaseCase (Berlin, Germany). In their capacities as consultants for BaseCase software, GAAH and DMG have performed consulting work for Becton Dickinson. This did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. DB, MJP, and JML declare no competing interests.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Coello R, 1997, J HOSP INFECT, V37, P39, DOI 10.1016/S0195-6701(97)90071-2; Conterno LO, 2007, J HOSP INFECT, V65, P354, DOI 10.1016/j.jhin.2006.12.014; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Gold MR, 1996, COST EFFECTIVENESS H; Gould IM, 2006, INT J ANTIMICROB AG, V28, P379, DOI 10.1016/j.ijantimicag.2006.09.001; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Harbarth S, 1998, ARCH INTERN MED, V158, P182, DOI 10.1001/archinte.158.2.182; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Herr CEW, 2003, INFECT CONT HOSP EP, V24, P673, DOI 10.1086/502274; *HLTH COUNC NETH, 2006, 2006 PUBL HLTH COUNC; Hori S, 2002, J HOSP INFECT, V50, P25, DOI 10.1053/jhin.2001.1130; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Keshtgar MRS, 2008, BRIT J SURG, V95, P381, DOI 10.1002/bjs.6013; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P1174, DOI 10.1128/JCM.01253-07; Luteijn JM, 2011, CLIN MICROBIOL INFEC, V17, P146, DOI 10.1111/j.1469-0691.2010.03202.x; Nijssen S, 2005, CLIN INFECT DIS, V40, P405, DOI 10.1086/427281; PANLILIO AL, 1992, INFECT CONT HOSP EP, V13, P582; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Ritchie K, 2007, CLIN COST EFFECTIVEN; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Smith DL, 2005, P NATL ACAD SCI USA, V102, P3153, DOI 10.1073/pnas.0409523102; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P466, DOI 10.1111/j.1469-0691.2005.01153.x; Wigglesworth N, 2006, J HOSP INFECT, V63, P156, DOI 10.1016/j.jhin.2006.02.008; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	36	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e14783	10.1371/journal.pone.0014783	http://dx.doi.org/10.1371/journal.pone.0014783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483492	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200002
J	Matsumoto, Y; Sumiya, E; Sugita, T; Sekimizu, K				Matsumoto, Yasuhiko; Sumiya, Eriko; Sugita, Takuya; Sekimizu, Kazuhisa			An Invertebrate Hyperglycemic Model for the Identification of Anti-Diabetic Drugs	PLOS ONE			English	Article							ADVANCED GLYCATION; SILKWORM LARVAE; INFECTION MODEL; DIABETIC-RATS; BOMBYX-MORI; GLUCOSE; AMINOGUANIDINE; METABOLISM; VIRULENCE; FRUCTOSE	The number of individuals diagnosed with type 2 diabetes mellitus, which is caused by insulin resistance and/or abnormal insulin secretion, is increasing worldwide, creating a strong demand for the development of more effective anti-diabetic drugs. However, animal-based screening for anti-diabetic compounds requires sacrifice of a large number of diabetic animals, which presents issues in terms of animal welfare. Here, we established a method for evaluating the anti-diabetic effects of compounds using an invertebrate animal, the silkworm, Bombyx mori. Sugar levels in silkworm hemolymph increased immediately after feeding silkworms a high glucose-containing diet, resulting in impaired growth. Human insulin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), an AMP-activated protein kinase (AMPK) activator, decreased the hemolymph sugar levels of the hyperglycemic silkworms and restored growth. Treatment of the isolated fat body with human insulin in an in vitro culture system increased total sugar in the fat body and stimulated Akt phosphorylation. These responses were inhibited by wortmannin, an inhibitor of phosphoinositide 3 kinase. Moreover, AICAR stimulated AMPK phosphorylation in the silkworm fat body. Administration of aminoguanidine, a Maillard reaction inhibitor, repressed the accumulation of Maillard reaction products (advanced glycation end-products; AGEs) in the hyperglycemic silkworms and restored growth, suggesting that the growth defect of hyperglycemic silkworms is caused by AGE accumulation in the hemolymph. Furthermore, we identified galactose as a hypoglycemic compound in jiou, an herbal medicine for diabetes, by monitoring its hypoglycemic activity in hyperglycemic silkworms. These results suggest that the hyperglycemic silkworm model is useful for identifying anti-diabetic drugs that show therapeutic effects in mammals.	[Matsumoto, Yasuhiko; Sumiya, Eriko; Sugita, Takuya; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan	University of Tokyo	Matsumoto, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Matsumoto, Yasuhiko/H-5767-2019	Matsumoto, Yasuhiko/0000-0002-0796-2304	National Institute of Biomedical Innovation (NIBIO) [21790062]; Ministry of Health, Labour and Welfare; Suzuken Memorial Foundation; Genome Pharmaceuticals Institute Co., Ltd (Tokyo, Japan)	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Suzuken Memorial Foundation; Genome Pharmaceuticals Institute Co., Ltd (Tokyo, Japan)	The project was supported by a Grant-in-Aid for Scientific Research (21790062) and also in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the grant from the Ministry of Health, Labour and Welfare (Research on Biological Resources and Animal Models for Drug Development), the research grant of Suzuken Memorial Foundation, and Genome Pharmaceuticals Institute Co., Ltd (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami Yukihiro, 2010, BMC Pharmacology, V10, P7, DOI 10.1186/1471-2210-10-7; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Coughlan MT, 2008, ANN NY ACAD SCI, V1126, P190, DOI 10.1196/annals.1433.018; Drel VR, 2007, EUR J PHARMACOL, V569, P48, DOI 10.1016/j.ejphar.2007.05.055; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Hamamoto A, 2005, INT J ANTIMICROB AG, V26, P38, DOI 10.1016/j.ijantimicag.2005.03.008; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hedge J.E., 1962, CARBOHYDRATE CHEM, Vseventeenth; Iwami M, 2000, ZOOL SCI, V17, P1035, DOI 10.2108/zsj.17.1035; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; KIHO T, 1992, YAKUGAKU ZASSHI, V112, P393, DOI 10.1248/yakushi1947.112.6_393; Kurokawa K, 2007, METHOD ENZYMOL, V422, P233, DOI 10.1016/S0076-6879(06)22011-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Miura J, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00183-6; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nagata S, 2008, COMP BIOCHEM PHYS B, V151, P355, DOI 10.1016/j.cbpb.2008.08.002; Orihara Y, 2008, J GEN VIROL, V89, P188, DOI 10.1099/vir.0.83208-0; Russell WMS., 1959, MED J AUSTRALIA; Soulis T, 1997, DIABETOLOGIA, V40, P1141, DOI 10.1007/s001250050799; Stadler K, 2005, DIABETES-METAB RES, V21, P189, DOI 10.1002/dmrr.501; Summers SA, 1999, ANN NY ACAD SCI, V892, P169, DOI 10.1111/j.1749-6632.1999.tb07795.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	67	72	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18292	10.1371/journal.pone.0018292	http://dx.doi.org/10.1371/journal.pone.0018292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479175	gold, Green Published, Green Submitted			2022-12-25	WOS:000289055700044
J	Fry, AM; Lu, XY; Olsen, SJ; Chittaganpitch, M; Sawatwong, P; Chantra, S; Baggett, HC; Erdman, D				Fry, Alicia M.; Lu, Xiaoyan; Olsen, Sonja J.; Chittaganpitch, Malinee; Sawatwong, Pongpun; Chantra, Somrak; Baggett, Henry C.; Erdman, Dean			Human Rhinovirus Infections in Rural Thailand: Epidemiological Evidence for Rhinovirus as Both Pathogen and Bystander	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ACUTE RESPIRATORY ILLNESS; CLINICAL SYMPTOMS; PNEUMONIA; VIRUSES; SURVEILLANCE; CHILDREN; TRACT; HOSPITALIZATIONS; INFLUENZA	Background: We describe human rhinovirus (HRV) detections in SaKaeo province, Thailand. Methods: From September 1, 2003-August 31, 2005, we tested hospitalized patients with acute lower respiratory illness and outpatient controls without fever or respiratory symptoms for HRVs with polymerase chain reaction and molecularly-typed select HRVs. We compared HRV detection among hospitalized patients and controls and estimated enrollment adjusted incidence. Results: HRVs were detected in 315 (16%) of 1919 hospitalized patients and 27 (9.6%) of 280 controls. Children had the highest frequency of HRV detections (hospitalized: <1 year: 29%, 1-4 year: 29%, >= 65 years: 9%; controls: <1 year: 24%, 1-4 year: 14%, >= 65 years: 2.8%). Enrollment adjusted hospitalized HRV detection rates were highest among persons aged <1 year (1038/100,000 persons/year), 1-4 years (457), and >= 65 years (71). All three HRV species were identified, HRV-A was the most common species in most age groups including children aged <1 year (61%) and all adult age groups. HRV-C was the most common species in the 1-4 year (51%) and 5-19 year age groups (54%). Compared to controls, hospitalized adults (>= 19 years) and children were more likely to have HRV detections (odds ratio [OR]: 4.8, 95% confidence interval [CI]: 1.5, 15.8; OR: 2.0, CI: 1.2, 3.3, respectively) and hospitalized children were more likely to have HRV-A (OR 1.7, CI: 0.8, 3.5) or HVR-C (OR 2.7, CI: 1.2, 5.9) detection. Conclusions: HRV rates were high among hospitalized children and the elderly but asymptomatic children also had substantial HRV detection. HRV (all species), and HRV-A and HRV-C detections were epidemiologically-associated with hospitalized illness. Treatment or prevention modalities effective against HRV could reduce hospitalizations due to HRV in Thailand.	[Fry, Alicia M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Lu, Xiaoyan; Erdman, Dean] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Olsen, Sonja J.] Ctr Dis Control & Prevent, Div Emerging Infect & Surveillance Serv, Atlanta, GA USA; [Chittaganpitch, Malinee] Thailand Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand; [Sawatwong, Pongpun; Chantra, Somrak; Baggett, Henry C.] Thai MOPH US CDC Collaborat, Int Emerging Infect Program, Nonthaburi, Thailand	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Fry, AM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	afry@cdc.gov						[Anonymous], POP PROJ THAIL 2000; Cheuk DKL, 2007, PEDIATR INFECT DIS J, V26, P995, DOI 10.1097/INF.0b013e3181586b63; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; Falsey AR, 2002, J INFECT DIS, V185, P1338, DOI 10.1086/339881; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Garbino J, 2004, CHEST, V125, P1033, DOI 10.1378/chest.125.3.1033; Garbino J, 2009, THORAX, V64, P399, DOI 10.1136/thx.2008.105155; Gerna G, 2009, J MED VIROL, V81, P1498, DOI 10.1002/jmv.21548; Ghosh S, 1999, CLIN INFECT DIS, V29, P528, DOI 10.1086/598627; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; LU X, 2009, 25 ANN CLIN VIR S AN; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Phares CR, 2007, CLIN INFECT DIS, V45, pE147, DOI 10.1086/523003; Roghmann M, 2003, BONE MARROW TRANSPL, V32, P1085, DOI 10.1038/sj.bmt.1704257; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; van Kraaij MGJ, 2005, CLIN INFECT DIS, V40, P662, DOI 10.1086/427801; Winther B, 2006, J MED VIROL, V78, P644, DOI 10.1002/jmv.20588; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; Wright PF, 2007, J CLIN MICROBIOL, V45, P2126, DOI 10.1128/JCM.02553-06	32	87	91	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17780	10.1371/journal.pone.0017780	http://dx.doi.org/10.1371/journal.pone.0017780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479259	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600016
J	Hong, MY; Kefaloyianni, E; Bao, L; Malester, B; Delaroche, D; Neubert, TA; Coetzee, WA				Hong, Miyoun; Kefaloyianni, Eirini; Bao, Li; Malester, Brian; Delaroche, Diane; Neubert, Thomas A.; Coetzee, William A.			Cardiac ATP-sensitive K+ channel associates with the glycolytic enzyme complex	FASEB JOURNAL			English	Article						sulfonylurea receptor; energy metabolism; Kir6.2; SUR2A	PIG VENTRICULAR CELLS; GUINEA-PIG; FUNCTIONAL COMPARTMENTALIZATION; RAT-HEART; METABOLISM; MEMBRANE; MODULATION; ACTIVATION; SECRETION; RELEASE	Being gated by high-energy nucleotides, cardiac ATP-sensitive potassium (K-ATP) channels are exquisitely sensitive to changes in cellular energy metabolism. An emerging view is that proteins associated with the K-ATP channel provide an additional layer of regulation. Using putative sulfonylurea receptor (SUR) coiled-coil domains as baits in a 2-hybrid screen against a rat cardiac cDNA library, we identified glycolytic enzymes (GAPDH and aldolase A) as putative interacting proteins. Interaction between aldolase and SUR was confirmed using GST pulldown assays and coimmunoprecipitation assays. Mass spectrometry of proteins from K-ATP channel immunoprecipitates of rat cardiac membranes identified glycolysis as the most enriched biological process. Coimmunoprecipitation assays confirmed interaction for several glycolytic enzymes throughout the glycolytic pathway. Immunocytochemistry colocalized many of these enzymes with K-ATP channel subunits in rat cardiac myocytes. The catalytic activities of aldolase and pyruvate kinase functionally modulate K-ATP channels in patch-clamp experiments, whereas D-glucose was without effect. Overall, our data demonstrate close physical association and functional interaction of the glycolytic process (particularly the distal ATP-generating steps) with cardiac K-ATP channels.- Hong, M., Kefaloyianni, E., Bao, L., Malester, B., Delaroche, D., Neubert, T. A., Coetzee, W. A. Cardiac ATP-sensitive K+ channel associates with the glycolytic enzyme complex. FASEB J. 25, 2456-2467 (2011). www.fasebj.org	[Neubert, Thomas A.] NYU, Sch Med, Skirball Inst, Struct Biol Program, New York, NY 10016 USA; [Coetzee, William A.] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; [Neubert, Thomas A.; Coetzee, William A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Hong, Miyoun; Kefaloyianni, Eirini; Bao, Li; Malester, Brian; Delaroche, Diane; Coetzee, William A.] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Coetzee, WA (corresponding author), NYU, Sch Med, Dept Pediat Cardiol, New York, NY 10016 USA.	william.coetzee@med.nyu.edu	Kefalogianni, Eirini/T-6913-2019	Coetzee, William/0000-0003-1522-8326; Hong, Miyoun/0000-0003-4475-1140; Kefalogianni, Eirini/0000-0001-9132-3902	U.S. National Institutes of Health [HL-085820]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085820] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Dr. Hon-Chi Lee (Mayo Clinic, Rochester, MN, USA) for the generous gift of a rabbit polyclonal anti-Kir6.2 antibody, Dr. Asa Wahlander for mass spectrometry, and Dr. Guoan Zhang and Steven Blais for assistance with mass spectrometry data analysis. This work was supported by U.S. National Institutes of Health grant HL-085820 (to W. A. C. and T.A.N.).	Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; Alekseev AE, 2010, CELL METAB, V11, P58, DOI 10.1016/j.cmet.2009.11.009; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Bricknell O L, 1976, Recent Adv Stud Cardiac Struct Metab, V11, P509; COETZEE WA, 1995, AM J PHYSIOL-HEART C, V269, pH1625, DOI 10.1152/ajpheart.1995.269.5.H1625; DAVIDHEISER S, 1984, AM J PHYSIOL, V247, pC335, DOI 10.1152/ajpcell.1984.247.5.C335; Dhar-Chowdhury P, 2007, CELL MOL LIFE SCI, V64, P3069, DOI 10.1007/s00018-007-7332-3; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Dizon J, 1998, AM J PHYSIOL-HEART C, V274, pH1082, DOI 10.1152/ajpheart.1998.274.4.H1082; Dubinsky WP, 1998, AM J PHYSIOL-CELL PH, V275, pC1653, DOI 10.1152/ajpcell.1998.275.6.C1653; GEISBUHLER T, 1984, CIRC RES, V54, P536, DOI 10.1161/01.RES.54.5.536; Gross GJ, 1999, CIRC RES, V84, P973, DOI 10.1161/01.RES.84.9.973; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HATAO K, 1985, Diabetes Research and Clinical Practice, V1, P49, DOI 10.1016/S0168-8227(85)80028-0; HEARSE DJ, 1995, CARDIOVASC RES, V30, P1; Jovanovic S, 2005, EMBO REP, V6, P848, DOI 10.1038/sj.embor.7400489; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; KORGE P, 1995, INT J SPORTS MED, V16, P172, DOI 10.1055/s-2007-972987; KRAMER JH, 1983, AM J PHYSIOL, V245, pH313, DOI 10.1152/ajpheart.1983.245.2.H313; Lei B, 2004, J MOL CELL CARDIOL, V36, P567, DOI 10.1016/j.yjmcc.2004.02.004; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; MALAISSE WJ, 1976, ACTA DIABETOL LAT, V13, P202, DOI 10.1007/BF02581118; NAKAMURA S, 1989, CARDIOVASC RES, V23, P286, DOI 10.1093/cvr/23.4.286; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Oe K, 1999, CARDIOVASC RES, V43, P125, DOI 10.1016/S0008-6363(99)00052-8; OPIE LH, 1980, J PHYSIOLOGY PARIS, V76, P821; PAUL RJ, 1983, AM J PHYSIOL, V244, pC399, DOI 10.1152/ajpcell.1983.244.5.C399; Pountney DJ, 2001, J MOL CELL CARDIOL, V33, P1541, DOI 10.1006/jmcc.2001.1407; Saegusa N, 2005, CARDIOVASC RES, V67, P60, DOI 10.1016/j.cardiores.2005.03.011; SCHAFFER SW, 1985, AM J MED, V79, P48, DOI 10.1016/S0002-9343(85)80007-3; Shigematsu S, 1997, CARDIOVASC RES, V35, P273, DOI 10.1016/S0008-6363(97)00092-8; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Suarez E, 2001, J BIOL CHEM, V276, P18257, DOI 10.1074/jbc.M008100200; Tsuchiya K, 1997, CIRCULATION, V96, P3129, DOI 10.1161/01.CIR.96.9.3129; WEISS JN, 1989, J GEN PHYSIOL, V94, P911, DOI 10.1085/jgp.94.5.911; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Yoshida H, 2004, J MOL CELL CARDIOL, V37, P857, DOI 10.1016/j.yjmcc.2004.05.022	40	38	38	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2456	2467		10.1096/fj.10-176669	http://dx.doi.org/10.1096/fj.10-176669			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21482559	Green Published			2022-12-25	WOS:000292242200036
J	Vanderperre, B; Staskevicius, AB; Tremblay, G; Mccoy, M; O'Neill, MA; Cashman, NR; Roucou, X				Vanderperre, Benoit; Staskevicius, Antanas B.; Tremblay, Guillaume; McCoy, Marie; O'Neill, Megan A.; Cashman, Neil R.; Roucou, Xavier			An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein	FASEB JOURNAL			English	Article						alternative translation initiation; PrP; mitochondria	ENDOPLASMIC-RETICULUM STRESS; ALTERNATIVE TRANSLATION INITIATION; CULTURED-CELLS; SCRAPIE PRION; ER STRESS; PRP; DISEASES; BAX; PROTEASOME; CONVERSION	The prion protein gene PRNP directs the synthesis of one of the most intensively studied mammalian proteins, the prion protein (PrP). Yet the physiological function of PrP has remained elusive and has created controversies in the literature. We found a downstream alternative translation initiation AUG codon surrounded by an optimal Kozak sequence in the +3 reading frame of PRNP. The corresponding alternative open reading frame encodes a polypeptide termed alternative prion protein (AltPrP) with a completely different amino acid sequence from PrP. We introduced a hemagglutinin (HA) tag in frame with AltPrP in PrP cDNAs from different species to test the expression of this novel polypeptide using anti-HA antibodies. AltPrP is constitutively coexpressed with human, bovine, sheep, and deer PrP. AltPrP is localized at the mitochondria and is up-regulated by endoplasmic reticulum stress and proteasomal inhibition. Generation of anti-AltPrP antibodies allowed us to test for endogenous expression of AltPrP in wild-type human cells expressing PrP. By transfecting cells with siRNA against PrP mRNA, we repressed expression of both PrP and AltPrP, confirming endogenous expression of AltPrP from PRNP. AltPrP was also detected in human brain homogenate, primary neurons, and peripheral blood mononuclear cells. These results demonstrate an unexpected function for PRNP, which, in addition to plasma membrane-anchored PrP, also encodes a second polypeptide termed AltPrP.-Vanderperre, B., Staskevicius, A. B., Tremblay, G., McCoy, M., O'Neill, M. A., Cashman, N. R., Roucou, X. An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein. FASEB J. 25, 2373-2386 (2011). www.fasebj.org	[Vanderperre, Benoit; Staskevicius, Antanas B.; Tremblay, Guillaume; McCoy, Marie; Roucou, Xavier] Univ Sherbrooke, Dept Biochem, Fac Med, Sherbrooke, PQ J1H 5N4, Canada; [O'Neill, Megan A.; Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Sherbrooke; University of British Columbia	Roucou, X (corresponding author), Univ Sherbrooke, Dept Biochem, Fac Med, 3001 12Eme Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	xavier.roucou@usherbrooke.ca		Vanderperre, Benoit/0000-0002-2111-1071	PrioNet Canada	PrioNet Canada	The authors thank Debbie McKenzie and Judd Aiken (Alberta Centre for Prion and Protein Folding Diseases, University of Alberta, Edmonton, AB, Canada) for their gift of the deer PrP cDNA clone, Michael Tranulis (Norwegian School of Veterinary Science, Institute of Basic Sciences and Aquatic Medicine, Oslo, Norway) for providing the sheep PrP cDNA clone, and David Fortin (Department of Surgery, Universite de Sherbrooke, QC, Canada) for the kind gift of the U-118 and U-87 cell lines. Human brain tissue was kindly provided by Dr. Cheryl Wellington (University of British Columbia, Vancouver, BC, Canada). The authors also thank Catherine Grenier for her technical help in the initial stages of this project, and Alireza Roostaee for critical review of the manuscript. This research was funded by PrioNet Canada. X. R. is a senior research scholar of the Fonds de la Recherche en Sante du Quebec. Nucleotide sequence data reported in Fig. 1 are available in the Third Party Annotation Section of the DDBJ/EMBL/GenBank databases under accession numbers TPA: BK007887-BK007890.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Deriziotis P, 2008, BBA-MOL BASIS DIS, V1782, P713, DOI 10.1016/j.bbadis.2008.06.011; Ding QX, 2003, J ALZHEIMERS DIS, V5, P241, DOI 10.3233/JAD-2003-5307; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Dubot A, 2004, BIOCHEM BIOPH RES CO, V313, P687, DOI 10.1016/j.bbrc.2003.12.013; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Harrison PM, 2010, GENOMICS, V95, P268, DOI 10.1016/j.ygeno.2010.02.008; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Horowitz Michal, 2010, Front Biosci (Schol Ed), V2, P1068; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Krakauer DC, 1998, J MOL EVOL, V47, P133, DOI 10.1007/PL00006370; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lund C, 2009, J BIOL CHEM, V284, P19668, DOI 10.1074/jbc.M109.003566; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Martins VR, 2001, BRAZ J MED BIOL RES, V34, P585, DOI 10.1590/S0100-879X2001000500005; Mastrangelo P, 2001, BIOCHEM CELL BIOL, V79, P613, DOI 10.1139/bcb-79-5-613; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Premzl M, 2009, J MOL EVOL, V68, P205, DOI 10.1007/s00239-008-9176-3; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Roostaee A, 2009, J BIOL CHEM, V284, P30907, DOI 10.1074/jbc.M109.057950; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Sakudo A, 2009, CURR MED CHEM, V16, P380, DOI 10.2174/092986709787002673; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Steinacker P, 2010, AM J PATHOL, V176, P1409, DOI 10.2353/ajpath.2010.090355; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yamasaki K, 1999, J VIROL, V73, P8519, DOI 10.1128/JVI.73.10.8519-8526.1999; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052	50	35	40	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2373	2386		10.1096/fj.10-173815	http://dx.doi.org/10.1096/fj.10-173815			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21478263				2022-12-25	WOS:000292242200029
J	Adler, A; Park, YD; Larsen, P; Nagarajan, V; Wollenberg, K; Qiu, J; Myers, TG; Williamson, PR				Adler, Amos; Park, Yoon-Dong; Larsen, Peter; Nagarajan, Vijayaraj; Wollenberg, Kurt; Qiu, Jin; Myers, Timothy G.; Williamson, Peter R.			A Novel Specificity Protein 1 (SP1)-like Gene Regulating Protein Kinase C-1 (Pkc1)-dependent Cell Wall Integrity and Virulence Factors in Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; CANDIDA-ALBICANS; LACCASE; CALCINEURIN; STRESS; IDENTIFICATION; EXPRESSION; INFECTION	Eukaryotic cells utilize complex signaling systems to detect their environments, responding and adapting as new conditions arise during evolution. The basidiomycete fungus Cryptococcus neoformans is a leading cause of AIDS-related death worldwide and utilizes the calcineurin and protein kinase C-1 (Pkc1) signaling pathways for host adaptation and expression of virulence. In the present studies, a C-terminal zinc finger transcription factor, homologous both to the calcineurin-responsive zinc fingers (Crz1) of ascomycetes and to the Pkc1-dependent specificity protein-1 (Sp1) transcription factors of metazoans, was identified and named SP1 because of its greater similarity to the metazoan factors. Structurally, the Cryptococcus neoformans Sp1 (Cn Sp1) protein was found to have acquired an additional zinc finger motif from that of Crz1 and showed Pkc1-dependent phosphorylation, nuclear localization, and whole genome epistatic associations under starvation conditions. Transcriptional targets of Cn Sp1 shared functional similarities with Crz1 factors, such as cell wall synthesis, but gained the regulation of processes involved in carbohydrate metabolism, including trehalose metabolism, and lost others, such as the induction of autophagy. In addition, overexpression of Cn Sp1 in a pkc1 Delta mutant showed restoration of altered phenotypes involved in virulence, including cell wall stability, nitrosative stress, and extracellular capsule production. Cn Sp1 was also found to be important for virulence of the fungus using a mouse model. In summary, these data suggest an evolutionary shift in C-terminal zinc finger proteins during fungal evolution, transforming them from calcineurin-dependent to PKC1-dependent transcription factors, helping to shape the role of fungal pathogenesis of C. neoformans.	Univ Chicago, Sect Pediat Infect Dis, Dept Pediat, Chicago, IL 60637 USA; [Adler, Amos; Williamson, Peter R.] Univ Illinois, Infect Dis Sect, Dept Med, Coll Med, Chicago, IL 60612 USA; [Park, Yoon-Dong; Qiu, Jin; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Nagarajan, Vijayaraj; Wollenberg, Kurt] NIAID, Bioinformat & Computat Biosciences Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Larsen, Peter] Argonne Natl Lab, Biosci Div, Lemont, IL 60439 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Energy (DOE); Argonne National Laboratory	Williamson, PR (corresponding author), 9000 Rockville Pike,Bldg 10,Rm 11N234,MSC 1888, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov		Myers, Timothy Gene/0000-0002-7059-5906	National Institutes of Health [AI45995, AI49371]; National Institutes of Health, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001123, R01AI045995, ZICAI001051, R01AI049371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI45995 and AI49371 and by the Intramural Research Program of the National Institutes of Health, NIAID.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bichile L S, 2001, J Assoc Physicians India, V49, P377; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Chang YC, 1996, INFECT IMMUN, V64, P1977, DOI 10.1128/IAI.64.6.1977-1983.1996; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Cox GM, 1996, J MED VET MYCOL, V34, P385; Cramer T, 2008, CELL SIGNAL, V20, P60, DOI 10.1016/j.cellsig.2007.08.016; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Dromer F, 1996, CLIN INFECT DIS, V23, P82, DOI 10.1093/clinids/23.1.82; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Gerik KJ, 2008, EUKARYOT CELL, V7, P1685, DOI 10.1128/EC.00146-08; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Jain N, 2009, INFECT IMMUN, V77, P128, DOI 10.1128/IAI.01079-08; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kartsonis NA, 2003, DRUG RESIST UPDATE, V6, P197, DOI 10.1016/S1368-7646(03)00064-5; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; Lee J, 2010, J PHYS CHEM B, V114, P7662, DOI 10.1021/jp1017289; Liu L, 1999, INFECT IMMUN, V67, P6034, DOI 10.1128/IAI.67.11.6034-6039.1999; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Maeng S, 2010, EUKARYOT CELL, V9, P360, DOI 10.1128/EC.00309-09; Maligie MA, 2005, ANTIMICROB AGENTS CH, V49, P2851, DOI 10.1128/AAC.49.7.2851-2856.2005; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park YD, 2010, J BIOL CHEM, V285, P34746, DOI 10.1074/jbc.M110.136812; Perez P, 2002, J BIOCHEM, V132, P513, DOI 10.1093/oxfordjournals.jbchem.a003250; Rafty LA, 2001, NUCLEIC ACIDS RES, V29, P1027, DOI 10.1093/nar/29.5.1027; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheth CC, 2008, FUNGAL GENET BIOL, V45, P1075, DOI 10.1016/j.fgb.2008.04.004; Sorrell TC, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P595; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thompson JR, 1999, J BACTERIOL, V181, P444, DOI 10.1128/JB.181.2.444-453.1999; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Waterman SR, 2007, INFECT IMMUN, V75, P714, DOI 10.1128/IAI.01351-06; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yashiroda H, 1998, GENE, V225, P39, DOI 10.1016/S0378-1119(98)00535-6; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Yue CL, 1999, GENETICS, V153, P1601; Zhang SR, 2006, MOL MICROBIOL, V62, P1090, DOI 10.1111/j.1365-2958.2006.05422.x; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	55	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20977	20990		10.1074/jbc.M111.230268	http://dx.doi.org/10.1074/jbc.M111.230268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487010	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000291267600082
J	Krycer, JR; Brown, AJ				Krycer, James Robert; Brown, Andrew John			Cross-talk between the Androgen Receptor and the Liver X Receptor IMPLICATIONS FOR CHOLESTEROL HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; FATTY-ACID SYNTHASE; OXYSTEROL RECEPTOR; HUMAN MACROPHAGES; GENE-EXPRESSION; REGULATED GENE; MESSENGER-RNA; ALPHA GENE; LXR-ALPHA; ACTIVATION	High cholesterol levels are associated with prostate cancer development. Androgens promote cholesterol accumulation by activating the sterol-regulatory element-binding protein isoform 2 (SREBP-2) transcription factor. However, SREBP-2 is in balance with the liver X receptor (LXR; NR1H2/NR1H3), a transcription factor that prevents cholesterol accumulation. Here, we show that LXR activity is down-regulated by the androgen receptor (AR; NR3C4). In turn, this reduces LXR target gene expression. This antagonism on LXR is also exerted by other steroid hormone receptors, including the estrogen, glucocorticoid, and progesterone receptors. This suggests a generalizable mechanism, but the AR does not affect LXR mRNA levels, protein degradation, or DNA binding. We also found that the AR does not require protein synthesis to influence LXR, suggesting a direct antagonism. However, the AR does not directly bind LXR. The AR N-terminal domain (involved in transactivation), but not its DNA-binding domain, is required to suppress LXR activity, suggesting coactivator competition. Overall, this androgen-mediated antagonism of LXR complements SREBP-2 activation, providing a more complete picture as to how androgens increase cellular cholesterol levels in a prostate cancer setting. Given the cross-talk between other steroid hormone receptors and LXR, hormonal regulation of cholesterol via LXR may occur in a variety of cellular contexts.	[Krycer, James Robert; Brown, Andrew John] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Krycer, James/0000-0003-1536-7270	Petre Foundation; Prostate Cancer Foundation of Australia [PG2710]	Petre Foundation; Prostate Cancer Foundation of Australia	Recipient of the Petre Foundation Scholarship.; Supported by Prostate Cancer Foundation of Australia Grant PG2710.	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Bieche I, 2001, CARCINOGENESIS, V22, P1521, DOI 10.1093/carcin/22.9.1521; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Bruggenwirth HT, 1998, ENDOCRINOLOGY, V139, P103, DOI 10.1210/en.139.1.103; Chaturvedi NK, 2010, MOL CELL BIOCHEM, V345, P291, DOI 10.1007/s11010-010-0583-6; Chuang KH, 2005, MOL ENDOCRINOL, V19, P1200, DOI 10.1210/me.2004-0181; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Costet P, 2000, J BIOL CHEM, V275, P28240; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Fukuchi J, 2004, CANCER RES, V64, P7686, DOI 10.1158/0008-5472.CAN-04-2332; Gong HB, 2007, MOL ENDOCRINOL, V21, P1781, DOI 10.1210/me.2007-0187; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Heinlein CA, 1999, J BIOL CHEM, V274, P16147, DOI 10.1074/jbc.274.23.16147; Hodgson MC, 2007, CANCER RES, V67, P8388, DOI 10.1158/0008-5472.CAN-07-0617; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; KAIGHN ME, 1979, INVEST UROL, V17, P16; Khor VK, 2008, ENDOCRINOLOGY, V149, P5440, DOI 10.1210/en.2008-0271; Kielar D, 2001, CLIN CHEM, V47, P2089; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kramer PR, 2002, J STEROID BIOCHEM, V81, P203, DOI 10.1016/S0960-0760(02)00065-1; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Lee JH, 2008, ENDOCRINOLOGY, V149, P3778, DOI 10.1210/en.2007-1605; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lo Sasso G, 2010, HEPATOLOGY, V51, P1334, DOI 10.1002/hep.23436; Lundholm L, 2004, J MOL ENDOCRINOL, V32, P879, DOI 10.1677/jme.0.0320879; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rossi S, 2003, MOL CANCER RES, V1, P707; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schmidt LJ, 2009, PROSTATE, V69, P1730, DOI 10.1002/pros.21022; Sekine Y, 2010, MOL CANCER RES, V8, P1284, DOI 10.1158/1541-7786.MCR-10-0008; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Singh J, 2006, CANCER LETT, V237, P298, DOI 10.1016/j.canlet.2005.06.008; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V312, P716, DOI 10.1016/j.bbrc.2003.10.174; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Swyer GIM, 1942, CANCER RES, V2, P372; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Trasino SE, 2009, MOL CANCER THER, V8, P1934, DOI 10.1158/1535-7163.MCT-09-0020; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Wang JH, 2008, GENE REGUL SYST BIO, V2, P97; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	64	55	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20637	20647		10.1074/jbc.M111.227082	http://dx.doi.org/10.1074/jbc.M111.227082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489984	Green Published, hybrid			2022-12-25	WOS:000291267600050
J	van Eijk, M; Bruinsma, L; Hartshorn, KL; White, MR; Rynkiewicz, MJ; Seaton, BA; Hemrika, W; Romijn, RA; van Balkom, BW; Haagsman, HP				van Eijk, Martin; Bruinsma, Laurie; Hartshorn, Kevan L.; White, Mitchell R.; Rynkiewicz, Michael J.; Seaton, Barbara A.; Hemrika, Wieger; Romijn, Roland A.; van Balkom, Bas W.; Haagsman, Henk P.			Introduction of N-Linked Glycans in the Lectin Domain of Surfactant Protein D IMPACT ON INTERACTIONS WITH INFLUENZA A VIRUSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; INNATE IMMUNE PROTEINS; PULMONARY COLLECTINS; EXPRESSION; BINDING; LUNG; GLYCOSYLATION; MECHANISMS; MODULATE; OPSONIN	Porcine surfactant protein D (pSP-D) displays distinctively strong, broad-range inhibitory activity against influenza A virus (IAV). N-Linked glycosylation of the carbohydrate recognition domain (CRD) of pSP-D contributes to the high affinity of this collectin for IAV. To investigate the role of the N-linked glycan further, HEK293E protein expression was used to produce recombinant pSP-D (RpSP-D) that has similar structural and antiviral properties as NpSP-D. We introduced an additional N-linked glycan in the CRD of RpSP-D but this modification did not alter the antiviral activity. Human SP-D is unglycosylated in its CRD and less active against IAV compared with pSP-D. In an attempt to modify its antiviral properties, several recombinant human SP-D (RhSP-D) mutants were constructed with N-linked glycans introduced at various locations within its CRD. To retain lectin activity, necessary for the primary interactions between SP-D and IAV, N-linked glycosylation of RhSP-D was shown to be restricted to the corresponding position in the CRD of either pSP-D or surfactant protein A (SP-A). These N-glycosylated RhSP-D mutants, however, did not show increased neutralization activity against IAV. By developing RhSP-D mutants that also have the pSP-D-specific Ser-Gly-Ala loop inserted in the CRD, we could demonstrate that the N-linked glycan-mediated interactions between pSP-D and IAV involves additional structural prerequisites of the pSP-D CRD. Ultimately, these studies will help to develop highly effective SP-D-based therapeutic and prophylactic drugs against IAV.	[van Eijk, Martin; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Hartshorn, Kevan L.; White, Mitchell R.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Rynkiewicz, Michael J.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Phys & Biophys, Boston, MA 02118 USA; [Hemrika, Wieger; Romijn, Roland A.] U Prot Express BV, Sci Pk Utrecht, NL-3584 CH Utrecht, Netherlands; [van Balkom, Bas W.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CH Utrecht, Netherlands	Utrecht University; Boston University; Boston University; Utrecht University; Utrecht University Medical Center	van Eijk, M (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	m.vaneijk@uu.nl	Haagsman, Henk P/F-8919-2010	Hartshorn, Kevan/0000-0002-7196-7433; Rynkiewicz, Michael/0000-0002-4717-5700; Seaton, Barbara/0000-0003-4654-7709	European Union [LSHM-CT-2004-512093]	European Union(European Commission)	This work was supported by European Union FP6 Specific Targeted Research Project Grant LSHM-CT-2004-512093.	Aye TT, 2010, MOL BIOSYST, V6, P1917, DOI 10.1039/c004495d; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1993, J IMMUNOL, V151, P6265; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hartshorn KL, 2002, BIOCHEM J, V366, P87, DOI 10.1042/BJ20011868; HARTSHORN KL, 1988, J IMMUNOL, V141, P1295; Hartshorn KL, 1996, BLOOD, V87, P3450, DOI 10.1182/blood.V87.8.3450.bloodjournal8783450; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Herias MV, 2007, MOL IMMUNOL, V44, P3324, DOI 10.1016/j.molimm.2007.02.025; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Khoshnoodi J, 2007, J MASS SPECTROM, V42, P370, DOI 10.1002/jms.1170; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mikerov AN, 2008, MED MICROBIOL IMMUN, V197, P9, DOI 10.1007/s00430-007-0051-4; Morlot C, 2007, ACTA CRYSTALLOGR F, V63, P689, DOI 10.1107/S1744309107033027; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Reading PC, 2007, ADV EXP MED BIOL, V598, P279; SCHOLTISSEK C, 1994, EUR J EPIDEMIOL, V10, P455, DOI 10.1007/BF01719674; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; van Eijk M, 2000, J IMMUNOL, V164, P1442, DOI 10.4049/jimmunol.164.3.1442; Vogels MW, 2011, PROTEOMICS, V11, P64, DOI 10.1002/pmic.201000309; White MR, 2008, EXPERT REV CLIN IMMU, V4, P497, DOI 10.1586/1744666X.4.4.497; White MR, 2005, AM J PHYSIOL-LUNG C, V289, pL606, DOI 10.1152/ajplung.00130.2005; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	45	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20137	20151		10.1074/jbc.M111.224469	http://dx.doi.org/10.1074/jbc.M111.224469			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489996	Green Published, hybrid			2022-12-25	WOS:000291267600003
J	Porcu, P; O'Buckley, TK; Song, SC; Harenza, JL; Lu, L; Wang, XS; Williams, RW; Miles, MF; Morrow, AL				Porcu, Patrizia; O'Buckley, Todd K.; Song, Soomin C.; Harenza, Jo Lynne; Lu, Lu; Wang, Xusheng; Williams, Robert W.; Miles, Michael F.; Morrow, A. Leslie			Genetic Analysis of the Neurosteroid Deoxycorticosterone and Its Relation to Alcohol Phenotypes: Identification of QTLs and Downstream Gene Regulation	PLOS ONE			English	Article							RECOMBINANT INBRED STRAINS; QUANTITATIVE TRAIT LOCI; PITUITARY-ADRENAL AXIS; NEUROACTIVE STEROIDS; CYNOMOLGUS MONKEYS; PREFRONTAL CORTEX; COMPLEX TRAITS; ETHANOL ACTION; A RECEPTOR; RAT-BRAIN	Background: Deoxycorticosterone (DOC) is an endogenous neurosteroid found in brain and serum, precursor of the GABAergic neuroactive steroid (3 alpha,5 alpha)-3,21-dihydroxypregnan-20-one (tetrahydrodeoxycorticosterone, THDOC) and the glucocorticoid corticosterone. These steroids are elevated following stress or ethanol administration, contribute to ethanol sensitivity, and their elevation is blunted in ethanol dependence. Methodology/Principal Findings: To systematically define the genetic basis, regulation, and behavioral significance of DOC levels in plasma and cerebral cortex we examined such levels across 47 young adult males from C57BL/6J (B6) x 6DBA/2J (D2) (BXD) mouse strains for quantitative trait loci (QTL) and bioinformatics analyses of behavior and gene regulation. Mice were injected with saline or 0.075 mg/kg dexamethasone sodium salt at 8:00 am and were sacrificed 6 hours later. DOC levels were measured by radioimmunoassay. Basal cerebral cortical DOC levels ranged between 1.4 and 12.2 ng/g (8.7-fold variation, p<0.0001) with a heritability of, similar to 0.37. Basal plasma DOC levels ranged between 2.8 and 12.1 ng/ml (4.3-fold variation, p<0.0001) with heritability of similar to 0.32. QTLs for basal DOC levels were identified on chromosomes 4 (cerebral cortex) and 14 (plasma). Dexamethasone-induced changes in DOC levels showed a 4.4-fold variation in cerebral cortex and a 4.1-fold variation in plasma, but no QTLs were identified. DOC levels across BXD strains were further shown to be coregulated with networks of genes linked to neuronal, immune, and endocrine function. DOC levels and its responses to dexamethasone were associated with several behavioral measures of ethanol sensitivity previously determined across the BXD strains by multiple laboratories. Conclusions/Significance: Both basal and dexamethasone-suppressed DOC levels are positively correlated with ethanol sensitivity suggesting that the neurosteroid DOC may be a putative biomarker of alcohol phenotypes. DOC levels were also strongly correlated with networks of genes associated with neuronal function, innate immune pathways, and steroid metabolism, likely linked to behavioral phenotypes.	[Porcu, Patrizia; Morrow, A. Leslie] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27515 USA; [Porcu, Patrizia; O'Buckley, Todd K.; Song, Soomin C.; Morrow, A. Leslie] Univ N Carolina, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA; [Harenza, Jo Lynne; Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Harenza, Jo Lynne; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol Toxicol, Richmond, VA USA; [Harenza, Jo Lynne; Miles, Michael F.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA; [Morrow, A. Leslie] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Porcu, P (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27515 USA.	pporcu1@gmail.com	Porcu, Patrizia/B-8400-2015; Williams, Robert W./H-8789-2016	Porcu, Patrizia/0000-0003-0848-7258; Rokita, Jo Lynne/0000-0003-2171-3627; O'Buckley, Todd/0000-0001-8723-734X; Williams, Robert W./0000-0001-8924-4447	National Institutes of Health [INIA-NIAAA AA013614, AA016672, AA010564, AA016662, AA014425, AA13499, AA13513, AA017590]; University of North Carolina at Chapel Hill; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA013641, U01AA013513, U01AA014425, R37AA010564, R01AA013678, U01AA016672, P20AA017828, U01AA016667, U24AA013641, U01AA017590, U01AA013499, R01AA010564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the National Institutes of Health grants INIA-NIAAA AA013614 (PP), AA016672 and AA010564 (ALM), AA016662 (MFM), AA014425 (LL-RWW), AA13499, AA13513 and AA017590 (RWW) and by the University Research Council Grant from the University of North Carolina at Chapel Hill (PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Barbaccia ML, 1999, EUR J PHARMACOL, V384, pR1, DOI 10.1016/S0014-2999(99)00678-0; BELELLI D, 1989, EUR J PHARMACOL, V166, P325, DOI 10.1016/0014-2999(89)90077-0; Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; Boehm SL, 2002, PSYCHOPHARMACOLOGY, V161, P54, DOI 10.1007/s00213-002-1000-y; Boyd KN, 2010, J NEUROCHEM, V112, P784, DOI 10.1111/j.1471-4159.2009.06509.x; Cerqueira JJ, 2008, BRAIN BEHAV IMMUN, V22, P630, DOI 10.1016/j.bbi.2008.01.005; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Corpechot C, 1997, BRAIN RES, V766, P276, DOI 10.1016/S0006-8993(97)00749-X; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; Crabbe JC, 1999, TRENDS NEUROSCI, V22, P173, DOI 10.1016/S0166-2236(99)01393-4; Crabbe JC, 2008, PHILOS T R SOC B, V363, P3201, DOI 10.1098/rstb.2008.0101; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; DICURZIO DL, 2011, MAMM GENOME IN PRESS; Doerge RW, 1996, GENETICS, V142, P285; Eser D, 2006, NEUROSCIENCE, V138, P1041, DOI 10.1016/j.neuroscience.2005.07.007; Gelernter J, 2009, HUM GENET, V126, P91, DOI 10.1007/s00439-009-0701-2; George O, 2010, NEUROSCI BIOBEHAV R, V35, P232, DOI 10.1016/j.neubiorev.2010.05.002; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; GORAMASLAK G, 1991, PSYCHOPHARMACOLOGY, V104, P413, DOI 10.1007/BF02245643; Groenink L, 2002, BIOL PSYCHIAT, V51, P875, DOI 10.1016/S0006-3223(02)01334-3; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hirani K, 2005, PSYCHOPHARMACOLOGY, V180, P267, DOI 10.1007/s00213-005-2169-7; Hirani K, 2002, NEUROPHARMACOLOGY, V43, P1339, DOI 10.1016/S0028-3908(02)00330-1; Khisti RT, 2005, BRAIN RES, V1049, P104, DOI 10.1016/j.brainres.2005.05.007; Khisti RT, 2003, BRAIN RES, V980, P255, DOI 10.1016/S0006-8993(03)02978-0; Kirstein SL, 2002, J PHARMACOL EXP THER, V302, P1238, DOI 10.1124/jpet.302.3.1238; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Matthews DB, 2002, ALCOHOL CLIN EXP RES, V26, P1747, DOI 10.1097/01.ALC.0000037219.79257.17; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; Morrow A Leslie, 2006, Dialogues Clin Neurosci, V8, P463; Morrow AL, 2009, ALCOHOL, V43, P521, DOI 10.1016/j.alcohol.2009.04.002; Morrow AL, 2001, BRAIN RES REV, V37, P98, DOI 10.1016/S0165-0173(01)00127-8; Morrow AL, 1999, ALCOHOL CLIN EXP RES, V23, P1933, DOI 10.1111/j.1530-0277.1999.tb04094.x; MORROW AL, 2009, NEUROPSYCHIATRIC BIO, P47; O'Dell LE, 2004, EUR J PHARMACOL, V484, P241, DOI 10.1016/j.ejphar.2003.11.031; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Pierucci-Lagha A, 2005, NEUROPSYCHOPHARMACOL, V30, P1193, DOI 10.1038/sj.npp.1300688; Porcu P, 2004, BRAIN RES, V1012, P160, DOI 10.1016/j.brainres.2004.03.059; Porcu P, 2008, PSYCHONEUROENDOCRINO, V33, P214, DOI 10.1016/j.psyneuen.2007.11.003; Porcu P, 2006, PSYCHOPHARMACOLOGY, V186, P293, DOI 10.1007/s00213-005-0132-2; Porcu P, 2010, ALCOHOL CLIN EXP RES, V34, P432, DOI 10.1111/j.1530-0277.2009.01123.x; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Reddy DS, 2002, J NEUROSCI, V22, P3795; RIVIER C, 1984, J PHARMACOL EXP THER, V229, P127; Roberts AJ, 1995, BEHAV NEUROSCI, V109, P1199, DOI 10.1037/0735-7044.109.6.1199; RODRIGUEZ LA, 1994, ALCOHOL CLIN EXP RES, V18, P1416, DOI 10.1111/j.1530-0277.1994.tb01444.x; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; Rosen Glenn D, 2007, Methods Mol Biol, V401, P287, DOI 10.1007/978-1-59745-520-6_16; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; SCHENKMAN JB, 1992, J STEROID BIOCHEM, V43, P1023, DOI 10.1016/0960-0760(92)90329-H; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; Schuckit MA, 2006, J STUD ALCOHOL, V67, P215, DOI 10.15288/jsa.2006.67.215; Schuckit MA, 2005, ALCOHOL CLIN EXP RES, V29, P1976, DOI 10.1097/01.alc.0000187598.82921.27; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schuckit MA, 2009, J SUBST ABUSE TREAT, V36, pS5, DOI 10.1016/j.jsat.2008.05.012; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; VanDoren MJ, 2000, J NEUROSCI, V20, P1982; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Wilhelmsen KC, 2003, ALCOHOL CLIN EXP RES, V27, P1041, DOI 10.1097/01.ALC.0000075551.02714.63; Williams RW, 2001, GENOME BIOL, V2	74	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18405	10.1371/journal.pone.0018405	http://dx.doi.org/10.1371/journal.pone.0018405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494628	Green Published, gold			2022-12-25	WOS:000289292800013
J	Zhao, W; Dhar, S				Zhao, Wei; Dhar, Sumitrajit			Fast and Slow Effects of Medial Olivocochlear Efferent Activity in Humans	PLOS ONE			English	Article							SPONTANEOUS OTOACOUSTIC EMISSIONS; OTO-ACOUSTIC EMISSIONS; COCHLEAR HAIR-CELLS; GUINEA-PIG COCHLEA; STIMULATION; FREQUENCY; ACETYLCHOLINE; RECEPTOR; REFLEX; EAR	Background: The medial olivocochlear (MOC) pathway modulates basilar membrane motion and auditory nerve activity on both a fast (10-100 ms) and a slow (10-100 s) time scale in guinea pigs. The slow MOC modulation of cochlear activity is postulated to aide in protection against acoustic trauma. However in humans, the existence and functional roles of slow MOC effects remain unexplored. Methodology/Principal Findings: By employing contralateral noise at moderate to high levels (68 and 83 dB SPL) as an MOC reflex elicitor, and spontaneous otoacoustic emissions (SOAEs) as a non-invasive probe of the cochlea, we demonstrated MOC modulation of human cochlear output both on a fast and a slow time scale, analogous to the fast and slow MOC efferent effects observed on basilar membrane vibration and auditory nerve activity in guinea pigs. The magnitude of slow effects was minimal compared with that of fast effects. Consistent with basilar membrane and auditory nerve activity data, SOAE level was reduced by both fast and slow MOC effects, whereas SOAE frequency was elevated by fast and reduced by slow MOC effects. The magnitudes of fast and slow effects on SOAE level were positively correlated. Conclusions/Significance: Contralateral noise up to 83 dB SPL elicited minimal yet significant changes in both SOAE level and frequency on a slow time scale, consistent with a high threshold or small magnitude of slow MOC effects in humans.	[Zhao, Wei; Dhar, Sumitrajit] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Zhao, Wei; Dhar, Sumitrajit] Northwestern Univ, Interdept Neurosci Program, Evanston, IL USA; [Dhar, Sumitrajit] Northwestern Univ, Hugh Knowles Ctr, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University	Zhao, W (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	weizhao2008@u.northwestern.edu	Dhar, Sumit/B-6319-2009	Dhar, Sumitrajit/0000-0002-4496-6355	National Institute on Deafness and Other Communication Disorders [DC008420]; Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008420] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Northwestern University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by grant number DC008420 from the National Institute on Deafness and Other Communication Disorders, and by Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper NP, 2003, J PHYSIOL-LONDON, V548, P307, DOI 10.1113/jphysiol.2003.039081; daCosta DL, 1997, J NEUROPHYSIOL, V78, P1826, DOI 10.1152/jn.1997.78.4.1826; Dallos P, 1997, J NEUROSCI, V17, P2212; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039; FUCHS PA, 1992, J NEUROSCI, V12, P800; Goodman SS, 2006, JARO-J ASSOC RES OTO, V7, P125, DOI 10.1007/s10162-006-0028-9; Guinan JJ, 2003, JARO-J ASSOC RES OTO, V4, P521, DOI 10.1007/s10162-002-3037-3; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; HARRISON WA, 1993, J ACOUST SOC AM, V94, P2649, DOI 10.1121/1.407349; HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065; Kalluri R, 2007, J ACOUST SOC AM, V122, P3562, DOI 10.1121/1.2793604; Kemp D. T., 1980, PSYCHOPHYSICAL PHYSL, P34; KEMP DT, 1979, SCAND AUDIOL, P35; KEMP DT, 1979, ARCH OTO-RHINO-LARYN, V224, P37, DOI 10.1007/BF00455222; Larsen E, 2009, HEARING RES, V256, P1, DOI 10.1016/j.heares.2009.02.002; Lilaonitkul W, 2009, J NEUROPHYSIOL, V101, P1394, DOI 10.1152/jn.90925.2008; Long GR, 1997, J ACOUST SOC AM, V102, P2831, DOI 10.1121/1.420339; Maison SF, 2007, J NEUROPHYSIOL, V97, P3269, DOI 10.1152/jn.00067.2007; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; MOTT JB, 1989, HEARING RES, V38, P229, DOI 10.1016/0378-5955(89)90068-3; Murugasu E, 1996, J NEUROSCI, V16, P325; RABINOWITZ WM, 1984, J ACOUST SOC AM, V76, P1713, DOI 10.1121/1.391618; REITER ER, 1995, J NEUROPHYSIOL, V73, P506, DOI 10.1152/jn.1995.73.2.506; ROBLES L, 2008, SENSES COMPREHENSIVE; SCHLOTH E, 1983, HEARING RES, V11, P285, DOI 10.1016/0378-5955(83)90063-1; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Shera CA, 2003, J ACOUST SOC AM, V114, P244, DOI 10.1121/1.1575750; SRIDHAR TS, 1995, J NEUROSCI, V15, P3667; Sridhar TS, 1997, J NEUROSCI, V17, P428, DOI 10.1523/JNEUROSCI.17-01-00428.1997; Talmadge CL, 1998, J ACOUST SOC AM, V104, P1517, DOI 10.1121/1.424364; Zhao W, 2010, JARO-J ASSOC RES OTO, V11, P53, DOI 10.1007/s10162-009-0189-4; ZWEIG G, 1995, J ACOUST SOC AM, V98, P2018, DOI 10.1121/1.413320	34	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18725	10.1371/journal.pone.0018725	http://dx.doi.org/10.1371/journal.pone.0018725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494578	gold, Green Published, Green Submitted			2022-12-25	WOS:000289292800040
J	Sighoko, D; Curado, MP; Bourgeois, D; Mendy, M; Hainaut, P; Bah, E				Sighoko, Dominique; Curado, Maria Paula; Bourgeois, Denis; Mendy, Maimuna; Hainaut, Pierre; Bah, Ebrima			Increase in Female Liver Cancer in The Gambia, West Africa: Evidence from 19 Years of Population-Based Cancer Registration (1988-2006)	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATITIS-B; TOBACCO USE; INFECTION; AFLATOXIN; OBESITY; METAANALYSIS; CHILDREN; ENZYMES; COUNTRY	Background: Hepatocellular Carcinoma (HCC) is a common malignancy worldwide with a high burden in West Africa. Male to female ratios show consistent bias toward males, the biological bases and variations of which are not well understood. We have used data from the Gambian National Cancer Registry to compare trends in incidence of HCC in both genders. Methods and Findings: Two periods were compared, 1988-1997 (early) and 1998-2006 (recent). In addition, the regression program joinpoint was used to assess trends over 19 years. Differences with self-reported ethnicity were assessed for the recent period using population data from 2003 census. Male to female ratio showed a significant decrease between the two periods from 3.28:1 (95% CI, [2.93-3.65]) to 2.2:1 (95% CI, [1.99-2.43]). Although rates in males were relatively stable (38.36 and 32.84 for, respectively, early and recent periods), they increased from 11.71 to 14.9 in females with a significant Annual Percentage Change of 3.01 [0.3-5.8] over 19 years and an increase in number of cases of 80.28% (compared to 26% in males). Significant variations in HCC risk, but not in gender ratio were observed in relation with ethnicity. Conclusion: This analysis of the only national, population-based cancer registry in West Africa shows a significant increase in HCC in females over recent years. This increase may be the consequence of major changes in lifestyle or viral risk factors, in particular obesity and hepatitis C, which have both been documented to increase in West Africa during recent years.	[Sighoko, Dominique; Curado, Maria Paula; Hainaut, Pierre; Bah, Ebrima] Int Agcy Res Canc, F-69372 Lyon, France; [Sighoko, Dominique; Bourgeois, Denis] Fac Odontol, Lyon, France; [Mendy, Maimuna] MRC, Fajara, Gambia; [Bah, Ebrima] Gambia Hepatitis Intervent Study, Fajara, Gambia	World Health Organization; International Agency for Research on Cancer (IARC); University of London; London School of Hygiene & Tropical Medicine	Sighoko, D (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	hainaut@iarc.fr	Mendy, Maimuna/ABD-5038-2021; Curado, Maria Paula/M-6200-2013; Bourgeois, Denis/AAH-9280-2020; Bourgeois, Denis/ABI-3060-2020; Hainaut, Pierre/B-6018-2012	Curado, Maria Paula/0000-0001-8172-2483; Bourgeois, Denis/0000-0003-4754-2512; Hainaut, Pierre/0000-0002-1303-1610	International Agency for Research on Cancer; Medical Research Council [MC_U190081996] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW009112] Funding Source: NIH RePORTER; MRC [MC_U190081996] Funding Source: UKRI	International Agency for Research on Cancer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the International Agency for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; [Anonymous], 2006, CANC EPIDEMIOLOGY PR; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; Coleman M P, 1991, IARC Sci Publ, P267; Curado MP, 2008, CANC INCIDENCE 5 CON, VIX, DOI 10.1007/978-3-642-85851-2; Souza PSD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-246; Jallow M, 2009, NAT GENET; JEANSELLIER, 2003, ATLAS PEUPLES AFRIQ, P115; JENSEN OM, 1996, ENREGISTREMENT CANCE, P142; Jie X, 2007, ONCOGENE, V26, P5741, DOI 10.1038/sj.onc.1210362; Kirk GD, 2005, CANCER EPIDEM BIOMAR, V14, P373, DOI 10.1158/1055-9965.EPI-04-0161; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Ocama P, 2009, BRIT J CANCER, V100, P799, DOI 10.1038/sj.bjc.6604893; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Siervo M, 2006, EUR J CLIN NUTR, V60, P455, DOI 10.1038/sj.ejcn.1602337; Sighoko D, 2010, INT J CANCER, V127, P2248, DOI 10.1002/ijc.25244; SILVA ID, 1999, EPIDEMIOLOGIE CANC P, P334; Szymanska K, 2004, INT J CANCER, V110, P374, DOI 10.1002/ijc.20103; Turner PC, 2000, TROP MED INT HEALTH, V5, P837, DOI 10.1046/j.1365-3156.2000.00664.x; Umoh NJ, 2011, LIVER INT, V31, P215, DOI 10.1111/j.1478-3231.2010.02418.x; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; *WHO, 2009, GLOB STAT REP ALC 20; WILD CP, 1993, CANCER EPIDEM BIOMAR, V2, P555; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252	27	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18415	10.1371/journal.pone.0018415	http://dx.doi.org/10.1371/journal.pone.0018415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490972	gold, Green Published, Green Submitted			2022-12-25	WOS:000289238700013
J	Dejean, A; Corbara, B; Leroy, C; Delabie, JHC; Rossi, V; Cereghino, R				Dejean, Alain; Corbara, Bruno; Leroy, Celine; Delabie, Jacques H. C.; Rossi, Vivien; Cereghino, Regis			Inherited Biotic Protection in a Neotropical Pioneer Plant	PLOS ONE			English	Article							OPTIMAL DEFENSE HYPOTHESIS; SPATIOTEMPORAL PATTERNS; EXTRAFLORAL NECTAR; IRLBACHIA-ALATA; ANT-ACACIA; VOLATILES; MUTUALISM; CONFLICT; BEHAVIOR; COSTS	Chelonanthus alatus is a bat-pollinated, pioneer Gentianaceae that clusters in patches where still-standing, dried-out stems are interspersed among live individuals. Flowers bear circum-floral nectaries (CFNs) that are attractive to ants, and seed dispersal is both barochorous and anemochorous. Although, in this study, live individuals never sheltered ant colonies, dried-out hollow stems - that can remain standing for 2 years - did. Workers from species nesting in dried-out stems as well as from ground-nesting species exploited the CFNs of live C. alatus individuals in the same patches during the daytime, but were absent at night (when bat pollination occurs) on 60.5% of the plants. By visiting the CFNs, the ants indirectly protect the flowers - but not the plant foliage - from herbivorous insects. We show that this protection is provided mostly by species nesting in dried-out stems, predominantly Pseudomyrmex gracilis. That dried-out stems remain standing for years and are regularly replaced results in an opportunistic, but stable association where colonies are sheltered by one generation of dead C. alatus while the live individuals nearby, belonging to the next generation, provide them with nectar; in turn, the ants protect their flowers from herbivores. We suggest that the investment in wood by C. alatus individuals permitting still-standing, dried-out stems to shelter ant colonies constitutes an extended phenotype because foraging workers protect the flowers of live individuals in the same patch. Also, through this process these dried-out stems indirectly favor the reproduction (and so the fitness) of the next generation including both their own offspring and that of their siblings, all adding up to a potential case of inclusive fitness in plants.	[Dejean, Alain; Leroy, Celine] CNRS, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Cereghino, Regis] Univ Toulouse, UPS, INPT, EcoLab, Toulouse, France; [Corbara, Bruno] CNRS, UMR 6023, LMGE, Aubiere, France; [Corbara, Bruno] Univ Clermont Ferrand, LMGE, Clermont Univ, Clermont Ferrand, France; [Delabie, Jacques H. C.] CEPLAC, Ctr Pesquisas Cacau, Convenio UESC CEPEC, Lab Mirmecol, Itabuna, BA, Brazil; [Rossi, Vivien] CIRAD, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Cereghino, Regis] CNRS, UMR 5245, EcoLab, Lab Ecol Fonct, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universidade Estadual de Santa Cruz; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Dejean, A (corresponding author), CNRS, Ecol Forets Guyane UMR CNRS 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr	CEREGHINO, Regis/G-9500-2011; Delabie, Jacques H C/F-3405-2010; Leroy, Celine/I-4857-2016; Rossi, Vivien/C-9721-2009	Delabie, Jacques H C/0000-0002-2695-1061; Leroy, Celine/0000-0003-4859-8040; Rossi, Vivien/0000-0001-5458-1523; CORBARA, Bruno/0000-0003-4232-8234; Dejean, Alain/0000-0002-3561-2248; Cereghino, Regis/0000-0003-3981-3159	French Centre National de la Recherche Scientifique [2ID]; European Community; Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq)	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission); Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). JHCD acknowledges the Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq) for his research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLABY M, 2004, INCLUSIVE FITNESS DI; Beattie Andrew J., 2002, P211; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; CHARLESDOMINIQU.P, 2001, PUBLICATIONS SCI MNH, V49, P188; Clement LW, 2008, BEHAV ECOL SOCIOBIOL, V62, P953, DOI 10.1007/s00265-007-0520-1; Coley Phyllis D., 1996, P305; DAWKINS, 1982, EXTENDED PHENOTYPE; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2008, BIOL J LINN SOC, V93, P63, DOI 10.1111/j.1095-8312.2007.00927.x; Delabie JHC, 2009, CR BIOL, V332, P673, DOI 10.1016/j.crvi.2009.01.006; Gibernau M, 2008, J TROP ECOL, V24, P689, DOI 10.1017/S0266467408005488; Heil M, 2004, J TROP ECOL, V20, P573, DOI 10.1017/S0266467404001567; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hernandez-Cumplido J, 2010, J TROP ECOL, V26, P555, DOI 10.1017/S0266467410000234; Holland JN, 2011, OIKOS, V120, P381, DOI 10.1111/j.1600-0706.2010.18958.x; Holland JN, 2009, J ECOL, V97, P89, DOI 10.1111/j.1365-2745.2008.01446.x; Hossaert-McKey M, 2001, ECOSCIENCE, V8, P325, DOI 10.1080/11956860.2001.11682660; Hunter P, 2009, EMBO REP, V10, P212, DOI 10.1038/embor.2009.18; Jensen SR, 2002, GENTIANACEAE SYSTEMA, P573, DOI DOI 10.1017/CBO9780511541865.007; Lu Q, 1999, J NAT PROD, V62, P824, DOI 10.1021/np980425n; Machado ICS, 1998, PLANT SYST EVOL, V209, P231, DOI 10.1007/BF00985230; McCullagh P, 1989, GEN LINEAR MODELS; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; McKey D, 1979, HERBIVORES THEIR INT, P55; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Nicklen EF, 2006, OECOLOGIA, V148, P81, DOI 10.1007/s00442-006-0359-6; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Orivel J, 2002, SOCIOBIOLOGY, V39, P65; R Development Core Team, 2006, R LANG ENV STAT COMP; Radhika V, 2008, PLANTA, V228, P449, DOI 10.1007/s00425-008-0749-6; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; Rhoades DF, 1979, HERBIVORES THEIR INT, P4; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RICOGRAY V, 1989, BIOL J LINN SOC, V38, P173, DOI 10.1111/j.1095-8312.1989.tb01572.x; Romero GQ, 2004, J TROP ECOL, V20, P675, DOI 10.1017/S0266467404001749; Rostas M, 2008, CHEMOECOLOGY, V18, P29, DOI 10.1007/s00049-007-0390-z; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Sarthou C, 2009, FLORA, V204, P396, DOI 10.1016/j.flora.2008.05.004; SRUWE L, 2009, TAXON, V58, P479; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; TOTH PL, 2007, ELONGATE TWIG ANT ME; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Vogel S, 1998, FLORA, V193, P1; WARD PS, 1991, ANT - PLANT INTERACTIONS, P335; WHITCOMB W H, 1972, Florida Entomologist, V55, P31, DOI 10.2307/3493638; Willmer PG, 2009, FUNCT ECOL, V23, P888, DOI 10.1111/j.1365-2435.2009.01632.x; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102	48	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18071	10.1371/journal.pone.0018071	http://dx.doi.org/10.1371/journal.pone.0018071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483861	Green Published, gold			2022-12-25	WOS:000289057200023
J	Kim, EJ; Ables, JL; Dickel, LK; Eisch, AJ; Johnson, JE				Kim, Euiseok J.; Ables, Jessica L.; Dickel, Lauren K.; Eisch, Amelia J.; Johnson, Jane E.			Ascl1 (Mash1) Defines Cells with Long-Term Neurogenic Potential in Subgranular and Subventricular Zones in Adult Mouse Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; IN-VIVO ANALYSIS; DENTATE GYRUS; MAINTENANCE; INHIBITION; QUIESCENT; NEURONS; LINEAGE; MICE	Ascl1 (Mash1) is a bHLH transcription factor essential for neural differentiation during embryogenesis but its role in adult neurogenesis is less clear. Here we show that in the adult brain Ascl1 is dynamically expressed during neurogenesis in the dentate gyrus subgranular zone (SGZ) and more rostral subventricular zone (SVZ). Specifically, we find Ascl1 levels low in SGZ Type-1 cells and SVZ B cells but increasing as the cells transition to intermediate progenitor stages. In vivo genetic lineage tracing with a tamoxifen (TAM) inducible Ascl1(CreERT2) knock-in mouse strain shows that Ascl1 lineage cells continuously generate new neurons over extended periods of time. There is a regionally-specific difference in neuron generation, with mice given TAM at postnatal day 50 showing new dentate gyrus neurons through 30 days post-TAM, but showing new olfactory bulb neurons even 180 days post-TAM. These results show that Ascl1 is not restricted to transit amplifying populations but is also found in a subset of neural stem cells with long-term neurogenic potential in the adult brain.	[Kim, Euiseok J.; Dickel, Lauren K.; Johnson, Jane E.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Ables, Jessica L.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, EJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	Jane.Johnson@utsouthwestern.edu		/0000-0002-8605-2746; Eisch, Amelia/0000-0001-6476-5385; Ables, Jessica L./0000-0003-1818-3506	National Institutes of Health [R01 NS32817, R21 DA023701, K02 DA023555, T32 MH076690]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH076690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023555, R21DA023701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health (http://www.nih.gov/) R01 NS32817 to JEJ, R21 DA023701 and K02 DA023555 to AJE, and T32 MH076690 to JLA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Gage FH, 2008, ADULT NEUROGENESIS; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rousseau A, 2006, J NEUROPATH EXP NEUR, V65, P1149, DOI 10.1097/01.jnen.0000248543.90304.2b; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037	26	188	191	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18472	10.1371/journal.pone.0018472	http://dx.doi.org/10.1371/journal.pone.0018472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483754	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200084
J	Ran, QA; Hao, P; Xiao, YN; Zhao, JA; Ye, XD; Li, ZJ				Ran, Qian; Hao, Ping; Xiao, Yanni; Zhao, Jiang; Ye, Xingde; Li, Zhongjun			Effect of Irradiation and/or Leucocyte Filtration on RBC Storage Lesions	PLOS ONE			English	Article							RED-BLOOD-CELLS; CLINICAL CONSEQUENCES; STATIC PRESSURE; STORED RBCS; SHEAR-RATE; TRANSFUSION; ACCUMULATION; CONCENTRATE; OXIDATION; VESICLES	Red blood cell (RBC) storage lesions have been shown to be associated with some adverse reactions; numerous studies have focused on the lesions caused by storage, and few data on the RBC storage lesions caused by prestorage treatments of leucocyte filtration and irradiation. In this study, we examined the changes related with the RBC storage lesions, including 2,3-diphosphatidylglyceric acid (2,3-DPG), pH, free hemoglobin (Hb), supernatant free K(+) and Na(+) concentration, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH). Along with the increasing storage time, decreases in 2, 3-DPG levels, pH and Na(+) concentration, increases in K(+) and free Hb concentrations, and significant morphological changes in RBC in all groups were found. The changes in the groups of irradiation, leucocyte filtration and the combined irradiation and leucocyte filtration were more significant than those in the untreated group. Meanwhile, the MCV levels of the three treated groups were significantly lower than those in the untreated group, while the MCH variations were significantly higher. Our results suggest that irradiation and leucocyte filtration before storage may aggravate blood storage lesions.	[Ran, Qian; Xiao, Yanni; Zhao, Jiang; Ye, Xingde; Li, Zhongjun] Third Mil Med Univ, Xinqiao Hosp, Dept Blood Transfus, Chongqing, Peoples R China; [Hao, Ping] Third Mil Med Univ, Xinqiao Hosp, Ctr Oncol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Ran, QA (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Blood Transfus, Chongqing, Peoples R China.	lizhungjun@yahoo.com.cn			XinQiao Hospital; Third Military Medical University of Chinese PLA [2007D046]	XinQiao Hospital; Third Military Medical University of Chinese PLA	This study was supported by XinQiao Hospital "1520 project" special foundation and Scientific Researching Fund Projects of the Third Military Medical University of Chinese PLA (NO:2007D046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2005, INDIAN J MED RES, V122, P385; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; BOTTER-JENSEN L, 1972, Acta Radiologica Supplementum, V313, P247; Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x; Hogman CF, 2006, TRANSFUSION, V46, P1543, DOI 10.1111/j.1537-2995.2006.00893.x; Holme S, 2005, TRANSFUS APHER SCI, V33, P55, DOI 10.1016/j.transci.2005.02.004; Karon BS, 2009, TRANSFUSION, V49, P1435, DOI 10.1111/j.1537-2995.2009.02133.x; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; Kriebardis AG, 2007, J CELL MOL MED, V11, P148, DOI 10.1111/j.1582-4934.2007.00008.x; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; Nielsen HJ, 1999, BURNS, V25, P162, DOI 10.1016/S0305-4179(98)00157-0; Niinisto K, 2008, VET J, V176, P227, DOI 10.1016/j.tvjl.2007.02.015; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Reverberi Roberto, 2007, Ann Ist Super Sanita, V43, P176; Sparrow RL, 2007, TRANSFUSION, V47, P966, DOI 10.1111/j.1537-2995.2007.01230.x; Sugawara A, 2010, ARCH PATHOL LAB MED, V134, P771, DOI 10.1043/1543-2165-134.5.771; Tinmouth A, 2001, TRANSFUS MED REV, V15, P91, DOI 10.1053/tmrv.2001.22613; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Williamson LM, 1995, BLOOD REV, V9, P251, DOI 10.1016/S0268-960X(95)90016-0; Yasuda T, 2002, ARTIF ORGANS, V26, P27, DOI 10.1046/j.1525-1594.2002.06786.x; Yasuda T, 2001, ASAIO J, V47, P351, DOI 10.1097/00002480-200107000-00011; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1; Zimmermann R, 2009, TRANSFUSION, V49, P75, DOI 10.1111/j.1537-2995.2008.01920.x	25	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18328	10.1371/journal.pone.0018328	http://dx.doi.org/10.1371/journal.pone.0018328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483835	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200059
J	Srinivasan, S; Patric, IRP; Somasundaram, K				Srinivasan, Sujaya; Patric, Irene Rosita Pia; Somasundaram, Kumaravel			A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; GROWTH-FACTOR RECEPTOR; LUNG-CANCER; POOR-PROGNOSIS; MICRORNA; GLIOMA; ASTROCYTOMAS; P27(KIP1); PROLIFERATION; PROFILES	Glioblastoma (GBM) is the most common and aggressive primary brain tumor with very poor patient median survival. To identify a microRNA (miRNA) expression signature that can predict GBM patient survival, we analyzed the miRNA expression data of GBM patients (n = 222) derived from The Cancer Genome Atlas (TCGA) dataset. We divided the patients randomly into training and testing sets with equal number in each group. We identified 10 significant miRNAs using Cox regression analysis on the training set and formulated a risk score based on the expression signature of these miRNAs that segregated the patients into high and low risk groups with significantly different survival times (hazard ratio [HR] = 2.4; 95% CI = 1.4-3.8; p < 0.0001). Of these 10 miRNAs, 7 were found to be risky miRNAs and 3 were found to be protective. This signature was independently validated in the testing set (HR = 1.7; 95% CI = 1.1-2.8; p = 0.002). GBM patients with high risk scores had overall poor survival compared to the patients with low risk scores. Overall survival among the entire patient set was 35.0% at 2 years, 21.5% at 3 years, 18.5% at 4 years and 11.8% at 5 years in the low risk group, versus 11.0%, 5.5%, 0.0 and 0.0% respectively in the high risk group (HR = 2.0; 95% CI = 1.4-2.8; p < 0.0001). Cox multivariate analysis with patient age as a covariate on the entire patient set identified risk score based on the 10 miRNA expression signature to be an independent predictor of patient survival (HR = 1.120; 95% CI = 1.04-1.20; p = 0.003). Thus we have identified a miRNA expression signature that can predict GBM patient survival. These findings may have implications in the understanding of gliomagenesis, development of targeted therapy and selection of high risk cancer patients for adjuvant therapy.	[Srinivasan, Sujaya; Patric, Irene Rosita Pia; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Srinivasan, S (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			Department of Biotechnology, Government of India [BT/01/CEIB/09/VI/01]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study is supported by a grant from Department of Biotechnology, Government of India (D.O.No. BT/01/CEIB/09/VI/01; http://dbtindia.nic.in/index. asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Alonso MM, 2005, JNCI-J NATL CANCER I, V97, P1589, DOI 10.1093/jnci/dji340; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; CARAMUTA S, J INVEST DERMATOL, V130, P2062; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CHOU CK, THYROID, V20, P489; CHUNZHI Z, BMC CANC, V10, P367; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Greither T, INT J CANC, V126, P73; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kirla RM, 2003, CANCER, V97, P644, DOI 10.1002/cncr.11079; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; LIU C, CLIN EXP MED; LIU CJ, CANC RES, V70, P1635; LIU X, J CLIN INVEST, V120, P1298; LOPEZROMERO P, BMC RES NOTES, V3, P18; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Mizumatsu S, 1999, CLIN CANCER RES, V5, P551; Noushmehr H, CANC CELL, V17, P510; Palanichamy Kamalakannan, 2006, Curr Treat Options Oncol, V7, P490, DOI 10.1007/s11864-006-0024-7; Pan W, J IMMUNOL, V184, P6773; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; PU XX, J GASTROENTEROL HEPA, V25, P1674; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sallinen SL, 1999, J PATHOL, V188, P289; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Simon R, 2007, CANCER INFORM, V3, P11; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tamiya T, 2001, ACTA NEUROPATHOL, V101, P334; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Verhaak RG, CANC CELL, V17, P98; WONG QW, CLIN CANC RES, V16, P867; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Yue JM, 2006, CANCER BIOL THER, V5, P573, DOI 10.4161/cbt.5.6.2872; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6; ZHI F, EUR J CANC, V46, P1640	56	156	160	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17438	10.1371/journal.pone.0017438	http://dx.doi.org/10.1371/journal.pone.0017438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483847	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000289057200006
J	Balaban, PM; Malyshev, AY; Ierusalimsky, VN; Aseyev, N; Korshunova, TA; Bravarenko, NI; Lemak, MS; Roshchin, M; Zakharov, IS; Popova, Y; Boyle, R				Balaban, Pavel M.; Malyshev, Aleksey Y.; Ierusalimsky, Victor N.; Aseyev, Nikolay; Korshunova, Tania A.; Bravarenko, Natasha I.; Lemak, M. S.; Roshchin, Matvey; Zakharov, Igor S.; Popova, Yekaterina; Boyle, Richard			Functional Changes in the Snail Statocyst System Elicited by Microgravity	PLOS ONE			English	Article							STATIC VESTIBULOOCULAR REFLEX; HAIR-CELL; EXPRESSION; NEURONS; EXCITABILITY; FMRFAMIDE; TADPOLES; ENHANCEMENT; EXPERIENCE; DURATION	Background: The mollusk statocyst is a mechanosensing organ detecting the animal's orientation with respect to gravity. This system has clear similarities to its vertebrate counterparts: a weight-lending mass, an epithelial layer containing small supporting cells and the large sensory hair cells, and an output eliciting compensatory body reflexes to perturbations. Methodology/Principal Findings: In terrestrial gastropod snail we studied the impact of 16-(Foton M-2) and 12-day (Foton M-3) exposure to microgravity in unmanned orbital missions on: (i) the whole animal behavior (Helix lucorum L.), (ii) the statoreceptor responses to tilt in an isolated neural preparation (Helix lucorum L.), and (iii) the differential expression of the Helix pedal peptide (HPep) and the tetrapeptide FMRFamide genes in neural structures (Helix aspersa L.). Experiments were performed 13-42 hours after return to Earth. Latency of body re-orientation to sudden 90 degrees head-down pitch was significantly reduced in postflight snails indicating an enhanced negative gravitaxis response. Statoreceptor responses to tilt in postflight snails were independent of motion direction, in contrast to a directional preference observed in control animals. Positive relation between tilt velocity and firing rate was observed in both control and postflight snails, but the response magnitude was significantly larger in postflight snails indicating an enhanced sensitivity to acceleration. A significant increase in mRNA expression of the gene encoding HPep, a peptide linked to ciliary beating, in statoreceptors was observed in postflight snails; no differential expression of the gene encoding FMRFamide, a possible neurotransmission modulator, was observed. Conclusions/Significance: Upregulation of statocyst function in snails following microgravity exposure parallels that observed in vertebrates suggesting fundamental principles underlie gravi-sensing and the organism's ability to adapt to gravity changes. This simple animal model offers the possibility to describe general subcellular mechanisms of nervous system's response to conditions on Earth and in space.	[Balaban, Pavel M.; Malyshev, Aleksey Y.; Ierusalimsky, Victor N.; Aseyev, Nikolay; Korshunova, Tania A.; Bravarenko, Natasha I.; Lemak, M. S.; Roshchin, Matvey] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Zakharov, Igor S.] Russian Acad Sci, Koltzov Inst Dev Biol, Moscow, Russia; [Popova, Yekaterina; Boyle, Richard] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Balaban, PM (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia.	balaban@ihna.msk.ru; richard.boyle@nasa.gov	Aseyev, Nikolay/O-1030-2017; Malyshev, Alexey/P-2775-2015; Korshunova, Tatiana/T-7821-2017; Roshchin, Matvey/AAO-3021-2020; Balaban, Pavel M/I-5811-2014; Zakharov, Igor S/K-5488-2013; Malyshev, Aleksey/R-8471-2018	Aseyev, Nikolay/0000-0002-7165-3514; Roshchin, Matvey/0000-0002-9707-7746; Balaban, Pavel M/0000-0001-9248-8207; Ierusalimsky, Victor/0000-0002-9254-6099; Malyshev, Aleksey/0000-0002-4633-7691	RF President Council; Russian Foundation for Basic Research; Russian Academy of Science; NASA [03-OBPR-04]; Fundamental Space Biology Program	RF President Council; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Science(Russian Academy of Sciences); NASA(National Aeronautics & Space Administration (NASA)); Fundamental Space Biology Program	This research was supported by grants from the RF President Council for grants to P. Balaban, Russian Foundation for Basic Research, Russian Academy of Science, NASA 03-OBPR-04 and a Fundamental Space Biology Program grant to R. Boyle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKON DL, 1989, SCI AM, V261, P42, DOI 10.1038/scientificamerican0789-42; ALKON DL, 1973, J GEN PHYSIOL, V61, P619, DOI 10.1085/jgp.61.5.619; Balaban PM, 2002, NEUROSCI BIOBEHAV R, V26, P597, DOI 10.1016/S0149-7634(02)00022-2; BALABAN PM, 2008, J GRAV PHYSL, V15, pP273; BALABAN PM, 2006, J GRAV PHYSIO, V13, pP201; BALLARINO J, 1984, AM J PHYSIOL, V246, pR305, DOI 10.1152/ajpregu.1984.246.3.R305; BELL CC, 1981, J COMP NEUROL, V195, P391, DOI 10.1002/cne.901950303; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; Boser S, 2008, ARCH ITAL BIOL, V146, P1; Boyle R, 2001, J NEUROPHYSIOL, V86, P2118, DOI 10.1152/jn.2001.86.4.2118; Boyle R, 2009, J NEUROPHYSIOL, V102, P1513, DOI 10.1152/jn.91367.2008; Brugeaud A, 2006, NEUROREPORT, V17, P1697, DOI 10.1097/01.wnr.0000239961.98813.19; Brusca RC, 2003, INVERTEBRATES; Chabbert C, 2003, EUR J NEUROSCI, V17, P2497, DOI 10.1046/j.1460-9568.2003.02682.x; Chrachri A, 1998, J NEUROPHYSIOL, V80, P656, DOI 10.1152/jn.1998.80.2.656; Cohen B, 2005, ADV SPACE B, V10, P105, DOI 10.1016/S1569-2574(05)10005-7; COLMERS WF, 1982, NEUROSCIENCE, V7, P461, DOI 10.1016/0306-4522(82)90280-9; CROW T, 1988, TRENDS NEUROSCI, V11, P136, DOI 10.1016/0166-2236(88)90138-5; Crow T, 1997, J NEUROPHYSIOL, V78, P3460, DOI 10.1152/jn.1997.78.6.3460; DETWILER PB, 1973, J GEN PHYSIOL, V62, P618, DOI 10.1085/jgp.62.5.618; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; EATOCK RA, 1987, J NEUROSCI, V7, P2821; ELEKES K, 1990, CELL TISSUE RES, V262, P177, DOI 10.1007/BF00327760; FARLEY J, 1990, BEHAV NEUROSCI, V104, P135, DOI 10.1037/0735-7044.104.1.135; Farley J, 1997, J NEUROPHYSIOL, V77, P1861, DOI 10.1152/jn.1997.77.4.1861; FENCHEL T, 1984, J EXP BIOL, V110, P17; FERANDEZ C, 1963, ARCHIV OTOLARYNGOL, V77, P449; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339; FLOCK A, 1973, J PHYSIOL-LONDON, V235, P591, DOI 10.1113/jphysiol.1973.sp010406; Frysztak RJ, 1997, J NEUROSCI, V17, P4426; FRYSZTAK RJ, 1993, J NEUROSCI, V13, P2889; FRYSZTAK RJ, 1994, J NEUROSCI, V14, P1245, DOI 10.1523/JNEUROSCI.14-03-01245.1994; GOLDBERG JM, 1990, J NEUROPHYSIOL, V63, P781, DOI 10.1152/jn.1990.63.4.781; Gorgiladze G I, 2002, Aviakosm Ekolog Med, V36, P41; Gorgiladze GI, 2002, B EXP BIOL MED+, V133, P114, DOI 10.1023/A:1015570032353; Horn ER, 2006, J EXP BIOL, V209, P2847, DOI 10.1242/jeb.02298; HOWLAND HC, 1981, VESTIBULAR SYSTEM FU, P77; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; LIM DJ, 1974, AEROSPACE MED, V45, P705; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLOYD PE, 1989, J NEUROSCI, V9, P312; Lychakov D V, 1991, Physiologist, V34, pS204; LYCHAKOV DV, 1985, KOSM BIOL AVIAK MED+, V19, P48; Moorman SJ, 2002, DEV DYNAM, V223, P285, DOI 10.1002/dvdy.10052; O'Brien EK, 2003, EVOL DEV, V5, P572, DOI 10.1046/j.1525-142X.2003.03062.x; Ohsuga K, 2000, CELL TISSUE RES, V300, P165, DOI 10.1007/s004410000186; Poteryaev DA, 1997, NEUROREPORT, V8, P3631, DOI 10.1097/00001756-199711100-00041; Reason JT., 1975, MOTION SICKNESS; Ross M D, 1993, J Vestib Res, V3, P241; Ross MD, 2000, ACTA OTO-LARYNGOL, V120, P490, DOI 10.1080/000164800750045983; Sahley CL, 1998, LEARN MEMORY, P197; Sakakibara M, 2005, J NEUROPHYSIOL, V94, P3884, DOI 10.1152/jn.01163.2004; Sebastian C, 2001, J NEUROBIOL, V46, P59, DOI 10.1002/1097-4695(200101)46:1<59::AID-NEU6>3.0.CO;2-X; Sebastian C, 1998, NEUROSCI LETT, V253, P171, DOI 10.1016/S0304-3940(98)00633-8; Sebastian C, 1996, EXP BRAIN RES, V112, P213; SHEPHERD GMG, 1990, P NATL ACAD SCI USA, V87, P8627, DOI 10.1073/pnas.87.21.8627; Smith CA, 1967, 3 S ROL VEST ORG SPA, P183; SMITH CUM, 2000, BIOL SENSORY SYSTEMS; Sondag HNPM, 1996, BRAIN RES BULL, V40, P353, DOI 10.1016/0361-9230(96)00127-X; SONDAG HNPM, 1995, ACTA OTO-LARYNGOL, V115, P227, DOI 10.3109/00016489509139297; SPOENDLIN H, 1969, ACTA OTO-LARYNGOL, V67, P239, DOI 10.3109/00016486909125448; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; Suzuki M, 1993, J Vestib Res, V3, P253; Tsubata N, 2003, NEUROSCI LETT, V337, P46, DOI 10.1016/S0304-3940(02)01289-2; VINNIKOV YA, 1983, ZH OBSHCH BIOL, V44, P147; VINNIKOV YA, 1976, ARKHIV ANATOMII GIST, V1, P11; WELTMAN JK, 1973, P NATL ACAD SCI USA, V70, P3230, DOI 10.1073/pnas.70.11.3230; Wiederhold M L, 2000, J Gravit Physiol, V7, pP39; Wiederhold M L, 1997, J Gravit Physiol, V4, pP51; Willows AOD, 1997, J EXP BIOL, V200, P1433; WOLFF HG, 1969, Z ZELLFORSCH MIK ANA, V100, P251, DOI 10.1007/BF00343882; WOLFF HG, 1970, Z VERGL PHYSIOL, V70, P401, DOI 10.1007/BF00298194; Zaitseva O V, 1994, Neurosci Behav Physiol, V24, P47, DOI 10.1007/BF02355652	75	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17710	10.1371/journal.pone.0017710	http://dx.doi.org/10.1371/journal.pone.0017710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479267	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600015
J	Leonardi, E; Andreazza, S; Vanin, S; Busolin, G; Nobile, C; Tosatto, SCE				Leonardi, Emanuela; Andreazza, Simonetta; Vanin, Stefano; Busolin, Giorgia; Nobile, Carlo; Tosatto, Silvio C. E.			A Computational Model of the LGI1 Protein Suggests a Common Binding Site for ADAM Proteins	PLOS ONE			English	Article							LEUCINE-RICH-REPEAT; LATERAL TEMPORAL EPILEPSY; AUTOSOMAL-DOMINANT; STABILITY CHANGES; STRUCTURAL INFORMATION; SYNAPTIC-TRANSMISSION; STRUCTURE PREDICTION; SECONDARY STRUCTURE; MAXIMUM-LIKELIHOOD; QUALITY ESTIMATION	Mutations of human leucine-rich glioma inactivated (LGI1) gene encoding the epitempin protein cause autosomal dominant temporal lateral epilepsy (ADTLE), a rare familial partial epileptic syndrome. The LGI1 gene seems to have a role on the transmission of neuronal messages but the exact molecular mechanism remains unclear. In contrast to other genes involved in epileptic disorders, epitempin shows no homology with known ion channel genes but contains two domains, composed of repeated structural units, known to mediate protein-protein interactions. A three dimensional in silico model of the two epitempin domains was built to predict the structure-function relationship and propose a functional model integrating previous experimental findings. Conserved and electrostatic charged regions of the model surface suggest a possible arrangement between the two domains and identifies a possible ADAM protein binding site in the b-propeller domain and another protein binding site in the leucine-rich repeat domain. The functional model indicates that epitempin could mediate the interaction between proteins localized to different synaptic sides in a static way, by forming a dimer, or in a dynamic way, by binding proteins at different times. The model was also used to predict effects of known disease-causing missense mutations. Most of the variants are predicted to alter protein folding while several other map to functional surface regions. In agreement with experimental evidence, this suggests that non-secreted LGI1 mutants could be retained within the cell by quality control mechanisms or by altering interactions required for the secretion process.	[Leonardi, Emanuela; Andreazza, Simonetta; Vanin, Stefano; Tosatto, Silvio C. E.] Univ Padua, Dept Biol, Padua, Italy; [Vanin, Stefano] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Busolin, Giorgia; Nobile, Carlo] CNR, Inst Neurosci, Padua, Italy	University of Padua; University of Huddersfield; Consiglio Nazionale delle Ricerche (CNR)	Leonardi, E (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	silvio@cribi.unipd.it	Tosatto, Silvio/B-2840-2009; Busolin, Giorgia/K-7623-2014	Tosatto, Silvio/0000-0003-4525-7793; Nobile, Carlo/0000-0002-0634-2218; Vanin, Stefano/0000-0003-1676-5916; Andreazza, Simonetta/0000-0001-8816-4955; Leonardi, Emanuela/0000-0001-8486-8461	Genetics Commission of Italian League Against Epilepsy; University of Padua [CPDA098382]	Genetics Commission of Italian League Against Epilepsy; University of Padua	This study was supported by the Genetics Commission of Italian League Against Epilepsy (grant to CN) and by a "Progetto di Ateneo" (No. CPDA098382/09) from the University of Padua to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2003, PROTEIN ENG, V16, P459, DOI 10.1093/protein/gzg063; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, PROTEINS, V77, P173, DOI 10.1002/prot.22532; Bindewald E, 2003, PROTEIN ENG, V16, P785, DOI 10.1093/protein/gzg106; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu WL, 2005, MOL BIOL EVOL, V22, P2209, DOI 10.1093/molbev/msi214; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herranz-Perez V, 2010, BRAIN RES, V1307, P177, DOI 10.1016/j.brainres.2009.10.013; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kajava AV, 2002, PROTEIN SCI, V11, P1082, DOI 10.1110/ps.4010102; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunapuli P, 2004, J BIOL CHEM, V279, P23151, DOI 10.1074/jbc.M314192200; Kunapuli P, 2003, ONCOGENE, V22, P3985, DOI 10.1038/sj.onc.1206584; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Marsella L, 2009, BIOINFORMATICS, V25, pI289, DOI 10.1093/bioinformatics/btp232; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Michelucci R, 2003, EPILEPSIA, V44, P1289, DOI 10.1046/j.1528-1157.2003.20003.x; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Owuor K, 2009, MOL CELL NEUROSCI, V42, P448, DOI 10.1016/j.mcn.2009.09.008; Ozkaynak E, 2010, J NEUROSCI, V30, P3857, DOI 10.1523/JNEUROSCI.6287-09.2010; Paoli M, 2001, NAT STRUCT BIOL, V8, P744, DOI 10.1038/nsb0901-744; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; Sagane K, 2008, INT J BIOL SCI, V4, P387; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Sirerol-Piquer MS, 2006, HUM MOL GENET, V15, P3436, DOI 10.1093/hmg/ddl421; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sommer I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-364; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Stirnimann C. U., 2010, TRENDS BIOCH SCI; Strimmer K, 1997, MOL BIOL EVOL, V14, P210, DOI 10.1093/oxfordjournals.molbev.a025756; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316; Tosatto SCE, 2002, PROTEIN ENG, V15, P279, DOI 10.1093/protein/15.4.279; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	64	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18142	10.1371/journal.pone.0018142	http://dx.doi.org/10.1371/journal.pone.0018142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479274	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000289054600030
J	Nady, N; Lemak, A; Walker, JR; Avvakumov, GV; Kareta, MS; Achour, M; Xue, S; Duan, SL; Allali-Hassani, A; Zuo, XB; Wang, YX; Bronner, C; Chedin, F; Arrowsmith, CH; Dhe-Paganon, S				Nady, Nataliya; Lemak, Alexander; Walker, John R.; Avvakumov, George V.; Kareta, Michael S.; Achour, Mayada; Xue, Sheng; Duan, Shili; Allali-Hassani, Abdellah; Zuo, Xiaobing; Wang, Yun-Xing; Bronner, Christian; Chedin, Frederic; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano			Recognition of Multivalent Histone States Associated with Heterochromatin by UHRF1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; BINDING-PROTEIN; DIPOLAR COUPLINGS; STRUCTURAL BASIS; MULTIDOMAIN PROTEIN; LYSINE METHYLATION; TUDOR DOMAIN; NP95; H3; REPLICATION	Histone modifications and DNA methylation represent two layers of heritable epigenetic information that regulate eukaryotic chromatin structure and gene activity. UHRF1 is a unique factor that bridges these two layers; it is required for maintenance DNA methylation at hemimethylated CpG sites, which are specifically recognized through its SRA domain and also interacts with histone H3 trimethylated on lysine 9 (H3K9me3) in an unspecified manner. Here we show that UHRF1 contains a tandem Tudor domain (TTD) that recognizes H3 tail peptides with the heterochromatin-associated modification state of trimethylated lysine 9 and unmodified lysine 4 (H3K4me0/K9me3). Solution NMR and crystallographic data reveal the TTD simultaneously recognizes H3K9me3 through a conserved aromatic cage in the first Tudor subdomain and unmodified H3K4 within a groove between the tandem subdomains. The subdomains undergo a conformational adjustment upon peptide binding, distinct from previously reported mechanisms for dual histone mark recognition. Mutant UHRF1 protein deficient for H3K4me0/K9me3 binding shows altered localization to heterochromatic chromocenters and fails to reduce expression of a target gene, p16(INK4A), when overexpressed. Our results demonstrate a novel recognition mechanism for the combinatorial readout of histone modification states associated with gene silencing and add to the growing evidence for coordination of, and cross-talk between, the modification states of H3K4 and H3K9 in regulation of gene expression.	[Nady, Nataliya; Lemak, Alexander; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Nady, Nataliya; Lemak, Alexander; Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Walker, John R.; Avvakumov, George V.; Xue, Sheng; Allali-Hassani, Abdellah; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Kareta, Michael S.; Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Achour, Mayada; Bronner, Christian] Fac Pharm, CNRS UMR7213, Lab Biophoton & Pharmacol, F-67401 Illkirch Graffenstaden, France; [Zuo, Xiaobing; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, NIH, Frederick, MD 21702 USA; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Structural Genomics Consortium; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto	Arrowsmith, CH (corresponding author), 101 Coll St,Ste 700, Toronto, ON M5G 1L7, Canada.	carrow@uhnres.utoronto.ca; sirano.dhepaganon@utoronto.ca	Bronner, Christian/R-8488-2016; Zuo, Xiaobing/F-1469-2010	Bronner, Christian/0000-0002-3101-9279; /0000-0002-5255-895X; Chedin, Frederic/0000-0002-1306-5335; Kareta, Michael/0000-0002-6980-9065; Arrowsmith, Cheryl/0000-0002-4971-3250; Zuo, Xiaobing/0000-0002-0134-4804	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886, DE-AC02-06CH11357]; Canadian Institutes for Health Research (CIHR) [1097737]; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; MerckCo., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Ontario Ministry of Health and Long Term Care; Cancer Research Coordinating Committee; California Institute of Regenerative Medicine; NATIONAL CANCER INSTITUTE [ZIABC010379] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet(Genome CanadaCanada Foundation for InnovationGlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); MerckCo., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Cancer Research Coordinating Committee; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Use of the National Synchrotron Light Source, Brookhaven National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-98CH10886. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (1097737) that receives funds from the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck&Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. This work was supported in part by the Ontario Ministry of Health and Long Term Care (to C. H. A.), the Cancer Research Coordinating Committee (to F. C.), a Stem Cell training grant from the California Institute of Regenerative Medicine (to M. S. K.). a Frederick Banting and Charles Best Canada Doctoral Research Award from the CIHR (to N. N.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Binda O, 2010, EPIGENETICS-US, V5, P767, DOI 10.4161/epi.5.8.13278; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chen WY, 2000, P NATL ACAD SCI USA, V97, P377, DOI 10.1073/pnas.97.1.377; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DHAYALAN A, 2011, HUM MOL GEN IN PRESS; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Garske AL, 2010, NAT CHEM BIOL, V6, P283, DOI [10.1038/NCHEMBIO.319, 10.1038/nchembio.319]; GODDARD TD, 2006, SPARKY 3 V 3 113; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Hopfner R, 2000, CANCER RES, V60, P121; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krauss V, 2008, GENETICA, V133, P93, DOI 10.1007/s10709-007-9184-z; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Mittermaier A, 2001, J AM CHEM SOC, V123, P6892, DOI 10.1021/ja010595d; Miura M, 2001, EXP CELL RES, V263, P202, DOI 10.1006/excr.2000.5115; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Papait R, 2007, MOL BIOL CELL, V18; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Santiveri CM, 2008, J MOL BIOL, V382, P1107, DOI 10.1016/j.jmb.2008.07.081; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Uemura T, 2000, CELL STRUCT FUNCT, V25, P149, DOI 10.1247/csf.25.149; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	72	140	147	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24300	24311		10.1074/jbc.M111.234104	http://dx.doi.org/10.1074/jbc.M111.234104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21489993	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000292294900071
J	Hellmann, J; Tang, YN; Kosuri, M; Bhatnagar, A; Spite, M				Hellmann, Jason; Tang, Yunan; Kosuri, Madhavi; Bhatnagar, Aruni; Spite, Matthew			Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice	FASEB JOURNAL			English	Article						lipid mediators; resolution of inflammation; obesity	INFLAMMATION; RESISTANCE; RESOLUTION; GLUCOSE; EXPRESSION; INTERLEUKIN-6; POLARIZATION; ADIPONECTIN; HOMEOSTASIS; ADIPOCYTES	Type 2 diabetes and obesity have emerged as global public health crises. Adipose tissue expansion in obesity promotes accumulation of classically activated macrophages that perpetuate chronic inflammation and sustain insulin resistance. Acute inflammation normally resolves in an actively orchestrated series of molecular and cellular events that ensures return to homeostasis after an inflammatory insult, a process regulated in part by endogenous lipid mediators such as the resolvins. In this study, we sought to determine whether stimulating resolution with resolvin D1 (RvD1) improves insulin sensitivity by resolving chronic inflammation associated with obesity. In male leptin receptor-deficient (db/db) mice, treatment with RvD1 (2 mu g/kg) improved glucose tolerance, decreased fasting blood glucose, and increased insulin-stimulated Akt phosphorylation in adipose tissue relative to vehicle-treated mice. Treatment with RvD1 increased adiponectin production, while expression of IL-6 in adipose tissue was decreased. The formation of crown-like structures rich in inflammatory F4/80(+)CD11c(+) macrophages was reduced by > 50% in adipose tissue by RvD1 and was associated with an increased percentage of F4/80(+) cells expressing macrophage galactose-type C-type lectin 1 (MGL-1), a marker of alternatively activated macrophages. These results suggest that stimulating resolution with the endogenous proresolving mediator RvD1 could provide a novel therapeutic strategy for treating obesity-induced diabetes.-Hellmann, J., Tang, Y., Kosuri, M., Bhatnagar, A., Spite, M. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25, 2399-2407 (2011). www.fasebj.org	[Hellmann, Jason; Tang, Yunan; Kosuri, Madhavi; Bhatnagar, Aruni; Spite, Matthew] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Spite, Matthew] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Spite, M (corresponding author), Univ Louisville, Diabet & Obes Ctr, 580 S Preston St,Rm 404F,Delia Baxter Bldg, Louisville, KY 40202 USA.	matthew.spite@louisville.edu	Spite, Matthew/B-3337-2010; Hellmann, Jason/B-9360-2012		U.S. National Institutes of Health [P20RR024489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the U.S. National Institutes of Health-sponsored Diabetes and Obesity Center (P20RR024489).	Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sun YY, 2007, WAVE RANDOM COMPLEX, V17, P1, DOI 10.1080/17455030600791694; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	42	212	218	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2399	2407		10.1096/fj.10-178657	http://dx.doi.org/10.1096/fj.10-178657			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21478260	Green Published			2022-12-25	WOS:000292242200031
J	Canul-Tec, JC; Riano-Umbarila, L; Rudino-Pinera, E; Becerril, B; Possani, LD; Torres-Larios, A				Carlos Canul-Tec, Juan; Riano-Umbarila, Lidia; Rudino-Pinera, Enrique; Becerril, Baltazar; Possani, Lourival D.; Torres-Larios, Alfredo			Structural Basis of Neutralization of the Major Toxic Component from the Scorpion Centruroides noxius Hoffmann by a Human-derived Single-chain Antibody Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNELS; CRYSTAL-STRUCTURE; VOLTAGE SENSOR; ENHANCED ACTIVATION; RECEPTOR-SITES; BETA-TOXIN; STABILIZATION; SPECIFICITY; RESIDUES; SEQUENCE	It has previously been reported that several single-chain antibody fragments of human origin (scFv) neutralize the effects of two different scorpion venoms through interactions with the primary toxins of Centruroides noxius Hoffmann (Cn2) and Centruroides suffusus suffusus (Css2). Here we present the crystal structure of the complex formed between one scFv (9004G) and the Cn2 toxin, determined in two crystal forms at 2.5 and 1.9 angstrom resolution. A 15-residue span of the toxin is recognized by the antibody through a cleft formed by residues from five of the complementarity-determining regions of the scFv. Analysis of the interface of the complex reveals three features. First, the epitope of toxin Cn2 overlaps with essential residues for the binding of beta-toxins to its Na+ channel receptor site. Second, the putative recognition of Css2 involves mainly residues that are present in both Cn2 and Css2 toxins. Finally, the effect on the increase of affinity of previously reported key residues during the maturation process of different scFvs can be inferred from the structure. Taken together, these results provide the structural basis that explain the mechanism of the 9004G neutralizing activity and give insight into the process of directed evolution that gave rise to this family of neutralizing scFvs.	[Carlos Canul-Tec, Juan; Riano-Umbarila, Lidia; Rudino-Pinera, Enrique; Becerril, Baltazar; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico; [Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Possani, LD (corresponding author), Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.	possani@ibt.unam.mx; torres@ifc.unam.mx	Possani, Lourival D/J-2397-2013	Rudino-Pinera, Enrique/0000-0001-8170-6379; Torres-Larios, Alfredo/0000-0002-0702-350X; Canul Tec, Juan Carlos/0000-0003-0513-545X; Riano-Umbarila, Lidia/0000-0002-2531-9232	Instituto Bioclon [P-156]; Consejo Nacional de Ciencia y Tecnologia [60127-Q, 45248]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) [IN202910, IN204110]; Instituto de Ciencia y Tecnologia del Distrito Federal [PIFUTP09-279]	Instituto Bioclon; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal	This work was supported by Grant P-156 from Instituto Bioclon (to L. D. P.), Consejo Nacional de Ciencia y Tecnologia Grant 60127-Q (to A. T.-L.), Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) Grants IN202910 (to A. T.-L.) and IN204110 (to L. D. P.), and Instituto de Ciencia y Tecnologia del Distrito Federal Grant PIFUTP09-279 (to A. T.-L.).; Recipient of Consejo Nacional de Ciencia y Tecnologia Scholarship 45248.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; COURAUD F, 1982, TOXICON, V20, P9, DOI 10.1016/0041-0101(82)90138-6; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Estrada G, 2007, BBA-GEN SUBJECTS, V1770, P1161, DOI 10.1016/j.bbagen.2007.04.006; GETZOFF ED, 1988, ADV IMMUNOL, V43, P1; Gordon D, 2003, EUR J BIOCHEM, V270, P2663, DOI 10.1046/j.1432-1033.2003.03643.x; Gordon D, 1998, J TOXICOL-TOXIN REV, V17, P131, DOI 10.3109/15569549809009247; Hernandez-Salgado K, 2009, IMMUNOL LETT, V125, P93, DOI 10.1016/j.imlet.2009.06.001; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JOVER E, 1980, BIOCHEM BIOPH RES CO, V95, P1607, DOI 10.1016/S0006-291X(80)80082-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann M, 2002, J MOL BIOL, V318, P135, DOI 10.1016/S0022-2836(02)00038-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leysath CE, 2009, J MOL BIOL, V387, P680, DOI 10.1016/j.jmb.2009.02.003; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Praveen S, 2008, J APPL CRYSTALLOGR, V41, P952, DOI 10.1107/S0021889808022073; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Riano-Umbarila L, 2011, J BIOL CHEM, V286, P6143, DOI 10.1074/jbc.M110.189175; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; VANDENBURG B, 1994, EUR J BIOCHEM, V220, P981; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yun YS, 2005, FEBS J, V272, P1999, DOI 10.1111/j.1742-4658.2005.04627.x; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x	50	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20892	20900		10.1074/jbc.M111.238410	http://dx.doi.org/10.1074/jbc.M111.238410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489992	Green Published, hybrid			2022-12-25	WOS:000291267600073
J	Zhang, J; Zhao, FB; Zhao, Y; Wang, J; Pei, L; Sun, N; Shi, J				Zhang, Jing; Zhao, Fengbo; Zhao, Yin; Wang, Jing; Pei, Lei; Sun, Ning; Shi, Jing			Hypoxia Induces an Increase in Intracellular Magnesium via Transient Receptor Potential Melastatin 7 (TRPM7) Channels in Rat Hippocampal Neurons in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FUNCTIONAL-CHARACTERIZATION; GLOBAL-ISCHEMIA; ION CHANNELS; MG2+; CALCIUM; CA2+; HOMEOSTASIS; PROTEIN; STROKE	TRPM7, a divalent cation channel, plays an important role in neurons damaged from cerebral ischemia due to permitting intracellular calcium overload. This study aimed to explore whether magnesium was transported via a TRPM7 channel into the intracellular space of rat hippocampal neurons after 1 h of oxygen-glucose deprivation (OGD) and acute chemical ischemia (CI) by using methods of the Mg2+ fluorescent probe Mag-Fura-2 to detect intracellular magnesium concentration ([Mg2+](i)) and flame atomic absorption spectrometry to measure extracellular magnesium concentration ([Mg2+](o)). The results showed that the neuronal [Mg2+](i) was 1.51-fold higher after 1 h of OGD at a basal level, and the increase of neuronal [Mg2+](i) reached a peak after 1 h of OGD and was kept for 60 min with re-oxygenation. Meanwhile, the [Mg2+](o) decreased after 1 h of OGD and recovered to the pre-ischemic level within 15 min after re-oxygenation. In the case of CI, the [Mg2+](i) peak immediately appeared in hippocampal neurons. This increase of [Mg2+](i) declined by removing extracellular magnesium in OGD or CI. Furthermore, by using Gd3+ or 2-aminoethoxydiphenyl borate to inhibit TRPM7 channels, the [Mg2+](i) increase, which was induced by OGD or CI, was attenuated without altering the basal level of [Mg2+](i). By silencing TRPM7 with shRNA in hippocampal neurons, it was found that not only was the increase of [Mg2+](i) induced by OGD or CI but also the basal levels of [Mg2+](i) were attenuated. In contrast, overexpression of TRPM7 in HEK293 cells exaggerated both the basal levels and increased [Mg2+](i) after 1 h of OGD/CI. These results suggest that anoxia induced the increase of [Mg2+](i) via TRPM7 channels in rat hippocampal neurons.	[Shi, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurobiol, Wuhan 430030, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Neurol Dis Hubei Prov, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Shi, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurobiol, 13 Hangkong Rd, Wuhan 430030, Peoples R China.	sj@mails.tjmu.edu.cn	Zhao, Yin/AAA-5891-2019		National Natural Science Foundation of China [30870793]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 30870793.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.physiol.53.1.299; Altura B M, 1991, Magnes Trace Elem, V10, P182; BEYENBACH KW, 1990, MAGNESIUM TRACE ELEM, V9, P233; BLAIR JL, 1989, STROKE, V20, P507, DOI 10.1161/01.STR.20.4.507; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; CHOI DW, 1987, J NEUROSCI, V7, P369; CROMPTON M, 1976, BIOCHEM J, V154, P735, DOI 10.1042/bj1540735; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Gabriel TE, 2007, ARCH BIOCHEM BIOPHYS, V458, P3, DOI 10.1016/j.abb.2006.07.007; GASBARRINI A, 1992, J BIOL CHEM, V267, P6654; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gotoh H, 1999, BRAIN RES, V828, P163, DOI 10.1016/S0006-8993(99)01298-6; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; GRUBBS RD, 1987, MAGNESIUM, V6, P113; HAUGLAND RP, 1996, HDB FLUORESCENT PROB, P507; He Y, 2005, CIRC RES, V96, P207, DOI 10.1161/01.RES.0000152967.88472.3e; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kato H, 1998, BRAIN RES, V779, P329, DOI 10.1016/S0006-8993(97)01232-8; Kennedy HJ, 1998, EXP PHYSIOL, V83, P449, DOI 10.1113/expphysiol.1998.sp004128; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; Lee EJ, 1999, J NEUROSCI RES, V58, P442, DOI 10.1002/(SICI)1097-4547(19991101)58:3<442::AID-JNR10>3.0.CO;2-4; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lin MC, 2004, J AM COLL NUTR, V23, p561S, DOI 10.1080/07315724.2004.10719404; LOEW LM, 1994, P NATL ACAD SCI USA, V91, P12579, DOI 10.1073/pnas.91.26.12579; LONDON RE, 1991, ANNU REV PHYSIOL, V53, P241, DOI 10.1146/annurev.physiol.53.1.241; Miles AN, 2001, NEUROSURGERY, V49, P1443, DOI 10.1097/00006123-200112000-00025; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nakamura T, 1999, NEUROSCIENCE, V88, P57, DOI 10.1016/S0306-4522(98)00207-3; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Pignataro G, 2004, STROKE, V35, P2566, DOI 10.1161/01.STR.0000143730.29964.93; Pisani A, 2000, J CEREBR BLOOD F MET, V20, P839, DOI 10.1097/00004647-200005000-00011; Planells-Cases R, 2006, CURR PHARM DESIGN, V12, P3583, DOI 10.2174/138161206778522092; QUAMME GA, 1990, BIOCHEM BIOPH RES CO, V167, P1406, DOI 10.1016/0006-291X(90)90679-H; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; RHIAN M, 2008, AM J PHYSIOL-HEART C, V294, pH1103; ROMANI A, 1993, CIRC RES, V72, P1139, DOI 10.1161/01.RES.72.6.1139; Romani AMP, 2007, FRONT BIOSCI-LANDMRK, V12, P308, DOI 10.2741/2066; Rubin H, 2007, ARCH BIOCHEM BIOPHYS, V458, P16, DOI 10.1016/j.abb.2006.03.026; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Sato Yoshiaki, 2004, Clin Calcium, V14, P50; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SCHWARTZ PH, 1992, STROKE, V23, P539, DOI 10.1161/01.STR.23.4.539; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; SUGIYAMA T, 1995, AM J PHYSIOL-CELL PH, V269, pC698, DOI 10.1152/ajpcell.1995.269.3.C698; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Tian SL, 2007, NEUROSCI LETT, V419, P93, DOI 10.1016/j.neulet.2007.04.020; Wang M, 2007, ARCH BIOCHEM BIOPHYS, V458, P65, DOI 10.1016/j.abb.2006.10.022; WHITE RJ, 1995, J NEUROSCI, V15, P1318; WOLF FI, 1994, BIOCHEM BIOPH RES CO, V202, P1209, DOI 10.1006/bbrc.1994.2059; Zhang J, 2007, AM J PHYSIOL-HEART C, V292, pH415, DOI 10.1152/ajpheart.01214.2005; Zhao L, 2007, LIFE SCI, V81, P1211, DOI 10.1016/j.lfs.2007.08.034; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zhu DH, 2004, NEUROSCI RES, V49, P347, DOI 10.1016/j.neures.2004.04.001	64	32	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20194	20207		10.1074/jbc.M110.148494	http://dx.doi.org/10.1074/jbc.M110.148494			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487014	Green Published, hybrid			2022-12-25	WOS:000291267600007
J	Giuffre, C; Hinow, P; Vogel, R; Ahmed, T; Stocker, R; Consi, TR; Strickler, JR				Giuffre, Carl; Hinow, Peter; Vogel, Ryan; Ahmed, Tanvir; Stocker, Roman; Consi, Thomas R.; Strickler, J. Rudi			The Ciliate Paramecium Shows Higher Motility in Non-Uniform Chemical Landscapes	PLOS ONE			English	Article							CHEMOTAXIS; MICROORGANISMS; TRANSDUCTION; MEMBRANE; CELLS; MODEL	We study the motility behavior of the unicellular protozoan Paramecium tetraurelia in a microfluidic device that can be prepared with a landscape of attracting or repelling chemicals. We investigate the spatial distribution of the positions of the individuals at different time points with methods from spatial statistics and Poisson random point fields. This makes quantitative the informal notion of ``uniform distribution'' (or lack thereof). Our device is characterized by the absence of large systematic biases due to gravitation and fluid flow. It has the potential to be applied to the study of other aquatic chemosensitive organisms as well. This may result in better diagnostic devices for environmental pollutants.	[Giuffre, Carl; Consi, Thomas R.; Strickler, J. Rudi] Univ Wisconsin, Great Lakes WATER Inst, Milwaukee, WI 53201 USA; [Hinow, Peter] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; [Vogel, Ryan] St Louis Univ, Sch Med, St Louis, MO USA; [Ahmed, Tanvir; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; Saint Louis University; Massachusetts Institute of Technology (MIT)	Giuffre, C (corresponding author), Univ Wisconsin, Great Lakes WATER Inst, Milwaukee, WI 53201 USA.	hinow@uwm.edu	Strickler, J. Rudi/A-8926-2009; Ahmed, Tanvir/AAL-3026-2020; Stocker, Roman/N-8987-2019; Stocker, Roman/T-9456-2017	Stocker, Roman/0000-0002-3199-0508	University of Wisconsin-Milwaukee; National Science Foundation [DMS-016214, OCE-0744641-CAREER]	University of Wisconsin-Milwaukee; National Science Foundation(National Science Foundation (NSF))	We thank Dr. Thomas Doak (University of Indiana) for providing us with Paramecium tetraurelia type 51s and for helpful suggestions, Greg Barske for constructing our actuator, and Tracy Harvey for helping to maintain the cell cultures. CG and RV were supported by a SURF (Salary for Undergraduate Research Fellows) Award from the University of Wisconsin-Milwaukee. PH is partially supported by NSF grant DMS-016214 and RS acknowledges support from NSF grant OCE-0744641-CAREER.	Bell WE, 2007, J EXP BIOL, V210, P357, DOI 10.1242/jeb.02642; Diggle P., 2003, STAT ANAL SPATIAL PO; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Erban R, 2007, J MATH BIOL, V54, P847, DOI 10.1007/s00285-007-0070-1; HENNESSEY TM, 1994, J COMP PHYSIOL A, V175, P655; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; HINRICHSEN RD, 1988, TRENDS NEUROSCI, V11, P27, DOI 10.1016/0166-2236(88)90046-X; Illian J, 2008, STAT ANAL MODELLING; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; Kingman J., 1993, POISSON PROCESSES; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pearse V., 1987, LIVING INVERTEBRATES; PRESTON RR, 1987, J COMP PHYSIOL A, V160, P537, DOI 10.1007/BF00615087; Seymour JR, 2008, LIMNOL OCEANOGR-METH, V6, P477, DOI 10.4319/lom.2008.6.477; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Stoyan D., 1994, FRACTALS RANDOM SHAP; VANHOUTEN J, 1994, TRENDS NEUROSCI, V17, P62, DOI 10.1016/0166-2236(94)90076-0; WINET H, 1973, J EXP BIOL, V59, P753; Yang WQ, 1997, J CELL SCI, V110, P2567	20	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e15274	10.1371/journal.pone.0015274	http://dx.doi.org/10.1371/journal.pone.0015274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494596	gold, Green Published			2022-12-25	WOS:000289354100001
J	Merlini, E; Bai, F; Bellistri, GM; Tincati, C; Monforte, AD; Marchetti, G				Merlini, Esther; Bai, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Monforte, Antonella d'Arminio; Marchetti, Giulia			Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy	PLOS ONE			English	Article							MICROBIAL TRANSLOCATION; ACTIVATION; RECONSTITUTION	In advanced HIV infection, the homeostatic balance between gastrointestinal indigenous bacteria and gut immunity fails and microbes are able to overcome the intestinal barrier and gain the systemic circulation. Because microbial translocation is not fully controlled by antiviral therapy and is associated with inefficient CD4+ reconstitution, we investigated the profile of translocating bacteria in peripheral blood of 44 HIV-infected patients starting therapy with advanced CD4+ T-lymphopenia and displaying poor CD4+ recovery on virologically suppressive HAART. According to CD4+ reconstitution at 12-months HAART, patients were considered Partial Immunological Responders, PIRs (CD4+>= 250/mu l, n = 29) and Immunological non Responders, INRs (CD4+< 200/mu l, n = 15)). We show that PIRs and INRs present similarly elevated plasma levels of lipopolysaccharide (LPS) and its ligand sCD14 that were not lowered by virologically suppressive therapy. Bacterial 16S rRNA gene amplification and sequencing resulted in a highly polymicrobic peripheral blood microbiota both prior and after 12-month HAART. Several differences in bacterial composition were shown between patients' groups, mainly the lack of probiotic Lactobacillaceae both prior and after therapy in INRs. Failure to control microbial translocation on HAART is associated with a polymicrobic flora circulating in peripheral blood that is not substantially modified by therapy.	[Merlini, Esther; Bai, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Monforte, Antonella d'Arminio; Marchetti, Giulia] Univ Milan, Dept Med Surg & Dent, Clin Infect Dis, San Paolo Hosp, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan	Merlini, E (corresponding author), Univ Milan, Dept Med Surg & Dent, Clin Infect Dis, San Paolo Hosp, Milan, Italy.	giulia.marchetti@unimi.it	Marchetti, Giulia/GPX-7655-2022; Bai, Francesca/K-4823-2018; Gori, Andrea/AAC-6078-2022; TINCATI, CAMILLA/K-4501-2018; MARCHETTI, GIULIA CARLA/K-4384-2018	TINCATI, CAMILLA/0000-0002-3083-2962; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST); Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy [30G.50, 30G.63, 50G]	Fondo Interno Ricerca Scientifica e Tecnologica (FIRST); Universita degli Studi di Milano; Istituto Superiore di Sanita, Italy	The work was supported by grants from Fondo Interno Ricerca Scientifica e Tecnologica (FIRST) 2009 Universita degli Studi di Milano, and from Istituto Superiore di Sanita, National research program on AIDS, grants #30G.50; 30G.63, 50G; 2006, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Diggle MA, 2004, MOL BIOTECHNOL, V28, P129, DOI 10.1385/MB:28:2:129; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; FERRI E, J INFECT DIS, V202, P178; Ferri E, 2010, J INFECT DIS, V202, P176, DOI 10.1086/653215; GORI A, 2007, J CLIN MICROBIOL; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; MARCHETTI G, 2010, ROLE MICROBIAL TRANS; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Paiardini M, 2008, AIDS REV, V10, P36; Perdigon G, 1999, J DAIRY SCI, V82, P1108, DOI 10.3168/jds.S0022-0302(99)75333-6; SANDLER NG, J INFECT DIS; VANTLAND B, 2008, SPECIFIC MIXTURE PRE	26	92	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18580	10.1371/journal.pone.0018580	http://dx.doi.org/10.1371/journal.pone.0018580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494598	Green Published, Green Submitted, gold			2022-12-25	WOS:000289354100023
J	Zhou, ZQ; Shung, CY; Ota, S; Akiyama, H; Keene, DR; Hurlin, PJ				Zhou, Zi-Qiang; Shung, Chia-Yi; Ota, Sara; Akiyama, Haruhiko; Keene, Douglas R.; Hurlin, Peter J.			Sequential and Coordinated Actions of c-Myc and N-Myc Control Appendicular Skeletal Development	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; ENDOCHONDRAL BONE-FORMATION; CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; LIMB DEVELOPMENT; STEM-CELLS; EXPRESSION; CARTILAGE; SOX9; VEGF	Background: During limb development, chondrocytes and osteoblasts emerge from condensations of limb bud mesenchyme. These cells then proliferate and differentiate in separate but adjacent compartments and function cooperatively to promote bone growth through the process of endochondral ossification. While many aspects of limb skeletal formation are understood, little is known about the mechanisms that link the development of undifferentiated limb bud mesenchyme with formation of the precartilaginous condensation and subsequent proliferative expansion of chondrocyte and osteoblast lineages. The aim of this study was to gain insight into these processes by examining the roles of c-Myc and N-Myc in morphogenesis of the limb skeleton. Methodology/Principal Findings: To investigate c-Myc function in skeletal development, we characterized mice in which floxed c-Myc alleles were deleted in undifferentiated limb bud mesenchyme with Prx1-Cre, in chondro-osteoprogenitors with Sox9-Cre and in osteoblasts with Osx1-Cre. We show that c-Myc promotes the proliferative expansion of both chondrocytes and osteoblasts and as a consequence controls the process of endochondral growth and ossification and determines bone size. The control of proliferation by c-Myc was related to its effects on global gene transcription, as phosphorylation of the C-Terminal Domain (pCTD) of RNA Polymerase II, a marker of general transcription initiation, was tightly coupled to cell proliferation of growth plate chondrocytes where c-Myc is expressed and severely downregulated in the absence of c-Myc. Finally, we show that combined deletion of N-Myc and c-Myc in early limb bud mesenchyme gives rise to a severely hypoplastic limb skeleton that exhibits features characteristic of individual c-Myc and N-Myc mutants. Conclusions/Significance: Our results show that N-Myc and c-Myc act sequentially during limb development to coordinate the expansion of key progenitor populations responsible for forming the limb skeleton.	[Zhou, Zi-Qiang; Shung, Chia-Yi; Ota, Sara; Keene, Douglas R.; Hurlin, Peter J.] Shriners Hosp Children Portland, Portland, OR USA; [Shung, Chia-Yi; Hurlin, Peter J.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Akiyama, Haruhiko] Kyoto Univ, Dept Orthopaed, Kyoto, Japan	Oregon Health & Science University; Kyoto University	Zhou, ZQ (corresponding author), Shriners Hosp Children Portland, Portland, OR USA.	pjh@shcc.org			Shriners Hospitals for Children	Shriners Hospitals for Children	This study was funded by a grant from Shriners Hospitals for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Carlevaro MF, 2000, J CELL SCI, V113, P59; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; HIRNING U, 1991, MECH DEVELOP, V33, P119, DOI 10.1016/0925-4773(91)90078-K; Huang RJ, 2006, ANAT EMBRYOL, V211, pS65, DOI 10.1007/s00429-006-0126-9; IWAMOTO M, 1993, J BIOL CHEM, V268, P9645; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Malynn BA, 2000, GENE DEV, V14, P1390; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MOTOYAMA J, 1994, FEBS LETT, V338, P323, DOI 10.1016/0014-5793(94)80292-0; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Piedra ME, 2002, CELL GROWTH DIFFER, V13, P185; Queva C, 1998, ONCOGENE, V16, P967, DOI 10.1038/sj.onc.1201611; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Varlakhanova NV, 2009, CANCER RES, V69, P7487, DOI 10.1158/0008-5472.CAN-08-4832; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	44	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18795	10.1371/journal.pone.0018795	http://dx.doi.org/10.1371/journal.pone.0018795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494559	Green Submitted, Green Published, gold			2022-12-25	WOS:000289354100041
J	Clemente-Casares, P; Lopez-Jimenez, AJ; Bellon-Echeverria, I; Encinar, JA; Martinez-Alfaro, E; Perez-Flores, R; Mas, A				Clemente-Casares, Pilar; Lopez-Jimenez, Alberto J.; Bellon-Echeverria, Itxaso; Antonio Encinar, Jose; Martinez-Alfaro, Elisa; Perez-Flores, Ricardo; Mas, Antonio			De Novo Polymerase Activity and Oligomerization of Hepatitis C Virus RNA-Dependent RNA-Polymerases from Genotypes 1 to 5	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; BINDING-SITE; IDENTIFICATION; NS5B; REPLICATION; INHIBITORS; INITIATION; COMPLEX; GENOME	Hepatitis C virus (HCV) shows a great geographical diversity reflected in the high number of circulating genotypes and subtypes. The response to HCV treatment is genotype specific, with the predominant genotype 1 showing the lowest rate of sustained virological response. Virally encoded enzymes are candidate targets for intervention. In particular, promising antiviral molecules are being developed to target the viral NS3/4A protease and NS5B polymerase. Most of the studies with the NS5B polymerase have been done with genotypes 1b and 2a, whilst information about other genotypes is scarce. Here, we have characterized the de novo activity of NS5B from genotypes 1 to 5, with emphasis on conditions for optimum activity and kinetic constants. Polymerase cooperativity was determined by calculating the Hill coefficient and oligomerization through a new FRET-based method. The V-max/K-m ratios were statistically different between genotype 1 and the other genotypes (p<0.001), mainly due to differences in V-max values, but differences in the Hill coefficient and NS5B oligomerization were noted. Analysis of sequence changes among the studied polymerases and crystal structures show the alpha F helix as a structural component probably involved in NS5B-NS5B interactions. The viability of the interaction of alpha F and alpha T helixes was confirmed by docking studies and calculation of electrostatic surface potentials for genotype 1 and point mutants corresponding to mutations from different genotypes. Results presented in this study reveal the existence of genotypic differences in NS5B de novo activity and oligomerization. Furthermore, these results allow us to define two regions, one consisting of residues Glu128, Asp129, and Glu248, and the other consisting of residues of alpha T helix possibly involved in NS5B-NS5B interactions.	[Clemente-Casares, Pilar; Lopez-Jimenez, Alberto J.; Bellon-Echeverria, Itxaso; Mas, Antonio] Univ Castilla La Mancha, Ctr Reg Invest Biomed CRIB, Albacete, Spain; [Lopez-Jimenez, Alberto J.; Martinez-Alfaro, Elisa] Complejo Hosp Univ Albacete, Infect Dis Unit, Albacete, Spain; [Perez-Flores, Ricardo] Complejo Hosp Univ Albacete, Digest Dept, Albacete, Spain; [Antonio Encinar, Jose] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain	Universidad de Castilla-La Mancha; Universidad Miguel Hernandez de Elche	Clemente-Casares, P (corresponding author), Univ Castilla La Mancha, Ctr Reg Invest Biomed CRIB, Albacete, Spain.	Antonio.Mas@uclm.es	Romo, José A./J-3024-2012; Lopez, Alberto/GWC-5652-2022; Mas, Antonio/F-2505-2011; Clemente-Casares, Pilar/M-3738-2018; Encinar, José Antonio/AAE-9141-2020; Encinar, José A/F-2946-2013	Romo, José A./0000-0003-2907-580X; Mas, Antonio/0000-0003-2563-570X; Encinar, José Antonio/0000-0002-7219-3863; Encinar, José A/0000-0002-7219-3863; Bellon-Echeverria, Itxaso/0000-0002-3135-8799; Lopez Jimenez, Alberto Jose/0000-0002-4992-631X	Fondo de Investigaciones Sanitarias [PI060584]; Consejeria de Educacion de Castilla La Mancha [PPII10-0243-6857]; Fundacion para la Investigacion Sanitaria de Castilla-La Mancha [MOV-2006_JI/06, MOV-2008_JI/1]; Fondo de Investigaciones Sanitarias and a Ramon y Cajal; Ministerio de Ciencia e Innovacion	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Consejeria de Educacion de Castilla La Mancha; Fundacion para la Investigacion Sanitaria de Castilla-La Mancha; Fondo de Investigaciones Sanitarias and a Ramon y Cajal; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Fondo de Investigaciones Sanitarias [grant number PI060584], and Consejeria de Educacion de Castilla La Mancha [grant number PPII10-0243-6857]. I. B. E. and A.J.L.J. were supported by predoctoral fellowships from Fundacion para la Investigacion Sanitaria de Castilla-La Mancha [grant numbers MOV-2006_JI/06 and MOV-2008_JI/1]. P. C. C. and A. M. were supported by a "Sara Borrell" contract from Fondo de Investigaciones Sanitarias and a Ramon y Cajal contract (Ministerio de Ciencia e Innovacion cofinanced with FEDER funds), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bellon-Echeverria I, 2010, ANTIVIR RES, V87, P57, DOI 10.1016/j.antiviral.2010.04.009; Biswal BK, 2006, J MOL BIOL, V361, P33, DOI 10.1016/j.jmb.2006.05.074; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; COPELAND RA, 1996, ENZYMES; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Fan XF, 2006, BIOCHEM BIOPH RES CO, V346, P1163, DOI 10.1016/j.bbrc.2006.06.039; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Heck JA, 2008, ANTIMICROB AGENTS CH, V52, P1901, DOI 10.1128/AAC.01496-07; Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0; Huang PY, 2008, ANTIMICROB AGENTS CH, V52, P1419, DOI 10.1128/AAC.00525-07; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Kaiser WJ, 2006, J GEN VIROL, V87, P363, DOI 10.1099/vir.0.81456-0; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu Y, 2008, BIOORG MED CHEM LETT, V18, P3173, DOI 10.1016/j.bmcl.2008.04.068; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Love RA, 2003, J VIROL, V77, P7575, DOI 10.1128/JVI.77.13.7575-7581.2003; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Maulik A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S19; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; PATA JD, 1995, RNA, V1, P466; Pauwels F, 2007, J VIROL, V81, P6909, DOI 10.1128/JVI.01543-06; Perelson AS, 2005, HEPATOLOGY, V42, P749, DOI 10.1002/hep.20882; Poranen MM, 2008, NUCLEIC ACIDS RES, V36, P6633, DOI 10.1093/nar/gkn632; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Versieck J., 1989, TRACE ELEMENTS HUMAN; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	59	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18515	10.1371/journal.pone.0018515	http://dx.doi.org/10.1371/journal.pone.0018515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490973	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700019
J	Kelly, TR; Johnson, CK				Kelly, Terra R.; Johnson, Christine K.			Lead Exposure in Free-Flying Turkey Vultures Is Associated with Big Game Hunting in California	PLOS ONE			English	Article							COEUR-DALENE RIVER; SHOT INGESTION; MINING SITE; ACCUMULATION; AMMUNITION; WATERFOWL; HAZARDS; EAGLES; SWANS; BIRDS	Predatory and scavenging birds are at risk of lead exposure when they feed on animals injured or killed by lead ammunition. While lead ammunition has been banned from waterfowl hunting in North America for almost two decades, lead ammunition is still widely used for hunting big game and small game animals. In this study, we evaluated the association between big game hunting and blood lead concentration in an avian scavenger species that feeds regularly on large mammals in California. We compared blood lead concentration in turkey vultures within and outside of the deer hunting season, and in areas with varying wild pig hunting intensity. Lead exposure in turkey vultures was significantly higher during the deer hunting season compared to the off-season, and blood lead concentration was positively correlated with increasing wild pig hunting intensity. Our results link lead exposure in turkey vultures to deer and wild pig hunting activity at these study sites, and we provide evidence that spent lead ammunition in carrion poses a significant risk of lead exposure to scavengers.	[Kelly, Terra R.; Johnson, Christine K.] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis	Kelly, TR (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.	trkelly@ucdavis.edu			State Wildlife Grant [T-12-1]	State Wildlife Grant	This research was funded by a State Wildlife Grant # T-12-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WL, 2000, J WILDLIFE MANAGE, V64, P848, DOI 10.2307/3802755; [Anonymous], [No title captured]; BATES F Y, 1968, Bulletin of the Wildlife Disease Association, V4, P116; BELLROSE FRANK C., 1959, ILLINOIS NAT HIST SURV BULL, V27, P235; BLUS L, 1991, ARCH ENV CONTAMINATI, V48, P108; Blus LJ, 1999, ECOTOXICOLOGY, V8, P125, DOI 10.1023/A:1008918819661; BUERGER TT, 1986, J WILDLIFE MANAGE, V50, P1, DOI 10.2307/3801479; Burger J, 2005, NEUROTOXICOLOGY, V26, P615, DOI 10.1016/j.neuro.2005.01.005; *CA DEP FISH GAM, 2007, HUNT SPORT FISH REG; *CA DEP FISH GAM, 2010, CERT NONL AMM; *CA DEP FISH GAM, 2006, REP 2006 GAM TAK HUN; Carpenter JW, 2003, J WILDLIFE DIS, V39, P96, DOI 10.7589/0090-3558-39.1.96; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Clark AJ, 2003, ECOTOXICOLOGY, V12, P23, DOI 10.1023/A:1022576510445; Colegrove Kathleen M., 2005, Aquatic Mammals, V31, P1, DOI 10.1578/AM.31.1.2005.1; COLEMAN JS, 1989, J WILDLIFE MANAGE, V53, P782, DOI 10.2307/3809213; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; Craighead Derek, 2009, P202, DOI 10.4080/ilsa.2009.0206; CUSTER TW, 1984, J WILDLIFE DIS, V20, P39, DOI 10.7589/0090-3558-20.1.39; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Franson J. Christian, 1996, P265; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; GARDNER IA, 1990, PREV VET MED, V8, P157, DOI 10.1016/0167-5877(90)90008-6; GILL CE, 1994, CAN VET J, V35, P303; HALL MJ, 2007, SERIES ORNITHOLOGY, V2, P163; Henckel E, 1981, N AM BIRD BANDER, V6, P106; HENNY CJ, 1994, ENVIRON MONIT ASSESS, V29, P267, DOI 10.1007/BF00547991; HENNY CJ, 1991, ARCH ENVIRON CON TOX, V21, P415, DOI 10.1007/BF01060365; HOFFMAN DJ, 1981, J WILDLIFE DIS, V17, P423, DOI 10.7589/0090-3558-17.3.423; HOFFMAN DJ, 1985, ARCH ENVIRON CON TOX, V14, P89, DOI 10.1007/BF01055766; HOLM S, 1979, SCAND J STAT, V6, P65; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt W. Grainger, 2007, P79; IRWIN J C, 1972, Journal of Wildlife Diseases, V8, P149; Kelly A, 2005, WATERBIRDS, V28, P331, DOI 10.1675/1524-4695(2005)028[0331:AMSWEB]2.0.CO;2; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Kirk David A., 1998, BIRDS N AM; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Kramer JL, 1997, J RAPTOR RES, V31, P327; Locke Louis N., 1996, P108; LOPAKA L, 2009, NADA NONDETECTS DATA; Martina PA, 2008, SCI TOTAL ENVIRON, V391, P96, DOI 10.1016/j.scitotenv.2007.11.012; Pain Deborah J., 1996, P251; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; PAIN DJ, 1993, IBIS, V135, P379, DOI 10.1111/j.1474-919X.1993.tb02109.x; PATTEE OH, 1990, CONDOR, V92, P931, DOI 10.2307/1368729; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; Pineda-Krch M, 2010, AM J VET RES, V71, P82, DOI 10.2460/ajvr.71.1.82; R Development Core Team, 2009, R FDN STAT COMP; REDIG PT, 1991, ARCH ENVIRON CON TOX, V21, P72, DOI 10.1007/BF01055559; ROGERS T, 2009, INGESTION LEAD SPENT, P206, DOI DOI 10.4080/ILSA.2009.0121; Sileo L, 2001, ARCH ENVIRON CON TOX, V41, P364, DOI 10.1007/s002440010260; Snoeijs T, 2004, ARCH ENVIRON CON TOX, V46, P399, DOI 10.1007/s00244-003-2195-6; Snyder NFR., 2000, CALIFORNIA CONDOR SA; Sorenson Kelly J., 2007, P185; STEPHENS R, 2009, INGESTION LEAD SPENT, P232, DOI DOI 10.4080/ILSA.2009.0212; Tranel Molly A., 2009, P318, DOI 10.4080/ilsa.2009.0307; *UN FISH WILDL SER, 1986, US LEAD SHOT HUNT S; *US FISH WILDL SER, 2010, NONT SHOT REG HUNT W; USDA, 2010, MORT CALV CATTL US B; *USDA, 2005, SHEEP LAMB DEATH LOS; WAITHMAN J, 2001, GUIDE HUNTING WILD P, P44; Wayland M, 1999, ENVIRON POLLUT, V104, P341, DOI 10.1016/S0269-7491(98)00201-2; WIEMEYER SN, 1986, ENVIRON MONIT ASSESS, V6, P91, DOI 10.1007/BF00394290	64	36	38	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e15350	10.1371/journal.pone.0015350	http://dx.doi.org/10.1371/journal.pone.0015350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494326	gold, Green Published			2022-12-25	WOS:000289192400001
J	Peng, JP; Yang, JA; Jin, Q				Peng, Junping; Yang, Jian; Jin, Qi			An Integrated Approach for Finding Overlooked Genes in Shigella	PLOS ONE			English	Article							RNA-ENCODING GENES; MOLECULAR EVOLUTIONARY HISTORY; COMPLETE GENOME SEQUENCE; SMALL NONCODING RNAS; ESCHERICHIA-COLI; COMPUTATIONAL APPROACH; INTERGENIC REGIONS; SOLUBLE-RNAS; IDENTIFICATION; PREDICTION	Background: The completion of numerous genome sequences introduced an era of whole-genome study. However, many genes are missed during genome annotation, including small RNAs (sRNAs) and small open reading frames (sORFs). In order to improve genome annotation, we aimed to identify novel sRNAs and sORFs in Shigella, the principal etiologic agents of bacillary dysentery. Methodology/Principal Findings: We identified 64 sRNAs in Shigella, which were experimentally validated in other bacteria based on sequence conservation. We employed computer-based and tiling array-based methods to search for sRNAs, followed by RT-PCR and northern blots, to identify nine sRNAs in Shigella flexneri strain 301 (Sf301) and 256 regions containing possible sRNA genes. We found 29 candidate sORFs using bioinformatic prediction, array hybridization and RTPCR verification. We experimentally validated 557 (57.9%) DOOR operon predictions in the chromosomes of Sf301 and 46 (76.7%) in virulence plasmid. We found 40 additional co-expressed gene pairs that were not predicted by DOOR. Conclusions/Significance: We provide an updated and comprehensive annotation of the Shigella genome. Our study increased the expected numbers of sORFs and sRNAs, which will impact on future functional genomics and proteomics studies. Our method can be used for large scale reannotation of sRNAs and sORFs in any microbe with a known genome sequence.	[Peng, Junping; Yang, Jian; Jin, Qi] Chinese Acad Med Sci, Peking Union Med Coll, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Peking Union Medical College	Peng, JP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China.	zdsys@vip.sina.com	Jin, Qi/B-5379-2009		National Natural Science Foundation of China [30700033]; Institute of Pathogen Biology [2008IPB112]; National Major Science and Technology Project for Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases [2009ZX10004-303]; National Basic Research Program of China [2009CB522603, 2005CB522904, 2011CB504901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology; National Major Science and Technology Project for Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases; National Basic Research Program of China(National Basic Research Program of China)	JP is supported by the National Natural Science Fund (Grant No. 30700033) from the National Natural Science Foundation of China and an intramural grant from Institute of Pathogen Biology (Grant No. 2008IPB112). JY is supported by the National Major Science and Technology Project for Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases (2009ZX10004-303) and the National Basic Research Program (2009CB522603) of China. QJ is supported by the National Basic Research Program (Grants No. 2005CB522904 and 2011CB504901) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GIANGROSSI M, 2010, NUCL ACIDS RES; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; He HS, 2007, GENOME RES, V17, P1471, DOI 10.1101/gr.6611807; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Nie H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-173; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Ohtani K, 2002, FEMS MICROBIOL LETT, V209, P113, DOI 10.1111/j.1574-6968.2002.tb11118.x; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Peng JP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-218; Peng JP, 2009, INFECT GENET EVOL, V9, P147, DOI 10.1016/j.meegid.2008.10.003; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pupo GM, 1997, INFECT IMMUN, V65, P2685, DOI 10.1128/IAI.65.7.2685-2692.1997; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Saito S, 2009, GENE, V428, P2, DOI 10.1016/j.gene.2008.09.024; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Tsui HCT, 2010, J BACTERIOL, V192, P264, DOI 10.1128/JB.01204-09; Wang LL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-255; Wang XF, 2006, BIOINFORMATICS, V22, P2955, DOI 10.1093/bioinformatics/btl525; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wei CD, 2008, PROTEOMICS, V8, P4209, DOI 10.1002/pmic.200800226; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09	71	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18509	10.1371/journal.pone.0018509	http://dx.doi.org/10.1371/journal.pone.0018509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483688	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300026
J	Sohn, CS; Cheng, TT; Drummond, ML; Peng, ED; Vermont, SJ; Xia, D; Cheng, SJ; Wastling, JM; Bradley, PJ				Sohn, Catherine S.; Cheng, Tim T.; Drummond, Michael L.; Peng, Eric D.; Vermont, Sarah J.; Xia, Dong; Cheng, Stephen J.; Wastling, Jonathan M.; Bradley, Peter J.			Identification of Novel Proteins in Neospora caninum Using an Organelle Purification and Monoclonal Antibody Approach	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; TACHYZOITE SURFACE PROTEIN; DENSE GRANULE PROTEIN; TOXOPLASMA-GONDII; PARASITOPHOROUS VACUOLE; APICOMPLEXAN PARASITES; HOST-CELLS; INVASION; FAMILY; ROP2	Neospora caninum is an important veterinary pathogen that causes abortion in cattle and neuromuscular disease in dogs. Neospora has also generated substantial interest because it is an extremely close relative of the human pathogen Toxoplasma gondii, yet does not appear to infect humans. While for Toxoplasma there are a wide array of molecular tools and reagents available for experimental investigation, relatively few reagents exist for Neospora. To investigate the unique biological features of this parasite and exploit the recent sequencing of its genome, we have used an organelle isolation and monoclonal antibody approach to identify novel organellar proteins and develop a wide array of probes for subcellular localization. We raised a panel of forty-six monoclonal antibodies that detect proteins from the rhoptries, micronemes, dense granules, inner membrane complex, apicoplast, mitochondrion and parasite surface. A subset of the proteins was identified by immunoprecipitation and mass spectrometry and reveal that we have identified and localized many of the key proteins involved in invasion and host interaction in Neospora. In addition, we identified novel secretory proteins not previously studied in any apicomplexan parasite. Thus, this organellar monoclonal antibody approach not only greatly enhances the tools available for Neospora cell biology, but also identifies novel components of the unique biological characteristics of this important veterinary pathogen.	[Sohn, Catherine S.; Cheng, Tim T.; Drummond, Michael L.; Peng, Eric D.; Cheng, Stephen J.; Bradley, Peter J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Sohn, Catherine S.] Univ Calif Los Angeles, Div Lab Anim Med, Los Angeles, CA USA; [Vermont, Sarah J.; Xia, Dong; Wastling, Jonathan M.] Univ Liverpool, Dept Infect Biol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Liverpool	Sohn, CS (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	pbradley@ucla.edu		Xia, Dong/0000-0003-4571-2776	National Institutes of Health (NIH) [R01 (AI064616)]; BBSRC [BBS/B/03807]; Biotechnology and Biological Sciences Research Council [BBS/B/03807] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064616] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was funded by a National Institutes of Health (NIH) Grant R01 (AI064616) to P.J.B. and BBSRC (BBS/B/03807) funding to J.M.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Beck HP, 2009, INT J PARASITOL, V39, P175, DOI 10.1016/j.ijpara.2008.10.001; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bradley PJ, 2002, MOL BIOCHEM PARASIT, V125, P189, DOI 10.1016/S0166-6851(02)00162-7; Bradley PJ, 2001, INT J PARASITOL, V31, P1177, DOI 10.1016/S0020-7519(01)00242-9; Bradley PJ, 1999, MOL BIOCHEM PARASIT, V100, P103, DOI 10.1016/S0166-6851(99)00035-3; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Carruthers Vern B., 2008, V47, P33; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; DeRocher AE, 2008, EUKARYOT CELL, V7, P1518, DOI 10.1128/EC.00081-08; Dubey JP, 2006, J COMP PATHOL, V134, P267, DOI 10.1016/j.jcpa.2005.11.004; Dubey John P., 2003, Korean Journal of Parasitology, V41, P1, DOI 10.3347/kjp.2003.41.1.1; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; Fuchs N, 1999, INT J PARASITOL, V29, P1597, DOI 10.1016/S0020-7519(99)00118-6; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Gondim LFP, 2006, TRENDS PARASITOL, V22, P247, DOI 10.1016/j.pt.2006.03.008; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hemphill A, 1997, PARASITOLOGY, V115, P371, DOI 10.1017/S0031182097001455; Hemphill A, 1997, PARASITOLOGY, V115, P581, DOI 10.1017/S0031182097001650; Hemphill A, 2006, PARASITOLOGY, V133, P261, DOI 10.1017/S0031182006000485; Hemphill A, 1998, INT J PARASITOL, V28, P429, DOI 10.1016/S0020-7519(97)00193-8; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Lally N, 1997, MOL BIOCHEM PARASIT, V87, P239, DOI 10.1016/S0166-6851(97)00070-4; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Lovett JL, 2000, MOL BIOCHEM PARASIT, V107, P33, DOI 10.1016/S0166-6851(99)00228-5; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mather MW, 2008, J BIOENERG BIOMEMBR, V40, P425, DOI 10.1007/s10863-008-9176-4; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Naguleswaran A, 2003, EXP PARASITOL, V104, P149, DOI 10.1016/S0014-4894(03)00137-1; Naguleswaran A, 2002, INT J PARASITOL, V32, P695, DOI 10.1016/S0020-7519(02)00014-0; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Rome ME, 2008, INFECT IMMUN, V76, P4865, DOI 10.1128/IAI.00782-08; Scapigliati G, 1999, BIOL REPROD, V60, P783, DOI 10.1095/biolreprod60.4.783; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Sonda S, 1998, MOL BIOCHEM PARASIT, V97, P97, DOI 10.1016/S0166-6851(98)00133-9; SPEER CA, 1989, J PROTOZOOL, V36, P458, DOI 10.1111/j.1550-7408.1989.tb01081.x; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiesner J, 2008, CURR PHARM DESIGN, V14, P855, DOI 10.2174/138161208784041105; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	63	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18383	10.1371/journal.pone.0018383	http://dx.doi.org/10.1371/journal.pone.0018383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483743	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000289058700022
J	de Picoli, S; Teixeira, JJV; Ribeiro, HV; Malacarne, LC; dos Santos, RPB; Mendes, RD				de Picoli Junior, Sergio; Vieira Teixeira, Jorge Juarez; Ribeiro, Haroldo Valentin; Malacarne, Luis Carlos; Barbosa dos Santos, Ricardo Paupitz; Mendes, Renio dos Santos			Spreading Patterns of the Influenza A (H1N1) Pandemic	PLOS ONE			English	Article							VIRUS; TRAVEL; WILL; LAWS	We investigate the dynamics of the 2009 influenza A (H1N1/S-OIV) pandemic by analyzing data obtained from World Health Organization containing the total number of laboratory-confirmed cases of infections - by country - in a period of 69 days, from 26 April to 3 July, 2009. Specifically, we find evidence of exponential growth in the total number of confirmed cases and linear growth in the number of countries with confirmed cases. We also find that, i) at early stages, the cumulative distribution of cases among countries exhibits linear behavior on log-log scale, being well approximated by a power law decay; ii) for larger times, the cumulative distribution presents a systematic curvature on log-log scale, indicating a gradual change to lognormal behavior. Finally, we compare these empirical findings with the predictions of a simple stochastic model. Our results could help to select more realistic models of the dynamics of influenza-type pandemics.	[de Picoli Junior, Sergio; Ribeiro, Haroldo Valentin; Malacarne, Luis Carlos; Barbosa dos Santos, Ricardo Paupitz; Mendes, Renio dos Santos] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Vieira Teixeira, Jorge Juarez] Univ Estadual Maringa, Dept Anal Clin & Biomed, Maringa, Parana, Brazil; [Ribeiro, Haroldo Valentin; Mendes, Renio dos Santos] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	de Picoli, S (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	junior@dfi.uem.br	Malacarne, Luis Carlos/D-7286-2018; Ribeiro, Haroldo Valentin/C-8614-2012; Paupitz, Ricardo/D-9594-2013	Malacarne, Luis Carlos/0000-0002-9436-6497; Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Paupitz, Ricardo/0000-0003-1254-6353				Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Butler D, 2009, NATURE, V459, P14, DOI 10.1038/459014a; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Cohen J, 2009, SCIENCE, V324, P572, DOI 10.1126/science.324_572; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Flahault A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-129; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gurevich KG, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-23; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Liao CM, 2009, INT J INFECT DIS, V13, P589, DOI 10.1016/j.ijid.2008.09.019; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Michaelis M, 2009, INFECTION, V37, P381, DOI 10.1007/s15010-009-9181-5; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0; Somette D., 2006, CRITICAL PHENOMENA N; *WHO, 2010, INFL; World Health Organization (WHO), 2009, SIT UPD PAND H1N1; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	20	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17823	10.1371/journal.pone.0017823	http://dx.doi.org/10.1371/journal.pone.0017823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483857	Green Published, gold, Green Submitted			2022-12-25	WOS:000289057200010
J	Holmberg, J; He, XB; Peredo, I; Orrego, A; Hesselager, G; Ericsson, C; Hovatta, O; Oba-Shinjo, SM; Marie, SKN; Nister, M; Muhr, J				Holmberg, Johan; He, Xiaobing; Peredo, Inti; Orrego, Abiel; Hesselager, Goran; Ericsson, Christer; Hovatta, Outi; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue; Nister, Monica; Muhr, Jonas			Activation of Neural and Pluripotent Stem Cell Signatures Correlates with Increased Malignancy in Human Glioma	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL NETWORK; PROGENITOR IDENTITY; ENDODERM FORMATION; BRAIN-TUMORS; ES CELLS; GLIOBLASTOMA; EXPRESSION; CANCER	The presence of stem cell characteristics in glioma cells raises the possibility that mechanisms promoting the maintenance and self-renewal of tissue specific stem cells have a similar function in tumor cells. Here we characterized human gliomas of various malignancy grades for the expression of stem cell regulatory proteins. We show that cells in high grade glioma co-express an array of markers defining neural stem cells (NSCs) and that these proteins can fulfill similar functions in tumor cells as in NSCs. However, in contrast to NSCs glioma cells co-express neural proteins together with pluripotent stem cell markers, including the transcription factors Oct4, Sox2, Nanog and Klf4. In line with this finding, in high grade gliomas mesodermal-and endodermal-specific transcription factors were detected together with neural proteins, a combination of lineage markers not normally present in the central nervous system. Persistent presence of pluripotent stem cell traits could only be detected in solid tumors, and observations based on in vitro studies and xenograft transplantations in mice imply that this presence is dependent on the combined activity of intrinsic and extrinsic regulatory cues. Together these results demonstrate a general deregulated expression of neural and pluripotent stem cell traits in malignant human gliomas, and indicate that stem cell regulatory factors may provide significant targets for therapeutic strategies.	[Holmberg, Johan; Muhr, Jonas] Karolinska Inst, Ludwig Inst Canc Res, Stockholm, Sweden; [Holmberg, Johan; Muhr, Jonas] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [He, Xiaobing; Orrego, Abiel; Ericsson, Christer; Nister, Monica] Karolinska Univ Hosp Solna, Dept Oncol Pathol, Karolinska Inst, CCK R8 05, Stockholm, Sweden; [Peredo, Inti] Karolinska Univ Hosp Solna, Dept Clin Neurosci, Karolinska Inst, Stockholm, Sweden; [Hesselager, Goran] Uppsala Univ, Univ Hosp, Dept Neurosci, Uppsala, Sweden; [Hovatta, Outi] Karolinska Univ Hosp Huddinge, Dept Clin Sci Intervent & Technol, Karolinska Inst, Stockholm, Sweden; [Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Universidade de Sao Paulo	Holmberg, J (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Stockholm, Sweden.	johan.holmberg@licr.ki.se; jonas.muhr@licr.ki.se	Oba-Shinjo, Sueli M./C-4017-2012; Marie, Suely Kazue Nagahashi/D-1870-2012; Ericsson, Christer/I-5887-2014	Oba-Shinjo, Sueli M./0000-0002-1650-5973; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Ericsson, Christer/0000-0002-8709-2264	Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council; Karolinska Institutet; Karolinska University Hospital; Cancer Society in Stockholm; King Gustaf V Jubilee Fund	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); Cancer Society in Stockholm; King Gustaf V Jubilee Fund	This project was supported by the Swedish Cancer Society and The Swedish Childhood Cancer Foundation. J.H., M.N. and J.M. are also supported by the Swedish Research Council and J.H., M.N., J.M. and C.E. have received support from Karolinska Institutet or the Karolinska University Hospital. M.N. was supported by the Cancer Society in Stockholm and the King Gustaf V Jubilee Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Holmberg J, 2008, DEVELOPMENT, V135, P1843, DOI 10.1242/dev.020180; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Technau U, 2003, INT J DEV BIOL, V47, P531; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xia Y, 2000, CANCER RES, V60, P6303; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	58	65	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18454	10.1371/journal.pone.0018454	http://dx.doi.org/10.1371/journal.pone.0018454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483788	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200082
J	Hou, J; Xu, J; Liu, M; Zhao, RZ; Luo, HB; Ke, HM				Hou, Jing; Xu, Jie; Liu, Ming; Zhao, Ruizhi; Luo, Hai-Bin; Ke, Hengming			Structural Asymmetry of Phosphodiesterase-9, Potential Protonation of a Glutamic Acid, and Role of the Invariant Glutamine	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; MECHANICAL CALCULATIONS; INHIBITOR SELECTIVITY; SUBSTRATE-SPECIFICITY; BINDING; INSIGHT; MEMORY; CGMP	PDE9 inhibitors show potential for treatment of diseases such as diabetes. To help with discovery of PDE9 inhibitors, we performed mutagenesis, kinetic, crystallographic, and molecular dynamics analyses on the active site residues of Gln453 and its stabilizing partner Glu406. The crystal structures of the PDE9 Q453E mutant (PDE9Q453E) in complex with inhibitors IBMX and (S)-BAY73-6691 showed asymmetric binding of the inhibitors in two subunits of the PDE9Q453E dimer and also the significant positional change of the M-loop at the active site. The kinetic analysis of the Q453E and E406A mutants suggested that the invariant glutamine is critical for binding of substrates and inhibitors, but is unlikely to play a key role in the differentiation between substrates of cGMP and cAMP. The molecular dynamics simulations suggest that residue Glu406 may be protonated and may thus explain the hydrogen bond distance between two side chain oxygens of Glu453 and Glu406 in the crystal structure of the PDE9Q453E mutant. The information from these studies may be useful for design of PDE9 inhibitors.	[Hou, Jing; Xu, Jie; Liu, Ming; Zhao, Ruizhi; Luo, Hai-Bin; Ke, Hengming] Sun Yat Sen Univ, Struct Biol Lab, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ke, Hengming] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Ke, Hengming] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Sun Yat Sen University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hou, J (corresponding author), Sun Yat Sen Univ, Struct Biol Lab, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	luohb77@mail.sysu.edu.cn; hke@med.unc.edu	, PEP-MX Core/AGV-4051-2022		US NIH [GM59791]; Important National Science and Technology Specific Projects of China [2009ZX09304-003]; Natural Science Foundation of China [30870481]; Natural Science Foundation of Guangdong Province [9451008901001994]; Research Fund for the Doctoral Program of Higher Education of China [20090171120057]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Important National Science and Technology Specific Projects of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is financially supported by US NIH grant GM59791 (HK), Important National Science and Technology Specific Projects of China (2009ZX09304-003), Natural Science Foundation of China (30870481), Natural Science Foundation of Guangdong Province (9451008901001994), and the Research Fund for the Doctoral Program of Higher Education of China (20090171120057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AS, 2004, Patent No. [WO 2004096811, 2004096811]; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BLACK SC, 2005, Patent No. 2005041972; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deninno M. P., 2003, Patent No. [WO 03/037899, 03037899]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRYBURG DA, 2003, Patent No. 03037432; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huai Q, 2004, P NATL ACAD SCI USA, V101, P9624, DOI 10.1073/pnas.0401120101; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Liu SP, 2008, P NATL ACAD SCI USA, V105, P13309, DOI 10.1073/pnas.0708850105; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Miyamoto S, 1992, J COMPUT CHEM, V13, P8952; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Sharma RK, 2006, INT J MOL MED, V18, P95; STOTE RH, 1995, PROTEINS, V23, P12, DOI 10.1002/prot.340230104; van der Staay FJ, 2008, NEUROPHARMACOLOGY, V55, P908, DOI 10.1016/j.neuropharm.2008.07.005; Wang HC, 2007, J MOL BIOL, V371, P302, DOI 10.1016/j.jmb.2007.05.060; Wang HC, 2007, P NATL ACAD SCI USA, V104, P5782, DOI 10.1073/pnas.0700279104; Wang HC, 2010, J MED CHEM, V53, P1726, DOI 10.1021/jm901519f; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wunder F, 2005, MOL PHARMACOL, V68, P1775, DOI 10.1124/mol.105.017608; Xiong Y, 2006, BIOPHYS J, V91, P1858, DOI 10.1529/biophysj.106.086835; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zoraghi R, 2006, J BIOL CHEM, V281, P5553, DOI 10.1074/jbc.M510372200	37	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18092	10.1371/journal.pone.0018092	http://dx.doi.org/10.1371/journal.pone.0018092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483814	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200026
J	Thormann, B; Raupach, MJ; Wagner, T; Wagele, JW; Peters, MK				Thormann, Birthe; Raupach, Michael J.; Wagner, Thomas; Waegele, Johann W.; Peters, Marcell K.			Testing a Short Nuclear Marker for Inferring Staphylinid Beetle Diversity in an African Tropical Rain Forest	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; SPECIES RICHNESS; DNA BARCODES; BIODIVERSITY; TAXONOMY; PARATAXONOMY; CONSERVATION; ASSEMBLAGES; DISTURBANCE; COLEOPTERA	Background: The use of DNA based methods for assessing biodiversity has become increasingly common during the last years. Especially in speciose biomes as tropical rain forests and/or in hyperdiverse or understudied taxa they may efficiently complement morphological approaches. The most successful molecular approach in this field is DNA barcoding based on cytochrome c oxidase I (COI) marker, but other markers are used as well. Whereas most studies aim at identifying or describing species, there are only few attempts to use DNA markers for inventorying all animal species found in environmental samples to describe variations of biodiversity patterns. Methodology/Principal Findings: In this study, an analysis of the nuclear D3 region of the 28S rRNA gene to delimit species-like units is compared to results based on distinction of morphospecies. Data derived from both approaches are used to assess diversity and composition of staphylinid beetle communities of a Guineo-Congolian rain forest in Kenya. Beetles were collected with a standardized sampling design across six transects in primary and secondary forests using pitfall traps. Sequences could be obtained of 99% of all individuals. In total, 76 molecular operational taxonomic units (MOTUs) were found in contrast to 70 discernible morphospecies. Despite this difference both approaches revealed highly similar biodiversity patterns, with species richness being equal in primary and secondary forests, but with divergent species communities in different habitats. The D3-MOTU approach proved to be an efficient tool for biodiversity analyses. Conclusions/Significance: Our data illustrate that the use of MOTUs as a proxy for species can provide an alternative to morphospecies identification for the analysis of changes in community structure of hyperdiverse insect taxa. The efficient amplification of the D3-marker and the ability of the D3-MOTUs to reveal similar biodiversity patterns as analyses of morphospecies recommend its use in future molecular studies on biodiversity.	[Thormann, Birthe; Waegele, Johann W.] Zool Res Museum Alexander Koenig, Bonn, Germany; [Raupach, Michael J.] German Ctr Marine Biodivers Res, Res Inst Senckenberg, Wilhelmshaven, Germany; [Wagner, Thomas] Univ Koblenz Landau, Abt Biol, Inst Integrierte Nat Wissensch, Koblenz, Germany; [Peters, Marcell K.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, Wurzburg, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Koblenz & Landau; University of Wurzburg	Thormann, B (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	birthe.thormann.zfmk@uni-bonn.de	Raupach, Michael J./AAF-7566-2020; Raupach, Michael/G-7072-2012	Raupach, Michael J./0000-0001-8299-6697; Peters, Marcell/0000-0002-1262-0827	German Federal Ministry of Education and Research (BMBF) [E16 [01LC0625A2]]; German Science Foundation (DFG) [INST 427/1-1, INST 427/1-2]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Science Foundation (DFG)(German Research Foundation (DFG))	Funding for this study was provided by the BIOTA East Africa project within the BIOLOG Program of the German Federal Ministry of Education and Research (BMBF; BIOTA subproject E16 [01LC0625A2]) as well as by grants of the German Science Foundation (DFG) to J.W.W. (INST 427/1-1,1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; ALTHOF AJ, 2005, THESIS U KOBLENZLAND; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Bestelmeyer Brandon T., 2000, P122; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FRANK JH, 1999, EENY114 U FLOR I FOO, P1; Garcia Francisco Hita, 2009, Journal of East African Natural History, V98, P147; Grebennikov VV, 2009, EUR J ENTOMOL, V106, P275, DOI 10.14411/eje.2009.035; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Lomolino MV, 2006, BIOGEOGRAPHY; LUFF ML, 1975, OECOLOGIA, V19, P345, DOI 10.1007/BF00348110; Majka C. G., 2006, Animal Biodiversity and Conservation, V29, P149; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; OLIVER I, 1993, CONSERV BIOL, V7, P562, DOI 10.1046/j.1523-1739.1993.07030562.x; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; PRIMACK R, 2005, TROPICAL RAIN FOREST, P336; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SMETANA A, 1995, INSECTS SO AFRICA, P210; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; THAYER MK, 2005, HDB ZOOLOGY, V4, P296, DOI 10.1515/9783110904550; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wagner P, 2008, J BIOGEOGR, V35, P1349, DOI 10.1111/j.1365-2699.2008.01883.x; Wagner T, 2000, BIOTROPICA, V32, P502, DOI 10.1111/j.1744-7429.2000.tb00496.x; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230; Ward Darren F., 2005, New Zealand Entomologist, V27, P3; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WHITMORE TC, 1990, INTRO TROPICAL RAIN; Work TT, 2002, ENVIRON ENTOMOL, V31, P438, DOI 10.1603/0046-225X-31.3.438; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x	61	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18101	10.1371/journal.pone.0018101	http://dx.doi.org/10.1371/journal.pone.0018101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483872	gold, Green Published, Green Submitted			2022-12-25	WOS:000289057200028
J	Iwasa, Y; Michor, F				Iwasa, Yoh; Michor, Franziska			Evolutionary Dynamics of Intratumor Heterogeneity	PLOS ONE			English	Article							TUMOR HETEROGENEITY; CANCER; MODEL; POLYMORPHISM; PROGRESSION; DIVERSITY; HYPOXIA; CELLS	Intraneoplastic diversity in human tumors is a widespread phenomenon of critical importance for tumor progression and the response to therapeutic intervention. Insights into the evolutionary events that control tumor heterogeneity would be a major breakthrough in our comprehension of cancer development and could lead to more effective prevention methods and therapies. In this paper, we design an evolutionary mathematical framework to study the dynamics of heterogeneity over time. We consider specific situations arising during tumorigenesis, such as the emergence of positively selected mutations ("drivers") and the accumulation of neutral variation ("passengers"). We perform exact computer simulations of the emergence of diverse tumor cell clones over time, and derive analytical estimates for the extent of heterogeneity within a population of cancer cells. Our methods contribute to a quantitative understanding of tumor heterogeneity and the impact of heritable alterations on this tumor trait.	[Iwasa, Yoh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Iwasa, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	michor@jimmy.harvard.edu	Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852	National Cancer Institute (NCI) initiative [U54CA143798]; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	National Cancer Institute (NCI) initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI) initiative to fund Physical Science-Oncology Centers (grant U54CA143798) (F.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUADE M, 1989, GENETICS, V122, P607; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Chevin LM, 2008, GENETICS, V180, P1645, DOI 10.1534/genetics.108.093351; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEXTER DL, 1986, J CLIN ONCOL, V4, P244, DOI 10.1200/JCO.1986.4.2.244; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Durrett R., 2002, PROB APPL S; DURRETT R, 2011, GENETICS IN PRESS; Durrett R, 2010, THEOR POPUL BIOL, V78, P54, DOI 10.1016/j.tpb.2010.05.001; FIDLER IJ, 1978, CANCER RES, V38, P2651; Frank SA, 2003, GENETICS, V163, P1527; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Grimmett G., 1992, PROBABILITY RANDOM P; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HEPPNER GH, 1984, CANCER RES, V44, P2259; Ichim CV, 2006, LEUKEMIA LYMPHOMA, V47, P2017, DOI 10.1080/10428190600733325; KAPLAN NL, 1989, GENETICS, V123, P887; KIMURA M, 1964, GENETICS, V49, P725; LEITH JT, 1987, CANCER RES, V47, P1045; Magurran A.E, 2003, MEASURING BIOL DIVER; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Michor F, 2003, P ROY SOC B-BIOL SCI, V270, P2017, DOI 10.1098/rspb.2003.2483; Moran P., 1962, STAT PROCESSES EVOLU; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pepper JW, 2007, PLOS COMPUT BIOL, V3, P2532, DOI 10.1371/journal.pcbi.0030250; Przeworski M, 2002, GENETICS, V160, P1179; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SIMONSEN KL, 1995, GENETICS, V141, P413; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STEPHAN W, 1989, GENETICS, V121, P89, DOI 10.1093/genetics/121.1.89; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Vincent TL, 2008, INT J ONCOL, V32, P729; WIEHE THE, 1993, MOL BIOL EVOL, V10, P842, DOI 10.1093/oxfordjournals.molbev.a040046; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011	39	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17866	10.1371/journal.pone.0017866	http://dx.doi.org/10.1371/journal.pone.0017866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479218	gold, Green Published			2022-12-25	WOS:000289055700016
J	Kim, SM; Park, KS; Nam, H; Ahn, SW; Kim, S; Sung, JJ; Lee, KW				Kim, Sung-Min; Park, Kyung Seok; Nam, Hyunwoo; Ahn, Suk-Won; Kim, Suhyun; Sung, Jung-Joon; Lee, Kwang-Woo			Capnography for Assessing Nocturnal Hypoventilation and Predicting Compliance with Subsequent Noninvasive Ventilation in Patients with ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; POSITIVE-PRESSURE VENTILATION; QUALITY-OF-LIFE; SLEEP-APNEA; MANAGEMENT; ANESTHESIA; DIAGNOSIS; SURVIVAL; ACCURACY; DISEASE	Background: Patients with amyotrophic lateral sclerosis (ALS) suffer from hypoventilation, which can easily worsen during sleep. This study evaluated the efficacy of capnography monitoring in patients with ALS for assessing nocturnal hypoventilation and predicting good compliance with subsequent noninvasive ventilation (NIV) treatment. Methods: Nocturnal monitoring and brief wake screening by capnography/pulse oximetry, functional scores, and other respiratory signs were assessed in 26 patients with ALS. Twenty-one of these patients were treated with NIV and had their treatment compliance evaluated. Results: Nocturnal capnography values were reliable and strongly correlated with the patients' respiratory symptoms (R(2) = 0.211-0.305, p = 0.004-0.021). The duration of nocturnal hypercapnea obtained by capnography exhibited a significant predictive power for good compliance with subsequent NIV treatment, with an area-under-the-curve value of 0.846 (p=0.018). In contrast, no significant predictive values for nocturnal pulse oximetry or functional scores for nocturnal hypoventilation were found. Brief waking supine capnography was also useful as a screening tool before routine nocturnal capnography monitoring. Conclusion: Capnography is an efficient tool for assessing nocturnal hypoventilation and predicting good compliance with subsequent NIV treatment of ALS patients, and may prove useful as an adjunctive tool for assessing the need for NIV treatment in these patients.	[Kim, Sung-Min; Park, Kyung Seok; Sung, Jung-Joon; Lee, Kwang-Woo] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Sung-Min; Park, Kyung Seok] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Gyeonggi, South Korea; [Nam, Hyunwoo] Boramae Hosp, Dept Neurol, Seoul, South Korea; [Ahn, Suk-Won] Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea; [Kim, Suhyun] Natl Canc Ctr, Dept Neurol, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; National Cancer Center - Korea (NCC)	Kim, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	jjsaint@snu.ac.kr; sueh916@gmail.com	Lee, Kwang Woo/J-5571-2012; Park, Kyung Seok/J-5472-2012; Nam, Hyunwoo/J-5457-2012		Korea Health Industry Development Institute [A-102044]; Seoul National University [21-2004-0240]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Seoul National University	This work was supported by Grant No. A-102044 from Korea Health Industry Development Institute funds and by Grant No. 21-2004-0240 from the Seoul National University Hospital Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2007, AMYOTROPH LATERAL SC, V8, P195, DOI 10.1080/17482960701262376; Atalaia A, 2007, AMYOTROPH LATERAL SC, V8, P101, DOI 10.1080/17482960601029883; Bach JR, 2006, CHEST, V130, P1949, DOI 10.1378/chest.130.6.1949; Bach JR, 2004, CHEST, V126, P1502, DOI 10.1378/chest.126.5.1502; BACH JR, 2004, MANAGEMENT PATIENTS, pR16; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Bourke SC, 2003, NEUROLOGY, V61, P171, DOI 10.1212/01.WNL.0000076182.13137.38; Braunwald E., 2001, HARRISONS PRINCIPLES; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Buhre W, 2003, LANCET, V362, P1839, DOI 10.1016/S0140-6736(03)14905-7; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Kim SM, 2007, J NEUROL NEUROSUR PS, V78, P1387, DOI 10.1136/jnnp.2006.111195; Kirk VG, 2006, SLEEP, V29, P1601, DOI 10.1093/sleep/29.12.1601; Kotterba S, 2001, CLIN NEUROL NEUROSUR, V103, P87, DOI 10.1016/S0303-8467(01)00120-2; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Lechtzin N, 2002, CHEST, V121, P436, DOI 10.1378/chest.121.2.436; LEGER P, 1994, CHEST, V105, P100, DOI 10.1378/chest.105.1.100; Leigh PN, 2003, J NEUROL NEUROSUR PS, V74, P32; LIU SY, 1992, CHEST, V102, P1512, DOI 10.1378/chest.102.5.1512; Lo Coco D, 2006, NEUROLOGY, V67, P761, DOI 10.1212/01.wnl.0000227785.73714.64; MAGNAN A, 1993, CHEST, V103, P129, DOI 10.1378/chest.103.1.129; Miller RG, 1999, MUSCLE NERVE, V22, P1104, DOI 10.1002/(SICI)1097-4598(199908)22:8<1104::AID-MUS15>3.0.CO;2-2; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; Newsom-Davis IC, 2001, J NEUROL NEUROSUR PS, V71, P482, DOI 10.1136/jnnp.71.4.482; Radunovic A, 2007, LANCET NEUROL, V6, P913, DOI 10.1016/S1474-4422(07)70244-2; SANDERS MH, 1994, CHEST, V106, P472, DOI 10.1378/chest.106.2.472; SCHIFFMAN PL, 1993, CHEST, V103, P508, DOI 10.1378/chest.103.2.508; Tuggey JM, 2005, THORAX, V60, P859, DOI 10.1136/thx.2005.041327; WHITESELL R, 1981, ANESTH ANALG, V60, P508	29	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17893	10.1371/journal.pone.0017893	http://dx.doi.org/10.1371/journal.pone.0017893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479202	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700018
J	Bhogal, RH; Hodson, J; Bartlett, DC; Weston, CJ; Curbishley, SM; Haughton, E; Williams, KT; Reynolds, GM; Newsome, PN; Adams, DH; Afford, SC				Bhogal, Ricky H.; Hodson, James; Bartlett, David C.; Weston, Christopher J.; Curbishley, Stuart M.; Haughton, Emma; Williams, Kevin T.; Reynolds, Gary M.; Newsome, Phillip N.; Adams, David H.; Afford, Simon C.			Isolation of Primary Human Hepatocytes from Normal and Diseased Liver Tissue: A One Hundred Liver Experience	PLOS ONE			English	Article								Successful and consistent isolation of primary human hepatocytes remains a challenge for both cell-based therapeutics/transplantation and laboratory research. Several centres around the world have extensive experience in the isolation of human hepatocytes from non-diseased livers obtained from donor liver surplus to surgical requirement or at hepatic resection for tumours. These livers are an important but limited source of cells for therapy or research. The capacity to isolate cells from diseased liver tissue removed at transplantation would substantially increase availability of cells for research. However no studies comparing the outcome of human hepatocytes isolation from diseased and non-diseased livers presently exist. Here we report our experience isolating human hepatocytes from organ donors, non-diseased resected liver and cirrhotic tissue. We report the cell yields and functional qualities of cells isolated from the different types of liver and demonstrate that a single rigorous protocol allows the routine harvest of good quality primary hepatocytes from the most commonly accessible human liver tissue samples.	[Bhogal, Ricky H.; Bartlett, David C.; Weston, Christopher J.; Curbishley, Stuart M.; Haughton, Emma; Williams, Kevin T.; Reynolds, Gary M.; Newsome, Phillip N.; Adams, David H.; Afford, Simon C.] Univ Birmingham, Liver Res Ctr, Inst Biomed Res, Birmingham, W Midlands, England; [Hodson, James] Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Bhogal, RH (corresponding author), Univ Birmingham, Liver Res Ctr, Inst Biomed Res, Birmingham, W Midlands, England.	balsin@hotmail.com	Newsome, Philip N/D-4495-2018; Reynolds, Gary/F-8641-2014; Shepherd, Emma/ADY-7280-2022; Adams, David H/C-9092-2009	Newsome, Philip N/0000-0001-6085-3652; Reynolds, Gary/0000-0002-3250-0582; Shepherd, Emma/0000-0002-1345-1746; Adams, David H/0000-0001-6776-0336; Bartlett, David/0000-0001-8564-9420; Hodson, James/0000-0003-3487-0090; Weston, Chris/0000-0002-9651-1264	Wellcome Trust [DDDP. RCHX14183]; MRC [G0901952] Funding Source: UKRI; Medical Research Council [G0901952] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by the Wellcome Trust (grant number DDDP. RCHX14183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova K, 2005, CELL TRANSPLANT, V14, P845, DOI 10.3727/000000005783982530; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Dhawan A, 2005, ACTA GASTRO-ENT BELG, V68, P457; Gonzalez R, 2007, FREE RADICAL BIO MED, V43, P1439, DOI 10.1016/j.freeradbiomed.2007.07.023; Guicciardi ME, 1998, HEPATOLOGY, V28, P1721, DOI 10.1002/hep.510280639; Hewes JC, 2006, J HEPATOL, V45, P263, DOI 10.1016/j.jhep.2006.02.015; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Kawahara T, 2010, LIVER TRANSPLANT, V16, P974, DOI 10.1002/lt.22099; Laba A, 2005, ARCH IMMUNOL THER EX, V53, P442; LeCluyse EL, 2010, METHODS MOL BIOL, V640, P57, DOI 10.1007/978-1-60761-688-7_3; Li AP, 2007, CHEM-BIOL INTERACT, V168, P16, DOI 10.1016/j.cbi.2007.01.001; LI AP, 1992, J TISSUE CULT METHOD, V14, P139; Mitry RR, 2003, CELL TRANSPLANT, V12, P69, DOI 10.3727/000000003783985197; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Sagias FG, 2010, CELL TRANSPLANT, V19, P1487, DOI 10.3727/096368910X514620; Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209; VORDNAN FW, 2008, ARTIF ORGANS, V32, P205	19	98	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18222	10.1371/journal.pone.0018222	http://dx.doi.org/10.1371/journal.pone.0018222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479238	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600034
J	Figueroa, KP; Waters, MF; Garibyan, V; Bird, TD; Gomez, CM; Ranum, LPW; Minassian, NA; Papazian, DM; Pulst, SM				Figueroa, Karla P.; Waters, Michael F.; Garibyan, Vartan; Bird, Thomas D.; Gomez, Christopher M.; Ranum, Laura P. W.; Minassian, Natali A.; Papazian, Diane M.; Pulst, Stefan M.			Frequency of KCNC3 DNA Variants as Causes of Spinocerebellar Ataxia 13 (SCA13)	PLOS ONE			English	Article							DOMINANT CEREBELLAR-ATAXIA; POTASSIUM CHANNEL; MUTATIONS	Background: Gain-of function or dominant-negative mutations in the voltage-gated potassium channel KCNC3 (Kv3.3) were recently identified as a cause of autosomal dominant spinocerebellar ataxia. Our objective was to describe the frequency of mutations associated with KCNC3 in a large cohort of index patients with sporadic or familial ataxia presenting to three US ataxia clinics at academic medical centers. Methodology: DNA sequence analysis of the coding region of the KCNC3 gene was performed in 327 index cases with ataxia. Analysis of channel function was performed by expression of DNA variants in Xenopus oocytes. Principal Findings: Sequence analysis revealed two non-synonymous substitutions in exon 2 and five intronic changes, which were not predicted to alter splicing. We identified another pedigree with the p.Arg423His mutation in the highly conserved S4 domain of this channel. This family had an early-onset of disease and associated seizures in one individual. The second coding change, p.Gly263Asp, subtly altered biophysical properties of the channel, but was unlikely to be disease-associated as it occurred in an individual with an expansion of the CAG repeat in the CACNA1A calcium channel. Conclusions: Mutations in KCNC3 are a rare cause of spinocerebellar ataxia with a frequency of less than 1%. The p.Arg423His mutation is recurrent in different populations and associated with early onset. In contrast to previous p.Arg423His mutation carriers, we now observed seizures and mild mental retardation in one individual. This study confirms the wide phenotypic spectrum in SCA13.	[Figueroa, Karla P.; Garibyan, Vartan; Pulst, Stefan M.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Waters, Michael F.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Waters, Michael F.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Bird, Thomas D.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Bird, Thomas D.] Vet Affairs Med Ctr, Seattle, WA 98108 USA; [Gomez, Christopher M.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Ranum, Laura P. W.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Ranum, Laura P. W.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA; [Minassian, Natali A.; Papazian, Diane M.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Pulst, Stefan M.] Univ Utah, Inst Brain, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah	Figueroa, KP (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	stefan.pulst@hsc.utah.edu			Veterans Affairs Research Funds; National Institutes of Health [R01 NS058500, 5R01NS033123-10]; American Academy of Neurology Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033123, R01NS040389, R01NS058500, R01NS056158] Funding Source: NIH RePORTER	Veterans Affairs Research Funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Neurology Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	funding sources for this work are: Thomas D. Bird, MD - Veterans Affairs Research Funds, Role: Salary and supplies, Diane M. Papazian PhD National Institutes of Health R01 NS058500, Role: Salary and supplies, Stefan M. Pulst MD, Dr Med - National Institutes of Health 5R01NS033123-10, Role: Salary and supplies, Michael F. Waters - Raymond D. Adams Clinical Research Training Fellowship from the American Academy of Neurology Foundation, Role: Salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	den Dunnen JT, 2000, HUM MUTAT, V15, P7; Figueroa KP, 2010, HUM MUTAT, V31, P191, DOI 10.1002/humu.21165; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; HOFFMAN EP, 1995, CELL, V80, P681, DOI 10.1016/0092-8674(95)90345-3; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Kuzmenkin A, 2003, PFLUG ARCH EUR J PHY, V447, P71, DOI 10.1007/s00424-003-1137-5; Mariotti C, 2008, CEREBELLUM, V7, P184, DOI 10.1007/s12311-008-0053-9; Matsumura R, 1997, NEUROLOGY, V49, P1238, DOI 10.1212/WNL.49.5.1238; Moseley ML, 1998, NEUROLOGY, V51, P1666, DOI 10.1212/WNL.51.6.1666; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pujana MA, 1999, HUM GENET, V104, P516, DOI 10.1007/s004390050997; Rae JL, 2000, EXP EYE RES, V70, P339, DOI 10.1006/exer.1999.0796; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schols L, 2000, HUM GENET, V107, P132, DOI 10.1007/s004390000346; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; Yabe I, 2003, ARCH NEUROL-CHICAGO, V60, P1749, DOI 10.1001/archneur.60.12.1749	21	40	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17811	10.1371/journal.pone.0017811	http://dx.doi.org/10.1371/journal.pone.0017811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479265	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600017
J	Fukuma, A; Abe, M; Morikawa, Y; Miyazawa, T; Yasuda, J				Fukuma, Aiko; Abe, Masumi; Morikawa, Yuko; Miyazawa, Takayuki; Yasuda, Jiro			Cloning and Characterization of the Antiviral Activity of Feline Tetherin/BST-2	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MOLECULAR-CLONING; VIRUS; PROTEIN; RESTRICTION; DETERMINES; RELEASE; MARKER; CELLS; GENE	Human Tetherin/BST-2 has recently been identified as a cellular antiviral factor that blocks the release of various enveloped viruses. In this study, we cloned a cDNA fragment encoding a feline homolog of Tetherin/BST-2 and characterized the protein product. The degree of amino acid sequence identity between human Tetherin/BST-2 and the feline homolog was 44.4%. Similar to human Tetherin/BST-2, the expression of feline Tetherin/BST-2 mRNA was inducible by type I interferon (IFN). Exogenous expression of feline Tetherin/BST-2 efficiently inhibited the release of feline endogenous retrovirus RD-114. The extracellular domain of feline Tetherin/BST-2 has two putative N-linked glycosylation sites, N79 and N119. Complete loss of N-linked glycosylation by introduction of mutations into both sites resulted in almost complete abolition of its antiviral activity. In addition, feline Tetherin/BST-2 was insensitive to antagonism by HIV-1 Vpu, although the antiviral activity of human Tetherin/BST-2 was antagonized by HIV-1 Vpu. Our data suggest that feline Tetherin/BST-2 functions as a part of IFN-induced innate immunity against virus infection and that the induction of feline Tetherin/BST-2 in vivo may be effective as a novel antiviral strategy for viral infection.	[Fukuma, Aiko; Yasuda, Jiro] Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan; [Fukuma, Aiko; Abe, Masumi; Yasuda, Jiro] Natl Res Inst Police Sci, Dept Forens Sci 1, Biol Sect Microbiol 5, Kashiwa, Chiba 2270882, Japan; [Fukuma, Aiko; Morikawa, Yuko] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Fukuma, Aiko; Morikawa, Yuko] Kitasato Univ, Grad Sch Infect Control, Tokyo, Japan; [Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto 606, Japan	Nagasaki University; Kitasato University; Kitasato University; Kyoto University	Fukuma, A (corresponding author), Nagasaki Univ, Dept Emerging Infect Dis, Inst Trop Med, Nagasaki 852, Japan.	j-yasuda@nagasaki-u.ac.jp		Miyazawa, Takayuki/0000-0003-1938-9661; Yasuda, Jiro/0000-0001-9928-5621	Bio-Oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science	Bio-Oriented Technology Research Advancement Institution; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Bio-Oriented Technology Research Advancement Institution and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Baumann JG, 1998, J VIROL, V72, P7685, DOI 10.1128/JVI.72.9.7685-7687.1998; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; DUNN KJ, 1993, J VIROL, V67, P4704, DOI 10.1128/JVI.67.8.4704-4711.1993; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Miyazawa T, 2010, J VIROL, V84, P3690, DOI 10.1128/JVI.02715-09; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; REEVES RH, 1985, J VIROL, V56, P303, DOI 10.1128/JVI.56.1.303-306.1985; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sakaguchi S, 2008, J VET MED SCI, V70, P785, DOI 10.1292/jvms.70.785; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Urata S, 2006, J VIROL, V80, P4191, DOI 10.1128/JVI.80.8.4191-4195.2006; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998; Yoshikawa R, 2010, J CLIN MICROBIOL, V48, P3366, DOI 10.1128/JCM.00992-10; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	32	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18247	10.1371/journal.pone.0018247	http://dx.doi.org/10.1371/journal.pone.0018247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479233	Green Submitted, Green Published, gold			2022-12-25	WOS:000289054600037
J	Hoeke, RK; Jokiel, PL; Buddemeier, RW; Brainard, RE				Hoeke, Ron K.; Jokiel, Paul L.; Buddemeier, Robert W.; Brainard, Russell E.			Projected Changes to Growth and Mortality of Hawaiian Corals over the Next 100 Years	PLOS ONE			English	Article							ZONE CHLOROPHYLL FRONT; CLIMATE-CHANGE; OCEAN ACIDIFICATION; CALCIFICATION RATE; TEMPERATURE; REEFS; ADAPTATION; RESILIENCE; PACIFIC; IMPACTS	Background: Recent reviews suggest that the warming and acidification of ocean surface waters predicated by most accepted climate projections will lead to mass mortality and declining calcification rates of reef-building corals. This study investigates the use of modeling techniques to quantitatively examine rates of coral cover change due to these effects. Methodology/Principal Findings: Broad-scale probabilities of change in shallow-water scleractinian coral cover in the Hawaiian Archipelago for years 2000-2099 A. D. were calculated assuming a single middle-of-the-road greenhouse gas emissions scenario. These projections were based on ensemble calculations of a growth and mortality model that used sea surface temperature (SST), atmospheric carbon dioxide (CO2), observed coral growth (calcification) rates, and observed mortality linked to mass coral bleaching episodes as inputs. SST and CO2 predictions were derived from the World Climate Research Programme (WCRP) multi-model dataset, statistically downscaled with historical data. Conclusions/Significance: The model calculations illustrate a practical approach to systematic evaluation of climate change effects on corals, and also show the effect of uncertainties in current climate predictions and in coral adaptation capabilities on estimated changes in coral cover. Despite these large uncertainties, this analysis quantitatively illustrates that a large decline in coral cover is highly likely in the 21(st) Century, but that there are significant spatial and temporal variances in outcomes, even under a single climate change scenario.	[Hoeke, Ron K.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Hoeke, Ron K.; Brainard, Russell E.] NOAA, CRED, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Jokiel, Paul L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Buddemeier, Robert W.] Kansas Geol Survey, Lawrence, KS 66044 USA	University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System	Hoeke, RK (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	hoeke@hawaii.edu	Hoeke, Ron K/F-4085-2014	Hoeke, Ron K/0000-0003-0576-9436	EPA [R832224-010]; NOAA-NOS MOA; U.S. Environmental Protection Agency's (EPA's) Office of Atmospheric Programs [68-W-02-027]; Office of Research and Development [R832224]	EPA(United States Environmental Protection Agency); NOAA-NOS MOA; U.S. Environmental Protection Agency's (EPA's) Office of Atmospheric Programs(United States Environmental Protection Agency); Office of Research and Development	This work was partially supported by EPA Star Grant R832224-010 and NOAA-NOS MOA "Research in Support of the NWHI Coral Reef Ecosystem Reserve, HIMB, SOEST, UH Manoa". Additional support was provided by the NOAA Coral Reef Conservation Program. The COMBO model was developed and tested with the financial support of the U.S. Environmental Protection Agency's (EPA's) Office of Atmospheric Programs (Contract #68-W-02-027) and Office of Research and Development (STAR Grant #R832224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; Atkinson MJ, 2008, MAR ECOL PROG SER, V373, P249, DOI 10.3354/meps07867; Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bograd SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020637; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Buddemeier RW, 2008, LIMNOL OCEANOGR-METH, V6, P395, DOI 10.4319/lom.2008.6.395; BUDDEMEIER RW, MODELING RE IN PRESS; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; DONNER SD, 2007, P NATL ACAD SCI USA, V104, P5259; Grigg R.W., 1982, Coral Reefs, V1, P29, DOI 10.1007/BF00286537; Grigg Richard W., 2008, V1, P573, DOI 10.1007/978-1-4020-6847-8_14; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoeke RK, 2009, J OPER OCEANOGR, V2, P3, DOI 10.1080/1755876X.2009.12027737; Hoeke Ronald, 2006, Atoll Research Bulletin, P489; Houck J. E, 1977, Proceedings int Coral Reef Symp, V3, P425; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1974, PAC SCI, V28, P1; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Joos F, 2001, GLOBAL BIOGEOCHEM CY, V15, P891, DOI 10.1029/2000GB001375; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knutti R, 2006, J CLIMATE, V19, P4224, DOI 10.1175/JCLI3865.1; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Murphy J, 1999, J CLIMATE, V12, P2256, DOI 10.1175/1520-0442(1999)012<2256:AEOSAD>2.0.CO;2; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; Sheppard C, 2005, MAR ENVIRON RES, V60, P389, DOI 10.1016/j.marenvres.2004.12.006; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P8292, DOI 10.1073/pnas.94.16.8292; VAZGUEZ J, 1998, NOAA NASA AVHRR OCEA; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x	56	43	44	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18038	10.1371/journal.pone.0018038	http://dx.doi.org/10.1371/journal.pone.0018038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479235	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000289054600025
J	Wiley, M; Teygong, C; Phelps, E; Radke, J; Blader, IJ				Wiley, Mandi; Teygong, Crystal; Phelps, Eric; Radke, Jay; Blader, Ira J.			Serum Response Factor Regulates Immediate Early Host Gene Expression in Toxoplasma gondii-Infected Host Cells	PLOS ONE			English	Article							ANTHRAX LETHAL FACTOR; TRANSCRIPTION; ACTIVATION; SRF; PHOSPHORYLATION; DOMAIN; FIBROBLASTS; INHIBITION; APOPTOSIS; KINASES	Toxoplasma gondii is a wide spread pathogen that can cause severe and even fatal disease in fetuses and immune-compromised hosts. As an obligate intracellular parasite, Toxoplasma must alter the environment of its host cell in order to establish its replicative niche. This is accomplished, in part, by secretion of factors into the host cell that act to modulate processes such as transcription. Previous studies demonstrated that genes encoding transcription factors such as c-jun, junB, EGR1, and EGR2 were amongst the host genes that were the most rapidly upregulated following infection. In cells stimulated with growth factors, these genes are regulated by a transcription factor named Serum Response Factor. Serum Response Factor is a ubiquitously expressed DNA binding protein that regulates growth and actin cytoskeleton genes via MAP kinase or actin cytoskeletal signaling, respectively. Here, we report that Toxoplasma infection leads to the rapid activation of Serum Response Factor. Serum Response Factor activation is a Toxoplasma-specific event since the transcription factor is not activated by the closely related protozoan parasite, Neospora caninum. We further demonstrate that Serum Response Factor activation requires a parasite-derived secreted factor that signals via host MAP kinases but independently of the host actin cytoskeleton. Together, these data define Serum Response Factor as a host cell transcription factor that regulates immediate early gene expression in Toxoplasma-infected cells.	[Wiley, Mandi; Teygong, Crystal; Phelps, Eric; Blader, Ira J.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Radke, Jay] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Radke, Jay] Montana State Univ, Ctr Immunotherapies Zoonot Dis, Bozeman, MT 59717 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Wiley, M (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	iblader@ouhsc.edu			NIH [AI069986, AIO74355-01, P20 RR020185]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI069986 to I.J.B. and AIO74355-01 and P20 RR020185 to J.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; COPPENS I, 2001, EXPERT REV MOL MED, P1; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Goebel S, 2001, J CELL SCI, V114, P3495; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KHAN A, 2009, PHENOTYPIC GENE EXPR, P1828; Kim Ji-Young, 2006, Korean Journal of Parasitology, V44, P197, DOI 10.3347/kjp.2006.44.3.197; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Leaner VD, 2003, ONCOGENE, V22, P5619, DOI 10.1038/sj.onc.1206644; Masek KS, 2006, J CELL SCI, V119, P4565, DOI 10.1242/jcs.03206; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Payne TM, 2003, J CELL SCI, V116, P4345, DOI 10.1242/jcs.00756; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Phelps ED, 2008, INFECT IMMUN, V76, P4703, DOI 10.1128/IAI.01447-07; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Ravindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008143; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Sinai AP, 1997, J CELL SCI, V110, P2117; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Spyres LM, 2001, INFECT IMMUN, V69, P599, DOI 10.1128/IAI.69.1.599-601.2001; SWEENEY KR, 2010, EUKARYOTIC CELL; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Witteck A, 2003, EXP CELL RES, V287, P106, DOI 10.1016/S0014-4827(03)00129-0; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703	49	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18335	10.1371/journal.pone.0018335	http://dx.doi.org/10.1371/journal.pone.0018335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479245	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600045
J	Boulay, PL; Schlienger, S; Lewis-Saravalli, S; Vitale, N; Ferbeyre, G; Claing, A				Boulay, P-L; Schlienger, S.; Lewis-Saravalli, S.; Vitale, N.; Ferbeyre, G.; Claing, A.			ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein	ONCOGENE			English	Article						ADP-ribosylation factor; breast cancer; cell cycle; proliferation; retinoblastoma protein	ADP-RIBOSYLATION FACTOR; CELLULAR SENESCENCE; CYCLIN D1; IN-VIVO; TUMOR SUPPRESSION; ONCOGENIC RAS; ACTIVATION; PATHWAY; GENE; INHIBITION	The ADP-ribosylation factors (ARFs) 1 and 6 are small GTP-binding proteins, highly expressed and activated in several breast cancer cell lines and are associated with enhanced migration and invasiveness. In this study, we report that ARF1 has a critical role in cell proliferation. Depletion of this GTPase or expression of a dominant negative form, which both resulted in diminished ARF1 activity, led to sustained cell-growth arrest. This cellular response was associated with the induction of senescent markers in highly invasive breast cancer cells as well as in control mammary epithelial cells by a mechanism regulating retinoblastoma protein (pRB) function. When examining the role of ARF1, we found that this GTPase was highly activated in normal proliferative conditions, and that a limited amount could be found in the nucleus, associated with the chromatin of MDA-MB-231 cells. However, when cells were arrested in the G(0)/G(1) phase or transfected with a dominant negative form of ARF1, the total level of activated ARF1 was markedly reduced and the GTPase significantly enriched in the chromatin. Using biochemical approaches, we demonstrated that the GDP-bound form of ARF1 directly interacted with pRB, but not other members of this family of proteins. In addition, depletion of ARF1 or expression of ARF1T(31)N resulted in the constitutive association of pRB and E2F1, thereby stabilizing the interaction of E2F1 as well as pRB at endogenous sites of target gene promoters, preventing expression of E2F target genes, such as cyclin D1, Mcm6 and E2F1, important for cell-cycle progression. These novel findings provide direct physiological and molecular evidence for the role of ARF1 in controlling cell proliferation, dependent on its ability to regulate pRB/E2F1 activity and gene expression for enhanced proliferation and breast cancer progression. Oncogene (2011) 30, 3846-3861; doi:10.1038/onc.2011.100; published online 11 April 2011	[Boulay, P-L; Schlienger, S.; Lewis-Saravalli, S.; Claing, A.] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Ferbeyre, G.; Claing, A.] Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Vitale, N.] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, Unite Propre Rech 3212, Strasbourg, France	Universite de Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Claing, A (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, POB 6128, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca	Vitale, Nicolas/G-5967-2014; Ferbeyre, Gerardo/A-1569-2010	Vitale, Nicolas/0000-0002-4752-4907; Ferbeyre, Gerardo/0000-0002-2146-618X	Canadian Institutes of Health Research (CIHR) [MOP-79470]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We would like to thank Dr Tony Kouzarides (The Gurdon Institute, University of Cambridge, UK) for GST-pRB. We thank Raphaelle Lambert from genomic platform of IRIC (Montreal, Canada). We are grateful to Dr Christian Beausejour (University of Montreal, Montreal, Canada) for reagents and helpful discussion. We thank Dr Stephane A Laporte (McGill University, Montreal, Canada) for the use of his confocal microscope and Dr Denis de Blois and Julie-Emilie Huot-Marchand (University of Montreal, Montreal, Canada) for the use of their photo-microscopy plateform. We thank Dr Veronique Bourdeau (University of Montreal, Montreal, Canada) for helpful discussion and critical reading of the paper. This work was supported by the Canadian Institutes of Health Research (CIHR) grant MOP-79470 to AC. PLB is the recipient of a Frederick Banting and Charles Best PhD Research Award from the CIHR. AC is the recipient of a New Investigator Award from the CIHR.	Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Azab AK, 2009, BLOOD, V114, P619, DOI 10.1182/blood-2009-01-199281; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Boyer SN, 1996, CANCER RES, V56, P4620; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010; Dubois T, 2003, BIOCHEM BIOPH RES CO, V301, P502, DOI 10.1016/S0006-291X(02)03010-3; Dunphy JL, 2007, TRAFFIC, V8, P661, DOI 10.1111/j.1600-0854.2007.00561.x; DURO D, 1995, ONCOGENE, V11, P21; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hui R, 2000, CLIN CANCER RES, V6, P2777; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lin CY, 2002, J CELL SCI, V115, P4433, DOI 10.1242/jcs.00123; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Mitchell R, 2003, J BIOL CHEM, V278, P33818, DOI 10.1074/jbc.M305825200; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita Y, 2002, CANCER RES, V62, P6764; NEVINS JR, 1991, COLD SPRING HARB SYM, V56, P157; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ohtani K, 1999, ONCOGENE, V18, P2299, DOI 10.1038/sj.onc.1202544; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Padilla PI, 2008, P NATL ACAD SCI USA, V105, P3357, DOI 10.1073/pnas.0712387105; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Roninson IB, 2003, J CELL BIOCHEM, V88, P83, DOI 10.1002/jcb.10320; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SOULE HD, 1990, CANCER RES, V50, P6075; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Takahashi Y, 2000, GENE DEV, V14, P804; Takano Y, 1999, J CANCER RES CLIN, V125, P505, DOI 10.1007/s004320050309; Tonic I, 2010, J BIOL CHEM, V285, P23790, DOI 10.1074/jbc.M110.104372; Vernier M, 2011, GENE DEV, V25, P41, DOI 10.1101/gad.1975111; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Watanabe G, 1998, MOL CELL BIOL, V18, P3212, DOI 10.1128/MCB.18.6.3212; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; YAGATA H, 2011, BREAST CANC; Yakes FM, 2002, CANCER RES, V62, P4132; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	62	37	37	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	36					3846	3861		10.1038/onc.2011.100	http://dx.doi.org/10.1038/onc.2011.100			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	817PV	21478909				2022-12-25	WOS:000294687200003
J	Gorelik, M; Stanger, K; Davidson, AR				Gorelik, Maryna; Stanger, Karen; Davidson, Alan R.			A Conserved Residue in the Yeast Bem1p SH3 Domain Maintains the High Level of Binding Specificity Required for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION NETWORKS; SACCHAROMYCES-CEREVISIAE; RECOGNITION MODULES; SYMMETRY-BREAKING; PEPTIDE; AFFINITY; COMPLEX; CDC42P; MOTIF; PHOSPHORYLATION	The yeast Bem1p SH3b and Nbp2p SH3 domains are unusual because they bind to peptides containing the same consensus sequence, yet they perform different functions and display low sequence similarity. In this work, by analyzing the interactions of these domains with six biologically relevant peptides containing the consensus sequence, they are shown to possess finely tuned and distinct binding specificities. We also identify a residue in the Bem1p SH3b domain that inhibits binding, yet is highly conserved for the purpose of preventing nonspecific interactions. Substitution of this residue results in a marked reduction of in vivo function that is caused by titration of the domain away from its proper targets through nonspecific interactions with other proteins. This work provides a clear illustration of the importance of intrinsic binding specificity for the function of protein-protein interaction modules, and the key role of "negative" interactions in determining the specificity of a domain.	[Gorelik, Maryna; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Stanger, Karen; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca			Canadian Institutes of Health Research [MOP-13609]; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-13609 and by a Natural Sciences and Engineering Research Council PGS-D scholarship (to M. G.).	Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FELLER SM, 1995, ONCOGENE, V10, P1465; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Hiipakka M, 2007, FEBS LETT, V581, P1735, DOI 10.1016/j.febslet.2007.03.044; Hoelz A, 2006, J MOL BIOL, V358, P509, DOI 10.1016/j.jmb.2006.02.027; Hruby A, 2011, J CELL SCI, V124, P35, DOI 10.1242/jcs.077065; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Jen-Jacobson Linda, 1997, Biopolymers, V44, P153, DOI 10.1002/(SICI)1097-0282(1997)44:2<153::AID-BIP4>3.0.CO;2-U; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mayer BJ, 2001, J CELL SCI, V114, P1253; Ohkuni K, 2003, GENETICS, V165, P517; Panni S, 2002, J BIOL CHEM, V277, P21666, DOI 10.1074/jbc.M109788200; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Takaku T, 2010, J BIOL CHEM, V285, P19346, DOI 10.1074/jbc.M110.116749; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	42	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19470	19477		10.1074/jbc.M111.229294	http://dx.doi.org/10.1074/jbc.M111.229294			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21489982	Green Published, hybrid			2022-12-25	WOS:000291027700030
J	Hughes, LAE; Simons, CCJM; van den Brandt, PA; Goldbohm, RA; de Goeij, AF; de Bruine, AP; van Engeland, M; Weijenberg, MP				Hughes, Laura A. E.; Simons, Colinda C. J. M.; van den Brandt, Piet A.; Goldbohm, R. Alexandra; de Goeij, Anton F.; de Bruine, Adriaan P.; van Engeland, Manon; Weijenberg, Matty P.			Body Size, Physical Activity and Risk of Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; SCALE PROSPECTIVE COHORT; POPULATION-BASED SAMPLE; LIFE-STYLE FACTORS; COLON-CANCER; MICROSATELLITE INSTABILITY; NETHERLANDS COHORT; PROMOTER METHYLATION; ENERGY RESTRICTION; TUMOR-SUPPRESSOR	Background: We investigated how body size and physical activity influence the risk of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC). Methods: In the Netherlands Cohort Study (n = 120,852), risk factors were self-reported at baseline in 1986. After 7.3 years of follow-up, 603 cases and 4,631 sub-cohort members were available. CIMP status according to the Weisenberger markers was determined using methylation specific PCR on DNA from paraffin embedded tumor tissue. Hazard rate ratios (HR) and 95% confidence intervals for CIMP (27.7%) and non-CIMP (72.3%) tumors were calculated according to BMI, BMI at age 20, BMI change, trouser/skirt size, height, and physical activity. Results: BMI modeled per 5 kg/m(2) increase was associated with both CIMP and non-CIMP tumors, however, HRs were attenuated when additionally adjusted for trouser/skirt size. Trouser/skirt size, per 2 size increase, was associated with both tumor subtypes, even after adjustment for BMI (CIMP HR: 1.20, 95% CI: 1.01-1.43; non-CIMP HR: 1.14, 95% CI: 1.04-1.28). Height per 5 cm was associated with both tumor sub-types, but HRs were attenuated when adjusted for body weight. BMI at age 20 was positively associated with increased risk of CIMP tumors and the association was significantly less pronounced for non-CIMP tumors (P-heterogeneity = 0.01). Physical activity was inversely associated with both subtypes, but a dose-response association was observed only for non-CIMP tumors (P-trend = 0.02). Conclusions: Body size, especially central adiposity, may increase the risk of both CIMP and non-CIMP tumors. Body fat at young age may differentially influence risk. Physical activity appears to decrease the risk of CRC regardless of these molecular subtypes.	[Hughes, Laura A. E.; Simons, Colinda C. J. M.; van den Brandt, Piet A.; Weijenberg, Matty P.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Goldbohm, R. Alexandra] TNO Qual Life, Dept Prevent & Hlth, Leiden, Netherlands; [de Goeij, Anton F.; de Bruine, Adriaan P.; van Engeland, Manon] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, Maastricht, Netherlands	Maastricht University; Netherlands Organization Applied Science Research; Maastricht University	Hughes, LAE (corresponding author), Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands.	laura.hughes@maastrichtuniversity.nl	van Engeland, Manon/A-7479-2009; Toon, Christopher W/G-3610-2012	van Engeland, Manon/0000-0002-7952-6843; van den Brandt, Piet/0000-0001-8781-8099	World Cancer Research Fund (WCRF) [2007/54]	World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	This project was funded by the World Cancer Research Fund (WCRF), grant # 2007/54 to Matty P. Weijenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; Derks S, 2004, CELL ONCOL, V26, P291; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Dirx MJM, 2003, CANCER-AM CANCER SOC, V97, P46, DOI 10.1002/cncr.11052; Ferguson LR, 2004, ENVIRON MOL MUTAGEN, V44, P36, DOI 10.1002/em.20029; Frankel S, 1998, BMJ-BRIT MED J, V316, P499, DOI 10.1136/bmj.316.7130.499; Frazier ML, 2003, CANCER RES, V63, P4805; Gebhard H, 1989, ERMITTLUNG ARBEITSEN; GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Hughes LAE, 2009, EPIDEMIOLOGY, V20, P673, DOI 10.1097/EDE.0b013e3181a66eb5; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kang GH, 2003, AM J PATHOL, V163, P1551, DOI 10.1016/S0002-9440(10)63511-0; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Okasha M, 2002, BEST PRACT RES CL EN, V16, P225, DOI 10.1053/beem.2002.0204; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Pylypchuk RD, 2009, AM J EPIDEMIOL, V170, P297, DOI 10.1093/aje/kwp123; Samowitz WS, 2007, J MOL DIAGN, V9, P281, DOI 10.2353/jmoldx.2007.070031; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2010, CANCER CAUSE CONTROL, V21, P1237, DOI 10.1007/s10552-010-9551-4; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wong JJL, 2007, GUT, V56, P140, DOI 10.1136/gut.2005.088799; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	52	57	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18571	10.1371/journal.pone.0018571	http://dx.doi.org/10.1371/journal.pone.0018571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483668	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300029
J	Zhu, DM; Shi, JA; Liu, SL; Liu, YX; Zheng, DX				Zhu, Dan-Ming; Shi, Juan; Liu, Shilian; Liu, Yanxin; Zheng, Dexian			HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; MEDIATED APOPTOSIS; TUMORICIDAL ACTIVITY; MONOCLONAL-ANTIBODY; ACTIVATION; INHIBITION; PATHWAY; FAMILY; BCL-2	Background: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) could induce apoptosis of HIV-1-infected monocyte-derived macrophage (MDM), but the molecular mechanisms are not well understood. Methodology/Principal Findings: By using an HIV-1 Env-pseudotyped virus (HIV-1 PV)-infected MDM cell model we demonstrate that HIV-1 PV infection down-regulates the expression of TRAIL decoy receptor 1 (DcR1) and 2 (DcR2), and cellular FLICE-inhibitory protein (c-FLIP), but dose not affect the expression of death receptor 4 and 5 (DR4, DR5), and Bcl-2 family members in MDM cells. Furthermore, recombinant soluble TRAIL and an agonistic anti-DR5 antibody, AD5-10, treatment stimulates reactive oxygen species (ROS) generation and JNK phosphorylation. Conclusions/Significance: HIV infection facilitates TRIAL-induced cell death in MDM by down-regulating the expression of TRAIL decoy receptors and intracellular c-FLIP. Meanwhile, the agonistic anti-DR5 antibody, AD5-10, induces apoptosis synergistically with TRAIL in HIV-1-infected cells. ROS generation and JNK phosphorylation are involved in this process. These findings potentiate clinical usage of the combination of TRAIL and AD5-10 in eradication of HIV-infected macrophage and AIDS.	[Zhu, Dan-Ming] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhu, DM (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	liuyx2000@tom.com; zhengdx@pumc.edu.cn	Serei, Virian D/B-4616-2015		Natural Science Foundation of China [30721063, 30623009, 30972684]; State Key Basic Research Program of China [2007CB507404, 2006CB504200]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program of China(National Basic Research Program of China)	This work was partially supported by the Natural Science Foundation of China (Grant No. 30721063, 30623009 and 30972684) and the State Key Basic Research Program of China (Grant No. 2007CB507404 and 2006CB504200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aillet F, 1998, J VIROL, V72, P9698, DOI 10.1128/JVI.72.12.9698-9705.1998; Andrews JI, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.031; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chen CF, 2009, CELL RES, V19, P984, DOI 10.1038/cr.2009.60; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Crowe SM, 1995, AUST NZ J MED, V25, P777, DOI 10.1111/j.1445-5994.1995.tb02881.x; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dharmapatni AASSK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2603; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Erdmann N, 2009, J NEUROCHEM, V109, P551, DOI 10.1111/j.1471-4159.2009.05989.x; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Guo YB, 2005, J BIOL CHEM, V280, P41940, DOI 10.1074/jbc.M503621200; Gura T, 1997, SCIENCE, V277, P768, DOI 10.1126/science.277.5327.768; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Huang YL, 2006, J IMMUNOL, V177, P2304, DOI 10.4049/jimmunol.177.4.2304; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; KARACOSTAS V, 1989, P NATL ACAD SCI USA, V86, P8964, DOI 10.1073/pnas.86.22.8964; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Ma H, 2005, INT J CANCER, V116, P314, DOI 10.1002/ijc.20982; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saeki K, 2002, BIOCHEM J, V368, P705, DOI 10.1042/BJ20020101; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shih CM, 2004, J CELL BIOCHEM, V91, P384, DOI 10.1002/jcb.10761; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Toro-Nieves DM, 2009, J NEUROVIROL, V15, P36, DOI 10.1080/13550280802385505; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; van Noesel MM, 2002, CANCER RES, V62, P2157; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	44	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18291	10.1371/journal.pone.0018291	http://dx.doi.org/10.1371/journal.pone.0018291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483669	gold, Green Published, Green Submitted			2022-12-25	WOS:000289191300016
J	Buschard, K; Hansen, AK; Jensen, K; Lindenbergh-Kortleve, DJ; de Ruiter, LF; Krohn, TC; Hufeldt, MR; Vogensen, FK; Aasted, B; Osterbye, T; Roep, BO; de Haar, C; Nieuwenhuis, EE				Buschard, Karsten; Hansen, Axel Kornerup; Jensen, Karen; Lindenbergh-Kortleve, Dicky J.; de Ruiter, Lilian F.; Krohn, Thomas C.; Hufeldt, Majbritt R.; Vogensen, Finn K.; Aasted, Bent; Osterbye, Thomas; Roep, Bart O.; de Haar, Colin; Nieuwenhuis, Edward E.			Alcohol Facilitates CD1d Loading, Subsequent Activation of NKT Cells, and Reduces the Incidence of Diabetes in NOD Mice	PLOS ONE			English	Article							T-CELLS; INFLAMMATORY MARKERS; INSULIN SENSITIVITY; BODY-COMPOSITION; CONSUMPTION; EXPRESSION; PREVENTS; MOUSE; GALACTOSYLCERAMIDE; RISK	Background: Ethanol ('alcohol') is a partly hydrophobic detergent that may affect the accessibility of glycolipids thereby influencing immunological effects of these molecules. Methods: The study included cellular in vitro tests using alpha-galactosylceramide (alpha GalCer), and in vivo NOD mice experiments detecting diabetes incidence and performing behavioural and bacterial analyses. Results: Alcohol in concentrations from 0.6% to 2.5% increased IL-2 production from NKT cells stimulated with alpha GalCer by 60% (p < 0.05). CD1d expressed on HeLa cells contained significantly increasing amounts of alpha GalCer with increasing concentrations of alcohol, suggesting that alcohol facilitated the passive loading of alpha GalCer to CD1d. NOD mice were found to tolerate 5% ethanol in their drinking water without signs of impairment in liver function. Giving this treatment, the diabetes incidence declined significantly. Higher numbers of CD3+CD49b+ NKT cells were found in spleen and liver of the alcohol treated compared to the control mice (p < 0.05), whereas the amount of CD4+Foxp3+ regulator T cells did not differ. Increased concentrations of IFN-gamma were detected in 24-hour blood samples of alcohol treated mice. Behavioural studies showed no change in attitude of the ethanol-consuming mice, and bacterial composition of caecum samples was not affected by alcohol, disqualifying these as protective mechanisms. Conclusion: Alcohol facilitates the uptake of glycolipids and the stimulation of NKT cells, which are known to counteract Type 1 diabetes development. We propose that this is the acting mechanism by which treatment with alcohol reduces the incidence of diabetes in NOD mice. This is corroborated by epidemiology showing beneficial effect of alcohol to reduce the severity of atherosclerosis and related diseases.	[Buschard, Karsten; Osterbye, Thomas] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Hansen, Axel Kornerup; Jensen, Karen; Krohn, Thomas C.; Hufeldt, Majbritt R.; Aasted, Bent] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Lindenbergh-Kortleve, Dicky J.; de Ruiter, Lilian F.] Erasmus MC, Pediat Lab, Rotterdam, Netherlands; [Lindenbergh-Kortleve, Dicky J.; de Ruiter, Lilian F.] Erasmus MC, Dept Pediat Gastroenterol, Rotterdam, Netherlands; [Vogensen, Finn K.] Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg, Denmark; [Roep, Bart O.] Leiden Univ, Dept Immunohaematol & Blood Transfus, Med Ctr, Leiden, Netherlands; [de Haar, Colin] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Nieuwenhuis, Edward E.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Gastroenterol, Utrecht, Netherlands	Rigshospitalet; University of Copenhagen; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Buschard, K (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	buschard@dadlnet.dk	Roep, Bart/AAD-7609-2021; Vogensen, Finn/E-1245-2015	Vogensen, Finn/0000-0003-2151-7802; Buschard, Karsten/0000-0002-0126-7423; de Haar, Colin/0000-0003-4358-2410	Tuborgfondet	Tuborgfondet	Tuborgfondet is thanked for financial support. None of the authors have or have had any employment or any consultancy, patents, products in development or marketed products related to Tuborgfondet or associated companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Beaudoin L, 2002, IMMUNITY, V17, P725, DOI 10.1016/S1074-7613(02)00473-9; Blomqvist M, 2003, J CELL BIOCHEM, V89, P301, DOI 10.1002/jcb.10513; Buschard K, 2001, AUTOIMMUNITY, V34, P9, DOI 10.3109/08916930108994121; Chen L, 2004, J APPL PHYSIOL, V96, P167, DOI 10.1152/japplphysiol.00751.2003; Colgan SP, 2003, J CLIN INVEST, V112, P745, DOI 10.1172/JC1200317241; Falcone M, 2004, J IMMUNOL, V172, P5908, DOI 10.4049/jimmunol.172.10.5908; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Hansen AK, 2006, DIABETES-METAB RES, V22, P220, DOI 10.1002/dmrr.609; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; HUFELDT A, 2010, COMPARATIVE MED, V60, P336; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, P1581, DOI 10.1111/j.1530-0277.2007.00452.x; KLATSKY AL, 1995, AM J PUBLIC HEALTH, V85, P16, DOI 10.2105/AJPH.85.1.16; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lau AH, 2006, J LEUKOCYTE BIOL, V79, P941, DOI 10.1189/jlb.0905517; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Maraldi C, 2006, ARCH INTERN MED, V166, P1490, DOI 10.1001/archinte.166.14.1490; MARMOT MG, 1981, LANCET, V1, P580; Novak J, 2005, J IMMUNOL, V174, P1954, DOI 10.4049/jimmunol.174.4.1954; Pai JK, 2006, ATHEROSCLEROSIS, V186, P113, DOI 10.1016/j.atherosclerosis.2005.06.037; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Razay G, 1997, BRIT MED J, V314, P443, DOI 10.1136/bmj.314.7078.443a; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shi FD, 2001, P NATL ACAD SCI USA, V98, P6777, DOI 10.1073/pnas.121169698; Ting JW, 2006, PHARMACOL THERAPEUT, V111, P346, DOI 10.1016/j.pharmthera.2005.10.004; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; van der Vliet HJJ, 2001, CLIN IMMUNOL, V100, P144, DOI 10.1006/clim.2001.5060; Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	34	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2011	6	4							e17931	10.1371/journal.pone.0017931	http://dx.doi.org/10.1371/journal.pone.0017931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZB	21483778	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058300005
J	Bagrow, JP; Wang, DS; Barabasi, AL				Bagrow, James P.; Wang, Dashun; Barabasi, Albert-Laszlo			Collective Response of Human Populations to Large-Scale Emergencies	PLOS ONE			English	Article							MOBILE COMMUNICATION-NETWORKS; PREDICTABILITY; EPIDEMICS; BEHAVIOR; LAWS	Despite recent advances in uncovering the quantitative features of stationary human activity patterns, many applications, from pandemic prediction to emergency response, require an understanding of how these patterns change when the population encounters unfamiliar conditions. To explore societal response to external perturbations we identified real-time changes in communication and mobility patterns in the vicinity of eight emergencies, such as bomb attacks and earthquakes, comparing these with eight non-emergencies, like concerts and sporting events. We find that communication spikes accompanying emergencies are both spatially and temporally localized, but information about emergencies spreads globally, resulting in communication avalanches that engage in a significant manner the social network of eyewitnesses. These results offer a quantitative view of behavioral changes in human activity under extreme conditions, with potential long-term impact on emergency detection and response.	[Bagrow, James P.; Wang, Dashun; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Bagrow, James P.; Wang, Dashun; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Bagrow, JP (corresponding author), Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA.	bagrowjp@gmail.com	Barabasi, Albert-Laszlo/S-6474-2017; Bagrow, James/E-1701-2016	Barabasi, Albert/0000-0002-4028-3522; Bagrow, James/0000-0002-4614-0792	James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; National Science Foundation within the Information Technology Research [DMR-0426737]; Defense Threat Reduction Agency [HDTRA1-08-1-0027]; United States Army Research Laboratory [W911NF-09-2-0053]; United States Office of Naval Research [N000141010968];  [IIS-0513650]	James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; National Science Foundation within the Information Technology Research; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); United States Army Research Laboratory; United States Office of Naval Research(Office of Naval Research); 	The authors were funded by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems, National Science Foundation within the Information Technology Research (DMR-0426737) and IIS-0513650 programs, the Defense Threat Reduction Agency award HDTRA1-08-1-0027, the Network Science Collaborative Technology Alliance sponsored by the United States Army Research Laboratory under agreement number W911NF-09-2-0053, and the United States Office of Naval Research Award (N000141010968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Butts Carter T., 2008, INT J MASS EMERGENCI, V28, P133; Caldarelli G., 2007, SCALE FREE NETWORKS; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gabrielli A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02046; Goncalves B, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026123; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168001; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Kapoor A., 2010, P AAAI ART INT DEV A, P51; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lind BE, 2008, INT J EMERG MANAG, V5, P75, DOI 10.1504/IJEM.2008.019908; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela J.-P., 2010, P NATL ACAD SCI; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rodriguez H, 2006, HDB DISASTER RES; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; SHEETZ S, 2010, J EMERGENCY MANAGEME; Singer HM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026113; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	30	194	195	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17680	10.1371/journal.pone.0017680	http://dx.doi.org/10.1371/journal.pone.0017680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479206	Green Submitted, gold, Green Published			2022-12-25	WOS:000289055700014
J	Strelnikov, K; Rosito, M; Barone, P				Strelnikov, Kuzma; Rosito, Maxime; Barone, Pascal			Effect of Audiovisual Training on Monaural Spatial Hearing in Horizontal Plane	PLOS ONE			English	Article							SOUND-LOCALIZATION; AUDITORY-CORTEX; MULTISENSORY CONVERGENCE; ACOUSTICAL VISION; VISUAL AREAS; INTEGRATION; CONNECTIONS; PLASTICITY; IDENTIFICATION; PROJECTION	The article aims to test the hypothesis that audiovisual integration can improve spatial hearing in monaural conditions when interaural difference cues are not available. We trained one group of subjects with an audiovisual task, where a flash was presented in parallel with the sound and another group in an auditory task, where only sound from different spatial locations was presented. To check whether the observed audiovisual effect was similar to feedback, the third group was trained using the visual feedback paradigm. Training sessions were administered once per day, for 5 days. The performance level in each group was compared for auditory only stimulation on the first and the last day of practice. Improvement after audiovisual training was several times higher than after auditory practice. The group trained with visual feedback demonstrated a different effect of training with the improvement smaller than the group with audiovisual training. We conclude that cross-modal facilitation is highly important to improve spatial hearing in monaural conditions and may be applied to the rehabilitation of patients with unilateral deafness and after unilateral cochlear implantation.	[Strelnikov, Kuzma; Rosito, Maxime; Barone, Pascal] Univ Toulouse 3, Univ Toulouse, CerCo, Toulouse, France; [Strelnikov, Kuzma; Rosito, Maxime; Barone, Pascal] Fac Med Rangueil, CNRS, UMR 5549, Toulouse, France; [Strelnikov, Kuzma] Ctr Hosp Univ, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Strelnikov, K (corresponding author), Univ Toulouse 3, Univ Toulouse, CerCo, Toulouse, France.	pascal.barone@cerco.ups-tlse.fr	BARONE, Pascal/AHE-2323-2022; Barone, Pascal/A-4008-2009	BARONE, Pascal/0000-0003-0125-7468; Strelnikov, Kuzma/0000-0002-6613-2300	Federation pour la Recherche sur le Cerveau; ANR Hearing Loss [ANR-06-Neuro-021-04]; CNRS	Federation pour la Recherche sur le Cerveau; ANR Hearing Loss(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	Federation pour la Recherche sur le Cerveau (to PB), ANR Hearing Loss (ANR-06-Neuro-021-04 to PB), CNRS Atip+ program (to KS, BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011283; Barone P, 2010, PHYS LIFE REV, V7, P291, DOI 10.1016/j.plrev.2010.07.002; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beer AL, 2009, EXP BRAIN RES, V198, P353, DOI 10.1007/s00221-009-1769-6; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; BUTLER RA, 1987, PERCEPT PSYCHOPHYS, V41, P1, DOI 10.3758/BF03208206; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Cappe C, 2009, CEREB CORTEX, V19, P2025, DOI 10.1093/cercor/bhn228; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Clarey JC, 1992, MAMMALIAN AUDITORY P, P232, DOI [10.1007/978-1-4612-2838-7_5, DOI 10.1007/978-1-4612-2838-7_5]; COLLETTI V, 1988, British Journal of Audiology, V22, P113, DOI 10.3109/03005368809077805; Darwin CJ, 2004, J ACOUST SOC AM, V116, P502, DOI 10.1121/1.1760794; Falchier A, 2002, J NEUROSCI, V22, P5749; Falchier A, 2010, CEREB CORTEX, V20, P1529, DOI 10.1093/cercor/bhp213; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Frassinetti F, 2005, J COGNITIVE NEUROSCI, V17, P1442, DOI 10.1162/0898929054985446; Frassinetti F, 2002, J COGNITIVE NEUROSCI, V14, P62, DOI 10.1162/089892902317205320; Fu SM, 2003, PSYCHOPHYSIOLOGY, V40, P770, DOI 10.1111/1469-8986.00077; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Giraud AL, 2001, NEURON, V30, P657, DOI 10.1016/S0896-6273(01)00318-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Grantham DW, 2008, LARYNGOSCOPE, V118, P145, DOI 10.1097/MLG.0b013e31815661f9; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Hervais-Adelman A, 2008, J EXP PSYCHOL HUMAN, V34, P460, DOI 10.1037/0096-1523.34.2.460; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Ison JR, 1998, J ACOUST SOC AM, V104, P1689, DOI 10.1121/1.424381; JENKINS WM, 1982, J NEUROPHYSIOL, V47, P987, DOI 10.1152/jn.1982.47.6.987; Kaas JH, 2000, J COMP NEUROL, V421, P143, DOI 10.1002/(SICI)1096-9861(20000529)421:2<143::AID-CNE1>3.0.CO;2-H; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; Kawase T, 2009, NEUROREPORT, V20, P1231, DOI 10.1097/WNR.0b013e32832fbef8; Kayser J, 2007, PSYCHOPHYSIOLOGY, V44, P949, DOI 10.1111/j.1469-8986.2007.00562.x; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; King AJ, 1996, PROG BRAIN RES, V112, P335; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; King AJ, 2009, PHILOS T R SOC B, V364, P331, DOI 10.1098/rstb.2008.0230; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; Kumpik DP, 2010, J NEUROSCI, V30, P4883, DOI 10.1523/JNEUROSCI.5488-09.2010; Ladavas E, 2008, ANN NY ACAD SCI, V1124, P98, DOI 10.1196/annals.1440.008; Lehmann S, 2005, COGNITIVE BRAIN RES, V24, P326, DOI 10.1016/j.cogbrainres.2005.02.005; Leo F, 2008, BRAIN, V131, P855, DOI 10.1093/brain/awn003; Lewald J, 1998, J ACOUST SOC AM, V104, P1586, DOI 10.1121/1.424371; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; Luntz Michal, 2005, Cochlear Implants Int, V6, P1, DOI 10.1179/cim.2005.6.Supplement-1.1; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Merabet LB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003046; Middlebrooks JC, 2002, NEUROSCIENTIST, V8, P73, DOI 10.1177/107385840200800112; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; MUSICANT AD, 1984, HEARING RES, V14, P185, DOI 10.1016/0378-5955(84)90017-0; Nava E, 2009, HEARING RES, V255, P91, DOI 10.1016/j.heares.2009.06.007; NEFF WD, 1977, J NEUROPHYSIOL, V40, P44, DOI 10.1152/jn.1977.40.1.44; Nodal FR, 2010, J NEUROPHYSIOL, V103, P1209, DOI 10.1152/jn.00991.2009; PANDYA DN, 1969, BRAIN RES, V14, P49, DOI 10.1016/0006-8993(69)90030-4; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; SAMSON FK, 1993, J NEUROPHYSIOL, V70, P492, DOI 10.1152/jn.1993.70.2.492; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; SHAMS L, 2010, PHYS LIFE REV; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shub DE, 2008, J ACOUST SOC AM, V124, P3132, DOI 10.1121/1.2981634; SLATTERY WH, 1994, HEARING RES, V75, P38, DOI 10.1016/0378-5955(94)90053-1; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; Sperdin HF, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.002.2009; Stein BE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.021.2009; Stein BE., 1993, MERGING SENSES; Strelnikov K, 2009, NEUROPSYCHOLOGIA, V47, P972, DOI 10.1016/j.neuropsychologia.2008.10.017; SWETS JA, 1978, PERCEPT PSYCHOPHYS, V23, P275, DOI 10.3758/BF03199711; Van Wanrooij MM, 2007, J NEUROPHYSIOL, V97, P715, DOI 10.1152/jn.00260.2006; Van Wanrooij MM, 2005, J NEUROSCI, V25, P5413, DOI 10.1523/JNEUROSCI.0850-05.2005; Van Wanrooij MM, 2004, J NEUROSCI, V24, P4163, DOI 10.1523/JNEUROSCI.0048-04.2004; Wang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-79; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; WELCH RB, 1986, HDB PERCEPTION HUMAN, P1; WITHINGTONWRAY DJ, 1990, DEV BRAIN RES, V51, P225, DOI 10.1016/0165-3806(90)90279-8; Wright BA, 2006, INT J AUDIOL, V45, pS92, DOI 10.1080/14992020600783004; Zwiers MP, 2003, NAT NEUROSCI, V6, P175, DOI 10.1038/nn999	88	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18344	10.1371/journal.pone.0018344	http://dx.doi.org/10.1371/journal.pone.0018344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479241	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600046
J	Wolfs, TGAM; Kallapur, SG; Polglase, GR; Pillow, JJ; Nitsos, I; Newnham, JP; Chougnet, CA; Kroon, E; Spierings, J; Willems, CHMP; Jobe, AH; Kramer, BW				Wolfs, Tim G. A. M.; Kallapur, Suhas G.; Polglase, Graeme R.; Pillow, J. Jane; Nitsos, Ilias; Newnham, John P.; Chougnet, Claire A.; Kroon, Elke; Spierings, Julia; Willems, Coen H. M. P.; Jobe, Alan H.; Kramer, Boris W.			IL-1 alpha Mediated Chorioamnionitis Induces Depletion of FoxP3+Cells and Ileal Inflammation in the Ovine Fetal Gut	PLOS ONE			English	Article							REGULATORY T-CELLS; INTESTINAL LAMINA PROPRIA; NECROTIZING ENTEROCOLITIS; TNF-ALPHA; TGF-BETA; PRETERM; DISEASE; LUNG; INDUCTION; FOXP3	Background: Endotoxin induced chorioamnionitis increases IL-1 and provokes an inflammatory response in the fetal ileum that interferes with intestinal maturation. In the present study, we tested in an ovine chorioamnionitis model whether IL-1 is a major cytokine driving the inflammatory response in the fetal ileum. Method: Sheep bearing singleton fetuses received a single intraamniotic injection of recombinant ovine IL-1 alpha at 7, 3 or 1 d before caesarian delivery at 125 days gestational age (term = 150 days). Results: 3 and 7 d after IL-1 alpha administration, intestinal mRNA levels for IL-4, IL-10, IFN-gamma and TNF-alpha were strongly elevated. Numbers of CD3+ and CD4+ T-lymphocytes and myeloidperoxidase+ cells were increased whereas FoxP3+ T-cells were detected at low frequency. This increased proinflammatory state was associated with ileal mucosal barrier loss as demonstrated by decreased levels of the intestinal fatty acid binding protein and disruption of the tight junctional protein ZO-1. Conclusion: Intraamniotic IL-1 alpha causes an acute detrimental inflammatory response in the ileum, suggesting that induction of IL-1 is a critical element in the pathophysiological effects of endotoxin induced chorioamnionitis. A disturbed balance between T-effector and FoxP3+ cells may contribute to this process.	[Wolfs, Tim G. A. M.; Kroon, Elke; Spierings, Julia; Willems, Coen H. M. P.; Kramer, Boris W.] Maastricht Univ Med Ctr MUMC, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Wolfs, Tim G. A. M.; Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Sch Med, Dept Neonatol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Polglase, Graeme R.; Pillow, J. Jane; Nitsos, Ilias; Newnham, John P.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Chougnet, Claire A.] Univ Cincinnati, Dept Pediat, Div Mol Immunol, Cincinnati Childrens Hosp Med Ctr,Sch Med, Cincinnati, OH 45221 USA	Maastricht University; Maastricht University Medical Centre (MUMC); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Wolfs, TGAM (corresponding author), Maastricht Univ Med Ctr MUMC, Dept Pediat, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands.	b.kramer@mumc.nl	Willems, Coen/G-6347-2013; Spierings, Julia/ABI-1737-2020; Pillow, Jane/A-3335-2009; Kramer, Boris/AAO-3183-2021	Pillow, Jane/0000-0002-6500-0138; Wolfs, Tim/0000-0003-4417-4144; Newnham, John/0000-0001-9983-7457; Polglase, Graeme/0000-0002-8906-614X; Spierings, Julia/0000-0002-2546-312X	National Institutes of Health [HD-57869]; Dutch Scientific Research Organization [016.096.141]; Royal Netherlands Academy of Arts and Sciences; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Scientific Research Organization; Royal Netherlands Academy of Arts and Sciences; Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institutes of Health Grant HD-57869 (to S. Kallapur), the Dutch Scientific Research Organization Veni Grant 016.096.141 (to B.W. Kramer), the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences (to T. G. A. M. Wolfs) and the Research School for Oncology and Developmental Biology (GROW), Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Arntzen KJ, 1998, J PERINAT MED, V26, P17, DOI 10.1515/jpme.1998.26.1.17; BAERGEN R, 1994, ARCH PATHOL LAB MED, V118, P52; Baud O, 1999, BRIT J OBSTET GYNAEC, V106, P72, DOI 10.1111/j.1471-0528.1999.tb08088.x; BERRY CA, 2011, REPROD SCI IN PRESS; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; Challis JRG, 2001, ANN NY ACAD SCI, V943, P225, DOI 10.1111/j.1749-6632.2001.tb03804.x; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Graham PL, 2006, PEDIATR INFECT DIS J, V25, P113, DOI 10.1097/01.inf.0000199310.52875.10; Ikegami M, 2003, AM J PHYSIOL-LUNG C, V285, pL121, DOI 10.1152/ajplung.00393.2002; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Makita S, 2007, J IMMUNOL, V178, P4937, DOI 10.4049/jimmunol.178.8.4937; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Presicce P, 2010, CYTOM PART A, V77A, P571, DOI 10.1002/cyto.a.20875; ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Sosenko IRS, 2006, PEDIATR RES, V60, P294, DOI 10.1203/01.pdr.0000233115.51309.d3; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2010, MOL IMMUNOL, V48, P137, DOI 10.1016/j.molimm.2010.08.017; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Westendorf AM, 2005, GUT, V54, P60, DOI 10.1136/gut.2003.037663; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Willet KE, 2002, AM J PHYSIOL-LUNG C, V282, pL411, DOI 10.1152/ajplung.00097.2001; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837	38	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18355	10.1371/journal.pone.0018355	http://dx.doi.org/10.1371/journal.pone.0018355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479249	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600047
J	Fagerli, UM; Ullrich, K; Stuhmer, T; Holien, T; Kochert, K; Holt, RU; Bruland, O; Chatterjee, M; Nogai, H; Lenz, G; Shaughnessy, JD; Mathas, S; Sundan, A; Bargou, RC; Dorken, B; Borset, M; Janz, M				Fagerli, U-M; Ullrich, K.; Stuehmer, T.; Holien, T.; Koechert, K.; Holt, R. U.; Bruland, O.; Chatterjee, M.; Nogai, H.; Lenz, G.; Shaughnessy, J. D., Jr.; Mathas, S.; Sundan, A.; Bargou, R. C.; Doerken, B.; Borset, M.; Janz, M.			Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells	ONCOGENE			English	Article						multiple myeloma; cytokines; SGK1; STAT3	PROTEIN-KINASE; BONE-MARROW; EPITHELIAL-CELLS; SURVIVAL; SERUM; PATHWAY; ACTIVATION; EXPRESSION; APOPTOSIS; DOWNSTREAM	Multiple myeloma (MM) is a paradigm for a malignant disease that exploits external stimuli of the microenvironment for growth and survival. A thorough understanding of the complex interactions between malignant plasma cells and their surrounding requires a detailed analysis of the transcriptional response of myeloma cells to environmental signals. We determined the changes in gene expression induced by interleukin (IL)-6, tumor necrosis factor-alpha, IL-21 or co-culture with bone marrow stromal cells in myeloma cell lines. Among a limited set of genes that were consistently activated in response to growth factors, a prominent transcriptional target of cytokine-induced signaling in myeloma cells was the gene encoding the serine/threonine kinase serum/glucocorticoid-regulated kinase 1 (SGK1), which is a down-stream effector of PI3-kinase. We could demonstrate a rapid, strong and sustained induction of SGK1 in the cell lines INA-6, ANBL-6, IH-1, OH-2 and MM.1S as well as in primary myeloma cells. Pharmacologic inhibition of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway abolished STAT3 phosphorylation and SGK1 induction. In addition, small hairpin RNA (shRNA)-mediated knock-down of STAT3 reduced basal and induced SGK1 levels. Furthermore, downregulation of SGK1 by shRNAs resulted in decreased proliferation of myeloma cell lines and reduced cell numbers. On the molecular level, this was reflected by the induction of cell cycle inhibitory genes, for example, CDKNA1/p21, whereas positively acting factors such as CDK6 and RBL2/p130 were downregulated. Our results indicate that SGK1 is a highly cytokine-responsive gene in myeloma cells promoting their malignant growth. Oncogene (2011) 30, 3198-3206; doi:10.1038/onc.2011.79; published online 11 April 2011	[Ullrich, K.; Koechert, K.; Nogai, H.; Lenz, G.; Mathas, S.; Doerken, B.; Janz, M.] Campus Virchow Klinikum, Univ Med Sch Berlin, Charite, Dept Hematol Oncol & Tumorimmunol, D-13092 Berlin, Germany; [Fagerli, U-M; Holien, T.; Holt, R. U.; Sundan, A.; Borset, M.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Fagerli, U-M] St Olavs Univ Hosp, Dept Oncol, Trondheim, Norway; [Ullrich, K.; Koechert, K.; Mathas, S.; Doerken, B.; Janz, M.] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Stuehmer, T.; Chatterjee, M.; Bargou, R. C.] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Stuehmer, T.; Chatterjee, M.; Bargou, R. C.] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Div Hematol, Wurzburg, Germany; [Holt, R. U.] Sor Trondelag Univ Coll, Fac Technol, Dept Biomed Sci, Trondheim, Norway; [Bruland, O.] Haukeland Univ Hosp Bergen, Ctr Med Genet & Mol Med, Bergen, Norway; [Shaughnessy, J. D., Jr.] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA; [Borset, M.] St Olavs Univ Hosp, Dept Immunol & Transfus Med, Trondheim, Norway	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; University of Wurzburg; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Norwegian University of Science & Technology (NTNU)	Janz, M (corresponding author), Campus Virchow Klinikum, Univ Med Sch Berlin, Charite, Dept Hematol Oncol & Tumorimmunol, Robert Rossle Str 10, D-13092 Berlin, Germany.	mjanz@mdc-berlin.de	Mathas, Stephan/I-5589-2015; Borset, Magne/AAY-1713-2021; Lenz, Georg/I-6844-2012; Holien, Toril/M-6253-2018	Borset, Magne/0000-0001-5179-2835; Kochert, Karl/0000-0002-5548-2022; Bruland, Oyvind Sverre/0000-0003-1631-3733; Janz, Martin/0000-0002-1127-0044; Holien, Toril/0000-0002-2051-5824	Deutsche Krebshilfe [10-2225-Ja 1]; Berlin Cancer Society; Deutsche Forschungsgemeinschaft [KFO 216]; Norwegian Cancer Society; St Olavs Hospital, Trondheim; Research Council of Norway	Deutsche Krebshilfe(Deutsche Krebshilfe); Berlin Cancer Society; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Norwegian Cancer Society(Norwegian Cancer Society); St Olavs Hospital, Trondheim; Research Council of Norway(Research Council of Norway)	We thank Brigitte Wollert-Wulf, Mandy Terne, Pia Herrmann (Berlin), Berit Stordal and Hanne Hella (Trondheim) for excellent technical assistance and Hans-Peter Rahn (Berlin) for cell sorting. Reuven Agami (Amsterdam, The Netherlands) kindly provided the pSUPER vector and Matthias Truss (Berlin) the pRepH1 construct. This work was supported by grants from the Deutsche Krebshilfe (10-2225-Ja 1), the Berlin Cancer Society, the Deutsche Forschungsgemeinschaft (KFO 216 to TS, MC and RCB), the Norwegian Cancer Society, the Cancer Fund of St Olavs Hospital, Trondheim, and the Research Council of Norway.	Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Ogata A, 1997, CLIN CANCER RES, V3, P1017; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Sahoo S, 2005, EUR J CANCER, V41, P2754, DOI 10.1016/j.ejca.2005.07.018; Shanmugam I, 2007, CELL DEATH DIFFER, V14, P2085, DOI 10.1038/sj.cdd.4402227; Tu YP, 2000, CANCER RES, V60, P6763; van Zaanen HCT, 1998, BRIT J HAEMATOL, V102, P783; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Zollinger A, 2008, BLOOD, V112, P3403, DOI 10.1182/blood-2007-11-119362	22	57	60	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	28					3198	3206		10.1038/onc.2011.79	http://dx.doi.org/10.1038/onc.2011.79			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	792FQ	21478911				2022-12-25	WOS:000292726300008
J	Kaulfurst-Soboll, H; Rips, S; Koiwa, H; Kajiura, H; Fujiyama, K; von Schaewen, A				Kaulfuerst-Soboll, Heidi; Rips, Stephan; Koiwa, Hisashi; Kajiura, Hiroyuki; Fujiyama, Kazuhito; von Schaewen, Antje			Reduced Immunogenicity of Arabidopsis hgl1 Mutant N-Glycans Caused by Altered Accessibility of Xylose and core Fucose Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-MANNOSIDASE-II; ASPARAGINE-LINKED GLYCANS; INSECT GLYCOPROTEIN; CARBOHYDRATE MOIETY; MAJOR GLYCOPROTEIN; PLANT; GLYCOSYLATION; THALIANA; OLIGOSACCHARIDES; PEROXIDASE	Arabidopsis N-glycosylation mutants with enhanced salt sensitivity show reduced immunoreactivity of complex N-glycans. Among them, hybrid glycosylation 1 (hgl1) alleles lacking Golgi alpha-mannosidase II are unique, because their glycoprotein N-glycans are hardly labeled by anti-complex glycan antibodies, even though they carry beta 1,2-xylose and alpha 1,3-fucose epitopes. To dissect the contribution of xylose and core fucose residues to plant stress responses and immunogenic potential, we prepared Arabidopsis hgl1 xylT double and hgl1 fucTa fucTb triple mutants by crossing previously established T-DNA insertion lines and verified them by mass spectrometry analyses. Root growth assays revealed that hgl1 fucTa fucTb but not hgl1 xylT plants are more salt-sensitive than hgl1, hinting at the importance of core fucose modification and masking of xylose residues. Detailed immunoblot analyses with anti-beta 1,2-xylose and anti-alpha 1,3-fucose rabbit immunoglobulin G antibodies as well as cross-reactive carbohydrate determinant-specific human immunoglobulin E antibodies ( present in sera of allergy patients) showed that xylose-specific reactivity of hgl1 N-glycans is indeed reduced. Based on three-dimensional modeling of plant N-glycans, we propose that xylose residues are tilted by 30 degrees because of untrimmed mannoses in hgl1 mutants. Glycosidase treatments of protein extracts restored immunoreactivity of hgl1 N-glycans supporting these models. Furthermore, among allergy patient sera, untrimmed mannoses persisting on the alpha 1,6-arm of hgl1 N-glycans were inhibitory to immunoreaction with core fucoses to various degrees. In summary, incompletely trimmed glycoprotein N-glycans conformationally prevent xylose and, to lesser extent, core fucose accessibility. Thus, in addition to N-acetylglucosaminyltransferase I, Golgi alpha-mannosidase II emerges as a so far unrecognized target for lowering the immunogenic potential of plant-derived glycoproteins.	[Kaulfuerst-Soboll, Heidi; Rips, Stephan; von Schaewen, Antje] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Koiwa, Hisashi] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, Dept Hort Sci, College Stn, TX 77843 USA; [Koiwa, Hisashi] Texas A&M Univ, Mol & Environm Plant Sci Program, College Stn, TX 77843 USA; [Kajiura, Hiroyuki; Fujiyama, Kazuhito] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan	University of Munster; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Osaka University	von Schaewen, A (corresponding author), Schlossgarten 3, D-48149 Munster, Germany.	Schaewen@uni-muenster.de	Koiwa, Hisashi/AAA-8182-2019; Koiwa, Hisashi/AAO-6512-2020	Koiwa, Hisashi/0000-0002-7421-340X; Kajiura, Hiroyuki/0000-0001-5811-1625	Deutsche Forschungsgemeinschaft [SCHA 541/9, SCHA 541/11]; U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service (CSREES) [2008-34402-19195, 2009-34402-19831, 2010-34402-20875]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SCHA 541/9 and 11 (to A. v. S.) and by U.S. Department of Agriculture Cooperative State Research, Education, and Extension Service (CSREES) Designing Food for Health Grants 2008-34402-19195, 2009-34402-19831, and 2010-34402-20875 (to H.K.).	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Bencur P, 2005, BIOCHEM J, V388, P515, DOI 10.1042/BJ20042091; Bencurova M, 2004, GLYCOBIOLOGY, V14, P457, DOI 10.1093/glycob/cwh058; BREWER CF, 1986, J BIOL CHEM, V261, P7306; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Ebo DG, 2004, CLIN EXP ALLERGY, V34, P137, DOI 10.1111/j.1365-2222.2004.01837.x; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; FAYE L, 1988, GLYCOCONJUGATE J, V5, P245, DOI 10.1007/BF01049085; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; GarciaCasado G, 1996, GLYCOBIOLOGY, V6, P471, DOI 10.1093/glycob/6.4.471; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Henquet M, 2008, PLANT CELL, V20, P1652, DOI 10.1105/tpc.108.060731; Hossain MA, 2009, BIOSCI BIOTECH BIOCH, V73, P140, DOI 10.1271/bbb.80561; ISHIHARA H, 1979, J BIOL CHEM, V254, P715; Jin CS, 2006, GLYCOBIOLOGY, V16, P349, DOI 10.1093/glycob/cwj071; Kajiura H, 2010, GLYCOBIOLOGY, V20, P736, DOI 10.1093/glycob/cwq028; KALADAS PM, 1983, MOL IMMUNOL, V20, P727, DOI 10.1016/0161-5890(83)90050-0; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kaulfurst-Soboll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017800; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; LAURIERE M, 1989, PLANT PHYSIOL, V90, P1182, DOI 10.1104/pp.90.3.1182; Lerouxel O, 2005, PLANT J, V42, P455, DOI 10.1111/j.1365-313X.2005.02392.x; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Lommerse JPM, 2002, CARBOHYD RES, V337, P2279, DOI 10.1016/S0008-6215(02)00212-4; LOMMERSE JPM, 1995, J BIOMOL NMR, V6, P79, DOI 10.1007/BF00417494; PRENNER C, 1992, BIOCHEM J, V284, P377, DOI 10.1042/bj2840377; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; RAMIREZSOTO D, 1991, CARBOHYD RES, V213, P27, DOI 10.1016/S0008-6215(00)90595-0; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; SONNEWALD U, 1989, PLANTA, V178, P176, DOI 10.1007/BF00393192; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; STURM A, 1990, PLANT CELL, V2, P1107, DOI 10.1105/tpc.2.11.1107; STURM A, 1986, PLANT PHYSIOL, V81, P320, DOI 10.1104/pp.81.1.320; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Wenderoth I, 2000, PLANT PHYSIOL, V123, P1097, DOI 10.1104/pp.123.3.1097; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Wuhrer M, 2005, BBA-GEN SUBJECTS, V1723, P229, DOI 10.1016/j.bbagen.2005.02.013	50	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22955	22964		10.1074/jbc.M110.196097	http://dx.doi.org/10.1074/jbc.M110.196097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21478158	Green Published, hybrid			2022-12-25	WOS:000292025000030
J	Reifert, J; Hartung-Cranston, D; Feinstein, SC				Reifert, Jack; Hartung-Cranston, DeeAnn; Feinstein, Stuart C.			Amyloid beta-Mediated Cell Death of Cultured Hippocampal Neurons Reveals Extensive Tau Fragmentation without Increased Full-length Tau Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; INDUCED NEUROTOXICITY; MICROTUBULE DYNAMICS; CALPAIN ACTIVATION; PROTEIN OLIGOMERS; CASPASE CLEAVAGE; PATHOGENESIS; EXPRESSION; MECHANISM	A variety of genetic and biochemical evidence suggests that amyloid beta (A beta) oligomers promote downstream errors in Tau action, in turn inducing neuronal dysfunction and cell death in Alzheimer and related dementias. To better understand molecular mechanisms involved in A beta-mediated neuronal cell death, we have treated primary rat hippocampal cultures with A beta oligomers and examined the resulting cellular changes occurring before and during the induction of cell death with a focus on altered Tau biochemistry. The most rapid neuronal responses upon A beta administration are activation of caspase 3/7 and calpain proteases. A beta also appears to reduce Akt and Erk1/2 kinase activities while increasing GSK3 beta and Cdk5 activities. Shortly thereafter, substantial Tau degradation begins, generating relatively stable Tau fragments. Only a very small fraction of full-length Tau remains intact after 4 h of A beta treatment. In conflict with expectations based on suggested increases of GSK3 beta and Cdk5 activities, A beta does not cause any major increases in phosphorylation of full-length Tau as assayed by immunoblotting one-dimensional gels with 11 independent site-and phosphospecific anti-Tau antibodies as well as by immunoblotting two-dimensional gels probed with a pan-Tau antibody. There are, however, subtle and transient increases in Tau phosphorylation at 3-4 specific sites before its degradation. Taken together, these data are consistent with the notion that A beta-mediated neuronal cell death involves the loss of full-length Tau and/or the generation of toxic fragments but does not involve or require hyperphosphorylation of full-length Tau.	[Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu			National Institutes of Health [NS-35010]; California Department of Health Services [07-65802]; Santa Barbara Cottage Hospital Research Committee; University of California Santa Barbara Academic Senate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Department of Health Services; Santa Barbara Cottage Hospital Research Committee; University of California Santa Barbara Academic Senate(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-35010. This work was also supported by the California Department of Health Services (Alzheimer's Disease Program Grant 07-65802) and the Santa Barbara Cottage Hospital Research Committee and the University of California Santa Barbara Academic Senate.	Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BEYREUTHER K, 1991, ANN NY ACAD SCI, V640, P129; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Bloom GS, 2005, BBA-MOL BASIS DIS, V1739, P116, DOI 10.1016/j.bbadis.2004.08.008; Buee L, 1999, BRAIN PATHOL, V9, P681; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; FEDOROFF S, 2001, PROTOCOLS NEURAL CEL, P255; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Glantz SB, 2007, BIOCHEMISTRY-US, V46, P502, DOI 10.1021/bi061504y; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Janke C, 1996, FEBS LETT, V379, P222, DOI 10.1016/0014-5793(95)01522-1; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LAI RYK, 1995, NEUROBIOL AGING, V16, P433, DOI 10.1016/0197-4580(95)00041-C; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Mi Kaihong, 2006, Current Alzheimer Research, V3, P449, DOI 10.2174/156720506779025279; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sergeant N, 1997, J NEUROCHEM, V69, P834; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	60	66	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20797	20811		10.1074/jbc.M111.234674	http://dx.doi.org/10.1074/jbc.M111.234674			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21482827	Green Published, hybrid			2022-12-25	WOS:000291267600065
J	Vecchio, AJ; Malkowski, MG				Vecchio, Alex J.; Malkowski, Michael G.			The Structural Basis of Endocannabinoid Oxygenation by Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; AMINO-ACID DETERMINANTS; MOLECULAR-GRAPHICS; GLYCEROL ESTERS; PROSTAGLANDIN; 2-ARACHIDONYLGLYCEROL; CRYSTALLOGRAPHY; METABOLISM; INHIBITION; ANANDAMIDE	The cyclooxygenases (COX-1 and COX-2) oxygenate arachidonic acid (AA) in the committed step of prostaglandin biogenesis. Substitutions of I434V, H513R, and I523V constitute the only differences in residues lining the cyclooxygenase channel between COX-1 and COX-2. These changes create a hydrophobic pocket in COX-2, with Arg-513 located at the base of the pocket, which has been exploited in the design of COX-2-selective inhibitors. Previous studies have shown that COX-2, but not COX-1, can oxygenate endocannabinoid substrates, including 2-arachidonoyl glycerol (2-AG). To investigate the isoform-specific structural basis of endocannabinoid binding to COX-2, we determined the crystal structure of the 2-AG isomer 1-arachidonoyl glycerol (1-AG) in complex with wild type and R513H murine (mu) COX-2 to 2.2 and 2.35 angstrom, respectively, and R513H muCOX-2 in complex with AA to 2.45 angstrom resolution. The 2,3-dihydroxypropyl moiety of 1-AG binds near the opening of the cyclooxygenase channel in the space vacated by the movement of the Leu-531 side chain, validating our previous hypothesis implicating the flexibility of the Leu-531 side chain as a determinant for the ability of COX-2 to oxygenate endocannabinoid substrates. Functional analyses carried out to compliment our structural findings indicated that Y355F and R513H muCOX-2 constructs had no effect on the oxygenation of 1-AG and 2-AG, whereas substitutions that resulted in a shortened side chain for Leu-531 had only modest effects. Both AA and 1-AG bind to R513H muCOX-2 in conformations similar to those observed in the co-crystal structures of these substrates with wild type enzyme.	[Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	malkowski@hwi.buffalo.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463; Vecchio, Alex/0000-0002-4222-7874	National Institutes of Health [R01 GM077176]; Arthritis Foundation, Segal Osteoarthritis Initiative; National Science Foundation [DMR-0225180]; National Institutes of Health through the National Center for Research Resources [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation, Segal Osteoarthritis Initiative; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM077176. This work was also supported by an Arthritis Investigator Award from the Arthritis Foundation as part of the Segal Osteoarthritis Initiative. This work is also based upon research conducted at the Cornell High Energy Synchrotron Source, which is supported by the National Science Foundation under Award DMR-0225180, using the macromolecular diffraction facility at the Cornell High Energy Synchrotron Source, which is supported by Award RR-01646 from the National Institutes of Health through the National Center for Research Resources.	Bisogno T, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2008.01676.x; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2003, BIOCHEMISTRY-US, V42, P9041, DOI 10.1021/bi034471k; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prusakiewicz JJ, 2002, BIOCHEM BIOPH RES CO, V296, P612, DOI 10.1016/S0006-291X(02)00915-4; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; So OY, 1998, J BIOL CHEM, V273, P5801, DOI 10.1074/jbc.273.10.5801; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	45	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20736	20745		10.1074/jbc.M111.230367	http://dx.doi.org/10.1074/jbc.M111.230367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21489986	Green Published, hybrid			2022-12-25	WOS:000291267600059
J	Maltby, S; Freeman, S; Gold, MJ; Baker, JHE; Minchinton, AI; Gold, MR; Roskelley, CD; McNagny, KM				Maltby, Steven; Freeman, Spencer; Gold, Matthew J.; Baker, Jennifer H. E.; Minchinton, Andrew I.; Gold, Michael R.; Roskelley, Calvin D.; McNagny, Kelly M.			Opposing Roles for CD34 in B16 Melanoma Tumor Growth Alter Early Stage Vasculature and Late Stage Immune Cell Infiltration	PLOS ONE			English	Article							MAST-CELLS; ALLERGEN EXPOSURE; SOLID TUMORS; ANGIOGENESIS; MICE; EOSINOPHILS; EXPRESSION; CARCINOGENESIS; ADHESION	Tumor growth and metastasis are determined by the complex interplay of factors, including those intrinsic to tumor cells and extrinsic factors associated with the tumor microenvironment. Our previous work demonstrated key roles for CD34 in the maintenance of vascular integrity and eosinophil and mast cell homing. Since both of these functions affect tumor development, we characterized the effect of CD34 ablation on tumor growth using the B16F1 melanoma model. Intriguingly, we found that CD34 plays a biphasic role in tumor progression. In early growth, both subcutaneous-injected tumors and intravenous-injected lung metastases grew more slowly in Cd34(-/-) mice. This correlated with abnormal vessel morphology and increased vascular permeability in these mice. Bone marrow transplantation experiments confirmed that this reflects a non-hematopoietic function of CD34. At later stages, subcutaneous tumor growth was accelerated in Cd34(-/-) mice and surpassed growth in wildtype mice. Bone marrow chimera experiments demonstrated this difference was due to a hematopoietic function for CD34 and, correspondingly we found reduced intra-tumor mast cell numbers in Cd34(-/-) mice. In aggregate, our analysis reveals a novel role for CD34 in both early and late tumor growth and provides novel insights into the role of the tumor microenvironment in tumor progression.	[Maltby, Steven; Gold, Matthew J.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Freeman, Spencer; Gold, Michael R.; Roskelley, Calvin D.] Univ British Columbia, I3 Grp, Vancouver, BC, Canada; [Freeman, Spencer; Gold, Michael R.; Roskelley, Calvin D.] Univ British Columbia, CELL Res Grp, Vancouver, BC, Canada; [Baker, Jennifer H. E.; Minchinton, Andrew I.] Univ British Columbia, Dept Med Biophys, British Columbia Canc Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Maltby, S (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	kelly@brc.ubc.ca	Gold, Michael/AAF-2081-2021; MALTBY, STEVEN/G-8368-2013; McNagny, Kelly/P-5239-2014; Roskelley, Calvin D/F-4630-2011; Hughes, Michael/N-6039-2015	Gold, Michael/0000-0003-1222-3191; McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Maltby, Steven/0000-0003-1240-5964	CIHR [MIF-79631/M0P-84545]; AllerGen [3.14]; Centre for Blood Research (CBR); CIHR/Michael Smith Foundation for Health Research (MSFHR); AllerGen's Canadian Allergy and Immune Diseases Advanced Training Initiative (CAIDATI)	CIHR(Canadian Institutes of Health Research (CIHR)); AllerGen; Centre for Blood Research (CBR); CIHR/Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); AllerGen's Canadian Allergy and Immune Diseases Advanced Training Initiative (CAIDATI)	Research was funded through the following sources: CIHR Grant #MIF-79631/M0P-84545; AllerGen Grant #3.14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr Chris Parish for providing the B16F1-OVA cells, Takahide Murakami for genotyping, Lori Zbytnuik for technical expertise, Vicki MacDonald for producing the model figure and the BRC Animal Care Facility. SM held a Canadian Institutes of Health Research (CIHR) and Heart and Stroke Foundation of Canada Transfusion Science Fellowship from the Centre for Blood Research (CBR) and MG holds fellowships from the CIHR/Michael Smith Foundation for Health Research (MSFHR) Transplantation Training Program and AllerGen's Canadian Allergy and Immune Diseases Advanced Training Initiative (CAIDATI). KMM is a MSFHR Scholar (Senior) and CBR Member.	Baker JHE, 2008, CLIN CANCER RES, V14, P2171, DOI 10.1158/1078-0432.CCR-07-4465; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Blanchet MR, 2007, BLOOD, V110, P2005, DOI 10.1182/blood-2006-12-062448; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Chen L, 2009, BIOCHEM BIOPH RES CO, V386, P374, DOI 10.1016/j.bbrc.2009.06.042; Cormier SA, 2006, J LEUKOCYTE BIOL, V79, P1131, DOI 10.1189/jlb.0106027; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; DELIA D, 1993, BLOOD, V81, P1001; Drew E, 2005, BLOOD, V106, P1885, DOI 10.1182/blood-2005-03-1291; Drew E, 2005, IMMUNITY, V22, P43, DOI 10.1016/j.immuni.2004.11.014; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Freeman SA, 2010, CANCER RES, V70, P4590, DOI 10.1158/0008-5472.CAN-09-3414; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Murakami J, 2009, INT J CANCER, V124, P1685, DOI 10.1002/ijc.24085; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Quon H, 2010, J NEURO-ONCOL, V96, P277, DOI 10.1007/s11060-009-9961-x; Radinger M, 2004, J ALLERGY CLIN IMMUN, V113, P1109, DOI 10.1016/j.jaci.2004.03.022; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; STARKEY JR, 1988, INT J CANCER, V42, P48, DOI 10.1002/ijc.2910420110; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Tardio JC, 2008, J CUTAN PATHOL, V35, P1079, DOI 10.1111/j.1600-0560.2008.01124.x; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128	31	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18160	10.1371/journal.pone.0018160	http://dx.doi.org/10.1371/journal.pone.0018160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494591	Green Submitted, Green Published, gold			2022-12-25	WOS:000289354100005
J	Rodriguez, I				Rodriguez, Isabel			Drosophila TIEG Is a Modulator of Different Signalling Pathways Involved in Wing Patterning and Cell Proliferation	PLOS ONE			English	Article							INDUCIBLE EARLY GENE; FINGER TRANSCRIPTION FACTOR; MORPHOGEN GRADIENT; GROWTH-REGULATION; IMAGINAL DISCS; DPP TARGETS; BETA; IDENTIFICATION; BRINKER; BMP	Acquisition of a final shape and size during organ development requires a regulated program of growth and patterning controlled by a complex genetic network of signalling molecules that must be coordinated to provide positional information to each cell within the corresponding organ or tissue. The mechanism by which all these signals are coordinated to yield a final response is not well understood. Here, I have characterized the Drosophila ortholog of the human TGF-beta Inducible Early Gene 1 (dTIEG). TIEG are zinc-finger proteins that belong to the Kruppel-like factor (KLF) family and were initially identified in human osteoblasts and pancreatic tumor cells for the ability to enhance TGF-beta response. Using the developing wing of Drosophila as "in vivo" model, the dTIEG function has been studied in the control of cell proliferation and patterning. These results show that dTIEG can modulate Dpp signalling. Furthermore, dTIEG also regulates the activity of JAK/STAT pathway suggesting a conserved role of TIEG proteins as positive regulators of TGF-beta signalling and as mediators of the crosstalk between signalling pathways acting in a same cellular context.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez, I (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	irodriguez@cbm.uam.es	Rodriguez, Isabel/J-2636-2017	Rodriguez, Isabel/0000-0002-7322-4756	Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Fundacion Areces	Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Fundacion Areces(Comunidad de MadridMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Ministerio de Ciencia e Innovacion, Comunidad de Madrid, and Fundacion Areces. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alvarez-Rodiguez R, 2007, J BIOL CHEM, V282, P37170, DOI 10.1074/jbc.M705414200; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Ekas LA, 2006, DEVELOPMENT, V133, P4721, DOI 10.1242/dev.02675; Estella C, 2003, DEVELOPMENT, V130, P5929, DOI 10.1242/dev.00832; Gohla G, 2008, J CELL BIOCHEM, V104, P850, DOI 10.1002/jcb.21669; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Johnsen SA, 2002, J CELL BIOCHEM, V87, P233, DOI 10.1002/jcb.10299; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lee-Hoeflich ST, 2005, FEBS LETT, V579, P4615, DOI 10.1016/j.febslet.2005.06.088; Lopez-Onieva L, 2008, DEVELOPMENT, V135, P533, DOI 10.1242/dev.016121; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Miyake M, 2010, BIOCHEM BIOPH RES CO, V393, P762, DOI 10.1016/j.bbrc.2010.02.077; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487; Munoz-Descalzo S, 2005, DEV BIOL, V287, P168, DOI 10.1016/j.ydbio.2005.08.048; Munoz-Descalzo S, 2007, DEV GENES EVOL, V217, P289, DOI 10.1007/s00427-007-0144-5; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; Parker L, 2004, PROG MOLEC, V34, P73; PFLUGFELDER GO, 1990, GENETICS, V126, P91; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sander V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010383; Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spittau B, 2007, J CELL BIOCHEM, V101, P712, DOI 10.1002/jcb.21228; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2010, BIOCHEM BIOPH RES CO, V392, P72, DOI 10.1016/j.bbrc.2009.12.171; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Terriente-Felix A, 2010, GENETICS, V185, P671, DOI 10.1534/genetics.109.113670; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Wang ZY, 2004, GENE, V325, P25, DOI 10.1016/j.gene.2003.09.045; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	59	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18418	10.1371/journal.pone.0018418	http://dx.doi.org/10.1371/journal.pone.0018418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494610	Green Published, gold			2022-12-25	WOS:000289292800015
J	Atashili, J; Smith, JS; Adimora, AA; Eron, J; Miller, WC; Myers, E				Atashili, Julius; Smith, Jennifer S.; Adimora, Adaora A.; Eron, Joseph; Miller, William C.; Myers, Evan			Potential Impact of Antiretroviral Therapy and Screening on Cervical Cancer Mortality in HIV-Positive Women in Sub-Saharan Africa: A Simulation	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS; COST-EFFECTIVENESS; ERA; INFECTION; NEOPLASIA	Background: Despite having high cervical cancer incidence and mortality rates, screening for cervical precancerous lesions remains infrequent in sub-Saharan Africa. The need to screen HIV-positive women because of the higher prevalence and faster progression of cervical precancerous lesions may be heightened by the increased access to highly-active antiretroviral therapy (HAART). Policymakers need quantitative data on the effect of HAART and screening to better allocate limited resources. Our aim was to quantify the potential effect of these interventions on cervical cancer mortality. Methods and Findings: We constructed a Markov state-transition model of a cohort of HIV-positive women in Cameroon. Published data on the prevalence, progression and regression of lesions as well as mortality rates from HIV, cervical cancer and other causes were incorporated into the model. We examined the potential impact, on cumulative cervical cancer mortality, of four possible scenarios: no HAART and no screening (NHNS), HAART and no screening (HNS), HAART and screening once on HAART initiation (HSHI), and HAART and screening once at age 35 (HS35). Our model projected that, compared to NHNS, lifetime cumulative cervical cancer mortality approximately doubled with HNS. It will require 262 women being screened at HAART initiation to prevent one cervical cancer death amongst women on HAART. The magnitudes of these effects were most sensitive to the rate of progression of precancerous lesions. Conclusions: Screening, even when done once, has the potential of reducing cervical cancer mortality among HIV-positive women in Africa. The most feasible and cost-effective screening strategy needs to be determined in each setting.	[Atashili, Julius] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Smith, Jennifer S.; Adimora, Adaora A.; Eron, Joseph; Miller, William C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Myers, Evan] Duke Univ, Duke Med Sch, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University	Atashili, J (corresponding author), Univ Buea, Fac Hlth Sci, Buea, Cameroon.	atashili@yahoo.ie	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	GSK; Digene; GenProbe; Merck Co.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD059358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	GSK(GlaxoSmithKline); Digene; GenProbe; Merck Co.(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JA has previously received honoraria from GSK and research supplies from Digene. JSS has received research grants, honoraria, or consulting fees during the last three years from GSK, Digene and GenProbe. ERM has received research funding and done consulting for Merck & Co.	[Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2008, WORLD HLTH STAT 2008; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; FERLAY J, 2004, IARC CANC BASE, V5; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Hawes SE, 2006, J NATL CANCER I, V98, P100, DOI 10.1093/jnci/djj010; Massad LS, 2001, J ACQ IMMUN DEF SYND, V27, P432, DOI 10.1097/00126334-200108150-00003; Mbu Enow R, 2008, Reprod Health, V5, P3, DOI 10.1186/1742-4755-5-3; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Naimark D, 1997, MED DECIS MAKING, V17, P152, DOI 10.1177/0272989X9701700205; Palefsky JM, 2003, CURR OPIN ONCOL, V15, P382, DOI 10.1097/00001622-200309000-00007; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Schuman P, 2003, J INFECT DIS, V188, P128, DOI 10.1086/375783; Six C, 1998, AIDS, V12, P1047, DOI 10.1097/00002030-199809000-00012; *UN STAT DIV, 2009, WORLD STAT POCK; *UNAIDS, 2007, REP GLOB AIDS EP 200; WHO, 2006, COMPR CERV CONTR GUI; World Health Organization, 2001, MACR HLTH INV HLTH E	22	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18527	10.1371/journal.pone.0018527	http://dx.doi.org/10.1371/journal.pone.0018527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483701	Green Published, gold, Green Submitted			2022-12-25	WOS:000289058700031
J	Miranda, A; Pericuesta, E; Ramirez, MA; Gutierrez-Adan, A				Miranda, Alberto; Pericuesta, Eva; Angel Ramirez, Miguel; Gutierrez-Adan, Alfonso			Prion Protein Expression Regulates Embryonic Stem Cell Pluripotency and Differentiation	PLOS ONE			English	Article							MESSENGER-RNA; MICE LACKING; NANOG; PRP; BEHAVIOR; NETWORKS; SUPPORTS; INTEGRIN	Cellular prion protein (PRNP) is a glycoprotein involved in the pathogenesis of transmissible spongiform encephalopathies (TSEs). Although the physiological function of PRNP is largely unknown, its key role in prion infection has been extensively documented. This study examines the functionality of PRNP during the course of embryoid body (EB) differentiation in mouse Prnp-null (KO) and WT embryonic stem cell (ESC) lines. The first feature observed was a new population of EBs that only appeared in the KO line after 5 days of differentiation. These EBs were characterized by their expression of several primordial germ cell (PGC) markers until Day 13. In a comparative mRNA expression analysis of genes playing an important developmental role during ESC differentiation to EBs, Prnp was found to participate in the transcription of a key pluripotency marker such as Nanog. A clear switching off of this gene on Day 5 was observed in the KO line as opposed to the WT line, in which maximum Prnp and Nanog mRNA levels appeared at this time. Using a specific antibody against PRNP to block PRNP pathways, reduced Nanog expression was confirmed in the WT line. In addition, antibody-mediated inhibition of ITGB5 (integrin alpha v beta 5) in the KO line rescued the low expression of Nanog on Day 5, suggesting the regulation of Nanog transcription by Prnp via this Itgb5. mRNA expression analysis of the PRNP-related proteins PRND (Doppel) and SPRN (Shadoo), whose PRNP function is known to be redundant, revealed their incapacity to compensate for the absence of PRNP during early ESC differentiation. Our findings provide strong evidence for a relationship between Prnp and several key pluripotency genes and attribute Prnp a crucial role in regulating self-renewal/differentiation status of ESC, confirming the participation of PRNP during early embryogenesis.	[Miranda, Alberto; Pericuesta, Eva; Angel Ramirez, Miguel; Gutierrez-Adan, Alfonso] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain; [Miranda, Alberto] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Miranda, A (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain.	miranda.alberto@inia.es	Gutierrez-Adan, Alfonso/A-1485-2014; de Paz, Miguel Ángel Ramírez/H-3171-2015	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; de Paz, Miguel Ángel Ramírez/0000-0002-5868-2134; Miranda-Bedate, Alberto/0000-0003-2623-2857	Spanish Ministry of Science and Innovation [AGL2009-11358]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Grant AGL2009-11358 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez MA, 2009, BIOL REPROD, V80, P1216, DOI 10.1095/biolreprod.108.075044; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brown DR, 1998, BIOCHEM J, V334, P423, DOI 10.1042/bj3340423; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Castilla J, 2004, J NEUROSCI, V24, P2156, DOI 10.1523/JNEUROSCI.3811-03.2004; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Coitinho AS, 2003, NEUROREPORT, V14, P1375, DOI 10.1097/01.wnr.0000078541.07662.90; Colling SB, 1997, BRAIN RES, V755, P28, DOI 10.1016/S0006-8993(97)00087-5; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Faustino RS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r6; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Fujisawa M, 2004, J REPROD DEVELOP, V50, P565, DOI 10.1262/jrd.50.565; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Hajj GNM, 2009, J COMP NEUROL, V517, P371, DOI 10.1002/cne.22157; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hiyama K, 2005, INT J ONCOL, V27, P87; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Ishii M, 2006, J REPROD DEVELOP, V52, P461, DOI 10.1262/jrd.17111; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; MEHRPOUR M, 2009, CANC LETT; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; MORITAFUJIMURA Y, 2009, DEV GROWTH DIFFER, P6; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muras AG, 2009, INT J CANCER, V125, P1523, DOI 10.1002/ijc.24425; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Qin J, 2009, BIOLOGICALS, V37, P235, DOI 10.1016/j.biologicals.2009.03.001; Ramirez MA, 2007, INT J DEV BIOL, V51, P397, DOI 10.1387/ijdb.062255mr; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Stella R, 2010, MOL CELL BIOL, V30, P4864, DOI 10.1128/MCB.01040-09; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Walker JL, 2002, DEV DYNAM, V223, P273, DOI 10.1002/dvdy.10050; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	60	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18422	10.1371/journal.pone.0018422	http://dx.doi.org/10.1371/journal.pone.0018422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483752	gold, Green Submitted, Green Published			2022-12-25	WOS:000289058700027
J	Meijaard, E; Mengersen, K; Buchori, D; Nurcahyo, A; Ancrenaz, M; Wich, S; Atmoko, SSU; Tjiu, A; Prasetyo, D; Nardiyono; Hadiprakarsa, Y; Christy, L; Wells, J; Albar, G; Marshall, AJ				Meijaard, Erik; Mengersen, Kerrie; Buchori, Damayanti; Nurcahyo, Anton; Ancrenaz, Marc; Wich, Serge; Atmoko, Sri Suci Utami; Tjiu, Albertus; Prasetyo, Didik; Nardiyono; Hadiprakarsa, Yokyok; Christy, Lenny; Wells, Jessie; Albar, Guillaume; Marshall, Andrew J.			Why Don't We Ask? A Complementary Method for Assessing the Status of Great Apes	PLOS ONE			English	Article							TROPICAL CONSERVATION; POPULATION-DENSITY; PONGO-PYGMAEUS; AERIAL SURVEYS; ORANGUTANS; SUMATRA; TRENDS; BIODIVERSITY; KALIMANTAN; KNOWLEDGE	Species conservation is difficult. Threats to species are typically high and immediate. Effective solutions for counteracting these threats, however, require synthesis of high quality evidence, appropriately targeted activities, typically costly implementation, and rapid re-evaluation and adaptation. Conservation management can be ineffective if there is insufficient understanding of the complex ecological, political, socio-cultural, and economic factors that underlie conservation threats. When information about these factors is incomplete, conservation managers may be unaware of the most urgent threats or unable to envision all consequences of potential management strategies. Conservation research aims to address the gap between what is known and what knowledge is needed for effective conservation. Such research, however, generally addresses a subset of the factors that underlie conservation threats, producing a limited, simplistic, and often biased view of complex, real world situations. A combination of approaches is required to provide the complete picture necessary to engage in effective conservation. Orangutan conservation (Pongo spp.) offers an example: standard conservation assessments employ survey methods that focus on ecological variables, but do not usually address the socio-cultural factors that underlie threats. Here, we evaluate a complementary survey method based on interviews of nearly 7,000 people in 687 villages in Kalimantan, Indonesia. We address areas of potential methodological weakness in such surveys, including sampling and questionnaire design, respondent biases, statistical analyses, and sensitivity of resultant inferences. We show that interview-based surveys can provide cost-effective and statistically robust methods to better understand poorly known populations of species that are relatively easily identified by local people. Such surveys provide reasonably reliable estimates of relative presence and relative encounter rates of such species, as well as quantifying the main factors that threaten them. We recommend more extensive use of carefully designed and implemented interview surveys, in conjunction with more traditional field methods.	[Meijaard, Erik] People & Nat Consulting Int, Bali, Indonesia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Palaeoanthropol, Canberra, ACT, Australia; [Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Buchori, Damayanti; Nardiyono; Hadiprakarsa, Yokyok; Christy, Lenny] Nature Conservancy, Indonesia Program, Jakarta, Indonesia; [Nurcahyo, Anton] Borneo Orangutan Survival Fdn, Orangutan Reintro Program Cent Kalimantan, Palangka Raya, Indonesia; [Ancrenaz, Marc] Kinabatangan Orang Utan Conservat Project, Sandakan, Sabah, Malaysia; [Wich, Serge] Sumatran Orangutan Conservat Program PanEco YEL, Medan, Indonesia; [Wich, Serge] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Atmoko, Sri Suci Utami] Univ Nas, Fak Biol, Jakarta, Indonesia; [Atmoko, Sri Suci Utami; Prasetyo, Didik] Perhimpunan Ahli Dan Pemerhati Primata Indonesia, Bogor, Indonesia; [Tjiu, Albertus] World Wide Fund Nat Indonesia, Pontianak, Indonesia; [Wells, Jessie] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Albar, Guillaume] Soc Ornithol Polynesie, Taravao, Tahiti, France; [Marshall, Andrew J.] Univ Calif Davis, Grad Grp Ecol, Dept Anthropol, Davis, CA 95616 USA; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Anim Behav Grad Grp, Davis, CA 95616 USA	People & Nature Consulting International; Australian National University; Queensland University of Technology (QUT); The Nature Conservancy Indonesia; University of Zurich; Universitas Nasional Pionir Perubahan; University of Queensland; University of California System; University of California Davis; University of California System; University of California Davis	Meijaard, E (corresponding author), People & Nat Consulting Int, Bali, Indonesia.	emeijaard@pnc-int.com	Mengersen, Kerrie/AHC-4096-2022; Meijaard, Erik/A-2687-2016; Buchori, Damayanti/L-5878-2017; Wells, Jessie A/F-7318-2010	Meijaard, Erik/0000-0001-8685-3685; Buchori, Damayanti/0000-0002-2843-0737; Wells, Jessie A/0000-0002-3555-5108; Mengersen, Kerrie/0000-0001-8625-9168; Prasetyo, Didik/0000-0001-5486-2624; Wich, Serge/0000-0003-3954-5174; Hadiprakarsa, Yokyok/0000-0001-5186-6742	Nature Conservancy's Adopt and Acre program; United States Agency for International Development (USAID); Sall Family Foundation; Indonesian Ministry of Forestry	Nature Conservancy's Adopt and Acre program; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Sall Family Foundation(European Commission); Indonesian Ministry of Forestry(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	The studies were financially supported by donors of the Nature Conservancy's Adopt and Acre program, the United States Agency for International Development (USAID) (www.usaid.gov/), and the Sall Family Foundation, who paid the salaries of Erik Meijaard and Nardiyono. USAID agreed to the study being conducted. USAID, the Sall Family Foundation, and PNCI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the 18 NGOs who conducted the surveys, the Directorate General for Forest Protection and Nature Conservation (PHKA) of the Indonesian Ministry of Forestry for their support, and our many interview respondents for providing their time and knowledge.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Anderman E., 2006, PSYCHOL ACAD CHEATIN; [Anonymous], 1985, J OFF STAT; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Boyko RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010754; Brncic TM., 2010, SIERRA LEONE NATL CH; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; CHAMBLESS LE, 1985, COMMUN STAT-THEOR M, V14, P1377, DOI 10.1080/03610928508828982; Connelly N.A., 2000, HUM DIMENS WILDL, V5, P19, DOI DOI 10.1080/10871200009359192; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; FREY R, 1978, BIOTROP SPECIAL PUBL, P199; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Goldstein H, 2009, STAT MODEL, V9, P173, DOI 10.1177/1471082X0800900301; Groves RM., 2011, SURV METHODOL; Hellier A, 1999, BIODIVERS CONSERV, V8, P869, DOI 10.1023/A:1008862005556; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jones JPG, 2008, J APPL ECOL, V45, P1205, DOI 10.1111/j.1365-2664.2008.01487.x; Kainer KA, 2006, CONSERV BIOL, V20, P3, DOI 10.1111/j.1523-1739.2006.00356.x; Kroll AJ, 2007, J WILDLIFE MANAGE, V71, P226, DOI 10.2193/2005-714; Lury, 1987, DATA COLLECTION DEV; MARSHALL AJ, 2008, ASSESSING ACCURACY S; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; Marshall AJ, 2009, ORYX, V43, P416, DOI 10.1017/S0030605309001513; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; Meijaard E, 2007, BIODIVERS CONSERV, V16, P3053, DOI 10.1007/s10531-007-9161-y; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Muir MJ, 2009, CONSERV BIOL, V23, P1357, DOI 10.1111/j.1523-1739.2009.01325.x; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Nyhus PJ, 2003, ENVIRON CONSERV, V30, P192, DOI 10.1017/S0376892903000183; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; Rijksen HD, 1999, OUR VANISHING RELATI; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; SINGLETON I, 2004, ORANGUTAN P IN PRESS; Singleton I., 2004, ORANGUTAN POPULATION; Spehar SN, 2010, BIOTROPICA, V42, P748, DOI 10.1111/j.1744-7429.2010.00651.x; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; TILSON R, 1993, OR UT POP HAB QUAL A; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; van der Hoeven Christiaan A., 2004, Journal for Nature Conservation (Jena), V12, P193, DOI 10.1016/j.jnc.2004.06.003; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Whitten T, 2001, CONSERV BIOL, V15, P1, DOI 10.1046/j.1523-1739.2001.01_01.x; Wich S. A., 2009, ORANGUTANS GEOGRAPHI; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Zhang YH, 2010, NATURE, V467, P153, DOI 10.1038/467153d	50	41	47	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18008	10.1371/journal.pone.0018008	http://dx.doi.org/10.1371/journal.pone.0018008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483859	Green Published, Green Accepted, gold			2022-12-25	WOS:000289057200018
J	Nikooyan, AA; van der Helm, FCT; Westerhoff, P; Graichen, F; Bergmann, G; Veeger, HEJ				Nikooyan, Ali Asadi; van der Helm, Frans C. T.; Westerhoff, Peter; Graichen, Friedmar; Bergmann, Georg; Veeger, H. E. J. (Dirkjan)			Comparison of Two Methods for In Vivo Estimation of the Glenohumeral Joint Rotation Center (GH-JRC) of the Patients with Shoulder Hemiarthroplasty	PLOS ONE			English	Article							HELICAL AXIS ESTIMATION; KINEMATICS; VALIDATION; POSITION; ELBOW	Determination of an accurate glenohumeral-joint rotation center (GH-JRC) from marker data is essential for kinematic and dynamic analysis of shoulder motions. Previous studies have focused on the evaluation of the different functional methods for the estimation of the GH-JRC for healthy subjects. The goal of this paper is to compare two widely used functional methods, namely the instantaneous helical axis (IHA) and symmetrical center of rotation (SCoRE) methods, for estimating the GH-JRC in vivo for patients with implanted shoulder hemiarthroplasty. The motion data of five patients were recorded while performing three different dynamic motions (circumduction, abduction, and forward flexion). The GH-JRC was determined using the CT-images of the subjects (geometric GH-JRC) and was also estimated using the two IHA and SCoRE methods. The rotation centers determined using the IHA and SCoRE methods were on average 1.47 +/- 0.62 cm and 2.07 +/- 0.55 cm away from geometric GH-JRC, respectively. The two methods differed significantly (two-tailed p-value from paired t-Test similar to 0.02, post-hoc power similar to 0.30). The SCoRE method showed a significant lower (two-tailed p-value from paired t-Test similar to 0.03, post-hoc power similar to 0.68) repeatability error calculated between the different trials of each motion and each subject and averaged across all measured subjects (0.62 +/- 0.10 cm for IHA vs. 0.43 +/- 0.12 cm for SCoRE). It is concluded that the SCoRE appeared to be a more repeatable method whereas the IHA method resulted in a more accurate estimation of the GH-JRC for patients with endoprostheses.	[Nikooyan, Ali Asadi; van der Helm, Frans C. T.; Veeger, H. E. J. (Dirkjan)] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Westerhoff, Peter; Graichen, Friedmar; Bergmann, Georg] Univ Med, Charite, Julius Wolff Inst, Berlin, Germany; [Veeger, H. E. J. (Dirkjan)] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands	Delft University of Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vrije Universiteit Amsterdam	Nikooyan, AA (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	a.asadinikooyan@tudelft.nl	veeger, dirkjan/E-6183-2013	veeger, dirkjan/0000-0003-0292-6520	Dutch Technology Foundation STW [07354]	Dutch Technology Foundation STW(Technologiestichting STW)	This project was partially financed by the Dutch Technology Foundation STW. Project number: 07354. URL: www.stw.nl. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	[Anonymous], P C SIM VIS SIMVIS; Barnett ND, 1999, CLIN BIOMECH, V14, P287, DOI 10.1016/S0268-0033(98)00106-5; Begon M, 2007, GAIT POSTURE, V25, P353, DOI 10.1016/j.gaitpost.2006.04.010; Campbell AC, 2009, J BIOMECH, V42, P1527, DOI 10.1016/j.jbiomech.2009.03.039; Cereatti A, 2009, J BIOMECH, V42, P818, DOI 10.1016/j.jbiomech.2009.01.031; Chang LY, 2007, J BIOMECH, V40, P1392, DOI 10.1016/j.jbiomech.2006.05.010; Ehrig RM, 2006, J BIOMECH, V39, P2798, DOI 10.1016/j.jbiomech.2005.10.002; Gamage SSHU, 2002, J BIOMECH, V35, P87, DOI 10.1016/S0021-9290(01)00160-9; Graichen H, 2000, J BIOMECH, V33, P609, DOI 10.1016/S0021-9290(99)00209-2; Halvorsen K, 2003, J BIOMECH, V36, P999, DOI 10.1016/S0021-9290(03)00070-8; Halvorsen K, 1999, J BIOMECH, V32, P1221, DOI 10.1016/S0021-9290(99)00120-7; Karduna AR, 2001, J BIOMECH ENG-T ASME, V123, P184, DOI 10.1115/1.1351892; Lempereur M, 2010, J BIOMECH, V43, P370, DOI 10.1016/j.jbiomech.2009.09.029; Meskers CGM, 1998, J BIOMECH, V31, P93, DOI 10.1016/S0021-9290(97)00101-2; Meskers CGM, 1998, CLIN BIOMECH, V13, P280, DOI 10.1016/S0268-0033(98)00095-3; Monnet T, 2007, J BIOMECH, V40, P3487, DOI 10.1016/j.jbiomech.2007.05.030; Nikooyan AA, 2010, J BIOMECH, V43, P3007, DOI 10.1016/j.jbiomech.2010.06.015; Stokdijk M, 2000, J BIOMECH, V33, P1629, DOI 10.1016/S0021-9290(00)00121-4; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; VANDERHELM FCT, 1992, J BIOMECH, V25, P129, DOI 10.1016/0021-9290(92)90270-B; VANDERHELM FCT, 1989, J BIOMECH, V22, P1092; Veeger HEJ, 2000, J BIOMECH, V33, P1711, DOI 10.1016/S0021-9290(00)00141-X; VELDPAUS FE, 1988, J BIOMECH, V21, P45, DOI 10.1016/0021-9290(88)90190-X; Woltring H. J., 1990, BIOMECHANICS HUMAN M; WOLTRING HJ, 1994, J BIOMECH, V27, P1415, DOI 10.1016/0021-9290(94)90192-9; WOLTRING HJ, 1985, J BIOMECH, V18, P379, DOI 10.1016/0021-9290(85)90293-3; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18488	10.1371/journal.pone.0018488	http://dx.doi.org/10.1371/journal.pone.0018488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483808	Green Published, gold			2022-12-25	WOS:000289057200086
J	Hut, RA; Pilorz, V; Boerema, AS; Strijkstra, AM; Daan, S				Hut, Roelof A.; Pilorz, Violetta; Boerema, Ate S.; Strijkstra, Arjen M.; Daan, Serge			Working for Food Shifts Nocturnal Mouse Activity into the Day	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ANTICIPATORY CIRCADIAN-RHYTHMS; CLOCK; RATS; TEMPERATURE; EXPRESSION; LESIONS; ENTRAINMENT; BEHAVIOR	Nocturnal rodents show diurnal food anticipatory activity when food access is restricted to a few hours in daytime. Timed food access also results in reduced food intake, but the role of food intake in circadian organization per se has not been described. By simulating natural food shortage in mice that work for food we show that reduced food intake alone shifts the activity phase from the night into the day and eventually causes nocturnal torpor (natural hypothermia). Release into continuous darkness with ad libitum food, elicits immediate reversal of activity to the previous nocturnal phase, indicating that the classical circadian pacemaker maintained its phase to the light-dark cycle. This flexibility in behavioral timing would allow mice to exploit the diurnal temporal niche while minimizing energy expenditure under poor feeding conditions in nature. This study reveals an intimate link between metabolism and mammalian circadian organization.	[Hut, Roelof A.; Pilorz, Violetta; Boerema, Ate S.; Strijkstra, Arjen M.; Daan, Serge] Univ Groningen, Ctr Behav & Neurosci, Chronobiol Unit, Groningen, Netherlands	University of Groningen	Hut, RA (corresponding author), Univ Groningen, Ctr Behav & Neurosci, Chronobiol Unit, Groningen, Netherlands.	r.a.hut@rug.nl	Boerema, A.S./W-9810-2018; Hut, Roelof A./I-3483-2012	Boerema, A.S./0000-0002-4771-5156; 	EC [018741, 221095]; EMBO [666828]	EC(European CommissionEuropean Commission Joint Research Centre); EMBO(European Molecular Biology Organization (EMBO))	The study was supported by EC-FP6 Integrated Project 018741 "EUCLOCK", EMBO fellowship 666828 to RAH, and EC-FP6 Marie-Curie fellowship 221095 "ClockWork" to VP (project supervisor RAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Challet E, 1996, BEHAV BRAIN RES, V77, P155, DOI 10.1016/0166-4328(95)00224-3; Challet E, 1998, BRAIN RES, V801, P244, DOI 10.1016/S0006-8993(98)00590-3; Challet E, 1997, BRAIN RES BULL, V43, P209, DOI 10.1016/S0361-9230(96)00439-X; Challet E, 1996, NEUROSCI LETT, V216, P214, DOI 10.1016/S0304-3940(96)13012-3; DAAN S, 2011, J BIOL RHYT IN PRESS, V26; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Froy O, 2008, NEUROSCIENCE, V155, P1152, DOI 10.1016/j.neuroscience.2008.06.060; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; HONMA KI, 1986, PHYSIOL BEHAV, V38, P687, DOI 10.1016/0031-9384(86)90265-9; HOOGENBOOM I, 1984, OECOLOGIA, V61, P18, DOI 10.1007/BF00379084; KAWAMURA H, 1979, BIOL RHYTHMS THEIR C, P335; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Landry GJ, 2007, J BIOL RHYTHM, V22, P484, DOI 10.1177/0748730407307811; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Mendoza J, 2008, J NEUROENDOCRINOL, V20, P251, DOI 10.1111/j.1365-2826.2007.01636.x; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; MISTLBERGER RE, 1984, PHYSIOL BEHAV, V33, P227, DOI 10.1016/0031-9384(84)90104-5; Mohawk JA, 2009, P NATL ACAD SCI USA, V106, P3519, DOI 10.1073/pnas.0813366106; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Schubert KA, 2010, BIOL LETTERS, V6, P132, DOI 10.1098/rsbl.2009.0569; Spoelstra K, 2004, J BIOL RHYTHM, V19, P518, DOI 10.1177/0748730404268122; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; Stephan Friedrich K., 2001, Handbook of Behavioral Neurobiology, V12, P223; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Wiersma P, 2005, J EXP BIOL, V208, P4091, DOI 10.1242/jeb.01854	35	74	74	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17527	10.1371/journal.pone.0017527	http://dx.doi.org/10.1371/journal.pone.0017527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479166	Green Submitted, Green Published, gold			2022-12-25	WOS:000289055700013
J	Zheng, X; Zheng, H; Lan, R; Ye, C; Wang, Y; Zhang, J; Jing, H; Chen, C; Segura, M; Gottschalk, M; Xu, J				Zheng, Xiao; Zheng, Han; Lan, Ruiting; Ye, Changyun; Wang, Yiting; Zhang, Ji; Jing, Huaiqi; Chen, Chen; Segura, Mariela; Gottschalk, Marcelo; Xu, Jianguo			Identification of Genes and Genomic Islands Correlated with High Pathogenicity in Streptococcus suis Using Whole Genome Tilling Microarrays	PLOS ONE			English	Article							CAPSULAR TYPES; SEQUENCE TYPE-7; SEROTYPE 14; MENINGITIS; VIRULENCE; RESTRICTION; EXPRESSION; PHAGOCYTOSIS; PATHOGENESIS; INFECTIONS	Streptococcus suis is an important zoonotic pathogen that can cause meningitis and sepsis in both pigs and humans. Infections in humans have been sporadic worldwide but two severe outbreaks occurred in China in recent years, while infections in pigs are a major problem in the swine industry. Some S. suis strains are more pathogenic than others with 2 sequence types (ST), ST1 and ST7, being well recognized as highly pathogenic. We analyzed 31 isolates from 23 serotypes and 25 STs by NimbleGen tiling microarray using the genome of a high pathogenicity (HP) ST1 strain, GZ1, as reference and a new algorithm to detect gene content difference. The number of genes absent in a strain ranged from 49 to 225 with a total of 632 genes absent in at least one strain, while 1346 genes were found to be invariably present in all strains as the core genome of S. suis, accounting for 68% of the GZ1 genome. The majority of genes are located in chromosomal blocks with two or more contiguous genes. Sixty two blocks are absent in two or more strains and defined as regions of difference (RDs), among which 26 are putative genomic islands (GIs). Clustering and statistical analyses revealed that 8 RDs including 6 putative GIs and 21 genes within these RDs are significantly associated with HP. Three RDs encode known virulence related factors including the extracellular factor, the capsular polysaccharide and a SrtF pilus. The strains were divided into 5 groups based on population genetic analysis of multilocus sequence typing data and the distribution of the RDs among the groups revealed gain and loss of RDs in different groups. Our study elucidated the gene content diversity of S. suis and identified genes that potentially promote HP.	[Zheng, Xiao; Zheng, Han; Ye, Changyun; Wang, Yiting; Zhang, Ji; Jing, Huaiqi; Chen, Chen; Xu, Jianguo] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zheng, Xiao; Zheng, Han; Ye, Changyun; Wang, Yiting; Zhang, Ji; Jing, Huaiqi; Chen, Chen; Xu, Jianguo] Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Segura, Mariela; Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of New South Wales Sydney; Universite de Montreal	Zheng, X (corresponding author), State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xujianguo@icdc.cn	CHEN, CHEN/HDM-6657-2022; Gottschalk, Marcelo/I-8116-2012; Segura, Mariela/AAG-5708-2020; chen, chen/AAQ-1805-2021; Zheng, Han/AAH-6977-2019	chen, chen/0000-0003-1765-8899; Lan, Ruiting/0000-0001-9834-5258	China-Canada Collaboration grant [2008DFA31830]; Ministry of Science and Technology, People's Republic of China [2008ZX10004-001, 2009ZX10004-101]; Wellcome Trust	China-Canada Collaboration grant; Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Wellcome Trust(Wellcome Trust)	This work was supported by China-Canada Collaboration grant to JX (no. 2008DFA31830) and by funds from the Ministry of Science and Technology, People's Republic of China (no. 2008ZX10004-001 and 2009ZX10004-101).; This work made use of the Multi Locus Sequence Typing website (http://www.mlst.net) at Imperial College London developed by David Aanensen and funded by the Wellcome Trust. We thank Drs Pengcheng Du and Luxi Wang from ICDC for their technical assistance with microarray data processing.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Ando T, 2002, CANCER RES, V62, P2385; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Bart A, 2001, INFECT IMMUN, V69, P1816, DOI 10.1128/IAI.69.3.1816-1820.2001; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; CHANTER N, 1993, VET MICROBIOL, V36, P39, DOI 10.1016/0378-1135(93)90127-S; Charland N, 1996, FEMS IMMUNOL MED MIC, V14, P195, DOI 10.1111/j.1574-695X.1996.tb00287.x; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falush D, 2003, GENETICS, V164, P1567; Feil EJ, 2000, GENETICS, V154, P1439; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; GOTTSCHALK M, 1991, J CLIN MICROBIOL, V29, P2590, DOI 10.1128/JCM.29.11.2590-2594.1991; Gottschalk M, 1999, J CLIN MICROBIOL, V37, P4202, DOI 10.1128/JCM.37.12.4202-4203.1999; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Haleis A, 2009, EMERG INFECT DIS, V15, P350, DOI 10.3201/eid1502.080842; HIGGINS R, 1995, J VET DIAGN INVEST, V7, P405, DOI 10.1177/104063879500700322; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Ibrahim YM, 2005, INFECT IMMUN, V73, P730, DOI 10.1128/IAI.73.2.730-740.2005; Jackson SA, 2007, FORENSIC SCI INT, V168, P183, DOI 10.1016/j.forsciint.2006.06.079; Jiang H, 2009, VET MICROBIOL, V133, P309, DOI 10.1016/j.vetmic.2008.07.014; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Kopic J, 2002, SCAND J INFECT DIS, V34, P683, DOI 10.1080/00365540210147769; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lalonde M, 2000, MICROBIOL-SGM, V146, P1913, DOI 10.1099/00221287-146-8-1913; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; MURRAY NE, 1993, MOL MICROBIOL, V9, P133, DOI 10.1111/j.1365-2958.1993.tb01675.x; Nair S, 2000, MOL MICROBIOL, V35, P800, DOI 10.1046/j.1365-2958.2000.01752.x; Nair S, 2000, INFECT IMMUN, V68, P7061, DOI 10.1128/IAI.68.12.7061-7068.2000; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; PERCH B, 1983, J CLIN MICROBIOL, V17, P993, DOI 10.1128/JCM.17.6.993-996.1983; Poggenborg R, 2008, SCAND J INFECT DIS, V40, P346, DOI 10.1080/00365540701716825; Pouillot F, 2007, MICROBIOL-SGM, V153, P2426, DOI 10.1099/mic.0.2007/005736-0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; REAMS RY, 1994, J VET DIAGN INVEST, V6, P326, DOI 10.1177/104063879400600308; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Segura M, 2002, INFECT IMMUN, V70, P4312, DOI 10.1128/IAI.70.8.4312-4322.2002; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith HE, 1999, INFECT IMMUN, V67, P1750; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tay CY, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-126; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	68	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17987	10.1371/journal.pone.0017987	http://dx.doi.org/10.1371/journal.pone.0017987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479213	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700020
J	Armstrong, AW; Lin, SW; Chambers, CJ; Sockolov, ME; Chin, DL				Armstrong, April W.; Lin, Steven W.; Chambers, Cynthia J.; Sockolov, Mary E.; Chin, David L.			Psoriasis and Hypertension Severity: Results from a Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; VASCULAR-DISEASES; POPULATION; MORTALITY; ASSOCIATION; PREVALENCE	Background: Epidemiologic studies have provided new insights into the association between psoriasis and cardiovascular diseases. Previous population studies have examined hypertension frequency in psoriasis patients. However, the relationship between severity of hypertension and psoriasis has not been characterized. Objective: We sought to investigate whether patients with psoriasis have more difficult-to-manage hypertension compared to non-psoriatic hypertensive patients. Approach: We performed a case-control study using the University of California Davis electronic medical records. The cases were defined as patients diagnosed with both psoriasis and hypertension, and controls were defined as patients with hypertension and without psoriasis. In this identified population, 835 cases were matched on age, sex, and body mass index (BMI) to 2418 control patients. Key Results: Treatment with multiple anti-hypertensives was significantly associated with the presence of psoriasis using univariate (p < 0.0001) and multivariable analysis, after adjusting for diabetes, hyperlipidemia, and race (p < 0.0001). Compared to hypertensive patients without psoriasis, psoriasis patients with hypertension were 5 times more likely to be on a monotherapy antihypertensive regimen (95% CI 3.607.05), 9.5 times more likely to be on dual antihypertensive therapy (95% CI 6.68-13.65), 16.5 times more likely to be on triple antihypertensive regimen (95% CI 11.01-24.84), and 19.9 times more likely to be on quadruple therapy or centrally-acting agent (95% CI 10.58-37.33) in multivariable analysis after adjusting for traditional cardiac risk factors. Conclusions: Psoriasis patients appear to have more difficult-to-control hypertension compared to non-psoriatic, hypertensive patients.	[Armstrong, April W.; Lin, Steven W.; Chambers, Cynthia J.; Sockolov, Mary E.] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Chin, David L.] Univ Calif Davis, Ctr Healthcare Policy & Res, Grad Grp Epidemiol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Armstrong, AW (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA.	aprilarmstrong@post.harvard.edu	Chin, David L/M-3956-2015	Chin, David L/0000-0002-2341-6207				Altobelli E, 2009, EUR J DERMATOL, V19, P252, DOI 10.1684/ejd.2009.0644; BETTMAN S, 1926, DERMAT WCHNSCHR, V83; Boehncke WH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5666; Bonifati C, 1998, ACTA DERM-VENEREOL, V78, P22; BRAVERMA.IM, 1972, J INVEST DERMATOL, V59, P91, DOI 10.1111/1523-1747.ep12625852; Cohen AD, 2010, ACTA DERM-VENEREOL, V90, P23, DOI 10.2340/00015555-0741; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Dreiher J, 2008, ACTA DERM-VENEREOL, V88, P561, DOI 10.2340/00015555-0510; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x; Gisondi P, 2009, SEMIN THROMB HEMOST, V35, P313, DOI 10.1055/s-0029-1222610; Huerta C, 2007, ARCH DERMATOL, V143, P1559, DOI 10.1001/archderm.143.12.1559; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JEA S, 2006, J AM ACAD DERMATOL, V56, P629; Kaye JA, 2008, BRIT J DERMATOL, V159, P895, DOI 10.1111/j.1365-2133.2008.08707.x; Kim S, 2000, PHARMACOL REV, V52, P11; Kimball AB, 2008, DERMATOLOGY, V217, P27, DOI 10.1159/000121333; KULKA JP, 1964, ANN NY ACAD SCI, V116, P1018, DOI 10.1111/j.1749-6632.1964.tb52565.x; LAWLER JC, 1960, ARCH DERMATOL, V82, P190, DOI 10.1001/archderm.1960.01580020032004; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; MCDONALD CJ, 1978, BRIT J DERMATOL, V99, P469, DOI 10.1111/j.1365-2133.1978.tb02012.x; MEHTA N, 2009, EUR HEART J; Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Prodanovich S, 2009, ARCH DERMATOL, V145, P700, DOI 10.1001/archdermatol.2009.94; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Shapiro J, 2007, J AM ACAD DERMATOL, V56, P629, DOI 10.1016/j.jaad.2006.09.017; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Sowers JR, 2002, NEW ENGL J MED, V346, P1999, DOI 10.1056/NEJMe020054; The Seventh Report of the Joint National Committee on Prevention, 2004, 7 JOINT NAT COMM PRE	33	58	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18227	10.1371/journal.pone.0018227	http://dx.doi.org/10.1371/journal.pone.0018227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479272	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600035
J	Garlapati, S; Saraiya, AA; Wang, CC				Garlapati, Srinivas; Saraiya, Ashesh A.; Wang, Ching C.			A La Autoantigen Homologue Is Required for the Internal Ribosome Entry Site Mediated Translation of Giardiavirus	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; POLIOVIRUS RNA; 5'-NONCODING REGION; CELLULAR-PROTEINS; MESSENGER-RNA; INITIATION; BINDS; IDENTIFICATION; PICORNAVIRUS; TRANSCRIPT	Translation of Giardiavirus (GLV) mRNA is initiated at an internal ribosome entry site (IRES) in the viral transcript. The IRES localizes to a downstream portion of 59 untranslated region (UTR) and a part of the early downstream coding region of the transcript. Recent studies indicated that the IRES does not require a pre-initiation complex to initiate translation but may directly recruit the small ribosome subunit with the help of a number of trans-activating protein factors. A La autoantigen homologue in the viral host Giardia lamblia, GlLa, was proposed as one of the potential trans-activating factors based on its specific binding to GLV-IRES in vitro. In this study, we further elucidated the functional role of GlLa in GLV-IRES mediated translation in Giardia by knocking down GlLa with antisense morpholino oligo, which resulted in a reduction of GLV-IRES activity by 40%. An over-expression of GlLa in Giardia moderately stimulated GLV-IRES activity by 20%. A yeast inhibitory RNA (IRNA), known to bind mammalian and yeast La autoantigen and inhibit Poliovirus and Hepatitis C virus IRES activities in vitro and in vivo, was also found to bind to GlLa protein in vitro and inhibited GLV-IRES function in vivo. The C-terminal domain of La autoantigen interferes with the dimerization of La and inhibits its function. An over-expression of the C-terminal domain (200-348aa) of GlLa in Giardia showed a dominant-negative effect on GLV-IRES activity, suggesting a potential inhibition of GlLa dimerization. HA tagged GlLa protein was detected mainly in the cytoplasm of Giardia, thus supporting a primary role of GlLa in translation initiation in Giardiavirus.	[Garlapati, Srinivas; Saraiya, Ashesh A.; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Garlapati, S (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			National Institutes of Health [R01 AI-30475]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021786, R01AI030475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a National Institutes of Health grant R01 AI-30475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; BACHMANN M, 1989, MOL CELL BIOCHEM, V85, P103, DOI 10.1007/BF00577106; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Craig AWB, 1997, MOL CELL BIOL, V17, P163, DOI 10.1128/MCB.17.1.163; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Das S, 1996, J VIROL, V70, P1624, DOI 10.1128/JVI.70.3.1624-1632.1996; DAS S, 1994, J VIROL, V68, P7200, DOI 10.1128/JVI.68.11.7200-7211.1994; Dasgupta A, 2004, FEMS MICROBIOL LETT, V234, P189, DOI 10.1016/j.femsle.2004.03.045; EHRENFELD E, 1996, TRANSLATIONAL CONTRO, P549; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gamarnik AV, 1997, RNA, V3, P882; Garlapati S, 2005, EUKARYOT CELL, V4, P742, DOI 10.1128/EC.4.4.742-754.2005; Garlapati S, 2004, J BIOL CHEM, V279, P3389, DOI 10.1074/jbc.M307565200; Garlapati S, 2002, RNA, V8, P601, DOI 10.1017/S135583820202071X; Garlapati S, 2001, J MOL BIOL, V308, P623, DOI 10.1006/jmbi.2001.4568; Garlapati S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007435; Gourguechon S, 2011, EUKARYOT CELL, V10, P142, DOI 10.1128/EC.00190-10; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Izumi RE, 2004, J VIROL, V78, P3763, DOI 10.1128/JVI.78.7.3763-3776.2004; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim YK, 1999, J GEN VIROL, V80, P3159, DOI 10.1099/0022-1317-80-12-3159; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Le SY, 1996, VIRUS GENES, V12, P135, DOI 10.1007/BF00572952; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Maraia RJ, 2002, GENE EXPRESSION, V10, P41; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; Merrick WC., 1996, TRANSLATION CONTROL, P31; Niepmann M, 1997, J VIROL, V71, P8330, DOI 10.1128/JVI.71.11.8330-8339.1997; Pudi R, 2005, J VIROL, V79, P9842, DOI 10.1128/JVI.79.15.9842-9853.2005; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sun CH, 2000, MOL BIOCHEM PARASIT, V105, P51, DOI 10.1016/S0166-6851(99)00163-2; SVITKIN YV, 1994, J VIROL, V68, P1544, DOI 10.1128/JVI.68.3.1544-1550.1994; Venkatesan A, 1999, NUCLEIC ACIDS RES, V27, P562, DOI 10.1093/nar/27.2.562; WANG AL, 1986, MOL BIOCHEM PARASIT, V21, P269, DOI 10.1016/0166-6851(86)90132-5; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; YU DC, 1995, MOL CELL BIOL, V15, P4867	46	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18263	10.1371/journal.pone.0018263	http://dx.doi.org/10.1371/journal.pone.0018263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479239	gold, Green Submitted, Green Published			2022-12-25	WOS:000289054600040
J	Piek, E; van der Meer, K; Hoogendijk, WJG; Penninx, BWJH; Nolen, WA				Piek, Ellen; van der Meer, Klaas; Hoogendijk, Witte J. G.; Penninx, Brenda W. J. H.; Nolen, Willem A.			Most Antidepressant Use in Primary Care Is Justified; Results of the Netherlands Study of Depression and Anxiety	PLOS ONE			English	Article							DIAGNOSTIC INTERVIEW CIDI; GENERAL-PRACTICE; FOLLOW-UP; RELIABILITY; DISORDER; RECOGNITION; APPROPRIATENESS; FEASIBILITY; POPULATION; GUIDELINES	Background: Depression is a common illness, often treated in primary care. Many studies have reported undertreatment with antidepressants in primary care. Recently, some studies also reported overtreatment with antidepressants. The present study was designed to assess whether treatment with antidepressants in primary care is in accordance with current guidelines, with a special focus on overtreatment. Methodology: We used baseline data of primary care respondents from the Netherlands Study of Depression and Anxiety (NESDA) (n = 1610). Seventy-nine patients with treatment in secondary care were excluded. We assessed justification for treatment with antidepressant according to the Dutch primary care guidelines for depression and for anxiety disorders. Use of antidepressants was based on drug-container inspection or, if unavailable, on self-report. Results were recalculated to the original population of primary care patients from which the participants in NESDA were selected (n = 10,677). Principal Findings: Of 1531 included primary care patients, 199 (13%) used an antidepressant, of whom 188 (94.5%) (possibly) justified. After recalculating these numbers to the original population (n = 10,677), we found 908 (95% CI 823 to 994) antidepressant users. Forty-nine (95% CI 20 to 78) of them (5.4%) had no current justification for an antidepressant, but 27 of them (54.5%) had a justified reason for an antidepressant at some earlier point in their life. Conclusions: We found that overtreatment with antidepressants in primary care is not a frequent problem. Too long continuation of treatment seems to explain the largest proportion of overtreatment as opposed to inappropriate initiation of treatment.	[Piek, Ellen; van der Meer, Klaas] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Penninx, Brenda W. J. H.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Hoogendijk, Witte J. G.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Piek, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	e.piek@med.umcg.nl	Nolen, Willem A/E-9006-2014; Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672	Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Ely Lilly; Lundbeck; Servier; Bristol-Myers Squibb; Organon; European Union; Stanley Medical Research Institute; Astra Zeneca; GlaxoSmithKline; Wyeth	Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Ely Lilly; Lundbeck(Lundbeck Corporation); Servier(Servier); Bristol-Myers Squibb(Bristol-Myers Squibb); Organon; European Union(European Commission); Stanley Medical Research Institute; Astra Zeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Wyeth(Wyeth)	The infrastructure for De Nederlandse Studie naar Depressie en Angst (NESDA) study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E Piek: None. K van der Meer: None. WJG Hoogendijk: Lectured and advised for, and received unrestricted research grants from Ely Lilly, Lundbeck, Servier, Bristol-Myers Squibb and Organon for which payments were made to the independent research foundation of GGZ inGeest. Hoogendijk holds a patent for gene-expression profiling in peripheral blood as a biomarker for depression. All these activities are not directly related to the present study and, therefore, do not form a conflict of interest. BWJH Penninx: None. WA Nolen: received grants from the Netherlands Organisation for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth, received honoraria and speaker's fees from Astra Zeneca, Eli Lilly, Pfizer, Servier and Wyeth, and participated in advisory boards of Astra Zeneca, Cyberonics, Pfizer and Servier.	Ackermann RT, 2002, J GEN INTERN MED, V17, P293, DOI 10.1046/j.1525-1497.2002.10350.x; Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Andrews G, 1999, PSYCHOL MED, V29, P787, DOI 10.1017/S0033291799008648; [Anonymous], 2004, GUARDIAN; [Anonymous], 2009, ENCY BRITANNICA; Balestrieri M, 2004, SOC PSYCH PSYCH EPID, V39, P171, DOI 10.1007/s00127-004-0722-z; Beck CA, 2005, SOC PSYCH PSYCH EPID, V40, P799, DOI 10.1007/s00127-005-0968-0; Berardi D, 2005, PSYCHOTHER PSYCHOSOM, V74, P225, DOI 10.1159/000085146; Bosmans JE, 2008, J AFFECT DISORDERS, V111, P106, DOI 10.1016/j.jad.2008.02.002; *CAMD ISL MENT HLT, 2003, DEPR GUID; Cameron IM, 2009, BRIT J GEN PRACT, V59, P644, DOI 10.3399/bjgp09X454061; Denicoff KD, 1997, J PSYCHIAT RES, V31, P593, DOI 10.1016/S0022-3956(96)00027-1; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Hermens MLM, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-36; Honig A, 2001, PATIENT EDUC COUNS, V43, P43, DOI 10.1016/S0738-3991(00)00144-0; Institute for Clinical Systems Improvement, 2009, ICSI HLTH CAR GUID M; Kennedy SH, 2001, CAN J PSYCHIAT, V46, p38S; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lecrubier Y, 2007, J CLIN PSYCHIAT, V68, P36; MEEUWISSEN JC, 2009, RICHTLIJNHERZIENING; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; *NAT ADV COMM HLTH, 1996, GUID TREATM MAN DEPR; National Collaborating Centre for Mental Health, 2009, DEPR TREATM MAN DEPR; Ormel O, 2003, NED TIJDSCHR GENEES, V147, P1005; Patten S B, 2000, Chronic Dis Can, V21, P68; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pinto-Meza A, 2008, PSYCHIAT SERV, V59, P78, DOI 10.1176/ps.2008.59.1.78; ROSHOLM JU, 1995, SCAND J PRIM HEALTH, V13, P281, DOI 10.3109/02813439508996776; Sihvo S, 2008, J AFFECT DISORDERS, V110, P94, DOI 10.1016/j.jad.2008.01.012; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Stafford Randall S., 2000, Prim Care Companion J Clin Psychiatry, V2, P211; SUNDERLAND M, 2010, SOC PSYCHIA IN PRESS; Susser E, 2000, SCHIZOPHR RES, V42, P67, DOI 10.1016/S0920-9964(99)00088-2; ten Doesschate MC, 2009, J AFFECT DISORDERS, V115, P167, DOI 10.1016/j.jad.2008.07.011; TERLUIN B, 2004, HUISARTS WET, V47, P26; Van der Veen WJ, 2009, INT J METH PSYCH RES, V18, P229, DOI 10.1002/mpr.297; van Geffen ECG, 2009, BRIT J GEN PRACT, V59, P81, DOI 10.3399/bjgp09X395067; Van Os TWDP, 2006, EUR PSYCHIAT, V21, P87, DOI 10.1016/j.eurpsy.2005.05.002; VANMARWIJK HWJ, 2003, HUISARTS WET, V46, P614; Wells JE, 2004, PSYCHOL MED, V34, P1001, DOI 10.1017/S0033291703001843; Wilson I, 2003, FAM PRACT, V20, P685, DOI 10.1093/fampra/cmg611; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Wittchen HU, 2002, HUM PSYCHOPHARM CLIN, V17, pS1, DOI 10.1002/hup.398	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e14784	10.1371/journal.pone.0014784	http://dx.doi.org/10.1371/journal.pone.0014784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YC	21479264	gold, Green Published, Green Submitted			2022-12-25	WOS:000289054600003
J	Wagner, V; Antunes, PM; Ristow, M; Lechner, U; Hensen, I				Wagner, Viktoria; Antunes, Pedro M.; Ristow, Michael; Lechner, Ute; Hensen, Isabell			Prevailing Negative Soil Biota Effect and No Evidence for Local Adaptation in a Widespread Eurasian Grass	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; AMMOPHILA-ARENARIA; SEEDLING MORTALITY; AUSTRALIAN ACACIA; TEMPERATE TREE; PLANT; PATHOGENS; FEEDBACK; GROWTH; RESISTANCE	Background: Soil biota effects are increasingly accepted as an important driver of the abundance and distribution of plants. While biogeographical studies on alien invasive plant species have indicated coevolution with soil biota in their native distribution range, it is unknown whether adaptation to soil biota varies among populations within the native distribution range. The question of local adaptation between plants and their soil biota has important implications for conservation of biodiversity and may justify the use of seed material from local provenances in restoration campaigns. Methodology/Principal Findings: We studied soil biota effects in ten populations of the steppe grass Stipa capillata from two distinct regions, Europe and Asia. We tested for local adaptation at two different scales, both within (ca. 10-80 km) and between (ca. 3300 km) regions, using a reciprocal inoculation experiment in the greenhouse for nine months. Generally, negative soil biota effects were consistent. However, we did not find evidence for local adaptation: both within and between regions, growth of plants in their 'home soil' was not significantly larger relative to that in soil from other, more distant, populations. Conclusions/Significance: Our study suggests that negative soil biota effects can prevail in different parts of a plant species' range. Absence of local adaptation points to the possibility of similar rhizosphere biota composition across populations and regions, sufficient gene flow to prevent coevolution, selection in favor of plasticity, or functional redundancy among different soil biota. From the point of view of plant - soil biota interactions, our findings indicate that the current practice of using seeds exclusively from local provenances in ecosystem restoration campaigns may not be justified.	[Wagner, Viktoria; Hensen, Isabell] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, Halle, Germany; [Antunes, Pedro M.] Algoma Univ, Dept Biol, Sault Ste Marie, ON, Canada; [Ristow, Michael] Univ Potsdam, Inst Biol Plant Ecol & Nat Conservat, Potsdam, Germany; [Lechner, Ute] Univ Halle Wittenberg, Inst Biol Microbiol, Halle, Germany	Martin Luther University Halle Wittenberg; Algoma University; University of Potsdam; Martin Luther University Halle Wittenberg	Wagner, V (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, Halle, Germany.	viktoria.wagner@botanik.uni-halle.de	Wagner, Viktoria/D-9897-2011; Madeira Antunes, Pedro/C-2949-2008	Madeira Antunes, Pedro/0000-0003-3596-6983; Wagner, Viktoria/0000-0002-2665-9888	German Academic Exchange Service, DAAD	German Academic Exchange Service, DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This study was made possible through a grant from the German Academic Exchange Service, DAAD, to V. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Brinkman EP, 2010, J ECOL, V98, P1063, DOI 10.1111/j.1365-2745.2010.01695.x; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Canty A., 2010, BOOT BOOTSTRAP R S P; Carvalho LM, 2010, OIKOS, V119, P1172, DOI 10.1111/j.1600-0706.2009.18148.x; de la Pena E, 2009, PLANT SOIL, V324, P307, DOI 10.1007/s11104-009-9958-4; Dyer AR, 1997, ECOL APPL, V7, P484, DOI 10.1890/1051-0761(1997)007[0484:IADCTR]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; FOX LR, 1981, AM ZOOL, V21, P853; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI [10.1111/j.1558-5646.1997.tb02384.x, 10.2307/2410956]; Gray AJ, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P66; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoeksema JD, 2007, J EVOLUTION BIOL, V20, P1148, DOI 10.1111/j.1420-9101.2006.01287.x; Katan J., 2002, Plant roots: the hidden half, P949; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Knevel IC, 2004, OECOLOGIA, V141, P502, DOI 10.1007/s00442-004-1662-8; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Lavrenko E. M., 1970, BOT ZH, V55, P1734; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; LINHART YB, 1991, TRENDS ECOL EVOL, V6, P392, DOI 10.1016/0169-5347(91)90160-Y; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; McCarthy-Neumann S, 2010, J ECOL, V98, P396, DOI 10.1111/j.1365-2745.2009.01619.x; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mukhin VA, 2006, RUSS J ECOL+, V37, P1, DOI 10.1134/S1067413606010012; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; PARKER MA, 1995, ECOLOGY, V76, P1525, DOI 10.2307/1938154; Parker MA, 1999, AM NAT, V153, pS48, DOI 10.1086/303211; Parker MA, 2006, DIVERS DISTRIB, V12, P563, DOI 10.1111/j.1366-9516.2006.00255.x; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; PONOMAREV A. N., 1961, Botanicheskii Zhurnal, V46, P1229; R Development Core, 2010, R LANG ENV STAT COMP; Reinhart KO, 2005, J ECOL, V93, P890, DOI 10.1111/j.1365-2745.2005.01028.x; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Ronsheim ML, 2001, OECOLOGIA, V128, P77, DOI 10.1007/s004420000625; Shi ZY, 2007, SCI CHINA SER D, V50, P135, DOI 10.1007/s11430-007-5014-5; Stinchcombe JR, 2001, AM NAT, V158, P376, DOI 10.1086/321990; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; SVENNING MM, 1991, PHYSIOL PLANTARUM, V83, P381, DOI 10.1111/j.1399-3054.1991.tb00109.x; Sylvia DM, 2003, MYCORRHIZA, V13, P177, DOI 10.1007/s00572-003-0232-y; Thompson J. N., 2005, INTERSPEC INTERACT; Thrall PH, 2007, J ECOL, V95, P1110, DOI 10.1111/j.1365-2745.2007.01278.x; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; van der Heijden MGA, 2004, ECOL LETT, V7, P293, DOI 10.1111/j.1461-0248.2004.00577.x; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Van Grunsven RHA, 2009, S AFR J BOT, V75, P172, DOI 10.1016/j.sajb.2008.09.003; van Grunsven RHA, 2010, GLOBAL CHANGE BIOL, V16, P380, DOI 10.1111/j.1365-2486.2009.01996.x; VANDERPUTTEN WH, 1993, NATURE, V362, P53; WAGNER V, ECOGRAPHY IN PRESS; Zuur Alain F., 2009, P1	65	11	11	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17580	10.1371/journal.pone.0017580	http://dx.doi.org/10.1371/journal.pone.0017580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479262	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600013
J	Cheng, JC; Auersperg, N; Leung, PCK				Cheng, J-C; Auersperg, N.; Leung, P. C. K.			Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells	ONCOGENE			English	Article						serous borderline ovarian tumors; p53; ovarian cancer; DNMT1; E-cadherin; methylation	EPITHELIAL-MESENCHYMAL TRANSITION; DE-NOVO METHYLATION; MOLECULE E-CADHERIN; EPIGENETIC REGULATION; SUPPRESSOR GENE; LOW-GRADE; CANCER; CPG; TUMORIGENESIS; PROTEIN	The mechanisms underlying the progression of noninvasive serous borderline ovarian tumors (SBOT) to low-grade invasive carcinomas are poorly understood. We recently showed that inhibition of p53 induces SBOT invasion by activating the PI3K/Akt pathway and transcriptionally repressing E-cadherin. In human cancers, aberrant DNA methylation is a common phenomenon, and it is thought to be involved in the progression from noninvasive to invasive ovarian carcinomas. In this study, we tested the hypothesis that inhibition of p53 downregulates E-cadherin by regulating the methylation of its promoter in SBOT cells. Here, we show that DNA methyltransferase-1 (DNMT1), but not DNMT3a or DNMT3b, was increased in SV40 LT-infected SBOT4 cells, SBOT4-LT and the low-grade invasive serous ovarian carcinoma-derived cell line MPSC1. Treatment with 5-Aza-dC, a DNMT1 inhibitor, restored E-cadherin promoter methylation and expression, and inhibited cell invasion in both invasive SBOT4-LT and MPSC1 cells. Moreover, knockdown of endogenous p53 using siRNA in SBOT3.1 cells induced DNMT1 expression and led to an increase in E-cadherin promoter methylation. Additionally, activation of the PI3K/Akt pathway is required for p53 inhibition-induced DNMT1 expression. The increase in DNMT1 was associated with the inhibition of p53-induced downregulation of E-cadherin and cell invasion. Our findings show an important role for p53 in the progression of SBOT to an invasive carcinoma, and suggest that downregulation of E-cadherin by DNMT1-mediated promoter methylation contributes to this process. Oncogene (2011) 30, 3930-3942; doi:10.1038/onc.2011.117; published online 11 April 2011	[Cheng, J-C; Auersperg, N.; Leung, P. C. K.] Univ British Columbia, Dept Obstet & Gynecol, Child & Family Res Inst, Vancouver, BC V6H 3V5, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, Dept Obstet & Gynecol, Child & Family Res Inst, Vancouver, BC V6H 3V5, Canada.	peleung@interchange.ubc.ca	Cheng, Jung-Chien/T-4258-2019	Cheng, Jung-Chien/0000-0002-5399-9327; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research; National Cancer Institute of Canada; Canadian Cancer Society; Child & Family Research Institute; University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Child & Family Research Institute; University of British Columbia	This work was supported by grants from the Canadian Institutes of Health Research to PCKL and National Cancer Institute of Canada with funds from the Canadian Cancer Society to NA. PCKL is the recipient of a Child & Family Research Institute Distinguished Investigator Award. JCC is the recipient of four year fellowships for PhD students from University of British Columbia.	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P299, DOI 10.1006/gyno.2001.6284; Asadollahi R, 2010, GYNECOL ONCOL, V118, P81, DOI 10.1016/j.ygyno.2010.03.015; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cheng JC, 2011, ONCOGENE, V30, P1020, DOI 10.1038/onc.2010.486; Cheng P, 1997, BRIT J CANCER, V75, P396, DOI 10.1038/bjc.1997.64; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Fan H, 2007, EUR J GASTROEN HEPAT, V19, P952, DOI 10.1097/MEG.0b013e3282c3a89e; Gershenson DM, 1998, CANCER, V83, P2157, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; GRAFF JR, 1995, CANCER RES, V55, P5195; Grille SJ, 2003, CANCER RES, V63, P2172; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee JO, 2005, ONCOGENE, V24, P6617, DOI 10.1038/sj.onc.1208827; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Makarla PB, 2005, CLIN CANCER RES, V11, P5365, DOI 10.1158/1078-0432.CCR-04-2455; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; Peterson EJ, 2003, CANCER RES, V63, P6579; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Rahnama F, 2009, ENDOCRINOLOGY, V150, P1466, DOI 10.1210/en.2008-1142; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Schuijer M, 2003, HUM MUTAT, V21, P285, DOI 10.1002/humu.10181; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Shi HD, 2003, CANCER RES, V63, P2164; Shieh YS, 2005, CANCER-AM CANCER SOC, V104, P1013, DOI 10.1002/cncr.21278; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; Tam KF, 2007, J CANCER RES CLIN, V133, P331, DOI 10.1007/s00432-006-0178-5; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Vergara D, 2010, CURR CANCER DRUG TAR, V10, P107, DOI 10.2174/156800910790980269; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Woo MMM, 2007, IN VITRO CELL DEV-AN, V43, P7, DOI 10.1007/s11626-006-9002-4; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	53	25	25	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	37					3930	3942		10.1038/onc.2011.117	http://dx.doi.org/10.1038/onc.2011.117			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	820FG	21478913				2022-12-25	WOS:000294890400003
J	Diefenbacher, M; Thorsteinsdottir, H; Spang, A				Diefenbacher, Melanie; Thorsteinsdottir, Holmfridur; Spang, Anne			The Dsl1 Tethering Complex Actively Participates in Soluble NSF (N-Ethylmaleimide-sensitive Factor) Attachment Protein Receptor (SNARE) Complex Assembly at the Endoplasmic Reticulum in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE TRANSPORT; MEMBRANE-FUSION; COPII VESICLES; GOLGI; YEAST; ER; RETRIEVAL; COAT; INTERACTS; COMPONENT	Intracellular transport is largely dependent on vesicles that bud off from one compartment and fuse with the target compartment. The first contact of an incoming vesicle with the target membrane is mediated by tethering factors. The tethering factor responsible for recruiting Golgi-derived vesicles to the ER is the Dsl1 tethering complex, which is comprised of the essential proteins Dsl1p, Dsl3p, and Tip20p. We investigated the role of the Tip20p subunit at the ER by analyzing two mutants, tip20-5 and tip20-8. Both mutants contained multiple mutations that were scattered throughout the TIP20 sequence. Individual mutations could not reproduce the temperature-sensitive phenotype of tip20-5 and tip20-8, indicating that the overall structure of Tip20p might be altered in the mutants. Using molecular dynamics simulations comparing Tip20p and Tip20-8p revealed that some regions, particularly the N-terminal domain and parts of the stalk region, were more flexible in the mutant protein, consistent with its increased susceptibility to proteolysis. Both Tip20-5p and Tip20-8p mutants prevented proper ER trans-SNARE complex assembly in vitro. Moreover, Tip20p mutant proteins disturbed the interaction between Dsl1p and the coatomer coat complex, indicating that the Dsl1p-coatomer interaction could be stabilized or regulated by Tip20p. We provide evidence for a direct role of the Dsl1 complex, in particular Tip20p, in the formation and stabilization of ER SNARE complexes.	[Diefenbacher, Melanie; Thorsteinsdottir, Holmfridur; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203	Swiss National Science Foundation; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was supported by the Swiss National Science Foundation and the University of Basel.	Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; BRZOVIC PS, 1992, J BIOL CHEM, V267, P13028; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Cosson P, 1997, EUR J CELL BIOL, V73, P93; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Galiano L, 2009, J AM CHEM SOC, V131, P430, DOI 10.1021/ja807531v; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gotte M, 1997, FEBS LETT, V411, P48, DOI 10.1016/S0014-5793(97)00575-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Tsui MMK, 2000, J CELL SCI, V113, P145; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	64	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25027	25038		10.1074/jbc.M110.215657	http://dx.doi.org/10.1074/jbc.M110.215657			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21482823	Green Published, hybrid			2022-12-25	WOS:000292547900051
J	Bishop, KA; Coy, HM; Nerenz, RD; Meyer, MB; Pike, JW				Bishop, Kathleen A.; Coy, Heidi M.; Nerenz, Robert D.; Meyer, Mark B.; Pike, J. Wesley			Mouse Rankl Expression Is Regulated in T Cells by c-Fos through a Cluster of Distal Regulatory Enhancers Designated the T Cell Control Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-LIGAND; TUMOR-NECROSIS-FACTOR; BONE-MINERAL DENSITY; OSTEOCLAST DIFFERENTIATION FACTOR; TNF FAMILY-MEMBER; RECEPTOR ACTIVATOR; HUMAN GENOME; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; DNA-BINDING	Receptor activator of NF-kappa B ligand (Rankl) is a TNF-like factor that induces the formation of osteoclasts responsible for bone resorption. Although T cell activation up-regulates this gene, the molecular mechanism of its transcriptional control remains unknown. We used ChIP-chip analysis in mouse primary T cells and a T cell hybridoma to define the regulatory enhancers responsible for this up-regulation and to characterize their properties. Elevated H3/H4 acetylation and increased RNA polymerase II density were evident at mRL-D5, a known enhancer located 76 kb upstream of the TSS, as well as at a cluster of regulatory sites located even further upstream between -123 to -156 kb, termed the T cell control region (TCCR). Based upon the ability of calcium signaling and MAPK inhibitors to block Rankl expression, we conducted further ChIP-chip analysis of the transcriptional mediators c-Fos, NF-kappa B, and Nfat. T cell activation induced c-Fos binding at the mRL-D5 enhancer and within the TCCR. The interaction of NF-kappa B was observed at the transcriptional start site and at mRL-D5. Both mRL-D5 and segments of the TCCR exhibited robust transcriptional activity in reporter assays, and site-specific mutagenesis of c-Fos and Nfat elements abrogated reporter activity, suggesting a role for both factors in the control of enhancer-mediated Rankl transcription. Finally, chromosome conformation capture analysis confirmed that mRL-D5 and segments of the TCCR were located in proximity to the Rankl gene promoter and thus potentially able to influence directly Rankl gene promoter activity. We conclude that both mRL-D5 and the TCCR represent control segments that play an integral role in Rankl expression in T cells.	[Bishop, Kathleen A.; Coy, Heidi M.; Nerenz, Robert D.; Meyer, Mark B.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-74993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-74993 (to J. W. P.).	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bishop KA, 2009, MOL ENDOCRINOL, V23, P2095, DOI 10.1210/me.2009-0209; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Burkiewicz JS, 2009, ANN PHARMACOTHER, V43, P1445, DOI 10.1345/aph.1M102; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fionda C, 2007, J IMMUNOL, V178, P4039, DOI 10.4049/jimmunol.178.7.4039; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Josien R, 1999, J IMMUNOL, V162, P2562; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Kim S, 2007, MOL ENDOCRINOL, V21, P197, DOI 10.1210/me.2006-0315; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MARTOWICZ ML, 2011, J CELL BIOC IN PRESS; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Nakashima T, 2003, CURR OPIN RHEUMATOL, V15, P280, DOI 10.1097/00002281-200305000-00016; Nerenz RD, 2008, MOL ENDOCRINOL, V22, P1044, DOI 10.1210/me.2007-0380; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Silverman Stuart L, 2009, Curr Osteoporos Rep, V7, P91; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsubaki M, 2007, MOL CELL BIOCHEM, V304, P53, DOI 10.1007/s11010-007-9485-7; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang RX, 2002, EUR J IMMUNOL, V32, P1090, DOI 10.1002/1521-4141(200204)32:4<1090::AID-IMMU1090>3.0.CO;2-P; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	53	39	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20880	20891		10.1074/jbc.M111.231548	http://dx.doi.org/10.1074/jbc.M111.231548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487009	hybrid, Green Published			2022-12-25	WOS:000291267600072
J	Lucki, NC; Sewer, MB				Lucki, Natasha C.; Sewer, Marion B.			Genistein Stimulates MCF-7 Breast Cancer Cell Growth by Inducing Acid Ceramidase (ASAH1) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SOY PHYTOESTROGEN GENISTEIN; ESTROGEN-RECEPTOR; PROSTATE-CANCER; SPHINGOLIPID METABOLISM; SPHINGOSINE KINASE; IN-VIVO; SIGNALING PATHWAYS; UP-REGULATION; TUMOR-GROWTH	Sphingolipid metabolites, such as ceramide (Cer), sphingosine (SPH), and sphingosine 1-phosphate (S1P), contribute to multiple aspects of carcinogenesis including cell proliferation, migration, angiogenesis, and tumor resistance. The cellular balance between Cer and S1P levels, for example, is an important determinant of cell fate, with the former inducing apoptosis and the later mitogenesis. Acid ceramidase (ASAH1) plays a pivotal role in regulating the intracellular concentration of these two metabolites by hydrolyzing Cer into SPH, which is rapidly phosphorylated to form S1P. Genistein is a phytoestrogen isoflavone that exerts agonist and antagonist effects on the proliferation of estrogen-dependent MCF-7 cells in a dose-dependent manner, primarily as a ligand for estrogen receptors. Genistein can also activate signaling through GPR30, a G-protein-coupled cell surface receptor. Based on the relationship between bioactive sphingolipids and tumorigenesis, we sought to determine the effect of genistein on ASAH1 transcription in MCF-7 breast cancer cells. We show herein that nanomolar concentrations of genistein induce ASAH1 transcription through a GPR30-dependent, pertussis toxin-sensitive pathway that requires the activation of c-Src and extracellular signal regulated kinase 1/2 (ERK1/2). Activation of this pathway promotes histone acetylation and recruitment of phospho-estrogen receptor alpha and specificity protein-1 to the ASAH1 promoter, ultimately culminating in increased ceramidase activity. Finally, we show that genistein stimulates cyclin B2 expression and cell proliferation in an ASAH1-dependent manner. Collectively, these data identify a mechanism through which genistein promotes sphingolipid metabolism and support a role for ASAH1 in breast cancer cell growth.	[Lucki, Natasha C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sewer, Marion B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego	Sewer, MB (corresponding author), 9500 Gilman Dr,MC 0704, La Jolla, CA 92093 USA.	msewer@ucsd.edu			National Institutes of Health [DK08417]; American Heart Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant DK08417 (to M. B. S.) and an American Heart Association Predoctoral Fellowship (to N. C. L.).	Albanito L, 2008, ENVIRON HEALTH PERSP, V116, P1648, DOI 10.1289/ehp.11297; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Allred CD, 2001, CANCER RES, V61, P5045; Allred CD, 2001, CARCINOGENESIS, V22, P1667, DOI 10.1093/carcin/22.10.1667; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Bai AP, 2009, BIOORGAN MED CHEM, V17, P1840, DOI 10.1016/j.bmc.2009.01.057; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Brown NM, 2000, CELL GROWTH DIFFER, V11, P255; Buteau-Lozano H, 2008, J ENDOCRINOL, V196, P399, DOI 10.1677/JOE-07-0198; Cotroneo MS, 2002, CARCINOGENESIS, V23, P1467, DOI 10.1093/carcin/23.9.1467; Dammer EB, 2007, MOL ENDOCRINOL, V21, P415, DOI 10.1210/me.2006-0361; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; El Touny LH, 2009, CANCER RES, V69, P3695, DOI 10.1158/0008-5472.CAN-08-2958; Elojeimy S, 2007, MOL THER, V15, P1259, DOI 10.1038/sj.mt.6300167; Fan YJ, 2009, CANCER LETT, V284, P189, DOI 10.1016/j.canlet.2009.04.024; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; French KJ, 2003, CANCER RES, V63, P5962; Fu Z, 2010, ENDOCRINOLOGY, V151, P3026, DOI 10.1210/en.2009-1294; Gikas PD, 2005, INT J FERTIL WOMEN M, V50, P250; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gupta S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-26; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Hsieh CY, 1998, CANCER RES, V58, P3833; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Jiang XG, 2008, ENDOCRINOLOGY, V149, P5366, DOI 10.1210/en.2008-0857; Ju YH, 2002, CANCER RES, V62, P2474; Ju YH, 2001, J NUTR, V131, P2957, DOI 10.1093/jn/131.11.2957; Kanda N, 2004, J INVEST DERMATOL, V123, P319, DOI 10.1111/j.0022-202X.2004.12645.x; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lamartiniere CA, 2000, AM J CLIN NUTR, V71, p1705S, DOI 10.1093/ajcn/71.6.1705S; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lavieu Gregory, 2008, V445, P159, DOI 10.1007/978-1-59745-157-4_11; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li CM, 1999, GENOMICS, V62, P223, DOI 10.1006/geno.1999.5940; Li CM, 1998, GENOMICS, V50, P267, DOI 10.1006/geno.1998.5334; Li Y, 2010, MOL ENDOCRINOL, V24, P969, DOI 10.1210/me.2009-0148; Liu B, 2005, CANCER RES, V65, P879, DOI 10.1158/0008-5472.CAN-04-3714; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Lucki N, 2009, BBA-MOL CELL BIOL L, V1791, P706, DOI 10.1016/j.bbalip.2009.03.005; Lucki Natasha C., 2008, V49, P387, DOI 10.1007/978-1-4020-8831-5_15; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2001, MOL PHARMACOL, V60, P595; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Messina M, 2006, JNCI-J NATL CANCER I, V98, P1275, DOI 10.1093/jnci/djj356; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479; Moller FJ, 2010, TOXICOL LETT, V196, P142, DOI 10.1016/j.toxlet.2010.03.1117; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Park JH, 2005, BBA-GENE STRUCT EXPR, V1732, P82, DOI 10.1016/j.bbaexp.2006.01.002; Peeters PHM, 2003, BREAST CANCER RES TR, V77, P171, DOI 10.1023/A:1021381101632; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ruckhaberle E, 2009, CLIMACTERIC, V12, P502, DOI 10.3109/13697130902939913; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Selzner M, 2001, CANCER RES, V61, P1233; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wang C, 2008, MOL ENDOCRINOL, V22, P636, DOI 10.1210/me.2007-0359; WANG E, 1991, J BIOL CHEM, V266, P14486; Wang TTY, 1996, CARCINOGENESIS, V17, P271, DOI 10.1093/carcin/17.2.271; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012; Yang XH, 2003, CANCER RES, V63, P2425	86	61	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19399	19409		10.1074/jbc.M110.195826	http://dx.doi.org/10.1074/jbc.M110.195826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21493710	hybrid, Green Published			2022-12-25	WOS:000291027700022
J	Barba, I; del Blanco, BG; Abdul-Jawad, O; Barrabes, JA; Marti, G; Domingo, E; Angel, J; Garcia-Dorado, D				Barba, Ignasi; Garcia del Blanco, Bruno; Abdul-Jawad, Omar; Barrabes, Jose A.; Marti, Gerard; Domingo, Enric; Angel, Joan; Garcia-Dorado, David			MRI Discriminates Thrombus Composition and ST Resolution after Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ATHEROSCLEROTIC PLAQUE; PRIMARY ANGIOPLASTY; ARTERIAL THROMBUS; RUPTURE; DEATH	Histological composition of material obtained by thrombus aspiration during percutaneous coronary intervention (PCI) in patients with ST-segment elevation acute myocardial infarction (STEMI) is highly variable. We aimed to characterize this material using magnetic resonance imaging (MRI) and to correlate MRI findings with the success of PCI in terms of ST-segment resolution. Thrombus aspiration during primary or rescue PCI was attempted in 100 consecutive STEMI patients, of whom enough material for MRI was obtained in 59. MR images were obtained at 9.4T and T1 and T2 values were measured. Patients with (n = 31) and without (n = 28) adequate ST resolution 120 min after PCI (>= 70% of pre-PCI value) had similar baseline characteristics except for a higher prevalence of diabetes mellitus in the latter (10 vs. 43%, p = 0.003). T1 values were similar in both groups (1248 +/- 112 vs. 1307 +/- 85 ms, respectively, p = 0.7). T2 values averaged 31.2 +/- 10.3 and 36.6 +/- 12.2 ms; in thrombus from patients with and without adequate ST resolution (p = 0.09). After adjusting for diabetes and other baseline characteristics, lower T2 values were significantly associated with inadequate ST resolution (odds ratio for 1 ms increase 1.08, CI 95% 1.01-1.16, p = 0.027). Histology classified thrombus in 3 groups: coagulated blood (n = 38), fibrin rich (n = 9) and lipid-rich (n = 3). Thrombi composed mostly of coagulated blood were characterized as being of short (n = 10), intermediate (n = 15) or long evolution (n = 13), T2 values being 34.0 +/- 13.2, 31.9 +/- 8.3 and 31.5 +/- 7.9 ms respectively (p = NS). In this subgroup, T2 was significantly higher in specimens from patients with inadequate perfusion (35.9 +/- 10.3 versus 28.6 +/- 6.7 ms, p = 0.02). This can be of clinical interest as it provides information on the probability of adequate ST resolution, a surrogate for effective myocardial reperfusion.	[Barba, Ignasi] Univ Autonoma Barcelona, Dept Cardiol, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Res Inst, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Barba, I (corresponding author), Univ Autonoma Barcelona, Dept Cardiol, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain.	dgdorado@vhebron.net	Barba, Ignasi/A-5221-2011; Barba, Ignasi/H-5104-2013	Barba, Ignasi/0000-0001-9886-3776; Garcia del Blanco, Bruno/0000-0002-4527-1600; Barrabes, Jose A./0000-0001-7062-6277	Spanish Ministries of Science [SAF2008-03067]; Redes tematicas de investigacion cooperativa sanitaria-Red investigacion enfermedades cardiovasculares, RETICS-RECAVA [RD06/0014/0025]; Ramon y Cajal fellowship	Spanish Ministries of Science; Redes tematicas de investigacion cooperativa sanitaria-Red investigacion enfermedades cardiovasculares, RETICS-RECAVA; Ramon y Cajal fellowship(Spanish Government)	This work was supported by the Spanish Ministries of Science (SAF2008-03067 and Redes tematicas de investigacion cooperativa sanitaria-Red investigacion enfermedades cardiovasculares, RETICS-RECAVA, RD06/0014/0025); I. Barba is a recipient of a Ramon y Cajal fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corti R, 2006, PHARMACOL THERAPEUT, V110, P57, DOI 10.1016/j.pharmthera.2005.09.004; Corti R, 2002, J AM COLL CARDIOL, V39, P1366, DOI 10.1016/S0735-1097(02)01754-0; Corti R, 2001, CIRCULATION, V103, P2420; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; FALK E, 1983, BRIT HEART J, V50, P127; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Fayad ZA, 2001, CIRC RES, V89, P305, DOI 10.1161/hh1601.095596; Fuster V, 2005, CIRCULATION, V112, P135, DOI 10.1161/01.CIR.0000155618.37779.A0; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hore P.J., 1995, NUCL MAGNETIC RESONA; Jaffe R, 2009, J AM COLL CARDIOL, V53, P1148, DOI 10.1016/j.jacc.2008.09.064; Kawasaki T, 2009, JACC-CARDIOVASC IMAG, V2, P720, DOI 10.1016/j.jcmg.2009.01.016; Kelle S, 2009, MAGN RESON IMAGING C, V17, P145, DOI 10.1016/j.mric.2008.12.003; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Kramer MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005817; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Ojio S, 2000, CIRCULATION, V102, P2063, DOI 10.1161/01.CIR.102.17.2063; Prasad A, 2005, J AM COLL CARDIOL, V45, P508, DOI 10.1016/j.jacc.2004.10.054; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Sharma Rakesh, 2004, Thromb J, V2, P5, DOI 10.1186/1477-9560-2-5; Shinnar M, 1999, ARTERIOSCL THROM VAS, V19, P2756, DOI 10.1161/01.ATV.19.11.2756; Sirol M, 2005, CIRCULATION, V112, P1594, DOI 10.1161/CIRCULATIONAHA.104.522110; Stuber M, 1999, J AM COLL CARDIOL, V34, P524, DOI 10.1016/S0735-1097(99)00223-5; Stuber M, 2007, J MAGN RESON IMAGING, V26, P219, DOI 10.1002/jmri.20949; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Worthley SG, 2000, ATHEROSCLEROSIS, V150, P321, DOI 10.1016/S0021-9150(99)00386-X	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18459	10.1371/journal.pone.0018459	http://dx.doi.org/10.1371/journal.pone.0018459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494632	gold, Green Submitted, Green Published			2022-12-25	WOS:000289292800018
J	Deng, Y; Zhang, WY; Farhat, K; Oberland, S; Gisselmann, G; Neuhaus, EM				Deng, Ying; Zhang, Weiyi; Farhat, Katja; Oberland, Sonja; Gisselmann, Guenter; Neuhaus, Eva M.			The Stimulatory G alpha(s) Protein Is Involved in Olfactory Signal Transduction in Drosophila	PLOS ONE			English	Article							MOSQUITO ANOPHELES-GAMBIAE; HAWKMOTH MANDUCA-SEXTA; ODORANT RECEPTOR; ADULT DROSOPHILA; PHOSPHOLIPASE-C; MOLECULAR-BASIS; IN-VIVO; CHEMOSENSORY RECEPTORS; FUNCTIONAL EXPRESSION; MEMBRANE TOPOLOGY	Seven-transmembrane receptors typically mediate olfactory signal transduction by coupling to G-proteins. Although insect odorant receptors have seven transmembrane domains like G-protein coupled receptors, they have an inverted membrane topology, constituting a key difference between the olfactory systems of insects and other animals. While heteromeric insect ORs form ligand-activated non-selective cation channels in recombinant expression systems, the evidence for an involvement of cyclic nucleotides and G-proteins in odor reception is inconsistent. We addressed this question in vivo by analyzing the role of G-proteins in olfactory signaling using electrophysiological recordings. We found that G alpha(s) plays a crucial role for odorant induced signal transduction in OR83b expressing olfactory sensory neurons, but not in neurons expressing CO2 responsive proteins GR21a/GR63a. Moreover, signaling of Drosophila ORs involved G alpha(s) also in a heterologous expression system. In agreement with these observations was the finding that elevated levels of cAMP result in increased firing rates, demonstrating the existence of a cAMP dependent excitatory signaling pathway in the sensory neurons. Together, we provide evidence that G alpha(s) plays a role in the OR mediated signaling cascade in Drosophila.	[Deng, Ying] Huazhong Univ Sci & Technol, Sino France Joint Ctr Drug Res & Screening, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Deng, Ying; Zhang, Weiyi; Farhat, Katja; Gisselmann, Guenter] Ruhr Univ Bochum, Bochum, Germany; [Zhang, Weiyi] Bioduro Beijing Co Ltd, Changping, Peoples R China; [Farhat, Katja] Univ Gottingen, Dept Cardiovasc Physiol, Gottingen, Germany; [Oberland, Sonja; Neuhaus, Eva M.] Charite, Neurosci Res Ctr, Berlin, Germany	Huazhong University of Science & Technology; Ruhr University Bochum; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Deng, Y (corresponding author), Huazhong Univ Sci & Technol, Sino France Joint Ctr Drug Res & Screening, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	eva.neuhaus@charite.de	Neuhaus, Eva M./L-1428-2015	Neuhaus, Eva M./0000-0003-3363-1231	NE [755/3-1]; Max-Planck-Research School for Chemical Biology (IMPRS-CB)	NE; Max-Planck-Research School for Chemical Biology (IMPRS-CB)	Funding was provided by NE 755/3-1 www.dfg.de, EXC257 www.dfg.de, and Max-Planck-Research School for Chemical Biology (IMPRS-CB)www.mpg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BOEKHOFF I, 1990, CELL SIGNAL, V2, P49, DOI 10.1016/0898-6568(90)90032-6; Boto T, 2010, CHEM SENSES, V35, P183, DOI 10.1093/chemse/bjp095; BREDENDIEK N, 2010, CHEM SENSES IN PRESS; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chambers RS, 2003, NAT BIOTECHNOL, V21, P1088, DOI 10.1038/nbt858; Chatterjee Abhishek, 2009, BMC Physiology, V9, P22, DOI 10.1186/1472-6793-9-22; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Deckert CM, 2006, J RECEPT SIG TRANSD, V26, P647, DOI 10.1080/10799890600920670; Dubin AE, 1998, J NEUROSCI, V18, P5603; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Ge H, 2006, CHEM SENSES, V31, P49, DOI 10.1093/chemse/bjj005; Gisselmann GN, 2005, INSECT BIOCHEM MOLEC, V35, P505, DOI 10.1016/j.ibmb.2005.02.001; Gomez-Diaz C, 2004, BEHAV GENET, V34, P395, DOI 10.1023/B:BEGE.0000023645.02710.fe; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krishnan P, 2008, CURR BIOL, V18, P803, DOI 10.1016/j.cub.2008.04.060; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laue M, 1997, CELL TISSUE RES, V288, P149, DOI 10.1007/s004410050802; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Marx Thomas, 1999, Invertebrate Neuroscience, V4, P55, DOI 10.1007/s101580050007; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; Merrill CE, 2005, J NEUROBIOL, V63, P15, DOI 10.1002/neu.20113; Merrill CE, 2002, P NATL ACAD SCI USA, V99, P1633, DOI 10.1073/pnas.022505499; Miura N, 2005, J COMP NEUROL, V485, P143, DOI 10.1002/cne.20488; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Pelz D, 2006, J NEUROBIOL, V66, P1544, DOI 10.1002/neu.20333; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Rutzler M, 2006, J COMP NEUROL, V499, P533, DOI 10.1002/cne.21083; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; TALLURI S, 1995, P NATL ACAD SCI USA, V92, P11475, DOI 10.1073/pnas.92.25.11475; Tanoue S, 2008, CURR BIOL, V18, P787, DOI 10.1016/j.cub.2008.04.062; Ueda T, 2003, J NEUROSCI, V23, P7376; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; VAUGHAN J, 1988, ADV ENZYMOL RELAT AR, V61, P303; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Walker WB, 2008, J INSECT PHYSIOL, V54, P680, DOI 10.1016/j.jinsphys.2008.01.007; WEST RE, 1985, J BIOL CHEM, V260, P4428; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Wicher D, 2006, J NEUROPHYSIOL, V95, P2314, DOI 10.1152/jn.01007.2005; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wolfgang WJ, 2001, GENETICS, V158, P1189; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	83	57	58	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18605	10.1371/journal.pone.0018605	http://dx.doi.org/10.1371/journal.pone.0018605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490930	Green Submitted, gold, Green Published			2022-12-25	WOS:000289238700028
J	Hautier, L; Lebrun, R; Saksiri, S; Michaux, J; Vianey-Liaud, M; Marivaux, L				Hautier, Lionel; Lebrun, Renaud; Saksiri, Soonchan; Michaux, Jacques; Vianey-Liaud, Monique; Marivaux, Laurent			Hystricognathy vs Sciurognathy in the Rodent Jaw: A New Morphometric Assessment of Hystricognathy Applied to the Living Fossil Laonastes (Diatomyidae)	PLOS ONE			English	Article							MASTICATORY MUSCLE ARCHITECTURE; CAVIOMORPH RODENTS; MOLECULAR EVIDENCE; EVOLUTION; MAMMALIA; EOCENE; PHYLOGENY; TIMESCALE; THAILAND	While exceptional for an intense diversification of lineages, the evolutionary history of the order Rodentia comprises only a limited number of morphological morphotypes for the mandible. This situation could partly explain the intense debates about the taxonomic position of the latest described member of this clade, the Laotian rock rat Laonastes aenigmamus (Diatomyidae). This discovery has re-launched the debate on the definition of the Hystricognathi suborder identified using the angle of the jaw relative to the plane of the incisors. Our study aims to end this ambiguity. For clarity, it became necessary to revisit the entire morphological diversity of the mandible in extant and extinct rodents. However, current and past rodent diversity brings out the limitations of the qualitative descriptive approach and highlights the need for a quantitative approach. Here, we present the first descriptive comparison of the masticatory apparatus within the Ctenohystrica clade, in combining classic comparative anatomy with morphometrical methods. First, we quantified the shape of the mandible in rodents using 3D landmarks. Then, the analysis of osteological features was compared to myological features in order to understand the biomechanical origin of this morphological diversity. Among the morphological variation observed, the mandible of Laonastes aenigmamus displays an intermediate association of features that could be considered neither as sciurognathous nor as hystricognathous.	[Hautier, Lionel] Univ Cambridge, Museum Zool, Cambridge, England; [Lebrun, Renaud] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Lebrun, Renaud; Michaux, Jacques; Vianey-Liaud, Monique; Marivaux, Laurent] Univ Montpellier 2, Lab Paleontol, Inst Sci Evolut Montpellier, UMR CNRS 5554, Montpellier, France; [Saksiri, Soonchan] Mahasarakham Univ, Dept Biol, Fac Sci, Maha Sarakham, Thailand	University of Cambridge; University of Zurich; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Mahasarakham University	Hautier, L (corresponding author), Univ Cambridge, Museum Zool, Cambridge, England.	ljh75@cam.ac.uk	Kostur, Karol/F-8212-2010	Kostur, Karol/0000-0002-5789-7184; Lebrun, Renaud/0000-0002-5819-2653; Hautier, Lionel/0000-0001-8701-5421	University of Montpellier; French government; MRT; Leverhulme Trust	University of Montpellier; French government; MRT; Leverhulme Trust(Leverhulme Trust)	The University of Montpellier and French government (via a ministerial fellowship, MRT), the European Commission's Research Infrastructure Action (via the SYNTHESYS Project), ANR-PALASIAFRICA Program (ANR-08-JCJC-0017, ANR-ERC), and the Leverhulme Trust have supported the present work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becht G., 1953, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V56C, P508; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Brandt JF., 1855, MEM ACAD IMP ST PETE, V7, P1; Bryant J. Daniel, 1995, American Museum Novitates, V3156, P1; Bugge J., 1985, EVOLUTIONARY RELATIO, P381; BUTLER PM, 1980, FUNCTIONAL ASPECTS E, P249; Carleton M.D., 1984, P255; CROMPTON AW, 1969, NATURE, V222, P678, DOI 10.1038/222678b0; Dawson Mary R., 2010, Vertebrata Palasiatica, V48, P328; Dawson MR, 2006, SCIENCE, V311, P1456, DOI 10.1126/science.1124187; de Leon MSP, 2007, VERTEBR PALEOBIOL PA, P71; DEQUEIROZ K, 1994, SYST BIOL, V43, P497, DOI 10.1093/sysbio/43.4.497; Dryden I., 1998, STAT ANAL SHAPE; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GREAVES WS, 1980, AM NAT, V116, P432, DOI 10.1086/283636; Hautier L, 2010, MAMMALIA, V74, P153, DOI 10.1515/MAMM.2010.025; Hautier L, 2010, PALAIOS, V25, P6, DOI 10.2110/palo.2009.p09-047r; Hautier L, 2009, J ANAT, V215, P401, DOI 10.1111/j.1469-7580.2009.01130.x; Hautier L, 2008, ZOOL J LINN SOC-LOND, V154, P807, DOI 10.1111/j.1096-3642.2008.00453.x; Hiiemae K.M., 1978, P359; HIIEMAE KM, 1967, J DENT RES, V46, P883; Honeycutt RL, 2003, MOL PHYLOGENET EVOL, V26, P476, DOI 10.1016/S1055-7903(02)00368-8; Huchon D, 2000, P ROY SOC B-BIOL SCI, V267, P393, DOI 10.1098/rspb.2000.1014; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Jaeger J.-J., 1985, EVOLUTIONARY RELATIO, P567; Jaeger JJ, 2010, ZOOL J LINN SOC-LOND, V160, P195, DOI 10.1111/j.1096-3642.2009.00600.x; Jenkins PD, 2004, SYST BIODIVERS, V2, P419, DOI DOI 10.1017/S1477200004001549; LANDRY SO, 1999, MITT MUS NAT BERL ZO, V2, P283; LANDRY STUART O., 1957, UNIV CALIFORNIA PUBL ZOOL, V56, P1; Lavocat R., 1976, Palaeovertebrata, V7, P15; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; Lebrun R, 2008, THESIS U MONTPELLIER; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; Luckett W. P., 1993, Journal of Mammalian Evolution, V1, P127, DOI 10.1007/BF01041591; Luckett WP, 1985, EVOLUTIONARY RELATIO, P685; MARCUS LF, 1996, ADV MORPHOMETRICS; Marivaux L, 2000, CR ACAD SCI II A, V331, P427, DOI 10.1016/S1251-8050(00)01427-0; Marivaux L, 2004, GEODIVERSITAS, V26, P493; Marivaux L, 2002, ZOOL SCR, V31, P225, DOI 10.1046/j.1463-6409.2002.00074.x; Marivaux L, 2004, ZOOL J LINN SOC-LOND, V142, P105, DOI 10.1111/j.1096-3642.2004.00131.x; Mouchaty SK, 2001, MOL PHYLOGENET EVOL, V18, P127, DOI 10.1006/mpev.2000.0870; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nedbal Michael A., 1996, Journal of Mammalian Evolution, V3, P201, DOI 10.1007/BF01458181; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; Opazo JC, 2005, MOL PHYLOGENET EVOL, V37, P932, DOI 10.1016/j.ympev.2005.05.002; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rowe DL, 2002, MOL BIOL EVOL, V19, P263, DOI 10.1093/oxfordjournals.molbev.a004080; Sallam HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016525; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Specht M, 2007, THESIS U ZURICH IRCH; Specht M, 2007, VISUAL COMPUT, V23, P743, DOI 10.1007/s00371-007-0156-1; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Tullberg T., 1899, NOVA ACTA REG SOC, V3, P1; Vassallo Aldo I., 2001, Boletin de la Sociedad de Biologia de Concepcion, V72, P145; Wang Banyue, 2001, American Museum Novitates, V3317, P1, DOI 10.1206/0003-0082(2001)317<0001:OTRMOA>2.0.CO;2; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson L. A. B., 2009, P ROYAL SOC B, V277, P1227; Wood A.E., 1968, EARLY CENOZOIC MAMMA, P23; WOOD AE, 1972, SCIENCE, V175, P1250, DOI 10.1126/science.175.4027.1250; WOOD AE, 1965, EVOLUTION, V19, P115, DOI 10.2307/2406300; WOOD AE, 1958, SYST ZOOL, V7, P169, DOI 10.2307/2411716; WOOD AE, 1975, STUDIES CENOZOIC PAL, P75; WOOD ALBERT E., 1962, TRANS AMER PHIL SOC, V52, P1; Woods CA., 1982, MAMMALIAN BIOL S AM, P377; Woods CA., 1985, EVOLUTIONARY RELATIO, P515	66	49	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18698	10.1371/journal.pone.0018698	http://dx.doi.org/10.1371/journal.pone.0018698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490933	Green Published, Green Submitted, gold			2022-12-25	WOS:000289238700038
J	Lewis, J; Abas, Z; Dadousis, C; Lykidis, D; Paschou, P; Drineas, P				Lewis, Jamey; Abas, Zafiris; Dadousis, Christos; Lykidis, Dimitrios; Paschou, Peristera; Drineas, Petros			Tracing Cattle Breeds with Principal Components Analysis Ancestry Informative SNPs	PLOS ONE			English	Article							MICROSATELLITE DNA VARIATION; EUROPEAN CATTLE; GENETIC-STRUCTURE; POPULATION-STRUCTURE; BEEF-CATTLE; MARKERS; ADMIXTURE; FOOD; IDENTIFICATION; EVOLUTION	The recent release of the Bovine HapMap dataset represents the most detailed survey of bovine genetic diversity to date, providing an important resource for the design and development of livestock production. We studied this dataset, comprising more than 30,000 Single Nucleotide Polymorphisms (SNPs) for 19 breeds (13 taurine, three zebu, and three hybrid breeds), seeking to identify small panels of genetic markers that can be used to trace the breed of unknown cattle samples. Taking advantage of the power of Principal Components Analysis and algorithms that we have recently described for the selection of Ancestry Informative Markers from genomewide datasets, we present a decision-tree which can be used to accurately infer the origin of individual cattle. In doing so, we present a thorough examination of population genetic structure in modern bovine breeds. Performing extensive cross-validation experiments, we demonstrate that 250-500 carefully selected SNPs suffice in order to achieve close to 100% prediction accuracy of individual ancestry, when this particular set of 19 breeds is considered. Our methods, coupled with the dense genotypic data that is becoming increasingly available, have the potential to become a valuable tool and have considerable impact in worldwide livestock production. They can be used to inform the design of studies of the genetic basis of economically important traits in cattle, as well as breeding programs and efforts to conserve biodiversity. Furthermore, the SNPs that we have identified can provide a reliable solution for the traceability of breed-specific branded products.	[Lewis, Jamey; Drineas, Petros] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Abas, Zafiris; Dadousis, Christos] Democritus Univ Thrace, Dept Agr Dev, Orestiada, Greece; [Lykidis, Dimitrios; Paschou, Peristera] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece	Rensselaer Polytechnic Institute; Democritus University of Thrace; Democritus University of Thrace	Lewis, J (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.	ppaschou@mbg.duth.gr; drinep@cs.rpi.edu		DADOUSIS, CHRISTOS/0000-0002-7689-6443; Paschou, Peristera/0000-0002-9783-1024	National Science Foundation (NSF) [CCF 0447950, CCF 0824684]; EMBO [ASTF 235-2009]	National Science Foundation (NSF)(National Science Foundation (NSF)); EMBO(European Molecular Biology Organization (EMBO))	This work was supported, in part, by a National Science Foundation (NSF) CCF 0447950 CAREER award to PD, an NSF CCF 0824684 award to PD, and an EMBO ASTF 235-2009 Short Term Fellowship to PD. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beja-Pereira A, 2003, J HERED, V94, P243, DOI 10.1093/jhered/esg055; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Canon J, 2001, GENET SEL EVOL, V33, P311, DOI 10.1051/gse:2001121; Capoferri R, 2006, J FOOD PROTECT, V69, P1971, DOI 10.4315/0362-028X-69.8.1971; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; DEAN M, 1994, AM J HUM GENET, V55, P788; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Edwards CJ, 2000, ANIM GENET, V31, P329, DOI 10.1046/j.1365-2052.2000.00651.x; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Goodman D, 2004, SOCIOL RURALIS, V44, P3, DOI 10.1111/j.1467-9523.2004.00258.x; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Ilbery B, 2005, LAND USE POLICY, V22, P331, DOI 10.1016/j.landusepol.2004.06.002; Ilbery B, 2000, J RURAL STUD, V16, P217, DOI 10.1016/S0743-0167(99)00041-8; Khatkar MS, 2007, GENETICS, V176, P763, DOI 10.1534/genetics.106.069369; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; MACHUGH DE, 1994, P ROY SOC B-BIOL SCI, V256, P25, DOI 10.1098/rspb.1994.0044; MacHugh DE, 1997, GENETICS, V146, P1071; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Negrini R, 2008, MEAT SCI, V80, P1212, DOI 10.1016/j.meatsci.2008.05.021; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parrott N, 2002, EUR URBAN REG STUD, V9, P241, DOI 10.1177/096977640200900304; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rischkowsky B, 2007, STAT WORLDS AN GEN R; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WILLHAM RL, 1986, J ANIM SCI, V62, P1742, DOI 10.2527/jas1986.6261742x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	42	29	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18007	10.1371/journal.pone.0018007	http://dx.doi.org/10.1371/journal.pone.0018007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490966	Green Submitted, gold, Green Published			2022-12-25	WOS:000289238700003
J	Nishiyama, T; Kii, I; Kashima, TG; Kikuchi, Y; Ohazama, A; Shimazaki, M; Fukayama, M; Kudo, A				Nishiyama, Takashi; Kii, Isao; Kashima, Takeshi G.; Kikuchi, Yoshinao; Ohazama, Atsushi; Shimazaki, Masashi; Fukayama, Masashi; Kudo, Akira			Delayed Re-Epithelialization in Periostin-Deficient Mice during Cutaneous Wound Healing	PLOS ONE			English	Article							LAMININ-5 GAMMA-2 CHAIN; STEM-CELLS; EXTRACELLULAR-MATRIX; HAIR FOLLICLE; KERATINOCYTE MIGRATION; SKIN; EXPRESSION; PROTEIN; GROWTH; DEFECTS	Background: Matricellular proteins, including periostin, are important for tissue regeneration. Methods and Findings: Presently we investigated the function of periostin in cutaneous wound healing by using periostin-deficient (-/-) mice. Periostin mRNA was expressed in both the epidermis and hair follicles, and periostin protein was located at the basement membrane in the hair follicles together with fibronectin and laminin gamma 2. Periostin was associated with laminin gamma 2, and this association enhanced the proteolytic cleavage of the laminin gamma 2 long form to produce its short form. To address the role of periostin in wound healing, we employed a wound healing model using WT and periostin-/- mice and the scratch wound assay in vitro. We found that the wound closure was delayed in the periostin-/- mice coupled with a delay in re-epithelialization and with reduced proliferation of keratinocytes. Furthermore, keratinocyte proliferation was enhanced in periostin-overexpressing HaCaT cells along with up-regulation of phosphorylated NF-kappa B. Conclusion: These results indicate that periostin was essential for keratinocyte proliferation for re-epithelialization during cutaneous wound healing.	[Nishiyama, Takashi; Kii, Isao; Shimazaki, Masashi; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Kashima, Takeshi G.; Kikuchi, Yoshinao; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Human Pathol, Tokyo, Japan; [Ohazama, Atsushi] Showa Univ, Sch Dent, Dept Pediodontol, Tokyo 142, Japan	Tokyo Institute of Technology; University of Tokyo; Showa University	Nishiyama, T (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 227, Japan.	akudo@bio.titech.ac.jp	KII, Isao/C-4117-2017; Nishiyama, Takashi/ABC-8965-2021; Kikuchi, Yoshinao/AAH-1914-2020; Kudo, Akira/C-7340-2015	KII, Isao/0000-0002-6153-6250; Nishiyama, Takashi/0000-0002-4496-240X; Kudo, Akira/0000-0001-6289-3391	Ministry of Education, Science, Culture, and Sports of Japan; Japan Space Forum	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan, and by grants from the Ground-based Research Program for Space Utilization promoted by Japan Space Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; BLANPAIN C, 2010, SCIENCE, V464, P686; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Decline F, 2001, J CELL SCI, V114, P811; DIPIETRO LA, 2003, WOUND HEALING METHOD, P17; Eyden B, 2009, INT J CANCER, V125, P1743, DOI 10.1002/ijc.24550; Fukushima N, 2008, MODERN PATHOL, V21, P1044, DOI 10.1038/modpathol.2008.77; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Natarajan E, 2006, AM J PATHOL, V168, P1821, DOI 10.2353/ajpath.2006.051027; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Ono Y, 1999, CANCER, V85, P2315, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2315::AID-CNCR3>3.0.CO;2-Y; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tanabe H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012234; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; WATT FM, 1993, J CELL SCI, V106, P175; Zhou HM, 2010, J CELL COMMUN SIGNAL, V4, P99, DOI 10.1007/s12079-010-0090-2	38	99	99	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18410	10.1371/journal.pone.0018410	http://dx.doi.org/10.1371/journal.pone.0018410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490918	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700012
J	Giret, MTM; Miraglia, JL; Sucupira, MCA; Nishiya, A; Levi, JE; Diaz, RS; Sabino, EC; Kallas, EG				Giret, Maria Teresa M.; Miraglia, Joao Luiz; Araripe Sucupira, Maria Cecilia; Nishiya, Anna; Levi, Jose Eduardo; Diaz, Ricardo S.; Sabino, Ester C.; Kallas, Esper G.			Prevalence, Incidence Density, and Genotype Distribution of GB Virus C Infection in a Cohort of Recently HIV-1-Infected Subjects in Sao Paulo, Brazil	PLOS ONE			English	Article							HEPATITIS-G VIRUS; C/HEPATITIS-G-VIRUS; EARLY HIV-1 INFECTION; ANTIRETROVIRAL THERAPY; PHYLOGENETIC ANALYSIS; DISEASE PROGRESSION; REGION SEQUENCES; NONCODING REGION; BLOOD-DONORS; NO INFLUENCE	Background: The results of previous studies elsewhere have indicated that GB virus C (GBV-C) infection is frequent in patients infected with the human immunodeficiency virus type 1 (HIV-1) due to similar transmission routes of both viruses. The aim of this study was to determine the prevalence, incidence density and genotypic characteristics of GBV-C in this population. Methodology/Principal Findings: The study population included 233 patients from a cohort primarily comprised of homosexual men recently infected with HIV-1 in Sao Paulo, Brazil. The presence of GBV-C RNA was determined in plasma samples by reverse transcriptase-nested polymerase chain reaction and quantified by real-time PCR. GBV-C genotypes were determined by direct sequencing. HIV viral load, CD4+ T lymphocyte and CD8+ T lymphocyte count were also tested in all patients. The overall prevalence of GBV-C infection was 0.23 (95% CI: 0.18 to 0.29) in the study group. There was no significant difference between patients with and without GBV-C infection and Glycoprotein E2 antibody presence regarding age, sex, HIV-1 viral load, CD4+ and CD8+ T cell counts and treatment with antiretroviral drugs. An inverse correlation was observed between GBV-C and HIV-1 loads at enrollment and after one year. Also, a positive but not significant correlation was observed between GBV-C load and CD4+ T lymphocyte. Phylogenetic analysis of the GBV-C isolates revealed the presence of genotype 1 and genotype 2, these sub classified into subtype 2a and 2b. Conclusion/Significance: GBV-C infection is common in recently HIV -1 infected patients in Sao Paulo, Brazil and the predominant genotype is 2b. This study provides the first report of the GBV-C prevalence at the time of diagnosis of HIV-1 and the incidence density of GBV-C infection in one year.	[Giret, Maria Teresa M.; Miraglia, Joao Luiz; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Araripe Sucupira, Maria Cecilia; Diaz, Ricardo S.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Nishiya, Anna; Sabino, Ester C.] Sao Paulo Blood Bank, Sao Paulo, Brazil; [Levi, Jose Eduardo] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Giret, MTM (corresponding author), Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil.	esper.kallas@gmail.com	Kallas, Esper G/C-9539-2012; Sabino, Ester C/F-7750-2010; Araripe Sucupira, Maria Cecilia/K-1931-2012; Nishiya, Anna/Q-8156-2016; Diaz, Ricardo/K-3978-2012; Miraglia, Joao/H-5294-2013	Sabino, Ester C/0000-0003-2623-5126; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382; Kallas, Esper/0000-0003-2026-6925; Miraglia, Joao Luiz/0000-0002-4788-6254	Ministry of Health [914/BRA/3014-UNESCO/Kallas]; Sao Paulo City Health Department [2004-0.168.922-7/Kallas]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Diaz, Sabino Kallas, 05/01072-9/Levi]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education	Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported with funding from the Brazilian Program for STD and AIDS, Ministry of Health (914/BRA/3014-UNESCO/Kallas), the Sao Paulo City Health Department (2004-0.168.922-7/Kallas), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Diaz, Sabino & Kallas; and 05/01072-9/Levi). T.M.G. was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, NEW ENGL J MED, V336, P741, DOI 10.1056/NEJM199703133361101; Barbosa AD, 2009, REV SOC BRAS MED TRO, V42, P591, DOI 10.1590/S0037-86822009000500021; Barbour JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001080; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Berzsenyi MD, 2005, J CLIN VIROL, V33, P257, DOI 10.1016/j.jcv.2005.04.002; Birk M, 2002, AIDS, V16, P2482, DOI 10.1097/00002030-200212060-00017; Bjorkman P, 2004, AIDS, V18, P877, DOI [10.1097/01.aids.0000125908.52357.4c, 10.1097/00002030-200404090-00005]; Branco C, 2010, J MED VIROL, V82, P452, DOI 10.1002/jmv.21703; Brumme ZL, 2002, AIDS, V16, P1929, DOI 10.1097/00002030-200209270-00010; Compston LI, 2009, J MED VIROL, V81, P1860, DOI 10.1002/jmv.21614; Gallian P, 1998, J MED VIROL, V56, P310, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt;310::AID-JMV4&gt;3.0.CO;2-4; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; Hammad AM, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-36; Handajani R, 2000, J CLIN MICROBIOL, V38, P662, DOI 10.1128/JCM.38.2.662-668.2000; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Hosseini-Moghaddam SM, 2008, J MED VIROL, V80, P1260, DOI 10.1002/jmv.21161; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jarvis LM, 1996, LANCET, V348, P1352, DOI 10.1016/S0140-6736(96)04041-X; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Katayama K, 1998, ARCH VIROL, V143, P1063, DOI 10.1007/s007050050356; Lampe E, 1998, J MED VIROL, V56, P39, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;39::AID-JMV7&gt;3.0.CO;2-O; Lampe E, 1997, J MED VIROL, V52, P61, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;61::AID-JMV10&gt;3.0.CO;2-3; Lau DTY, 1999, J INFECT DIS, V180, P1334, DOI 10.1086/315031; Leao GC, 2007, JPN J CLIN ONCOL, V37, P632, DOI 10.1093/jjco/hym063; Levi José Eduardo, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P75, DOI 10.1590/S0036-46652003000200004; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Loureiro CL, 2002, J MED VIROL, V68, P357, DOI 10.1002/jmv.10211; Lyra AC, 2005, BRAZ J MED BIOL RES, V38, P767, DOI 10.1590/S0100-879X2005000500015; Maidana Maria Teresa, 2005, Braz J Infect Dis, V9, P122, DOI 10.1590/S1413-86702005000200001; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Massud I, 2002, MEDICINA-BUENOS AIRE, V62, P173; *MIN SAUD SECR VIG, ANT THER REC HIV INF; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Muerhoff AS, 2003, J MED VIROL, V70, P141, DOI 10.1002/jmv.10375; MUERHOFF AS, 1995, J VIROL, V69, P5621, DOI 10.1128/JVI.69.9.5621-5630.1995; Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5; Muerhoff AS, 1997, J VIROL, V71, P6501, DOI 10.1128/JVI.71.9.6501-6508.1997; Mukaide M, 1997, FEBS LETT, V407, P51, DOI 10.1016/S0014-5793(97)00136-1; Naito H, 1999, J CLIN MICROBIOL, V37, P1217, DOI 10.1128/JCM.37.4.1217-1220.1999; Naito H, 2001, J VIROL METHODS, V91, P3, DOI 10.1016/S0166-0934(00)00207-X; Nishiya Anna S., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P213, DOI 10.1590/S0036-46652003000400007; Okamoto H, 1997, J GEN VIROL, V78, P737, DOI 10.1099/0022-1317-78-4-737; Oliveira LA, 2002, MEM I OSWALDO CRUZ, V97, P953, DOI 10.1590/S0074-02762002000700005; Pereira LMMB, 2002, J MED VIROL, V67, P27, DOI 10.1002/jmv.2188; Pinho J. R. R., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P243, DOI 10.1590/S0036-46651996000300016; Pinho Joao Renato Rebello, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P441, DOI 10.1590/S0036-46651996000600010; Pinho JRR, 1999, J CLIN MICROBIOL, V37, P1634, DOI 10.1128/JCM.37.5.1634-1637.1999; Quiros-Roldan E, 2002, AIDS, V16, P1430, DOI 10.1097/00002030-200207050-00019; Ramezani A, 2008, J GASTROINTEST LIVER, V17, P269; Ramezani A, 2008, INT J INFECT DIS, V12, P57, DOI 10.1016/j.ijid.2007.04.010; Ramos R, 2004, MEM I OSWALDO CRUZ, V99, P639, DOI 10.1590/S0074-02762004000600019; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; Ribeiro-dos-Santos G, 2002, EUR J CLIN MICROBIOL, V21, P438, DOI 10.1007/s10096-002-0752-y; Ryt-Hansen R, 2006, AIDS RES HUM RETROV, V22, P496, DOI 10.1089/aid.2006.22.496; Sa D, 2007, AIDS RES HUM RETROV, V23, P1087, DOI 10.1089/aid.2006.0173; Sathar MA, 2004, CLIN INFECT DIS, V38, P405, DOI 10.1086/381092; SCHLAUDER GG, 1995, LANCET, V346, P447, DOI 10.1016/S0140-6736(95)92821-9; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; SIMONS JN, 1995, P NATL ACAD SCI USA, V92, P3401, DOI 10.1073/pnas.92.8.3401; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Smith DB, 1997, J GEN VIROL, V78, P1533, DOI 10.1099/0022-1317-78-7-1533; Souza IE, 2006, HIV MED, V7, P25, DOI 10.1111/j.1468-1293.2005.00339.x; STAPLETON JT, 2010, J GEN VIROL; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Supapol WB, 2011, J MED VIROL, V83, P33, DOI 10.1002/jmv.21946; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Tucker TJ, 1999, J MED VIROL, V59, P52, DOI 10.1002/(SICI)1096-9071(199909)59:1&lt;52::AID-JMV9&gt;3.0.CO;2-D; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Watanabe MAE, 2003, RENAL FAILURE, V25, P67, DOI 10.1081/JDI-120017469; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000	74	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18407	10.1371/journal.pone.0018407	http://dx.doi.org/10.1371/journal.pone.0018407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483671	gold, Green Submitted, Green Published			2022-12-25	WOS:000289191300021
J	Ma, ZH; Lavebratt, C; Almgren, M; Portwood, N; Forsberg, LE; Branstrom, R; Berglund, E; Falkmer, S; Sundler, F; Wierup, N; Bjorklund, A				Ma, Zuheng; Lavebratt, Catharina; Almgren, Malin; Portwood, Neil; Forsberg, Lars E.; Branstrom, Robert; Berglund, Erik; Falkmer, Sture; Sundler, Frank; Wierup, Nils; Bjorklund, Anneli			Evidence for Presence and Functional Effects of Kv1.1 Channels in beta-Cells: General Survey and Results from mceph/mceph Mice	PLOS ONE			English	Article							GATED POTASSIUM CHANNEL; K+ CHANNELS; EXPRESSION; SECRETION; BRAIN; MOUSE	Background: Voltage-dependent K+ channels (Kv) mediate repolarisation of beta-cell action potentials, and thereby abrogate insulin secretion. The role of the Kv1.1 K+ channel in this process is however unclear. We tested for presence of Kv1.1 in different species and tested for a functional role of Kv1.1 by assessing pancreatic islet function in BALB/cByJ (wild-type) and megencephaly (mceph/mceph) mice, the latter having a deletion in the Kv1.1 gene. Methodology/Principal Findings: Kv1.1 expression was detected in islets from wild-type mice, SD rats and humans, and expression of truncated Kv1.1 was detected in mceph/mceph islets. Full-length Kv1.1 protein was present in islets from wildtype mice, but, as expected, not in those from mceph/mceph mice. Kv1.1 expression was localized to the beta-cell population and also to alpha-and delta-cells, with evidence of over-expression of truncated Kv1.1 in mceph/mceph islets. Blood glucose, insulin content, and islet morphology were normal in mceph/mceph mice, but glucose-induced insulin release from batch-incubated islets was (moderately) higher than that from wild-type islets. Reciprocal blocking of Kv1.1 by dendrotoxin-K increased insulin secretion from wild-type but not mceph/mceph islets. Glucose-induced action potential duration, as well as firing frequency, was increased in mceph/mceph mouse beta-cells. This duration effect on action potential in beta-cells from mceph/mceph mice was mimicked by dendrotoxin-K in beta-cells from wild-type mice. Observations concerning the effects of both the mceph mutation, and of dendrotoxin-K, on glucose-induced insulin release were confirmed in pancreatic islets from Kv1.1 null mice. Conclusion/Significance: Kv1.1 channels are expressed in the beta-cells of several species, and these channels can influence glucose-stimulated insulin release.	[Ma, Zuheng; Lavebratt, Catharina; Almgren, Malin; Portwood, Neil; Forsberg, Lars E.; Branstrom, Robert; Berglund, Erik; Bjorklund, Anneli] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Falkmer, Sture] Ryhov Hosp, Lab Pathol & Clin Cytol, Jonkoping, Sweden; [Sundler, Frank; Wierup, Nils] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Karolinska Institutet; Karolinska University Hospital; Lund University	Ma, ZH (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	anneli.bjorklund@ki.se		Berglund, Erik/0000-0001-7049-7348; Ma, Zuheng/0000-0003-1186-9396; Branstrom, Robert/0000-0001-6245-7223; Lavebratt, Catharina/0000-0003-4987-2718	Swedish Research Council; Swedish Society of Medicine; Karolinska Institutet; Magnus Bergwall Foundation; Fredrik and Ingrid Thuring Foundation; Ragnhild and Einar Lundstrom Foundation; Ake Wiberg Foundation; Loo Foundation and Hans Osterman Foundation; NovoNordisk Foundation; Royal Physiographic Society in Lund; Gyllenstiernska Krapperup Foundation; Tore Nilsson Foundation; Albert Pahlson Foundation; Ahlen Foundation; Foundation for Clinical Cancer Research in Jokoping	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Karolinska Institutet(Karolinska Institutet); Magnus Bergwall Foundation; Fredrik and Ingrid Thuring Foundation; Ragnhild and Einar Lundstrom Foundation; Ake Wiberg Foundation; Loo Foundation and Hans Osterman Foundation; NovoNordisk Foundation(Novo Nordisk Foundation); Royal Physiographic Society in Lund; Gyllenstiernska Krapperup Foundation; Tore Nilsson Foundation; Albert Pahlson Foundation; Ahlen Foundation; Foundation for Clinical Cancer Research in Jokoping	The authors thank the Swedish Research Council, the Swedish Society of Medicine, Funds of Karolinska Institutet, the Magnus Bergwall, the Fredrik and Ingrid Thuring, the Ragnhild and Einar Lundstrom, Ake Wiberg, the Loo and Hans Osterman Foundations, the NovoNordisk Foundation, the Royal Physiographic Society in Lund, the Gyllenstiernska Krapperup, the Tore Nilsson, Albert Pahlson, Ahlen Foundations as well as the Foundation for Clinical Cancer Research in Jokoping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETSHOLTZ C, 1990, FEBS LETT, V263, P121, DOI 10.1016/0014-5793(90)80719-Y; BJORKLUND A, 1993, ENDOCRINOLOGY, V132, P1319, DOI 10.1210/en.132.3.1319; Diez M, 2003, EUR J NEUROSCI, V18, P3218, DOI 10.1111/j.1460-9568.2003.02994.x; Donahue LR, 1996, MAMM GENOME, V7, P871, DOI 10.1007/s003359900259; Escobar LI, 2004, AM J PHYSIOL-CELL PH, V286, pC965, DOI 10.1152/ajpcell.00074.2003; GRILL V, 1981, DIABETOLOGIA, V20, P495, DOI 10.1007/BF00253414; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hatton WJ, 2001, J PHYSIOL-LONDON, V533, P315, DOI 10.1111/j.1469-7793.2001.0315a.x; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; Persson AS, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-10; Persson AS, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-65; Petersson S, 2003, EUR J NEUROSCI, V18, P3231, DOI 10.1111/j.1460-9568.2003.03044.x; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597	22	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18213	10.1371/journal.pone.0018213	http://dx.doi.org/10.1371/journal.pone.0018213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483673	Green Submitted, Green Published, gold			2022-12-25	WOS:000289191300012
J	Lee, J; Repasy, T; Papavinasasundaram, K; Sassetti, C; Kornfeld, H				Lee, Jinhee; Repasy, Teresa; Papavinasasundaram, Kadamba; Sassetti, Christopher; Kornfeld, Hardy			Mycobacterium tuberculosis Induces an Atypical Cell Death Mode to Escape from Infected Macrophages	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; CYTOCHROME-C RELEASE; DEPENDENT FASHION; TRANSITION PORE; APOPTOSIS; VIRULENCE; MITOCHONDRIA; MECHANISM; INVASION; NECROSIS	Background: Macrophage cell death following infection with Mycobacterium tuberculosis plays a central role in tuberculosis disease pathogenesis. Certain attenuated strains induce extrinsic apoptosis of infected macrophages but virulent strains of M. tuberculosis suppress this host response. We previously reported that virulent M. tuberculosis induces cell death when bacillary load exceeds,20 per macrophage but the precise nature of this demise has not been defined. Methodology/Principal Findings: We analyzed the characteristics of cell death in primary murine macrophages challenged with virulent or attenuated M. tuberculosis complex strains. We report that high intracellular bacillary burden causes rapid and primarily necrotic death via lysosomal permeabilization, releasing hydrolases that promote Bax/Bak-independent mitochondrial damage and necrosis. Cell death was independent of cathepsins B or L and notable for ultrastructural evidence of damage to lipid bilayers throughout host cells with depletion of several host phospholipid species. These events require viable bacteria that can respond to intracellular cues via the PhoPR sensor kinase system but are independent of the ESX1 system. Conclusions/Significance: Cell death caused by virulent M. tuberculosis is distinct from classical apoptosis, pyroptosis or pyronecrosis. Mycobacterial genes essential for cytotoxicity are regulated by the PhoPR two-component system. This atypical death mode provides a mechanism for viable bacilli to exit host macrophages for spreading infection and the eventual transition to extracellular persistence that characterizes advanced pulmonary tuberculosis.	[Lee, Jinhee; Repasy, Teresa; Kornfeld, Hardy] Univ Massachusetts Med Sch, Dept Med, Worcester, MA 01655 USA; [Papavinasasundaram, Kadamba; Sassetti, Christopher] Univ Massachusetts Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Sassetti, Christopher] Univ Massachusetts Med Sch, Howard Hughes Med Inst, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Lee, J (corresponding author), Univ Massachusetts Med Sch, Dept Med, Worcester, MA 01655 USA.	hardy.kornfeld@umassmed.edu	Kornfeld, Hardy/AAS-2903-2021	PAPAVINASASUNDARAM, KADAMBA/0000-0001-7837-1344	National Institutes of Health [HL064884, AI064282, DK32520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grants HL064884, AI064282, and DK32520(http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2004, J LIPID RES, V45, P667, DOI 10.1194/jlr.M300342-JLR200; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Dhillon J, 2001, J ANTIMICROB CHEMOTH, V48, P869, DOI 10.1093/jac/48.6.869; Dini L, 1996, EXP CELL RES, V223, P340, DOI 10.1006/excr.1996.0089; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Ferrer NL, 2009, MICROBES INFECT, V11, P115, DOI 10.1016/j.micinf.2008.10.013; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; KRISTIANSEN JE, 1986, ACTA PATH MICRO IM B, V94, P393; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lahiri R, 2010, J INFECT DIS, V201, P1736, DOI 10.1086/652499; Larsen MH, 2009, VACCINE, V27, P4709, DOI 10.1016/j.vaccine.2009.05.050; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; MELLORS A, 1967, BIOCHIM BIOPHYS ACTA, V143, P299, DOI 10.1016/0005-2728(67)90084-9; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Pelicic V, 1996, FEMS MICROBIOL LETT, V144, P161, DOI 10.1016/0378-1097(96)00354-0; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; PERI P, 2010, J GEN VIROL     0929; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; RUTH RC, 1980, J PHARMACOL EXP THER, V212, P361; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Willhite DC, 2004, CELL MICROBIOL, V6, P143, DOI 10.1046/j.1462-5822.2003.00347.x; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	43	65	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18367	10.1371/journal.pone.0018367	http://dx.doi.org/10.1371/journal.pone.0018367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483832	Green Published, gold			2022-12-25	WOS:000289057200065
J	Brauer, PM; Zheng, Y; Evans, MD; Dominguez-Brauer, C; Peehl, DM; Tyner, AL				Brauer, Patrick M.; Zheng, Yu; Evans, Mark D.; Dominguez-Brauer, Carmen; Peehl, Donna M.; Tyner, Angela L.			The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of beta-Catenin	PLOS ONE			English	Article							BREAST-TUMOR KINASE; PROSTATE-CANCER; GASTROINTESTINAL-TRACT; ANDROGEN RECEPTOR; OXIDATIVE STRESS; DISTINCT FAMILY; SMALL-INTESTINE; CELL FACTOR; BRK; EXPRESSION	Protein tyrosine kinase 6 (PTK6), also called breast tumor kinase (BRK), is expressed in epithelial cells of various tissues including the prostate. Previously it was shown that PTK6 is localized to epithelial cell nuclei in normal prostate, but becomes cytoplasmic in human prostate tumors. PTK6 is also primarily cytoplasmic in the PC3 prostate adenocarcinoma cell line. Sequencing revealed expression of wild type full-length PTK6 transcripts in addition to an alternative transcript lacking exon 2 in PC3 cells. The alternative transcript encodes a 134 amino acid protein, referred to here as ALT-PTK6, which shares the first 77 amino acid residues including the SH3 domain with full length PTK6. RT-PCR was used to show that ALT-PTK6 is coexpressed with full length PTK6 in established human prostate and colon cell lines, as well as in primary cell lines derived from human prostate tissue and tumors. Although interaction between full-length PTK6 and ALT-PTK6 was not detected, ALT-PTK6 associates with the known PTK6 substrates Sam68 and beta-catenin in GST pull-down assays. Coexpression of PTK6 and ALT-PTK6 led to suppression of PTK6 activity and reduced association of PTK6 with tyrosine phosphorylated proteins. While ALT-PTK6 alone did not influence beta-catenin/TCF transcriptional activity in a luciferase reporter assay, it enhanced PTK6-mediated inhibition of beta-catenin/TCF transcription by promoting PTK6 nuclear functions. Ectopic expression of ALT-PTK6 led to reduced expression of the beta-catenin/TCF targets Cyclin D1 and c-Myc in PC3 cells. Expression of tetracycline-inducible ALT-PTK6 blocked the proliferation and colony formation of PC3 cells. Our findings suggest that ALT-PTK6 is able to negatively regulate growth and modulate PTK6 activity, protein-protein associations and/or subcellular localization. Fully understanding functions of ALT-PTK6 and its impact on PTK6 signaling will be critical for development of therapeutic strategies that target PTK6 in cancer.	[Brauer, Patrick M.; Zheng, Yu; Evans, Mark D.; Dominguez-Brauer, Carmen; Tyner, Angela L.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Peehl, Donna M.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University	Brauer, PM (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	atyner@uic.edu		Tyner, Angela/0000-0001-7448-8625	National Institutes of Health [DK044525, DK068503]; Department of Defense (DOD) [81XWH-05-1-0111, W81XWH-06-1-000]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK044525, R01DK068503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK044525 and DK068503 (A.L.T.), and Department of Defense (DOD) grant 81XWH-05-1-0111 (D.P.). P.M.B. was supported by a DOD Predoctoral Traineeship Award, Army W81XWH-06-1-000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Brauer PM, 2010, CELL CYCLE, V9, P4190, DOI 10.4161/cc.9.20.13518; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Brignatz C, 2009, MOL CELL BIOL, V29, P6438, DOI 10.1128/MCB.00398-09; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; CHAN E, 2010, INT J CANC; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cohen CD, 2005, J AM SOC NEPHROL, V16, P1958, DOI 10.1681/ASN.2005020204; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Dominguez-Brauer C, 2009, EMBO REP, V10, P1036, DOI 10.1038/embor.2009.139; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Greco-Stewart VS, 2006, VIROLOGY, V356, P35, DOI 10.1016/j.virol.2006.06.040; Haegebarth A, 2005, CELL CYCLE, V4, P1239, DOI 10.4161/cc.4.9.1965; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Haegebarth A, 2009, GASTROENTEROLOGY, V137, P945, DOI 10.1053/j.gastro.2009.05.054; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; IRIE HY, PLOS ONE, V5; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kasprzycka M, 2006, AM J PATHOL, V168, P1631, DOI 10.2353/ajpath.2006.050521; Kim HI, 2007, BIOCHEM BIOPH RES CO, V362, P829, DOI 10.1016/j.bbrc.2007.08.055; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Ko S, 2009, BIOCHEM BIOPH RES CO, V384, P236, DOI 10.1016/j.bbrc.2009.04.103; Lee HY, 1998, MOL CELLS, V8, P401; LEE ST, 1993, ONCOGENE, V8, P3403; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; OSTRANDER JH, 2010, CURR OPIN PHARM; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; PASCO MY, 2010, NEUROBIOL DIS; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; PEEHL DM, 1992, CULTURE EPITHELIAL C, P159; Petro BJ, 2004, ORAL ONCOL, V40, P1040, DOI 10.1016/j.oraloncology.2004.05.010; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rasband W., 2006, IMAGEJ; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Serfas MS, 2003, ONCOL RES, V13, P409; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Takahashi-Yanaga F, CLIN CANC RES, V16, P3153; Vasioukhin V, 1997, P NATL ACAD SCI USA, V94, P14477, DOI 10.1073/pnas.94.26.14477; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Verras M, 2005, MOL ENDOCRINOL, V19, P391, DOI 10.1210/me.2004-0208; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang TC, 2005, BRIT J DERMATOL, V153, P282, DOI 10.1111/j.1365-2133.2005.06604.x; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10	64	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e14789	10.1371/journal.pone.0014789	http://dx.doi.org/10.1371/journal.pone.0014789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479203	Green Published, gold			2022-12-25	WOS:000289055700002
J	Valsesia, A; Rimoldi, D; Martinet, D; Ibberson, M; Benaglio, P; Quadroni, M; Waridel, P; Gaillard, M; Pidoux, M; Rapin, B; Rivolta, C; Xenarios, I; Simpson, AJG; Antonarakis, SE; Beckmann, JS; Jongeneel, CV; Iseli, C; Stevenson, BJ				Valsesia, Armand; Rimoldi, Donata; Martinet, Danielle; Ibberson, Mark; Benaglio, Paola; Quadroni, Manfredo; Waridel, Patrice; Gaillard, Muriel; Pidoux, Mireille; Rapin, Blandine; Rivolta, Carlo; Xenarios, Ioannis; Simpson, Andrew J. G.; Antonarakis, Stylianos E.; Beckmann, Jacques S.; Jongeneel, C. Victor; Iseli, Christian; Stevenson, Brian J.			Network-Guided Analysis of Genes with Altered Somatic Copy Number and Gene Expression Reveals Pathways Commonly Perturbed in Metastatic Melanoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CIRCULAR BINARY SEGMENTATION; PROTEIN-COUPLED RECEPTORS; FIBROBLAST-GROWTH-FACTOR; ARRAY CGH DATA; SIGNALING PATHWAYS; HUMAN BREAST; HUMAN CANCER; FRS2 FAMILY; CELL-LINES	Cancer genomes frequently contain somatic copy number alterations (SCNA) that can significantly perturb the expression level of affected genes and thus disrupt pathways controlling normal growth. In melanoma, many studies have focussed on the copy number and gene expression levels of the BRAF, PTEN and MITF genes, but little has been done to identify new genes using these parameters at the genome-wide scale. Using karyotyping, SNP and CGH arrays, and RNA-seq, we have identified SCNA affecting gene expression ('SCNA-genes') in seven human metastatic melanoma cell lines. We showed that the combination of these techniques is useful to identify candidate genes potentially involved in tumorigenesis. Since few of these alterations were recurrent across our samples, we used a protein network-guided approach to determine whether any pathways were enriched in SCNA-genes in one or more samples. From this unbiased genome-wide analysis, we identified 28 significantly enriched pathway modules. Comparison with two large, independent melanoma SCNA datasets showed less than 10% overlap at the individual gene level, but network-guided analysis revealed 66% shared pathways, including all but three of the pathways identified in our data. Frequently altered pathways included WNT, cadherin signalling, angiogenesis and melanogenesis. Additionally, our results emphasize the potential of the EPHA3 and FRS2 gene products, involved in angiogenesis and migration, as possible therapeutic targets in melanoma. Our study demonstrates the utility of network-guided approaches, for both large and small datasets, to identify pathways recurrently perturbed in cancer.	[Valsesia, Armand; Rimoldi, Donata; Jongeneel, C. Victor; Iseli, Christian; Stevenson, Brian J.] Ludwig Inst Canc Res, Lausanne, Switzerland; [Valsesia, Armand; Ibberson, Mark; Xenarios, Ioannis; Jongeneel, C. Victor; Iseli, Christian; Stevenson, Brian J.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Valsesia, Armand; Benaglio, Paola; Rivolta, Carlo; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Martinet, Danielle; Gaillard, Muriel; Pidoux, Mireille; Rapin, Blandine; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Quadroni, Manfredo; Waridel, Patrice] Ctr Integrat Genom, Prot Anal Facil, Lausanne, Switzerland; [Simpson, Andrew J. G.] Ludwig Inst Canc Res, New York, NY USA; [Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Jongeneel, C. Victor] Univ Illinois, Inst Genom Biol, Champaign, IL USA; [Jongeneel, C. Victor] Univ Illinois, Natl Ctr Supercomp Applicat, Champaign, IL USA	Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ludwig Institute for Cancer Research; University of Geneva; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Valsesia, A (corresponding author), Ludwig Inst Canc Res, Lausanne, Switzerland.	Christian.Iseli@unil.ch; Brian.Stevenson@unil.ch	Xenarios, Ioannis/ABD-5045-2021; Beckmann, Jacques S/A-9772-2008; Jongeneel, Cornelis V/B-2135-2012; Antonarakis, Stylianos E/N-8866-2014; Iseli, Christian/AAM-3878-2020; Valsesia, Armand/F-1724-2010	Xenarios, Ioannis/0000-0002-3413-6841; Beckmann, Jacques S/0000-0002-9741-1900; Antonarakis, Stylianos E/0000-0001-8907-5823; Iseli, Christian/0000-0002-2296-2863; Rivolta, Carlo/0000-0002-0733-9950; Jongeneel, Cornelis Victor/0000-0002-3922-1906; Quadroni, Manfredo/0000-0002-2720-4084; Ibberson, Mark/0000-0003-3152-5670; Valsesia, Armand/0000-0003-0746-9664	Ludwig Institute for Cancer Research Ltd.	Ludwig Institute for Cancer Research Ltd.	This work was supported by the Ludwig Institute for Cancer Research Ltd. (www.licr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PMS, 2003, CANCER RES, V63, P8476; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BECHER R, 1983, CANCER RES, V43, P5010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen HIH, 2008, BIOINFORMATICS, V24, P1749, DOI 10.1093/bioinformatics/btn321; Chiari R, 2000, CANCER RES, V60, P4855; Colzani M, 2008, MOL CELL PROTEOMICS, V7, P927, DOI 10.1074/mcp.M700440-MCP200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gast A, 2010, GENE CHROMOSOME CANC, V49, P733, DOI 10.1002/gcc.20785; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiser LM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r31; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Jin M, 2008, CANCER SCI, V99, P1656, DOI 10.1111/j.1349-7006.2008.00866.x; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klijn C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000631; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lee HJ, 2008, PIGM CELL MELANOMA R, V21, P415, DOI 10.1111/j.1755-148X.2008.00478.x; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Ma DX, 2010, ANN HEMATOL, V89, P155, DOI 10.1007/s00277-009-0790-y; Martinet D, 2008, AM J MED GENET A, V146A, P2094, DOI 10.1002/ajmg.a.32414; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mitelman F, 2010, MITELMAN DATABASE CH; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OZISIK YY, 1994, CANCER GENET CYTOGEN, V77, P69, DOI 10.1016/0165-4608(94)90152-X; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pende D, 2002, CANCER RES, V62, P6178; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Sato T, 2009, EXPERT OPIN THER TAR, V13, P689, DOI 10.1517/14728220902942330; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Staaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-382; Stahl JM, 2003, CANCER RES, V63, P2881; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tatsumi T, 2003, CANCER RES, V63, P4481; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; VANRAAMSDONK CD, 2010, N ENGL J MED; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang YP, 1997, NAT MED, V3, P887, DOI 10.1038/nm0897-887; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270	93	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18369	10.1371/journal.pone.0018369	http://dx.doi.org/10.1371/journal.pone.0018369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494657	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000289292800011
J	Bertolo, A; Pepino, M; Adams, J; Magnan, P				Bertolo, Andrea; Pepino, Marc; Adams, Julie; Magnan, Pierre			Behavioural Thermoregulatory Tactics in Lacustrine Brook Charr, Salvelinus fontinalis	PLOS ONE			English	Article							THERMAL BIOLOGY; TEMPERATURE REGULATION; LOCOMOTOR-ACTIVITY; NEIGHBOR MATRICES; ECOLOGICAL DATA; BROWN TROUT; GROWTH; PHYSIOLOGY; FISHES; SALMON	The need to vary body temperature to optimize physiological processes can lead to thermoregulatory behaviours, particularly in ectotherms. Despite some evidence of within-population phenotypic variation in thermal behaviour, the occurrence of alternative tactics of this behaviour is rarely explicitly considered when studying natural populations. The main objective of this study was to determine whether different thermal tactics exist among individuals of the same population. We studied the behavioural thermoregulation of 33 adult brook charr in a stratified lake using thermo-sensitive radio transmitters that measured hourly individual temperature over one month. The observed behavioural thermoregulatory patterns were consistent between years and suggest the existence of four tactics: two "warm'' tactics with both crepuscular and finer periodicities, with or without a diel periodicity, and two "cool'' tactics, with or without a diel periodicity. Telemetry data support the above findings by showing that the different tactics are associated with different patterns of diel horizontal movements. Taken together, our results show a clear spatio-temporal segregation of individuals displaying different tactics, suggesting a reduction of niche overlap. To our knowledge, this is the first study showing the presence of behavioural thermoregulatory tactics in a vertebrate.	[Bertolo, Andrea; Pepino, Marc; Adams, Julie; Magnan, Pierre] Univ Quebec, Ctr Rech Interact Basins Versants Ecosyst Aquat R, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Magnan, P (corresponding author), Univ Quebec, Ctr Rech Interact Basins Versants Ecosyst Aquat R, Trois Rivieres, PQ GA9 5H7, Canada.	Pierre.Magnan@uqtr.ca	Magnan, Pierre/U-9342-2019	Magnan, Pierre/0000-0003-3122-7163; Bertolo, Andrea/0000-0002-6018-816X	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs)	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair Program to P. Magnan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Aubret F, 2010, J EXP BIOL, V213, P242, DOI 10.1242/jeb.035931; Azumaya T, 2005, FISH OCEANOGR, V14, P81, DOI 10.1111/j.1365-2419.2004.00323.x; BEAMISH FWH, 1964, CAN J ZOOLOG, V42, P177, DOI 10.1139/z64-016; Besson AA, 2010, OECOLOGIA, V163, P571, DOI 10.1007/s00442-010-1571-y; BEUCHAT CA, 1987, ECOL MONOGR, V57, P45, DOI 10.2307/1942638; Bicego KC, 2007, COMP BIOCHEM PHYS A, V147, P616, DOI 10.1016/j.cbpa.2006.06.032; Biro PA, 1998, T AM FISH SOC, V127, P212, DOI 10.1577/1548-8659(1998)127<0212:SCBTDS>2.0.CO;2; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BOUJARD T, 1992, ENVIRON BIOL FISH, V35, P109, DOI 10.1007/BF00002186; Bourke P, 1996, J FISH BIOL, V49, P1174; Bourke P, 1997, J FISH BIOL, V51, P783, DOI 10.1111/j.1095-8649.1997.tb01999.x; BRANDT SB, 1980, T AM FISH SOC, V109, P469, DOI 10.1577/1548-8659(1980)109<469:SSOAAY>2.0.CO;2; BRETT JR, 1971, AM ZOOL, V11, P99; Dorcas ME, 1997, PHYSIOL ZOOL, V70, P292, DOI 10.1086/639601; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; Fry F.E.J., 1947, U TORONTO STUD BIOL, V55, P1; Fry F.E.J, 1947, U TORONTO STUDIES BI, V55; Glanville EJ, 2006, J EXP BIOL, V209, P4869, DOI 10.1242/jeb.02585; Grans A, 2010, J EXP BIOL, V213, P3198, DOI 10.1242/jeb.043570; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2006, ANAL STAT DONNEES SP, P425; MAGNAN P, 1988, CAN J FISH AQUAT SCI, V45, P999, DOI 10.1139/f88-123; MAGNUSON JJ, 1990, T AM FISH SOC, V119, P254, DOI 10.1577/1548-8659(1990)119<0254:PCITTH>2.3.CO;2; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Magoulick DD, 1998, T AM FISH SOC, V127, P708, DOI 10.1577/1548-8659(1998)127<0708:EOTAMO>2.0.CO;2; MEDVICK PA, 1981, COPEIA, P9; NEILL WH, 1974, T AM FISH SOC, V103, P663, DOI 10.1577/1548-8659(1974)103<663:DEABTO>2.0.CO;2; NEVERMAN D, 1994, OECOLOGIA, V98, P247, DOI 10.1007/BF00324211; Ojanguren AF, 2001, J THERM BIOL, V26, P165, DOI 10.1016/S0306-4565(00)00038-3; Oksanen J, 2007, MULTIVARIATE ANAL EC; Power G, 1980, CHARRS SALMONID FISH, P141; Proulx R, 2004, EVOL ECOL RES, V6, P503; R Development Core Team, 2007, R LANG ENV STAT COMP; REYNOLDS WW, 1978, COMP BIOCHEM PHYS A, V59, P225, DOI 10.1016/0300-9629(78)90211-6; REYNOLDS WW, 1979, HYDROBIOLOGIA, V62, P79, DOI 10.1007/BF00012567; Roscoe DW, 2010, ECOL FRESHW FISH, V19, P51, DOI 10.1111/j.1600-0633.2009.00388.x; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; SCHWARZKOPF L, 1991, OECOLOGIA, V88, P562, DOI 10.1007/BF00317720; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; WINTER DW, 1983, FISHERIES TECHNIQUES, P371; Wismer DA, 1987, GREAT LAKES FISHERY, V87-3; Xu CL, 2010, FRESHWATER BIOL, V55, P2253, DOI 10.1111/j.1365-2427.2010.02430.x	52	25	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18603	10.1371/journal.pone.0018603	http://dx.doi.org/10.1371/journal.pone.0018603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490935	Green Submitted, Green Published, gold			2022-12-25	WOS:000289238700027
J	Yi, JZ; Liu, CQ				Yi, Jianzhong; Liu, Chengqian			Efficient Silencing of Gene Expression by an ASON-Bulge-DNAzyme Complex	PLOS ONE			English	Article							CLEAVING DNA ENZYME; NUCLEIC-ACIDS; MESSENGER-RNA; ANTISENSE OLIGONUCLEOTIDES; HAMMERHEAD RIBOZYMES; CELLULAR UPTAKE; INTERFERENCE; DEOXYRIBOZYMES; INHIBITION; MECHANISM	Background: DNAzymes are DNA molecules that can directly cleave cognate mRNA, and have been developed to silence gene expression for research and clinical purposes. The advantage of DNAzymes over ribozymes is that they are inexpensive to produce and exhibit good stability. The "10-23 DNA enzyme'' is composed of a catalytic domain of 15 deoxynucleotides, flanked by two substrate-recognition domains of approximately eight nucleotides in each direction, which provides the complementary sequence required for specific binding to RNA substrates. However, these eight nucleotides might not afford sufficient binding energy to hold the RNA substrate along with the DNAzyme, which would interfere with the efficiency of the DNAzyme or cause side effects, such as the cleavage of non-cognate mRNAs. Methodology: In this study, we inserted a nonpairing bulge at the 59 end of the "10-23 DNA enzyme'' to enhance its efficiency and specificity. Different sizes of bulges were inserted at different positions in the 59 end of the DNAzyme. The non-matching bulge will avoid strong binding between the DNAzyme and target mRNA, which may interfere with the efficiency of the DNAzyme. Conclusions: Our novel DNAzyme constructs could efficiently silence the expression of target genes, proving a powerful tool for gene silencing. The results showed that the six oligo bulge was the most effective when the six oligo bulge was 12-15 bp away from the core catalytic domain.	[Yi, Jianzhong; Liu, Chengqian] Shanghai Acad Agr Sci, Inst Anim Husb Vet Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Yi, JZ (corresponding author), Shanghai Acad Agr Sci, Inst Anim Husb Vet Sci, Shanghai, Peoples R China.	yijianzhong@yahoo.com			Science and Technology Commission of Shanghai Municipality [07pj14074]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was sponsored by the Pujiang Program from Science and Technology Commission of Shanghai Municipality (Project no. 07pj14074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 1998, CURR OPIN CHEM BIOL, V2, P519, DOI 10.1016/S1367-5931(98)80129-4; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Breaker RR, 2000, SCIENCE, V290, P2095, DOI 10.1126/science.290.5499.2095; Breaker RR, 2004, NATURE, V432, P838, DOI 10.1038/nature03195; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; Cairns MJ, 1999, NAT BIOTECHNOL, V17, P480, DOI 10.1038/8658; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chan SH, 2011, NUCLEIC ACIDS RES, V39, P1, DOI 10.1093/nar/gkq742; Dass CR, 2002, ANTISENSE NUCLEIC A, V12, P289, DOI 10.1089/108729002761381276; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Emilsson GM, 2002, CELL MOL LIFE SCI, V59, P596, DOI 10.1007/s00018-002-8452-4; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Franzen S, 2010, CURR OPIN MOL THER, V12, P223; GALDERISI U, 1990, J CELL PHYSL, V181, P251; GAO WY, 1992, MOL PHARMACOL, V41, P223; Gewirtz A M, 1998, Curr Opin Hematol, V5, P59; GUVAKOVA MA, 1995, J BIOL CHEM, V270, P2620, DOI 10.1074/jbc.270.6.2620; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kurreck J, 2002, J BIOL CHEM, V277, P7099, DOI 10.1074/jbc.M107206200; Lam JCF, 2010, J MOL BIOL, V400, P689, DOI 10.1016/j.jmb.2010.05.047; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Mastroyiannopoulos NP, 2010, MOLECULES, V15, P5460, DOI 10.3390/molecules15085460; MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966; NIELSEN PE, 1993, ANTI-CANCER DRUG DES, V8, P53; Ota N, 1998, NUCLEIC ACIDS RES, V26, P3385, DOI 10.1093/nar/26.14.3385; PATERSON BM, 1977, P NATL ACAD SCI USA, V74, P4370, DOI 10.1073/pnas.74.10.4370; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Schlosser K, 2009, NUCLEIC ACIDS RES, V37, P413, DOI 10.1093/nar/gkn930; Schubert S, 2003, NUCLEIC ACIDS RES, V31, P5982, DOI 10.1093/nar/gkg791; Schubert S, 2004, CURR DRUG TARGETS, V5, P667, DOI 10.2174/1389450043345092; Silverman SK, 2010, ANGEW CHEM INT EDIT, V49, P7180, DOI 10.1002/anie.200906345; Sun LQ, 2000, PHARMACOL REV, V52, P325; Wang TH, 2008, OLIGONUCLEOTIDES, V18, P295, DOI 10.1089/oli.2008.0138; WERNER M, 1995, NUCLEIC ACIDS RES, V23, P2092, DOI 10.1093/nar/23.12.2092; Wong Jonathan P, 2010, Front Biosci (Schol Ed), V2, P791; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280	43	2	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18629	10.1371/journal.pone.0018629	http://dx.doi.org/10.1371/journal.pone.0018629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490924	Green Submitted, Green Published, gold			2022-12-25	WOS:000289238700030
J	Yuan, YY; Li, CT; Windram, O				Yuan, Yinyin; Li, Chang-Tsun; Windram, Oliver			Directed Partial Correlation: Inferring Large-Scale Gene Regulatory Network through Induced Topology Disruptions	PLOS ONE			English	Article							METABOLISM; COLD; ABA; DNA	Inferring regulatory relationships among many genes based on their temporal variation in transcript abundance has been a popular research topic. Due to the nature of microarray experiments, classical tools for time series analysis lose power since the number of variables far exceeds the number of the samples. In this paper, we describe some of the existing multivariate inference techniques that are applicable to hundreds of variables and show the potential challenges for small-sample, large-scale data. We propose a directed partial correlation (DPC) method as an efficient and effective solution to regulatory network inference using these data. Specifically for genomic data, the proposed method is designed to deal with large-scale datasets. It combines the efficiency of partial correlation for setting up network topology by testing conditional independence, and the concept of Granger causality to assess topology change with induced interruptions. The idea is that when a transcription factor is induced artificially within a gene network, the disruption of the network by the induction signifies a genes role in transcriptional regulation. The benchmarking results using GeneNetWeaver, the simulator for the DREAM challenges, provide strong evidence of the outstanding performance of the proposed DPC method. When applied to real biological data, the inferred starch metabolism network in Arabidopsis reveals many biologically meaningful network modules worthy of further investigation. These results collectively suggest DPC is a versatile tool for genomics research. The R package DPC is available for download (http://code.google.com/p/dpcnet/).	[Yuan, Yinyin] Cambridge Res Inst, Canc Res UK, Cambridge, England; [Yuan, Yinyin] Univ Cambridge, Dept Oncol, Cambridge, England; [Li, Chang-Tsun] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Windram, Oliver] Univ Warwick, Warwick Hort Res Inst, Wellesbourne, Warwick, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Warwick; University of Warwick	Yuan, YY (corresponding author), Cambridge Res Inst, Canc Res UK, Cambridge, England.	yy341@cam.ac.uk	Li, Chang-Tsun/C-1125-2018	Li, Chang-Tsun/0000-0003-4735-6138; Yuan, Yinyin/0000-0002-8556-4707	Department of Computer Science at the University of Warwick; Warwick HRI	Department of Computer Science at the University of Warwick; Warwick HRI	This work was supported by the Department of Computer Science at the University of Warwick through a PhD Studentship for Yinyin Yuan to conduct the work under Chang-Tsun Li's supervision. Oliver Windram is supported by Warwick HRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P459; Bro R, 2002, J CHEMOMETR, V16, P387, DOI 10.1002/cem.734; Egan J., 1975, SERIES COGNITION PER; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Lebre S, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1294; Lee H, 2008, BIOINFORMATICS, V24, P889, DOI 10.1093/bioinformatics/btn034; LIN CT, 1992, PLANT PHYSIOL, V99, P519, DOI 10.1104/pp.99.2.519; LTKEPOHL H, 2006, INTRO MULTIPLE TIME; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Marinazzo D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056215; MUKHOPADHYAY NDD, 2006, CAUSALITY PATHWAY SE; Opgen-Rhein R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S3; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Veiga DFT, 2007, GENET MOL RES, V6, P730; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; WILHELM KS, 1993, PLANT MOL BIOL, V23, P1073, DOI 10.1007/BF00021822; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122	30	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e16835	10.1371/journal.pone.0016835	http://dx.doi.org/10.1371/journal.pone.0016835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494330	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400002
J	Villalonga-Planells, R; Coll-Mulet, L; Martinez-Soler, F; Castano, E; Acebes, JJ; Gimenez-Bonafe, P; Gil, J; Tortosa, A				Villalonga-Planells, Ruth; Coll-Mulet, Llorenc; Martinez-Soler, Fina; Castano, Esther; Acebes, Juan-Jose; Gimenez-Bonafe, Pepita; Gil, Joan; Tortosa, Avelina			Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; IN-VITRO; GENETIC ALTERATIONS; SIGNALING PATHWAYS; MDM2; CANCER; CELLS; SURVIVIN; VIVO; QUIESCENCE	Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults. Despite concerted efforts to improve current therapies and develop novel clinical approaches, patient survival remains poor. As such, increasing attention has focused on developing new therapeutic strategies that specifically target the apoptotic pathway in order to improve treatment responses. Recently, nutlins, small-molecule antagonists of MDM2, have been developed to inhibit p53-MDM2 interaction and activate p53 signaling in cancer cells. Glioma cell lines and primary cultured glioblastoma cells were treated with nutlin-3a. Nutlin-3a induced p53-dependent G1- and G2-M cell cycle arrest and apoptosis in glioma cell lines with normal TP53 status. In addition, nutlin-arrested glioma cells show morphological features of senescence and persistent induction of p21 protein. Furthermore, senescence induced by nutlin-3a might be depending on mTOR pathway activity. In wild-type TP53 primary cultured cells, exposure to nutlin-3a resulted in variable degrees of apoptosis as well as cellular features of senescence. Nutlin-3a-induced apoptosis and senescence were firmly dependent on the presence of functional p53, as revealed by the fact that glioblastoma cells with knockdown p53 with specific siRNA, or cells with mutated or functionally impaired p53 pathway, were completely insensitive to the drug. Finally, we also found that nutlin-3a increased response of glioma cells to radiation therapy. The results provide a basis for the rational use of MDM2 antagonists as a novel treatment option for glioblastoma patients.	[Villalonga-Planells, Ruth; Coll-Mulet, Llorenc; Martinez-Soler, Fina; Gimenez-Bonafe, Pepita; Gil, Joan] Bellvitge Univ Barcelona, Inst Invest Biomed, Dept Ciencies Fisiol 2, Barcelona, Spain; [Martinez-Soler, Fina; Tortosa, Avelina] Bellvitge Univ Barcelona, Inst Invest Biomed, Dept Basic Nursing, Barcelona, Spain; [Castano, Esther] Univ Barcelona, Unitat Biol Bellvitge, Serv Cientificotecn, Barcelona, Spain; [Acebes, Juan-Jose] Bellvitge Hosp Bellvitge, Inst Invest Biomed, Serv Neurocirurgia, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital	Villalonga-Planells, R (corresponding author), Bellvitge Univ Barcelona, Inst Invest Biomed, Dept Ciencies Fisiol 2, Barcelona, Spain.	atortosa@ub.edu	Tortosa, Avelina/O-7788-2016	Tortosa, Avelina/0000-0002-9080-2976; Castano, Esther/0000-0002-7140-2272; Gil, Joan/0000-0002-3686-3903; Gimenez-Bonafe, Pepita/0000-0002-4713-903X	Spanish Ministry of Health [FIS 05/0689, FIS 08/1085]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Science and Innovation [ISCIII-RETIC RD06/0020/0097]; Fundacion Medica Mutua Madrilena; Spanish Ministry of Education and Science; FEDER [SAF2007-60964]; Catalonia regional government [2005SGR00549]; IDIBELL; Jose Carreras International Leukemia Foundation; ISCIII-RETIC [RD06/0020/0097]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); FEDER(European Commission); Catalonia regional government; IDIBELL; Jose Carreras International Leukemia Foundation; ISCIII-RETIC(Instituto de Salud Carlos III)	This study was supported by grants from the Spanish Ministry of Health (FIS 05/0689; FIS 08/1085), Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation (ISCIII-RETIC RD06/0020/0097), Fundacion Medica Mutua Madrilena 2007, Spanish Ministry of Education and Science and FEDER (SAF2007-60964), and Catalonia regional government (2005SGR00549). RV and LCM are the recipients of fellowships from IDIBELL and the Jose Carreras International Leukemia Foundation, respectively. FMS has a research scientist position funded by ISCIII-RETIC RD06/0020/0097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Drakos E, 2007, CLIN CANCER RES, V13, P3380, DOI 10.1158/1078-0432.CCR-06-2581; Eldering E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng153; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Korotchkina LG, 2009, CELL CYCLE, V8, P3777, DOI 10.4161/cc.8.22.10121; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Logan IR, 2007, PROSTATE, V67, P900, DOI 10.1002/pros.20568; Long JS, 2010, CELL CYCLE, V9, P4050, DOI 10.4161/cc.9.20.13747; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Poyurovsky MV, 2010, AGING-US, V2, P380, DOI 10.18632/aging.100179; Serrano M, 2010, CELL CYCLE, V9, P4256, DOI 10.4161/cc.9.21.13785; Siegelin MD, 2009, NEURO-ONCOLOGY, V11, P122, DOI 10.1215/15228517-2008-085; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; The WHO, 2020, CLASSIFICATION TUMOU; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Uchida H, 2004, MOL THER, V10, P162, DOI 10.1016/j.ymthe.2004.05.006; VanderBorght A, 2006, ONCOGENE, V25, P6672, DOI 10.1038/sj.onc.1209667; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584	44	88	91	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18588	10.1371/journal.pone.0018588	http://dx.doi.org/10.1371/journal.pone.0018588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483692	Green Published, gold			2022-12-25	WOS:000289191300030
J	Arama, C; Giusti, P; Bostrom, S; Dara, V; Traore, B; Dolo, A; Doumbo, O; Varani, S; Troye-Blomberg, M				Arama, Charles; Giusti, Pablo; Bostrom, Stephanie; Dara, Victor; Traore, Boubacar; Dolo, Amagana; Doumbo, Ogobara; Varani, Stefania; Troye-Blomberg, Marita			Interethnic Differences in Antigen-Presenting Cell Activation and TLR Responses in Malian Children during Plasmodium falciparum Malaria	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSES; SYMPATRIC ETHNIC-GROUPS; CEREBRAL MALARIA; WEST-AFRICA; PERIPHERAL-BLOOD; T-LYMPHOCYTES; INFECTION; INTERFERON	The Fulani ethnic group from West Africa is relatively better protected against Plasmodium falciparum malaria as compared to other sympatric ethnic groups, such as the Dogon. However, the mechanisms behind this lower susceptibility to malaria are largely unknown, particularly those concerning innate immunity. Antigen-presenting cells (APCs), and in particular dendritic cells (DCs) are important components of the innate and adaptive immune systems. Therefore, in this study we investigated whether APCs obtained from Fulani and Dogon children exhibited differences in terms of activation status and toll-like receptor (TLR) responses during malaria infection. Lower frequency and increased activation was observed in circulating plasmacytoid DCs and BDCA-3(+) myeloid DCs of infected Fulani as compared to their uninfected counterparts. Conversely, a higher frequency and reduced activation was observed in the same DC subsets obtained from peripheral blood of P. falciparum-infected Dogon children as compared to their uninfected peers. Moreover, infected individuals of both ethnic groups exhibited higher percentages of both classical and inflammatory monocytes that were less activated as compared to their non-infected counterparts. In line with APC impairment during malaria infection, TLR4, TLR7 and TLR9 responses were strongly inhibited by P. falciparum infection in Dogon children, while no such TLR inhibition was observed in the Fulani children. Strikingly, the TLR-induced IFN-gamma release was completely abolished in the Dogon undergoing infection while no difference was seen within infected and non-infected Fulani. Thus, P. falciparum infection is associated with altered activation status of important APC subsets and strongly inhibited TLR responses in peripheral blood of Dogon children. In contrast, P. falciparum induces DC activation and does not affect the innate response to specific TLR ligands in Fulani children. These findings suggest that DCs and TLR signalling may be of importance for the protective immunity against malaria observed in the Fulani.	[Arama, Charles; Giusti, Pablo; Bostrom, Stephanie; Varani, Stefania; Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Arama, Charles; Dara, Victor; Traore, Boubacar; Dolo, Amagana; Doumbo, Ogobara] Univ Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali; [Varani, Stefania] Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Huddinge, Sweden; [Varani, Stefania] Univ Bologna, Dept Haematol & Clin Oncol, Bologna, Italy	Stockholm University; University of Bamako; Karolinska Institutet; Karolinska University Hospital; University of Bologna	Arama, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden.	charles.arama@wgi.su.se	Troye-Blomberg, Marita/B-9210-2016; Varani, Stefania/AAZ-1856-2021	Troye-Blomberg, Marita/0000-0002-2804-0325; VARANI, STEFANIA/0000-0003-0862-4937	Swedish Agency for Research and Development [Sida/SAREC SWE 1995-117]; European and Developing Countries [EDCTP CG-TA 05 40204_003]; BioMalPar European Network of Excellence [LSHP-CT-2004-503578]; European Community [FP7/2007-2013, 242095]	Swedish Agency for Research and Development; European and Developing Countries; BioMalPar European Network of Excellence; European Community(European Commission)	This work was supported by grants from the Swedish Agency for Research and Development with Developing Countries, http://www.sida.se (Sida/SAREC SWE 1995-117), the European and Developing Countries Clinical Partnership's grant, http://www.edctp.org (EDCTP CG-TA 05 40204_003), as well as a grant within the BioMalPar European Network of Excellence, http://www.biomalpar.org (LSHP-CT-2004-503578) and from the European Community's Seventh Framework Programme, http://www.evimalar.org/ (FP7/2007-2013) under grant agreement No 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bereczky S, 2006, T ROY SOC TROP MED H, V100, P248, DOI 10.1016/j.trstmh.2005.03.011; Bolad A, 2005, SCAND J IMMUNOL, V61, P380, DOI 10.1111/j.1365-3083.2005.01587.x; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Chimma P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000631; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; DeSouza JB, 1997, INFECT IMMUN, V65, P1593, DOI 10.1128/IAI.65.5.1593-1598.1997; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Farouk SE, 2005, MICROBES INFECT, V7, P110, DOI 10.1016/j.micinf.2004.09.012; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Israelsson E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-175; Jaworowski A, 2007, J INFECT DIS, V196, P38, DOI 10.1086/518443; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Luoni G, 2001, GENES IMMUN, V2, P411, DOI 10.1038/sj.gene.6363797; Luty AJF, 2000, INFECT IMMUN, V68, P3909, DOI 10.1128/IAI.68.7.3909-3915.2000; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; McCall MBB, 2010, J INFECT DIS, V201, P142, DOI 10.1086/648596; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Ogonda LA, 2010, INFECT IMMUN, V78, P2173, DOI 10.1128/IAI.01078-09; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Pinto LA, 2005, CYTOM PART B-CLIN CY, V63B, P47, DOI 10.1002/cyto.b.20038; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Todryk SM, 2008, FUTURE MICROBIOL, V3, P279, DOI 10.2217/17460913.3.3.279; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Urban BC, 2002, CURR OPIN IMMUNOL, V14, P458, DOI 10.1016/S0952-7915(02)00368-0; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Vafa M, 2009, ACTA TROP, V109, P12, DOI 10.1016/j.actatropica.2008.09.001; Vafa M, 2007, MICROBES INFECT, V9, P1043, DOI 10.1016/j.micinf.2007.04.011; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	63	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18319	10.1371/journal.pone.0018319	http://dx.doi.org/10.1371/journal.pone.0018319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483827	Green Published, gold			2022-12-25	WOS:000289057200056
J	Cheng, SB; Ferland, P; Webster, P; Bearer, EL				Cheng, Shi-Bin; Ferland, Paulette; Webster, Paul; Bearer, Elaine L.			Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; TYPE-1 GLYCOPROTEIN-E; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; ANTEROGRADE TRANSPORT; PSEUDORABIES VIRUS; NEURONAL AXONS; FC-RECEPTOR; IN-VITRO; IMMUNOELECTRON MICROSCOPY	Herpes simplex type 1 (HSV1) replicates in epithelial cells and secondarily enters local sensory neuronal processes, traveling retrograde to the neuronal nucleus to enter latency. Upon reawakening newly synthesized viral particles travel anterograde back to the epithelial cells of the lip, causing the recurrent cold sore. HSV1 co-purifies with amyloid precursor protein (APP), a cellular transmembrane glycoprotein and receptor for anterograde transport machinery that when proteolyzed produces A-beta, the major component of senile plaques. Here we focus on transport inside epithelial cells of newly synthesized virus during its transit to the cell surface. We hypothesize that HSV1 recruits cellular APP during transport. We explore this with quantitative immuno-fluorescence, immuno-gold electron-microscopy and live cell confocal imaging. After synchronous infection most nascent VP26-GFP-labeled viral particles in the cytoplasm co-localize with APP (72.8+/-6.7%) and travel together with APP inside living cells (81.1+/-28.9%). This interaction has functional consequences: HSV1 infection decreases the average velocity of APP particles (from 1.1+/-0.2 to 0.3+/-0.1 mu m/s) and results in APP mal-distribution in infected cells, while interplay with APP-particles increases the frequency (from 10% to 81% motile) and velocity (from 0.3+/-0.1 to 0.4+/-0.1 mu m/s) of VP26-GFP transport. In cells infected with HSV1 lacking the viral Fc receptor, gE, an envelope glycoprotein also involved in viral axonal transport, APP-capsid interactions are preserved while the distribution and dynamics of dual-label particles differ from wild-type by both immuno-fluorescence and live imaging. Knock-down of APP with siRNA eliminates APP staining, confirming specificity. Our results indicate that most intracellular HSV1 particles undergo frequent dynamic interplay with APP in a manner that facilitates viral transport and interferes with normal APP transport and distribution. Such dynamic interactions between APP and HSV1 suggest a mechanistic basis for the observed clinical relationship between HSV1 seropositivity and risk of Alzheimer's disease.	[Cheng, Shi-Bin; Ferland, Paulette; Bearer, Elaine L.] Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02912 USA; [Webster, Paul] House Ear Res Inst, Los Angeles, CA USA; [Bearer, Elaine L.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Bearer, Elaine L.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA	Brown University; House Research Institute; University of New Mexico; University of New Mexico	Cheng, SB (corresponding author), Brown Univ, Dept Pathol & Lab Med, Alpert Med Sch, Providence, RI 02912 USA.	ebearer@salud.unm.edu		Webster, Paul/0000-0002-1980-6931	NIDCD [5 P-30 DC006276-03]; Ahmanson Foundation; Lucille Markey Foundation; NIGMS [GM47368]; NINDS [NS046810, NS062184]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062184, R01NS046810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC006276] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Ahmanson Foundation; Lucille Markey Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Grants from the NIDCD (5 P-30 DC006276-03) and the Ahmanson Foundation supported the Imaging Core where the immunoEM part of this work was performed; the Zeiss confocal microscope at Brown University was purchased with funds from the Lucille Markey Foundation (ELB); and the Bearer Laboratories at Brown University and at University of New Mexico are supported by NIGMS GM47368 (ELB), and NINDS NS046810 (ELB) and NS062184 (ELB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinone SE, 2006, J VIROL, V80, P11235, DOI 10.1128/JVI.01441-06; AVITABILE E, 1995, J VIROL, V69, P7472, DOI 10.1128/JVI.69.12.7472-7482.1995; Baker ML, 2006, PLOS COMPUT BIOL, V2, P1313, DOI 10.1371/journal.pcbi.0020146; BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; BAUCKE RB, 1979, J VIROL, V32, P779, DOI 10.1128/JVI.32.3.779-789.1979; Bearer EL, 2000, P NATL ACAD SCI USA, V97, P8146, DOI 10.1073/pnas.97.14.8146; BEARER EL, 1992, J NEUROSCI, V12, P750; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Brown WD, 2010, J CHILD NEUROL, V25, P901, DOI 10.1177/0883073809353449; CAI WZ, 1988, J MOL BIOL, V201, P575, DOI 10.1016/0022-2836(88)90639-0; CAMPADELLI G, 1993, P NATL ACAD SCI USA, V90, P2798, DOI 10.1073/pnas.90.7.2798; CAMPADELLIFIUME G, 1990, J VIROL, V64, P6070, DOI 10.1128/JVI.64.12.6070-6079.1990; CAMPADELLIFIUME G, 1988, J VIROL, V62, P159, DOI 10.1128/JVI.62.1.159-167.1988; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Carter CJ, 2008, NEUROCHEM INT, V52, P920, DOI 10.1016/j.neuint.2007.11.003; Ch'ng TH, 2005, J VIROL, V79, P10875, DOI 10.1128/JVI.79.17.10875-10889.2005; Chermann J C, 1987, Antibiot Chemother (1971), V38, P13; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; del Rio T, 2005, J VIROL, V79, P3903, DOI 10.1128/JVI.79.7.3903-3919.2005; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Diefenbach RJ, 2008, REV MED VIROL, V18, P35, DOI 10.1002/rmv.560; Dohner K, 2006, J VIROL, V80, P8211, DOI 10.1128/JVI.02528-05; DOLLERY SJ, J VIROL IN PRESS; Enquist LW, 2002, VET MICROBIOL, V86, P5, DOI 10.1016/S0378-1135(01)00486-2; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Farnsworth A, 2006, J VIROL, V80, P3167, DOI 10.1128/JVI.80.7.3167-3179.2006; GAJDUSEK DC, 1967, SCIENCE, V155, P212; GERSHON AA, 1994, J VIROL, V68, P6372, DOI 10.1128/JVI.68.10.6372-6390.1994; Granzow H, 2001, J VIROL, V75, P3675, DOI 10.1128/JVI.75.8.3675-3684.2001; Harley CA, 2001, J VIROL, V75, P1236, DOI 10.1128/JVI.75.3.1236-1251.2001; Holland DJ, 1999, J VIROL, V73, P8503, DOI 10.1128/JVI.73.10.8503-8511.1999; HONESS RW, 1973, J VIROL, V12, P1347, DOI 10.1128/JVI.12.6.1347-1365.1973; JOHANSSON PJH, 1985, J VIROL, V56, P489, DOI 10.1128/JVI.56.2.489-494.1985; JOHNSON DC, 1983, CELL, V32, P987, DOI 10.1016/0092-8674(83)90083-1; Johnson DC, 2001, J VIROL, V75, P821, DOI 10.1128/JVI.75.2.821-833.2001; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KOMURO M, 1989, EUR J CELL BIOL, V50, P398; Kotsakis A, 2001, J VIROL, V75, P8697, DOI 10.1128/JVI.75.18.8697-8711.2001; KRISTENSSON K, 1986, J GEN VIROL, V67, P2023, DOI 10.1099/0022-1317-67-9-2023; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; LaVail JH, 2007, NEUROSCIENCE, V146, P974, DOI 10.1016/j.neuroscience.2007.02.010; Lee GE, 2006, J VIROL, V80, P4264, DOI 10.1128/JVI.80.9.4264-4275.2006; Lengyel J, 2002, J VIROL, V76, P11866, DOI 10.1128/JVI.76.23.11866-11879.2002; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; LYCKE E, 1984, J GEN VIROL, V65, P55, DOI 10.1099/0022-1317-65-1-55; LYCKE E, 1988, ARCH VIROL, V101, P87, DOI 10.1007/BF01314654; MARESCH C, 2010, J VIROL; McGraw HM, 2009, J VIROL, V83, P8315, DOI 10.1128/JVI.00633-09; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Ohara PT, 2000, J VIROL, V74, P4776, DOI 10.1128/JVI.74.10.4776-4786.2000; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Remillard-Labrosse G, 2009, TRAFFIC, V10, P1074, DOI 10.1111/j.1600-0854.2009.00939.x; Saldanha CE, 2000, J VIROL, V74, P6712, DOI 10.1128/JVI.74.15.6712-6719.2000; Sallustio F, 2010, FASEB J, V24, P514, DOI 10.1096/fj.09-136481; Satpute-Krishnan P, 2003, AGING CELL, V2, P305, DOI 10.1046/j.1474-9728.2003.00069.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; SNYDER A, 2008, J VIROL; Snyder A, 2008, J VIROL, V82, P10613, DOI 10.1128/JVI.01241-08; Snyder A, 2007, J VIROL, V81, P8337, DOI 10.1128/JVI.00520-07; Snyder A, 2006, J VIROL, V80, P11165, DOI 10.1128/JVI.01107-06; Sprague ER, 2006, PLOS BIOL, V4, P975, DOI 10.1371/journal.pbio.0040148; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stokin GB, 2006, J PHYSIOL-PARIS, V99, P193, DOI 10.1016/j.jphysparis.2005.12.085; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Tomishima MJ, 2002, J VIROL, V76, P8310, DOI 10.1128/JVI.76.16.8310-8317.2002; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; Wang FS, 2005, J VIROL, V79, P13362, DOI 10.1128/JVI.79.21.13362-13372.2005; Wang F, 2010, VIROLOGY, V405, P269, DOI 10.1016/j.virol.2010.06.006; Ward PL, 1998, VIROLOGY, V241, P189, DOI 10.1006/viro.1997.8972; WASCO W, 1993, ANN NY ACAD SCI, V695, P203, DOI 10.1111/j.1749-6632.1993.tb23053.x; WHEALY ME, 1992, J VIROL, V66, P3803, DOI 10.1128/JVI.66.6.3803-3810.1992; Whiteley A, 1999, J VIROL, V73, P9515, DOI 10.1128/JVI.73.11.9515-9520.1999; Willard M, 2002, J VIROL, V76, P5220, DOI 10.1128/JVI.76.10.5220-5232.2002; Wisner T, 2000, J VIROL, V74, P2278, DOI 10.1128/JVI.74.5.2278-2287.2000; Wisner TW, 2004, J VIROL, V78, P11519, DOI 10.1128/JVI.78.21.11519-11535.2004; Wolfstein A, 2006, TRAFFIC, V7, P227, DOI 10.1111/j.1600-0854.2005.00379.x; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	100	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e17966	10.1371/journal.pone.0017966	http://dx.doi.org/10.1371/journal.pone.0017966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483850	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200015
J	Mochel, F; Durant, B; Durr, A; Schiffmann, R				Mochel, Fanny; Durant, Brandon; Durr, Alexandra; Schiffmann, Raphael			Altered Dopamine and Serotonin Metabolism in Motorically Asymptomatic R6/2 Mice	PLOS ONE			English	Article							PRECLINICAL HUNTINGTONS-DISEASE; FOCUSED MICROWAVE IRRADIATION; TRANSGENIC MOUSE MODEL; EXPRESSION; STRIATUM; CHOREA; DYSREGULATION; NEUROGENESIS; SYMPTOMS; BEHAVIOR	The pattern of cerebral dopamine (DA) abnormalities in Huntington disease (HD) is complex, as reflected by the variable clinical benefit of both DA antagonists and agonists in treating HD symptoms. In addition, little is known about serotonin metabolism despite the early occurrence of anxiety and depression in HD. Post-mortem enzymatic changes are likely to interfere with the in vivo profile of biogenic amines. Hence, in order to reliably characterize the regional and chronological profile of brain neurotransmitters in a HD mouse model, we used a microwave fixation system that preserves in vivo concentrations of dopaminergic and serotoninergic amines. DA was decreased in the striatum of R6/2 mice at 8 and 12 weeks of age while DA metabolites, 3-methoxytyramine and homovanillic acid, were already significantly reduced in 4-week-old motorically asymptomatic R6/2 mice. In the striatum, hippocampus and frontal cortex of 4, 8 and 12-week-old R6/2 mice, serotonin and its metabolite 5-hydroxyindoleacetic acid were significantly decreased in association with a decreased turnover of serotonin. In addition, automated high-resolution behavioural analyses displayed stress-like behaviours such as jumping and grooming and altered spatial learning in R6/2 mice at age 4 and 6 weeks respectively. Therefore, we describe the earliest alterations of DA and serotonin metabolism in a HD murine model. Our findings likely underpin the neuropsychological symptoms at time of disease onset in HD.	[Mochel, Fanny; Durr, Alexandra] Hop La Pitie Salpetriere, Inst Cerveau & Moelle, INSERM UMR S975, Paris, France; [Mochel, Fanny; Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Mochel, Fanny] Univ Paris 06, Paris, France; [Mochel, Fanny; Durant, Brandon; Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Baylor Scott & White Health; Baylor University Medical Center	Mochel, F (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle, INSERM UMR S975, Paris, France.	fanny.mochel@upmc.fr	Durant, Brandon/HCH-8003-2022	Durant, Brandon/0000-0003-3028-6161	Cure Huntington's Disease Initiative Foundation (CHDI) in New York	Cure Huntington's Disease Initiative Foundation (CHDI) in New York	This work was funded by the Cure Huntington's Disease Initiative Foundation (CHDI) in New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAR CA, 1987, J NEUROCHEM, V48, P390, DOI 10.1111/j.1471-4159.1987.tb04106.x; CARACENI T, 1977, J NEUROL NEUROSUR PS, V40, P581, DOI 10.1136/jnnp.40.6.581; CROSS A, 1983, EUR J PHARMACOL, V88, P223, DOI 10.1016/0014-2999(83)90009-2; CUNHA L, 1981, J NEUROL NEUROSUR PS, V44, P258, DOI 10.1136/jnnp.44.3.258; Delaney SM, 1996, J NEUROSCI METH, V64, P151, DOI 10.1016/0165-0270(95)00119-0; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217; Gonzalez-Burgos I, 2008, PROG BRAIN RES, V172, P603, DOI 10.1016/S0079-6123(08)00928-X; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haskins, 2000, Curr Treat Options Neurol, V2, P243, DOI 10.1007/s11940-000-0007-0; Hickey MA, 2002, J NEUROCHEM, V81, P46, DOI 10.1046/j.1471-4159.2002.00804.x; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; Johnson MA, 2007, J NEUROCHEM, V103, P2102, DOI 10.1111/j.1471-4159.2007.04908.x; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Karolewicz B, 1998, POL J PHARMACOL, V50, P425; Kloppel S, 2010, NEUROPSYCHOLOGIA, V48, P549, DOI 10.1016/j.neuropsychologia.2009.10.016; Lawrence AD, 1998, BRAIN, V121, P1343, DOI 10.1093/brain/121.7.1343; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; O'Callaghan JP, 2004, J NEUROSCI METH, V135, P159, DOI 10.1016/j.jneumeth.2003.12.006; Ortiz AN, 2010, J NEUROCHEM, V112, P755, DOI 10.1111/j.1471-4159.2009.06501.x; Pandaranandaka J, 2009, BEHAV BRAIN RES, V198, P142, DOI 10.1016/j.bbr.2008.10.043; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Peng Q, 2008, EXP NEUROL, V210, P154, DOI 10.1016/j.expneurol.2007.10.015; Reynolds GP, 1999, J NEUROCHEM, V72, P1773, DOI 10.1046/j.1471-4159.1999.721773.x; Rudenko O, 2009, BEHAV BRAIN RES, V203, P188, DOI 10.1016/j.bbr.2009.04.034; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; STAHL SM, 1986, ARCH GEN PSYCHIAT, V43, P161; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STEWARD LJ, 1993, EUR J PHARMACOL, V242, P137, DOI 10.1016/0014-2999(93)90073-Q; Tedroff J, 1999, NEUROLOGY, V53, P1605, DOI 10.1212/WNL.53.7.1605; van Oostrom JCH, 2005, NEUROLOGY, V65, P941, DOI 10.1212/01.wnl.0000176071.08694.cc; Vetter JM, 2003, J NEUROCHEM, V85, P1054, DOI 10.1046/j.1471-4159.2003.01704.x; Wolf RC, 2008, EXP NEUROL, V213, P137, DOI 10.1016/j.expneurol.2008.05.017; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104	36	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18336	10.1371/journal.pone.0018336	http://dx.doi.org/10.1371/journal.pone.0018336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483838	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200062
J	Nelson, CE; Carlson, CA				Nelson, Craig E.; Carlson, Craig A.			Differential Response of High-Elevation Planktonic Bacterial Community Structure and Metabolism to Experimental Nutrient Enrichment	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; SIERRA-NEVADA; BACTERIOPLANKTON GROWTH; PHOSPHORUS LIMITATION; NITROGEN DEPOSITION; MOUNTAIN LAKES; COLORADO; CATCHMENTS; CALIFORNIA; RETENTION	Nutrient enrichment of high-elevation freshwater ecosystems by atmospheric deposition is increasing worldwide, and bacteria are a key conduit for the metabolism of organic matter in these oligotrophic environments. We conducted two distinct in situ microcosm experiments in a high-elevation lake (Emerald Lake, Sierra Nevada, California, USA) to evaluate responses in bacterioplankton growth, carbon utilization, and community structure to short-term enrichment by nitrate and phosphate. The first experiment, conducted just following ice-off, employed dark dilution culture to directly assess the impact of nutrients on bacterioplankton growth and consumption of terrigenous dissolved organic matter during snowmelt. The second experiment, conducted in transparent microcosms during autumn overturn, examined how bacterioplankton in unmanipulated microbial communities responded to nutrients concomitant with increasing phytoplankton-derived organic matter. In both experiments, phosphate enrichment (but not nitrate) caused significant increases in bacterioplankton growth, changed particulate organic stoichiometry, and induced shifts in bacterial community composition, including consistent declines in the relative abundance of Actinobacteria. The dark dilution culture showed a significant increase in dissolved organic carbon removal in response to phosphate enrichment. In transparent microcosms nutrient enrichment had no effect on concentrations of chlorophyll, carbon, or the fluorescence characteristics of dissolved organic matter, suggesting that bacterioplankton responses were independent of phytoplankton responses. These results demonstrate that bacterioplankton communities in unproductive high-elevation habitats can rapidly alter their taxonomic composition and metabolism in response to short-term phosphate enrichment. Our results reinforce the key role that phosphorus plays in oligotrophic lake ecosystems, clarify the nature of bacterioplankton nutrient limitation, and emphasize that evaluation of eutrophication in these habitats should incorporate heterotrophic microbial communities and processes.	[Nelson, Craig E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Nelson, CE (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	craig.nelson@lifesci.ucsb.edu	Nelson, Craig E/H-3323-2019	Nelson, Craig E/0000-0003-2525-3496	University of California Center for Water Resources [W988]; NSF DDIG [0709975]; NSF LTREB [0614207]; NSF Santa Barbara Channel LTER [OCE-0620276]	University of California Center for Water Resources(University of California System); NSF DDIG(National Science Foundation (NSF)); NSF LTREB(National Science Foundation (NSF)); NSF Santa Barbara Channel LTER	Financial support was provided by the University of California Center for Water Resources grant W988 to John M. Melack and CAC, NSF DDIG grant 0709975 to CEN, NSF LTREB grant 0614207 to John M. Melack and James O. Sickman and the NSF Santa Barbara Channel LTER grant OCE-0620276. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Biddanda B, 2001, LIMNOL OCEANOGR, V46, P730, DOI 10.4319/lo.2001.46.3.0730; BRATBAK G, 1985, MAR ECOL PROG SER, V25, P23, DOI 10.3354/meps025023; Burns DA, 2004, ENVIRON POLLUT, V127, P257, DOI 10.1016/S0269-7491(03)00264-1; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; Carlsson P, 2001, LIMNOL OCEANOGR, V46, P108, DOI 10.4319/lo.2001.46.1.0108; Carrera G, 2002, ENVIRON SCI TECHNOL, V36, P2581, DOI 10.1021/es0102585; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; DETTINGER MD, 1995, J CLIMATE, V8, P606, DOI 10.1175/1520-0442(1995)008<0606:LSAFOR>2.0.CO;2; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; Hood E, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001738; Jansson M, 2006, MICROB ECOL, V52, P358, DOI 10.1007/s00248-006-9013-4; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Lindstrom ES, 2004, J PLANKTON RES, V26, P241, DOI 10.1093/plankt/fbh010; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Matz C, 2003, MICROB ECOL, V45, P384, DOI 10.1007/s00248-003-2000-0; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; McCune B., 1999, MULTIVARIATE ANAL EC; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; MELACK JM, 1991, REGIONAL CASE STUDIE, P503; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; MORRIS DP, 1992, LIMNOL OCEANOGR, V37, P1179, DOI 10.4319/lo.1992.37.6.1179; MORRIS DP, 1988, FRESHWATER BIOL, V20, P315, DOI 10.1111/j.1365-2427.1988.tb00457.x; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Olsen LM, 2002, MICROBIAL ECOL, V43, P353, DOI 10.1007/s00248-002-2009-9; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Perez MT, 2006, LIMNOL OCEANOGR, V51, P2527, DOI 10.4319/lo.2006.51.6.2527; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sadro S, 2011, LIMNOL OCEANOGR, V56, P540, DOI 10.4319/lo.2011.56.2.0540; Salcher MM, 2007, FEMS MICROBIOL ECOL, V60, P40, DOI 10.1111/j.1574-6941.2006.00274.x; Sickman JO, 2003, LIMNOL OCEANOGR, V48, P1885, DOI 10.4319/lo.2003.48.5.1885; Sickman JO, 2003, BIOGEOCHEMISTRY, V64, P1, DOI 10.1023/A:1024928317057; Sickman JO, 2002, BIOGEOCHEMISTRY, V57, P341, DOI 10.1023/A:1016564816701; Sickman JO, 2001, WATER RESOUR RES, V37, P1445, DOI 10.1029/2000WR900371; SICKMAN JO, 2001, THESIS U CALIFORNIA; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Smith EM, 2004, LIMNOL OCEANOGR, V49, P137, DOI 10.4319/lo.2004.49.1.0137; SommarugaWograth S, 1997, NATURE, V387, P64, DOI 10.1038/387064a0; Sorensen T, 1948, K DAN VIDENSK SELSK, V5, P1, DOI DOI 10.1234/12345678; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114; Vadstein O, 2003, FEMS MICROBIOL ECOL, V46, P307, DOI 10.1016/S0168-6496(03)00195-8; Vadstein O, 2000, ADV MICROB ECOL, V16, P115; Villar-Argaiz M, 2002, AQUAT MICROB ECOL, V29, P253, DOI 10.3354/ame029253; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2005, APPL ENVIRON MICROB, V71, P5551, DOI 10.1128/AEM.71.9.5551-5559.2005; WILLIAMS MW, 1991, WATER RESOUR RES, V27, P1575, DOI [10.1029/90WR02774, 10.1029/90WR02773]; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005	54	21	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18320	10.1371/journal.pone.0018320	http://dx.doi.org/10.1371/journal.pone.0018320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483836	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200057
J	Pathak, A; Kumar, S				Pathak, Amit; Kumar, Sanjay			From Molecular Signal Activation to Locomotion: An Integrated, Multiscale Analysis of Cell Motility on Defined Matrices	PLOS ONE			English	Article							MIGRATION; MODEL; ADHESIONS; SUBSTRATE; RIGIDITY; MUSCLE; ACTIN; FIBROBLASTS; PROTRUSION; MECHANICS	The adhesion, mechanics, and motility of eukaryotic cells are highly sensitive to the ligand density and stiffness of the extracellular matrix (ECM). This relationship bears profound implications for stem cell engineering, tumor invasion and metastasis. Yet, our quantitative understanding of how ECM biophysical properties, mechanotransductive signals, and assembly of contractile and adhesive structures collude to control these cell behaviors remains extremely limited. Here we present a novel multiscale model of cell migration on ECMs of defined biophysical properties that integrates local activation of biochemical signals with adhesion and force generation at the cell-ECM interface. We capture the mechanosensitivity of individual cellular components by dynamically coupling ECM properties to the activation of Rho and Rac GTPases in specific portions of the cell with actomyosin contractility, cell-ECM adhesion bond formation and rupture, and process extension and retraction. We show that our framework is capable of recreating key experimentally-observed features of the relationship between cell migration and ECM biophysical properties. In particular, our model predicts for the first time recently reported transitions from filopodial to "stick-slip" to gliding motility on ECMs of increasing stiffness, previously observed dependences of migration speed on ECM stiffness and ligand density, and high-resolution measurements of mechanosensitive protrusion dynamics during cell motility we newly obtained for this study. It also relates the biphasic dependence of cell migration speed on ECM stiffness to the tendency of the cell to polarize. By enabling the investigation of experimentally-inaccessible microscale relationships between mechanotransductive signaling, adhesion, and motility, our model offers new insight into how these factors interact with one another to produce complex migration patterns across a variety of ECM conditions.	[Pathak, Amit; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Pathak, A (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	skumar@berkeley.edu	Pathak, Amit/H-3049-2013	Pathak, Amit/0000-0003-4006-5119	Arnold and Mabel Beckman Young Investigator Award; NSF [CMMI 0727420]; Army Research Office [W911NF-09-1-0507]; NIH Physical Sciences Oncology Center [1U54CA143836]; NIH [1DP2OD004213]; NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004213] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Young Investigator Award; NSF(National Science Foundation (NSF)); Army Research Office; NIH Physical Sciences Oncology Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Arnold and Mabel Beckman Young Investigator Award, the NSF (CMMI 0727420), a PECASE award from the Army Research Office (W911NF-09-1-0507), an NIH Physical Sciences Oncology Center Grant (1U54CA143836), and an NIH Director's New Innovator Award (1DP2OD004213), a part of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Herant M, 2003, BIOPHYS J, V84, P3389, DOI 10.1016/S0006-3495(03)70062-9; Herant M, 2010, BIOPHYS J, V98, P1408, DOI 10.1016/j.bpj.2009.12.4303; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Nishimura SI, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000310; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zemel A., 2010, NAT PHYS	35	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18423	10.1371/journal.pone.0018423	http://dx.doi.org/10.1371/journal.pone.0018423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483802	gold, Green Submitted, Green Published			2022-12-25	WOS:000289057200073
J	Rueckert, S; Simdyanov, TG; Aleoshin, VV; Leander, BS				Rueckert, Sonja; Simdyanov, Timur G.; Aleoshin, Vladimir V.; Leander, Brian S.			Identification of a Divergent Environmental DNA Sequence Clade Using the Phylogeny of Gregarine Parasites (Apicomplexa) from Crustacean Hosts	PLOS ONE			English	Article							MICROBIAL EUKARYOTES; LIFE-CYCLE; DIVERSITY; INFECTION; TAXONOMY; REVISION; MORPHOLOGY; INFERENCE; CHECKLIST; KINGDOMS	Background: Environmental SSU rDNA surveys have significantly improved our understanding of microeukaryotic diversity. Many of the sequences acquired using this approach are closely related to lineages previously characterized at both morphological and molecular levels, making interpretation of these data relatively straightforward. Some sequences, by contrast, appear to be phylogenetic orphans and are sometimes inferred to represent "novel lineages" of unknown cellular identity. Consequently, interpretation of environmental DNA surveys of cellular diversity rely on an adequately comprehensive database of DNA sequences derived from identified species. Several major taxa of microeukaryotes, however, are still very poorly represented in these databases, and this is especially true for diverse groups of single-celled parasites, such as gregarine apicomplexans. Methodology/Principal Findings: This study attempts to address this paucity of DNA sequence data by characterizing four different gregarine species, isolated from the intestines of crustaceans, at both morphological and molecular levels: Thiriotia pugettiae sp. n. from the graceful kelp crab (Pugettia gracilis), Cephaloidophora cf. communis from two different species of barnacles (Balanus glandula and B. balanus), Heliospora cf. longissima from two different species of freshwater amphipods (Eulimnogammarus verrucosus and E. vittatus), and Heliospora caprellae comb. n. from a skeleton shrimp (Caprella alaskana). SSU rDNA sequences were acquired from isolates of these gregarine species and added to a global apicomplexan alignment containing all major groups of gregarines characterized so far. Molecular phylogenetic analyses of these data demonstrated that all of the gregarines collected from crustacean hosts formed a very strongly supported clade with 48 previously unidentified environmental DNA sequences. Conclusions/Significance: This expanded molecular phylogenetic context enabled us to establish a major clade of intestinal gregarine parasites and infer the cellular identities of several previously unidentified environmental SSU rDNA sequences, including several sequences that have formerly been discussed broadly in the literature as a suspected "novel" lineage of eukaryotes.	[Rueckert, Sonja; Leander, Brian S.] Univ British Columbia, Dept Bot, Program Integrated Microbial Biodivers, Canadian Inst Adv Res, Vancouver, BC, Canada; [Rueckert, Sonja; Leander, Brian S.] Univ British Columbia, Dept Zool, Canadian Inst Adv Res, Vancouver, BC, Canada; [Rueckert, Sonja] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka, Japan; [Simdyanov, Timur G.] Moscow MV Lomonosov State Univ, Dept Invertebrate Zool, Fac Biol, Moscow, Russia; [Aleoshin, Vladimir V.] Moscow MV Lomonosov State Univ, Dept Evolutionary Biochem, Belozersky Inst Physicochem Biol, Moscow, Russia	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of Tsukuba; Lomonosov Moscow State University; Lomonosov Moscow State University	Rueckert, S (corresponding author), Univ British Columbia, Dept Bot, Program Integrated Microbial Biodivers, Canadian Inst Adv Res, Vancouver, BC, Canada.	bleander@interchange.ubc.ca	Rueckert, Sonja/E-4695-2011; Aleoshin, Vladimir/AAE-9707-2022; Aleoshin, Vladimir/AFE-8409-2022; Simdyanov, Timur G/H-8279-2012	Aleoshin, Vladimir/0000-0002-3299-9950; Simdyanov, Timur G/0000-0003-2478-9301	Tula Foundation (Centre for Microbial Diversity and Evolution); National Science and Engineering Research Council of Canada (NSERC) [283091-09]; Canadian Institute for Advanced Research; Russian Foundation of Basic Researches [RFBR 09-04-01682, 09-04-01150, 09-04-92741]; Ministry of Education and Science of Russia	Tula Foundation (Centre for Microbial Diversity and Evolution); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation)	SR and BSL were supported by grants from the Tula Foundation (Centre for Microbial Diversity and Evolution), the National Science and Engineering Research Council of Canada (NSERC 283091-09) and the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. TGS and VVA were supported by grants from Russian Foundation of Basic Researches (RFBR 09-04-01682, 09-04-01150, and 09-04-92741), and Ministry of Education and Science of Russia (Federal Target Program "Scientific and scientific-pedagogical personnel of innovative Russia" for 2009-2013). In this study the authors used the resources of the Chebyshov Supercomputer Center of Moscow State University (http://parallel.ru/cluster) and the University of Oslo Bioportal (www.bioportal.uio.no) for tree inferences. DNA sequencing was performed in the Interinstitutional Center of collective usage "GENOM" (http://www.genome-centre.narod.ru/) of the Institute for Molecular Biology (Russian Academy of Sciences), established by support of Russian Foundation of Basic Researches. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2007, SYST BIOL, V56, P684, DOI 10.1080/10635150701494127; Avdeev V.V., 1989, P40; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; CHAKRAVARTY M. M., 1959, PROC ZOOL SOC, V12, P71; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; CLEARY AC, 2011, ASLO 2011 AQ SCI M S; CLEARY AC, 2010, OC SCI 2010 M PORTL; Clopton RE, 2009, COMP PARASITOL, V76, P167, DOI 10.1654/4388.1; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; DESPORTES I, 1977, ANN SCI NAT ZOOL, V19, P261; Duplessis MR, 2004, MAR BIOL, V145, P551, DOI 10.1007/s00227-004-1350-6; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; EDGCOMB VP, 2010, ENV MICROBI IN PRESS; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FRENZEL J, 1848, ARCH MIKROSK ANAT, V24, P545; GOODRICH HP, 1949, Q J MICROSC SCI, V90, P27; Grasse P.-P., 1953, TRAITE ZOOL, P590; Groisillier A, 2006, AQUAT MICROB ECOL, V42, P277, DOI 10.3354/ame042277; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harada A, 2007, PROTIST, V158, P337, DOI 10.1016/j.protis.2007.03.005; HENRY DORA PRIAULX, 1938, ARCH PROTISTENK, V90, P414; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huxley JS, 1910, Q J MICROSC SCI, V55, P155; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; JONES I, 1968, J PROTOZOOL, V15, P414, DOI 10.1111/j.1550-7408.1968.tb02150.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Lecroq B., 2009, Marine Biodiversity, V39, P45; Lee JJ, 2000, ILLUSTRATED GUIDE PR; Leger L., 1925, Travaux de la Station Zoologique de Wimereux, V9, P126; LEVINE ND, 1977, J PROTOZOOL, V24, P41, DOI 10.1111/j.1550-7408.1977.tb05279.x; LEVINE ND, 1971, J PROTOZOOL, V18, P704, DOI 10.1111/j.1550-7408.1971.tb03401.x; LEVINE ND, 1976, T AM MICROSC SOC, V95, P695, DOI 10.2307/3225395; LEVINE ND, 1979, J PROTOZOOL, V26, P532, DOI 10.1111/j.1550-7408.1979.tb04190.x; LEVINE ND, 1985, ILLUSTRATED GUIDE PR, P322; LIPA JERZY J., 1968, ACTA PROTOZOOL, V5, P257; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; MADDISON DR, 2000, MACCLADE 4; Martin DL, 2006, MAR ECOL PROG SER, V319, P155, DOI 10.3354/meps319155; MAWRODIADI P, 1908, MEM SOC NAT NOUVELLE, V32, P101; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mingazzini P., 1891, ATTI R ACCAD LINCEI, V7, P407; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Mori KI, 2007, FISH PATHOL, V42, P49, DOI 10.3147/jsfp.42.49; PATIL CC, 1985, ARCH PROTISTENKD, V129, P179, DOI 10.1016/S0003-9365(85)80019-1; Perkins Frank O., 2002, P190; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prokopowicz AJ, 2010, POLAR BIOL, V33, P1339, DOI 10.1007/s00300-010-0821-0; Prytherch HF, 1940, J MORPHOL, V66, P39, DOI 10.1002/jmor.1050660106; REGER JF, 1966, J CELL BIOL, V31, pA134; Richards TA, 2005, CURR OPIN MICROBIOL, V8, P240, DOI 10.1016/j.mib.2005.04.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rueckert S, 2010, INT J SYST EVOL MICR, V60, P2681, DOI 10.1099/ijs.0.016436-0; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Simdyanov T. G., 2009, Parazitologiya (St. Petersburg), V43, P273; Skovgaard A, 2005, PROTIST, V156, P413, DOI 10.1016/j.protis.2005.08.002; Skovgaard A, 2008, PROTIST, V159, P401, DOI 10.1016/j.protis.2008.02.003; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Takishita K, 2007, EXTREMOPHILES, V11, P563, DOI 10.1007/s00792-007-0068-z; THEODORIDES J, 1975, Protistologica, V11, P205; THEODORIDES J, 1972, CR ACAD SCI D NAT, V274, P3251; TUZET ODETTE, 1956, ANN PARASITOL HUMAINE ET COMP, V31, P317; WALSH RD, 1976, MOSQ NEWS, V36, P154; Wise MR, 2000, J PARASITOL, V86, P602, DOI 10.1645/0022-3395(2000)086[0602:HSIMSN]2.0.CO;2; ZVETKOV V, 1928, ZWEI NEUE GREGARINEN, P47	70	53	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18163	10.1371/journal.pone.0018163	http://dx.doi.org/10.1371/journal.pone.0018163			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483868	Green Published, gold			2022-12-25	WOS:000289057200037
J	Crumbley, C; Burris, TP				Crumbley, Christine; Burris, Thomas P.			Direct Regulation of CLOCK Expression by REV-ERB	PLOS ONE			English	Article							CIRCADIAN TRANSCRIPTION; NUCLEAR RECEPTORS; TARGET GENE; ALPHA; LIGAND; CLONING; NPAS2; HEME	Circadian rhythms are regulated at the cellular level by transcriptional feedback loops leading to oscillations in expression of key proteins including CLOCK, BMAL1, PERIOD (PER), and CRYPTOCHROME (CRY). The CLOCK and BMAL1 proteins are members of the bHLH class of transcription factors and form a heterodimer that regulates the expression of the PER and CRY genes. The nuclear receptor REV-ERB alpha plays a key role in regulation of oscillations in BMAL1 expression by directly binding to the BMAL1 promoter and suppressing its expression at certain times of day when REV-ERB alpha expression levels are elevated. We recently demonstrated that REV-ERB alpha also regulates the expression of NPAS2, a heterodimer partner of BMAL1. Here, we show that REV-ERB alpha also regulates the expression another heterodimer partner of BMAL1, CLOCK. We identified a REV-ERB alpha binding site within the 1(st) intron of the CLOCK gene using a chromatin immunoprecipitation microarray screen. Suppression of REV-ERB alpha expression resulted in elevated CLOCK mRNA expression consistent with REV-ERB alpha's role as a transcriptional repressor. A REV-ERB response element (RevRE) was identified within this region of the CLOCK gene and was conserved between humans and mice. Additionally, the CLOCK RevRE conferred REV-ERB responsiveness to a heterologous reporter gene. Our data suggests that REV-ERB alpha plays a dual role in regulation of the activity of the BMAL1/CLOCK heterodimer by regulation of expression of both the BMAL1 and CLOCK genes.	[Crumbley, Christine; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute	Crumbley, C (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health (NIH) [R01DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (NIH) R01DK080201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; GRANT D, ACS CHEM BIOL, V5, P925; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KOJETIN D, ACS CHEM BIOL; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Stayrook KR, 2008, MOL PHARMACOL, V73, P607, DOI 10.1124/mol.107.039099; Steeves TDL, 1999, GENOMICS, V57, P189, DOI 10.1006/geno.1998.5675; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200	20	112	116	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17290	10.1371/journal.pone.0017290	http://dx.doi.org/10.1371/journal.pone.0017290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479263	Green Submitted, gold, Green Published			2022-12-25	WOS:000289054600008
J	Huang, WC; Chen, YJ; Li, LY; Wei, YL; Hsu, SC; Tsai, SL; Chiu, PC; Huang, WP; Wang, YN; Chen, CH; Chang, WC; Chang, WC; Chen, AJE; Tsai, CH; Hung, MC				Huang, Wei-Chien; Chen, Yun-Ju; Li, Long-Yuan; Wei, Ya-Ling; Hsu, Sheng-Chieh; Tsai, Shing-Ling; Chiu, Pei-Chun; Huang, Wei-Pang; Wang, Ying-Nai; Chen, Chung-Hsuan; Chang, Wei-Chao; Chang, Wen-Chang; Chen, Andy Jer-En; Tsai, Chang-Hai; Hung, Mien-Chie			Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; LUNG-CANCER; ACQUIRED-RESISTANCE; EGF RECEPTOR; MULTIDRUG-RESISTANCE; GENE-MUTATIONS; ZD1839 IRESSA; ACTIVATION; BINDING; LOCALIZATION	Epidermal growth factor receptor (EGFR), an aberrantly over-expressed or activated receptor-tyrosine kinase in many cancers, plays a pivotal role in cancer progression and has been an attractive target for cancer therapy. Gefitinib and erlotinib, two EGFR-tyrosine kinase inhibitors, have been approved for non-small cell lung cancer. However, durable clinical efficacy of these EGFR inhibitors is severely limited by the emergence of acquired resistance. For example, the expression of breast cancer-resistant protein (BCRP/ABCG2) has been shown to confer acquired resistance of wild-type EGFR (wtEGFR)-expressing cancer cells to gefitinib. However, the underlying molecular mechanisms still remain unclear. Here, we show that wtEGFR expression is elevated in the nucleus of acquired gefitinib-resistant cancer cells. Moreover, nuclear translocation of EGFR requires phosphorylation at Ser-229 by Akt. In the nucleus, EGFR then targets the proximal promoter of BCRP/ABCG2 and thereby enhances its gene transcription. The nuclear EGFR-mediated BCRP/ABCG2 expression may contribute at least in part to the acquired resistance of wtEGFR-expressing cancer cells to gefitinib. Our findings shed light on the role of nuclear EGFR in the sensitivity of wtEGFR-expressing cancer cells to EGFR tyro-sine kinase inhibitors and also deciphered a putative molecular mechanism contributing to gefitinib resistance through BCRP/ABCG2 expression.	[Huang, Wei-Chien; Chen, Yun-Ju; Li, Long-Yuan; Wei, Ya-Ling; Hsu, Sheng-Chieh; Chiu, Pei-Chun; Chang, Wei-Chao; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung 404, Taiwan; [Huang, Wei-Chien; Li, Long-Yuan; Tsai, Shing-Ling; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Huang, Wei-Chien; Li, Long-Yuan] China Med Univ, Ph D Program Canc Biol & Drug Discovery, Taichung 404, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Huang, Wei-Chien; Li, Long-Yuan] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung 413, Taiwan; [Chen, Yun-Ju; Wang, Ying-Nai; Chen, Andy Jer-En; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Huang, Wei-Pang] Natl Taiwan Univ, Inst Zool, Taipei 106, Taiwan; [Huang, Wei-Pang] Natl Taiwan Univ, Dept Life Sci, Taipei 106, Taiwan; [Chen, Yun-Ju; Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 701, Taiwan; [Chen, Yun-Ju; Chang, Wen-Chang] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 701, Taiwan; [Chen, Chung-Hsuan; Chang, Wei-Chao] Acad Sinica, Inst Phys, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Chung-Hsuan; Chang, Wei-Chao] Acad Sinica, Inst Atom & Mol Sci, Taipei 115, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Cheng Kung University; National Cheng Kung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Huang, WC (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Chen, Chung-Hsuan/F-7940-2012; Huang, Wei-Chien/H-3126-2019; Huang, Wei-Chien/D-1740-2012	Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; HUANG, WEI-PANG/0000-0001-8410-6555; Li, Long-Yuan/0000-0001-7472-8318; Wang, Ying-Nai/0000-0002-5275-6729	National Institutes of Health (NIH) [PO1 CA099031, RO1 CA109311]; National Breast Cancer Foundation, Inc.; Cancer Center Research of Excellence [DOH-99-TDC-111-05, NSC-2632-B-039-001-MY3, NSC-3111-B-039-002, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002, NSC-96-2917-I-006-004, NHRI-EX-98-9812BC, NHRI-EX98-9603BC, DOH97-TD-G-111-027]; University of Texas M. D. Anderson-China Medical University and Hospital; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Cancer Center Research of Excellence; University of Texas M. D. Anderson-China Medical University and Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 CA099031 and RO1 CA109311. This work was supported by the following grants: National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Cancer Center Research of Excellence DOH-99-TDC-111-05 (to M.-C. H.), NSC-2632-B-039-001-MY3 (to M.-C. H.), NSC-3111-B-039-002 (to M.-C. H. and L.-Y. L.), NSC-97-2320-B-039-033-MY3 (to W.-C. H.), NSC-98-3112-B-039-002 (to W.-C. H.), NSC-99-3112-B-039-002 (to W.-C. H.), NSC-96-2917-I-006-004 (to Y.-J. C.), NHRI-EX-98-9812BC (to W.-C. H.), NHRI-EX98-9603BC (to L.-Y. L.), DOH97-TD-G-111-027 (to M.-C. H.), and The University of Texas M. D. Anderson-China Medical University and Hospital Sister Institution Fund.	Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; Arteaga CL, 2007, NAT MED, V13, P675, DOI 10.1038/nm0607-675; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chou CK, 2009, MOL CARCINOGEN, V48, P1048, DOI 10.1002/mc.20557; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2008, RADIOTHER ONCOL, V86, P375, DOI 10.1016/j.radonc.2008.01.007; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Moasser MM, 2001, CANCER RES, V61, P7184; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	62	124	132	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20558	20568		10.1074/jbc.M111.240796	http://dx.doi.org/10.1074/jbc.M111.240796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21487020	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000291267600042
J	Cho, SJ; Kim, YJ; Surh, YJ; Kim, BM; Lee, SK				Cho, Seung-Ju; Kim, Young-Jong; Surh, Young-Joon; Kim, B. Moon; Lee, Seung-Ki			Ibulocydine Is a Novel Prodrug Cdk Inhibitor That Effectively Induces Apoptosis in Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; RNA-POLYMERASE-II; MULTIPLE-MYELOMA CELLS; RETINOBLASTOMA PROTEIN; DOWN-REGULATION; CYCLE; PHOSPHORYLATION; SURVIVAL; MCL-1; DEATH	Hepatocellular carcinoma (HCC) is frequently associated with abnormalities in cell cycle regulation, leading to increased activity of cyclin-dependent kinases (Cdks) due to the loss, or low expression of, Cdk inhibitors. In this study, we showed that ibulocydine (an isobutyrate prodrug of the specific Cdk inhibitor, BMK-Y101) is a candidate anti-cancer drug for HCC. Ibulocydine has high activity against Cdk7/cyclin H/Mat1 and Cdk9/cyclin T. Ibulocydine inhibited the growth of HCC cells more effectively than other Cdk inhibitors, including olomoucine and roscovitine, whereas ibulocydine as well as the other Cdk inhibitors and BMK-Y101 minimally influenced the growth of normal hepatocyte cells. Ibulocydine induced apoptosis in HCC cells, most likely by inhibiting Cdk7 and Cdk9. In vitro treatment of HCC cells with ibulocydine rapidly blocked phosphorylation of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II, a process mediated by Cdk7/9. Anti-apoptotic gene products such as Mcl-1, survivin, and X-linked IAP (XIAP) are crucial for the survival of many cell types, including HCC. Following the inhibition of RNA polymerase II phosphorylation, ibulocydine caused rapid down-regulation of Mcl-1, survivin, and XIAP, thus inducing apoptosis. Furthermore, ibulocydine effectively induced apoptosis in HCC xenografts with no toxic side effects. These results suggest that ibulocydine is a strong candidate anti-cancer drug for the treatment of HCC.	[Cho, Seung-Ju; Surh, Young-Joon; Lee, Seung-Ki] Seoul Natl Univ, Div Pharmaceut Biosci, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Cho, Seung-Ju; Kim, Young-Jong; Kim, B. Moon] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BM (corresponding author), Seoul Natl Univ, Dept Chem, 599 Gwanakro, Seoul 151747, South Korea.	kimbm@snu.ac.kr; sklcrs@snu.ac.kr			Korea Science and Engineering Foundation [M108KB010025-08K0201-02510]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Fund for Functional Analysis of the Human Genome Grant M108KB010025-08K0201-02510, managed by The Center for Functional Analysis of Human Genome, from the 21st Century Frontier Research and Development program of the National Research and Development programs of the Korea Science and Engineering Foundation.	Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bregman DB, 2000, FRONT BIOSCI, V5, pD244, DOI 10.2741/Bregman; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen R, 2009, BLOOD, V113, P4637, DOI 10.1182/blood-2008-12-190256; Cho SJ, 2010, CANCER LETT, V287, P196, DOI 10.1016/j.canlet.2009.06.011; Coultas L, 2003, SEMIN CANCER BIOL, V13, P115, DOI 10.1016/S1044-579X(02)00129-3; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Gomez-Bougie P, 2004, EUR J IMMUNOL, V34, P3156, DOI 10.1002/eji.200424981; Hahntow IN, 2004, LEUKEMIA, V18, P747, DOI 10.1038/sj.leu.2403295; Hirose Y, 2000, GENE DEV, V14, P1415; HUANG CC, 1992, J NATL CANCER I, V84, P262, DOI 10.1093/jnci/84.4.262; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Lam LT, 2001, GENOME BIOL, V2; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Mendizabal M, 2009, MED CLIN N AM, V93, P885, DOI 10.1016/j.mcna.2009.03.004; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Senderowicz AM, 2004, CURR OPIN CELL BIOL, V16, P670, DOI 10.1016/j.ceb.2004.09.014; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Silverman R.B, 2004, ORGANIC CHEM DRUG DE, P497; Sinhababu AK, 1996, ADV DRUG DELIVER REV, V19, P241, DOI 10.1016/0169-409X(95)00109-K; Svendsen A, 2000, BBA-PROTEIN STRUCT M, V1543, P223, DOI 10.1016/S0167-4838(00)00239-9; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Wu KM, 2009, PHARMACEUTICALS, V2, P77, DOI 10.3390/ph2030077; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Yankulov KY, 1997, EMBO J, V16, P1638, DOI 10.1093/emboj/16.7.1638; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885	39	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19662	19671		10.1074/jbc.M110.209551	http://dx.doi.org/10.1074/jbc.M110.209551			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21478145	Green Published, hybrid			2022-12-25	WOS:000291027700049
J	Wang, F; Xu, L; Guo, CY; Ke, AW; Hu, GY; Xu, XF; Mo, WH; Yang, LJ; Huang, YS; He, SS; Wang, XP				Wang, Feng; Xu, Ling; Guo, Chuanyong; Ke, Aiwu; Hu, Guoyong; Xu, Xuanfu; Mo, Wenhui; Yang, Lijuan; Huang, Yinshi; He, Shanshan; Wang, Xingpeng			Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer	PLOS ONE			English	Article							SONIC HEDGEHOG; DUCTAL ADENOCARCINOMA; GASTRIC-CANCER; IV; EXPRESSION; TUMOR; SERUM; CARCINOGENESIS; METASTASIS; ACTIVATION	Background and Aims: GLI1 is the key transcriptional factor in the Hedgehog signaling pathway in pancreatic cancer. RegIV is associated with regeneration, and cell growth, survival, adhesion and resistance to apoptosis. We aimed to study RegIV expression in pancreatic cancer and its relationship to GLI1. Methods: GLI1 and RegIV expression were evaluated in tumor tissue and adjacent normal tissues of pancreatic cancer patients and 5 pancreatic cancer cell lines by qRT-PCR, Western blot, and immunohistochemistry (IHC), and the correlation between them. The GLI1-shRNA lentiviral vector was constructed and transfected into PANC-1, and lentiviral vector containing the GLI1 expression sequence was constructed and transfected into BxPC-3. GLI1 and RegIV expression were evaluated by qRT-PCR and Western blot. Finally we demonstrated RegIV to be the target of GLI1 by chromatin immunoprecipitation (CHIP) and electrophoretic mobility shift assays (EMSA). Results: The results of IHC and qRT-PCR showed that RegIV and GLI1 expression was higher in pancreatic cancer tissues versus adjacent normal tissues (p < 0.001). RegIV expression correlated with GLI1 expression in these tissues (R = 0.795, p < 0.0001). These results were verified for protein (R = 0.939, p = 0.018) and mRNA expression (R = 0.959, p = 0.011) in 5 pancreatic cancer cell lines. RegIV mRNA and protein expression was decreased (94.7 +/- 0.3%, 84.1 +/- 0.5%; respectively) when GLI1 was knocked down (82.1 +/- 3.2%, 76.7 +/- 2.2%; respectively) by the RNAi technique. GLI1 overexpression in mRNA and protein level (924.5 +/- 5.3%, 362.1 +/- 3.5%; respectively) induced RegIV overexpression (729.1 +/- 4.3%, 339.0 +/- 3.7%; respectively). Moreover, CHIP and EMSA assays showed GLI1 protein bound to RegIV promotor regions (GATCATCCA) in pancreatic cancer cells. Conclusion: GLI1 promotes RegIV transcription by binding to the RegIV gene promoter in pancreatic cancer.	[Wang, Feng; Yang, Lijuan; Wang, Xingpeng] Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Xu, Ling; Guo, Chuanyong; Ke, Aiwu; Hu, Guoyong; Xu, Xuanfu; Mo, Wenhui; Huang, Yinshi; He, Shanshan; Wang, Xingpeng] Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Wang, F (corresponding author), Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	wangxingpeng@hotmail.com	He, Shanshan/P-5691-2014	wang, feng/0000-0003-4068-3339; Guo, Chuanyong/0000-0002-6527-4673; Ke, Ai-Wu/0000-0002-7964-6909	National Natural Science Foundation of China [81072065]; Foundation for Shanghai Science and Technology Committee [09JC1412200, 09410705400]; Ministry of Education of China [20090072110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Shanghai Science and Technology Committee; Ministry of Education of China(Ministry of Education, China)	This work was supported in part by National Natural Science Foundation of China (No. 81072065), Foundation for Shanghai Science and Technology Committee (No. 09JC1412200, No. 09410705400), and Doctoral Fund of Ministry of Education of China (No. 20090072110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Bishnupuri KS, 2010, GASTROENTEROLOGY, V138, P616, DOI 10.1053/j.gastro.2009.10.050; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Eguchi H, 2009, PANCREAS, V38, P791, DOI 10.1097/MPA.0b013e3181ac5337; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Klein WM, 2002, MODERN PATHOL, V15, P441, DOI 10.1038/modpathol.3880544; Kuniyasu H, 2009, CELL PROLIFERAT, V42, P110, DOI 10.1111/j.1365-2184.2008.00577.x; Lee J, 1997, DEVELOPMENT, V124, P2537; Legoffic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007495; Li FY, 2010, J ZHEJIANG UNIV-SC B, V11, P258, DOI 10.1631/jzus.B0900383; Li XH, 2010, HISTOL HISTOPATHOL, V25, P473, DOI 10.14670/HH-25.473; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nanakin A, 2007, LAB INVEST, V87, P304, DOI 10.1038/labinvest.3700507; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Sekikawa A, 2005, GASTROENTEROLOGY, V128, P642, DOI 10.1053/j.gastro.2004.12.045; Takayama R, 2010, J GASTROENTEROL, V45, P52, DOI 10.1007/s00535-009-0114-y; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Tamura H, 2009, HUM PATHOL, V40, P1686, DOI 10.1016/j.humpath.2009.06.001; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Violette S, 2003, INT J CANCER, V103, P185, DOI 10.1002/ijc.10788; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635; Zhang YW, 2003, CANCER LETT, V200, P69, DOI 10.1016/S0304-3835(03)00460-9	44	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18434	10.1371/journal.pone.0018434	http://dx.doi.org/10.1371/journal.pone.0018434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494603	Green Submitted, Green Published, gold			2022-12-25	WOS:000289354100014
J	Burridge, PW; Thompson, S; Millrod, MA; Weinberg, S; Yuan, XA; Peters, A; Mahairaki, V; Koliatsos, VE; Tung, L; Zambidis, ET				Burridge, Paul W.; Thompson, Susan; Millrod, Michal A.; Weinberg, Seth; Yuan, Xuan; Peters, Ann; Mahairaki, Vasiliki; Koliatsos, Vassilis E.; Tung, Leslie; Zambidis, Elias T.			A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability	PLOS ONE			English	Article							CARDIOMYOCYTE DIFFERENTIATION; FUNCTIONAL-PROPERTIES; DEFINED MEDIUM; LINES; MESODERM; INDUCTION; ENDODERM	Background: The production of cardiomyocytes from human induced pluripotent stem cells (hiPSC) holds great promise for patient-specific cardiotoxicity drug testing, disease modeling, and cardiac regeneration. However, existing protocols for the differentiation of hiPSC to the cardiac lineage are inefficient and highly variable. We describe a highly efficient system for differentiation of human embryonic stem cells (hESC) and hiPSC to the cardiac lineage. This system eliminated the variability in cardiac differentiation capacity of a variety of human pluripotent stem cells (hPSC), including hiPSC generated from CD34(+) cord blood using non-viral, non-integrating methods. Methodology/Principal Findings: We systematically and rigorously optimized > 45 experimental variables to develop a universal cardiac differentiation system that produced contracting human embryoid bodies (hEB) with an improved efficiency of 94.7 +/- 2.4% in an accelerated nine days from four hESC and seven hiPSC lines tested, including hiPSC derived from neonatal CD34+ cord blood and adult fibroblasts using non-integrating episomal plasmids. This cost-effective differentiation method employed forced aggregation hEB formation in a chemically defined medium, along with staged exposure to physiological (5%) oxygen, and optimized concentrations of mesodermal morphogens BMP4 and FGF2, polyvinyl alcohol, serum, and insulin. The contracting hEB derived using these methods were composed of high percentages (64-89%) of cardiac troponin I+ cells that displayed ultrastructural properties of functional cardiomyocytes and uniform electrophysiological profiles responsive to cardioactive drugs. Conclusion/Significance: This efficient and cost-effective universal system for cardiac differentiation of hiPSC allows a potentially unlimited production of functional cardiomyocytes suitable for application to hPSC-based drug development, cardiac disease modeling, and the future generation of clinically-safe nonviral human cardiac cells for regenerative medicine.	[Burridge, Paul W.; Millrod, Michal A.; Yuan, Xuan; Peters, Ann; Zambidis, Elias T.] Johns Hopkins Univ, Sch Med, Johns Hopkins Inst Cell Engn, Baltimore, MD 21218 USA; [Thompson, Susan; Weinberg, Seth; Tung, Leslie] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Mahairaki, Vasiliki; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Burridge, PW (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Inst Cell Engn, Baltimore, MD 21218 USA.	paul.burridge@jhmi.edu; ezambid1@jhmi.edu	Burridge, Paul Wesley/AAI-2717-2021	Weinberg, Seth/0000-0003-1170-0419	Maryland Stem Cell Research Fund; NHLBI Progenitor Biology Consortium (National Institutes of Health) [U01HL099775, U01HL100397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775, R03HL096220, U01HL100397, K08HL077595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund; NHLBI Progenitor Biology Consortium (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Maryland Stem Cell Research Fund (E.T.Z., L.T.), and the NHLBI Progenitor Biology Consortium (National Institutes of Health U01HL099775 and U01HL100397 (E.T.Z)). P.W.B. and V.M. are supported by postdoctoral fellowship grants from the Maryland Stem Cell Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Bettiol E, 2007, DIFFERENTIATION, V75, P669, DOI 10.1111/j.1432-0436.2007.00174.x; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Chen Chi-Shuo, 2008, J Vis Exp, DOI 10.3791/692; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; FRESHNEY RI, 2005, CULTURE ANIMAL CELLS, pR26; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; ITZHAKI I, 2011, NATURE; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Kaichi S, 2010, CARDIOVASC RES, V88, P314, DOI 10.1093/cvr/cvq189; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lowry WE, 2010, J CELL SCI, V123, P643, DOI 10.1242/jcs.054304; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Moore JC, 2008, BIOCHEM BIOPH RES CO, V372, P553, DOI 10.1016/j.bbrc.2008.05.076; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Niebruegge S, 2009, BIOTECHNOL BIOENG, V102, P493, DOI 10.1002/bit.22065; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542; PETERS A, 2011, METHODS MOL IN PRESS; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Proetzel G, 2002, Methods Mol Biol, V185, P17; Pryzhkova MV, 2010, REPROD BIOMED ONLINE, V21, P196, DOI 10.1016/j.rbmo.2010.04.017; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Segev H, 2005, DEV GROWTH DIFFER, V47, P295; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weinberg S, 2010, METHODS MOL BIOL, V660, P215, DOI 10.1007/978-1-60761-705-1_14; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2006, STEM CELLS DEV, V15, P931, DOI 10.1089/scd.2006.15.931; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	56	286	308	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18293	10.1371/journal.pone.0018293	http://dx.doi.org/10.1371/journal.pone.0018293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494607	Green Submitted, gold, Green Published			2022-12-25	WOS:000289292800007
J	Tennant, SM; Zhang, YX; Galen, JE; Geddes, CD; Levine, MM				Tennant, Sharon M.; Zhang, Yongxia; Galen, James E.; Geddes, Chris D.; Levine, Myron M.			Ultra-Fast and Sensitive Detection of Non-Typhoidal Salmonella Using Microwave-Accelerated Metal-Enhanced Fluorescence ("MAMEF")	PLOS ONE			English	Article							REAL-TIME PCR; COMMUNITY-ACQUIRED BACTEREMIA; POLYMERASE-CHAIN-REACTION; LABORATORY DIAGNOSIS; RAPID DETECTION; MULTIPLEX PCR; BLOOD; CHILDREN; TYPHI; INFECTIONS	Certain serovars of Salmonella enterica subsp. enterica cause invasive disease (e.g., enteric fever, bacteremia, septicemia, meningitis, etc.) in humans and constitute a global public health problem. A rapid, sensitive diagnostic test is needed to allow prompt initiation of therapy in individual patients and for measuring disease burden at the population level. An innovative and promising new rapid diagnostic technique is microwave-accelerated metal-enhanced fluorescence (MAMEF). We have adapted this assay platform to detect the chromosomal oriC locus common to all Salmonella enterica subsp. enterica serovars. We have shown efficient lysis of biologically relevant concentrations of Salmonella spp. suspended in bacteriological media using microwave-induced lysis. Following lysis and DNA release, as little as 1 CFU of Salmonella in 1 ml of medium can be detected in < 30 seconds. Furthermore the assay is sensitive and specific: it can detect oriC from Salmonella serovars Typhi, Paratyphi A, Paratyphi B, Paratyphi C, Typhimurium, Enteritidis and Choleraesuis but does not detect Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae or Acinetobacter baumanii. We have also performed preliminary experiments using a synthetic Salmonella oriC oligonucleotide suspended in whole human blood and observed rapid detection when the sample was diluted 1: 1 with PBS. These pre-clinical data encourage progress to the next step to detect Salmonella in blood ( and other ordinarily sterile, clinically relevant body fluids).	[Tennant, Sharon M.; Galen, James E.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Zhang, Yongxia; Geddes, Chris D.] Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Tennant, SM (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	stennant@medicine.umaryland.edu			National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) [2 U54 AI057168-06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Middle Atlantic RCE Program, National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) 2 U54 AI057168-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Ali A, 2009, EPIDEMIOL INFECT, V137, P102, DOI 10.1017/S0950268808000654; Almeida C, 2010, APPL ENVIRON MICROB, V76, P4476, DOI 10.1128/AEM.01678-09; Aslan K, 2005, J FLUORESC, V15, P643, DOI 10.1007/s10895-005-2970-z; Aslan K, 2008, ANALYST, V133, P1469, DOI 10.1039/b808292h; Aslan K, 2008, PLASMONICS, V3, P89, DOI 10.1007/s11468-008-9059-x; Aslan K, 2008, ANAL CHEM, V80, P4125, DOI 10.1021/ac800519r; Aslan K, 2007, ANALYST, V132, P1130, DOI 10.1039/b707876e; Aslan Kadir, 2010, Nano Biomed Eng, V2, P1; Aslan K, 2006, J IMMUNOL METHODS, V312, P137, DOI 10.1016/j.jim.2006.03.009; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; DRAGAN AI, 2011, J IMMUNOL METHODS; Durmaz G, 2003, J CLIN MICROBIOL, V41, P819, DOI 10.1128/JCM.41.2.819-821.2003; FRANKEL G, 1994, J CLIN MICROBIOL, V32, P1415, DOI 10.1128/JCM.32.5.1415-.1994; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Gradel KO, 2006, EUR J CLIN MICROBIOL, V25, P151, DOI 10.1007/s10096-006-0110-6; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Haque A, 2001, JPN J INFECT DIS, V54, P237; Hatta M, 2007, AM J TROP MED HYG, V76, P139, DOI 10.4269/ajtmh.2007.76.139; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Kumar A, 2002, INFECT GENET EVOL, V2, P107, DOI 10.1016/S1567-1348(02)00090-4; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; LEPAGE P, 1987, LANCET, V1, P1458; LEVINE MM, 2004, VACCINES, P1057; Levy H, 2008, J CLIN MICROBIOL, V46, P1861, DOI 10.1128/JCM.00109-08; Malorny B, 2008, APPL ENVIRON MICROB, V74, P1299, DOI 10.1128/AEM.02489-07; Malorny B, 2009, FOOD ANAL METHOD, V2, P81, DOI 10.1007/s12161-008-9057-9; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Massi Muhammad Nasrum, 2003, Journal of Infection and Chemotherapy, V9, P233, DOI 10.1007/s10156-003-0256-4; Michota A, 2001, J RAMAN SPECTROSC, V32, P345, DOI 10.1002/jrs.703; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Paolucci M, 2009, J MED MICROBIOL, V58, P533, DOI 10.1099/jmm.0.003848-0; Papaevangelou V, 2004, SCAND J INFECT DIS, V36, P547, DOI 10.1080/00365540410016744; Prakash P, 2005, J CLIN MICROBIOL, V43, P431, DOI 10.1128/JCM.43.1.431-432.2005; Reisner BS, 1999, J CLIN MICROBIOL, V37, P2024, DOI 10.1128/JCM.37.6.2024-2026.1999; Sanchez-Jimenez MM, 2004, J MED MICROBIOL, V53, P875, DOI 10.1099/jmm.0.45630-0; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; SONG JH, 1993, J CLIN MICROBIOL, V31, P1439, DOI 10.1128/JCM.31.6.1439-1443.1993; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; THRELFALL EJ, 1992, J CLIN PATHOL, V45, P34, DOI 10.1136/jcp.45.1.34; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Wain J, 2008, J INFECT DEV COUNTR, V2, P421, DOI 10.3855/jidc.164; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; WATSON KC, 1955, J LAB CLIN MED, V46, P128; WIDJOJOATMODJO MN, 1991, EUR J CLIN MICROBIOL, V10, P935, DOI 10.1007/BF02005447; Woods DF, 2008, J CLIN MICROBIOL, V46, P4018, DOI 10.1128/JCM.01229-08; ZHANG Y, 2010, IEEE T BIOMED ENG; Zhou LQ, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-14	59	27	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18700	10.1371/journal.pone.0018700	http://dx.doi.org/10.1371/journal.pone.0018700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494634	gold, Green Published, Green Submitted			2022-12-25	WOS:000289292800039
J	Baxter, EJ; Sturt, MM; Ruane, NM; Doyle, TK; McAllen, R; Harman, L; Rodger, HD				Baxter, Emily J.; Sturt, Michael M.; Ruane, Neil M.; Doyle, Thomas K.; McAllen, Rob; Harman, Luke; Rodger, Hamish D.			Gill Damage to Atlantic Salmon (Salmo salar) Caused by the Common Jellyfish (Aurelia aurita) under Experimental Challenge	PLOS ONE			English	Article							BLOOMS; WATERS; POPULATIONS; SCYPHOZOA; ABUNDANCE; COASTAL; DISEASE	Background: Over recent decades jellyfish have caused fish kill events and recurrent gill problems in marine-farmed salmonids. Common jellyfish (Aurelia spp.) are among the most cosmopolitan jellyfish species in the oceans, with populations increasing in many coastal areas. The negative interaction between jellyfish and fish in aquaculture remains a poorly studied area of science. Thus, a recent fish mortality event in Ireland, involving Aurelia aurita, spurred an investigation into the effects of this jellyfish on marine-farmed salmon. Methodology/Principal Findings: To address the in vivo impact of the common jellyfish (A. aurita) on salmonids, we exposed Atlantic salmon (Salmo salar) smolts to macerated A. aurita for 10 hrs under experimental challenge. Gill tissues of control and experimental treatment groups were scored with a system that rated the damage between 0 and 21 using a range of primary and secondary parameters. Our results revealed that A. aurita rapidly and extensively damaged the gills of S. salar, with the pathogenesis of the disorder progressing even after the jellyfish were removed. After only 2 hrs of exposure, significant multi-focal damage to gill tissues was apparent. The nature and extent of the damage increased up to 48 hrs from the start of the challenge. Although the gills remained extensively damaged at 3 wks from the start of the challenge trial, shortening of the gill lamellae and organisation of the cells indicated an attempt to repair the damage suffered. Conclusions: Our findings clearly demonstrate that A. aurita can cause severe gill problems in marine-farmed fish. With aquaculture predicted to expand worldwide and evidence suggesting that jellyfish populations are increasing in some areas, this threat to aquaculture is of rising concern as significant losses due to jellyfish could be expected to increase in the future.	[Baxter, Emily J.] Univ Coll Cork, Environm Res Inst, Coastal & Marine Res Ctr, Cork, Ireland; [Baxter, Emily J.; Sturt, Michael M.; McAllen, Rob; Harman, Luke] Univ Coll Cork, Sch Biol Earth & Environm Sci, Dept Zool Ecol & Plant Sci, Cork, Ireland; [Baxter, Emily J.] Univ Coll Cork, Sch Biol Earth & Environm Sci, Aquaculture & Fisheries Dev Ctr, Cork, Ireland; [Ruane, Neil M.] Marine Inst Co, Fish Hlth Unit, Galway, Ireland; [Rodger, Hamish D.] Vet Aqua Int Co, Galway, Ireland	University College Cork; University College Cork; University College Cork; Marine Institute Ireland	Baxter, EJ (corresponding author), Univ Coll Cork, Environm Res Inst, Coastal & Marine Res Ctr, Cork, Ireland.	e.baxter@ucc.ie		Ruane, Neil/0000-0002-2001-9652; Rodger, Hamish/0000-0002-5336-8912; Doyle, Thomas/0000-0003-1616-5590	Marine Institute [PBA/AF/08/002(01)]; Marine Research Sub-Programme of the National Development Plan; European Regional Development Fund	Marine Institute; Marine Research Sub-Programme of the National Development Plan; European Regional Development Fund(European Commission)	This project [Grant-Aid Agreement No PBA/AF/08/002(01)] was carried out under the Sea Change strategy with the support of the Marine Institute and the Marine Research Sub-Programme of the National Development Plan 2007-2013, co-financed under the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamstedt U, 1998, SARSIA, V83, P79, DOI 10.1080/00364827.1998.10413673; Burke W. A., 2002, DERMATOL THER, V15, P18, DOI DOI 10.1046/J.1529-8019.2002.01508.X; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; FAO, 2009, STAT WORLD FISH AQ 2; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Fossa J., 2003, FISK HAVET, V2, P99; Graham WM, 2001, HYDROBIOLOGIA, V451, P97, DOI 10.1023/A:1011844208119; HAMNER WM, 1994, MAR BIOL, V119, P347, DOI 10.1007/BF00347531; Helmholz H, 2010, HYDROBIOLOGIA, V645, P223, DOI 10.1007/s10750-010-0216-9; Lo WT, 2008, ICES J MAR SCI, V65, P453, DOI 10.1093/icesjms/fsm185; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Purcell JE, 2000, MAR ECOL PROG SER, V195, P145, DOI 10.3354/meps195145; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Roberts R.J., 2001, P55; Rodger H, 2007, J FISH DIS, V30, P157, DOI 10.1111/j.1365-2761.2007.00799.x; Rodger H. D., 2007, Fish Veterinary Journal, P38; RODGER HD, 2011, REV FISH BI IN PRESS, DOI DOI 10.1007/S11160-11010-19182-11166; Suchman CL, 2005, DEEP-SEA RES PT II, V52, P51, DOI 10.1016/j.dsr2.2004.09.017; Willcox S, 2008, MAR BIOL, V154, P661, DOI 10.1007/s00227-008-0959-2; Yasuda T, 1988, STUDIES COMMON JELLY	22	53	53	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18529	10.1371/journal.pone.0018529	http://dx.doi.org/10.1371/journal.pone.0018529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490977	gold, Green Submitted, Green Published			2022-12-25	WOS:000289238700020
J	Begovic, E; Lindberg, DR				Begovic, Emina; Lindberg, David R.			Genetic Population Structure of Tectura paleacea: Implications for the Mechanisms Regulating Population Structure in Patchy Coastal Habitats	PLOS ONE			English	Article							LARVAL DISPERSAL; DNA-SEQUENCES; MARINE; FLOW; PATTERNS; GROWTH; SHELL; PHYLOGEOGRAPHY; INVERTEBRATES; SPECIATION	The seagrass limpet Tectura paleacea (Gastropoda; Patellogastropoda) belongs to a seagrass obligate lineage that has shifted from the Caribbean in the late Miocene, across the Isthmus of Panama prior to the closing of the Panamanian seaway, and then northward to its modern Baja California - Oregon distribution. To address whether larval entrainment by seagrass beds contributes to population structuring, populations were sampled at six California/Oregon localities approximately 2 degrees latitude apart during two post-settlement periods in July 2002 and June 2003. Partial cytochrome oxidase b (Cytb) sequences were obtained from 20 individuals (10 per year) from each population in order to determine the levels of population subdivision/connectivity. From the 120 individuals sequenced, there were eighty-one unique haplotypes, with the greatest haplotype diversity occurring in southern populations. The only significant genetic break detected was consistent with a peri-Point Conception (PPC) biogeographic boundary while populations north and south of Point Conception were each panmictic. The data further indicate that populations found south of the PPC biogeographic boundary originated from northern populations. This pattern of population structure suggests that seagrass patches are not entraining the larvae of T. paleacea by altering flow regimes within their environment; a process hypothesized to produce extensive genetic subdivision on fine geographic scales. In contrast to the haplotype data, morphological patterns vary significantly over very fine geographic scales that are inconsistent with the observed patterns of genetic population structure, indicating that morphological variation in T. paleacea might be attributed to differential ecophenotypic expression in response to local habitat variability throughout its distribution. These results suggest that highly localized conservation efforts may not be as effective as large-scale conservation efforts in near shore marine environments.	[Begovic, Emina] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lindberg, David R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Begovic, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	emina@Berkeley.edu	Lindberg, David R/D-8138-2011		Lerner-Gray Fund; Sigma-Xi; University of California Museum of Paleontology; Department of Integrative Biology at UC Berkeley	Lerner-Gray Fund; Sigma-Xi; University of California Museum of Paleontology; Department of Integrative Biology at UC Berkeley	Funding for this research was provided by grants in part by the Lerner-Gray Fund, Sigma-Xi, the University of California Museum of Paleontology, and the Department of Integrative Biology at UC Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Arsenault DJ, 2001, P ROY SOC B-BIOL SCI, V268, P2149, DOI 10.1098/rspb.2001.1776; AVISE JC, 1994, MOL MARKERS NATURAL, V14; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; BARBOUR MG, 1979, AM J BOT, V66, P301, DOI 10.2307/2442606; BEGOVIC E, 2004, POPULATION STRUCTURI; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Coates Anthony G., 1996, P21; Collins TM, 1996, EVOLUTION, V50, P2287, DOI 10.1111/j.1558-5646.1996.tb03617.x; DAVIS BJ, 1981, MAR BIOL, V65, P17, DOI 10.1007/BF00397063; Dawson MN, 2001, EVOLUTION, V55, P1167; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; DEN HARTOG C., 1970, SEA GRASSES WORLD; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Duda TF, 1999, MAR BIOL, V134, P705, DOI 10.1007/s002270050586; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FISHLYN DA, 1980, BIOL B WOODS HOLE, V158; FISHLYN DA, 1976, W SOC MALACOLOGISTS, V16; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; FRITCHMAN HARRY K., 1962, VELIGER, V4, P134; FRITCHMAN HARRY K. II, 1961, VELIGER, V3, P95; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Gilg MR, 2003, EVOLUTION, V57, P1061, DOI 10.1111/j.0014-3820.2003.tb00316.x; GRANT AR, 1938, SYSTEMATIC REVISION; Hamm DE, 2000, J EXP MAR BIOL ECOL, V254, P235, DOI 10.1016/S0022-0981(00)00283-5; HARVEY PH, 1996, NEW USES NEW PHYLOGE, V11; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; HORGAN DA, 1976, POPULATION STUDIES S, P17; Kay MC, 2002, INVERTEBR BIOL, V121, P11; KEEN AM, 1942, OREGON STATE MONOGRA, V3, P1; Kelly RP, 2007, EVOLUTION, V61, P700, DOI 10.1111/j.1558-5646.2007.00055.x; KEMP P, 1984, P NATL ACAD SCI-BIOL, V81, P811, DOI 10.1073/pnas.81.3.811; KITCHING JA, 1966, J ANIM ECOL, V35, P113, DOI 10.2307/2693; KUO J, 1995, CAN J BOT, V73, P827, DOI 10.1139/b95-091; LINDBERG D R, 1982, Bulletin Southern California Academy of Sciences, V81, P87; LINDBERG DR, 1987, AM MALACOLOGIC UNION; LINDBERG DR, 2007, LIGHT SMITHS MANUAL; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; MCMILLAN C, 1981, CAN J BOT, V59, P1494, DOI 10.1139/b81-203; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Moberg PE, 2000, MAR BIOL, V136, P773, DOI 10.1007/s002270000281; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; PALUMBI SR, 1984, SCIENCE, V225, P1478, DOI 10.1126/science.225.4669.1478; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 1996, SE AL SEQUENCE ALIGN; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schneider S., 2000, ARLEQUIN VER 2 000 S; SLATKIN M, 1991, GENETICS, V129, P555; Sober E, 2002, PHILOS SCI, V69, pS112, DOI 10.1086/341839; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; STEWART JG, 1980, AQUAT BOT, V9, P73, DOI 10.1016/0304-3770(80)90006-6; STRATHMANN MF, 1987, REPROD DEV MARINE IN, V12; Swofford DL, 1998, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TEST AR, 1945, ECOLOGY, V26, P395; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Todd CD, 1998, HYDROBIOLOGIA, V375-76, P1, DOI 10.1023/A:1017007527490; Trussell GC, 2001, GENETICA, V112, P321, DOI 10.1023/A:1013364527698; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Verduin JJ, 2000, ESTUAR COAST SHELF S, V50, P185, DOI 10.1006/ecss.1999.0567; VERMEIJ GJ, 1973, MAR BIOL, V20, P319, DOI 10.1007/BF00354275; Wares JP, 2001, EVOLUTION, V55, P295; Wright S., 1978, EVOLUTION GENETICS P	76	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18408	10.1371/journal.pone.0018408	http://dx.doi.org/10.1371/journal.pone.0018408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490969	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700011
J	Louie, JK; Jean, C; Acosta, M; Samuel, MC; Matyas, BT; Schechter, R				Louie, Janice K.; Jean, Cynthia; Acosta, Meileen; Samuel, Michael C.; Matyas, Bela T.; Schechter, Robert			A Review of Adult Mortality Due to 2009 Pandemic (H1N1) Influenza A in California	PLOS ONE			English	Article							INFECTION; VACCINE; DEATH	Background: While children and young adults had the highest attack rates due to 2009 pandemic (H1N1) influenza A (2009 H1N1), studies of hospitalized cases noted high fatality in older adults. We analyzed California public health surveillance data to better characterize the populations at risk for dying due to 2009 H1N1. Methods and Findings: A case was an adult >= 20 years who died with influenza-like symptoms and laboratory results indicative of 2009 H1N1. Demographic and clinical data were abstracted from medical records using a standardized case report form. From April 3, 2009 - August 10, 2010, 541 fatal cases >= 20 years with 2009 H1N1 were reported. Influenza fatality rates per 100,000 population were highest in persons 50-59 years (3.5; annualized rate = 2.6) and 60-69 years (2.3; annualized rate = 1.7) compared to younger and older age groups (0.4-1.9; annualized rates = 0.3-1.4). Of 486 cases hospitalized prior to death, 441 (91%) required intensive care unit (ICU) admission. ICU admission rates per 100,000 population were highest in adults 50-59 years (8.6). ICU case-fatality ratios among adults ranged from 24-42%, with the highest ratios in persons 70-79 years. A total of 425 (80%) cases had co-morbid conditions associated with severe seasonal influenza. The prevalence of most co-morbid conditions increased with increasing age, but obesity, pregnancy and obstructive sleep apnea decreased with age. Rapid testing was positive in 97 (35%) of 276 tested. Of 482 cases with available data, 384 (80%) received antiviral treatment, including 49 (15%) of 328 within 48 hours of symptom onset. Conclusions: Adults aged 50-59 years had the highest fatality due to 2009 H1N1; older adults may have been spared due to pre-existing immunity. However, once infected and hospitalized in intensive care, case-fatality ratios were high for all adults, especially in those over 60 years. Vaccination of adults older than 50 years should be encouraged.	[Louie, Janice K.; Jean, Cynthia; Acosta, Meileen; Samuel, Michael C.; Matyas, Bela T.; Schechter, Robert] Calif Dept Publ Hlth, Richmond, CA USA	California Department of Public Health	Louie, JK (corresponding author), Calif Dept Publ Hlth, Richmond, CA USA.	Janice.louie@cdph.ca.gov			California Department of Public Health	California Department of Public Health	This work was funded by the California Department of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P993; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Ikonen N, 2010, EURO SURVEILL, V15; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; 2000, PRACT GUID ID EV TRE; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Pebody RG, 2010, EUROSURVEILLANCE, V15; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	15	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18221	10.1371/journal.pone.0018221	http://dx.doi.org/10.1371/journal.pone.0018221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483677	gold, Green Published, Green Submitted			2022-12-25	WOS:000289191300013
J	Ma, L; Zhang, GD; Doyle, MP				Ma, Li; Zhang, Guodong; Doyle, Michael P.			Green Fluorescent Protein Labeling of Listeria, Salmonella, and Escherichia coli O157:H7 for Safety-Related Studies	PLOS ONE			English	Article							SPECIES-SPECIFIC MARKER; VECTORS; EXPRESSION; SURVIVAL; MUTANTS; MEDIA; GENE; DNA	Many food safety-related studies require tracking of introduced foodborne pathogens to monitor their fate in complex environments. The green fluorescent protein (GFP) gene (gfp) provides an easily detectable phenotype so has been used to label many microorganisms for ecological studies. The objectives of this study were to label major foodborne pathogens and related bacteria, including Listeria monocytogenes, Listeria innocua, Salmonella, and Escherichia coli O157:H7 strains, with GFP and characterize the labeled strains for stability of the GFP plasmid and the plasmid's effect on bacterial growth. GFP plasmids were introduced into these strains by a CaCl2 procedure, conjugation or electroporation. Stability of the label was determined through sequential propagation of labeled strains in the absence of selective pressure, and rates of plasmid-loss were calculated. Stability of the GFP plasmid varied among the labeled species and strains, with the most stable GFP label observed in E. coli O157:H7. When grown in nonselective media for two consecutive subcultures (ca. 20 generations), the rates of plasmid loss among labeled E. coli O157:H7, Salmonella and Listeria strains ranged from 0%-30%, 15.8%-99.9% and 8.1%-93.4%, respectively. Complete loss (>99.99%) of the plasmid occurred in some labeled strains after five consecutive subcultures in the absence of selective pressure, whereas it remained stable in others. The GFP plasmid had an insignificant effect on growth of most labeled strains. E. coli O157:H7, Salmonella and Listeria strains can be effectively labeled with the GFP plasmid which can be stable in some isolates for many generations without adversely affecting growth rates.	[Ma, Li] Oklahoma State Univ, Dept Entomol & Plant Pathol, Natl Inst Microbial Forens & Food & Agr Biosecur, Stillwater, OK 74078 USA; [Zhang, Guodong] Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Doyle, Michael P.] Univ Georgia, Ctr Food Safety, Griffin, GA USA	Oklahoma State University System; Oklahoma State University - Stillwater; US Food & Drug Administration (FDA); University System of Georgia; University of Georgia	Ma, L (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Natl Inst Microbial Forens & Food & Agr Biosecur, Stillwater, OK 74078 USA.	mdoyle@uga.edu		ma, li/0000-0002-9778-6032	University of Georgia Center for Food Safety	University of Georgia Center for Food Safety	The University of Georgia Center for Food Safety supported this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DG, 2007, J APPL MICROBIOL, V103, P318, DOI 10.1111/j.1365-2672.2006.03243.x; Aspiras MB, 2000, APPL ENVIRON MICROB, V66, P4074, DOI 10.1128/AEM.66.9.4074-4083.2000; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Cabello AE, 2005, J EXP MAR BIOL ECOL, V327, P157, DOI 10.1016/j.jembe.2005.06.009; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cho JC, 1999, J MICROBIOL METH, V36, P227, DOI 10.1016/S0167-7012(99)00038-X; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dandie CE, 2001, LETT APPL MICROBIOL, V32, P26, DOI 10.1046/j.1472-765x.2001.00848.x; Erickson MC, 2010, BIORESOURCE TECHNOL, V101, P1014, DOI 10.1016/j.biortech.2009.08.105; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Gandhi M, 2001, J FOOD PROTECT, V64, P1891, DOI 10.4315/0362-028X-64.12.1891; JIN DJ, 1989, J BACTERIOL, V171, P5229, DOI 10.1128/jb.171.9.5229-5231.1989; Kornacki JL, 2003, J FOOD PROTECT, V66, P1727, DOI 10.4315/0362-028X-66.9.1727; Leff LG, 1996, APPL ENVIRON MICROB, V62, P3486, DOI 10.1128/AEM.62.9.3486-3488.1996; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; MOSSEL DAA, 1980, J APPL BACTERIOL, V49, P439, DOI 10.1111/j.1365-2672.1980.tb04719.x; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SIMON FP, 1990, GENE, V94, P129; Skillman LC, 1998, MICROBIOL-SGM, V144, P2095, DOI 10.1099/00221287-144-8-2095; Tombolini R, 1997, FEMS MICROBIOL ECOL, V22, P17, DOI 10.1111/j.1574-6941.1997.tb00352.x; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Zhang G, 2007, J FOOD PROTECT, V70, P1857, DOI 10.4315/0362-028X-70.8.1857; Zhang GD, 2009, J FOOD PROTECT, V72, P2028, DOI 10.4315/0362-028X-72.10.2028	26	50	50	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18083	10.1371/journal.pone.0018083	http://dx.doi.org/10.1371/journal.pone.0018083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483738	gold, Green Submitted, Green Published			2022-12-25	WOS:000289058700008
J	Baines, KJ; Simpson, JL; Gibson, PG				Baines, Katherine Joanne; Simpson, Jodie Louise; Gibson, Peter Gerard			Innate Immune Responses Are Increased in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; CIRCULATING NEUTROPHILS; AIRWAY INFLAMMATION; ADHESION MOLECULES; INDUCED SPUTUM; ONCOSTATIN-M; EXPRESSION; ACTIVATION; INTERLEUKIN-8; PATHOGENESIS	Background: Chronic obstructive pulmonary disease (COPD) is characterised by irreversible airflow obstruction, neutrophilic airway inflammation and chronic bacterial colonisation, however the role of the innate immune response in the pathogenesis of COPD remains unclear. Methods: Induced sputum was obtained from adults with COPD (n = 22), and healthy controls (n = 29) and was processed for differential cell counts. The sputum supernatant was assayed for innate immune mediators using ELISA, whilst sputum gene expression was measured using real-time PCR. Peripheral blood neutrophils were isolated and their response to lipopolysaccaride (LPS) stimulation was assessed in a subgroup of participants with COPD (n = 13) and healthy controls (n = 21). Results: Participants with COPD had significantly higher protein levels of interleukin (IL)-8, and neutrophil elastase (NE) and detection of oncostatin M (OSM) compared to healthy controls. Gene expression for toll-like receptor (TLR) 2, IL-8 and OSM were also significantly higher in COPD participants. The level of IL-1 beta, surfactant protein (SP)-A, matrix metalloproteinase (MMP)-9 and TLR4 mRNA was not significantly different between groups. The level of innate immune response markers were highly associated with the presence of sputum neutrophils, each other and the degree of airflow limitation (FEV1/FVC). Peripheral blood neutrophils from participants with COPD had an increased response to stimulation by LPS; with a greater fold increase in the production of IL-8 and MMP-9 protein, and gene expression of IL-8, TLR2 and TLR4. Conclusions: The innate immune response is increased in the airways and circulating neutrophils in COPD, and may be an important mechanism involved in disease pathogenesis.	[Baines, Katherine Joanne; Simpson, Jodie Louise; Gibson, Peter Gerard] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; [Baines, Katherine Joanne; Simpson, Jodie Louise; Gibson, Peter Gerard] John Hunter Hosp, Dept Resp & Sleep Med, Hunter Med Res Inst, New Lambton, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Baines, KJ (corresponding author), Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	katherine.baines@newcastle.edu.au	BAINES, KATHERINE JOANNE/G-7654-2013; SIMPSON, JODIE LOUISE/G-7639-2013; gibson, peter/G-6194-2014	BAINES, KATHERINE JOANNE/0000-0002-4240-6581; SIMPSON, JODIE LOUISE/0000-0002-3626-680X; gibson, peter/0000-0001-5865-489X	National Health and Medical Research Council; Hunter Medical Research Institute; NHMRC Centre for Respiratory and Sleep Medicine	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; NHMRC Centre for Respiratory and Sleep Medicine(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a project grant from the National Health and Medical Research Council and Hunter Medical Research Institute. Katherine Baines holds an HMRI Xstrata Coal Asthma Research Fellowship, Jodie Simpson is supported by the NHMRC Centre for Respiratory and Sleep Medicine and Professor Peter Gibson holds an NHMRC Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Baines KJ, 2009, EXP LUNG RES, V35, P554, DOI 10.1080/01902140902777490; BAINES KJ, 2009, EUR RESP J       SEP; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; KENT LM, 2009, INT IMMUNOPHARM 1007; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MORTAZ E, 2009, EUR RESP J      1019; Noguera A, 1998, AM J RESP CRIT CARE, V158, P1664, DOI 10.1164/ajrccm.158.5.9712092; Noguera A, 2004, CHEST, V125, P1837, DOI 10.1378/chest.125.5.1837; Noguera A, 2001, THORAX, V56, P432, DOI 10.1136/thorax.56.6.432; O'Hara KA, 2003, CLIN EXP ALLERGY, V33, P1026, DOI 10.1046/j.1365-2222.2003.01714.x; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; Oudijk EJD, 2003, EUR RESPIR J, V22, p5S, DOI 10.1183/09031936.03.00004603a; Parr DG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-136; Peleman RA, 1999, EUR RESPIR J, V13, P839, DOI 10.1034/j.1399-3003.1999.13d24.x; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Reed CE, 2001, J ALLERGY CLIN IMMUN, V108, P157, DOI 10.1067/mai.2001.116862; Sabroe I, 2007, BIOCHEM SOC T, V35, P1492, DOI 10.1042/BST0351492; Sabroe I, 2005, IMMUNOLOGY, V115, P90, DOI 10.1111/j.1365-2567.2005.02133.x; Sabroe I, 2002, EUR RESPIR J, V19, P350, DOI 10.1183/09031936.02.00253602; Simpson JL, 2005, AM J RESP CRIT CARE, V172, P559, DOI 10.1164/rccm.200503-369OC; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Simpson JL, 2009, EXP LUNG RES, V35, P781, DOI 10.3109/01902140902906412; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; SOCIETY AT, 1995, AM J RESP CRIT CARE, V152, P2185; Stockley RA, 2002, CHEST, V121, p151S, DOI 10.1378/chest.121.5_suppl.151S; YAMAMOTO C, 1997, AIRWAY INFLAMMATION, V8	40	60	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18426	10.1371/journal.pone.0018426	http://dx.doi.org/10.1371/journal.pone.0018426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483784	Green Published, Green Submitted, gold			2022-12-25	WOS:000289057200075
J	Drevillon, L; Tanguy, G; Hinzpeter, A; Arous, N; de Becdelievre, A; Aissat, A; Tarze, A; Goossens, M; Fanen, P				Drevillon, Loic; Tanguy, Gaelle; Hinzpeter, Alexandre; Arous, Nicole; de Becdelievre, Alix; Aissat, Abdel; Tarze, Agathe; Goossens, Michel; Fanen, Pascale			COMMD1-Mediated Ubiquitination Regulates CFTR Trafficking	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM-CHANNEL; NF-KAPPA-B; CYSTIC-FIBROSIS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; COPPER TOXICOSIS; COMMD PROTEINS; WILD-TYPE; MURR1; DEGRADATION	The CFTR (cystic fibrosis transmembrane conductance regulator) protein is a large polytopic protein whose biogenesis is inefficient. To better understand the regulation of CFTR processing and trafficking, we conducted a genetic screen that identified COMMD1 as a new CFTR partner. COMMD1 is a protein associated with multiple cellular pathways, including the regulation of hepatic copper excretion, sodium uptake through interaction with ENaC (epithelial sodium channel) and NF-kappaB signaling. In this study, we show that COMMD1 interacts with CFTR in cells expressing both proteins endogenously. This interaction promotes CFTR cell surface expression as assessed by biotinylation experiments in heterologously expressing cells through regulation of CFTR ubiquitination. In summary, our data demonstrate that CFTR is protected from ubiquitination by COMMD1, which sustains CFTR expression at the plasma membrane. Thus, increasing COMMD1 expression may provide an approach to simultaneously inhibit ENaC absorption and enhance CFTR trafficking, two major issues in cystic fibrosis.	[Drevillon, Loic; Tanguy, Gaelle; Hinzpeter, Alexandre; Arous, Nicole; de Becdelievre, Alix; Aissat, Abdel; Tarze, Agathe; Goossens, Michel; Fanen, Pascale] Hop Henri Mondor, INSERM, Unite U955, F-94010 Creteil, France; [Drevillon, Loic; Tanguy, Gaelle; de Becdelievre, Alix; Aissat, Abdel; Tarze, Agathe; Goossens, Michel; Fanen, Pascale] Univ Paris Est, Fac Med, UMR S 955, Creteil, France; [de Becdelievre, Alix; Goossens, Michel; Fanen, Pascale] AP HP, Grp Henri Mondor Albert Chenevier, Serv Biochim Genet, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Drevillon, L (corresponding author), Hop Henri Mondor, INSERM, Unite U955, F-94010 Creteil, France.	pascale.fanen@inserm.fr	de Becdelievre, Alix/R-6745-2018; Tarze, Agathe/R-4379-2018	de Becdelievre, Alix/0000-0002-0488-3475; Tarze, Agathe/0000-0001-6101-069X; Fanen, Pascale/0000-0002-3273-5349	Institut National de la Sante et de la Recherche Medicale (INSERM); Chancellerie des Universites de Paris; French Association "Vaincre la Mucoviscidose"	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Chancellerie des Universites de Paris; French Association "Vaincre la Mucoviscidose"	This work was supported by public grants from Institut National de la Sante et de la Recherche Medicale (INSERM) and Chancellerie des Universites de Paris, and the French Association "Vaincre la Mucoviscidose". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; BOMBERGER JM, 2009, J BIOL CHEM; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clain J, 2001, J BIOL CHEM, V276, P9045, DOI 10.1074/jbc.M008979200; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Himmel B, 2004, EMBO REP, V5, P85, DOI 10.1038/sj.embor.7400034; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Tanguy G, 2008, BBA-MOL CELL RES, V1783, P1189, DOI 10.1016/j.bbamcr.2008.01.010; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; YE S, 2010, J BIOL CHEM; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	36	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18334	10.1371/journal.pone.0018334	http://dx.doi.org/10.1371/journal.pone.0018334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483833	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200061
J	Qian, D; Jiang, L; Lu, L; Wei, CH; Li, Y				Qian, Dan; Jiang, Lin; Lu, Lu; Wei, Chunhong; Li, Yi			Biochemical and Structural Properties of Cyanases from Arabidopsis thaliana and Oryza sativa	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; ALKALINE CONDITIONS; CYANIDE OXYGENASE; PLANT-RESPONSES; ETHYLENE; ENZYME; STRESS; GENE; THIOCYANATE; METABOLISM	Cyanate is toxic to all organisms. Cyanase converts cyanate to CO2 and NH3 in a bicarbonate-dependent reaction. The biophysical functions and biochemical characteristics of plant cyanases are poorly studied, although it has been investigated in a variety of proteobacteria, cyanobacteria and fungi. In this study, we characterised plant cyanases from Arabidopsis thaliana and Oryza sativa (AtCYN and OsCYN). Prokaryotic-expressed AtCYN and OsCYN both showed cyanase activity in vitro. Temperature had a similar influence on the activity of both cyanases, but pH had a differential impact on AtCYN and OsCYN activity. Homology modelling provided models of monomers of AtCYN and OsCYN, and a coimmunoprecipitation assay and gel filtration indicated that AtCYN and OsCYN formed homodecamers. The analysis of single-residue mutants of AtCYN indicated that the conserved catalytic residues also contributed to the stability of the homodecamer. KCNO treatment inhibited Arabidopsis germination and early seedling growth. Plants containing AtCYN or OsCYN exhibited resistance to KCNO stress, which demonstrated that one role of cyanases in plants is detoxification. Transcription level of AtCYN was higher in the flower than in other organs of Arabidopsis. AtCYN transcription was not significantly affected by KCNO treatment in Arabidopsis, but was induced by salt stress. This research broadens our knowledge on plant detoxification of cyanate via cyanase.	[Qian, Dan; Jiang, Lin; Lu, Lu; Wei, Chunhong; Li, Yi] Peking Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Qian, D (corresponding author), Peking Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	liyi@pku.edu.cn			Ministry of Agriculture; Transgenic program [2008ZX08010-001, 2008ZX08011-001]; National Basic Research Program of China (973 Program) [2006CB10195]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Transgenic program; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the Ministry of Agriculture, The Transgenic program (2008ZX08010-001 and 2008ZX08011-001) and the National Basic Research Program of China (973 Program) (No. 2006CB10195) http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Aichi Makiko, 1998, Plant and Cell Physiology, V39, pS135; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON PM, 1980, BIOCHEMISTRY-US, V19, P2882, DOI 10.1021/bi00554a010; ANDERSON PM, 1986, BIOCHEMISTRY-US, V25, P1621, DOI 10.1021/bi00355a026; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Askari H, 2006, PROTEOMICS, V6, P2542, DOI 10.1002/pmic.200500328; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; CHIN CCQ, 1983, J BIOL CHEM, V258, P276; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DIRNHUBER P, 1948, BIOCHEM J, V42, P628, DOI 10.1042/bj0420628; DORR PK, 1989, FEMS MICROBIOL LETT, V60, P289; Ebbs S, 2004, CURR OPIN BIOTECH, V15, P231, DOI 10.1016/j.copbio.2004.03.006; Elleuche S, 2008, FUNGAL GENET BIOL, V45, P1458, DOI 10.1016/j.fgb.2008.08.005; Espie GS, 2007, J BACTERIOL, V189, P1013, DOI 10.1128/JB.01328-06; Grigor'eva NV, 2006, MICROBIOLOGY+, V75, P266, DOI 10.1134/S0026261706030040; Gyorgyey J, 2000, MOL PLANT MICROBE IN, V13, P62, DOI 10.1094/MPMI.2000.13.1.62; Harano Y, 1997, J BACTERIOL, V179, P5744, DOI 10.1128/jb.179.18.5744-5750.1997; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; JOHNSON WV, 1987, J BIOL CHEM, V262, P9021; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; KUNZ DA, 1989, APPL ENVIRON MICROB, V55, P256, DOI 10.1128/AEM.55.1.256-258.1989; Kunz DA, 2001, BIOCHEM BIOPH RES CO, V287, P514, DOI 10.1006/bbrc.2001.5611; LAWRIE AC, 1979, J BACTERIOL, V139, P115, DOI 10.1128/JB.139.1.115-119.1979; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Luque-Almagro VM, 2008, APPL ENVIRON MICROB, V74, P6280, DOI 10.1128/AEM.00916-08; Luque-Almagro VM, 2005, APPL ENVIRON MICROB, V71, P940, DOI 10.1128/AEM.71.2.940-947.2005; Malhotra S, 2005, J CHEM TECHNOL BIOT, V80, P13, DOI 10.1002/jctb.1127; MILLER AG, 1994, ARCH MICROBIOL, V162, P151, DOI 10.1007/BF00314468; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potel F, 2009, FEBS J, V276, P4061, DOI 10.1111/j.1742-4658.2009.07114.x; RADER WS, 1995, ENVIRON POLLUT, V90, P331, DOI 10.1016/0269-7491(95)00020-R; Sancho J, 2005, 19 INT MIN WAT C, P413; Siegien I, 2006, ACTA PHYSIOL PLANT, V28, P483, DOI 10.1007/BF02706632; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Sorokin DY, 2001, APPL ENVIRON MICROB, V67, P528, DOI 10.1128/AEM.67.2.528-538.2001; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; SUNG YC, 1992, J BACTERIOL, V174, P3645, DOI 10.1128/JB.174.11.3645-3650.1992; SUNG YC, 1987, J BACTERIOL, V169, P2639, DOI 10.1128/jb.169.6.2639-2642.1987; TAUSSIG A, 1960, BIOCHIM BIOPHYS ACTA, V44, P510, DOI 10.1016/0006-3002(60)91605-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walsh MA, 2000, STRUCTURE, V8, P505, DOI 10.1016/S0969-2126(00)00134-9; Wang HH, 2009, PLANTA, V230, P293, DOI 10.1007/s00425-009-0946-y; Wood AP, 1998, ARCH MICROBIOL, V169, P148, DOI 10.1007/s002030050554; Wu Z, 2007, PARASITOL RES, V101, P1567, DOI 10.1007/s00436-007-0677-6; YIP WK, 1988, PLANT PHYSIOL, V88, P473, DOI 10.1104/pp.88.2.473; Zanetti ME, 2002, J EXP BOT, V53, P2455, DOI 10.1093/jxb/; Zhao XC, 2004, FEBS LETT, V562, P189, DOI 10.1016/S0014-5793(04)00238-8; ZIMMERMAN WM. E., 1950, GREENKEEPERS REPORTER, V18, P5	55	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18300	10.1371/journal.pone.0018300	http://dx.doi.org/10.1371/journal.pone.0018300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21494323	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200054
J	Veraart, AJ; de Klein, JJM; Scheffer, M				Veraart, Annelies J.; de Klein, Jeroen J. M.; Scheffer, Marten			Warming Can Boost Denitrification Disproportionately Due to Altered Oxygen Dynamics	PLOS ONE			English	Article							NITROUS-OXIDE; ESTUARINE SEDIMENTS; GASEOUS NITROGEN; FRESH-WATER; TEMPERATURE; NITRATE; NITRIFICATION; ECOSYSTEMS; SOILS; MODEL	Background: Global warming and the alteration of the global nitrogen cycle are major anthropogenic threats to the environment. Denitrification, the biological conversion of nitrate to gaseous nitrogen, removes a substantial fraction of the nitrogen from aquatic ecosystems, and can therefore help to reduce eutrophication effects. However, potential responses of denitrification to warming are poorly understood. Although several studies have reported increased denitrification rates with rising temperature, the impact of temperature on denitrification seems to vary widely between systems. Methodology/Principal Findings: We explored the effects of warming on denitrification rates using microcosm experiments, field measurements and a simple model approach. Our results suggest that a three degree temperature rise will double denitrification rates. By performing experiments at fixed oxygen concentrations as well as with oxygen concentrations varying freely with temperature, we demonstrate that this strong temperature dependence of denitrification can be explained by a systematic decrease of oxygen concentrations with rising temperature. Warming decreases oxygen concentrations due to reduced solubility, and more importantly, because respiration rates rise more steeply with temperature than photosynthesis. Conclusions/Significance: Our results show that denitrification rates in aquatic ecosystems are strongly temperature dependent, and that this is amplified by the temperature dependencies of photosynthesis and respiration. Our results illustrate the broader phenomenon that coupling of temperature dependent reactions may in some situations strongly alter overall effects of temperature on ecological processes.	[Veraart, Annelies J.; de Klein, Jeroen J. M.; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands	Wageningen University & Research	Veraart, AJ (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands.	annelies.veraart@wur.nl	Veraart, Annelies J/E-1927-2014; Scheffer, Marten/C-1852-2012; Veraart, Annelies/AFR-8009-2022	Veraart, Annelies J/0000-0001-6286-7484; 	STOWA (Dutch Foundation for Applied Water Research); 14 Dutch water boards	STOWA (Dutch Foundation for Applied Water Research); 14 Dutch water boards	Funding for this project was provided by STOWA (Dutch Foundation for Applied Water Research) and 14 Dutch water boards (project PLONS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Anderson-Teixeira KJ, 2008, P NATL ACAD SCI USA, V105, P228, DOI 10.1073/pnas.0710214104; Bachand PAM, 2000, ECOL ENG, V14, P17; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Castaldi S, 2000, BIOL FERT SOILS, V32, P67, DOI 10.1007/s003740000218; Dalsgaard T, 2000, PROTOCOL HDB NICE NI; DAWSON RN, 1972, WATER RES, V6, P71, DOI 10.1016/0043-1354(72)90174-1; FOCHT DD, 1974, SOIL SCI, V118, P173, DOI 10.1097/00010694-197409000-00007; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; GRANELI W, 1978, OIKOS, V30, P7, DOI 10.2307/3543519; Gruca-Rokosz R, 2009, ENVIRON PROT ENG, V35, P5; Holtan-Hartwig L, 2002, SOIL BIOL BIOCHEM, V34, P1797, DOI 10.1016/S0038-0717(02)00169-4; JENKINS MC, 1984, LIMNOL OCEANOGR, V29, P609, DOI 10.4319/lo.1984.29.3.0609; Jeppesen E, 2011, HYDROBIOLOGIA, V663, P1, DOI 10.1007/s10750-010-0547-6; Kadlec RH, 2001, WATER ENVIRON RES, V73, P543, DOI 10.2175/106143001X139614; KEENEY DR, 1979, SOIL SCI SOC AM J, V43, P1124, DOI 10.2136/sssaj1979.03615995004300060012x; KING D, 1984, J GEN MICROBIOL, V130, P2935; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Ogilvie BG, 1997, FEMS MICROBIOL ECOL, V23, P11, DOI 10.1016/S0168-6496(97)00004-4; Pina-Ochoa E, 2006, BIOGEOCHEMISTRY, V81, P111, DOI 10.1007/s10533-006-9033-7; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Smith KA, 1997, GLOBAL CHANGE BIOL, V3, P327, DOI 10.1046/j.1365-2486.1997.00100.x; SORRELL BK, 1987, AQUAT BOT, V28, P63, DOI 10.1016/0304-3770(87)90056-8; Spellman F. R., 1996, STREAM ECOLOGY SELF; STANFORD G, 1975, SOIL SCI SOC AM J, V39, P867, DOI 10.2136/sssaj1975.03615995003900050024x; Thomann R.V., 1987, PRINCIPLES SURFACE W; TIEDJE JM, 1982, A VAN LEEUW J MICROB, V48, P569, DOI 10.1007/BF00399542; Tscherko D, 2001, SOIL BIOL BIOCHEM, V33, P491, DOI 10.1016/S0038-0717(00)00190-5; Van Luijn F, 1999, WATER RES, V33, P33, DOI 10.1016/S0043-1354(98)00201-2; Veraart AJ, 2011, BIOGEOCHEMISTRY, V104, P267, DOI 10.1007/s10533-010-9500-z; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	34	106	108	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18508	10.1371/journal.pone.0018508	http://dx.doi.org/10.1371/journal.pone.0018508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483809	Green Submitted, Green Published, gold			2022-12-25	WOS:000289057200087
J	Matheron, E; Kapoula, Z				Matheron, Eric; Kapoula, Zoi			Vertical Heterophoria and Postural Control in Nonspecific Chronic Low Back Pain	PLOS ONE			English	Article							WEIGHT DISTRIBUTION; SPECTACLE LENSES; HEALTHY-YOUNG; ADAPTATION; STABILITY; BALANCE; STANCE; PRISM; PROPRIOCEPTION; REHABILITATION	The purpose of this study was to test postural control during quiet standing in nonspecific chronic low back pain (LBP) subjects with vertical heterophoria (VH) before and after cancellation of VH; also to compare with healthy subjects with, and without VH. Fourteen subjects with LBP took part in this study. The postural performance was measured through the center of pressure displacements with a force platform while the subjects fixated on a target placed at either 40 or 200 cm, before and after VH cancellation with an appropriate prism. Their postural performance was compared to that of 14 healthy subjects with VH and 12 without VH (i.e. vertical orthophoria) studied previously in similar conditions. For LBP subjects, cancellation of VH with a prism improved postural performance. With respect to control subjects (with or without VH), the variance of speed of the center of pressure was higher, suggesting more energy was needed to stabilize their posture in quiet upright stance. Similarly to controls, LBP subjects showed higher postural sway when they were looking at a target at a far distance than at a close distance. The most important finding is that LBP subjects with VH can improve their performance after prism-cancellation of their VH. We suggest that VH reflects mild conflict between sensory and motor inputs involved in postural control i.e. a non optimal integration of the various signals. This could affect the performance of postural control and perhaps lead to pain. Nonspecific chronic back pain may results from such prolonged conflict.	[Matheron, Eric; Kapoula, Zoi] Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, CNRS, Grp IRIS,FRE 3375, Paris, France; [Matheron, Eric; Kapoula, Zoi] Hop Robert Debre, ORL, Serv Ophtalmol, F-75019 Paris, France; [Matheron, Eric] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Matheron, E (corresponding author), Hop Europeen Georges Pompidou, Serv Ophtalmol ORL Stomatol, CNRS, Grp IRIS,FRE 3375, Paris, France.	matheron@wanadoo.fr			Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study is funded by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KM, 1998, J ORTHOP SPORT PHYS, V28, P378, DOI 10.2519/jospt.1998.28.6.378; Allison Christine L, 2007, Optometry, V78, P644, DOI 10.1016/j.optm.2007.05.012; Amiridis IG, 2003, NEUROSCI LETT, V350, P137, DOI 10.1016/S0304-3940(03)00878-4; AMOS FJ, 1987, DIAGNOSIS MANAGEMENT, P515; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; [Anonymous], 2004, EUROPEAN GUIDELINES; Atlas SJ, 2003, MUSCLE NERVE, V27, P265, DOI 10.1002/mus.10311; BARON J, 1952, Trans Am Acad Ophthalmol Otolaryngol, V56, P916; BERGIN PS, 1995, J NEUROL NEUROSUR PS, V58, P335, DOI 10.1136/jnnp.58.3.335; BLES W, 1980, ACTA OTO-LARYNGOL, V89, P534, DOI 10.3109/00016488009127171; Bloem BR, 2000, EXP BRAIN RES, V130, P375, DOI 10.1007/s002219900259; Brandt T., 1986, DISORDERS POSTURE, P157; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; BYL NN, 1991, SPINE, V16, P325, DOI 10.1097/00007632-199103000-00012; Casillas EC, 2006, OPTOMETRY VISION SCI, V83, P237, DOI 10.1097/01.opx.0000214316.50270.24; CATSBARIL WL, 1991, SPINE, V16, P605, DOI 10.1097/00007632-199106000-00001; Cheeseman EW, 1999, ARCH OPHTHALMOL-CHIC, V117, P1188; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; DACUNHA HM, 1986, J FR OPHTALMOL, V9, P747; DAUM KM, 1991, CLIN PROCEDURES OPTO, P72; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; Demer JL, 2008, PROG BRAIN RES, V171, P21, DOI 10.1016/S0079-6123(08)00604-3; DEYO RA, 1988, ARCH PHYS MED REHAB, V69, P1044; DIENER HC, 1989, PROG BRAIN RES, V80, P481; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Ebenbichler GR, 2001, MED SCI SPORT EXER, V33, P1889, DOI 10.1097/00005768-200111000-00014; Gagey P M, 1987, Agressologie, V28, P925; Gagey P M, 1999, POSTUROLOGIE REGULAT, P45; GAGEY PM, 1980, DISORDERS POSTURE GA, P253; Hagen EM, 2006, SPINE, V31, P1491, DOI 10.1097/01.brs.0000219947.71168.08; Hamaoui A, 2004, NEUROSCI LETT, V357, P135, DOI 10.1016/j.neulet.2003.12.047; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Henry SM, 2006, CLIN BIOMECH, V21, P881, DOI 10.1016/j.clinbiomech.2006.04.016; Hestbaek L, 2003, J MANIP PHYSIOL THER, V26, P243, DOI 10.1016/S0161-4754(03)00003-4; Huang MA, 2006, OPTOMETRY VISION SCI, V83, P242, DOI 10.1097/01.opx.0000214298.73085.b5; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Jones KE, 2001, NEUROREPORT, V12, P4029, DOI 10.1097/00001756-200112210-00035; Jonsson E, 2005, CLIN BIOMECH, V20, P202, DOI 10.1016/j.clinbiomech.2004.09.008; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Kertesz AE., 1983, VERGENCE EYE MOVEMEN, P317; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P673; Le TT, 2006, VISION RES, V46, P3586, DOI 10.1016/j.visres.2006.06.018; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; MARUCCHI C, 1988, Agressologie, V29, P693; MATHERON E, 2007, POSTUROLOGIE CLIN DY, P44; MATHERON E, 2005, GAIT POSTURE S1, V21, pS132, DOI DOI 10.1016/S0966-6362(05)80437-0; Matheron E, 2000, KINESITHER SCI, V34, P23; Matheron E, 2008, CLIN NEUROPHYSIOL, V119, P2314, DOI 10.1016/j.clinph.2008.06.016; Matheron E, 2008, NEUROSCI LETT, V444, P176, DOI 10.1016/j.neulet.2008.08.025; Matheron E, 2007, NEUROSCI LETT, V423, P236, DOI 10.1016/j.neulet.2007.07.016; Mazzocchio R, 2001, BMC Musculoskelet Disord, V2, P4, DOI 10.1186/1471-2474-2-4; Mazzocchio R, 2000, J SPINAL DISORD, V13, P487, DOI 10.1097/00002517-200012000-00004; McCabe CS, 2007, RHEUMATOLOGY, V46, P1587, DOI 10.1093/rheumatology/kem204; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; Mientjes MIV, 1999, CLIN BIOMECH, V14, P710, DOI 10.1016/S0268-0033(99)00025-X; Missaoui B, 2008, NEUROPHYSIOL CLIN, V38, P447, DOI 10.1016/j.neucli.2008.09.004; Mok NW, 2004, SPINE, V29, pE107, DOI 10.1097/01.BRS.0000115134.97854.C9; Padula WV, 2009, BRAIN INJURY, V23, P566, DOI 10.1080/02699050902926283; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; PAULUS W, 1989, EXP BRAIN RES, V78, P243; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Pisella L, 2006, CURR OPIN NEUROL, V19, P534, DOI 10.1097/WCO.0b013e328010924b; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; SCATTERGOOD KD, 1983, AM J OPHTHALMOL, V96, P439, DOI 10.1016/S0002-9394(14)77906-1; SCHEIMAN M, 1994, CLIN MANAGEMENT BINO, P405; Speers RA, 2002, GAIT POSTURE, V16, P20, DOI 10.1016/S0966-6362(02)00003-6; Stokes IAF, 2006, EUR SPINE J, V15, P658, DOI 10.1007/s00586-005-0893-7; SUCHOFF IB, 2004, J AM OPTOM ASSOC, V75, P305; Sunartpin Peenaraya, 2005, Journal of the Medical Association of Thailand, V88, P1905; Takagi A., 1985, VESTIBULAR VISUAL CO, P74; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; USHIO N, 1980, AGRESSOLOGIE, V21, P143; USHIO N, 1980, AGRESSOLOGIE, V21, P153; van Rijn LJ, 1998, VISION RES, V38, P2973, DOI 10.1016/S0042-6989(98)00079-0; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; Von Noorden GK, 2002, BINOCULAR VISION OCU, V6th; Vuillerme N, 2006, GAIT POSTURE, V24, P169, DOI 10.1016/j.gaitpost.2005.07.011; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; WADDELL G, 1993, ANN RHEUM DIS, V52, P317, DOI 10.1136/ard.52.5.317; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; Wang Y, 2006, CLIN NEUROPHYSIOL, V117, P41, DOI 10.1016/j.clinph.2005.09.002; *WHO, 1992, HLTH PROM CHRON ILLN, P141; Wong AMF, 2002, OPHTHALMOLOGY, V109, P1315, DOI 10.1016/S0161-6420(02)01067-9; YGGE J, 1995, VISION RES, V35, P3169, DOI 10.1016/0042-6989(95)00125-J	90	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18110	10.1371/journal.pone.0018110	http://dx.doi.org/10.1371/journal.pone.0018110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479210	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700027
J	Wang, W; Ackermann, D; Mehlich, AM; Konig, S				Wang, Weiqun; Ackermann, Doreen; Mehlich, Anna-Maria; Koenig, Simone			Impact of Quenching Failure of Cy Dyes in Differential Gel Electrophoresis	PLOS ONE			English	Article							TECHNOLOGY	Background: Differential gel electrophoresis (DIGE) is a technology widely used for protein expression analysis. It is based on labelling with fluorescent Cy dyes. In comparative fluorescence gel electrophoresis experiments, however, unspecific labelling using N-hydroxy-succinimide-ester-based labelling protocols was recently detected. Cross-talk was observed due to failure of the quenching process. Here, the impact of this effect for DIGE experiments was investigated. Methodology/Principal Findings: Experiments to test quenching efficiency were performed in replicate using Escherichia coli lysate. Parameters such as the amount of dye and quencher were varied. Labelling and quenching were reversed in one experiment. Differences in protein spot volumes due to limited quenching were determined. For some spots twice the volume was detected underscoring the importance of proper control of silencing of active dye. Conclusions/Significance: It could be demonstrated that uncontrolled labelling increased protein spot volume, even doubling it in some cases. Moreover, proteins responded differently to the protocol. Such unpredictable and unspecific processes are not acceptable in protein regulation studies so that it is necessary to validate the correct amount of quencher for individual samples before the DIGE experiment is performed. Increase of the concentration of lysine, which is used as quencher, from 10 mM to 2500 mM, was sufficient to silence the dye. Alternatively, active dye molecules can be removed by filtration.	[Wang, Weiqun; Ackermann, Doreen; Mehlich, Anna-Maria; Koenig, Simone] Univ Munster, Fac Med, Clin Res Ctr, Core Unit Interdisciplinary, Munster, Germany	University of Munster	Wang, W (corresponding author), Univ Munster, Fac Med, Clin Res Ctr, Core Unit Interdisciplinary, Munster, Germany.	koenigs@uni-muenster.de	König, Simone/B-6504-2008	König, Simone/0000-0003-0672-7246	BMWi ProINNO II; BMWi	BMWi ProINNO II; BMWi(Federal Ministry for Economic Affairs and Energy (BMWi))	Funding from the BMWi ProINNO II project DALLImag is gratefully acknowledged. http://www.forschungskoop.de/10_proinno/10_start.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BMWi is a federal funding source which funds collaborative research projects of universities with small industry. None of the authors is employed in this company or dependent on it. This collaboration does not alter the authors' adherence to all PLoS ONE policies sharing data and materials.	*GE HEALTHC, 2003, ETT DIGE US MAN; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Tonge R, 2001, PROTEOMICS, V1, P377; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234; Wang WQ, 2010, PROTEOMICS, V10, P1525, DOI 10.1002/pmic.200900679	6	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18098	10.1371/journal.pone.0018098	http://dx.doi.org/10.1371/journal.pone.0018098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479167	gold, Green Published, Green Submitted			2022-12-25	WOS:000289055700025
J	Goldman, SJ; Chen, E; Taylor, R; Zhang, S; Petrosky, W; Reiss, M; Jin, SK				Goldman, Scott J.; Chen, Elizabeth; Taylor, Robert; Zhang, Sheng; Petrosky, Whitney; Reiss, Michael; Jin, Shengkan			Use of the ODD-Luciferase Transgene for the Non-Invasive Imaging of Spontaneous Tumors in Mice	PLOS ONE			English	Article							BREAST-CANCER; MOUSE MODELS; SUPPRESSOR; HYPOXIA; GROWTH	Background: In humans, imaging of tumors provides rapid, accurate assessment of tumor growth and location. In laboratory animals, however, the imaging of spontaneously occurring tumors continues to pose many technical and logistical problems. Recently a mouse model was generated in which a chimeric protein consisting of HIF-1 alpha oxygen-dependent degradation domain (ODD) fused to luciferase was ubiquitously expressed in all tissues. Hypoxic stress leads to the accumulation of ODD-luciferase in the tissues of this mouse model which can be identified by non-invasive bioluminescence measurement. Since solid tumors often contain hypoxic regions, we performed proof-of-principle experiments testing whether this transgenic mouse model may be used as a universal platform for non-invasive imaging analysis of spontaneous solid tumors. Methods and Materials: ODD-luciferase transgenic mice were bred with MMTV-neu/beclin1+/- mice. Upon injection of luciferin, bioluminescent background of normal tissues in the transgenic mice and bioluminescent signals from spontaneously mammary carcinomas were measured non-invasively with an IVIS Spectrum imaging station. Tumor volumes were measured manually and the histology of tumor tissues was analyzed. Conclusion: Our results show that spontaneous mammary tumors in ODD-luciferase transgenic mice generate substantial bioluminescent signals, which are clearly discernable from background tissue luminescence. Moreover, we demonstrate a strong quantitative correlation between the bioluminescent tumor contour and the volume of palpable tumors. We further demonstrate that shrinkage of the volume of spontaneous tumors in response to chemotherapeutic treatment can be determined quantitatively using this system. Finally, we show that the growth and development of spontaneous tumors can be monitored longitudinally over several weeks. Thus, our results suggest that this model could potentially provide a practical, reliable, and cost-effective non-invasive quantitative method for imaging spontaneous solid tumors in mice.	[Goldman, Scott J.; Chen, Elizabeth; Taylor, Robert] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Petrosky, Whitney; Reiss, Michael; Jin, Shengkan] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Zhang, Sheng] Cent S Univ, Dept Oral & Maxillofacial Surg, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Goldman, Scott J.; Chen, Elizabeth; Taylor, Robert; Petrosky, Whitney; Reiss, Michael; Jin, Shengkan] CINJ, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Central South University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Goldman, SJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	jinsh@umdnj.edu		Reiss, Michael/0000-0001-8543-8092	National Institutes of Health [1R01CA116088]; Department of Defense [BC060538]; NATIONAL CANCER INSTITUTE [R01CA116088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research is funded by National Institutes of Health (1R01CA116088) and Department of Defense (BC060538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanell J, 1999, J MAMMARY GLAND BIOL, V4, P337, DOI 10.1023/A:1018762216147; Dennis C, 2006, NATURE, V442, P739, DOI 10.1038/442739a; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; KIM JB, PLOS ONE, V5, pE9364; KYRIAZI S, NAT REV CLIN ONCOL, V7, P381; MULLER WJ, 1991, CANCER METAST REV, V10, P217, DOI 10.1007/BF00050793; Muller WJ, 1996, MOL CELL BIOL, V16, P5726; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Oyen WJG, 2009, NAT REV CLIN ONCOL, V6, P609, DOI 10.1038/nrclinonc.2009.139; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; SCHETTER AJ, CARCINOGENESIS, V31, P37; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; TENNANT DA, NAT REV CANC, V10, P267; Tuveson DA, 2002, CURR OPIN GENET DEV, V12, P105, DOI 10.1016/S0959-437X(01)00272-6; Waldman AD, 2009, NAT REV CLIN ONCOL, V6, P445, DOI 10.1038/nrclinonc.2009.92; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	26	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18269	10.1371/journal.pone.0018269	http://dx.doi.org/10.1371/journal.pone.0018269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479246	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600041
J	Hollis, KL; Cogswell, H; Snyder, K; Guillette, LM; Nowbahari, E				Hollis, Karen L.; Cogswell, Heather; Snyder, Kenzie; Guillette, Lauren M.; Nowbahari, Elise			Specialized Learning in Antlions (Neuroptera: Myrmeleontidae), Pit-Digging Predators, Shortens Vulnerable Larval Stage	PLOS ONE			English	Article							JAPANESE-QUAIL; BEHAVIOR; HOST; CONSTRUCTION; SELECTION; PATTERNS; SUCCESS; NEURONS; CONTEXT; PREY	Unique in the insect world for their extremely sedentary predatory behavior, pit-dwelling larval antlions dig pits, and then sit at the bottom and wait, sometimes for months, for prey to fall inside. This sedentary predation strategy, combined with their seemingly innate ability to detect approaching prey, make antlions unlikely candidates for learning. That is, although scientists have demonstrated that many species of insects possess the capacity to learn, each of these species, which together represent multiple families from every major insect order, utilizes this ability as a means of navigating the environment, using learned cues to guide an active search for food and hosts, or to avoid noxious events. Nonetheless, we demonstrate not only that sedentary antlions can learn, but also, more importantly, that learning provides an important fitness benefit, namely decreasing the time to pupate, a benefit not yet demonstrated in any other species. Compared to a control group in which an environmental cue was presented randomly vis-a-vis daily prey arrival, antlions given the opportunity to associate the cue with prey were able to make more efficient use of prey and pupate significantly sooner, thus shortening their long, highly vulnerable larval stage. Whereas "median survival time," the point at which half of the animals in each group had pupated, was 46 days for antlions receiving the Learning treatment, that point never was reached in antlions receiving the Random treatment, even by the end of the experiment on Day 70. In addition, we demonstrate a novel manifestation of antlions' learned response to cues predicting prey arrival, behavior that does not match the typical "learning curve" but which is well-adapted to their sedentary predation strategy. Finally, we suggest that what has long appeared to be instinctive predatory behavior is likely to be highly modified and shaped by learning.	[Hollis, Karen L.; Cogswell, Heather; Snyder, Kenzie; Guillette, Lauren M.] Mt Holyoke Coll, Interdisciplinary Program Neurosci & Behav, S Hadley, MA 01075 USA; [Hollis, Karen L.; Cogswell, Heather; Snyder, Kenzie; Guillette, Lauren M.] Mt Holyoke Coll, Dept Psychol, S Hadley, MA 01075 USA; [Nowbahari, Elise] Univ Paris 13, Lab Ethol Expt & Comparee, EA 4443, F-93430 Villetaneuse, France	Mount Holyoke College; Mount Holyoke College; Universite Paris 13	Hollis, KL (corresponding author), Mt Holyoke Coll, Interdisciplinary Program Neurosci & Behav, S Hadley, MA 01075 USA.	khollis@mtholyoke.edu	Guillette, Lauren/K-8154-2013	Guillette, Lauren/0000-0002-8777-6543	Harap Fund; Mount Holyoke College; University of Alberta	Harap Fund; Mount Holyoke College; University of Alberta(University of Alberta)	The Harap Fund (http://www.mtholyoke.edu/acad/psychology/resources.html) and Mount Holyoke College (http://www.mtholyoke.edu/) provided financial support. LMG is supported by an Izaak Walton Killam Memorial Scholarship at the University of Alberta. Website at: http://www.gradstudies.ualberta.ca/killam/izaakmemorial.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2003, P ROY SOC B-BIOL SCI, V270, P1685, DOI 10.1098/rspb.2003.2421; Bernays Elizabeth A., 1993, P1; Crowley PH, 1999, ECOLOGY, V80, P2271, DOI 10.1890/0012-9658(1999)080[2271:AFTPAS]2.0.CO;2; DEVETAK D, 1985, Bioloski Vestnik, V33, P11; Devetak D, 2007, PHYSIOL ENTOMOL, V32, P268, DOI 10.1111/j.1365-3032.2007.00580.x; Domjan M.P, 2009, PRINCIPLES LEARNING; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; Dukas R, 2006, ANIM BIOL, V56, P125, DOI 10.1163/157075606777304258; Dunlap AS, 2009, P ROY SOC B-BIOL SCI, V276, P3201, DOI 10.1098/rspb.2009.0602; Fertin A, 2006, J EXP BIOL, V209, P3510, DOI 10.1242/jeb.02401; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GOTELLI NJ, 1993, ECOLOGY, V74, P226, DOI 10.2307/1939517; Gotelli NJ, 1997, ECOLOGY, V78, P1761, DOI 10.1890/0012-9658(1997)078[1761:CACOLA]2.0.CO;2; Greenspan RJ, 2007, COLD SPRING HARB MON, V49, P647; GRIFFITHS D, 1985, J ANIM ECOL, V54, P573, DOI 10.2307/4499; GRIFFITHS D, 1986, J ANIM ECOL, V55, P39, DOI 10.2307/4691; HOLLIS KL, 1982, ADV STUD BEHAV, V12, P1, DOI 10.1016/S0065-3454(08)60045-5; Hollis KL, 1997, J COMP PSYCHOL, V111, P219, DOI 10.1037/0735-7036.111.3.219; Hollis KL, 2004, ANIM BEHAV, V68, P1155, DOI 10.1016/j.anbehav.2003.11.022; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; London KB, 2005, J KANSAS ENTOMOL SOC, V78, P134, DOI 10.2317/0405.06.1; LUCAS JR, 1982, ANIM BEHAV, V30, P651, DOI 10.1016/S0003-3472(82)80135-8; Mahometa MJ, 2005, ANIM BEHAV, V69, P983, DOI 10.1016/j.anbehav.2004.06.023; Mansell M.W., 1999, STAPFIA, V60, P49; Mansell M. W., 1992, PHOENIX, V5, P20; Mansell MV, 1996, PURE AND APPLIED RESEARCH IN NEUROPTEROLOGY, P161; MATSURA T, 1987, RES POPUL ECOL, V29, P17, DOI 10.1007/BF02515422; Mencinger Bojana, 1998, Acta Zoologica Fennica, V209, P157; Mencinger-Vracko B, 2008, ZOOLOGY, V111, P2, DOI 10.1016/j.zool.2007.05.002; Menzel R., 1974, P195; MUENCHOW G, 1986, ECOLOGY, V67, P246, DOI 10.2307/1938524; Nicolaidis S., 1977, The chemical senses and nutrition, P123; North G, 2007, COLD SPRING HARB MON, V49, pIX; Papaj D. R., 2003, ENCY INSECTS, P624; Papaj D.R., 1993, INSECT LEARNING ECOL; Pszczolkowski MA, 2005, PHYSIOL BEHAV, V86, P168, DOI 10.1016/j.physbeh.2005.07.007; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2009, CURR BIOL, V19, pR486, DOI 10.1016/j.cub.2009.04.047; Sakura M, 2001, ZOOL SCI, V18, P21, DOI 10.2108/zsj.18.21; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; Shettleworth S. J., 2009, COGNITION EVOLUTION; SIMPSON SJ, 1990, ANIM BEHAV, V40, P506, DOI 10.1016/S0003-3472(05)80531-7; Skiri HT, 2005, J EXP BIOL, V208, P787, DOI 10.1242/jeb.01431; Snell-Rood EC, 2009, AM NAT, V173, P615, DOI 10.1086/597609; Stephens David W., 1993, P195; TOPOFF H, 1977, NAT HIST, V86, P64; Watanabe H, 2006, J EXP BIOL, V209, P766, DOI 10.1242/jeb.02049	50	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e17958	10.1371/journal.pone.0017958	http://dx.doi.org/10.1371/journal.pone.0017958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479229	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600023
J	Suh, YH; Yoshimoto-Furusawa, A; Weih, KA; Tessarollo, L; Roche, KW; Mackem, S; Roche, PA				Suh, Young Ho; Yoshimoto-Furusawa, Aki; Weih, Karis A.; Tessarollo, Lino; Roche, Katherine W.; Mackem, Susan; Roche, Paul A.			Deletion of SNAP-23 Results in Pre-Implantation Embryonic Lethality in Mice	PLOS ONE			English	Article							PANCREATIC ACINAR-CELLS; REGULATED EXOCYTOSIS; KNOCKOUT MICE; MAST-CELLS; STEM-CELLS; SNARE; TRAFFICKING; SURFACE; MECHANISMS; SYNTAXIN	SNARE-mediated membrane fusion is a pivotal event for a wide-variety of biological processes. SNAP-25, a neuron-specific SNARE protein, has been well-characterized and mouse embryos lacking Snap25 are viable. However, the phenotype of mice lacking SNAP-23, the ubiquitously expressed SNAP-25 homolog, remains unknown. To reveal the importance of SNAP-23 function in mouse development, we generated Snap23-null mice by homologous recombination. We were unable to obtain newborn SNAP-23-deficient mice, and analysis of pre-implantation embryos from Snap23(Delta/wt) matings revealed that Snap23-null blastocysts were dying prior to implantation at embryonic day E3.5. Thus these data reveal a critical role for SNAP-23 during embryogenesis.	[Suh, Young Ho; Weih, Karis A.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho; Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho] Ajou Univ, Sch Med, Dept Pharmacol, Grad Program Neurosci, Suwon 441749, South Korea; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, CCR, NIH, Frederick, MD 21701 USA; [Yoshimoto-Furusawa, Aki; Mackem, Susan] NCI, Canc & Dev Biol Lab, CCR, NIH, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Ajou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Suh, YH (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	paul.roche@nih.gov	Suh, Young Ho/AAJ-6405-2021; Roche, Katherine/W-9893-2019	Suh, Young Ho/0000-0003-3979-1615; Roche, Paul/0000-0002-8949-9172; Roche, Katherine/0000-0001-7282-6539	NCI; NINDS; Integrative Neural Immune Program; NATIONAL CANCER INSTITUTE [ZIABC011035, ZICBC011265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Integrative Neural Immune Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the NCI Intramural Research Program (Y.H.S., A.Y.-F., L.T, S.M. and P.A.R.), the NINDS Intramural Research Program (Y.H.S., and K.W.R.), and the Integrative Neural Immune Program (Y.H.S. fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; DOOLEY TP, 1989, DEVELOPMENT, V107, P945; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Fournier KM, 2006, NEUROCHEM INT, V48, P596, DOI 10.1016/j.neuint.2005.12.030; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Huang XH, 2001, PANCREAS, V23, P125, DOI 10.1097/00006676-200108000-00002; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Nagy A, 2002, MANIPULATING MOUSE E, P800; PURI N, 2008, P NATL ACAD SCI US; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Reid Susan W., 2009, V530, P269, DOI 10.1007/978-1-59745-471-1_14; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Southon Eileen, 2009, V530, P165, DOI 10.1007/978-1-59745-471-1_9; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tessarollo Lino, 2009, V530, P141, DOI 10.1007/978-1-59745-471-1_8; Vaidyanathan VV, 2000, GENE, V247, P181, DOI 10.1016/S0378-1119(00)00100-1; Vaidyanathan VV, 2001, J BIOL CHEM, V276, P25101, DOI 10.1074/jbc.M103536200; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001	32	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18444	10.1371/journal.pone.0018444	http://dx.doi.org/10.1371/journal.pone.0018444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479242	Green Published, Green Submitted, gold			2022-12-25	WOS:000289054600052
J	Malik, S; Khalique, H; Buch, S; Seth, P				Malik, Shaily; Khalique, Hena; Buch, Shilpa; Seth, Pankaj			A Growth Factor Attenuates HIV-1 Tat and Morphine Induced Damage to Human Neurons: Implication in HIV/AIDS-Drug Abuse Cases	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; ACTIVE ANTIRETROVIRAL THERAPY; CELL-DEATH; MEMBRANE PERMEABILIZATION; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; CYTOCHROME-C; TNF-ALPHA; IN-VITRO	The neuropathological abnormalities of human immunodeficiency virus (HIV)-1 patients abusing illicit drugs suggest extensive interactions between the two agents, thereby leading to increased rate of progression to neurodegeneration. The role of HIV-1 transactivating protein, Tat has been elucidated in mediating neuronal damage via apoptosis, a hallmark of HIV-associated dementia (HAD), however the underlying mechanisms involved in enhanced neurodegeneration by illicit drugs remain elusive. In this study, we demonstrated that morphine enhances HIV-Tat induced toxicity in human neurons and neuroblastoma cells. Enhanced toxicity by Tat and morphine was accompanied by increased numbers of TUNEL positive apoptotic neurons, elevated caspase-3 levels and decreased ratio of anti- and pro-apoptotic proteins, Bcl2/Bax. Tat and morphine together elicited high levels of reactive oxygen species that were NADPH dependent. Significant alterations in mitochondrial membrane homeostasis were also observed with co-exposure of these agents. Extensive studies of mitogen activated protein kinase (MAPK) signaling pathways revealed the involvement of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase-1/2 (ERK1/2) pathways in enhanced toxicity of Tat and morphine. In addition to this, we found that pre-treatment of cells with platelet derived growth factor (PDGF-BB) protected neurons from HIV-Tat and morphine induced damage. PDGF-BB alleviated ROS production, maintained mitochondrial membrane potential, decreased caspase-3 activation and hence protected the cells from undergoing apoptosis. PDGF-BB mediated protection against Tat and morphine involved the phosphatidylinositol-3 kinase (PI3K) pathway, as specific inhibitor of PI3K abrogated the protection conferred by PDGF-BB. This study demonstrates the mechanism of enhanced toxicity in human neurons subjected to co-exposure of HIV protein Tat and morphine, thus implying its importance in HIV positive drug abusers, where damage to the brain is reported to be more severe than non-drug abusers. We have also showed for the first time that PDGF-BB can protect against simultaneous exposure of Tat and morphine, strengthening its role as a neuroprotective agent that could be considered for therapeutic intervention.	[Malik, Shaily; Khalique, Hena; Seth, Pankaj] Natl Brain Res Ctr, Gurgaon, Haryana, India; [Buch, Shilpa] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); University of Nebraska System; University of Nebraska Medical Center	Malik, S (corresponding author), Natl Brain Res Ctr, Gurgaon, Haryana, India.	pseth@nbrc.ac.in		Seth, Pankaj/0000-0003-1021-7839; Buch, Shilpa/0000-0002-3103-6685	Department of Biotechnology, India [BT/PR6615/MED/14/857/2005]; National Brain Research Centre, India; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024442] Funding Source: NIH RePORTER	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Brain Research Centre, India; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a research grant (BT/PR6615/MED/14/857/2005) from Department of Biotechnology, India and intramural support from National Brain Research Centre, Manesar, India to P. Seth, and DA024442 from the National Institutes of Health to S. Buch. S. Malik and H. Khalique were supported by Integrated MS-PhD fellowship and Project Assistant-ship, respectively, from National Brain Research Centre, India. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2001, NEUROSCI LETT, V305, P5, DOI 10.1016/S0304-3940(01)01786-4; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bachis A, 2005, ANN NY ACAD SCI, V1053, P247, DOI 10.1196/annals.1344.022; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bell JE, 1998, BRAIN, V121, P2043, DOI 10.1093/brain/121.11.2043; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Boscia F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006486; Bouwman FH, 1998, NEUROLOGY, V50, P1814, DOI 10.1212/WNL.50.6.1814; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen Quan, 2003, Korean Journal of Biological Sciences, V7, P1; Cherner M, 2005, NEUROLOGY, V64, P1343, DOI 10.1212/01.WNL.0000158328.26897.0D; Corasaniti MT, 2005, CELL DEATH DIFFER, V12, P999, DOI 10.1038/sj.cdd.4401644; Crews L, 2008, J NEUROVIROL, V14, P327, DOI 10.1080/13550280802132840; Dey S, 2007, J NEUROCHEM, V103, P542, DOI 10.1111/j.1471-4159.2007.04750.x; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; Ferri KF, 2000, ANN NY ACAD SCI, V926, P149; Gandhi N, 2010, J NEUROVIROL, V16, P294, DOI 10.3109/13550284.2010.499891; GIACOBINI MMJ, 1993, NEUROSCIENCE, V57, P923, DOI 10.1016/0306-4522(93)90038-H; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Gurwell JA, 2001, NEUROSCIENCE, V102, P555, DOI 10.1016/S0306-4522(00)00461-9; Hauser KF, 2009, GLIA, V57, P194, DOI 10.1002/glia.20746; Hu SX, 2002, NEUROPHARMACOLOGY, V42, P829, DOI 10.1016/S0028-3908(02)00030-8; Jiao HY, 2007, J NEUROCHEM, V103, P840, DOI 10.1111/j.1471-4159.2007.04840.x; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Li Y, 2010, BIOCHEM BIOPH RES CO, V391, P426, DOI 10.1016/j.bbrc.2009.11.074; Lin X, 2009, FEBS J, V276, P2022, DOI 10.1111/j.1742-4658.2009.06938.x; Mahajan SD, 2008, J CLIN IMMUNOL, V28, P528, DOI 10.1007/s10875-008-9208-1; Mallon PWG, 2007, CURR OPIN HIV AIDS, V2, P282, DOI 10.1097/COH.0b013e3281e72ca0; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; Mellon RD, 1998, BRAIN RES, V789, P56, DOI 10.1016/S0006-8993(97)01529-1; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Mishra M, 2010, J NEUROVIROL, V16, P355, DOI 10.3109/13550284.2010.513028; Moore DJ, 2006, AIDS, V20, P879, DOI 10.1097/01.aids.0000218552.69834.00; NAKAJIMA M, 1994, BRAIN RES, V641, P350, DOI 10.1016/0006-8993(94)90165-1; Nath A, 2001, J NEUROVIROL, V7, P66; Nath A, 1999, SEMIN NEUROL, V19, P113, DOI 10.1055/s-2008-1040830; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Noel RJ, 2006, VIROLOGY, V349, P440, DOI 10.1016/j.virol.2006.03.032; NUGENT AL, 2010, J NEUROIMMU IN PRESS; Peng FW, 2008, EUR J NEUROSCI, V28, P1255, DOI 10.1111/j.1460-9568.2008.06444.x; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; Perry W, 2005, AIDS, V19, pS79, DOI 10.1097/01.aids.0000192074.18691.31; Persidsky Y, 2002, J NEUROVIROL, V8, P49, DOI 10.1080/13550280290167993; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Sacktor NC, 2000, J NEUROVIROL, V6, P84, DOI 10.3109/13550280009006385; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; Schifitto G, 2007, AIDS, V21, P1877, DOI 10.1097/QAD.0b013e32813384e8; Seth P, 2005, NEUROTOX RES, V8, P83, DOI 10.1007/BF03033821; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Svensson AL, 2008, P NATL ACAD SCI USA, V105, P7304, DOI 10.1073/pnas.0802531105; Turchan-Cholewo J, 2006, NEUROBIOL DIS, V23, P109, DOI 10.1016/j.nbd.2006.02.005; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; Valcour VG, 2004, AIDS, V18, pS79, DOI 10.1097/00002030-200401001-00012; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Williams R, 2008, J NEUROVIROL, V14, P292, DOI 10.1080/13550280802074539; Williams R, 2010, GLIA, V58, P611, DOI 10.1002/glia.20949; Wright KM, 2007, CELL DEATH DIFFER, V14, P625, DOI 10.1038/sj.cdd.4402024; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhu XH, 2009, TOXICOL APPL PHARM, V240, P286, DOI 10.1016/j.taap.2009.06.020	75	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2011	6	3							e18116	10.1371/journal.pone.0018116	http://dx.doi.org/10.1371/journal.pone.0018116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740RG	21483469	Green Published, Green Submitted, gold			2022-12-25	WOS:000288811500024
J	Huijbers, W; Pennartz, CMA; Cabeza, R; Daselaar, SM				Huijbers, Willem; Pennartz, Cyriel M. A.; Cabeza, Roberto; Daselaar, Sander M.			The Hippocampus Is Coupled with the Default Network during Memory Retrieval but Not during Memory Encoding	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESTING-STATE NETWORKS; EPISODIC MEMORY; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; BRAIN; FMRI; ATTENTION; SYSTEM; CORTEX	The brain's default mode network (DMN) is activated during internally-oriented tasks and shows strong coherence in spontaneous rest activity. Despite a surge of recent interest, the functional role of the DMN remains poorly understood. Interestingly, the DMN activates during retrieval of past events but deactivates during encoding of novel events into memory. One hypothesis is that these opposing effects reflect a difference between attentional orienting towards internal events, such as retrieved memories, vs. external events, such as to-be-encoded stimuli. Another hypothesis is that hippocampal regions are coupled with the DMN during retrieval but decoupled from the DMN during encoding. The present fMRI study investigated these two hypotheses by combining a resting-state coherence analysis with a task that measured the encoding and retrieval of both internally-generated and externally-presented events. Results revealed that the main DMN regions were activated during retrieval but deactivated during encoding. Counter to the internal orienting hypothesis, this pattern was not modulated by whether memory events were internal or external. Consistent with the hippocampal coupling hypothesis, the hippocampus behaved like other DMN regions during retrieval but not during encoding. Taken together, our findings clarify the relationship between the DMN and the neural correlates of memory retrieval and encoding.	[Huijbers, Willem; Pennartz, Cyriel M. A.; Daselaar, Sander M.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Cabeza, Roberto] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Cabeza, Roberto] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of Amsterdam; Duke University; Duke University	Huijbers, W (corresponding author), Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	s.m.daselaar@uva.nl	daselaar, sander/J-3054-2012; Huijbers, Willem/D-5273-2013; Pennartz, Cyriel/B-7508-2015	daselaar, sander/0000-0003-2995-6877; Huijbers, Willem/0000-0003-3958-4069; Pennartz, Cyriel/0000-0001-8328-1175	The Netherlands Organisation for Scientific Research (NWO) [918.46.609, 916.66.022]; National Institutes of Health [AG19731, AG23770]; NATIONAL INSTITUTE ON AGING [R01AG023770, R01AG019731, R56AG023770] Funding Source: NIH RePORTER	The Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CP was supported by The Netherlands Organisation for Scientific Research (NWO) grant 918.46.609 (VICI); RC was supported by the National Institutes of Health grants AG19731 and AG23770; SD was supported by NWO grant 916.66.022 (VENI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daselaar SM, 2008, CEREB CORTEX, V18, P217, DOI 10.1093/cercor/bhm048; Daselaar SM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.013.2009; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; DAVACHI L, 2003, P NATL ACAD SCI US; Eichenbaum H, 2006, CURR BIOL, V16, pR643, DOI 10.1016/j.cub.2006.07.026; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Huijbers W, 2009, PLOS BIOL, V7, P63, DOI 10.1371/journal.pbio.1000011; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shrager Y, 2008, NEURON, V59, P547, DOI 10.1016/j.neuron.2008.07.022; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wagner AD, 2001, CURR BIOL, V11, pR964, DOI 10.1016/S0960-9822(01)00575-9; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055	49	94	94	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e17463	10.1371/journal.pone.0017463	http://dx.doi.org/10.1371/journal.pone.0017463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494597	Green Published, gold			2022-12-25	WOS:000289354100002
J	Lundin, V; Herland, A; Berggren, M; Jager, EWH; Teixeira, AI				Lundin, Vanessa; Herland, Anna; Berggren, Magnus; Jager, Edwin W. H.; Teixeira, Ana I.			Control of Neural Stem Cell Survival by Electroactive Polymer Substrates	PLOS ONE			English	Article							BENDING BEAM METHOD; ELECTROCHEMICAL APPLICATIONS; POLYPYRROLE ACTUATORS; DOPED POLYPYRROLE; DIFFERENTIATION; SURFACE; FILMS; SPECIFICATION; BIOMATERIALS; FABRICATION	Stem cell function is regulated by intrinsic as well as microenvironmental factors, including chemical and mechanical signals. Conducting polymer-based cell culture substrates provide a powerful tool to control both chemical and physical stimuli sensed by stem cells. Here we show that polypyrrole (PPy), a commonly used conducting polymer, can be tailored to modulate survival and maintenance of rat fetal neural stem cells (NSCs). NSCs cultured on PPy substrates containing different counter ions, dodecylbenzenesulfonate (DBS), tosylate (TsO), perchlorate (ClO(4)) and chloride (Cl), showed a distinct correlation between PPy counter ion and cell viability. Specifically, NSC viability was high on PPy(DBS) but low on PPy containing TsO, ClO(4) and Cl. On PPy(DBS), NSC proliferation and differentiation was comparable to standard NSC culture on tissue culture polystyrene. Electrical reduction of PPy(DBS) created a switch for neural stem cell viability, with widespread cell death upon polymer reduction. Coating the PPy(DBS) films with a gel layer composed of a basement membrane matrix efficiently prevented loss of cell viability upon polymer reduction. Here we have defined conditions for the biocompatibility of PPy substrates with NSC culture, critical for the development of devices based on conducting polymers interfacing with NSCs.	[Lundin, Vanessa; Herland, Anna; Teixeira, Ana I.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Berggren, Magnus; Jager, Edwin W. H.] Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden	Karolinska Institutet; Linkoping University	Lundin, V (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Ana.Teixeira@ki.se	Berggren, Magnus/J-6401-2015; Jager, Edwin/F-1481-2013; Herland, Anna/J-2923-2012	Berggren, Magnus/0000-0001-5154-0291; Jager, Edwin/0000-0002-2071-7768; Teixeira, Ana/0000-0001-8169-8815; Herland, Anna/0000-0002-5002-2537	Swedish Research Council (VR); Swedish Foundation for Strategic Research (SSF; the OBOE center); Karolinska Institute; VR; Onnesjo Foundation; Linkoping University	Swedish Research Council (VR)(Swedish Research Council); Swedish Foundation for Strategic Research (SSF; the OBOE center)(Swedish Foundation for Strategic Research); Karolinska Institute(Karolinska Institutet); VR(Swedish Research Council); Onnesjo Foundation; Linkoping University	The authors would like to acknowledge funding from the Swedish Research Council (VR) and the Swedish Foundation for Strategic Research (SSF; the OBOE center). V.L. was supported by a KID fellowship from the Karolinska Institute and A.H. was supported by a post-doctoral grant from VR. M.B. wishes to thank the Onnesjo Foundation and Linkoping University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay L, 2002, POLYMER, V43, P3527, DOI 10.1016/S0032-3861(02)00105-2; Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419; Causley J, 2005, SYNTHETIC MET, V151, P60, DOI 10.1016/j.synthmet.2005.04.001; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fonner JM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034124; Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040; George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037; Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Jager EWH, 2000, SCIENCE, V288, P2335, DOI 10.1126/science.288.5475.2335; Johanson U, 2005, ELECTROCHIM ACTA, V50, P1523, DOI 10.1016/j.electacta.2004.10.016; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6; PEI QB, 1993, SOLID STATE IONICS, V60, P161, DOI 10.1016/0167-2738(93)90291-A; PEI QB, 1993, J PHYS CHEM-US, V97, P6034, DOI 10.1021/j100124a041; Pyo M, 2003, CHEM MATER, V15, P916, DOI 10.1021/cm020312w; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Robinson L, 2006, SURF SCI, V600, pL148, DOI 10.1016/j.susc.2006.03.039; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Salto C, 2008, LANGMUIR, V24, P14133, DOI 10.1021/la8028337; Svennersten K, 2009, BIOMATERIALS, V30, P6257, DOI 10.1016/j.biomaterials.2009.07.059; Tamm J, 2004, RUSS J ELECTROCHEM+, V40, P344, DOI 10.1023/B:RUEL.0000019674.41564.01; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013; Wanekaya AK, 2006, ELECTROANAL, V18, P1047, DOI 10.1002/elan.200603507; Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176	28	64	66	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18624	10.1371/journal.pone.0018624	http://dx.doi.org/10.1371/journal.pone.0018624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494605	Green Published, Green Submitted, gold			2022-12-25	WOS:000289354100027
J	Schmidt, JP; Drake, JM				Schmidt, John Paul; Drake, John M.			Why Are Some Plant Genera More Invasive Than Others?	PLOS ONE			English	Article							PREDICTING INVASIONS; BIOLOGICAL INVASIONS; NATURALIZATION; PATTERNS; SUCCESS; TREES; RISK	Determining how biological traits are related to the ability of groups of organisms to become economically damaging when established outside of their native ranges is a major goal of population biology, and important in the management of invasive species. Little is known about why some taxonomic groups are more likely to become pests than others among plants. We investigated traits that discriminate vascular plant genera, a level of taxonomic generality at which risk assessment and screening could be more effectively performed, according to the proportion of naturalized species which are pests. We focused on the United States and Canada, and, because our purpose is ultimately regulatory, considered species classified as weeds or noxious. Using contingency tables, we identified 11 genera of vascular plants that are disproportionately represented by invasive species. Results from boosted regression tree analyses show that these categories reflect biological differences. In summary, approximately 25% of variation in genus proportions of weeds or noxious species was explained by biological covariates. Key explanatory traits included genus means for wetland habitat affinity, chromosome number, and seed mass.	[Schmidt, John Paul; Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schmidt, JP (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jps@uga.edu	Schmidt, John Paul/A-3583-2013; Drake, John/D-6622-2012	Drake, John/0000-0003-4646-1235; Schmidt, John Paul/0000-0001-8549-0587	U.S. Department of Agriculture [10-21-RR551]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Research was funded by U.S. Department of Agriculture (http://www.usda.gov/wps/portal/usda/usdahome) agreement no. 10-21-RR551. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AM, 2008, EVOLUTION PHYLOGENY, P73; [Anonymous], 2001, GREAT RESHUFFLING HU; APGII, 2003, LINNEAN, V141, P399; Barrett S.C.H., 1986, P21; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; DAEHLER CC, 2000, BIOL INVASIONS, V2, P93, DOI DOI 10.1023/A:1010002005024; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; FITTER AH, 1994, J ECOL, V82, P415, DOI 10.2307/2261309; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Goldblatt P., 1979, INDEX PLANT CHROMOSO; Goodwin BJ, 1999, CONSERV BIOL, V13, P422, DOI 10.1046/j.1523-1739.1999.013002422.x; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; HOLM S, 1979, SCAND J STAT, V6, P65; HOTHORN T, 2009, CONDITIONAL INFERENC; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Krivanek M, 2006, DIVERS DISTRIB, V12, P319, DOI 10.1111/j.1366-9516.2006.00249.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Liu K., 2008, SEED INFORM DATABASE; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Mooney H.A., 2000, INVASIVE SPECIES CHA; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pemberton RW, 2009, ECOLOGY, V90, P69, DOI 10.1890/07-1516.1; Pessarakli M., 1997, HDB PHOTOSYNTHESIS, V2nd; PYSEK P, 2007, ECOL STU AN, V193; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Ridgeway G., 1999, COMPUT SCI STAT, P172; Ruiz G. M, 2003, INVASIVE SPECIES VEC; Sage R., 1999, C4 PLANT BIOL, P551, DOI DOI 10.1016/B978-012614440-6/50017-3; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Stacey G., 1992, BIOL NITROGEN FIXATI; Vamosi JC, 2005, DIVERS DISTRIB, V11, P25, DOI 10.1111/j.1366-9516.2005.00119.x; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Zar JH, 1999, BIOSTATISTICAL ANAL	49	20	20	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18654	10.1371/journal.pone.0018654	http://dx.doi.org/10.1371/journal.pone.0018654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494563	Green Published, gold, Green Submitted			2022-12-25	WOS:000289354100029
J	Wang, YB; Zhang, H; Li, HC; Miao, XX				Wang, Yubing; Zhang, Hao; Li, Haichao; Miao, Xuexia			Second-Generation Sequencing Supply an Effective Way to Screen RNAi Targets in Large Scale for Potential Application in Pest Insect Control	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE; COTTON BOLLWORM; TRYPSIN-LIKE; BT CROPS; RESISTANCE; MIDGUT; LEPIDOPTERA; KNOCKDOWN; INGESTION	The key of RNAi approach success for potential insect pest control is mainly dependent on careful target selection and a convenient delivery system. We adopted second-generation sequencing technology to screen RNAi targets. Illumina's RNA-seq and digital gene expression tag profile (DGE-tag) technologies were used to screen optimal RNAi targets from Ostrinia furnalalis. Total 14690 stage specific genes were obtained which can be considered as potential targets, and 47 were confirmed by qRT-PCR. Ten larval stage specific expression genes were selected for RNAi test. When 50 ng/mu l dsRNAs of the genes DS10 and DS28 were directly sprayed on the newly hatched larvae which placed on the filter paper, the larval mortalities were around 40 similar to 50%, while the dsRNAs of ten genes were sprayed on the larvae along with artificial diet, the mortalities reached 73% to 100% at 5 d after treatment. The qRT-PCR analysis verified the correlation between larval mortality and the down-regulation of the target gene expression. Topically applied fluorescent dsRNA confirmed that dsRNA did penetrate the body wall and circulate in the body cavity. It seems likely that the combination of DGE-tag with RNA-seq is a rapid, high-throughput, cost less and an easy way to select the candidate target genes for RNAi. More importantly, it demonstrated that dsRNAs are able to penetrate the integument and cause larval developmental stunt and/or death in a lepidopteron insect. This finding largely broadens the target selection for RNAi from just gut-specific genes to the targets in whole insects and may lead to new strategies for designing RNAi-based technology against insect damage.	[Wang, Yubing; Zhang, Hao; Li, Haichao; Miao, Xuexia] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, YB (corresponding author), Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	xxm@sippe.ac.cn	WANG, Yubing/GYV-3345-2022; Li, Haichao/AGY-6004-2022	Li, Haichao/0000-0002-1359-4640	Ministry of Agriculture of China [2008ZX08009-003-001]; National Natural Foundation of China [31030060]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Transgenic Great Subject from the Ministry of Agriculture of China (2008ZX08009-003-001) and the National Natural Foundation Key Program of China (31030060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Broehan G, 2007, J EXP BIOL, V210, P3636, DOI 10.1242/jeb.008334; Chen MH, 2007, EXPERT REV MOL DIAGN, V7, P281, DOI 10.1586/14737159.7.3.281; Coates BS, 2006, INSECT MOL BIOL, V15, P13, DOI 10.1111/j.1365-2583.2006.00598.x; Dawid IB, 1998, TRENDS GENET, V14, P480, DOI 10.1016/S0168-9525(98)01615-1; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gallagher S.R., 1992, GUS PROTOCOLS USING; GAUR RK, 1993, FEBS LETT, V315, P56, DOI 10.1016/0014-5793(93)81132-J; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hegedus D, 2003, ARCH INSECT BIOCHEM, V53, P30, DOI 10.1002/arch.10084; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Joanisse DR, 1996, PHYSIOL ZOOL, V69, P1079, DOI 10.1086/physzool.69.5.30164247; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kuttenkeuler David, 2004, Briefings in Functional Genomics & Proteomics, V3, P168, DOI 10.1093/bfgp/3.2.168; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu Y, 2009, ARCH INSECT BIOCHEM, V72, P74, DOI 10.1002/arch.20324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Pechanova O, 2008, INSECT MOL BIOL, V17, P261, DOI 10.1111/j.1365-2583.2008.00801.x; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Zhang C, 2010, J INSECT PHYSIOL, V56, P788, DOI 10.1016/j.jinsphys.2010.02.001	46	109	137	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2011	6	4							e18644	10.1371/journal.pone.0018644	http://dx.doi.org/10.1371/journal.pone.0018644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747XH	21494551	Green Published, Green Submitted, gold			2022-12-25	WOS:000289354100028
J	Rimbert, M; Hamidou, M; Braudeau, C; Puechal, X; Teixeira, L; Caillon, H; Neel, A; Audrain, M; Guillevin, L; Josien, R				Rimbert, Marie; Hamidou, Mohamed; Braudeau, Cecile; Puechal, Xavier; Teixeira, Luis; Caillon, Helene; Neel, Antoine; Audrain, Marie; Guillevin, Loic; Josien, Regis			Decreased Numbers of Blood Dendritic Cells and Defective Function of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANCA-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; SUPPRESSOR FUNCTION; IMMUNE SUPPRESSION; TH17 CELLS; EXPRESSION; AUTOANTIBODIES	Background: Dendritic cells (DC) and regulatory cells (Treg) play pivotal roles in controlling both normal and autoimmune adaptive immune responses. DC are the main antigen-presenting cells to T cells, and they also control Treg functions. In this study, we examined the frequency and phenotype of DC subsets, and the frequency and function of Treg from patients with ANCA-associated vasculitis (AAV). Methodology/Principal Findings: Blood samples from 19 untreated patients with AAV during flares and before any immunosuppressive treatment were analyzed, along with 15 AAV patients in remission and 18 age-matched healthy controls. DC and Treg numbers, and phenotypes were assessed by flow cytometry, and in vitro suppressive function of Treg was determined by co-culture assay. When compared to healthy volunteers, absolute numbers of conventional and plasmacytoid DC were decreased in AAV patients. During the acute phase this decrease was significantly more pronounced and was associated with an increased DC expression of CD62L. Absolute numbers of Treg (CD4(+)CD25(high)CD127(low/-) Tcells) were moderately decreased in patients. FOXP3 and CD39 were expressed at similar levels on Treg from patients as compared to controls. The suppressive function of Treg from AAV patients was dramatically decreased as compared to controls, and this defect was more pronounced during flares than remission. This Treg functional deficiency occurred in the absence of obvious Th17 deviation. Conclusion: In conclusion, these data show that AAV flares are associated with both a decrease number and altered phenotype of circulating DC and point to a role for Treg functional deficiency in the pathogenesis of AAV.	[Rimbert, Marie; Braudeau, Cecile; Caillon, Helene; Audrain, Marie; Josien, Regis] CHU Nantes, Immunol Lab, F-44035 Nantes 01, France; [Rimbert, Marie; Braudeau, Cecile; Josien, Regis] ITUN, Nantes, France; [Rimbert, Marie; Josien, Regis] INSERM, UMR643, Nantes, France; [Rimbert, Marie; Hamidou, Mohamed; Neel, Antoine; Josien, Regis] Univ Nantes, Fac Med, Nantes, France; [Hamidou, Mohamed; Neel, Antoine] CHU Nantes, Serv Med Interne, F-44035 Nantes 01, France; [Puechal, Xavier] CH Le Mans, Le Mans, France; [Teixeira, Luis; Guillevin, Loic] Hop Cochin, AP HP, Serv Med Interne, F-75674 Paris, France; [Teixeira, Luis; Guillevin, Loic] Univ Paris 05, Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rimbert, M (corresponding author), CHU Nantes, Immunol Lab, F-44035 Nantes 01, France.	Regis.josien@univ-nantes.fr	Josien, Regis/U-4405-2019; Josien, Regis/L-7468-2015; Puéchal, Xavier/P-1555-2017	Josien, Regis/0000-0001-7900-7413; Puéchal, Xavier/0000-0003-3573-9203; Neel, Antoine/0000-0002-7707-5794; Teixeira, Luis/0000-0003-1049-9661	Delegation Regionale a la Recherche Clinique et Innovation (DRCI) [05/2-J, 09/06-A]; Region des Pays de la Loire	Delegation Regionale a la Recherche Clinique et Innovation (DRCI); Region des Pays de la Loire(Region Pays de la Loire)	This work was supported by grants from the Delegation Regionale a la Recherche Clinique et Innovation (DRCI), Appel d'offre Interne # 05/2-J and # 09/06-A, CHU Nantes. This study was also supported in part by a grant from the Region des Pays de la Loire (IMBIO project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulahad WH, 2006, KIDNEY INT, V70, P938, DOI 10.1038/sj.ki.5001670; Abdulahad WH, 2008, ARTHRITIS RHEUM-US, V58, P2196, DOI 10.1002/art.23557; Abdulahad WH, 2007, ARTHRITIS RHEUM, V56, P2080, DOI 10.1002/art.22692; Abdulahad WH, 2009, NEPHROLOGY, V14, P26, DOI 10.1111/j.1440-1797.2008.01069.x; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Blomberg S, 2003, ARTHRITIS RHEUM, V48, P2524, DOI 10.1002/art.11225; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; BROUWER E, 1991, CLIN EXP IMMUNOL, V83, P379; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Ciccocioppo R, 2007, CLIN EXP IMMUNOL, V149, P487, DOI 10.1111/j.1365-2249.2007.03431.x; Clayton AR, 2000, ARTHRITIS RES, V2, P260, DOI 10.1186/ar98; Csernok E, 2006, BLOOD, V107, P4440, DOI 10.1182/blood-2005-05-1875; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Gomez-Puerta JA, 2009, AM J PATHOL, V175, P1790, DOI 10.2353/ajpath.2009.090533; Huang Zhi-xiang, 2009, Zhonghua Yi Xue Za Zhi, V89, P2476; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Klapa S, 2010, CLIN EXP RHEUMATOL, V28, pS72; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Lamprecht P, 2005, CLIN EXP IMMUNOL, V141, P201, DOI 10.1111/j.1365-2249.2005.02808.x; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marinaki S, 2005, CLIN EXP IMMUNOL, V140, P181, DOI 10.1111/j.1365-2249.2005.02731.x; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Migita K, 2005, CLIN EXP IMMUNOL, V142, P84, DOI 10.1111/j.1365-2249.2005.02897.X; MORGAN MD, 2010, IMMUNOLOGY; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; NOGUEIRA E, 2010, NEPHROL DIAL TRANSPL; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilde B, 2009, NEPHROL DIAL TRANSPL, V24, P2151, DOI 10.1093/ndt/gfp019; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499	63	56	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18734	10.1371/journal.pone.0018734	http://dx.doi.org/10.1371/journal.pone.0018734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494636	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800041
J	Ross, A; Maire, N; Sicuri, E; Smith, T; Conteh, L				Ross, Amanda; Maire, Nicolas; Sicuri, Elisa; Smith, Thomas; Conteh, Lesong			Determinants of the Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants and Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RANDOMIZED CONTROLLED-TRIAL; ANEMIA CONTROL; DOUBLE-BLIND; ANTIMALARIAL TREATMENT; ROUTINE VACCINATIONS; EPIDEMIOLOGIC MODEL; TANZANIAN INFANTS; HEALTH; AMODIAQUINE	Background: Trials of intermittent preventive treatment in infants (IPTi) and children (IPTc) have shown promising results in reducing malaria episodes but with varying efficacy and cost-effectiveness. The effects of different intervention and setting characteristics are not well known. We simulate the effects of the different target age groups and delivery channels, seasonal or year-round delivery, transmission intensity, seasonality, proportions of malaria fevers treated and drug characteristics. Methods: We use a dynamic, individual-based simulation model of Plasmodium falciparum malaria epidemiology, antimalarial drug action and case management to simulate DALYs averted and the cost per DALY averted by IPTi and IPTc. IPT cost components were estimated from economic studies alongside trials. Results: IPTi and IPTc were predicted to be cost-effective in most of the scenarios modelled. The cost-effectiveness is driven by the impact on DALYs, particularly for IPTc, and the low costs, particularly for IPTi which uses the existing delivery strategy, EPI. Cost-effectiveness was predicted to decrease with low transmission, badly timed seasonal delivery in a seasonal setting, short-acting and more expensive drugs, high frequencies of drug resistance and high levels of treatment of malaria fevers. Seasonal delivery was more cost-effective in seasonal settings, and year-round in constant transmission settings. The difference was more pronounced for IPTc than IPTi due to the different proportions of fixed costs and also different assumed drug spacing during the transmission season. The number of DALYs averted was predicted to decrease as a target five-year age-band for IPTc was shifted from children under 5 years into older ages, except at low transmission intensities. Conclusions: Modelling can extend the information available by predicting impact and cost-effectiveness for scenarios, for outcomes and for multiple strategies where, for practical reasons, trials cannot be carried out. Both IPTi and IPTc are generally cost-effective but could be rendered cost-ineffective by characteristics of the setting, drug or implementation.	[Ross, Amanda; Maire, Nicolas; Smith, Thomas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ross, Amanda; Maire, Nicolas; Smith, Thomas] Univ Basel, Basel, Switzerland; [Sicuri, Elisa] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Sicuri, Elisa] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London	Ross, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	amanda.ross@unibas.ch	Sicuri, Elisa/L-8012-2014; Smith, Thomas/B-5569-2015; Conteh, Lesong/ABE-9550-2020; Agyemang, Samuel/H-8377-2014	Sicuri, Elisa/0000-0002-2499-2732; Smith, Thomas/0000-0002-3650-9381; Conteh, Lesong/0000-0002-0719-3672; Ross, Amanda/0000-0001-6027-5645	Bill and Melinda Gates Foundation [39777, 38479, 33679]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by The Bill and Melinda Gates Foundation grant numbers 39777, 38479 and 33679. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006627; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Aponte JJ, 2007, PLOS MED, V4, P2014, DOI 10.1371/journal.pmed.0040359; Arnesen T, 1999, BMJ-BRIT MED J, V319, P1423, DOI 10.1136/bmj.319.7222.1423; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; AsensoOkyere WK, 1997, SOC SCI MED, V45, P659, DOI 10.1016/S0277-9536(96)00383-8; Barger B, 2009, TROP MED INT HEALTH, V14, P784, DOI 10.1111/j.1365-3156.2009.02294.x; Beeson JG, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000410; Bojang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011225; Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Buffet PA, 2008, TRENDS PARASITOL, V24, P482, DOI 10.1016/j.pt.2008.07.007; Bureau of Labor Statistics, 2010, CPI INFL CALC; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; CHANDRAMOHAN D, 2007, TROP MED INT HEALTH, V12, P1; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012223; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; de Sousa A, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60047-5; Deressa W, 2007, TROP MED INT HEALTH, V12, P1148, DOI 10.1111/j.1365-3156.2007.01901.x; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Egan A, 2005, TROP MED INT HEALTH, V10, P815, DOI 10.1111/j.1365-3156.2005.01474.x; Gold MR, 1996, COST EFFECTIVENESS H; Goodman C, 2000, EC ANAL MALARIA CONT; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; GROBUSCH M, 2006, J INFECT DIS, V196, P1595; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Hastings IM, 2006, TRENDS PARASITOL, V22, P71, DOI 10.1016/j.pt.2005.12.011; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Manzi F, 2009, T ROY SOC TROP MED H, V103, P79, DOI 10.1016/j.trstmh.2008.08.014; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; McGready R, 2009, LANCET, V374, P1478, DOI 10.1016/S0140-6736(09)61629-9; Meremikwu MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003756.pub3; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; O'Meara Wendy Prudhomme, 2005, Malar J, V4, P33, DOI 10.1186/1475-2875-4-33; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Orrell C, 2008, EUR J CLIN PHARMACOL, V64, P683, DOI 10.1007/s00228-007-0452-8; Owusu-Agyei S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-103; PATOUILLARD E, 2011, COVERAGE COSTS UNPUB; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; PUSSARD E, 1987, EUR J CLIN PHARMACOL, V33, P409, DOI 10.1007/BF00637639; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Rohner F, 2010, J NUTR, V140, P635, DOI 10.3945/jn.109.114256; Ross A, 2006, AM J TROP MED HYG, V75, P74, DOI 10.4269/ajtmh.2006.75.74; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Ross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002661; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Sachs JD, 2001, MACR HLTH INV HLTH E; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Sesay S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-2; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; TAGBOR H, 2011, TROP MED INT HLTH; Tediosi F, 2006, AM J TROP MED HYG, V75, P131, DOI 10.4269/ajtmh.2006.75.131; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; Tediosi F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-127; Temperley M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-196; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Vinetz JM, 2010, AM J TROP MED HYG, V82, P755, DOI 10.4269/ajtmh.2010.825editorial; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WILSON A, 2010, PLOS ONE, V6; WINSTANLEY PA, 1990, BRIT J CLIN PHARMACO, V29, P695, DOI 10.1111/j.1365-2125.1990.tb03690.x; Wiseman V, 2006, TROP MED INT HEALTH, V11, P419, DOI 10.1111/j.1365-3156.2006.01586.x; *WORLD BANK, 1993, WORLD DEV REP; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	87	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18391	10.1371/journal.pone.0018391	http://dx.doi.org/10.1371/journal.pone.0018391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746IN	21490967	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700009
J	Rudolphi, J; Gustafsson, L				Rudolphi, Jorgen; Gustafsson, Lena			Forests Regenerating after Clear-Cutting Function as Habitat for Bryophyte and Lichen Species of Conservation Concern	PLOS ONE			English	Article							PICEA-ABIES; EPIPHYTIC LICHENS; OLD-GROWTH; POPULUS-TREMULA; SPATIAL SCALES; BOREAL FOREST; LANDSCAPE; RICHNESS; FRAGMENTATION; COLONIZATION	The majority of managed forests in Fennoscandia are younger than 70 years old but yet little is known about their potential to host rare and threatened species. In this study, we examined red-listed bryophytes and lichens in 19 young stands originating from clear-cutting (30-70 years old) in the boreal region, finding 19 red-listed species (six bryophytes and 13 lichens). We used adjoining old stands, which most likely never had been clear-cut, as reference. The old stands contained significantly more species, but when taking the amount of biological legacies (i.e., remaining deciduous trees and dead wood) from the previous forest generation into account, bryophyte species number did not differ between old and young stands, and lichen number was even higher in young stands. No dispersal effect could be detected from the old to the young stands. The amount of wetlands in the surroundings was important for bryophytes, as was the area of old forest for both lichens and bryophytes. A cardinal position of young stands to the north of old stands was beneficial to red-listed bryophytes as well as lichens. We conclude that young forest plantations may function as habitat for red-listed species, but that this depends on presence of structures from the previous forest generation, and also on qualities in the surrounding landscape. Nevertheless, at repeated clear-cuttings, a successive decrease in species populations in young production stands is likely, due to increased fragmentation and reduced substrate amounts. Retention of dead wood and deciduous trees might be efficient conservation measures. Although priority needs to be given to preservation of remnant old-growth forests, we argue that young forests rich in biological legacies and located in landscapes with high amounts of old forests may have a conservation value.	[Rudolphi, Jorgen; Gustafsson, Lena] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Rudolphi, J (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	jorgen.rudolphi@slu.se	Rudolphi, Jörgen/C-9363-2013; Sjögren, Jörgen/GXG-8007-2022	Rudolphi, Jörgen/0000-0002-0538-8265; Sjögren, Jörgen/0000-0002-0538-8265; Gustafsson, Lena/0000-0003-2467-7289	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	Funding for this study was received from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (www.formas.se), grant to L. Gustafsson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; AXELSSON AL, 2001, THESIS SWEDISH U AGR; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Botting RS, 2006, CAN J BOT, V84, P120, DOI [10.1139/B05-146, 10.1139/b05-146]; Bunnell FL, 2008, CAN J FOREST RES, V38, P1033, DOI 10.1139/X07-206; Bunnell FL, 2007, WEST J APPL FOR, V22, P94, DOI 10.1093/wjaf/22.2.94; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BUSBY JR, 1978, CAN J BOT, V56, P1551, DOI 10.1139/b78-184; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caruso A, 2007, SCAND J FOREST RES, V22, P219, DOI 10.1080/02827580701346031; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Coxson DS, 2005, FOREST ECOL MANAG, V204, P97, DOI 10.1016/j.foreco.2004.09.002; De Vries P.G., 1986, SAMPLING THEORY FORE; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Franklin J.F., 1997, CREATING FORESTRY 21, P111; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; FRIES C, 2000, DIFFERENT MANAGEMENT, P1; G?rdenfors U, 2000, RODLISTADE ARTER SVE; Ghisletta P, 2004, J EDUC BEHAV STAT, V29, P421, DOI 10.3102/10769986029004421; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gregoire T.G., 2008, SAMPLING STRATEGIES; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hallingback T., 1998, RODLISTADE MOSSOR SV; Hedenas H, 2003, ECOL APPL, V13, P1124, DOI 10.1890/1051-0761(2003)13[1124:ROELOP]2.0.CO;2; Hilmo O, 2001, BIOL CONSERV, V102, P251, DOI 10.1016/S0006-3207(01)00100-8; Hilmo O, 2009, LICHENOLOGIST, V41, P97, DOI 10.1017/S0024282909007865; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Hylander K, 2005, J APPL ECOL, V42, P518, DOI 10.1111/j.1365-2664.2005.01033.x; Hylander K, 2009, ECOLOGY, V90, P160, DOI 10.1890/08-0042.1; Jasinski JPP, 2005, ECOL MONOGR, V75, P561, DOI 10.1890/04-1621; Kivisto L, 2000, LICHENOLOGIST, V32, P387, DOI 10.1006/lich.2000.0282; Kruys N, 1999, CAN J FOREST RES, V29, P1295, DOI 10.1139/cjfr-29-8-1295; LESICA P, 1991, CAN J BOT, V69, P1745, DOI 10.1139/b91-222; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; Lindroth A, 2009, GLOBAL CHANGE BIOL, V15, P346, DOI 10.1111/j.1365-2486.2008.01719.x; Lohmus A, 2008, RESTOR ECOL, V16, P231, DOI 10.1111/j.1526-100X.2007.00266.x; Lohmus A, 2007, BIOL CONSERV, V135, P405, DOI 10.1016/j.biocon.2006.10.015; Longton Royce E., 1992, P32; McCullagh P, 1989, GEN LINEAR MODELS; McGee GG, 2002, CAN J FOREST RES, V32, P1562, DOI 10.1139/X02-083; Muir PS, 2006, ECOL APPL, V16, P1207, DOI 10.1890/1051-0761(2006)016[1207:IOOROG]2.0.CO;2; Niklasson M, 2000, ECOLOGY, V81, P1484, DOI 10.1890/0012-9658(2000)081[1484:NASOFL]2.0.CO;2; Palmqvist K, 2000, PLANT CELL ENVIRON, V23, P1, DOI 10.1046/j.1365-3040.2000.00529.x; Pharo EJ, 2004, J APPL ECOL, V41, P910, DOI 10.1111/j.0021-8901.2004.00947.x; Pharo EJ, 2007, BIOL CONSERV, V135, P315, DOI 10.1016/j.biocon.2006.10.016; Proctor MCF, 2008, BRYOPHYTE BIOL, P237, DOI [10.1017/CBO9780511754807.007, DOI 10.1017/CBO9780511754807.007]; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; Reese H, 2003, AMBIO, V32, P542, DOI 10.1639/0044-7447(2003)032[0542:CEOFVU]2.0.CO;2; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; Sillett SC, 1998, BRYOLOGIST, V101, P20, DOI 10.1639/0007-2745(1998)101[20:SAGOCT]2.0.CO;2; Sillett SC, 2000, BRYOLOGIST, V103, P661, DOI 10.1639/0007-2745(2000)103[0661:FYOECI]2.0.CO;2; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; SODERSTROM L, 1988, BIOL CONSERV, V45, P169, DOI 10.1016/0006-3207(88)90137-1; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000484; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Thor G., 1999, RODLISTADE LAVAR SVE; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Ulanova NG, 2000, FOREST ECOL MANAG, V135, P155, DOI 10.1016/S0378-1127(00)00307-8; Walser JC, 2001, MOL ECOL, V10, P2129, DOI 10.1046/j.1365-294X.2001.01353.x; 2007, WARSZ MIN C PROT FOR	63	32	33	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18639	10.1371/journal.pone.0018639	http://dx.doi.org/10.1371/journal.pone.0018639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21490926	Green Published, gold, Green Submitted			2022-12-25	WOS:000289238700031
J	Ramonet, D; Daher, JPL; Lin, BM; Stafa, K; Kim, J; Banerjee, R; Westerlund, M; Pletnikova, O; Glauser, L; Yang, LC; Liu, Y; Swing, DA; Beal, MF; Troncoso, JC; McCaffery, JM; Jenkins, NA; Copeland, NG; Galter, D; Thomas, B; Lee, MK; Dawson, TM; Dawson, VL; Moore, DJ				Ramonet, David; Daher, Joao Paulo L.; Lin, Brian M.; Stafa, Klodjan; Kim, Jaekwang; Banerjee, Rebecca; Westerlund, Marie; Pletnikova, Olga; Glauser, Liliane; Yang, Lichuan; Liu, Ying; Swing, Deborah A.; Beal, M. Flint; Troncoso, Juan C.; McCaffery, J. Michael; Jenkins, Nancy A.; Copeland, Neal G.; Galter, Dagmar; Thomas, Bobby; Lee, Michael K.; Dawson, Ted M.; Dawson, Valina L.; Moore, Darren J.			Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; ALPHA-SYNUCLEIN; R1441C MUTATION; GTP-BINDING; GENE LRRK2; LOCALIZATION; NEURODEGENERATION; MODELS	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause late-onset, autosomal dominant familial Parkinson's disease (PD) and also contribute to idiopathic PD. LRRK2 mutations represent the most common cause of PD with clinical and neurochemical features that are largely indistinguishable from idiopathic disease. Currently, transgenic mice expressing wild-type or disease-causing mutants of LRRK2 have failed to produce overt neurodegeneration, although abnormalities in nigrostriatal dopaminergic neurotransmission have been observed. Here, we describe the development and characterization of transgenic mice expressing human LRRK2 bearing the familial PD mutations, R1441C and G2019S. Our study demonstrates that expression of G2019S mutant LRRK2 induces the degeneration of nigrostriatal pathway dopaminergic neurons in an age-dependent manner. In addition, we observe autophagic and mitochondrial abnormalities in the brains of aged G2019S LRRK2 mice and markedly reduced neurite complexity of cultured dopaminergic neurons. These new LRRK2 transgenic mice will provide important tools for understanding the mechanism(s) through which familial mutations precipitate neuronal degeneration and PD.	[Ramonet, David; Stafa, Klodjan; Glauser, Liliane; Moore, Darren J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Daher, Joao Paulo L.; Lin, Brian M.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, Baltimore, MD USA; [Daher, Joao Paulo L.; Lin, Brian M.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Daher, Joao Paulo L.; Lin, Brian M.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Daher, Joao Paulo L.] Univ Fed Fluminense, Sch Med, Dept Pathol, Niteroi, RJ, Brazil; [Kim, Jaekwang; Pletnikova, Olga; Liu, Ying; Troncoso, Juan C.; Lee, Michael K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Kim, Jaekwang; Lee, Michael K.] Univ Minnesota, Dept Neurosci, Inst Translat Neurosci, Minneapolis, MN USA; [Banerjee, Rebecca; Yang, Lichuan; Beal, M. Flint; Thomas, Bobby] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; [Westerlund, Marie; Galter, Dagmar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [McCaffery, J. Michael] Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Swing, Deborah A.; Jenkins, Nancy A.; Copeland, Neal G.] NCI, Mouse Canc Genet Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidade Federal Fluminense; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Cornell University; Karolinska Institutet; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University; Johns Hopkins University	Ramonet, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland.	vdawson@jhmi.edu; darren.moore@epfl.ch	Lee, Michael K/D-9491-2013; Galter, Dagmar/C-4826-2011; Dawson, Valina/Y-9757-2019	Lee, Michael K/0000-0001-5865-9682; Galter, Dagmar/0000-0001-6485-6244; Kim, Jaekwang/0000-0002-7312-4077; Dawson, Valina/0000-0002-2915-3970; Moore, Darren/0000-0003-2359-5679; Ramonet, David/0000-0002-5058-7757	National Parkinson Foundation; Swiss National Science Foundation [310030_127478]; Parkinson Schweiz; American Parkinson Disease Association; Ecole Polytechnique Federale de Lausanne; Swedish Research Council; National Institutes of Health [NS060885, NS062165, NS03877]; NATIONAL CANCER INSTITUTE [ZICBC010903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS060885, R21NS062165] Funding Source: NIH RePORTER	National Parkinson Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Parkinson Schweiz; American Parkinson Disease Association; Ecole Polytechnique Federale de Lausanne; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Parkinson Foundation (D.J.M., V. L. D.); Swiss National Science Foundation (grant no. 310030_127478 to D.J.M.); Parkinson Schweiz (D.J.M.); American Parkinson Disease Association (D.J.M.); Ecole Polytechnique Federale de Lausanne (D.J.M.); Swedish Research Council (D.G.); and the National Institutes of Health (grant no. NS060885 and NS062165 to B. T., and NS03877 to T. M. D. and V. L. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Geyer MA, 2006, NEUROTOX RES, V10, P211, DOI 10.1007/BF03033358; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Haugarvoll K, 2006, CURR NEUROL NEUROSCI, V6, P287, DOI 10.1007/s11910-006-0020-0; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Higashi S, 2007, BRAIN RES, V1155, P208, DOI 10.1016/j.brainres.2007.04.034; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Liu Y, 2008, J NEUROSCI, V28, P13805, DOI 10.1523/JNEUROSCI.4218-08.2008; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Marin I, 2006, MOL BIOL EVOL, V23, P2423, DOI 10.1093/molbev/msl114; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Moore DJ, 2008, CURR NEUROL NEUROSCI, V8, P288, DOI 10.1007/s11910-008-0045-7; Moore Darren J, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS92, DOI 10.1016/j.parkreldis.2008.04.010; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wang CY, 2005, J GENE MED, V7, P945, DOI 10.1002/jgm.742; Wang DL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-3; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	61	289	292	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18568	10.1371/journal.pone.0018568	http://dx.doi.org/10.1371/journal.pone.0018568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494637	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400039
J	Choo, SW; White, R; Russell, S				Choo, Siew Woh; White, Robert; Russell, Steven			Genome-Wide Analysis of the Binding of the Hox Protein Ultrabithorax and the Hox Cofactor Homothorax in Drosophila	PLOS ONE			English	Article							HOMEOTIC GENE ULTRABITHORAX; POLYCOMB GROUP PROTEINS; BITHORAX COMPLEX; DNA-BINDING; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN; HALTERE DEVELOPMENT; IMAGINAL DISC; TARGET GENE; NEGATIVE REGULATION	Hox genes encode a family of transcription factors that are key developmental regulators with a highly conserved role in specifying segmental diversity along the metazoan body axis. Although they have been shown to regulate a wide variety of downstream processes, direct transcriptional targets have been difficult to identify and this has been a major obstacle to our understanding of Hox gene function. We report the identification of genome-wide binding sites for the Hox protein Ultrabithorax (Ubx) using a YFP-tagged Drosophila protein-trap line together with chromatin immunoprecipitation and microarray analysis. We identify 1,147 genes bound by Ubx at high confidence in chromatin from the haltere imaginal disc, a prominent site of Ubx function where it specifies haltere versus wing development. The functional relevance of these genes is supported by their overlap with genes differentially expressed between wing and haltere imaginal discs. The Ubx-bound gene set is highly enriched in genes involved in developmental processes and contains both high-level regulators as well as genes involved in more basic cellular functions. Several signalling pathways are highly enriched in the Ubx target gene set and our analysis supports the view that Hox genes regulate many levels of developmental pathways and have targets distributed throughout the gene network. We also performed genome-wide analysis of the binding sites for the Hox cofactor Homothorax (Hth), revealing a striking similarity with the Ubx binding profile. We suggest that these binding profiles may be strongly influenced by chromatin accessibility and provide evidence of a link between Ubx/Hth binding and chromatin state at genes regulated by Polycomb silencing. Overall, we define a set of direct Ubx targets in the haltere imaginal disc and suggest that chromatin accessibility has important implications for Hox target selection and for transcription factor binding in general.	[Choo, Siew Woh; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Choo, Siew Woh; White, Robert] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EH, England; [Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge; University of Cambridge	Choo, SW (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	rw108@cam.ac.uk	Russell, Steve/A-4072-2011; Choo, Siew Woh/E-3406-2010; White, Rob A H/G-4835-2012	Russell, Steve/0000-0003-0546-3031; 	Malaysian Government; University of Malaya	Malaysian Government; University of Malaya(Universiti Malaya)	SWC was supported by a scholarship from the Malaysian Government and the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Beuchle D, 2001, DEVELOPMENT, V128, P993; Biggin MD, 1997, DEVELOPMENT, V124, P4425; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; BODMER R, 1993, DEVELOPMENT, V118, P719; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; CAPOVILLA M, 1994, CELL, V76, P461, DOI 10.1016/0092-8674(94)90111-2; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; CASANOVA J, 1985, J EMBRYOL EXP MORPH, V90, P179; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Casares F, 2000, DEVELOPMENT, V127, P1499; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; Chan SK, 1997, DEVELOPMENT, V124, P2007; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; CHRISTEN B, 1994, MECH DEVELOP, V48, P255, DOI 10.1016/0925-4773(94)90064-7; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Curtiss J, 1997, DEV BIOL, V190, P129, DOI 10.1006/dbio.1997.8659; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; Galant R, 2002, DEVELOPMENT, V129, P3115; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; GONZALEZCRESPO S, 1995, DEVELOPMENT, V121, P2117; GOULD AP, 1990, NATURE, V348, P308, DOI 10.1038/348308a0; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; Hersh BM, 2007, DEV BIOL, V302, P717, DOI 10.1016/j.ydbio.2006.11.011; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Huen DS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-359; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurant E, 1998, DEVELOPMENT, V125, P1037; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; LEVINE M, 1983, EMBO J, V2, P2037, DOI 10.1002/j.1460-2075.1983.tb01697.x; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1964, ROLE CHROMOSOMES DEV, P231; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; Lu Q, 1996, MOL CELL BIOL, V16, P1632; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; MANAK JR, 1994, DEVELOPMENT, V120, P3605; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; McCall K, 1996, EMBO J, V15, P569, DOI 10.1002/j.1460-2075.1996.tb00389.x; MCCORMICK AM, 1995, DEVELOPMENT, V121, P2799; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mihaly J, 2006, DEVELOPMENT, V133, P2983, DOI 10.1242/dev.02451; Mohit P, 2006, DEV BIOL, V291, P356, DOI 10.1016/j.ydbio.2005.12.022; Molnar C, 2006, GENETICS, V174, P1635, DOI 10.1534/genetics.106.061283; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Pallavi SK, 2006, DEV BIOL, V296, P340, DOI 10.1016/j.ydbio.2006.05.035; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; PAVLOPOULOS A, 2011, P NATL ACAD IN PRESS; Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Roch F, 2000, DEVELOPMENT, V127, P97; Ryder E, 2009, BIOINFORMATICS, V25, P548, DOI 10.1093/bioinformatics/btp012; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; SCHLOSSHERR J, 1994, MOL GEN GENET, V243, P453; Shashidhara LS, 1999, DEV BIOL, V212, P491, DOI 10.1006/dbio.1999.9341; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; White RAH, 2000, MECH DEVELOP, V91, P217, DOI 10.1016/S0925-4773(99)00306-8; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; WIRZ J, 1986, EMBO J, V5, P3327, DOI 10.1002/j.1460-2075.1986.tb04647.x; Wu J, 1999, DEVELOPMENT, V126, P109	89	45	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e14778	10.1371/journal.pone.0014778	http://dx.doi.org/10.1371/journal.pone.0014778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483667	Green Submitted, Green Published, gold			2022-12-25	WOS:000289191300002
J	Jang, Y; Waterworth, D; Lee, JE; Song, K; Kim, S; Kim, HS; Park, KW; Cho, HJ; Oh, IY; Park, JE; Lee, BS; Ku, HJ; Shin, DJ; Lee, JH; Jee, SH; Han, BG; Jang, HY; Cho, EY; Vallance, P; Whittaker, J; Cardon, L; Mooser, V				Jang, Yangsoo; Waterworth, Dawn; Lee, Jong-Eun; Song, Kijoung; Kim, Sujin; Kim, Hyo-Soo; Park, Kyung Woo; Cho, Hyun-Jai; Oh, Il-Young; Park, Jeong Euy; Lee, Bok-Soo; Ku, Hyo Jeong; Shin, Dong-Jik; Lee, Jong Ho; Jee, Sun Ha; Han, Bok-Ghee; Jang, Hye-Yoon; Cho, Eun-Young; Vallance, Patrick; Whittaker, John; Cardon, Lon; Mooser, Vincent			Carriage of the V279F Null Allele within the Gene Encoding Lp-PLA(2) Is Protective from Coronary Artery Disease in South Korean Males	PLOS ONE			English	Article							FACTOR ACETYLHYDROLASE DEFICIENCY; PHOSPHOLIPASE A(2) ACTIVITY; HEART-DISEASE; CHROMOSOME 9P21; MISSENSE MUTATION; CARDIOVASCULAR-DISEASE; PAF ACETYLHYDROLASE; QUANTITATIVE TRAITS; JAPANESE POPULATION; ASSOCIATION	Background: The Asia-specific PLA2G7 994G-T transversion leads to V279F substitution within the lipoprotein-associated phospholipase-A2 (Lp-PLA(2)) and to absence of enzyme activity in plasma. This variant offers a unique natural experiment to assess the role of Lp-PLA(2) in the pathogenesis of coronary artery disease (CAD) in humans. Given conflicting results from mostly small studies, a large two-stage case-control study was warranted. Methodology/Principal Findings: PLA2G7 V279F genotypes were initially compared in 2890 male cases diagnosed with CAD before age 60 with 3128 male controls without CAD at age 50 and above and subsequently in a second independent male dataset of 877 CAD cases and 1230 controls. In the first dataset, the prevalence of the 279F null allele was 11.5% in cases and 12.8% in controls. After adjustment for age, body mass index, diabetes, smoking, glucose and lipid levels, the OR (95% CI) for CAD for this allele was 0.80 (0.66-0.97, p = 0.02). The results were very similar in the second dataset, despite lower power, with an allele frequency of 11.2% in cases and 12.5% in controls, leading to a combined OR of 0.80 (0.69-0.92), p = 0.002. The magnitude and direction of this genetic effect were fully consistent with large epidemiological studies on plasma Lp-PLA(2) activity and CAD risk. Conclusions: Natural deficiency in Lp-PLA(2) activity due to carriage of PLA2G7 279F allele protects from CAD in Korean men. These results provide evidence for a causal relationship between Lp-PLA(2) and CAD, and support pharmacological inhibition of this enzyme as an innovative way to prevent CAD.	[Jang, Yangsoo; Shin, Dong-Jik] Yonsei Univ, Coll Med, Cardiovasc Genome Ctr, Div Cardiol, Yonsei, South Korea; [Waterworth, Dawn; Song, Kijoung; Whittaker, John; Cardon, Lon; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet, Med Discovery & Dev, Res & Dev, Philadelphia, PA USA; [Waterworth, Dawn; Song, Kijoung; Whittaker, John; Cardon, Lon; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet, Med Discovery & Dev, Res & Dev, Greenford, Middx, England; [Lee, Jong-Eun; Kim, Sujin; Jang, Hye-Yoon; Cho, Eun-Young] DNA Link Inc, Seoul, South Korea; [Kim, Hyo-Soo; Park, Kyung Woo; Cho, Hyun-Jai; Oh, Il-Young] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Kim, Hyo-Soo; Park, Kyung Woo; Cho, Hyun-Jai; Oh, Il-Young] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea; [Park, Jeong Euy; Lee, Bok-Soo; Ku, Hyo Jeong] Sungkyunkwan Univ, Samsung Med Ctr, Div Cardiovasc Dis, Seoul, South Korea; [Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Han, Bok-Ghee] Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; GlaxoSmithKline; GlaxoSmithKline; DNA Link, Inc.; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Jang, Y (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Genome Ctr, Div Cardiol, Yonsei, South Korea.	Dawn.M.Waterworth@gsk.com	Park, Kyung Woo/AAX-3046-2020; Jang, Yang Soo/D-4803-2012; Kim, Hyo Soo/J-2753-2012; Whittaker, John C/B-8609-2012	Whittaker, John C/0000-0002-3529-2379; Jee, Sun Ha/0000-0001-9519-3068; Jang, Yangsoo/0000-0002-2169-3112	Ministry of Health and Welfare, Republic of Korea [A050558]; GlaxoSmithKline	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); GlaxoSmithKline(GlaxoSmithKline)	This work was funded in part by a grant (A050558 to J.E. Lee) from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea. The present study was also sponsored in part by GlaxoSmithKline which funded genotyping of the samples. Scientists at GlaxoSmithKline and DNA Link, Inc. designed together the study, performed collaboratively the analysis and were involved in the interpretation of the data. GlaxoSmithKline scientists wrote the first draft of the manuscript. Decision to submit the manuscript for publication was made collaboratively. Samples were stored and genotyped at DNA Link, Inc. in Seoul, South Korea.	Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; Balta G, 2001, THROMB RES, V101, P231, DOI 10.1016/S0049-3848(00)00394-7; Casas JP, 2010, CIRCULATION, V121, P2284, DOI 10.1161/CIRCULATIONAHA.109.923383; Cha SH, 2007, CLIN CHIM ACTA, V382, P129, DOI 10.1016/j.cca.2007.03.017; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Hou LP, 2009, HUM GENET, V125, P11, DOI 10.1007/s00439-008-0587-4; Jang Y, 2006, J CLIN ENDOCR METAB, V91, P3521, DOI 10.1210/jc.2006-0116; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Orwin R.G., 1994, HDB RES SYNTHESIS; Packard CJ, 2009, CURR OPIN CARDIOL, V24, P358, DOI 10.1097/HCO.0b013e32832bcb22; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Park KW, 2003, J BIOCHEM MOL BIOL, V36, P237; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Satoh N, 1999, AM J RESP CRIT CARE, V159, P974, DOI 10.1164/ajrccm.159.3.9807093; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Shen GQ, 2008, ARTERIOSCL THROM VAS, V28, P360, DOI 10.1161/ATVBAHA.107.157248; Shimokata K, 2004, ATHEROSCLEROSIS, V172, P167, DOI 10.1016/j.atherosclerosis.2003.09.019; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Unno N, 2002, ANN SURG, V235, P297, DOI 10.1097/00000658-200202000-00020; Wang T, 2009, AM J HYPERTENS, V22, P742, DOI 10.1038/ajh.2009.70; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5; Yamada Y, 2000, ATHEROSCLEROSIS, V150, P209, DOI 10.1016/S0021-9150(99)00385-8; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yoon SJ, 2008, METABOLISM, V57, P853, DOI 10.1016/j.metabol.2008.01.031; Zhang SY, 2007, HYPERTENS RES, V30, P403, DOI 10.1291/hypres.30.403; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	36	34	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18208	10.1371/journal.pone.0018208	http://dx.doi.org/10.1371/journal.pone.0018208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21490708	Green Published, Green Submitted, gold			2022-12-25	WOS:000289191300011
J	Kaplan, NA; Colosimo, PF; Liu, XP; Tolwinski, NS				Kaplan, Nicole A.; Colosimo, Pamela F.; Liu, Xiaoping; Tolwinski, Nicholas S.			Complex Interactions between GSK3 and aPKC in Drosophila Embryonic Epithelial Morphogenesis	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; PROTEIN-KINASE-C; PLANAR POLARITY; CDC42; POLARIZATION; ARMADILLO; PATHWAYS; BAZOOKA; SIGNAL; AXIN	Generally, epithelial cells must organize in three dimensions to form functional tissue sheets. Here we investigate one such sheet, the Drosophila embryonic epidermis, and the morphogenetic processes organizing cells within it. We report that epidermal morphogenesis requires the proper distribution of the apical polarity determinant aPKC. Specifically, we find roles for the kinases GSK3 and aPKC in cellular alignment, asymmetric protein distribution, and adhesion during the development of this polarized tissue. Finally, we propose a model explaining how regulation of aPKC protein levels can reorganize both adhesion and the cytoskeleton.	[Kaplan, Nicole A.; Colosimo, Pamela F.; Liu, Xiaoping; Tolwinski, Nicholas S.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Kaplan, NA (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, 1275 York Ave, New York, NY 10021 USA.	tolwinsn@mskcc.org	Tolwinski, Nicholas/D-1481-2014; Tolwinski, Nicholas/Q-5782-2019	Tolwinski, Nicholas/0000-0002-8507-2737				Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; CHOU TB, 1992, GENETICS, V131, P643; Colosimo PF, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000009; Colosimo PF, 2010, DEV DYNAM, V239, P115, DOI 10.1002/dvdy.21963; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; Hatini V, 2001, TRENDS GENET, V17, P574, DOI 10.1016/S0168-9525(01)02448-9; HILLMAN R, 1970, J MORPHOL, V131, P383, DOI 10.1002/jmor.1051310403; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Kaplan NA, 2010, J CELL SCI, V123, P3157, DOI 10.1242/jcs.069898; Kaplan NA, 2009, GENETICS, V183, P897, DOI 10.1534/genetics.109.108878; KIM NG, 2009, P NATL ACAD SCI US; MARTINEZ ARIAS A., 1993, DEV PATTERNING LARVA; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; PEIFER M, 1994, DEVELOPMENT, V120, P369; PRICE MH, 2006, J CELL SCI; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Simone RP, 2010, DEVELOPMENT, V137, P1385, DOI 10.1242/dev.048520; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tolwinski NS, 2009, GENETICS, V181, P1169, DOI 10.1534/genetics.108.098236; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Walters JW, 2006, DEV BIOL, V297, P323, DOI 10.1016/j.ydbio.2006.04.454; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	40	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2011	6	4							e18616	10.1371/journal.pone.0018616	http://dx.doi.org/10.1371/journal.pone.0018616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UD	21483653	Green Submitted, Green Published, gold			2022-12-25	WOS:000289191300033
J	Mutsaers, HAM; van den Heuvel, LP; Ringens, LHJ; Dankers, ACA; Russel, FGM; Wetzels, JFM; Hoenderop, JG; Masereeuw, R				Mutsaers, Henricus A. M.; van den Heuvel, Lambertus P.; Ringens, Lauke H. J.; Dankers, Anita C. A.; Russel, Frans G. M.; Wetzels, Jack F. M.; Hoenderop, Joost G.; Masereeuw, Rosalinde			Uremic Toxins Inhibit Transport by Breast Cancer Resistance Protein and Multidrug Resistance Protein 4 at Clinically Relevant Concentrations	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTER; RENAL-FAILURE; INDOXYL SULFATE; EFFLUX PUMP; KIDNEY; EXPRESSION; MEMBRANE; ABCG2; ACID; MRP4/ABCC4	During chronic kidney disease (CKD), there is a progressive accumulation of toxic solutes due to inadequate renal clearance. Here, the interaction between uremic toxins and two important efflux pumps, viz. multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP) was investigated. Membrane vesicles isolated from MRP4- or BCRP-overexpressing human embryonic kidney cells were used to study the impact of uremic toxins on substrate specific uptake. Furthermore, the concentrations of various uremic toxins were determined in plasma of CKD patients using high performance liquid chromatography and liquid chromatography/tandem mass spectrometry. Our results show that hippuric acid, indoxyl sulfate and kynurenic acid inhibit MRP4-mediated [(3)H]-methotrexate ([(3)H]-MTX) uptake (calculated Ki values: 2.5 mM, 1 mM, 25 mu M, respectively) and BCRP-mediated [(3)H]-estrone sulfate ([(3)H]-E1S) uptake (Ki values: 4 mM, 500 mu M and 50 mu M, respectively), whereas indole-3-acetic acid and phenylacetic acid reduce [(3)H]-MTX uptake by MRP4 only (Ki value: 2 mM and IC(50) value: 7 mM, respectively). In contrast, p-cresol, p-toluenesulfonic acid, putrescine, oxalate and quinolinic acid did not alter transport mediated by MRP4 or BCRP. In addition, our results show that hippuric acid, indole-3-acetic acid, indoxyl sulfate, kynurenic acid and phenylacetic acid accumulate in plasma of end-stage CKD patients with mean concentrations of 160 mu M, 4 mu M, 129 mu M, 1 mu M and 18 mu M, respectively. Moreover, calculated Ki values are below the maximal plasma concentrations of the tested toxins. In conclusion, this study shows that several uremic toxins inhibit active transport by MRP4 and BCRP at clinically relevant concentrations.	[Mutsaers, Henricus A. M.; Ringens, Lauke H. J.; Dankers, Anita C. A.; Russel, Frans G. M.; Masereeuw, Rosalinde] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, Nijmegen, Netherlands; [Mutsaers, Henricus A. M.; Hoenderop, Joost G.] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, Nijmegen, Netherlands; [van den Heuvel, Lambertus P.] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Nijmegen, Netherlands; [Wetzels, Jack F. M.] Radboud Univ Nijmegen Med Ctr, Dept Nephrol, Nijmegen, Netherlands; [van den Heuvel, Lambertus P.] Catholic Univ Louvain, Dept Pediat, B-3000 Louvain, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Universite Catholique Louvain	Mutsaers, HAM (corresponding author), Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Pharmacol & Toxicol, Nijmegen, Netherlands.	r.masereeuw@pharmtox.umcn.nl	Masereeuw, Roos/I-5276-2016; van den Heuvel, Lambertus/AAM-1772-2021; Mutsaers, Henricus/AAK-6321-2020; Hoenderop, Joost G.J./H-8047-2014; Wetzels, Jack F.M./A-1720-2014; Russel, Frans G.M./B-3184-2014; Masereeuw, Roos/N-3582-2014; van den Heuvel, L.P.W.J./H-8044-2014	Masereeuw, Roos/0000-0002-1560-1074; van den Heuvel, Lambertus/0000-0003-3917-6727; Mutsaers, Henricus/0000-0002-9553-8860; Hoenderop, Joost G.J./0000-0002-1816-8544; Wetzels, Jack F.M./0000-0002-0650-6921; Russel, Frans G.M./0000-0002-7959-2314; van den Heuvel, L.P.W.J./0000-0003-3917-6727	Dutch Kidney Foundation [IK08.03]; European Science Foundation	Dutch Kidney Foundation; European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by the Dutch Kidney Foundation (grant number IK08.03; www.nierstichting.nl). J.G. Hoenderop was supported by an EURYI award from the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Brener ZZ, 2010, AM J MED SCI, V339, P453, DOI 10.1097/MAJ.0b013e3181cf7d5b; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; Cohen G, 2007, NEPHROL DIAL TRANSPL, V22, P3381, DOI 10.1093/ndt/gfm210; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; Deguchi T, 2002, KIDNEY INT, V61, P1760, DOI 10.1046/j.1523-1755.2002.00318.x; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Huang ZH, 2000, EUR J PHARMACOL, V406, P453, DOI 10.1016/S0014-2999(00)00699-3; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Huls M, 2006, KIDNEY INT, V69, P2186, DOI 10.1038/sj.ki.5000407; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Jankowski J, 2003, J CLIN INVEST, V112, P256, DOI 10.1172/JCI200315524; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Laouari D, 2001, AM J PHYSIOL-RENAL, V280, pF636, DOI 10.1152/ajprenal.2001.280.4.F636; Lee CT, 2010, PERITON DIALYSIS INT, V30, P456, DOI 10.3747/pdi.2009.00092; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Lu H, 2008, DRUG METAB DISPOS, V36, P16, DOI 10.1124/dmd.107.014845; Masereeuw R, 1998, J PHARM PHARMACOL, V50, P1397, DOI 10.1111/j.2042-7158.1998.tb03366.x; Masereeuw R, 1996, J PHARM PHARMACOL, V48, P560, DOI 10.1111/j.2042-7158.1996.tb05974.x; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nakagawa T, 2006, BLOOD PURIFICAT, V24, P67, DOI 10.1159/000089440; Pick A, 2010, CHEMMEDCHEM, V5, P1498, DOI 10.1002/cmdc.201000216; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106	34	102	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2011	6	4							e18438	10.1371/journal.pone.0018438	http://dx.doi.org/10.1371/journal.pone.0018438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743ZC	21483698	gold, Green Published, Green Submitted			2022-12-25	WOS:000289058700028
J	Sola, S; Xavier, JM; Santos, DM; Aranha, MM; Morgado, AL; Jepsen, K; Rodrigues, CMP				Sola, Susana; Xavier, Joana M.; Santos, Daniela M.; Aranha, Marcia M.; Morgado, Ana L.; Jepsen, Kristen; Rodrigues, Cecilia M. P.			p53 Interaction with JMJD3 Results in Its Nuclear Distribution during Mouse Neural Stem Cell Differentiation	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; SELF-RENEWAL; PATHWAY; DEMETHYLASE; PLURIPOTENT; CONTRIBUTES; METHYLATION; REPRESSION; GENERATION; APOPTOSIS	Conserved elements of apoptosis are also integral components of cellular differentiation. In this regard, p53 is involved in neurogenesis, being required for neurite outgrowth in primary neurons and for axonal regeneration in mice. Interestingly, demethylases regulate p53 activity and its interaction with co-activators by acting on non-histone proteins. In addition, the histone H3 lysine 27-specific demethylase JMJD3 induces ARF expression, thereby stabilizing p53 in mouse embryonic fibroblasts. We hypothesized that p53 interacts with key regulators of neurogenesis to redirect stem cells to differentiation, as an alternative to cell death. Specifically, we investigated the potential cross-talk between p53 and JMJD3 during mouse neural stem cell (NSC) differentiation. Our results demonstrated that JMJD3 mRNA and protein levels were increased early in mouse NSC differentiation, when JMJD3 activity was readily detected. Importantly, modulation of JMJD3 in NSCs resulted in changes of total p53 protein, coincident with increased ARF mRNA and protein expression. ChIP analysis revealed that JMJD3 was present at the promoter and exon 1 regions of ARF during neural differentiation, although without changes in H3K27me3. Immunoprecipitation assays demonstrated a direct interaction between p53 and JMJD3, independent of the C-terminal region of JMJD3, and modulation of p53 methylation by JMJD3-demethylase activity. Finally, transfection of mutant JMJD3 showed that the demethylase activity of JMJD3 was crucial in regulating p53 cellular distribution and function. In conclusion, JMJD3 induces p53 stabilization in mouse NSCs through ARF-dependent mechanisms, directly interacts with p53 and, importantly, causes nuclear accumulation of p53. This suggests that JMJD3 and p53 act in a common pathway during neurogenesis.	[Sola, Susana; Xavier, Joana M.; Santos, Daniela M.; Aranha, Marcia M.; Morgado, Ana L.; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Jepsen, Kristen] Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, San Diego, CA 92103 USA	Universidade de Lisboa; Howard Hughes Medical Institute; University of California System; University of California San Diego	Sola, S (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal.	susana.sola@ff.ul.pt	Morgado, Ana Luísa/A-8683-2015; iMed.ULisboa, CellFun/A-4244-2014; Solá, Susana/M-5251-2013; Solá, Susana/AAI-4580-2021; Santos, Daniela/W-3903-2019; Aranha, Marcia/AAO-7240-2021; Rodrigues, Cecilia MP/M-3572-2013	Morgado, Ana Luísa/0000-0003-3153-4665; Solá, Susana/0000-0003-2036-797X; Solá, Susana/0000-0003-2036-797X; Rodrigues, Cecilia MP/0000-0002-4829-754X; Moutinho Dos Santos, Daniela/0000-0002-3740-1305; Aranha, Marcia/0000-0001-9842-4335	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal [PTDC/BIA-BCM/67922/2006]; FCT [SFRH/BD/42008/2007, SFRH/BD/28429/2006]	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grant PTDC/BIA-BCM/67922/2006 from Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal. Santos DM and Aranha MA were recipients of PhD fellowships from FCT (SFRH/BD/42008/2007 and SFRH/BD/28429/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Allison SJ, 2003, CANCER RES, V63, P6674; Amaral JD, 2010, CURR PHARM DESIGN, V16, P2493; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Ferecatu I, 2009, FRONT BIOSCI-LANDMRK, V14, P4214, DOI 10.2741/3524; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HE J, 2010, MED ONCOL       0817; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jones RS, 2007, NATURE, V450, P357, DOI 10.1038/450357a; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Selvaraj V, 2010, TRENDS BIOTECHNOL, V28, P214, DOI 10.1016/j.tibtech.2010.01.002; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	47	45	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e18421	10.1371/journal.pone.0018421	http://dx.doi.org/10.1371/journal.pone.0018421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483786	gold, Green Submitted, Green Published			2022-12-25	WOS:000289057200072
J	Burger, C; Both, C				Burger, Claudia; Both, Christiaan			Translocation as a Novel Approach to Study Effects of a New Breeding Habitat on Reproductive Output in Wild Birds	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; DISPERSAL; FAMILIARITY; DISTANCE; CONSEQUENCES; SELECTION; SURVIVAL; FITNESS	Environmental conditions under which species reproduce have major consequences on breeding success and subsequent fitness. Therefore breeding habitat choice is ultimately important. Studies rarely address the potential fitness pay-offs of alternative natural breeding habitats by experimental translocation. Here we present a new tool to study fitness consequences of free living birds in different habitats. We translocated a migratory passerine, the pied flycatcher (Ficedula hypoleuca), to a novel site, where pairs were subjected to a short stay (2-4 days) in a nest box-equipped aviary before being released. We show that it is technically possible to retain birds in the new area for breeding, allowing the study of reproductive consequences of dispersal under natural conditions. The translocation resulted in an extension of the interval between arrival and egg laying of four days, highlighting the importance of having an adequate control group. Clutch size and nestling parameters did not differ significantly between translocated and unmanipulated females, which suggests that the procedure did not affect birds in their reproductive performance later on. This method could be applied broadly in evolutionary and ecological research, e. g., to study the potential fitness benefits and costs for dispersing to more northern latitudes as a way of adapting to climate change.	[Burger, Claudia; Both, Christiaan] Univ Groningen, Ctr Life Sci, Anim Ecol Grp, Groningen, Netherlands	University of Groningen	Burger, C (corresponding author), Univ Groningen, Ctr Life Sci, Anim Ecol Grp, Groningen, Netherlands.	c.burger@rug.nl	Both, Christiaan/E-6459-2011	Both, Christiaan/0000-0001-7099-9831	Dutch Science Foundation (N.W.O.)	Dutch Science Foundation (N.W.O.)(Netherlands Organization for Scientific Research (NWO))	The study was funded by a VIDI grant of the Dutch Science Foundation (N.W.O.) awarded to C. Both. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; ARMSTRONG DP, 1995, BIOL CONSERV, V71, P133, DOI 10.1016/0006-3207(94)00027-N; ARTEMYEV AV, 2004, TERRITORIAL BEHAV BI, P28; BERNDT R, 1969, Journal fuer Ornithologie, V110, P22, DOI 10.1007/BF01671133; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Brown CR, 2008, ANIM BEHAV, V76, P1201, DOI 10.1016/j.anbehav.2008.03.028; Chernetsov N, 2006, CONDOR, V108, P711, DOI 10.1650/0010-5422(2006)108[711:sndopf]2.0.co;2; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doligez B, 2008, J ANIM ECOL, V77, P1199, DOI 10.1111/j.1365-2656.2008.01446.x; DRENT PJ, 1987, ARDEA, V75, P59; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; KOMDEUR J, 1994, BIOL CONSERV, V67, P143, DOI 10.1016/0006-3207(94)90360-3; Lambrechts MM, 1999, P ROY SOC B-BIOL SCI, V266, P1311, DOI 10.1098/rspb.1999.0780; Lundberg A, 1992, PIED FLYCATCHER; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Nichols J., 2001, DISPERSAL; Part T, 2007, J ORNITHOL, V148, pS327, DOI 10.1007/s10336-007-0226-1; PARTRIDGE L, 1974, NATURE, V247, P573, DOI 10.1038/247573a0; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schoech SJ, 2008, OECOLOGIA, V157, P369, DOI 10.1007/s00442-008-1091-1; Shields WM, 1982, PHILOPATRY INBREEDIN; SIIKAMAKI P, 1995, ECOLOGY, V76, P308, DOI 10.2307/1940652; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Winkel Wolfgang, 1993, Vogelwarte, V37, P50; Yoder JM, 2004, BEHAV ECOL, V15, P469, DOI 10.1093/beheco/arh037	38	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18143	10.1371/journal.pone.0018143	http://dx.doi.org/10.1371/journal.pone.0018143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479183	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700032
J	Dmitriew, C; Rowe, L				Dmitriew, Caitlin; Rowe, Locke			The Effects of Larval Nutrition on Reproductive Performance in a Food-Limited Adult Environment	PLOS ONE			English	Article							DEVELOPMENTAL TRADE-OFFS; EARLY GROWTH-CONDITIONS; COMPENSATORY GROWTH; PHYSIOLOGICAL COSTS; THRIFTY PHENOTYPE; BODY-SIZE; FLIGHT; EVOLUTION; CRICKETS; AGE	It is often assumed that larval food stress reduces lifetime fitness regardless of the conditions subsequently faced by adults. However, according to the environment-matching hypothesis, a plastic developmental response to poor nutrition results in an adult phenotype that is better adapted to restricted food conditions than one having developed in high food conditions. Such a strategy might evolve when current conditions are a reliable predictor of future conditions. To test this hypothesis, we assessed the effects of larval food conditions (low, improving and high food) on reproductive fitness in both low and high food adults environments. Contrary to this hypothesis, we found no evidence that food restriction in larval ladybird beetles produced adults that were better suited to continuing food stress. In fact, reproductive rate was invariably lower in females that were reared at low food, regardless of whether adults were well fed or food stressed. Juveniles that encountered improving conditions during the larval stage compensated for delayed growth by accelerating subsequent growth, and thus showed no evidence of a reduced reproductive rate. However, these same individuals lost more mass during the period of starvation in adults, which indicates that accelerated growth results in an increased risk of starvation during subsequent periods of food stress.	[Dmitriew, Caitlin] Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland; [Rowe, Locke] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Zurich; University of Toronto	Dmitriew, C (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland.	c.dmitriew@utoronto.ca			Natural Sciences and Engineering Research Council (NSERC); Canada Research Chairs program	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	This research was funded by a Natural Sciences and Engineering Research Council (NSERC) PGS-D scholarship to C. D. and by grants from NSERC (http://www.nserc-crsng.gc.ca/) and the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/) to L.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Andersson Malte, 1994; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; BARKER DJP, 1989, J EPIDEMIOL COMMUN H, V43, P237, DOI 10.1136/jech.43.3.237; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Coll M, 2004, ENVIRON ENTOMOL, V33, P1471, DOI 10.1603/0046-225X-33.5.1471; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; Dingle Hugh, 2001, Symposia of the Royal Entomological Society of London, V20, P159, DOI 10.1079/9780851994567.0159; Dmitriew C, 2007, J EVOLUTION BIOL, V20, P1298, DOI 10.1111/j.1420-9101.2007.01349.x; Dmitriew C, 2009, CAN J ZOOL, V87, P175, DOI 10.1139/Z09-001; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Fischer K, 2004, EVOL ECOL, V18, P343, DOI 10.1007/s10682-004-2004-3; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Hahn DA, 2005, J INSECT PHYSIOL, V51, P1210, DOI 10.1016/j.jinsphys.2005.06.011; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Karlsson B, 2008, P ROY SOC B-BIOL SCI, V275, P2131, DOI 10.1098/rspb.2008.0404; Koch RL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.32; Lorenz MW, 2007, J INSECT PHYSIOL, V53, P819, DOI 10.1016/j.jinsphys.2007.03.011; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Pellegroms B, 2009, ECOL ENTOMOL, V34, P387, DOI 10.1111/j.1365-2311.2009.01090.x; Prasad NG, 2003, J GENET, V82, P45, DOI 10.1007/BF02715881; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Saglam IK, 2008, J EVOLUTION BIOL, V21, P997, DOI 10.1111/j.1420-9101.2008.01548.x; Scharf I, 2009, OECOLOGIA, V160, P453, DOI 10.1007/s00442-009-1316-y; Scott DE, 2007, OECOLOGIA, V153, P521, DOI 10.1007/s00442-007-0755-6; Stevens DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1049, DOI 10.1098/rspb.1999.0742; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Zajitschek F, 2009, FUNCT ECOL, V23, P602, DOI 10.1111/j.1365-2435.2008.01520.x; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zera AJ, 2006, AM NAT, V167, P889, DOI 10.1086/503578	44	87	89	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17399	10.1371/journal.pone.0017399	http://dx.doi.org/10.1371/journal.pone.0017399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479211	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700011
J	Owen, AD; Hayward, RD; Koenig, HG; Steffens, DC; Payne, ME				Owen, Amy D.; Hayward, R. David; Koenig, Harold G.; Steffens, David C.; Payne, Martha E.			Religious Factors and Hippocampal Atrophy in Late Life	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TEMPORAL-LOBE EPILEPSY; MAJOR DEPRESSION; CHRONIC STRESS; ALZHEIMER NEUROPATHOLOGY; GERIATRIC DEPRESSION; NEGATIVE INTERACTION; SYNAPTIC PLASTICITY; GESCHWIND-SYNDROME; PRELIMINARY SPECT	Despite a growing interest in the ways spiritual beliefs and practices are reflected in brain activity, there have been relatively few studies using neuroimaging data to assess potential relationships between religious factors and structural neuroanatomy. This study examined prospective relationships between religious factors and hippocampal volume change using high-resolution MRI data of a sample of 268 older adults. Religious factors assessed included life-changing religious experiences, spiritual practices, and religious group membership. Hippocampal volumes were analyzed using the GRID program, which is based on a manual point-counting method and allows for semi-automated determination of region of interest volumes. Significantly greater hippocampal atrophy was observed for participants reporting a life-changing religious experience. Significantly greater hippocampal atrophy was also observed from baseline to final assessment among born-again Protestants, Catholics, and those with no religious affiliation, compared with Protestants not identifying as born-again. These associations were not explained by psychosocial or demographic factors, or baseline cerebral volume. Hippocampal volume has been linked to clinical outcomes, such as depression, dementia, and Alzheimer's Disease. The findings of this study indicate that hippocampal atrophy in late life may be uniquely influenced by certain types of religious factors.	[Owen, Amy D.; Koenig, Harold G.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Hayward, R. David; Koenig, Harold G.; Steffens, David C.; Payne, Martha E.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Hayward, R. David; Payne, Martha E.] Duke Univ, Med Ctr, Neuropsychiat Imaging Res Lab, Durham, NC 27710 USA; [Koenig, Harold G.; Steffens, David C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Owen, AD (corresponding author), Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA.	david.hayward@duke.edu	Hayward, R. David/A-8654-2009; Koenig, Harold G/F-7379-2011	Hayward, R. David/0000-0002-9845-6131; 	National Institutes of Health [MH54846, MH60451, MH70027]; John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054846, P50MH060451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by National Institutes of Health grants MH54846, MH60451, and MH70027, and the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts J, 1997, SOC SCI MED, V45, P3, DOI 10.1016/S0277-9536(96)00302-4; Ai AL, 2004, J HEALTH PSYCHOL, V9, P435, DOI 10.1177/1359105304042352; Ai AL, 2010, J HEALTH PSYCHOL, V15, P186, DOI 10.1177/1359105309345556; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; [Anonymous], 2000, INT J PSYCHOL RELIG, DOI DOI 10.1207/S15327582IJPR1004_04; [Anonymous], 2008, US REL LANDSC SURV; Azari N.P., 2005, INT J PSYCHOL RELIG, V15, P263, DOI [10.1207/s15327582ijpr1504_1, DOI 10.1207/S15327582IJPR1504_]; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Britton WB, 2004, PSYCHOL SCI, V15, P254, DOI 10.1111/j.0956-7976.2004.00661.x; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Collins M.L., 2008, HDB DEV COGNITIVE NE; Conrad CD, 2008, REV NEUROSCIENCE, V19, P395; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; DEWHURST K, 1970, BRIT J PSYCHIAT, V117, P497, DOI 10.1192/bjp.117.540.497; GEORGE LK, 1989, BRIT J PSYCHIAT, V154, P478, DOI 10.1192/bjp.154.4.478; GOLD PW, 1988, NEW ENGL J MED, V319, P348, DOI 10.1056/NEJM198808113190606; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Han SH, 2008, SOC NEUROSCI-UK, V3, P1, DOI 10.1080/17470910701469681; Harris S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007272; Hays JC, 2001, AM J PSYCHIAT, V158, P1850, DOI 10.1176/appi.ajp.158.11.1850; HERZOG H, 1991, NEUROPSYCHOBIOLOGY, V23, P182, DOI 10.1159/000119450; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Idler EL, 2009, J GERONTOL B-PSYCHOL, V64, P528, DOI 10.1093/geronb/gbp028; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; Jevning R, 1996, PHYSIOL BEHAV, V59, P399, DOI 10.1016/0031-9384(95)02006-3; Joels M, 2004, STRESS, V7, P221, DOI 10.1080/10253890500070005; Kapogiannis D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007180; Koenig HG, 2004, J AM GERIATR SOC, V52, P554, DOI 10.1111/j.1532-5415.2004.52161.x; Koenig HG, 2001, INT REV PSYCHIATR, V13, P67; Krause N, 2000, REV RELIG RES, V41, P510, DOI 10.2307/3512318; Krause N, 1998, J SCI STUD RELIG, V37, P725, DOI 10.2307/1388153; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; Lou HC, 1999, HUM BRAIN MAPP, V7, P98; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Lupien SJ, 2005, J PSYCHIATR NEUROSCI, V30, P328; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; MACFALL JR, 1994, PSYCHIAT RES-NEUROIM, V55, P167, DOI 10.1016/0925-4927(94)90024-8; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Model S, 2002, INT MIGR REV, V36, P1061; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Mortimer JA, 2004, NEUROLOGY, V62, P428, DOI 10.1212/01.WNL.0000106463.66966.65; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.6.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2006, PSYCHIAT RES-NEUROIM, V148, P67, DOI 10.1016/j.pscychresns.2006.07.001; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; O'Reilly D, 2008, SOC SCI MED, V66, P1637, DOI 10.1016/j.socscimed.2007.12.004; Pargament KI, 2002, PSYCHOL INQ, V13, P168, DOI 10.1207/S15327965PLI1303_02; Pargament KI, 2001, ARCH INTERN MED, V161, P1881, DOI 10.1001/archinte.161.15.1881; Payne ME, 2002, PSYCHIAT RES-NEUROIM, V115, P63, DOI 10.1016/S0925-4927(02)00009-4; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rosenbrock H, 2005, BRAIN RES, V1040, P55, DOI 10.1016/j.brainres.2005.01.065; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schjodt U, 2008, NEUROSCI LETT, V443, P165, DOI 10.1016/j.neulet.2008.07.068; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steffens DC, 2000, BIOL PSYCHIAT, V48, P301, DOI 10.1016/S0006-3223(00)00829-5; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P62, DOI 10.1176/appi.ajgp.10.1.62; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Trimble M, 2006, EPILEPSY BEHAV, V9, P407, DOI 10.1016/j.yebeh.2006.05.006; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; van Elst LT, 2003, EPILEPSY BEHAV, V4, P291, DOI 10.1016/S1525-5050(03)00084-2; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wuerfel J, 2004, J NEUROL NEUROSUR PS, V75, P640, DOI 10.1136/jnnp.2003.06973	81	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e17006	10.1371/journal.pone.0017006	http://dx.doi.org/10.1371/journal.pone.0017006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743YK	21479219	Green Published, Green Submitted, gold			2022-12-25	WOS:000289055700008
J	Xia, X; Li, YW; Huang, DQ; Wang, ZY; Luo, LY; Song, Y; Zhao, LA; Wen, R				Xia, Xin; Li, Yiwen; Huang, Deqiang; Wang, Zhengying; Luo, Lingyu; Song, Ying; Zhao, Lian; Wen, Rong			Oncostatin M Protects Rod and Cone Photoreceptors and Promotes Regeneration of Cone Outer Segment in a Rat Model of Retinal Degeneration	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; PHOTOTRANSDUCTION MACHINERY; GROWTH-REGULATOR; TRANSGENIC RATS; EXPRESSION; CYTOKINES; RECEPTORS; CELLS; CARDIOTROPHIN-1	Retinitis pigmentosa (RP) is a group of photoreceptor degenerative disorders that lead to loss of vision. Typically, rod photoreceptors degenerate first, resulting in loss of night and peripheral vision. Secondary cone degeneration eventually affects central vision, leading to total blindness. Previous studies have shown that photoreceptors could be protected from degeneration by exogenous neurotrophic factors, including ciliary neurotrophic factor (CNTF), a member of the IL-6 family of cytokines. Using a transgenic rat model of retinal degeneration (the S334-ter rat), we investigated the effects of Oncostatin M (OSM), another member of the IL-6 family of cytokines, on photoreceptor protection. We found that exogenous OSM protects both rod and cone photoreceptors. In addition, OSM promotes regeneration of cone outer segments in early stages of cone degeneration. Further investigation showed that OSM treatment induces STAT3 phosphorylation in Muller cells but not in photoreceptors, suggesting that OSM not directly acts on photoreceptors and that the protective effects of OSM on photoreceptors are mediated by Muller cells. These findings support the therapeutic strategy using members of IL-6 family of cytokines for retinal degenerative disorders. They also provide evidence that activation of the STAT3 pathway in Muller cells promotes photoreceptor survival. Our work highlights the importance of Muller cell-photoreceptor interaction in the retina, which may serve as a model of glia-neuron interaction in general.	[Xia, Xin; Li, Yiwen; Huang, Deqiang; Wang, Zhengying; Luo, Lingyu; Wen, Rong] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Xia, Xin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Xia, Xin] Shanghai Key Lab Ocular Fundus Dis, Shanghai, Peoples R China; [Song, Ying; Zhao, Lian] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Wen, Rong] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami; Shanghai Jiao Tong University; University of Pennsylvania; University of Miami	Xia, X (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	rwen@med.miami.edu			National Institutes of Health [R01EY018586, P30EY14801]; Hope for Vision; James and Esther King Biomedical Research Program of the State of Florida; Department of Defense [W81XWH-09-1-0674]; Shanghai First People's Hospital; Shanghai Key Laboratory for Ocular Fundus Diseases; Chinese Scholarship Council; Research to Prevent Blindness Inc.; NATIONAL EYE INSTITUTE [R01EY018586, P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; James and Esther King Biomedical Research Program of the State of Florida; Department of Defense(United States Department of Defense); Shanghai First People's Hospital; Shanghai Key Laboratory for Ocular Fundus Diseases; Chinese Scholarship Council(China Scholarship Council); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from National Institutes of Health (R01EY018586 to RW, P30EY14801 to Bascom Palmer Eye Institute), Hope for Vision (RW), the James and Esther King Biomedical Research Program of the State of Florida (YL), and the Department of Defense (W81XWH-09-1-0674 to RW). Xin Xia was supported in part by grants and scholarships from Shanghai First People's Hospital, Shanghai Key Laboratory for Ocular Fundus Diseases, and Chinese Scholarship Council. Additional support was provided by an unrestricted grant from Research to Prevent Blindness Inc. to Bascom Palmer Eye Institute. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Bruce A. Gregory, 1992, Progress in Growth Factor Research, V4, P157, DOI 10.1016/0955-2235(92)90029-H; BRUCE AG, 1992, J IMMUNOL, V149, P1271; Chen SH, 2004, CYTOKINE GROWTH F R, V15, P379, DOI 10.1016/j.cytogfr.2004.06.002; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; Ensoli F, 1999, J IMMUNOL, V162, P6268; Ensoli F, 2002, MULT SCLER J, V8, P284, DOI 10.1191/1352458502ms817oa; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; GEISTERFER M, 1995, CYTOKINE, V7, P503, DOI 10.1006/cyto.1995.0068; Grant SL, 1999, MOL MED TODAY, V5, P406, DOI 10.1016/S1357-4310(99)01540-3; Grotzinger J, 2002, BBA-MOL CELL RES, V1592, P215, DOI 10.1016/S0167-4889(02)00316-6; Hanisch A, 2000, J CLIN ENDOCR METAB, V85, P4411, DOI 10.1210/jc.85.11.4411; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Ito Y, 2000, NEUROCHEM RES, V25, P1113, DOI 10.1023/A:1007674113440; Jankowsky JL, 1999, EXP NEUROL, V159, P333, DOI 10.1006/exnr.1999.7137; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; Liu CD, 1999, J NEUROSCI, V19, P4778; Loy JK, 1999, TOXICOL PATHOL, V27, P151, DOI 10.1177/019262339902700201; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4; Moidunny S, 2010, J NEUROCHEM, V114, P1667, DOI 10.1111/j.1471-4159.2010.06881.x; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; Rosell DR, 2003, NEUROSCIENCE, V122, P329, DOI 10.1016/S0306-4522(03)00593-1; Ruprecht K, 2001, J NEUROPATH EXP NEUR, V60, P1087, DOI 10.1093/jnen/60.11.1087; Sarup V, 2004, BRAIN RES, V1013, P152, DOI 10.1016/j.brainres.2004.03.030; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Song Y, 2003, INVEST OPHTH VIS SCI, V44, P4069, DOI 10.1167/iovs.02-1130; SPORENO E, 1994, CYTOKINE, V6, P255, DOI 10.1016/1043-4666(94)90021-3; TALCOTT KE, 2010, INVEST OPHTHALMOL VI; Wallace PM, 1999, J IMMUNOL, V162, P5547; Weiss TW, 2006, FASEB J, V20, P2369, DOI 10.1096/fj.06-5850fje; Wen R, 2008, ADV EXP MED BIOL, V613, P407, DOI 10.1007/978-0-387-74904-4_48; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Znoyko I, 2005, ANAT REC PART A, V283A, P182, DOI 10.1002/ar.a.20159	40	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e18282	10.1371/journal.pone.0018282	http://dx.doi.org/10.1371/journal.pone.0018282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	21479182	Green Published, gold, Green Submitted			2022-12-25	WOS:000289055700043
J	Fujita, H; Toyokura, K; Okada, K; Kawaguchi, M				Fujita, Hironori; Toyokura, Koichi; Okada, Kiyotaka; Kawaguchi, Masayoshi			Reaction-Diffusion Pattern in Shoot Apical Meristem of Plants	PLOS ONE			English	Article							STEM-CELL HOMEOSTASIS; LASER-ABLATION ANALYSIS; ARABIDOPSIS; WUSCHEL; CLAVATA3; KINASE; GROWTH; MODEL; CLV3; GENE	A fundamental question in developmental biology is how spatial patterns are self-organized from homogeneous structures. In 1952, Turing proposed the reaction-diffusion model in order to explain this issue. Experimental evidence of reaction-diffusion patterns in living organisms was first provided by the pigmentation pattern on the skin of fishes in 1995. However, whether or not this mechanism plays an essential role in developmental events of living organisms remains elusive. Here we show that a reaction-diffusion model can successfully explain the shoot apical meristem (SAM) development of plants. SAM of plants resides in the top of each shoot and consists of a central zone (CZ) and a surrounding peripheral zone (PZ). SAM contains stem cells and continuously produces new organs throughout the lifespan. Molecular genetic studies using Arabidopsis thaliana revealed that the formation and maintenance of the SAM are essentially regulated by the feedback interaction between WUSHCEL (WUS) and CLAVATA (CLV). We developed a mathematical model of the SAM based on a reaction-diffusion dynamics of the WUS-CLV interaction, incorporating cell division and the spatial restriction of the dynamics. Our model explains the various SAM patterns observed in plants, for example, homeostatic control of SAM size in the wild type, enlarged or fasciated SAM in clv mutants, and initiation of ectopic secondary meristems from an initial flattened SAM in wus mutant. In addition, the model is supported by comparing its prediction with the expression pattern of WUS in the wus mutant. Furthermore, the model can account for many experimental results including reorganization processes caused by the CZ ablation and by incision through the meristem center. We thus conclude that the reaction-diffusion dynamics is probably indispensable for the SAM development of plants.	[Fujita, Hironori; Kawaguchi, Masayoshi] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, Okazaki, Aichi 4448585, Japan; [Toyokura, Koichi; Okada, Kiyotaka] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Plant Organ Dev, Okazaki, Aichi 4448585, Japan; [Toyokura, Koichi] Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto, Japan; [Kawaguchi, Masayoshi] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Fujita, H (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Symbiot Syst, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	hfujita@nibb.ac.jp		Kawaguchi, Masayoshi/0000-0002-1032-6261; Fujita, Hironori/0000-0003-4916-2994; Toyokura, Koichi/0000-0001-7775-7886	Ministry of Education, Culture, Sports, Science and Technology of Japan [21027011]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid Science Research on Priority Areas (Grant No. 21027011) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, PLANT CELL, V9, P1067, DOI 10.1105/tpc.9.7.1067; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hohm T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009189; Holloway DM, 2010, BIOCHEM SOC T, V38, P645, DOI 10.1042/BST0380645; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kondo S, 2009, INT J DEV BIOL, V53, P851, DOI 10.1387/ijdb.072502sk; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2003, DEVELOPMENT, V130, P3163, DOI 10.1242/dev.00525; Lyndon RF, 1998, SHOOT APICAL MERISTE; Madzvamuse A, 2003, J COMPUT PHYS, V190, P478, DOI 10.1016/S0021-9991(03)00294-8; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meinhardt H., 1995, ALGORITHMIC BEAUTY S; Meinhardt H., 1982, MODELS BIOL PATTERN; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mordhorst AP, 1998, GENETICS, V149, P549; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Murray JD, 2003, MATH BIOL, V3; Nikolaev S. V., 2007, Russian Journal of Developmental Biology, V38, P383, DOI 10.1134/S1062360407060069; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Reddy GV, 2008, CURR OPIN PLANT BIOL, V11, P88, DOI 10.1016/j.pbi.2007.10.012; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Reinhardt D, 2005, DEVELOPMENT, V132, P15, DOI 10.1242/dev.01544; Reinhardt D, 2003, DEVELOPMENT, V130, P4073, DOI 10.1242/dev.00596; Rieu I, 2009, SEMIN CELL DEV BIOL, V20, P1083, DOI 10.1016/j.semcdb.2009.09.013; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shoji H, 2003, J THEOR BIOL, V224, P339, DOI 10.1016/S0022-5193(03)00170-X; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Wu XL, 2005, CURR BIOL, V15, P436, DOI 10.1016/j.cub.2004.12.079; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	47	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2011	6	3							e18243	10.1371/journal.pone.0018243	http://dx.doi.org/10.1371/journal.pone.0018243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YC	21479227	Green Published, gold, Green Submitted			2022-12-25	WOS:000289054600036
J	Chen, ZG; Phillips, LK; Gould, E; Campisi, J; Lee, SW; Ormerod, BK; Zwierzchoniewska, M; Martinez, OM; Palmer, TD				Chen, Zhiguo; Phillips, Lori K.; Gould, Elizabeth; Campisi, Jay; Lee, Star W.; Ormerod, Brandi K.; Zwierzchoniewska, Monika; Martinez, Olivia M.; Palmer, Theo D.			MHC Mismatch Inhibits Neurogenesis and Neuron Maturation in Stem Cell Allografts	PLOS ONE			English	Article							PROGENITOR CELLS; DOPAMINE NEURONS; TRANSPLANTATION; RAT; TISSUE; BRAIN; ANTIGENS; DIFFERENTIATION; IMMUNOGENICITY; RECOGNITION	Background: The role of histocompatibility and immune recognition in stem cell transplant therapy has been controversial, with many reports arguing that undifferentiated stem cells are protected from immune recognition due to the absence of major histocompatibility complex (MHC) markers. This argument is even more persuasive in transplantation into the central nervous system (CNS) where the graft rejection response is minimal. Methodology/Principal Findings: In this study, we evaluate graft survival and neuron production in perfectly matched vs. strongly mismatched neural stem cells transplanted into the hippocampus in mice. Although allogeneic cells survive, we observe that MHC-mismatch decreases surviving cell numbers and strongly inhibits the differentiation and retention of graft-derived as well as endogenously produced new neurons. Immune suppression with cyclosporine-A did not improve outcome but non-steroidal anti-inflammatory drugs, indomethacin or rosiglitazone, were able to restore allogeneic neuron production, integration and retention to the level of syngeneic grafts. Conclusions/Significance: These results suggest an important but unsuspected role for innate, rather than adaptive, immunity in the survival and function of MHC-mismatched cellular grafts in the CNS.	[Chen, Zhiguo; Gould, Elizabeth; Lee, Star W.; Ormerod, Brandi K.; Palmer, Theo D.] Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Chen, Zhiguo; Gould, Elizabeth; Lee, Star W.; Ormerod, Brandi K.; Palmer, Theo D.] Dept Neurosurg, Stanford, CA USA; [Phillips, Lori K.; Campisi, Jay; Zwierzchoniewska, Monika; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	Stanford University	Chen, ZG (corresponding author), Merrimack Coll, N Andover, MA 01845 USA.	zchen1@stanford.edu	Palmer, Theo/GSI-6635-2022; Ormerod, Brandi/H-7037-2012; Whittaker, Anna/A-3577-2013	Ormerod, Brandi/0000-0003-0982-0788; , Olivia/0000-0002-2798-0251; Palmer, Theo/0000-0002-6266-1862; Chen, Zhiguo/0000-0003-1508-510X; Whittaker, Anna/0000-0002-5461-0598	National Institutes of Health [R01NS045113, R21NS050549, R01MH071472]; California Institute for Regenerative Medicine [RC1-00134-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045113, R21NS050549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants from the National Institutes of Health (R01NS045113, R21NS050549, and R01MH071472) and the California Institute for Regenerative Medicine (RC1-00134-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker RA, 2000, J NEUROSCI, V20, P3415, DOI 10.1523/JNEUROSCI.20-09-03415.2000; Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Chaturvedi RK, 2008, J NEUROCHEM, V106, P506, DOI 10.1111/j.1471-4159.2008.05388.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CORRY RJ, 1973, TRANSPLANT P, V5, P733; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; DUAN WM, 1995, NEUROSCIENCE, V64, P629, DOI 10.1016/0306-4522(94)00416-3; Duan WM, 1997, EXP NEUROL, V148, P334, DOI 10.1006/exnr.1997.6656; FEITOZA CQ, 2009, INFLAMM RES; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imitola J, 2004, AM J PATHOL, V164, P1615, DOI 10.1016/S0002-9440(10)63720-0; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pan Y, 2005, EXP NEUROL, V192, P365, DOI 10.1016/j.expneurol.2004.11.011; RAO K, 1989, TRANSPLANTATION, V48, P1018, DOI 10.1097/00007890-198912000-00025; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sayles M, 2004, TRANSPL IMMUNOL, V12, P321, DOI 10.1016/j.trim.2003.12.012; Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003; Shetty AK, 1999, J NEUROBIOL, V38, P391, DOI 10.1002/(SICI)1097-4695(19990215)38:3<391::AID-NEU8>3.0.CO;2-4; SLOAN DJ, 1990, PROG BRAIN RES, V82, P141; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TZE WJ, 1989, TRANSPLANTATION, V47, P1053, DOI 10.1097/00007890-198906000-00027; WIDNER H, 1993, CELL TRANSPLANT, V2, P307, DOI 10.1177/096368979300200413; WIDNER H, 1989, EXP BRAIN RES, V76, P187; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	49	105	109	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2011	6	3							e14787	10.1371/journal.pone.0014787	http://dx.doi.org/10.1371/journal.pone.0014787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YK	22205957	gold, Green Submitted, Green Published			2022-12-25	WOS:000289055700001
J	Yu, ZY; Wang, R; Xu, LY; Xie, SW; Dong, JH; Jing, YK				Yu, Zhiying; Wang, Rui; Xu, Liying; Xie, Siwei; Dong, Jinhua; Jing, Yongkui			beta-Elemene Piperazine Derivatives Induce Apoptosis in Human Leukemia Cells through Downregulation of c-FLIP and Generation of ROS	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; LUNG-CANCER CELLS; PEROXIDE-DEPENDENT PATHWAY; ARSENIC TRIOXIDE; PROSTATE-CANCER; UP-REGULATION; PROTEIN; DEATH; EXPRESSION; TARGET	beta-Elemene is an active component of the herb medicine Curcuma Wenyujin with reported antitumor activity. To improve its antitumor ability, five novel piperazine derivatives of beta-elemene, 13-(3-methyl-1-piperazinyl)-beta-elemene (DX1), 13-(cis-3,5-dimethyl-1-piperazinyl)-beta-elemene (DX2), 13-(4-ethyl-1-piperazinyl)-beta-elemene (DX3), 13-(4-isopropyl-1-piperazinyl)-beta-elemene (DX4) and 13-piperazinyl-beta-elemene (DX5), were synthesized. The antiproliferative and apoptotic effects of these derivatives were determined in human leukemia HL-60, NB4, K562 and HP100-1 cells. DX1, DX2 and DX5, which contain a secondary amino moiety, were more active in inhibiting cell growth and in inducing apoptosis than DX3 and DX4. The apoptosis induction ability of DX1 was associated with the generation of hydrogen peroxide (H(2)O(2)), a decrease of mitochondrial membrane potential (MMP), and the activation of caspase-8. Pretreatment with the antioxidants N-acetylcysteine and catalase completely blocked DX1-induced H(2)O(2) production, but only partially its activation of caspase-8 and induction of apoptosis. HL-60 cells were more sensitive than its H(2)O(2)-resistant subclone HP100-1 cells to DX1-induced apoptosis. The activation of caspase-8 by these compounds was correlated with the decrease in the levels of cellular FLICE-inhibitory protein (c-FLIP). The proteasome inhibitor MG-132 augmented the decrease in c-FLIP levels and apoptosis induced by these derivatives. FADD-and caspase-8-deficient Jurkat subclones have a decreased response to DX1-induced apoptosis. Our data indicate that these novel beta-elemene piperazine derivatives induce apoptosis through the decrease in c-FLIP levels and the production of H(2)O(2) which leads to activation of both death receptor-and mitochondrial-mediated apoptotic pathways.	[Yu, Zhiying] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Xu, Liying; Xie, Siwei; Dong, Jinhua] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Peoples R China; [Wang, Rui; Jing, Yongkui] Mt Sinai Sch Med, Dept Med, Tisch Canc Inst, New York, NY USA	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University; Icahn School of Medicine at Mount Sinai	Yu, ZY (corresponding author), Guangdong Food & Drug Vocat Coll, Guangzhou, Guangdong, Peoples R China.	yongkui.jing@mssm.edu		Bonini, Nancy/0000-0003-0226-5291; Gitler, Aaron/0000-0001-8603-1526	National Natural Science Foundation of China [30328030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the past funding from National Natural Science Foundation of China (No. 30328030) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Day TW, 2006, BIOCHEM PHARMACOL, V71, P1551, DOI 10.1016/j.bcp.2006.02.015; Decaudin D, 1998, INT J ONCOL, V12, P141; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; KASUGAI I, 1992, LEUKEMIA RES, V16, P173, DOI 10.1016/0145-2126(92)90129-U; KAUH J, PLOS ONE, V5; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kouhara J, 2007, INT J ONCOL, V30, P679; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Li X, 2005, CELL MOL LIFE SCI, V62, P894, DOI 10.1007/s00018-005-5027-1; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lombard C, 2005, LEUKEMIA RES, V29, P915, DOI 10.1016/j.leukres.2005.01.014; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Nakazato T, 2005, CLIN CANCER RES, V11, P6040, DOI 10.1158/1078-0432.CCR-04-2273; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Peter Marcus E, 2004, Biochem J, V382, pe1; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Wang YZ, 2005, DRUG DEV IND PHARM, V31, P769, DOI 10.1080/03639040500216329; Xia LJ, 2005, MOL CANCER THER, V4, P381; Xu LY, 2006, BIOORGAN MED CHEM, V14, P5351, DOI 10.1016/j.bmc.2006.03.041; YAMADA M, 1991, DNA CELL BIOL, V10, P735, DOI 10.1089/dna.1991.10.735; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Yu ZY, 2008, CANCER LETT, V269, P165, DOI 10.1016/j.canlet.2008.04.034; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249	36	171	176	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15843	10.1371/journal.pone.0015843	http://dx.doi.org/10.1371/journal.pone.0015843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21283566	Green Published, gold, Green Submitted			2022-12-25	WOS:000286661400015
J	Pawlowski, DR; Metzger, DJ; Raslawsky, A; Howlett, A; Siebert, G; Karalus, RJ; Garrett, S; Whitehouse, CA				Pawlowski, David R.; Metzger, Daniel J.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.; Garrett, Stephanie; Whitehouse, Chris A.			Entry of Yersinia pestis into the Viable but Nonculturable State in a Low-Temperature Tap Water Microcosm	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIBRIO-VULNIFICUS; RESUSCITATION; SURVIVAL; CELLS; STARVATION; VIRULENCE; PERSISTENCE; POPULATION; RECOVERY	Yersinia pestis, the causative agent of plague, has caused several pandemics throughout history and remains endemic in the rodent populations of the western United States. More recently, Y. pestis is one of several bacterial pathogens considered to be a potential agent of bioterrorism. Thus, elucidating potential mechanisms of survival and persistence in the environment would be important in the event of an intentional release of the organism. One such mechanism is entry into the viable but non-culturable (VBNC) state, as has been demonstrated for several other bacterial pathogens. In this study, we showed that Y. pestis became nonculturable by normal laboratory methods after 21 days in a low-temperature tap water microcosm. We further show evidence that, after the loss of culturability, the cells remained viable by using a variety of criteria, including cellular membrane integrity, uptake and incorporation of radiolabeled amino acids, and protection of genomic DNA from DNase I digestion. Additionally, we identified morphological and ultrastructural characteristics of Y. pestis VBNC cells, such as cell rounding and large periplasmic spaces, by electron microscopy, which are consistent with entry into the VBNC state in other bacteria. Finally, we demonstrated resuscitation of a small number of the non-culturable cells. This study provides compelling evidence that Y. pestis persists in a low-temperature tap water microcosm in a viable state yet is unable to be cultured under normal laboratory conditions, which may prove useful in risk assessment and remediation efforts, particularly in the event of an intentional release of this organism.	[Pawlowski, David R.; Raslawsky, Amy; Howlett, Amy; Siebert, Gretchen; Karalus, Richard J.] CUBRC Inc, Buffalo, NY USA; [Garrett, Stephanie; Whitehouse, Chris A.] USA, Med Res Inst Infect Dis, Frederick, MD USA; [Pawlowski, David R.; Metzger, Daniel J.; Karalus, Richard J.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pawlowski, DR (corresponding author), CUBRC Inc, Buffalo, NY USA.	pawlowski@cubrc.org		Pawlowski, Jan/0000-0003-2421-388X; Shahbazkia, Hamid Reza/0000-0002-5661-0612; Christen, Richard/0000-0002-3396-4362; Guillou, Laure/0000-0003-1032-7958	CUBRC [00291.01]; USAMRIID [114509]; Oak Ridge Institute for Science and Education	CUBRC; USAMRIID; Oak Ridge Institute for Science and Education(General Electric)	The authors acknowledge the CUBRC Internal Research and Development program (no. 00291.01) and the USAMRIID In-House Laboratory Research program (no. 114509) for financial support. This research was supported in part by an appointment to the Student Research Participation Program at USAMRIID by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Albertini MC, 2006, CYTOM PART A, V69A, P260, DOI 10.1002/cyto.a.20263; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Bjergbaek LA, 2005, J APPL MICROBIOL, V99, P1090, DOI 10.1111/j.1365-2672.2005.02706.x; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; Breneva N. V., 2006, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P7; Buzoleva LS, 2000, B EXP BIOL MED+, V129, P374, DOI 10.1007/BF02439275; Chaiyanan S, 2001, SYST APPL MICROBIOL, V24, P331, DOI 10.1078/0723-2020-00032; Chaiyanan S, 2007, ENVIRON MICROBIOL, V9, P393, DOI 10.1111/j.1462-2920.2006.01150.x; Czyzewska Izabela, 2003, Przegl Epidemiol, V57, P263; Du M, 2007, APPL ENVIRON MICROB, V73, P1349, DOI 10.1128/AEM.02243-06; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Forsman M, 2000, FEMS MICROBIOL ECOL, V31, P217, DOI 10.1111/j.1574-6941.2000.tb00686.x; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Garcia-Armisen T, 2004, J MICROBIOL METH, V58, P269, DOI 10.1016/j.mimet.2004.04.014; Halvorson HO, 1933, J BACTERIOL, V25, P101, DOI 10.1128/JB.25.2.101-121.1933; Heim S, 2002, J BACTERIOL, V184, P6739, DOI 10.1128/JB.184.23.6739-6745.2002; Jang KI, 2007, J MICROBIOL BIOTECHN, V17, P202; Keep NH, 2006, CELL MOL LIFE SCI, V63, P2555, DOI 10.1007/s00018-006-6188-2; LINDER K, 1989, APPL ENVIRON MICROB, V55, P2837, DOI 10.1128/AEM.55.11.2837-2842.1989; Lleo MM, 2001, J APPL MICROBIOL, V91, P1095, DOI 10.1046/j.1365-2672.2001.01476.x; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; NOVITSKY JA, 1976, APPL ENVIRON MICROB, V32, P617, DOI 10.1128/AEM.32.4.617-622.1976; Oliver James D., 2005, Journal of Water and Health, V3, P249; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oliver JD, 2005, J MICROBIOL, V43, P93; OLIVER JD, 2005, FOODBORNE PATHOGENS; RAHMAN I, 1994, APPL ENVIRON MICROB, V60, P3573, DOI 10.1128/AEM.60.10.3573-3578.1994; Rose LJ, 2007, APPL ENVIRON MICROB, V73, P3437, DOI 10.1128/AEM.00051-07; Rose LJ, 2003, APPL ENVIRON MICROB, V69, P2166, DOI 10.1128/AEM.69.4.2166-2171.2003; ROSZAK DB, 1987, APPL ENVIRON MICROB, V53, P2889, DOI 10.1128/AEM.53.12.2889-2893.1987; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; SMITH JJ, 1994, APPL ENVIRON MICROB, V60, P2977, DOI 10.1128/AEM.60.8.2977-2984.1994; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Suchkov Iu G, 1997, Zh Mikrobiol Epidemiol Immunobiol, P42; Torosian SD, 2009, CAN J MICROBIOL, V55, P1125, DOI [10.1139/W09-061, 10.1139/w09-061]; Torosian SD, 2009, CAN J MICROBIOL, V55, P1119, DOI [10.1139/w09-060, 10.1139/W09-060]; Troitskaia V V, 1996, Zh Mikrobiol Epidemiol Immunobiol, P13; Whitesides MD, 1997, APPL ENVIRON MICROB, V63, P1002, DOI 10.1128/AEM.63.3.1002-1005.1997; WILM, 1897, HYGIENISCHE RUNDSCHA, V7, P285; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662	44	92	96	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2011	6	3							e17585	10.1371/journal.pone.0017585	http://dx.doi.org/10.1371/journal.pone.0017585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SI	21483744	Green Published, Green Submitted, gold			2022-12-25	WOS:000288514000003
